Citrus Sinensis ID: 039533
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 949 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.947 | 0.890 | 0.422 | 0.0 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.932 | 0.858 | 0.410 | 0.0 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.937 | 0.868 | 0.422 | 0.0 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.902 | 0.873 | 0.353 | 1e-131 | |
| Q9M2Z1 | 1002 | Leucine-rich repeat recep | no | no | 0.898 | 0.851 | 0.319 | 1e-113 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.861 | 0.654 | 0.326 | 1e-107 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.855 | 0.736 | 0.326 | 1e-107 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.871 | 0.705 | 0.319 | 1e-107 | |
| Q8VZG8 | 1045 | Probable LRR receptor-lik | no | no | 0.864 | 0.784 | 0.304 | 1e-106 | |
| O49545 | 1003 | Leucine-rich repeat recep | no | no | 0.892 | 0.844 | 0.316 | 1e-106 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 700 bits (1807), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 421/996 (42%), Positives = 580/996 (58%), Gaps = 97/996 (9%)
Query: 18 GTGNETDRVALLEFKSKSTYDPVGVLGTWNESIHFCKWYGVTCSRRHQRVTLLDLRSLKL 77
G +ETDR ALL+FKS+ + D VL +WN S C W GVTC R+++RVT L+L L+L
Sbjct: 19 GFTDETDRQALLQFKSQVSEDKRVVLSSWNHSFPLCNWKGVTCGRKNKRVTHLELGRLQL 78
Query: 78 AGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCS 137
G +S IGNLSFL L L N F IP E+G L RL+ L + N + G IP + CS
Sbjct: 79 GGVISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCS 138
Query: 138 TLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYN-- 195
L+ + +N+L G + S SL+ LNL N++ G +P+SLGNL+ + ++L++N
Sbjct: 139 RLLNLRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNL 198
Query: 196 ----------------------NLDGTIPNSFGWFENLVFLSLAANNLS----------- 222
N G P + +L L + N+ S
Sbjct: 199 EGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILL 258
Query: 223 -------------------------------VVENKLTGEVPSLEKLQRLQHFTITSNSL 251
+ EN LTG +P+ + L+ + +NSL
Sbjct: 259 PNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIPTFGNVPNLKLLFLHTNSL 318
Query: 252 GSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIP 311
GS + DL FL SLTN T+L + I N GG LP I+NLS + TL L I GSIP
Sbjct: 319 GSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIP 378
Query: 312 AGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNL 371
IGN +NLQ+L + N LSG +P ++G+L NL+ L L N+LSG IP IGN+ ML L
Sbjct: 379 YDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETL 438
Query: 372 FLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSL 431
L++N E +P+SLG C L+E+ + +N L+GTIP + + L + LD S N L GSL
Sbjct: 439 DLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQL-LRLDMSGNSLIGSL 497
Query: 432 PIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRV 491
P ++G L+ L L + +N+L G++P T GNC+ +E L + GNLF G I L L G++
Sbjct: 498 PQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPD-LKGLVGVKE 556
Query: 492 LDLSQNNLSGEIPKFLAGLS-LNNLNLSYNDLEGMVTTEGVFKNASATRILGNSKLCGGI 550
+DLS N+LSG IP++ A S L LNLS+N+LEG V +G+F+NA+ I+GN+ LCGGI
Sbjct: 557 VDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGI 616
Query: 551 SEFKLPTCVS------KKSKRRRLTFVPTLVIAIVFRLLGLALALFGLVLCLVRKIKEKE 604
F+L C+S KK R V + + I LL ++ + L +K KE
Sbjct: 617 MGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETN 676
Query: 605 NPSSSIYSLLY--LSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ 662
NP+ S +L+ +SY DL NAT+GFSS+N+VG GSFG+VYK ++ + +AVKV N+Q
Sbjct: 677 NPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQ 736
Query: 663 HHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPF 722
GA +SF+AEC++LK IRHRNLVK+LTAC D++GN+F+A +YEFM GSL+ WLHP
Sbjct: 737 RRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPE 796
Query: 723 TGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782
E EI R L LL+RLNIAID+A L+YLH C AHCDLKPSNVLLDD +TA V
Sbjct: 797 EVE-EIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHV 855
Query: 783 GDFGLARIL-----SPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELV 837
DFGLAR+L Q SS V+G++GY APEYGVG + S NGDVYS+GILLLE+
Sbjct: 856 SDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMF 915
Query: 838 IGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARIN-SI 896
GK+P + +F G+ L+++ + ALP+ ++DIVD S+L R+ +
Sbjct: 916 TGKRPTNELFGGNFTLNSYTKSALPERILDIVDESIL-------------HIGLRVGFPV 962
Query: 897 IECLISMVRIGVACSMELPQDRTNMTNVVHELQSIK 932
+ECL + +G+ C E P +R + VV EL SI+
Sbjct: 963 VECLTMVFEVGLRCCEESPMNRLATSIVVKELISIR 998
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 672 bits (1734), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 410/999 (41%), Positives = 563/999 (56%), Gaps = 114/999 (11%)
Query: 21 NETDRVALLEFKSK-STYDPVGVLGTWNESIHFCKWYGVTCSRRHQRVTLLDLRSLKLAG 79
NETD ALLEFKS+ S + VL +WN S FC W GVTC RR +RV L+L KL G
Sbjct: 28 NETDMQALLEFKSQVSENNKREVLASWNHSSPFCNWIGVTCGRRRERVISLNLGGFKLTG 87
Query: 80 SVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTL 139
+S IGNLSFL+ L L NSF IP ++G L RL+ L ++ N + G IP+++S CS L
Sbjct: 88 VISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNCSRL 147
Query: 140 IPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDG 199
+ +N L + S SLSK IL+L N+LTG+ P+SLGNL+S+ + AYN + G
Sbjct: 148 STVDLSSNHLGHGVPSELGSLSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMRG 207
Query: 200 TIPNSFGWFENLVFLSLAAN-----------NLSVVE----------------------- 225
IP+ +VF +A N N+S +E
Sbjct: 208 EIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLPN 267
Query: 226 --------NKLTGEVP-SLEKLQRLQHFTITSNSLGSGGNDDLSF--------------- 261
N+ TG +P +L + L+ F I+SN L G+ LSF
Sbjct: 268 LRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLS--GSIPLSFGKLRNLWWLGIRNNS 325
Query: 262 -----------LCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSI 310
+ ++ N T+L ++ + N GG LP I+NLS T+ +LFL N I G+I
Sbjct: 326 LGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTI 385
Query: 311 PAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLN 370
P IGN V+LQ L + N LSG +P + G+L NL+++ L N +SG IP GN+ L
Sbjct: 386 PHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQK 445
Query: 371 LFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGS 430
L LN N IP SLG+C L+++ + N L+GTIP + + SL+ +D S N LTG
Sbjct: 446 LHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAY-IDLSNNFLTGH 504
Query: 431 LPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLR 490
P EVGKL++L L N+L G++P G C+ +E L M GN F G I + L L+
Sbjct: 505 FPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLK 563
Query: 491 VLDLSQNNLSGEIPKFLAGL-SLNNLNLSYNDLEGMVTTEGVFKNASATRILGNSKLCGG 549
+D S NNLSG IP++LA L SL NLNLS N EG V T GVF+NA+A + GN+ +CGG
Sbjct: 564 NVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGG 623
Query: 550 ISEFKLPTCVSKKSKRRR--LTFVPTLVIAIVFRLLGLALALFGLVLCLVRKIKEKEN-- 605
+ E +L C+ + S R+R L+ +V I + L L + LC K K+K N
Sbjct: 624 VREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNAS 683
Query: 606 ---PSSSIYSLLY---LSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVF 659
PS S ++ +SY++L++ATS FSS NL+G G+FG+V+KG++ +AVKV
Sbjct: 684 DGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVL 743
Query: 660 NLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWL 719
NL HGA++SF+AEC+ K IRHRNLVK++T C D GNDF+A VYEFM GSL+ WL
Sbjct: 744 NLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWL 803
Query: 720 HPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMT 779
+ +++ R+L ++LNIAID+A AL YLH C AHCD+KPSN+LLDD +T
Sbjct: 804 Q-LEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLT 862
Query: 780 ARVGDFGLARILSPDH-----TQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLL 834
A V DFGLA++L Q SS V+G++GY APEYG+G + S GDVYS+GILLL
Sbjct: 863 AHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLL 922
Query: 835 ELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARIN 894
E+ GKKP D F GD NLH++ + IL+G + N
Sbjct: 923 EMFSGKKPTDESFAGDYNLHSYTKS---------------------ILSGCTSSGGS--N 959
Query: 895 SIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKN 933
+I E L ++++G+ CS E P+DR V EL SI++
Sbjct: 960 AIDEGLRLVLQVGIKCSEEYPRDRMRTDEAVRELISIRS 998
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 655 bits (1691), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 422/1000 (42%), Positives = 570/1000 (57%), Gaps = 110/1000 (11%)
Query: 22 ETDRVALLEFKSKSTYDPVGVLGTWNESIHFCKWYGVTCSRRHQRVTLLDLRSLKLAGSV 81
ETD+ ALLEFKS+ + VLG+WN+S+ C W GV C +H+RVT +DL LKL G V
Sbjct: 38 ETDKQALLEFKSQVSETSRVVLGSWNDSLPLCSWTGVKCGLKHRRVTGVDLGGLKLTGVV 97
Query: 82 SHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIP 141
S F+GNLSFL+ L L N F IPSE+G L RL+ L ++NN G IP +S CS+L
Sbjct: 98 SPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNCSSLST 157
Query: 142 IHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTI 201
+ +N L + F SLSK +L+LG N+LTG P+SLGNL+S+ + YN ++G I
Sbjct: 158 LDLSSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEGEI 217
Query: 202 PNSFGWFENLVFLSLAAN---------------------------------------NLS 222
P + ++F +A N NL
Sbjct: 218 PGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPNLQ 277
Query: 223 VVE---NKLTGEVP-SLEKLQRLQHFTITSNSLGSG------------------------ 254
++ N TG +P +L + L+ I SN L
Sbjct: 278 ILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGNY 337
Query: 255 GNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGI 314
+ DL FL +LTN ++L ++++ N GG LP I+NLS + L L N I GSIP GI
Sbjct: 338 SSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPHGI 397
Query: 315 GNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLN 374
GN V+LQ LD+ N L+G +PP++GEL L+ + L N LSG IP S+GN+ L L+L
Sbjct: 398 GNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLL 457
Query: 375 DNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIE 434
+N E SIPSSLG C L+++NL N L+G+IP + L SL + L+ S N L G L +
Sbjct: 458 NNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVV-LNVSFNLLVGPLRQD 516
Query: 435 VGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDL 494
+GKLK L L V N+L G+IP T NC+ LE L + GN F GPI G L GLR LDL
Sbjct: 517 IGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTGLRFLDL 575
Query: 495 SQNNLSGEIPKFLAGLS-LNNLNLSYNDLEGMVTTEGVFKNASATRILGNSKLCGGISEF 553
S+NNLSG IP+++A S L NLNLS N+ +G V TEGVF+N SA + GN LCGGI
Sbjct: 576 SKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSL 635
Query: 554 KLPTCVSKKSKRRRLTFVPTLVIAIVFRLLGLALALFGLVLCLVRKIKEKE--------- 604
+L C S + RR + + I + + L L +V K++ K
Sbjct: 636 QLQPC-SVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNEND 694
Query: 605 ---NPSSSIYSLLYLSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNL 661
+P S Y +SY +LY T GFSS+NL+G G+FG+V+KG + +A+KV NL
Sbjct: 695 RSFSPVKSFYE--KISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNL 752
Query: 662 QHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHP 721
GA++SFIAEC+AL IRHRNLVK++T C +D+ GNDF+A VYEFM G+L+ WLHP
Sbjct: 753 CKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHP 812
Query: 722 FTGEDEIDEA---PRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM 778
DEI+E R L L RLNIAID+A AL YLH C AHCD+KPSN+LLD +
Sbjct: 813 ----DEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDL 868
Query: 779 TARVGDFGLARIL-----SPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILL 833
TA V DFGLA++L H Q SS V+G++GY APEYG+G S GDVYS+GI+L
Sbjct: 869 TAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVL 928
Query: 834 LELVIGKKPIDIMFEGDINLHNFGRKALPD-DVMDIVDSSLLPDDEDLILTGNQRQKQAR 892
LE+ GK+P + +F + LH+F + AL +DI D ++L R A+
Sbjct: 929 LEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETIL------------RGAYAQ 976
Query: 893 INSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIK 932
+++ECL + R+GV+CS E P +R +M + +L SI+
Sbjct: 977 HFNMVECLTLVFRVGVSCSEESPVNRISMAEAISKLVSIR 1016
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 469 bits (1206), Expect = e-131, Method: Compositional matrix adjust.
Identities = 336/951 (35%), Positives = 503/951 (52%), Gaps = 95/951 (9%)
Query: 50 IHFCKWYGVTCSRRHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEI 109
+ C W GV C++ +V LD+ L G +S I NL+ L L L N F +IP EI
Sbjct: 51 VDVCNWSGVKCNKESTQVIELDISGRDLGGEISPSIANLTGLTVLDLSRNFFVGKIPPEI 110
Query: 110 GGLRR-LKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRF---SSLSKTEI 165
G L LK L+L+ N + G IP + + L+ + +N+L G I + S S +
Sbjct: 111 GSLHETLKQLSLSENLLHGNIPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQY 170
Query: 166 LNLGSNHLTGSIPSSLG-NLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVV 224
++L +N LTG IP + +L + + L N L GT+P+S NL ++ L +N LS
Sbjct: 171 IDLSNNSLTGEIPLNYHCHLKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESNMLS-- 228
Query: 225 ENKLTGEVPS--LEKLQRLQHFTITSNSLGSGGNDD--LSFLCSLTNATRLTWMHINSNN 280
GE+PS + K+ +LQ ++ N S N+ F SL N++ L + + N+
Sbjct: 229 -----GELPSQVISKMPQLQFLYLSYNHFVSHNNNTNLEPFFASLANSSDLQELELAGNS 283
Query: 281 FGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIG------------------------N 316
GG + + +LS + + L+ N+I+GSIP I
Sbjct: 284 LGGEITSSVRHLSVNLVQIHLDQNRIHGSIPPEISNLLNLTLLNLSSNLLSGPIPRELCK 343
Query: 317 FVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDN 376
L+R+ + NN L+G IP +G++ L +L ++RN LSG+IP S GNL L L L N
Sbjct: 344 LSKLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGN 403
Query: 377 FLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFS-LSSLSISLDWSRNKLTGSLPIEV 435
L ++P SLG+C +L ++LS+NNL+GTIP + S L +L + L+ S N L+G +P+E+
Sbjct: 404 HLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLEL 463
Query: 436 GKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLS 495
K+ ++ + + N L G+IP G+CI LE L + N F + SSLG L L+ LD+S
Sbjct: 464 SKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVS 523
Query: 496 QNNLSGEI-PKFLAGLSLNNLNLSYNDLEGMVTTEGVFKNASATRILGNSKLCGGISEFK 554
N L+G I P F +L +LN S+N L G V+ +G F + LG+S LCG I +
Sbjct: 524 FNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQ 583
Query: 555 LPTCVSKKSKRRRLTFVPTLVIAI-VFRLLGLAL---ALFGLVLCLVRK----IKEKENP 606
C K L V +IA V + G L + FG L + K +EK+N
Sbjct: 584 --ACKKKHKYPSVLLPVLLSLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQ 641
Query: 607 SSSIYSLLYLSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-G 665
+ Y +SYQ L AT GF++++L+G G FG VYKG++ T +AVKV + +
Sbjct: 642 NDPKYP--RISYQQLIAATGGFNASSLIGSGRFGHVYKGVL-RNNTKVAVKVLDPKTALE 698
Query: 666 ASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGE 725
S SF EC+ LK RHRNL++++T C F A V M GSLE L+P GE
Sbjct: 699 FSGSFKRECQILKRTRHRNLIRIITTC-----SKPGFNALVLPLMPNGSLERHLYP--GE 751
Query: 726 DEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785
+ +NL+L+Q +NI D+A + YLHH HCDLKPSN+LLDD MTA V DF
Sbjct: 752 ----YSSKNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDF 807
Query: 786 GLARILSP-DHTQTSSFSVK---------GSLGYIAPEYGVGCEVSTNGDVYSYGILLLE 835
G++R++ + T ++ SV GS+GYIAPEYG+G ST+GDVYS+G+LLLE
Sbjct: 808 GISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLE 867
Query: 836 LVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINS 895
+V G++P D++ +LH F + PD + I++ +L ++ + Q +
Sbjct: 868 IVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGIIEQAL-----------SRWKPQGKPEK 916
Query: 896 I----IECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILLGVELCP 942
E ++ M+ +G+ C+ P R +M +V HE+ +K L CP
Sbjct: 917 CEKLWREVILEMIELGLVCTQYNPSTRPDMLDVAHEMGRLKEYLFA---CP 964
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 409 bits (1051), Expect = e-113, Method: Compositional matrix adjust.
Identities = 321/1005 (31%), Positives = 473/1005 (47%), Gaps = 152/1005 (15%)
Query: 23 TDRVALLEFKSKSTYDPVG-VLGTWNESIHFCKWYGVTCSRRHQRVTLLDLRSLKLAGSV 81
T+ ALL KS T D +L +WN S FC W GVTC + VT LDL L L+G++
Sbjct: 26 TELHALLSLKSSFTIDEHSPLLTSWNLSTTFCSWTGVTCDVSLRHVTSLDLSGLNLSGTL 85
Query: 82 SHFIGNLSFLKQLYLQVNSFTHEIPSEIG-------------------------GLRRLK 116
S + +L L+ L L N + IP +I GL L+
Sbjct: 86 SSDVAHLPLLQNLSLAANQISGPIPPQISNLYELRHLNLSNNVFNGSFPDELSSGLVNLR 145
Query: 117 VLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGS 176
VL L NN++ G++P +++ + L +H N GKI + + + E L + N LTG
Sbjct: 146 VLDLYNNNLTGDLPVSLTNLTQLRHLHLGGNYFSGKIPATYGTWPVLEYLAVSGNELTGK 205
Query: 177 IPSSLGNLSSIHTISLAY-NNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVP-S 234
IP +GNL+++ + + Y N + +P G LV AAN LTGE+P
Sbjct: 206 IPPEIGNLTTLRELYIGYYNAFENGLPPEIGNLSELVRFD-AANC------GLTGEIPPE 258
Query: 235 LEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSK 294
+ KLQ+L + N+ +L + SL + M +++N F G +P S L K
Sbjct: 259 IGKLQKLDTLFLQVNAFTGTITQELGLISSLKS------MDLSNNMFTGEIPTSFSQL-K 311
Query: 295 TIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKL 354
+ L L NK+YG+IP IG L+ L +W N +G+IP +GE L IL L+ NKL
Sbjct: 312 NLTLLNLFRNKLYGAIPEFIGEMPELEVLQLWENNFTGSIPQKLGENGRLVILDLSSNKL 371
Query: 355 SGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLS 414
+G +PP++ + L+ L NFL SIP SLG+CESL I + N L+G+IP + F L
Sbjct: 372 TGTLPPNMCSGNRLMTLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFGLP 431
Query: 415 SLSI------------------------SLDWSRNKLTGSLPIEVGKLKILEFLYVYENR 450
LS + S N+L+GSLP +G L ++ L + N+
Sbjct: 432 KLSQVELQDNYLTGELPISGGGVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDGNK 491
Query: 451 LEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL 510
G IP G +L +L NLF G I+ + + L +DLS+N LSG+IP L G+
Sbjct: 492 FSGSIPPEIGRLQQLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGM 551
Query: 511 -------------------------SLNNLNLSYNDLEGMVTTEGVFKNASATRILGNSK 545
SL +++ SYN+L G+V + G F + T +GNS
Sbjct: 552 KILNYLNLSRNHLVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSH 611
Query: 546 LCG--------GISEFKL-PTCVSKKSKRRRLTFVPTLVIAIVFRLLGLALALFGLVLCL 596
LCG G + + P + K ++V AIV + +L
Sbjct: 612 LCGPYLGPCGKGTHQSHVKPLSATTKLLLVLGLLFCSMVFAIVAIIKARSL--------- 662
Query: 597 VRKIKEKENPSSSIYSLLYLSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAV 656
R E + + + L + D+ ++ N++G G G VYKG + +G +AV
Sbjct: 663 -RNASEAKAWRLTAFQRLDFTCDDVLDS---LKEDNIIGKGGAGIVYKGTMPKG-DLVAV 717
Query: 657 KVFNLQHHGASRS--FIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGS 714
K HG+S F AE + L IRHR++V++L C +++ N VYE+M GS
Sbjct: 718 KRLATMSHGSSHDHGFNAEIQTLGRIRHRHIVRLLGFC--SNHETNLL---VYEYMPNGS 772
Query: 715 LEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL 774
L E LH G +L+ R IA++ A L YLHHDC P+ H D+K +N+LL
Sbjct: 773 LGEVLHGKKG--------GHLHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILL 824
Query: 775 DDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLL 834
D A V DFGLA+ L T ++ GS GYIAPEY +V DVYS+G++LL
Sbjct: 825 DSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLL 884
Query: 835 ELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVD--SSLLPDDEDLILTGNQRQKQAR 892
EL+ GKKP+ FG D +DIV S+ ++D +L + R
Sbjct: 885 ELITGKKPVG----------EFG------DGVDIVQWVRSMTDSNKDCVL----KVIDLR 924
Query: 893 INSI-IECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILL 936
++S+ + + + + + C E +R M VV L I I L
Sbjct: 925 LSSVPVHEVTHVFYVALLCVEEQAVERPTMREVVQILTEIPKIPL 969
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 391 bits (1005), Expect = e-107, Method: Compositional matrix adjust.
Identities = 296/906 (32%), Positives = 450/906 (49%), Gaps = 88/906 (9%)
Query: 66 RVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSI 125
+T L L + L G++S I NL+ L+ L L N+ ++P EI LR+L+VL L N
Sbjct: 385 ELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRF 444
Query: 126 CGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLS 185
GEIP I C++L I N G+I L + +L+L N L G +P+SLGN
Sbjct: 445 SGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCH 504
Query: 186 SIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVP-SLEKLQRLQHF 244
++ + LA N L G+IP+SFG+ + L L + N L G +P SL L+ L
Sbjct: 505 QLNILDLADNQLSGSIPSSFGFLKGL-------EQLMLYNNSLQGNLPDSLISLRNLTRI 557
Query: 245 TITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNN 304
++ N L N + LC ++ + +N F +P + N S+ + L L N
Sbjct: 558 NLSHNRL----NGTIHPLCG---SSSYLSFDVTNNGFEDEIPLELGN-SQNLDRLRLGKN 609
Query: 305 KIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGN 364
++ G IP +G L LDM +N L+GTIP + + L + LN N LSG IPP +G
Sbjct: 610 QLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGK 669
Query: 365 LKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSR 424
L L L L+ N S+P+ L C L+ ++L N+L+G+IP + +L +L++ L+ +
Sbjct: 670 LSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNV-LNLDK 728
Query: 425 NKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQ-LGMGGNLFQGPISSSL 483
N+ +GSLP +GKL L L + N L GEIP G L+ L + N F G I S++
Sbjct: 729 NQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTI 788
Query: 484 GSLRGLRVLDLSQNNLSGEIPKFLAGL-SLNNLNLSYNDLEGMVTTEGVFKNASATRILG 542
G+L L LDLS N L+GE+P + + SL LN+S+N+L G + + F A LG
Sbjct: 789 GTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQ--FSRWPADSFLG 846
Query: 543 NSKLCGGISEFKLPTC--VSKKSKRRRLTFVPTLVIAIVFRLLGLALALFGLVLCLVRKI 600
N+ LCG L C V +K++ L+ ++I+ + L A+ L LV+ L K
Sbjct: 847 NTGLCGS----PLSRCNRVRSNNKQQGLSARSVVIISAISALT--AIGLMILVIALFFKQ 900
Query: 601 K----EKENPSSSIYSLLY-------------------LSYQDLYNATSGFSSANLVGVG 637
+ +K S+ Y+ + ++D+ AT S ++G G
Sbjct: 901 RHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSG 960
Query: 638 SFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADY 697
G VYK ++ G T K+ +++SF E K L IRHR+LVK++ C
Sbjct: 961 GSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYC---SS 1017
Query: 698 RGNDFKASVYEFMHYGSLEEWLHPFTGEDE--IDEAPRNLNLLQRLNIAIDIAYALNYLH 755
+ +YE+M GS+ +WLH ED+ +++ + L+ RL IA+ +A + YLH
Sbjct: 1018 KSEGLNLLIYEYMKNGSIWDWLH----EDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLH 1073
Query: 756 HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSP--DHTQTSSFSVKGSLGYIAPE 813
HDC P H D+K SNVLLD M A +GDFGLA++L+ D S+ S GYIAPE
Sbjct: 1074 HDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPE 1133
Query: 814 YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP------DDVMD 867
Y + + DVYS GI+L+E+V GK P D +F ++++ + L D ++D
Sbjct: 1134 YAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLID 1193
Query: 868 IVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927
LLP +ED ++ I + C+ PQ+R +
Sbjct: 1194 PKLKPLLPFEED-------------------AACQVLEIALQCTKTSPQERPSSRQACDS 1234
Query: 928 LQSIKN 933
L + N
Sbjct: 1235 LLHVYN 1240
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 390 bits (1003), Expect = e-107, Method: Compositional matrix adjust.
Identities = 304/932 (32%), Positives = 450/932 (48%), Gaps = 120/932 (12%)
Query: 65 QRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNS 124
+R+T ++GS+ IG L L L N + E+P EIG L++L + L N
Sbjct: 193 KRLTSFRAGQNMISGSLPSEIGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENE 252
Query: 125 ICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNL 184
G IP IS C++L + NQLVG I L E L L N L G+IP +GNL
Sbjct: 253 FSGFIPREISNCTSLETLALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNL 312
Query: 185 SSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVP-SLEKLQRLQH 243
S I + N L G IP G E L L L EN+LTG +P L L+ L
Sbjct: 313 SYAIEIDFSENALTGEIPLELGNIEGLELLYL-------FENQLTGTIPVELSTLKNLSK 365
Query: 244 FTITSNSLGSGGNDDLSFLCSL------------TNATRLTW------MHINSNNFGGLL 285
++ N+L +L L T +L W + ++ N+ G +
Sbjct: 366 LDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRI 425
Query: 286 PGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLK 345
P + L + L L N + G+IP GI L +L + N L G P + + N+
Sbjct: 426 PSYLC-LHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVT 484
Query: 346 ILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGT 405
+ L +N+ G+IP +GN L L L DN +P +G L +N+S+N L+G
Sbjct: 485 AIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGE 544
Query: 406 IPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRL 465
+P + F+ L LD N +G+LP EVG L LE L + N L G IP GN RL
Sbjct: 545 VPSEIFNCKMLQ-RLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRL 603
Query: 466 EQLGMGGNLFQGPISSSLGSLRGLRV-LDLSQNNLSGEIPKFLAGL-------------- 510
+L MGGNLF G I LGSL GL++ L+LS N L+GEIP L+ L
Sbjct: 604 TELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLS 663
Query: 511 -----------SLNNLNLSYNDLEGMVTTEGVFKNASATRILGNSKLCGGISEFKLPTCV 559
SL N SYN L G + + +N S + +GN LCG L C+
Sbjct: 664 GEIPSSFANLSSLLGYNFSYNSLTGPIP---LLRNISMSSFIGNEGLCGP----PLNQCI 716
Query: 560 S------KKSKRRRLTFVPTLVIAIVFRLLG-LALALFGLVLCLVRKI-------KEKEN 605
+S + + +IAI ++G ++L L L++ L+R+ +
Sbjct: 717 QTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQ 776
Query: 606 PSSSIYSLLY-----LSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFN 660
PS + + ++QDL AT F + +VG G+ G+VYK ++ G T +AVK
Sbjct: 777 PSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYT-LAVKKLA 835
Query: 661 LQHHGASR-----SFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSL 715
H G + SF AE L +IRHRN+VK+ C +++G++ +YE+M GSL
Sbjct: 836 SNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFC---NHQGSNLL--LYEYMPKGSL 890
Query: 716 EEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD 775
E LH + NL+ +R IA+ A L YLHHDC+P H D+K +N+LLD
Sbjct: 891 GEILH---------DPSCNLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLD 941
Query: 776 DYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLE 835
D A VGDFGLA+++ H+++ S ++ GS GYIAPEY +V+ D+YSYG++LLE
Sbjct: 942 DKFEAHVGDFGLAKVIDMPHSKSMS-AIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLE 1000
Query: 836 LVIGKKPIDIMFEGDINLHNFGRKALPDDVMD--IVDSSLLPDDEDLILTGNQRQKQARI 893
L+ GK P+ + +G ++ N+ R + D + ++D+ L +DE
Sbjct: 1001 LLTGKAPVQPIDQGG-DVVNWVRSYIRRDALSSGVLDARLTLEDE--------------- 1044
Query: 894 NSIIECLISMVRIGVACSMELPQDRTNMTNVV 925
I+ ++++++I + C+ P R +M VV
Sbjct: 1045 -RIVSHMLTVLKIALLCTSVSPVARPSMRQVV 1075
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 389 bits (998), Expect = e-107, Method: Compositional matrix adjust.
Identities = 305/956 (31%), Positives = 472/956 (49%), Gaps = 129/956 (13%)
Query: 69 LLDLRSLKLA-----GSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNN 123
LL+L+SL L G + IGN S L QL L N T +IP+E+G L +L+ L + N
Sbjct: 239 LLNLQSLVLTENLLEGDIPAEIGNCSSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKN 298
Query: 124 SICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGN 183
+ IP+++ R + L + N LVG I L E+L L SN+ TG P S+ N
Sbjct: 299 KLTSSIPSSLFRLTQLTHLGLSENHLVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITN 358
Query: 184 LSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLS-----------------VVEN 226
L ++ +++ +NN+ G +P G NL LS N L+ + N
Sbjct: 359 LRNLTVLTVGFNNISGELPADLGLLTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHN 418
Query: 227 KLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCS-------------------LTN 267
++TGE+P L +I N DD+ F CS +
Sbjct: 419 QMTGEIPRGFGRMNLTFISIGRNHFTGEIPDDI-FNCSNLETLSVADNNLTGTLKPLIGK 477
Query: 268 ATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWN 327
+L + ++ N+ G +P I NL K + L+L++N G IP + N LQ L M++
Sbjct: 478 LQKLRILQVSYNSLTGPIPREIGNL-KDLNILYLHSNGFTGRIPREMSNLTLLQGLRMYS 536
Query: 328 NQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLG 387
N L G IP + +++ L +L L+ NK SG IP L+ L L L N SIP+SL
Sbjct: 537 NDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLK 596
Query: 388 QCESLIEINLSNNNLSGTIPPQFF-SLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYV 446
L ++S+N L+GTIP + SL ++ + L++S N LTG++P E+GKL++++ + +
Sbjct: 597 SLSLLNTFDISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDL 656
Query: 447 YENRLEGEIPSTFGNC-----IRLEQLGMGG--------------------NLFQGPISS 481
N G IP + C + Q + G N F G I
Sbjct: 657 SNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQ 716
Query: 482 SLGSLRGLRVLDLSQNNLSGEIPKFLAGLS-LNNLNLSYNDLEGMVTTEGVFKNASATRI 540
S G++ L LDLS NNL+GEIP+ LA LS L +L L+ N+L+G V GVFKN +A+ +
Sbjct: 717 SFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDL 776
Query: 541 LGNSKLCGGISEFKLPTCVSKKSKRRRLTFVPTLVIAIVFRLLGLALALFGLVLCLVRKI 600
+GN+ LCG K T K S + T V +++ LL + L + L C ++
Sbjct: 777 MGNTDLCGSKKPLKPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEK 836
Query: 601 KEKENPSSSI------YSLLYLSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTI 654
K + + SS+ L ++L AT F+SAN++G S +VYKG +++G T I
Sbjct: 837 KIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDG-TVI 895
Query: 655 AVKVFNLQHHGAS--RSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHY 712
AVKV NL+ A + F E K L ++HRNLVK+L G + KA V FM
Sbjct: 896 AVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKIL----GFAWESGKTKALVLPFMEN 951
Query: 713 GSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNV 772
G+LE+ +H AP +LL+++++ + IA ++YLH HCDLKP+N+
Sbjct: 952 GNLEDTIHG-------SAAPIG-SLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANI 1003
Query: 773 LLDDYMTARVGDFGLARILS--PDHTQTSSFSV-KGSLGYIAPEYGVGCEVSTNGDVYSY 829
LLD A V DFG ARIL D + T+S S +G++GY+APE+ +V+T DV+S+
Sbjct: 1004 LLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSF 1063
Query: 830 GILLLELVIGKKPIDIMFEG--DINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQR 887
GI+++EL+ ++P + E D+ L K++ GN R
Sbjct: 1064 GIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSI----------------------GNGR 1101
Query: 888 QKQARI------NSII-----ECLISMVRIGVACSMELPQDRTNMTNVVHELQSIK 932
+ R+ +SI+ E + +++ + C+ P+DR +M ++ L ++
Sbjct: 1102 KGMVRVLDMELGDSIVSLKQEEAIEDFLKLCLFCTSSRPEDRPDMNEILTHLMKLR 1157
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 387 bits (994), Expect = e-106, Method: Compositional matrix adjust.
Identities = 308/1012 (30%), Positives = 467/1012 (46%), Gaps = 192/1012 (18%)
Query: 16 VAGTGNETDRVALLEFKSKST-YDPVGVLGTW---NESIHFCKWYGVTCS---------- 61
V+ T E + ALL++KS T L +W N S WYGV CS
Sbjct: 44 VSATVEEAN--ALLKWKSTFTNQTSSSKLSSWVNPNTSSFCTSWYGVACSLGSIIRLNLT 101
Query: 62 -------------RRHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSE 108
+T +DL + +G++S G S L+ L +N EIP E
Sbjct: 102 NTGIEGTFEDFPFSSLPNLTFVDLSMNRFSGTISPLWGRFSKLEYFDLSINQLVGEIPPE 161
Query: 109 IGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNL 168
+G L L L L N + G IP+ I R + + I +N L G I S F +L+K L L
Sbjct: 162 LGDLSNLDTLHLVENKLNGSIPSEIGRLTKVTEIAIYDNLLTGPIPSSFGNLTKLVNLYL 221
Query: 169 GSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKL 228
N L+GSIPS +GNL ++ + L NNL G IP+SFG +N+ L++ EN+L
Sbjct: 222 FINSLSGSIPSEIGNLPNLRELCLDRNNLTGKIPSSFGNLKNVTLLNM-------FENQL 274
Query: 229 TGEV-PSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPG 287
+GE+ P + + L ++ +N L +L N L +H+ N G +P
Sbjct: 275 SGEIPPEIGNMTALDTLSLHTNKLTG------PIPSTLGNIKTLAVLHLYLNQLNGSIPP 328
Query: 288 CISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKIL 347
+ + I L ++ NK+ G +P G L+ L + +NQLSG IPP I L +L
Sbjct: 329 ELGEMESMID-LEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANSTELTVL 387
Query: 348 GLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEIN----------- 396
L+ N +G +P +I L NL L+DN E +P SL C+SLI +
Sbjct: 388 QLDTNNFTGFLPDTICRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNSFSGDIS 447
Query: 397 -------------------------------------LSNNNLSGTIPPQFFSLSSLSIS 419
LSNN+++G IPP+ ++++ LS
Sbjct: 448 EAFGVYPTLNFIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLS-Q 506
Query: 420 LDWSRNKLTGSLPI------EVGKLKI------------------LEFLYVYENRLEGEI 455
LD S N++TG LP + KL++ LE+L + NR EI
Sbjct: 507 LDLSSNRITGELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEI 566
Query: 456 PSTFGNCIR------------------------LEQLGMGGNLFQGPISSSLGSLRGLRV 491
P T N R L+ L + N G ISS SL+ L
Sbjct: 567 PPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLER 626
Query: 492 LDLSQNNLSGEI-PKFLAGLSLNNLNLSYNDLEGMVTTEGVFKNASATRILGNSKLCGGI 550
LDLS NNLSG+I P F L+L ++++S+N+L+G + F+NA GN LCG +
Sbjct: 627 LDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSV 686
Query: 551 SEFK-LPTC---VSKKSKRRRLTFVPTLVIAIVFRLLGLALAL---FGLVLCLVRKIKEK 603
+ + L C SKKS + R L+I I+ ++G + L G+ +C ++ K+
Sbjct: 687 NTTQGLKPCSITSSKKSHKDR-----NLIIYILVPIIGAIIILSVCAGIFICFRKRTKQI 741
Query: 604 ENPSS--------SIYSLL-YLSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTI 654
E + SI+S + YQ++ AT F L+G G G VYK + +
Sbjct: 742 EEHTDSESGGETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA--IM 799
Query: 655 AVKVFN------LQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYE 708
AVK N + + + F+ E +AL IRHRN+VK+ C +R N F VYE
Sbjct: 800 AVKKLNETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFC---SHRRNTFL--VYE 854
Query: 709 FMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLK 768
+M GSL + L E D+ + L+ +R+N+ +A+AL+Y+HHD P H D+
Sbjct: 855 YMERGSLRKVL-------ENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDIS 907
Query: 769 PSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYS 828
N+LL + A++ DFG A++L PD + S +V G+ GY+APE +V+ DVYS
Sbjct: 908 SGNILLGEDYEAKISDFGTAKLLKPDSSNWS--AVAGTYGYVAPELAYAMKVTEKCDVYS 965
Query: 829 YGILLLELVIGKKPIDIMF-------EGDINLHNFGRKALPDDVMDIVDSSL 873
+G+L LE++ G+ P D++ + ++L + LP+ +I + L
Sbjct: 966 FGVLTLEVIKGEHPGDLVSTLSSSPPDATLSLKSISDHRLPEPTPEIKEEVL 1017
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 385 bits (989), Expect = e-106, Method: Compositional matrix adjust.
Identities = 323/1020 (31%), Positives = 467/1020 (45%), Gaps = 173/1020 (16%)
Query: 27 ALLEFKSKST---YDPVGVLGTWNESIHFCKWYGVTC--SRRHQRVTLLDLRSLKLAGS- 80
ALL K+ T D L +W S FC W GVTC SRRH VT LDL L L+G+
Sbjct: 28 ALLSLKTSLTGAGDDKNSPLSSWKVSTSFCTWIGVTCDVSRRH--VTSLDLSGLNLSGTL 85
Query: 81 ---VSHF--------------------IGNLSFLKQLYLQVNSFTHEIPSEIG-GLRRLK 116
VSH I +LS L+ L L N F P EI GL L+
Sbjct: 86 SPDVSHLRLLQNLSLAENLISGPIPPEISSLSGLRHLNLSNNVFNGSFPDEISSGLVNLR 145
Query: 117 VLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGS 176
VL + NN++ G++P +++ + L +H N GKI + S E L + N L G
Sbjct: 146 VLDVYNNNLTGDLPVSVTNLTQLRHLHLGGNYFAGKIPPSYGSWPVIEYLAVSGNELVGK 205
Query: 177 IPSSLGNLSSIHTISLAY-NNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVP-S 234
IP +GNL+++ + + Y N + +P G LV A LTGE+P
Sbjct: 206 IPPEIGNLTTLRELYIGYYNAFEDGLPPEIGNLSELVRFDGA-------NCGLTGEIPPE 258
Query: 235 LEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSK 294
+ KLQ+L + N +L L SL + M +++N F G +P + L K
Sbjct: 259 IGKLQKLDTLFLQVNVFSGPLTWELGTLSSLKS------MDLSNNMFTGEIPASFAEL-K 311
Query: 295 TIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKL 354
+ L L NK++G IP IG+ L+ L +W N +G+IP +GE L ++ L+ NKL
Sbjct: 312 NLTLLNLFRNKLHGEIPEFIGDLPELEVLQLWENNFTGSIPQKLGENGKLNLVDLSSNKL 371
Query: 355 SGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLS 414
+G +PP++ + L L NFL SIP SLG+CESL I + N L+G+IP F L
Sbjct: 372 TGTLPPNMCSGNKLETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKGLFGLP 431
Query: 415 SLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNL 474
L+ ++ N L+G LP+ G L + + N+L G +P GN +++L + GN
Sbjct: 432 KLT-QVELQDNYLSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKLLLDGNK 490
Query: 475 FQGPISSSLGSLRGLR------------------------VLDLSQNNLSGEIPKFLAGL 510
FQGPI S +G L+ L +DLS+N LSGEIP + +
Sbjct: 491 FQGPIPSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNEITAM 550
Query: 511 -------------------------SLNNLNLSYNDLEGMVTTEGVFKNASATRILGNSK 545
SL +L+ SYN+L G+V G F + T LGN
Sbjct: 551 KILNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTSFLGNPD 610
Query: 546 LCG--------GI------SEFKLPTCVSKKSKRRRLTFVPTLVIAIVFRLLGLALALFG 591
LCG G+ S K P S K V ++ A+V + +L
Sbjct: 611 LCGPYLGPCKDGVAKGGHQSHSKGPLSASMKLLLVLGLLVCSIAFAVVAIIKARSL---- 666
Query: 592 LVLCLVRKIKEKENPSSSIYSLLYLSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGR 651
+K E + + L + D+ ++ N++G G G VYKG++ G
Sbjct: 667 ------KKASESRAWRLTAFQRLDFTCDDVLDS---LKEDNIIGKGGAGIVYKGVMPNG- 716
Query: 652 TTIAVKVFNLQHHGASRS--FIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEF 709
+AVK G+S F AE + L IRHR++V++L C +++ N VYE+
Sbjct: 717 DLVAVKRLAAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFC--SNHETNLL---VYEY 771
Query: 710 MHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKP 769
M GSL E LH G +L+ R IA++ A L YLHHDC P+ H D+K
Sbjct: 772 MPNGSLGEVLHGKKG--------GHLHWDTRYKIALEAAKGLCYLHHDCSPLIVHRDVKS 823
Query: 770 SNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSY 829
+N+LLD A V DFGLA+ L T ++ GS GYIAPEY +V DVYS+
Sbjct: 824 NNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSF 883
Query: 830 GILLLELVIGKKPIDIMFEGDINLHNFGRKAL---PDDVMDIVDSSLLPDDEDLILTGNQ 886
G++LLELV G+KP+ +G +++ + RK D V+ ++D
Sbjct: 884 GVVLLELVTGRKPVGEFGDG-VDIVQWVRKMTDSNKDSVLKVLD---------------- 926
Query: 887 RQKQARINSI-IECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILLGVELCPPCK 945
R++SI I + + + + C E +R M VV L I + PP K
Sbjct: 927 ----PRLSSIPIHEVTHVFYVAMLCVEEQAVERPTMREVVQILTEIPKL-------PPSK 975
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 949 | ||||||
| 255581223 | 1015 | receptor-kinase, putative [Ricinus commu | 0.957 | 0.895 | 0.520 | 0.0 | |
| 359486510 | 965 | PREDICTED: probable LRR receptor-like se | 0.930 | 0.915 | 0.537 | 0.0 | |
| 255585471 | 963 | serine-threonine protein kinase, plant-t | 0.881 | 0.869 | 0.523 | 0.0 | |
| 224119102 | 1007 | predicted protein [Populus trichocarpa] | 0.952 | 0.897 | 0.495 | 0.0 | |
| 224119022 | 1021 | predicted protein [Populus trichocarpa] | 0.953 | 0.886 | 0.507 | 0.0 | |
| 255570308 | 1033 | receptor-kinase, putative [Ricinus commu | 0.959 | 0.881 | 0.503 | 0.0 | |
| 224097752 | 1025 | predicted protein [Populus trichocarpa] | 0.985 | 0.912 | 0.478 | 0.0 | |
| 359482058 | 1040 | PREDICTED: probable LRR receptor-like se | 0.965 | 0.880 | 0.481 | 0.0 | |
| 147853780 | 1904 | hypothetical protein VITISV_030954 [Viti | 0.966 | 0.481 | 0.480 | 0.0 | |
| 224116466 | 1008 | predicted protein [Populus trichocarpa] | 0.954 | 0.898 | 0.484 | 0.0 |
| >gi|255581223|ref|XP_002531424.1| receptor-kinase, putative [Ricinus communis] gi|223528974|gb|EEF30966.1| receptor-kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 916 bits (2368), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 518/995 (52%), Positives = 646/995 (64%), Gaps = 86/995 (8%)
Query: 20 GNETDRVALLEFKSKSTYDPVGVLGTWNESIHFCKWYGVTCSRRHQRVTLLDLRSLKLAG 79
GN TDR+ALL+FK+K T DP+G + WN+S HFC+WYGVTCSRRHQRV +L+LRSL+LAG
Sbjct: 30 GNLTDRLALLDFKAKITDDPLGFMPLWNDSTHFCQWYGVTCSRRHQRVAILNLRSLQLAG 89
Query: 80 SVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTL 139
S+S IGNLSFL+ LYLQ NSF+H IP E+G LRRL+ L L+NNS+ G IP+NIS CS L
Sbjct: 90 SISPHIGNLSFLRDLYLQNNSFSHGIPPEVGRLRRLQRLRLSNNSLTGNIPSNISACSKL 149
Query: 140 IPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDG 199
I+ NQL G+I S L+K +++++ N+ +GSIP S+GNLSS+ +S N L G
Sbjct: 150 SEIYFAYNQLEGEIPEELSLLAKLQVISIQKNYFSGSIPPSIGNLSSLQVLSAPENYLSG 209
Query: 200 TIPNSFGWFENLVFLSLAANNLS-----------------VVENKLTGEVP--------- 233
IP++ G NL+F+SL+ NNLS +V N++ G +P
Sbjct: 210 NIPDAIGQLNNLIFISLSVNNLSGTIPPSIYNLSSINTLNIVYNQIQGRLPSNLGITLPN 269
Query: 234 ----------------------------------------SLEKLQRLQHFTITSNSLGS 253
SLE+L LQ + N LG
Sbjct: 270 LQVFAIARNDFIGSIPSSFSNASNLVWLIMSENKLTGRVPSLEQLHNLQILGLGYNYLGL 329
Query: 254 GGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAG 313
N DL F+ SL N T L + I++N F G+LP ISN S T L + N I G IP+
Sbjct: 330 EAN-DLDFVSSLVNCTNLWRLEIHNNKFHGVLPESISNFSTTFSQLVIAENNIAGRIPSS 388
Query: 314 IGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFL 373
I N VNL+RL+M NNQLSG IP G L LK+L L NKLSG IP S+GNL MLL L
Sbjct: 389 ISNLVNLERLEMANNQLSGNIPSNFGNLNMLKVLHLFGNKLSGTIPSSLGNLTMLLTLSF 448
Query: 374 NDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPI 433
DN L+ IPSSL +CE+L+ ++L+ NNLSG+IP Q F LSSLSI+LD S N TG +P+
Sbjct: 449 YDNNLQGRIPSSLAECENLMVLDLAKNNLSGSIPLQVFGLSSLSIALDLSANHFTGVIPM 508
Query: 434 EVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLD 493
EVG LK LE L + +N L G IP + G+CI+LE L + GN F G + SSL SLRGLRVLD
Sbjct: 509 EVGNLKDLEQLGISDNMLSGRIPDSLGSCIKLEVLALQGNFFDGLVPSSLSSLRGLRVLD 568
Query: 494 LSQNNLSGEIPKFLAGLS-LNNLNLSYNDLEGMVTTEGVFKNASATRILGNSKLCGGISE 552
S NNLSGEIP+FL L +LNLSYN+ EG V EG+F+NAS T ++GN KLCGGI E
Sbjct: 569 FSSNNLSGEIPEFLQSFDLLESLNLSYNNFEGRVPVEGIFRNASTTLVMGNDKLCGGIPE 628
Query: 553 FKLPTCVSKKSKRRRLTFVPTLVIAIVFRLLGLALAL-FGLVLCLVRKIKEKENPSSSIY 611
F L C +K K +LT + +VI+ + LLGL+ L F L L +K KE P+S Y
Sbjct: 629 FHLAKCNAKSPK--KLTLLLKIVISTICSLLGLSFILIFALTFWLRKK---KEEPTSDPY 683
Query: 612 S--LLYLSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRS 669
LL +S+Q L AT GFSSANL+G GSFG VYKG +DEG TIAVKV NL HHGAS S
Sbjct: 684 GHLLLNVSFQSLLRATDGFSSANLIGRGSFGHVYKGFLDEGNVTIAVKVLNLLHHGASTS 743
Query: 670 FIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEID 729
FIAEC+AL++IRHRNLVKVLTAC G DY+GNDFKA VYE+M GSLEEWLHP +E+
Sbjct: 744 FIAECEALRNIRHRNLVKVLTACSGIDYQGNDFKALVYEYMVNGSLEEWLHPIPRTEEV- 802
Query: 730 EAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLAR 789
E PR+LNLLQRLNIAID+A AL+YLH+ C HCDLKPSNVLLD M V DFGLA+
Sbjct: 803 EPPRSLNLLQRLNIAIDVASALDYLHNQCTTPIVHCDLKPSNVLLDSEMNGHVSDFGLAK 862
Query: 790 ILSPDH-----TQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPID 844
ILS +Q+SS V+G++G+ PEYGVG VST GDVYSYGILLLEL GK+P D
Sbjct: 863 ILSESTNSFPVSQSSSIGVRGTVGFAPPEYGVGSNVSTYGDVYSYGILLLELFTGKRPTD 922
Query: 845 IMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMV 904
MF+ D+NLHNF A D + ++ D LL + N R+ Q + ECL SM+
Sbjct: 923 DMFKEDLNLHNFAEIAFRDQLAEVADPILLQETAVRETRLNSRKCQ----RLEECLFSML 978
Query: 905 RIGVACSMELPQDRTNMTNVVHELQSIKNILLGVE 939
RIGVACS E+PQ+R + +VV L +I++ L+ +
Sbjct: 979 RIGVACSTEMPQERMKINDVVTGLHAIRDKLVRIR 1013
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359486510|ref|XP_002271317.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like, partial [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 911 bits (2354), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 513/955 (53%), Positives = 642/955 (67%), Gaps = 72/955 (7%)
Query: 57 GVTCSRRHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLK 116
GV C RRHQRVT+LDL+S KL GS+S IGNLSFL+ L L+ N F HEIP EIG LRRL+
Sbjct: 1 GVKCGRRHQRVTMLDLQSQKLVGSISPHIGNLSFLRVLQLEENGFNHEIPPEIGHLRRLQ 60
Query: 117 VLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGS 176
+L L+NNS+ GEIP N+S CS L+ I+ N+LVGKI + SLSK + L + +N L+G
Sbjct: 61 MLFLSNNSLSGEIPANLSSCSKLMYIYVGWNRLVGKIPAELGSLSKLQYLFIHANSLSGG 120
Query: 177 IPSSLGNLSSIHTISLAYNN------------------------LDGTIPNSFGWFENLV 212
IP S GNLSS+ +S NN L GTIP S +L+
Sbjct: 121 IPRSFGNLSSLERLSATQNNIVGTIPASLFQLITLTHVALNANGLSGTIPPSLSNLSSLI 180
Query: 213 FLSLAANNL------------------------------------------SVVENKLTG 230
F +++ N+L S N LTG
Sbjct: 181 FFAVSFNHLHGNLPSNLGITLPNLQDLSLSGNRFTGSIPVSLSNASNLEYFSCNGNNLTG 240
Query: 231 EVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCIS 290
+VPSLEKLQRL F++TSN+LG+G +DL FL SLTN + L + +N NNFGG+LP I
Sbjct: 241 KVPSLEKLQRLHFFSVTSNNLGNGEIEDLGFLSSLTNVSNLEVLALNVNNFGGVLPESIG 300
Query: 291 NLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLN 350
N S + TL L+ NKI GSIPAGIGN V+L+RL+MW NQLSG+IP IG+LQNL++L L
Sbjct: 301 NWSTKLATLLLDGNKIGGSIPAGIGNLVSLERLEMWENQLSGSIPVDIGKLQNLRVLMLI 360
Query: 351 RNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQF 410
+NKLSG +P S+GNL+ L+ L L N+ + IPSSLG+C++L+ ++LS NNLSGTIPPQ
Sbjct: 361 KNKLSGILPSSLGNLENLIQLVLGRNYFQGKIPSSLGKCQNLLFLDLSLNNLSGTIPPQV 420
Query: 411 FSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGM 470
SLSSLSISLD S N+LTG+LPIEVG LK L L V N L G IPS+ G+C LE L M
Sbjct: 421 VSLSSLSISLDISDNRLTGALPIEVGNLKNLGVLDVSNNMLSGGIPSSVGSCTSLEYLSM 480
Query: 471 GGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLSLNNLNLSYNDLEGMVTTEG 530
GN FQG I SS SLRG+R+LDLS NNLSG+IP+FL + +NLSYND EG++ TEG
Sbjct: 481 KGNFFQGSIPSSFSSLRGIRILDLSHNNLSGKIPEFLQDIHFQLVNLSYNDFEGILPTEG 540
Query: 531 VFKNASATRILGNSKLCGGISEFKLPTCVSKKSKRRRLTFVPTLVIAIVFRLLGLALALF 590
VFKN SAT I+GNSKLCGGI EF+LP C ++ K+R L+ ++IA V LL + L
Sbjct: 541 VFKNVSATSIMGNSKLCGGIPEFQLPKCNLQEPKKRGLSLALKIIIATVSGLLAITCVLS 600
Query: 591 GLVLCLVRKIKEKENPSSSIYSLLYLSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEG 650
L+ +RK K + SSS SLL +SYQ L AT GFSS+NL+GVGSFGSVYKGI+D
Sbjct: 601 FLIFLWLRKKKGEPASSSSEKSLLKVSYQSLLRATDGFSSSNLIGVGSFGSVYKGILDHD 660
Query: 651 RTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFM 710
T IAVKV NL GAS+SFIAEC+AL++IRHRNLVKVLTAC G DY+GNDFKA VYEFM
Sbjct: 661 GTAIAVKVLNLLRKGASKSFIAECEALRNIRHRNLVKVLTACSGVDYQGNDFKAVVYEFM 720
Query: 711 HYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPS 770
GSLE+WLHP E PR LN LQRLNIAID+A AL+YLHH CQ HCDLKPS
Sbjct: 721 VNGSLEQWLHPTPTTAEASAPPRKLNFLQRLNIAIDVACALDYLHHQCQTPIVHCDLKPS 780
Query: 771 NVLLDDYMTARVGDFGLARILSPDHT-----QTSSFSVKGSLGYIAPEYGVGCEVSTNGD 825
NVLLD MT VGDFG+A+ L T Q+SS ++G++GY APEYG+G EVST+GD
Sbjct: 781 NVLLDTEMTGHVGDFGIAKFLPEAATRVPEIQSSSIGIRGTIGYAAPEYGMGSEVSTSGD 840
Query: 826 VYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGN 885
VYS+GILLLE+ GK+P + MF+ +N+HNF + A+P+ V +I D LL + ++ T +
Sbjct: 841 VYSFGILLLEMFTGKRPTEDMFKDSLNIHNFVKTAVPERVAEIADPVLLQEGVEMDNTTS 900
Query: 886 QRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILLGVEL 940
QR + A + ECLIS+ IG+ACS ELP++R N+T+ EL S+++I LG L
Sbjct: 901 QR-RMASSHDAQECLISIFGIGLACSAELPRERKNITDAAAELNSVRDIFLGTGL 954
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255585471|ref|XP_002533428.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526716|gb|EEF28948.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 901 bits (2329), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 489/934 (52%), Positives = 617/934 (66%), Gaps = 97/934 (10%)
Query: 17 AGTGNETDRVALLEFKSKSTYDPVGVLGTWNESIHFCKWYGVTCSRRHQRVTLLDLRSLK 76
A +GNETD ALLEFKSK T+DP VL +WNE+IHFC+W GVTC H+RVT+LDL SLK
Sbjct: 33 AISGNETDLQALLEFKSKITHDPFQVLRSWNETIHFCQWQGVTCGLLHRRVTVLDLHSLK 92
Query: 77 LAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRC 136
++GS+S +IGNLSFL+ L +Q NSF HEIP +IG LRRL+ L LNNNS+ G+IPTNISRC
Sbjct: 93 ISGSISPYIGNLSFLRALNIQNNSFGHEIPQQIGYLRRLEELRLNNNSVGGKIPTNISRC 152
Query: 137 STLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNN 196
S L+ I N+L G + LS ++L++ N LTGSIP SLGNLS + +SLA N
Sbjct: 153 SNLVFISLGKNKLEGNVPEELGVLSNLQVLSIFGNKLTGSIPHSLGNLSQLQRLSLAENR 212
Query: 197 LDGTIPNSFGWFENLVFLSLAANNLS---------------------------------- 222
+ G +PNS GW NL FLSL +N LS
Sbjct: 213 MVGEVPNSLGWLRNLTFLSLRSNRLSGTIPSSLFNLSSIRNLDIGENNFHGNLPSDIGFL 272
Query: 223 --------VVENKLTGEVP------------------------SLEKLQRLQHFTITSNS 250
+ N+ TG++P SL KL RL+ F++TSN+
Sbjct: 273 LPNIRWFAISSNEFTGKIPVSLSNATNLESLLLLQNNLTGEVPSLAKLDRLRVFSLTSNN 332
Query: 251 LGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSI 310
LG+G DDLSFL SLTN T L + +N NNFGG+LP I+NLS T++ L L+NN+I GSI
Sbjct: 333 LGTGKADDLSFLHSLTNTTALEELGVNGNNFGGMLPDSIANLSTTLRILLLDNNRIIGSI 392
Query: 311 PAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLN 370
P+GI N V+L+ ++WNNQLSG IP +IG+LQNL +L LN N LSG+IP S+GNL L+
Sbjct: 393 PSGIENLVSLEDFEVWNNQLSGFIPDSIGKLQNLVVLALNSNMLSGHIPSSLGNLTNLIQ 452
Query: 371 LFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGS 430
L + DN L IPS LG+C++++ ++LS NN SG+IPP+ S+SSLSI LD S+N LTG+
Sbjct: 453 LLVEDNNLSGRIPSDLGRCQNMLGLSLSQNNFSGSIPPEVISISSLSIYLDLSQNNLTGT 512
Query: 431 LPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLR 490
LP+EVG LK L V N+L GEIP T G+CI LE L M GN FQG I SSL SLR L+
Sbjct: 513 LPMEVGNLKSLSEFDVSGNKLSGEIPRTLGSCISLEILNMAGNNFQGLIPSSLSSLRALQ 572
Query: 491 VLDLSQNNLSGEIPKFLAGLSLNNLNLSYNDLEGMVTTEGVFKNASATRILGNSKLCGGI 550
+LDLS N+LS GMV ++G+FKNASAT + GN+ LCGGI
Sbjct: 573 ILDLSNNHLS-----------------------GMVPSKGIFKNASATSVEGNNMLCGGI 609
Query: 551 SEFKLPTCVSKKSKRRRLTFVPTLVIAIVFRLLGLALALFGLVLCLVRKIKEKENPSS-S 609
EF+LP C S + K+ RLT V VI+ + G+A + L L R+ K E + S
Sbjct: 610 PEFQLPVCNSARHKKNRLTPVLKTVISAIS---GMAFLILMLYLFWFRQKKVNETTADFS 666
Query: 610 IYSLLYLSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRS 669
++ LSYQ+L+ AT GFSSAN++G+GSFGSVYKG +D T IAVKVFNL G +S
Sbjct: 667 EKKIMELSYQNLHKATDGFSSANIIGMGSFGSVYKGRLDREGTLIAVKVFNLMRRGGFKS 726
Query: 670 FIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEID 729
F+AEC+AL++IRHRNL+KVLTAC DY GNDFKA VYEFM GSLEEWLHP +E +
Sbjct: 727 FLAECEALRNIRHRNLLKVLTACSSLDYHGNDFKALVYEFMVNGSLEEWLHPPVATNEAE 786
Query: 730 EAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLAR 789
R LN LQRLNIAID+A AL YLHH C+P HCDLKPSN+LLD+ +T VGDFGLAR
Sbjct: 787 LETRKLNFLQRLNIAIDVASALYYLHHHCEPQIVHCDLKPSNILLDEELTGHVGDFGLAR 846
Query: 790 IL----SPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDI 845
L +TQ+SS V+G++GY PEYG+ EVST GDVYSYGILLLE+ GK+P+D
Sbjct: 847 FLLDATQNHYTQSSSIGVRGTVGYAPPEYGMSSEVSTYGDVYSYGILLLEMFTGKRPMDD 906
Query: 846 MFEGDINLHNFGRKALPDDVMDIVDSSLLPDDED 879
MF+ NLHNF + ALP+ V++IVD +LLP+ E+
Sbjct: 907 MFKDGFNLHNFVKAALPNQVVEIVDPNLLPEIEE 940
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119102|ref|XP_002331325.1| predicted protein [Populus trichocarpa] gi|222873908|gb|EEF11039.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 886 bits (2290), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 491/990 (49%), Positives = 644/990 (65%), Gaps = 86/990 (8%)
Query: 21 NETDRVALLEFKSKSTYDPVGVLGTWNESIHFCKWYGVTCSRRHQRVTLLDLRSLKLAGS 80
NETDR+ALL+FKSK T+DP+G++ WN SIHFC W+GVTCS++HQRV +LDL+SLKL+GS
Sbjct: 32 NETDRLALLDFKSKITHDPLGIMRLWNSSIHFCHWFGVTCSQKHQRVAVLDLQSLKLSGS 91
Query: 81 VSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLI 140
VS +IGNLSFL+ LYLQ NSF+HEIP++IG L RL++LAL+NNS GEIP ++S L+
Sbjct: 92 VSPYIGNLSFLRNLYLQHNSFSHEIPAQIGHLHRLQILALHNNSFTGEIPASMSSSYNLV 151
Query: 141 PIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGT 200
+ NN+L G+I F S K L + N+L G+IP SLGN+SS+ + L NNL G
Sbjct: 152 SLILDNNKLTGEIPKEFGSFLKLTDLYIDDNNLVGTIPPSLGNISSLQELWLDDNNLFGN 211
Query: 201 IP------------------------------NSFGWFE-------------------NL 211
+P +S F+ NL
Sbjct: 212 LPATLSKLVNLRVLSLFNNRFSGTIPPSMLNLSSLRTFQVGLNHFQGNLPPDLGISLPNL 271
Query: 212 VFLSLAAN--------------NLSVVE---NKLTGEVPSLEKLQRLQHFTITSNSLGSG 254
F S+ +N NL ++E NKL G++PSLEKLQRL TI SN+LGSG
Sbjct: 272 EFFSIYSNQFTGSVPVSISNLSNLEMLELNLNKLRGKMPSLEKLQRLLSITIASNNLGSG 331
Query: 255 GNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGI 314
+DLSFL SLTNAT L + I NNF G LP ISNLS T++ + L++N ++GSIP GI
Sbjct: 332 EANDLSFLSSLTNATNLEELIITQNNFQGQLPPQISNLSTTLEIMGLDSNLLFGSIPDGI 391
Query: 315 GNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLN 374
N ++L ++ NN LSG IP IG+LQNL+ILGL N SG+IP S+GNL L+ L+LN
Sbjct: 392 ENLISLNDFEVQNNHLSGIIPSTIGKLQNLEILGLALNNFSGDIPSSLGNLTNLIGLYLN 451
Query: 375 DNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIE 434
D ++ SIPSSL C L+E++LS N ++G+IPP F LSSLSI+LD SRN L+GSLP E
Sbjct: 452 DINVQGSIPSSLANCNKLLELDLSGNYITGSIPPGIFGLSSLSINLDLSRNHLSGSLPKE 511
Query: 435 VGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDL 494
VG L+ LE + N + G+IPS+ CI L+ L + N F+G + SSL +LRG++ +
Sbjct: 512 VGNLENLEIFAISGNMISGKIPSSLAQCISLQFLYLDANFFEGSVPSSLSTLRGIQEFNF 571
Query: 495 SQNNLSGEIPKFLAGL-SLNNLNLSYNDLEGMVTTEGVFKNASATRILGNSKLCGGISEF 553
S NNLSG+I +F SL L+LSYN+ EGMV G+FKNA+AT ++GNSKLCGG +F
Sbjct: 572 SHNNLSGKIHEFFQDFRSLEILDLSYNNFEGMVPFRGIFKNATATSVIGNSKLCGGTPDF 631
Query: 554 KLPTCVSKKSKRRRLTFVPTLVIAIVFRLLGLALALFGLVLCLVRKIKEKENPSSSIYSL 613
+LP C K KR L + I ++ LL +A+ + GL L RK + + PSS L
Sbjct: 632 ELPPCNFKHPKRLSLKM--KITIFVISLLLAVAVLITGLFLFWSRKKRREFTPSSDGNVL 689
Query: 614 LYLSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAE 673
L +SYQ L AT+GFSS NL+G GSFGSVYKGI+D T +AVKV NL+ GAS+SF+AE
Sbjct: 690 LKVSYQSLLKATNGFSSINLIGTGSFGSVYKGILDHNGTAVAVKVLNLRRQGASKSFMAE 749
Query: 674 CKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPR 733
C+AL ++RHRNLVKV+TAC G DY GNDFKA VYEFM GSLE WLHP DE+
Sbjct: 750 CEALPNVRHRNLVKVVTACSGVDYHGNDFKALVYEFMVNGSLETWLHPSRATDEVRGI-- 807
Query: 734 NLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSP 793
L+L QRL+IAID+A+AL+Y HH C+ HCDLKP NVLLDD M VGDFGLA+ L
Sbjct: 808 -LDLTQRLSIAIDVAHALDYFHHQCEKQIVHCDLKPGNVLLDDEMVGHVGDFGLAKFLLE 866
Query: 794 D--HTQT---SSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFE 848
D H T SS ++G++GY PEYG G EVS GDVYSYGILLLE+ GK+P D +F
Sbjct: 867 DTLHHSTNPSSSIGIRGTIGYTPPEYGAGNEVSAYGDVYSYGILLLEMFTGKRPTDDLFN 926
Query: 849 GDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGV 908
G +NLH++ + LP+ V+ I D +L + GN ++ N +++CL+S+ G+
Sbjct: 927 G-LNLHSYVKTFLPEKVLQIADPTL----PQINFEGNSIEQ----NRVLQCLVSVFTTGI 977
Query: 909 ACSMELPQDRTNMTNVVHELQSIKNILLGV 938
+CS+E PQ+R + +V+ +L S +N LLG
Sbjct: 978 SCSVESPQERMGIADVIAQLFSARNELLGT 1007
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119022|ref|XP_002331306.1| predicted protein [Populus trichocarpa] gi|222873889|gb|EEF11020.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 883 bits (2281), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 503/991 (50%), Positives = 639/991 (64%), Gaps = 86/991 (8%)
Query: 21 NETDRVALLEFKSKSTYDPVGVLGTWNESIHFCKWYGVTCSRRHQRVTLLDLRSLKLAGS 80
NETD +AL++FK+K DP+G++ +WN +IHFC+W+GV+C RRHQRV +L L+SLKL+G+
Sbjct: 27 NETDLLALIQFKNKIVDDPLGIMSSWNSTIHFCQWHGVSCGRRHQRVRVLALQSLKLSGT 86
Query: 81 VSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLI 140
+S IGNLSFL++L+LQ NSF HEIP ++G LR L++ +L+NNSI G+IP +IS CS LI
Sbjct: 87 ISPHIGNLSFLRELHLQNNSFFHEIPPQVGRLRSLQIFSLHNNSISGQIPPSISDCSNLI 146
Query: 141 PIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNN---- 196
I + N L G+I SL K + L L N LTG+IP SLGNLSS+ + L N
Sbjct: 147 SIKIEFNNLTGEIPMELGSLLKLKNLTLEVNGLTGTIPPSLGNLSSLEILRLEKNKILFG 206
Query: 197 ---------------------LDGTIPNS-------------FGWFE------------N 210
L G IP S F F N
Sbjct: 207 NVPSTLGKLKNLRILNLMDNRLSGVIPPSIFNLSSLTALDIGFNLFHGNLPSDIGISLPN 266
Query: 211 LVFLSLAANN-----------------LSVVENKLTGEVPSLEKLQRLQHFTITSNSLGS 253
L F S+A+N L V N LTGEVP+LEKL RL FT+ SN LGS
Sbjct: 267 LEFFSIASNQFTGSIPVSISNASNIELLQVSLNNLTGEVPTLEKLHRLNFFTLFSNHLGS 326
Query: 254 GGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAG 313
G +DLSFL SLTNAT L ++ I NNFGG LP ISNLS + + L N I GSIPAG
Sbjct: 327 GQANDLSFLSSLTNATTLEYLSIKRNNFGGELPKQISNLSTMLGVISLPENNILGSIPAG 386
Query: 314 IGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFL 373
I VNL+ D+ NN++SG IP +IGELQNL+ L L+ N LSG IP S+GNL L+ L+L
Sbjct: 387 IEKLVNLKVFDVGNNKISGIIPSSIGELQNLEGLVLDYNNLSGRIPSSVGNLTKLMALYL 446
Query: 374 NDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPI 433
DN LE SIPSSLG C+ L+ + L NNLSG IPP F + SL + + +S+N +GSLPI
Sbjct: 447 GDNSLEGSIPSSLGNCKKLLVLTLCGNNLSGDIPPGLFGIFSL-LYICFSKNHFSGSLPI 505
Query: 434 EVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLD 493
E+GKL LEFL V N L GEIPS+ G CI LE L M N F G I S+L SLRG+ +
Sbjct: 506 EIGKLINLEFLDVSGNMLSGEIPSSLGGCISLEDLYMNSNFFHGSIPSALSSLRGVLQFN 565
Query: 494 LSQNNLSGEIPKFLAGL-SLNNLNLSYNDLEGMVTTEGVFKNASATRILGNSKLCGGISE 552
S NNLSG+IP+F G SL L+LSYN+ EGM+ EG+FKN++A ++GNS+LCGG +E
Sbjct: 566 FSHNNLSGKIPEFFQGFNSLEMLDLSYNNFEGMIPDEGIFKNSTAVSVIGNSQLCGGNTE 625
Query: 553 FKLPTCVSKKSKRRRLTFVPTLVIAIVFRLLGLALALFGLVLCLVRKIKEKENPSSSIYS 612
LP C + KR +L + I + LL LAL + L LC R+ + + SS
Sbjct: 626 LGLPRCKVHQPKRLKLKL--KIAIFAITVLLALALVVTCLFLCSSRRKRREIKLSSMRNE 683
Query: 613 LLYLSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIA 672
LL +SYQ L AT+GFSS+NLVG+GSFGSVYKG++D+ IAVKV NL GASRSFIA
Sbjct: 684 LLEVSYQILLKATNGFSSSNLVGIGSFGSVYKGMLDQNGMVIAVKVLNLMRQGASRSFIA 743
Query: 673 ECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAP 732
EC+AL++IRHRNLVKVLTAC DY GNDFKA VYEFM GSLE+WLHP
Sbjct: 744 ECEALRNIRHRNLVKVLTACSSIDYHGNDFKAIVYEFMANGSLEDWLHPTGTGGGTTLT- 802
Query: 733 RNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILS 792
LNLLQRLNIAID+A AL YLHH C+ AHCDLKPSNVLLDD +T VGDFGLA+ LS
Sbjct: 803 --LNLLQRLNIAIDVACALEYLHHHCEMPIAHCDLKPSNVLLDDELTGHVGDFGLAKFLS 860
Query: 793 P---DH--TQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMF 847
D+ +++S V+G++GY PEYGVG EVS GD YSYGILLLE+ GK+P D MF
Sbjct: 861 GASLDYPTNESTSIGVRGTIGYAPPEYGVGGEVSAYGDTYSYGILLLEMFTGKRPTDEMF 920
Query: 848 EGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQ---ARINSIIECLISMV 904
NLHNF ++A+P+ V I D +LL ++ TG+ + + R + +ECL S++
Sbjct: 921 REGSNLHNFVKRAVPEQVKQITDPTLLQEEP----TGDDDKHEISSMRNSRPLECLNSIL 976
Query: 905 RIGVACSMELPQDRTNMTNVVHELQSIKNIL 935
RIG++CS+E P++R +++ V +L S++N L
Sbjct: 977 RIGISCSVEFPRERMKISDAVAQLHSVRNEL 1007
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255570308|ref|XP_002526114.1| receptor-kinase, putative [Ricinus communis] gi|223534611|gb|EEF36308.1| receptor-kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 872 bits (2254), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 500/994 (50%), Positives = 638/994 (64%), Gaps = 83/994 (8%)
Query: 20 GNETDRVALLEFKSKSTYDPVGVLGTWNESIHFCKWYGVTCSRRHQRVTLLDLRSLKLAG 79
GNETD++ALL FK++ T DP+ +L +WN + HFC W GVTC RHQRV L+L SLKL+G
Sbjct: 31 GNETDKLALLSFKAQITDDPLELLQSWNATSHFCDWRGVTCGNRHQRVVKLELYSLKLSG 90
Query: 80 SVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTL 139
S+ H IGNLSFL+ L L NS + EIPSEIG LRRL+VL L NNSI G+IP NIS CS+L
Sbjct: 91 SLPHHIGNLSFLRVLDLHNNSLSGEIPSEIGYLRRLQVLNLRNNSIVGKIPANISSCSSL 150
Query: 140 IPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSS------------- 186
+ + N+L+G I S LSK + N LTGSIPSS GNLSS
Sbjct: 151 LHFNVGGNRLMGDIPSALGKLSKLVFFGVDRNTLTGSIPSSFGNLSSLQVLAIHVNKMNG 210
Query: 187 ----------------IHT-------------------ISLAYNNLDGTIPNSFGW-FEN 210
+HT + L+ NN G +P++ G N
Sbjct: 211 NIPDELGRLTNVLDFIVHTNNFSGAIPPPIFNLSSLVRMDLSVNNFRGNLPSNMGISLPN 270
Query: 211 LVFLSLAANN------------------LSVVENKLTGEVPSLEKLQRLQHFTITSNSLG 252
L F S+ N ++ NK TGEVP+LE L L+ ++TSN LG
Sbjct: 271 LQFFSVLMNYEFTGPIPISISNASNLLYFNLAGNKFTGEVPTLENLHELEALSLTSNHLG 330
Query: 253 SGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPA 312
S G +DLSFLC+LTN T + IN NNFGG LPGCI N S ++ L +++N I GS+PA
Sbjct: 331 SAGTNDLSFLCTLTNGTNFRRLAINLNNFGGDLPGCIGNFSTRLRLLSMSDNMISGSMPA 390
Query: 313 GIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLF 372
IGN V+L DM NNQ SG++PP+I +LQ LK+L L NK SG IP +GNL +L L
Sbjct: 391 EIGNLVSLDVFDMGNNQFSGSLPPSITKLQQLKVLYLQANKFSGEIPHYLGNLTLLTELM 450
Query: 373 LNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLP 432
LNDN IP SLG+C++L+ ++L+NNNL+G+IPP+ F LSSLS L S N L G+L
Sbjct: 451 LNDNSFRGMIPLSLGRCQNLLLLDLANNNLNGSIPPELFDLSSLSAYLRLSHNHLVGALS 510
Query: 433 IEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVL 492
+V L L LYV N L GEIPS+ G+CIRLE+L M N F+G I SSL +LRGL+V+
Sbjct: 511 EKVQNLNNLGVLYVDHNFLSGEIPSSLGSCIRLERLNMRDNSFKGSIPSSLSALRGLQVV 570
Query: 493 DLSQNNLSGEIPKFLAGLS-LNNLNLSYNDLEGMVTTEGVFKNASATRILGNSKLCGGIS 551
DLS NNLSG+IP+FL L +LNLS+ND EG+V TEGVFKNAS+T ++GN+KLCGG+S
Sbjct: 571 DLSHNNLSGQIPEFLGSFPFLQSLNLSFNDFEGLVPTEGVFKNASSTSVMGNNKLCGGVS 630
Query: 552 EFKLPTCVSKKSKRRRLTFVPTLVIAIVFRLLGLALALFGLVLCLVRKIKEKENPSSSIY 611
+F L C + S RRL +IA V LLG L L L++ RK + SS I
Sbjct: 631 DFHLLACNIRSSTNRRLKL--KAIIASVAVLLGALLMLSFLLILRSRKKSQAPALSSEI- 687
Query: 612 SLLYLSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFI 671
LL +SYQ+L++AT GFSS+NL+ VG FGSVY+G++ E +AVKV N+QH A++SF+
Sbjct: 688 PLLRVSYQNLHDATKGFSSSNLINVGGFGSVYQGVLGESGQLVAVKVLNVQHQTAAKSFM 747
Query: 672 AECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEA 731
EC+ LKSIRHRNLVKVLTAC DY+GNDFKA VYEFM GSLEEWLHP D DE
Sbjct: 748 VECEVLKSIRHRNLVKVLTACSSIDYQGNDFKALVYEFMVNGSLEEWLHPVV-VDGSDEP 806
Query: 732 PRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARIL 791
P+ L+LLQRLNIAIDIA AL YL + C+ HCDLKPSNVLLD +T V DFG+A+ L
Sbjct: 807 PKKLDLLQRLNIAIDIASALEYLQNHCETTIVHCDLKPSNVLLDAELTGHVSDFGIAKFL 866
Query: 792 SPDHTQ-----TSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIM 846
D+ +SS ++G++GY PEYG+G +VS GD+YSYGILLLE+ GK+P + M
Sbjct: 867 LKDNNNRSTNLSSSVQLRGTIGYAPPEYGMGGQVSIFGDIYSYGILLLEMFTGKRPTNDM 926
Query: 847 FEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRI 906
F+ +NLH F + ALPD V +I+D LL + +G + R I++CLIS+V I
Sbjct: 927 FKEGLNLHKFAKSALPDGVAEILDPVLLQE------SGEIDSRSIRTKKIMDCLISIVDI 980
Query: 907 GVACSMELPQDRTNMTNVVHELQSIKNILLGVEL 940
GV+CS ELP DR ++V +L SI++ LL EL
Sbjct: 981 GVSCSAELPGDRVCTSDVALKLSSIRSKLLWTEL 1014
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224097752|ref|XP_002311067.1| predicted protein [Populus trichocarpa] gi|222850887|gb|EEE88434.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 859 bits (2219), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 489/1022 (47%), Positives = 646/1022 (63%), Gaps = 87/1022 (8%)
Query: 1 LPIVSDEFLW----------VRASLVAGTGNETDRVALLEFKSKSTYDPVGVLGTWNESI 50
LP +S LW + SL G GNETDR++LL KS+ T DP G+L +WNES+
Sbjct: 3 LPGMSSCILWLLFLQIIQLPIPFSLPTG-GNETDRLSLLALKSQITNDPFGMLSSWNESL 61
Query: 51 HFCKWYGVTCSRRHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIG 110
HFC W GV C +RH+RV +DL S +L GS+S IGNLSFL+ L L+ N F+H IP E+G
Sbjct: 62 HFCDWSGVICGKRHRRVVEIDLHSAQLVGSLSPHIGNLSFLRILKLENNRFSHNIPQELG 121
Query: 111 GLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGS 170
L RL++L+L NN+ G+IP NIS CS L+ + N L GK+ SLSK ++
Sbjct: 122 HLFRLRMLSLENNTFDGKIPVNISHCSNLLILSLSGNNLTGKLPIELGSLSKLQVFFFQF 181
Query: 171 NHLTGSIPSSLGNLS------------------------SIHTISLAYNNLDGTIPNSFG 206
N+L G IPSS GNLS S+ + S NN+ G IP S
Sbjct: 182 NYLVGGIPSSFGNLSAIIQIFGAGNYLQGGIPNSIGQLKSLKSFSFGRNNMTGMIPPSIY 241
Query: 207 WFENLVFLSLAANNL---------------------------------------SVVE-- 225
+L+ ++ N L +V+E
Sbjct: 242 NLSSLMRFAVPVNQLHGNLPPDLGLTLPNLEILLMSFNRFSGSIPPTFSNASTIAVIELS 301
Query: 226 -NKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGL 284
N LTG VP L L +L+ + N LG+G +DDLSFL L N T L + IN NNFGGL
Sbjct: 302 NNNLTGRVPDLSSLSKLRWLIVDVNYLGNGNDDDLSFLPPLANKTSLEELSINDNNFGGL 361
Query: 285 LPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNL 344
LP ISN S+ +K + N+I GSIP+GIGN + L L + NQL+G IP +IG+LQNL
Sbjct: 362 LPKIISNFSENLKRMTFGRNQIRGSIPSGIGNLIGLDTLGLEMNQLTGVIPNSIGKLQNL 421
Query: 345 KILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSG 404
+L L NK+SGNIP S+GN+ LL ++L+ N L+ IPSSLG C++L+ ++L NNLSG
Sbjct: 422 GVLALGGNKISGNIPSSMGNITSLLEVYLSANNLQGRIPSSLGNCQNLLILHLDQNNLSG 481
Query: 405 TIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIR 464
+IP + S+ S S L S N+LTGSLP+EVGKL L + + NRL GEIP T G+C+
Sbjct: 482 SIPKEVISIPSSSRILVLSENQLTGSLPLEVGKLANLGYFNLSHNRLSGEIPRTLGSCVS 541
Query: 465 LEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLS-LNNLNLSYNDLE 523
LE L M GNLFQGPI SL SLR L++L+LS NNLSGEIPKFLA L L +L+LS+N+LE
Sbjct: 542 LEFLYMEGNLFQGPIPESLSSLRALQILNLSHNNLSGEIPKFLAELKLLTSLDLSFNNLE 601
Query: 524 GMVTTEGVFKNASATRILGNSKLCGGISEFKLPTCVSKKSKRRRLTFVPTLVIAIVFRLL 583
G V +G+F AS +LGN KLCGG+ + L C SKKS++ + + L+IAI +
Sbjct: 602 GEVPVQGIFARASGFSMLGNKKLCGGMPQLNLSRCTSKKSRKLKSSTKLKLIIAIPCGFV 661
Query: 584 GLALALFGLVLCLVRKIKEKENPSSSIYSLLY-LSYQDLYNATSGFSSANLVGVGSFGSV 642
G+ L + ++ +++ K + S S ++Y+DL AT+GFS ANL+G GSFGSV
Sbjct: 662 GIILVVSYMLFFFLKEKKSRPASGSPWESTFQRVAYEDLLQATNGFSPANLIGAGSFGSV 721
Query: 643 YKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702
YKGI+ +AVKVFNL GAS+SF+AEC AL +IRHRNLVKVLTAC G D++GNDF
Sbjct: 722 YKGILRSDGAAVAVKVFNLLREGASKSFMAECAALINIRHRNLVKVLTACSGIDFQGNDF 781
Query: 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVT 762
KA VYEFM GSLEEWLHP DE R+L+LLQRLNIAID+A AL+YLH+ CQ
Sbjct: 782 KALVYEFMVNGSLEEWLHPAQISDEAHRR-RDLSLLQRLNIAIDVASALDYLHNHCQIAI 840
Query: 763 AHCDLKPSNVLLDDYMTARVGDFGLARIL-SPDHT----QTSSFSVKGSLGYIAPEYGVG 817
HCDLKPSNVLLD +TA VGDFGLAR+L H QTSS +KG++GY APEYG+G
Sbjct: 841 VHCDLKPSNVLLDGDLTAHVGDFGLARLLPQASHQLCLDQTSSIGLKGTIGYAAPEYGLG 900
Query: 818 CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDD 877
EVS GDVYSYGILLLE+ G++P D +F+ +NLHNF + ALP V +++D L+ +
Sbjct: 901 SEVSPYGDVYSYGILLLEVFTGRRPTDGLFKDGLNLHNFAKTALPISVAEVLDPVLVTEA 960
Query: 878 EDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILLG 937
E+ +G+ ++ + I + +ECL ++V++GVACS E P++R +++V EL+ I++ILLG
Sbjct: 961 EE--TSGDASRRMSHIGNHMECLAAIVKVGVACSAEFPRERMEISSVAVELRRIRHILLG 1018
Query: 938 VE 939
+
Sbjct: 1019 PQ 1020
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482058|ref|XP_002274540.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 852 bits (2202), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 479/995 (48%), Positives = 623/995 (62%), Gaps = 79/995 (7%)
Query: 21 NETDRVALLEFKSKSTYDPVGVLGTWNESIHFCKWYGVTCSRRHQRVTLLDLRSLKLAGS 80
NETDR+ALL K++ T DP+G+ +WN+S+HFC W GVTC RHQRV L+L SL L GS
Sbjct: 37 NETDRLALLAIKAQITQDPLGITTSWNDSVHFCNWTGVTCGHRHQRVNTLNLNSLHLVGS 96
Query: 81 VSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLI 140
+S IGNL+FL L L++N+F +IP E+G L RL+ L L NNS GEIP N+SRCS L+
Sbjct: 97 LSPSIGNLTFLTGLNLELNNFHGQIPQELGRLSRLRALNLTNNSFSGEIPANLSRCSNLV 156
Query: 141 PIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGT 200
N L+G+I S S K + L N+LTG +P SLGNL+SI ++S A N+L+G+
Sbjct: 157 YFRLGFNNLIGRIPSWLGSYPKVVRMQLHYNNLTGPVPDSLGNLTSIKSLSFAVNHLEGS 216
Query: 201 IPNSFGWFENLVFLSLAAN-----------NLSVVE------NKLTGEVP---------- 233
IP + G + L F+ L N N+S +E NKL G +P
Sbjct: 217 IPQALGQLQTLEFMGLGMNGFSGIIPSSVYNMSSLEVFSLPYNKLYGSLPWDLAFTLPNL 276
Query: 234 ----------------SLEKLQRLQHFTIT------------------------SNSLGS 253
SL L F IT SN LG
Sbjct: 277 QVLNIGNNDFTGSLPSSLSNASNLLEFDITMSNFTGKVSIDFGGMPNLWGLFLASNPLGK 336
Query: 254 GGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAG 313
G DDLSFL SL L + ++ + FGG+LP I+NLS + L L+NN++ G+IP G
Sbjct: 337 GEADDLSFLNSLMKCRALKVLDLSGSQFGGVLPNSIANLSTQLMKLKLDNNQLSGTIPPG 396
Query: 314 IGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFL 373
IGN VNL L + NN +G+IP IG LQ L + L+RN+LSG+IP S+GN+ L +L L
Sbjct: 397 IGNLVNLTDLILANNDFTGSIPVLIGNLQMLGRIDLSRNQLSGHIPSSLGNITRLYSLHL 456
Query: 374 NDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPI 433
+N L IPSS G L E++LS N+L+GTIP + L SL+ISL+ +RN+LTG LP
Sbjct: 457 QNNHLSGKIPSSFGNLLYLQELDLSYNSLNGTIPEKVMDLVSLTISLNLARNQLTGLLPS 516
Query: 434 EVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLD 493
EV KLK L L V EN+L GEIP G+C+ LE L M GN F+G I S SLRGL LD
Sbjct: 517 EVRKLKNLGHLDVSENKLSGEIPDGLGSCLTLEHLHMEGNFFKGSIPPSFISLRGLLDLD 576
Query: 494 LSQNNLSGEIPKFLAGLSLNNLNLSYNDLEGMVTTEGVFKNASATRILGNSKLCGGISEF 553
LS+NNLSG+IP+FL LSL+NLNLS+N+ EG + T+GVF NA++T + GN+KLCGGI E
Sbjct: 577 LSRNNLSGQIPEFLQQLSLSNLNLSFNNFEGQLPTKGVFNNATSTSVAGNNKLCGGIPEL 636
Query: 554 KLPTCVSKKSKRRRLTFVPTLVIAIVFRLLGLALALFGLVLCLVRKIKEK--ENPSSSIY 611
LP C K K L+I ++ LGL L + LV+ +R++K + + +SS
Sbjct: 637 HLPACPVTKPKTGESKRGLKLMIGLLTGFLGLVLIMSLLVINRLRRVKREPSQTSASSKD 696
Query: 612 SLLYLSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFI 671
+L +SY L+ AT GFSSANL+G G FGSVYKGI+ + T +AVKV L GA +SF
Sbjct: 697 LILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGILGQDETVVAVKVIQLHQRGAVKSFK 756
Query: 672 AECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEA 731
AEC+AL++IRHRNLVKVLT C DY+GNDFKA VYEFM GSLE WLHP DEI++
Sbjct: 757 AECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEFMPNGSLENWLHPVPTPDEINDV 816
Query: 732 PRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARIL 791
R L+L QRLNIAID+A AL+YLHH C HCDLKPSN+LLD+ MTA VGDFGLAR +
Sbjct: 817 LRILSLPQRLNIAIDVASALDYLHHHCHKPIVHCDLKPSNILLDNDMTAHVGDFGLARFI 876
Query: 792 SPDH------TQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDI 845
P+ +Q+SS +KG++GY APEYG+G +VS GD YSYGILLLE+ GK+P +
Sbjct: 877 -PEAAGRSHPSQSSSIGLKGTIGYAAPEYGMGTKVSALGDTYSYGILLLEMFTGKRPTES 935
Query: 846 MFEGDINLHNFGRKALPDDVMDIVDSSLL---PDDEDLILTGNQRQKQARINSIIECLIS 902
MF +NLHNF + ALP+ + DI+D L +E+ + + + ECLIS
Sbjct: 936 MFSDQLNLHNFVKMALPERIADIIDPFFLSSEAKEEETTAADSSNLAHMKREKMHECLIS 995
Query: 903 MVRIGVACSMELPQDRTNMTNVVHELQSIKNILLG 937
++RIGV+CS+E P++R +T + ELQ I+ ILLG
Sbjct: 996 ILRIGVSCSLESPRERMAITEAIKELQLIRKILLG 1030
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147853780|emb|CAN83822.1| hypothetical protein VITISV_030954 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 851 bits (2198), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 479/996 (48%), Positives = 623/996 (62%), Gaps = 79/996 (7%)
Query: 20 GNETDRVALLEFKSKSTYDPVGVLGTWNESIHFCKWYGVTCSRRHQRVTLLDLRSLKLAG 79
GNETDR+ALL K++ T DP+G+ +WN+S+HFC W GVTC RHQRV L+L SL L G
Sbjct: 67 GNETDRLALLAIKAQITQDPLGITTSWNDSVHFCNWTGVTCGHRHQRVNTLNLSSLHLVG 126
Query: 80 SVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTL 139
S+S IGNL+FL L L++N+F +IP E+G L RL+ L L NNS GEIP N+SRCS L
Sbjct: 127 SLSPSIGNLTFLTGLNLELNNFHGQIPQELGRLSRLRALNLTNNSFSGEIPANLSRCSNL 186
Query: 140 IPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDG 199
+ N L+G+I S S K + L N+LTG +P SLGNL+SI ++S A N+L+G
Sbjct: 187 VYFRLGFNNLIGRIPSWLGSYPKVVRMQLHYNNLTGPVPDSLGNLTSIKSLSFAVNHLEG 246
Query: 200 TIPNSFGWFENLVFLSLAAN-----------NLSVVE------NKLTGEVP--------- 233
+IP + G + L F+ L N N+S +E NKL G +P
Sbjct: 247 SIPQALGQLQTLEFMGLGMNGFSGIIPSSVYNMSSLEVFSLPYNKLYGSLPWDLAFTLPN 306
Query: 234 -----------------SLEKLQRLQHFTIT------------------------SNSLG 252
SL L F IT SN LG
Sbjct: 307 LQVLNIGNNDFTGPLPSSLSNASNLLEFDITMSNFTGKVSIDFGGMPNLWGLFLASNPLG 366
Query: 253 SGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPA 312
G DDLSFL SL L + ++ + FGG+LP I+NLS + L L+NN++ G+IP
Sbjct: 367 KGEADDLSFLNSLMKCRALKVLDLSGSQFGGVLPNSIANLSTQLMKLKLDNNQLSGTIPP 426
Query: 313 GIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLF 372
GIGN VNL L + NN +G+IP IG LQ L + L+RN+LSG+IP S+GN+ L +L
Sbjct: 427 GIGNLVNLTDLILANNDFTGSIPVLIGNLQMLGRIDLSRNQLSGHIPSSLGNITRLYSLH 486
Query: 373 LNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLP 432
L +N L IPSS G L E++LS N+L+GTIP + L SL+ISL+ +RN+LTG LP
Sbjct: 487 LQNNHLSGKIPSSFGNLLYLQELDLSYNSLNGTIPEKVMDLVSLTISLNLARNQLTGLLP 546
Query: 433 IEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVL 492
EV KLK L L V EN+L GEIP G+C+ LE L M GN F+G I S SLRGL L
Sbjct: 547 SEVRKLKNLGHLDVSENKLSGEIPDGLGSCLTLEHLHMEGNFFKGSIPPSFISLRGLLDL 606
Query: 493 DLSQNNLSGEIPKFLAGLSLNNLNLSYNDLEGMVTTEGVFKNASATRILGNSKLCGGISE 552
DLS+NNLSG+IP+FL LSL+NLNLS+N+ EG + T+GVF NA++T + GN+KLCGGI E
Sbjct: 607 DLSRNNLSGQIPEFLQQLSLSNLNLSFNNFEGQLPTKGVFNNATSTSVAGNNKLCGGIPE 666
Query: 553 FKLPTCVSKKSKRRRLTFVPTLVIAIVFRLLGLALALFGLVLCLVRKIKEK--ENPSSSI 610
LP C K K L+I ++ LGL L + LV+ +R++K + + +SS
Sbjct: 667 LHLPACPVTKPKTGESKRGLKLMIGLLTGFLGLVLIMSLLVINRLRRVKREPSQTSASSK 726
Query: 611 YSLLYLSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSF 670
+L +SY L+ AT GFSSANL+G G FGSVYKG + + T +AVKV L GA +SF
Sbjct: 727 DLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGXLGQDETVVAVKVIQLHQRGAVKSF 786
Query: 671 IAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDE 730
AEC+AL++IRHRNLVKVLT C DY+GNDFKA VYEFM GSLE WLHP DEI++
Sbjct: 787 KAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEFMPNGSLENWLHPVPTPDEIND 846
Query: 731 APRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARI 790
R L+L QRLNIAID+A AL+YLHH C HCDLKPSN+LLD+ MTA VGDFGLAR
Sbjct: 847 VLRILSLPQRLNIAIDVASALDYLHHHCHKPIVHCDLKPSNILLDNDMTAHVGDFGLARF 906
Query: 791 LSPDH------TQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPID 844
+ P+ +Q+SS +KG++GY APEYG+G +VS GD YSYGILLLE+ GK+P +
Sbjct: 907 I-PEAAGRSHPSQSSSIGLKGTIGYAAPEYGMGTKVSALGDTYSYGILLLEMFTGKRPTE 965
Query: 845 IMFEGDINLHNFGRKALPDDVMDIVDSSLL---PDDEDLILTGNQRQKQARINSIIECLI 901
MF +NLHNF + ALP+ + DI+D L +E+ + + + ECLI
Sbjct: 966 SMFSDQLNLHNFVKMALPERIADIIDPFFLSSEAKEEETTAADSSNLAHMKREKMHECLI 1025
Query: 902 SMVRIGVACSMELPQDRTNMTNVVHELQSIKNILLG 937
S++RIGV+CS+E P++R +T + ELQ I+ ILLG
Sbjct: 1026 SILRIGVSCSLESPRERMAITEAIKELQLIRKILLG 1061
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116466|ref|XP_002331904.1| predicted protein [Populus trichocarpa] gi|222874576|gb|EEF11707.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 851 bits (2198), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 480/990 (48%), Positives = 634/990 (64%), Gaps = 84/990 (8%)
Query: 20 GNETDRVALLEFKSKSTYDPVGVLGTWNESIHFCKWYGVTCSRRHQRVTLLDLRSLKLAG 79
G+E D+++LL FK++ + DP L +WNES+HFC+W GV C R+HQRV LDL S +L G
Sbjct: 25 GSEIDKLSLLAFKAQIS-DPTTKLSSWNESLHFCQWSGVKCGRQHQRVIELDLHSSQLVG 83
Query: 80 SVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTL 139
S+S IGNLSFL+ L L+ NSFT+ IP EIG L RL+ L L NNS GEIP+NIS CS L
Sbjct: 84 SLSPSIGNLSFLRLLSLENNSFTNAIPQEIGRLVRLQTLILGNNSFSGEIPSNISHCSNL 143
Query: 140 IPIHPQNNQLVGKILSRFSSLSKTEILN-------------------------------- 167
+ ++ + N L G + + SLSK ++ +
Sbjct: 144 LKLNLEGNNLTGNLPAGLGSLSKLQVFSFRKNNLDGKIPLSFENLSSIIEIDGTLNNIQG 203
Query: 168 ----------------LGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGW-FEN 210
LGSN+L+G+IP+SL N+SS+ SL YN GT+P + G N
Sbjct: 204 GIPSSIGKLKTLNFFSLGSNNLSGTIPASLYNISSLIHFSLPYNQFHGTLPPNIGLTLPN 263
Query: 211 LVFLSLAANNLS-----------------VVENKLTGEVPSLEKLQRLQHFTITSNSLGS 253
L +L + N LS + NK TG+VP+L + L+ ++ N LG
Sbjct: 264 LQYLGIHDNRLSGQLPATLINATKFTEIYLSYNKFTGKVPTLAIMPNLRILSMEENGLGK 323
Query: 254 GGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAG 313
G +DDLSFL +L+N+++L ++I++NNFGG+LP ISN S +K + +N+I G+IP G
Sbjct: 324 GEDDDLSFLYTLSNSSKLEDLYIDNNNFGGVLPDIISNFSTKLKQMAFGSNQIRGTIPDG 383
Query: 314 IGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFL 373
IGN V+L L + N L+G+IP +IG+LQNL LN NKLSG+IP S+GN+ L+ +
Sbjct: 384 IGNLVSLDTLGLEANHLTGSIPSSIGKLQNLADFFLNENKLSGSIPSSLGNITSLMQINF 443
Query: 374 NDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPI 433
+ N L+ SIP SLG C++L+ + LS NNLSG IP + S+SSLS+ L S N+LTGSLP
Sbjct: 444 DQNNLQGSIPPSLGNCQNLLVLALSQNNLSGPIPKEVLSISSLSMYLVLSENQLTGSLPF 503
Query: 434 EVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLD 493
EVGKL L ++ + +NRL GEIP++ G+C LE L + GN QGPIS SL SLR L+ L+
Sbjct: 504 EVGKLVTLGYMDISKNRLSGEIPASLGSCESLEHLYLDGNFLQGPISESLRSLRALQDLN 563
Query: 494 LSQNNLSGEIPKFLAGLSLNNLNLSYNDLEGMVTTEGVFKNASATRILGNSKLCGGISEF 553
LS NNLSG+IPKFL L L +L+LS+NDLEG V GVF+N SA I GN LCGGI +
Sbjct: 564 LSHNNLSGQIPKFLGDLKLQSLDLSFNDLEGEVPMHGVFENTSAVSIAGNKNLCGGILQL 623
Query: 554 KLPTCVSKKSKRRRLTFVPTLVIAIVFRLLGLA-LALFGLVLCLVRKIKEKENPSSSIYS 612
LPTC SK +K + T + TL +AI +GL +A F + CL + +++ +N S
Sbjct: 624 NLPTCRSKSTKPKSSTKL-TLTVAIPCGFIGLIFIASFLFLCCLKKSLRKTKNELSCEMP 682
Query: 613 LLYLSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIA 672
++Y+DL AT+GFSS NLVG GSFGSVYKG++ T+AVKVFNL GAS+SF+
Sbjct: 683 FRTVAYKDLLQATNGFSSGNLVGAGSFGSVYKGVLAFDGVTVAVKVFNLLREGASKSFMR 742
Query: 673 ECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAP 732
EC AL +IRHRNLVKVL AC G D +GNDFKA VYEFM GSLEEWLHP D P
Sbjct: 743 ECAALLNIRHRNLVKVLFACAGVDVQGNDFKALVYEFMINGSLEEWLHPIHTLDLEVHQP 802
Query: 733 RNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARIL- 791
+NLNL+QRLNIAID+A AL+YLH+ C+ HCDLKPSNVLLD MTA VGDFGL + L
Sbjct: 803 KNLNLIQRLNIAIDVANALDYLHNQCKMPIVHCDLKPSNVLLDGDMTAHVGDFGLLKFLS 862
Query: 792 ----SPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMF 847
+QTSS +KG++GY APEYG+G EVST GDV+SYGILLLE++ GK+P D MF
Sbjct: 863 EASCQSSSSQTSSVGLKGTVGYAAPEYGIGSEVSTFGDVHSYGILLLEMITGKRPTDSMF 922
Query: 848 EGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIG 907
+ + LH++ + ALPD V+DI D LL + + + I+ECLIS+ +IG
Sbjct: 923 KDGLELHSYVKIALPDRVVDIADPKLL----------TEVDQGKGTDQIVECLISISKIG 972
Query: 908 VACSMELPQDRTNMTNVVHELQSIKNILLG 937
V CS + P++R +++NVV EL K LG
Sbjct: 973 VFCSEKFPKERMDISNVVAELNRTKANFLG 1002
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 949 | ||||||
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.886 | 0.832 | 0.397 | 1.2e-150 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.906 | 0.839 | 0.372 | 2.4e-140 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.886 | 0.820 | 0.383 | 4.4e-139 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.889 | 0.836 | 0.374 | 5.6e-139 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.828 | 0.762 | 0.377 | 1.9e-138 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.890 | 0.835 | 0.366 | 5.8e-137 | |
| TAIR|locus:2047525 | 980 | AT2G24130 [Arabidopsis thalian | 0.888 | 0.860 | 0.321 | 2e-102 | |
| TAIR|locus:2175703 | 502 | AT5G39390 [Arabidopsis thalian | 0.343 | 0.649 | 0.447 | 1e-101 | |
| UNIPROTKB|O24435 | 813 | O24435 "Receptor kinase-like p | 0.703 | 0.821 | 0.354 | 1.7e-98 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.868 | 0.702 | 0.306 | 3.2e-88 |
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1470 (522.5 bits), Expect = 1.2e-150, P = 1.2e-150
Identities = 351/882 (39%), Positives = 489/882 (55%)
Query: 69 LLDLR--SLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSIC 126
LL+LR S +L GSV +G+L+ L QL L N+ ++P+ +G L L+ LAL++N++
Sbjct: 140 LLNLRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLE 199
Query: 127 GEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNL-S 185
GEIP+++++ + + + N G +LS ++L +G NH +G + LG L
Sbjct: 200 GEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLP 259
Query: 186 SIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFT 245
++ + ++ N G+IP + N+ L L + EN LTG +P+ + L+
Sbjct: 260 NLLSFNMGGNYFTGSIPTTLS---NISTLE----RLGMNENNLTGSIPTFGNVPNLKLLF 312
Query: 246 ITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNK 305
+ +NSLGS + DL FL SLTN T+L + I N GG LP I+NLS + TL L
Sbjct: 313 LHTNSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTL 372
Query: 306 IYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGXX 365
I GSIP IGN +NLQ+L + N LSG +P ++G+L NL+ L L N+LSG IP IG
Sbjct: 373 ISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNM 432
Query: 366 XXXXXXXXXXXXXEVSIPSSLGQCXXXXXXXXXXXXXXGTIPPQFFXXXXXXXXXDWSRN 425
E +P+SLG C GTIP + D S N
Sbjct: 433 TMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRL-DMSGN 491
Query: 426 KLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPIXXXXXX 485
L GSLP ++G L+ L L + +N+L G++P T GNC+ +E L + GNLF G I
Sbjct: 492 SLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKGL 551
Query: 486 XXXXXXXXXXQNNLSGEIPKFLAGXXXXXXXXXXXD-LEGMVTTEGVFKNASATRILGNS 544
N+LSG IP++ A + LEG V +G+F+NA+ I+GN+
Sbjct: 552 VGVKEVDLS-NNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNN 610
Query: 545 KLCGGISEFKLPTCVS------KKSKRRRLTFVPTLVIAIVXXXXXXXXXXXXXXXXXXX 598
LCGGI F+L C+S KK R V + + I
Sbjct: 611 DLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRK 670
Query: 599 KIKEKENPXXXXXXXXXXXXXXXX--NATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAV 656
K KE NP NAT+GFSS+N+VG GSFG+VYK ++ + +AV
Sbjct: 671 KNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAV 730
Query: 657 KVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLE 716
KV N+Q GA +SF+AEC++LK IRHRNLVK+LTAC D++GN+F+A +YEFM GSL+
Sbjct: 731 KVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLD 790
Query: 717 EWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD 776
WLHP E EI R L LL+RLNIAID+A L+YLH C AHCDLKPSNVLLDD
Sbjct: 791 MWLHPEEVE-EIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDD 849
Query: 777 YMTARVGDFGLARILSP-DH----TQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGI 831
+TA V DFGLAR+L D Q SS V+G++GY APEYGVG + S NGDVYS+GI
Sbjct: 850 DLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGI 909
Query: 832 LLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQA 891
LLLE+ GK+P + +F G+ L+++ + ALP+ ++DIVD S+L G
Sbjct: 910 LLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILH-------IG------L 956
Query: 892 RIN-SIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIK 932
R+ ++ECL + +G+ C E P +R + VV EL SI+
Sbjct: 957 RVGFPVVECLTMVFEVGLRCCEESPMNRLATSIVVKELISIR 998
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1373 (488.4 bits), Expect = 2.4e-140, P = 2.4e-140
Identities = 331/888 (37%), Positives = 460/888 (51%)
Query: 66 RVTLLDLRSLKLAGSVSHFIG-NLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNS 124
++T LDL +L G + IG +L L LYL N + EIPS +G L L+ L+ N
Sbjct: 152 KLTSLDLSHNQLRGMIPREIGASLKHLSNLYLYKNGLSGEIPSALGNLTSLQEFDLSFNR 211
Query: 125 ICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSS-LGN 183
+ G IP+++ + S+L+ ++ N L G I + +LS ++ N L G IP++
Sbjct: 212 LSGAIPSSLGQLSSLLTMNLGQNNLSGMIPNSIWNLSSLRAFSVRENKLGGMIPTNAFKT 271
Query: 184 LSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQH 243
L + I + N G IP S +L + + N S + +T +L+ L
Sbjct: 272 LHLLEVIDMGTNRFHGKIPASVANASHLTVIQIYGNLFSGI---ITS---GFGRLRNLTE 325
Query: 244 FTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNN 303
+ N + DD F+ LTN ++L +++ NN GG+LP SNLS ++ L L
Sbjct: 326 LYLWRNLFQTREQDDWGFISDLTNCSKLQTLNLGENNLGGVLPNSFSNLSTSLSFLALEL 385
Query: 304 NKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIG 363
NKI GSIP IGN + LQ L + NN G++P ++G L+NL IL N LSG+IP +IG
Sbjct: 386 NKITGSIPKDIGNLIGLQHLYLCNNNFRGSLPSSLGRLKNLGILLAYENNLSGSIPLAIG 445
Query: 364 XXXXXXXXXXXXXXXEVSIPSSLGQCXXXXXXXXXXXXXXGTIPPQFFXXXXXXXXXDWS 423
IP +L G IP + F + S
Sbjct: 446 NLTELNILLLGTNKFSGWIPYTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVS 505
Query: 424 RNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPIXXXX 483
+N L GS+P E+G LK L + NRL G+IP+T G+C L L + NL G I
Sbjct: 506 KNNLEGSIPQEIGHLKNLVEFHAESNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSAL 565
Query: 484 XXXXXXXXXXXXQNNLSGEIPKFLAGXXXXXXXXXXXD-LEGMVTTEGVFKNASATRILG 542
NNLSG+IP LA + G V T G F AS I G
Sbjct: 566 GQLKGLETLDLSSNNLSGQIPTSLADITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQG 625
Query: 543 NSKLCGGISEFKLPTCVSKKSKRRRLTFVPTLVIAIVXXXXXXXXXXXXXXXXXXXKIKE 602
N+KLCGGI + LP C R+ P L I++ + K+
Sbjct: 626 NAKLCGGIPDLHLPRCCPLLENRKHF---PVLPISVSLAAALAILSSLYLLITWHKRTKK 682
Query: 603 KENPXXXXXXXXXXXXXXXXNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ 662
AT GF+ NL+G GSFGSVYKG ++ + +AVKV L+
Sbjct: 683 GAPSRTSMKGHPLVSYSQLVKATDGFAPTNLLGSGSFGSVYKGKLNI-QDHVAVKVLKLE 741
Query: 663 HHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPF 722
+ A +SF AEC+AL+++RHRNLVK++T C D RGNDFKA VY+FM GSLE+W+HP
Sbjct: 742 NPKALKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPE 801
Query: 723 TGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLH-HDCQPVTAHCDLKPSNVLLDDYMTAR 781
T D+ D+ R+LNL +R+ I +D+A AL+YLH H +PV HCD+K SNVLLD M A
Sbjct: 802 TN-DQADQ--RHLNLHRRVTILLDVACALDYLHRHGPEPVV-HCDIKSSNVLLDSDMVAH 857
Query: 782 VGDFGLARIL----SPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELV 837
VGDFGLARIL S TSS G++GY APEYGVG ST+GD+YSYGIL+LE+V
Sbjct: 858 VGDFGLARILVDGTSLIQQSTSSMGFIGTIGYAAPEYGVGLIASTHGDIYSYGILVLEIV 917
Query: 838 IGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSII 897
GK+P D F D+ L + L V D+VD+ L+ D E+ + + N + I
Sbjct: 918 TGKRPTDSTFRPDLGLRQYVELGLHGRVTDVVDTKLILDSENWLNSTNN----SPCRRIT 973
Query: 898 ECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILLGVELCPPCK 945
EC++ ++R+G++CS ELP RT +++ EL +IK L G L P C+
Sbjct: 974 ECIVWLLRLGLSCSQELPSSRTPTGDIIDELNAIKQNLSG--LFPVCE 1019
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1361 (484.2 bits), Expect = 4.4e-139, P = 4.4e-139
Identities = 340/887 (38%), Positives = 472/887 (53%)
Query: 67 VTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSIC 126
++ LDL S L V G+LS L L L N+ T + P+ +G L L++L N I
Sbjct: 155 LSTLDLSSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIE 214
Query: 127 GEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNL-S 185
GEIP +I+R +I N+ G +LS L++ N +G++ G+L
Sbjct: 215 GEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLP 274
Query: 186 SIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVP-SLEKLQRLQHF 244
++ + + N+ GTIP E L +S + L + N LTG++P S +LQ L
Sbjct: 275 NLQILYMGINSFTGTIP------ETLSNIS-SLRQLDIPSNHLTGKIPLSFGRLQNLLLL 327
Query: 245 TITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNN 304
+ +NSLG+ + DL FL +LTN ++L ++++ N GG LP I+NLS + L L N
Sbjct: 328 GLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGN 387
Query: 305 KIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGX 364
I GSIP GIGN V+LQ LD+ N L+G +PP++GEL L+ + L N LSG IP S+G
Sbjct: 388 LISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGN 447
Query: 365 XXXXXXXXXXXXXXEVSIPSSLGQCXXXXXXXXXXXXXXGTIPPQFFXXXXXXXXXDWSR 424
E SIPSSLG C G+IP + + S
Sbjct: 448 ISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVL-NVSF 506
Query: 425 NKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPIXXXXX 484
N L G L ++GKLK L L V N+L G+IP T NC+ LE L + GN F GPI
Sbjct: 507 NLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG 566
Query: 485 XXXXXXXXXXXQNNLSGEIPKFLAGXXXXXXXXXXXD-LEGMVTTEGVFKNASATRILGN 543
+NNLSG IP+++A + +G V TEGVF+N SA + GN
Sbjct: 567 LTGLRFLDLS-KNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGN 625
Query: 544 SKLCGGISEFKLPTCVSK-----KSKRRRLTF-VPTLVIAIVXXXXXXXXXXXXXXXXXX 597
LCGGI +L C + S R+ +T V ++ A++
Sbjct: 626 INLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKS 685
Query: 598 XKIKEKENPXXXX---XXXXXXXXXXXXNATSGFSSANLVGVGSFGSVYKGIIDEGRTTI 654
+ EN T GFSS+NL+G G+FG+V+KG + +
Sbjct: 686 VRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAV 745
Query: 655 AVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGS 714
A+KV NL GA++SFIAEC+AL IRHRNLVK++T C +D+ GNDF+A VYEFM G+
Sbjct: 746 AIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGN 805
Query: 715 LEEWLHPFTGEDEIDEA--P-RNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSN 771
L+ WLHP DEI+E P R L L RLNIAID+A AL YLH C AHCD+KPSN
Sbjct: 806 LDMWLHP----DEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSN 861
Query: 772 VLLDDYMTARVGDFGLARIL---SPD--HTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDV 826
+LLD +TA V DFGLA++L D H Q SS V+G++GY APEYG+G S GDV
Sbjct: 862 ILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDV 921
Query: 827 YSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPD-DVMDIVDSSLLPDDEDLILTGN 885
YS+GI+LLE+ GK+P + +F + LH+F + AL +DI D ++L
Sbjct: 922 YSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETIL----------- 970
Query: 886 QRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIK 932
R A+ +++ECL + R+GV+CS E P +R +M + +L SI+
Sbjct: 971 -RGAYAQHFNMVECLTLVFRVGVSCSEESPVNRISMAEAISKLVSIR 1016
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1360 (483.8 bits), Expect = 5.6e-139, P = 5.6e-139
Identities = 330/882 (37%), Positives = 464/882 (52%)
Query: 66 RVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSI 125
R+ LDL S L V +G+L L LYL +N + P I L L VL L N +
Sbjct: 139 RLLYLDLFSNNLGDGVPSELGSLRKLLYLYLGLNDLKGKFPVFIRNLTSLIVLNLGYNHL 198
Query: 126 CGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNL- 184
GEIP +I+ S ++ + N G F +LS E L L N +G++ GNL
Sbjct: 199 EGEIPDDIAMLSQMVSLTLTMNNFSGVFPPAFYNLSSLENLYLLGNGFSGNLKPDFGNLL 258
Query: 185 SSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEV-PSLEKLQRLQH 243
+IH +SL N L G IP + N+ L + + +N++TG + P+ KL+ L +
Sbjct: 259 PNIHELSLHGNFLTGAIPTTLA---NISTLEM----FGIGKNRMTGSISPNFGKLENLHY 311
Query: 244 FTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNN 303
+ +NSLGS DL+FL +LTN + L + ++ N GG LP I N+S + L L
Sbjct: 312 LELANNSLGSYSFGDLAFLDALTNCSHLHGLSVSYNRLGGALPTSIVNMSTELTVLNLKG 371
Query: 304 NKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIG 363
N IYGSIP IGN + LQ L + +N L+G +P ++G L L L L N+ SG IP IG
Sbjct: 372 NLIYGSIPHDIGNLIGLQSLLLADNLLTGPLPTSLGNLVGLGELILFSNRFSGEIPSFIG 431
Query: 364 XXXXXXXXXXXXXXXEVSIPSSLGQCXXXXXXXXXXXXXXGTIPPQFFXXXXXXXXXDWS 423
E +P SLG C GTIP + +
Sbjct: 432 NLTQLVKLYLSNNSFEGIVPPSLGDCSHMLDLQIGYNKLNGTIPKEIMQIPTLVHL-NME 490
Query: 424 RNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPIXXXX 483
N L+GSLP ++G+L+ L L + N L G +P T G C+ +E + + N F G I
Sbjct: 491 SNSLSGSLPNDIGRLQNLVELLLGNNNLSGHLPQTLGKCLSMEVIYLQENHFDGTIPDIK 550
Query: 484 XXXXXXXXXXXXQNNLSGEIPKFLAGXXXXXXXXXXXD-LEGMVTTEGVFKNASATRILG 542
NNLSG I ++ + EG V TEG+F+NA+ + G
Sbjct: 551 GLMGVKNVDLS-NNNLSGSISEYFENFSKLEYLNLSDNNFEGRVPTEGIFQNATLVSVFG 609
Query: 543 NSKLCGGISEFKLPTCVSKKS--KRRRLTFVPTLVIAI-VXXXXXXXXXXXXXXXXXXXK 599
N LCG I E KL C+++ + R + + + I + V K
Sbjct: 610 NKNLCGSIKELKLKPCIAQAPPVETRHPSLLKKVAIGVSVGIALLLLLFIVSLSWFKKRK 669
Query: 600 IKEKEN---PXXXXXXXXXXXXXXXXNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAV 656
+K N P NAT GFSS+N+VG GSFG+V+K ++ +AV
Sbjct: 670 NNQKINNSAPFTLEIFHEKLSYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAV 729
Query: 657 KVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLE 716
KV N+Q GA +SF+AEC++LK IRHRNLVK+LTAC D++GN+F+A +YEFM GSL+
Sbjct: 730 KVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLD 789
Query: 717 EWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD 776
+WLHP E EI R L LL+RLNIAID+A L+YLH C AHCDLKPSN+LLDD
Sbjct: 790 KWLHPEEVE-EIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNILLDD 848
Query: 777 YMTARVGDFGLARILSP-DH----TQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGI 831
+TA V DFGLAR+L D Q SS V+G++GY APEYG+G + S +GDVYS+G+
Sbjct: 849 DLTAHVSDFGLARLLLKFDQESFFNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGV 908
Query: 832 LLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQA 891
L+LE+ GK+P + +F G+ L+++ + ALP+ V+DI D S+L +G
Sbjct: 909 LVLEMFTGKRPTNELFGGNFTLNSYTKAALPERVLDIADKSILH-------SG------L 955
Query: 892 RIN-SIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIK 932
R+ ++ECL ++ +G+ C E P +R + EL SI+
Sbjct: 956 RVGFPVLECLKGILDVGLRCCEESPLNRLATSEAAKELISIR 997
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1301 (463.0 bits), Expect = 1.9e-138, Sum P(2) = 1.9e-138
Identities = 307/814 (37%), Positives = 426/814 (52%)
Query: 66 RVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSI 125
R++ +DL S L V +G+LS L L L N+ T P+ +G L L+ L N +
Sbjct: 146 RLSTVDLSSNHLGHGVPSELGSLSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQM 205
Query: 126 CGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNL- 184
GEIP ++R + ++ N G ++S E L+L N +G++ + G L
Sbjct: 206 RGEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLL 265
Query: 185 SSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVP-SLEKLQRLQH 243
++ + L N G IP + +L +++N LS G +P S KL+ L
Sbjct: 266 PNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLS-------GSIPLSFGKLRNLWW 318
Query: 244 FTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNN 303
I +NSLG+ + L F+ ++ N T+L ++ + N GG LP I+NLS T+ +LFL
Sbjct: 319 LGIRNNSLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQ 378
Query: 304 NKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIG 363
N I G+IP IGN V+LQ L + N LSG +P + G+L NL+++ L N +SG IP G
Sbjct: 379 NLISGTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFG 438
Query: 364 XXXXXXXXXXXXXXXEVSIPSSLGQCXXXXXXXXXXXXXXGTIPPQFFXXXXXXXXXDWS 423
IP SLG+C GTIP + D S
Sbjct: 439 NMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYI-DLS 497
Query: 424 RNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPIXXXX 483
N LTG P EVGKL++L L N+L G++P G C+ +E L M GN F G I
Sbjct: 498 NNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPDIS 557
Query: 484 XXXXXXXXXXXXQNNLSGEIPKFLAGXXXXXXXXXXXD-LEGMVTTEGVFKNASATRILG 542
NNLSG IP++LA + EG V T GVF+NA+A + G
Sbjct: 558 RLVSLKNVDFS-NNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFG 616
Query: 543 NSKLCGGISEFKLPTCVSKKSKRRR--LTFVPTLVIAIVXXXXXXXXXXXXXXXXXXXKI 600
N+ +CGG+ E +L C+ + S R+R L+ +V I K
Sbjct: 617 NTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKR 676
Query: 601 KEKEN-----PXXXXXXXXXXXXXXXX---NATSGFSSANLVGVGSFGSVYKGIIDEGRT 652
K+K N P +ATS FSS NL+G G+FG+V+KG++
Sbjct: 677 KKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENK 736
Query: 653 TIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHY 712
+AVKV NL HGA++SF+AEC+ K IRHRNLVK++T C D GNDF+A VYEFM
Sbjct: 737 LVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPK 796
Query: 713 GSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNV 772
GSL+ WL + +++ R+L ++LNIAID+A AL YLH C AHCD+KPSN+
Sbjct: 797 GSLDMWLQ-LEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNI 855
Query: 773 LLDDYMTARVGDFGLARILSP-DH----TQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVY 827
LLDD +TA V DFGLA++L D Q SS V+G++GY APEYG+G + S GDVY
Sbjct: 856 LLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVY 915
Query: 828 SYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861
S+GILLLE+ GKKP D F GD NLH++ + L
Sbjct: 916 SFGILLLEMFSGKKPTDESFAGDYNLHSYTKSIL 949
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1341 (477.1 bits), Expect = 5.8e-137, P = 5.8e-137
Identities = 324/883 (36%), Positives = 466/883 (52%)
Query: 66 RVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSI 125
R+ LDL S L V +G+L+ L L L N+ ++P +G L LK L +N+I
Sbjct: 139 RLLNLDLYSNPLRQGVPSELGSLTKLVILDLGRNNLKGKLPRSLGNLTSLKSLGFTDNNI 198
Query: 126 CGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNL- 184
GE+P ++R S ++ + N+ G +LS E L L + +GS+ GNL
Sbjct: 199 EGEVPDELARLSQMVGLGLSMNKFFGVFPPAIYNLSALEDLFLFGSGFSGSLKPDFGNLL 258
Query: 185 SSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEV-PSLEKLQRLQH 243
+I ++L N+L G IP + N+ L + +N +TG + P+ K+ LQ+
Sbjct: 259 PNIRELNLGENDLVGAIPTTLS---NISTLQ----KFGINKNMMTGGIYPNFGKVPSLQY 311
Query: 244 FTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNN 303
++ N LGS DL F+ SLTN T L + + GG LP I+N+S + +L L
Sbjct: 312 LDLSENPLGSYTFGDLEFIDSLTNCTHLQLLSVGYTRLGGALPTSIANMSTELISLNLIG 371
Query: 304 NKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIG 363
N +GSIP IGN + LQRL + N L+G +P ++G+L L +L L N++SG IP IG
Sbjct: 372 NHFFGSIPQDIGNLIGLQRLQLGKNMLTGPLPTSLGKLLRLGLLSLYSNRMSGEIPSFIG 431
Query: 364 XXXXXXXXXXXXXXXEVSIPSSLGQCXXXXXXXXXXXXXXGTIPPQFFXXXXXXXXXDWS 423
E +P SLG+C GTIP +
Sbjct: 432 NLTQLEILYLSNNSFEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEIMQIPTLVNLS-ME 490
Query: 424 RNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPIXXXX 483
N L+GSLP ++G L+ L L + N+ G +P T GNC+ +EQL + GN F G I
Sbjct: 491 GNSLSGSLPNDIGSLQNLVKLSLENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGAIPNIR 550
Query: 484 XXXXXXXXXXXXQNNLSGEIPKFLAGXXXXXXXXXXXD-LEGMVTTEGVFKNASATRILG 542
N+LSG IP++ A + G V ++G F+N++ + G
Sbjct: 551 GLMGVRRVDLS-NNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPSKGNFQNSTIVFVFG 609
Query: 543 NSKLCGGISEFKLPTCVSKK----SKRR-RLTFVPTLV-IAIVXXXXXXXXXXXXXXXXX 596
N LCGGI + KL C++++ +K L V LV I I
Sbjct: 610 NKNLCGGIKDLKLKPCLAQEPPVETKHSSHLKKVAILVSIGIALLLLLVIASMVLCWFRK 669
Query: 597 XXKIKEKEN--PXXXXXXXXXXXXXXXXNATSGFSSANLVGVGSFGSVYKGIIDEGRTTI 654
K ++ N P NAT+GFSS+N+VG GSFG+V+K ++ +
Sbjct: 670 RRKNQQTNNLVPSKLEIFHEKISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIV 729
Query: 655 AVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGS 714
AVKV N+Q GA +SF+AEC++LK RHRNLVK+LTAC D++GN+F+A +YE++ GS
Sbjct: 730 AVKVLNMQRRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGS 789
Query: 715 LEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL 774
++ WLHP E EI PR L LL+RLNI ID+A L+YLH C AHCDLKPSNVLL
Sbjct: 790 VDMWLHPEEVE-EIRRPPRTLTLLERLNIVIDVASVLDYLHVHCHEPIAHCDLKPSNVLL 848
Query: 775 DDYMTARVGDFGLARILSP-DH----TQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSY 829
+D +TA V DFGLAR+L D Q SS V+G++GY APEYG+G + S +GDVYS+
Sbjct: 849 EDDLTAHVSDFGLARLLLKFDKESFLNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSF 908
Query: 830 GILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQK 889
G+LLLE+ GK+P D +F G++ LH++ + ALP+ V +I D ++L + L R
Sbjct: 909 GVLLLEMFTGKRPTDELFGGNLTLHSYTKLALPEKVFEIADKAIL----HIGLRVGFRTA 964
Query: 890 QARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIK 932
ECL ++ +G+ C E P +R + V EL SI+
Sbjct: 965 --------ECLTLVLEVGLRCCEEYPTNRLATSEVAKELISIR 999
|
|
| TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1015 (362.4 bits), Expect = 2.0e-102, P = 2.0e-102
Identities = 291/906 (32%), Positives = 429/906 (47%)
Query: 67 VTLLDLRSLKLAGSVSHFIGNL-SFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSI 125
+T+LDL G + IG+L LKQL L N IP E+G L RL L L +N +
Sbjct: 92 LTVLDLSRNFFVGKIPPEIGSLHETLKQLSLSENLLHGNIPQELGLLNRLVYLDLGSNRL 151
Query: 126 CGEIPTNI---SRCSTLIPIHPQNNQLVGKI-LSRFSSLSKTEILNLGSNHLTGSIPSSL 181
G IP + S+L I NN L G+I L+ L + L L SN LTG++PSSL
Sbjct: 152 NGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNYHCHLKELRFLLLWSNKLTGTVPSSL 211
Query: 182 GNLSSIHTISLAYNNLDGTIPNS-FGWFENLVFLSLAANNLSVVENKLTGEVP---SLEK 237
N +++ + L N L G +P+ L FL L+ N+ V N T P SL
Sbjct: 212 SNSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLSYNHF-VSHNNNTNLEPFFASLAN 270
Query: 238 LQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIK 297
LQ + NSLG + L + L +H++ N G +P ISNL +
Sbjct: 271 SSDLQELELAGNSLGGEITSSVRHL-----SVNLVQIHLDQNRIHGSIPPEISNLLN-LT 324
Query: 298 TLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGN 357
L L++N + G IP + L+R+ + NN L+G IP +G++ L +L ++RN LSG+
Sbjct: 325 LLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGS 384
Query: 358 IPPSIGXXXXXXXXXXXXXXXEVSIPSSLGQCXXXXXXXXXXXXXXGTIPPQFFXXXXXX 417
IP S G ++P SLG+C GTIP +
Sbjct: 385 IPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRNL 444
Query: 418 XXX-DWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQ 476
+ S N L+G +P+E+ K+ ++ + + N L G+IP G+CI LE L + N F
Sbjct: 445 KLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFS 504
Query: 477 GPIXXXXXXXXXXXXXXXXQNNLSGEIP-KFLAGXXXXXXXXXXXDLEGMVTTEGVFKNA 535
+ N L+G IP F L G V+ +G F
Sbjct: 505 STLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKL 564
Query: 536 SATRILGNSKLCGGISEFKLPTCVSKKSKRRR------LTFVPTLVIAIVXX-XXXXXXX 588
+ LG+S LCG I + C KK K L+ + T V+ +
Sbjct: 565 TIESFLGDSLLCGSIKGMQ--AC-KKKHKYPSVLLPVLLSLIATPVLCVFGYPLVQRSRF 621
Query: 589 XXXXXXXXXXKIKEKENPXXXXXXXXXXXXXXXXNATSGFSSANLVGVGSFGSVYKGIID 648
+++++E AT GF++++L+G G FG VYKG++
Sbjct: 622 GKNLTVYAKEEVEDEEKQNQNDPKYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVL- 680
Query: 649 EGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVY 707
T +AVKV + + S SF EC+ LK RHRNL++++T C G F A V
Sbjct: 681 RNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRIITTC---SKPG--FNALVL 735
Query: 708 EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDL 767
M GSLE L+P GE + +NL+L+Q +NI D+A + YLHH HCDL
Sbjct: 736 PLMPNGSLERHLYP--GE----YSSKNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDL 789
Query: 768 KPSNVLLDDYMTARVGDFGLARILSP-DHTQTSSFSVK---------GSLGYIAPEYGVG 817
KPSN+LLDD MTA V DFG++R++ + T ++ SV GS+GYIAPEYG+G
Sbjct: 790 KPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMG 849
Query: 818 CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDD 877
ST+GDVYS+G+LLLE+V G++P D++ +LH F + PD + I++ +L
Sbjct: 850 KRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGIIEQALS--- 906
Query: 878 EDLILTGNQRQKQARINSII-ECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILL 936
+ K + + E ++ M+ +G+ C+ P R +M +V HE+ +K L
Sbjct: 907 -----RWKPQGKPEKCEKLWREVILEMIELGLVCTQYNPSTRPDMLDVAHEMGRLKEYLF 961
Query: 937 GVELCP 942
CP
Sbjct: 962 A---CP 964
|
|
| TAIR|locus:2175703 AT5G39390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 719 (258.2 bits), Expect = 1.0e-101, Sum P(3) = 1.0e-101
Identities = 155/346 (44%), Positives = 206/346 (59%)
Query: 521 DLEGMVTTEGVFKNASATRILGNSKLCGGISEFKLPTCVSKKSKRRRLTFVPTLVIAIVX 580
+ EG V T+GVF+N + + GN LCGG+ E +L C+ +S R++ F +A+
Sbjct: 116 EFEGSVPTKGVFQNGTTVSVFGNENLCGGVIEMQLKPCI--ESPRQKKPFSLGEKVAVGV 173
Query: 581 XXXXXXXXXXXXXXXXXXKIKEKENPXXXXXXXXXXXXXXXXNATSGFSSANLVGVGSFG 640
K +K NATSGFSS+NL+G G+F
Sbjct: 174 GVALLFLFIIVASLSWFKKKNDK------------ISYEELYNATSGFSSSNLIGSGNFS 221
Query: 641 SVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700
V+KG++ +AVKV NL HGA++SFIAEC++ K IRHRNL K++T C D +GN
Sbjct: 222 DVFKGLLGLEEKLVAVKVLNLLKHGATKSFIAECESFKGIRHRNLAKLITVCSSLDSQGN 281
Query: 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQP 760
DF+A VYEFM GSL+ WL P E + + R+L +++NIAID+A AL YLH C
Sbjct: 282 DFRALVYEFMPKGSLDMWLQPEDLESANNHS-RSLTFAEKVNIAIDVASALEYLHVYCHD 340
Query: 761 VTAHCDLKPSNVLLDDYMTARVGDFGLARILS--PDHT---QTSSFSVKGSLGYIAPEYG 815
AHCD+KPSNVLLDD +TA V DFGLAR+L + T Q SS V+G++GY APEYG
Sbjct: 341 PVAHCDIKPSNVLLDDDLTAHVSDFGLARLLYNFDEKTFLNQFSSAGVRGTIGYAAPEYG 400
Query: 816 VGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861
+G + S GDVYS+G+LLLE+ GKKP D F G NLH + + L
Sbjct: 401 MGSKPSIQGDVYSFGVLLLEMFTGKKPTDNSFGGGYNLHGYTKSVL 446
|
|
| UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 978 (349.3 bits), Expect = 1.7e-98, P = 1.7e-98
Identities = 244/688 (35%), Positives = 351/688 (51%)
Query: 63 RHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNN 122
R R+ L L L+G + +GNL+ L L L N+ + IPS +G L L LAL
Sbjct: 124 RLSRLQQLVLNFNSLSGEIPAALGNLTSLSVLELTNNTLSGAIPSSLGKLTGLTDLALAE 183
Query: 123 NSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSS-L 181
N++ G IP++ + L + N L G I ++S I + SN L+G++P++
Sbjct: 184 NTLSGSIPSSFGQLRRLSFLSLAFNNLSGAIPDPIWNISSLTIFEVISNKLSGTLPTNAF 243
Query: 182 GNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRL 241
NL S+ + + YN G IP S G N+ ++ N+ S V + E+ + LQRL
Sbjct: 244 SNLPSLQEVYMYYNQFHGRIPASIGNASNISIFTIGLNSFSGV---VPPEIGRMRNLQRL 300
Query: 242 QHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFL 301
+ + + +D F+ +LTN + L + + FGG+LP +SNLS ++ +L +
Sbjct: 301 E---LPETLSEAEETNDWKFMTALTNCSNLQEVELGGCKFGGVLPDSVSNLSSSLVSLSI 357
Query: 302 NNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPS 361
+NKI GS+P IGN VNLQ L + NN L+G++P + +L+NL+ L ++ NKL G++P +
Sbjct: 358 RDNKISGSLPRDIGNLVNLQYLSLANNSLTGSLPSSFSKLKNLRRLTVDNNKLIGSLPLT 417
Query: 362 IGXXXXXXXXXXXXXXXEVSIPSSLGQCXXXXXXXXXXXXXXGTIPPQFFXXXXXXXXXD 421
IG +IPS+LG G IP + F D
Sbjct: 418 IGNLTQLTNMEVQFNAFGGTIPSTLGNLTKLFQINLGHNNFIGQIPIEIFSIPALSEILD 477
Query: 422 WSRNKLTGSLPIEVGKLK-ILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPIX 480
S N L GS+P E+GKLK I+EF + N+L GE PST G C L+ L + N G I
Sbjct: 478 VSHNNLEGSIPKEIGKLKNIVEF-HADSNKLSGENPSTIGECQLLQHLFLQNNFLNGSIP 536
Query: 481 XXXXXXXXXXXXXXXQNNLSGEIPKFLAGXXXXXXXXXXXD-LEGMVTTEGVFKNASATR 539
NNLSG+IP L + G V T GVF NAS
Sbjct: 537 IALTQLKGLDTLDLSGNNLSGQIPMSLGDMPLLHSLNLSFNSFHGEVPTNGVFANASEIY 596
Query: 540 ILGNSKLCGGISEFKLPTCVSKKSKRRRLTFVPTLVIAIVXXXXXXXXXXXXXXXXXXXK 599
I GN+ +CGGI E LPTC K K+++ + L++ ++ K
Sbjct: 597 IQGNAHICGGIPELHLPTCSLKSRKKKKHQIL--LLVVVICLVSTLAVFSLLYMLLTCHK 654
Query: 600 IKEKENPXXXXXXXX-XXXXXXXXNATSGFSSANLVGVGSFGSVYKGIID--EGRTT--I 654
++KE P AT GFSS++L+G GSFGSVYKG D +G T +
Sbjct: 655 RRKKEVPATTSMQGHPMITYKQLVKATDGFSSSHLLGSGSFGSVYKGEFDSQDGEITSLV 714
Query: 655 AVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGS 714
AV+V L+ A +SF AEC+ L++ RHRNLVK++T C D RGNDFKA VY+FM GS
Sbjct: 715 AVRVLKLETPKALKSFTAECETLRNTRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGS 774
Query: 715 LEEWLHPFTGEDEIDEAPRNLNLLQRLN 742
LE+WLHP T D+ ++ R+L L QR++
Sbjct: 775 LEDWLHPETN-DQAEQ--RHLTLHQRVS 799
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 881 (315.2 bits), Expect = 3.2e-88, P = 3.2e-88
Identities = 274/894 (30%), Positives = 420/894 (46%)
Query: 63 RHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNN 122
R ++T L L L G +S IG L L+ L L N+FT E P I LR L VL +
Sbjct: 310 RLTQLTHLGLSENHLVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGF 369
Query: 123 NSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLG 182
N+I GE+P ++ + L + +N L G I S S+ + ++L+L N +TG IP G
Sbjct: 370 NNISGELPADLGLLTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFG 429
Query: 183 NLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEV-PSLEKLQRL 241
++ + IS+ N+ G IP+ NL LSV +N LTG + P + KLQ+L
Sbjct: 430 RMN-LTFISIGRNHFTGEIPDDIFNCSNL-------ETLSVADNNLTGTLKPLIGKLQKL 481
Query: 242 QHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFL 301
+ ++ NSL +G + N L ++++SN F G +P +SNL+ ++ L +
Sbjct: 482 RILQVSYNSL-TG-----PIPREIGNLKDLNILYLHSNGFTGRIPREMSNLT-LLQGLRM 534
Query: 302 NNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPS 361
+N + G IP + + L LD+ NN+ SG IP +L++L L L NK +G+IP S
Sbjct: 535 YSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPAS 594
Query: 362 IGXXXXXXXXXXXXXXXEVSIPSSL--GQCXXXXXXXXXXXXXXGTIPPQFFXXXXXXXX 419
+ +IP L GTIP +
Sbjct: 595 LKSLSLLNTFDISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKEL-GKLEMVQE 653
Query: 420 XDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPS-TFGNCIRLEQLGMGGNLFQGP 478
D S N +GS+P + K + L +N L G IP F + L + N F G
Sbjct: 654 IDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGE 713
Query: 479 IXXXXXXXXXXXXXXXXQNNLSGEIPKFLAGXXXXXXXXXXXD-LEGMVTTEGVFKNASA 537
I NNL+GEIP+ LA + L+G V GVFKN +A
Sbjct: 714 IPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINA 773
Query: 538 TRILGNSKLCGGISEFKLPTCVSKKSKRRRLTFVPTLVIAIVXXXXXXXXXXXXXXXXXX 597
+ ++GN+ LCG K T K S + T V ++ I+
Sbjct: 774 SDLMGNTDLCGSKKPLKPCTIKQKSSHFSKRTRV---ILIILGSAAALLLVLLLVLILTC 830
Query: 598 XKIKEK--ENPXXXXXXXXXXXXXXXX-------NATSGFSSANLVGVGSFGSVYKGIID 648
K KEK EN AT F+SAN++G S +VYKG ++
Sbjct: 831 CKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLE 890
Query: 649 EGRTTIAVKVFNLQHHGASRS--FIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASV 706
+G T IAVKV NL+ A F E K L ++HRNLVK+L G + KA V
Sbjct: 891 DG-TVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKIL----GFAWESGKTKALV 945
Query: 707 YEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCD 766
FM G+LE+ +H G AP +LL+++++ + IA ++YLH HCD
Sbjct: 946 LPFMENGNLEDTIH---GS----AAPIG-SLLEKIDLCVHIASGIDYLHSGYGFPIVHCD 997
Query: 767 LKPSNVLLDDYMTARVGDFGLARILS--PDHTQTSSFSV-KGSLGYIAPEYGVGCEVSTN 823
LKP+N+LLD A V DFG ARIL D + T+S S +G++GY+APE+ +V+T
Sbjct: 998 LKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTK 1057
Query: 824 GDVYSYGILLLELVIGKKPIDIMFEG--DINLHNFGRKALPDD---VMDIVDSSLLPDDE 878
DV+S+GI+++EL+ ++P + E D+ L K++ + ++ ++D L
Sbjct: 1058 ADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVLDMEL----G 1113
Query: 879 DLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIK 932
D I++ +Q++A IE +++ + C+ P+DR +M ++ L ++
Sbjct: 1114 DSIVS--LKQEEA-----IE---DFLKLCLFCTSSRPEDRPDMNEILTHLMKLR 1157
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| C0LGP4 | Y3475_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4226 | 0.9473 | 0.8900 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 949 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-103 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-37 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-34 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-33 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-30 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-28 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-28 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-28 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-21 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-21 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-21 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-21 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-20 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-19 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-19 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-19 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-18 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-17 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-16 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-16 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-16 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-16 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-15 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-15 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-15 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-15 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-15 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-14 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-14 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-14 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-14 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-14 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-14 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-13 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-13 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-13 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-13 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-12 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-12 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-12 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-12 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-11 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-11 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-11 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-11 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-11 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-11 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-11 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-10 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-10 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-10 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-10 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-10 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-10 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-09 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-09 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-09 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-09 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-09 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-09 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 9e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-08 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-08 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-08 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-08 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-07 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-07 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-07 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-07 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-07 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-06 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-06 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-06 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-06 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-06 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-06 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-06 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-06 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-06 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-06 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-06 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-06 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-06 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-06 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 7e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 9e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-05 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-05 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-05 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 9e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-05 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-04 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-04 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-04 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-04 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-04 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-04 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 7e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 8e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.001 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 0.003 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.003 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 0.003 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.003 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.003 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 0.004 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 344 bits (884), Expect = e-103
Identities = 288/986 (29%), Positives = 440/986 (44%), Gaps = 152/986 (15%)
Query: 28 LLEFKSKSTYDPVGVLGTWNESIHFCKWYGVTCSRRHQRVTLLDLRSLKLAGSVSHFI-- 85
LL FKS S DP+ L WN S C W G+TC+ RV +DL ++G +S I
Sbjct: 34 LLSFKS-SINDPLKYLSNWNSSADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFR 91
Query: 86 ---------------------------------------------GNLSFLKQLYLQVNS 100
G++ L+ L L N
Sbjct: 92 LPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNM 151
Query: 101 FTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSL 160
+ EIP++IG LKVL L N + G+IP +++ ++L + +NQLVG+I +
Sbjct: 152 LSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQM 211
Query: 161 SKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANN 220
+ + LG N+L+G IP +G L+S++ + L YNNL G IP+S G +NL +L L
Sbjct: 212 KSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFL---- 267
Query: 221 LSVVENKLTGEVP-SLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSN 279
+NKL+G +P S+ LQ+L ++ NSL SG +L + L N L +H+ SN
Sbjct: 268 ---YQNKLSGPIPPSIFSLQKLISLDLSDNSL-SGEIPEL--VIQLQN---LEILHLFSN 318
Query: 280 NFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIG 339
NF G +P +++L + ++ L L +NK G IP +G NL LD+ N L+G IP +
Sbjct: 319 NFTGKIPVALTSLPR-LQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLC 377
Query: 340 ELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSN 399
NL L L N L G IP S+G + L + L DN +PS + + +++SN
Sbjct: 378 SSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISN 437
Query: 400 NNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTF 459
NNL G I + + + SL + L +RNK G LP G K LE L + N+ G +P
Sbjct: 438 NNLQGRINSRKWDMPSLQM-LSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKL 495
Query: 460 GNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLA--------GLS 511
G+ L QL + N G I L S + L LDLS N LSG+IP + LS
Sbjct: 496 GSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLS 555
Query: 512 LNNL-----------------NLSYNDLEGMVTTEGVFKNASATRILGNSKLCGGISEFK 554
N L N+S+N L G + + G F +A+ + GN LCGG +
Sbjct: 556 QNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSG 615
Query: 555 LPTC-VSKKSKRRRLTFVPTLVIAIVFRLLGLALALFGLVLCLVRK---IKEKENPSSSI 610
LP C +K+ TL L LAL FG V R +K EN
Sbjct: 616 LPPCKRVRKTPSWWFYITCTLGA-----FLVLALVAFGFVFIRGRNNLELKRVEN-EDGT 669
Query: 611 YSLLYLSYQDLYNAT-----SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG 665
+ L + + + T S N++ G G+ YKG + VK N +
Sbjct: 670 WELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIN-DVNS 728
Query: 666 ASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGE 725
S IA+ + ++H N+VK++ C R ++E++ +L E L
Sbjct: 729 IPSSEIAD---MGKLQHPNIVKLIGLC-----RSEKGAYLIHEYIEGKNLSEVL------ 774
Query: 726 DEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785
RNL+ +R IAI IA AL +LH C P +L P +++D +
Sbjct: 775 -------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL--- 824
Query: 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDI 845
LS + S Y+APE +++ D+Y +G++L+EL+ GK P D
Sbjct: 825 ----RLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880
Query: 846 MFEGDINLHNFGRKALPDDVMDI-VDSSLLPDDEDLILTGNQRQKQARINSIIECLISMV 904
F ++ + R D +D+ +D S+ D ++ NQ + ++ ++
Sbjct: 881 EFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD-----VSVNQNE-----------IVEVM 924
Query: 905 RIGVACSMELPQDRTNMTNVVHELQS 930
+ + C+ P R +V+ L+S
Sbjct: 925 NLALHCTATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 7e-37
Identities = 63/220 (28%), Positives = 102/220 (46%), Gaps = 22/220 (10%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASR-SFIAECKALKSIRHRNLVKVLTAC 692
+G G FG+VY + +A+K+ + + + E + LK + H N+VK+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLY--- 57
Query: 693 LGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALN 752
+ + V E+ GSL++ L E L+ + L I + I L
Sbjct: 58 --GVFEDENHLYLVMEYCEGGSLKDLLK---------ENEGKLSEDEILRILLQILEGLE 106
Query: 753 YLHHDCQPVTAHCDLKPSNVLLD-DYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIA 811
YLH + H DLKP N+LLD D ++ DFGL+++L+ D + + G+ Y+A
Sbjct: 107 YLHS--NGI-IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI--VGTPAYMA 161
Query: 812 PEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
PE +G S D++S G++L EL K I M + D
Sbjct: 162 PEVLLGKGYYSEKSDIWSLGVILYELPELKDLIRKMLQKD 201
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 8e-34
Identities = 74/262 (28%), Positives = 108/262 (41%), Gaps = 47/262 (17%)
Query: 632 NLVGVGSFGSVYKGI-IDEGRTTIAVKVFNLQHHGASR-SFIAECKALKSIRHRNLVKVL 689
+G GSFG VY G+ +A+KV + R + E K LK ++H N+V++
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKL-VAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLY 63
Query: 690 TACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAID 746
D +Y E+ G L + L L+ +
Sbjct: 64 DVFEDEDK--------LYLVMEYCEGGDLFDLLK----------KRGRLSEDEARFYLRQ 105
Query: 747 IAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGS 806
I AL YLH + + H DLKP N+LLD+ ++ DFGLAR L P T+ G+
Sbjct: 106 ILSALEYLH--SKGI-VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV---GT 159
Query: 807 LGYIAPE------YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860
Y+APE YG D++S G++L EL+ GK P F GD L +K
Sbjct: 160 PEYMAPEVLLGKGYGKAV------DIWSLGVILYELLTGKPP----FPGDDQLLELFKKI 209
Query: 861 LPDDVMDIVDSSLLPDD-EDLI 881
+ + +DLI
Sbjct: 210 GKPKPPFPPPEWDISPEAKDLI 231
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 25/219 (11%)
Query: 635 GVGSFGSVYKGII----DEGRTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVL 689
G G+FG VYKG + + T +AVK F+ E +K + H N+V++L
Sbjct: 8 GEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLL 67
Query: 690 TACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAY 749
C + V E+M G L ++L + L L L +A+ IA
Sbjct: 68 GVCTQGEPL-----YIVTEYMPGGDLLDFLR---------KHGEKLTLKDLLQMALQIAK 113
Query: 750 ALNYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLG 808
+ YL + V H DL N L+ + + ++ DFGL+R + D K +
Sbjct: 114 GMEYLESKNF--V--HRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK 169
Query: 809 YIAPEYGVGCEVSTNGDVYSYGILLLELV-IGKKPIDIM 846
++APE + ++ DV+S+G+LL E+ +G++P M
Sbjct: 170 WMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM 208
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 76/261 (29%), Positives = 115/261 (44%), Gaps = 43/261 (16%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTA 691
+G GSFG+VYK +AVK+ + ++ E + L+ + H N+V+++
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI-- 64
Query: 692 CLGADYRGNDFKASVYEFMHY---GSLEEWLH---PFTGEDEIDEAPRNLNLLQRLNIAI 745
A + +Y M Y G L ++L P + EDE IA+
Sbjct: 65 --DAFEDKDH----LYLVMEYCEGGDLFDYLSRGGPLS-EDEA------------KKIAL 105
Query: 746 DIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKG 805
I L YLH + H DLKP N+LLD+ ++ DFGLA+ L + ++F G
Sbjct: 106 QILRGLEYLHS--NGI-IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTF--VG 160
Query: 806 SLGYIAPE-YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDIN---LHNFGRKAL 861
+ Y+APE G DV+S G++L EL+ GK P F G+ L R
Sbjct: 161 TPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP----FSGENILDQLQLIRRILG 216
Query: 862 PDDVMDIVDSSLLPDD-EDLI 881
P D S ++ +DLI
Sbjct: 217 PPLEFDEPKWSSGSEEAKDLI 237
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 62/222 (27%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 632 NLVGVGSFGSVYKGI---IDEGRTTIAVKVFNLQHHGASRS----FIAECKALKSIRHRN 684
+G G+FG VYKG D T +AVK AS F+ E + +K + H N
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKT---LKEDASEEERKDFLKEARVMKKLGHPN 57
Query: 685 LVKVLTACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRL 741
+V++L C + +Y E+M G L ++L + L+L L
Sbjct: 58 VVRLLGVCTEEE--------PLYLVLEYMEGGDLLDYLRK-SRPVFPSPEKSTLSLKDLL 108
Query: 742 NIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSF 801
+ AI IA + YL + H DL N L+ + + ++ DFGL+R + D
Sbjct: 109 SFAIQIAKGMEYLAS--KKFV-HRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT 165
Query: 802 SVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
K + ++APE ++ DV+S+G+LL E+ +G P
Sbjct: 166 GGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVL 689
L+G GSFGSVY + + +AVK L + E + L S++H N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVR-- 63
Query: 690 TACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAID 746
G++ ++ K ++ E++ GSL L F E ++++
Sbjct: 64 --YYGSER--DEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE--------PVIRKY--TRQ 109
Query: 747 IAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGS 806
I L YLH V H D+K +N+L+D ++ DFG A+ L T + SV+G+
Sbjct: 110 ILEGLAYLH-SNGIV--HRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166
Query: 807 LGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
++APE G E D++S G ++E+ GK P
Sbjct: 167 PYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 61/219 (27%), Positives = 98/219 (44%), Gaps = 33/219 (15%)
Query: 635 GVGSFGSVYKGI----IDEGRTTIAVKVFNLQHHGASRS-FIAECKALKSIRHRNLVKVL 689
G G+FG VYKG D +AVK F+ E + ++ + H N+VK+L
Sbjct: 8 GEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLL 67
Query: 690 TACLGAD--YRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDI 747
C + V E+M G L ++L P+ L+L L+ A+ I
Sbjct: 68 GVCTEEEPLMI-------VMEYMPGGDLLDYLR--------KNRPKELSLSDLLSFALQI 112
Query: 748 AYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSL 807
A + YL + H DL N L+ + + ++ DFGL+R L D K +
Sbjct: 113 ARGMEYLES--KNFI-HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVK-GGKLPI 168
Query: 808 GYIAPE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
++APE G ++ DV+S+G+LL E+ +G++P
Sbjct: 169 RWMAPESLKEGK---FTSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 9e-27
Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 33/212 (15%)
Query: 635 GVGSFGSVYKGI----IDEGRTTIAVKVFNLQHHGASRS-FIAECKALKSIRHRNLVKVL 689
G G+FG VYKG + + +AVK F+ E + ++ + H N+VK+L
Sbjct: 8 GEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLL 67
Query: 690 TACLGAD--YRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDI 747
C + Y V E+M G L +L + L+L L+ A+ I
Sbjct: 68 GVCTEEEPLYI-------VMEYMEGGDLLSYLR---------KNRPKLSLSDLLSFALQI 111
Query: 748 AYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSL 807
A + YL + H DL N L+ + + ++ DFGL+R L D K +
Sbjct: 112 ARGMEYLES--KNFI-HRDLAARNCLVGENLVVKISDFGLSRDL-YDDDYYRKRGGKLPI 167
Query: 808 GYIAPE---YGVGCEVSTNGDVYSYGILLLEL 836
++APE G ++ DV+S+G+LL E+
Sbjct: 168 RWMAPESLKEGK---FTSKSDVWSFGVLLWEI 196
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 8e-22
Identities = 64/219 (29%), Positives = 101/219 (46%), Gaps = 40/219 (18%)
Query: 635 GVGSFGSVYKGI-IDEGRTTIAVKVFNLQHHGASRSFIA-ECKALKSIRHRNLVKVLTAC 692
G GS G VYK G+ A+K ++ R + E K L+S +VK C
Sbjct: 10 GQGSSGVVYKVRHKPTGKI-YALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----C 64
Query: 693 LGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLN---------I 743
GA Y+ + + V E+M GSL + LL+++ I
Sbjct: 65 YGAFYKEGEI-SIVLEYMDGGSLAD-------------------LLKKVGKIPEPVLAYI 104
Query: 744 AIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSV 803
A I L+YLH + H D+KPSN+L++ ++ DFG++++L Q ++F
Sbjct: 105 ARQILKGLDYLHTKRHII--HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV- 161
Query: 804 KGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
G++ Y++PE G S D++S G+ LLE +GK P
Sbjct: 162 -GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 68/215 (31%), Positives = 102/215 (47%), Gaps = 30/215 (13%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACL 693
+G G FG V++G+ + T +AVK F+AE + +K +RH L+++ C
Sbjct: 14 LGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 694 GAD--YRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYAL 751
+ Y V E M YGSL E+L A R L L Q +++A +A +
Sbjct: 72 LEEPIY-------IVTELMKYGSLLEYLQ--------GGAGRALKLPQLIDMAAQVASGM 116
Query: 752 NYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDH---TQTSSFSVKGSLG 808
YL H DL NVL+ + +V DFGLAR++ D + + F +K
Sbjct: 117 AYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK---- 169
Query: 809 YIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKP 842
+ APE + S DV+S+GILL E+V G+ P
Sbjct: 170 WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 69/223 (30%), Positives = 104/223 (46%), Gaps = 35/223 (15%)
Query: 632 NLVGVGSFGSVYKGI-IDEGRTTIAVKVFNLQ--HHGASRSFIAECKALKSIRHRNLVKV 688
N +G G+FG VY + +D G +AVK +Q + E K L+ ++H NLVK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGEL-MAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK- 63
Query: 689 LTACLGADYRGNDFKASVYEFMHY---GSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAI 745
G + VY FM Y G+LEE L DE ++++ +
Sbjct: 64 ---YYGVEVHREK----VYIFMEYCSGGTLEELLEHGRILDE--------HVIRVY--TL 106
Query: 746 DIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKG 805
+ L YLH H D+KP+N+ LD ++GDFG A L ++T T V+
Sbjct: 107 QLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK-NNTTTMGEEVQS 162
Query: 806 SLG---YIAPEYGVGCEVSTNG---DVYSYGILLLELVIGKKP 842
G Y+APE G + +G D++S G ++LE+ GK+P
Sbjct: 163 LAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 65/207 (31%), Positives = 98/207 (47%), Gaps = 30/207 (14%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTAC 692
+G G FG V G G+ +AVK A+++F+AE + ++RH NLV++L
Sbjct: 13 TIGKGEFGDVMLGDY-RGQK-VAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 693 LGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAY 749
L + +Y E+M GSL ++L + L Q+L A+D+
Sbjct: 70 LQGN--------PLYIVTEYMAKGSLVDYLR--------SRGRAVITLAQQLGFALDVCE 113
Query: 750 ALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGY 809
+ YL V H DL NVL+ + + A+V DFGLA+ S + VK +
Sbjct: 114 GMEYLEEK-NFV--HRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-SGKLPVK----W 165
Query: 810 IAPEYGVGCEVSTNGDVYSYGILLLEL 836
APE + ST DV+S+GILL E+
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 25/213 (11%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVK 687
F+ +G G FG V++G+ + R +A+K+ + F E +ALK +RH++L+
Sbjct: 8 FTLERKLGSGYFGEVWEGLW-KNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66
Query: 688 VLTACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIA 744
+ C + VY E M GSL +L G + L + +++A
Sbjct: 67 LFAVCSVGE--------PVYIITELMEKGSLLAFLRSPEG--------QVLPVASLIDMA 110
Query: 745 IDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVK 804
+A + YL + + H DL N+L+ + + +V DFGLAR++ D +S K
Sbjct: 111 CQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS--DKK 165
Query: 805 GSLGYIAPEYGVGCEVSTNGDVYSYGILLLELV 837
+ APE ST DV+S+GILL E+
Sbjct: 166 IPYKWTAPEAASHGTFSTKSDVWSFGILLYEMF 198
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 66/217 (30%), Positives = 103/217 (47%), Gaps = 36/217 (16%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLG 694
G G FG V+ G + G T +AVK + +F+ E + +K +RH LV++ C
Sbjct: 15 GAGQFGEVWMGTWN-GTTKVAVKTLK-PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 695 AD--YRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALN 752
+ Y V E+M GSL ++L G + L L Q +++A IA +
Sbjct: 73 EEPIY-------IVTEYMSKGSLLDFLKSGEG--------KKLRLPQLVDMAAQIAEGMA 117
Query: 753 YLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDH---TQTSSFSVKGSLGY 809
YL H DL N+L+ + + ++ DFGLAR++ D + + F +K +
Sbjct: 118 YLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK----W 170
Query: 810 IAPE---YGVGCEVSTNGDVYSYGILLLELVI-GKKP 842
APE YG + DV+S+GILL E+V G+ P
Sbjct: 171 TAPEAANYGR---FTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 4e-21
Identities = 65/219 (29%), Positives = 92/219 (42%), Gaps = 28/219 (12%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVK 687
F +G G FG VYK +A+KV L+ I E + LK +H N+VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 688 VLTACLGADYRGNDFKASVYEFMHYGSLEE----WLHPFTGEDEIDEAPRNLNLLQRLNI 743
+ Y D V EF GSL++ T E +I A LL+
Sbjct: 62 YYGS-----YLKKDELWIVMEFCSGGSLKDLLKSTNQTLT-ESQI--AYVCKELLK---- 109
Query: 744 AIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSV 803
L YLH + H D+K +N+LL ++ DFGL+ LS D ++
Sbjct: 110 ------GLEYLHSNGI---IHRDIKAANILLTSDGEVKLIDFGLSAQLS-DTKARNTMV- 158
Query: 804 KGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
G+ ++APE G D++S GI +EL GK P
Sbjct: 159 -GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 95.6 bits (236), Expect = 8e-21
Identities = 73/282 (25%), Positives = 116/282 (41%), Gaps = 36/282 (12%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRH-RNLVKV 688
+G GSFG VY R +A+KV + F+ E + L S+ H N+VK+
Sbjct: 7 KLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 689 LTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIA 748
++ V E++ GSLE+ L L+ + L I I
Sbjct: 64 YDF-----FQDEGSLYLVMEYVDGGSLEDLLKK-------IGRKGPLSESEALFILAQIL 111
Query: 749 YALNYLHHDCQPVTAHCDLKPSNVLLD-DYMTARVGDFGLARILSPDHTQTSSF----SV 803
AL YLH H D+KP N+LLD D ++ DFGLA++L + +S +
Sbjct: 112 SALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTS 168
Query: 804 KGSLGYIAPEYGVGCE---VSTNGDVYSYGILLLELVIGKKP------IDIMFEGDINLH 854
G+ GY+APE +G S++ D++S GI L EL+ G P + +
Sbjct: 169 VGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL 228
Query: 855 NFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSI 896
+L + + DL+ + + R++S
Sbjct: 229 ELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSS 270
|
Length = 384 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 18/205 (8%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTA 691
+ +G G +G VY+G+ + T+AVK + F+ E +K I+H NLV++L
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 692 CLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYAL 751
C R F + EFM YG+L ++L E++ + LL +A I+ A+
Sbjct: 71 CT----REPPFYI-ITEFMTYGNLLDYLRE-CNRQEVNA----VVLLY---MATQISSAM 117
Query: 752 NYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIA 811
YL H DL N L+ + +V DFGL+R+++ D T T+ K + + A
Sbjct: 118 EYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTA 173
Query: 812 PEYGVGCEVSTNGDVYSYGILLLEL 836
PE + S DV+++G+LL E+
Sbjct: 174 PESLAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 28/218 (12%)
Query: 635 GVGSFGSVYKGI-IDEGRTT---IAVKVF-NLQHHGASRSFIAECKALKSIRHRNLVKVL 689
G G+FG+VYKG+ I EG +A+KV A++ + E + S+ H ++V++L
Sbjct: 16 GSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLL 75
Query: 690 TACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAY 749
CL + + + M G L +++ N+ LN + IA
Sbjct: 76 GICLSSQV------QLITQLMPLGCLLDYVRNHKD---------NIGSQYLLNWCVQIAK 120
Query: 750 ALNYL--HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSL 807
++YL H DL NVL+ ++ DFGLA++L D + + K +
Sbjct: 121 GMSYLEEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPI 175
Query: 808 GYIAPEYGVGCEVSTNGDVYSYGILLLELV-IGKKPID 844
++A E + + DV+SYG+ + EL+ G KP +
Sbjct: 176 KWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 57/222 (25%), Positives = 95/222 (42%), Gaps = 32/222 (14%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKA----LKSIRHR 683
+ +L+G G+FG VYKG+ E +A+K +L + LK+++H
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISL--EKIKEEALKSIMQEIDLLKNLKHP 59
Query: 684 NLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNI 743
N+VK + + +D + E+ GSL + + F +
Sbjct: 60 NIVKYIGS-----IETSDSLYIILEYAENGSLRQIIKKFGP-------------FPESLV 101
Query: 744 AIDIAYALN---YLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSS 800
A+ + L YLH Q V H D+K +N+L ++ DFG+A L+
Sbjct: 102 AVYVYQVLQGLAYLHE--QGVI-HRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--D 156
Query: 801 FSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
SV G+ ++APE ST D++S G ++EL+ G P
Sbjct: 157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 6e-19
Identities = 65/248 (26%), Positives = 102/248 (41%), Gaps = 59/248 (23%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGAS--RSFIAECKALKSIRHRNLVKVL 689
+G GSFG VY +K +L + + E K LK + H N++K
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK-- 63
Query: 690 TACLGADYRGNDFKA--SVYEFMHY---GSLEEWLH-------PFTGEDEIDEAPRNLNL 737
Y F+ + M Y G L + + PF E++I
Sbjct: 64 -------YY-ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFP-EEQI--------- 105
Query: 738 LQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQ 797
L+ + + AL YLH + + H D+KP N+ L ++GDFG++++LS T
Sbjct: 106 ---LDWFVQLCLALKYLHS--RKIL-HRDIKPQNIFLTSNGLVKLGDFGISKVLS--STV 157
Query: 798 TSSFSVKGSLGYIAPE------YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDI 851
+ +V G+ Y++PE Y + D++S G +L EL K P FEG+
Sbjct: 158 DLAKTVVGTPYYLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHP----FEGE- 206
Query: 852 NLHNFGRK 859
NL K
Sbjct: 207 NLLELALK 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 9e-19
Identities = 60/219 (27%), Positives = 107/219 (48%), Gaps = 28/219 (12%)
Query: 634 VGVGSFGSVYKGII-----DEGRTTIAVKVFNLQHHGASRS-FIAECKALKSIRHRNLVK 687
+G G+FG VYKG + T++A+K + F E + + ++H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 688 VLTACLGADYRGNDFKASV-YEFMHYGSLEEWL---HPFTG---EDEIDEAPRNLNLLQR 740
+L C + + +E++ +G L E+L P + E + +L+
Sbjct: 73 LLGVCT------KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126
Query: 741 LNIAIDIAYALNYL--HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLAR-ILSPDHTQ 797
L+IAI IA + YL HH H DL N L+ + +T ++ DFGL+R I S D+ +
Sbjct: 127 LHIAIQIAAGMEYLSSHHFV-----HRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYR 181
Query: 798 TSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLEL 836
S S+ + ++ PE + + +T D++S+G++L E+
Sbjct: 182 VQSKSLL-PVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 21/211 (9%)
Query: 632 NLVGVGSFGSVYKGIID--EGRTT--IAVKVFNLQHHGASRS-FIAECKALKSIRHRNLV 686
+G G FG V D T +AVK N RS F E + L+++ H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 687 KVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAID 746
K C R + E++ GSL ++L + +NL + L +
Sbjct: 70 KYKGVCEKPGGRSLRL---IMEYLPSGSLRDYL-QRHRD--------QINLKRLLLFSSQ 117
Query: 747 IAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGS 806
I ++YL + + H DL N+L++ ++ DFGLA++L D S
Sbjct: 118 ICKGMDYLG-SQRYI--HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES 174
Query: 807 -LGYIAPEYGVGCEVSTNGDVYSYGILLLEL 836
+ + APE + S+ DV+S+G+ L EL
Sbjct: 175 PIFWYAPECLRTSKFSSASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-18
Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACL 693
+G G FG V+ G + G T +A+K + +F+ E + +K +RH LV++
Sbjct: 14 LGQGCFGEVWMGTWN-GTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV- 70
Query: 694 GADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNY 753
+ V E+M GSL ++L G + L L Q +++A IA + Y
Sbjct: 71 -----SEEPIYIVTEYMSKGSLLDFLKGEMG--------KYLRLPQLVDMAAQIASGMAY 117
Query: 754 LHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPE 813
+ + H DL+ +N+L+ + + +V DFGLAR++ D+ T+ K + + APE
Sbjct: 118 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE 173
Query: 814 YGVGCEVSTNGDVYSYGILLLELVI-GKKP 842
+ + DV+S+GILL EL G+ P
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 8e-18
Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACL 693
+G G FG V+ G + G T +AVK + SF+ E + +K +RH LV++
Sbjct: 14 LGNGQFGEVWMGTWN-GNTKVAVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQLYAVV- 70
Query: 694 GADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNY 753
+ V E+M GSL ++L D R L L +++A +A + Y
Sbjct: 71 -----SEEPIYIVTEYMSKGSLLDFLK--------DGEGRALKLPNLVDMAAQVAAGMAY 117
Query: 754 LHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPE 813
+ + H DL+ +N+L+ D + ++ DFGLAR++ D+ T+ K + + APE
Sbjct: 118 IE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPE 173
Query: 814 YGVGCEVSTNGDVYSYGILLLELVI-GKKP 842
+ + DV+S+GILL ELV G+ P
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 65/229 (28%), Positives = 102/229 (44%), Gaps = 37/229 (16%)
Query: 634 VGVGSFGSVYKG-----IIDEGRTTIAVKVF-NLQHHGASRSFIAECKALKSIRHRNLVK 687
+G G+FG V+ G + + +AVK + A + F E + L + +H N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 688 VLTACLGADYRGNDFKASVYEFMHYGSLEEWLHP----FTGEDEIDEAPRNLNLLQRLNI 743
C G D V+E+M +G L ++L D L L Q L I
Sbjct: 73 FYGVCT----EG-DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 744 AIDIAYALNYL--HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSF 801
A+ IA + YL H H DL N L+ + ++GDFG++R D T +
Sbjct: 128 AVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYY 178
Query: 802 SVKGS----LGYIAPE---YGVGCEVSTNGDVYSYGILLLEL-VIGKKP 842
V G + ++ PE Y + +T DV+S+G++L E+ GK+P
Sbjct: 179 RVGGHTMLPIRWMPPESIMYR---KFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 30/218 (13%)
Query: 634 VGVGSFGSVYKGII-----DEGRTTIAVKVFNLQHHGASR-SFIAECKALKSIRHRNLVK 687
+G GSFG VY+G+ E T +A+K N R F+ E +K ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 688 VLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDI 747
+L G V E M G L+ +L E E + L + + +A +I
Sbjct: 74 LLGVVS----TGQP-TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128
Query: 748 AYALNYLH--HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLAR-ILSPDHTQTSSFSVK 804
A + YL H DL N ++ + +T ++GDFG+ R I D+ + K
Sbjct: 129 ADGMAYLAAKKFV-----HRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGG---K 180
Query: 805 GSLG--YIAPEY---GVGCEVSTNGDVYSYGILLLELV 837
G L ++APE GV +T DV+S+G++L E+
Sbjct: 181 GLLPVRWMAPESLKDGV---FTTKSDVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 3e-17
Identities = 61/222 (27%), Positives = 88/222 (39%), Gaps = 43/222 (19%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLT 690
+G GSFG V + A+KV + + E L I H +VK+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 691 A-------CLGADY-RGNDFKASVYEFMHYGSL-EEWLHPFTGEDEIDEAPRNLNLLQRL 741
A L +Y G + G EE + E
Sbjct: 61 AFQTEEKLYLVLEYAPGGEL---FSHLSKEGRFSEERARFYAAE---------------- 101
Query: 742 NIAIDIAYALNYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSS 800
I AL YLH + DLKP N+LLD ++ DFGLA+ LS + ++T++
Sbjct: 102 -----IVLALEYLHSLG----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT 152
Query: 801 FSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
F G+ Y+APE +G D +S G+LL E++ GK P
Sbjct: 153 FC--GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 5e-17
Identities = 66/218 (30%), Positives = 107/218 (49%), Gaps = 24/218 (11%)
Query: 633 LVGVGSFGSVYKGI-IDEGRTT---IAVKVFN-LQHHGASRSFIAECKALKSIRHRNLVK 687
++G G+FG+VYKGI + EG T +A+K+ N A+ F+ E + S+ H +LV+
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 688 VLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDI 747
+L CL + V + M +G L +++H E N+ LN + I
Sbjct: 74 LLGVCLSPTIQ------LVTQLMPHGCLLDYVH---------EHKDNIGSQLLLNWCVQI 118
Query: 748 AYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSL 807
A + YL + H DL NVL+ ++ DFGLAR+L D + ++ K +
Sbjct: 119 AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI 175
Query: 808 GYIAPEYGVGCEVSTNGDVYSYGILLLELV-IGKKPID 844
++A E + + DV+SYG+ + EL+ G KP D
Sbjct: 176 KWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 59/229 (25%), Positives = 100/229 (43%), Gaps = 38/229 (16%)
Query: 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH---GASRSFIAECKALKSIRHR 683
F ++G G+FG V + + A+K N Q G+ R+ + E + L+ + H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 684 NLVKVLTACLGADYRGNDFKASVYEFMHYGSLE---EWLHPFTGEDEIDEAPRNLNLLQR 740
LV + + ++ + V + + G L F+ E+++ +
Sbjct: 61 FLVNLWYS-----FQDEENMYLVVDLLLGGDLRYHLSQKVKFS-EEQV-----------K 103
Query: 741 LNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSS 800
I +I AL YLH + + H D+KP N+LLD+ + DF +A ++PD T +
Sbjct: 104 FWIC-EIVLALEYLHS--KGII-HRDIKPDNILLDEQGHVHITDFNIATKVTPD---TLT 156
Query: 801 FSVKGSLGYIAPE----YGVGCEVSTNGDVYSYGILLLELVIGKKPIDI 845
S G+ GY+APE G V D +S G+ E + GK+P
Sbjct: 157 TSTSGTPGYMAPEVLCRQGYSVAV----DWWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 57/221 (25%), Positives = 93/221 (42%), Gaps = 29/221 (13%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTA 691
+G G++G VYK +A+K L+ G ++ + E K LK + H N++K+L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 692 CLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYAL 751
+R V+EFM + I + R L + + L
Sbjct: 67 -----FRHKGDLYLVFEFMDTDLYKL----------IKDRQRGLPESLIKSYLYQLLQGL 111
Query: 752 NYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYI 810
+ H H H DLKP N+L++ ++ DFGLAR + + V + Y
Sbjct: 112 AFCHSHGI----LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV--TRWYR 165
Query: 811 APEYGVGCEV-STNGDVYSYGILLLELVIGKKPIDIMFEGD 850
APE +G + ST D++S G + EL+ + +F G
Sbjct: 166 APELLLGDKGYSTPVDIWSVGCIFAELLSRR----PLFPGK 202
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 63/210 (30%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACL 693
+G G FG V+ G + G T +A+K +F+ E + +K +RH LV +
Sbjct: 14 LGQGCFGEVWMGTWN-GTTKVAIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV- 70
Query: 694 GADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNY 753
+ V EFM GSL ++L G + L L Q +++A IA + Y
Sbjct: 71 -----SEEPIYIVTEFMGKGSLLDFLKEGDG--------KYLKLPQLVDMAAQIADGMAY 117
Query: 754 LHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPE 813
+ + H DL+ +N+L+ D + ++ DFGLAR++ D+ T+ K + + APE
Sbjct: 118 IE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPE 173
Query: 814 YGVGCEVSTNGDVYSYGILLLELVI-GKKP 842
+ + DV+S+GILL ELV G+ P
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 3e-16
Identities = 65/230 (28%), Positives = 111/230 (48%), Gaps = 36/230 (15%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVK---V 688
+G G++G VYK + +A+K +++ G + I E K L+ +RH N+V+ +
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 689 LTACLGADYRGNDFKASVYEFMHY---GSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAI 745
+T+ +G+ + V+E+M + G L+ FT E +I + + Q L
Sbjct: 67 VTSKG----KGSIYM--VFEYMDHDLTGLLDSPEVKFT-ESQI----KCY-MKQLLE--- 111
Query: 746 DIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKG 805
L YLH + H D+K SN+L+++ ++ DFGLAR + ++ + V
Sbjct: 112 ----GLQYLHS-NGIL--HRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI- 163
Query: 806 SLGYIAPEYGVGCEVSTNG-DVYSYGILLLELVIGKKPIDIMFEGDINLH 854
+L Y PE +G D++S G +L EL +G KPI F+G L
Sbjct: 164 TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLG-KPI---FQGSTELE 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 32/207 (15%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACL 693
+G G FG V G D +AVK +++ +++F+AE + +RH NLV++L +
Sbjct: 14 IGKGEFGDVMLG--DYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 694 GADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYA 750
+ K +Y E+M GSL ++L G + L ++D+ A
Sbjct: 70 -------EEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGD-------CLLKFSLDVCEA 114
Query: 751 LNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQ-TSSFSVKGSLGY 809
+ YL + H DL NVL+ + A+V DFGL + S TQ T VK +
Sbjct: 115 MEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--TQDTGKLPVK----W 165
Query: 810 IAPEYGVGCEVSTNGDVYSYGILLLEL 836
APE + ST DV+S+GILL E+
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 4e-16
Identities = 79/315 (25%), Positives = 126/315 (40%), Gaps = 54/315 (17%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTT---IAVKVFNLQHHGAS--RSFIAECKALKSIRH 682
++G G FGSV +G + + + +AVK L H S F++E +K H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 683 RNLVKVLTACLGADYRGNDFKASV-YEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRL 741
N++K++ C A K V FM +G L H F + P L L L
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDL----HSFLLYSRLGGLPEKLPLQTLL 116
Query: 742 NIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLAR-ILSPDH---TQ 797
+DIA + YL + H DL N +L + MT V DFGL++ I S D+ +
Sbjct: 117 KFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGR 173
Query: 798 TSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLE-LVIGKKPIDIMFEGDINLHNF 856
+ VK +IA E ++ DV+++G+ + E G+ P + G N +
Sbjct: 174 IAKMPVK----WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP----YPGVENHEIY 225
Query: 857 GRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQ 916
D + GN R+ +CL + + +C P+
Sbjct: 226 ----------------------DYLRHGN------RLKQPEDCLDELYDLMYSCWRADPK 257
Query: 917 DRTNMTNVVHELQSI 931
DR T + L++I
Sbjct: 258 DRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 33/227 (14%)
Query: 634 VGVGSFGSVYKG-----IIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKV 688
+G G+FG V+ + ++ + +AVK A + F E + L ++H+++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 689 LTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEI-----DEAPRNLNLLQRLNI 743
C V+E+M +G L +L + +I D AP L L Q L I
Sbjct: 73 YGVCTEGR-----PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 744 AIDIAYALNYL---HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSS 800
A IA + YL H H DL N L+ + ++GDFG++R D T
Sbjct: 128 ASQIASGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDY 177
Query: 801 FSVKGS----LGYIAPEYGVGCEVSTNGDVYSYGILLLEL-VIGKKP 842
+ V G + ++ PE + + +T D++S+G++L E+ GK+P
Sbjct: 178 YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 7e-16
Identities = 69/243 (28%), Positives = 118/243 (48%), Gaps = 43/243 (17%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGAS-RSFIAECKALKSIRHRNLVK---VL 689
+G G FG V+ G + G T +A+K +L+ S +F+AE +K ++H LV+ V+
Sbjct: 14 LGAGQFGEVWMGYYN-GHTKVAIK--SLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV 70
Query: 690 TACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAID 746
T + +Y E+M GSL ++L G L + + +++A
Sbjct: 71 T------------QEPIYIITEYMENGSLVDFLKTPEGIK--------LTINKLIDMAAQ 110
Query: 747 IAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGS 806
IA + ++ + H DL+ +N+L+ + + ++ DFGLAR++ D+ T+ K
Sbjct: 111 IAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIE-DNEYTAREGAKFP 166
Query: 807 LGYIAPE---YGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDI--NLHNFGRKA 860
+ + APE YG + DV+S+GILL E+V G+ P M ++ NL R
Sbjct: 167 IKWTAPEAINYGT---FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP 223
Query: 861 LPD 863
PD
Sbjct: 224 RPD 226
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 59/230 (25%), Positives = 91/230 (39%), Gaps = 49/230 (21%)
Query: 634 VGVGSFGSVYKGI------------IDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIR 681
+G GSFG+V K ID G T K + ++E L+ ++
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK----------QQLVSEVNILRELK 57
Query: 682 HRNLVKVLTACLGADYRGNDF---KASVYEFMHY---GSLEEWLHPFTGEDE-IDEAPRN 734
H N+V+ Y ++Y M Y G L + + E + I+E
Sbjct: 58 HPNIVR---------YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEE--- 105
Query: 735 LNLLQRLNIAIDIAYALNYLHH--DCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILS 792
I + AL H+ D H DLKP+N+ LD ++GDFGLA+IL
Sbjct: 106 ----FIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG 161
Query: 793 PDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
D + ++ G+ Y++PE D++S G L+ EL P
Sbjct: 162 HDSSFAKTYV--GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 27/210 (12%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACL 693
+G G FG+V +G + +AVK N++ +++F+ E + + H+NLV++L L
Sbjct: 14 IGEGEFGAVLQGEYTGQK--VAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 694 GADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNY 753
+ G V E M G+L +L ++++Q L ++D+A + Y
Sbjct: 70 ---HNGLYI---VMELMSKGNLVNFLR--------TRGRALVSVIQLLQFSLDVAEGMEY 115
Query: 754 LHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPE 813
L H DL N+L+ + A+V DFGLAR+ S VK + APE
Sbjct: 116 LE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARV-GSMGVDNSKLPVK----WTAPE 167
Query: 814 YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
+ S+ DV+SYG+LL E+ G+ P
Sbjct: 168 ALKHKKFSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-15
Identities = 91/274 (33%), Positives = 131/274 (47%), Gaps = 13/274 (4%)
Query: 246 ITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNK 305
+ +L N L SL+ L + + + + +L LN N+
Sbjct: 47 VNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGS--ENLLNLLPLPSLDLNLNR 104
Query: 306 IYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGEL-QNLKILGLNRNKLSGNIPPSIGN 364
+ +I + NL LD+ NN ++ IPP IG L NLK L L+ NK+ ++P + N
Sbjct: 105 LRSNISE-LLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRN 161
Query: 365 LKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSR 424
L L NL L+ N L +P L +L ++LS N +S +PP+ LS+L LD S
Sbjct: 162 LPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALE-ELDLSN 218
Query: 425 NKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLG 484
N + L + LK L L + N+LE ++P + GN LE L + N Q SSLG
Sbjct: 219 NSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNN--QISSISSLG 274
Query: 485 SLRGLRVLDLSQNNLSGEIPKFLAGLSLNNLNLS 518
SL LR LDLS N+LS +P L L L L+
Sbjct: 275 SLTNLRELDLSGNSLSNALPLIALLLLLLELLLN 308
|
Length = 394 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (191), Expect = 3e-15
Identities = 63/228 (27%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTA 691
+G G++G VYK + +A+K L + G + + E LK ++H N+VK+L
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66
Query: 692 CLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIA 748
+ +Y E+ L + +D+ P L+ +I +
Sbjct: 67 IHT--------ERKLYLVFEYCDMD-----LKKY-----LDKRPGPLSPNLIKSIMYQLL 108
Query: 749 YALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILS-PDHTQTSSFSVKGSL 807
L Y H H DLKP N+L++ ++ DFGLAR P T T V +L
Sbjct: 109 RGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH--EVV-TL 162
Query: 808 GYIAPEYGVGCEV-STNGDVYSYGILLLELVIGKKPIDIMFEGDINLH 854
Y APE +G + ST D++S G + E++ G KP+ F GD +
Sbjct: 163 WYRAPEILLGSKHYSTAVDIWSVGCIFAEMITG-KPL---FPGDSEID 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 76/271 (28%), Positives = 114/271 (42%), Gaps = 42/271 (15%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNL-----QHHGASRSFIAECKALKSIRHRNLVK 687
L+G GSFGSVY+G+ + AVK +L A + E L ++H N+V+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 688 VLTACLGADYRGNDF-KASVYEFMHY---GSLEEWLHPFTGEDEIDEAPRNLNLLQRLNI 743
Y G + + ++Y F+ GSL + L + E L Q
Sbjct: 67 ---------YLGTEREEDNLYIFLELVPGGSLAKLLKKY---GSFPEPVIRLYTRQ---- 110
Query: 744 AIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSV 803
I L YLH T H D+K +N+L+D ++ DFG+A+ + + + S
Sbjct: 111 ---ILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVV---EFSFAKSF 161
Query: 804 KGSLGYIAPEYGVGCEV-STNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGR-KAL 861
KGS ++APE D++S G +LE+ GK P EG + GR K L
Sbjct: 162 KGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWS-QLEGVAAVFKIGRSKEL 220
Query: 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQAR 892
P + L + +D IL QR R
Sbjct: 221 PP-----IPDHLSDEAKDFILKCLQRDPSLR 246
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 64/218 (29%), Positives = 95/218 (43%), Gaps = 33/218 (15%)
Query: 634 VGVGSFGSV----YKGIIDEGRTTIAVKVFNLQHHGA--SRSFIAECKALKSIRHRNLVK 687
+G G FG V ++G ID +A+K+ GA FI E K + + H NLV+
Sbjct: 12 LGSGQFGVVHLGKWRGKID-----VAIKMI---REGAMSEDDFIEEAKVMMKLSHPNLVQ 63
Query: 688 VLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDI 747
+ C + F V E+M G L +L E L L++ D+
Sbjct: 64 LYGVCT---KQRPIF--IVTEYMANGCLLNYLR---------ERKGKLGTEWLLDMCSDV 109
Query: 748 AYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSL 807
A+ YL + H DL N L+ + +V DFGLAR + D TSS K +
Sbjct: 110 CEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSSQGTKFPV 165
Query: 808 GYIAPEYGVGCEVSTNGDVYSYGILLLEL-VIGKKPID 844
+ PE S+ DV+S+G+L+ E+ GK P +
Sbjct: 166 KWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 4e-15
Identities = 61/285 (21%), Positives = 109/285 (38%), Gaps = 67/285 (23%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKAL-KSIRHRNLVKV 688
++G GSF +V E A+K+ + + + E + L + H ++K+
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 689 LTACLGADYRGNDFKAS-----VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNI 743
F+ V E+ G L +++ + +L+
Sbjct: 68 YYT----------FQDEENLYFVLEYAPNGELLQYIRKY----------GSLDEKCTRFY 107
Query: 744 AIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPD--------- 794
A +I AL YLH H DLKP N+LLD M ++ DFG A++L P+
Sbjct: 108 AAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGD 164
Query: 795 -----------HTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPI 843
+ +SF G+ Y++PE + D+++ G ++ +++ GK P
Sbjct: 165 ATNIDSQIEKNRRRFASFV--GTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP- 221
Query: 844 DIMFEGDINLHNFGR---------KALPDDVMDIVDSSLLPDDED 879
F G F + P D D+++ L+ D +D
Sbjct: 222 ---FRGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQD 263
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 24/216 (11%)
Query: 633 LVGVGSFGSVYKGI-IDEGRTT-IAVKVFNLQHHGASRSFIA---ECKALKSIRHRNLVK 687
L+G G FG+V+KGI I EG + I V + +Q ++F A+ S+ H +V+
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 688 VLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDI 747
+L C GA + V + GSL + + +L+ + LN + I
Sbjct: 74 LLGICPGASLQ------LVTQLSPLGSLLDHVRQHRD---------SLDPQRLLNWCVQI 118
Query: 748 AYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSL 807
A + YL H +L N+LL ++ DFG+A +L PD + K +
Sbjct: 119 AKGMYYLEEHRM---VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPI 175
Query: 808 GYIAPEYGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
++A E + + DV+SYG+ + E++ G +P
Sbjct: 176 KWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 21/211 (9%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIA-ECKALKSIRHRNLVKVLTACL 693
G G+ G V K + +AVK L+ + A + I E L +V
Sbjct: 10 GAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVG----FY 65
Query: 694 GADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNY 753
GA Y D + E+M GSL++ L + I E L + IA+ + L Y
Sbjct: 66 GAFYNNGDISICM-EYMDGGSLDKILK--EVQGRIPERI-----LGK--IAVAVLKGLTY 115
Query: 754 LHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPE 813
LH + + H D+KPSN+L++ ++ DFG++ L +T G+ Y+APE
Sbjct: 116 LHEKHKII--HRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV----GTSSYMAPE 169
Query: 814 YGVGCEVSTNGDVYSYGILLLELVIGKKPID 844
G + S D++S G+ L+EL G+ P
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGRFPYP 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 60/232 (25%), Positives = 102/232 (43%), Gaps = 36/232 (15%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAEC----KALKSIRHR 683
F N +G GSFG V+K + + A+K +L +R E + L +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLS--KMNRREREEAIDEARVLAKLDSS 59
Query: 684 NLVKVLTACLGADYRGNDFKAS-VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLN 742
+++ + L + K + V E+ G L + L G P + + R
Sbjct: 60 YIIRYYESFL------DKGKLNIVMEYAENGDLHKLLKMQRGR------PLPEDQVWRFF 107
Query: 743 IAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSF- 801
I I + L +LH H D+K N+ LD Y ++GD G+A++LS + ++F
Sbjct: 108 IQILLG--LAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN----TNFA 158
Query: 802 -SVKGSLGYIAPEYGVGCE---VSTNGDVYSYGILLLELVIGKKPIDIMFEG 849
++ G+ Y++PE CE + DV++ G++L E GK P D +G
Sbjct: 159 NTIVGTPYYLSPEL---CEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG 207
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 63/223 (28%), Positives = 106/223 (47%), Gaps = 24/223 (10%)
Query: 634 VGVGSFGSV-----YKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKV 688
+G G+FG V Y + + +AVK A + F E + L +++H ++VK
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 689 LTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDE---IDEAPRN----LNLLQRL 741
C D V+E+M +G L ++L G D +D PR L L Q L
Sbjct: 73 YGVCGDGDPL-----IMVFEYMKHGDLNKFLRAH-GPDAMILVDGQPRQAKGELGLSQML 126
Query: 742 NIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLAR-ILSPDHTQTSS 800
+IA IA + YL H DL N L+ + ++GDFG++R + S D+ +
Sbjct: 127 HIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG 183
Query: 801 FSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLEL-VIGKKP 842
++ + ++ PE + + +T DV+S+G++L E+ GK+P
Sbjct: 184 HTML-PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 74/270 (27%), Positives = 118/270 (43%), Gaps = 43/270 (15%)
Query: 633 LVGVGSFGSVYK-GIIDEGRTTIAVKVFNLQH----------HGASRSFIAECKALK-SI 680
+G G+FG VYK + G+ +A+K N+ + + ++E +K +
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 681 RHRNLVKVLTACLGAD--YRGNDF--KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLN 736
RH N+V+ L D Y D A + E H+ SL+E FT E+ I
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGE--HFNSLKEKKQRFT-EERI-------- 115
Query: 737 LLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHT 796
NI + + AL YLH + + V H DL P+N++L + + DFGLA+ P+
Sbjct: 116 ----WNIFVQMVLALRYLHKEKRIV--HRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK 169
Query: 797 QTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPI--DIMFEGDINLH 854
T SV G++ Y PE DV+++G +L ++ + P M +
Sbjct: 170 LT---SVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIV 226
Query: 855 NFGRKALPD-----DVMDIVDSSLLPDDED 879
+ LP+ DV D++ S L PD E
Sbjct: 227 EAVYEPLPEGMYSEDVTDVITSCLTPDAEA 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-14
Identities = 35/92 (38%), Positives = 55/92 (59%)
Query: 296 IKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLS 355
I L L+N + G IP I +LQ +++ N + G IPP++G + +L++L L+ N +
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 356 GNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLG 387
G+IP S+G L L L LN N L +P++LG
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-14
Identities = 34/90 (37%), Positives = 58/90 (64%), Gaps = 3/90 (3%)
Query: 276 INSNNFG--GLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGT 333
+ +N G G +P IS L ++++ L+ N I G+IP +G+ +L+ LD+ N +G+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRH-LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 334 IPPAIGELQNLKILGLNRNKLSGNIPPSIG 363
IP ++G+L +L+IL LN N LSG +P ++G
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 3e-14
Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 21/212 (9%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACL 693
+G G FG V+ G E + +A+K + + FI E + + + H LV++ C
Sbjct: 12 IGSGQFGLVWLGYWLE-KRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 694 GADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNY 753
V+EFM +G L ++L G+ + L + +D+ + Y
Sbjct: 70 E-----RSPICLVFEFMEHGCLSDYLRAQRGK---------FSQETLLGMCLDVCEGMAY 115
Query: 754 LHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPE 813
L H DL N L+ + +V DFG+ R + D TSS K + + +PE
Sbjct: 116 LESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWSSPE 171
Query: 814 YGVGCEVSTNGDVYSYGILLLELVI-GKKPID 844
+ S+ DV+S+G+L+ E+ GK P +
Sbjct: 172 VFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 3e-14
Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 27/225 (12%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACL 693
+G G FG V G G+ +A+K+ + + FI E K + + H LV++ C
Sbjct: 12 LGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 694 GADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYA 750
+ +Y E+M G L +L E + Q L + D+
Sbjct: 70 K--------QRPIYIVTEYMSNGCLLNYLR---------EHGKRFQPSQLLEMCKDVCEG 112
Query: 751 LNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYI 810
+ YL Q + H DL N L+DD +V DFGL+R + D TSS K + +
Sbjct: 113 MAYLESK-QFI--HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWS 168
Query: 811 APEYGVGCEVSTNGDVYSYGILLLELV-IGKKPIDIMFEGDINLH 854
PE + + S+ DV+++G+L+ E+ +GK P + +
Sbjct: 169 PPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK 213
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 3e-14
Identities = 66/230 (28%), Positives = 105/230 (45%), Gaps = 40/230 (17%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIA-ECKALKSIRHRNLVKVLT 690
N +G G+ G+VYK I A+KV H R I E + L+ + H N+VK
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK--- 136
Query: 691 ACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYA 750
C + + + EFM GSLE G DE ++A I
Sbjct: 137 -CHDMFDHNGEIQV-LLEFMDGGSLE-------GTHIADEQ-------FLADVARQILSG 180
Query: 751 LNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYI 810
+ YLH + H D+KPSN+L++ ++ DFG++RIL+ T S G++ Y+
Sbjct: 181 IAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA--QTMDPCNSSVGTIAYM 235
Query: 811 APEYGVGCEVSTN----------GDVYSYGILLLELVIGKKPIDIMFEGD 850
+PE ++T+ GD++S G+ +LE +G+ P + +GD
Sbjct: 236 SPE-----RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD 280
|
Length = 353 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 73/228 (32%), Positives = 107/228 (46%), Gaps = 32/228 (14%)
Query: 632 NLVGVGSFGSVYKG----IIDEGRTTIAVKVFNLQHHGASRS----FIAECKALKSIRHR 683
N +G G+FG VY+G I+ G I V V L+ GA+ F+ E + + H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRK-GATDQEKKEFLKEAHLMSNFNHP 59
Query: 684 NLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNI 743
N+VK+L CL N+ + + E M G L L P L L + L+I
Sbjct: 60 NIVKLLGVCLL-----NEPQYIIMELMEGGDL---LSYLRDARVERFGPPLLTLKELLDI 111
Query: 744 AIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD--DYMTARV---GDFGLAR-ILSPDHTQ 797
+D+A YL Q H DL N L+ Y RV GDFGLAR I D+ +
Sbjct: 112 CLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR 168
Query: 798 TSSFSVKGSLG--YIAPEYGVGCEVSTNGDVYSYGILLLE-LVIGKKP 842
+G L ++APE + + +T DV+S+G+L+ E L +G++P
Sbjct: 169 KEG---EGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 4e-14
Identities = 61/220 (27%), Positives = 106/220 (48%), Gaps = 21/220 (9%)
Query: 634 VGVGSFGSV-----YKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKV 688
+G G+FG V Y ++ + +AVK A + F E + L +++H ++VK
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 689 LTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEA----PRNLNLLQRLNIA 744
C+ D V+E+M +G L ++L G D + A P L Q L+IA
Sbjct: 73 YGVCVEGDPL-----IMVFEYMKHGDLNKFLRAH-GPDAVLMAEGNRPAELTQSQMLHIA 126
Query: 745 IDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLAR-ILSPDHTQTSSFSV 803
IA + YL H DL N L+ + + ++GDFG++R + S D+ + ++
Sbjct: 127 QQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM 183
Query: 804 KGSLGYIAPEYGVGCEVSTNGDVYSYGILLLEL-VIGKKP 842
+ ++ PE + + +T DV+S G++L E+ GK+P
Sbjct: 184 L-PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 64/216 (29%), Positives = 107/216 (49%), Gaps = 33/216 (15%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACL 693
+G G FG V+ ++ T +AVK +F+AE +K+++H LVK L A +
Sbjct: 14 LGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVK-LHAVV 70
Query: 694 GADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYA 750
K +Y EFM GSL ++L DE + P L + ++ + IA
Sbjct: 71 T--------KEPIYIITEFMAKGSLLDFLK----SDEGSKQP----LPKLIDFSAQIAEG 114
Query: 751 LNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYI 810
+ ++ Q H DL+ +N+L+ + ++ DFGLAR++ D+ T+ K + +
Sbjct: 115 MAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWT 170
Query: 811 APE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
APE +G + DV+S+GILL+E+V G+ P
Sbjct: 171 APEAINFG---SFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 6e-14
Identities = 60/218 (27%), Positives = 95/218 (43%), Gaps = 31/218 (14%)
Query: 634 VGVGSFGSVYKGII---DEGRTTIAVKVFNLQHHGASRS-FIAECKALKSIRHRNLVKVL 689
+G G+FGSV KG+ +AVK +H A + F+ E + + H +V+++
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 690 TACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAY 749
C G V E G L ++L + R + + +A +A
Sbjct: 63 GVCKGEPL------MLVMELAPLGPLLKYL----------KKRREIPVSDLKELAHQVAM 106
Query: 750 ALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQ-TSSFSVKGSLG 808
+ YL V H DL NVLL + A++ DFG++R L ++ + + L
Sbjct: 107 GMAYLE-SKHFV--HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLK 163
Query: 809 YIAPE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
+ APE YG + S+ DV+SYG+ L E G KP
Sbjct: 164 WYAPECINYG---KFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 60/219 (27%), Positives = 109/219 (49%), Gaps = 29/219 (13%)
Query: 633 LVGVGSFGSVYKGIID-EGRTTIAVKVFNLQ---HHGASRSFIAECKALKSIRHRNLVKV 688
++G G FG V++GI+ GR +AV + L+ + F++E + H N++++
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 689 LTACLGADYRGNDFKAS--VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAID 746
FK + + E+M G+L+++L GE + Q + +
Sbjct: 72 EGVV-------TKFKPAMIITEYMENGALDKYLRDHDGE---------FSSYQLVGMLRG 115
Query: 747 IAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILS--PDHTQTSSFSVK 804
IA + YL D V H DL N+L++ + +V DFGL+R+L P+ T T+S K
Sbjct: 116 IAAGMKYLS-DMNYV--HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGG-K 171
Query: 805 GSLGYIAPEYGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
+ + APE + ++ DV+S+GI++ E++ G++P
Sbjct: 172 IPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 7e-14
Identities = 63/220 (28%), Positives = 108/220 (49%), Gaps = 22/220 (10%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACL 693
+G G FG V+ G + T +AVK + ++F+ E +K+++H LV+ L
Sbjct: 14 LGAGQFGEVWMGYYNNS-TKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVR-----L 66
Query: 694 GADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNY 753
A + + E+M GSL ++L DE + + L + ++ + IA + Y
Sbjct: 67 YAVVTKEEPIYIITEYMAKGSLLDFLKS-------DEGGK-VLLPKLIDFSAQIAEGMAY 118
Query: 754 LHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPE 813
+ + H DL+ +NVL+ + + ++ DFGLAR++ D+ T+ K + + APE
Sbjct: 119 IE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPE 174
Query: 814 -YGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDI 851
G + DV+S+GILL E+V GK P M D+
Sbjct: 175 AINFGS-FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV 213
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 7e-14
Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 633 LVGVGSFGSV----YKGIIDEGRTTIAVKVFNLQHHGAS--RSFIAECKALKSIRHRNLV 686
+G G+FGSV Y + D +AVK LQH A R F E + LKS++H N+V
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVK--KLQHSTAEHLRDFEREIEILKSLQHDNIV 68
Query: 687 KVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAID 746
K C A R V E++ YGSL ++L + +D + L ++ ++
Sbjct: 69 KYKGVCYSAGRRNLRL---VMEYLPYGSLRDYLQ--KHRERLD-HRKLLLYASQICKGME 122
Query: 747 IAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVK-- 804
+ Y+H D L N+L++ ++GDFGL ++L D + V+
Sbjct: 123 YLGSKRYVHRD---------LATRNILVESENRVKIGDFGLTKVLPQD---KEYYKVREP 170
Query: 805 --GSLGYIAPEYGVGCEVSTNGDVYSYGILLLEL 836
+ + APE + S DV+S+G++L EL
Sbjct: 171 GESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 7e-14
Identities = 60/223 (26%), Positives = 104/223 (46%), Gaps = 24/223 (10%)
Query: 628 FSSANLVGVGSFGSVYKGI-IDEG---RTTIAVKVF-NLQHHGASRSFIAECKALKSIRH 682
F ++G G+FG+VYKG+ I EG + +A+K A++ + E + S+ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 683 RNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLN 742
++ ++L CL + + + + M +G L D + E N+ LN
Sbjct: 69 PHVCRLLGICLTSTVQ------LITQLMPFGCLL---------DYVREHKDNIGSQYLLN 113
Query: 743 IAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFS 802
+ IA +NYL + H DL NVL+ ++ DFGLA++L D + +
Sbjct: 114 WCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG 170
Query: 803 VKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELV-IGKKPID 844
K + ++A E + + DV+SYG+ + EL+ G KP D
Sbjct: 171 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 8e-14
Identities = 77/305 (25%), Positives = 126/305 (41%), Gaps = 56/305 (18%)
Query: 633 LVGVGSFGSVYKGI-IDEG---RTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVK 687
++G G+FG+VYKGI I +G + +A+KV A++ + E + + + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 688 VLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDI 747
+L CL + + V + M YG L D + E + LN + I
Sbjct: 74 LLGICLTSTVQ------LVTQLMPYGCLL---------DYVRENKDRIGSQDLLNWCVQI 118
Query: 748 AYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSL 807
A ++YL + + V H DL NVL+ ++ DFGLAR+L D T+ + K +
Sbjct: 119 AKGMSYLE-EVRLV--HRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPI 175
Query: 808 GYIAPEYGVGCEVSTNGDVYSYGILLLELV-IGKKPIDIMFEGDINLHNFGRKALPDDVM 866
++A E + + DV+SYG+ + EL+ G KP D + +PD
Sbjct: 176 KWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD----------GIPAREIPD--- 222
Query: 867 DIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926
+L +R Q I C I + I V C M + R +V
Sbjct: 223 --------------LLEKGERLPQPPI-----CTIDVYMIMVKCWMIDSECRPRFRELVD 263
Query: 927 ELQSI 931
E +
Sbjct: 264 EFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 9e-14
Identities = 57/219 (26%), Positives = 93/219 (42%), Gaps = 31/219 (14%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIA-ECKALKSIRHRNLVKVLTAC 692
+GVG+ VY I +A+K +L+ S + E +A+ H N+VK T+
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS- 67
Query: 693 LGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALN 752
+ D V ++ GSL + + +DEA L + L L
Sbjct: 68 ----FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLK-------GLE 116
Query: 753 YLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGL-ARILSP-DHTQTSSFSVKGSLGYI 810
YLH + Q H D+K N+LL + + ++ DFG+ A + D T+ + G+ ++
Sbjct: 117 YLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWM 173
Query: 811 APE-------YGVGCEVSTNGDVYSYGILLLELVIGKKP 842
APE Y D++S+GI +EL G P
Sbjct: 174 APEVMEQVHGYDFK------ADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 56/221 (25%), Positives = 100/221 (45%), Gaps = 32/221 (14%)
Query: 632 NLVGVGSFGSVYKGIIDE-GRTTIAVKVFNLQHHGAS----RSFIAECKALKSIRHRNLV 686
++G G FG V +G + G+ I V + L G+S F+ E + H N++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 687 KVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAID 746
++ G + + E+M GSL+++L G+ + Q + +
Sbjct: 69 RLE----GVVTKSRPVMI-ITEYMENGSLDKFLRENDGK---------FTVGQLVGMLRG 114
Query: 747 IAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARIL-SPDHTQTSSFSVKG 805
IA + YL H DL N+L++ + +V DFGL+R L + T T+ K
Sbjct: 115 IASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK-GGKI 170
Query: 806 SLGYIAPE---YGVGCEVSTNGDVYSYGILLLE-LVIGKKP 842
+ + APE Y + ++ DV+S+GI++ E + G++P
Sbjct: 171 PIRWTAPEAIAYR---KFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 68/216 (31%), Positives = 101/216 (46%), Gaps = 33/216 (15%)
Query: 634 VGVGSFGSVYKGIID-EGRTT---IAVKVFNLQHHGA-SRSFIAECKALKSIRHRNLVKV 688
+G G FG V D EG T +AVK + G E + L+++ H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 689 LTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRN---LNLLQRLNIAI 745
C + GN K + EF+ GSL+E+L PRN +NL Q+L A+
Sbjct: 72 KGIC--TEDGGNGIKL-IMEFLPSGSLKEYL------------PRNKNKINLKQQLKYAV 116
Query: 746 DIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKG 805
I ++YL Q V H DL NVL++ ++GDFGL + + D ++VK
Sbjct: 117 QICKGMDYLGSR-QYV--HRDLAARNVLVESEHQVKIGDFGLTKAIETDK---EYYTVKD 170
Query: 806 SLG----YIAPEYGVGCEVSTNGDVYSYGILLLELV 837
L + APE + + DV+S+G+ L EL+
Sbjct: 171 DLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 64/233 (27%), Positives = 95/233 (40%), Gaps = 47/233 (20%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACL 693
+G G++G VYK +A+KV L+ E LK RH N+V A
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIV----AYF 66
Query: 694 GADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAY---- 749
G+ Y D V E+ GSL++ L+ LQ IAY
Sbjct: 67 GS-YLRRDKLWIVMEYCGGGSLQDIYQ---------VTRGPLSELQ-------IAYVCRE 109
Query: 750 ---ALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGS 806
L YLH + H D+K +N+LL + ++ DFG++ L+ T S G+
Sbjct: 110 TLKGLAYLHETGK---IHRDIKGANILLTEDGDVKLADFGVSAQLT--ATIAKRKSFIGT 164
Query: 807 LGYIAPEYGVGCEVSTNG-----DVYSYGILLLELVIGKKPIDIMFEGDINLH 854
++APE V G D+++ GI +EL + P MF +LH
Sbjct: 165 PYWMAPE--VAAVERKGGYDGKCDIWALGITAIELAELQPP---MF----DLH 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 66/256 (25%), Positives = 99/256 (38%), Gaps = 44/256 (17%)
Query: 633 LVGVGSFGSVYKGIIDEG---RTTIAVKVF---NLQHHGASRSFIAECKALKSIRHRNLV 686
+G GSFG V +G +AVK L F+ E + S+ H NL+
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLI 59
Query: 687 K----VLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLN 742
+ VLT L V E GSL + L +A + + +
Sbjct: 60 RLYGVVLTHPL----------MMVTELAPLGSLLDRLR--------KDALGHFLISTLCD 101
Query: 743 IAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARIL--SPDHTQTSS 800
A+ IA + YL H DL N+LL ++GDFGL R L + DH
Sbjct: 102 YAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH-YVME 157
Query: 801 FSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLEL-VIGKKP------IDIMFEGDINL 853
+K + APE S DV+ +G+ L E+ G++P I+ + D
Sbjct: 158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG 217
Query: 854 HNFGR-KALPDDVMDI 868
R +A P D+ ++
Sbjct: 218 ERLERPEACPQDIYNV 233
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-13
Identities = 38/85 (44%), Positives = 54/85 (63%)
Query: 323 LDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSI 382
L + N L G IP I +L++L+ + L+ N + GNIPPS+G++ L L L+ N SI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 383 PSSLGQCESLIEINLSNNNLSGTIP 407
P SLGQ SL +NL+ N+LSG +P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 62/216 (28%), Positives = 95/216 (43%), Gaps = 33/216 (15%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTAC 692
+G GS+GSVYK I E +A+KV ++ + I E LK +VK
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVE--EDLQEIIKEISILKQCDSPYIVK----- 62
Query: 693 LGADYRGNDFKAS----VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIA 748
Y G+ FK + V E+ GS+ D + + L + I
Sbjct: 63 ----YYGSYFKNTDLWIVMEYCGAGSV---------SDIMKITNKTLTEEEIAAILYQTL 109
Query: 749 YALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLG 808
L YLH H D+K N+LL++ A++ DFG++ L+ T +V G+
Sbjct: 110 KGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLT--DTMAKRNTVIGTPF 164
Query: 809 YIAPEYGVGCEVSTN--GDVYSYGILLLELVIGKKP 842
++APE V E+ N D++S GI +E+ GK P
Sbjct: 165 WMAPE--VIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 31/223 (13%)
Query: 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKV--FNLQHHGASRSFIAECKALKSIRHR 683
+ F N +G G++G VY+ +A+K + + G S + E L ++RH
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHP 66
Query: 684 NLVKVLTACLGADYRGNDFKASVYEFMHY-----GSLEEWLHPFTGEDEIDEAPRNLNLL 738
N+V++ +G S++ M Y SL +D P +
Sbjct: 67 NIVELKEVVVG------KHLDSIFLVMEYCEQDLASL------------LDNMPTPFSES 108
Query: 739 QRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQT 798
Q + + + L YLH + H DLK SN+LL D ++ DFGLAR
Sbjct: 109 QVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM 165
Query: 799 SSFSVKGSLGYIAPEYGVGCEVSTNG-DVYSYGILLLELVIGK 840
+ V +L Y APE +GC T D+++ G +L EL+ K
Sbjct: 166 TPKVV--TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 58/221 (26%), Positives = 91/221 (41%), Gaps = 32/221 (14%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIA-ECKALKSIRHRNLV 686
F+ +G GSFG VYK I +A+KV +L+ I E + L R +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 687 KVLTACLGADYRGNDFKAS----VYEFMHYGSLEEWLHPFT-GEDEIDEAPRNLNLLQRL 741
K Y G+ K S + E+ GS + L P E I
Sbjct: 63 K---------YYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF----------- 102
Query: 742 NIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSF 801
I ++ L YLH + H D+K +N+LL + ++ DFG++ L+ T +
Sbjct: 103 -ILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLT--STMSKRN 156
Query: 802 SVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
+ G+ ++APE D++S GI +EL G+ P
Sbjct: 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 4e-13
Identities = 58/223 (26%), Positives = 93/223 (41%), Gaps = 42/223 (18%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-----HGASRSFIAECKALKSIRHRNLV 686
+G G++ VYK E +A+K L G + + + E K L+ ++H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 687 KVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLN--LLQRLNIA 744
L G V+EFM LE+ + + I P ++ +L L
Sbjct: 66 G-LLDVFGHK----SNINLVFEFME-TDLEKVIK----DKSIVLTPADIKSYMLMTLR-- 113
Query: 745 IDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVK 804
L YLH + H DLKP+N+L+ ++ DFGLAR + + + V
Sbjct: 114 -----GLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV- 164
Query: 805 GSLGYIAPE-------YGVGCEVSTNGDVYSYGILLLELVIGK 840
+ Y APE YGVG D++S G + EL++
Sbjct: 165 -TRWYRAPELLFGARHYGVGV------DMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 68/261 (26%), Positives = 111/261 (42%), Gaps = 36/261 (13%)
Query: 634 VGVGSFGSVYKGI-IDEGRTTI--AVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLT 690
+G G F VYK I + +GR V++F + A + + E LK + H N++K L
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYL- 68
Query: 691 ACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYA 750
A + N+ V E G L + F + + + + A
Sbjct: 69 ----ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYF------VQLCSA 118
Query: 751 LNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYI 810
L ++H H D+KP+NV + ++GD GL R S T++ S+ G+ Y+
Sbjct: 119 LEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYM 173
Query: 811 APEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD-INLHNFGRK-------ALP 862
+PE + D++S G LL E+ + P F GD +NL++ +K LP
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLYSLCKKIEKCDYPPLP 229
Query: 863 DD-----VMDIVDSSLLPDDE 878
D + D+V + PD E
Sbjct: 230 ADHYSEELRDLVSRCINPDPE 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 4e-13
Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 16/223 (7%)
Query: 628 FSSANLVGVGSFGSVYKGII---DEGRTTIAVKVFNLQHHGAS--RSFIAECKALKSIRH 682
F+ ++G G FGSV + + D +AVK+ +S F+ E +K H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 683 RNLVKVLTACLGADYRGN-DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRL 741
N++K++ L + +G + FM +G L H F I E P L L +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDL----HTFLLMSRIGEEPFTLPLQTLV 116
Query: 742 NIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLAR-ILSPDHTQTSS 800
IDIA + YL H DL N +L++ MT V DFGL++ I S D+ +
Sbjct: 117 RFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGC 173
Query: 801 FSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKP 842
S K + ++A E +T+ DV+++G+ + E++ G+ P
Sbjct: 174 AS-KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 66/234 (28%), Positives = 102/234 (43%), Gaps = 42/234 (17%)
Query: 622 YNATSGFSSANLV-----GVGSFGSVYK----GIIDEGRT-TIAVKVFNLQHHGASR-SF 670
Y+ F NL G G+FG V + G+ +AVK+ H + R +
Sbjct: 26 YDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREAL 85
Query: 671 IAECKALKSI-RHRNLVKVLTACL--GADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDE 727
++E K + + H N+V +L AC G + E+ YG L +L
Sbjct: 86 MSELKIMSHLGNHENIVNLLGACTIGGPIL-------VITEYCCYGDLLNFLR------- 131
Query: 728 IDEAPRNLNLLQRLNIAIDIAYALNYL-HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFG 786
+ L L L+ + +A + +L +C H DL NVLL ++ DFG
Sbjct: 132 -RKRESFLTLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFG 186
Query: 787 LARILSPDHTQTSSFSVKGS----LGYIAPEYGVGCEVSTNGDVYSYGILLLEL 836
LAR + D S++ VKG+ + ++APE C + DV+SYGILL E+
Sbjct: 187 LARDIMND----SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 6e-13
Identities = 63/222 (28%), Positives = 95/222 (42%), Gaps = 38/222 (17%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTAC 692
++G G++G VY + IA+K + + E ++HRN+V+
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQY---- 70
Query: 693 LGADYRGNDFKASVYEFMHY---GSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAY 749
LG+D FK FM GSL L G + +E Q I
Sbjct: 71 LGSDSENGFFKI----FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ-------ILE 119
Query: 750 ALNYLHHDCQPVTAHCDLKPSNVLLDDYM-TARVGDFGLARILSPDHTQTSSFSVKGSLG 808
L YL HD Q V H D+K NVL++ Y ++ DFG ++ L+ + T +F G+L
Sbjct: 120 GLKYL-HDNQIV--HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF--TGTLQ 174
Query: 809 YIAPE--------YGVGCEVSTNGDVYSYGILLLELVIGKKP 842
Y+APE YG D++S G ++E+ GK P
Sbjct: 175 YMAPEVIDKGPRGYGAP------ADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 61/222 (27%), Positives = 106/222 (47%), Gaps = 34/222 (15%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVK 687
F+ +G GSFG V+KGI + + +A+K+ +L+ AE ++ I+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--------AE-DEIEDIQQE--IT 54
Query: 688 VLTACLG---ADYRGNDFKAS----VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQR 740
VL+ C Y G+ K + + E++ GS + L P +DE Q
Sbjct: 55 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP----GPLDET-------QI 103
Query: 741 LNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSS 800
I +I L+YLH + + H D+K +NVLL ++ ++ DFG+A L+ + ++
Sbjct: 104 ATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 160
Query: 801 FSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
F G+ ++APE + D++S GI +EL G+ P
Sbjct: 161 FV--GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-13
Identities = 62/235 (26%), Positives = 101/235 (42%), Gaps = 39/235 (16%)
Query: 634 VGVGSFGSVYKGIIDE-----GRTTIAVKVFNLQHHGAS----RSFIAECKALKSIRHRN 684
+G G FG V K G TT+AVK+ AS R ++E LK + H +
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK---ENASSSELRDLLSEFNLLKQVNHPH 64
Query: 685 LVKVLTACL--GADYRGNDFKASVYEFMHYGSLEEWLH-------PFTGED-----EIDE 730
++K+ AC G + E+ YGSL +L + G D +
Sbjct: 65 VIKLYGACSQDGPLLL-------IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLD 117
Query: 731 AP--RNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLA 788
P R L + ++ A I+ + YL + H DL NVL+ + ++ DFGL+
Sbjct: 118 NPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLS 174
Query: 789 RILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
R + + + + + ++A E +T DV+S+G+LL E+V +G P
Sbjct: 175 RDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 8e-13
Identities = 52/179 (29%), Positives = 81/179 (45%), Gaps = 35/179 (19%)
Query: 427 LTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSL 486
L G +P ++ KL+ L+ + + N + G IP + G+ LE L + N F G I SLG L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 487 RGLRVLDLSQNNLSGEIPKFLAGLSLNNLNLSYNDLEGMVTTEGVFKNASATRILGNSKL 546
LR+L+L+ N+LSG +P L G L+ + ++ D N+ L
Sbjct: 490 TSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTD---------------------NAGL 528
Query: 547 CGGISEFKLPTCVSKKSKRRRLTFVPTLVIAIVFRLLGLALALFGLVLCLVRKIKEKEN 605
CG L C S + I I F G+++A LV+C + K ++N
Sbjct: 529 CGIPG---LRACGPHLSVGAK--------IGIAF---GVSVAFLFLVICAMCWWKRRQN 573
|
Length = 623 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 8e-13
Identities = 61/220 (27%), Positives = 96/220 (43%), Gaps = 26/220 (11%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQ--HHGASRSFIAECKALKSIRHRNLVKVLTA 691
+G G+ G V+K E T+A+K L+ G + E KAL++ +H +VK+L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 692 CLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYAL 751
G+ F V E+M L E L + R L Q + + +
Sbjct: 68 FP----HGSGF-VLVMEYM-PSDLSEVLR---------DEERPLPEAQVKSYMRMLLKGV 112
Query: 752 NYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIA 811
Y+H H DLKP+N+L+ ++ DFGLAR+ S + + S V + Y A
Sbjct: 113 AYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRA 168
Query: 812 PEYGVGCEVSTNG-DVYSYGILLLELVIGKKPIDIMFEGD 850
PE G G D+++ G + EL + P+ F G+
Sbjct: 169 PELLYGARKYDPGVDLWAVGCIFAEL-LNGSPL---FPGE 204
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 61/224 (27%), Positives = 105/224 (46%), Gaps = 38/224 (16%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVK 687
F+ +G GSFG V+KGI + + +A+K+ +L+ AE ++ I+ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--------AE-DEIEDIQQE--IT 54
Query: 688 VLTACLGA---DYRGNDFKAS----VYEFMHYGSLEEWLH--PFTGEDEIDEAPRNLNLL 738
VL+ C Y G+ K + + E++ GS + L PF DE
Sbjct: 55 VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPF---DE----------F 101
Query: 739 QRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQT 798
Q + +I L+YLH + + H D+K +NVLL + ++ DFG+A L+ +
Sbjct: 102 QIATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158
Query: 799 SSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
++F G+ ++APE + D++S GI +EL G+ P
Sbjct: 159 NTFV--GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 24/211 (11%)
Query: 634 VGVGSFGSVYKGIIDEGRT--TIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTA 691
+G G+ G VYK + T +A+K L+ I E +K +H N+V +
Sbjct: 27 IGEGASGEVYKAT--DRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDS 83
Query: 692 CLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYAL 751
Y D V E+M GSL D I + +N Q + ++ L
Sbjct: 84 -----YLVGDELWVVMEYMDGGSLT---------DIITQNFVRMNEPQIAYVCREVLQGL 129
Query: 752 NYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIA 811
YLH Q V H D+K N+LL + ++ DFG A L+ + ++ +S V G+ ++A
Sbjct: 130 EYLHS--QNVI-HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMA 184
Query: 812 PEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
PE + D++S GI+ +E+ G+ P
Sbjct: 185 PEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 59/230 (25%), Positives = 104/230 (45%), Gaps = 31/230 (13%)
Query: 633 LVGVGSFGSVYKG---IIDEGRTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVK- 687
++G G FG V +G + + +A+K + R F++E + H N++
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 688 --VLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAI 745
V+T + EFM G+L+ +L G+ ++Q + +
Sbjct: 71 EGVVTKSRPV--------MIITEFMENGALDSFLRQNDGQ---------FTVIQLVGMLR 113
Query: 746 DIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARIL---SPDHTQTSSFS 802
IA + YL + H DL N+L++ + +V DFGL+R L + D T TSS
Sbjct: 114 GIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLG 170
Query: 803 VKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELV-IGKKPIDIMFEGDI 851
K + + APE + ++ DV+SYGI++ E++ G++P M D+
Sbjct: 171 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 220
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 62/212 (29%), Positives = 93/212 (43%), Gaps = 27/212 (12%)
Query: 634 VGVGSFGSV----YKGIIDEGRTTIAVKVFNLQHHGASRS-FIAECKALKSIRHRNLVKV 688
+G G FG V Y D +AVK + + S + E LK++ H N+VK
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 689 LTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRN-LNLLQRLNIAIDI 747
C +G + E++ GSL ++L P++ LNL Q L A I
Sbjct: 72 KGCC---SEQGGKGLQLIMEYVPLGSLRDYL------------PKHKLNLAQLLLFAQQI 116
Query: 748 AYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGS- 806
+ YLH H DL NVLLD+ ++GDFGLA+ + P+ + G
Sbjct: 117 CEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDS 172
Query: 807 -LGYIAPEYGVGCEVSTNGDVYSYGILLLELV 837
+ + A E + S DV+S+G+ L EL+
Sbjct: 173 PVFWYAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 60/222 (27%), Positives = 102/222 (45%), Gaps = 34/222 (15%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVK 687
F+ +G GSFG VYKGI + + +A+K+ +L+ AE ++ I+ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--------AE-DEIEDIQQE--IT 54
Query: 688 VLTACLG---ADYRGNDFKAS----VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQR 740
VL+ C Y G+ K + + E++ GS + L P E+
Sbjct: 55 VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA---------- 104
Query: 741 LNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSS 800
I +I L+YLH + + H D+K +NVLL + ++ DFG+A L+ + ++
Sbjct: 105 -TILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160
Query: 801 FSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
F G+ ++APE D++S GI +EL G+ P
Sbjct: 161 FV--GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 69/229 (30%), Positives = 107/229 (46%), Gaps = 43/229 (18%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGAS-----RSFIA----ECKALKSIRHR 683
L+G GSFGSVY G+ +AVK L AS RS + E LK ++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 684 NLVKVLTACLGADYRGNDF-----KASVYEFM-HYGSLEEWLHPFTGEDEIDEAPRNLNL 737
N+V+ L + L AD+ N F SV + +YG+ EE L
Sbjct: 67 NIVQYLGSSLDADHL-NIFLEYVPGGSVAALLNNYGAFEETL------------------ 107
Query: 738 LQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQ 797
N I LNYLH+ H D+K +N+L+D+ ++ DFG+++ L +
Sbjct: 108 --VRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLS 162
Query: 798 TSSF----SVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
T + S++GS+ ++APE + D++S G L++E++ GK P
Sbjct: 163 TKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 60/238 (25%), Positives = 116/238 (48%), Gaps = 21/238 (8%)
Query: 621 LYNATSGFSSANLVGVGSFGSVYKGII--DEGRTTIAVKVFNLQHHGASRS----FIAEC 674
+ + + ++L+ G+FG ++ GI+ ++ V V ++ H AS + E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQES 59
Query: 675 KALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRN 734
L + H+N++ +L C+ + +Y +M++G+L+ +L P+
Sbjct: 60 CLLYGLSHQNILPILHVCI----EDGEPPFVLYPYMNWGNLKLFLQ--QCRLGEANNPQA 113
Query: 735 LNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPD 794
L+ Q +++AI IA ++YLH + H D+ N ++D+ + ++ D L+R L P
Sbjct: 114 LSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPM 170
Query: 795 HTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELV-IGKKP---IDIMFE 848
+ + ++A E V E S+ DV+S+G+LL EL+ +G+ P ID FE
Sbjct: 171 DYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-FE 227
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 36/226 (15%)
Query: 634 VGVGSFGSVYK----GII-DEGRTTIAVKVFNLQHHGAS----RSFIAECKALKSIRHRN 684
+G G+FG V++ G++ E T +AVK+ AS F E + H N
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAALMAEFDHPN 69
Query: 685 LVKVLTAC-LGADYRGNDFKASVYEFMHYGSLEEWL------------HPFTGEDEIDEA 731
+VK+L C +G ++E+M YG L E+L H + +
Sbjct: 70 IVKLLGVCAVGKPM------CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLN 123
Query: 732 PRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLAR-I 790
P L+ ++L IA +A + YL + H DL N L+ + M ++ DFGL+R I
Sbjct: 124 PLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 180
Query: 791 LSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLEL 836
S D+ + S + + ++ PE +T DV++YG++L E+
Sbjct: 181 YSADYYKASE-NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-12
Identities = 34/90 (37%), Positives = 50/90 (55%), Gaps = 1/90 (1%)
Query: 371 LFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGS 430
L L++ L IP+ + + L INLS N++ G IPP S++SL + LD S N GS
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEV-LDLSYNSFNGS 481
Query: 431 LPIEVGKLKILEFLYVYENRLEGEIPSTFG 460
+P +G+L L L + N L G +P+ G
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 5e-12
Identities = 63/252 (25%), Positives = 112/252 (44%), Gaps = 47/252 (18%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASR----SFIAECKALKSIRHRNLVKV 688
+VG G+FG V+ + + +K + ++ + EC+ LK + H N+++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPV--EQMTKDERLAAQNECQVLKLLSHPNIIEY 64
Query: 689 LTACLGADYRGNDFKASVYEFMHYGSLEEWLH----PFTGEDEIDEAPRNLNLLQRLNIA 744
L V E+ G+L E++ ED I L+
Sbjct: 65 YENFLEDKALM-----IVMEYAPGGTLAEYIQKRCNSLLDEDTI------------LHFF 107
Query: 745 IDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDY-MTARVGDFGLARILSPDHTQTSSFSV 803
+ I AL+++H + H DLK N+LLD + M ++GDFG+++ILS +++ +++V
Sbjct: 108 VQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTV 161
Query: 804 KGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPD 863
G+ YI+PE G + D+++ G +L EL K+ FE LP
Sbjct: 162 VGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRA----FEA---------ANLPA 208
Query: 864 DVMDIVDSSLLP 875
V+ I+ + P
Sbjct: 209 LVLKIMSGTFAP 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 38/221 (17%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIA-ECKALKSIRH---RNLVKV 688
L+G G++G+VY+G +A+K+ NL S I E L +R N+ K
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITK- 66
Query: 689 LTACLGADYRGNDFKAS----VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIA 744
Y G+ K + E+ GS+ + I E + ++++ R
Sbjct: 67 --------YYGSYLKGPRLWIIMEYAEGGSVRTLMKA----GPIAE--KYISVIIR---- 108
Query: 745 IDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG--DFGLARILSPDHTQTSSFS 802
++ AL Y+H V H D+K +N+L+ T V DFG+A +L+ + ++ S+F
Sbjct: 109 -EVLVALKYIHKV--GVI-HRDIKAANILVT--NTGNVKLCDFGVAALLNQNSSKRSTFV 162
Query: 803 VKGSLGYIAPEYGV-GCEVSTNGDVYSYGILLLELVIGKKP 842
G+ ++APE G T D++S GI + E+ G P
Sbjct: 163 --GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-12
Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 15/216 (6%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRS----FIAECKALKSIRHRNLVKVL 689
+G G FGSV +G +++ + + V V ++ +RS F++E +K H N+++++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 690 TACL-GADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIA 748
CL + G + FM +G L H F + + P+ L + DIA
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDL----HSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122
Query: 749 YALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLA-RILSPDHTQTSSFSVKGSL 807
+ YL H DL N +L++ M V DFGL+ +I + D+ + + K +
Sbjct: 123 SGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIA-KMPV 178
Query: 808 GYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKP 842
+IA E +T DV+S+G+ + E+ G+ P
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 27/211 (12%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIA--ECKALKSIRHRNLVKVLTA 691
+G GS+G V+K E +A+K F IA E + LK ++H NLV ++
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 692 CLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYAL 751
+R V+E+ + L +E+++ PR + I A+
Sbjct: 69 -----FRRKRKLHLVFEYCDHTVL----------NELEKNPRGVPEHLIKKIIWQTLQAV 113
Query: 752 NYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILS-PDHTQTSSFSVKGSLGY 809
N+ H H+C H D+KP N+L+ ++ DFG ARIL+ P T + + Y
Sbjct: 114 NFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR---WY 166
Query: 810 IAPEYGVG-CEVSTNGDVYSYGILLLELVIG 839
APE VG + DV++ G + EL+ G
Sbjct: 167 RAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 24/214 (11%)
Query: 634 VGVGSFGSVYKGII-----DEGRTTIAVKVFNLQHHGASR-SFIAECKALKSIRHRNLVK 687
+G GSFG VY+GI DE T +A+K N R F+ E +K ++V+
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 688 VLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDI 747
+L G +G + E M G L+ +L E E + +L + + +A +I
Sbjct: 74 LL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI 128
Query: 748 AYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSL 807
A + YL+ + H DL N ++ + T ++GDFG+ R D +T + KG
Sbjct: 129 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYR-KGGK 180
Query: 808 G-----YIAPEYGVGCEVSTNGDVYSYGILLLEL 836
G +++PE +T DV+S+G++L E+
Sbjct: 181 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 8e-12
Identities = 64/228 (28%), Positives = 109/228 (47%), Gaps = 34/228 (14%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGAS---RSFIAECKALKSI-RHRNLVK 687
+++G G+FG V K I + + + ++ + + R F E + L + H N++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 688 VLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEA-------PRNLNLLQR 740
+L AC ++RG + A E+ +G+L ++L + E D A L+ Q
Sbjct: 73 LLGAC---EHRGYLYLA--IEYAPHGNLLDFLRK-SRVLETDPAFAIANSTASTLSSQQL 126
Query: 741 LNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSS 800
L+ A D+A ++YL Q H DL N+L+ + A++ DFGL+R
Sbjct: 127 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQE 175
Query: 801 FSVKGSLG-----YIAPEYGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
VK ++G ++A E +TN DV+SYG+LL E+V +G P
Sbjct: 176 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 66/228 (28%), Positives = 107/228 (46%), Gaps = 34/228 (14%)
Query: 632 NLVGVGSFGSVYKGII--DEGRTTIAVKVFN-LQHHGASRSFIAECKAL-KSIRHRNLVK 687
+++G G+FG V + +I D + A+K+ R F E + L K H N++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 688 VLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEA-------PRNLNLLQR 740
+L AC + RG + A E+ YG+L ++L + E D A L Q
Sbjct: 68 LLGAC---ENRGYLYIA--IEYAPYGNLLDFLRK-SRVLETDPAFAKEHGTASTLTSQQL 121
Query: 741 LNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSS 800
L A D+A + YL + Q + H DL NVL+ + + +++ DFGL+R
Sbjct: 122 LQFASDVATGMQYLS-EKQFI--HRDLAARNVLVGENLASKIADFGLSR--------GEE 170
Query: 801 FSVKGSLG-----YIAPEYGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
VK ++G ++A E +T DV+S+G+LL E+V +G P
Sbjct: 171 VYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 30/209 (14%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVF--NLQHHGASRSFIAECKALKSIRHRNLVKVLT 690
L+G G+FG V+KG + + +T +AVK +L + F++E + LK H N+VK++
Sbjct: 2 LLGKGNFGEVFKGTLKD-KTPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIG 59
Query: 691 ACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYA 750
C + +Y M ++L + + L Q + A+D A
Sbjct: 60 VCTQ--------RQPIYIVMELVPGGDFLSFLRKKKD------ELKTKQLVKFALDAAAG 105
Query: 751 LNYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGY 809
+ YL +C H DL N L+ + ++ DFG++R D +SS + + +
Sbjct: 106 MAYLESKNC----IHRDLAARNCLVGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKW 160
Query: 810 IAPE---YGVGCEVSTNGDVYSYGILLLE 835
APE YG S+ DV+SYGILL E
Sbjct: 161 TAPEALNYG---RYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 39/225 (17%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGAS------RSFIAECKALKSIRHRNLV 686
+G G+F S Y+ + T +AVK + +S + E + + + H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 687 KVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAID 746
+ LGA + F V E+M GS+ L + EA Q
Sbjct: 67 R----MLGATCEDSHFNLFV-EWMAGGSVSHLLSKY---GAFKEAVIINYTEQ------- 111
Query: 747 IAYALNYLHHDCQPVTAHCDLKPSNVLLDDY-MTARVGDFGLARILSPDHTQTSSFSVK- 804
+ L+YLH + Q + H D+K +N+L+D R+ DFG A L+ T F +
Sbjct: 112 LLRGLSYLH-ENQII--HRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQL 168
Query: 805 -GSLGYIAPE------YGVGCEVSTNGDVYSYGILLLELVIGKKP 842
G++ ++APE YG C DV+S G +++E+ K P
Sbjct: 169 LGTIAFMAPEVLRGEQYGRSC------DVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 62/215 (28%), Positives = 95/215 (44%), Gaps = 41/215 (19%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTA 691
+G G+FG VYKG++ +G T +AVK R F+ E + LK H N+VK++
Sbjct: 2 KIGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 692 CLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIA 748
C+ K +Y E + GSL +L L + + L +++D A
Sbjct: 61 CVQ--------KQPIYIVMELVPGGSLLTFLRKKKNR---------LTVKKLLQMSLDAA 103
Query: 749 YALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLG 808
+ YL H DL N L+ + ++ DFG++R + ++V L
Sbjct: 104 AGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSR-----EEEGGIYTVSDGLK 155
Query: 809 YI-----APE---YGVGCEVSTNGDVYSYGILLLE 835
I APE YG ++ DV+SYGILL E
Sbjct: 156 QIPIKWTAPEALNYG---RYTSESDVWSYGILLWE 187
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 1e-11
Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTAC 692
+G GS+ +VYKG +A+KV LQ G + I E LK ++H N+V
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIV-----L 67
Query: 693 LGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALN 752
L + V+E++H L +++ G + L L Q L L+
Sbjct: 68 LHDIIHTKETLTLVFEYVH-TDLCQYMDKHPGGLHPENV--KLFLFQLLR-------GLS 117
Query: 753 YLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILS-PDHTQTSSFSVKGSLGYIA 811
Y+H Q H DLKP N+L+ D ++ DFGLAR S P HT ++ +L Y
Sbjct: 118 YIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV---TLWYRP 171
Query: 812 PEYGVG-CEVSTNGDVYSYGILLLELVIG 839
P+ +G E ST D++ G + +E++ G
Sbjct: 172 PDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 66/230 (28%), Positives = 100/230 (43%), Gaps = 34/230 (14%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNL--QHHGASRSFIAECKALKSIRHRNL 685
F +G G++G VYK +A+K L + G + I E LK + H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 686 VKVLTACLGADYRGNDFKAS-VYEFMHYGSLEEWLHPFTGEDEIDEAPRNL--NLLQRLN 742
VK+L D + K V+EF+H + L F + P L + L +L
Sbjct: 62 VKLL------DVIHTENKLYLVFEFLH-----QDLKKFMDASPLSGIPLPLIKSYLFQLL 110
Query: 743 IAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILS-PDHTQTSSF 801
+ ++ LH D LKP N+L++ ++ DFGLAR P T T
Sbjct: 111 QGLAFCHSHRVLHRD---------LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 161
Query: 802 SVKGSLGYIAPEYGVGCEV-STNGDVYSYGILLLELVIGKKPIDIMFEGD 850
+L Y APE +GC+ ST D++S G + E+V + +F GD
Sbjct: 162 V---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 61/225 (27%), Positives = 92/225 (40%), Gaps = 33/225 (14%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRS-FIAECKALKSIRHRNLVKVLTAC 692
+G G FG V+ G + R I V + + S FI E K + + H LV++ C
Sbjct: 12 LGSGQFGVVHLG---KWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 693 LGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAY 749
+ +Y EFM G L +L G+ D L++ D+
Sbjct: 69 TQ--------QKPLYIVTEFMENGCLLNYLRQRQGKLSKD---------MLLSMCQDVCE 111
Query: 750 ALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGY 809
+ YL + H DL N L+ +V DFG+ R + D TSS K + +
Sbjct: 112 GMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YTSSSGAKFPVKW 167
Query: 810 IAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINL 853
PE + S+ DV+S+G+L+ E+ GK P FE N
Sbjct: 168 SPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP----FEKKSNY 208
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 58/219 (26%), Positives = 88/219 (40%), Gaps = 36/219 (16%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLG 694
G G+FG VYK E A K+ ++ F+ E L +H N+V + A
Sbjct: 14 GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF- 72
Query: 695 ADYRGNDFKASVY-EFMHYGSL----EEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAY 749
+ K + EF G+L E T E +I +L+
Sbjct: 73 -----YENKLWILIEFCDGGALDSIMLELERGLT-EPQI--RYVCRQMLE---------- 114
Query: 750 ALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGY 809
ALN+LH H DLK N+LL ++ DFG++ + +F G+ +
Sbjct: 115 ALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI--GTPYW 169
Query: 810 IAPEYGVGCEVSTN------GDVYSYGILLLELVIGKKP 842
+APE V CE + D++S GI L+EL + P
Sbjct: 170 MAPEV-VACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 33/221 (14%)
Query: 633 LVGVGSFGSVYKGIID-EGRTTIAVKVFNLQ---HHGASRSFIAECKALKSIRHRNLVK- 687
++G G FG V G + G+ I V + L+ R F++E + H N++
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 688 --VLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAI 745
V+T V E+M GSL+ +L G+ ++Q + +
Sbjct: 71 EGVVTKSKPV--------MIVTEYMENGSLDAFLRKHDGQ---------FTVIQLVGMLR 113
Query: 746 DIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKG 805
IA + YL D V H DL N+L++ + +V DFGL+R+L D ++++ +G
Sbjct: 114 GIASGMKYLS-DMGYV--HRDLAARNILVNSNLVCKVSDFGLSRVLEDD--PEAAYTTRG 168
Query: 806 S---LGYIAPEYGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
+ + APE + ++ DV+SYGI++ E++ G++P
Sbjct: 169 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 71/238 (29%), Positives = 112/238 (47%), Gaps = 34/238 (14%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNL 685
F +G G++G VYK + +A+K L + G + I E K L+ + HRN+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 686 VKVLTACLGADYRGNDFKAS------VYEFM-H--YGSLEEWLHPFTGEDEIDEAPRNLN 736
V L + DFK V+E+M H G LE L F+ ED I +
Sbjct: 69 VN-LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFS-EDHIK------S 120
Query: 737 LLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHT 796
+++L ++ + N+LH D +K SN+LL++ ++ DFGLAR+ + + +
Sbjct: 121 FMKQLLEGLNYCHKKNFLHRD---------IKCSNILLNNKGQIKLADFGLARLYNSEES 171
Query: 797 QTSSFSVKGSLGYIAPEYGVGCEVSTNG-DVYSYGILLLELVIGKKPIDIMFEGDINL 853
+ + V +L Y PE +G E DV+S G +L EL KKPI F+ + L
Sbjct: 172 RPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI---FQANQEL 224
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 58/237 (24%), Positives = 105/237 (44%), Gaps = 42/237 (17%)
Query: 633 LVGVGSFGSVYKGI-IDEGRTTIAVKVFNL------QHHGASRSFI----AECKALKSIR 681
L+G G++G VY + + G +AVK L +H + + +E + LK +
Sbjct: 8 LIGKGTYGRVYLALNVTTGEM-MAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 682 HRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRL 741
H N+V LG + ++ + E++ GS+ L + +E ++
Sbjct: 67 HLNIV----QYLGFE-TTEEYLSIFLEYVPGGSIGSCLRTYGRFEE----QLVRFFTEQ- 116
Query: 742 NIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSF 801
+ L YLH H DLK N+L+D ++ DFG+++ + +
Sbjct: 117 -----VLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNM 168
Query: 802 SVKGSLGYIAPE----YGVGCEVSTNGDVYSYGILLLELVIGKKP------IDIMFE 848
S++GS+ ++APE Y G S D++S G ++LE+ G++P I MF+
Sbjct: 169 SMQGSVFWMAPEVIHSYSQG--YSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK 223
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 4e-11
Identities = 65/226 (28%), Positives = 99/226 (43%), Gaps = 28/226 (12%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVK--VFNLQHHGASRSFIAEC---KALKSIRHRNLV 686
+G G++G+VYK +A+K L G S + E K L+S H N+V
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 687 KVLTACLGADYRGNDFKASVYEFMHYGSLEEWL--HPFTGEDEIDEAPRNLNLLQRLNIA 744
++L C G V+E + L +L P G E ++L + Q L
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPP--ETIKDL-MRQLLR-- 118
Query: 745 IDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVK 804
+++LH H DLKP N+L+ ++ DFGLARI S + T SV
Sbjct: 119 -----GVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALT---SVV 167
Query: 805 GSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
+L Y APE + +T D++S G + EL ++P+ F G
Sbjct: 168 VTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRPL---FRGT 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 68/274 (24%), Positives = 112/274 (40%), Gaps = 46/274 (16%)
Query: 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVK---VFNLQHHGASRSFIAECKALKSIRH 682
+ F +G G F VY+ +A+K +F+L A I E LK + H
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61
Query: 683 RNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLN 742
N++K + + N+ V E G L + F + + P
Sbjct: 62 PNVIKYYASFI----EDNELNI-VLELADAGDLSRMIKHFKKQKRL--IPEK----TVWK 110
Query: 743 IAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFS 802
+ + AL ++H H D+KP+NV + ++GD GL R S T++ S
Sbjct: 111 YFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHS 165
Query: 803 VKGSLGYIAPEYGVGCEVSTNG-----DVYSYGILLLELVIGKKPIDIMFEGD-INLHNF 856
+ G+ Y++PE + NG D++S G LL E+ + P F GD +NL++
Sbjct: 166 LVGTPYYMSPE-----RIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLYSL 216
Query: 857 GRK-------ALPDD-----VMDIVDSSLLPDDE 878
+K LP D + +V+ + PD E
Sbjct: 217 CKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPE 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 7e-11
Identities = 68/225 (30%), Positives = 101/225 (44%), Gaps = 35/225 (15%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTA 691
+G G++G VYK TIA+K L+ G + I E LK ++H N+V+ L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVR-LQD 68
Query: 692 CLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAP---RNLNLLQRLNIAIDIA 748
+ ++ R +Y Y L+ H +D +P +N L++ I
Sbjct: 69 VVHSEKR-------LYLVFEYLDLDLKKH-------MDSSPDFAKNPRLIKTYLYQILRG 114
Query: 749 YALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA-RVGDFGLARILS-PDHTQTSSFSVKGS 806
A + H H DLKP N+L+D A ++ DFGLAR P T T +
Sbjct: 115 IAYCHSHR-----VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV---T 166
Query: 807 LGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
L Y APE +G ST D++S G + E+V +KP +F GD
Sbjct: 167 LWYRAPEILLGSRHYSTPVDIWSVGCIFAEMV-NQKP---LFPGD 207
|
Length = 294 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 8e-11
Identities = 33/89 (37%), Positives = 50/89 (56%)
Query: 118 LALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSI 177
L L+N + G IP +IS+ L I+ N + G I S++ E+L+L N GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 178 PSSLGNLSSIHTISLAYNNLDGTIPNSFG 206
P SLG L+S+ ++L N+L G +P + G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 9e-11
Identities = 35/90 (38%), Positives = 53/90 (58%), Gaps = 1/90 (1%)
Query: 347 LGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTI 406
LGL+ L G IP I L+ L ++ L+ N + +IP SLG SL ++LS N+ +G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 407 PPQFFSLSSLSISLDWSRNKLTGSLPIEVG 436
P L+SL I L+ + N L+G +P +G
Sbjct: 483 PESLGQLTSLRI-LNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 9e-11
Identities = 63/230 (27%), Positives = 104/230 (45%), Gaps = 31/230 (13%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGAS------RSFIAECKALKSIR 681
++ ++G G++G+VY G+ ++G+ IAVK L E LKS++
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQ-LIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60
Query: 682 HRNLVKVLTACLGADYRGNDFKASVY-EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQR 740
H N+V+ L CL +D S++ EF+ GS+ L+ F E +L
Sbjct: 61 HVNIVQYLGTCL------DDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD- 113
Query: 741 LNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILS--PDHTQT 798
+ YLH++C H D+K +NV+L ++ DFG AR L+ H
Sbjct: 114 ---------GVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTH 161
Query: 799 SSF--SVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIM 846
S+ S+ G+ ++APE D++S G + E+ GK P+ M
Sbjct: 162 SNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM 211
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-10
Identities = 34/90 (37%), Positives = 53/90 (58%), Gaps = 8/90 (8%)
Query: 146 NNQ-LVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNS 204
+NQ L G I + S L + +NL N + G+IP SLG+++S+ + L+YN+ +G+IP S
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485
Query: 205 FGWFENLVFLSLAANNLSVVENKLTGEVPS 234
G +L L+L N+LS G VP+
Sbjct: 486 LGQLTSLRILNLNGNSLS-------GRVPA 508
|
Length = 623 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 32/220 (14%)
Query: 633 LVGVGSFGSVYKGI-IDEGRTTIAVKVFNLQHHGAS-----RSFIAECKALKSIRHRNLV 686
L+G G+FG VY +D GR +AVK + E + LK+++H +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRE-LAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 687 KVLTACLGADYRGNDFKASVYEFMHY---GSLEEWLHPFTGEDEIDEAPRNLNLLQRLNI 743
+ CL D ++ FM Y GS+++ L + + ++
Sbjct: 68 QYY-GCLRDD-------ETLSIFMEYMPGGSVKDQLKAY--------GALTETVTRKY-- 109
Query: 744 AIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSF-S 802
I + YLH + + H D+K +N+L D ++GDFG ++ L + + S
Sbjct: 110 TRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS 166
Query: 803 VKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
V G+ +++PE G DV+S G ++E++ K P
Sbjct: 167 VTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 64/228 (28%), Positives = 100/228 (43%), Gaps = 42/228 (18%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNL---QHHGASRSFIAECKALKSIRHRN 684
F+ +G GSFG+VY +A+K + Q + + I E + L+ +RH N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 685 LVKVLTACLGADYRGNDFKASV-YEFMHY--GSLEEWLHPFTGEDEIDEAPRNLNLLQRL 741
+ +Y+G + + M Y GS + L E+ + P LQ +
Sbjct: 77 TI---------EYKGCYLREHTAWLVMEYCLGSASDIL-------EVHKKP-----LQEV 115
Query: 742 NIAI---DIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQT 798
IA L YLH H D+K N+LL + T ++ DFG A ++SP
Sbjct: 116 EIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP----A 168
Query: 799 SSFSVKGSLGYIAPEYGVGC-EVSTNG--DVYSYGILLLELVIGKKPI 843
+SF G+ ++APE + E +G DV+S GI +EL K P+
Sbjct: 169 NSFV--GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 60/232 (25%), Positives = 93/232 (40%), Gaps = 38/232 (16%)
Query: 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNL--QHHGASRSFIAECKALKSIRHRN 684
F +G GS+GSVYK A+K +L + E + L S+ H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 685 LVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWL-------HPFTGEDEIDEAPRNLNL 737
++ A L GN V E+ +G L + + E EI
Sbjct: 61 IISYKEAFL----DGNKL-CIVMEYAPFGDLSKAISKRKKKRKLIP-EQEI--------- 105
Query: 738 LQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQ 797
I I + L LH + + + H DLK +N+LL ++GD G++++L +
Sbjct: 106 ---WRIFIQLLRGLQALH-EQKIL--HRDLKSANILLVANDLVKIGDLGISKVL----KK 155
Query: 798 TSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEG 849
+ + G+ Y+APE G S D++S G LL E+ P FE
Sbjct: 156 NMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP----FEA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 67/274 (24%), Positives = 112/274 (40%), Gaps = 75/274 (27%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKV----FNLQHHGASRSFIAECKALKSIRHR 683
+ + + VG G++G V + +A+K F H A R++ E + LK + H
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIH-AKRTY-RELRLLKHMDHE 74
Query: 684 NLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLL---QR 740
N++ +L DF+ VY H G D LN + Q+
Sbjct: 75 NVIGLLD-VFTPASSLEDFQ-DVYLVTH----------LMGAD--------LNNIVKCQK 114
Query: 741 LN------IAIDIAYALNYLHHDCQPVTA---HCDLKPSNVLLDDYMTARVGDFGLARIL 791
L+ + I L Y+H +A H DLKPSN+ +++ ++ DFGLAR
Sbjct: 115 LSDDHIQFLVYQILRGLKYIH------SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168
Query: 792 SPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNG-------DVYSYGILLLELVIGKKPID 844
+ T GY+A + E+ N D++S G ++ EL+ GK
Sbjct: 169 DDEMT-----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK---- 213
Query: 845 IMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDE 878
+F G ++ R +M++V + PD+E
Sbjct: 214 TLFPGSDHIDQLKR------IMNLVGT---PDEE 238
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-10
Identities = 43/124 (34%), Positives = 66/124 (53%), Gaps = 14/124 (11%)
Query: 725 EDEIDEAPRNLNLLQRLNIAIDIAYALNYL-HHDCQPVTAHCDLKPSNVLLDDYMTARVG 783
++E E L+L L + +A +++L +C H D+ NVLL D A++
Sbjct: 199 DEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKIC 254
Query: 784 DFGLARILSPDHTQTSSFSVKGS----LGYIAPEYGVGCEVSTNGDVYSYGILLLELV-I 838
DFGLAR + D S++ VKG+ + ++APE C + DV+SYGILL E+ +
Sbjct: 255 DFGLARDIMND----SNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL 310
Query: 839 GKKP 842
GK P
Sbjct: 311 GKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 58/254 (22%), Positives = 103/254 (40%), Gaps = 39/254 (15%)
Query: 637 GSFGSVYKGIIDEGRTT---IAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACL 693
G+FGSVY + + R+T A+KV + +++ + KA ++I A L
Sbjct: 7 GAFGSVY---LAKKRSTGDYFAIKVLK-KSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62
Query: 694 GADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNY 753
++ D+ V E+++ G + G E D A ++ +
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPE-DWAK---------QYIAEVVLGVED 112
Query: 754 LHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARI--LSPDHTQTSSFSVKGSLGYIA 811
LH H D+KP N+L+D ++ DFGL+R + F G+ Y+A
Sbjct: 113 LHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK------FV--GTPDYLA 161
Query: 812 PEYGVGCEVSTNGDVYSYGILLLELVIGKKPI-----DIMFE----GDINLHNFGRKALP 862
PE +G D +S G ++ E + G P D +F+ IN ++
Sbjct: 162 PETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCS 221
Query: 863 DDVMDIVDSSLLPD 876
+ +D+++ L D
Sbjct: 222 PEAVDLINRLLCMD 235
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 57/219 (26%), Positives = 100/219 (45%), Gaps = 28/219 (12%)
Query: 634 VGVGSFGSVYKGII----DEGRTTIAVKVF----NLQHHGASRSFIAECKALKSIRHRNL 685
+G +FG +YKG + + +A+K N Q G F E + + H N+
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWG---EFQQEASLMAELHHPNI 69
Query: 686 VKVLTACLGADYRGNDFKASVYEFMHYGSLEEWL-----HPFTG--EDEIDEAPRNLNLL 738
V CL ++E+++ G L E+L H G DE +L+
Sbjct: 70 V-----CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124
Query: 739 QRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLAR-ILSPDHTQ 797
L+IAI IA + YL H DL N+L+ + + ++ D GL+R I S D+ +
Sbjct: 125 DFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYR 181
Query: 798 TSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLEL 836
S+ + ++ PE + + S++ D++S+G++L E+
Sbjct: 182 VQPKSLL-PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 634 VGVGSFGSVYKGIID-----EGRTTIAVKVFNLQHHGASR-SFIAECKALKSIRHRNLVK 687
+G GSFG VY+G E T +AVK N R F+ E +K ++V+
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 688 VLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDI 747
+L G +G V E M +G L+ +L E E + L + + +A +I
Sbjct: 74 LL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 748 AYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLAR-ILSPDHTQTSSFSVKGS 806
A + YL+ H DL N ++ T ++GDFG+ R I D+ + KG
Sbjct: 129 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG---KGL 182
Query: 807 L--GYIAPEYGVGCEVSTNGDVYSYGILLLEL 836
L ++APE +T+ D++S+G++L E+
Sbjct: 183 LPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGA---SRSFIAECKALKSIRHRNLVKVLT 690
+G G FG V G ++ G T V V L+ + F+ E + +S++H NL++ L
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 691 ACLGA-DYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAY 749
C Y V EF G L+ +L + + P LQR+ A +IA
Sbjct: 63 QCTEVTPY------LLVMEFCPLGDLKGYLRSCRKAELMTPDPT---TLQRM--ACEIAL 111
Query: 750 ALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGY 809
L +LH + H DL N LL +T ++GD+GL+ + + + L +
Sbjct: 112 GLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRW 168
Query: 810 IAPE-----YG--VGCEVSTNGDVYSYGILLLELV-IGKKP 842
IAPE +G + + + +V+S G+ + EL +G +P
Sbjct: 169 IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 29/222 (13%)
Query: 633 LVGVGSFGSVYKGI---ID--EGRTTIAVKVFNLQHHGASRS-FIAECKALKSI-RHRNL 685
+G G+FG V K +D +T+AVK+ S ++E + +K I +H+N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 686 VKVLTACLGADYRGNDFKASVYEFMHYGSLEEWL--HPFTGEDEIDEAPRNL--NLLQR- 740
+ +L C G + V E+ +G+L ++L GE + PR L Q+
Sbjct: 79 INLLGVCTQE---GPLY--VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 741 -LNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLAR-ILSPDH--- 795
++ A +A + +L H DL NVL+ + ++ DFGLAR I D+
Sbjct: 134 LVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190
Query: 796 TQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELV 837
T VK ++APE + DV+S+G+LL E+
Sbjct: 191 TTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 58/243 (23%), Positives = 103/243 (42%), Gaps = 34/243 (13%)
Query: 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVK---VFNLQHHGASRSFIAECKALKSIRH 682
+ F +G G F VY+ R +A+K +F + A + + E LK + H
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61
Query: 683 RNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLN 742
N++K L + + ++ V E G L + + F + + +L
Sbjct: 62 PNVIKYLDS-----FIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC 116
Query: 743 IAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFS 802
A++ ++ +H D +KP+NV + ++GD GL R S T++ S
Sbjct: 117 SAVEHMHSRRVMHRD---------IKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHS 165
Query: 803 VKGSLGYIAPEYGVGCEVSTNG-----DVYSYGILLLELVIGKKPIDIMFEGD-INLHNF 856
+ G+ Y++PE + NG D++S G LL E+ + P F GD +NL +
Sbjct: 166 LVGTPYYMSPE-----RIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLFSL 216
Query: 857 GRK 859
+K
Sbjct: 217 CQK 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 67/252 (26%), Positives = 113/252 (44%), Gaps = 35/252 (13%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQ--HHGASRSFIAECKALKSIR---HRNLVKV 688
+GVG++G+VYK +A+K +Q G S + E LK + H N+V++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 689 LTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPR-NLNLLQRLNIAIDI 747
+ C A R + F H +++ L + +D+ P L ++
Sbjct: 68 MDVC--ATSRTDRETKVTLVFEH---VDQDLRTY-----LDKVPPPGLPAETIKDLMRQF 117
Query: 748 AYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSL 807
L++LH +C H DLKP N+L+ ++ DFGLARI S Q + V +L
Sbjct: 118 LRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYS---CQMALTPVVVTL 171
Query: 808 GYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMD 867
Y APE + +T D++S G + E+ +KP +F G+ G+ + D
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEM-FRRKP---LFCGNSEADQLGK------IFD 221
Query: 868 IVDSSLLPDDED 879
++ LP ++D
Sbjct: 222 LIG---LPPEDD 230
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 3e-10
Identities = 65/233 (27%), Positives = 100/233 (42%), Gaps = 37/233 (15%)
Query: 634 VGVGSFGSVYKGIIDEGRTT--IAVKVF---NLQHHGASRSFIAECKALKSIRHRNLVKV 688
+G G++G VYK G+ A+K F Q+ G S+S E L+ ++H N+V +
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 689 LTACLGADYRGNDFKASVYEFMHYGSLEEW----LHPFTGEDEIDEAP-RNLNLLQRLNI 743
+ L SVY Y + W H I + ++L L Q LN
Sbjct: 68 VEVFL------EHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSL-LWQILN- 119
Query: 744 AIDIAYALNYLHHDCQPVTAHCDLKPSNVLL--DDYMTARV--GDFGLARIL-SPDHTQT 798
++YLH H DLKP+N+L+ + V GD GLAR+ +P
Sbjct: 120 ------GVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170
Query: 799 SSFSVKGSLGYIAPEYGVGCEVSTNG-DVYSYGILLLELVIGKKPIDIMFEGD 850
V ++ Y APE +G T D+++ G + EL + +PI F+G
Sbjct: 171 DLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAEL-LTLEPI---FKGR 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-10
Identities = 67/278 (24%), Positives = 112/278 (40%), Gaps = 56/278 (20%)
Query: 618 YQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKAL 677
Y DL +G GS G V+ + + +AVK L + + + E K +
Sbjct: 7 YMDLRP----------LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKII 56
Query: 678 KSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNL 737
+ + H N+VKV LG G+D V S+ + ++ ++ N+
Sbjct: 57 RRLDHDNIVKVYEV-LGP--SGSDLTEDVGSLTELNSV------YIVQEYMETDLANVLE 107
Query: 738 LQRL--NIAIDIAY----ALNYLHHDCQPVTAHCDLKPSNVLLD-DYMTARVGDFGLARI 790
L A Y L Y+H H DLKP+NV ++ + + ++GDFGLARI
Sbjct: 108 QGPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARI 164
Query: 791 LSPDHTQTSSFSVKGSLG-------YIAPEYGVGCEVSTNG-DVYSYGILLLELVIGKKP 842
+ P +S KG L Y +P + T D+++ G + E++ GK
Sbjct: 165 VDPH------YSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-- 216
Query: 843 IDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDL 880
+F G L + + I++S + +ED
Sbjct: 217 --PLFAGAHEL---------EQMQLILESVPVVREEDR 243
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 4e-10
Identities = 60/227 (26%), Positives = 92/227 (40%), Gaps = 46/227 (20%)
Query: 632 NLVGVGSFGSVYKGIIDEGR-TTIAVK----VFNLQHHGASRSFIAECKALKSIRHRNLV 686
+G G++G V + D+ +A+K VF+ A R E K L+ +RH N++
Sbjct: 6 KPIGSGAYGVVCSAV-DKRTGRKVAIKKISNVFDDLID-AKRIL-REIKLLRHLRHENII 62
Query: 687 KVLTACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNI 743
+L DF VY E M L + + +P+ L
Sbjct: 63 GLLDILRPPSP--EDFN-DVYIVTELME-TDLHKVIK----------SPQPLTDDHIQYF 108
Query: 744 AIDIAYALNYLHHDCQPVTA---HCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSS 800
I L YLH +A H DLKPSN+L++ ++ DFGLAR + PD +
Sbjct: 109 LYQILRGLKYLH------SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF 162
Query: 801 FSVKGSLGYI------APEYGVGCEVSTNG-DVYSYGILLLELVIGK 840
+ Y+ APE + T D++S G + EL+ K
Sbjct: 163 LT-----EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 60/222 (27%), Positives = 103/222 (46%), Gaps = 24/222 (10%)
Query: 622 YNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ-HHGASRSFIAECKALKSI 680
+ A + + + +G GS+ +VYKGI +A+KV +++ G + I E LK +
Sbjct: 1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL 60
Query: 681 RHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQR 740
+H N+V L + V+E+MH L +++ G P N+ L
Sbjct: 61 KHANIV-----LLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPG----GLHPYNVRLFM- 109
Query: 741 LNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILS-PDHTQTS 799
+ L Y+H Q + H DLKP N+L+ ++ DFGLAR S P T +S
Sbjct: 110 ----FQLLRGLAYIHG--QHIL-HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSS 162
Query: 800 SFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGK 840
+L Y P+ +G + S+ D++ G + +E++ G+
Sbjct: 163 EVV---TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 7e-10
Identities = 59/233 (25%), Positives = 98/233 (42%), Gaps = 50/233 (21%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGAS---RSFIAECKALKSIRHRNLVKVL 689
+VG G++G V K +A+K F + ++ + E K L+ +RH N+V +
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 690 TACLGADYRGNDFKAS-----VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIA 744
A F+ V+E++ LE ++ +P L +
Sbjct: 67 EA----------FRRKGRLYLVFEYVERTLLEL----------LEASPGGLPPDAVRSYI 106
Query: 745 IDIAYALNYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILS--PDHTQTSSF 801
+ A+ Y H H+ H D+KP N+L+ + ++ DFG AR L P T
Sbjct: 107 WQLLQAIAYCHSHNI----IHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV 162
Query: 802 SVKGSLGYIAPEYGVGCEVSTN----GDVYSYGILLLELVIGKKPIDIMFEGD 850
+ + Y APE VG TN DV++ G ++ EL+ G+ +F GD
Sbjct: 163 ATR---WYRAPELLVG---DTNYGKPVDVWAIGCIMAELLDGEP----LFPGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 7e-10
Identities = 55/189 (29%), Positives = 84/189 (44%), Gaps = 32/189 (16%)
Query: 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLH-HDCQPVTAH 764
V E++ G L L DE D A R+ IA +I AL YLH + H
Sbjct: 71 VMEYLPGGDLASLLENVGSLDE-DVA--------RIYIA-EIVLALEYLHSNGI----IH 116
Query: 765 CDLKPSNVLLDDYMTARVGDFGLARI-LSPDHTQTSSFSVK-----GSLGYIAPEYGVGC 818
DLKP N+L+D ++ DFGL+++ L + + G+ YIAPE +G
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176
Query: 819 EVSTNGDVYSYGILLLELVIGKKPI-----DIMFE----GDINLHNFGRKALPDDVMDIV 869
S D +S G +L E ++G P + +F+ G I + D+ +D++
Sbjct: 177 GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEAIDLI 234
Query: 870 DSSLLPDDE 878
L+PD E
Sbjct: 235 SKLLVPDPE 243
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 8e-10
Identities = 65/228 (28%), Positives = 109/228 (47%), Gaps = 34/228 (14%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGAS---RSFIAECKAL-KSIRHRNLVK 687
+++G G+FG V K I + + + ++ + + R F E + L K H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 688 VLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEA-------PRNLNLLQR 740
+L AC ++RG + A E+ +G+L ++L + E D A L+ Q
Sbjct: 61 LLGAC---EHRGYLYLA--IEYAPHGNLLDFLRK-SRVLETDPAFAIANSTASTLSSQQL 114
Query: 741 LNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSS 800
L+ A D+A ++YL Q H DL N+L+ + A++ DFGL+R
Sbjct: 115 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQE 163
Query: 801 FSVKGSLG-----YIAPEYGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
VK ++G ++A E +TN DV+SYG+LL E+V +G P
Sbjct: 164 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 8e-10
Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 21/209 (10%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACL 693
+G G+ G+V+ I +A+K NLQ I E +K +++ N+V L +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS-- 84
Query: 694 GADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNY 753
+ D V E++ GSL + E +DEA Q + + AL +
Sbjct: 85 ---FLVGDELFVVMEYLAGGSLTD----VVTETCMDEA-------QIAAVCRECLQALEF 130
Query: 754 LHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPE 813
LH + H D+K NVLL + ++ DFG ++P+ ++ S ++ G+ ++APE
Sbjct: 131 LHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTPYWMAPE 185
Query: 814 YGVGCEVSTNGDVYSYGILLLELVIGKKP 842
D++S GI+ +E+V G+ P
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 8e-10
Identities = 58/230 (25%), Positives = 91/230 (39%), Gaps = 41/230 (17%)
Query: 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGA-SRSFIAECKALKSIRHRNL 685
+ +G G+ GSV K + A+K + + + E + KS + +
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI 61
Query: 686 VKVLTACLGADYRGNDFKASVY---EFMHYGSLEEWLHPF------TGEDEIDEAPRNLN 736
VK A L ++ +S+ E+ GSL+ GE +
Sbjct: 62 VKYYGAFL------DESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVL-------- 107
Query: 737 LLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLA--RILSPD 794
IA + L+YLH H D+KPSN+LL ++ DFG++ + S
Sbjct: 108 ----GKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA 160
Query: 795 HTQT-SSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPI 843
T T +SF Y+APE G S DV+S G+ LLE+ + P
Sbjct: 161 GTFTGTSF-------YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 9e-10
Identities = 61/223 (27%), Positives = 97/223 (43%), Gaps = 31/223 (13%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIA--ECKALKSIRHRNLVKVLT 690
LVG GS+G V K E +A+K F IA E + LK +RH NLV ++
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 691 ACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYA 750
R V+EF+ + L D++++ P L+ + I
Sbjct: 68 VF-----RRKKRLYLVFEFVDHTVL----------DDLEKYPNGLDESRVRKYLFQILRG 112
Query: 751 LNYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARIL-SPDHTQTSSFSVKGSLG 808
+ + H H+ H D+KP N+L+ ++ DFG AR L +P T + +
Sbjct: 113 IEFCHSHN----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR---W 165
Query: 809 YIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
Y APE VG + D+++ G L+ E++ G + +F GD
Sbjct: 166 YRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG----EPLFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 85/326 (26%), Positives = 128/326 (39%), Gaps = 32/326 (9%)
Query: 89 SFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICG--EIPTNISRCSTLIPIHPQN 146
+ +L L ++S T + L RL L L + S + N+ L +
Sbjct: 45 VAVNRLALNLSSNTLLL--LPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNL 102
Query: 147 NQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFG 206
N+L I L+ L+L +N++T IP +G L S +N ++P+
Sbjct: 103 NRLRSNISELLE-LTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIESLPSPLR 160
Query: 207 WFENLVFLSLAANNLSVVENKLTGEVPSLEKL----------QRLQHFTITSNSLGSGGN 256
NL L L+ N+LS + KL + +L L L N
Sbjct: 161 NLPNLKNLDLSFNDLSDLP-KLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNN 219
Query: 257 DDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGN 316
+ L SL+N L+ + + SNN LP I NLS ++TL L+NN+I S + +G+
Sbjct: 220 SIIELLSSLSNLKNLSGLEL-SNNKLEDLPESIGNLS-NLETLDLSNNQI--SSISSLGS 275
Query: 317 FVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDN 376
NL+ LD+ N LS P I L L L N L + +LLN + N
Sbjct: 276 LTNLRELDLSGNSLS-NALPLIALLLLLLE--LLLNLLLTLKALELKLNSILLNNNILSN 332
Query: 377 FLEVSIPSSLGQCESLIEINLSNNNL 402
+ I S NNL
Sbjct: 333 --------GETSSPEALSILESLNNL 350
|
Length = 394 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 1e-09
Identities = 58/227 (25%), Positives = 91/227 (40%), Gaps = 56/227 (24%)
Query: 634 VGVGSFGSVYKGIIDEGRTT--IAVKVFN---------LQHHGASRSFIAECKALKSIRH 682
+G GSFG V ++ + A+K+ + ++H + E + L+SIRH
Sbjct: 9 LGTGSFGRVM--LVRHKGSGKYYALKILSKAKIVKLKQVEH------VLNEKRILQSIRH 60
Query: 683 RNLVKVLTACLGADYRGNDFK--ASVYEFMHY---GSLEEWLHPFTGEDEIDEAPRNLNL 737
LV + + F+ +++Y M Y G L L
Sbjct: 61 PFLVNLYGS----------FQDDSNLYLVMEYVPGGELFSHL----------RKSGRFPE 100
Query: 738 LQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQ 797
A + AL YLH V + DLKP N+LLD ++ DFG A+ + T
Sbjct: 101 PVARFYAAQVVLALEYLHS-LDIV--YRDLKPENLLLDSDGYIKITDFGFAKRV-KGRTY 156
Query: 798 TSSFSVKGSLGYIAPE--YGVGCEVSTNGDVYSYGILLLELVIGKKP 842
T G+ Y+APE G + D ++ GIL+ E++ G P
Sbjct: 157 TLC----GTPEYLAPEIILSKGYGKAV--DWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 1e-09
Identities = 77/274 (28%), Positives = 118/274 (43%), Gaps = 78/274 (28%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVK-VF----NLQHHGASRSFIAECKALKSIR-HRNLVK 687
+G G++G V+K I + +A+K +F N A R+F E L+ + H N+VK
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATD--AQRTF-REIMFLQELGDHPNIVK 71
Query: 688 VLTACLGADYRGNDFKAS-------VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQR 740
+L N KA V+E+M E LH A N+L+
Sbjct: 72 LL----------NVIKAENDKDIYLVFEYM-----ETDLH----------AVIRANILED 106
Query: 741 LN---IAIDIAYALNYLHHDCQPVTA---HCDLKPSNVLLDDYMTARVGDFGLARILSPD 794
++ I + AL Y+H + H DLKPSN+LL+ ++ DFGLAR LS +
Sbjct: 107 VHKRYIMYQLLKALKYIH------SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS-E 159
Query: 795 HTQTSSFSVKGSLG-------YIAPEYGVGCEVSTNG-DVYSYGILLLELVIGKKPIDIM 846
+ V L Y APE +G T G D++S G +L E+++GK +
Sbjct: 160 LEENPENPV---LTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKP----L 212
Query: 847 FEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDL 880
F G L+ + I++ P ED+
Sbjct: 213 FPGTSTLNQLEK---------IIEVIGPPSAEDI 237
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACL 693
+G G+ G+VY I +A+K NLQ I E ++ +H N+V L +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS-- 84
Query: 694 GADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNY 753
Y D V E++ GSL + E +DE Q + + AL +
Sbjct: 85 ---YLVGDELWVVMEYLAGGSLTD----VVTETCMDEG-------QIAAVCRECLQALEF 130
Query: 754 LHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPE 813
LH + H D+K N+LL + ++ DFG ++P+ ++ S ++ G+ ++APE
Sbjct: 131 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTPYWMAPE 185
Query: 814 YGVGCEVSTNGDVYSYGILLLELVIGKKP 842
D++S GI+ +E+V G+ P
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 28/221 (12%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTA 691
+G G++G VYK +A+K L+ G + I E LK + H N+V++L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 692 CLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYAL 751
+ ++ + V+EF+ L++++ D + L++ + +
Sbjct: 67 -VHSENK----LYLVFEFLDL-DLKKYM------DSSPLTGLDPPLIKSY--LYQLLQGI 112
Query: 752 NYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILS-PDHTQTSSFSVKGSLGYI 810
Y H H DLKP N+L+D ++ DFGLAR P T T +L Y
Sbjct: 113 AYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV---TLWYR 166
Query: 811 APEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
APE +G + ST D++S G + E+ + ++P+ F GD
Sbjct: 167 APEILLGSRQYSTPVDIWSIGCIFAEM-VNRRPL---FPGD 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 60/229 (26%), Positives = 86/229 (37%), Gaps = 58/229 (25%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLT 690
+GVG FG V + T A+K +H G +E + L+ H +VK+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 691 ACLGADYRGNDFKASVY---------EFMHY----GSLEEWLHPFTGEDEIDEAPRNLNL 737
YR K +Y E G +E+ F
Sbjct: 59 ------YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARF--------------- 97
Query: 738 LQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQ 797
+ A YLH+ + DLKP N+LLD ++ DFG A+ L +
Sbjct: 98 -----YIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLK-SGQK 148
Query: 798 TSSFSVKGSLGYIAPEY----GVGCEVSTNGDVYSYGILLLELVIGKKP 842
T +F G+ Y+APE G V D +S GILL EL+ G+ P
Sbjct: 149 TWTFC--GTPEYVAPEIILNKGYDFSV----DYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 56/210 (26%), Positives = 89/210 (42%), Gaps = 32/210 (15%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVK-VFNLQHHGASRSFIAECKALKSIRHRNLVKVLTAC 692
+G G+FG V+ G + T +AVK F+ E + LK H N+V+++ C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 693 LGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAY 749
K +Y E + G +L E PR L + + + + + A
Sbjct: 63 TQ--------KQPIYIVMELVQGGDFLTFLR--------TEGPR-LKVKELIQMVENAAA 105
Query: 750 ALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKG-SLG 808
+ YL H DL N L+ + ++ DFG++R D S+ +K +
Sbjct: 106 GMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSR-EEEDGVYASTGGMKQIPVK 161
Query: 809 YIAPE---YGVGCEVSTNGDVYSYGILLLE 835
+ APE YG S+ DV+S+GILL E
Sbjct: 162 WTAPEALNYG---RYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 57/216 (26%), Positives = 91/216 (42%), Gaps = 30/216 (13%)
Query: 632 NLVGVGSFGSVYKGII---DEGRTTIAVKVFN-LQHHGASRSFIAECKALKSIRHRNLVK 687
++G G FG VY G + D + AVK N + F+ E +K H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 688 VLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDI 747
+L CL ++ V +M +G L + I N + + + +
Sbjct: 61 LLGICLPSE----GSPLVVLPYMKHGDLRNF---------IRSETHNPTVKDLIGFGLQV 107
Query: 748 AYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARIL------SPDHTQTSSF 801
A + YL H DL N +LD+ T +V DFGLAR + S + +
Sbjct: 108 AKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL 164
Query: 802 SVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELV 837
VK ++A E + +T DV+S+G+LL EL+
Sbjct: 165 PVK----WMALESLQTQKFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACL 693
+G G+ G+VY I +A+K NLQ I E ++ ++ N+V L +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS-- 84
Query: 694 GADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNY 753
Y D V E++ GSL + E +DE Q + + AL++
Sbjct: 85 ---YLVGDELWVVMEYLAGGSLTD----VVTETCMDEG-------QIAAVCRECLQALDF 130
Query: 754 LHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPE 813
LH + H D+K N+LL + ++ DFG ++P+ ++ S ++ G+ ++APE
Sbjct: 131 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTPYWMAPE 185
Query: 814 YGVGCEVSTNGDVYSYGILLLELVIGKKP 842
D++S GI+ +E+V G+ P
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 65/224 (29%), Positives = 99/224 (44%), Gaps = 39/224 (17%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVK----VFNLQHHGASRSFIAECKALKSIRHRNLVKVL 689
+G G++G V I +A+K F++ A R+ E K L+ +H N++ +
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV-PTLAKRTL-RELKILRHFKHDNIIAIR 70
Query: 690 TACLGADYRGNDFKASVYEFMHYGSLEEWLH-------PFTGEDEIDEAPRNLNLLQRLN 742
G DFK VY M +E LH P T E+ I L Q L
Sbjct: 71 DILRP---PGADFK-DVYVVMDL--MESDLHHIIHSDQPLT-EEHI-----RYFLYQLLR 118
Query: 743 IAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFS 802
L Y+H H DLKPSN+L+++ R+GDFG+AR LS T+ F
Sbjct: 119 -------GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFM 168
Query: 803 VK--GSLGYIAPEYG-VGCEVSTNGDVYSYGILLLELVIGKKPI 843
+ + Y APE E +T D++S G + E+ +G++ +
Sbjct: 169 TEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM-LGRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 64/222 (28%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNL---QHHGASRSFIAECKALKSIRHRNLVKVLT 690
+G GSFG+VY +AVK + Q + + I E K L+ ++H N +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTI---- 84
Query: 691 ACLGADYRGNDFKA-SVYEFMHY--GSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDI 747
+Y+G K + + M Y GS + L E+ + P LQ + IA
Sbjct: 85 -----EYKGCYLKEHTAWLVMEYCLGSASDLL-------EVHKKP-----LQEVEIAAIT 127
Query: 748 AYALN---YLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVK 804
AL YLH H D+K N+LL + ++ DFG A SP + S
Sbjct: 128 HGALQGLAYLHSHNM---IHRDIKAGNILLTEPGQVKLADFGSASKSSPAN------SFV 178
Query: 805 GSLGYIAPEYGVGC-EVSTNG--DVYSYGILLLELVIGKKPI 843
G+ ++APE + E +G DV+S GI +EL K P+
Sbjct: 179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 59/237 (24%), Positives = 99/237 (41%), Gaps = 36/237 (15%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQHH---GASRSFIAECKALKSIRHRNLVKVLTA 691
G G+FG VYK + +A+K L H+ G + + E K LK ++H N+V ++
Sbjct: 17 GEGTFGEVYKARQIKTGRVVALKKI-LMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 692 CLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPR-NLNLLQRLNIAIDIAYA 750
+ + + SVY Y H +G + E P L Q + +
Sbjct: 76 AVERPDKSKRKRGSVYMVTPYMD-----HDLSG---LLENPSVKLTESQIKCYMLQLLEG 127
Query: 751 LNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLG-- 808
+NYLH + H D+K +N+L+D+ ++ DFGLAR P + G G
Sbjct: 128 INYLH--ENHIL-HRDIKAANILIDNQGILKIADFGLAR---PYDGPPPNPKGGGGGGTR 181
Query: 809 ----------YIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLH 854
Y PE +G +T D++ G + E+ ++PI +G ++
Sbjct: 182 KYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEM-FTRRPI---LQGKSDID 234
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 633 LVGVGSFGSVYKGI-IDEGRTTIAVKV-FNLQHHGASRSFIA-EC--KALKSIRHRNLVK 687
L+G G+FG VY +D GR A +V F+ + S+ A EC + LK+++H +V+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 688 VLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDI 747
CL R E+M GS+++ L + E +L+
Sbjct: 69 YY-GCLRD--RAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILE-------- 117
Query: 748 AYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLA-RILSPDHTQTSSFSVKGS 806
++YLH + + H D+K +N+L D ++GDFG + R+ + + T SV G+
Sbjct: 118 --GMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172
Query: 807 LGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
+++PE G DV+S G ++E++ K P
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 65/221 (29%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQ--HHGASRSFIAECKALKSIRHRNLVKVLTA 691
+G G++G VYKG + +A+K L+ G + I E LK ++H N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVC-LQD 66
Query: 692 CLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYAL 751
L + R ++EF+ L+++L +D L Q L I ++
Sbjct: 67 VLMQESR----LYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQ-GILFCHSR 120
Query: 752 NYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILS-PDHTQTSSFSVKGSLGYI 810
LH DLKP N+L+D+ ++ DFGLAR P T +L Y
Sbjct: 121 RVLHR---------DLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV---TLWYR 168
Query: 811 APEYGVGCE-VSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
APE +G ST D++S G + E+ KKP +F GD
Sbjct: 169 APEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKP---LFHGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 35/99 (35%), Positives = 47/99 (47%), Gaps = 6/99 (6%)
Query: 744 AIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSV 803
A I L +LH Q + DLKP NVLLDD+ R+ D GLA L
Sbjct: 101 AAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR--- 154
Query: 804 KGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
G+ GY+APE G + D ++ G L E++ G+ P
Sbjct: 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 66/255 (25%), Positives = 112/255 (43%), Gaps = 40/255 (15%)
Query: 634 VGVGSFGSVYKGI-IDEGRTTIAVKVFNLQ--HHGASRSFIAEC---KALKSIRHRNLVK 687
+G G++G V+K + G +A+K +Q G S I E + L++ H N+V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 688 VLTACLGADYRGNDFKASVYEFMHYG---SLEEWLHPFTGEDEIDEAPRNLNLLQRLNIA 744
+ C + V+E + L++ P + I + LL+
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM--MFQLLR----- 121
Query: 745 IDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVK 804
L++LH H DLKP N+L+ ++ DFGLARI S Q + SV
Sbjct: 122 -----GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVV 170
Query: 805 GSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDD 864
+L Y APE + +T D++S G + E+ +KP +F G ++ G+
Sbjct: 171 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM-FRRKP---LFRGSSDVDQLGK------ 220
Query: 865 VMDIVDSSLLPDDED 879
++D++ LP +ED
Sbjct: 221 ILDVIG---LPGEED 232
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 77/299 (25%), Positives = 126/299 (42%), Gaps = 58/299 (19%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNL---QHHGASRSFIAECKALKSIRHRN 684
FS +G GSFG+VY +A+K + Q + + I E + L+ +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 685 LVKVLTACLGADYRGNDFKA-SVYEFMHY--GSLEEWLHPFTGEDEIDEAPRNLNLLQRL 741
+ YRG + + + M Y GS + L E+ + P LQ +
Sbjct: 77 TI---------QYRGCYLREHTAWLVMEYCLGSASDLL-------EVHKKP-----LQEV 115
Query: 742 NIAIDIAYALN---YLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQ 797
IA AL YLH H+ H D+K N+LL + ++GDFG A I++P +
Sbjct: 116 EIAAVTHGALQGLAYLHSHN----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-- 169
Query: 798 TSSFSVKGSLGYIAPEYGVGC-EVSTNG--DVYSYGILLLELVIGKKPIDIMFEGDINLH 854
G+ ++APE + E +G DV+S GI +EL K P+ M L+
Sbjct: 170 ----XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALY 224
Query: 855 NFGRKALP--------DDVMDIVDSSL--LPDDE---DLILTGNQRQKQARINSIIECL 900
+ + P + + VDS L +P D +++L ++ I++ +
Sbjct: 225 HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI 283
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 64/224 (28%), Positives = 98/224 (43%), Gaps = 56/224 (25%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLV------- 686
G GS+ +VYKG +A+K L+H GA + I E LK ++H N+V
Sbjct: 14 GEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIH 73
Query: 687 --KVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLN-------L 737
K LT V+E++ L++++ D+ L+ L
Sbjct: 74 TKKTLTL--------------VFEYLD-TDLKQYM---------DDCGGGLSMHNVRLFL 109
Query: 738 LQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILS-PDHT 796
Q L L Y H + V H DLKP N+L+ + ++ DFGLAR S P +
Sbjct: 110 FQLLR-------GLAYCHQ--RRVL-HRDLKPQNLLISERGELKLADFGLARAKSVP--S 157
Query: 797 QTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIG 839
+T S V +L Y P+ +G E ST+ D++ G + E+ G
Sbjct: 158 KTYSNEVV-TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 55/219 (25%), Positives = 94/219 (42%), Gaps = 32/219 (14%)
Query: 633 LVGVGSFGSVYKGI----IDEGRTTIAVKVFNLQHHGASRS-FIAECKALKSIRHRNLVK 687
+G G FG VY+G+ +E + +AVK + R F+ E ++ H ++VK
Sbjct: 13 CIGEGQFGDVYQGVYMSPENE-KIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 688 VLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDI 747
++ + V E G L +L +L+L + + +
Sbjct: 72 LIGVIT------ENPVWIVMELAPLGELRSYL---------QVNKYSLDLASLILYSYQL 116
Query: 748 AYALNYLHH-DCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGS 806
+ AL YL H D+ NVL+ ++GDFGL+R L + +S KG
Sbjct: 117 STALAYLESKRF----VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKAS---KGK 169
Query: 807 L--GYIAPEYGVGCEVSTNGDVYSYGILLLE-LVIGKKP 842
L ++APE ++ DV+ +G+ + E L++G KP
Sbjct: 170 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 64/221 (28%), Positives = 104/221 (47%), Gaps = 32/221 (14%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTAC 692
+G G++ +V+KG +A+K L+H GA + I E LK+++H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIV-TLHDI 71
Query: 693 LGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAI---DIAY 749
+ + V+E++ L+++L D NL+ N+ I +
Sbjct: 72 IHTERC----LTLVFEYLD-SDLKQYL---------DNCG---NLMSMHNVKIFMFQLLR 114
Query: 750 ALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGY 809
L+Y H H DLKP N+L+++ ++ DFGLAR S T+T S V +L Y
Sbjct: 115 GLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVP-TKTYSNEVV-TLWY 169
Query: 810 IAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEG 849
P+ +G E ST D++ G +L E+ G+ MF G
Sbjct: 170 RPPDVLLGSTEYSTPIDMWGVGCILYEMATGRP----MFPG 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-09
Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 22/217 (10%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRS-FIAECKALKSIRHRNLV 686
F + +G G+ G V K +A K+ +L+ A R+ I E + L H
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL----HECNS 62
Query: 687 KVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAID 746
+ GA Y + + E M GSL++ L E P + L +++IA+
Sbjct: 63 PYIVGFYGAFYSDGEISICM-EHMDGGSLDQVL------KEAKRIPEEI--LGKVSIAV- 112
Query: 747 IAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGS 806
L YL Q H D+KPSN+L++ ++ DFG++ L + + S G+
Sbjct: 113 -LRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGT 165
Query: 807 LGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPI 843
Y++PE G S D++S G+ L+EL IG+ PI
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 54/218 (24%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 634 VGVGSFGSVYKGII-----DEGRTTIAVKVFNLQHHGASRS-FIAECKALKSIRHRNLVK 687
+G FG VYKG + E +A+K + G R F E ++H N+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV- 71
Query: 688 VLTACLGADYRGNDFKASVYEFMHYGSLEEWL-----HPFTGEDEIDEAPRN-LNLLQRL 741
CL + ++ + + L E+L H G + D+ ++ L +
Sbjct: 72 ----CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV 127
Query: 742 NIAIDIAYALNYL--HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLAR-ILSPDHTQT 798
+I IA + +L HH H DL NVL+ D + ++ D GL R + + D+ +
Sbjct: 128 HIVTQIAAGMEFLSSHHVV-----HKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKL 182
Query: 799 SSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLEL 836
S+ + +++PE + + S + D++SYG++L E+
Sbjct: 183 MGNSLL-PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 747 IAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGS 806
I L +LH Q + DLKP NVLLD+ R+ D GLA L ++T ++ G+
Sbjct: 106 IISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA--GT 160
Query: 807 LGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
G++APE G E + D ++ G+ L E++ + P
Sbjct: 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTAC 692
+G G++ +VYKG +A+K L+H GA + I E LK ++H N+V
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV------ 67
Query: 693 LGADYRGNDFKASVYEFMHYGSLEEWLHPFTGED---EIDEAPRNLNLLQRLNIAIDIAY 749
++++ +H + + +D +D+ ++N+ +
Sbjct: 68 ------------TLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLR 115
Query: 750 ALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGY 809
LNY H + H DLKP N+L+++ ++ DFGLAR S T+T S V +L Y
Sbjct: 116 GLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP-TKTYSNEVV-TLWY 170
Query: 810 IAPEYGVG-CEVSTNGDVYSYGILLLELVIGK 840
P+ +G + ST D++ G + E+ G+
Sbjct: 171 RPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 9e-09
Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 24/217 (11%)
Query: 633 LVGVGSFGSVYKGI-IDEGRTTIAVKV-FNLQHHGASRSFIA-EC--KALKSIRHRNLVK 687
L+G G+FG VY D GR +V F+ S+ A EC + LK++RH +V+
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 688 VLTACLGADYRGNDFKASVY-EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAID 746
CL + K S++ E+M GS+++ L + E N+ +R
Sbjct: 69 YY-GCL---RDPEEKKLSIFVEYMPGGSIKDQLKAYGALTE--------NVTRRYTR--Q 114
Query: 747 IAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLA-RILSPDHTQTSSFSVKG 805
I ++YLH + + H D+K +N+L D ++GDFG + RI + + T SV G
Sbjct: 115 ILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTG 171
Query: 806 SLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
+ +++PE G DV+S ++E++ K P
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 9e-09
Identities = 21/42 (50%), Positives = 22/42 (52%), Gaps = 1/42 (2%)
Query: 21 NETDRVALLEFKSKSTYDPVGVLGTWNES-IHFCKWYGVTCS 61
DR ALL FKS DP G L +WN S C W GVTC
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-08
Identities = 42/128 (32%), Positives = 66/128 (51%), Gaps = 16/128 (12%)
Query: 764 HCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVST 822
H DLKPSN+LL+ ++ DFGLAR S + + V + Y APE + C E +T
Sbjct: 131 HRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV--TRWYRAPELLLNCSEYTT 188
Query: 823 NGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLIL 882
DV+S G + EL +G+KP+ F G +H + +++ S P +EDL
Sbjct: 189 AIDVWSVGCIFAEL-LGRKPL---FPGKDYVHQLKL------ITELLGS---PSEEDLGF 235
Query: 883 TGNQRQKQ 890
N++ ++
Sbjct: 236 IRNEKARR 243
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 41/115 (35%), Positives = 65/115 (56%), Gaps = 8/115 (6%)
Query: 744 AIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARI-LSPDHTQTSSFS 802
A +I ALN+LH + + DLK NVLLD ++ D+G+ + L P T TS+F
Sbjct: 102 AAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT-TSTFC 157
Query: 803 VKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEG-DINLHNF 856
G+ YIAPE G E + D ++ G+L+ E++ G+ P DI+ + D+N ++
Sbjct: 158 --GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDY 210
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 36/107 (33%), Positives = 56/107 (52%), Gaps = 9/107 (8%)
Query: 744 AIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSV 803
A +I L +LH + DLK NVLLD ++ DFG+ + + S+F
Sbjct: 102 AAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC- 157
Query: 804 KGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
G+ YIAPE G + + + D +S+G+LL E++IG+ P F G+
Sbjct: 158 -GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP----FHGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 59/224 (26%), Positives = 89/224 (39%), Gaps = 48/224 (21%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNL---------QH-HGASRSFIAECKALKSIRH 682
VG G+FG V+ A+KV + QH H E + LK + H
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHN-------EKRVLKEVSH 60
Query: 683 RNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLN 742
++++ F + E++ G L +L + L
Sbjct: 61 PFIIRLFWT-----EHDQRFLYMLMEYVPGGELFSYL----------RNSGRFSNSTGLF 105
Query: 743 IAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFS 802
A +I AL YLH + DLKP N+LLD ++ DFG A+ L D T T
Sbjct: 106 YASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR-DRTWT---- 157
Query: 803 VKGSLGYIAPEY----GVGCEVSTNGDVYSYGILLLELVIGKKP 842
+ G+ Y+APE G V D ++ GIL+ E+++G P
Sbjct: 158 LCGTPEYLAPEVIQSKGHNKAV----DWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 51/210 (24%), Positives = 96/210 (45%), Gaps = 22/210 (10%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQ-HHGASRSFIAECKALKSIRHRNLVKVLTAC 692
+G G++ +VYKG +A+K +L G + I E +K ++H N+V++
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL---- 63
Query: 693 LGADYRGNDFKAS-VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYAL 751
D + K V+E+M L++++ + L+ + + +
Sbjct: 64 --HDVIHTENKLMLVFEYMD-KDLKKYM-------DTHGVRGALDPNTVKSFTYQLLKGI 113
Query: 752 NYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIA 811
+ H + H DLKP N+L++ ++ DFGLAR S+ V +L Y A
Sbjct: 114 AFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRA 168
Query: 812 PEYGVGCEV-STNGDVYSYGILLLELVIGK 840
P+ +G ST+ D++S G ++ E++ G+
Sbjct: 169 PDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 64/221 (28%), Positives = 97/221 (43%), Gaps = 35/221 (15%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFN--LQHHGASRSFIAECKALKSIRHRNLVKVLT 690
++G GS+G V I +A+K N +H + + E K L+ +RH ++V++
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 691 ACLGADYRGNDFKA--SVYEFMHYGSLEEWLHPFTG-EDEIDEAPRNLNLLQRLNIAIDI 747
L R +FK V+E M E LH D++ L Q L
Sbjct: 67 IMLPPSRR--EFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLLR----- 114
Query: 748 AYALNYLHHDCQPVTA---HCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVK 804
AL Y+H TA H DLKP N+L + ++ DFGLAR+ D T T+ F
Sbjct: 115 --ALKYIH------TANVFHRDLKPKNILANADCKLKICDFGLARVAFND-TPTAIFWTD 165
Query: 805 --GSLGYIAPEYGVGC---EVSTNGDVYSYGILLLELVIGK 840
+ Y APE G + + D++S G + E++ GK
Sbjct: 166 YVATRWYRAPEL-CGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 63/211 (29%), Positives = 92/211 (43%), Gaps = 30/211 (14%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACL 693
+G G+FG VYK E A KV + + ++ E L S H N+VK+L A
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF- 71
Query: 694 GADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNY 753
Y N+ + EF G+++ + E R L Q + ALNY
Sbjct: 72 ---YYENNLWILI-EFCAGGAVDAVML---------ELERPLTEPQIRVVCKQTLEALNY 118
Query: 754 LHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQT--SSFSVKGSLGYIA 811
LH + H DLK N+L ++ DFG +S +T+T S G+ ++A
Sbjct: 119 LHEN---KIIHRDLKAGNILFTLDGDIKLADFG----VSAKNTRTIQRRDSFIGTPYWMA 171
Query: 812 PEYGVGCEVSTN------GDVYSYGILLLEL 836
PE V CE S + DV+S GI L+E+
Sbjct: 172 PEV-VMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 39/106 (36%), Positives = 60/106 (56%), Gaps = 7/106 (6%)
Query: 746 DIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARI-LSPDHTQTSSFSVK 804
+I+ ALNYLH + + DLK NVLLD ++ D+G+ + L P T TS+F
Sbjct: 104 EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TSTFC-- 157
Query: 805 GSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
G+ YIAPE G + + D ++ G+L+ E++ G+ P DI+ D
Sbjct: 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.7 bits (136), Expect = 2e-08
Identities = 51/209 (24%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACL 693
+G G+ G+VY + +A++ NLQ I E ++ ++ N+V L +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS-- 85
Query: 694 GADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNY 753
Y D V E++ GSL + E +DE Q + + AL +
Sbjct: 86 ---YLVGDELWVVMEYLAGGSLTD----VVTETCMDEG-------QIAAVCRECLQALEF 131
Query: 754 LHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPE 813
LH + H D+K N+LL + ++ DFG ++P+ ++ S ++ G+ ++APE
Sbjct: 132 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTPYWMAPE 186
Query: 814 YGVGCEVSTNGDVYSYGILLLELVIGKKP 842
D++S GI+ +E++ G+ P
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 64/227 (28%), Positives = 99/227 (43%), Gaps = 40/227 (17%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGAS-----RSFIAECKALKSIRH 682
F+ +G GSFG+VY + RT V + + + G + I E K L+ I+H
Sbjct: 27 FTDLREIGHGSFGAVY--FARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84
Query: 683 RNLVKVLTACLGADYRGNDFKA-SVYEFMHY--GSLEEWLHPFTGEDEIDEAPRNLNLLQ 739
N + +Y+G + + + M Y GS + L E+ + P LQ
Sbjct: 85 PNSI---------EYKGCYLREHTAWLVMEYCLGSASDLL-------EVHKKP-----LQ 123
Query: 740 RLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTS 799
+ IA AL L + H D+K N+LL + ++ DFG A I SP +
Sbjct: 124 EVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN---- 179
Query: 800 SFSVKGSLGYIAPEYGVGC-EVSTNG--DVYSYGILLLELVIGKKPI 843
S G+ ++APE + E +G DV+S GI +EL K P+
Sbjct: 180 --SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 37/155 (23%)
Query: 743 IAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFS 802
+AID + L Y+H D +KP NVLLD R+ DFG L D T S+ +
Sbjct: 113 LAIDSVHQLGYVHRD---------IKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA 163
Query: 803 VKGSLGYIAPE-----------YGVGCEVSTNGDVYSYGILLLELVIGKKPI--DIMFE- 848
V G+ YI+PE YG C D +S G+ + E++ G+ P + + E
Sbjct: 164 V-GTPDYISPEILQAMEDGKGRYGPEC------DWWSLGVCMYEMLYGETPFYAESLVET 216
Query: 849 -GDINLHNFGRKALPDDVMDIVDSSLLPDDEDLIL 882
G I +++ P DV D+ + + +DLI
Sbjct: 217 YGKI-MNHKEHFQFPPDVTDVSEEA-----KDLIR 245
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 52/216 (24%), Positives = 87/216 (40%), Gaps = 29/216 (13%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASR---SFIAECKALKSIRHRNLVKVLT 690
+G G FG V G G + V V L+ F+ E + + + H N+++ L
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 691 ACLGA-DYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAY 749
C+ + Y V EF G L+ +L G +LQR+ A ++A
Sbjct: 63 QCIESIPY------LLVLEFCPLGDLKNYLRSNRGMVAQMAQKD---VLQRM--ACEVAS 111
Query: 750 ALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGY 809
L +LH Q H DL N L ++ ++GD+GLA P+ + L +
Sbjct: 112 GLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRW 168
Query: 810 IAPEYGVGCEVSTN---------GDVYSYGILLLEL 836
+APE + + +++S G+ + EL
Sbjct: 169 LAPE--LVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 54/218 (24%), Positives = 101/218 (46%), Gaps = 23/218 (10%)
Query: 634 VGVGSFGSVYKGI--IDEGRTTIAVKVFNLQHHGASR-SFIAECKALKSIRHRNLVKVLT 690
+G G+FG V KG+ + + + +A+KV ++ + R + E + + + + +V+++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 691 ACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYA 750
C V E G L ++L +G+ + + L+ ++++ +
Sbjct: 63 VCEAEAL------MLVMEMASGGPLNKFL---SGKKDEITVSNVVELMHQVSMGMKYLEG 113
Query: 751 LNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSV-KGSLGY 809
N++H DL NVLL + A++ DFGL++ L D + + S K L +
Sbjct: 114 KNFVHR---------DLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKW 164
Query: 810 IAPEYGVGCEVSTNGDVYSYGILLLE-LVIGKKPIDIM 846
APE + S+ DV+SYGI + E G+KP M
Sbjct: 165 YAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM 202
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 5/99 (5%)
Query: 744 AIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSV 803
A +I L +LH + DLK N+LLD ++ DFG+ + +T +F
Sbjct: 102 AAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC- 157
Query: 804 KGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
G+ YIAPE +G + +T+ D +S+G+LL E++IG+ P
Sbjct: 158 -GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 34/99 (34%), Positives = 50/99 (50%), Gaps = 6/99 (6%)
Query: 744 AIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSV 803
A +I L LH Q + DLKP N+LLDD+ R+ D GLA + T
Sbjct: 108 AAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-- 162
Query: 804 KGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
G++GY+APE + + D ++ G LL E++ G+ P
Sbjct: 163 -GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (134), Expect = 5e-08
Identities = 54/186 (29%), Positives = 79/186 (42%), Gaps = 59/186 (31%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSF--IAEC---KALKSIR----HRN 684
+G G+FGSVY E +A+K + F EC + +KS+R H N
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 685 LVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLH---------PFTGEDEIDEAPRNL 735
+VK+ +R ND V+E+M E L+ PF+ E I R++
Sbjct: 60 IVKLKEV-----FRENDELYFVFEYM-----EGNLYQLMKDRKGKPFS-ESVI----RSI 104
Query: 736 NLLQRLNIAIDIAYALNYLHHDCQPVTA---HCDLKPSNVLLDDYMTARVGDFGLAR-IL 791
+ Q I L ++H H DLKP N+L+ ++ DFGLAR I
Sbjct: 105 -IYQ-------ILQGLAHIHK------HGFFHRDLKPENLLVSGPEVVKIADFGLAREIR 150
Query: 792 S-PDHT 796
S P +T
Sbjct: 151 SRPPYT 156
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 50/224 (22%), Positives = 99/224 (44%), Gaps = 25/224 (11%)
Query: 634 VGVGSFGSVYKGI--IDEGRTTIAVKVFNLQHHGAS--RSFIAECKALKSIRHRNLVKVL 689
+G G+FG+V KG+ + + T+AVK+ ++ + + E ++ + + +V+++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 690 TACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAY 749
C + V E G L ++L + +++ + ++
Sbjct: 63 GICEAESW------MLVMELAELGPLNKFL----------QKNKHVTEKNITELVHQVSM 106
Query: 750 ALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSV-KGSLG 808
+ YL + H DL NVLL A++ DFGL++ L D + + K +
Sbjct: 107 GMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK 163
Query: 809 YIAPEYGVGCEVSTNGDVYSYGILLLE-LVIGKKPIDIMFEGDI 851
+ APE + S+ DV+S+G+L+ E G+KP M ++
Sbjct: 164 WYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV 207
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 6e-08
Identities = 39/114 (34%), Positives = 58/114 (50%), Gaps = 14/114 (12%)
Query: 743 IAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFS 802
IA+ I AL YLH + H D+KPSNVL++ ++ DFG++ L +T
Sbjct: 108 IAVSIVKALEYLHSKLSVI--HRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID-- 163
Query: 803 VKGSLGYIAPEYGVGCEVSTNG-----DVYSYGILLLELVIGKKPID---IMFE 848
G Y+APE + E++ G DV+S GI ++EL G+ P D F+
Sbjct: 164 -AGCKPYMAPER-INPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ 215
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 6e-08
Identities = 38/109 (34%), Positives = 53/109 (48%), Gaps = 13/109 (11%)
Query: 744 AIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLAR--ILSPDHTQTSSF 801
A +I L +LH + + DLK NVLLD ++ DFG+ + IL T T F
Sbjct: 102 AAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST--F 156
Query: 802 SVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
G+ YIAPE D ++ G+LL E++ G+ P FEGD
Sbjct: 157 C--GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSP----FEGD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 60/209 (28%), Positives = 89/209 (42%), Gaps = 26/209 (12%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACL 693
+G G+FG VYK E A KV + ++ E + L + H +VK+ L
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKL----L 75
Query: 694 GADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNY 753
GA Y + EF G+++ + E+D R L Q I + AL Y
Sbjct: 76 GAFYWDGKLWIMI-EFCPGGAVDAIML------ELD---RGLTEPQIQVICRQMLEALQY 125
Query: 754 LHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPE 813
LH H DLK NVLL ++ DFG++ + SF G+ ++APE
Sbjct: 126 LH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI--GTPYWMAPE 180
Query: 814 YGVGCEVSTN------GDVYSYGILLLEL 836
V CE + D++S GI L+E+
Sbjct: 181 V-VMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 22/209 (10%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTAC 692
+G G++ +V+KG +A+K L+H GA + I E LK ++H N+V
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV------ 67
Query: 693 LGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALN 752
++++ +H + + +D N++ N+ I + L
Sbjct: 68 ------------TLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILR 115
Query: 753 YLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAP 812
L + + H DLKP N+L+++ ++ DFGLAR S T+T S V +L Y P
Sbjct: 116 GLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP-TKTYSNEVV-TLWYRPP 173
Query: 813 EYGVG-CEVSTNGDVYSYGILLLELVIGK 840
+ +G E ST D++ G + E+ G+
Sbjct: 174 DVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 56/226 (24%), Positives = 96/226 (42%), Gaps = 33/226 (14%)
Query: 628 FSSANL-----VGVGSFGSVY----KGIIDEG-RTTIAVKVFNLQHHGASRS-FIAECKA 676
F +NL +G G FG V+ KGI +EG T + VK +S F E
Sbjct: 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 677 LKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLN 736
+ + H+N+V++L C R + + E+ G L+++L +DE + P L+
Sbjct: 62 FRKLSHKNVVRLLGLC-----REAEPHYMILEYTDLGDLKQFLRATKSKDEKLK-PPPLS 115
Query: 737 LLQRLNIAIDIAYALNYL--HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPD 794
Q++ + IA +++L H DL N L+ +V L++ +
Sbjct: 116 TKQKVALCTQIALGMDHLSNAR-----FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS 170
Query: 795 ----HTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLEL 836
L ++APE + ST DV+S+G+L+ E+
Sbjct: 171 EYYKLRNA-----LIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 7e-08
Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQ-HHGASRSFIAECKALKSIRHRNLVKVLTAC 692
+G G+ G+VYK R +AVKV L + ++E + L ++
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY--- 65
Query: 693 LGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALN 752
GA + N EFM GSL+ + +I E ++L R IA+ + L
Sbjct: 66 -GAFFVENRISICT-EFMDGGSLDVY-------RKIPE-----HVLGR--IAVAVVKGLT 109
Query: 753 YLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAP 812
YL H D+KPSN+L++ ++ DFG++ L +T G+ Y+AP
Sbjct: 110 YL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV----GTNAYMAP 162
Query: 813 EYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
E G + + DV+S GI +EL +G+ P
Sbjct: 163 ERISGEQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 58/236 (24%), Positives = 98/236 (41%), Gaps = 48/236 (20%)
Query: 628 FSSANL-----VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGAS-RSFIAECKALKSIR 681
F++ +L +G G+FG+V K + T +AVK + + + + R
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVM--R 58
Query: 682 HRNLVKVLTACLGADYRGNDFKASV----YEFMHYGSLEEWLHPFT---GEDEIDEAPRN 734
+ ++ + G F+ E M SL++ + + + I E
Sbjct: 59 SSDCPYIVK------FYGALFREGDCWICMELMDI-SLDK-FYKYVYEVLKSVIPE---- 106
Query: 735 LNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPD 794
+L + IA+ ALNYL + + + H D+KPSN+LLD ++ DFG++ L
Sbjct: 107 -EILGK--IAVATVKALNYLKEELKII--HRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161
Query: 795 HTQTSSFSVKGSLGYIAPEYGVGCEVSTNG--------DVYSYGILLLELVIGKKP 842
+T G Y+APE + + DV+S GI L E+ GK P
Sbjct: 162 IAKTRD---AGCRPYMAPE-----RIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 7e-08
Identities = 62/254 (24%), Positives = 106/254 (41%), Gaps = 22/254 (8%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACL 693
VG G++G VYK +G+ + ++ G S S E L+ ++H N++ + L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 694 GADYRGNDFKASVYEFMHYGSLEEW-LHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALN 752
R V+ Y + W + F + ++ P L ++ I ++
Sbjct: 69 SHSDR------KVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 753 YLHHDCQPVTAHCDLKPSNVLL----DDYMTARVGDFGLARIL-SPDHTQTSSFSVKGSL 807
YLH + H DLKP+N+L+ + ++ D G AR+ SP V +
Sbjct: 123 YLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 808 GYIAPEYGVGCEVSTNG-DVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVM 866
Y APE +G T D+++ G + EL+ +PI + DI N D +
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDIKTSN----PFHHDQL 234
Query: 867 DIVDSSL-LPDDED 879
D + S + P D+D
Sbjct: 235 DRIFSVMGFPADKD 248
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 9e-08
Identities = 32/100 (32%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 744 AIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSV 803
A +I L ++H+ + DLKP+N+LLD++ R+ D GLA D ++ +
Sbjct: 103 ATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHAS 155
Query: 804 KGSLGYIAPE-YGVGCEVSTNGDVYSYGILLLELVIGKKP 842
G+ GY+APE G ++ D +S G +L +L+ G P
Sbjct: 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 36/107 (33%), Positives = 56/107 (52%), Gaps = 9/107 (8%)
Query: 744 AIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSV 803
A +I L +LH + DLK NV+LD ++ DFG+ + + S+F
Sbjct: 102 AAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC- 157
Query: 804 KGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
G+ YIAPE G + + + D +S+G+LL E++IG+ P F GD
Sbjct: 158 -GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP----FHGD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 66/251 (26%), Positives = 98/251 (39%), Gaps = 38/251 (15%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKA--LKSIRHRNLVKVLTA 691
VG GS+G V +K NL++ AE +A L ++H N+V +
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 692 CLGADYRGNDFKASVYEFMHY---GSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIA 748
G D +Y M + G L L G+ P N Q + + IA
Sbjct: 68 WEGED-------GLLYIVMGFCEGGDLYHKLKEQKGK----LLPEN----QVVEWFVQIA 112
Query: 749 YALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLG 808
AL YLH + H DLK NV L +VGD G+AR+L S ++ G+
Sbjct: 113 MALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS--TLIGTPY 167
Query: 809 YIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDI 868
Y++PE + DV++ G + E+ K H F K + V I
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLK-------------HAFNAKDMNSLVYRI 214
Query: 869 VDSSLLPDDED 879
++ L P +D
Sbjct: 215 IEGKLPPMPKD 225
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 35/104 (33%), Positives = 61/104 (58%), Gaps = 9/104 (8%)
Query: 746 DIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKG 805
++A AL++LH + DLKP N+LLD+ ++ DFGL++ S DH + ++S G
Sbjct: 106 ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEK-KAYSFCG 160
Query: 806 SLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEG 849
++ Y+APE + + D +S+G+L+ E++ G P F+G
Sbjct: 161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP----FQG 200
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 36/104 (34%), Positives = 60/104 (57%), Gaps = 7/104 (6%)
Query: 744 AIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARI-LSPDHTQTSSFS 802
+ +I+ ALN+LH + + DLK NVLLD ++ D+G+ + + P T TS+F
Sbjct: 102 SAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT-TSTFC 157
Query: 803 VKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIM 846
G+ YIAPE G + + D ++ G+L+ E++ G+ P DI+
Sbjct: 158 --GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 199
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 51/195 (26%), Positives = 89/195 (45%), Gaps = 26/195 (13%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVK--VFNLQHHGASRSFIAECKALKSIRHRNLVKVLTA 691
+G G+FG V+K + + +A+K + + G + + E K L+ ++H N+V ++
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 692 CLGADYRGNDFKASVY---EFMHY---GSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAI 745
C N +K S Y EF + G L FT EI + + L LN
Sbjct: 80 CRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFT-LSEIKKVMKML-----LN--- 130
Query: 746 DIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILS-PDHTQTSSFSVK 804
L Y+H + H D+K +N+L+ ++ DFGLAR S +++ + ++ +
Sbjct: 131 ----GLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNR 183
Query: 805 -GSLGYIAPEYGVGC 818
+L Y PE +G
Sbjct: 184 VVTLWYRPPELLLGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 68/234 (29%), Positives = 102/234 (43%), Gaps = 47/234 (20%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRT--TIAVKVFNLQHHGASR--SFIAECKALKSIRHR 683
F +LVG G FG V ++ E T A+KV A SF E + + SI +
Sbjct: 3 FDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 684 NLVKVLTACLGADYRGNDFKASVYEFMHY---GSLEEWLHPFTGEDEIDEAPRNLNLLQR 740
+ L Y D K ++Y M Y G L L+ + ED+ DE + +
Sbjct: 61 PWIPQL------QYAFQD-KDNLYLVMEYQPGGDLLSLLNRY--EDQFDED------MAQ 105
Query: 741 LNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSS 800
+A ++ A++ +H Q H D+KP NVL+D ++ DFG A L+ + S
Sbjct: 106 FYLA-ELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSK 161
Query: 801 FSVKGSLGYIAPE------------YGVGCEVSTNGDVYSYGILLLELVIGKKP 842
V G+ YIAPE YGV C D +S G++ E++ G+ P
Sbjct: 162 LPV-GTPDYIAPEVLTTMNGDGKGTYGVEC------DWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 73/317 (23%), Positives = 117/317 (36%), Gaps = 71/317 (22%)
Query: 632 NLVGVGSFGSVYKGII-----DEGRTTIAVKVFNLQHHGASRS-FIAECKALKSIRHRNL 685
+G G+FG VY+G+ D +AVK S F+ E + H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 686 VKVLTACLGADYRGNDFKASVYEFMHYGSLEEWL-----HPFTGEDEIDEAPRNLNLLQR 740
V+ +G + + + E M G L+ +L P E P +L +
Sbjct: 72 VR----LIGVSFERLP-RFILLELMAGGDLKSFLRENRPRP--------ERPSSLTMKDL 118
Query: 741 LNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV---GDFGLARILSPDHTQ 797
L A D+A YL + H D+ N LL RV DFG+AR D +
Sbjct: 119 LFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR----DIYR 171
Query: 798 TSSFSVKGS----LGYIAPEYGVGCEVSTNGDVYSYGILLLELV-IGKKPIDIMFEGDIN 852
S + G + ++ PE + ++ DV+S+G+LL E+ +G P
Sbjct: 172 ASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYP-------G 224
Query: 853 LHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSM 912
N +VM+ V R++ C + RI C
Sbjct: 225 RTN-------QEVMEFVTGG------------------GRLDPPKGCPGPVYRIMTDCWQ 259
Query: 913 ELPQDRTNMTNVVHELQ 929
P+DR N ++ +Q
Sbjct: 260 HTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-07
Identities = 39/131 (29%), Positives = 58/131 (44%), Gaps = 27/131 (20%)
Query: 764 HCDLKPSNVLL---DDYMTARVGDFGLARILSPDH-----TQTSSFSVKGSLGYIAPEYG 815
H DLKP N+++ A+V DFG+ +L T T + V G+ Y APE
Sbjct: 102 HRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL 161
Query: 816 VGCEVSTNGDVYSYGILLLELVIGKK----------------PIDIMFEGDINLHNFG-- 857
G V+ N D+Y++G++ LE + G++ P+D+ I H G
Sbjct: 162 RGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQV 221
Query: 858 -RKALPDDVMD 867
RKAL D
Sbjct: 222 LRKALNKDPRQ 232
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 36/110 (32%), Positives = 52/110 (47%), Gaps = 21/110 (19%)
Query: 743 IAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFS 802
+ + I AL+YL + H D+KPSN+LLD ++ DFG++ L +T S
Sbjct: 119 MTVAIVKALHYLKEKHGVI--HRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS-- 174
Query: 803 VKGSLGYIAPE----------YGVGCEVSTNGDVYSYGILLLELVIGKKP 842
G Y+APE Y + DV+S GI L+EL G+ P
Sbjct: 175 -AGCAAYMAPERIDPPDPNPKYDI------RADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 38/121 (31%), Positives = 61/121 (50%), Gaps = 14/121 (11%)
Query: 728 IDEAPRNLNLLQRLNIAIDIAYALNYL-HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFG 786
++E L+ L+ + +A +++L +C H DL N+LL ++ DFG
Sbjct: 204 LEEDELALDTEDLLSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFG 259
Query: 787 LARILSPDHTQTSSFSVKGS----LGYIAPEYGVGCEVSTNGDVYSYGILLLELV-IGKK 841
LAR D S++ VKG+ + ++APE C + DV+SYGILL E+ +G
Sbjct: 260 LAR----DIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSS 315
Query: 842 P 842
P
Sbjct: 316 P 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-07
Identities = 37/134 (27%), Positives = 63/134 (47%), Gaps = 15/134 (11%)
Query: 754 LHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPE 813
+HH H D+K +N+LL ++GDFG +++ + + + G+ Y+APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 814 YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA-------LPDDV- 865
S D++S G+LL EL+ K+P F+G+ N+ K LP +
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRP----FDGE-NMEEVMHKTLAGRYDPLPPSIS 270
Query: 866 --MDIVDSSLLPDD 877
M + ++LL D
Sbjct: 271 PEMQEIVTALLSSD 284
|
Length = 496 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 34/100 (34%), Positives = 52/100 (52%), Gaps = 8/100 (8%)
Query: 744 AIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLA-RILSPDHTQTSSFS 802
A +I L LH + T + DLKP N+LLDDY R+ D GLA +I + +
Sbjct: 108 AAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV-- 162
Query: 803 VKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
G++GY+APE + + D + G L+ E++ G+ P
Sbjct: 163 --GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 36/99 (36%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 744 AIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSV 803
A +I L LH + + DLKP N+LLDDY R+ D GLA + P+ +T V
Sbjct: 108 AAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLA-VEIPE-GETIRGRV 162
Query: 804 KGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
G++GY+APE + + D + G L+ E++ GK P
Sbjct: 163 -GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 56/254 (22%), Positives = 92/254 (36%), Gaps = 50/254 (19%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNL----QHHGASRSFIAEC----------KAL 677
+G G++G V K +A+K + R + C K +
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 678 KSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNL 737
I+H N++ ++ Y DF V + M L++ + + L
Sbjct: 75 NEIKHENIMGLV-----DVYVEGDFINLVMDIMAS-DLKK----------VVDRKIRLTE 118
Query: 738 LQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQ 797
Q I + I LN LH + H DL P+N+ ++ ++ DFGLAR
Sbjct: 119 SQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYS 175
Query: 798 TSSFSVKGS------------LGYIAPEYGVGCEVSTNG-DVYSYGILLLELVIGKKPID 844
+ + L Y APE +G E D++S G + EL+ GK
Sbjct: 176 DTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP--- 232
Query: 845 IMFEGDINLHNFGR 858
+F G+ + GR
Sbjct: 233 -LFPGENEIDQLGR 245
|
Length = 335 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 62/226 (27%), Positives = 98/226 (43%), Gaps = 47/226 (20%)
Query: 640 GSVYKGIIDEGRTTI-----AVKV----FNLQHHGASRSFIAECKALKSIRHRNLVKVLT 690
GS +GI+ T+ AVK F Q H A R++ E LK + H+N++ +L
Sbjct: 30 GSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTH-AKRAY-RELVLLKCVNHKNIISLLN 87
Query: 691 ACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAID---I 747
F SLEE+ + + +D NL Q +++ +D +
Sbjct: 88 V-----------------FTPQKSLEEFQDVYLVMELMDA-----NLCQVIHMELDHERM 125
Query: 748 AYALNYL----HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSV 803
+Y L + H H DLKPSN+++ T ++ DFGLAR + T
Sbjct: 126 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVT 185
Query: 804 KGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEG 849
+ Y APE +G N D++S G ++ ELV G ++F+G
Sbjct: 186 R---YYRAPEVILGMGYKENVDIWSVGCIMGELVKGS----VIFQG 224
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 22/217 (10%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRS-FIAECKALKSIRHRNLV 686
F + +G G+ G V+K +A K+ +L+ A R+ I E + L H
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL----HECNS 62
Query: 687 KVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAID 746
+ GA Y + + E M GSL++ L I E +L +++IA+
Sbjct: 63 PYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKK---AGRIPE-----QILGKVSIAV- 112
Query: 747 IAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGS 806
L YL + H D+KPSN+L++ ++ DFG++ L + + S G+
Sbjct: 113 -IKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGT 165
Query: 807 LGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPI 843
Y++PE G S D++S G+ L+E+ IG+ PI
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 65/234 (27%), Positives = 104/234 (44%), Gaps = 42/234 (17%)
Query: 634 VGVGSFGSVYKGI---IDEGR----TTIAVKVFNLQHHGASRSF---IAECKALKSI-RH 682
+G G FG V + ID+ R T+AVK+ L+ + + I+E + +K I +H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKM--LKDNATDKDLADLISEMELMKLIGKH 77
Query: 683 RNLVKVLTACL--GADYRGNDFKASVYEFMHYGSLEEWLH---PFTGEDEID--EAPRN- 734
+N++ +L C G Y + E+ G+L E+L P + D + P
Sbjct: 78 KNIINLLGVCTQEGPLY-------VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQ 130
Query: 735 LNLLQRLNIAIDIAYALNYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLAR---- 789
L+ ++ A +A + YL C H DL NVL+ + ++ DFGLAR
Sbjct: 131 LSFKDLVSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHD 186
Query: 790 ILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLEL-VIGKKP 842
I T VK ++APE + DV+S+GIL+ E+ +G P
Sbjct: 187 IDYYKKTSNGRLPVK----WMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 62/229 (27%), Positives = 96/229 (41%), Gaps = 38/229 (16%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVK 687
F ++G G+FG V + A+K+ N + R+ A + + + +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILN-KWEMLKRAETACFREERDVLVNGDNQ 61
Query: 688 VLTACLGADYRGNDFKASVYEFMHY---GSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIA 744
+T A N+ +Y M Y G L L F ED + E L + + IA
Sbjct: 62 WITTLHYAFQDENN----LYLVMDYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMV-IA 114
Query: 745 IDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVK 804
ID + L+Y+H D +KP N+L+D R+ DFG L D T SS +V
Sbjct: 115 IDSVHQLHYVHRD---------IKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV- 164
Query: 805 GSLGYIAPE-----------YGVGCEVSTNGDVYSYGILLLELVIGKKP 842
G+ YI+PE YG C D +S G+ + E++ G+ P
Sbjct: 165 GTPDYISPEILQAMEDGKGKYGPEC------DWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 32/100 (32%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 744 AIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSV 803
A +I L ++H+ + DLKP+N+LLD++ R+ D GLA D ++ +
Sbjct: 103 AAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHAS 155
Query: 804 KGSLGYIAPE-YGVGCEVSTNGDVYSYGILLLELVIGKKP 842
G+ GY+APE G ++ D +S G +L +L+ G P
Sbjct: 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 4e-07
Identities = 60/253 (23%), Positives = 105/253 (41%), Gaps = 20/253 (7%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACL 693
VG G++G VYK +G+ + ++ G S S E L+ ++H N++ + L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 694 GADYRGNDFKASVYEFMHYGSLEEW-LHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALN 752
R V+ Y + W + F + ++ P L ++ I ++
Sbjct: 69 SHADR------KVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122
Query: 753 YLHHDCQPVTAHCDLKPSNVLL----DDYMTARVGDFGLARIL-SPDHTQTSSFSVKGSL 807
YLH + H DLKP+N+L+ + ++ D G AR+ SP V +
Sbjct: 123 YLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 808 GYIAPEYGVGCEVSTNG-DVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVM 866
Y APE +G T D+++ G + EL+ +PI + DI N D +
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDIKTSNPYHHDQLDRIF 238
Query: 867 DIVDSSLLPDDED 879
+++ P D+D
Sbjct: 239 NVMG---FPADKD 248
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 28/100 (28%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 745 IDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVK 804
I A++Y+H + H D+K N+ L ++GDFG+++IL +++ +V
Sbjct: 108 FQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE--TVV 162
Query: 805 GSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPID 844
G+ Y++PE G + + D+++ G +L EL+ K+ D
Sbjct: 163 GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFD 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 62/231 (26%), Positives = 98/231 (42%), Gaps = 37/231 (16%)
Query: 623 NATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIA-ECKALKSIR 681
N + VG G++G VYK AVK+ L+ G S I E +K +
Sbjct: 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSLIQQEIFMVKECK 64
Query: 682 HRNLVKVLTACLGADYRGNDFKASVYEFMHY---GSLEEWLHPFTGEDEIDEAPRNLNLL 738
H N+V + L + ++ M Y GSL++ H TG L+ L
Sbjct: 65 HCNIVAYFGSYLS--------REKLWICMEYCGGGSLQDIYH-VTGP---------LSEL 106
Query: 739 QRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQT 798
Q + + L YLH + H D+K +N+LL D ++ DFG+A ++ +
Sbjct: 107 QIAYVCRETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR 163
Query: 799 SSFSVKGSLGYIAPEYGVGCEVSTNG------DVYSYGILLLELVIGKKPI 843
SF G+ ++APE V NG D+++ GI +EL + P+
Sbjct: 164 KSFI--GTPYWMAPEVAA---VEKNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 38/151 (25%), Positives = 67/151 (44%), Gaps = 30/151 (19%)
Query: 634 VGVGSFGSVYKGIIDE-------GRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLV 686
+G G+F ++KGI E +T + +KV + H S SF + + H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 687 KVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRN---LNLLQRLNI 743
C+ D V E++ +GSL+ +L +N +N+ +L +
Sbjct: 63 LNYGVCVCGDE-----SIMVQEYVKFGSLDTYLK------------KNKNLINISWKLEV 105
Query: 744 AIDIAYALNYLHHDCQPVTAHCDLKPSNVLL 774
A +A+AL++L H ++ NVLL
Sbjct: 106 AKQLAWALHFLEDKGLT---HGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-07
Identities = 57/232 (24%), Positives = 94/232 (40%), Gaps = 50/232 (21%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFN--LQHHGASRSFIAECKALKSIRHRNLVKVLTA 691
VG G++GSV R +AVK + Q +R E + LK ++H N++ +L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 692 CLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLN------IAI 745
F S+E + + + + N+ Q+L+ +
Sbjct: 83 -----------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIY 125
Query: 746 DIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKG 805
+ L Y+H H DLKPSNV +++ R+ DFGLAR + T
Sbjct: 126 QLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT--------- 173
Query: 806 SLGYIAPEYGVGCEVSTNG-------DVYSYGILLLELVIGKKPIDIMFEGD 850
GY+A + E+ N D++S G ++ EL+ GK +F G+
Sbjct: 174 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK----ALFPGN 219
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 6e-07
Identities = 57/219 (26%), Positives = 100/219 (45%), Gaps = 31/219 (14%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGAS-RSFIAECKALKSIRHRNLVKVLTAC 692
+G G++GSVYK + T+A+K L+ + I E L H+ + +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDIL----HKAVSPYIVDF 64
Query: 693 LGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAY 749
GA + + +VY E+M GSL++ + I E ++L+R I +
Sbjct: 65 YGAFF----IEGAVYMCMEYMDAGSLDKLYAGGVATEGIPE-----DVLRR--ITYAVVK 113
Query: 750 ALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGY 809
L +L + + H D+KP+NVL++ ++ DFG++ L +T+ G Y
Sbjct: 114 GLKFLKEEHNII--HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI----GCQSY 167
Query: 810 IAPEYGVGCEVSTNG------DVYSYGILLLELVIGKKP 842
+APE + N DV+S G+ +LE+ +G+ P
Sbjct: 168 MAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 6e-07
Identities = 44/159 (27%), Positives = 74/159 (46%), Gaps = 30/159 (18%)
Query: 746 DIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKG 805
+I+ AL +LH Q + + DLKP N+LLD ++ DFGL + + T T +F G
Sbjct: 108 EISLALEHLHQ--QGII-YRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC--G 162
Query: 806 SLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIG---------KKPIDIMFEGDINLHNF 856
++ Y+APE + D +S G L+ +++ G KK ID + +G +NL +
Sbjct: 163 TIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPY 222
Query: 857 GRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINS 895
L P+ DL+ +R +R+ +
Sbjct: 223 ----------------LTPEARDLLKKLLKRNPSSRLGA 245
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 47/195 (24%), Positives = 93/195 (47%), Gaps = 25/195 (12%)
Query: 654 IAVKVFNLQHHGASRS-FIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHY 712
+AVK+ +R+ F+ E K + +++ N++++L C+ +D + E+M
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVS-----DDPLCMITEYMEN 101
Query: 713 GSLEEWLH------PFTGEDEIDEAPRNLNLLQRLNIAIDIAY--ALNYLHHDCQPVTAH 764
G L ++L FT + I L + IA + Y +LN++H D
Sbjct: 102 GDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRD------- 154
Query: 765 CDLKPSNVLLDDYMTARVGDFGLARIL-SPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTN 823
L N L+ ++ T ++ DFG++R L S D+ + +V + ++A E + + +T
Sbjct: 155 --LATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVL-PIRWMAWESILLGKFTTA 211
Query: 824 GDVYSYGILLLELVI 838
DV+++G+ L E+
Sbjct: 212 SDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 61/224 (27%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSI-RHRNLV 686
F LVG G++G VYKG + A+KV ++ E LK HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIA 66
Query: 687 KVLTACLGADYRGNDFKA-SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAI 745
A + + G D + V EF GS+ + + G N L+ IA
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-----------NTLKEEWIAY 115
Query: 746 DIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKG 805
L L H Q H D+K NVLL + ++ DFG++ L D T + G
Sbjct: 116 ICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIG 173
Query: 806 SLGYIAPEYGVGCEVSTNG------DVYSYGILLLELVIGKKPI 843
+ ++APE + C+ + + D++S GI +E+ G P+
Sbjct: 174 TPYWMAPEV-IACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 7e-07
Identities = 60/214 (28%), Positives = 91/214 (42%), Gaps = 26/214 (12%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACL 693
+G G+ GSV K T +A KV H GA S + I H + +
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVV---HIGAKSSVRKQILRELQIMHECRSPYIVSFY 69
Query: 694 GADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNY 753
GA N+ + EFM GSL+ P + +L + IA+ + L Y
Sbjct: 70 GAFLNENNICMCM-EFMDCGSLDRIYKKG--------GPIPVEILGK--IAVAVVEGLTY 118
Query: 754 L---HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYI 810
L H H D+KPSN+L++ ++ DFG++ L T G+ Y+
Sbjct: 119 LYNVHR-----IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT----FVGTSTYM 169
Query: 811 APEYGVGCEVSTNGDVYSYGILLLELVIGKKPID 844
+PE G + + DV+S GI ++EL +GK P
Sbjct: 170 SPERIQGGKYTVKSDVWSLGISIIELALGKFPFA 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 22/218 (10%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIR-HRNLVKVLTAC 692
+G G++G V+K + + + AVK+ + H AE LK++ H N+VK
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 693 LGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALN 752
D + D V E + GS+ + + F E E P IA + AL
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI---------IAYILHEALM 135
Query: 753 YLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGL-ARILSPDHTQTSSFSVKGSLGYIA 811
L H T H D+K +N+LL ++ DFG+ A++ S + +S G+ ++A
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV---GTPFWMA 192
Query: 812 PEYGVGCEVSTNG------DVYSYGILLLELVIGKKPI 843
PE + CE + DV+S GI +EL G P+
Sbjct: 193 PEV-IACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 9e-07
Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTA 691
+G G++G+V+K E +A+K L G S + E LK ++H+N+V++
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY-- 65
Query: 692 CLGADYRGNDFKAS-VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYA 750
D +D K + V+E+ L+++ G +ID + Q L + ++
Sbjct: 66 ----DVLHSDKKLTLVFEYCDQ-DLKKYFDSCNG--DIDPEIVKSFMFQLLK-GLAFCHS 117
Query: 751 LNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYI 810
N LH DLKP N+L++ ++ DFGLAR S+ V +L Y
Sbjct: 118 HNVLHR---------DLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYR 166
Query: 811 APEYGVGCEV-STNGDVYSYGILLLELVIGKKPI 843
P+ G ++ ST+ D++S G + EL +P+
Sbjct: 167 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 9e-07
Identities = 65/258 (25%), Positives = 108/258 (41%), Gaps = 26/258 (10%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACL 693
+G GS G V +AVK +L+ E ++ H N+V + +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNS-- 87
Query: 694 GADYRGNDFKASVYEFMHYGSLEEWL-HPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALN 752
Y D V EF+ G+L + + H E++I + + + AL+
Sbjct: 88 ---YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI------------ATVCLSVLRALS 132
Query: 753 YLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAP 812
YLH+ Q V H D+K ++LL ++ DFG +S + + S G+ ++AP
Sbjct: 133 YLHN--QGVI-HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV--GTPYWMAP 187
Query: 813 EYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVD-S 871
E T D++S GI+++E++ G+ P E + R LP V D S
Sbjct: 188 EVISRLPYGTEVDIWSLGIMVIEMIDGEPP--YFNEPPLQAMRRIRDNLPPRVKDSHKVS 245
Query: 872 SLLPDDEDLILTGNQRQK 889
S+L DL+L Q+
Sbjct: 246 SVLRGFLDLMLVREPSQR 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 59/197 (29%), Positives = 87/197 (44%), Gaps = 7/197 (3%)
Query: 340 ELQNLKILGLNRNKL--SGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINL 397
L L L L S + ++ NL L +L LN N L +I S L + +L ++L
Sbjct: 65 SLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNI-SELLELTNLTSLDL 123
Query: 398 SNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPS 457
NNN++ P S+L LD S NK+ SLP + L L+ L + N L ++P
Sbjct: 124 DNNNITDIPPLIGLLKSNLK-ELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPK 180
Query: 458 TFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLSLNNLNL 517
N L L + GN + + L L LDLS N++ + +L+ L L
Sbjct: 181 LLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLEL 239
Query: 518 SYNDLEGMVTTEGVFKN 534
S N LE + + G N
Sbjct: 240 SNNKLEDLPESIGNLSN 256
|
Length = 394 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 63/246 (25%), Positives = 101/246 (41%), Gaps = 47/246 (19%)
Query: 622 YNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVK--VFNLQHHGASRSFIAECKALKS 679
+ T+ + VG+G+FG V +A+K + ++ E K LK
Sbjct: 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKH 65
Query: 680 IRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGS--LEEWLHPFTGEDEIDEAPRNLNL 737
+RH N++ + +D S E +++ + L LH + P
Sbjct: 66 LRHENIISL-----------SDIFISPLEDIYFVTELLGTDLHRL-----LTSRPLEKQF 109
Query: 738 LQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQ 797
+Q I L Y+H H DLKPSN+L+++ ++ DFGLARI D
Sbjct: 110 IQYF--LYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI--QDPQM 162
Query: 798 TSSFSVKGSLGYIAPE-------YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
T S + Y APE Y V EV D++S G + E++ GK +F G
Sbjct: 163 TGYVSTR---YYRAPEIMLTWQKYDV--EV----DIWSAGCIFAEMLEGKP----LFPGK 209
Query: 851 INLHNF 856
+++ F
Sbjct: 210 DHVNQF 215
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 34/106 (32%), Positives = 54/106 (50%), Gaps = 5/106 (4%)
Query: 739 QRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQT 798
Q + A +I+ L +LH + + DLK NV+LD ++ DFG+ + D T
Sbjct: 102 QAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT 158
Query: 799 SSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPID 844
+F G+ YIAPE + D ++YG+LL E++ G+ P D
Sbjct: 159 RTFC--GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 63/234 (26%), Positives = 104/234 (44%), Gaps = 42/234 (17%)
Query: 634 VGVGSFGSVYKGI---IDEGR----TTIAVKVFNLQHHGASRSF---IAECKALKSI-RH 682
+G G FG V ID+ + T+AVK+ L+ + ++E + +K I +H
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKM--LKDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 683 RNLVKVLTACL--GADYRGNDFKASVYEFMHYGSLEEWLHPF--TGEDEIDEAPR----N 734
+N++ +L AC G Y + E+ G+L E+L G D + +
Sbjct: 78 KNIINLLGACTQDGPLY-------VLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQ 130
Query: 735 LNLLQRLNIAIDIAYALNYL-HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLAR-ILS 792
L ++ A +A + YL C H DL NVL+ + ++ DFGLAR + +
Sbjct: 131 LTFKDLVSCAYQVARGMEYLASQKC----IHRDLAARNVLVTEDNVMKIADFGLARDVHN 186
Query: 793 PDH---TQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLEL-VIGKKP 842
D+ T VK ++APE + DV+S+G+LL E+ +G P
Sbjct: 187 IDYYKKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 32/89 (35%), Positives = 50/89 (56%), Gaps = 7/89 (7%)
Query: 764 HCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVK--GSLGYIAPEYGVGCEVS 821
H DLKP N+L++ ++ DFGLAR S + + + F + + Y APE + +
Sbjct: 128 HRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSY 187
Query: 822 TNG-DVYSYGILLLELVIGKKPIDIMFEG 849
T DV+S G +L EL +G+KP +F+G
Sbjct: 188 TKAIDVWSVGCILAEL-LGRKP---VFKG 212
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 52/186 (27%), Positives = 77/186 (41%), Gaps = 41/186 (22%)
Query: 750 ALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARI-------------LSPDHT 796
AL YLH+ H DLKP N+L+ ++ DFGL++I + D
Sbjct: 113 ALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 797 QTSSFSVKGSLGYIAPEY----GVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDIN 852
+ V G+ YIAPE G G V D ++ GI+L E ++G P F GD
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPV----DWWAMGIILYEFLVGCVP----FFGDTP 221
Query: 853 LHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSM 912
FG + + DD+ LP D +++ RQ + R+G +
Sbjct: 222 EELFG-QVISDDIEWPEGDEALPADAQDLISRLLRQN------------PLERLGTGGAF 268
Query: 913 ELPQDR 918
E+ Q R
Sbjct: 269 EVKQHR 274
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 62/233 (26%), Positives = 102/233 (43%), Gaps = 40/233 (17%)
Query: 634 VGVGSFGSVY--KGIIDEGRTTI---AVKVFNLQHHGASRSFIAECKALKSIRHRNLVKV 688
+G GSFG +Y K D I + ++ AS+ E L ++H N+V
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK---EVILLAKMKHPNIVTF 64
Query: 689 LTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTG----EDEIDEAPRNLNLLQRLNIA 744
A ++ N V E+ G L + ++ G ED+I L+
Sbjct: 65 F-----ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQI------------LSWF 107
Query: 745 IDIAYALNYLHHDCQPVTAHCDLKPSNVLLD-DYMTARVGDFGLARILSPDHTQTSSFSV 803
+ I+ L ++H H D+K N+ L + M A++GDFG+AR L + + +++
Sbjct: 108 VQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL--NDSMELAYTC 162
Query: 804 KGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNF 856
G+ Y++PE + D++S G +L EL K P FEG+ NLH
Sbjct: 163 VGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP----FEGN-NLHQL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-06
Identities = 51/205 (24%), Positives = 86/205 (41%), Gaps = 50/205 (24%)
Query: 659 FNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEW 718
F H A R++ E +K + H+N++ +L F SLEE+
Sbjct: 53 FQNVTH-AKRAY-RELVLMKLVNHKNIIGLLNV-----------------FTPQKSLEEF 93
Query: 719 LHPFTGEDEIDEAPRNLNLLQRLNIAID---IAY-------ALNYLHHDCQPVTA---HC 765
+ + +D NL Q + + +D ++Y + +LH +A H
Sbjct: 94 QDVYLVMELMDA-----NLCQVIQMDLDHERMSYLLYQMLCGIKHLH------SAGIIHR 142
Query: 766 DLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGD 825
DLKPSN+++ T ++ DFGLAR T + Y APE +G N D
Sbjct: 143 DLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKENVD 199
Query: 826 VYSYGILLLELVIGKKPIDIMFEGD 850
++S G ++ E++ G ++F G
Sbjct: 200 IWSVGCIMGEMIRGT----VLFPGT 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 16/101 (15%)
Query: 746 DIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKG 805
++ A YLH + + DLKP N+LLD+ +V DFG A+ + PD T F++ G
Sbjct: 126 ELVLAFEYLH-SKDII--YRDLKPENLLLDNKGHVKVTDFGFAKKV-PDRT----FTLCG 177
Query: 806 SLGYIAPEY----GVGCEVSTNGDVYSYGILLLELVIGKKP 842
+ Y+APE G G V D ++ G+LL E + G P
Sbjct: 178 TPEYLAPEVIQSKGHGKAV----DWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 25/73 (34%), Positives = 38/73 (52%)
Query: 764 HCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTN 823
H DL N+LL + ++ DFGLAR + D + L ++APE +T
Sbjct: 196 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQ 255
Query: 824 GDVYSYGILLLEL 836
DV+S+G+LL E+
Sbjct: 256 SDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 38/127 (29%), Positives = 59/127 (46%), Gaps = 29/127 (22%)
Query: 729 DEAPRNLN--LLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFG 786
D P ++ + + +AI + L+Y+H D +KP NVLLD R+ DFG
Sbjct: 97 DRLPEDMARFYIAEMVLAIHSIHQLHYVHRD---------IKPDNVLLDMNGHIRLADFG 147
Query: 787 LARILSPDHTQTSSFSVKGSLGYIAPE-----------YGVGCEVSTNGDVYSYGILLLE 835
++ D T SS +V G+ YI+PE YG C D +S G+ + E
Sbjct: 148 SCLKMNQDGTVQSSVAV-GTPDYISPEILQAMEDGMGKYGPEC------DWWSLGVCMYE 200
Query: 836 LVIGKKP 842
++ G+ P
Sbjct: 201 MLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 62/229 (27%), Positives = 100/229 (43%), Gaps = 32/229 (13%)
Query: 634 VGVGSFGSVYKGI---IDEGR----TTIAVKVFNLQHHGASRS-FIAECKALKSI-RHRN 684
+G G FG V +D+ + T +AVK+ S I+E + +K I +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 685 LVKVLTACL--GADYRGNDFKASVYEFMHYGSLEEWLH---PFTGED--EIDEAP-RNLN 736
++ +L AC G Y + E+ G+L E+L P E + P L+
Sbjct: 86 IINLLGACTQDGPLY-------VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLS 138
Query: 737 LLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHT 796
++ A +A + YL H DL NVL+ + ++ DFGLAR + H
Sbjct: 139 FKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--HI 193
Query: 797 QTSSFSVKGSL--GYIAPEYGVGCEVSTNGDVYSYGILLLEL-VIGKKP 842
+ G L ++APE + DV+S+G+LL E+ +G P
Sbjct: 194 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 58/230 (25%), Positives = 102/230 (44%), Gaps = 34/230 (14%)
Query: 634 VGVGSFGSVYKGI---IDEGR----TTIAVKVFNLQHHGASRSF---IAECKALKSI-RH 682
+G G FG V ID+ + T+AVK+ L+ + ++E + +K I +H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 80
Query: 683 RNLVKVLTACL--GADYRGNDFKASVYEFMHYGSLEEWLH---PFTGEDEIDEA---PRN 734
+N++ +L AC G Y + E+ G+L E+L P E D A
Sbjct: 81 KNIINLLGACTQDGPLY-------VIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133
Query: 735 LNLLQRLNIAIDIAYALNYL-HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSP 793
+ ++ +A + YL C H DL NVL+ + ++ DFGLAR ++
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDVNN 189
Query: 794 DHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLEL-VIGKKP 842
+ + + + ++APE + DV+S+G+L+ E+ +G P
Sbjct: 190 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 34/100 (34%), Positives = 47/100 (47%), Gaps = 4/100 (4%)
Query: 766 DLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGD 825
D+KP NVLLDD R+ D GLA L T T G+ GY+APE S D
Sbjct: 120 DMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR---AGTNGYMAPEILKEEPYSYPVD 176
Query: 826 VYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDV 865
++ G + E+V G+ P + + R+ L D+V
Sbjct: 177 WFAMGCSIYEMVAGRTPFK-DHKEKVAKEELKRRTLEDEV 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 36/109 (33%), Positives = 53/109 (48%), Gaps = 21/109 (19%)
Query: 744 AIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLAR--ILSPDHTQTSSF 801
A +IA L +LH + DLK NV+LD ++ DFG+ + I T+T F
Sbjct: 107 AAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT--F 161
Query: 802 SVKGSLGYIAPE------YGVGCEVSTNGDVYSYGILLLELVIGKKPID 844
G+ YIAPE YG D +++G+LL E++ G+ P D
Sbjct: 162 C--GTPDYIAPEIIAYQPYGKSV------DWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 58/227 (25%), Positives = 95/227 (41%), Gaps = 29/227 (12%)
Query: 623 NATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRH 682
N F +G G++G VYK A+KV L+ E +K +H
Sbjct: 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKH 65
Query: 683 RNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLN 742
N+V A G+ R + + EF GSL++ H TG L+ Q
Sbjct: 66 SNIV----AYFGSYLRRDKLWICM-EFCGGGSLQDIYH-VTGP---------LSESQIAY 110
Query: 743 IAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFS 802
++ + L YLH + H D+K +N+LL D ++ DFG++ ++ + SF
Sbjct: 111 VSRETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI 167
Query: 803 VKGSLGYIAPEYGVGCEVSTNG------DVYSYGILLLELVIGKKPI 843
G+ ++APE V G D+++ GI +EL + P+
Sbjct: 168 --GTPYWMAPEVAA---VERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 3e-06
Identities = 68/255 (26%), Positives = 105/255 (41%), Gaps = 49/255 (19%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIA----ECKALKSIRHRN---LV 686
VG G++G+V + + RT V + L S F E + LK ++H N L+
Sbjct: 23 VGSGAYGTVCSAL--DRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 687 KVLTACLGADYRGNDFKASVYEFM--HYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIA 744
V T L D R +DF V FM G L + H ED I +
Sbjct: 81 DVFTPDLSLD-RFHDFYL-VMPFMGTDLGKLMK--HEKLSEDRIQ------------FLV 124
Query: 745 IDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVK 804
+ L Y+H H DLKP N+ +++ ++ DFGLAR T +
Sbjct: 125 YQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYV 176
Query: 805 GSLGYIAPEYGVGCEVSTNG-DVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPD 863
+ Y APE + T D++S G ++ E++ GK +F+G +L D
Sbjct: 177 VTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKP----LFKGHDHL---------D 223
Query: 864 DVMDIVDSSLLPDDE 878
+M+I+ + P E
Sbjct: 224 QLMEIMKVTGTPSKE 238
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 61/228 (26%), Positives = 97/228 (42%), Gaps = 31/228 (13%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSI-RHRNLV 686
F +VG G++G VYKG + A+KV ++ E LK HRN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIA 76
Query: 687 KVLTACLGADYRGNDFKA-SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAI 745
A + G+D + V EF GS+ + + G N L+ IA
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-----------NALKEDWIAY 125
Query: 746 ---DIAYALNYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSF 801
+I L +LH H H D+K NVLL + ++ DFG++ L D T
Sbjct: 126 ICREILRGLAHLHAHK----VIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRN 179
Query: 802 SVKGSLGYIAPEYGVGCEVSTNG------DVYSYGILLLELVIGKKPI 843
+ G+ ++APE + C+ + + D++S GI +E+ G P+
Sbjct: 180 TFIGTPYWMAPEV-IACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 3e-06
Identities = 55/185 (29%), Positives = 85/185 (45%), Gaps = 37/185 (20%)
Query: 673 ECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHY------GSLEEWLHPFTGED 726
E L ++H N+V V +G++ +Y M Y +E PF +
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLD------KIYMVMEYVEHDLKSLMETMKQPFL-QS 106
Query: 727 EIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFG 786
E+ + L +LQ L+ + +LH + H DLK SN+LL++ ++ DFG
Sbjct: 107 EV----KCL-MLQLLS-------GVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFG 151
Query: 787 LARIL-SPDHTQTSSFSVKGSLGYIAPEYGVGCEV-STNGDVYSYGILLLELVIGKKPID 844
LAR SP T + +L Y APE +G + ST D++S G + EL + KKP
Sbjct: 152 LAREYGSPLKPYT---QLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAEL-LTKKP-- 205
Query: 845 IMFEG 849
+F G
Sbjct: 206 -LFPG 209
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 28/219 (12%)
Query: 633 LVGVGSFGSVYKGI-IDEGRTTIAVKV--FNLQHHGASRSFIA-EC--KALKSIRHRNLV 686
L+G G+FG VY D GR +AVK F+ + S+ A EC + LK++ H +V
Sbjct: 9 LLGQGAFGRVYLCYDADTGRE-LAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 687 KVLTACLGADYRGNDFKA-SVY-EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIA 744
+ CL R + S++ E M GS+++ L + E N+ ++
Sbjct: 68 QYY-GCL----RDPMERTLSIFMEHMPGGSIKDQLKSYGALTE--------NVTRKY--T 112
Query: 745 IDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPD-HTQTSSFSV 803
I ++YLH + + H D+K +N+L D ++GDFG ++ L + T SV
Sbjct: 113 RQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV 169
Query: 804 KGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
G+ +++PE G D++S G ++E++ K P
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-06
Identities = 36/109 (33%), Positives = 51/109 (46%), Gaps = 5/109 (4%)
Query: 729 DEAPRNLNLLQRLNIAIDIAYALNYL-HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGL 787
D+ L L L+ +A + +L +C H DL NVLL ++ DFGL
Sbjct: 228 DDGSEGLTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFGL 283
Query: 788 ARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLEL 836
AR + D S S + ++APE +T DV+SYGILL E+
Sbjct: 284 ARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-06
Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 30/217 (13%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKV--- 688
N++G GSFG VY+ I + +A+K +R E +K++ H N++ +
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR----ELLIMKNLNHINIIFLKDY 127
Query: 689 -LTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAI-- 745
T C + + N F V EF+ P T + RN + L + +
Sbjct: 128 YYTECFKKNEK-NIFLNVVMEFI----------PQTVHKYMKHYARNNHALPLFLVKLYS 176
Query: 746 -DIAYALNYLHHDCQPVTAHCDLKPSNVLLD-DYMTARVGDFGLARILSPDHTQTSSFSV 803
+ AL Y+H H DLKP N+L+D + T ++ DFG A+ L S S
Sbjct: 177 YQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ---RSVSY 230
Query: 804 KGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIG 839
S Y APE +G +T+ D++S G ++ E+++G
Sbjct: 231 ICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 4e-06
Identities = 53/201 (26%), Positives = 88/201 (43%), Gaps = 44/201 (21%)
Query: 659 FNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEW 718
F Q H A R++ E +K + H+N++ +L F SLEE+
Sbjct: 61 FQNQTH-AKRAY-RELVLMKCVNHKNIIGLLNV-----------------FTPQKSLEEF 101
Query: 719 LHPFTGEDEIDEAPRNLNLLQRLNIAID---IAYALNYL----HHDCQPVTAHCDLKPSN 771
+ + +D NL Q + + +D ++Y L + H H DLKPSN
Sbjct: 102 QDVYIVMELMDA-----NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 156
Query: 772 VLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSL---GYIAPEYGVGCEVSTNGDVYS 828
+++ T ++ DFGLAR T +SF + + Y APE +G N D++S
Sbjct: 157 IVVKSDCTLKILDFGLAR------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWS 210
Query: 829 YGILLLELVIGKKPIDIMFEG 849
G ++ E++ G ++F G
Sbjct: 211 VGCIMGEMIKGG----VLFPG 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 23/210 (10%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACL 693
+G GS G V + +AVK +L+ E ++ +H N+V++ +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-- 85
Query: 694 GADYRGNDFKASVYEFMHYGSLEEWL-HPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALN 752
Y D V EF+ G+L + + H E++I + + + AL+
Sbjct: 86 ---YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA------------AVCLAVLKALS 130
Query: 753 YLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAP 812
LH Q V H D+K ++LL ++ DFG +S + + S G+ ++AP
Sbjct: 131 VLH--AQGVI-HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV--GTPYWMAP 185
Query: 813 EYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
E D++S GI+++E+V G+ P
Sbjct: 186 ELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 5e-06
Identities = 36/132 (27%), Positives = 57/132 (43%), Gaps = 28/132 (21%)
Query: 55 WYGVTC----SRRHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIG 110
W G C ++ + L L + L G + + I L L+ + L NS IP +G
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG 463
Query: 111 GLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGS 170
+ L+VL L+ NS G IP ++ + ++L ILNL
Sbjct: 464 SITSLEVLDLSYNSFNGSIPESLGQLTSL------------------------RILNLNG 499
Query: 171 NHLTGSIPSSLG 182
N L+G +P++LG
Sbjct: 500 NSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 5e-06
Identities = 61/230 (26%), Positives = 98/230 (42%), Gaps = 48/230 (20%)
Query: 634 VGVGSFGSV---YKGIIDEGRTTIAVKV----FNLQHHGASRSFIAECKALKSIRHRNLV 686
+G G+ G V Y ++D +A+K F Q H A R++ E +K + H+N++
Sbjct: 25 IGSGAQGIVCAAYDAVLDR---NVAIKKLSRPFQNQTH-AKRAY-RELVLMKCVNHKNII 79
Query: 687 KVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAID 746
+L F SLEE+ + + +D NL Q + + +D
Sbjct: 80 SLLNV-----------------FTPQKSLEEFQDVYLVMELMDA-----NLCQVIQMELD 117
Query: 747 ---IAYALNYL----HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTS 799
++Y L + H H DLKPSN+++ T ++ DFGLAR T
Sbjct: 118 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 177
Query: 800 SFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEG 849
+ Y APE +G N D++S G ++ E+V K I+F G
Sbjct: 178 YVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPG 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 5e-06
Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACL 693
+G GS G V +AVK+ +L+ E ++ +H+N+V++ + L
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 694 GADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNY 753
G + + EF+ G+L D + + LN Q + + AL Y
Sbjct: 89 ----VGEELWV-LMEFLQGGALT---------DIVSQT--RLNEEQIATVCESVLQALCY 132
Query: 754 LHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPE 813
LH Q V H D+K ++LL ++ DFG +S D + S G+ ++APE
Sbjct: 133 LH--SQGVI-HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV--GTPYWMAPE 187
Query: 814 YGVGCEVSTNGDVYSYGILLLELVIGKKP 842
T D++S GI+++E+V G+ P
Sbjct: 188 VISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 5e-06
Identities = 34/105 (32%), Positives = 55/105 (52%), Gaps = 7/105 (6%)
Query: 740 RLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTS 799
R+ IA +I AL++LH Q + D+K N+LLD + DFGL++ + +
Sbjct: 108 RVYIA-EIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-R 162
Query: 800 SFSVKGSLGYIAPEYGVGCEVSTNG--DVYSYGILLLELVIGKKP 842
++S G++ Y+APE G + D +S G+L EL+ G P
Sbjct: 163 AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 5e-06
Identities = 32/111 (28%), Positives = 57/111 (51%), Gaps = 8/111 (7%)
Query: 746 DIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKG 805
+I AL +LH + + D+K N+LLD + DFGL++ D + ++S G
Sbjct: 113 EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCG 168
Query: 806 SLGYIAPEYGVGCEVSTNG--DVYSYGILLLELVIGKKPIDIMFEGDINLH 854
++ Y+AP+ G + + D +S G+L+ EL+ G P + +G+ N
Sbjct: 169 TIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV--DGEKNSQ 217
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 5e-06
Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 633 LVGVGSFGSVYKGIID-EGRTTIAVKVFNLQHHGAS----RSFIAECKALKSIRHRNLVK 687
++G G FG + +G + + + V + L+ G S R F+AE L H N+V+
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRA-GCSDKQRRGFLAEALTLGQFDHSNIVR 70
Query: 688 VLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDI 747
+ G RGN V E+M G+L+ +L G+ L Q + + +
Sbjct: 71 LE----GVITRGNTMMI-VTEYMSNGALDSFLRKHEGQ---------LVAGQLMGMLPGL 116
Query: 748 AYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQT--SSFSVKG 805
A + YL + H L VL++ + ++ F R L D ++ ++ S K
Sbjct: 117 ASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGF---RRLQEDKSEAIYTTMSGKS 170
Query: 806 SLGYIAPEYGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
+ + APE S+ DV+S+GI++ E++ G++P
Sbjct: 171 PVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 6e-06
Identities = 60/237 (25%), Positives = 94/237 (39%), Gaps = 35/237 (14%)
Query: 621 LYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSI 680
L + T F ++G G++G VYK + +A+K+ ++ E L+
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKY 59
Query: 681 -RHRNLVKVLTACLGADYRGNDFKA-SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLL 738
H N+ A + + GND + V E GS+ D
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSV------------TDLVKGLRKKG 107
Query: 739 QRLNIAIDIAY-------ALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARIL 791
+RL IAY L YLH + H D+K N+LL ++ DFG++ L
Sbjct: 108 KRLKEEW-IAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL 163
Query: 792 SPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTN------GDVYSYGILLLELVIGKKP 842
D T + G+ ++APE + C+ + DV+S GI +EL GK P
Sbjct: 164 --DSTLGRRNTFIGTPYWMAPEV-IACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 6e-06
Identities = 38/123 (30%), Positives = 62/123 (50%), Gaps = 10/123 (8%)
Query: 744 AIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSV 803
A ++ AL +LH + + DLK N+LLD ++ DFG+ + + T++F
Sbjct: 102 AAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC- 157
Query: 804 KGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPD 863
G+ YIAPE E + D ++ G+L+ E++ G+ P FE D N + L D
Sbjct: 158 -GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP----FEAD-NEDDLFESILHD 211
Query: 864 DVM 866
DV+
Sbjct: 212 DVL 214
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 7e-06
Identities = 58/240 (24%), Positives = 102/240 (42%), Gaps = 49/240 (20%)
Query: 622 YNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVK-VFNLQHHGASRSFIAECKALKSI 680
++ + + + +G G++G V +A+K + +H + + E K L+
Sbjct: 1 FDVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF 60
Query: 681 RHRNLVKVLTACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNL 737
+H N++ +L + F VY E M E L+ L
Sbjct: 61 KHENIIGILDIIRPPSF--ESFN-DVYIVQELM-----ETDLY---------------KL 97
Query: 738 LQRLNIAID-IAY-------ALNYLHHDCQPVTA---HCDLKPSNVLLDDYMTARVGDFG 786
++ +++ D I Y L Y+H +A H DLKPSN+LL+ ++ DFG
Sbjct: 98 IKTQHLSNDHIQYFLYQILRGLKYIH------SANVLHRDLKPSNLLLNTNCDLKICDFG 151
Query: 787 LARILSPDHTQTSSFSVK--GSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPI 843
LARI P+H T F + + Y APE + + D++S G +L E++ +P+
Sbjct: 152 LARIADPEHDHT-GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 7e-06
Identities = 57/225 (25%), Positives = 93/225 (41%), Gaps = 39/225 (17%)
Query: 628 FSSANLVGVGSFGSV----YKGIIDEGRTTIAVKVFN----LQHHGASRSFIAECKALKS 679
F+ +G GSFG V YK +E +A+K F ++ F +E K L
Sbjct: 32 FNFIRTLGTGSFGRVILATYK---NEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILNY 87
Query: 680 IRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQ 739
I H V L ++ + V EF+ G FT P ++
Sbjct: 88 INHPFCVN-----LYGSFKDESYLYLVLEFVIGGEF------FTFLRRNKRFPNDVGCFY 136
Query: 740 RLNIAIDIAY--ALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQ 797
I + Y +LN ++ D LKP N+LLD ++ DFG A+++
Sbjct: 137 AAQIVLIFEYLQSLNIVYRD---------LKPENLLLDKDGFIKMTDFGFAKVV-----D 182
Query: 798 TSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
T ++++ G+ YIAPE + D ++ GI + E+++G P
Sbjct: 183 TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-06
Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 9/107 (8%)
Query: 744 AIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSV 803
A +IA L +LH + DLK NV+LD ++ DFG+ + D T +F
Sbjct: 107 AAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC- 162
Query: 804 KGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
G+ YIAPE + D +++G+LL E++ G+ P FEG+
Sbjct: 163 -GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP----FEGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 47/179 (26%), Positives = 78/179 (43%), Gaps = 9/179 (5%)
Query: 666 ASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGE 725
A R F + + KS + R + + D R +ASV S +P
Sbjct: 105 AKREFFSPYRE-KSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163
Query: 726 DEIDEAPRNLNLLQRLNIAIDIAYALNYL-HHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784
D++ ++P L + + + +A + +L C H DL N+LL + ++ D
Sbjct: 164 DDLWKSP--LTMEDLICYSFQVARGMEFLASRKC----IHRDLAARNILLSENNVVKICD 217
Query: 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
FGLAR + D S + L ++APE +T DV+S+G+LL E+ +G P
Sbjct: 218 FGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 32/101 (31%), Positives = 56/101 (55%), Gaps = 6/101 (5%)
Query: 743 IAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFS 802
I+I + L YL + + H D+KPSN+L++ ++ DFG++ L + +SF
Sbjct: 104 ISIAVLRGLTYLREKHKIM--HRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFV 159
Query: 803 VKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPI 843
G+ Y++PE G + D++S G+ L+E+ IG+ PI
Sbjct: 160 --GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 27/77 (35%), Positives = 41/77 (53%), Gaps = 3/77 (3%)
Query: 766 DLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGD 825
DLKP N+LLDD R+ D GLA + T G++GY+APE + + + D
Sbjct: 127 DLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV---GTVGYMAPEVINNEKYTFSPD 183
Query: 826 VYSYGILLLELVIGKKP 842
+ G L+ E++ G+ P
Sbjct: 184 WWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 60/233 (25%), Positives = 89/233 (38%), Gaps = 56/233 (24%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFN---LQHHGASRSFIAECKALKSIRHRNLVKVLT 690
VG G +G V+ + +A+K L R + E L + + LVK+L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 691 ACLGADYRGNDFKASVYEFMHY---GSLEEWLHPFTGEDEIDEAPRNLNLLQ----RLNI 743
A +Y +Y M Y G L+ NL +L R +
Sbjct: 69 AFQDDEY--------LYLAMEYVPGGDFRTLLN-------------NLGVLSEDHARFYM 107
Query: 744 -----AIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLAR-ILSPDHTQ 797
A+D + L Y+H D KP N L+D ++ DFGL++ I++ +
Sbjct: 108 AEMFEAVDALHELGYIHRDL---------KPENFLIDASGHIKLTDFGLSKGIVTYAN-- 156
Query: 798 TSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
SV GS Y+APE G D +S G +L E + G P F G
Sbjct: 157 ----SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP----FSGS 201
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 70/320 (21%), Positives = 124/320 (38%), Gaps = 70/320 (21%)
Query: 584 GLALALFGLVLCLVRKIKEKENPSSSIYSLLYLSYQDLYNATSGFSSANLVGVGSFGSVY 643
GL ++ L +RK K +N + Y +DL + ++G G+FG V
Sbjct: 2 GLDALVYDLDFPALRKNKNIDNFLNR-YKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQ 60
Query: 644 KGIIDEGRTTIAVKV---FNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700
R A+K+ F + S F E + +V++ A ++ +
Sbjct: 61 LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA-----FQDD 115
Query: 701 DFKASVYEFMHYGSL----------EEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYA 750
+ V E+M G L E+W +T E + +A+D ++
Sbjct: 116 RYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAE---------------VVLALDAIHS 160
Query: 751 LNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYI 810
+ ++H D +KP N+LLD ++ DFG ++ + +V G+ YI
Sbjct: 161 MGFIHRD---------VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYI 210
Query: 811 APE----------YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860
+PE YG C D +S G+ L E+++G P F D + + +
Sbjct: 211 SPEVLKSQGGDGYYGREC------DWWSVGVFLYEMLVGDTP----FYADSLVGTYSK-- 258
Query: 861 LPDDVMDIVDSSLLPDDEDL 880
+M+ +S PDD D+
Sbjct: 259 ----IMNHKNSLTFPDDNDI 274
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 28/87 (32%), Positives = 45/87 (51%), Gaps = 8/87 (9%)
Query: 166 LNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVE 225
L L + L G IP+ + L + +I+L+ N++ G IP S G +L L L+ N+ +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN--- 479
Query: 226 NKLTGEVP-SLEKLQRLQHFTITSNSL 251
G +P SL +L L+ + NSL
Sbjct: 480 ----GSIPESLGQLTSLRILNLNGNSL 502
|
Length = 623 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 73/275 (26%), Positives = 112/275 (40%), Gaps = 45/275 (16%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFN----LQHHGASRSFIAECKALKSIRHRNLVKV 688
++G GSFG V + E AVKV LQ + + E + L R+ +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECT-MTEKRILSLARNHPFLTQ 60
Query: 689 LTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIA 748
L C ++ D V EF++ G L + DEA A +I
Sbjct: 61 LYCC----FQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARF-------YAAEIT 106
Query: 749 YALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLG 808
AL +LH + DLK NVLLD ++ DFG+ + + TS+F G+
Sbjct: 107 SALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC--GTPD 161
Query: 809 YIAPE------YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862
YIAPE YG D ++ G+LL E++ G P + E D+ +A+
Sbjct: 162 YIAPEILQEMLYGPSV------DWWAMGVLLYEMLCGHAPFEAENEDDL------FEAIL 209
Query: 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQA-RINSI 896
+D ++V + L D IL + R+ S+
Sbjct: 210 ND--EVVYPTWLSQDAVDILKAFMTKNPTMRLGSL 242
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 40/113 (35%), Positives = 59/113 (52%), Gaps = 17/113 (15%)
Query: 746 DIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLAR-ILSPDHTQTSSFSVK 804
+I AL +LH + + D+K N+LLD + DFGL++ LS + +T SF
Sbjct: 113 EIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC-- 167
Query: 805 GSLGYIAPEY-----GVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDIN 852
G++ Y+APE G G V D +S GIL+ EL+ G P + EG+ N
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAV----DWWSLGILIFELLTGASPFTL--EGERN 214
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 50/215 (23%), Positives = 97/215 (45%), Gaps = 21/215 (9%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVF--NLQHHGASRSFIAECKALKSIRHRNL 685
F +VG G++G V K E + +A+K F + ++ + + E K L++++ N+
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 686 VKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAI 745
V++ A +R V+E++ LE ++E P + + +
Sbjct: 63 VELKEA-----FRRRGKLYLVFEYVEKNMLEL----------LEEMPNGVPPEKVRSYIY 107
Query: 746 DIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKG 805
+ A+++ H + H D+KP N+L+ ++ DFG AR LS + + +
Sbjct: 108 QLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVA 163
Query: 806 SLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGK 840
+ Y +PE +G D++S G +L EL G+
Sbjct: 164 TRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 34/106 (32%), Positives = 54/106 (50%), Gaps = 15/106 (14%)
Query: 747 IAYALNYLHHDCQPVTA---HCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSV 803
I L YLH +A H D+KP N+L++ ++ DFGLAR+ PD ++ + V
Sbjct: 112 ILRGLKYLH------SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEV 165
Query: 804 KGSLGYIAPEYGVGCEVSTNG-DVYSYGILLLELVIGKKPIDIMFE 848
Y APE +G T+ D++S G + EL+ + I+F+
Sbjct: 166 VTQY-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR----ILFQ 206
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 766 DLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGD 825
DLKP N+LLD + DFGL ++ D +T++F G+ Y+APE +G + D
Sbjct: 118 DLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC--GTPEYLAPELLLGHGYTKAVD 175
Query: 826 VYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPD 863
++ G+LL E++ G P D N++ RK L +
Sbjct: 176 WWTLGVLLYEMLTGLPPF-----YDENVNEMYRKILQE 208
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 37/117 (31%), Positives = 59/117 (50%), Gaps = 7/117 (5%)
Query: 728 IDEAPRNLNLLQRLNIAIDIAYALNYL-HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFG 786
I+E+P L+ + + + +A + +L +C H DL NVL+ + ++ DFG
Sbjct: 230 INESPA-LSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFG 284
Query: 787 LARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLEL-VIGKKP 842
LAR + D S S L ++APE +T DV+S+GILL E+ +G P
Sbjct: 285 LARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTP 341
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 3e-05
Identities = 45/179 (25%), Positives = 75/179 (41%), Gaps = 23/179 (12%)
Query: 665 GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTG 724
A F+ E K L + N+ ++L C + + E+M G L ++L
Sbjct: 61 NAREDFLKEVKILSRLSDPNIARLLGVC-----TVDPPLCMIMEYMENGDLNQFLQ--KH 113
Query: 725 EDEIDEAPRNLNLLQR---LNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781
E N L L +A IA + YL H DL N L+ T +
Sbjct: 114 VAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIK 170
Query: 782 VGDFGLARIL-SPDHTQTSSFSVKGS----LGYIAPEYGVGCEVSTNGDVYSYGILLLE 835
+ DFG++R L S D+ + V+G + ++A E + + +T DV+++G+ L E
Sbjct: 171 IADFGMSRNLYSSDY-----YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWE 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-05
Identities = 30/107 (28%), Positives = 51/107 (47%), Gaps = 10/107 (9%)
Query: 733 RNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLAR--I 790
R L + Q L I I L YLH H D+K N+ ++D +GD G A+ +
Sbjct: 152 RPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208
Query: 791 LSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELV 837
++P + G++ APE + ++ D++S GI+L E++
Sbjct: 209 VAPAF-----LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 4e-05
Identities = 46/195 (23%), Positives = 78/195 (40%), Gaps = 61/195 (31%)
Query: 706 VYEFMHYGSL----------EEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLH 755
V E+M G L E+W +T E + +A+D +++ ++H
Sbjct: 121 VMEYMPGGDLVNLMSNYDIPEKWARFYTAE---------------VVLALDAIHSMGFIH 165
Query: 756 HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPE-- 813
D +KP N+LLD ++ DFG + + +V G+ YI+PE
Sbjct: 166 RD---------VKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVL 215
Query: 814 --------YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDV 865
YG C D +S G+ L E+++G P F D + + + +
Sbjct: 216 KSQGGDGYYGREC------DWWSVGVFLYEMLVGDTP----FYADSLVGTYSK------I 259
Query: 866 MDIVDSSLLPDDEDL 880
MD +S PDD ++
Sbjct: 260 MDHKNSLTFPDDIEI 274
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 54/217 (24%), Positives = 89/217 (41%), Gaps = 36/217 (16%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG---ASRSFIAECKALKSIRHRNLVKVLT 690
VG G++GSV + +AVK + A R++ E + LK ++H N++ +L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 83
Query: 691 ACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLN------IA 744
F SLEE+ + + N+ Q+L +
Sbjct: 84 V-----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 126
Query: 745 IDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVK 804
I L Y+H H DLKPSN+ +++ ++ DFGLAR HT
Sbjct: 127 YQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYV 178
Query: 805 GSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGK 840
+ Y APE + + D++S G ++ EL+ G+
Sbjct: 179 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 5e-05
Identities = 50/229 (21%), Positives = 94/229 (41%), Gaps = 45/229 (19%)
Query: 635 GVGSFGSVYKGI-IDEGRTTIAVKVFNL--------QHHGASRSFIAECKALKSIRHRNL 685
G G+F ++YKG+ + I + H S +F + + H++L
Sbjct: 4 GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHL 63
Query: 686 VKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAI 745
VK+ C+ + V E++ +G L+ +LH N++L +L++A
Sbjct: 64 VKLYGVCVRDEN------IMVEEYVKFGPLDVFLH---------REKNNVSLHWKLDVAK 108
Query: 746 DIAYALNYLHHDCQPVTAHCDLKPSNVLLDDY-------MTARVGDFGLAR-ILSPDHTQ 797
+A AL+YL H ++ N+L+ Y ++ D G+ +LS +
Sbjct: 109 QLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERV 165
Query: 798 TSSFSVKGSLGYIAPEY--GVGCEVSTNGDVYSYGILLLELVI-GKKPI 843
+IAPE ++ D +S+G LLE+ G++P+
Sbjct: 166 ERI-------PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPL 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 5e-05
Identities = 59/232 (25%), Positives = 98/232 (42%), Gaps = 41/232 (17%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG---ASRSFIAECKALKSIRHRN 684
++S VG G++GSV I +A+K + A R++ E LK ++H N
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY-RELTLLKHMQHEN 75
Query: 685 LVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIA 744
++ +L A G++F+ Y M Y + L G ++ + L + Q L
Sbjct: 76 VIGLLDVFTSAV-SGDEFQ-DFYLVMPYMQTD--LQKIMGHPLSEDKVQYL-VYQMLC-- 128
Query: 745 IDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVK 804
L Y+H H DLKP N+ +++ ++ DFGLAR D T
Sbjct: 129 -----GLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMT------ 172
Query: 805 GSLGYIAPEYGVGCEVSTNG-------DVYSYGILLLELVIGKKPIDIMFEG 849
GY+ + EV N D++S G ++ E++ GK +F+G
Sbjct: 173 ---GYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKT----LFKG 217
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 6e-05
Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 35/216 (16%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACL 693
+G GS G V +AVK +L+ E ++ +H N+V++ ++
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS-- 84
Query: 694 GADYRGNDFKASVYEFMHYGSLEEWL-HPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALN 752
Y D V EF+ G+L + + H E++I A L +L+ AL+
Sbjct: 85 ---YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI--ATVCLAVLK----------ALS 129
Query: 753 YLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAP 812
+LH Q V H D+K ++LL ++ DFG +S + + S G+ ++AP
Sbjct: 130 FLH--AQGVI-HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV--GTPYWMAP 184
Query: 813 E------YGVGCEVSTNGDVYSYGILLLELVIGKKP 842
E YG T D++S GI+++E+V G+ P
Sbjct: 185 EVISRLPYG------TEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 26/80 (32%), Positives = 40/80 (50%), Gaps = 1/80 (1%)
Query: 764 HCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTN 823
H DL N+LL + ++ DFGLAR + D + L ++APE +
Sbjct: 202 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ 261
Query: 824 GDVYSYGILLLELV-IGKKP 842
DV+S+G+LL E+ +G P
Sbjct: 262 SDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 9e-05
Identities = 56/226 (24%), Positives = 92/226 (40%), Gaps = 27/226 (11%)
Query: 84 FIGNLSFLKQLYLQVNSFTHEIPSEIGGL-RRLKVLALNNNSICGEIPTNISRCSTLIPI 142
+ L+ L L L N+ T +IP IG L LK L L++N I +P+ + L +
Sbjct: 111 ELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNL 168
Query: 143 HPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIP 202
N L + S+LS L+L N ++ +P + LS++ + L+ N++ +
Sbjct: 169 DLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELL 225
Query: 203 NSFGWFENLVFLSLAAN----------NLSVVE-----NKLTGEVPSLEKLQRLQHFTIT 247
+S +NL L L+ N NLS +E N + SL L L+ ++
Sbjct: 226 SSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQISSISSLGSLTNLRELDLS 285
Query: 248 SNSLGSGGNDDLS--FLCSLTNATRLTW----MHINSNNFGGLLPG 287
NSL + L L LT + +NS +
Sbjct: 286 GNSLSNALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNILS 331
|
Length = 394 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 9e-05
Identities = 47/198 (23%), Positives = 95/198 (47%), Gaps = 24/198 (12%)
Query: 654 IAVKVFNLQHHGASRS-FIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHY 712
+AVK+ + +R+ F+ E K L ++ N++++L C+ D + E+M
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPL-----CMITEYMEN 103
Query: 713 GSLEEWLHPFTGEDEIDEAPRNLNLLQR-----------LNIAIDIAYALNYLHHDCQPV 761
G L ++L +D+ E N + L++A+ IA + YL
Sbjct: 104 GDLNQFLSSHHLDDK--EENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLN 158
Query: 762 TAHCDLKPSNVLLDDYMTARVGDFGLARIL-SPDHTQTSSFSVKGSLGYIAPEYGVGCEV 820
H DL N L+ + +T ++ DFG++R L + D+ + +V + ++A E + +
Sbjct: 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVL-PIRWMAWECILMGKF 217
Query: 821 STNGDVYSYGILLLELVI 838
+T DV+++G+ L E+++
Sbjct: 218 TTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 9e-05
Identities = 36/109 (33%), Positives = 55/109 (50%), Gaps = 17/109 (15%)
Query: 740 RLNIAIDIAYALNYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQT 798
+ IA ++ AL +LH +D + DLKP N+LLD + DFGL++ D+ T
Sbjct: 99 KFYIA-ELVLALEHLHKYD----IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT 153
Query: 799 SSFSVKGSLGYIAPEY-----GVGCEVSTNGDVYSYGILLLELVIGKKP 842
++F G+ Y+APE G V D +S G+L+ E+ G P
Sbjct: 154 NTFC--GTTEYLAPEVLLDEKGYTKHV----DFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 36/148 (24%), Positives = 62/148 (41%), Gaps = 36/148 (24%)
Query: 746 DIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARIL-------------S 792
++ AL+ +H H D+KP N+LLD + ++ DFG + +
Sbjct: 150 EVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGT 206
Query: 793 PDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDIN 852
PD+ +G GY YG C D +S G+ L E+++G P F D
Sbjct: 207 PDYISPEVLKSQGGDGY----YGREC------DWWSVGVFLFEMLVGDTP----FYADSL 252
Query: 853 LHNFGRKALPDDVMDIVDSSLLPDDEDL 880
+ + + +MD +S P+D ++
Sbjct: 253 VGTYSK------IMDHKNSLNFPEDVEI 274
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 26/102 (25%), Positives = 46/102 (45%), Gaps = 5/102 (4%)
Query: 741 LNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSS 800
L + + + ++H + H D+K N+ L ++GDFG AR+L+ +
Sbjct: 103 LQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT--SPGAYA 157
Query: 801 FSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
+ G+ Y+ PE + D++S G +L EL K P
Sbjct: 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 38/150 (25%), Positives = 60/150 (40%), Gaps = 51/150 (34%)
Query: 735 LNLLQRLNI---------AIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785
+NLL R ++ ++ AL+ +H + H D+KP N+L+D ++ DF
Sbjct: 89 MNLLIRKDVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADF 145
Query: 786 GLA-------------------------RILSPDHTQTS--SFSVKGSLGYIAPE----- 813
GL + DH Q + S G+ YIAPE
Sbjct: 146 GLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT 205
Query: 814 -YGVGCEVSTNGDVYSYGILLLELVIGKKP 842
YG+ C D +S G++L E++ G P
Sbjct: 206 PYGLEC------DWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 3/96 (3%)
Query: 747 IAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGS 806
I AL+ +H H DLK +N+ L ++GDFG ++ S + + S G+
Sbjct: 178 IVLALDEVHSRKM---MHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGT 234
Query: 807 LGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
Y+APE S D++S G++L EL+ +P
Sbjct: 235 PYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 34/99 (34%), Positives = 46/99 (46%), Gaps = 5/99 (5%)
Query: 744 AIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSV 803
A +IA AL YLH + DLKP N+LLD + DFGL + TS+F
Sbjct: 102 AAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC- 157
Query: 804 KGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
G+ Y+APE D + G +L E++ G P
Sbjct: 158 -GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 44/187 (23%), Positives = 89/187 (47%), Gaps = 14/187 (7%)
Query: 654 IAVKVFNLQHHGASRS-FIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHY 712
+AVK+ + +R+ F+ E K + ++ N++++L C+ +D + E+M
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPL-----CMITEYMEN 103
Query: 713 GSLEEWL--HPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPS 770
G L ++L H E + ++ + +A IA + YL H DL
Sbjct: 104 GDLNQFLSRHEPQEAAEKADVV-TISYSTLIFMATQIASGMKYLS---SLNFVHRDLATR 159
Query: 771 NVLLDDYMTARVGDFGLARIL-SPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSY 829
N L+ T ++ DFG++R L S D+ + +V + +++ E + + +T DV+++
Sbjct: 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVL-PIRWMSWESILLGKFTTASDVWAF 218
Query: 830 GILLLEL 836
G+ L E+
Sbjct: 219 GVTLWEI 225
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 33/120 (27%), Positives = 51/120 (42%), Gaps = 7/120 (5%)
Query: 731 APRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARI 790
A RN+ + L I + A+ YLH + H D+K N+ ++ +GDFG A
Sbjct: 175 AKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFG-AAC 230
Query: 791 LSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
D + G++ APE D++S GI+L E+ D +FE D
Sbjct: 231 FPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH---DSLFEKD 287
|
Length = 391 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 34/142 (23%), Positives = 51/142 (35%), Gaps = 57/142 (40%)
Query: 743 IAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTS--- 799
+AID + L Y+H D +KP N+LLD ++ DFGL L H
Sbjct: 112 LAIDSIHKLGYIHRD---------IKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRI 162
Query: 800 ---------------------------------SFSVKGSLGYIAPE------YGVGCEV 820
++S G+ YIAPE Y C
Sbjct: 163 LSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKEC-- 220
Query: 821 STNGDVYSYGILLLELVIGKKP 842
D +S G+++ E+++G P
Sbjct: 221 ----DWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 66/244 (27%), Positives = 104/244 (42%), Gaps = 28/244 (11%)
Query: 611 YSLLYLSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSF 670
Y+ L + L + T + +G G++G VYK + + AVK+ +
Sbjct: 7 YNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEI 65
Query: 671 IAECKALKSI-RHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEID 729
AE L+S+ H N+VK AD V E + GS+ E +
Sbjct: 66 EAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGL------- 118
Query: 730 EAPRNLNLLQRLNIAIDIAY----ALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785
L QRL+ A+ I+Y AL L H H D+K +N+LL ++ DF
Sbjct: 119 -----LICGQRLDEAM-ISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDF 172
Query: 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCE------VSTNGDVYSYGILLLELVIG 839
G++ L+ + ++ SV G+ ++APE + CE DV+S GI +EL G
Sbjct: 173 GVSAQLTSTRLRRNT-SV-GTPFWMAPEV-IACEQQYDYSYDARCDVWSLGITAIELGDG 229
Query: 840 KKPI 843
P+
Sbjct: 230 DPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 34/99 (34%), Positives = 47/99 (47%), Gaps = 5/99 (5%)
Query: 744 AIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSV 803
A +IA AL YLH + DLKP N+LLD + DFGL + + TS+F
Sbjct: 102 AAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC- 157
Query: 804 KGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
G+ Y+APE D + G +L E++ G P
Sbjct: 158 -GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 56/257 (21%), Positives = 96/257 (37%), Gaps = 66/257 (25%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVF---------NLQHHGASRSFIAECKALK 678
F S ++G G+FG V + A+K+ + H A R + E +L
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 679 SIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLL 738
+VK+ Y D K ++Y M + + + +D + E +
Sbjct: 63 ------VVKMF-------YSFQD-KLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA 108
Query: 739 QRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDH--- 795
+ + +AID + L ++H D +KP N+LLD ++ DFGL L H
Sbjct: 109 ETV-LAIDSIHQLGFIHRD---------IKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158
Query: 796 ------------------------------TQTSSFSVKGSLGYIAPEYGVGCEVSTNGD 825
+ +FS G+ YIAPE + + D
Sbjct: 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCD 218
Query: 826 VYSYGILLLELVIGKKP 842
+S G+++ E++IG P
Sbjct: 219 WWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 29/97 (29%), Positives = 49/97 (50%), Gaps = 4/97 (4%)
Query: 746 DIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKG 805
+I AL+YLH + V + DLK N++LD ++ DFGL + D +F G
Sbjct: 103 EIVSALDYLHSEKNVV--YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC--G 158
Query: 806 SLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
+ Y+APE + D + G+++ E++ G+ P
Sbjct: 159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (101), Expect = 5e-04
Identities = 35/115 (30%), Positives = 53/115 (46%), Gaps = 14/115 (12%)
Query: 742 NIAIDIAYALNYLH-HDCQPVTAHCDLKPSNVLLDDYMT-ARVGDFGLARILSPDHTQTS 799
I + ALN LH H + H D+K NVL D + D+GL +I+ T
Sbjct: 113 KIIRQLVEALNDLHKH--NII--HNDIKLENVLYDRAKDRIYLCDYGLCKII---GTP-- 163
Query: 800 SFSV-KGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINL 853
S G+L Y +PE G + D ++ G+L EL+ GK P + +++L
Sbjct: 164 --SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL 216
|
Length = 267 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-04
Identities = 61/214 (28%), Positives = 90/214 (42%), Gaps = 24/214 (11%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFN---LQHHGASRSFIAECKAL-KSIRHRNLVKV 688
++G GSFG V AVKV + + + +AE L K+++H LV
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG- 60
Query: 689 LTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIA 748
L ++ + V +F++ G L + H E E PR R A +IA
Sbjct: 61 ----LHYSFQTTEKLYFVLDFVNGGEL--FFH-LQRERSFPE-PR-----ARFYAA-EIA 106
Query: 749 YALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLG 808
AL YLH + DLKP N+LLD + DFGL + T++F G+
Sbjct: 107 SALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC--GTPE 161
Query: 809 YIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
Y+APE D + G +L E++ G P
Sbjct: 162 YLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-04
Identities = 35/112 (31%), Positives = 54/112 (48%), Gaps = 12/112 (10%)
Query: 744 AIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARI-LSPDHTQTSSFS 802
A ++A A+ YLH + DLKP N+LLD + DFGL + + P+ T TS+F
Sbjct: 102 AAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET-TSTFC 157
Query: 803 VKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP-----IDIMFEG 849
G+ Y+APE D + G +L E++ G P + M++
Sbjct: 158 --GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDN 207
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 7e-04
Identities = 56/243 (23%), Positives = 94/243 (38%), Gaps = 25/243 (10%)
Query: 209 ENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNA 268
L L L N L K L L+ ++ N G S L LT
Sbjct: 23 LCLQVLRLEGNTLGEEAAKALASA--LRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKG 80
Query: 269 TRLTWMHINSNNFGGLLPGCISNLSK--TIKTLFLNNNKIYGSIPAGIG-----NFVNLQ 321
L + ++ N G G + +L + +++ L LNNN + + L+
Sbjct: 81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALE 140
Query: 322 RLDMWNNQLSGTIPPAIGEL----QNLKILGLNRNKLSGNIPPSIGN-LKMLLNL---FL 373
+L + N+L G A+ + ++LK L L N + ++ LK NL L
Sbjct: 141 KLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDL 200
Query: 374 NDNFLE----VSIPSSLGQCESLIEINLSNNNLSG----TIPPQFFSLSSLSISLDWSRN 425
N+N L ++ +L +SL +NL +NNL+ + S + ++L S N
Sbjct: 201 NNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCN 260
Query: 426 KLT 428
+T
Sbjct: 261 DIT 263
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 7e-04
Identities = 34/114 (29%), Positives = 53/114 (46%), Gaps = 22/114 (19%)
Query: 746 DIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKG 805
+I AL YLH C V + DLK N++LD ++ DFGL + D +F G
Sbjct: 103 EIVSALGYLH-SCDVV--YRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC--G 157
Query: 806 SLGYIAPE------YGVGCEVSTNGDVYSYGILLLELVIGKKPI-----DIMFE 848
+ Y+APE YG D + G+++ E++ G+ P + +FE
Sbjct: 158 TPEYLAPEVLEDNDYGRAV------DWWGLGVVMYEMMCGRLPFYNQDHEKLFE 205
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 8e-04
Identities = 18/58 (31%), Positives = 29/58 (50%)
Query: 164 EILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNL 221
+ L+L +N LT + L ++ + L+ NNL P +F +L L L+ NNL
Sbjct: 3 KSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 8e-04
Identities = 50/218 (22%), Positives = 91/218 (41%), Gaps = 29/218 (13%)
Query: 641 SVYKGIIDEGRTTIAVKVFNLQHHGA---SRSFIAECKALKSIRHRNLVKVLTACLGADY 697
S+YKGI + + ++ F H G E K L+ I N++K+
Sbjct: 35 SIYKGIFNN--KEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG------- 85
Query: 698 RGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLH-H 756
F + + + SL E+ + ++L+ +L++AID L L+ +
Sbjct: 86 ----FIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKY 141
Query: 757 DCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGS---LGYIAPE 813
+P + +L + L+ + ++ GL +ILS + +F V S L I E
Sbjct: 142 TNKP---YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSE 198
Query: 814 YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDI 851
Y + D+YS G++L E+ GK P + + +I
Sbjct: 199 YTI------KDDIYSLGVVLWEIFTGKIPFENLTTKEI 230
|
Length = 283 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 51/215 (23%), Positives = 90/215 (41%), Gaps = 28/215 (13%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASR---SFIAECKALKSIRHRNLVKVLT 690
+G G FG V I V V L+ + +S+ F+ + + ++H N+++ L
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 691 ACLGA-DYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAY 749
C+ A Y V+E+ G L+ +L + RN LL +A +IA
Sbjct: 63 QCVEAIPY------LLVFEYCELGDLKSYLS------QEQWHRRNSQLLLLQRMACEIAA 110
Query: 750 ALNYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLG 808
+ ++H H+ H DL N L +T +VGD+G+ + + L
Sbjct: 111 GVTHMHKHN----FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR 166
Query: 809 YIAPEYG-------VGCEVSTNGDVYSYGILLLEL 836
++APE + E + +V++ G+ L EL
Sbjct: 167 WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 34/133 (25%), Positives = 52/133 (39%), Gaps = 42/133 (31%)
Query: 743 IAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSP--------- 793
+AID + L ++H D +KP N+LLD ++ DFGL L
Sbjct: 112 LAIDAIHQLGFIHRD---------IKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRN 162
Query: 794 -DHTQTSSFSVK-----------------------GSLGYIAPEYGVGCEVSTNGDVYSY 829
H S FS + G+ YIAPE + + D +S
Sbjct: 163 LTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222
Query: 830 GILLLELVIGKKP 842
G+++ E++IG P
Sbjct: 223 GVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.003
Identities = 23/61 (37%), Positives = 30/61 (49%), Gaps = 2/61 (3%)
Query: 343 NLKILGLNRNKLSGNIPPSI-GNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNN 401
NLK L L+ N+L+ IP L L L L+ N L P + SL ++LS NN
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 402 L 402
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.003
Identities = 28/97 (28%), Positives = 47/97 (48%), Gaps = 5/97 (5%)
Query: 746 DIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKG 805
+I AL+YLH + DLK N++LD ++ DFGL + D +F G
Sbjct: 103 EIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC--G 157
Query: 806 SLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
+ Y+APE + D + G+++ E++ G+ P
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.003
Identities = 28/104 (26%), Positives = 51/104 (49%), Gaps = 3/104 (2%)
Query: 732 PRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARIL 791
R L L Q +A + A++Y+H + + H D+K NVL++ +GDFG A
Sbjct: 254 LRPLGLAQVTAVARQLLSAIDYIH--GEGII-HRDIKTENVLVNGPEDICLGDFGAACFA 310
Query: 792 SPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLE 835
+ + + G++ APE G + + D++S G+++ E
Sbjct: 311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.003
Identities = 30/90 (33%), Positives = 43/90 (47%), Gaps = 10/90 (11%)
Query: 764 HCDLKPSNVLLDDY-MTARVGDFGLARILS-PDHTQTSSFSVKGSLGYIAPEYGVGC-EV 820
H DLKP N+L+D ++ D GL R S P + T +L Y APE +G
Sbjct: 133 HRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV---TLWYRAPEVLLGSTHY 189
Query: 821 STNGDVYSYGILLLELVIGKKPIDIMFEGD 850
ST D++S G + E+ + +F GD
Sbjct: 190 STPVDIWSVGCIFAEMSRKQP----LFPGD 215
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 28/99 (28%), Positives = 48/99 (48%), Gaps = 8/99 (8%)
Query: 742 NIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLAR--ILSPDHTQTS 799
NI D+ L Y+H + +H D+KP N+++D + D+G+A I+ H + S
Sbjct: 130 NIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYS 186
Query: 800 SFSV---KGSLGYIAPEYGVGCEVSTNGDVYSYGILLLE 835
+G+L Y + G V+ GD+ S G +L+
Sbjct: 187 KEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.003
Identities = 56/199 (28%), Positives = 83/199 (41%), Gaps = 30/199 (15%)
Query: 648 DEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVY 707
DE R + VK ++ E LK+I HR ++ ++ A YR +K++V
Sbjct: 116 DEQRKKVIVKAVT-----GGKTPGREIDILKTISHRAIINLIHA-----YR---WKSTVC 162
Query: 708 EFM-HYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCD 766
M Y FT D P L Q + I + AL YLH H D
Sbjct: 163 MVMPKYKC-----DLFTYVDRSGPLP----LEQAITIQRRLLEALAYLH---GRGIIHRD 210
Query: 767 LKPSNVLLDDYMTARVGDFGLARIL--SPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNG 824
+K N+ LD+ A +GDFG A L PD Q +S G+L +PE
Sbjct: 211 VKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWS--GTLETNSPELLALDPYCAKT 268
Query: 825 DVYSYGILLLELVIGKKPI 843
D++S G++L E+ + +
Sbjct: 269 DIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.004
Identities = 22/60 (36%), Positives = 34/60 (56%), Gaps = 1/60 (1%)
Query: 468 LGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL-SLNNLNLSYNDLEGMV 526
LG+ +G I + + LR L+ ++LS N++ G IP L + SL L+LSYN G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.004
Identities = 26/89 (29%), Positives = 47/89 (52%), Gaps = 8/89 (8%)
Query: 228 LTGEVPS-LEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLP 286
L G +P+ + KL+ LQ ++ NS+ SL + T L + ++ N+F G +P
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGN------IPPSLGSITSLEVLDLSYNSFNGSIP 483
Query: 287 GCISNLSKTIKTLFLNNNKIYGSIPAGIG 315
+ L+ +++ L LN N + G +PA +G
Sbjct: 484 ESLGQLT-SLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 949 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.91 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.79 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.73 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.7 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.69 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.65 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.65 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.62 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.54 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.53 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.52 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.52 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.5 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.5 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.45 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.43 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.39 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.37 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.34 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.32 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.2 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.2 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.2 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.19 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.18 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.15 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.1 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.09 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 99.06 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.06 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.05 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.04 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.03 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.01 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.0 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.99 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.98 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.97 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.97 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.97 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.93 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.89 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.88 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.85 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.79 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.79 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.77 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.73 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.7 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.46 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.42 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.39 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.38 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.37 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.37 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.36 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-108 Score=1036.45 Aligned_cols=856 Identities=31% Similarity=0.483 Sum_probs=586.1
Q ss_pred hcCCCChhhHHHHHHHHhccCCCCCCCccCccCCCCcceeeeeEEeCCCCcEEEEEcCCCCCCccccCCCCCCCCCceee
Q 039533 16 VAGTGNETDRVALLEFKSKSTYDPVGVLGTWNESIHFCKWYGVTCSRRHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLY 95 (949)
Q Consensus 16 ~~~~~~~~~~~aLl~~k~~~~~~~~~~l~sW~~~~~~C~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~ 95 (949)
..+...++|+.||++||+++ .||.+.+.+|+.+.+||.|.||+|++ .++|+.|||++++++|.+++.+..+++|+.|+
T Consensus 22 ~~~~~~~~~~~~l~~~~~~~-~~~~~~~~~w~~~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~ 99 (968)
T PLN00113 22 NFSMLHAEELELLLSFKSSI-NDPLKYLSNWNSSADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTIN 99 (968)
T ss_pred HccCCCHHHHHHHHHHHHhC-CCCcccCCCCCCCCCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEE
Confidence 45555789999999999987 47888899998888999999999986 46899999999999999998899999999999
Q ss_pred ccCceeccccCCccc-CcccCcEEeeccccccCcC----------------------CCCCCCCccceeecCCCcccccc
Q 039533 96 LQVNSFTHEIPSEIG-GLRRLKVLALNNNSICGEI----------------------PTNISRCSTLIPIHPQNNQLVGK 152 (949)
Q Consensus 96 L~~n~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~----------------------p~~~~~l~~L~~L~l~~n~l~~~ 152 (949)
|++|+++|.+|..+. ++++|++|+|++|+++|.+ |..++++++|++|++++|.+.+.
T Consensus 100 Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~ 179 (968)
T PLN00113 100 LSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGK 179 (968)
T ss_pred CCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCccccc
Confidence 999999888887654 6777777777766665544 44455555555555555555555
Q ss_pred ccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCcccccc-c------
Q 039533 153 ILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVV-E------ 225 (949)
Q Consensus 153 ~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~------ 225 (949)
.|..|+++++|++|+|++|.+++.+|..++++++|++|+|++|++++.+|..|+++++|++|+|++|.++.. +
T Consensus 180 ~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l 259 (968)
T PLN00113 180 IPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNL 259 (968)
T ss_pred CChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCC
Confidence 555555555555555555555555555555555555555555555555555555555555555555554311 0
Q ss_pred ----------ccccCCCC-ChhhhccccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccc
Q 039533 226 ----------NKLTGEVP-SLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSK 294 (949)
Q Consensus 226 ----------~~l~~~~~-~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~ 294 (949)
+.+.+.+| .+..+++|++|++++|.+... .+..+.++++|+.|++++|.+++.+|..+..++
T Consensus 260 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~------~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~- 332 (968)
T PLN00113 260 KNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGE------IPELVIQLQNLEILHLFSNNFTGKIPVALTSLP- 332 (968)
T ss_pred CCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccC------CChhHcCCCCCcEEECCCCccCCcCChhHhcCC-
Confidence 11222222 233344444444444443321 112233445555555555555555555555442
Q ss_pred cccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecc
Q 039533 295 TIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLN 374 (949)
Q Consensus 295 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 374 (949)
+|+.|+|++|++++.+|..++.+++|+.|+|++|++++.+|..+..+++|+.|++++|++.+.+|..+.++++|+.|+++
T Consensus 333 ~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~ 412 (968)
T PLN00113 333 RLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQ 412 (968)
T ss_pred CCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECc
Confidence 35555555555555555555555555555555555554444444444444444444444444444444444444444444
Q ss_pred cccccccCCCCCC------------------------CCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCC
Q 039533 375 DNFLEVSIPSSLG------------------------QCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGS 430 (949)
Q Consensus 375 ~N~l~~~~p~~~~------------------------~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~ 430 (949)
+|++++.+|..|. .+++|+.|++++|++.+.+|..+ ...+| +.|++++|++++.
T Consensus 413 ~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L-~~L~ls~n~l~~~ 490 (968)
T PLN00113 413 DNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRL-ENLDLSRNQFSGA 490 (968)
T ss_pred CCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccc-eEEECcCCccCCc
Confidence 4444444444444 44444444444444444444433 23445 6788888888888
Q ss_pred CccccccccccceeeeccccccccCCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCcCcccccCC
Q 039533 431 LPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL 510 (949)
Q Consensus 431 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 510 (949)
+|..+..+++|+.|+|++|++.+.+|..++++++|+.|+|++|.+++.+|..|..+++|+.|||++|+++|.+|..+..+
T Consensus 491 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 570 (968)
T PLN00113 491 VPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNV 570 (968)
T ss_pred cChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999888
Q ss_pred c-cceEeCCCCcCcCcccccccccccccccccCCCCCCCCCCCCCCCcccccCCcCcccccccceeeeehhHHHHHHHHH
Q 039533 511 S-LNNLNLSYNDLEGMVTTEGVFKNASATRILGNSKLCGGISEFKLPTCVSKKSKRRRLTFVPTLVIAIVFRLLGLALAL 589 (949)
Q Consensus 511 ~-L~~l~ls~N~l~~~~~~~~~~~~~~~~~~~gn~~~c~~~~~~~~~~c~~~~~~~~~~~~~~~~i~~~~~~~l~~~~~~ 589 (949)
+ |+.|++++|+++|.+|..+.|..+.+..+.||+.+||+......+.|.... +.. ..+.+++++++++++++++
T Consensus 571 ~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~---~~~--~~~~~~~~~~~~~~~~~~~ 645 (968)
T PLN00113 571 ESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVR---KTP--SWWFYITCTLGAFLVLALV 645 (968)
T ss_pred cccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcccc---ccc--eeeeehhHHHHHHHHHHHH
Confidence 7 999999999999999999999999999999999999987655556664321 111 1111121222222222222
Q ss_pred hhheeeEEeecccccCC---Ccccccc--------cccCHHHHHHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEE
Q 039533 590 FGLVLCLVRKIKEKENP---SSSIYSL--------LYLSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKV 658 (949)
Q Consensus 590 ~~~~~~~~~~~~~~~~~---~~~~~~~--------~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~ 658 (949)
++++++++++++.+... ....+.. ..+++++ ....|...++||+|+||.||+|++..+++.||||+
T Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~ 722 (968)
T PLN00113 646 AFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITIND---ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKE 722 (968)
T ss_pred HHHHHHHHhhhcccccccccccccccccccccccchhhhHHH---HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEE
Confidence 22222222221111110 0111111 1123333 33567888999999999999999988899999999
Q ss_pred EecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHH
Q 039533 659 FNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLL 738 (949)
Q Consensus 659 ~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~ 738 (949)
++.... ....|++.+++++||||++++++|...+ ..++||||+++|+|.++++ .++|.
T Consensus 723 ~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~-----~~~lv~Ey~~~g~L~~~l~-------------~l~~~ 780 (968)
T PLN00113 723 INDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEK-----GAYLIHEYIEGKNLSEVLR-------------NLSWE 780 (968)
T ss_pred ccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCC-----CCEEEEeCCCCCcHHHHHh-------------cCCHH
Confidence 864332 1235688999999999999999986554 7899999999999999995 27899
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCC
Q 039533 739 QRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC 818 (949)
Q Consensus 739 ~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 818 (949)
++.+|+.|+|+|++|||+.++++|+||||||+||+++.++.+++. ||.+....... ...||..|+|||++.+.
T Consensus 781 ~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~------~~~~t~~y~aPE~~~~~ 853 (968)
T PLN00113 781 RRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDT------KCFISSAYVAPETRETK 853 (968)
T ss_pred HHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCC------CccccccccCcccccCC
Confidence 999999999999999997767799999999999999999888875 66554332211 23588999999999999
Q ss_pred ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCc-hhhhcccCCCCCchhhhhhhchhhhhhhhhhHH
Q 039533 819 EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDD-VMDIVDSSLLPDDEDLILTGNQRQKQARINSII 897 (949)
Q Consensus 819 ~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~ 897 (949)
.++.++|||||||++|||+||+.||+...........|.+..+.+. ...++|+.+..... ...
T Consensus 854 ~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~ 917 (968)
T PLN00113 854 DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS----------------VNQ 917 (968)
T ss_pred CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCC----------------ccH
Confidence 9999999999999999999999999755444455555655444332 33444444432111 112
Q ss_pred HHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhh
Q 039533 898 ECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNIL 935 (949)
Q Consensus 898 ~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~ 935 (949)
++..++.+++.+||+.||++||||+||++.|+++....
T Consensus 918 ~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 918 NEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred HHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 44567889999999999999999999999999986643
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-52 Score=526.57 Aligned_cols=450 Identities=33% Similarity=0.488 Sum_probs=352.8
Q ss_pred cEEEEEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCC
Q 039533 66 RVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQ 145 (949)
Q Consensus 66 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 145 (949)
++..|||++|.+.+.+|..++++++|++|+|++|.+.+.+|..|+++++|++|+|++|.+.+.+|..++++++|++|+++
T Consensus 141 ~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 220 (968)
T PLN00113 141 NLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLG 220 (968)
T ss_pred CCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECc
Confidence 45566666666666677777777777777777777777777777777777777777777777777777777777777777
Q ss_pred CccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCcccccc-
Q 039533 146 NNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVV- 224 (949)
Q Consensus 146 ~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~- 224 (949)
+|.+.+.+|..|.++++|++|+|++|.+++.+|..|+++++|++|+|++|++++.+|..++++++|++|+|++|.++..
T Consensus 221 ~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~ 300 (968)
T PLN00113 221 YNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI 300 (968)
T ss_pred CCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCC
Confidence 7777777777777777777777777777777777777777777777777777777777777777777777777765421
Q ss_pred ----------------cccccCCCCC-hhhhccccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCc
Q 039533 225 ----------------ENKLTGEVPS-LEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPG 287 (949)
Q Consensus 225 ----------------~~~l~~~~~~-l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~ 287 (949)
.|.+.+.+|. +..+++|+.|++++|++... .+..+..+++|+.|++++|++++.+|.
T Consensus 301 p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~------~p~~l~~~~~L~~L~Ls~n~l~~~~p~ 374 (968)
T PLN00113 301 PELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGE------IPKNLGKHNNLTVLDLSTNNLTGEIPE 374 (968)
T ss_pred ChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCc------CChHHhCCCCCcEEECCCCeeEeeCCh
Confidence 1122222222 34444455555555544321 123345566677777777777777777
Q ss_pred hhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccc
Q 039533 288 CISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKM 367 (949)
Q Consensus 288 ~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 367 (949)
.+..+ .+|+.|++++|++.+.+|..++.+++|+.|+|++|++++.+|..|.++++|+.|+|++|++++.+|..+..+++
T Consensus 375 ~~~~~-~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 453 (968)
T PLN00113 375 GLCSS-GNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPS 453 (968)
T ss_pred hHhCc-CCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCC
Confidence 66665 35777777777777777888888888888889999888888888888999999999999999888888888999
Q ss_pred cceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeec
Q 039533 368 LLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVY 447 (949)
Q Consensus 368 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls 447 (949)
|+.|++++|.+.+.+|..+. .++|+.|++++|++++.+|..+..+++| +.|++++|++++.+|..++.+++|++|+|+
T Consensus 454 L~~L~L~~n~~~~~~p~~~~-~~~L~~L~ls~n~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 531 (968)
T PLN00113 454 LQMLSLARNKFFGGLPDSFG-SKRLENLDLSRNQFSGAVPRKLGSLSEL-MQLKLSENKLSGEIPDELSSCKKLVSLDLS 531 (968)
T ss_pred CcEEECcCceeeeecCcccc-cccceEEECcCCccCCccChhhhhhhcc-CEEECcCCcceeeCChHHcCccCCCEEECC
Confidence 99999999999988888764 6899999999999999999999999999 799999999999999999999999999999
Q ss_pred cccccccCCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCcCcccccCCccceEeCCCCc-CcC
Q 039533 448 ENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLSLNNLNLSYND-LEG 524 (949)
Q Consensus 448 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~ls~N~-l~~ 524 (949)
+|.++|.+|..|+.+++|+.|+|++|+++|.+|..+..+++|+.|++++|+++|.+|..-....+....+.+|+ ++|
T Consensus 532 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~ 609 (968)
T PLN00113 532 HNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCG 609 (968)
T ss_pred CCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccC
Confidence 99999999999999999999999999999999999999999999999999999999976443345556667776 444
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-49 Score=432.43 Aligned_cols=291 Identities=37% Similarity=0.650 Sum_probs=245.1
Q ss_pred cccccCHHHHHHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEee
Q 039533 612 SLLYLSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTA 691 (949)
Q Consensus 612 ~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 691 (949)
....|++.++..||++|...++||+|+||.||+|... +++.||||++........++|.+|++++.+++|||+|+++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 4667999999999999999999999999999999998 458999998865443214669999999999999999999999
Q ss_pred eecccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCC
Q 039533 692 CLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSN 771 (949)
Q Consensus 692 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~N 771 (949)
|.+.+. ..++|||||++|+|.++++... .. .++|.++++||.++|+||+|||+.+.++|+||||||+|
T Consensus 140 C~e~~~----~~~LVYEym~nGsL~d~L~~~~-------~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssN 207 (361)
T KOG1187|consen 140 CLEGGE----HRLLVYEYMPNGSLEDHLHGKK-------GE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSN 207 (361)
T ss_pred EecCCc----eEEEEEEccCCCCHHHHhCCCC-------CC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHH
Confidence 986551 4899999999999999998321 11 78999999999999999999999988899999999999
Q ss_pred eeecCCCceEEeecccceecCC-CCCccccccc-cCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCcccc-c
Q 039533 772 VLLDDYMTARVGDFGLARILSP-DHTQTSSFSV-KGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMF-E 848 (949)
Q Consensus 772 Ill~~~~~~kl~DfG~a~~~~~-~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~-~ 848 (949)
||+|+++++||+|||+|+.... ..... .. .||.+|+|||+...+..++|+|||||||++.|++||+.|.+... .
T Consensus 208 ILLD~~~~aKlsDFGLa~~~~~~~~~~~---~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~ 284 (361)
T KOG1187|consen 208 ILLDEDFNAKLSDFGLAKLGPEGDTSVS---TTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPR 284 (361)
T ss_pred eeECCCCCEEccCccCcccCCcccccee---eecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCc
Confidence 9999999999999999976544 22211 11 69999999999999999999999999999999999999988654 3
Q ss_pred cCchhhhhccccCCC-chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 849 GDINLHNFGRKALPD-DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 849 ~~~~~~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
+...+..|.+..+.+ .+.+++|+.+...... ..+...++.+++.+|++.+|++||+|.||+++
T Consensus 285 ~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~----------------~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~ 348 (361)
T KOG1187|consen 285 GELSLVEWAKPLLEEGKLREIVDPRLKEGEYP----------------DEKEVKKLAELALRCLRPDPKERPTMSQVVKE 348 (361)
T ss_pred ccccHHHHHHHHHHCcchhheeCCCccCCCCC----------------hHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHH
Confidence 445578887777666 4889999988632210 01456779999999999999999999999999
Q ss_pred HHHhHHh
Q 039533 928 LQSIKNI 934 (949)
Q Consensus 928 L~~i~~~ 934 (949)
|+.+...
T Consensus 349 L~~~~~~ 355 (361)
T KOG1187|consen 349 LEGILSL 355 (361)
T ss_pred HHhhccc
Confidence 9766543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=376.12 Aligned_cols=254 Identities=24% Similarity=0.328 Sum_probs=207.1
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
+.+..+.||+|..|+||+++++.+++.+|+|++..... ...+++.+|++++++.+||+||.+||+|.... . ..++
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~---~-~isI 155 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG---E-EISI 155 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC---c-eEEe
Confidence 34556899999999999999999999999999964433 34578999999999999999999999986543 1 5899
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
+||||++|+|++++. ..+.+++...-+|+.+|++||.|||+. ++||||||||+|||++..|++|||||
T Consensus 156 ~mEYMDgGSLd~~~k----------~~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDF 223 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILK----------RVGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDF 223 (364)
T ss_pred ehhhcCCCCHHHHHh----------hcCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccc
Confidence 999999999999997 236689999999999999999999963 28999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCch
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDV 865 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 865 (949)
|.++.+... .....+||..|||||.+.+..|+.++||||||++++|+.+|+.||....+.. ..+
T Consensus 224 GVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~------------~~~ 287 (364)
T KOG0581|consen 224 GVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY------------LDI 287 (364)
T ss_pred cccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC------------CCH
Confidence 999887655 2235679999999999999999999999999999999999999996431111 112
Q ss_pred hhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 866 MDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 866 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.++++......+. +.+. ..+.+++..++..|+++||.+|||++|+++
T Consensus 288 ~~Ll~~Iv~~ppP-------------~lP~-~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 288 FELLCAIVDEPPP-------------RLPE-GEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred HHHHHHHhcCCCC-------------CCCc-ccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 2222222221111 0000 035678999999999999999999999875
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=392.33 Aligned_cols=263 Identities=33% Similarity=0.468 Sum_probs=212.4
Q ss_pred CCCCeeeeecCceEEEEEEcCCCEE-EEEEEEecCCCcc--hHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 629 SSANLVGVGSFGSVYKGIIDEGRTT-IAVKVFNLQHHGA--SRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 629 ~~~~~lg~G~~g~Vy~~~~~~~~~~-vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
.+.+.+|+|+||+||+|.+. |+. ||||++....... .+.|.+|+.++.+++|||||+++|+|..... ..++
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~----~~~i 117 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG----SLCI 117 (362)
T ss_pred hhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----ceEE
Confidence 44566999999999999998 455 9999997554332 4589999999999999999999999875431 5799
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC-eEecCCCCCCeeecCCC-ceEEe
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPV-TAHCDLKPSNVLLDDYM-TARVG 783 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~-ivHrDlkp~NIll~~~~-~~kl~ 783 (949)
||||+++|+|.++++.. ....+++..++.|+.|||+|+.|||++ + ||||||||+|||++.++ ++||+
T Consensus 118 VtEy~~~GsL~~~l~~~--------~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~ 186 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKK--------RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIA 186 (362)
T ss_pred EEEeCCCCcHHHHHhhc--------ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEEC
Confidence 99999999999999831 256799999999999999999999988 5 99999999999999997 99999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccC--CCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGV--GCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
|||+++...... .......||+.|||||++. ...|+.|+||||||+++|||+||+.||.........
T Consensus 187 DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~--------- 255 (362)
T KOG0192|consen 187 DFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVA--------- 255 (362)
T ss_pred CCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHH---------
Confidence 999998766432 1122356999999999999 568999999999999999999999999754331111
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhhccCCCC
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILLGVELC 941 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~~~ 941 (949)
..++.....+. ...+++..+..++.+||+.||+.||++.|++..|+.+........+.
T Consensus 256 ----~~v~~~~~Rp~------------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~~~ 313 (362)
T KOG0192|consen 256 ----SAVVVGGLRPP------------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAGPE 313 (362)
T ss_pred ----HHHHhcCCCCC------------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccCcc
Confidence 11111111111 11236778899999999999999999999999999998877765333
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=371.05 Aligned_cols=277 Identities=26% Similarity=0.419 Sum_probs=210.0
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecC--CCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ--HHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
...+|...+.||+|+||+||+|+++.++..||||.+... .....+.+..|+++|+.++|||||++++++...+
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~----- 82 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD----- 82 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC-----
Confidence 356899999999999999999999999999999999766 3344567889999999999999999999977665
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCC----
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDY---- 777 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~---- 777 (949)
+.|+|||||.||+|.+|++ ..+.+++..++.++.|+|.||++||++ +||||||||+|||++..
T Consensus 83 ~i~lVMEyC~gGDLs~yi~----------~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~ 149 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIR----------RRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARND 149 (429)
T ss_pred eEEEEEEeCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCC
Confidence 8999999999999999998 345799999999999999999999988 89999999999999754
Q ss_pred --CceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhh
Q 039533 778 --MTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHN 855 (949)
Q Consensus 778 --~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~ 855 (949)
-.+||+|||+|+.+.+..... ...|++.|||||++..++|+.|+|+||.|+++|++++|+.||+.....+. ..
T Consensus 150 ~~~~LKIADFGfAR~L~~~~~a~---tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL--~~ 224 (429)
T KOG0595|consen 150 TSPVLKIADFGFARFLQPGSMAE---TLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKEL--LL 224 (429)
T ss_pred CCceEEecccchhhhCCchhHHH---HhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHH--HH
Confidence 568999999999987554322 46699999999999999999999999999999999999999974432211 11
Q ss_pred hccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhH
Q 039533 856 FGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIK 932 (949)
Q Consensus 856 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 932 (949)
+.++ ...........+.....+.+....++++..+.. ....+....+..+|.+|+.+.++-......+
T Consensus 225 ~~~k--~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~-------~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~ 292 (429)
T KOG0595|consen 225 YIKK--GNEIVPVLPAELSNPLRELLISLLQRNPKDRIS-------FEDFFDHPFLAANPQDRADAFELESRTDQVK 292 (429)
T ss_pred HHhc--cccccCchhhhccCchhhhhhHHHhcCccccCc-------hHHhhhhhhcccCcccccCcccccccccccc
Confidence 1110 011111111111111112222222222222211 1234566778888999988887766655543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=385.20 Aligned_cols=249 Identities=23% Similarity=0.327 Sum_probs=208.7
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecC---CCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ---HHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
.+|...+.||+|||+.||++++..+|..||+|++... .....+...+|+++.++++|||||+++++|.+.+ .
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~-----n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN-----N 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC-----c
Confidence 5699999999999999999999779999999999753 3344578899999999999999999999976555 8
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.|+|.|+|+.++|.++++ ..+.+++.+++.++.||+.||.|||+. +|+|||||-.|++++++.++||
T Consensus 93 VYivLELC~~~sL~el~K----------rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKI 159 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLK----------RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKI 159 (592)
T ss_pred eEEEEEecCCccHHHHHH----------hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEe
Confidence 999999999999999997 457799999999999999999999987 8999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
+|||+|..+..+..... ...||+.|.|||++.....+..+||||+|||+|-|++|++||+...-.+ .+.....
T Consensus 160 gDFGLAt~le~~~Erk~--TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke-ty~~Ik~---- 232 (592)
T KOG0575|consen 160 GDFGLATQLEYDGERKK--TLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE-TYNKIKL---- 232 (592)
T ss_pred cccceeeeecCcccccc--eecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH-HHHHHHh----
Confidence 99999999876644332 4679999999999999999999999999999999999999997431110 0000000
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
. .+..+.....+..+++..+++.||.+|||+++|+..
T Consensus 233 ------------~----------------~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 233 ------------N----------------EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ------------c----------------CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 000111334456889999999999999999999863
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=369.77 Aligned_cols=252 Identities=21% Similarity=0.264 Sum_probs=201.0
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-------cchHHHHHHHHHHHhcCCCcceeEEeeeeccccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-------GASRSFIAECKALKSIRHRNLVKVLTACLGADYR 698 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 698 (949)
+.|.+.+.||+|+||.|-+|..+.+++.||||+++.... .......+|+++|++++|||||++++++...+
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d-- 249 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD-- 249 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC--
Confidence 457788999999999999999999999999999974421 12345679999999999999999999976555
Q ss_pred CCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCC-
Q 039533 699 GNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDY- 777 (949)
Q Consensus 699 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~- 777 (949)
..|+||||++||+|.+++- ..+.+.+.....+++|++.|+.|||++ ||+||||||+|||+..+
T Consensus 250 ---s~YmVlE~v~GGeLfd~vv----------~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~ 313 (475)
T KOG0615|consen 250 ---SSYMVLEYVEGGELFDKVV----------ANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDA 313 (475)
T ss_pred ---ceEEEEEEecCccHHHHHH----------hccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCC
Confidence 7899999999999999996 345567777889999999999999988 99999999999999755
Q ss_pred --CceEEeecccceecCCCCCccccccccCccCccCccccCCCcc---CCccchHHHHHHHHHHHhCCCCCccccccCch
Q 039533 778 --MTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEV---STNGDVYSYGILLLELVIGKKPIDIMFEGDIN 852 (949)
Q Consensus 778 --~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~ 852 (949)
..+||+|||+|+..+...... ...||+.|.|||++.+..+ ..++|+||+||++|-+++|.+||.........
T Consensus 314 e~~llKItDFGlAK~~g~~sfm~---TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl 390 (475)
T KOG0615|consen 314 EDCLLKITDFGLAKVSGEGSFMK---TLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSL 390 (475)
T ss_pred cceEEEecccchhhccccceehh---hhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccH
Confidence 789999999999887443322 4679999999999887643 34789999999999999999999644322111
Q ss_pred hhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 853 LHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 853 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
....... ..... . +.+.++.++..+++.+|+..||++|||++|+++
T Consensus 391 ~eQI~~G------------~y~f~-------------p---~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 391 KEQILKG------------RYAFG-------------P---LQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred HHHHhcC------------ccccc-------------C---hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 1111110 00000 0 122366777899999999999999999999875
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=351.35 Aligned_cols=262 Identities=25% Similarity=0.357 Sum_probs=209.0
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
.+|.+.++||+|.||+||++....+|..||.|.++... ..+.+....|+.+|++++|||||++++.-. .++....
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f---~~~~evl 95 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSF---IEDNEVL 95 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh---hccchhh
Confidence 45888899999999999999999999999999987443 334467889999999999999999987432 2234458
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEecCCCCCCeeecCCCceE
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPV--TAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~--ivHrDlkp~NIll~~~~~~k 781 (949)
++||||+..|+|...++.++. ..+.+++..+++++.|++.||.++|+. -+. |+||||||.||+++.+|.+|
T Consensus 96 nivmE~c~~GDLsqmIk~~K~------qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvK 168 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKK------QKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVK 168 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHh------ccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCcee
Confidence 999999999999999985543 456799999999999999999999984 234 99999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
|+|||+++.+....+... +.+|||.||+||.+.+.+|+.||||||+||++|||+.-++||... ++.....+
T Consensus 169 LGDfGL~r~l~s~~tfA~--S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~K-- 239 (375)
T KOG0591|consen 169 LGDFGLGRFLSSKTTFAH--SLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCKK-- 239 (375)
T ss_pred eccchhHhHhcchhHHHH--hhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHHH--
Confidence 999999999876655433 578999999999999999999999999999999999999999632 22111111
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQS 930 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 930 (949)
+......+-|. .-.+..+.+++..|+..||+.||+...+++.+..
T Consensus 240 ------I~qgd~~~~p~------------------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 240 ------IEQGDYPPLPD------------------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred ------HHcCCCCCCcH------------------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 11111111111 1345678899999999999999996555554443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=377.43 Aligned_cols=255 Identities=30% Similarity=0.449 Sum_probs=212.3
Q ss_pred CCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEee
Q 039533 629 SSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYE 708 (949)
Q Consensus 629 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 708 (949)
+..+.||+|.||.||.|.++ +...||+|.++... ...+.|.+|+++|++++|++||+++++|...+ ..+||||
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-----piyIVtE 281 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-----PIYIVTE 281 (468)
T ss_pred HHHHHhcCCccceEEEEEEc-CCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCC-----ceEEEEE
Confidence 44578999999999999998 45689999997653 33478899999999999999999999997654 6899999
Q ss_pred eccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecccc
Q 039533 709 FMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLA 788 (949)
Q Consensus 709 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a 788 (949)
||+.|+|.+|++. ..+..+...+.+.++.|||+|++||+++ ++|||||.++||||+++..+||+|||+|
T Consensus 282 ~m~~GsLl~yLr~--------~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLA 350 (468)
T KOG0197|consen 282 YMPKGSLLDYLRT--------REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLA 350 (468)
T ss_pred ecccCcHHHHhhh--------cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccc
Confidence 9999999999973 2356788999999999999999999988 8999999999999999999999999999
Q ss_pred eecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCCchhh
Q 039533 789 RILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPDDVMD 867 (949)
Q Consensus 789 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 867 (949)
+...++.. .......-...|.|||.+..++++.|||||||||+||||+| |+.||..+...+ +.+
T Consensus 351 r~~~d~~Y-~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e--------------v~~ 415 (468)
T KOG0197|consen 351 RLIGDDEY-TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE--------------VLE 415 (468)
T ss_pred cccCCCce-eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH--------------HHH
Confidence 95544433 22223335678999999999999999999999999999999 999986442211 111
Q ss_pred hcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHh
Q 039533 868 IVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNI 934 (949)
Q Consensus 868 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 934 (949)
+...+.|.+.+..||..+.+++..||+.+|++|||++.+...++++...
T Consensus 416 ------------------~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 416 ------------------LLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred ------------------HHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 1223344555668999999999999999999999999999999887654
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=369.28 Aligned_cols=274 Identities=28% Similarity=0.428 Sum_probs=217.8
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc--chHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG--ASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
.+...+.+.||+|+||+||+|++.+ .||||++...... ..+.|++|+..+++-+|.||+-+.|||..+.
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~------ 461 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP------ 461 (678)
T ss_pred HHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc------
Confidence 3445677899999999999999983 4999999866543 4478999999999999999999999987655
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
..||+.+|+|-+|+.+++- ....++..+.+.||.|||+|+.|||++ +|||||||..||++.+++.|||
T Consensus 462 ~AIiTqwCeGsSLY~hlHv---------~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkI 529 (678)
T KOG0193|consen 462 LAIITQWCEGSSLYTHLHV---------QETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKI 529 (678)
T ss_pred eeeeehhccCchhhhhccc---------hhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEE
Confidence 4999999999999999982 345689999999999999999999988 9999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCC---ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC---EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
+|||++..-.............|...|||||++..+ +|++.+||||||+|+|||+||..||.....+.+.++ ..+.
T Consensus 530 gDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifm-VGrG 608 (678)
T KOG0193|consen 530 GDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFM-VGRG 608 (678)
T ss_pred ecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEE-eccc
Confidence 999999764433221111234488999999997754 689999999999999999999999972222211111 1111
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhhccCC
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILLGVE 939 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~ 939 (949)
+. .++.. .....+++++.+|+..||..+|++||.+.+|+..|+.+..+..+-.
T Consensus 609 ~l------------~pd~s---------------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~ 661 (678)
T KOG0193|consen 609 YL------------MPDLS---------------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKIN 661 (678)
T ss_pred cc------------Cccch---------------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccccc
Confidence 11 11111 1123678899999999999999999999999999999988776666
Q ss_pred CCCCcccc
Q 039533 940 LCPPCKVV 947 (949)
Q Consensus 940 ~~~~~~~~ 947 (949)
.+|.++++
T Consensus 662 RS~S~P~~ 669 (678)
T KOG0193|consen 662 RSASEPVL 669 (678)
T ss_pred cCcCccch
Confidence 66666654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=349.62 Aligned_cols=202 Identities=29% Similarity=0.388 Sum_probs=180.1
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
..++|++.++||+|+||.||.++.+++++.+|+|++++.. ....+...+|..++.+++||+||+++..|.+.+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~---- 98 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEE---- 98 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCC----
Confidence 3568999999999999999999999999999999997543 234577889999999999999999998765554
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
..|+|+||+.||.|..+|+ ..+.+++..++-++.+|+.||.|||+. +||||||||+|||+|++|++
T Consensus 99 -kLylVld~~~GGeLf~hL~----------~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi 164 (357)
T KOG0598|consen 99 -KLYLVLDYLNGGELFYHLQ----------REGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHI 164 (357)
T ss_pred -eEEEEEeccCCccHHHHHH----------hcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcE
Confidence 8999999999999999997 356789999999999999999999977 99999999999999999999
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCcc
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDI 845 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~ 845 (949)
+|+|||+++..-.....+. .+.||+.|||||++.+..|+.++|.||+|+++|||++|.+||..
T Consensus 165 ~LtDFgL~k~~~~~~~~t~--tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~ 227 (357)
T KOG0598|consen 165 KLTDFGLCKEDLKDGDATR--TFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA 227 (357)
T ss_pred EEeccccchhcccCCCccc--cccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC
Confidence 9999999996544433332 46799999999999999999999999999999999999999963
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=335.72 Aligned_cols=271 Identities=23% Similarity=0.284 Sum_probs=204.0
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
+.|+...++|+|+||.||+++++.+|+.||||++....+ ...+-.++|++++++++|+|+|.++++|.. ....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr-----krkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR-----KRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh-----ccee
Confidence 457788899999999999999999999999999964433 223567899999999999999999999643 4489
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++|+||++..-|.+.=+ .+..++...+.+++.|++.|+.|+|++ +++||||||+|||++.+|.+|||
T Consensus 77 hLVFE~~dhTvL~eLe~----------~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLC 143 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHELER----------YPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLC 143 (396)
T ss_pred EEEeeecchHHHHHHHh----------ccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEec
Confidence 99999998855554432 455688899999999999999999987 89999999999999999999999
Q ss_pred ecccceecCC-CCCccccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCchhh-hhcccc
Q 039533 784 DFGLARILSP-DHTQTSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLH-NFGRKA 860 (949)
Q Consensus 784 DfG~a~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~-~~~~~~ 860 (949)
|||+|+.+.. ....+ ..+.|.+|+|||.+.+ .+|+..+||||.||++.||++|.+-|....+-+.-+. ...-..
T Consensus 144 DFGFAR~L~~pgd~YT---DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~ 220 (396)
T KOG0593|consen 144 DFGFARTLSAPGDNYT---DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGN 220 (396)
T ss_pred cchhhHhhcCCcchhh---hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcc
Confidence 9999999874 33333 4568999999999888 6899999999999999999999999864433222111 001111
Q ss_pred CCCchhhhcccC------CCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 861 LPDDVMDIVDSS------LLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 861 ~~~~~~~~~d~~------l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
+.+....++... -.+++.+ +..-..........+.+++..|++.||++|++.+|++.
T Consensus 221 L~prhq~iF~~N~~F~Gv~lP~~~~---------~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 221 LIPRHQSIFSSNPFFHGVRLPEPEH---------PEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred cCHHHHHHhccCCceeeeecCCCCC---------ccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 112222222111 1111110 00001112234457899999999999999999999864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=359.95 Aligned_cols=254 Identities=23% Similarity=0.294 Sum_probs=207.1
Q ss_pred HHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhc-CCCcceeEEeeeecccc
Q 039533 622 YNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSI-RHRNLVKVLTACLGADY 697 (949)
Q Consensus 622 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 697 (949)
.....+|.+++.||+|+|++||+|+...+++.+|||++.+.. +...+.+..|-.+|.++ .||.|++++-.|.+..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~- 147 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE- 147 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc-
Confidence 345678999999999999999999999999999999997442 23345677899999999 8999999998866554
Q ss_pred cCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCC
Q 039533 698 RGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDY 777 (949)
Q Consensus 698 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~ 777 (949)
..|+|+||+++|+|.++|+ ..+.+++..++.++.||+.||+|||++ |||||||||+|||+|++
T Consensus 148 ----sLYFvLe~A~nGdll~~i~----------K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~d 210 (604)
T KOG0592|consen 148 ----SLYFVLEYAPNGDLLDLIK----------KYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKD 210 (604)
T ss_pred ----ceEEEEEecCCCcHHHHHH----------HhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCC
Confidence 8999999999999999998 346799999999999999999999977 99999999999999999
Q ss_pred CceEEeecccceecCCCCCc---------ccc--ccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccc
Q 039533 778 MTARVGDFGLARILSPDHTQ---------TSS--FSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIM 846 (949)
Q Consensus 778 ~~~kl~DfG~a~~~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~ 846 (949)
|++||+|||.|+.+.+.... ... ..++||..|.+||++.+...++.+|||+|||++|+|+.|++||...
T Consensus 211 mhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~ 290 (604)
T KOG0592|consen 211 GHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA 290 (604)
T ss_pred CcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc
Confidence 99999999999988654321 111 3578999999999999999999999999999999999999999643
Q ss_pred cccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 847 FEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 847 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.+- .. +.++++-. ++.+...++.+.+|+.+.+..||.+|+|++|+.+
T Consensus 291 Ney----li---------FqkI~~l~--------------------y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 291 NEY----LI---------FQKIQALD--------------------YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred cHH----HH---------HHHHHHhc--------------------ccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 211 00 01111100 0011123456788999999999999999977754
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=381.58 Aligned_cols=269 Identities=25% Similarity=0.403 Sum_probs=218.8
Q ss_pred cCCCCCCeeeeecCceEEEEEEcC-----CCEEEEEEEEecCCCc-chHHHHHHHHHHHhcCCCcceeEEeeeecccccC
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDE-----GRTTIAVKVFNLQHHG-ASRSFIAECKALKSIRHRNLVKVLTACLGADYRG 699 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 699 (949)
.+-...+.||+|.||.||+|+... +...||||.++..... ...+|++|++.+..++|||||+++|+|.+.+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~--- 562 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD--- 562 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC---
Confidence 344566889999999999998742 3467999999876665 6689999999999999999999999998776
Q ss_pred CccceeEeeeccCCChhhhcCCCCCCCcccc----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec
Q 039533 700 NDFKASVYEFMHYGSLEEWLHPFTGEDEIDE----APRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD 775 (949)
Q Consensus 700 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~----~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~ 775 (949)
..++|+|||..|||.+||.-......... .+..++..+.+.||.|||.|++||-++ .+|||||..+|+||.
T Consensus 563 --P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 563 --PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVG 637 (774)
T ss_pred --eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceec
Confidence 78999999999999999975443322221 245599999999999999999999988 799999999999999
Q ss_pred CCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhh
Q 039533 776 DYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLH 854 (949)
Q Consensus 776 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~ 854 (949)
++..|||+|||+++.....+.+.......-..+|||||.+..++++++||||||||+|||+++ |+.||.....++
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E---- 713 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE---- 713 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH----
Confidence 999999999999997655444332222234679999999999999999999999999999998 999986443221
Q ss_pred hhccccCCCchhhhc-ccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHH
Q 039533 855 NFGRKALPDDVMDIV-DSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKN 933 (949)
Q Consensus 855 ~~~~~~~~~~~~~~~-d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 933 (949)
+.+.+ +..+ ++.++.||.++++++..||+..|++||+++||...|+...+
T Consensus 714 ----------VIe~i~~g~l-------------------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 714 ----------VIECIRAGQL-------------------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred ----------HHHHHHcCCc-------------------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 11111 1122 22335889999999999999999999999999999998765
Q ss_pred hh
Q 039533 934 IL 935 (949)
Q Consensus 934 ~~ 935 (949)
.-
T Consensus 765 ~s 766 (774)
T KOG1026|consen 765 AS 766 (774)
T ss_pred cC
Confidence 53
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=372.66 Aligned_cols=448 Identities=27% Similarity=0.418 Sum_probs=382.9
Q ss_pred EEEEEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCC
Q 039533 67 VTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQN 146 (949)
Q Consensus 67 v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 146 (949)
...+++++|.+. .+.+.+.+|..|+.|++++|+++ ..|++++.+..++.|+.|+|+++ ++|+.++.+.+|+.|+.++
T Consensus 47 l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~ 123 (565)
T KOG0472|consen 47 LQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSS 123 (565)
T ss_pred hhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccc
Confidence 567889999988 67778899999999999999998 88999999999999999999998 9999999999999999999
Q ss_pred ccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCcccccccc
Q 039533 147 NQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVEN 226 (949)
Q Consensus 147 n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 226 (949)
|.+. ..++.++.+..|+.|+..+|+++ ..|+.++++.+|..|++.+|+++...|+.+. ++.|++||+..|-++.+|
T Consensus 124 n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~tlP- 199 (565)
T KOG0472|consen 124 NELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLETLP- 199 (565)
T ss_pred ccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhhcCC-
Confidence 9997 45667778889999999999999 8899999999999999999999966665555 999999999998877655
Q ss_pred cccCCCCChhhhccccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhh-cccccccEEEccCcc
Q 039533 227 KLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCIS-NLSKTIKTLFLNNNK 305 (949)
Q Consensus 227 ~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~-~l~~~L~~L~L~~N~ 305 (949)
|.++.+.+|..|+|..|.+. ++++|.++..|.+++++.|++. .+|.... ++ .++.+|||.+|+
T Consensus 200 ------~~lg~l~~L~~LyL~~Nki~--------~lPef~gcs~L~Elh~g~N~i~-~lpae~~~~L-~~l~vLDLRdNk 263 (565)
T KOG0472|consen 200 ------PELGGLESLELLYLRRNKIR--------FLPEFPGCSLLKELHVGENQIE-MLPAEHLKHL-NSLLVLDLRDNK 263 (565)
T ss_pred ------hhhcchhhhHHHHhhhcccc--------cCCCCCccHHHHHHHhcccHHH-hhHHHHhccc-ccceeeeccccc
Confidence 45788899999999999886 4557889999999999999998 4565555 55 569999999999
Q ss_pred ccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccc----------------------------
Q 039533 306 IYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGN---------------------------- 357 (949)
Q Consensus 306 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---------------------------- 357 (949)
++ ..|+.+..+++|.+||+|+|.|+ ..|.+++++ +|+.|-|.+|.+..+
T Consensus 264 lk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~s 340 (565)
T KOG0472|consen 264 LK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQS 340 (565)
T ss_pred cc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCC
Confidence 99 78999999999999999999999 688899999 999999999988621
Q ss_pred ----------cCc---ccccccccceeecccccccccCCCCCCCCCC---CcEEEeeCccccCCCCCcccCCcccceeec
Q 039533 358 ----------IPP---SIGNLKMLLNLFLNDNFLEVSIPSSLGQCES---LIEINLSNNNLSGTIPPQFFSLSSLSISLD 421 (949)
Q Consensus 358 ----------~p~---~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ 421 (949)
.+. ....+.+.+.|++++-+++ .+|+....-.. ...++++.|++. ++|..+..+..+...+.
T Consensus 341 e~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~ 418 (565)
T KOG0472|consen 341 EGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLV 418 (565)
T ss_pred cccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHH
Confidence 011 1123445677888888887 56665444333 778999999998 89999988888877788
Q ss_pred cCCCccCCCCccccccccccceeeeccccccccCCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCC
Q 039533 422 WSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSG 501 (949)
Q Consensus 422 ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 501 (949)
+++|.++ -+|..+..+++|..|+|++|-+. .+|.+++.+..|+.||+|+|+|. .+|..+..+..|+.+-.++|++..
T Consensus 419 lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~ 495 (565)
T KOG0472|consen 419 LSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGS 495 (565)
T ss_pred hhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccc
Confidence 8888887 88889999999999999999998 89999999999999999999998 788888888888888888899987
Q ss_pred cCcccccCCc-cceEeCCCCcCcCcccccccccccccccccCCCC
Q 039533 502 EIPKFLAGLS-LNNLNLSYNDLEGMVTTEGVFKNASATRILGNSK 545 (949)
Q Consensus 502 ~~p~~~~~~~-L~~l~ls~N~l~~~~~~~~~~~~~~~~~~~gn~~ 545 (949)
..|..+..+. |..|||.+|.+..++|..+...++..+.+.|||.
T Consensus 496 vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpf 540 (565)
T KOG0472|consen 496 VDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPF 540 (565)
T ss_pred cChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCcc
Confidence 6666677776 9999999999999988888888899999999974
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=352.20 Aligned_cols=277 Identities=23% Similarity=0.286 Sum_probs=207.7
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
+.|+.+++||+|.||.||+|++..+|+.||+|+++... .+-.....+||.+|++++||||+++.+...+. .....
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~~si 193 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LSGSI 193 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CCceE
Confidence 45677789999999999999999999999999998665 34456778999999999999999999987654 23478
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
|+|+|||++ +|..++.. ..-.+++.++..++.|++.||+|+|++ +|+|||||.+|||||.+|.+||+
T Consensus 194 YlVFeYMdh-DL~GLl~~---------p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKia 260 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSS---------PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIA 260 (560)
T ss_pred EEEEecccc-hhhhhhcC---------CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEec
Confidence 999999987 88888762 345689999999999999999999977 99999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhc---cc
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFG---RK 859 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~---~~ 859 (949)
|||+|+++....... .+..+-|..|+|||.+.|. .|+.++|+||.|||+.||++|++.|+...+-+. +.... ..
T Consensus 261 DFGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ-l~kIfklcGS 338 (560)
T KOG0600|consen 261 DFGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ-LHKIFKLCGS 338 (560)
T ss_pred cccceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH-HHHHHHHhCC
Confidence 999999887766543 2356689999999998876 699999999999999999999999864432211 11100 00
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.-.+.+. .. .+.. ............. ..+.....+....+++..++..||.+|.||.++++
T Consensus 339 P~e~~W~-~~--kLP~--~~~~kp~~~y~r~-l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 339 PTEDYWP-VS--KLPH--ATIFKPQQPYKRR-LRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CChhccc-cc--cCCc--ccccCCCCcccch-HHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0000011 00 0000 0000000000000 01112344567789999999999999999998875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=351.25 Aligned_cols=262 Identities=28% Similarity=0.380 Sum_probs=203.9
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
..+|...+.||+|+||+||++....+|+..|||.+........+.+.+|+.+|++++|||||+++|.....+ . ..++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~--~-~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE--N-DEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc--C-eeeE
Confidence 456788899999999999999999889999999997654333567899999999999999999998633222 1 3589
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC-CCceEEe
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD-YMTARVG 783 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~-~~~~kl~ 783 (949)
+.|||+++|+|.+++... +..+++..++.++.||++||+|||++ |||||||||+|||++. ++.+||+
T Consensus 93 i~mEy~~~GsL~~~~~~~---------g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~Kla 160 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRY---------GGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLA 160 (313)
T ss_pred eeeeccCCCcHHHHHHHc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEec
Confidence 999999999999999732 12599999999999999999999987 9999999999999999 7999999
Q ss_pred ecccceecCCCCC-ccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 784 DFGLARILSPDHT-QTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 784 DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
|||+++....... ........||+.|||||++.++ ....++||||+||++.||+||++||...........
T Consensus 161 DFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~------- 233 (313)
T KOG0198|consen 161 DFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALL------- 233 (313)
T ss_pred cCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHH-------
Confidence 9999987664111 2223356799999999999953 344699999999999999999999964311100000
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHh
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSI 931 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 931 (949)
.+......+. .+...+....+++.+|+..+|++||||+|+++.--..
T Consensus 234 -----~ig~~~~~P~------------------ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 234 -----LIGREDSLPE------------------IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred -----HHhccCCCCC------------------CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 0000000000 0113455678999999999999999999998865543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=357.39 Aligned_cols=250 Identities=21% Similarity=0.314 Sum_probs=209.1
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
..|..-++||+|+.|.||.|....+++.||||++........+-+.+|+.+|+..+|+|||++++.|... +..++
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-----deLWV 347 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-----DELWV 347 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc-----ceeEE
Confidence 3577778999999999999999999999999999887777777899999999999999999999886544 48999
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
|||||+||+|.+.+. ...+++.++..|++++++||+|||.+ +|+|||||.+|||++.+|.+||+||
T Consensus 348 VMEym~ggsLTDvVt-----------~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDF 413 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVT-----------KTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDF 413 (550)
T ss_pred EEeecCCCchhhhhh-----------cccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeee
Confidence 999999999999986 24489999999999999999999988 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCch
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDV 865 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 865 (949)
|++..+....... ...+||+.|||||+.....|++|+||||||++++||+-|++||-.... +..
T Consensus 414 GFcaqi~~~~~KR--~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P----lrA---------- 477 (550)
T KOG0578|consen 414 GFCAQISEEQSKR--STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP----LRA---------- 477 (550)
T ss_pred eeeeccccccCcc--ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh----HHH----------
Confidence 9999887766533 257899999999999999999999999999999999999999842100 000
Q ss_pred hhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 866 MDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 866 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.-++..... ..+.........+.+++.+|++.||++||+|.|+++
T Consensus 478 lyLIa~ng~----------------P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 478 LYLIATNGT----------------PKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred HHHHhhcCC----------------CCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 000000000 011122345677899999999999999999999976
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=322.68 Aligned_cols=272 Identities=18% Similarity=0.233 Sum_probs=220.6
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
..++|++.+.+|+|||+.||.++.-.+++.+|+|++.....+..+..++|++..++++|||++++++++....-++....
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 45689999999999999999999988999999999988877778899999999999999999999999887766677789
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
|++++|...|+|.+.+...+ ..+..+++.+.++|+.++++||++||+. .++++||||||.||++.+++.+++.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k------~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~ 171 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLK------IKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLM 171 (302)
T ss_pred EEEeehhccccHHHHHHHHh------hcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEE
Confidence 99999999999999997432 2345689999999999999999999988 5679999999999999999999999
Q ss_pred ecccceecCCCCC-------ccccccccCccCccCccccC---CCccCCccchHHHHHHHHHHHhCCCCCccccccCchh
Q 039533 784 DFGLARILSPDHT-------QTSSFSVKGSLGYIAPEYGV---GCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINL 853 (949)
Q Consensus 784 DfG~a~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~ 853 (949)
|||.++...-... ........+|..|+|||.+. +...++++|||||||++|+|+.|..||+...+....+
T Consensus 172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl 251 (302)
T KOG2345|consen 172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL 251 (302)
T ss_pred eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE
Confidence 9999976532211 11112345899999999865 4568899999999999999999999998654432222
Q ss_pred hhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHh
Q 039533 854 HNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSI 931 (949)
Q Consensus 854 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 931 (949)
.-.+ ..... .++.-...++.+.+++.+|++.||.+||++.|++..++.+
T Consensus 252 aLAv-----------~n~q~------------------s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 252 ALAV-----------QNAQI------------------SIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred EEee-----------ecccc------------------ccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 1110 01000 0111112467789999999999999999999999998865
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=353.25 Aligned_cols=272 Identities=21% Similarity=0.240 Sum_probs=208.8
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcch-HHHHHHHHHHHhcC-CCcceeEEeeeecccccCCc
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGAS-RSFIAECKALKSIR-HRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 701 (949)
..++|.+.++||.|.||.||+|+...++..||||.++..-.... -.-.+|+..|++++ ||||+++.+++.+.+ .
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~----~ 83 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND----R 83 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC----c
Confidence 34678999999999999999999999999999999975544332 23468999999998 999999999875443 2
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++|||||+. +|++.++. .++.+++.+++.|+.||++||+|+|.+ |+.|||+||+|||+.....+|
T Consensus 84 ~L~fVfE~Md~-NLYqLmK~---------R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iK 150 (538)
T KOG0661|consen 84 ILYFVFEFMDC-NLYQLMKD---------RNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIK 150 (538)
T ss_pred eEeeeHHhhhh-hHHHHHhh---------cCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeE
Confidence 78999999975 99999972 357799999999999999999999977 999999999999999889999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccC-CCccCCccchHHHHHHHHHHHhCCCCCccccccCchhh--hhcc
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGV-GCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLH--NFGR 858 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~--~~~~ 858 (949)
|+|||+|+.+......+ ..+.|..|+|||++. .+.|+.+.||||+|||++|+.+-++.|....+.|..+. +...
T Consensus 151 iaDFGLARev~SkpPYT---eYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLG 227 (538)
T KOG0661|consen 151 IADFGLAREVRSKPPYT---EYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLG 227 (538)
T ss_pred ecccccccccccCCCcc---hhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhC
Confidence 99999999887665544 456899999999866 45689999999999999999999999875544332111 1111
Q ss_pred ----ccCCCc--hhhhcccCCCCCchhhhhhhchhhhhhhh-hhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 859 ----KALPDD--VMDIVDSSLLPDDEDLILTGNQRQKQARI-NSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 859 ----~~~~~~--~~~~~d~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
..+++. +...+.-.+..... ..+ .-...+..+..+++.+|+++||++||||+|.++.
T Consensus 228 tP~~~~~~eg~~La~~mnf~~P~~~~------------~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 228 TPDKDSWPEGYNLASAMNFRFPQVKP------------SPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred CCccccchhHHHHHHHhccCCCcCCC------------CChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111110 11111111111100 000 0112356678999999999999999999998863
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=361.70 Aligned_cols=366 Identities=22% Similarity=0.236 Sum_probs=317.2
Q ss_pred eeecCCCccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCc
Q 039533 140 IPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAAN 219 (949)
Q Consensus 140 ~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 219 (949)
+.||+++|++..+.+..|.+|++|++++|.+|.++ .+|...+...+|+.|+|.+|.|+..-.+++..++.|+.||||.|
T Consensus 81 ~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN 159 (873)
T KOG4194|consen 81 QTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRN 159 (873)
T ss_pred eeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhc
Confidence 45777777777777788888888888888888888 78876666667999999999988777788888889999999999
Q ss_pred ccccccccccCCCCChhhhccccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEE
Q 039533 220 NLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTL 299 (949)
Q Consensus 220 ~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L 299 (949)
.|+.++. |++..-.++++|+|++|+|+..+.+ +|.++.+|..|.|++|+++...+..|.+++ .|+.|
T Consensus 160 ~is~i~~------~sfp~~~ni~~L~La~N~It~l~~~------~F~~lnsL~tlkLsrNrittLp~r~Fk~L~-~L~~L 226 (873)
T KOG4194|consen 160 LISEIPK------PSFPAKVNIKKLNLASNRITTLETG------HFDSLNSLLTLKLSRNRITTLPQRSFKRLP-KLESL 226 (873)
T ss_pred hhhcccC------CCCCCCCCceEEeeccccccccccc------cccccchheeeecccCcccccCHHHhhhcc-hhhhh
Confidence 9888764 3444556788889999998876654 456677899999999999988778888886 59999
Q ss_pred EccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeeccccccc
Q 039533 300 FLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLE 379 (949)
Q Consensus 300 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 379 (949)
+|..|+|.-.---.|.++++|+.|.|..|.|+..-...|..+.++++|+|+.|+++..-..++.+|++|+.|+|++|.|.
T Consensus 227 dLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~ 306 (873)
T KOG4194|consen 227 DLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQ 306 (873)
T ss_pred hccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhh
Confidence 99999998444667999999999999999999888889999999999999999999888899999999999999999999
Q ss_pred ccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccCCc--
Q 039533 380 VSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPS-- 457 (949)
Q Consensus 380 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-- 457 (949)
.+.+++...+++|++|+|++|+|+..-+..|..+..| +.|+|++|.++..-...|..+++|+.|||++|.|++.+.+
T Consensus 307 rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~L-e~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa 385 (873)
T KOG4194|consen 307 RIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQL-EELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAA 385 (873)
T ss_pred eeecchhhhcccceeEeccccccccCChhHHHHHHHh-hhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecch
Confidence 9999999999999999999999996667777778887 8899999999987788899999999999999999987764
Q ss_pred -ccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCcCcccccCCccceEeCCCC
Q 039533 458 -TFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLSLNNLNLSYN 520 (949)
Q Consensus 458 -~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~ls~N 520 (949)
.|.+|++|+.|+|.+|+|..+.-.+|.++++|+.|||.+|.|...-|+.|..+.|++|-+..-
T Consensus 386 ~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSs 449 (873)
T KOG4194|consen 386 VAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSS 449 (873)
T ss_pred hhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccchhhhhhhccc
Confidence 578899999999999999987778999999999999999999988899999888888776543
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=359.95 Aligned_cols=390 Identities=21% Similarity=0.240 Sum_probs=312.3
Q ss_pred EEEEcCCCCCCccccCCCCC-C-CCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCC
Q 039533 68 TLLDLRSLKLAGSVSHFIGN-L-SFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQ 145 (949)
Q Consensus 68 ~~l~l~~~~l~g~~~~~l~~-l-~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 145 (949)
..||.++++|...--..+.. | +.-+.|||++|.++..-+..|.++++|+.++|.+|.++ .||...+...+|+.|+|.
T Consensus 55 ~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~ 133 (873)
T KOG4194|consen 55 RLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLR 133 (873)
T ss_pred eeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeee
Confidence 44666666665432222221 2 34567999999999888889999999999999999998 899888888889999999
Q ss_pred CccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCccccccc
Q 039533 146 NNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVE 225 (949)
Q Consensus 146 ~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 225 (949)
+|.|.....+.++.++.|+.||||.|.|+...-.+|..-.++++|+|++|+|+......|.++.+|..|.|+.|+|+.++
T Consensus 134 ~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp 213 (873)
T KOG4194|consen 134 HNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLP 213 (873)
T ss_pred ccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccC
Confidence 99999999999999999999999999999555567888889999999999999888899999999999999999998776
Q ss_pred ccccCCCCChhhhccccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCcc
Q 039533 226 NKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNK 305 (949)
Q Consensus 226 ~~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~ 305 (949)
.. .+++|++|+.|+|..|+|.-.. ...|.++++|+.|.|..|.+...-.+.|..+. .+++|+|+.|+
T Consensus 214 ~r------~Fk~L~~L~~LdLnrN~irive------~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~-kme~l~L~~N~ 280 (873)
T KOG4194|consen 214 QR------SFKRLPKLESLDLNRNRIRIVE------GLTFQGLPSLQNLKLQRNDISKLDDGAFYGLE-KMEHLNLETNR 280 (873)
T ss_pred HH------Hhhhcchhhhhhccccceeeeh------hhhhcCchhhhhhhhhhcCcccccCcceeeec-ccceeecccch
Confidence 43 4677889999999999987532 23577888899999999999988888888884 59999999999
Q ss_pred ccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecccccccccCCCC
Q 039533 306 IYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSS 385 (949)
Q Consensus 306 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 385 (949)
++..-..++.+++.|+.|+||+|.|..+-++++.-.++|++|+|++|+|+...+.+|..|..|++|+|++|+++..-..+
T Consensus 281 l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~a 360 (873)
T KOG4194|consen 281 LQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGA 360 (873)
T ss_pred hhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhH
Confidence 99888888999999999999999999888888888999999999999999888888999999999999999999888888
Q ss_pred CCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccCCcccccccch
Q 039533 386 LGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRL 465 (949)
Q Consensus 386 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 465 (949)
|..+++|++|||++|.|++.|-+. ...|.+|++|+.|+|.+|+|+.+.-..|.+++.|
T Consensus 361 f~~lssL~~LdLr~N~ls~~IEDa----------------------a~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~L 418 (873)
T KOG4194|consen 361 FVGLSSLHKLDLRSNELSWCIEDA----------------------AVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEAL 418 (873)
T ss_pred HHHhhhhhhhcCcCCeEEEEEecc----------------------hhhhccchhhhheeecCceeeecchhhhccCccc
Confidence 999999999999999998655432 1234445555555555555553333455555555
Q ss_pred hhcccCccccccccCCCcCCCCCCCEEEC
Q 039533 466 EQLGMGGNLFQGPISSSLGSLRGLRVLDL 494 (949)
Q Consensus 466 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 494 (949)
++|||.+|.|..+-|.+|..+ .|+.|-+
T Consensus 419 E~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~ 446 (873)
T KOG4194|consen 419 EHLDLGDNAIASIQPNAFEPM-ELKELVM 446 (873)
T ss_pred ceecCCCCcceeecccccccc-hhhhhhh
Confidence 555555555555555555555 5555544
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=339.15 Aligned_cols=263 Identities=22% Similarity=0.306 Sum_probs=206.8
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc-chHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG-ASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
.++|...++||.|..++||+|+....++.||||++....-. ..+.+++|+..++.++||||++++..|.... ..
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~-----~L 99 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS-----EL 99 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecc-----ee
Confidence 46799999999999999999999988999999999855433 3488999999999999999999998877555 89
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
|+||+||.+|++.+.++.. .+..+++..+..|.+++++||.|||.+ |.||||||+.||||+.+|.+||+
T Consensus 100 WvVmpfMa~GS~ldIik~~--------~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLa 168 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTY--------YPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLA 168 (516)
T ss_pred EEeehhhcCCcHHHHHHHH--------ccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEc
Confidence 9999999999999999732 234488999999999999999999977 99999999999999999999999
Q ss_pred ecccceecCCCCC-cccc-ccccCccCccCccccCC--CccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 784 DFGLARILSPDHT-QTSS-FSVKGSLGYIAPEYGVG--CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 784 DfG~a~~~~~~~~-~~~~-~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
|||.+..+..... .... ...+||+.|||||+++. ..|+.|+||||||++..|+.+|..||........-+......
T Consensus 169 dFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~ 248 (516)
T KOG0582|consen 169 DFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQND 248 (516)
T ss_pred CceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC
Confidence 9998876654432 1111 34679999999999543 469999999999999999999999997443322222111110
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
... .. .... ..++.......+.+++..|++.||.+|||++++++
T Consensus 249 pp~-----~~---t~~~---------------~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 249 PPT-----LL---TSGL---------------DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CCC-----cc---cccC---------------ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 000 00 0000 01111233457889999999999999999999875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=317.96 Aligned_cols=274 Identities=22% Similarity=0.293 Sum_probs=206.1
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
.+|...+++|+|.||.||+|++..+|+.||||+++... .+......+|++.|+.++|+||+.++++|...+ ..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~-----~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKS-----NL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCC-----ce
Confidence 46888899999999999999999999999999998543 233467889999999999999999999976544 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
.+|+|||+. +|+..++. ....++..++..++.++.+|++|+|++ .|+||||||.|+|++.+|.+||+
T Consensus 77 ~lVfEfm~t-dLe~vIkd---------~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiA 143 (318)
T KOG0659|consen 77 SLVFEFMPT-DLEVVIKD---------KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIA 143 (318)
T ss_pred EEEEEeccc-cHHHHhcc---------cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEee
Confidence 999999975 89999872 456789999999999999999999977 89999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcc---c
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGR---K 859 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~---~ 859 (949)
|||+|+.+........ ..+-|..|+|||.+.|. .|+..+||||.|||+.||+-|.+-|....+-+. +....+ .
T Consensus 144 DFGLAr~f~~p~~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ-L~~If~~LGT 220 (318)
T KOG0659|consen 144 DFGLARFFGSPNRIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ-LSKIFRALGT 220 (318)
T ss_pred cccchhccCCCCcccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH-HHHHHHHcCC
Confidence 9999999886655333 23679999999998886 589999999999999999999987753322211 111111 1
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
..++.+.++ .-.++..+.- .... .........+.....+++..++..||.+|+|++|+++.
T Consensus 221 P~~~~WP~~---~~lpdY~~~~-~~P~---~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 221 PTPDQWPEM---TSLPDYVKIQ-QFPK---PPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CCcccCccc---cccccHHHHh-cCCC---CccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 111111111 0011111000 0000 00000112344556899999999999999999998764
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=339.72 Aligned_cols=265 Identities=21% Similarity=0.265 Sum_probs=206.0
Q ss_pred HHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--------------cchHHHHHHHHHHHhcCCCccee
Q 039533 622 YNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--------------GASRSFIAECKALKSIRHRNLVK 687 (949)
Q Consensus 622 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~ 687 (949)
....+.|++.+.||+|.||.|-+|++..+++.||||++.+... ...++..+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 3456789999999999999999999999999999999963321 12258899999999999999999
Q ss_pred EEeeeecccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 039533 688 VLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDL 767 (949)
Q Consensus 688 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDl 767 (949)
++++..+.. .+..|+|+|||..|.+.+.-. ....+++.++++|+.+++.||+|||.+ +||||||
T Consensus 173 LiEvLDDP~---s~~~YlVley~s~G~v~w~p~----------d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDI 236 (576)
T KOG0585|consen 173 LIEVLDDPE---SDKLYLVLEYCSKGEVKWCPP----------DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDI 236 (576)
T ss_pred EEEeecCcc---cCceEEEEEeccCCccccCCC----------CcccccHHHHHHHHHHHHHHHHHHHhc---Ceecccc
Confidence 999865443 457999999999887754322 122389999999999999999999988 9999999
Q ss_pred CCCCeeecCCCceEEeecccceecCCCCCc---cccccccCccCccCccccCCCc----cCCccchHHHHHHHHHHHhCC
Q 039533 768 KPSNVLLDDYMTARVGDFGLARILSPDHTQ---TSSFSVKGSLGYIAPEYGVGCE----VSTNGDVYSYGILLLELVIGK 840 (949)
Q Consensus 768 kp~NIll~~~~~~kl~DfG~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~----~~~~sDiwSlGvvl~elltg~ 840 (949)
||+|+|++++|++||+|||.+......... ..-...+||+.|+|||...++. .+.+.||||+||+||.++.|+
T Consensus 237 KPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~ 316 (576)
T KOG0585|consen 237 KPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQ 316 (576)
T ss_pred chhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhcc
Confidence 999999999999999999999876333211 1111356999999999877632 467899999999999999999
Q ss_pred CCCccccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC
Q 039533 841 KPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTN 920 (949)
Q Consensus 841 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 920 (949)
.||-..+.. +. ...++...+ .++...++.+.+.+++.+++++||++|.+
T Consensus 317 ~PF~~~~~~-----~l--------~~KIvn~pL------------------~fP~~pe~~e~~kDli~~lL~KdP~~Ri~ 365 (576)
T KOG0585|consen 317 LPFFDDFEL-----EL--------FDKIVNDPL------------------EFPENPEINEDLKDLIKRLLEKDPEQRIT 365 (576)
T ss_pred CCcccchHH-----HH--------HHHHhcCcc------------------cCCCcccccHHHHHHHHHHhhcChhheee
Confidence 999532111 00 111222111 12222355677899999999999999999
Q ss_pred HHHHHHHHHHhHH
Q 039533 921 MTNVVHELQSIKN 933 (949)
Q Consensus 921 ~~ev~~~L~~i~~ 933 (949)
..+|.....--+.
T Consensus 366 l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 366 LPDIKLHPWVTRD 378 (576)
T ss_pred hhhheecceeccC
Confidence 9999877655444
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=349.64 Aligned_cols=247 Identities=28% Similarity=0.377 Sum_probs=205.4
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+... .+.+.+.+|++++++++||||+.++++|. ...+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfE-----t~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFE-----TSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhc-----ccceE
Confidence 578899999999999999999999999999999975443 34567999999999999999999999854 44589
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++|+||+.| +|..++. ..+.++++.++.|+.|++.||.|||+. +|.|||+||.||+++..|++|++
T Consensus 77 ~vVte~a~g-~L~~il~----------~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~Klc 142 (808)
T KOG0597|consen 77 WVVTEYAVG-DLFTILE----------QDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLC 142 (808)
T ss_pred EEEehhhhh-hHHHHHH----------hccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeec
Confidence 999999987 9999997 467799999999999999999999977 99999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCC
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
|||+|+.++...... ..+.||+.|||||+..+..|+..+|+||+||++||+++|++||-..
T Consensus 143 dFg~Ar~m~~~t~vl--tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~----------------- 203 (808)
T KOG0597|consen 143 DFGLARAMSTNTSVL--TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR----------------- 203 (808)
T ss_pred hhhhhhhcccCceee--eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----------------
Confidence 999999877644322 3577999999999999999999999999999999999999999421
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.+..++...+..+.. + +......+..++...+.+||.+|.|..+++.
T Consensus 204 si~~Lv~~I~~d~v~--------------~--p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 204 SITQLVKSILKDPVK--------------P--PSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred HHHHHHHHHhcCCCC--------------C--cccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 111222111111110 0 0133456788889999999999999998864
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=357.94 Aligned_cols=271 Identities=25% Similarity=0.358 Sum_probs=205.3
Q ss_pred hcCCCCCCeeeeecCceEEEEEEc-----CCCEEEEEEEEecCCC-cchHHHHHHHHHHHhc-CCCcceeEEeeeecccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIID-----EGRTTIAVKVFNLQHH-GASRSFIAECKALKSI-RHRNLVKVLTACLGADY 697 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 697 (949)
.++|++.++||+|+||.||+|.+. .+++.||||+++.... ...+.+.+|+.++.++ +||||++++++|...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-- 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP-- 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC--
Confidence 467999999999999999999852 2456899999874332 2346789999999999 899999999987533
Q ss_pred cCCccceeEeeeccCCChhhhcCCCCCCCc--------------------------------------------------
Q 039533 698 RGNDFKASVYEFMHYGSLEEWLHPFTGEDE-------------------------------------------------- 727 (949)
Q Consensus 698 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------------------------------------------------- 727 (949)
....++||||+++|+|.+++........
T Consensus 84 --~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 84 --NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 2357899999999999999864211000
Q ss_pred --cccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecccceecCCCCCccccccccC
Q 039533 728 --IDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKG 805 (949)
Q Consensus 728 --~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~g 805 (949)
.......+++.++..++.|+++||+|||++ +|+||||||+||++++++.+||+|||+++...............+
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 000123588899999999999999999977 999999999999999999999999999987644333222223346
Q ss_pred ccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhh
Q 039533 806 SLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTG 884 (949)
Q Consensus 806 t~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 884 (949)
+..|+|||++.+..++.++|||||||++|||++ |..||....... .+.. .+.+.....
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~~~~-----------~~~~~~~~~--------- 297 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-EFCQ-----------RLKDGTRMR--------- 297 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-HHHH-----------HHhcCCCCC---------
Confidence 788999999998899999999999999999997 999986432111 0000 000000000
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHH
Q 039533 885 NQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKN 933 (949)
Q Consensus 885 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 933 (949)
....++..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 298 ----------~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 298 ----------APENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred ----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 001234568899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=340.95 Aligned_cols=250 Identities=23% Similarity=0.343 Sum_probs=205.8
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
...|+..+.||+|.||.||+|.+..+++.||+|++..... ....++++|+.++.+++++||.++|+.+.... ..
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~-----~L 86 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT-----KL 86 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecc-----cH
Confidence 3467788999999999999999999999999999986543 34578999999999999999999999977655 89
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
+++|||+.||++.+.++ ....+++....-|++++..|+.|||++ +.+|||||+.||++..+|.+|++
T Consensus 87 wiiMey~~gGsv~~lL~----------~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~ 153 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLK----------SGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLA 153 (467)
T ss_pred HHHHHHhcCcchhhhhc----------cCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEE
Confidence 99999999999999997 233346777778999999999999988 89999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCC
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
|||.+..+....... ..++||+.|||||++.+..|+.|+||||||++.+||.+|.+|+....+..
T Consensus 154 DfgVa~ql~~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr------------- 218 (467)
T KOG0201|consen 154 DFGVAGQLTNTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR------------- 218 (467)
T ss_pred ecceeeeeechhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce-------------
Confidence 999998776554433 36789999999999998899999999999999999999999986443211
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
+.-++-+.-.+..+ ....+.+.+++..|+..||+.||+|.++++
T Consensus 219 -vlflIpk~~PP~L~------------------~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 219 -VLFLIPKSAPPRLD------------------GDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred -EEEeccCCCCCccc------------------cccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 11111111111110 133556889999999999999999999865
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=332.20 Aligned_cols=286 Identities=20% Similarity=0.218 Sum_probs=213.1
Q ss_pred HHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEe--cCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 623 NATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFN--LQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 623 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
.....|...+.||+|+||.|+.|.+..+|+.||||.+. .......++..+|+++++.++|+||+.+.+.+.....+.-
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 34456777899999999999999999999999999987 4555567889999999999999999999999877555566
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
...|+|+|+|+ -+|...++ ....++...+.-+++|+++||+|+|+. +|+|||+||+|++++.+..+
T Consensus 99 ~DvYiV~elMe-tDL~~iik----------~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~l 164 (359)
T KOG0660|consen 99 NDVYLVFELME-TDLHQIIK----------SQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDL 164 (359)
T ss_pred ceeEEehhHHh-hHHHHHHH----------cCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCE
Confidence 77999999995 59999997 344589999999999999999999977 99999999999999999999
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccC-CCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGV-GCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
||+|||+|+...........+..+.|..|+|||++. ...|+.+.||||.|||+.||++|++-|.....- ........
T Consensus 165 KI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v--~Ql~lI~~ 242 (359)
T KOG0660|consen 165 KICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYV--HQLQLILE 242 (359)
T ss_pred EeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchH--HHHHHHHH
Confidence 999999999886542222334567899999999865 457999999999999999999999988633211 11111111
Q ss_pred cC---CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 860 AL---PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 860 ~~---~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
.. +++....+. .......+....+..+...............+++.+|+..||.+|+|++|.++.
T Consensus 243 ~lGtP~~e~l~~i~---s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 243 LLGTPSEEDLQKIR---SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred hcCCCCHHHHHHhc---cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11 111111110 000001111111111111122223445667899999999999999999998763
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=356.21 Aligned_cols=427 Identities=28% Similarity=0.414 Sum_probs=372.3
Q ss_pred cEEEEEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCC
Q 039533 66 RVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQ 145 (949)
Q Consensus 66 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 145 (949)
-.+.+++++|.+. +.|++++.+..++.|+.++|+++ .+|++++.+.+|+.|+.++|.+. ++|+.++.+..|..|+..
T Consensus 69 ~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~ 145 (565)
T KOG0472|consen 69 CLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDAT 145 (565)
T ss_pred ceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhcc
Confidence 3678999999998 89999999999999999999998 89999999999999999999998 899999999999999999
Q ss_pred CccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCccccccc
Q 039533 146 NNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVE 225 (949)
Q Consensus 146 ~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 225 (949)
+|++.. .|+.+.++.+|..|++.+|+++...|..+ +++.|++||...|.++ .+|..++.+.+|..|+|..|+|..+
T Consensus 146 ~N~i~s-lp~~~~~~~~l~~l~~~~n~l~~l~~~~i-~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~l- 221 (565)
T KOG0472|consen 146 NNQISS-LPEDMVNLSKLSKLDLEGNKLKALPENHI-AMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRFL- 221 (565)
T ss_pred cccccc-CchHHHHHHHHHHhhccccchhhCCHHHH-HHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccccC-
Confidence 999984 56677788899999999999995545444 5999999999999998 8999999999999999999998754
Q ss_pred ccccCCCCChhhhccccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCcc
Q 039533 226 NKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNK 305 (949)
Q Consensus 226 ~~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~ 305 (949)
|++..+..|++|+++.|++...+.+ .+.++.++..|||..|+++. .|+.+.-+ ++|++||+++|.
T Consensus 222 -------Pef~gcs~L~Elh~g~N~i~~lpae------~~~~L~~l~vLDLRdNklke-~Pde~clL-rsL~rLDlSNN~ 286 (565)
T KOG0472|consen 222 -------PEFPGCSLLKELHVGENQIEMLPAE------HLKHLNSLLVLDLRDNKLKE-VPDEICLL-RSLERLDLSNND 286 (565)
T ss_pred -------CCCCccHHHHHHHhcccHHHhhHHH------Hhcccccceeeecccccccc-CchHHHHh-hhhhhhcccCCc
Confidence 5677888999999999999765432 45688999999999999994 67777766 679999999999
Q ss_pred ccCCCCCCCCCCCcccEEEeecceeccc--------------------------------------CCCc---ccccCCC
Q 039533 306 IYGSIPAGIGNFVNLQRLDMWNNQLSGT--------------------------------------IPPA---IGELQNL 344 (949)
Q Consensus 306 l~~~~~~~~~~l~~L~~L~L~~N~l~~~--------------------------------------~p~~---~~~l~~L 344 (949)
|+ ..|.+++++ +|+.|.+.+|.+..+ .+.. ...+.+.
T Consensus 287 is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~t 364 (565)
T KOG0472|consen 287 IS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITT 364 (565)
T ss_pred cc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhh
Confidence 99 688999999 999999999987521 0111 1234568
Q ss_pred CEEecCCcccccccCcccccccc---cceeecccccccccCCCCCCCCCCCc-EEEeeCccccCCCCCcccCCcccceee
Q 039533 345 KILGLNRNKLSGNIPPSIGNLKM---LLNLFLNDNFLEVSIPSSLGQCESLI-EINLSNNNLSGTIPPQFFSLSSLSISL 420 (949)
Q Consensus 345 ~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~p~~~~~l~~l~~~L 420 (949)
+.|+++.=+++ .+|+....-.. .+..+++.|++. .+|..+..++.+. .+.+++|.++ .+|..++.++++ ..|
T Consensus 365 kiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kL-t~L 440 (565)
T KOG0472|consen 365 KILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKL-TFL 440 (565)
T ss_pred hhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcc-eee
Confidence 89999999999 77877665555 889999999998 7888888777764 5666666665 999999999999 789
Q ss_pred ccCCCccCCCCccccccccccceeeeccccccccCCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCC
Q 039533 421 DWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLS 500 (949)
Q Consensus 421 ~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 500 (949)
+|++|-+. .+|..++.+..|+.||+|.|++. .+|..+..+..|+.+-.++|++....|+.+.+|.+|..|||.+|.|.
T Consensus 441 ~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq 518 (565)
T KOG0472|consen 441 DLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ 518 (565)
T ss_pred ecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh
Confidence 99999998 89999999999999999999999 89999999999999999999999877777999999999999999998
Q ss_pred CcCcccccCCc-cceEeCCCCcCc
Q 039533 501 GEIPKFLAGLS-LNNLNLSYNDLE 523 (949)
Q Consensus 501 ~~~p~~~~~~~-L~~l~ls~N~l~ 523 (949)
.+|..++.+. |++|++++|++.
T Consensus 519 -~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 519 -QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred -hCChhhccccceeEEEecCCccC
Confidence 6777777776 999999999999
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=350.86 Aligned_cols=256 Identities=24% Similarity=0.315 Sum_probs=205.9
Q ss_pred HHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecC----CC-cchHHHHHHHHHHHhcC-CCcceeEEeeeeccc
Q 039533 623 NATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ----HH-GASRSFIAECKALKSIR-HRNLVKVLTACLGAD 696 (949)
Q Consensus 623 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 696 (949)
...++|.+.+.||+|+||.|+.|.+..+++.||+|++... .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3457899999999999999999999989999999987653 22 23456778999999998 999999999976555
Q ss_pred ccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC
Q 039533 697 YRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD 776 (949)
Q Consensus 697 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~ 776 (949)
..++||||+.+|+|.+++. ...++.+.++..++.|++.|++|+|++ ||+||||||+||+++.
T Consensus 94 -----~~~ivmEy~~gGdL~~~i~----------~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~ 155 (370)
T KOG0583|consen 94 -----KIYIVMEYCSGGDLFDYIV----------NKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDG 155 (370)
T ss_pred -----eEEEEEEecCCccHHHHHH----------HcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecC
Confidence 6999999999999999997 246688899999999999999999977 9999999999999999
Q ss_pred C-CceEEeecccceecC-CCCCccccccccCccCccCccccCCCc-cC-CccchHHHHHHHHHHHhCCCCCccccccCch
Q 039533 777 Y-MTARVGDFGLARILS-PDHTQTSSFSVKGSLGYIAPEYGVGCE-VS-TNGDVYSYGILLLELVIGKKPIDIMFEGDIN 852 (949)
Q Consensus 777 ~-~~~kl~DfG~a~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~ 852 (949)
+ +++||+|||++.... .+... ....||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||+.. +
T Consensus 156 ~~~~~Kl~DFG~s~~~~~~~~~l---~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~-----~ 227 (370)
T KOG0583|consen 156 NEGNLKLSDFGLSAISPGEDGLL---KTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS-----N 227 (370)
T ss_pred CCCCEEEeccccccccCCCCCcc---cCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc-----c
Confidence 9 999999999999873 22222 2456999999999999977 75 8899999999999999999999742 1
Q ss_pred hhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHH-HHHHHHHhhccccCCCCCCCCHHHHHHHHHHh
Q 039533 853 LHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIEC-LISMVRIGVACSMELPQDRTNMTNVVHELQSI 931 (949)
Q Consensus 853 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 931 (949)
.....++..... . .++ ... ...+..++.+|+..||.+|+|+.|++ .-.-+
T Consensus 228 ~~~l~~ki~~~~--------~------------------~~p--~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~ 278 (370)
T KOG0583|consen 228 VPNLYRKIRKGE--------F------------------KIP--SYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWF 278 (370)
T ss_pred HHHHHHHHhcCC--------c------------------cCC--CCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhh
Confidence 111111100000 0 000 011 45678999999999999999999999 55444
Q ss_pred HH
Q 039533 932 KN 933 (949)
Q Consensus 932 ~~ 933 (949)
+.
T Consensus 279 ~~ 280 (370)
T KOG0583|consen 279 QK 280 (370)
T ss_pred cc
Confidence 44
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=347.65 Aligned_cols=245 Identities=25% Similarity=0.368 Sum_probs=203.7
Q ss_pred CCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEeeec
Q 039533 631 ANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFM 710 (949)
Q Consensus 631 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 710 (949)
.+.||.|+.|.||+|+.+ ++.||||+++. .-..+|+.|++++||||+.+.|+|.... .+|||||||
T Consensus 129 LeWlGSGaQGAVF~Grl~--netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqsP-----cyCIiMEfC 194 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH--NETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQSP-----CYCIIMEFC 194 (904)
T ss_pred hhhhccCcccceeeeecc--CceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCCc-----eeEEeeecc
Confidence 478999999999999997 78999998752 2235788999999999999999998766 789999999
Q ss_pred cCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccccee
Q 039533 711 HYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARI 790 (949)
Q Consensus 711 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~ 790 (949)
..|-|++.++ .+..++......|..+||.|+.|||.+ .|||||||+-||||+.+..+||+|||-++.
T Consensus 195 a~GqL~~VLk----------a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e 261 (904)
T KOG4721|consen 195 AQGQLYEVLK----------AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKE 261 (904)
T ss_pred ccccHHHHHh----------ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHh
Confidence 9999999997 456788889999999999999999987 899999999999999999999999999987
Q ss_pred cCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhhhcc
Q 039533 791 LSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVD 870 (949)
Q Consensus 791 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d 870 (949)
..+-.+ ...+.||..|||||++...+.++|+||||||||||||+||..||.+.....+ ++.. ....
T Consensus 262 ~~~~ST---kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-----IwGV-GsNs----- 327 (904)
T KOG4721|consen 262 LSDKST---KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-----IWGV-GSNS----- 327 (904)
T ss_pred hhhhhh---hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee-----EEec-cCCc-----
Confidence 665432 3357799999999999999999999999999999999999999975422211 1000 0000
Q ss_pred cCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhhc
Q 039533 871 SSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILL 936 (949)
Q Consensus 871 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~ 936 (949)
...+.+..|++-+.-+++.||+..|..||++.+++..|+-....+.
T Consensus 328 --------------------L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell 373 (904)
T KOG4721|consen 328 --------------------LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELL 373 (904)
T ss_pred --------------------ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHh
Confidence 1112234778888999999999999999999999999876554443
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=321.24 Aligned_cols=275 Identities=21% Similarity=0.236 Sum_probs=206.6
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc--chHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG--ASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
.+.|+..++|++|.||.||+|+++.+++.||+|+++...+. -.-...+|+.++.+.+|||||.+-.+..+.. -+.
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~---~d~ 151 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN---MDK 151 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc---cce
Confidence 35688889999999999999999999999999999865432 2345689999999999999999999887655 346
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.|+||||++. +|...+.. ...++...++.-++.|+++|++|||.+ .|+||||||+|+|++..|.+||
T Consensus 152 iy~VMe~~Eh-DLksl~d~---------m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKi 218 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMET---------MKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKI 218 (419)
T ss_pred eeeeHHHHHh-hHHHHHHh---------ccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEe
Confidence 8999999987 89998873 335789999999999999999999977 8999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcc---
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGR--- 858 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~--- 858 (949)
+|||+|+.++.+... .+..+-|..|+|||.+.+. .|+++.|+||+|||+.|++++++-|....+-+..-.-+..
T Consensus 219 aDFGLAR~ygsp~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGt 296 (419)
T KOG0663|consen 219 ADFGLAREYGSPLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGT 296 (419)
T ss_pred cccchhhhhcCCccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCC
Confidence 999999998876432 2255679999999998876 4899999999999999999999998755433221111111
Q ss_pred ---ccCCCc-hhhhcc-cCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 859 ---KALPDD-VMDIVD-SSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 859 ---~~~~~~-~~~~~d-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
..++.- ....+. -.....+.. .-...|.... ..+.-.+++...+..||++|.||.|.++
T Consensus 297 Pte~iwpg~~~lp~~k~~~f~~~pyn--------~lr~kF~~~~-lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 297 PSEAIWPGYSELPAVKKMTFSEHPYN--------NLRKKFGALS-LSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred CccccCCCccccchhhccccCCCCch--------hhhhhccccc-cchhHHHHHHHHhccCccccccHHHhhc
Confidence 111110 000000 011111110 0011111111 2355678899999999999999998764
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.84 Aligned_cols=249 Identities=20% Similarity=0.267 Sum_probs=200.0
Q ss_pred HHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeeccccc
Q 039533 622 YNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYR 698 (949)
Q Consensus 622 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 698 (949)
....++|...++||+|+||.||+|+-+.+|..+|+|++++.. .+..+.++.|-.+|...++|.||++|..|.+.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~-- 214 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE-- 214 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC--
Confidence 345688999999999999999999999999999999998653 344567889999999999999999998866555
Q ss_pred CCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC
Q 039533 699 GNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM 778 (949)
Q Consensus 699 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~ 778 (949)
..|+||||++||++..+|. ....+++..++.++.+++-|++.+|.. |+|||||||+|+|||..|
T Consensus 215 ---~LYLiMEylPGGD~mTLL~----------~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~G 278 (550)
T KOG0605|consen 215 ---YLYLIMEYLPGGDMMTLLM----------RKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKG 278 (550)
T ss_pred ---eeEEEEEecCCccHHHHHH----------hcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCC
Confidence 8999999999999999997 346799999999999999999999966 999999999999999999
Q ss_pred ceEEeecccceecCC----------------------CCCc-----cc------------------cccccCccCccCcc
Q 039533 779 TARVGDFGLARILSP----------------------DHTQ-----TS------------------SFSVKGSLGYIAPE 813 (949)
Q Consensus 779 ~~kl~DfG~a~~~~~----------------------~~~~-----~~------------------~~~~~gt~~y~aPE 813 (949)
++||+|||++.-+.. .... .. ....+|||.|+|||
T Consensus 279 HiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPE 358 (550)
T KOG0605|consen 279 HIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPE 358 (550)
T ss_pred CEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchH
Confidence 999999999854311 0000 00 12457999999999
Q ss_pred ccCCCccCCccchHHHHHHHHHHHhCCCCCccccccC--chhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhh
Q 039533 814 YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD--INLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQA 891 (949)
Q Consensus 814 ~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~ 891 (949)
++.+..|+..+|+||+|||+||||.|.+||....... ..+..|... +.
T Consensus 359 Vll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~-------------l~----------------- 408 (550)
T KOG0605|consen 359 VLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET-------------LK----------------- 408 (550)
T ss_pred HHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh-------------cc-----------------
Confidence 9999999999999999999999999999996432221 112222110 10
Q ss_pred hhhhHHHHHHHHHHHhhccccCCCCCCCC
Q 039533 892 RINSIIECLISMVRIGVACSMELPQDRTN 920 (949)
Q Consensus 892 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 920 (949)
++.-..+..+..++|.+|+. ||++|-.
T Consensus 409 -fP~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 409 -FPEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred -CCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 11111233567889999999 9999986
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=316.34 Aligned_cols=199 Identities=28% Similarity=0.329 Sum_probs=178.4
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc---chHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG---ASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
.++|+..+.||.|+||.|.+++.+.+|..+|+|+++....- ..+...+|..+|+.+.||+++++++.|.+..
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~----- 117 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS----- 117 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCC-----
Confidence 35688899999999999999999999999999999755432 2355778999999999999999999876655
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||++||.|..+++ ..+++++..++-+|.||+.|++|||+. +|++||+||+|||+|.+|.+|
T Consensus 118 ~lymvmeyv~GGElFS~Lr----------k~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iK 184 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLR----------KSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIK 184 (355)
T ss_pred eEEEEEeccCCccHHHHHH----------hcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEE
Confidence 8999999999999999997 456799999999999999999999977 899999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccc
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIM 846 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~ 846 (949)
|+|||+|+..... +. ...||+.|+|||++....+..++|.|||||++|||+.|.+||...
T Consensus 185 itDFGFAK~v~~r-T~----TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~ 244 (355)
T KOG0616|consen 185 ITDFGFAKRVSGR-TW----TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD 244 (355)
T ss_pred EEeccceEEecCc-EE----EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC
Confidence 9999999987654 22 456999999999999999999999999999999999999999643
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=360.00 Aligned_cols=256 Identities=23% Similarity=0.434 Sum_probs=212.2
Q ss_pred CCCCCeeeeecCceEEEEEEcCCC---EEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 628 FSSANLVGVGSFGSVYKGIIDEGR---TTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 628 y~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
..+.++||.|.||.||+|+.+..+ ..||||.++.... ....+|..|+.||.+++||||+++.|+..... ..
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~-----Pv 705 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK-----PV 705 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc-----ee
Confidence 456789999999999999997555 4699999986543 34468999999999999999999999975444 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
+||+|||++|+|+.||+. ..+++++.+...+.++||.|++||-+. ++|||||..+|||++.+..+|++
T Consensus 706 MIiTEyMENGsLDsFLR~---------~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVs 773 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQ---------NDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVS 773 (996)
T ss_pred EEEhhhhhCCcHHHHHhh---------cCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEec
Confidence 999999999999999973 335589999999999999999999965 99999999999999999999999
Q ss_pred ecccceecCCCCCcc-ccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccC
Q 039533 784 DFGLARILSPDHTQT-SSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 784 DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
|||+++.+.++.... ....-.-..+|.|||.+...+++.+|||||||++|||.++ |.+||-++...+
T Consensus 774 DFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd----------- 842 (996)
T KOG0196|consen 774 DFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD----------- 842 (996)
T ss_pred cccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH-----------
Confidence 999999886665321 1111223578999999999999999999999999999887 999985443221
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIK 932 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 932 (949)
+...+ ....|.+.+.+||..+.+|+..||++|..+||.+.|++..|+++.
T Consensus 843 ---VIkaI------------------e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 843 ---VIKAI------------------EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred ---HHHHH------------------HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 11111 123344555689999999999999999999999999999999974
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=373.14 Aligned_cols=269 Identities=25% Similarity=0.422 Sum_probs=217.2
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCC-----EEEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGR-----TTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
.-+..+.||+|.||.||+|....-. ..||||.++... .+...+|.+|..+|++++|||||+++|.|....
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~---- 768 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG---- 768 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC----
Confidence 3455678999999999999986322 348999887543 455678999999999999999999999998755
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
..++++|||++|+|..|++..+.. ......++..+.+.++.|||+|+.||+++ ++|||||..+|+|+++...+
T Consensus 769 -~~~i~leyM~gGDL~sflr~~r~~---~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~V 841 (1025)
T KOG1095|consen 769 -PPLILLEYMEGGDLLSFLRESRPA---PFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVV 841 (1025)
T ss_pred -CcEEEehhcccCcHHHHHHhcccc---cCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcE
Confidence 789999999999999999854332 23467799999999999999999999987 89999999999999999999
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccc
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~ 859 (949)
||+|||+|+.+.............-...|||||.+..+.++.|+|||||||++||++| |..||......+.-
T Consensus 842 KIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~------- 914 (1025)
T KOG1095|consen 842 KIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL------- 914 (1025)
T ss_pred EEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH-------
Confidence 9999999995544433332222123468999999999999999999999999999999 99998643222110
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhhccC
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILLGV 938 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~~ 938 (949)
..+. .+.|.+.+..|+..+.+++..||+.+|++||++..+++++.+|.....+.
T Consensus 915 ------~~~~-------------------~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~ 968 (1025)
T KOG1095|consen 915 ------LDVL-------------------EGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT 968 (1025)
T ss_pred ------HHHH-------------------hCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence 0011 11133445688999999999999999999999999999999998877665
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=346.24 Aligned_cols=249 Identities=22% Similarity=0.263 Sum_probs=207.2
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
.+-|..++.||.|+.|.|-.|++..+|+.+|||++.... ......+.+|+.+|+.+.||||+++|+++.+ ..
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~-----~~ 85 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN-----KQ 85 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc-----Cc
Confidence 456889999999999999999999999999999997552 2234578899999999999999999999654 44
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
+.|+|.||+++|-|.+++- ..+.+++.++.+++.||+.|+.|+|+. +|+|||+||+|+|+|..+++|
T Consensus 86 ~lylvlEyv~gGELFdylv----------~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIK 152 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLV----------RKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIK 152 (786)
T ss_pred eEEEEEEecCCchhHHHHH----------hhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEe
Confidence 8999999999999999996 456799999999999999999999977 899999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCccC-CccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVS-TNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
|+|||+|..-.++.-.. ...|++.|.|||++.|.+|. .++||||+|||+|.|+||+.||++. ++....
T Consensus 153 IADFGMAsLe~~gklLe---TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-----Nir~LL--- 221 (786)
T KOG0588|consen 153 IADFGMASLEVPGKLLE---TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-----NIRVLL--- 221 (786)
T ss_pred eeccceeecccCCcccc---ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-----cHHHHH---
Confidence 99999998755544322 24599999999999999885 8999999999999999999999722 222111
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
.+.. ...++.+..++.+..+++.+|+..||++|.|++||.+.
T Consensus 222 ---------lKV~----------------~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 222 ---------LKVQ----------------RGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ---------HHHH----------------cCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 1111 11122234566778999999999999999999999874
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=337.12 Aligned_cols=252 Identities=21% Similarity=0.310 Sum_probs=199.0
Q ss_pred CCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcc---hHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEe
Q 039533 631 ANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGA---SRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVY 707 (949)
Q Consensus 631 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 707 (949)
...||+|++|.||+|... ++.||||+++...... .+.+.+|+.++++++||||+++++++.+.. ++....++||
T Consensus 25 ~~~i~~g~~~~v~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~ 101 (283)
T PHA02988 25 SVLIKENDQNSIYKGIFN--NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLIL 101 (283)
T ss_pred CeEEeeCCceEEEEEEEC--CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEE
Confidence 368999999999999984 8999999997543332 467889999999999999999999986521 2234678999
Q ss_pred eeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccc
Q 039533 708 EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGL 787 (949)
Q Consensus 708 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~ 787 (949)
||+++|+|.+++.. ...+++..+..++.|++.|++|||+.. +++||||||+||++++++.+||+|||+
T Consensus 102 Ey~~~g~L~~~l~~----------~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~ 169 (283)
T PHA02988 102 EYCTRGYLREVLDK----------EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGL 169 (283)
T ss_pred EeCCCCcHHHHHhh----------CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccch
Confidence 99999999999972 345889999999999999999999642 688999999999999999999999999
Q ss_pred ceecCCCCCccccccccCccCccCccccCC--CccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCch
Q 039533 788 ARILSPDHTQTSSFSVKGSLGYIAPEYGVG--CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDV 865 (949)
Q Consensus 788 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 865 (949)
++....... ...|+..|+|||++.+ ..++.++|||||||++|||++|+.||+.....+ ...
T Consensus 170 ~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~--~~~---------- 232 (283)
T PHA02988 170 EKILSSPPF-----KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE--IYD---------- 232 (283)
T ss_pred Hhhhccccc-----cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH--HHH----------
Confidence 986543321 2358899999999876 678999999999999999999999996432111 000
Q ss_pred hhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHH
Q 039533 866 MDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKN 933 (949)
Q Consensus 866 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 933 (949)
.+....... .....++..+.+++.+||+.||++|||++|+++.|+.++.
T Consensus 233 -~i~~~~~~~------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 233 -LIINKNNSL------------------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred -HHHhcCCCC------------------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 000000000 0001345578899999999999999999999999998753
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=359.53 Aligned_cols=265 Identities=20% Similarity=0.247 Sum_probs=212.5
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcC-CCcceeEEee-eecccccC-Ccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIR-HRNLVKVLTA-CLGADYRG-NDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~-~~~~~~~~-~~~ 702 (949)
.++++.+.|.+|||+.||.|++...+..||+|++-..++...+.+.+|+++|++++ |+|||.+++. .....-.+ ..+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 45677899999999999999999777999999998777777889999999999996 9999999993 32221122 356
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
+++.||||++|.|-+++... -...+++.++++|+.|+++|+++||.. +++|||||||-+||||+.+++.||
T Consensus 117 vllLmEyC~gg~Lvd~mn~R--------lq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KL 187 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTR--------LQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKL 187 (738)
T ss_pred EEeehhhccCCcHHHHHHHH--------HhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEe
Confidence 88999999999999999621 223499999999999999999999988 899999999999999999999999
Q ss_pred eecccceecCCCCCccc-------cccccCccCccCcccc---CCCccCCccchHHHHHHHHHHHhCCCCCccccccCch
Q 039533 783 GDFGLARILSPDHTQTS-------SFSVKGSLGYIAPEYG---VGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDIN 852 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~ 852 (949)
||||.|.......+... ......|+.|+|||++ .+..+++|+|||+|||+||-|+....||+....-.
T Consensus 188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la-- 265 (738)
T KOG1989|consen 188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA-- 265 (738)
T ss_pred CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee--
Confidence 99999975433331110 1123479999999974 46789999999999999999999999997431111
Q ss_pred hhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhH
Q 039533 853 LHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIK 932 (949)
Q Consensus 853 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 932 (949)
+++... .++....+...+.+||+.||+.||++||++.||++.+.++.
T Consensus 266 ---------------Ilng~Y------------------~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 266 ---------------ILNGNY------------------SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred ---------------EEeccc------------------cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence 111111 11111255678999999999999999999999999999987
Q ss_pred Hh
Q 039533 933 NI 934 (949)
Q Consensus 933 ~~ 934 (949)
..
T Consensus 313 ~~ 314 (738)
T KOG1989|consen 313 NK 314 (738)
T ss_pred cC
Confidence 65
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=327.56 Aligned_cols=286 Identities=21% Similarity=0.259 Sum_probs=203.8
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeE
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASV 706 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 706 (949)
.|...+++|.|+||.||+|....+++.||||++-.... --.+|+++|++++|||||++.-+|......++-...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 35667899999999999999998899999999854432 22479999999999999999988876543333456789
Q ss_pred eeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCC-CceEEeec
Q 039533 707 YEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDY-MTARVGDF 785 (949)
Q Consensus 707 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~-~~~kl~Df 785 (949)
||||+. +|+++++.+. ..+..++...+.-++.|+.+||+|||+. +|+||||||.|+|+|.+ |.+|||||
T Consensus 101 leymP~-tL~~~~r~~~------~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDF 170 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYT------RANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDF 170 (364)
T ss_pred HHhchH-HHHHHHHHHh------hcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccC
Confidence 999975 9999987432 2345678888899999999999999976 99999999999999965 99999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCc
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
|.|+....+.... ....|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|...... ..++... +.+...
T Consensus 171 GSAK~L~~~epni---SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~-dQL~eIi-k~lG~P 245 (364)
T KOG0658|consen 171 GSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV-DQLVEII-KVLGTP 245 (364)
T ss_pred CcceeeccCCCce---eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH-HHHHHHH-HHhCCC
Confidence 9999987776643 34589999999998876 5999999999999999999999998643211 1111111 111111
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH--HHHHhHH
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH--ELQSIKN 933 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~--~L~~i~~ 933 (949)
..+-+..+.... .+.........+..+ -.....+.+..+++.+++..+|.+|.++.|++. ..+++++
T Consensus 246 t~e~I~~mn~~y-~~~~~p~ik~~~~~~-~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 246 TREDIKSMNPNY-TEFKFPQIKAHPWHK-VFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred CHHHHhhcCccc-ccccCccccccccee-ecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 001110000000 000000000000000 011244567889999999999999999999874 3444443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=329.70 Aligned_cols=281 Identities=25% Similarity=0.314 Sum_probs=209.7
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHh--cCCCcceeEEeeeecccccCCccce
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKS--IRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.....+++|+|+||.||+|... ++.||||++.... .+.|++|-++.+. ++|+||++++++-...+-. ...++
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~eyw 284 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RMEYW 284 (534)
T ss_pred chhhHHHhhcCccceeehhhcc--CceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCcc-cccee
Confidence 3455688999999999999997 6999999996443 4567888777766 4899999999885443322 45789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhC------CCCCeEecCCCCCCeeecCCC
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHD------CQPVTAHCDLKPSNVLLDDYM 778 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~------~~~~ivHrDlkp~NIll~~~~ 778 (949)
+|++|.+.|+|.+|++ ...++|....+|+..+++||+|||+. ++++|+|||||++||||..|+
T Consensus 285 LVt~fh~kGsL~dyL~-----------~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl 353 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLK-----------ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL 353 (534)
T ss_pred EEeeeccCCcHHHHHH-----------hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC
Confidence 9999999999999997 35699999999999999999999975 378999999999999999999
Q ss_pred ceEEeecccceecCCCCCccccccccCccCccCccccCCCc------cCCccchHHHHHHHHHHHhCCCCCcc--ccccC
Q 039533 779 TARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCE------VSTNGDVYSYGILLLELVIGKKPIDI--MFEGD 850 (949)
Q Consensus 779 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDiwSlGvvl~elltg~~Pf~~--~~~~~ 850 (949)
++.|+|||+|..+.+..........+||.+|||||++.+.. .-.+.||||+|.|+|||++.-.-++. ..+..
T Consensus 354 TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yq 433 (534)
T KOG3653|consen 354 TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQ 433 (534)
T ss_pred cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCccc
Confidence 99999999999998887766666678999999999988742 12468999999999999986544321 10111
Q ss_pred chhhhhccccC-CCchhh-hcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 039533 851 INLHNFGRKAL-PDDVMD-IVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHEL 928 (949)
Q Consensus 851 ~~~~~~~~~~~-~~~~~~-~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 928 (949)
.-+...+...- -+++.+ ++.+..++...+. |.. ...+..+.+.+..||+.||+.|-|+.=|.+++
T Consensus 434 lpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~------------W~~-h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~ 500 (534)
T KOG3653|consen 434 LPFEAEVGNHPTLEEMQELVVRKKQRPKIPDA------------WRK-HAGMAVLCETIEECWDHDAEARLTAGCVEERM 500 (534)
T ss_pred CchhHHhcCCCCHHHHHHHHHhhccCCCChhh------------hhc-CccHHHHHHHHHHHcCCchhhhhhhHHHHHHH
Confidence 11111111110 111111 1222222222111 111 13456788999999999999999999999999
Q ss_pred HHhHHhhcc
Q 039533 929 QSIKNILLG 937 (949)
Q Consensus 929 ~~i~~~~~~ 937 (949)
.++....+.
T Consensus 501 ~~l~~~~~~ 509 (534)
T KOG3653|consen 501 AELMMLWED 509 (534)
T ss_pred HHHhccCCc
Confidence 998777653
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=339.40 Aligned_cols=272 Identities=20% Similarity=0.326 Sum_probs=201.9
Q ss_pred cCCCCCCeeeeecCceEEEEEEcC----------------CCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeE
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDE----------------GRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKV 688 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~ 688 (949)
++|.+.++||+|+||.||+|.+.. ++..||+|+++.... ....++.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578899999999999999998642 345799999875432 234578999999999999999999
Q ss_pred EeeeecccccCCccceeEeeeccCCChhhhcCCCCCCCcc---------ccCCCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 039533 689 LTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEI---------DEAPRNLNLLQRLNIAIDIAYALNYLHHDCQ 759 (949)
Q Consensus 689 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~---------~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~ 759 (949)
++++...+ ..++||||+++|+|.+++......... ......+++.++..++.|++.||+|||+.
T Consensus 85 ~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-- 157 (304)
T cd05096 85 LGVCVDED-----PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL-- 157 (304)
T ss_pred EEEEecCC-----ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC--
Confidence 99986544 689999999999999998642211110 11234578899999999999999999977
Q ss_pred CCeEecCCCCCCeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-
Q 039533 760 PVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI- 838 (949)
Q Consensus 760 ~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt- 838 (949)
+|+||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++
T Consensus 158 -~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~ 236 (304)
T cd05096 158 -NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILML 236 (304)
T ss_pred -CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHc
Confidence 899999999999999999999999999987654433222223346789999999988889999999999999999987
Q ss_pred -CCCCCccccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCC
Q 039533 839 -GKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQD 917 (949)
Q Consensus 839 -g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~ 917 (949)
+..||...... .................. ......++..+.+++.+||+.||++
T Consensus 237 ~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~li~~cl~~~p~~ 291 (304)
T cd05096 237 CKEQPYGELTDE--QVIENAGEFFRDQGRQVY-----------------------LFRPPPCPQGLYELMLQCWSRDCRE 291 (304)
T ss_pred cCCCCCCcCCHH--HHHHHHHHHhhhcccccc-----------------------ccCCCCCCHHHHHHHHHHccCCchh
Confidence 55677533211 111000000000000000 0000133567899999999999999
Q ss_pred CCCHHHHHHHHHH
Q 039533 918 RTNMTNVVHELQS 930 (949)
Q Consensus 918 RPs~~ev~~~L~~ 930 (949)
|||+.||.+.|++
T Consensus 292 RPs~~~i~~~l~~ 304 (304)
T cd05096 292 RPSFSDIHAFLTE 304 (304)
T ss_pred CcCHHHHHHHHhC
Confidence 9999999988763
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=349.20 Aligned_cols=285 Identities=20% Similarity=0.230 Sum_probs=201.1
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
+|++.+.||+|+||.||+|++..+++.||||+++... .....++.+|++++++++||||+++++++...........+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999999899999999986432 22345688999999999999999999988655444444689
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+. ++|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 81 lv~e~~~-~~L~~~l~----------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~D 146 (338)
T cd07859 81 VVFELME-SDLHQVIK----------ANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICD 146 (338)
T ss_pred EEEecCC-CCHHHHHH----------hcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEcc
Confidence 9999995 68998886 234588999999999999999999977 899999999999999999999999
Q ss_pred cccceecCCCCC-ccccccccCccCccCccccCC--CccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 785 FGLARILSPDHT-QTSSFSVKGSLGYIAPEYGVG--CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 785 fG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
||+++....... ........||..|+|||++.+ ..++.++|||||||++|||++|+.||...... ..........
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~--~~~~~~~~~~ 224 (338)
T cd07859 147 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV--HQLDLITDLL 224 (338)
T ss_pred CccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHHh
Confidence 999986533222 111123468999999999865 57899999999999999999999999643211 0000000000
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
.....+.....................+..........+..+.+++.+|++.||++|||++|+++.
T Consensus 225 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 225 GTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred CCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000000000000000000000000000000011234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=349.77 Aligned_cols=268 Identities=25% Similarity=0.376 Sum_probs=203.5
Q ss_pred cCCCCCCeeeeecCceEEEEEEcC-----CCEEEEEEEEecCCC-cchHHHHHHHHHHHhc-CCCcceeEEeeeeccccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDE-----GRTTIAVKVFNLQHH-GASRSFIAECKALKSI-RHRNLVKVLTACLGADYR 698 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 698 (949)
++|++.+.||+|+||.||+|++.. ++..||+|+++.... .....+.+|+++++++ +|+||++++++|...+
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~-- 115 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG-- 115 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC--
Confidence 478999999999999999998643 335799999975432 2345688999999999 8999999999976554
Q ss_pred CCccceeEeeeccCCChhhhcCCCCCC-----------------------------------------------------
Q 039533 699 GNDFKASVYEFMHYGSLEEWLHPFTGE----------------------------------------------------- 725 (949)
Q Consensus 699 ~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------------- 725 (949)
..++||||+++|+|.+++......
T Consensus 116 ---~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 116 ---PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred ---CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 789999999999999998532110
Q ss_pred -------CccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecccceecCCCCCcc
Q 039533 726 -------DEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQT 798 (949)
Q Consensus 726 -------~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 798 (949)
.........+++.++++|+.|++.||+|||++ +|+||||||+||++++++.+||+|||+++.........
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~ 269 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV 269 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence 00001123588999999999999999999977 99999999999999999999999999998764433222
Q ss_pred ccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCCchhhhcccCCCCCc
Q 039533 799 SSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDD 877 (949)
Q Consensus 799 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 877 (949)
......++..|+|||++.+..++.++|||||||++|||++ |+.||....... .. ...+........
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~------------~~~~~~~~~~~~ 336 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KF------------YKMVKRGYQMSR 336 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HH------------HHHHHcccCccC
Confidence 2222335678999999988899999999999999999997 999996432111 00 111110000000
Q ss_pred hhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhH
Q 039533 878 EDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIK 932 (949)
Q Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 932 (949)
....+..+.+++.+||+.||++|||+.||++.|+++.
T Consensus 337 ------------------~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 337 ------------------PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 0012456789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=321.59 Aligned_cols=271 Identities=24% Similarity=0.370 Sum_probs=204.7
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhc--CCCcceeEEeeeecccccCCccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSI--RHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
...+..+.||+|.||.||+|.++ |+.||||++...+ ++.+.+|.++.+.+ +|+||+.+++.-.... ......
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-gs~TQL 284 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDN-GSWTQL 284 (513)
T ss_pred heeEEEEEecCccccceeecccc--CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCC-CceEEE
Confidence 34566689999999999999998 7899999996443 45677888877765 9999999987743222 233457
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhC-----CCCCeEecCCCCCCeeecCCC
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHD-----CQPVTAHCDLKPSNVLLDDYM 778 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~-----~~~~ivHrDlkp~NIll~~~~ 778 (949)
++|++|.+.|||+|||. ...++....++++..+|.||+|||.. .+|.|+|||||+.||||..++
T Consensus 285 wLvTdYHe~GSL~DyL~-----------r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~ 353 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLN-----------RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 353 (513)
T ss_pred EEeeecccCCcHHHHHh-----------hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence 99999999999999997 25589999999999999999999964 489999999999999999999
Q ss_pred ceEEeecccceecCCCCC--ccccccccCccCccCccccCCC------ccCCccchHHHHHHHHHHHhC----------C
Q 039533 779 TARVGDFGLARILSPDHT--QTSSFSVKGSLGYIAPEYGVGC------EVSTNGDVYSYGILLLELVIG----------K 840 (949)
Q Consensus 779 ~~kl~DfG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDiwSlGvvl~elltg----------~ 840 (949)
.+.|+|+|+|........ .......+||.+|||||++... ..-..+||||||.|+||+... +
T Consensus 354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~ 433 (513)
T KOG2052|consen 354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ 433 (513)
T ss_pred cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence 999999999987765532 1222356799999999997653 223569999999999999763 3
Q ss_pred CCCccccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC
Q 039533 841 KPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTN 920 (949)
Q Consensus 841 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 920 (949)
.||.+..+.+..+.+...- +..+.+.+... .+|. ..++...+.++++.||..+|.-|-|
T Consensus 434 ~Pyyd~Vp~DPs~eeMrkV--------VCv~~~RP~ip------------nrW~-s~~~l~~m~klMkeCW~~Np~aRlt 492 (513)
T KOG2052|consen 434 LPYYDVVPSDPSFEEMRKV--------VCVQKLRPNIP------------NRWK-SDPALRVMAKLMKECWYANPAARLT 492 (513)
T ss_pred CCcccCCCCCCCHHHHhcc--------eeecccCCCCC------------cccc-cCHHHHHHHHHHHHhhcCCchhhhH
Confidence 5665444443333222111 11112222211 1111 1356778999999999999999999
Q ss_pred HHHHHHHHHHhHHh
Q 039533 921 MTNVVHELQSIKNI 934 (949)
Q Consensus 921 ~~ev~~~L~~i~~~ 934 (949)
+--+.+.|.++.+.
T Consensus 493 ALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 493 ALRIKKTLAKLSNS 506 (513)
T ss_pred HHHHHHHHHHHhcC
Confidence 99999999998754
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=347.55 Aligned_cols=266 Identities=24% Similarity=0.355 Sum_probs=202.7
Q ss_pred cCCCCCCeeeeecCceEEEEEE-----cCCCEEEEEEEEecCC-CcchHHHHHHHHHHHhc-CCCcceeEEeeeeccccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGII-----DEGRTTIAVKVFNLQH-HGASRSFIAECKALKSI-RHRNLVKVLTACLGADYR 698 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 698 (949)
++|++.+.||+|+||.||+|++ ..++..||||+++... ....+.+.+|+++++.+ +||||++++++|...+
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~-- 112 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG-- 112 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC--
Confidence 4689999999999999999975 3356789999987443 23345788999999999 8999999999976554
Q ss_pred CCccceeEeeeccCCChhhhcCCCCCCCc---------------------------------------------------
Q 039533 699 GNDFKASVYEFMHYGSLEEWLHPFTGEDE--------------------------------------------------- 727 (949)
Q Consensus 699 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------------------------------------------------- 727 (949)
..++||||+++|+|.+++........
T Consensus 113 ---~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 113 ---PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred ---cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 78999999999999999864221000
Q ss_pred --------------cccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecccceecCC
Q 039533 728 --------------IDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSP 793 (949)
Q Consensus 728 --------------~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~ 793 (949)
.......+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 001123578999999999999999999977 999999999999999999999999999987654
Q ss_pred CCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCCchhhhcccC
Q 039533 794 DHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSS 872 (949)
Q Consensus 794 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 872 (949)
...........++..|+|||++.+..++.++|||||||++|||++ |..||....... .. .+.+...
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~------------~~~~~~~ 333 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KF------------YKMIKEG 333 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HH------------HHHHHhC
Confidence 332222222335678999999999999999999999999999998 888986432111 11 1111110
Q ss_pred CCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 039533 873 LLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQS 930 (949)
Q Consensus 873 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 930 (949)
..... ....+.++.+++.+|++.||++|||++||++.|++
T Consensus 334 ~~~~~------------------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 334 YRMLS------------------PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ccCCC------------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 00000 00123468899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=341.07 Aligned_cols=200 Identities=26% Similarity=0.354 Sum_probs=174.5
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
.++|++.+.||+|+||.||+|++..++..||+|+++.... ...+++.+|++++++++||||+++++++...+ ..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-----EI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC-----EE
Confidence 3689999999999999999999998999999999875432 23467899999999999999999999976544 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.. +|+||||||+||+++.++.+||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~ 146 (331)
T cd06649 79 SICMEHMDGGSLDQVLKE----------AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLC 146 (331)
T ss_pred EEEeecCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEc
Confidence 999999999999999862 345888999999999999999999753 69999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCcc
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDI 845 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~ 845 (949)
|||++........ ....|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 147 Dfg~~~~~~~~~~----~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 147 DFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred cCccccccccccc----ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 9999976543221 134589999999999998999999999999999999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=334.94 Aligned_cols=252 Identities=22% Similarity=0.268 Sum_probs=197.7
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC---cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH---GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
.|+..+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.++++++|++|+++++++...+ ..
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~-----~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKD-----AL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC-----eE
Confidence 37778999999999999999988999999999864322 22346788999999999999999998875444 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++||||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+
T Consensus 76 ~lv~e~~~~g~L~~~~~~~--------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~ 144 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNM--------GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRIS 144 (285)
T ss_pred EEEEEecCCCcHHHHHHhh--------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEe
Confidence 9999999999999887521 123588999999999999999999977 99999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCC
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
|||++......... ....||..|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 145 Dfg~~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~------------ 209 (285)
T cd05631 145 DLGLAVQIPEGETV---RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK------------ 209 (285)
T ss_pred eCCCcEEcCCCCee---cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh------------
Confidence 99999876433222 134589999999999999999999999999999999999999964321100
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC-----HHHHHH
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTN-----MTNVVH 926 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~~ 926 (949)
.+.++....... .......+..+.+++.+|++.||++||+ ++|+++
T Consensus 210 --~~~~~~~~~~~~---------------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 210 --REEVDRRVKEDQ---------------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred --HHHHHHHhhccc---------------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 000000000000 0000123456789999999999999997 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=334.82 Aligned_cols=280 Identities=21% Similarity=0.240 Sum_probs=201.4
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|++++++++||||+++++++...+ ..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRG-----KL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCC-----EE
Confidence 47899999999999999999999889999999997543 223467889999999999999999998875443 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++||||++++.+..+.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 76 ~lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~ 142 (287)
T cd07848 76 YLVFEYVEKNMLELLEE----------MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLC 142 (287)
T ss_pred EEEEecCCCCHHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEe
Confidence 99999999887765543 234588999999999999999999977 99999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchh-hhhccccCC
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINL-HNFGRKALP 862 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~-~~~~~~~~~ 862 (949)
|||.++......... .....|+..|+|||++.+..++.++|||||||++|||++|+.||......+... ........+
T Consensus 143 Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 221 (287)
T cd07848 143 DFGFARNLSEGSNAN-YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLP 221 (287)
T ss_pred eccCccccccccccc-ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCC
Confidence 999998764332211 123458999999999998889999999999999999999999997432211100 000001111
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.......... +........................+..+.+++.+|++.||++|||++|+++
T Consensus 222 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 222 AEQMKLFYSN--PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred HHHHHhhhcc--chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1100000000 0000000000000000000001124567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=342.15 Aligned_cols=261 Identities=25% Similarity=0.386 Sum_probs=205.7
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCC----EEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeeccccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGR----TTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYR 698 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 698 (949)
++-...++||+|+||.||+|+....+ ..||||..+... .....++.+|++++++++|||||++||++....
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~-- 234 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE-- 234 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC--
Confidence 34455689999999999999997532 238999987522 445678999999999999999999999987665
Q ss_pred CCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC
Q 039533 699 GNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM 778 (949)
Q Consensus 699 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~ 778 (949)
..++|||+|.||+|.+||+.. ...++..++..++.++|.||+|||++ +++||||-.+|+|++.++
T Consensus 235 ---Pl~ivmEl~~gGsL~~~L~k~---------~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~ 299 (474)
T KOG0194|consen 235 ---PLMLVMELCNGGSLDDYLKKN---------KKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKG 299 (474)
T ss_pred ---ccEEEEEecCCCcHHHHHHhC---------CCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCC
Confidence 789999999999999999832 23589999999999999999999977 899999999999999999
Q ss_pred ceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhc
Q 039533 779 TARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFG 857 (949)
Q Consensus 779 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~ 857 (949)
.+||+|||+++.-..-.. ......-...|+|||.+....+++++|||||||++||+++ |..||......+ ...+
T Consensus 300 ~vKISDFGLs~~~~~~~~--~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~--v~~k- 374 (474)
T KOG0194|consen 300 VVKISDFGLSRAGSQYVM--KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE--VKAK- 374 (474)
T ss_pred eEEeCccccccCCcceee--ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH--HHHH-
Confidence 999999999876431111 1111234678999999999999999999999999999999 898986442221 1101
Q ss_pred cccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhhc
Q 039533 858 RKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILL 936 (949)
Q Consensus 858 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~ 936 (949)
++.... +.+.....+..+..++..||..+|++||+|.+|.+.++.+.....
T Consensus 375 ----------I~~~~~------------------r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 375 ----------IVKNGY------------------RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred ----------HHhcCc------------------cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 000000 000011346678888999999999999999999999999877655
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=339.69 Aligned_cols=244 Identities=22% Similarity=0.273 Sum_probs=200.1
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccC
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRG 699 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 699 (949)
..++|...++||+|.||.|++|..+.+++.+|||++++.. ..+.+..+.|.+++... +||.+++++.+|...+
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~--- 442 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE--- 442 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC---
Confidence 3467899999999999999999999999999999998654 34567788999998888 5999999999966555
Q ss_pred CccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCc
Q 039533 700 NDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMT 779 (949)
Q Consensus 700 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~ 779 (949)
+.++||||+.||++..+.+ ...+++..++-++..|+.||.|||++ +|||||||-+|||+|.+|+
T Consensus 443 --~l~fvmey~~Ggdm~~~~~-----------~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh 506 (694)
T KOG0694|consen 443 --HLFFVMEYVAGGDLMHHIH-----------TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGH 506 (694)
T ss_pred --eEEEEEEecCCCcEEEEEe-----------cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCc
Confidence 9999999999999544443 45699999999999999999999988 9999999999999999999
Q ss_pred eEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 780 ARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 780 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
+||+|||+++..-.... .+..+.||+.|||||++.+..|+.++|.|||||+||||+.|+.||....++
T Consensus 507 ~kiADFGlcKe~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe---------- 574 (694)
T KOG0694|consen 507 VKIADFGLCKEGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE---------- 574 (694)
T ss_pred EEecccccccccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH----------
Confidence 99999999986542222 223567999999999999999999999999999999999999999643222
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCH
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNM 921 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 921 (949)
+++|..+..++.- +.-.+.+...++.+++..+|++|-.+
T Consensus 575 -------e~FdsI~~d~~~y----------------P~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 575 -------EVFDSIVNDEVRY----------------PRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -------HHHHHHhcCCCCC----------------CCcccHHHHHHHHHHhccCcccccCC
Confidence 2233323222210 11335567888999999999999876
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=338.00 Aligned_cols=246 Identities=22% Similarity=0.247 Sum_probs=197.2
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC---cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH---GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+. ..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ-----RF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC-----Ce
Confidence 478999999999999999999998899999999874321 2345688999999999999999999886543 37
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl 142 (291)
T cd05612 76 LYMLMEYVPGGELFSYLR----------NSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKL 142 (291)
T ss_pred EEEEEeCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEE
Confidence 899999999999999986 234588899999999999999999977 9999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
+|||+++....... ...||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..
T Consensus 143 ~Dfg~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~--~~-------- 207 (291)
T cd05612 143 TDFGFAKKLRDRTW-----TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG--IY-------- 207 (291)
T ss_pred EecCcchhccCCcc-----cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HH--------
Confidence 99999986543221 3458999999999998889999999999999999999999996331110 00
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC-----HHHHHHH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTN-----MTNVVHE 927 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~~~ 927 (949)
..+...... . .......+.+++.+|++.||.+||+ ++|+++.
T Consensus 208 ---~~i~~~~~~-~-------------------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 208 ---EKILAGKLE-F-------------------PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ---HHHHhCCcC-C-------------------CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 000000000 0 0012345789999999999999995 7777643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=336.45 Aligned_cols=202 Identities=28% Similarity=0.424 Sum_probs=170.0
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
.++|.+.+.||+|+||.||+|++..+++.||||+++.... .....+.+|+.++++++||||+++++++...+ ..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKE-----TL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCC-----eE
Confidence 4789999999999999999999998899999999875432 23356788999999999999999999976544 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++||||++ ++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+
T Consensus 79 ~lv~e~~~-~~l~~~~~~---------~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~ 145 (303)
T cd07869 79 TLVFEYVH-TDLCQYMDK---------HPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLA 145 (303)
T ss_pred EEEEECCC-cCHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEC
Confidence 99999996 688887752 234578889999999999999999977 89999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccc
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIM 846 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~ 846 (949)
|||+++........ .....||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 146 Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 146 DFGLARAKSVPSHT--YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred CCCcceeccCCCcc--CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999764332211 1234589999999987654 5789999999999999999999999743
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=336.19 Aligned_cols=253 Identities=23% Similarity=0.314 Sum_probs=211.0
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
++|...+++|+|+||.++.++++.+++.+|+|.+..... ...+...+|+.++++++|||||.+.+.|.+.+ ...
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~----~~l 79 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG----QLL 79 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCC----ceE
Confidence 578899999999999999999999999999999975543 23346789999999999999999999876544 348
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
+|||+|++||++.+.+... .+..++++.+.+|+.|++.|+.|||++ .|+|||||+.||+++.++.+||+
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~--------k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLg 148 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQ--------KGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLG 148 (426)
T ss_pred EEEEeecCCCCHHHHHHHH--------hhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeec
Confidence 9999999999999999742 245689999999999999999999977 89999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCC
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
|||+|+.+.+...... .++||+.||+||++.+.+|..|+||||+||++|||++-+++|....-. ..
T Consensus 149 DfGlaK~l~~~~~~a~--tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~-----~L------- 214 (426)
T KOG0589|consen 149 DFGLAKILNPEDSLAS--TVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS-----EL------- 214 (426)
T ss_pred chhhhhhcCCchhhhh--eecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH-----HH-------
Confidence 9999999887653322 577999999999999999999999999999999999999999633111 11
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
+.++......+.+ .....++..++..|+..+|+.||++.|++..
T Consensus 215 -i~ki~~~~~~Plp-------------------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 215 -ILKINRGLYSPLP-------------------SMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -HHHHhhccCCCCC-------------------ccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1222222222222 2456678999999999999999999999987
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=329.30 Aligned_cols=256 Identities=21% Similarity=0.331 Sum_probs=200.4
Q ss_pred cCCCCCCeeeeecCceEEEEEEc---CCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIID---EGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
.+|++.+.||+|+||.||+|.+. ..+..||+|+++.... .....+.+|+..+++++||||+++++++...+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 79 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN----- 79 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC-----
Confidence 46889999999999999999875 3457899999875432 23457889999999999999999999976443
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++|+|.+++.. ....+++.+++.++.|++.||+|||++ +++||||||+||+++.++.+|
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~---------~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~ 147 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRK---------HEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCK 147 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEE
Confidence 78999999999999999862 124588999999999999999999977 899999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhcccc
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
++|||.+......... ......++..|+|||++.+..++.++|||||||++||+++ |+.||......+ ...
T Consensus 148 l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--~~~----- 219 (266)
T cd05064 148 ISGFRRLQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--VIK----- 219 (266)
T ss_pred ECCCcccccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHH-----
Confidence 9999987654322211 1112235678999999999899999999999999999875 999986432110 000
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHh
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSI 931 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 931 (949)
.+.+....+ ....++..+.+++.+||+.+|++||+++|+.+.|+++
T Consensus 220 ------~~~~~~~~~-------------------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 220 ------AVEDGFRLP-------------------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ------HHHCCCCCC-------------------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 000000000 0113456788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=340.52 Aligned_cols=242 Identities=21% Similarity=0.226 Sum_probs=192.7
Q ss_pred CeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEee
Q 039533 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYE 708 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 708 (949)
+.||+|+||.||+|++..+++.||+|+++... ......+.+|+.++++++||||+++++++...+ ..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-----~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD-----RLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC-----EEEEEEe
Confidence 47999999999999999899999999997432 223456788999999999999999998876544 7899999
Q ss_pred eccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecccc
Q 039533 709 FMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLA 788 (949)
Q Consensus 709 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a 788 (949)
|+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 76 ~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a 142 (323)
T cd05571 76 YANGGELFFHLS----------RERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLC 142 (323)
T ss_pred CCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCC
Confidence 999999999986 234588999999999999999999977 9999999999999999999999999998
Q ss_pred eecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhhh
Q 039533 789 RILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDI 868 (949)
Q Consensus 789 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 868 (949)
+........ .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... .... .+
T Consensus 143 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~~-----------~~ 207 (323)
T cd05571 143 KEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFE-----------LI 207 (323)
T ss_pred cccccCCCc--ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--HHHH-----------HH
Confidence 754322211 12345999999999999989999999999999999999999999532111 0000 00
Q ss_pred cccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 039533 869 VDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRT-----NMTNVVH 926 (949)
Q Consensus 869 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~ 926 (949)
..... .. .......+.+++.+|++.||++|| ++.|+++
T Consensus 208 ~~~~~-~~-------------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 208 LMEEI-RF-------------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HcCCC-CC-------------------CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 00000 00 012345678899999999999999 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=332.79 Aligned_cols=277 Identities=21% Similarity=0.284 Sum_probs=197.7
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
.++|.+.++||+|+||.||+|++..+++.||+|+++... ......+.+|++++++++||||+++++++...+ ..
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~ 78 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTER-----CL 78 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC-----eE
Confidence 357999999999999999999999899999999987443 223456789999999999999999999875433 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++||||+++ +|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+
T Consensus 79 ~lv~e~~~~-~l~~~l~~---------~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~ 145 (288)
T cd07871 79 TLVFEYLDS-DLKQYLDN---------CGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLA 145 (288)
T ss_pred EEEEeCCCc-CHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEC
Confidence 999999975 89988852 223478889999999999999999977 99999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCch--hhhhcccc
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDIN--LHNFGRKA 860 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~--~~~~~~~~ 860 (949)
|||+++........ .....|++.|+|||++.+ ..++.++||||+||++|||++|+.||......+.. ........
T Consensus 146 DfG~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 223 (288)
T cd07871 146 DFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTP 223 (288)
T ss_pred cCcceeeccCCCcc--ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99999765432221 123458999999998865 46899999999999999999999999643221100 00000000
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.++....+.+.. ........ ...................+++.+|++.||.+|||++|+++
T Consensus 224 ~~~~~~~~~~~~---~~~~~~~~--~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 224 TEETWPGITSNE---EFRSYLFP--QYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ChHHhhccccch---hhhccccC--ccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000000000 00000000 00000000000122345789999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=299.72 Aligned_cols=251 Identities=20% Similarity=0.280 Sum_probs=205.9
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
+.++|.+++.||+|.||.||.|+.+.++-.||+|++-+.. .+..+++.+|+++-+.++||||.++|++|.+..
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~---- 95 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK---- 95 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc----
Confidence 3467899999999999999999999999999999986432 334578999999999999999999999987655
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
..|+++||...|.++..+... ...++++.....++.|+|.|+.|+|.. +|+||||||+|+|++..+..
T Consensus 96 -riyLilEya~~gel~k~L~~~--------~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~l 163 (281)
T KOG0580|consen 96 -RIYLILEYAPRGELYKDLQEG--------RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGEL 163 (281)
T ss_pred -eeEEEEEecCCchHHHHHHhc--------ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCe
Confidence 899999999999999999732 234577888899999999999999966 89999999999999999999
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
||+|||-+...+.... ....||..|.|||+..+..++.++|+|++|+..||++.|.+||+....+ ..+.+...
T Consensus 164 kiAdfGwsV~~p~~kR----~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~-etYkrI~k-- 236 (281)
T KOG0580|consen 164 KIADFGWSVHAPSNKR----KTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS-ETYKRIRK-- 236 (281)
T ss_pred eccCCCceeecCCCCc----eeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH-HHHHHHHH--
Confidence 9999999876542222 2456999999999999999999999999999999999999999754311 11111100
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
.++.. +...+....+++.+|+..+|.+|.+..||+.-
T Consensus 237 -----~~~~~-------------------------p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 237 -----VDLKF-------------------------PSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -----ccccC-------------------------CcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 00001 11334567899999999999999999999864
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=336.38 Aligned_cols=260 Identities=25% Similarity=0.403 Sum_probs=203.6
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCE----EEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRT----TIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
.+|++.+.||+|+||.||+|++..+++ .||+|+++... ....+++.+|+.+++.++||||++++++|...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~----- 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-----
Confidence 568999999999999999999765444 48999986443 23456788999999999999999999998643
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
..++|+||+++|+|.+++.. ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~---------~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~ 148 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVRE---------HKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHV 148 (316)
T ss_pred -CceeeeecCCCCCHHHHHHh---------ccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcE
Confidence 46799999999999999872 224578889999999999999999977 89999999999999999999
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccc
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~ 859 (949)
||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||+...... +
T Consensus 149 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--~------ 220 (316)
T cd05108 149 KITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--I------ 220 (316)
T ss_pred EEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--H------
Confidence 9999999987654433222122334678999999999899999999999999999998 999986431110 0
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhh
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNIL 935 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~ 935 (949)
..++...... +....++..+.+++.+||+.+|++||++.|++..+.++....
T Consensus 221 ------~~~~~~~~~~------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 221 ------SSILEKGERL------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred ------HHHHhCCCCC------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 0111000000 000122345788999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=341.37 Aligned_cols=245 Identities=21% Similarity=0.206 Sum_probs=197.2
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+.++++++||||+++++++...+ .
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~ 92 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN-----R 92 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC-----E
Confidence 57889999999999999999999889999999997432 223457889999999999999999999876544 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 93 ~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl 159 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLR----------KAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKV 159 (329)
T ss_pred EEEEEcCCCCChHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEE
Confidence 899999999999999986 234578889999999999999999977 9999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
+|||+++....... ...||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..
T Consensus 160 ~Dfg~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-----~~----- 224 (329)
T PTZ00263 160 TDFGFAKKVPDRTF-----TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR-----IY----- 224 (329)
T ss_pred eeccCceEcCCCcc-----eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH-----HH-----
Confidence 99999987644322 3458999999999999889999999999999999999999995321100 00
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC-----HHHHHH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTN-----MTNVVH 926 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~~ 926 (949)
..+...... .+ ......+.+++.+|++.||++||+ ++|++.
T Consensus 225 ---~~i~~~~~~-~p-------------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 225 ---EKILAGRLK-FP-------------------NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred ---HHHhcCCcC-CC-------------------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 000000000 00 012345678999999999999997 577653
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=342.03 Aligned_cols=254 Identities=21% Similarity=0.249 Sum_probs=200.8
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|++++.+++||||+++++++...+ .
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~-----~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE-----Y 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC-----E
Confidence 46899999999999999999999889999999997432 223457889999999999999999999876544 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~e~~~g~~L~~~l~----------~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL 142 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLN----------NLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKL 142 (333)
T ss_pred EEEEEeCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEE
Confidence 899999999999999996 234588999999999999999999977 8999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...... ..
T Consensus 143 ~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~i~~--~~ 214 (333)
T cd05600 143 TDFGLSKGIVTY-----ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-WENLKY--WK 214 (333)
T ss_pred EeCcCCcccccc-----cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-HHHHHh--cc
Confidence 999999865431 1234589999999999998999999999999999999999999964321110 000000 00
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
..+......++ ....+..+.+++.+|+..+|++||+++|+++.
T Consensus 215 ----~~~~~~~~~~~------------------~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 215 ----ETLQRPVYDDP------------------RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ----ccccCCCCCcc------------------ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00000000000 01234567889999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=330.27 Aligned_cols=265 Identities=24% Similarity=0.426 Sum_probs=205.5
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCC-----EEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccC
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGR-----TTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRG 699 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 699 (949)
++|++.+.||+|+||.||+|.....+ ..||+|.++.... .....+.+|++++++++||||+++++++....
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~--- 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ--- 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC---
Confidence 46889999999999999999986544 6799999864432 23356889999999999999999999976443
Q ss_pred CccceeEeeeccCCChhhhcCCCCCCCcc------ccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCee
Q 039533 700 NDFKASVYEFMHYGSLEEWLHPFTGEDEI------DEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVL 773 (949)
Q Consensus 700 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIl 773 (949)
..+++|||+++++|.+++......... ......+++.+++.++.|++.||+|||+. +++||||||+||+
T Consensus 82 --~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil 156 (283)
T cd05048 82 --PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCL 156 (283)
T ss_pred --ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEE
Confidence 689999999999999999743211110 11125688999999999999999999977 8999999999999
Q ss_pred ecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCch
Q 039533 774 LDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDIN 852 (949)
Q Consensus 774 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~ 852 (949)
+++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......+
T Consensus 157 ~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~-- 234 (283)
T cd05048 157 VGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE-- 234 (283)
T ss_pred EcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH--
Confidence 99999999999999986544332222223346788999999988889999999999999999998 999986432111
Q ss_pred hhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 039533 853 LHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQS 930 (949)
Q Consensus 853 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 930 (949)
..+.+...... .....++.++.+++.+||+.||++||+++||.+.|++
T Consensus 235 ------------~~~~i~~~~~~------------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 235 ------------VIEMIRSRQLL------------------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ------------HHHHHHcCCcC------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111100000 0012456788999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=330.67 Aligned_cols=269 Identities=24% Similarity=0.394 Sum_probs=208.3
Q ss_pred cCCCCCCeeeeecCceEEEEEE-----cCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 626 SGFSSANLVGVGSFGSVYKGII-----DEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
++|.+.+.||+|+||.||++.. ..++..+|+|.+........+.+.+|++++++++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 80 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD---- 80 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC----
Confidence 5688999999999999999985 2345679999987655555678999999999999999999999976544
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCc---cccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCC
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDE---IDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDY 777 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~---~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~ 777 (949)
..++||||+++++|.+++........ .......+++.+++.++.|++.||+|||++ +++||||||+||+++++
T Consensus 81 -~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 81 -PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN 156 (288)
T ss_pred -ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence 78999999999999999963321111 111234589999999999999999999977 89999999999999999
Q ss_pred CceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhh
Q 039533 778 MTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNF 856 (949)
Q Consensus 778 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~ 856 (949)
+.+||+|||.++...............++..|+|||++.+..++.++|||||||++|||++ |..||......+ ...
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--~~~- 233 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIE- 233 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH-
Confidence 9999999999986543332222222335778999999998889999999999999999998 999985432111 000
Q ss_pred ccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHh
Q 039533 857 GRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNI 934 (949)
Q Consensus 857 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 934 (949)
.+........+ ...+..+.+++.+|++.+|.+|||+.||.+.|+++..+
T Consensus 234 ----------~i~~~~~~~~~-------------------~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 234 ----------CITQGRVLQRP-------------------RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred ----------HHHcCCcCCCC-------------------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 00000000000 02234689999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=330.26 Aligned_cols=273 Identities=22% Similarity=0.284 Sum_probs=199.4
Q ss_pred cCCCCCCeeeeecCceEEEEEEc-CCCEEEEEEEEecCCC--cchHHHHHHHHHHHhc---CCCcceeEEeeeecccccC
Q 039533 626 SGFSSANLVGVGSFGSVYKGIID-EGRTTIAVKVFNLQHH--GASRSFIAECKALKSI---RHRNLVKVLTACLGADYRG 699 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~ 699 (949)
++|++.+.||+|+||.||+|++. .+++.||+|+++.... .....+.+|+.+++++ +||||++++++|.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47899999999999999999984 3578899999874432 2234566788777766 6999999999987554445
Q ss_pred CccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCc
Q 039533 700 NDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMT 779 (949)
Q Consensus 700 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~ 779 (949)
....++||||++ ++|.+++... ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~--------~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~ 148 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV--------PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQ 148 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC--------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCC
Confidence 557899999996 6899988621 223588999999999999999999977 9999999999999999999
Q ss_pred eEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhc--
Q 039533 780 ARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFG-- 857 (949)
Q Consensus 780 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~-- 857 (949)
+||+|||+++....... .....||..|+|||++.+..++.++|||||||++|||++|++||......+ .+....
T Consensus 149 ~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~ 224 (290)
T cd07862 149 IKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDV 224 (290)
T ss_pred EEEccccceEeccCCcc---cccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHH
Confidence 99999999987654321 123458999999999988889999999999999999999999996432211 111100
Q ss_pred -cccCCCchhh---hcccCCCCCchhhhhhhchhhhhhhhh-hHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 858 -RKALPDDVMD---IVDSSLLPDDEDLILTGNQRQKQARIN-SIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 858 -~~~~~~~~~~---~~d~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
....++.... ......... +....+ .....+..+.+++.+|++.||++|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 225 IGLPGEEDWPRDVALPRQAFHSK------------SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hCCCChhhchhhhcccchhccCC------------CCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000000000 000000000 000000 01123456789999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=329.27 Aligned_cols=267 Identities=22% Similarity=0.357 Sum_probs=202.4
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcC-----CCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccc
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDE-----GRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADY 697 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 697 (949)
+.++|++.+.||+|+||.||+|.+.. .++.||+|++..... ....++.+|+.++++++||||+++++++....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~- 82 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ- 82 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-
Confidence 46789999999999999999998642 356799999864322 23456889999999999999999999975443
Q ss_pred cCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCC
Q 039533 698 RGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDY 777 (949)
Q Consensus 698 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~ 777 (949)
..++||||+++++|.+++...............+++..+..++.|++.||+|||+. +++||||||+||+++++
T Consensus 83 ----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~ 155 (277)
T cd05062 83 ----PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 155 (277)
T ss_pred ----CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCC
Confidence 78999999999999999964322111111234568889999999999999999976 89999999999999999
Q ss_pred CceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhh
Q 039533 778 MTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNF 856 (949)
Q Consensus 778 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~ 856 (949)
+.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...... ....
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--~~~~- 232 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--QVLR- 232 (277)
T ss_pred CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHH-
Confidence 9999999999876544332221112335788999999998889999999999999999999 78888532111 0000
Q ss_pred ccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 039533 857 GRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQS 930 (949)
Q Consensus 857 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 930 (949)
..........+ ..++..+.+++.+|++.+|++|||+.|+++.|++
T Consensus 233 ----------~~~~~~~~~~~-------------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 233 ----------FVMEGGLLDKP-------------------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred ----------HHHcCCcCCCC-------------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 00000000000 1234568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=334.67 Aligned_cols=201 Identities=25% Similarity=0.355 Sum_probs=174.0
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
.++|++.+.||+|+||.||+|.+..++..+|+|+++.... .....+.+|++++++++||||+++++++...+ ..
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-----EI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECC-----EE
Confidence 4689999999999999999999998899999999875432 23457889999999999999999999986544 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++||||+++++|.+++.. ...+++..+..++.|++.|++|||+.. +|+||||||+||+++.++.+||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~ 146 (333)
T cd06650 79 SICMEHMDGGSLDQVLKK----------AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLC 146 (333)
T ss_pred EEEEecCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEe
Confidence 999999999999999862 245788899999999999999999642 79999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccc
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIM 846 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~ 846 (949)
|||++........ ....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 147 Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 147 DFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred eCCcchhhhhhcc----ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 9999876533221 1345899999999999888999999999999999999999999643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=341.92 Aligned_cols=269 Identities=26% Similarity=0.366 Sum_probs=205.6
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcC-----CCEEEEEEEEecCCC-cchHHHHHHHHHHHhcC-CCcceeEEeeeecccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDE-----GRTTIAVKVFNLQHH-GASRSFIAECKALKSIR-HRNLVKVLTACLGADY 697 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 697 (949)
.++|++.++||+|+||.||+|++.. .+..||||+++.... ...+.+.+|+++++++. ||||++++++|...+
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~- 114 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG- 114 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC-
Confidence 4678999999999999999998742 235799999975433 23457899999999996 999999999986544
Q ss_pred cCCccceeEeeeccCCChhhhcCCCCCCCc--------------------------------------------------
Q 039533 698 RGNDFKASVYEFMHYGSLEEWLHPFTGEDE-------------------------------------------------- 727 (949)
Q Consensus 698 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------------------------------------------------- 727 (949)
..++||||+++|+|.++++.......
T Consensus 115 ----~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 115 ----PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ----ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 78999999999999999864211000
Q ss_pred ------------------------------------cccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCC
Q 039533 728 ------------------------------------IDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSN 771 (949)
Q Consensus 728 ------------------------------------~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~N 771 (949)
.......+++.++..++.|++.||+|||+. +|+||||||+|
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~N 267 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARN 267 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHh
Confidence 000123588899999999999999999977 89999999999
Q ss_pred eeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccC
Q 039533 772 VLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGD 850 (949)
Q Consensus 772 Ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~ 850 (949)
|++++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 9999999999999999987654333222223447788999999998889999999999999999997 999986432111
Q ss_pred chhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 039533 851 INLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQS 930 (949)
Q Consensus 851 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 930 (949)
.. ...+..... ......++..+.+++.+||+.||++||++.+|.+.|++
T Consensus 348 ~~-------------~~~~~~~~~------------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 348 TF-------------YNKIKSGYR------------------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred HH-------------HHHHhcCCC------------------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 00 000000000 00011345678899999999999999999999999998
Q ss_pred hH
Q 039533 931 IK 932 (949)
Q Consensus 931 i~ 932 (949)
+.
T Consensus 397 l~ 398 (400)
T cd05105 397 LL 398 (400)
T ss_pred Hc
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=336.14 Aligned_cols=242 Identities=21% Similarity=0.227 Sum_probs=192.2
Q ss_pred CeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEee
Q 039533 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYE 708 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 708 (949)
+.||+|+||.||+|++..+++.||+|+++... ......+.+|++++++++||||+++++++...+ ..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~-----~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD-----RLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC-----EEEEEEe
Confidence 47999999999999999899999999997432 223456778999999999999999999876444 7899999
Q ss_pred eccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecccc
Q 039533 709 FMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLA 788 (949)
Q Consensus 709 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a 788 (949)
|+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 76 ~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~ 142 (323)
T cd05595 76 YANGGELFFHLS----------RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLC 142 (323)
T ss_pred CCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHh
Confidence 999999998886 234588999999999999999999977 9999999999999999999999999998
Q ss_pred eecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhhh
Q 039533 789 RILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDI 868 (949)
Q Consensus 789 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 868 (949)
+........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ..+
T Consensus 143 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--~~-----------~~~ 207 (323)
T cd05595 143 KEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LF-----------ELI 207 (323)
T ss_pred ccccCCCCc--cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH--HH-----------HHH
Confidence 754322211 113458999999999999899999999999999999999999995321110 00 000
Q ss_pred cccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 039533 869 VDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRT-----NMTNVVH 926 (949)
Q Consensus 869 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~ 926 (949)
...... .+ ...+..+.+++.+|++.||++|| ++.|+++
T Consensus 208 ~~~~~~-~p-------------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 208 LMEEIR-FP-------------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred hcCCCC-CC-------------------CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 000000 00 12345678999999999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=352.79 Aligned_cols=254 Identities=19% Similarity=0.210 Sum_probs=201.2
Q ss_pred CCCCCCeeeeecCceEEEEEEcCC-CEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEG-RTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
.|.+.+.||+|++|.||+|....+ ++.||+|............+.+|+.++++++||||+++++++...+ ..++
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~-----~~~l 142 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDD-----KLLL 142 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC-----EEEE
Confidence 488899999999999999998776 7889999876555444567888999999999999999999976544 7999
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
||||+++|+|.+++.... .....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 143 v~E~~~gg~L~~~l~~~~------~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DF 213 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRL------KEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDF 213 (478)
T ss_pred EEECCCCCCHHHHHHHHH------hccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeC
Confidence 999999999999885211 1234588999999999999999999977 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCch
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDV 865 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 865 (949)
|+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..
T Consensus 214 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~-----~~-------- 280 (478)
T PTZ00267 214 GFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE-----IM-------- 280 (478)
T ss_pred cCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-----HH--------
Confidence 99987654433222234569999999999999899999999999999999999999986321110 00
Q ss_pred hhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 866 MDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 866 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
..+......+.+ ...+..+.+++.+|++.||++||+++|++.
T Consensus 281 ~~~~~~~~~~~~-------------------~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 281 QQVLYGKYDPFP-------------------CPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHhCCCCCCC-------------------ccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 000000000000 123346789999999999999999999864
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=342.08 Aligned_cols=271 Identities=18% Similarity=0.241 Sum_probs=197.5
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
.+|++.+.||+|+||.||+|.+..+++.||+|+.. .+.+.+|++++++++||||+++++++.... ..++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~~~l 160 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNK-----FTCL 160 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECC-----eeEE
Confidence 57999999999999999999999999999999743 235678999999999999999999875443 7899
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
|+|++. ++|.+++. ....+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 161 v~e~~~-~~L~~~l~----------~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DF 226 (391)
T PHA03212 161 ILPRYK-TDLYCYLA----------AKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDF 226 (391)
T ss_pred EEecCC-CCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeC
Confidence 999985 68888885 234578999999999999999999977 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCc------hhhhhccc
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDI------NLHNFGRK 859 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~------~~~~~~~~ 859 (949)
|+|+....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. .+......
T Consensus 227 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~ 305 (391)
T PHA03212 227 GAACFPVDINA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRR 305 (391)
T ss_pred Ccccccccccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHH
Confidence 99975432221 111235699999999999998999999999999999999999988742211100 00000000
Q ss_pred c--CCCchhhhcccCCCCCchhhh---hhhc--hhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 860 A--LPDDVMDIVDSSLLPDDEDLI---LTGN--QRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 860 ~--~~~~~~~~~d~~l~~~~~~~~---~~~~--~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
. .+.+.. .+. ........ .... .......+....+.+..+.+++.+|++.||++|||++|+++
T Consensus 306 ~g~~p~~~~--~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 306 SGTHPNEFP--IDA--QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hcCChhhcC--cch--hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 000000 000 00000000 0000 00001112223355678899999999999999999999985
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=323.40 Aligned_cols=262 Identities=21% Similarity=0.315 Sum_probs=206.7
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
++|++.+.||+|+||.||+|+...+++.||||.++... ......+.+|++++++++||||+++++++...+ .
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN-----E 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC-----e
Confidence 57999999999999999999998889999999886432 223356889999999999999999999876543 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++++|.+++.... .....++...+..++.|++.||+|||++ +++||||||+||+++.++.++|
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l 147 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFK------KQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKL 147 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhh------hccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEE
Confidence 899999999999999885321 1234578899999999999999999977 9999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
+|||.+.......... ....|+..|+|||.+.+..++.++||||||+++|||++|+.||...........
T Consensus 148 ~d~g~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~-------- 217 (267)
T cd08228 148 GDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLC-------- 217 (267)
T ss_pred CccccceeccchhHHH--hcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHH--------
Confidence 9999998765433211 134588899999999888899999999999999999999999853211111111
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIK 932 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 932 (949)
..+.....+. ......+..+.+++.+||+.+|++||++.||++.+++++
T Consensus 218 ----~~~~~~~~~~-----------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 218 ----QKIEQCDYPP-----------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ----HHHhcCCCCC-----------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 0000000000 001134566889999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=317.09 Aligned_cols=249 Identities=21% Similarity=0.297 Sum_probs=203.6
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc---chHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG---ASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
..+|.+.+.||+|.||.|-+|.....|+.||||.+++.... +.-.+++|+++|+.++||||+.+|.+|. +.+
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFE-----Nkd 126 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFE-----NKD 126 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhc-----CCc
Confidence 35688889999999999999999889999999999755433 3346789999999999999999999954 445
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
...+||||..+|.|++|+. ..+.+++.+++.+++||+.|+.|+|.+ +++|||||.+|||+|+++++|
T Consensus 127 KIvivMEYaS~GeLYDYiS----------er~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiK 193 (668)
T KOG0611|consen 127 KIVIVMEYASGGELYDYIS----------ERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIK 193 (668)
T ss_pred eEEEEEEecCCccHHHHHH----------HhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCee
Confidence 8999999999999999997 456799999999999999999999977 999999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCccC-CccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVS-TNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
|+|||++-.+....... .+.|++-|.+||+..|.+|. +.+|-||+||++|-++.|..||+.... ...++..
T Consensus 194 IADFGLSNly~~~kfLq---TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-----k~lvrQI 265 (668)
T KOG0611|consen 194 IADFGLSNLYADKKFLQ---TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-----KRLVRQI 265 (668)
T ss_pred eeccchhhhhccccHHH---HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-----HHHHHHh
Confidence 99999998887665433 45699999999999999874 899999999999999999999974311 1111110
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHEL 928 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 928 (949)
-..... ++ +.+....-++++|+..+|++|.|+.+|+...
T Consensus 266 s~GaYr---------EP--------------------~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 266 SRGAYR---------EP--------------------ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred hccccc---------CC--------------------CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 000000 00 1122345688999999999999999998654
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=335.92 Aligned_cols=239 Identities=22% Similarity=0.254 Sum_probs=189.2
Q ss_pred eeeecCceEEEEEEcCCCEEEEEEEEecC---CCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEeeec
Q 039533 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQ---HHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFM 710 (949)
Q Consensus 634 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 710 (949)
||+|+||.||+|++..+++.||+|+++.. .......+.+|+.++++++||||+++++++...+ ..++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPE-----KLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCC-----eEEEEEcCC
Confidence 69999999999999988999999998743 2233467788999999999999999998875443 789999999
Q ss_pred cCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccccee
Q 039533 711 HYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARI 790 (949)
Q Consensus 711 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~ 790 (949)
++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 76 ~~g~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~ 142 (312)
T cd05585 76 NGGELFHHLQR----------EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKL 142 (312)
T ss_pred CCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECccccc
Confidence 99999999862 34588999999999999999999977 899999999999999999999999999976
Q ss_pred cCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhhhcc
Q 039533 791 LSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVD 870 (949)
Q Consensus 791 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d 870 (949)
....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... .... .+..
T Consensus 143 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~-----~~~~--------~~~~ 207 (312)
T cd05585 143 NMKDDDK--TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-----EMYR--------KILQ 207 (312)
T ss_pred CccCCCc--cccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH-----HHHH--------HHHc
Confidence 4332221 12345899999999999989999999999999999999999999632111 0000 0110
Q ss_pred cCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC---HHHHH
Q 039533 871 SSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTN---MTNVV 925 (949)
Q Consensus 871 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~ev~ 925 (949)
..... ....+..+.+++.+|++.||++||+ +.|++
T Consensus 208 ~~~~~--------------------~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 208 EPLRF--------------------PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred CCCCC--------------------CCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 00000 0123456788999999999999986 45554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=326.73 Aligned_cols=250 Identities=31% Similarity=0.491 Sum_probs=191.7
Q ss_pred CCeeeeecCceEEEEEEc----CCCEEEEEEEEecCCCc-chHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 631 ANLVGVGSFGSVYKGIID----EGRTTIAVKVFNLQHHG-ASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 631 ~~~lg~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
.+.||.|.||.||+|.+. ..+..|+||+++..... ..+.+.+|++.+++++||||++++|++...+ ..++
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~-----~~~l 78 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE-----PLFL 78 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS-----SEEE
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccc-----cccc
Confidence 478999999999999998 44678999999654332 3678999999999999999999999987444 5899
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
||||+++|+|.+++... ....+++.++..|+.|+++||+|||++ +++||||+++||+++.++.+||+||
T Consensus 79 v~e~~~~g~L~~~L~~~--------~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f 147 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSK--------NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDF 147 (259)
T ss_dssp EEE--TTEBHHHHHHHT--------CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEEST
T ss_pred ccccccccccccccccc--------ccccccccccccccccccccccccccc---ccccccccccccccccccccccccc
Confidence 99999999999999732 235689999999999999999999987 8999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCCc
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
|++................+...|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~--~~~~-------- 217 (259)
T PF07714_consen 148 GLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE--IIEK-------- 217 (259)
T ss_dssp TTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH--HHHH--------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccc--------
Confidence 99988743333222223447789999999998889999999999999999999 788875431111 0000
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHEL 928 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 928 (949)
+.+.... +....++..+.+++..||+.+|++|||+.|+++.|
T Consensus 218 ---~~~~~~~-------------------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 218 ---LKQGQRL-------------------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---HHTTEET-------------------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---ccccccc-------------------eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 0000000 00113355688999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=338.63 Aligned_cols=249 Identities=27% Similarity=0.366 Sum_probs=191.2
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
++|+..+.||+|+||.||+|++..+++.||||++..... ...+.+.+|++++++++|+||+++++++...+ ..+
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 148 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG-----EIQ 148 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC-----eEE
Confidence 346677899999999999999988899999999865433 23467889999999999999999999875443 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++++|.+... .++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|
T Consensus 149 lv~e~~~~~~L~~~~~--------------~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~D 211 (353)
T PLN00034 149 VLLEFMDGGSLEGTHI--------------ADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIAD 211 (353)
T ss_pred EEEecCCCCccccccc--------------CCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcc
Confidence 9999999999865432 45667888999999999999977 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCC-----CccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-----CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
||+++........ .....||..|+|||++.. ...+.++|||||||++|||++|+.||......+ ......
T Consensus 212 fG~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~- 286 (353)
T PLN00034 212 FGVSRILAQTMDP--CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--WASLMC- 286 (353)
T ss_pred cccceeccccccc--ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHH-
Confidence 9999876533221 123469999999998743 234578999999999999999999996221111 000000
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
.+.... .. .....+...+.+++.+||+.||++|||+.|+++.
T Consensus 287 -------~~~~~~-~~------------------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 287 -------AICMSQ-PP------------------EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -------HHhccC-CC------------------CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 00 0001334568899999999999999999999874
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=324.77 Aligned_cols=259 Identities=24% Similarity=0.351 Sum_probs=200.0
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCE----EEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRT----TIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
++|++.+.||+|+||.||+|.+..+++ .|++|.+..... ....++..|+..+++++||||+++++++...
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~----- 81 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGA----- 81 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCC-----
Confidence 468889999999999999999865555 477777653322 2235677888899999999999999986422
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
..++++||+++|+|.+++.. ....+++..+..|+.|++.||+|||+. +++||||||+||++++++.+
T Consensus 82 -~~~~i~e~~~~gsL~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~ 148 (279)
T cd05111 82 -SLQLVTQLSPLGSLLDHVRQ---------HRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIV 148 (279)
T ss_pred -ccEEEEEeCCCCcHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcE
Confidence 46789999999999999962 234589999999999999999999977 89999999999999999999
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccc
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~ 859 (949)
||+|||.++...............++..|+|||+..+..++.++|||||||++||+++ |+.||.......
T Consensus 149 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--------- 219 (279)
T cd05111 149 QIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--------- 219 (279)
T ss_pred EEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---------
Confidence 9999999987654433222223447789999999988889999999999999999998 999986331110
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHh
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNI 934 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 934 (949)
..+++........ ...++..+.+++.+||..+|++|||+.|+++.|..+...
T Consensus 220 -----~~~~~~~~~~~~~------------------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 220 -----VPDLLEKGERLAQ------------------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred -----HHHHHHCCCcCCC------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 1111111000000 001233567889999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=335.33 Aligned_cols=243 Identities=22% Similarity=0.257 Sum_probs=193.1
Q ss_pred CeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEee
Q 039533 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYE 708 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 708 (949)
+.||+|+||.||+|++..+++.||+|++.... ......+.+|++++++++||||+++++++...+ ..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD-----RLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC-----EEEEEEe
Confidence 47999999999999999899999999997432 233457888999999999999999998865444 7899999
Q ss_pred eccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecccc
Q 039533 709 FMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLA 788 (949)
Q Consensus 709 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a 788 (949)
|+++|+|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 76 y~~~g~L~~~l~----------~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~ 142 (328)
T cd05593 76 YVNGGELFFHLS----------RERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLC 142 (328)
T ss_pred CCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCC
Confidence 999999999886 234588999999999999999999977 9999999999999999999999999998
Q ss_pred eecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhhh
Q 039533 789 RILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDI 868 (949)
Q Consensus 789 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 868 (949)
+........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. ........
T Consensus 143 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~--~~---~~~~~~~~---- 211 (328)
T cd05593 143 KEGITDAAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KL---FELILMED---- 211 (328)
T ss_pred ccCCCcccc--cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH--HH---HHHhccCC----
Confidence 754322211 12345999999999999889999999999999999999999999532111 00 00000000
Q ss_pred cccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHHH
Q 039533 869 VDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRT-----NMTNVVHE 927 (949)
Q Consensus 869 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~~ 927 (949)
..+ + ...+..+.+++.+|++.||++|| ++.|+++.
T Consensus 212 --~~~---p-------------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 212 --IKF---P-------------------RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred --ccC---C-------------------CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 000 0 12234578899999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=328.15 Aligned_cols=269 Identities=24% Similarity=0.380 Sum_probs=208.2
Q ss_pred cCCCCCCeeeeecCceEEEEEEc-----CCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 626 SGFSSANLVGVGSFGSVYKGIID-----EGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
.+|.+.+.||+|+||.||+|+.. .++..+++|.++.......+.+.+|++++++++|+||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD---- 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC----
Confidence 45788899999999999999863 245679999987555545577999999999999999999999976544
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCC------ccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeee
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGED------EIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL 774 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll 774 (949)
..++||||+++++|.+++....... ........+++..++.++.|++.|++|||++ +|+||||||+||++
T Consensus 81 -~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~ 156 (291)
T cd05094 81 -PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLV 156 (291)
T ss_pred -ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEE
Confidence 7899999999999999996432110 0011234589999999999999999999977 89999999999999
Q ss_pred cCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchh
Q 039533 775 DDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINL 853 (949)
Q Consensus 775 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~ 853 (949)
+.++.++|+|||.++...............++..|+|||++.+..++.++|||||||++|||+| |+.||....... .
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~ 234 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--V 234 (291)
T ss_pred ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--H
Confidence 9999999999999986544332222223446788999999998899999999999999999999 999985332110 0
Q ss_pred hhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHH
Q 039533 854 HNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKN 933 (949)
Q Consensus 854 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 933 (949)
.. .+........ ...++..+.+++.+|++.+|++||++.+|++.|+++.+
T Consensus 235 ~~------------~~~~~~~~~~------------------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 235 IE------------CITQGRVLER------------------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HH------------HHhCCCCCCC------------------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 00 0000000000 01234568899999999999999999999999999976
Q ss_pred h
Q 039533 934 I 934 (949)
Q Consensus 934 ~ 934 (949)
.
T Consensus 285 ~ 285 (291)
T cd05094 285 A 285 (291)
T ss_pred h
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=334.45 Aligned_cols=270 Identities=23% Similarity=0.321 Sum_probs=204.5
Q ss_pred cCCCCCCeeeeecCceEEEEEEcC-----CCEEEEEEEEecCCC-cchHHHHHHHHHHHhc-CCCcceeEEeeeeccccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDE-----GRTTIAVKVFNLQHH-GASRSFIAECKALKSI-RHRNLVKVLTACLGADYR 698 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 698 (949)
++|++.+.||+|+||.||+|.... +++.||+|+++.... ...+.+..|+.++.++ +|+||++++++|...+
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~-- 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG-- 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC--
Confidence 579999999999999999997532 347899999874332 2345678899999999 8999999999876432
Q ss_pred CCccceeEeeeccCCChhhhcCCCCCCCc---------------------------------------------------
Q 039533 699 GNDFKASVYEFMHYGSLEEWLHPFTGEDE--------------------------------------------------- 727 (949)
Q Consensus 699 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------------------------------------------------- 727 (949)
...+++|||+++++|.+++........
T Consensus 85 --~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 85 --GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred --CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 367899999999999999863221000
Q ss_pred cccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecccceecCCCCCccccccccCcc
Q 039533 728 IDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSL 807 (949)
Q Consensus 728 ~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~ 807 (949)
.......+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.+.............++.
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 000123689999999999999999999977 99999999999999999999999999998764433322222344678
Q ss_pred CccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhch
Q 039533 808 GYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQ 886 (949)
Q Consensus 808 ~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 886 (949)
.|+|||++.+..++.++|||||||++|||++ |..||......+ .+. ..+.......
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~------------~~~~~~~~~~---------- 296 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFC------------RRLKEGTRMR---------- 296 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHH------------HHHhccCCCC----------
Confidence 8999999999999999999999999999998 999986321111 000 0000000000
Q ss_pred hhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHH
Q 039533 887 RQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKN 933 (949)
Q Consensus 887 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 933 (949)
........+.+++.+|++.+|++||++.||++.|+++..
T Consensus 297 --------~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 297 --------APEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred --------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 001234568899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=338.14 Aligned_cols=247 Identities=21% Similarity=0.261 Sum_probs=196.5
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCC-EEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGR-TTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
.++|++.+.||+|+||.||+|.+..++ ..||+|++.... ....+.+.+|+++++.++||||+++++++.+.+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~---- 104 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES---- 104 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC----
Confidence 457999999999999999999876444 789999986432 233457889999999999999999999976544
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
..++||||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 105 -~~~lv~Ey~~~g~L~~~i~----------~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~i 170 (340)
T PTZ00426 105 -YLYLVLEFVIGGEFFTFLR----------RNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFI 170 (340)
T ss_pred -EEEEEEeCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCE
Confidence 7899999999999999996 234588999999999999999999977 99999999999999999999
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..
T Consensus 171 kL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--~~------- 236 (340)
T PTZ00426 171 KMTDFGFAKVVDTRT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL--LI------- 236 (340)
T ss_pred EEecCCCCeecCCCc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH--HH-------
Confidence 999999998764322 1345999999999999888999999999999999999999999632111 00
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHHH
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRT-----NMTNVVHE 927 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~~ 927 (949)
...+.+.... .+ ......+.+++.+|++.||++|+ +++|+++.
T Consensus 237 ----~~~i~~~~~~-~p-------------------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 237 ----YQKILEGIIY-FP-------------------KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ----HHHHhcCCCC-CC-------------------CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0001110000 00 01233467899999999999995 78887653
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=322.73 Aligned_cols=265 Identities=25% Similarity=0.416 Sum_probs=203.8
Q ss_pred CCCCCeeeeecCceEEEEEEcCC---CEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccc-cCCc
Q 039533 628 FSSANLVGVGSFGSVYKGIIDEG---RTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADY-RGND 701 (949)
Q Consensus 628 y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 701 (949)
|.+.+.||+|+||.||+|....+ +..||+|+++.... .....+.+|++.+++++||||+++++++...+. ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56789999999999999998643 37899999875432 234578999999999999999999998765442 2334
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++|+|.+++...... .....+++..+..++.|++.||+|||+. +++||||||+||++++++.+|
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~----~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~k 153 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLG----GLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVC 153 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhcc----CCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEE
Confidence 579999999999999998632211 1234689999999999999999999977 899999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhcccc
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
|+|||.++...............++..|+|||++.+..++.++|||||||++|||++ |..||...... .....
T Consensus 154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~---- 227 (273)
T cd05035 154 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDY---- 227 (273)
T ss_pred ECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH----
Confidence 999999987654433222222335678999999988889999999999999999999 88988532211 00000
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHh
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSI 931 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 931 (949)
+.+..... ....++..+.+++.+|++.||++|||+.||++.|+++
T Consensus 228 -------~~~~~~~~-------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 228 -------LRHGNRLK-------------------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -------HHcCCCCC-------------------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00000000 0112345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=322.55 Aligned_cols=258 Identities=22% Similarity=0.385 Sum_probs=203.0
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCC---CEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEG---RTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
.++|++.+.||+|+||.||+|.+... ...||||+++.... .....+.+|+.++++++||||+++++++...+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 78 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR---- 78 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCC----
Confidence 35789999999999999999998643 45799999875433 23457889999999999999999999875444
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
..++||||+++++|.+++.. ....+++.++..++.|++.|++|||+. +|+||||||+||++++++.+
T Consensus 79 -~~~iv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~ 145 (266)
T cd05033 79 -PVMIITEYMENGSLDKFLRE---------NDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVC 145 (266)
T ss_pred -ceEEEEEcCCCCCHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCE
Confidence 78999999999999999862 123689999999999999999999976 89999999999999999999
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccc
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~ 859 (949)
+|+|||.++...............++..|+|||...+..++.++||||||+++|||++ |..||...... .....
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~~--- 220 (266)
T cd05033 146 KVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKA--- 220 (266)
T ss_pred EECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHHH---
Confidence 9999999988753222211112335678999999998889999999999999999998 99998532111 00000
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHh
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSI 931 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 931 (949)
+.+....+. ...++..+.+++.+|++.+|++||++.||++.|+++
T Consensus 221 --------~~~~~~~~~-------------------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 221 --------VEDGYRLPP-------------------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --------HHcCCCCCC-------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000000000 113345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=352.22 Aligned_cols=265 Identities=21% Similarity=0.245 Sum_probs=205.9
Q ss_pred HHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeeccccc-
Q 039533 622 YNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADYR- 698 (949)
Q Consensus 622 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~- 698 (949)
....++|.+.+.||+|+||+||+|++..+++.||||++.... ......+.+|+..+..++|+||+++++.+...+..
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 345579999999999999999999998889999999987543 23345688999999999999999988776543211
Q ss_pred --CCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC
Q 039533 699 --GNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD 776 (949)
Q Consensus 699 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~ 776 (949)
.....++||||+++|+|.+++.... .....+++..+..++.|++.||.|||+. +|+||||||+||+++.
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~------~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~ 178 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRA------KTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCS 178 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhh------ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeC
Confidence 1123679999999999999986321 1235688999999999999999999977 9999999999999999
Q ss_pred CCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhh
Q 039533 777 YMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNF 856 (949)
Q Consensus 777 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~ 856 (949)
++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..
T Consensus 179 ~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~-----~~ 253 (496)
T PTZ00283 179 NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME-----EV 253 (496)
T ss_pred CCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-----HH
Confidence 9999999999998765433322223456999999999999989999999999999999999999999632111 11
Q ss_pred ccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 857 GRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 857 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
... .......+. ....+..+.+++.+||+.||++||++.|+++.
T Consensus 254 ~~~--------~~~~~~~~~-------------------~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 254 MHK--------TLAGRYDPL-------------------PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHH--------HhcCCCCCC-------------------CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 000 000000000 01234568899999999999999999999763
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=312.19 Aligned_cols=279 Identities=22% Similarity=0.272 Sum_probs=205.2
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCc-ceeEEeeeeccc-ccCCc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRN-LVKVLTACLGAD-YRGND 701 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~-~~~~~ 701 (949)
..|...++||+|.||+||+|+...+|+.||+|+++.... +......+|+.++++++|+| |+++++++.... ++...
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 346667889999999999999999999999999985543 45677899999999999999 999999987544 23334
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||++. +|.+++...... ...++...+..++.|+++||+|||++ +|+||||||+||+|+++|.+|
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~------~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lK 160 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKK------PQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLK 160 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhcccc------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEe
Confidence 67899999965 999999743211 13466688999999999999999988 999999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhc--c
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFG--R 858 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~--~ 858 (949)
|+|||+|+...-+... ....++|..|+|||++.+. .|+...||||+||+++||+++++-|....+.+....-+- .
T Consensus 161 laDFGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lG 238 (323)
T KOG0594|consen 161 LADFGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLG 238 (323)
T ss_pred eeccchHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcC
Confidence 9999999976633321 2245689999999999987 689999999999999999999998875544221111110 0
Q ss_pred ----ccCCCchhhhcccCC--CCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 859 ----KALPDDVMDIVDSSL--LPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 859 ----~~~~~~~~~~~d~~l--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
..++.. ....+-.. .... .+..-............+++.+|++.+|++|.|++.+++.
T Consensus 239 tP~e~~Wp~v-~~~~~~k~~f~~~~----------~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 239 TPNEKDWPGV-SSLPDYKAPFPKWP----------GPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccCCCCc-cccccccccCcCCC----------CccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 111110 00111000 0000 0000000001111367889999999999999999999875
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=321.34 Aligned_cols=251 Identities=24% Similarity=0.363 Sum_probs=197.0
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
++|++.+.||+|+||.||+|++. ++..+|+|.+.... ...+.+.+|++++++++||||+++++++...+ ..++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~i 76 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK-----PLYI 76 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCC-----CEEE
Confidence 46888899999999999999987 45689999876332 33467889999999999999999999975544 7899
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
||||+++|+|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 77 v~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~ 144 (256)
T cd05114 77 VTEFMENGCLLNYLRQ---------RQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDF 144 (256)
T ss_pred EEEcCCCCcHHHHHHh---------CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCC
Confidence 9999999999999862 123578999999999999999999977 8999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCCc
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
|.++......... .....++..|+|||++.+..++.++||||||+++|||++ |+.||...... .....
T Consensus 145 g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--~~~~~-------- 213 (256)
T cd05114 145 GMTRYVLDDEYTS-SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--EVVEM-------- 213 (256)
T ss_pred CCccccCCCceec-cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH--------
Confidence 9998654332211 112335678999999988889999999999999999999 89998533111 00000
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHEL 928 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 928 (949)
+........+ ...+..+.+++.+||+.+|++||+++|+++.|
T Consensus 214 ---i~~~~~~~~~-------------------~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 214 ---ISRGFRLYRP-------------------KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ---HHCCCCCCCC-------------------CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 0000000000 01234678999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=326.68 Aligned_cols=271 Identities=24% Similarity=0.366 Sum_probs=204.1
Q ss_pred cCCCCCCeeeeecCceEEEEEE----cCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 626 SGFSSANLVGVGSFGSVYKGII----DEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
.+|++.+.||+|+||.||+|.. ..+++.||+|++........+.+.+|++++++++||||+++++++... +..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC---CCC
Confidence 4688899999999999999984 346789999998765555567889999999999999999999987533 234
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+|
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~---------~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~ 148 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQK---------HRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVK 148 (284)
T ss_pred ceEEEEEecCCCCHHHHHHh---------cCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEE
Confidence 67899999999999999862 123588999999999999999999977 999999999999999999999
Q ss_pred EeecccceecCCCCCcc-ccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 782 VGDFGLARILSPDHTQT-SSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
|+|||+++......... ......++..|+|||+..+..++.++|||||||++|||++|..|+...... ........
T Consensus 149 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~ 225 (284)
T cd05081 149 IGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRMMGND 225 (284)
T ss_pred ECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhhcccc
Confidence 99999998765433211 111122445699999998888999999999999999999988775322110 00000000
Q ss_pred CC-Cc----hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhH
Q 039533 861 LP-DD----VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIK 932 (949)
Q Consensus 861 ~~-~~----~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 932 (949)
.. .. ..+.+... .+.+....++..+.+++.+||+.+|++||||.||++.|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 226 KQGQMIVYHLIELLKNN------------------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred cccccchHHHHHHHhcC------------------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 00 00 00111100 000111234567899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=325.49 Aligned_cols=271 Identities=23% Similarity=0.316 Sum_probs=203.2
Q ss_pred CC-CCCCeeeeecCceEEEEEE----cCCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 627 GF-SSANLVGVGSFGSVYKGII----DEGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 627 ~y-~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
+| ++.+.||+|+||+||++.. ..+++.||+|+++.... .....+.+|++++++++||||+++++++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 80 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ---GG 80 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CC
Confidence 44 8889999999999987653 34678899999875432 2346788999999999999999999987542 23
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
...++||||+++++|.+++. ...+++.++..++.|++.|++|||++ +|+||||||+||++++++.+
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~-----------~~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~ 146 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLP-----------KHKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLV 146 (283)
T ss_pred ceEEEEecCCCCCCHHHHHH-----------HcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcE
Confidence 46789999999999999986 13489999999999999999999977 89999999999999999999
Q ss_pred EEeecccceecCCCCCcc-ccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 781 RVGDFGLARILSPDHTQT-SSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
||+|||+++......... ......++..|+|||+..+..++.++||||||+++|||+||..||................
T Consensus 147 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~ 226 (283)
T cd05080 147 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQG 226 (283)
T ss_pred EEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccccc
Confidence 999999998765432211 1112235677999999988889999999999999999999999986432211111110000
Q ss_pred cC-CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhH
Q 039533 860 AL-PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIK 932 (949)
Q Consensus 860 ~~-~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 932 (949)
.. .....+.++.... .+....++..+.+++..||+.+|++|||+++|++.|+++.
T Consensus 227 ~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 227 QMTVVRLIELLERGMR------------------LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred ccchhhhhhhhhcCCC------------------CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 00 0001111111110 0011234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=326.76 Aligned_cols=265 Identities=26% Similarity=0.404 Sum_probs=204.7
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcC-----CCEEEEEEEEecCCCc-chHHHHHHHHHHHhcCCCcceeEEeeeeccccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDE-----GRTTIAVKVFNLQHHG-ASRSFIAECKALKSIRHRNLVKVLTACLGADYR 698 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 698 (949)
.++|.+.+.||+|+||.||+|+... +++.||||+++..... ..+.+.+|++++++++|+||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGD-- 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC--
Confidence 3468889999999999999998743 3578999998755443 3568999999999999999999999976544
Q ss_pred CCccceeEeeeccCCChhhhcCCCCCCCc----cccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeee
Q 039533 699 GNDFKASVYEFMHYGSLEEWLHPFTGEDE----IDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL 774 (949)
Q Consensus 699 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~----~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll 774 (949)
..++||||+++++|.+++........ .......+++.++..++.|++.|++|||+. +++||||||+||++
T Consensus 82 ---~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili 155 (280)
T cd05049 82 ---PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLV 155 (280)
T ss_pred ---CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEE
Confidence 78999999999999999974321110 012335688999999999999999999977 89999999999999
Q ss_pred cCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchh
Q 039533 775 DDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINL 853 (949)
Q Consensus 775 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~ 853 (949)
+.++.+||+|||.++...............++..|+|||++.+..++.++|||||||++|||++ |+.||....... .
T Consensus 156 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--~ 233 (280)
T cd05049 156 GYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--V 233 (280)
T ss_pred cCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--H
Confidence 9999999999999986543322111122346788999999999999999999999999999998 999985322110 1
Q ss_pred hhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 039533 854 HNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQ 929 (949)
Q Consensus 854 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 929 (949)
.... ........+ ...+..+.+++.+||+.||++||++.||++.|+
T Consensus 234 ~~~~-----------~~~~~~~~~-------------------~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 234 IECI-----------TQGRLLQRP-------------------RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHH-----------HcCCcCCCC-------------------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 0000 000000000 123456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=322.11 Aligned_cols=256 Identities=25% Similarity=0.429 Sum_probs=203.3
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
.+|++.+.||+|+||.||+|.+...++.||+|+++... ...+.+.+|++++++++|+||+++++++...+ ..++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l 79 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-----PFYI 79 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCC-----CcEE
Confidence 45788899999999999999998889999999986432 33467899999999999999999999976544 7899
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
||||+++++|.+++... ....+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+||
T Consensus 80 v~e~~~~~~L~~~~~~~--------~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df 148 (263)
T cd05052 80 ITEFMTYGNLLDYLREC--------NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADF 148 (263)
T ss_pred EEEeCCCCcHHHHHHhC--------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCC
Confidence 99999999999998621 234588999999999999999999977 8999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCCc
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
|.+.......... .....++..|+|||...+..++.++|||||||++|||++ |..||......+ .
T Consensus 149 ~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~----------- 214 (263)
T cd05052 149 GLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--V----------- 214 (263)
T ss_pred ccccccccceeec-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--H-----------
Confidence 9998765432211 112234668999999998899999999999999999998 999985321110 0
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHh
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSI 931 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 931 (949)
.+.+....... ....++..+.+++.+|++.+|++||++.|+++.|+.+
T Consensus 215 -~~~~~~~~~~~------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 215 -YELLEKGYRME------------------RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -HHHHHCCCCCC------------------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 00011000000 0012345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=324.51 Aligned_cols=261 Identities=26% Similarity=0.401 Sum_probs=203.6
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCE----EEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccC
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRT----TIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRG 699 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 699 (949)
.++|++.++||+|+||+||+|++..+++ .||+|+++.... ...+.+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---- 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS---- 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC----
Confidence 3578889999999999999999765554 589999875433 2346788999999999999999999987532
Q ss_pred CccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCc
Q 039533 700 NDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMT 779 (949)
Q Consensus 700 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~ 779 (949)
..+++|||+++|+|.+++.. ....+++.+++.++.|++.||+|||++ +|+||||||+||++++++.
T Consensus 82 --~~~l~~~~~~~g~l~~~l~~---------~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~ 147 (279)
T cd05109 82 --TVQLVTQLMPYGCLLDYVRE---------NKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNH 147 (279)
T ss_pred --CcEEEEEcCCCCCHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCc
Confidence 46799999999999999862 234588999999999999999999977 8999999999999999999
Q ss_pred eEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhcc
Q 039533 780 ARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGR 858 (949)
Q Consensus 780 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~ 858 (949)
+||+|||+++...............++..|+|||...+..++.++|||||||++|||++ |..||+...... .
T Consensus 148 ~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~----- 220 (279)
T cd05109 148 VKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE--I----- 220 (279)
T ss_pred EEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--H-----
Confidence 99999999987754333221112335678999999988889999999999999999998 899986321110 1
Q ss_pred ccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhh
Q 039533 859 KALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNIL 935 (949)
Q Consensus 859 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~ 935 (949)
...+....... ....++..+.+++.+||+.||++||++.|+++.++++....
T Consensus 221 -------~~~~~~~~~~~------------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 221 -------PDLLEKGERLP------------------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred -------HHHHHCCCcCC------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 11111100000 00123456789999999999999999999999998875553
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=322.43 Aligned_cols=254 Identities=22% Similarity=0.278 Sum_probs=199.8
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
++|++.+.||+|+||.||+|++..+++.||+|++..........+.+|+.++++++||||+++++++...+ ..++
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~-----~~~i 83 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE-----KLWI 83 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC-----EEEE
Confidence 57999999999999999999998889999999997655445567889999999999999999999976544 7899
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
||||+++++|.++++ ....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+||
T Consensus 84 v~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~df 150 (267)
T cd06646 84 CMEYCGGGSLQDIYH----------VTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADF 150 (267)
T ss_pred EEeCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcC
Confidence 999999999999986 224578999999999999999999977 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccC---CCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGV---GCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
|+++......... ....|+..|+|||.+. ...++.++|||||||++|||++|+.||......... ...
T Consensus 151 g~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-~~~------ 221 (267)
T cd06646 151 GVAAKITATIAKR--KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLM------ 221 (267)
T ss_pred ccceeeccccccc--CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-eee------
Confidence 9998764332211 1345889999999874 345788999999999999999999998533211100 000
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
........ ........+..+.+++.+|++.+|++||+++++++.
T Consensus 222 ------~~~~~~~~---------------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 222 ------SKSNFQPP---------------KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred ------ecCCCCCC---------------CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 00000000 000001234568899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=303.04 Aligned_cols=252 Identities=20% Similarity=0.263 Sum_probs=198.0
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecC--CCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ--HHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
++.|++.+.||+|.|+.||++....+|+.+|+|++... .....+++.+|+++.+.++||||+++.+.+. ...+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~-----~~~~ 84 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESF 84 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhc-----ccce
Confidence 35678889999999999999999999999999998632 2234578999999999999999999987744 4448
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec---CCCc
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD---DYMT 779 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~---~~~~ 779 (949)
.|+|+|+|+|++|..-+- .+..+++..+-..+.||++||.|+|++ +|||||+||+|+++. ..--
T Consensus 85 ~ylvFe~m~G~dl~~eIV----------~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~ 151 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIV----------AREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAA 151 (355)
T ss_pred eEEEEecccchHHHHHHH----------HHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCc
Confidence 899999999999977664 234578889999999999999999988 999999999999994 3446
Q ss_pred eEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 780 ARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 780 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
+||+|||+|..+...... ...+||++|||||++...+|+..+|||+.||++|-++.|.+||-.....+ .+......
T Consensus 152 vKL~~FGvAi~l~~g~~~---~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r-lye~I~~g 227 (355)
T KOG0033|consen 152 VKLADFGLAIEVNDGEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYEQIKAG 227 (355)
T ss_pred eeecccceEEEeCCcccc---ccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH-HHHHHhcc
Confidence 899999999998843332 25679999999999999999999999999999999999999995321111 00000000
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.+ ++ +. +.+....++..+++++|+..||.+|.|+.|.+.
T Consensus 228 ~y-----d~--------------------~~---~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 228 AY-----DY--------------------PS---PEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred cc-----CC--------------------CC---cccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 00 00 00 011234456678899999999999999988753
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=341.69 Aligned_cols=202 Identities=23% Similarity=0.299 Sum_probs=171.7
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
+.|++.+.||+|+||+||+|++..+++.||+|+++... ......+.+|++++++++||||+++++++.+.+ .
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~-----~ 75 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD-----N 75 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC-----E
Confidence 36888999999999999999999899999999997532 223457889999999999999999999976544 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++++||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~----------~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL 142 (381)
T cd05626 76 LYFVMDYIPGGDMMSLLIR----------MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKL 142 (381)
T ss_pred EEEEEecCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEE
Confidence 9999999999999999862 34578889999999999999999977 9999999999999999999999
Q ss_pred eecccceecCCCCC---------------------------------------------ccccccccCccCccCccccCC
Q 039533 783 GDFGLARILSPDHT---------------------------------------------QTSSFSVKGSLGYIAPEYGVG 817 (949)
Q Consensus 783 ~DfG~a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~ 817 (949)
+|||+++....... ........||..|+|||++.+
T Consensus 143 ~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 222 (381)
T cd05626 143 TDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR 222 (381)
T ss_pred eeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC
Confidence 99999764321000 000113469999999999998
Q ss_pred CccCCccchHHHHHHHHHHHhCCCCCcc
Q 039533 818 CEVSTNGDVYSYGILLLELVIGKKPIDI 845 (949)
Q Consensus 818 ~~~~~~sDiwSlGvvl~elltg~~Pf~~ 845 (949)
..++.++|||||||++|||++|+.||..
T Consensus 223 ~~~~~~~DiwSlG~il~elltG~~Pf~~ 250 (381)
T cd05626 223 KGYTQLCDWWSVGVILFEMLVGQPPFLA 250 (381)
T ss_pred CCCCCccceeehhhHHHHHHhCCCCCcC
Confidence 8899999999999999999999999964
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=298.24 Aligned_cols=253 Identities=23% Similarity=0.339 Sum_probs=203.1
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc----c----hHHHHHHHHHHHhc-CCCcceeEEeeeec
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG----A----SRSFIAECKALKSI-RHRNLVKVLTACLG 694 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~----~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 694 (949)
-...|...+.+|.|..++|-++..+.++..+|+|++...... . .+...+|+.+++++ .||+|+.+.+++..
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 345678889999999999999999999999999998633211 1 14567899999998 69999999999554
Q ss_pred ccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeee
Q 039533 695 ADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL 774 (949)
Q Consensus 695 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll 774 (949)
+.+.++|+|.|+.|.|.+|+. ..-.+++.+.++|++|+.+|++|||.. .||||||||+|||+
T Consensus 95 -----~sF~FlVFdl~prGELFDyLt----------s~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILl 156 (411)
T KOG0599|consen 95 -----DAFVFLVFDLMPRGELFDYLT----------SKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILL 156 (411)
T ss_pred -----cchhhhhhhhcccchHHHHhh----------hheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheee
Confidence 448999999999999999997 345689999999999999999999987 89999999999999
Q ss_pred cCCCceEEeecccceecCCCCCccccccccCccCccCccccCC------CccCCccchHHHHHHHHHHHhCCCCCccccc
Q 039533 775 DDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG------CEVSTNGDVYSYGILLLELVIGKKPIDIMFE 848 (949)
Q Consensus 775 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~ 848 (949)
|++.++||+|||+|+.+.++.... ...||++|.|||.+.- ..|+..+|+||+||++|.++.|.+||-
T Consensus 157 ddn~~i~isDFGFa~~l~~GekLr---elCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw---- 229 (411)
T KOG0599|consen 157 DDNMNIKISDFGFACQLEPGEKLR---ELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW---- 229 (411)
T ss_pred ccccceEEeccceeeccCCchhHH---HhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh----
Confidence 999999999999999987766533 4569999999997652 358899999999999999999999983
Q ss_pred cCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 849 GDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 849 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.++..- +...+ ..+ +-+.+-+++.+......+++.+|++.||.+|.|++|+++
T Consensus 230 --------HRkQml--MLR~I---meG------------kyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 230 --------HRKQML--MLRMI---MEG------------KYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred --------HHHHHH--HHHHH---Hhc------------ccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 111000 00000 000 011122334566777899999999999999999999976
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=322.04 Aligned_cols=265 Identities=24% Similarity=0.405 Sum_probs=201.2
Q ss_pred CCCCCeeeeecCceEEEEEEcCCCE--EEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccc-cCCcc
Q 039533 628 FSSANLVGVGSFGSVYKGIIDEGRT--TIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADY-RGNDF 702 (949)
Q Consensus 628 y~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 702 (949)
|.+.+.||+|+||.||+|++..++. .||+|.++... ....+.+.+|++++++++|+||+++++++..... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4577899999999999999876654 69999886432 2334678899999999999999999998754321 22335
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++|+|.+++..... ......+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl 153 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRL----GDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCV 153 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcc----cCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEE
Confidence 7899999999999998742111 11234589999999999999999999977 8999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
+|||+++...............++..|+|||+..+..++.++|||||||++|||++ |+.||...... .......
T Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~--- 228 (272)
T cd05075 154 ADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EIYDYLR--- 228 (272)
T ss_pred CCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHH---
Confidence 99999987654332221122336778999999998889999999999999999999 88998632111 1100000
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHh
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSI 931 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 931 (949)
....... ...++..+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 229 --------~~~~~~~-------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 229 --------QGNRLKQ-------------------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred --------cCCCCCC-------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0000000 012344578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=323.91 Aligned_cols=258 Identities=28% Similarity=0.468 Sum_probs=207.3
Q ss_pred HHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 623 NATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 623 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
+...+|++.+.||.|+||.||+|.+.. ++.+|+|++..........+.+|+.++++++|+||+++++++...+ .
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~ 76 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGE-----P 76 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCC-----C
Confidence 345678999999999999999999985 8899999997665545678999999999999999999999976544 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++++|.+++... ....+++..+..++.|++.|++|||++ +|+||||||+||++++++.+||
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl 145 (261)
T cd05148 77 VYIITELMEKGSLLAFLRSP--------EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKV 145 (261)
T ss_pred eEEEEeecccCCHHHHHhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEE
Confidence 89999999999999999732 234588999999999999999999977 8999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
+|||.+........... ...++..|+|||+..+..++.++||||||+++|+|++ |+.||.......
T Consensus 146 ~d~g~~~~~~~~~~~~~--~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~----------- 212 (261)
T cd05148 146 ADFGLARLIKEDVYLSS--DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE----------- 212 (261)
T ss_pred ccccchhhcCCcccccc--CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH-----------
Confidence 99999987644322111 2336778999999988889999999999999999998 899985332110
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHh
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSI 931 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 931 (949)
..+.+...... +....++..+.+++.+|++.||++|||++|+++.|+.+
T Consensus 213 ---~~~~~~~~~~~------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 213 ---VYDQITAGYRM------------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ---HHHHHHhCCcC------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 00000000000 00113456688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=324.96 Aligned_cols=267 Identities=24% Similarity=0.375 Sum_probs=204.3
Q ss_pred CCCCCCeeeeecCceEEEEEEcC-----CCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDE-----GRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
+|++.+.||+|+||.||+|+... +...+|+|.+..... ...+++.+|+.++++++||||+++++.+...+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG---- 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC----
Confidence 47888999999999999998752 235789998864432 23467889999999999999999999876544
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCC--------------ccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGED--------------EIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCD 766 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~--------------~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrD 766 (949)
..++||||+.+++|.+++....... ........+++.+++.++.|++.||+|||+. +|+|||
T Consensus 77 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~d 152 (290)
T cd05045 77 -PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRD 152 (290)
T ss_pred -CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhh
Confidence 6899999999999999986432110 0111234688999999999999999999977 999999
Q ss_pred CCCCCeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCcc
Q 039533 767 LKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDI 845 (949)
Q Consensus 767 lkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~ 845 (949)
|||+||++++++.+||+|||+++...............++..|+|||+..+..++.++||||||+++|||++ |..||..
T Consensus 153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred hhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999986544332222222345778999999988889999999999999999999 9999853
Q ss_pred ccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHH
Q 039533 846 MFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVV 925 (949)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~ 925 (949)
.... ++.+.++....... ...++..+.+++.+|++.+|++||+++|++
T Consensus 233 ~~~~--------------~~~~~~~~~~~~~~------------------~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~ 280 (290)
T cd05045 233 IAPE--------------RLFNLLKTGYRMER------------------PENCSEEMYNLMLTCWKQEPDKRPTFADIS 280 (290)
T ss_pred CCHH--------------HHHHHHhCCCCCCC------------------CCCCCHHHHHHHHHHccCCcccCCCHHHHH
Confidence 2111 11111111110000 012345688999999999999999999999
Q ss_pred HHHHHhHH
Q 039533 926 HELQSIKN 933 (949)
Q Consensus 926 ~~L~~i~~ 933 (949)
+.|+++..
T Consensus 281 ~~l~~~~~ 288 (290)
T cd05045 281 KELEKMMV 288 (290)
T ss_pred HHHHHHHh
Confidence 99998864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=318.52 Aligned_cols=249 Identities=23% Similarity=0.345 Sum_probs=194.7
Q ss_pred CeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEeeec
Q 039533 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFM 710 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 710 (949)
+.||+|+||.||+|++..+++.||+|.+..... .....+.+|++++++++||||+++++++.... ..++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ-----PIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC-----CeEEEEeec
Confidence 468999999999999988899999998764332 23467899999999999999999999976544 789999999
Q ss_pred cCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccccee
Q 039533 711 HYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARI 790 (949)
Q Consensus 711 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~ 790 (949)
++++|.+++.. ....+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+..
T Consensus 76 ~~~~L~~~~~~---------~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 143 (252)
T cd05084 76 QGGDFLTFLRT---------EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSRE 143 (252)
T ss_pred cCCcHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcc
Confidence 99999999862 223578999999999999999999977 899999999999999999999999999876
Q ss_pred cCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCCchhhhc
Q 039533 791 LSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPDDVMDIV 869 (949)
Q Consensus 791 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 869 (949)
..............++..|+|||.+.+..++.++|||||||++|||++ |..||....... ....+
T Consensus 144 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--------------~~~~~ 209 (252)
T cd05084 144 EEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--------------TREAI 209 (252)
T ss_pred cccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--------------HHHHH
Confidence 543221111111123467999999988889999999999999999998 888885332110 11111
Q ss_pred ccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 039533 870 DSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQ 929 (949)
Q Consensus 870 d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 929 (949)
....... ....++..+.+++.+|++.+|++|||+.||.+.|+
T Consensus 210 ~~~~~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 210 EQGVRLP------------------CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HcCCCCC------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 1100000 00123456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=341.35 Aligned_cols=202 Identities=23% Similarity=0.328 Sum_probs=173.3
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
++|++.+.||+|+||.||+|++..+++.||||+++... ......+.+|+++++.++||||+++++++...+ .
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~-----~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN-----Y 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC-----e
Confidence 47899999999999999999999889999999997432 233456788999999999999999999976544 8
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~E~~~~g~L~~~l~----------~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl 142 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLM----------KKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKL 142 (364)
T ss_pred EEEEECCCCCcHHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEE
Confidence 999999999999999986 234589999999999999999999977 8999999999999999999999
Q ss_pred eecccceecCCCCCcc------------------------------------ccccccCccCccCccccCCCccCCccch
Q 039533 783 GDFGLARILSPDHTQT------------------------------------SSFSVKGSLGYIAPEYGVGCEVSTNGDV 826 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDi 826 (949)
+|||+++......... ......||+.|+|||++.+..++.++||
T Consensus 143 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 222 (364)
T cd05599 143 SDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDW 222 (364)
T ss_pred eecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeee
Confidence 9999987653221100 0112359999999999999899999999
Q ss_pred HHHHHHHHHHHhCCCCCcc
Q 039533 827 YSYGILLLELVIGKKPIDI 845 (949)
Q Consensus 827 wSlGvvl~elltg~~Pf~~ 845 (949)
|||||++|||++|..||..
T Consensus 223 wSlG~il~el~~G~~Pf~~ 241 (364)
T cd05599 223 WSLGVIMYEMLVGYPPFCS 241 (364)
T ss_pred ecchhHHHHhhcCCCCCCC
Confidence 9999999999999999964
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=323.67 Aligned_cols=253 Identities=23% Similarity=0.261 Sum_probs=198.1
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC---cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH---GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
+|++.++||+|+||.||+|.+..+++.||+|++..... .....+.+|+.++++++||||+++++++...+ ..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD-----AL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC-----eE
Confidence 47888999999999999999988899999999864321 22345778999999999999999998875443 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++||||+++|+|.+++... ....+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+
T Consensus 76 ~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~ 144 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNM--------GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRIS 144 (285)
T ss_pred EEEEeccCCCcHHHHHHhc--------CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEe
Confidence 9999999999999888521 124588999999999999999999977 89999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCC
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
|||+++........ ....|+..|+|||++.+..++.++||||+||++|||++|+.||....... ...
T Consensus 145 Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-~~~--------- 211 (285)
T cd05605 145 DLGLAVEIPEGETI---RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-KRE--------- 211 (285)
T ss_pred eCCCceecCCCCcc---ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-HHH---------
Confidence 99999876433221 13458999999999998889999999999999999999999996321100 000
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHHH
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRT-----NMTNVVHE 927 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~~ 927 (949)
.+...+...... .....+..+.+++.+|++.||++|| +++++++.
T Consensus 212 ~~~~~~~~~~~~-------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 212 EVERRVKEDQEE-------------------YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHHHHhhhcccc-------------------cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 000000000000 0012355678999999999999999 88888653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=337.56 Aligned_cols=202 Identities=25% Similarity=0.316 Sum_probs=173.1
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
++|++.+.||+|+||+||+|++..+++.||+|+++... ......+.+|+.++.+++|+||+++++++.+.. .
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~-----~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL-----N 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC-----e
Confidence 47899999999999999999999889999999997432 223356788999999999999999999876544 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~E~~~gg~L~~~l~----------~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL 142 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLM----------KKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKL 142 (363)
T ss_pred EEEEEcCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEE
Confidence 899999999999999996 234588999999999999999999977 9999999999999999999999
Q ss_pred eecccceecCCCCCc---------------------------------cccccccCccCccCccccCCCccCCccchHHH
Q 039533 783 GDFGLARILSPDHTQ---------------------------------TSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSY 829 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSl 829 (949)
+|||+++........ .......||+.|+|||++.+..++.++|||||
T Consensus 143 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSl 222 (363)
T cd05628 143 SDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222 (363)
T ss_pred eeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhh
Confidence 999998764321100 00113469999999999999899999999999
Q ss_pred HHHHHHHHhCCCCCcc
Q 039533 830 GILLLELVIGKKPIDI 845 (949)
Q Consensus 830 Gvvl~elltg~~Pf~~ 845 (949)
||++|||++|+.||..
T Consensus 223 Gvil~ell~G~~Pf~~ 238 (363)
T cd05628 223 GVIMYEMLIGYPPFCS 238 (363)
T ss_pred HHHHHHHHhCCCCCCC
Confidence 9999999999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=353.36 Aligned_cols=271 Identities=20% Similarity=0.282 Sum_probs=206.6
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC---cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH---GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
++|++.++||+|+||.||+|++..+++.||+|+++.... ...+++.+|++++++++||||+++++++.+.+ .
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~-----~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD-----P 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC-----E
Confidence 579999999999999999999998899999999874322 22457899999999999999999999976544 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCcc-ccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEI-DEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
.++||||+++|+|.+++......... .......++..++.++.|+++||+|||+. +|+||||||+||+++.++.+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vK 153 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVV 153 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEE
Confidence 89999999999999998632111111 11234567888999999999999999977 899999999999999999999
Q ss_pred EeecccceecCCCCC----------------ccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCcc
Q 039533 782 VGDFGLARILSPDHT----------------QTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDI 845 (949)
Q Consensus 782 l~DfG~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~ 845 (949)
|+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 999999987621110 0011124699999999999999999999999999999999999999964
Q ss_pred ccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-CHHHH
Q 039533 846 MFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRT-NMTNV 924 (949)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~ev 924 (949)
......... .....+. ......+.+..+.+++.+|++.||++|| +++++
T Consensus 234 ~~~~ki~~~-----------------~~i~~P~-------------~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL 283 (932)
T PRK13184 234 KKGRKISYR-----------------DVILSPI-------------EVAPYREIPPFLSQIAMKALAVDPAERYSSVQEL 283 (932)
T ss_pred cchhhhhhh-----------------hhccChh-------------hccccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 211100000 0000000 0000123456688999999999999996 67788
Q ss_pred HHHHHHhHHh
Q 039533 925 VHELQSIKNI 934 (949)
Q Consensus 925 ~~~L~~i~~~ 934 (949)
.+.|+...+.
T Consensus 284 l~~Le~~lq~ 293 (932)
T PRK13184 284 KQDLEPHLQG 293 (932)
T ss_pred HHHHHHHHhc
Confidence 8888876553
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=323.84 Aligned_cols=263 Identities=24% Similarity=0.361 Sum_probs=202.1
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcC-----CCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccc
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDE-----GRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADY 697 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 697 (949)
++++|.+.+.||+|++|.||+|.+.. .+..||+|.+..... .....+.+|+.++++++|+||+++++++.+.+
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 82 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL- 82 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-
Confidence 35678999999999999999999976 678899998864432 23456899999999999999999999876544
Q ss_pred cCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCC
Q 039533 698 RGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDY 777 (949)
Q Consensus 698 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~ 777 (949)
..++||||+++++|.+++....... .....+++.+++.++.||+.|++|||+. +++||||||+||+++.+
T Consensus 83 ----~~~lv~e~~~g~~L~~~i~~~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~ 152 (277)
T cd05036 83 ----PRFILLELMAGGDLKSFLRENRPRP---ERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCK 152 (277)
T ss_pred ----CcEEEEecCCCCCHHHHHHHhCCCC---CCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEecc
Confidence 6799999999999999997432111 1234689999999999999999999977 89999999999999865
Q ss_pred C---ceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchh
Q 039533 778 M---TARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINL 853 (949)
Q Consensus 778 ~---~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~ 853 (949)
+ .+||+|||.++................+..|+|||++.+..++.++|||||||++|||++ |+.||+...... .
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--~ 230 (277)
T cd05036 153 GPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--V 230 (277)
T ss_pred CCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--H
Confidence 4 699999999987643322111112224568999999998889999999999999999997 999986432111 1
Q ss_pred hhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 039533 854 HNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQ 929 (949)
Q Consensus 854 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 929 (949)
.+.+....... ....++..+.+++.+|++.+|++||++.||++.|+
T Consensus 231 ------------~~~~~~~~~~~------------------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 231 ------------MEFVTGGGRLD------------------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ------------HHHHHcCCcCC------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11111000000 00123456889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=321.14 Aligned_cols=256 Identities=24% Similarity=0.394 Sum_probs=201.6
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.++|++.++||+|++|.||+|... ++..||+|.+.... ...+.+.+|+.++++++|+||+++++++...+ ..+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 77 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEE-----PIY 77 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-----CcE
Confidence 357899999999999999999976 56789999876433 23568899999999999999999998865443 689
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++++|.+++... ....+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|
T Consensus 78 lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~d 146 (261)
T cd05072 78 IITEYMAKGSLLDFLKSD--------EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIAD 146 (261)
T ss_pred EEEecCCCCcHHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECC
Confidence 999999999999998631 234578889999999999999999977 899999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCC
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
||.++......... .....++..|+|||+..+..++.++|||||||++|||+| |+.||....... .....
T Consensus 147 fg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~------ 217 (261)
T cd05072 147 FGLARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--VMSAL------ 217 (261)
T ss_pred CccceecCCCceec-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--HHHHH------
Confidence 99998765432211 112336778999999988889999999999999999998 999985321111 00000
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHh
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSI 931 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 931 (949)
..... .+.....+..+.+++.+|+..+|++||+++++.+.|+++
T Consensus 218 ------~~~~~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 218 ------QRGYR------------------MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ------HcCCC------------------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 00000 000012345678999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=324.82 Aligned_cols=254 Identities=25% Similarity=0.402 Sum_probs=212.0
Q ss_pred CCCCeeeeecCceEEEEEEcCC----CEEEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 629 SSANLVGVGSFGSVYKGIIDEG----RTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 629 ~~~~~lg~G~~g~Vy~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
+..+.||+|-||.||+|....- .-.||||..+... .+..+.|..|..+|++++||||++++|.|.+. ..
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~------P~ 465 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ------PM 465 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc------ce
Confidence 4457899999999999998532 3358999987643 34467899999999999999999999999754 47
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++|||.++.|.|..|++. ....++......++.||+.||+|||+. .+|||||..+|||+.....+|++
T Consensus 466 WivmEL~~~GELr~yLq~---------nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLa 533 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQ---------NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLA 533 (974)
T ss_pred eEEEecccchhHHHHHHh---------ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeec
Confidence 999999999999999983 234588899999999999999999987 89999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCC
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
|||+++.+.++.....+ ...-..-|||||.+...+++.++|||-|||++||++. |..||......+...
T Consensus 534 DFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~--------- 603 (974)
T KOG4257|consen 534 DFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG--------- 603 (974)
T ss_pred ccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE---------
Confidence 99999998877665543 2234567999999999999999999999999999997 999997543332111
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKN 933 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 933 (949)
....+.|.+.+..||+.+..++.+||+.||.+||++.|+...|+.+..
T Consensus 604 -----------------------~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 604 -----------------------HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred -----------------------EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 011233444556889999999999999999999999999999999876
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=323.30 Aligned_cols=264 Identities=22% Similarity=0.340 Sum_probs=210.4
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcc-hHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGA-SRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
+...+.++||+|-||.|.+++.. ++..||||.++...... .++|.+|+++|.+++||||++++|+|...+ ..+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-----Pic 611 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD-----PLC 611 (807)
T ss_pred hheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-----chH
Confidence 34567899999999999999987 47999999998665444 478999999999999999999999998766 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+++|||++|+|.+|+..... ..+..+...+|+.|||.|++||.+- ++||||+.++|+|+|.++++||+|
T Consensus 612 mI~EYmEnGDLnqFl~ahea--------pt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiad 680 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHEL--------PTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIAD 680 (807)
T ss_pred HHHHHHhcCcHHHHHHhccC--------cccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecC
Confidence 99999999999999974321 1234556677999999999999976 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh--CCCCCccccccCchhhhhccccCC
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI--GKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt--g~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
||.++-+............+-..+|||||.+.-+++++++|||+||+++||+++ .+.||....++ ..++-.....+
T Consensus 681 fgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e--~vven~~~~~~ 758 (807)
T KOG1094|consen 681 FGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE--QVVENAGEFFR 758 (807)
T ss_pred cccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH--HHHHhhhhhcC
Confidence 999997665555444444556789999999999999999999999999999876 78898654332 11111111121
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHh
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSI 931 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 931 (949)
..-...+ ...+.-|+..+.+++.+||..|-++||+++++...|++.
T Consensus 759 ~~~~~~~-----------------------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 759 DQGRQVV-----------------------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CCCccee-----------------------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1111111 112235677899999999999999999999999988764
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=341.51 Aligned_cols=368 Identities=28% Similarity=0.457 Sum_probs=265.5
Q ss_pred CCCCCCceeeccCceec-cccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCc
Q 039533 86 GNLSFLKQLYLQVNSFT-HEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTE 164 (949)
Q Consensus 86 ~~l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~ 164 (949)
+-|+..+-.|+++|.|+ +..|.....++++++|.|...++. .+|+.++.|.+|++|.+++|++.. +-+.++.|+.|+
T Consensus 4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~-vhGELs~Lp~LR 81 (1255)
T KOG0444|consen 4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLIS-VHGELSDLPRLR 81 (1255)
T ss_pred cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHh-hhhhhccchhhH
Confidence 34566677777888887 457777888888888888888877 788888888888888888887763 345667777888
Q ss_pred EEECCCCCCCC-CCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCcccccccccccCCCCChhhhccccc
Q 039533 165 ILNLGSNHLTG-SIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQH 243 (949)
Q Consensus 165 ~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~ 243 (949)
.+++.+|++.. -+|..+..+..|+.||||+|+++ ..|..+..-+++-.|+||+|+|..|||.+ +.+|+
T Consensus 82 sv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~l------finLt---- 150 (1255)
T KOG0444|consen 82 SVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSL------FINLT---- 150 (1255)
T ss_pred HHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchH------HHhhH----
Confidence 88888887763 35667777888888888888887 77877877888888888888887776653 23333
Q ss_pred cccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEE
Q 039533 244 FTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRL 323 (949)
Q Consensus 244 L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 323 (949)
.|-+||||+|++.. +|+.+..+ ..|++|.|++|.+...--..+-.+++|+.|
T Consensus 151 --------------------------DLLfLDLS~NrLe~-LPPQ~RRL-~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vL 202 (1255)
T KOG0444|consen 151 --------------------------DLLFLDLSNNRLEM-LPPQIRRL-SMLQTLKLSNNPLNHFQLRQLPSMTSLSVL 202 (1255)
T ss_pred --------------------------hHhhhccccchhhh-cCHHHHHH-hhhhhhhcCCChhhHHHHhcCccchhhhhh
Confidence 33444444444442 33334444 246666666666543333334456677777
Q ss_pred Eeecceec-ccCCCcccccCCCCEEecCCcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccc
Q 039533 324 DMWNNQLS-GTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNL 402 (949)
Q Consensus 324 ~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 402 (949)
.+++.+=+ .-+|.++..+.+|..+|||.|.+. ..|+.+.++++|+.|+|++|+|+ .+.-......+|+.|+||+|++
T Consensus 203 hms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQL 280 (1255)
T KOG0444|consen 203 HMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQL 280 (1255)
T ss_pred hcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchh
Confidence 77765533 356777777777777777777777 67777777777777777777777 4444556667777778888887
Q ss_pred cCCCCCcccCCcccceeeccCCCccCC-CCccccccccccceeeeccccccccCCcccccccchhhcccCccccccccCC
Q 039533 403 SGTIPPQFFSLSSLSISLDWSRNKLTG-SLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISS 481 (949)
Q Consensus 403 ~~~~p~~~~~l~~l~~~L~ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~ 481 (949)
+ .+|+.++.++.| +.|.+.+|+++- -+|..++.+.+|+++..++|.+. .+|+.++.|..|+.|.|++|++- .+|+
T Consensus 281 t-~LP~avcKL~kL-~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPe 356 (1255)
T KOG0444|consen 281 T-VLPDAVCKLTKL-TKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPE 356 (1255)
T ss_pred c-cchHHHhhhHHH-HHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echh
Confidence 7 777777777777 567777777653 47888888888888888888888 88888888888888888888888 6788
Q ss_pred CcCCCCCCCEEECCCCcCC
Q 039533 482 SLGSLRGLRVLDLSQNNLS 500 (949)
Q Consensus 482 ~~~~l~~L~~L~Ls~N~l~ 500 (949)
.+.-|+.|+.|||..|.=-
T Consensus 357 aIHlL~~l~vLDlreNpnL 375 (1255)
T KOG0444|consen 357 AIHLLPDLKVLDLRENPNL 375 (1255)
T ss_pred hhhhcCCcceeeccCCcCc
Confidence 8888888888888888644
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=331.44 Aligned_cols=245 Identities=22% Similarity=0.273 Sum_probs=190.5
Q ss_pred CCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHH---HhcCCCcceeEEeeeecccccCCc
Q 039533 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKAL---KSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 628 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
|++.+.||+|+||.||+|.+..+++.||||+++... ....+.+.+|++++ ++++||||+++++++...+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~----- 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTED----- 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC-----
Confidence 677899999999999999999889999999997432 22335566776665 4567999999999976544
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++++|..++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 76 ~~~lv~E~~~~~~L~~~~~-----------~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~k 141 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIH-----------TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVK 141 (324)
T ss_pred EEEEEEcCCCCCcHHHHhh-----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEE
Confidence 7899999999999998875 23589999999999999999999977 999999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
|+|||+++........ .....|++.|+|||++.+..++.++|||||||++|||++|+.||....... .
T Consensus 142 L~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~--~-------- 209 (324)
T cd05589 142 IADFGLCKEGMGFGDR--TSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE--V-------- 209 (324)
T ss_pred eCcccCCccCCCCCCc--ccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH--H--------
Confidence 9999998754322211 123568999999999999899999999999999999999999996331110 0
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC-----HHHHHH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTN-----MTNVVH 926 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~~ 926 (949)
...+...... . ....+..+.+++.+|++.||++||+ +.++++
T Consensus 210 ---~~~i~~~~~~-~-------------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 210 ---FDSIVNDEVR-Y-------------------PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ---HHHHHhCCCC-C-------------------CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 0000000000 0 0122455788999999999999994 555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=334.26 Aligned_cols=243 Identities=21% Similarity=0.241 Sum_probs=191.7
Q ss_pred CeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEee
Q 039533 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYE 708 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 708 (949)
+.||+|+||.||+|++..+++.||+|+++... ......+.+|+++++.++||||+++++++...+ ..++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~-----~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD-----RLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCC-----EEEEEEe
Confidence 47999999999999998899999999997432 223456788999999999999999998865444 7899999
Q ss_pred eccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecccc
Q 039533 709 FMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLA 788 (949)
Q Consensus 709 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a 788 (949)
|+++|+|.+++. ....+++..+..++.|++.||+|||+. .+|+||||||+||+++.++.+||+|||++
T Consensus 76 ~~~~~~L~~~l~----------~~~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~ 143 (325)
T cd05594 76 YANGGELFFHLS----------RERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLC 143 (325)
T ss_pred CCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCC
Confidence 999999999886 234588999999999999999999962 28999999999999999999999999998
Q ss_pred eecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhhh
Q 039533 789 RILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDI 868 (949)
Q Consensus 789 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 868 (949)
+......... ....||..|+|||++.+..++.++|||||||++|||++|+.||....... .... +
T Consensus 144 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~--~~~~-----------i 208 (325)
T cd05594 144 KEGIKDGATM--KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFEL-----------I 208 (325)
T ss_pred eecCCCCccc--ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH--HHHH-----------H
Confidence 7543222211 13459999999999999899999999999999999999999995321110 0000 0
Q ss_pred cccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 039533 869 VDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRT-----NMTNVVH 926 (949)
Q Consensus 869 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~ 926 (949)
..... ..+ ......+.+++.+|++.||++|+ ++.|+++
T Consensus 209 ~~~~~-~~p-------------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 209 LMEEI-RFP-------------------RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred hcCCC-CCC-------------------CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 00000 000 02234578899999999999996 8998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=340.02 Aligned_cols=252 Identities=22% Similarity=0.262 Sum_probs=200.6
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
++|.+.+.||+|+||+||+|++..+++.||||+++... ......+.+|++++..++||||+++++++.+.+ .
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEE-----H 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCC-----e
Confidence 47899999999999999999999899999999997432 234467889999999999999999998865443 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL 142 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIR----------KDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKL 142 (350)
T ss_pred EEEEEcCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEe
Confidence 8999999999999999962 24688999999999999999999976 9999999999999999999999
Q ss_pred eecccceecCCCC---------------------------CccccccccCccCccCccccCCCccCCccchHHHHHHHHH
Q 039533 783 GDFGLARILSPDH---------------------------TQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLE 835 (949)
Q Consensus 783 ~DfG~a~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~e 835 (949)
+|||+++...... .........||+.|+|||++.+..++.++|||||||++||
T Consensus 143 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 222 (350)
T cd05573 143 ADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222 (350)
T ss_pred ecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhh
Confidence 9999998765433 0011123458999999999999999999999999999999
Q ss_pred HHhCCCCCccccccCchhhhhccccCCCchhhhcc--cCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccC
Q 039533 836 LVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVD--SSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSME 913 (949)
Q Consensus 836 lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 913 (949)
|++|+.||....... .. ..+.. ..... +.....+..+.+++.+|+.
T Consensus 223 ll~g~~Pf~~~~~~~-~~------------~~i~~~~~~~~~------------------p~~~~~~~~~~~li~~ll~- 270 (350)
T cd05573 223 MLYGFPPFYSDTLQE-TY------------NKIINWKESLRF------------------PPDPPVSPEAIDLICRLLC- 270 (350)
T ss_pred hccCCCCCCCCCHHH-HH------------HHHhccCCcccC------------------CCCCCCCHHHHHHHHHHcc-
Confidence 999999996432110 00 00000 00000 0000134567889999997
Q ss_pred CCCCCCC-HHHHHHH
Q 039533 914 LPQDRTN-MTNVVHE 927 (949)
Q Consensus 914 dP~~RPs-~~ev~~~ 927 (949)
||++||+ ++|+++.
T Consensus 271 dp~~R~~s~~~ll~h 285 (350)
T cd05573 271 DPEDRLGSFEEIKSH 285 (350)
T ss_pred ChhhcCCCHHHHhcC
Confidence 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=338.80 Aligned_cols=256 Identities=20% Similarity=0.228 Sum_probs=198.4
Q ss_pred HHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccC
Q 039533 623 NATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRG 699 (949)
Q Consensus 623 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 699 (949)
...++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+.+++.++||||+++++++....
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~--- 116 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK--- 116 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC---
Confidence 34568999999999999999999999899999999996432 223355788999999999999999998865444
Q ss_pred CccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCc
Q 039533 700 NDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMT 779 (949)
Q Consensus 700 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~ 779 (949)
..++||||+++|+|.+++.. ..++...+..++.|++.||+|||+. +|+||||||+|||++.++.
T Consensus 117 --~~~lv~Ey~~gg~L~~~l~~-----------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ 180 (370)
T cd05596 117 --YLYMVMEYMPGGDLVNLMSN-----------YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGH 180 (370)
T ss_pred --EEEEEEcCCCCCcHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCC
Confidence 79999999999999999862 2477888999999999999999977 9999999999999999999
Q ss_pred eEEeecccceecCCCCCccccccccCccCccCccccCCC----ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhh
Q 039533 780 ARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC----EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHN 855 (949)
Q Consensus 780 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~ 855 (949)
+||+|||.++......... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .
T Consensus 181 ~kL~DfG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~--- 255 (370)
T cd05596 181 LKLADFGTCMKMDANGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-T--- 255 (370)
T ss_pred EEEEeccceeeccCCCccc-CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-H---
Confidence 9999999998765432211 1234699999999987653 47899999999999999999999996321110 0
Q ss_pred hccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCC--CCCHHHHHHH
Q 039533 856 FGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQD--RTNMTNVVHE 927 (949)
Q Consensus 856 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~ev~~~ 927 (949)
...+.+.... ..++.....+..+.+++.+|+..+|++ ||++.|+++.
T Consensus 256 ---------~~~i~~~~~~----------------~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 256 ---------YSKIMDHKNS----------------LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ---------HHHHHcCCCc----------------CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0111110000 000000123456788999999999988 9999999653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=330.65 Aligned_cols=242 Identities=22% Similarity=0.255 Sum_probs=190.2
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCC-cceeEEeeeecccccCCcc
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHR-NLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~ 702 (949)
+|++.+.||+|+||.||+|++..+++.||||+++... ....+.+..|.+++..+.|+ +|+++++++...+ .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-----~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD-----R 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC-----E
Confidence 5888999999999999999999888999999997432 23346678899999999765 5788888765443 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~E~~~~g~L~~~~~----------~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL 142 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQ----------QVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKI 142 (324)
T ss_pred EEEEEcCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEE
Confidence 899999999999999986 234578899999999999999999977 9999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
+|||+++........ .....||..|+|||++.+..++.++||||+||++|||+||+.||....... ..
T Consensus 143 ~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--~~-------- 210 (324)
T cd05587 143 ADFGMCKENIFGGKT--TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--LF-------- 210 (324)
T ss_pred eecCcceecCCCCCc--eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HH--------
Confidence 999998754322211 123458999999999999899999999999999999999999996332110 00
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNM 921 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 921 (949)
..+.+... ..+ ......+.+++.+|++.||++||+.
T Consensus 211 ---~~i~~~~~-~~~-------------------~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 211 ---QSIMEHNV-SYP-------------------KSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ---HHHHcCCC-CCC-------------------CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 00000000 000 0123457889999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=323.99 Aligned_cols=268 Identities=22% Similarity=0.339 Sum_probs=202.8
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcC-----CCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccc
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDE-----GRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADY 697 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 697 (949)
..++|++.+.||+|+||.||+|..+. .+..||+|.++.... .....+.+|+.++++++||||+++++++...+
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 82 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ- 82 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-
Confidence 45789999999999999999997642 356899998764332 22346788999999999999999999875444
Q ss_pred cCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCC
Q 039533 698 RGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDY 777 (949)
Q Consensus 698 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~ 777 (949)
..++||||+++|+|.+++................++..+..++.|++.||+|||++ +|+||||||+||+++++
T Consensus 83 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~ 155 (288)
T cd05061 83 ----PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD 155 (288)
T ss_pred ----CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCC
Confidence 78999999999999999974322111111234567788999999999999999977 99999999999999999
Q ss_pred CceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhh
Q 039533 778 MTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNF 856 (949)
Q Consensus 778 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~ 856 (949)
+.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......+ ...
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~--~~~- 232 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ--VLK- 232 (288)
T ss_pred CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH-
Confidence 9999999999986544332222222335678999999998889999999999999999999 788885321110 000
Q ss_pred ccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHh
Q 039533 857 GRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSI 931 (949)
Q Consensus 857 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 931 (949)
.+.+...... ...++..+.+++.+|++.+|++|||+.|+++.+++.
T Consensus 233 ----------~~~~~~~~~~-------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 233 ----------FVMDGGYLDQ-------------------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred ----------HHHcCCCCCC-------------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 0111100000 012345789999999999999999999999988874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=322.76 Aligned_cols=265 Identities=23% Similarity=0.352 Sum_probs=203.7
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCC-----CEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeeccccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEG-----RTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYR 698 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 698 (949)
.++|++.+.||+|+||.||+|.+... +..||+|.+..... .....+.+|+.++++++||||+++++++....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-- 82 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ-- 82 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC--
Confidence 35788999999999999999998643 37899999864432 33457889999999999999999999976543
Q ss_pred CCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC
Q 039533 699 GNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM 778 (949)
Q Consensus 699 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~ 778 (949)
..++||||+++++|.+++...............+++..++.++.|++.||.|||+. +|+||||||+||+++.++
T Consensus 83 ---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~ 156 (277)
T cd05032 83 ---PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDL 156 (277)
T ss_pred ---CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCC
Confidence 78999999999999999974332211111234578999999999999999999976 999999999999999999
Q ss_pred ceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhc
Q 039533 779 TARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFG 857 (949)
Q Consensus 779 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~ 857 (949)
.+||+|||+++...............++..|+|||...+..++.++|||||||++||+++ |+.||...... ......
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~~~ 234 (277)
T cd05032 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--EVLKFV 234 (277)
T ss_pred CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--HHHHHH
Confidence 999999999986654432222223346789999999988889999999999999999998 99998532111 111100
Q ss_pred cccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 039533 858 RKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQ 929 (949)
Q Consensus 858 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 929 (949)
.+......+ ..++..+.+++.+|++.+|++|||+.|+++.|+
T Consensus 235 -----------~~~~~~~~~-------------------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 -----------IDGGHLDLP-------------------ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -----------hcCCCCCCC-------------------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 000000000 123557889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=325.53 Aligned_cols=270 Identities=21% Similarity=0.351 Sum_probs=206.5
Q ss_pred HHhcCCCCCCeeeeecCceEEEEEEcC-----CCEEEEEEEEecCCC-cchHHHHHHHHHHHhc-CCCcceeEEeeeecc
Q 039533 623 NATSGFSSANLVGVGSFGSVYKGIIDE-----GRTTIAVKVFNLQHH-GASRSFIAECKALKSI-RHRNLVKVLTACLGA 695 (949)
Q Consensus 623 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 695 (949)
...++|++.+.||+|+||.||+|.... ....+|+|++..... ....++.+|+.+++++ +|+||+++++++...
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 344678899999999999999999863 337899999875332 2335688999999999 899999999997654
Q ss_pred cccCCccceeEeeeccCCChhhhcCCCCCCCc------cccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 039533 696 DYRGNDFKASVYEFMHYGSLEEWLHPFTGEDE------IDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKP 769 (949)
Q Consensus 696 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp 769 (949)
+ ..+++|||+++|+|.++++....... .......+++..++.++.|++.||+|||+. +|+||||||
T Consensus 89 ~-----~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp 160 (293)
T cd05053 89 G-----PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAA 160 (293)
T ss_pred C-----CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Cccccccce
Confidence 4 78999999999999999964321100 112345689999999999999999999977 999999999
Q ss_pred CCeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccc
Q 039533 770 SNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFE 848 (949)
Q Consensus 770 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~ 848 (949)
+||++++++.+||+|||.++.+.............++..|+|||++.+..++.++|||||||++||+++ |..||.....
T Consensus 161 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 240 (293)
T cd05053 161 RNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 240 (293)
T ss_pred eeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence 999999999999999999987654332222222335678999999988889999999999999999998 9999853211
Q ss_pred cCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 039533 849 GDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHEL 928 (949)
Q Consensus 849 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 928 (949)
.+ ..+.+...... .....++..+.+++.+|+..+|++||||.|+++.|
T Consensus 241 ~~--------------~~~~~~~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l 288 (293)
T cd05053 241 EE--------------LFKLLKEGYRM------------------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288 (293)
T ss_pred HH--------------HHHHHHcCCcC------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 10 00111100000 00112345688999999999999999999999999
Q ss_pred HHhH
Q 039533 929 QSIK 932 (949)
Q Consensus 929 ~~i~ 932 (949)
+++.
T Consensus 289 ~~~~ 292 (293)
T cd05053 289 DRML 292 (293)
T ss_pred HHhh
Confidence 9874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=322.50 Aligned_cols=265 Identities=22% Similarity=0.356 Sum_probs=201.5
Q ss_pred cCCCCCCeeeeecCceEEEEEEc----CCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 626 SGFSSANLVGVGSFGSVYKGIID----EGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
++|++.+.||+|+||.||+|... .++..||+|.++.... .....+.+|++++++++||||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 80 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ---- 80 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC----
Confidence 46788899999999999999852 3567899999874332 23357889999999999999999999975444
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCC-------ccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCee
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGED-------EIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVL 773 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~-------~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIl 773 (949)
..++||||+++++|.+++....... ........+++.++..++.|++.||+|||++ +++||||||+||+
T Consensus 81 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nil 156 (283)
T cd05090 81 -PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNIL 156 (283)
T ss_pred -ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEE
Confidence 7899999999999999985221100 0011134588999999999999999999977 8999999999999
Q ss_pred ecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCch
Q 039533 774 LDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDIN 852 (949)
Q Consensus 774 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~ 852 (949)
+++++.+||+|||+++...............++..|+|||+..+..++.++|||||||++|||++ |..||...... .
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~--~ 234 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--E 234 (283)
T ss_pred EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--H
Confidence 99999999999999987644332222223346778999999988889999999999999999998 99998532111 1
Q ss_pred hhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 039533 853 LHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQS 930 (949)
Q Consensus 853 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 930 (949)
. .+.++...... ....++..+.+++.+|++.||++||++.+|.+.|..
T Consensus 235 ~------------~~~~~~~~~~~------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 V------------IEMVRKRQLLP------------------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred H------------HHHHHcCCcCC------------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1 11111100000 001234567889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=339.95 Aligned_cols=202 Identities=23% Similarity=0.291 Sum_probs=171.5
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+ .
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~-----~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ-----Y 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-----e
Confidence 47899999999999999999999899999999986432 223456888999999999999999999976544 8
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~----------~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl 142 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIK----------YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKL 142 (377)
T ss_pred eEEEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEE
Confidence 9999999999999999862 34578889999999999999999977 9999999999999999999999
Q ss_pred eecccceecCCCCC------------cc---------------------------------ccccccCccCccCccccCC
Q 039533 783 GDFGLARILSPDHT------------QT---------------------------------SSFSVKGSLGYIAPEYGVG 817 (949)
Q Consensus 783 ~DfG~a~~~~~~~~------------~~---------------------------------~~~~~~gt~~y~aPE~~~~ 817 (949)
+|||+++.+..... .. ......||+.|+|||++.+
T Consensus 143 ~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 222 (377)
T cd05629 143 SDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ 222 (377)
T ss_pred eecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc
Confidence 99999964321100 00 0012459999999999999
Q ss_pred CccCCccchHHHHHHHHHHHhCCCCCcc
Q 039533 818 CEVSTNGDVYSYGILLLELVIGKKPIDI 845 (949)
Q Consensus 818 ~~~~~~sDiwSlGvvl~elltg~~Pf~~ 845 (949)
..++.++|||||||++|||++|+.||..
T Consensus 223 ~~~~~~~DiwSlGvil~elltG~~Pf~~ 250 (377)
T cd05629 223 QGYGQECDWWSLGAIMFECLIGWPPFCS 250 (377)
T ss_pred CCCCCceeeEecchhhhhhhcCCCCCCC
Confidence 8999999999999999999999999963
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=329.84 Aligned_cols=237 Identities=26% Similarity=0.296 Sum_probs=187.5
Q ss_pred CeeeeecCceEEEEEEcCCCEEEEEEEEecC---CCcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCCccceeEe
Q 039533 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ---HHGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGNDFKASVY 707 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 707 (949)
+.||+|+||.||+|++..+++.||||+++.. .....+.+..|..++... +||||+++++++...+ ..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~-----~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPD-----RLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCC-----EEEEEE
Confidence 4799999999999999988999999998743 223345677888888877 6999999999875544 789999
Q ss_pred eeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccc
Q 039533 708 EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGL 787 (949)
Q Consensus 708 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~ 787 (949)
||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 Ey~~~g~L~~~i~----------~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~ 142 (320)
T cd05590 76 EFVNGGDLMFHIQ----------KSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGM 142 (320)
T ss_pred cCCCCchHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCC
Confidence 9999999999886 234588999999999999999999977 999999999999999999999999999
Q ss_pred ceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhh
Q 039533 788 ARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMD 867 (949)
Q Consensus 788 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 867 (949)
++......... ....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... .
T Consensus 143 ~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--~~~-----------~ 207 (320)
T cd05590 143 CKEGIFNGKTT--STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD--LFE-----------A 207 (320)
T ss_pred CeecCcCCCcc--cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--HHH-----------H
Confidence 87643222211 23458999999999998899999999999999999999999996432110 000 0
Q ss_pred hcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCH
Q 039533 868 IVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNM 921 (949)
Q Consensus 868 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 921 (949)
+..... ..+ ...+..+.+++.+|++.||++||++
T Consensus 208 i~~~~~-~~~-------------------~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 208 ILNDEV-VYP-------------------TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HhcCCC-CCC-------------------CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 000000 000 0123457889999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=321.98 Aligned_cols=264 Identities=24% Similarity=0.366 Sum_probs=203.5
Q ss_pred cCCCCCCeeeeecCceEEEEEEc-----CCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 626 SGFSSANLVGVGSFGSVYKGIID-----EGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
.+|+..++||+|+||.||+|... .++..+|+|.+..........+.+|++++++++|+||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 80 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGR---- 80 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC----
Confidence 46788899999999999999743 346789999987665555678999999999999999999999876544
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCC-----ccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGED-----EIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD 775 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~ 775 (949)
..++||||+++++|.+++....... ........+++..++.++.|++.|++|||+. +++||||||+||+++
T Consensus 81 -~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~ 156 (280)
T cd05092 81 -PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVG 156 (280)
T ss_pred -ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEc
Confidence 6899999999999999997432110 0111224589999999999999999999977 999999999999999
Q ss_pred CCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhh
Q 039533 776 DYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLH 854 (949)
Q Consensus 776 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~ 854 (949)
+++.+||+|||+++...............++..|+|||+..+..++.++|||||||++|||++ |++||......+ ..
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~ 234 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--AI 234 (280)
T ss_pred CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--HH
Confidence 999999999999986644332222222335788999999998899999999999999999998 999985332111 00
Q ss_pred hhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 039533 855 NFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQ 929 (949)
Q Consensus 855 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 929 (949)
+........ .....++..+.+++.+||+.||++||++.||.+.|+
T Consensus 235 ------------~~~~~~~~~------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 235 ------------ECITQGREL------------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ------------HHHHcCccC------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 000000000 000123456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=316.66 Aligned_cols=255 Identities=30% Similarity=0.478 Sum_probs=201.2
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.++|++.+.||+|++|.||+|.+. +++.||+|.++... ...+.+.+|+.++++++||||+++++++.... ..+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 77 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEE-----PIY 77 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCC-----Cee
Confidence 456889999999999999999986 46789999986543 23567899999999999999999999875443 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++++|.+++... ....+++..+..++.|++.|+.|||+. +|+||||||+||++++++.+||+|
T Consensus 78 lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d 146 (261)
T cd05068 78 IVTELMKYGSLLEYLQGG--------AGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVAD 146 (261)
T ss_pred eeeecccCCcHHHHHhcc--------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECC
Confidence 999999999999999631 134589999999999999999999977 899999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCC
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
||.++......... ......+..|+|||+..+..++.++||||||+++|||++ |+.||....... .
T Consensus 147 fg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~---------- 213 (261)
T cd05068 147 FGLARVIKEDIYEA-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE--V---------- 213 (261)
T ss_pred cceEEEccCCcccc-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH--H----------
Confidence 99998775332211 111223457999999998899999999999999999999 999986331110 0
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQS 930 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 930 (949)
...++..... +.....+..+.+++.+|++.+|++||++.++.+.|++
T Consensus 214 --~~~~~~~~~~------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 214 --LQQVDQGYRM------------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred --HHHHHcCCCC------------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0001100000 0001234568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=327.85 Aligned_cols=241 Identities=22% Similarity=0.275 Sum_probs=187.0
Q ss_pred CeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCCccceeEe
Q 039533 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGNDFKASVY 707 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 707 (949)
+.||+|+||.||+|++..+++.||+|+++... ....+....|..++... +||||+++++++...+ ..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~-----~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE-----HLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCC-----EEEEEE
Confidence 47999999999999999889999999997432 22334556677777654 8999999998865443 789999
Q ss_pred eeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccc
Q 039533 708 EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGL 787 (949)
Q Consensus 708 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~ 787 (949)
||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~gg~L~~~~~----------~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~ 142 (316)
T cd05592 76 EYLNGGDLMFHIQ----------SSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGM 142 (316)
T ss_pred cCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcC
Confidence 9999999999986 234588899999999999999999977 999999999999999999999999999
Q ss_pred ceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhh
Q 039533 788 ARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMD 867 (949)
Q Consensus 788 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 867 (949)
++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... .
T Consensus 143 a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~--~~~~-----------~ 207 (316)
T cd05592 143 CKENMNGEGK--ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED--ELFD-----------S 207 (316)
T ss_pred CeECCCCCCc--cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH--HHHH-----------H
Confidence 9865332221 12345899999999999989999999999999999999999999633211 0000 0
Q ss_pred hcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHH-HHH
Q 039533 868 IVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMT-NVV 925 (949)
Q Consensus 868 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-ev~ 925 (949)
+.. .....+ ...+..+.+++.+|++.||++||++. ++.
T Consensus 208 i~~-~~~~~~-------------------~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 208 ILN-DRPHFP-------------------RWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred HHc-CCCCCC-------------------CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 000 000000 01234567899999999999999876 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=323.24 Aligned_cols=250 Identities=20% Similarity=0.288 Sum_probs=201.5
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
.+|++.+.||+|++|.||+|.+..+++.||+|.+........+.+.+|+.++++++|+||+++++++.... ..++
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~-----~~~l 94 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-----ELWV 94 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC-----EEEE
Confidence 57899999999999999999998889999999998666555678899999999999999999999876544 7899
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
||||+++++|.+++. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 95 v~e~~~~~~L~~~~~-----------~~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~df 160 (296)
T cd06654 95 VMEYLAGGSLTDVVT-----------ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDF 160 (296)
T ss_pred eecccCCCCHHHHHH-----------hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECcc
Confidence 999999999999985 13478889999999999999999977 8999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCch
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDV 865 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 865 (949)
|.+.......... ....|++.|+|||.+.+..++.++|||||||++|||++|+.||.......... ....
T Consensus 161 g~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~-~~~~------- 230 (296)
T cd06654 161 GFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIAT------- 230 (296)
T ss_pred ccchhcccccccc--CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH-HHhc-------
Confidence 9987654332211 13458899999999988889999999999999999999999996432111000 0000
Q ss_pred hhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 866 MDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 866 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
... +.. ......+..+.+++.+|+..+|++||++.|+++
T Consensus 231 ----~~~--~~~----------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 231 ----NGT--PEL----------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred ----CCC--CCC----------------CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 000 000 000123456788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=323.16 Aligned_cols=270 Identities=22% Similarity=0.340 Sum_probs=205.0
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCE--EEEEEEEecCC-CcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCCc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRT--TIAVKVFNLQH-HGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 701 (949)
++|++.+.||+|+||.||+|....++. .+++|.++... ....+.+.+|++++.++ +||||+++++++...+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~----- 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRG----- 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCC-----
Confidence 579999999999999999999876654 47888876322 23346788999999999 7999999999875544
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCc------cccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDE------IDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD 775 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~ 775 (949)
..++||||+++++|.+++........ .......+++..++.++.|++.|++|||++ +|+||||||+||+++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~ 153 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVG 153 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEEC
Confidence 78999999999999999964321110 011224588999999999999999999977 999999999999999
Q ss_pred CCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhh
Q 039533 776 DYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLH 854 (949)
Q Consensus 776 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~ 854 (949)
+++.+||+|||++......... .....+..|+|||+..+..++.++|||||||++|||++ |..||.......
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---- 226 (297)
T cd05089 154 ENLASKIADFGLSRGEEVYVKK---TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---- 226 (297)
T ss_pred CCCeEEECCcCCCccccceecc---CCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH----
Confidence 9999999999998643211111 11123567999999988889999999999999999997 999985332110
Q ss_pred hhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHh
Q 039533 855 NFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNI 934 (949)
Q Consensus 855 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 934 (949)
. .+.+....... ....++..+.+++.+|++.+|.+||+++++++.|+.+.++
T Consensus 227 -~---------~~~~~~~~~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 227 -L---------YEKLPQGYRME------------------KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred -H---------HHHHhcCCCCC------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 0 00000000000 0012345678999999999999999999999999999887
Q ss_pred hccC
Q 039533 935 LLGV 938 (949)
Q Consensus 935 ~~~~ 938 (949)
....
T Consensus 279 ~~~~ 282 (297)
T cd05089 279 RKAY 282 (297)
T ss_pred hccc
Confidence 6554
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=329.89 Aligned_cols=194 Identities=26% Similarity=0.329 Sum_probs=166.5
Q ss_pred CeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCCccceeEe
Q 039533 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGNDFKASVY 707 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 707 (949)
++||+|+||.||+|++..+++.||+|+++... ....+.+..|..+++++ +||||+++++++.... ..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~-----~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTES-----RLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCC-----EEEEEE
Confidence 47999999999999999899999999997532 22345678899999998 7999999999876544 789999
Q ss_pred eeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccc
Q 039533 708 EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGL 787 (949)
Q Consensus 708 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~ 787 (949)
||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~g~L~~~~~----------~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~ 142 (329)
T cd05588 76 EFVSGGDLMFHMQ----------RQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGM 142 (329)
T ss_pred eCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcc
Confidence 9999999998885 234689999999999999999999977 999999999999999999999999999
Q ss_pred ceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCcc
Q 039533 788 ARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDI 845 (949)
Q Consensus 788 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~ 845 (949)
++........ .....||..|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus 143 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 143 CKEGIRPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccccccCCCc--cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 8753222111 1234589999999999998999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=336.01 Aligned_cols=206 Identities=21% Similarity=0.295 Sum_probs=174.1
Q ss_pred HHHHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeeccc
Q 039533 620 DLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGAD 696 (949)
Q Consensus 620 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 696 (949)
++....++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++....
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 33445678999999999999999999999889999999986422 223456789999999999999999999875443
Q ss_pred ccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC
Q 039533 697 YRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD 776 (949)
Q Consensus 697 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~ 776 (949)
..++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||++++
T Consensus 117 -----~~~lv~Ey~~gg~L~~~l~~-----------~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~ 177 (370)
T cd05621 117 -----YLYMVMEYMPGGDLVNLMSN-----------YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDK 177 (370)
T ss_pred -----EEEEEEcCCCCCcHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECC
Confidence 79999999999999999862 2478889999999999999999977 9999999999999999
Q ss_pred CCceEEeecccceecCCCCCccccccccCccCccCccccCCC----ccCCccchHHHHHHHHHHHhCCCCCcc
Q 039533 777 YMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC----EVSTNGDVYSYGILLLELVIGKKPIDI 845 (949)
Q Consensus 777 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDiwSlGvvl~elltg~~Pf~~ 845 (949)
++.+||+|||+|+........ ......||+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus 178 ~~~~kL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~ 249 (370)
T cd05621 178 HGHLKLADFGTCMKMDETGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA 249 (370)
T ss_pred CCCEEEEecccceecccCCce-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC
Confidence 999999999999876543221 11245699999999998754 378899999999999999999999963
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=322.34 Aligned_cols=273 Identities=24% Similarity=0.309 Sum_probs=198.7
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhc---CCCcceeEEeeeecccccCCc
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSI---RHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~ 701 (949)
+|++.+.||+|+||.||+|++..+++.||+|+++.... .....+.+|+++++++ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 58889999999999999999998999999999875322 2234566787777766 699999999998765444455
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+.+ +|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~--------~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~k 148 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV--------PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVK 148 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEE
Confidence 78999999974 888888621 123489999999999999999999977 899999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcc---
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGR--- 858 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~--- 858 (949)
|+|||+++........ ....||..|+|||++.+..++.++||||+||++|||++|++||......+ .+.....
T Consensus 149 l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~ 224 (288)
T cd07863 149 LADFGLARIYSCQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIG 224 (288)
T ss_pred ECccCccccccCcccC---CCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHHHHHHhC
Confidence 9999999876533221 13458999999999998889999999999999999999999985432111 0100000
Q ss_pred ccCCCchhhhc---ccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 859 KALPDDVMDIV---DSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 859 ~~~~~~~~~~~---d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
........... .....+.. .........+....+.+++.+|++.||++|||+.|++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 225 LPPEDDWPRDVTLPRGAFSPRG-----------PRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CCChhhCcccccccccccCCCC-----------CCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000000 00000000 00000011134556789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=329.00 Aligned_cols=242 Identities=21% Similarity=0.246 Sum_probs=190.0
Q ss_pred CeeeeecCceEEEEEEc---CCCEEEEEEEEecCC----CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 632 NLVGVGSFGSVYKGIID---EGRTTIAVKVFNLQH----HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
+.||+|+||.||+|+.. .+++.||+|+++... ......+.+|+.++++++||||+++++++...+ ..+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~-----~~~ 76 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGG-----KLY 76 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCC-----eEE
Confidence 68999999999999874 367899999997432 223356788999999999999999999875443 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 77 lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~D 143 (323)
T cd05584 77 LILEYLSGGELFMHLE----------REGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTD 143 (323)
T ss_pred EEEeCCCCchHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEee
Confidence 9999999999999986 234577888999999999999999977 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCc
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
||+++......... ....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .
T Consensus 144 fg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~-----~-------- 208 (323)
T cd05584 144 FGLCKESIHEGTVT--HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK-----T-------- 208 (323)
T ss_pred CcCCeecccCCCcc--cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH-----H--------
Confidence 99987543322211 13458999999999998889999999999999999999999996321110 0
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRT-----NMTNVVH 926 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~ 926 (949)
...+...... .+ ......+.+++.+|++.||++|| ++.++++
T Consensus 209 ~~~~~~~~~~-~~-------------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 209 IDKILKGKLN-LP-------------------PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred HHHHHcCCCC-CC-------------------CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 0011111000 00 02234578999999999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=328.54 Aligned_cols=245 Identities=23% Similarity=0.316 Sum_probs=198.7
Q ss_pred eeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEeeeccC
Q 039533 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHY 712 (949)
Q Consensus 633 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~ 712 (949)
+||+|.||+||.|++..+...+|||.+........+-+..|+..-++++|.|||+++|.|.+.+ +.-|.||-++|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senG-----f~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENG-----FFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCC-----eEEEEeecCCC
Confidence 7999999999999999999999999998777777778999999999999999999999976555 78899999999
Q ss_pred CChhhhcCCCCCCCccccCCCCC--CHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec-CCCceEEeecccce
Q 039533 713 GSLEEWLHPFTGEDEIDEAPRNL--NLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD-DYMTARVGDFGLAR 789 (949)
Q Consensus 713 gsL~~~l~~~~~~~~~~~~~~~l--~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~-~~~~~kl~DfG~a~ 789 (949)
|+|.+.+...- +++ .+.+.--+.+||++||.|||++ .|||||||-+||||+ ..|.+||+|||-++
T Consensus 657 GSLSsLLrskW---------GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsK 724 (1226)
T KOG4279|consen 657 GSLSSLLRSKW---------GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSK 724 (1226)
T ss_pred CcHHHHHHhcc---------CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccch
Confidence 99999997432 333 5667777999999999999988 899999999999995 78999999999998
Q ss_pred ecCCCCCccccccccCccCccCccccCCC--ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhh
Q 039533 790 ILSPDHTQTSSFSVKGSLGYIAPEYGVGC--EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMD 867 (949)
Q Consensus 790 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 867 (949)
.+..-...+. .+.||..|||||++..+ .|+.++|||||||++.||.||++||-........+ +.-++.+
T Consensus 725 RLAginP~TE--TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM-------FkVGmyK 795 (1226)
T KOG4279|consen 725 RLAGINPCTE--TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM-------FKVGMYK 795 (1226)
T ss_pred hhccCCcccc--ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh-------hhhccee
Confidence 8765444332 45699999999998876 48899999999999999999999995332111000 0000000
Q ss_pred hcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 868 IVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 868 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
..+ +.+.+...+...++.+|+.+||.+||+|+++++
T Consensus 796 -----vHP------------------~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 796 -----VHP------------------PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred -----cCC------------------CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 000 112466777889999999999999999999976
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=315.80 Aligned_cols=261 Identities=22% Similarity=0.323 Sum_probs=206.9
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
++|++.+.||+|++|.||+|....+++.||+|.++... ....+.+.+|++++++++|+|++++++++...+ .
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~-----~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENN-----E 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC-----e
Confidence 57999999999999999999999889999999986432 223467889999999999999999999976544 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++++|.+++.... .....+++.++..++.|++.|++|||+. +|+||||||+||+++.++.++|
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l 147 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFK------KQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKL 147 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhc------ccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEE
Confidence 899999999999999986321 1234588999999999999999999977 9999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
+|||.+.......... ....++..|+|||...+..++.++|||||||++|||++|+.||...... .....
T Consensus 148 ~d~~~~~~~~~~~~~~--~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~----- 217 (267)
T cd08224 148 GDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLC----- 217 (267)
T ss_pred eccceeeeccCCCccc--ceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc---HHHHH-----
Confidence 9999988654332211 1245888999999998888999999999999999999999998532111 10000
Q ss_pred Cchhhhccc-CCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhH
Q 039533 863 DDVMDIVDS-SLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIK 932 (949)
Q Consensus 863 ~~~~~~~d~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 932 (949)
+.+.. ...+.+ ....+..+.+++.+|+..+|++|||+.+|++.++++.
T Consensus 218 ----~~~~~~~~~~~~------------------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 218 ----KKIEKCDYPPLP------------------ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ----hhhhcCCCCCCC------------------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 00000 000000 0133456889999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=330.02 Aligned_cols=194 Identities=25% Similarity=0.323 Sum_probs=166.0
Q ss_pred CeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCCccceeEe
Q 039533 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGNDFKASVY 707 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 707 (949)
+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+.++.++ +||||+++++++...+ ..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~-----~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES-----RLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCC-----EEEEEE
Confidence 47999999999999999899999999997542 22345677899888877 7999999999876544 789999
Q ss_pred eeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccc
Q 039533 708 EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGL 787 (949)
Q Consensus 708 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~ 787 (949)
||+++|+|..++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 76 E~~~~~~L~~~~~----------~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~ 142 (329)
T cd05618 76 EYVNGGDLMFHMQ----------RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGM 142 (329)
T ss_pred eCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCc
Confidence 9999999998885 234588999999999999999999977 999999999999999999999999999
Q ss_pred ceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCcc
Q 039533 788 ARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDI 845 (949)
Q Consensus 788 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~ 845 (949)
++........ .....||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 143 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 143 CKEGLRPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccccCCCCc--cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 8754322211 1234589999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=329.83 Aligned_cols=242 Identities=24% Similarity=0.295 Sum_probs=190.4
Q ss_pred CeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCCccceeEe
Q 039533 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGNDFKASVY 707 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 707 (949)
++||+|+||.||+|++..+++.||+|+++... ....+.+..|.+++..+ +||||+++++++...+ ..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~-----~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD-----RLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC-----eEEEEE
Confidence 46999999999999999889999999997432 23345677889988876 7999999999976544 789999
Q ss_pred eeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccc
Q 039533 708 EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGL 787 (949)
Q Consensus 708 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~ 787 (949)
||+++|+|..++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 E~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~ 142 (321)
T cd05591 76 EYVNGGDLMFQIQ----------RSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGM 142 (321)
T ss_pred eCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeeccc
Confidence 9999999999886 234588899999999999999999977 899999999999999999999999999
Q ss_pred ceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhh
Q 039533 788 ARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMD 867 (949)
Q Consensus 788 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 867 (949)
++......... ....||..|+|||++.+..++.++|||||||++|||++|+.||....... .. ..
T Consensus 143 ~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~--~~-----------~~ 207 (321)
T cd05591 143 CKEGILNGVTT--TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD--LF-----------ES 207 (321)
T ss_pred ceecccCCccc--cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH--HH-----------HH
Confidence 97643322211 23458999999999998899999999999999999999999996432111 00 00
Q ss_pred hcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-------CHHHHHH
Q 039533 868 IVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRT-------NMTNVVH 926 (949)
Q Consensus 868 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-------s~~ev~~ 926 (949)
+....... + ...+..+.+++.+|++.||++|| ++.++++
T Consensus 208 i~~~~~~~-p-------------------~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 208 ILHDDVLY-P-------------------VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred HHcCCCCC-C-------------------CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 00000000 0 01234578899999999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=340.35 Aligned_cols=362 Identities=27% Similarity=0.436 Sum_probs=301.9
Q ss_pred cEEEEEcCCCCCC-ccccCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecC
Q 039533 66 RVTLLDLRSLKLA-GSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHP 144 (949)
Q Consensus 66 ~v~~l~l~~~~l~-g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 144 (949)
-|..+|+++|.++ +..|.....++.++.|.|...++. .+|++++.|.+|++|.+++|++. .+-..++.|+.|+.+.+
T Consensus 8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~ 85 (1255)
T KOG0444|consen 8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIV 85 (1255)
T ss_pred eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhh
Confidence 4788999999998 567889999999999999999997 89999999999999999999998 77788899999999999
Q ss_pred CCccccc-cccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCC-cccCCCccccccccCcccc
Q 039533 145 QNNQLVG-KILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPN-SFGWFENLVFLSLAANNLS 222 (949)
Q Consensus 145 ~~n~l~~-~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~ 222 (949)
..|++.. -+|..+-.|..|++||||+|+++ ..|..+..-+++-.|+||+|+|. +||. -|-+++.|-+||||+|++.
T Consensus 86 R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe 163 (1255)
T KOG0444|consen 86 RDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE 163 (1255)
T ss_pred hccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh
Confidence 9999953 46777788999999999999999 88999999999999999999999 5555 5779999999999999987
Q ss_pred cccccccCCCCChhhhccccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCC-ccCCchhhcccccccEEEc
Q 039533 223 VVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFG-GLLPGCISNLSKTIKTLFL 301 (949)
Q Consensus 223 ~~~~~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~-~~~p~~~~~l~~~L~~L~L 301 (949)
.+| |....|..|++|.|++|.+... .+..+..+++|+.|++++.+-+ .-+|..+..+ .+|..+||
T Consensus 164 ~LP-------PQ~RRL~~LqtL~Ls~NPL~hf------QLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l-~NL~dvDl 229 (1255)
T KOG0444|consen 164 MLP-------PQIRRLSMLQTLKLSNNPLNHF------QLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDL-HNLRDVDL 229 (1255)
T ss_pred hcC-------HHHHHHhhhhhhhcCCChhhHH------HHhcCccchhhhhhhcccccchhhcCCCchhhh-hhhhhccc
Confidence 654 5688999999999999988642 2344567788888999887644 4567777776 46888888
Q ss_pred cCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeeccccccccc
Q 039533 302 NNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVS 381 (949)
Q Consensus 302 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 381 (949)
|.|.+. .+|+.+.++++|+.|+||+|+|+ .+....+...+|++|+||+|+++ .+|++++.+++|+.|++.+|+++..
T Consensus 230 S~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~Fe 306 (1255)
T KOG0444|consen 230 SENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFE 306 (1255)
T ss_pred cccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCccccc
Confidence 888888 78888888888888888888887 55566667778888888888888 7888888888888888888887633
Q ss_pred -CCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccc
Q 039533 382 -IPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRL 451 (949)
Q Consensus 382 -~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 451 (949)
+|+.++.+.+|+++..++|++. .+|+.++.+..| +.|.|+.|++- .+|+++.-++.|+.|||..|.=
T Consensus 307 GiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL-~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpn 374 (1255)
T KOG0444|consen 307 GIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKL-QKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPN 374 (1255)
T ss_pred CCccchhhhhhhHHHHhhccccc-cCchhhhhhHHH-HHhccccccee-echhhhhhcCCcceeeccCCcC
Confidence 6778888888888888888887 778888877777 66777777776 6777777777777777777753
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=308.89 Aligned_cols=248 Identities=23% Similarity=0.321 Sum_probs=207.4
Q ss_pred CCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEe
Q 039533 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVY 707 (949)
Q Consensus 628 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 707 (949)
|.+..+||+|+||+||+|.++.+|..||||.+... .+.+++..|+.++++.+.|+||++||.+.... ..++||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s-----DLWIVM 107 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS-----DLWIVM 107 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCC-----ceEeeh
Confidence 55678999999999999999999999999998644 34678999999999999999999999865444 789999
Q ss_pred eeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccc
Q 039533 708 EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGL 787 (949)
Q Consensus 708 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~ 787 (949)
|||-.|+..+.++ ..++.+++.++..++...++||+|||.- .-+|||||..|||++.+|++||+|||.
T Consensus 108 EYCGAGSiSDI~R---------~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGV 175 (502)
T KOG0574|consen 108 EYCGAGSISDIMR---------ARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGV 175 (502)
T ss_pred hhcCCCcHHHHHH---------HhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccc
Confidence 9999999999996 2457799999999999999999999965 789999999999999999999999999
Q ss_pred ceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhh
Q 039533 788 ARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMD 867 (949)
Q Consensus 788 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 867 (949)
|..+.+.... ...+.||+.|||||++..-.|+.++||||+|++..||..|++||.+.......+ .++
T Consensus 176 AGQLTDTMAK--RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF------MIP----- 242 (502)
T KOG0574|consen 176 AGQLTDTMAK--RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF------MIP----- 242 (502)
T ss_pred cchhhhhHHh--hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE------ecc-----
Confidence 9876544332 235779999999999999999999999999999999999999997543221111 001
Q ss_pred hcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 868 IVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 868 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
..+...+..+++....+.++++.|+...|++|-|+.++++
T Consensus 243 -------------------T~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 243 -------------------TKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred -------------------CCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 1122334445677788999999999999999999988865
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=321.43 Aligned_cols=270 Identities=22% Similarity=0.381 Sum_probs=208.9
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcC----CCEEEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeeccccc
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDE----GRTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGADYR 698 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 698 (949)
..++|.+.+.||+|+||.||+|.+.. .+..|++|++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--- 80 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED--- 80 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC---
Confidence 35678999999999999999999874 25789999886432 23346788999999999999999999987543
Q ss_pred CCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC
Q 039533 699 GNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM 778 (949)
Q Consensus 699 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~ 778 (949)
....++++||+++++|.+++....... ......+++.++..++.|++.||+|||+. +++||||||+||++++++
T Consensus 81 -~~~~~~~~~~~~~~~L~~~l~~~~~~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~ 154 (280)
T cd05043 81 -GEPPFVLYPYMNWGNLKLFLQQCRLGE--ANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEEL 154 (280)
T ss_pred -CCCCEEEEEcCCCCcHHHHHHhccccc--cccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCC
Confidence 346899999999999999986432111 11235689999999999999999999977 899999999999999999
Q ss_pred ceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhc
Q 039533 779 TARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFG 857 (949)
Q Consensus 779 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~ 857 (949)
.+||+|||+++.+.+...........++..|+|||++.+..++.++|||||||++||+++ |+.||...... ....+.
T Consensus 155 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~ 232 (280)
T cd05043 155 QVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF--EMAAYL 232 (280)
T ss_pred cEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH--HHHHHH
Confidence 999999999987654433222222346778999999988889999999999999999999 99998643111 111111
Q ss_pred cccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHh
Q 039533 858 RKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNI 934 (949)
Q Consensus 858 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 934 (949)
.. .... .....++..+.+++.+||+.||++|||+.||++.|+.+.+.
T Consensus 233 ~~------------~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 233 KD------------GYRL------------------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred Hc------------CCCC------------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 00 0000 00012345678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=335.20 Aligned_cols=252 Identities=21% Similarity=0.213 Sum_probs=197.5
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
++|.+.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+.+++.++|+||+++++++...+ .
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~-----~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD-----N 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC-----e
Confidence 47899999999999999999999899999999997432 223456889999999999999999998865443 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~e~~~~~~L~~~l~~---------~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL 143 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNR---------YEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKL 143 (330)
T ss_pred EEEEECCCCCCCHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEe
Confidence 8999999999999999962 124588999999999999999999977 9999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccC------CCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhh
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGV------GCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNF 856 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~ 856 (949)
+|||++.......... .....||+.|+|||++. +..++.++|||||||++|||++|+.||....... .+
T Consensus 144 ~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-~~--- 218 (330)
T cd05601 144 ADFGSAARLTANKMVN-SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-TY--- 218 (330)
T ss_pred ccCCCCeECCCCCcee-eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-HH---
Confidence 9999998765443321 12345899999999976 4567899999999999999999999996432110 00
Q ss_pred ccccCCCchhhhcccC-CCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 857 GRKALPDDVMDIVDSS-LLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 857 ~~~~~~~~~~~~~d~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
..+.... ....+ .....+..+.+++..|++ +|++||+++++++
T Consensus 219 ---------~~i~~~~~~~~~~-----------------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 219 ---------NNIMNFQRFLKFP-----------------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ---------HHHHcCCCccCCC-----------------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0000000 00000 001223457788889997 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=318.24 Aligned_cols=262 Identities=22% Similarity=0.297 Sum_probs=206.0
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC---cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH---GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
++|++.+.||+|++|.||+|+...+++.+|||.+..... ....++.+|+.+++.++||||+++++++...+ .
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN-----E 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC-----e
Confidence 478889999999999999999988899999998864322 23357889999999999999999999876544 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++++|.+++.... .....+++..+..++.|++.|++|||+. +++|+||||+||+++.++.++|
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l 147 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFK------KQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKL 147 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhh------ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEE
Confidence 899999999999999886321 1234689999999999999999999977 9999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
+|||.+.......... ....|+..|+|||+..+..++.++||||||+++|||++|..||.............
T Consensus 148 ~dfg~~~~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~------ 219 (267)
T cd08229 148 GDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK------ 219 (267)
T ss_pred CcchhhhccccCCccc--ccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhh------
Confidence 9999987664433211 13458899999999988889999999999999999999999985321110000000
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIK 932 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 932 (949)
+......+.+ ....+..+.+++.+|++.+|++||||.+|++.++++.
T Consensus 220 -----~~~~~~~~~~------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 220 -----IEQCDYPPLP------------------SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred -----hhcCCCCCCC------------------cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 0000000000 0134557889999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=316.63 Aligned_cols=252 Identities=24% Similarity=0.373 Sum_probs=197.6
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
++|++.+.||+|+||.||+|++. ++..||+|.++... ...+.+.+|+.++++++||||+++++++...+ ..++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l 76 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR-----PIYI 76 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCC-----CcEE
Confidence 46888999999999999999886 45569999886433 23467899999999999999999999975443 6899
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
||||+++++|.+++.. ....+++.+++.++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 77 v~e~~~~~~l~~~i~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~ 144 (256)
T cd05113 77 VTEYMSNGCLLNYLRE---------HGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDF 144 (256)
T ss_pred EEEcCCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCC
Confidence 9999999999999862 123588999999999999999999977 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCCc
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
|.++........ ......++..|+|||+..+..++.++|||||||++|||++ |+.||....... ...
T Consensus 145 g~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~--------- 212 (256)
T cd05113 145 GLSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--TVE--------- 212 (256)
T ss_pred ccceecCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHH---------
Confidence 999866443321 1112335678999999988889999999999999999999 999985322110 000
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQ 929 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 929 (949)
.+........+ ...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 213 --~~~~~~~~~~~-------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 213 --KVSQGLRLYRP-------------------HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --HHhcCCCCCCC-------------------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 00000000000 012456789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=325.55 Aligned_cols=278 Identities=21% Similarity=0.266 Sum_probs=198.7
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
++|.+.+.||+|+||.||+|++..+++.||+|+++.... .....+.+|++++++++||||+++++++...+ ..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDK-----SLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCC-----eEE
Confidence 579999999999999999999988899999999874432 23456788999999999999999999976544 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++ +|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 81 lv~e~~~~-~l~~~~~~---------~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~D 147 (309)
T cd07872 81 LVFEYLDK-DLKQYMDD---------CGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLAD 147 (309)
T ss_pred EEEeCCCC-CHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECc
Confidence 99999975 88888752 234578899999999999999999977 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCC
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
||+++......... ....++..|+|||++.+ ..++.++||||+||++|||+||+.||......+. ..... .....
T Consensus 148 fg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~-~~~~~ 223 (309)
T cd07872 148 FGLARAKSVPTKTY--SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE-LHLIF-RLLGT 223 (309)
T ss_pred cccceecCCCcccc--ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHH-HHhCC
Confidence 99997654332211 12357899999998765 4588999999999999999999999964322111 00000 00000
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
...+............. .......+..........+..+.+++.+|++.||++|||++|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 224 PTEETWPGISSNDEFKN-YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred CCHHHHhhhcchhhhhh-hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000000000000 000000000001111234556789999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=332.70 Aligned_cols=269 Identities=23% Similarity=0.331 Sum_probs=203.8
Q ss_pred hcCCCCCCeeeeecCceEEEEEEc-----CCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcC-CCcceeEEeeeecccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIID-----EGRTTIAVKVFNLQHH-GASRSFIAECKALKSIR-HRNLVKVLTACLGADY 697 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 697 (949)
.++|.+.+.||+|+||.||+|++. ..++.||+|+++.... ...+.+.+|++++.++. ||||++++++|...+
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~- 114 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG- 114 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC-
Confidence 346788899999999999999964 2456899999975432 22357889999999997 999999999986544
Q ss_pred cCCccceeEeeeccCCChhhhcCCCCCCC---------------------------------------------------
Q 039533 698 RGNDFKASVYEFMHYGSLEEWLHPFTGED--------------------------------------------------- 726 (949)
Q Consensus 698 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------------------------------------------- 726 (949)
..++||||+++|+|.++++......
T Consensus 115 ----~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 115 ----PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ----CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 7899999999999999997432100
Q ss_pred -------------------------------------ccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 039533 727 -------------------------------------EIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKP 769 (949)
Q Consensus 727 -------------------------------------~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp 769 (949)
........+++..+..++.|++.||+|||+. +++||||||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp 267 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAA 267 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCc
Confidence 0001123578889999999999999999976 999999999
Q ss_pred CCeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccc
Q 039533 770 SNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFE 848 (949)
Q Consensus 770 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~ 848 (949)
+||++++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 999999999999999999987543322222223347789999999988889999999999999999998 8999853311
Q ss_pred cCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 039533 849 GDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHEL 928 (949)
Q Consensus 849 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 928 (949)
.+. ..+.+....... ....++..+.+++.+||+.+|++||+++||++.|
T Consensus 348 ~~~-------------~~~~~~~~~~~~------------------~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 396 (401)
T cd05107 348 NEQ-------------FYNAIKRGYRMA------------------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLV 396 (401)
T ss_pred hHH-------------HHHHHHcCCCCC------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 110 001111000000 0012345688999999999999999999999999
Q ss_pred HHhH
Q 039533 929 QSIK 932 (949)
Q Consensus 929 ~~i~ 932 (949)
+++.
T Consensus 397 ~~~~ 400 (401)
T cd05107 397 GDLL 400 (401)
T ss_pred HHHh
Confidence 8863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=340.10 Aligned_cols=203 Identities=23% Similarity=0.282 Sum_probs=171.6
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
++|++.+.||+|+||.||+|++..+++.||||++.... ......+.+|++++++++||||+++++.+.+.+ .
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~-----~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD-----N 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-----E
Confidence 47999999999999999999999899999999986432 223456889999999999999999999876444 8
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~E~~~~g~L~~~i~~----------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL 142 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIR----------LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKL 142 (376)
T ss_pred EEEEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEE
Confidence 9999999999999999962 34578888999999999999999977 9999999999999999999999
Q ss_pred eecccceecCCCCC-----------------------------------------ccccccccCccCccCccccCCCccC
Q 039533 783 GDFGLARILSPDHT-----------------------------------------QTSSFSVKGSLGYIAPEYGVGCEVS 821 (949)
Q Consensus 783 ~DfG~a~~~~~~~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~ 821 (949)
+|||+|..+..... ........||+.|+|||++.+..++
T Consensus 143 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 222 (376)
T cd05598 143 TDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT 222 (376)
T ss_pred EeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC
Confidence 99999753311000 0001124699999999999999999
Q ss_pred CccchHHHHHHHHHHHhCCCCCccc
Q 039533 822 TNGDVYSYGILLLELVIGKKPIDIM 846 (949)
Q Consensus 822 ~~sDiwSlGvvl~elltg~~Pf~~~ 846 (949)
.++|||||||++|||++|+.||...
T Consensus 223 ~~~DiwSlGvilyell~G~~Pf~~~ 247 (376)
T cd05598 223 QLCDWWSVGVILYEMLVGQPPFLAD 247 (376)
T ss_pred cceeeeeccceeeehhhCCCCCCCC
Confidence 9999999999999999999999643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=326.26 Aligned_cols=241 Identities=24% Similarity=0.314 Sum_probs=188.5
Q ss_pred CeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCCccceeEe
Q 039533 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGNDFKASVY 707 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 707 (949)
+.||+|+||.||+|++..+++.||||+++... .........|..++... +||||+++++++...+ ..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~-----~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE-----NLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCC-----EEEEEE
Confidence 47999999999999999889999999997542 23345567788888765 8999999999976544 789999
Q ss_pred eeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccc
Q 039533 708 EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGL 787 (949)
Q Consensus 708 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~ 787 (949)
||+++|+|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 76 ey~~~g~L~~~l~----------~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~ 142 (316)
T cd05619 76 EYLNGGDLMFHIQ----------SCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGM 142 (316)
T ss_pred eCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCc
Confidence 9999999999986 234578899999999999999999977 999999999999999999999999999
Q ss_pred ceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhh
Q 039533 788 ARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMD 867 (949)
Q Consensus 788 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 867 (949)
++......... ....||..|+|||++.+..++.++|||||||++|||++|+.||...... .......
T Consensus 143 ~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~i~--------- 209 (316)
T cd05619 143 CKENMLGDAKT--CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQSIR--------- 209 (316)
T ss_pred ceECCCCCCce--eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHHHHHH---------
Confidence 87543222111 1345899999999999989999999999999999999999999632111 0000000
Q ss_pred hcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHH-HHH
Q 039533 868 IVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMT-NVV 925 (949)
Q Consensus 868 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-ev~ 925 (949)
...+... ......+.+++.+|++.||++||++. ++.
T Consensus 210 ~~~~~~~----------------------~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 210 MDNPCYP----------------------RWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred hCCCCCC----------------------ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 0000000 01234567899999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=322.84 Aligned_cols=265 Identities=21% Similarity=0.311 Sum_probs=201.1
Q ss_pred cCCCCCCeeeeecCceEEEEEEcC-----CCEEEEEEEEecCCCc-chHHHHHHHHHHHhcCCCcceeEEeeeecccccC
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDE-----GRTTIAVKVFNLQHHG-ASRSFIAECKALKSIRHRNLVKVLTACLGADYRG 699 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 699 (949)
.+|.+.+.||+|+||.||+|.+.. .+..||+|+++..... ....+.+|+.++++++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~--- 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ--- 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC---
Confidence 347778899999999999998753 3578999998754332 2356889999999999999999999976544
Q ss_pred CccceeEeeeccCCChhhhcCCCCCCC------ccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCee
Q 039533 700 NDFKASVYEFMHYGSLEEWLHPFTGED------EIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVL 773 (949)
Q Consensus 700 ~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIl 773 (949)
..++++||+++++|.+++....... ........+++..+..++.|++.||+|||+. +|+||||||+||+
T Consensus 82 --~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil 156 (283)
T cd05091 82 --PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVL 156 (283)
T ss_pred --ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheE
Confidence 6899999999999999985221100 0111234588999999999999999999977 8999999999999
Q ss_pred ecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCch
Q 039533 774 LDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDIN 852 (949)
Q Consensus 774 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~ 852 (949)
+++++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||...... .
T Consensus 157 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~ 234 (283)
T cd05091 157 VFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--D 234 (283)
T ss_pred ecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH--H
Confidence 99999999999999886544332222223346789999999988889999999999999999998 88887532111 0
Q ss_pred hhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 039533 853 LHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQS 930 (949)
Q Consensus 853 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 930 (949)
.. ..+.+....+. ..+++..+.+++..|++.+|++||+++||++.|+.
T Consensus 235 ~~-----------~~i~~~~~~~~-------------------~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 VI-----------EMIRNRQVLPC-------------------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HH-----------HHHHcCCcCCC-------------------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 00 00111110000 11345668899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=338.81 Aligned_cols=202 Identities=22% Similarity=0.290 Sum_probs=171.0
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
++|++.++||+|+||.||+|++..+++.||+|++.... ......+.+|++++++++||||+++++++.+.+ .
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~-----~ 75 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-----N 75 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC-----E
Confidence 36888999999999999999999899999999987432 223457889999999999999999999976544 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~----------~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL 142 (382)
T cd05625 76 LYFVMDYIPGGDMMSLLIR----------MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKL 142 (382)
T ss_pred EEEEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence 8999999999999999862 23578889999999999999999977 8999999999999999999999
Q ss_pred eecccceecCCCCC---------------------------------------------ccccccccCccCccCccccCC
Q 039533 783 GDFGLARILSPDHT---------------------------------------------QTSSFSVKGSLGYIAPEYGVG 817 (949)
Q Consensus 783 ~DfG~a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~ 817 (949)
+|||+++....... ........||+.|+|||++.+
T Consensus 143 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 222 (382)
T cd05625 143 TDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR 222 (382)
T ss_pred eECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC
Confidence 99999753211000 000112468999999999999
Q ss_pred CccCCccchHHHHHHHHHHHhCCCCCcc
Q 039533 818 CEVSTNGDVYSYGILLLELVIGKKPIDI 845 (949)
Q Consensus 818 ~~~~~~sDiwSlGvvl~elltg~~Pf~~ 845 (949)
..++.++||||+||++|||++|+.||..
T Consensus 223 ~~~~~~~DiwSlGvil~elltG~~Pf~~ 250 (382)
T cd05625 223 TGYTQLCDWWSVGVILYEMLVGQPPFLA 250 (382)
T ss_pred CCCCCeeeEEechHHHHHHHhCCCCCCC
Confidence 8999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=307.49 Aligned_cols=254 Identities=21% Similarity=0.253 Sum_probs=202.0
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC---cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH---GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
+.|+..+.||.|.-|+||+++...++..+|+|++.+... ....+...|-+||+.++||.++.+|+.+... ++
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~-----~~ 151 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD-----KY 151 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc-----ce
Confidence 346677899999999999999998889999999975432 3346788899999999999999999996544 48
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.|+|||||+||+|....+.+ ..+.+++..++-++.+++-||+|||.. |||+|||||+||||.++|++-|
T Consensus 152 ~cl~meyCpGGdL~~LrqkQ--------p~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIML 220 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQ--------PGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIML 220 (459)
T ss_pred eEEEEecCCCccHHHHHhhC--------CCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEe
Confidence 99999999999999998743 456799999999999999999999966 9999999999999999999999
Q ss_pred eecccceecCCC----------------------------------C--------------------CccccccccCccC
Q 039533 783 GDFGLARILSPD----------------------------------H--------------------TQTSSFSVKGSLG 808 (949)
Q Consensus 783 ~DfG~a~~~~~~----------------------------------~--------------------~~~~~~~~~gt~~ 808 (949)
+||.++....-. . ....+..++||-.
T Consensus 221 sDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThE 300 (459)
T KOG0610|consen 221 SDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHE 300 (459)
T ss_pred eeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccc
Confidence 999987543110 0 0011224679999
Q ss_pred ccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhh
Q 039533 809 YIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQ 888 (949)
Q Consensus 809 y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~ 888 (949)
|.|||++.|...+.++|+|+|||++|||+.|..||....... . +..++-+.+.
T Consensus 301 YlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~-T------------l~NIv~~~l~-------------- 353 (459)
T KOG0610|consen 301 YLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE-T------------LRNIVGQPLK-------------- 353 (459)
T ss_pred cccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh-h------------HHHHhcCCCc--------------
Confidence 999999999999999999999999999999999996432221 1 1222221111
Q ss_pred hhhhhhhHHHHHHHHHHHhhccccCCCCCCCC----HHHHHH
Q 039533 889 KQARINSIIECLISMVRIGVACSMELPQDRTN----MTNVVH 926 (949)
Q Consensus 889 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs----~~ev~~ 926 (949)
++...+.+....++|++.+.+||.+|-. |+||.+
T Consensus 354 ----Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 354 ----FPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred ----CCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 1111244567889999999999999998 776643
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=328.27 Aligned_cols=242 Identities=23% Similarity=0.259 Sum_probs=190.6
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCCcc
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 702 (949)
+|.+.+.||+|+||.||+|++..+++.||+|+++... ....+.+..|..++..+ +|++|+++++++...+ .
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-----~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD-----R 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC-----E
Confidence 5888999999999999999999889999999997432 22234567788888877 5899999998865444 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++|+|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||++++++.+||
T Consensus 76 ~~lv~E~~~~g~L~~~~~----------~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL 142 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQ----------QVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKI 142 (323)
T ss_pred EEEEEcCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEE
Confidence 899999999999999886 234588899999999999999999977 9999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
+|||+++......... ....||+.|+|||++.+..++.++|||||||++|||+||+.||....... ..
T Consensus 143 ~DfG~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~--~~-------- 210 (323)
T cd05616 143 ADFGMCKENMWDGVTT--KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--LF-------- 210 (323)
T ss_pred ccCCCceecCCCCCcc--ccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH--HH--------
Confidence 9999997643322211 23458999999999999999999999999999999999999996432110 00
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNM 921 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 921 (949)
..+.+.... .+ ......+.+++.+|++.||++|++.
T Consensus 211 ---~~i~~~~~~-~p-------------------~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 211 ---QSIMEHNVA-YP-------------------KSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ---HHHHhCCCC-CC-------------------CcCCHHHHHHHHHHcccCHHhcCCC
Confidence 001110000 00 1223457889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=322.41 Aligned_cols=272 Identities=18% Similarity=0.302 Sum_probs=201.7
Q ss_pred cCCCCCCeeeeecCceEEEEEEcC----------------CCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeE
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDE----------------GRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKV 688 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~ 688 (949)
++|++.+.||+|+||.||+|.... ++..||+|+++.... ....++.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 568999999999999999986432 345799999875432 334678999999999999999999
Q ss_pred EeeeecccccCCccceeEeeeccCCChhhhcCCCCCCCcc-ccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 039533 689 LTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEI-DEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDL 767 (949)
Q Consensus 689 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDl 767 (949)
++++...+ ..++||||+++++|.+++......... ......+++.++..++.|++.|++|||+. +++||||
T Consensus 85 ~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl 156 (296)
T cd05095 85 LAVCITSD-----PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDL 156 (296)
T ss_pred EEEEecCC-----ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccC
Confidence 99976544 689999999999999999743221111 12234588999999999999999999977 8999999
Q ss_pred CCCCeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh--CCCCCcc
Q 039533 768 KPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI--GKKPIDI 845 (949)
Q Consensus 768 kp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt--g~~Pf~~ 845 (949)
||+||+++.++.++|+|||.++.+.............++..|+|||+..+..++.++|||||||++|||++ |..||..
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred ChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 99999999999999999999986544332221112334678999999888889999999999999999998 7788753
Q ss_pred ccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHH
Q 039533 846 MFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVV 925 (949)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~ 925 (949)
....+ .... ..+........ ...+....++..+.+++.+||+.||++||++.||+
T Consensus 237 ~~~~~--~~~~--------~~~~~~~~~~~---------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~ 291 (296)
T cd05095 237 LSDEQ--VIEN--------TGEFFRDQGRQ---------------VYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIH 291 (296)
T ss_pred cChHH--HHHH--------HHHHHhhcccc---------------ccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 22111 0000 00000000000 00000112346788999999999999999999999
Q ss_pred HHHHH
Q 039533 926 HELQS 930 (949)
Q Consensus 926 ~~L~~ 930 (949)
+.|++
T Consensus 292 ~~l~~ 296 (296)
T cd05095 292 ATLLE 296 (296)
T ss_pred HHHhC
Confidence 99863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=320.41 Aligned_cols=248 Identities=23% Similarity=0.246 Sum_probs=191.9
Q ss_pred eeeecCceEEEEEEcCCCEEEEEEEEecCCC---cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEeeec
Q 039533 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH---GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFM 710 (949)
Q Consensus 634 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 710 (949)
||+|+||+||+|.+..+++.||+|++..... ...+.+..|++++++++|+||+++.+++.... ..++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-----~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKT-----DLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCC-----eEEEEEeCC
Confidence 6999999999999998999999999864322 12346778999999999999999998865433 789999999
Q ss_pred cCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccccee
Q 039533 711 HYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARI 790 (949)
Q Consensus 711 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~ 790 (949)
++|+|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||.+..
T Consensus 76 ~~g~L~~~~~~~~------~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 146 (280)
T cd05608 76 NGGDLRYHIYNVD------EENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVE 146 (280)
T ss_pred CCCCHHHHHHhcc------ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcccee
Confidence 9999998875211 1235689999999999999999999977 999999999999999999999999999987
Q ss_pred cCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhhhcc
Q 039533 791 LSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVD 870 (949)
Q Consensus 791 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d 870 (949)
........ ....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..... .....
T Consensus 147 ~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~--------~~~~~ 215 (280)
T cd05608 147 LKDGQSKT--KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELK--------QRILN 215 (280)
T ss_pred cCCCCccc--cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HHHHH--------Hhhcc
Confidence 65433221 134589999999999999999999999999999999999999963211100 00000 00000
Q ss_pred cCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 039533 871 SSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRT-----NMTNVVH 926 (949)
Q Consensus 871 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~ 926 (949)
... ......+..+.+++.+|++.||++|| +++|+++
T Consensus 216 ~~~--------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 216 DSV--------------------TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cCC--------------------CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 000 00012345678999999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=322.18 Aligned_cols=259 Identities=24% Similarity=0.366 Sum_probs=201.7
Q ss_pred cCCCCCCeeeeecCceEEEEEEc-----CCCEEEEEEEEecCCC-cchHHHHHHHHHHHhc-CCCcceeEEeeeeccccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIID-----EGRTTIAVKVFNLQHH-GASRSFIAECKALKSI-RHRNLVKVLTACLGADYR 698 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 698 (949)
++|.+.+.||+|+||.||+|... ..+..||+|+++.... ...+.+.+|+++++++ +||||+++++++...+
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-- 112 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG-- 112 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC--
Confidence 56899999999999999999852 3456899999875432 2345788999999999 7999999999976544
Q ss_pred CCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC
Q 039533 699 GNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM 778 (949)
Q Consensus 699 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~ 778 (949)
..++||||+.+|+|.++++.. ....+++.++..++.|++.|++|||++ +|+||||||+||+++.++
T Consensus 113 ---~~~lv~e~~~~~~L~~~i~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~ 178 (302)
T cd05055 113 ---PILVITEYCCYGDLLNFLRRK--------RESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGK 178 (302)
T ss_pred ---ceEEEEEcCCCCcHHHHHHhC--------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCC
Confidence 689999999999999999621 122389999999999999999999977 899999999999999999
Q ss_pred ceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhc
Q 039533 779 TARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFG 857 (949)
Q Consensus 779 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~ 857 (949)
.++++|||.++...............++..|+|||++.+..++.++||||+||++|||++ |+.||....... .
T Consensus 179 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~----- 252 (302)
T cd05055 179 IVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-K----- 252 (302)
T ss_pred eEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-H-----
Confidence 999999999986654332111122346788999999998889999999999999999998 999986432111 0
Q ss_pred cccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHh
Q 039533 858 RKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSI 931 (949)
Q Consensus 858 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 931 (949)
..+.++....... ....+..+.+++.+|+..+|++|||+.|+++.|++.
T Consensus 253 -------~~~~~~~~~~~~~------------------~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 253 -------FYKLIKEGYRMAQ------------------PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -------HHHHHHcCCcCCC------------------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1111111100000 001234688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=316.92 Aligned_cols=258 Identities=22% Similarity=0.415 Sum_probs=201.2
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCC---EEEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGR---TTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
.++|+..+.||+|+||.||+|....++ ..+|+|..+... ....+.+.+|++++++++||||+++.+++...+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 79 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK---- 79 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC----
Confidence 356888899999999999999986544 379999886543 233467889999999999999999999976544
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
..++||||+++++|.+++.. ....+++.++..++.|++.|++|||+. +++||||||+||++++++.+
T Consensus 80 -~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~ 146 (268)
T cd05063 80 -PAMIITEYMENGALDKYLRD---------HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLEC 146 (268)
T ss_pred -CcEEEEEcCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcE
Confidence 78999999999999999862 224588999999999999999999977 89999999999999999999
Q ss_pred EEeecccceecCCCCCcccc-ccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhcc
Q 039533 781 RVGDFGLARILSPDHTQTSS-FSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGR 858 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~ 858 (949)
||+|||++............ .....+..|+|||++.+..++.++|||||||++||+++ |+.||...... .
T Consensus 147 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--~------ 218 (268)
T cd05063 147 KVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--E------ 218 (268)
T ss_pred EECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--H------
Confidence 99999999876543221111 11223467999999988889999999999999999998 99998532111 0
Q ss_pred ccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHh
Q 039533 859 KALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSI 931 (949)
Q Consensus 859 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 931 (949)
....+...... +....++..+.+++.+|++.+|++||++.+|++.|+++
T Consensus 219 ------~~~~i~~~~~~------------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 219 ------VMKAINDGFRL------------------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ------HHHHHhcCCCC------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00111000000 00113355688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=320.96 Aligned_cols=272 Identities=22% Similarity=0.313 Sum_probs=203.4
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCC----------------CEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCccee
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEG----------------RTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVK 687 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 687 (949)
.++|++.+.||+|+||.||+|++... +..||+|++..... ...+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 45799999999999999999987643 35689999875432 33467889999999999999999
Q ss_pred EEeeeecccccCCccceeEeeeccCCChhhhcCCCCCCCcc-ccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 039533 688 VLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEI-DEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCD 766 (949)
Q Consensus 688 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrD 766 (949)
+++++...+ ..++||||+++++|.+++......... ......+++..++.++.|++.||+|||+. +|+|||
T Consensus 84 ~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~d 155 (296)
T cd05051 84 LLGVCTVDP-----PLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRD 155 (296)
T ss_pred EEEEEecCC-----CcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccc
Confidence 999976543 789999999999999999743221110 11234689999999999999999999977 899999
Q ss_pred CCCCCeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh--CCCCCc
Q 039533 767 LKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI--GKKPID 844 (949)
Q Consensus 767 lkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt--g~~Pf~ 844 (949)
|||+||+++.++.++|+|||.++...............++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred cchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999986544332222223446788999999988889999999999999999998 677775
Q ss_pred cccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHH
Q 039533 845 IMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNV 924 (949)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev 924 (949)
...... .............. .. ..+....++.++.+++.+|++.||++|||+.||
T Consensus 236 ~~~~~~--~~~~~~~~~~~~~~-----~~------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el 290 (296)
T cd05051 236 HLTDQQ--VIENAGHFFRDDGR-----QI------------------YLPRPPNCPKDIYELMLECWRRDEEDRPTFREI 290 (296)
T ss_pred CcChHH--HHHHHHhccccccc-----cc------------------cCCCccCCCHHHHHHHHHHhccChhcCCCHHHH
Confidence 322111 00000000000000 00 000011234578999999999999999999999
Q ss_pred HHHHH
Q 039533 925 VHELQ 929 (949)
Q Consensus 925 ~~~L~ 929 (949)
++.|+
T Consensus 291 ~~~L~ 295 (296)
T cd05051 291 HLFLQ 295 (296)
T ss_pred HHHhc
Confidence 99885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=326.72 Aligned_cols=242 Identities=23% Similarity=0.252 Sum_probs=191.4
Q ss_pred CeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCCccceeEe
Q 039533 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGNDFKASVY 707 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 707 (949)
+.||+|+||.||+|++..+++.||||+++... ......+..|.++++.+ +||||+++++++...+ ..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~-----~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD-----RLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC-----EEEEEE
Confidence 47999999999999999889999999997432 23345677899999888 6999999999875444 789999
Q ss_pred eeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccc
Q 039533 708 EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGL 787 (949)
Q Consensus 708 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~ 787 (949)
||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 76 e~~~~~~L~~~~~----------~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~ 142 (318)
T cd05570 76 EYVNGGDLMFHIQ----------RSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGM 142 (318)
T ss_pred cCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCC
Confidence 9999999999886 234589999999999999999999977 999999999999999999999999999
Q ss_pred ceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhh
Q 039533 788 ARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMD 867 (949)
Q Consensus 788 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 867 (949)
++......... ....|+..|+|||++.+..++.++|||||||++|||++|+.||...... .... .
T Consensus 143 ~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--~~~~-----------~ 207 (318)
T cd05570 143 CKEGILGGVTT--STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED--ELFQ-----------S 207 (318)
T ss_pred CeecCcCCCcc--cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--HHHH-----------H
Confidence 87532222211 1345899999999999999999999999999999999999999633211 0000 0
Q ss_pred hcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCH-----HHHHH
Q 039533 868 IVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNM-----TNVVH 926 (949)
Q Consensus 868 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~ev~~ 926 (949)
+...... . ....+..+.+++.+|++.||++||++ .++++
T Consensus 208 i~~~~~~-~-------------------~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 208 ILEDEVR-Y-------------------PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHcCCCC-C-------------------CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 0000000 0 01224467899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=314.22 Aligned_cols=251 Identities=24% Similarity=0.379 Sum_probs=202.1
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
+|++.+.||+|++|.||+|+...+++.|++|.+.... ....+.+.+|++++++++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKG-----KLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCC-----EEE
Confidence 4788899999999999999999889999999987432 334567889999999999999999999976544 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++++|.+++... ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|
T Consensus 76 lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~d 144 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQ--------RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGD 144 (256)
T ss_pred EEEEeCCCCcHHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcc
Confidence 999999999999999731 134688999999999999999999977 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCc
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
||.++......... ....|+..|+|||+..+..++.++|||||||++|||++|+.||....... ..
T Consensus 145 f~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~---------- 210 (256)
T cd08529 145 LGVAKLLSDNTNFA--NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA--LI---------- 210 (256)
T ss_pred cccceeccCccchh--hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--HH----------
Confidence 99998765443222 13458899999999998889999999999999999999999996332110 00
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
.......... .....+..+.+++.+|++.+|++||++.|+++.
T Consensus 211 -~~~~~~~~~~-------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 211 -LKIIRGVFPP-------------------VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -HHHHcCCCCC-------------------CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 0000000000 001334568999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=326.13 Aligned_cols=241 Identities=23% Similarity=0.267 Sum_probs=188.1
Q ss_pred CeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCCccceeEe
Q 039533 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGNDFKASVY 707 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 707 (949)
+.||+|+||.||+|++..+++.||+|+++... .........|..++... +||||+++++++...+ ..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-----~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKE-----HLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCC-----EEEEEE
Confidence 47999999999999999899999999997532 22345567788888765 8999999999875444 889999
Q ss_pred eeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccc
Q 039533 708 EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGL 787 (949)
Q Consensus 708 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~ 787 (949)
||+++|+|.+++. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 E~~~~g~L~~~i~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~ 142 (316)
T cd05620 76 EFLNGGDLMFHIQ----------DKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGM 142 (316)
T ss_pred CCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCC
Confidence 9999999999886 234578899999999999999999977 999999999999999999999999999
Q ss_pred ceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhh
Q 039533 788 ARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMD 867 (949)
Q Consensus 788 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 867 (949)
++........ .....||..|+|||++.+..++.++||||+||++|||++|+.||...... ....
T Consensus 143 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--~~~~------------ 206 (316)
T cd05620 143 CKENVFGDNR--ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--ELFE------------ 206 (316)
T ss_pred CeecccCCCc--eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHH------------
Confidence 8753322211 12355899999999999999999999999999999999999999632111 0000
Q ss_pred hcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHH-HHH
Q 039533 868 IVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMT-NVV 925 (949)
Q Consensus 868 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-ev~ 925 (949)
.+.......+ ......+.+++.+|++.||++||++. ++.
T Consensus 207 ~~~~~~~~~~-------------------~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 207 SIRVDTPHYP-------------------RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHhCCCCCC-------------------CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0000000000 01234567899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=329.70 Aligned_cols=283 Identities=20% Similarity=0.223 Sum_probs=200.1
Q ss_pred HHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccc-c
Q 039533 622 YNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADY-R 698 (949)
Q Consensus 622 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~ 698 (949)
....++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.++++++||||+++++++..... .
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 3456789999999999999999999988899999999864322 233567789999999999999999988754321 1
Q ss_pred CCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC
Q 039533 699 GNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM 778 (949)
Q Consensus 699 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~ 778 (949)
.....+++++++ +++|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~ 155 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVK-----------CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDC 155 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCC
Confidence 223568999988 789988875 23588999999999999999999977 999999999999999999
Q ss_pred ceEEeecccceecCCCCCccccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhc
Q 039533 779 TARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFG 857 (949)
Q Consensus 779 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~ 857 (949)
.+||+|||+++....... ...||..|+|||++.+ ..++.++|||||||++|||++|+.||......+ .+....
T Consensus 156 ~~kl~Dfg~~~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~ 229 (343)
T cd07878 156 ELRILDFGLARQADDEMT-----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-QLKRIM 229 (343)
T ss_pred CEEEcCCccceecCCCcC-----CccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHH
Confidence 999999999987543321 3458999999999877 468899999999999999999999996432110 000000
Q ss_pred cccCCCchhhhcccCCCCCchhhhhhhchhhhhhhh-hhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 858 RKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARI-NSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 858 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
........+...... ..............+...+ .........+.+++.+|++.||++|||+.|+++.
T Consensus 230 -~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 230 -EVVGTPSPEVLKKIS-SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred -HHhCCCCHHHHHhcc-hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000000 0000000000000000000 0011223457899999999999999999999854
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=334.93 Aligned_cols=282 Identities=20% Similarity=0.227 Sum_probs=200.0
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
+|++.+.||+|+||.||+|.+..+++.||||++.... ....+++.+|+++++.++||||+++++++...+.......+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999998889999999986432 22346788999999999999999999998655433334679
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+. ++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 81 lv~e~~~-~~l~~~~~----------~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~D 146 (372)
T cd07853 81 VVTELMQ-SDLHKIIV----------SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICD 146 (372)
T ss_pred EEeeccc-cCHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEecc
Confidence 9999996 57888775 234689999999999999999999977 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCC
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
||+++......... .....++..|+|||++.+. .++.++||||+||++|||++|+.||....... ...........
T Consensus 147 fg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~g~ 223 (372)
T cd07853 147 FGLARVEEPDESKH-MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ--QLDLITDLLGT 223 (372)
T ss_pred ccceeecccCcccc-CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHHcCC
Confidence 99998754432211 1234578999999998875 47899999999999999999999996432211 00000000000
Q ss_pred c-hhhhcccCCCCCchhhhhhhchhh--hhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 864 D-VMDIVDSSLLPDDEDLILTGNQRQ--KQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 864 ~-~~~~~d~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
. ..++.. ... .....+....... ....+....+..+.+.+++.+|++.||++|||+.|+++.
T Consensus 224 ~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 224 PSLEAMRS-ACE-GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred CCHHHHHH-hhH-HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0 000000 000 0000000000000 000000011224568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=318.25 Aligned_cols=253 Identities=22% Similarity=0.285 Sum_probs=198.2
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
++|++.+.||+|+||.||+|++..+++.||+|+++.........+.+|+.+++.++||||+++++++...+ ..++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~-----~~~l 83 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD-----KLWI 83 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC-----EEEE
Confidence 47888899999999999999998889999999997665444567889999999999999999999876544 7899
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
||||+++++|.+++. ....+++.++..++.|++.|+.|||+. +++||||||+||+++.++.+||+||
T Consensus 84 v~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~df 150 (267)
T cd06645 84 CMEFCGGGSLQDIYH----------VTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADF 150 (267)
T ss_pred EEeccCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcc
Confidence 999999999999986 234588999999999999999999977 8999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccC---CCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGV---GCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
|.+.......... ....|+..|+|||++. ...++.++|||||||++|||++|+.||.......... .....
T Consensus 151 g~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~-~~~~~--- 224 (267)
T cd06645 151 GVSAQITATIAKR--KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-LMTKS--- 224 (267)
T ss_pred eeeeEccCccccc--ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH-hhhcc---
Confidence 9987664332211 2345899999999874 4458899999999999999999999985332111000 00000
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
...+.. .......+..+.+++.+|++.+|++||+++||++
T Consensus 225 ---------~~~~~~---------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 225 ---------NFQPPK---------------LKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ---------CCCCCc---------------ccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 000000 0000012345788999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=321.19 Aligned_cols=271 Identities=20% Similarity=0.341 Sum_probs=206.2
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEc-------CCCEEEEEEEEecCC-CcchHHHHHHHHHHHhc-CCCcceeEEeeeec
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIID-------EGRTTIAVKVFNLQH-HGASRSFIAECKALKSI-RHRNLVKVLTACLG 694 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 694 (949)
..++|.+.+.||+|+||.||+|+.. .++..||+|+++... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3467889999999999999999752 234579999986432 23346788999999999 89999999999764
Q ss_pred ccccCCccceeEeeeccCCChhhhcCCCCCCCcc------ccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 039533 695 ADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEI------DEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLK 768 (949)
Q Consensus 695 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlk 768 (949)
.. ..++||||+++|+|.+++......... ......+++.++..++.|++.||+|||++ +++|||||
T Consensus 93 ~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlk 164 (304)
T cd05101 93 DG-----PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLA 164 (304)
T ss_pred CC-----ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccc
Confidence 43 789999999999999999743211100 01234688999999999999999999977 99999999
Q ss_pred CCCeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCcccc
Q 039533 769 PSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMF 847 (949)
Q Consensus 769 p~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~ 847 (949)
|+||++++++.+||+|||.++...............++..|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 165 p~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 165 ARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred cceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999987654333222222335678999999988889999999999999999998 788875321
Q ss_pred ccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 848 EGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 848 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
.. . ..+.+...... .....++..+.+++.+||+.+|++|||+.||++.
T Consensus 245 ~~-----~---------~~~~~~~~~~~------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 245 VE-----E---------LFKLLKEGHRM------------------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HH-----H---------HHHHHHcCCcC------------------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 11 0 00001000000 0001345668899999999999999999999999
Q ss_pred HHHhHHh
Q 039533 928 LQSIKNI 934 (949)
Q Consensus 928 L~~i~~~ 934 (949)
|+++...
T Consensus 293 l~~~~~~ 299 (304)
T cd05101 293 LDRILTL 299 (304)
T ss_pred HHHHHHh
Confidence 9998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=313.42 Aligned_cols=254 Identities=27% Similarity=0.438 Sum_probs=200.1
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
++|++.++||+|+||.||+|++..+ ..||+|+++.... ..+++.+|++++++++||||+++++++.. ...++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~l 77 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYI 77 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC------CCcEE
Confidence 5689999999999999999998744 5699999875332 34678999999999999999999987532 25789
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
||||+++|+|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 78 v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~df 146 (262)
T cd05071 78 VTEYMSKGSLLDFLKGE--------MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADF 146 (262)
T ss_pred EEEcCCCCcHHHHHhhc--------cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccC
Confidence 99999999999999621 224578999999999999999999977 8999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCCc
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
|.++......... .....++..|+|||+..+..++.++|||||||++|||+| |+.||.......
T Consensus 147 g~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-------------- 211 (262)
T cd05071 147 GLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------------- 211 (262)
T ss_pred Cceeecccccccc-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH--------------
Confidence 9998765433211 112346778999999988889999999999999999999 888885332110
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHh
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSI 931 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 931 (949)
..+....... .+...+.+..+.+++.+|++.+|++||+++++++.|+..
T Consensus 212 ~~~~~~~~~~------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 212 VLDQVERGYR------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HHHHHhcCCC------------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0000000000 000123456788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=326.88 Aligned_cols=271 Identities=24% Similarity=0.327 Sum_probs=202.9
Q ss_pred hcCCCCCCeeeeecCceEEEEEEc-----CCCEEEEEEEEecCCC-cchHHHHHHHHHHHhc-CCCcceeEEeeeecccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIID-----EGRTTIAVKVFNLQHH-GASRSFIAECKALKSI-RHRNLVKVLTACLGADY 697 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 697 (949)
.++|++.+.||+|+||.||+|.+. .+++.||||+++.... .....+.+|+.++.++ +||||+++++++...+
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~- 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG- 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC-
Confidence 357999999999999999999852 3568899999975432 2345788999999999 6899999999875432
Q ss_pred cCCccceeEeeeccCCChhhhcCCCCCCCc--------------------------------------------------
Q 039533 698 RGNDFKASVYEFMHYGSLEEWLHPFTGEDE-------------------------------------------------- 727 (949)
Q Consensus 698 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------------------------------------------------- 727 (949)
...++||||+++|+|.+++........
T Consensus 85 ---~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 85 ---GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred ---CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 357899999999999999864221000
Q ss_pred -------cccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecccceecCCCCCcccc
Q 039533 728 -------IDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSS 800 (949)
Q Consensus 728 -------~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 800 (949)
.......+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++...........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 238 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 238 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence 000113478899999999999999999977 9999999999999999999999999999875433322222
Q ss_pred ccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCCchhhhcccCCCCCchh
Q 039533 801 FSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDED 879 (949)
Q Consensus 801 ~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 879 (949)
....++..|+|||+..+..++.++||||||+++|||++ |..||....... .. ...+........
T Consensus 239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~------------~~~~~~~~~~~~-- 303 (343)
T cd05103 239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EF------------CRRLKEGTRMRA-- 303 (343)
T ss_pred CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-HH------------HHHHhccCCCCC--
Confidence 22345678999999988889999999999999999997 999985321110 00 000000000000
Q ss_pred hhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHH
Q 039533 880 LILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKN 933 (949)
Q Consensus 880 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 933 (949)
.......+.+++..||+.+|++|||+.||++.|+.+.+
T Consensus 304 ----------------~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 304 ----------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred ----------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00123457899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=339.42 Aligned_cols=285 Identities=21% Similarity=0.286 Sum_probs=197.5
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccC---Cc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRG---ND 701 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~---~~ 701 (949)
..+|++.+.||+|+||.||+|.+..+++.||||++.... ....+|+.++++++||||+++++++....+.. ..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 467999999999999999999998889999999885332 23457999999999999999998875433221 23
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC-ce
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM-TA 780 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~-~~ 780 (949)
..++||||+++ ++.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~------~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~v 210 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYA------RNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTL 210 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHh------hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCce
Confidence 46789999975 7777764211 1235688999999999999999999977 899999999999998654 79
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
||+|||+|+........ ....||+.|+|||++.+. .++.++|||||||++|||++|.+||......+ .+......
T Consensus 211 kL~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~~~ 286 (440)
T PTZ00036 211 KLCDFGSAKNLLAGQRS---VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVRIIQV 286 (440)
T ss_pred eeeccccchhccCCCCc---ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHH
Confidence 99999999876543322 134589999999998764 68999999999999999999999996432111 11111100
Q ss_pred cCCC--chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH--HHHHhH
Q 039533 860 ALPD--DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH--ELQSIK 932 (949)
Q Consensus 860 ~~~~--~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~--~L~~i~ 932 (949)
.-.. +......+... +..... ......+.......+..+.+++.+|++.||++|||+.|+++ .++.++
T Consensus 287 ~~~p~~~~~~~~~~~~~----~~~~~~-~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 287 LGTPTEDQLKEMNPNYA----DIKFPD-VKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred hCCCCHHHHHHhchhhh----cccCCc-cCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 0000 00000000000 000000 00000000001123457889999999999999999999984 344443
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=322.13 Aligned_cols=271 Identities=24% Similarity=0.333 Sum_probs=203.1
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCE--EEEEEEEecCC-CcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCC
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRT--TIAVKVFNLQH-HGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 700 (949)
.++|++.+.||+|+||.||+|.+..++. .+|+|.++... ....+.+.+|++++.++ +||||+++++++...+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~---- 81 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG---- 81 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC----
Confidence 4578999999999999999999876665 45777765332 22345788999999999 8999999999975544
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCc------cccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeee
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDE------IDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL 774 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll 774 (949)
..++||||+++++|.+++........ .......+++.+++.++.|++.|++|||+. +++||||||+||++
T Consensus 82 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili 157 (303)
T cd05088 82 -YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILV 157 (303)
T ss_pred -CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEe
Confidence 78999999999999999974321110 011234689999999999999999999977 99999999999999
Q ss_pred cCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchh
Q 039533 775 DDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINL 853 (949)
Q Consensus 775 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~ 853 (949)
++++.+||+|||+++...... ......++..|+|||++.+..++.++|||||||++|||+| |..||......+ .
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~ 232 (303)
T cd05088 158 GENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--L 232 (303)
T ss_pred cCCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--H
Confidence 999999999999986432111 1111224678999999988889999999999999999998 999985321110 0
Q ss_pred hhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHH
Q 039533 854 HNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKN 933 (949)
Q Consensus 854 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 933 (949)
.+.+...... +.....+..+.+++.+|++.+|++||++.++++.++++..
T Consensus 233 ------------~~~~~~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 233 ------------YEKLPQGYRL------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred ------------HHHHhcCCcC------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0000000000 0001224467899999999999999999999999998866
Q ss_pred hhccC
Q 039533 934 ILLGV 938 (949)
Q Consensus 934 ~~~~~ 938 (949)
.....
T Consensus 283 ~~~~~ 287 (303)
T cd05088 283 ERKTY 287 (303)
T ss_pred hhhhh
Confidence 65443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=319.51 Aligned_cols=271 Identities=20% Similarity=0.314 Sum_probs=199.2
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCC--------------CEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEe
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEG--------------RTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLT 690 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~--------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~ 690 (949)
++|++.+.||+|+||.||+|+.... ...||+|+++.... .....+.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 5799999999999999999987532 23589999875422 23457889999999999999999999
Q ss_pred eeecccccCCccceeEeeeccCCChhhhcCCCCCCCc--cccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 039533 691 ACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDE--IDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLK 768 (949)
Q Consensus 691 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlk 768 (949)
++...+ ..++||||+++++|.+++........ .......+++..++.++.|++.|++|||+. +++|||||
T Consensus 85 ~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlk 156 (295)
T cd05097 85 VCVSDD-----PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLA 156 (295)
T ss_pred EEcCCC-----ccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccC
Confidence 976444 78999999999999999863211100 011123478899999999999999999977 89999999
Q ss_pred CCCeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh--CCCCCccc
Q 039533 769 PSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI--GKKPIDIM 846 (949)
Q Consensus 769 p~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt--g~~Pf~~~ 846 (949)
|+||++++++.+||+|||++................++..|+|||+..+..++.++|||||||++|||++ |..||...
T Consensus 157 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 157 TRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred hhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 9999999999999999999976543332221222345778999999988889999999999999999998 66777532
Q ss_pred cccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 847 FEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 847 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.... ............. ....... ....+..+.+++.+|++.+|++||++++|++
T Consensus 237 ~~~~--~~~~~~~~~~~~~----~~~~~~~-------------------~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 237 SDEQ--VIENTGEFFRNQG----RQIYLSQ-------------------TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred ChHH--HHHHHHHhhhhcc----ccccCCC-------------------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 2111 0000000000000 0000000 0023457899999999999999999999999
Q ss_pred HHH
Q 039533 927 ELQ 929 (949)
Q Consensus 927 ~L~ 929 (949)
.|+
T Consensus 292 ~l~ 294 (295)
T cd05097 292 FLR 294 (295)
T ss_pred HHh
Confidence 886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=318.36 Aligned_cols=272 Identities=24% Similarity=0.346 Sum_probs=202.4
Q ss_pred CCCCCCeeeeecCceEEEEEE----cCCCEEEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 627 GFSSANLVGVGSFGSVYKGII----DEGRTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
-|++.+.||+|+||.||.|+. ..++..||+|.++... ....+.+.+|++++++++||||+++++++... +..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 81 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GGN 81 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CCC
Confidence 468889999999999999985 3467889999987443 23346789999999999999999999987643 234
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++++|.+++.. ....+++.++..++.|++.||+|||++ +++||||||+||+++.++.+|
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~---------~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~ 149 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPR---------NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVK 149 (284)
T ss_pred ceEEEEEccCCCCHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEE
Confidence 67899999999999999852 123589999999999999999999977 999999999999999999999
Q ss_pred EeecccceecCCCCCc-cccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 782 VGDFGLARILSPDHTQ-TSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
|+|||.++........ .......++..|+|||+..+..++.++|||||||++|||+|++.|+........ ......
T Consensus 150 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~---~~~~~~ 226 (284)
T cd05079 150 IGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFL---KMIGPT 226 (284)
T ss_pred ECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhh---hhcccc
Confidence 9999999876543321 111234467789999999888899999999999999999998877532211100 000000
Q ss_pred CCCc-hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHh
Q 039533 861 LPDD-VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSI 931 (949)
Q Consensus 861 ~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 931 (949)
..+. ....++ .+. ...+.+....++..+.+++.+|++.+|++|||++|+++.++++
T Consensus 227 ~~~~~~~~~~~---------~~~------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 227 HGQMTVTRLVR---------VLE------EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cccccHHHHHH---------HHH------cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000 000000 000 0000111123456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=330.07 Aligned_cols=204 Identities=24% Similarity=0.271 Sum_probs=170.6
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccc-cCC
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADY-RGN 700 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~ 700 (949)
..++|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+|+.+++.++||||+++++++..... ...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999998889999999986432 2334678899999999999999999998764331 122
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
...++||||+++ ++.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~------------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~ 162 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTL 162 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh------------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCE
Confidence 357999999975 5666654 2377888999999999999999977 99999999999999999999
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccc
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIM 846 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~ 846 (949)
||+|||+++........ ....||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 163 kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 163 KILDFGLARTACTNFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred EEecCCCccccccCccC---CCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 99999999764332221 1345899999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=329.49 Aligned_cols=252 Identities=21% Similarity=0.246 Sum_probs=192.6
Q ss_pred CCCCCCeeeeecCceEEEEEEc---CCCEEEEEEEEecCC----CcchHHHHHHHHHHHhc-CCCcceeEEeeeeccccc
Q 039533 627 GFSSANLVGVGSFGSVYKGIID---EGRTTIAVKVFNLQH----HGASRSFIAECKALKSI-RHRNLVKVLTACLGADYR 698 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 698 (949)
+|++.+.||+|+||.||+|+.. .+++.||+|+++... ....+.+..|+.+++++ +||+|+++++++...+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~-- 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA-- 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC--
Confidence 5888999999999999999874 367899999996422 22345678899999999 5999999998865443
Q ss_pred CCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC
Q 039533 699 GNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM 778 (949)
Q Consensus 699 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~ 778 (949)
..++||||+++|+|.+++. ....+++.++..++.|++.||+|||+. +|+||||||+|||++.++
T Consensus 79 ---~~~lv~e~~~~g~L~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~ 142 (332)
T cd05614 79 ---KLHLILDYVSGGEMFTHLY----------QRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEG 142 (332)
T ss_pred ---EEEEEEeCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCC
Confidence 7899999999999999986 234588999999999999999999977 899999999999999999
Q ss_pred ceEEeecccceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhc
Q 039533 779 TARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFG 857 (949)
Q Consensus 779 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~ 857 (949)
.+||+|||+++......... .....||..|+|||++.+. .++.++|||||||++|||+||+.||........ .....
T Consensus 143 ~~kl~DfG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~ 220 (332)
T cd05614 143 HVVLTDFGLSKEFLSEEKER-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVS 220 (332)
T ss_pred CEEEeeCcCCccccccCCCc-cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHH
Confidence 99999999998654332211 1234699999999998865 478999999999999999999999963211110 00000
Q ss_pred cccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 039533 858 RKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRT-----NMTNVVH 926 (949)
Q Consensus 858 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~ 926 (949)
..... .++.. ....+..+.+++.+|++.||++|| +++|+++
T Consensus 221 ~~~~~------~~~~~----------------------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 221 RRILK------CDPPF----------------------PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred HHHhc------CCCCC----------------------CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 00000 00000 012244578899999999999999 6667764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=313.22 Aligned_cols=253 Identities=21% Similarity=0.284 Sum_probs=199.5
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-----cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-----GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
++|.+.+.||+|++|.||+|....+++.||+|++..... ...+.+.+|++++++++||||+++++++...+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 77 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE---- 77 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC----
Confidence 579999999999999999999988899999999864322 12356888999999999999999999976544
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
..++||||+++++|.+++.. ...+++..+..++.|++.|++|||+. +|+||||+|+||++++++.+
T Consensus 78 -~~~~v~e~~~~~~l~~~~~~----------~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~ 143 (263)
T cd06625 78 -TLSIFMEYMPGGSVKDQLKA----------YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNV 143 (263)
T ss_pred -eEEEEEEECCCCcHHHHHHH----------hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCE
Confidence 89999999999999999862 24578889999999999999999977 99999999999999999999
Q ss_pred EEeecccceecCCCCCccc-cccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 781 RVGDFGLARILSPDHTQTS-SFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
+|+|||.++.......... .....|+..|+|||+..+..++.++||||+|+++|||++|+.||....... ...
T Consensus 144 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~----- 217 (263)
T cd06625 144 KLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA-AIF----- 217 (263)
T ss_pred EEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH-HHH-----
Confidence 9999999986543222111 113457889999999999889999999999999999999999985321110 000
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
......... .........+.+++.+|+..+|++|||+.|+++.
T Consensus 218 -------~~~~~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 218 -------KIATQPTNP------------------QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -------HHhccCCCC------------------CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 000000000 0001234567889999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=332.74 Aligned_cols=208 Identities=22% Similarity=0.299 Sum_probs=175.8
Q ss_pred HHHHHHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeec
Q 039533 618 YQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLG 694 (949)
Q Consensus 618 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 694 (949)
..++....++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3445566689999999999999999999999999999999986422 2233567889999999999999999998764
Q ss_pred ccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeee
Q 039533 695 ADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL 774 (949)
Q Consensus 695 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll 774 (949)
.. ..++||||+++|+|.+++.. ..++...+..++.|++.||+|||++ +|+||||||+||++
T Consensus 115 ~~-----~~~lv~Ey~~gg~L~~~~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll 175 (371)
T cd05622 115 DR-----YLYMVMEYMPGGDLVNLMSN-----------YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLL 175 (371)
T ss_pred CC-----EEEEEEcCCCCCcHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEE
Confidence 44 78999999999999999862 3478888999999999999999977 99999999999999
Q ss_pred cCCCceEEeecccceecCCCCCccccccccCccCccCccccCCC----ccCCccchHHHHHHHHHHHhCCCCCcc
Q 039533 775 DDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC----EVSTNGDVYSYGILLLELVIGKKPIDI 845 (949)
Q Consensus 775 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDiwSlGvvl~elltg~~Pf~~ 845 (949)
+.++.+||+|||+++......... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 176 ~~~~~ikL~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 249 (371)
T cd05622 176 DKSGHLKLADFGTCMKMNKEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (371)
T ss_pred CCCCCEEEEeCCceeEcCcCCccc-ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence 999999999999998765432211 1235699999999998754 378999999999999999999999963
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=317.52 Aligned_cols=259 Identities=23% Similarity=0.306 Sum_probs=201.2
Q ss_pred HHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccC-C
Q 039533 623 NATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRG-N 700 (949)
Q Consensus 623 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~-~ 700 (949)
.+++.|++.+.||+|+||.||+|....+++.||+|++.... .....+.+|+.+++++ +|+||+++++++...+..+ .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45678999999999999999999999889999999987543 3346788999999998 6999999999987544222 3
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
...++||||+.+++|.+++... ....+++..+..++.|++.|++|||++ +|+||||||+||++++++.+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~--------~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~ 150 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT--------KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEV 150 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCE
Confidence 4678999999999999998631 124588999999999999999999987 89999999999999999999
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccC-----CCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhh
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGV-----GCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHN 855 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~ 855 (949)
+|+|||++......... .....|+..|+|||++. +..++.++|||||||++|||++|+.||...........
T Consensus 151 ~l~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~- 227 (272)
T cd06637 151 KLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL- 227 (272)
T ss_pred EEccCCCceeccccccc--CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH-
Confidence 99999999865432221 12345899999999876 34578899999999999999999999853321110000
Q ss_pred hccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 856 FGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 856 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.... ...... ....+..+.+++.+|+..+|.+|||+.|+++
T Consensus 228 -----~~~~----~~~~~~---------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 228 -----IPRN----PAPRLK---------------------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -----HhcC----CCCCCC---------------------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0000 000000 0022345789999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=312.41 Aligned_cols=249 Identities=25% Similarity=0.399 Sum_probs=193.3
Q ss_pred eeeeecCceEEEEEEc--CCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEeee
Q 039533 633 LVGVGSFGSVYKGIID--EGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEF 709 (949)
Q Consensus 633 ~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 709 (949)
.||+|+||.||+|.+. .++..||+|+...... ...+.+.+|+.++++++||||+++++++.. +..++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~------~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA------EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC------CCeEEEEEe
Confidence 3899999999999875 3456799999875433 234568899999999999999999998642 257999999
Q ss_pred ccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecccce
Q 039533 710 MHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLAR 789 (949)
Q Consensus 710 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~ 789 (949)
+++++|.+++.. ....+++.+++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||.++
T Consensus 76 ~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~ 143 (257)
T cd05115 76 ASGGPLNKFLSG---------KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSK 143 (257)
T ss_pred CCCCCHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccc
Confidence 999999999862 234589999999999999999999977 89999999999999999999999999998
Q ss_pred ecCCCCCcc-ccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCCchhh
Q 039533 790 ILSPDHTQT-SSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPDDVMD 867 (949)
Q Consensus 790 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 867 (949)
......... ......++..|+|||++.+..++.++|||||||++||+++ |+.||....... +..
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------------~~~ 209 (257)
T cd05115 144 ALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--------------VMS 209 (257)
T ss_pred cccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--------------HHH
Confidence 654433211 1111224578999999988889999999999999999996 999986432111 011
Q ss_pred hcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHh
Q 039533 868 IVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSI 931 (949)
Q Consensus 868 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 931 (949)
.+........ ...++.++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 210 ~~~~~~~~~~------------------~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 210 FIEQGKRLDC------------------PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHCCCCCCC------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1111100000 013356788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=320.91 Aligned_cols=256 Identities=26% Similarity=0.426 Sum_probs=211.3
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeE
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASV 706 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 706 (949)
+....++||.|.||.||.|.|+.-...||||.++.. ....++|..|+.+|+.++|||+|+++|+|.... .+|||
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep-----PFYIi 341 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP-----PFYII 341 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCC-----CeEEE
Confidence 445678999999999999999988889999998643 344688999999999999999999999997544 68999
Q ss_pred eeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecc
Q 039533 707 YEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFG 786 (949)
Q Consensus 707 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG 786 (949)
+|||.+|+|.+|+..+. ...++....+.+|.||+.|++||..+ .+|||||..+|.|+.++..+|++|||
T Consensus 342 TEfM~yGNLLdYLRecn--------r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFG 410 (1157)
T KOG4278|consen 342 TEFMCYGNLLDYLRECN--------RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFG 410 (1157)
T ss_pred EecccCccHHHHHHHhc--------hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccc
Confidence 99999999999998432 23467777889999999999999977 89999999999999999999999999
Q ss_pred cceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCCch
Q 039533 787 LARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPDDV 865 (949)
Q Consensus 787 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 865 (949)
+++.+..+.. +......-..-|.|||-+....++.|+|||+|||+|||+.| |-.||...... .+
T Consensus 411 LsRlMtgDTY-TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS--------------qV 475 (1157)
T KOG4278|consen 411 LSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------------QV 475 (1157)
T ss_pred hhhhhcCCce-ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH--------------HH
Confidence 9998865432 22222334567999999999999999999999999999998 88888643111 11
Q ss_pred hhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhH
Q 039533 866 MDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIK 932 (949)
Q Consensus 866 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 932 (949)
.++++. ..|.+.++.|++.++++++.||++.|.+||+++|+.+.++.+-
T Consensus 476 Y~LLEk------------------gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 476 YGLLEK------------------GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred HHHHhc------------------cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 222221 2233344589999999999999999999999999999998764
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=317.01 Aligned_cols=247 Identities=22% Similarity=0.267 Sum_probs=190.4
Q ss_pred eeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEeeec
Q 039533 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFM 710 (949)
Q Consensus 634 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 710 (949)
||+|+||.||+++...+++.||+|++.... ....+.+..|++++++++||||+++++++... ...++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~-----~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESK-----THLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecC-----CeEEEEEecC
Confidence 699999999999999889999999986422 12234566799999999999999999886543 3789999999
Q ss_pred cCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccccee
Q 039533 711 HYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARI 790 (949)
Q Consensus 711 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~ 790 (949)
++++|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++..
T Consensus 76 ~g~~L~~~~~~~--------~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~ 144 (277)
T cd05607 76 NGGDLKYHIYNV--------GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVE 144 (277)
T ss_pred CCCCHHHHHHhc--------cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeee
Confidence 999999888521 223478899999999999999999977 999999999999999999999999999987
Q ss_pred cCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhhhcc
Q 039533 791 LSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVD 870 (949)
Q Consensus 791 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d 870 (949)
....... ....|+..|+|||++.+..++.++||||+||++|||++|+.||....... ......+. ...
T Consensus 145 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~~~~~~~~--------~~~ 212 (277)
T cd05607 145 LKDGKTI---TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-AKEELKRR--------TLE 212 (277)
T ss_pred cCCCcee---eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-hHHHHHHH--------hhc
Confidence 6543221 13458999999999998889999999999999999999999986321110 00000000 000
Q ss_pred cCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 871 SSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 871 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
...... ....+.++.+++.+|++.||++||+++|+++.
T Consensus 213 ~~~~~~-------------------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 213 DEVKFE-------------------HQNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred cccccc-------------------cccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 000000 01234457899999999999999999776643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=322.69 Aligned_cols=273 Identities=21% Similarity=0.334 Sum_probs=205.7
Q ss_pred hcCCCCCCeeeeecCceEEEEEEc-------CCCEEEEEEEEecCCC-cchHHHHHHHHHHHhc-CCCcceeEEeeeecc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIID-------EGRTTIAVKVFNLQHH-GASRSFIAECKALKSI-RHRNLVKVLTACLGA 695 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 695 (949)
.++|.+.+.||+|+||.||+|+.. .....||+|+++.... .....+.+|+.+++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 357889999999999999999863 2346799999874332 2345688999999999 699999999997644
Q ss_pred cccCCccceeEeeeccCCChhhhcCCCCCCCc------cccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 039533 696 DYRGNDFKASVYEFMHYGSLEEWLHPFTGEDE------IDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKP 769 (949)
Q Consensus 696 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp 769 (949)
. ..++||||+++|+|.+++........ .......+++.++..++.|++.||+|||++ +++||||||
T Consensus 91 ~-----~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp 162 (314)
T cd05099 91 G-----PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAA 162 (314)
T ss_pred C-----ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccc
Confidence 3 68999999999999999974321100 011234689999999999999999999977 999999999
Q ss_pred CCeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccc
Q 039533 770 SNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFE 848 (949)
Q Consensus 770 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~ 848 (949)
+||++++++.+||+|||.++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999986643322111112224567999999988889999999999999999999 8888853211
Q ss_pred cCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 039533 849 GDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHEL 928 (949)
Q Consensus 849 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 928 (949)
. .. .+.+...... +....++..+.+++.+|+..+|++|||+.|+++.|
T Consensus 243 ~--~~------------~~~~~~~~~~------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 290 (314)
T cd05099 243 E--EL------------FKLLREGHRM------------------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEAL 290 (314)
T ss_pred H--HH------------HHHHHcCCCC------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 1 00 0000000000 00012345678999999999999999999999999
Q ss_pred HHhHHhhcc
Q 039533 929 QSIKNILLG 937 (949)
Q Consensus 929 ~~i~~~~~~ 937 (949)
+++......
T Consensus 291 ~~~~~~~~~ 299 (314)
T cd05099 291 DKVLAAVSE 299 (314)
T ss_pred HHHHHHhcC
Confidence 999865443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=317.11 Aligned_cols=257 Identities=23% Similarity=0.404 Sum_probs=200.1
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCE---EEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRT---TIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
++|++.+.||+|+||.||+|....+++ .||||+++... .....++..|+.++++++||||+++++++...+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----- 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR----- 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC-----
Confidence 457889999999999999999875554 69999987542 233468999999999999999999999875443
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++++|.+++.. ....+++.+++.++.|++.|++|||++ +++||||||+||+++.++.+|
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~k 146 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQ---------NDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCK 146 (269)
T ss_pred ceEEEEecCCCCcHHHHHhh---------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEE
Confidence 78999999999999999862 234588999999999999999999977 999999999999999999999
Q ss_pred EeecccceecCCCCCcccccc-cc--CccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhc
Q 039533 782 VGDFGLARILSPDHTQTSSFS-VK--GSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFG 857 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~-~~--gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~ 857 (949)
|+|||.+.............. .. .+..|+|||++.+..++.++|||||||++||+++ |..||...... ......
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i 224 (269)
T cd05065 147 VSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAI 224 (269)
T ss_pred ECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHH
Confidence 999999876644322111111 11 2457999999998899999999999999999987 99998533111 111110
Q ss_pred cccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHh
Q 039533 858 RKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSI 931 (949)
Q Consensus 858 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 931 (949)
. ... +.+...+++..+.+++.+|++.+|++||++.+|+..|+++
T Consensus 225 ~------------~~~------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 225 E------------QDY------------------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred H------------cCC------------------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 000 0000113455678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=328.67 Aligned_cols=238 Identities=25% Similarity=0.260 Sum_probs=185.1
Q ss_pred CeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHH-HHHhcCCCcceeEEeeeecccccCCccceeEe
Q 039533 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECK-ALKSIRHRNLVKVLTACLGADYRGNDFKASVY 707 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 707 (949)
+.||+|+||+||+|++..+++.||+|++.... ....+.+..|.. +++.++||||+++++++...+ ..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~-----~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD-----KLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCC-----EEEEEE
Confidence 47999999999999999899999999997432 122344555554 567789999999998875444 789999
Q ss_pred eeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccc
Q 039533 708 EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGL 787 (949)
Q Consensus 708 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~ 787 (949)
||+++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~g~L~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~ 142 (323)
T cd05575 76 DYVNGGELFFHLQ----------RERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGL 142 (323)
T ss_pred cCCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCC
Confidence 9999999999986 234588899999999999999999977 999999999999999999999999999
Q ss_pred ceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhh
Q 039533 788 ARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMD 867 (949)
Q Consensus 788 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 867 (949)
++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ..
T Consensus 143 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-----~~~--------~~ 207 (323)
T cd05575 143 CKEGIEHSKT--TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-----EMY--------DN 207 (323)
T ss_pred CcccccCCCc--cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH-----HHH--------HH
Confidence 8754322211 12345899999999999989999999999999999999999999632111 000 00
Q ss_pred hcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHH
Q 039533 868 IVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMT 922 (949)
Q Consensus 868 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 922 (949)
+........ ...+..+.+++.+|++.||++||++.
T Consensus 208 i~~~~~~~~--------------------~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 208 ILNKPLRLK--------------------PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHcCCCCCC--------------------CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 111000000 01244578899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=312.34 Aligned_cols=253 Identities=27% Similarity=0.453 Sum_probs=199.3
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
++|++.+.||+|+||.||+|... ++..||+|.++.... ..+.+.+|+.++++++|++++++++++.. ...++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~l 77 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE------EPIYI 77 (260)
T ss_pred HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC------CCcEE
Confidence 57899999999999999999887 567799999875433 34678999999999999999999988632 24789
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
||||+++++|.++++.. ....+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+||
T Consensus 78 v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~df 146 (260)
T cd05070 78 VTEYMSKGSLLDFLKDG--------EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADF 146 (260)
T ss_pred EEEecCCCcHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCc
Confidence 99999999999998621 234588999999999999999999977 8999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCCc
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
|.+.......... .....++..|+|||+..+..++.++||||||+++|||++ |..||...... ..
T Consensus 147 g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~----------- 212 (260)
T cd05070 147 GLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--EV----------- 212 (260)
T ss_pred eeeeeccCccccc-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--HH-----------
Confidence 9998765433211 112335678999999988889999999999999999999 89998532111 00
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQS 930 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 930 (949)
.+.+...... +.....+..+.+++.+|++.+|++|||++++.+.|++
T Consensus 213 -~~~~~~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 213 -LEQVERGYRM------------------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -HHHHHcCCCC------------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111100000 0011334568999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=313.17 Aligned_cols=250 Identities=26% Similarity=0.406 Sum_probs=196.2
Q ss_pred CeeeeecCceEEEEEEcCCC---EEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEe
Q 039533 632 NLVGVGSFGSVYKGIIDEGR---TTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVY 707 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 707 (949)
++||+|+||.||+|.+...+ ..||+|.++.... ...+++.+|+.++++++|+||+++++++.. ...++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG------EPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC------CceEEEE
Confidence 47999999999999875444 7899999875443 244678999999999999999999998642 2579999
Q ss_pred eeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccc
Q 039533 708 EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGL 787 (949)
Q Consensus 708 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~ 787 (949)
||+++++|.+++.. ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.
T Consensus 75 e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~ 141 (257)
T cd05060 75 ELAPLGPLLKYLKK----------RREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGM 141 (257)
T ss_pred EeCCCCcHHHHHHh----------CCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccc
Confidence 99999999999972 23588999999999999999999977 899999999999999999999999999
Q ss_pred ceecCCCCCcc-ccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCCch
Q 039533 788 ARILSPDHTQT-SSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPDDV 865 (949)
Q Consensus 788 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 865 (949)
++......... ......++..|+|||...+..++.++|||||||++|||++ |..||...... ...........
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~--~~~~~~~~~~~--- 216 (257)
T cd05060 142 SRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA--EVIAMLESGER--- 216 (257)
T ss_pred cceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHcCCc---
Confidence 98765443321 1111224568999999988889999999999999999998 99998643211 11111100000
Q ss_pred hhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhH
Q 039533 866 MDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIK 932 (949)
Q Consensus 866 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 932 (949)
. . ....++..+.+++.+|+..+|++||++.|+++.|+++.
T Consensus 217 ------~--~-------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 217 ------L--P-------------------RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ------C--C-------------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 0 0 00123456889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=312.30 Aligned_cols=247 Identities=23% Similarity=0.379 Sum_probs=193.2
Q ss_pred eeeeecCceEEEEEE--cCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEee
Q 039533 633 LVGVGSFGSVYKGII--DEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYE 708 (949)
Q Consensus 633 ~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 708 (949)
.||+|+||.||+|.+ ..++..+|+|+++.... ...+.+.+|+.++++++||||+++++++.. +..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA------ESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC------CCcEEEEe
Confidence 689999999999975 34678899999864432 234678899999999999999999998642 25689999
Q ss_pred eccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecccc
Q 039533 709 FMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLA 788 (949)
Q Consensus 709 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a 788 (949)
|+++++|.+++. ....+++..+..++.|++.|++|||++ +|+||||||+||++++++.+||+|||.+
T Consensus 76 ~~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~ 142 (257)
T cd05116 76 LAELGPLNKFLQ----------KNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLS 142 (257)
T ss_pred cCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccc
Confidence 999999999986 224588999999999999999999977 8999999999999999999999999999
Q ss_pred eecCCCCCcc-ccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCCchh
Q 039533 789 RILSPDHTQT-SSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPDDVM 866 (949)
Q Consensus 789 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 866 (949)
+......... ......++..|+|||.+....++.++|||||||++|||++ |+.||...... .. .
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~------------~ 208 (257)
T cd05116 143 KALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EV------------T 208 (257)
T ss_pred cccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HH------------H
Confidence 8765443211 1112234578999999988889999999999999999998 99998643211 11 1
Q ss_pred hhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 039533 867 DIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQS 930 (949)
Q Consensus 867 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 930 (949)
+.++....... ...++..+.+++.+||+.||++||++++|.+.|++
T Consensus 209 ~~i~~~~~~~~------------------~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 209 QMIESGERMEC------------------PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred HHHHCCCCCCC------------------CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 11111110000 01234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=341.47 Aligned_cols=204 Identities=23% Similarity=0.302 Sum_probs=165.8
Q ss_pred HHHHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCC------CcceeEEeeee
Q 039533 620 DLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRH------RNLVKVLTACL 693 (949)
Q Consensus 620 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~~ 693 (949)
++....++|++.++||+|+||+||+|.+..+++.||||+++... ...+....|+.++++++| .+++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34455788999999999999999999998889999999986432 223456678888777754 45888888875
Q ss_pred cccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCee
Q 039533 694 GADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVL 773 (949)
Q Consensus 694 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIl 773 (949)
.. ..+.++|||++ +++|.+++. ....+++..+..|+.||+.||+|||++. +|+||||||+|||
T Consensus 202 ~~----~~~~~iv~~~~-g~~l~~~l~----------~~~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NIL 264 (467)
T PTZ00284 202 NE----TGHMCIVMPKY-GPCLLDWIM----------KHGPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENIL 264 (467)
T ss_pred cC----CceEEEEEecc-CCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEE
Confidence 32 24689999988 778988886 2345889999999999999999999632 8999999999999
Q ss_pred ecCCC----------------ceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHH
Q 039533 774 LDDYM----------------TARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELV 837 (949)
Q Consensus 774 l~~~~----------------~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ell 837 (949)
++.++ .+||+|||.+....... ....||..|+|||++.+..++.++|||||||++|||+
T Consensus 265 l~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~~-----~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ell 339 (467)
T PTZ00284 265 METSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSR-----TAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELY 339 (467)
T ss_pred EecCCcccccccccccCCCCceEEECCCCccccCcccc-----ccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHH
Confidence 98665 49999999876432221 2356999999999999999999999999999999999
Q ss_pred hCCCCCccc
Q 039533 838 IGKKPIDIM 846 (949)
Q Consensus 838 tg~~Pf~~~ 846 (949)
+|+.||+..
T Consensus 340 tG~~pf~~~ 348 (467)
T PTZ00284 340 TGKLLYDTH 348 (467)
T ss_pred hCCCCCCCC
Confidence 999999643
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=319.31 Aligned_cols=266 Identities=25% Similarity=0.395 Sum_probs=202.9
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcC-----CCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeeccccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDE-----GRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYR 698 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 698 (949)
.++|++.+.||+|+||.||+|.+.. ++..||+|+++.... ...+++.+|+.++++++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~-- 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK-- 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC--
Confidence 4679999999999999999998742 568899999875432 23467889999999999999999999876543
Q ss_pred CCccceeEeeeccCCChhhhcCCCCCCCc------------cccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 039533 699 GNDFKASVYEFMHYGSLEEWLHPFTGEDE------------IDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCD 766 (949)
Q Consensus 699 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------------~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrD 766 (949)
..++||||+++++|.+++........ .......+++.+++.++.|++.||+|||+. +++|||
T Consensus 82 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~d 155 (288)
T cd05050 82 ---PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRD 155 (288)
T ss_pred ---ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccc
Confidence 78999999999999999964321110 111234588999999999999999999977 899999
Q ss_pred CCCCCeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCcc
Q 039533 767 LKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDI 845 (949)
Q Consensus 767 lkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~ 845 (949)
|||+||++++++.++|+|||.+................++..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 156 LATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred ccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999886543322211112235678999999988899999999999999999998 8888753
Q ss_pred ccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHH
Q 039533 846 MFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVV 925 (949)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~ 925 (949)
....+ .. ..+.+......+ ...+.++.+++.+|++.+|++|||+.|++
T Consensus 236 ~~~~~-----~~--------~~~~~~~~~~~~-------------------~~~~~~l~~li~~~l~~~p~~Rpt~~el~ 283 (288)
T cd05050 236 MAHEE-----VI--------YYVRDGNVLSCP-------------------DNCPLELYNLMRLCWSKLPSDRPSFASIN 283 (288)
T ss_pred CCHHH-----HH--------HHHhcCCCCCCC-------------------CCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence 21110 00 000000000000 12345688999999999999999999999
Q ss_pred HHHHH
Q 039533 926 HELQS 930 (949)
Q Consensus 926 ~~L~~ 930 (949)
+.|++
T Consensus 284 ~~l~~ 288 (288)
T cd05050 284 RILQR 288 (288)
T ss_pred HHhhC
Confidence 99863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=331.33 Aligned_cols=204 Identities=22% Similarity=0.247 Sum_probs=171.4
Q ss_pred HHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccc-cC
Q 039533 623 NATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADY-RG 699 (949)
Q Consensus 623 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~ 699 (949)
...++|++.+.||+|+||.||+|.+...++.||||++.... ....+.+.+|+.+++.++||||+++++++..... ..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34578999999999999999999998889999999987432 2334678899999999999999999998764331 22
Q ss_pred CccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCc
Q 039533 700 NDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMT 779 (949)
Q Consensus 700 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~ 779 (949)
....++||||+++ ++.+++. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~------------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~ 157 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCT 157 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh------------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCC
Confidence 3457999999975 6766664 2378888999999999999999977 9999999999999999999
Q ss_pred eEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCcc
Q 039533 780 ARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDI 845 (949)
Q Consensus 780 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~ 845 (949)
+||+|||+++........ ....||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 158 ~kl~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 158 LKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred EEEeeCcccccCCCcccc---CCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999865433221 134589999999999998999999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=312.96 Aligned_cols=251 Identities=26% Similarity=0.379 Sum_probs=196.9
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
.+|++.+.||+|+||.||+|.+. ++..+|+|++.... .....+.+|++++++++||||+++++++...+ ..++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~l 76 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR-----PIFI 76 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC-----ceEE
Confidence 35888999999999999999986 56789999986433 23457889999999999999999999875444 7899
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
||||+++++|.+++.. ....+++..++.++.|++.|++|||+. +++||||||+||++++++.+||+||
T Consensus 77 v~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~df 144 (256)
T cd05059 77 VTEYMANGCLLNYLRE---------RKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDF 144 (256)
T ss_pred EEecCCCCCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCc
Confidence 9999999999999862 123588999999999999999999977 8999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCCc
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
|.++......... .....++..|+|||...+..++.++||||||+++||+++ |+.||+.....+ ...
T Consensus 145 g~~~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~--------- 212 (256)
T cd05059 145 GLARYVLDDQYTS-SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVE--------- 212 (256)
T ss_pred ccceecccccccc-cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--HHH---------
Confidence 9998654332211 111224567999999998899999999999999999999 899986332111 000
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHEL 928 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 928 (949)
.+...... .....++.++.+++.+|++.+|++|||+.|+++.|
T Consensus 213 ---~~~~~~~~------------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 213 ---SVSAGYRL------------------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ---HHHcCCcC------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 00000000 00012355789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=313.84 Aligned_cols=251 Identities=20% Similarity=0.257 Sum_probs=199.8
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
+|++.+.||+|+||.||++++..+++.+|+|.++... ....+.+.+|+.++++++|+||+++++++...+ ..++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG-----HLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC-----EEEE
Confidence 5788899999999999999999899999999986432 334567889999999999999999999875444 7899
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
||||+++++|.+++... ....++...+..++.|++.||.|||++ +|+|+||||+||++++++.++++||
T Consensus 76 v~e~~~~~~l~~~~~~~--------~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~df 144 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQ--------RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDF 144 (255)
T ss_pred EEeeCCCCcHHHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEccc
Confidence 99999999999988621 234578889999999999999999977 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCch
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDV 865 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 865 (949)
|.+.......... ....|+..|+|||++.+..++.++||||||+++|+|++|+.||....... ..
T Consensus 145 g~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-----~~-------- 209 (255)
T cd08219 145 GSARLLTSPGAYA--CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN-----LI-------- 209 (255)
T ss_pred Ccceeeccccccc--ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH-----HH--------
Confidence 9998765432211 13458899999999998889999999999999999999999996321100 00
Q ss_pred hhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 866 MDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 866 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
..+......+.+ ...+..+.+++.+||+.||++||++.|++.+
T Consensus 210 ~~~~~~~~~~~~-------------------~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 210 LKVCQGSYKPLP-------------------SHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHhcCCCCCCC-------------------cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 000000000000 1233457889999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=314.93 Aligned_cols=251 Identities=24% Similarity=0.326 Sum_probs=196.3
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
++|++.++||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 75 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVEN-----RIS 75 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC-----EEE
Confidence 36888999999999999999998889999999986542 223457889999999999999999999986544 688
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++++|..+.. +++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|
T Consensus 76 lv~e~~~~~~l~~~~~--------------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~d 138 (279)
T cd06619 76 ICTEFMDGGSLDVYRK--------------IPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCD 138 (279)
T ss_pred EEEecCCCCChHHhhc--------------CCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEee
Confidence 9999999999976532 67788899999999999999977 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCc
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
||++........ ....|+..|+|||++.+..++.++|||||||++|||++|+.||........... ...
T Consensus 139 fg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~-------~~~ 207 (279)
T cd06619 139 FGVSTQLVNSIA----KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM-------PLQ 207 (279)
T ss_pred CCcceecccccc----cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc-------hHH
Confidence 999986543321 134589999999999988899999999999999999999999964322111000 000
Q ss_pred hhhh-cccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 865 VMDI-VDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 865 ~~~~-~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
.... .+......+ ....+..+.+++.+|++.+|++||+++|+++.
T Consensus 208 ~~~~~~~~~~~~~~------------------~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 208 LLQCIVDEDPPVLP------------------VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHHhccCCCCCC------------------CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0000 000000000 01223467899999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=314.42 Aligned_cols=257 Identities=23% Similarity=0.393 Sum_probs=200.3
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCC---CEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEG---RTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
.+|++.+.||+|+||.||+|++..+ +..+|+|.++.... ...+.+.+|+.++++++||||+++++++...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 78 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK----- 78 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC-----
Confidence 5788999999999999999987533 34799998864332 23467899999999999999999999975443
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++++|.+++.. ....+++.++..++.|++.|++|||+. +++||||||+||+++.++.++
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~ 146 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRK---------HDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCK 146 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEE
Confidence 78999999999999999962 224578999999999999999999977 899999999999999999999
Q ss_pred EeecccceecCCCCCcccc-ccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccc
Q 039533 782 VGDFGLARILSPDHTQTSS-FSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~ 859 (949)
++|||.+............ ....++..|+|||++.+..++.++||||||+++||+++ |+.||......+ .....
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~~~~~-- 222 (267)
T cd05066 147 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--VIKAI-- 222 (267)
T ss_pred eCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--HHHHH--
Confidence 9999999876543321111 11223568999999998889999999999999999887 999985331110 00000
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHh
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSI 931 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 931 (949)
.+. .. .+....++..+.+++.+|++.+|++||+|.++++.|+++
T Consensus 223 ---------~~~-~~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 223 ---------EEG-YR------------------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ---------hCC-Cc------------------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 000 00 000112345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=336.23 Aligned_cols=196 Identities=23% Similarity=0.329 Sum_probs=167.6
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
...+|.+.+.||+|+||.||+|.+...++.||||... ...+.+|++++++++|+||+++++++...+ ..
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~-----~~ 235 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGG-----LT 235 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECC-----EE
Confidence 3457999999999999999999999889999999642 234678999999999999999999876544 68
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++|||++. ++|.+++.. ....+++.+++.|+.|++.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 236 ~lv~e~~~-~~L~~~l~~---------~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~ 302 (461)
T PHA03211 236 CLVLPKYR-SDLYTYLGA---------RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLG 302 (461)
T ss_pred EEEEEccC-CCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEc
Confidence 99999995 688888852 223589999999999999999999977 89999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCC
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPI 843 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf 843 (949)
|||+++...............||..|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 303 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 303 DFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 999998764433222222456999999999999999999999999999999999988765
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=317.28 Aligned_cols=271 Identities=23% Similarity=0.339 Sum_probs=206.7
Q ss_pred cCCCCCCeeeeecCceEEEEEEcC----CCEEEEEEEEecCCCc-chHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDE----GRTTIAVKVFNLQHHG-ASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
.+|++.+.||+|+||.||+|+... +++.||||+++..... ..+.+.+|++++++++||||+++++++... +.
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~---~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP---GG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC---CC
Confidence 357788999999999999998753 4789999999755443 457899999999999999999999987542 24
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
...++||||+++++|.+++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~---------~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~ 148 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQR---------HRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLV 148 (284)
T ss_pred CceEEEEecCCCCCHHHHHHh---------CccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCE
Confidence 478999999999999999972 123589999999999999999999977 89999999999999999999
Q ss_pred EEeecccceecCCCCCc-cccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 781 RVGDFGLARILSPDHTQ-TSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
+|+|||.+......... .......++..|+|||...+..++.++||||||+++|||++|+.||......... ....
T Consensus 149 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~ 225 (284)
T cd05038 149 KISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIGI 225 (284)
T ss_pred EEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---cccc
Confidence 99999999876533221 1111223566799999998888999999999999999999999998543221111 0000
Q ss_pred cCCCc----hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhH
Q 039533 860 ALPDD----VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIK 932 (949)
Q Consensus 860 ~~~~~----~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 932 (949)
..... +.+.+... .+.+....++.++.+++.+|++.+|++||||.||+++|++|+
T Consensus 226 ~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 226 AQGQMIVTRLLELLKEG------------------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred ccccccHHHHHHHHHcC------------------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 00000 11111110 011111234567899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=318.75 Aligned_cols=251 Identities=22% Similarity=0.299 Sum_probs=202.2
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
..+|++.+.||+|+||.||+|....+++.||+|.+........+.+.+|+.++++++|+||+++++++...+ ..+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~~ 92 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-----ELW 92 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-----EEE
Confidence 367999999999999999999998889999999998665555677889999999999999999999976544 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++++|.+++. ...+++.++..++.|++.||.|||+. +++||||||+||+++.++.++|+|
T Consensus 93 lv~e~~~~~~L~~~~~-----------~~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~D 158 (297)
T cd06656 93 VVMEYLAGGSLTDVVT-----------ETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTD 158 (297)
T ss_pred EeecccCCCCHHHHHH-----------hCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECc
Confidence 9999999999999985 13478889999999999999999977 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCc
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
||.+.......... ....+++.|+|||...+..++.++|||||||++|++++|+.||...........
T Consensus 159 fg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~---------- 226 (297)
T cd06656 159 FGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---------- 226 (297)
T ss_pred CccceEccCCccCc--CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee----------
Confidence 99998765433221 123588899999999988899999999999999999999999953321110000
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
..... .+. .......+..+.+++.+|++.+|++||+++|+++
T Consensus 227 ---~~~~~-~~~----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 227 ---IATNG-TPE----------------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ---eccCC-CCC----------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 000 0001123455788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=320.64 Aligned_cols=278 Identities=21% Similarity=0.262 Sum_probs=202.0
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
++|++.+.||+|+||.||+|.+..++..+|+|.++.... ....++.+|++++++++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG-----EIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-----EEE
Confidence 468999999999999999999998899999999875432 23356889999999999999999999976544 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++++|.+++.. ...+++..+..++.|+++||+|||+.+ +++||||||+||++++++.+||+|
T Consensus 76 lv~ey~~~~~L~~~l~~----------~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~d 143 (308)
T cd06615 76 ICMEHMDGGSLDQVLKK----------AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCD 143 (308)
T ss_pred EEeeccCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEcc
Confidence 99999999999999962 245788999999999999999999732 899999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC--
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP-- 862 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~-- 862 (949)
||.+........ ....|+..|+|||++.+..++.++|||||||++|||++|+.||...... ...........
T Consensus 144 fg~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~ 217 (308)
T cd06615 144 FGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK--ELEAMFGRPVSEG 217 (308)
T ss_pred CCCccccccccc----ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh--hHHHhhcCccccc
Confidence 999876533221 1345889999999998888999999999999999999999998633211 11111100000
Q ss_pred -Cc-hhhhcccCCCCCch-----hhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 039533 863 -DD-VMDIVDSSLLPDDE-----DLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHEL 928 (949)
Q Consensus 863 -~~-~~~~~d~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 928 (949)
.. .............. +.........+ ...+ .......+.+++.+|+..+|++|||+.||++.-
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 218 EAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPP-PKLP-SGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred cccCCcccccCCCCCccchhhHHHHHHHHhcCCC-ccCc-CcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 00 00000000000000 00000000000 0000 001345689999999999999999999998763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=328.99 Aligned_cols=244 Identities=25% Similarity=0.255 Sum_probs=187.8
Q ss_pred CeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHH-HHHhcCCCcceeEEeeeecccccCCccceeEe
Q 039533 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECK-ALKSIRHRNLVKVLTACLGADYRGNDFKASVY 707 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 707 (949)
+.||+|+||.||+|++..+++.||+|++.... ....+.+..|.. +++.++||||+++++++...+ ..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~-----~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE-----KLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCC-----EEEEEE
Confidence 47999999999999999899999999997432 222345555655 467789999999998875544 789999
Q ss_pred eeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccc
Q 039533 708 EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGL 787 (949)
Q Consensus 708 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~ 787 (949)
||+++|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 76 e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~ 142 (325)
T cd05604 76 DFVNGGELFFHLQ----------RERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGL 142 (325)
T ss_pred cCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCC
Confidence 9999999998886 234688999999999999999999977 999999999999999999999999999
Q ss_pred ceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhh
Q 039533 788 ARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMD 867 (949)
Q Consensus 788 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 867 (949)
++........ .....||..|+|||++.+..++.++|||||||++|||++|+.||...... ... ..
T Consensus 143 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-----~~~--------~~ 207 (325)
T cd05604 143 CKEGIAQSDT--TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-----EMY--------DN 207 (325)
T ss_pred cccCCCCCCC--cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-----HHH--------HH
Confidence 8753322211 12345899999999999989999999999999999999999999532111 000 01
Q ss_pred hcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 039533 868 IVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHEL 928 (949)
Q Consensus 868 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 928 (949)
+....+... ......+.+++.+|++.+|++||++.+.++.+
T Consensus 208 ~~~~~~~~~--------------------~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i 248 (325)
T cd05604 208 ILHKPLVLR--------------------PGASLTAWSILEELLEKDRQRRLGAKEDFLEI 248 (325)
T ss_pred HHcCCccCC--------------------CCCCHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence 111000000 01234567899999999999999987544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=321.60 Aligned_cols=270 Identities=22% Similarity=0.342 Sum_probs=204.5
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcC-------CCEEEEEEEEecCC-CcchHHHHHHHHHHHhc-CCCcceeEEeeeecc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDE-------GRTTIAVKVFNLQH-HGASRSFIAECKALKSI-RHRNLVKVLTACLGA 695 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 695 (949)
.++|.+.+.||+|+||.||+|.+.. ....+|+|+++... .....++.+|+++++++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3579999999999999999998642 23569999987543 23345688899999999 799999999997654
Q ss_pred cccCCccceeEeeeccCCChhhhcCCCCCCCc------cccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 039533 696 DYRGNDFKASVYEFMHYGSLEEWLHPFTGEDE------IDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKP 769 (949)
Q Consensus 696 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp 769 (949)
+ ..++||||+++|+|.+++........ .......+++.+++.++.|++.||+|||+. +++||||||
T Consensus 97 ~-----~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp 168 (307)
T cd05098 97 G-----PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAA 168 (307)
T ss_pred C-----ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccH
Confidence 4 78999999999999999974321110 001224589999999999999999999976 999999999
Q ss_pred CCeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccc
Q 039533 770 SNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFE 848 (949)
Q Consensus 770 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~ 848 (949)
+||++++++.+||+|||.++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 999999999999999999876543222111111224568999999988889999999999999999998 8888853211
Q ss_pred cCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 039533 849 GDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHEL 928 (949)
Q Consensus 849 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 928 (949)
. ++.+.+...... +.....+..+.+++.+|++.+|++|||+.||++.|
T Consensus 249 ~--------------~~~~~~~~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l 296 (307)
T cd05098 249 E--------------ELFKLLKEGHRM------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 296 (307)
T ss_pred H--------------HHHHHHHcCCCC------------------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 0 011111100000 00113345788899999999999999999999999
Q ss_pred HHhHHh
Q 039533 929 QSIKNI 934 (949)
Q Consensus 929 ~~i~~~ 934 (949)
+++...
T Consensus 297 ~~~~~~ 302 (307)
T cd05098 297 DRILAL 302 (307)
T ss_pred HHHHHH
Confidence 998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=327.84 Aligned_cols=242 Identities=24% Similarity=0.244 Sum_probs=186.3
Q ss_pred CeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHH-HHHhcCCCcceeEEeeeecccccCCccceeEe
Q 039533 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECK-ALKSIRHRNLVKVLTACLGADYRGNDFKASVY 707 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 707 (949)
+.||+|+||.||+|++..+++.||+|++.... ......+..|.. +++.++||||+++++++...+ ..++||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~-----~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD-----KLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCC-----eEEEEE
Confidence 47999999999999999889999999997432 122234444444 567789999999998875544 789999
Q ss_pred eeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccc
Q 039533 708 EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGL 787 (949)
Q Consensus 708 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~ 787 (949)
||+++|+|.+++. ....++...+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~ 142 (325)
T cd05602 76 DYINGGELFYHLQ----------RERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGL 142 (325)
T ss_pred eCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCC
Confidence 9999999999986 234577888899999999999999977 999999999999999999999999999
Q ss_pred ceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhh
Q 039533 788 ARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMD 867 (949)
Q Consensus 788 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 867 (949)
++........ .....||+.|+|||++.+..++.++||||+||++|||++|+.||....... .. ..
T Consensus 143 a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~--------~~ 207 (325)
T cd05602 143 CKENIEHNGT--TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-----MY--------DN 207 (325)
T ss_pred CcccccCCCC--cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH-----HH--------HH
Confidence 9754322221 123459999999999999899999999999999999999999996321110 00 00
Q ss_pred hcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 868 IVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 868 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
+....... ....+..+.+++.+|++.||.+||++.+.+.
T Consensus 208 i~~~~~~~--------------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 208 ILNKPLQL--------------------KPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred HHhCCcCC--------------------CCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 10000000 0022445788999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=311.54 Aligned_cols=250 Identities=27% Similarity=0.361 Sum_probs=197.7
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
.+|++.+.||+|+||.||+|... +..||+|.++.. ...+.+.+|+.++++++|+|++++++++... ....++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~l 77 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYI 77 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcC----CCceEE
Confidence 47889999999999999999875 678999998643 2346789999999999999999999876432 236799
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
||||+++++|.+++... ....+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+||
T Consensus 78 v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df 146 (256)
T cd05082 78 VTEYMAKGSLVDYLRSR--------GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDF 146 (256)
T ss_pred EEECCCCCcHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCC
Confidence 99999999999998621 123478999999999999999999977 8999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCCc
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
|+++....... ...++..|+|||+..+..++.++|||||||++|||++ |+.||...... .....
T Consensus 147 g~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~--~~~~~-------- 211 (256)
T cd05082 147 GLTKEASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPR-------- 211 (256)
T ss_pred ccceeccccCC-----CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH--------
Confidence 99886543221 2235678999999988889999999999999999998 99998532110 01000
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHh
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSI 931 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 931 (949)
+........ ...++..+.+++.+|++.+|++|||+.++++.|+++
T Consensus 212 ----~~~~~~~~~------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 212 ----VEKGYKMDA------------------PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ----HhcCCCCCC------------------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 000000000 013355788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=329.12 Aligned_cols=239 Identities=23% Similarity=0.239 Sum_probs=188.7
Q ss_pred CeeeeecCceEEEEEEc---CCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeE
Q 039533 632 NLVGVGSFGSVYKGIID---EGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASV 706 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 706 (949)
+.||+|+||.||+++.. .+++.||+|+++.... .....+.+|++++++++||||+++++++...+ ..++|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEG-----KLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCC-----EEEEE
Confidence 67999999999999863 4678999999974322 22346778999999999999999999876544 78999
Q ss_pred eeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecc
Q 039533 707 YEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFG 786 (949)
Q Consensus 707 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG 786 (949)
|||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 77 ~e~~~~~~L~~~l~----------~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg 143 (318)
T cd05582 77 LDFLRGGDLFTRLS----------KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFG 143 (318)
T ss_pred EcCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeecc
Confidence 99999999999986 234589999999999999999999977 89999999999999999999999999
Q ss_pred cceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchh
Q 039533 787 LARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVM 866 (949)
Q Consensus 787 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 866 (949)
+++........ .....||..|+|||++.+..++.++|||||||++|||++|+.||....... .. .
T Consensus 144 ~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~-----------~ 208 (318)
T cd05582 144 LSKESIDHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE--TM-----------T 208 (318)
T ss_pred CCcccCCCCCc--eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH--HH-----------H
Confidence 99865443221 123568999999999998889999999999999999999999996431110 00 0
Q ss_pred hhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHH
Q 039533 867 DIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTN 923 (949)
Q Consensus 867 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 923 (949)
.+..... ..+ ...+..+.+++.+|++.||++||++.+
T Consensus 209 ~i~~~~~-~~p-------------------~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 209 MILKAKL-GMP-------------------QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHcCCC-CCC-------------------CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 0000000 000 122345788999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=318.66 Aligned_cols=268 Identities=21% Similarity=0.289 Sum_probs=206.0
Q ss_pred HHHHHHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhc-CCCcceeEEeeeeccc
Q 039533 618 YQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSI-RHRNLVKVLTACLGAD 696 (949)
Q Consensus 618 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 696 (949)
++++..+.++|++.+.||+|+||.||+|.+..+++.+|+|+++... .....+.+|+.+++++ +||||+++++++....
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 4556678899999999999999999999998889999999986432 2345688899999999 6999999999986555
Q ss_pred ccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC
Q 039533 697 YRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD 776 (949)
Q Consensus 697 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~ 776 (949)
.......++||||+++++|.+++.... .....+++..+..++.|++.|+.|||+. +++||||||+||++++
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~ 159 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFL------KRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTT 159 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhh------ccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECC
Confidence 445567899999999999999875211 1234578899999999999999999977 8999999999999999
Q ss_pred CCceEEeecccceecCCCCCccccccccCccCccCccccCC-----CccCCccchHHHHHHHHHHHhCCCCCccccccCc
Q 039533 777 YMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-----CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDI 851 (949)
Q Consensus 777 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~ 851 (949)
++.+||+|||.++......... ....|+..|+|||++.. ..++.++||||+||++|||++|+.||.......
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~- 236 (286)
T cd06638 160 EGGVKLVDFGVSAQLTSTRLRR--NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR- 236 (286)
T ss_pred CCCEEEccCCceeecccCCCcc--ccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-
Confidence 9999999999998764332211 13458999999998753 447889999999999999999999986331110
Q ss_pred hhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 852 NLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 852 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
....... . ..... .. .......+.+++.+|++.||++|||+.|+++.
T Consensus 237 ~~~~~~~-----~----~~~~~-~~-------------------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 237 ALFKIPR-----N----PPPTL-HQ-------------------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred HHhhccc-----c----CCCcc-cC-------------------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0000000 0 00000 00 00123457889999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=310.81 Aligned_cols=251 Identities=29% Similarity=0.420 Sum_probs=201.4
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.++|++.+.||.|+||.||+|... ++.||+|.++.... ..+++.+|+.++++++|+||+++++++... ...+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 76 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQG-----NPLY 76 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCC-----CCeE
Confidence 357889999999999999999986 78899999975543 457899999999999999999999997643 3789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++++|.+++... ....+++..+..++.|++.|++|||++ +++||||||+||+++.++.+||+|
T Consensus 77 ~v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d 145 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSR--------GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSD 145 (256)
T ss_pred EEEEecCCCcHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcc
Confidence 999999999999998621 123589999999999999999999977 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCC
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
||.++....... ...++..|+|||++....++.++||||||+++||+++ |..||......+ ..
T Consensus 146 ~g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~--------- 209 (256)
T cd05039 146 FGLAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VV--------- 209 (256)
T ss_pred cccccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH--HH---------
Confidence 999987633222 1235678999999988889999999999999999997 999985331110 00
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHh
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSI 931 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 931 (949)
..+....... .....+..+.+++.+|+..+|++|||+.|++++|+.+
T Consensus 210 ---~~~~~~~~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 210 ---PHVEKGYRME------------------APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ---HHHhcCCCCC------------------CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0000000000 0012345688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=318.47 Aligned_cols=269 Identities=24% Similarity=0.274 Sum_probs=207.5
Q ss_pred cCHHHHHHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhc-CCCcceeEEeeeec
Q 039533 616 LSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSI-RHRNLVKVLTACLG 694 (949)
Q Consensus 616 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 694 (949)
++.+++..++++|.+.+.||+|+||.||+|....+++.+|+|++.... .....+.+|+.+++++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 455666778899999999999999999999998889999999986432 2345678899999999 79999999999876
Q ss_pred ccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeee
Q 039533 695 ADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL 774 (949)
Q Consensus 695 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll 774 (949)
.+.......++||||+++++|.++++... .....+++..++.++.|++.||+|||+. +++||||||+||++
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~------~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili 161 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLL------ICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILL 161 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhh------hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEE
Confidence 55444457899999999999999886211 1234588999999999999999999977 99999999999999
Q ss_pred cCCCceEEeecccceecCCCCCccccccccCccCccCccccCCC-----ccCCccchHHHHHHHHHHHhCCCCCcccccc
Q 039533 775 DDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-----EVSTNGDVYSYGILLLELVIGKKPIDIMFEG 849 (949)
Q Consensus 775 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~ 849 (949)
+.++.+||+|||.+.......... ....|+..|+|||++... .++.++|||||||++|||++|+.||......
T Consensus 162 ~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~ 239 (291)
T cd06639 162 TTEGGVKLVDFGVSAQLTSTRLRR--NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV 239 (291)
T ss_pred cCCCCEEEeecccchhcccccccc--cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH
Confidence 999999999999988654322211 124588999999987543 3689999999999999999999998643211
Q ss_pred CchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 850 DINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 850 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
. ......+.. . . .. ....+....+.+++.+|++.+|++||++.|+++
T Consensus 240 ~-~~~~~~~~~-~---~-----~~--------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 240 K-TLFKIPRNP-P---P-----TL--------------------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred H-HHHHHhcCC-C---C-----CC--------------------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0 000000000 0 0 00 000123346889999999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=329.92 Aligned_cols=204 Identities=21% Similarity=0.253 Sum_probs=171.7
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeeccc-ccCC
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGAD-YRGN 700 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~ 700 (949)
..++|++.+.||+|+||.||+|.+...++.||||++.... ....+.+.+|+.+++.++||||+++++++...+ ....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999998889999999986432 233467889999999999999999998875432 1233
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
...++||||+++ ++.+++. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~ 165 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTL 165 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH------------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcE
Confidence 457999999975 7777764 2377888999999999999999977 99999999999999999999
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccc
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIM 846 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~ 846 (949)
||+|||+++........ ....||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 166 kL~DfG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 166 KILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred EEEeCCCccccCCCCcc---cCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 99999999865433221 1345899999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=318.18 Aligned_cols=250 Identities=22% Similarity=0.285 Sum_probs=201.4
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
.+|++.+.||.|++|.||+|.+..+++.||+|.+........+.+.+|++++++++||||+++++++...+ ..++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD-----ELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc-----eEEE
Confidence 46889999999999999999998889999999997665555678899999999999999999999976544 7899
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
||||+++++|.+++. ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+||
T Consensus 94 v~e~~~~~~L~~~~~-----------~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~df 159 (296)
T cd06655 94 VMEYLAGGSLTDVVT-----------ETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDF 159 (296)
T ss_pred EEEecCCCcHHHHHH-----------hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccC
Confidence 999999999999885 23478999999999999999999977 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCch
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDV 865 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 865 (949)
|.+.......... ....++..|+|||.+.+..++.++|||||||++|+|++|+.||.......... .. .....
T Consensus 160 g~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~-~~-~~~~~--- 232 (296)
T cd06655 160 GFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LI-ATNGT--- 232 (296)
T ss_pred ccchhcccccccC--CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HH-HhcCC---
Confidence 9987654433211 13458899999999998889999999999999999999999996432211000 00 00000
Q ss_pred hhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 866 MDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 866 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
+.+ ......+..+.+++.+||..||++||++.++++
T Consensus 233 -----~~~--------------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 233 -----PEL--------------------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred -----ccc--------------------CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000 001123456788999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=312.73 Aligned_cols=256 Identities=22% Similarity=0.263 Sum_probs=197.9
Q ss_pred HHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 622 YNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 622 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
+-+++.+.....||+|+||.||+|++..+++.||+|.+........+.+.+|+.++++++|+||+++++++...+
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 78 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG----- 78 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC-----
Confidence 345566666789999999999999998889999999987665555678999999999999999999999976544
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCC--CHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC-CC
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNL--NLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD-YM 778 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l--~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~-~~ 778 (949)
..++|+||+++++|.+++... ...+ ++..+..++.|++.|++|||+. +|+||||||+||+++. ++
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~ 146 (268)
T cd06624 79 FFKIFMEQVPGGSLSALLRSK---------WGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSG 146 (268)
T ss_pred EEEEEEecCCCCCHHHHHHHh---------cccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCC
Confidence 789999999999999998621 1223 7788889999999999999977 9999999999999976 67
Q ss_pred ceEEeecccceecCCCCCccccccccCccCccCccccCCCc--cCCccchHHHHHHHHHHHhCCCCCccccccCchhhhh
Q 039533 779 TARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCE--VSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNF 856 (949)
Q Consensus 779 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~ 856 (949)
.++|+|||.+.......... ....|+..|+|||++.+.. ++.++||||||+++|+|++|+.||.......... +
T Consensus 147 ~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~--~ 222 (268)
T cd06624 147 VVKISDFGTSKRLAGINPCT--ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM--F 222 (268)
T ss_pred eEEEecchhheecccCCCcc--ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH--h
Confidence 99999999997654322211 1234889999999986643 7899999999999999999999985321111000 0
Q ss_pred ccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 857 GRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 857 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
... .... .+. ........+.+++.+|++.+|++|||+.|+++
T Consensus 223 ~~~---------~~~~-~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 223 KVG---------MFKI-HPE------------------IPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred hhh---------hhcc-CCC------------------CCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 000 0000 000 00123456789999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=314.58 Aligned_cols=253 Identities=28% Similarity=0.400 Sum_probs=198.3
Q ss_pred CCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchH--HHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASR--SFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 628 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
|++.+.||+|+||+||+|....+++.||+|++......... ...+|+.++++++||||+++++++.... ..++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN-----YLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS-----EEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc-----cccc
Confidence 56778999999999999999999999999999866543322 3456999999999999999999976543 7899
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
||||+++++|.+++. ....+++.++..++.|+++||+|||+. +|+||||||+||++++++.++|+||
T Consensus 76 v~~~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Df 142 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQ----------KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDF 142 (260)
T ss_dssp EEEEETTEBHHHHHH----------HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSG
T ss_pred ccccccccccccccc----------ccccccccccccccccccccccccccc---ccccccccccccccccccccccccc
Confidence 999999999999996 345689999999999999999999987 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccC-CCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCc
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGV-GCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
|.+........ ......++..|+|||+.. +..++.++||||+|+++|+|++|..||......+ ...
T Consensus 143 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~--~~~--------- 209 (260)
T PF00069_consen 143 GSSVKLSENNE--NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD--QLE--------- 209 (260)
T ss_dssp TTTEESTSTTS--EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH--HHH---------
T ss_pred ccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccchh--hhh---------
Confidence 99987522222 222456899999999998 7889999999999999999999999986431000 000
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.+ .....................+.+++.+|++.||++||++.|+++
T Consensus 210 ---~~------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 210 ---II------------EKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp ---HH------------HHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ---hh------------hhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 000000000000000111367899999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=323.88 Aligned_cols=194 Identities=25% Similarity=0.312 Sum_probs=166.4
Q ss_pred CeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCCccceeEe
Q 039533 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGNDFKASVY 707 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 707 (949)
+.||+|+||.||+|+...+++.||+|+++... ....+.+.+|+.++.++ +||+|+++++++...+ ..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTS-----RLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCC-----EEEEEE
Confidence 47999999999999999899999999997542 22345678899999888 6999999999875444 789999
Q ss_pred eeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccc
Q 039533 708 EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGL 787 (949)
Q Consensus 708 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~ 787 (949)
||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~~~L~~~~~----------~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~ 142 (327)
T cd05617 76 EYVNGGDLMFHMQ----------RQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGM 142 (327)
T ss_pred eCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEecccc
Confidence 9999999998886 234589999999999999999999977 999999999999999999999999999
Q ss_pred ceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCcc
Q 039533 788 ARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDI 845 (949)
Q Consensus 788 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~ 845 (949)
++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus 143 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 143 CKEGLGPGDT--TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred ceeccCCCCc--eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 8753322211 1234589999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=323.72 Aligned_cols=242 Identities=24% Similarity=0.271 Sum_probs=189.8
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcC-CCcceeEEeeeecccccCCcc
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIR-HRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 702 (949)
+|+..+.||+|+||.||+|++..+++.||+|+++... ....+.+..|..++..+. |++|+++++++...+ .
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-----~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD-----R 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC-----E
Confidence 4777899999999999999999899999999997432 233456778999998886 577888888765443 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++|+|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~Ey~~~g~L~~~i~----------~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL 142 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQ----------QVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKI 142 (323)
T ss_pred EEEEEcCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEE
Confidence 899999999999999986 234588999999999999999999977 9999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
+|||+++......... ....||+.|+|||++.+..++.++||||+||++|||++|+.||....... .
T Consensus 143 ~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--~--------- 209 (323)
T cd05615 143 ADFGMCKEHMVDGVTT--RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE--L--------- 209 (323)
T ss_pred eccccccccCCCCccc--cCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH--H---------
Confidence 9999987543322211 13458999999999998889999999999999999999999996432110 0
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNM 921 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 921 (949)
...+...... .+ ...+..+.+++.+|++.+|++|++.
T Consensus 210 --~~~i~~~~~~-~p-------------------~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 210 --FQSIMEHNVS-YP-------------------KSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --HHHHHhCCCC-CC-------------------ccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0001110000 00 0223456889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=312.57 Aligned_cols=258 Identities=23% Similarity=0.362 Sum_probs=202.1
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCC---CEEEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEG---RTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
++|++.+.||+|+||.||+|.+... ...||+|...... ....+.+.+|+.++++++||||+++++++...
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~------ 79 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN------ 79 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC------
Confidence 4688899999999999999987533 3568999886544 33456789999999999999999999987532
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++++|.+++.. ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.+|
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~ 147 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQV---------NKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVK 147 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeE
Confidence 46899999999999999962 123589999999999999999999977 899999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhcccc
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
|+|||+++........... ...++..|+|||.+....++.++||||||+++||+++ |+.||........ .. ..
T Consensus 148 l~d~g~~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-~~-~~--- 221 (270)
T cd05056 148 LGDFGLSRYLEDESYYKAS-KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV-IG-RI--- 221 (270)
T ss_pred EccCceeeecccccceecC-CCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH-HH-HH---
Confidence 9999999876544322111 2234568999999888889999999999999999996 9999864322110 00 00
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHh
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNI 934 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 934 (949)
.... +.....+++..+.+++.+|+..+|++|||+.|+++.|++++..
T Consensus 222 --------~~~~-------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 222 --------ENGE-------------------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred --------HcCC-------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0000 0000113455788999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=322.66 Aligned_cols=270 Identities=22% Similarity=0.348 Sum_probs=204.6
Q ss_pred cCCCCCCeeeeecCceEEEEEEcC-------CCEEEEEEEEecCC-CcchHHHHHHHHHHHhc-CCCcceeEEeeeeccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDE-------GRTTIAVKVFNLQH-HGASRSFIAECKALKSI-RHRNLVKVLTACLGAD 696 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 696 (949)
.+|++.+.||+|+||.||+|++.. .+..||+|+++... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 468999999999999999998642 22468999886432 22346788999999999 7999999999976544
Q ss_pred ccCCccceeEeeeccCCChhhhcCCCCCCCc------cccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 039533 697 YRGNDFKASVYEFMHYGSLEEWLHPFTGEDE------IDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPS 770 (949)
Q Consensus 697 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~ 770 (949)
..+++|||+++|+|.+++........ .......+++.+++.++.|++.||+|||+. +++||||||+
T Consensus 92 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~ 163 (334)
T cd05100 92 -----PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR 163 (334)
T ss_pred -----ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccc
Confidence 78999999999999999974321100 011234588999999999999999999977 9999999999
Q ss_pred CeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCcccccc
Q 039533 771 NVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEG 849 (949)
Q Consensus 771 NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~ 849 (949)
||++++++.+||+|||.++...............++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 243 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999987654332222222234578999999999889999999999999999998 88888532111
Q ss_pred CchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 039533 850 DINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQ 929 (949)
Q Consensus 850 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 929 (949)
+ . ...+......+ ....++..+.+++.+|++.+|++||++.|+++.|+
T Consensus 244 ~-----~---------~~~~~~~~~~~------------------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~ 291 (334)
T cd05100 244 E-----L---------FKLLKEGHRMD------------------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLD 291 (334)
T ss_pred H-----H---------HHHHHcCCCCC------------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 0 0 00000000000 00123456889999999999999999999999999
Q ss_pred HhHHhh
Q 039533 930 SIKNIL 935 (949)
Q Consensus 930 ~i~~~~ 935 (949)
++....
T Consensus 292 ~~~~~~ 297 (334)
T cd05100 292 RVLTVT 297 (334)
T ss_pred HHhhhc
Confidence 997543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=318.72 Aligned_cols=261 Identities=27% Similarity=0.412 Sum_probs=201.7
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCE----EEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccC
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRT----TIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRG 699 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 699 (949)
.++|+..+.||+|+||.||+|.+..++. .||+|++..... .....+.+|+.++++++||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~---- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP---- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC----
Confidence 3567888999999999999999865554 578888764432 2234688999999999999999999987532
Q ss_pred CccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCc
Q 039533 700 NDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMT 779 (949)
Q Consensus 700 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~ 779 (949)
..++++||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 82 --~~~~v~e~~~~g~l~~~~~~---------~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~ 147 (303)
T cd05110 82 --TIQLVTQLMPHGCLLDYVHE---------HKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNH 147 (303)
T ss_pred --CceeeehhcCCCCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCc
Confidence 35789999999999999862 223578899999999999999999977 8999999999999999999
Q ss_pred eEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhcc
Q 039533 780 ARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGR 858 (949)
Q Consensus 780 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~ 858 (949)
+||+|||+++...............++..|+|||++.+..++.++|||||||++||+++ |+.||....... ..
T Consensus 148 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~--~~---- 221 (303)
T cd05110 148 VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE--IP---- 221 (303)
T ss_pred eEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HH----
Confidence 99999999987654332222222345778999999998889999999999999999998 999985331110 11
Q ss_pred ccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhh
Q 039533 859 KALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNIL 935 (949)
Q Consensus 859 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~ 935 (949)
+++....... ....++..+.+++..||..+|++||+++|+++.++++....
T Consensus 222 --------~~~~~~~~~~------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 222 --------DLLEKGERLP------------------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred --------HHHHCCCCCC------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 1111000000 00012345788999999999999999999999999986554
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=315.19 Aligned_cols=250 Identities=24% Similarity=0.282 Sum_probs=196.4
Q ss_pred CCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEe
Q 039533 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVY 707 (949)
Q Consensus 628 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 707 (949)
|++.+.||+|+||.||+|.+..++..+++|.+........+.+.+|+++++.++||||+++++++.... ..++||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~-----~~~~v~ 81 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN-----NLWILI 81 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC-----EEEEEE
Confidence 567889999999999999999889999999987655555677889999999999999999999976544 789999
Q ss_pred eeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccc
Q 039533 708 EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGL 787 (949)
Q Consensus 708 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~ 787 (949)
||+++++|.+++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+
T Consensus 82 e~~~~~~l~~~~~~---------~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~ 149 (282)
T cd06643 82 EFCAGGAVDAVMLE---------LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGV 149 (282)
T ss_pred EecCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccc
Confidence 99999999988752 124589999999999999999999977 999999999999999999999999999
Q ss_pred ceecCCCCCccccccccCccCccCccccC-----CCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 788 ARILSPDHTQTSSFSVKGSLGYIAPEYGV-----GCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 788 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
+......... .....++..|+|||++. +..++.++|||||||++|||++|++||....... ......... .
T Consensus 150 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~-~ 225 (282)
T cd06643 150 SAKNTRTIQR--RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSE-P 225 (282)
T ss_pred cccccccccc--cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-HHHHHhhcC-C
Confidence 8765432211 12345899999999874 3457889999999999999999999986432111 000000000 0
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
... . .....+..+.+++.+||+.+|++||++.++++
T Consensus 226 --------~~~-~-------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 226 --------PTL-A-------------------QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred --------CCC-C-------------------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 0 00123456789999999999999999999865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=310.49 Aligned_cols=254 Identities=23% Similarity=0.300 Sum_probs=202.3
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
++|++.+.||+|+||.||+|....+++.+|+|++........+.+.+|++++++++||||+++++++.... ..++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~~l 77 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD-----KLWI 77 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC-----EEEE
Confidence 57889999999999999999998888999999998665556678999999999999999999999875443 7899
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
+|||+++++|.+++.. ....+++.++..++.|++.|++|||+. +++||||||+||++++++.+||+||
T Consensus 78 ~~e~~~~~~l~~~~~~---------~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~ 145 (262)
T cd06613 78 VMEYCGGGSLQDIYQV---------TRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADF 145 (262)
T ss_pred EEeCCCCCcHHHHHHh---------hccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECcc
Confidence 9999999999999862 124588999999999999999999977 8999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCC---ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC---EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
|.+......... .....++..|+|||...+. .++.++|||||||++|||++|+.||...........
T Consensus 146 g~~~~~~~~~~~--~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~-------- 215 (262)
T cd06613 146 GVSAQLTATIAK--RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL-------- 215 (262)
T ss_pred ccchhhhhhhhc--cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH--------
Confidence 998765432211 1134588899999998776 789999999999999999999999864321110000
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
......... ........+..+.+++.+|+..+|++|||+.||+.
T Consensus 216 -----~~~~~~~~~---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 216 -----ISKSNFPPP---------------KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -----HHhccCCCc---------------cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000 00011234567889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=313.38 Aligned_cols=258 Identities=25% Similarity=0.436 Sum_probs=202.6
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCE----EEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRT----TIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
.+|++.+.||+|+||.||+|.+..+++ .||+|+...... .....+.+|+.++++++||||+++++++..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------ 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence 568889999999999999999865543 689998865433 234678899999999999999999999864
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
...++||||+++|+|.+++.. ....+++..+..++.|++.|++|||++ +++||||||+||++++++.+
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~ 148 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRN---------HKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHV 148 (279)
T ss_pred CceEEEEecCCCCcHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeE
Confidence 268999999999999999862 223489999999999999999999976 99999999999999999999
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccc
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~ 859 (949)
||+|||.++...............++..|+|||......++.++||||||+++||+++ |+.||+.....+ .
T Consensus 149 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~------ 220 (279)
T cd05057 149 KITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--I------ 220 (279)
T ss_pred EECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH--H------
Confidence 9999999987654332221112224578999999988889999999999999999999 999986432111 1
Q ss_pred cCCCchhhhcccC-CCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHh
Q 039533 860 ALPDDVMDIVDSS-LLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNI 934 (949)
Q Consensus 860 ~~~~~~~~~~d~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 934 (949)
.+.+... ..+.+ ..+...+.+++.+||..+|++||++.++++.++++.+.
T Consensus 221 ------~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 221 ------PDLLEKGERLPQP-------------------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred ------HHHHhCCCCCCCC-------------------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 1111100 00000 01234578899999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=331.33 Aligned_cols=202 Identities=24% Similarity=0.318 Sum_probs=172.7
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
++|++.+.||+|+||.||+|+...+++.||+|+++... ......+.+|+.++.+++||+|+++++++.+.+ .
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~-----~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR-----N 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-----E
Confidence 46888999999999999999999889999999997432 233457888999999999999999999875444 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~E~~~gg~L~~~l~----------~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL 142 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLM----------KKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKL 142 (360)
T ss_pred EEEEEeCCCCccHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEE
Confidence 899999999999999986 234588999999999999999999977 9999999999999999999999
Q ss_pred eecccceecCCCCC---------------------------------ccccccccCccCccCccccCCCccCCccchHHH
Q 039533 783 GDFGLARILSPDHT---------------------------------QTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSY 829 (949)
Q Consensus 783 ~DfG~a~~~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSl 829 (949)
+|||+++....... ........||+.|+|||++.+..++.++|||||
T Consensus 143 ~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSl 222 (360)
T cd05627 143 SDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222 (360)
T ss_pred eeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccc
Confidence 99999875432110 000113469999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCcc
Q 039533 830 GILLLELVIGKKPIDI 845 (949)
Q Consensus 830 Gvvl~elltg~~Pf~~ 845 (949)
||++|||++|+.||..
T Consensus 223 Gvilyel~tG~~Pf~~ 238 (360)
T cd05627 223 GVIMYEMLIGYPPFCS 238 (360)
T ss_pred cceeeecccCCCCCCC
Confidence 9999999999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=324.79 Aligned_cols=238 Identities=24% Similarity=0.242 Sum_probs=184.1
Q ss_pred CeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHH-HHHhcCCCcceeEEeeeecccccCCccceeEe
Q 039533 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECK-ALKSIRHRNLVKVLTACLGADYRGNDFKASVY 707 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 707 (949)
++||+|+||.||+|++..+++.||+|++.... ......+..|.. +++.++||||+++++++...+ ..++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~-----~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE-----KLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCC-----EEEEEE
Confidence 47999999999999999899999999987432 122334555554 578889999999998875444 789999
Q ss_pred eeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccc
Q 039533 708 EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGL 787 (949)
Q Consensus 708 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~ 787 (949)
||+++++|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 142 (321)
T cd05603 76 DYVNGGELFFHLQ----------RERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGL 142 (321)
T ss_pred cCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCC
Confidence 9999999998885 234578889999999999999999977 999999999999999999999999999
Q ss_pred ceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhh
Q 039533 788 ARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMD 867 (949)
Q Consensus 788 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 867 (949)
++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ..
T Consensus 143 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~--------~~ 207 (321)
T cd05603 143 CKEGVEPEET--TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS-----QMY--------DN 207 (321)
T ss_pred CccCCCCCCc--cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH-----HHH--------HH
Confidence 8753222211 12345899999999999888999999999999999999999999532110 000 00
Q ss_pred hcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHH
Q 039533 868 IVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMT 922 (949)
Q Consensus 868 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 922 (949)
+....... + ......+.+++.+|++.||++||++.
T Consensus 208 i~~~~~~~-~-------------------~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 208 ILHKPLQL-P-------------------GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HhcCCCCC-C-------------------CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11000000 0 01234578899999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=311.43 Aligned_cols=257 Identities=22% Similarity=0.330 Sum_probs=188.7
Q ss_pred CeeeeecCceEEEEEEcC--CCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEee
Q 039533 632 NLVGVGSFGSVYKGIIDE--GRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYE 708 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 708 (949)
+.||+|+||.||+|.... ++..+|+|.++.... .....+.+|+.++++++||||+++++++.+.. ..++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT-----PYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC-----CcEEEEE
Confidence 468999999999998653 346799998865443 23357889999999999999999999876544 6899999
Q ss_pred eccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecccc
Q 039533 709 FMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLA 788 (949)
Q Consensus 709 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a 788 (949)
|+++|+|.+++...... .....++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||.+
T Consensus 76 ~~~~g~L~~~l~~~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~ 147 (269)
T cd05087 76 FCPLGDLKGYLRSCRKA-----ELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLS 147 (269)
T ss_pred CCCCCcHHHHHHHhhhc-----ccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCcccc
Confidence 99999999999632111 123467778889999999999999977 8999999999999999999999999999
Q ss_pred eecCCCCCccccccccCccCccCccccCCC-------ccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhcccc
Q 039533 789 RILSPDHTQTSSFSVKGSLGYIAPEYGVGC-------EVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 789 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
+...............++..|+|||++.+. .++.++||||||+++|||++ |+.||......+.. ...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~--~~~--- 222 (269)
T cd05087 148 HNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL--TYT--- 222 (269)
T ss_pred ccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH--HHH---
Confidence 765433322222234478889999987642 35789999999999999996 99999643222110 000
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQ 929 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 929 (949)
.........++.+.. ..+..+.+++..|+ .+|++|||++||.+.|+
T Consensus 223 ~~~~~~~~~~~~~~~----------------------~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 223 VREQQLKLPKPRLKL----------------------PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred hhcccCCCCCCccCC----------------------CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 000000111111100 12335677888998 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=309.43 Aligned_cols=253 Identities=24% Similarity=0.409 Sum_probs=199.6
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
++|++.++||+|+||.||+|... +++.||+|.+..... ...++.+|+.++++++|+||+++++++.. +..++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~ 77 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVTQ------EPIYI 77 (260)
T ss_pred HHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEcc------CCcEE
Confidence 56889999999999999999976 578899999874433 34678999999999999999999987532 25799
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
||||+++++|.+++... ....+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+||
T Consensus 78 v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~df 146 (260)
T cd05067 78 ITEYMENGSLVDFLKTP--------EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADF 146 (260)
T ss_pred EEEcCCCCCHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccC
Confidence 99999999999998621 234588999999999999999999976 8999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCCc
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
|.+.......... .....++..|+|||++.+..++.++||||||+++||+++ |+.||...... ....
T Consensus 147 g~~~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~--------- 214 (260)
T cd05067 147 GLARLIEDNEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--EVIQ--------- 214 (260)
T ss_pred cceeecCCCCccc-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--HHHH---------
Confidence 9998765322211 112346778999999988889999999999999999999 99998633211 0100
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQS 930 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 930 (949)
.+...... +.....+.++.+++.+|++.+|++||+++++.+.|+.
T Consensus 215 ---~~~~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 215 ---NLERGYRM------------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ---HHHcCCCC------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 00000000 0001234568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=315.29 Aligned_cols=252 Identities=23% Similarity=0.254 Sum_probs=198.2
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
+.|++.+.||.|+||.||+|++..+++.||+|++........+.+.+|+.++++++||||+++++++.... ..++
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l 86 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG-----KLWI 86 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC-----eEEE
Confidence 56899999999999999999999889999999998666555678899999999999999999999876443 7899
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
||||+++++|..++.. ....+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+||
T Consensus 87 v~e~~~~~~l~~~~~~---------~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~df 154 (292)
T cd06644 87 MIEFCPGGAVDAIMLE---------LDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADF 154 (292)
T ss_pred EEecCCCCcHHHHHHh---------hcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccC
Confidence 9999999999888752 234588999999999999999999976 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccC-----CCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGV-----GCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
|.+......... .....++..|+|||++. ...++.++|||||||++|||++|+.||....... .....
T Consensus 155 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~~~~---- 227 (292)
T cd06644 155 GVSAKNVKTLQR--RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKI---- 227 (292)
T ss_pred ccceeccccccc--cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH-HHHHH----
Confidence 998764332211 11345888999999874 3456889999999999999999999985321110 00000
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.... .+.. ......+..+.+++.+|++.+|++||++.|+++
T Consensus 228 --------~~~~-~~~~----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 228 --------AKSE-PPTL----------------SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred --------hcCC-CccC----------------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000 0000 000123445788999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=324.57 Aligned_cols=247 Identities=23% Similarity=0.372 Sum_probs=197.2
Q ss_pred CCCeeeeecCceEEEEEEcCCCEEEEEEEEe----cCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 630 SANLVGVGSFGSVYKGIIDEGRTTIAVKVFN----LQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 630 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~----~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
...+||+|+|-+||+|.+..+|..||--.++ .+.....++|..|+.+|+.++||||+++|+++.+.. ....-+
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~---n~~in~ 120 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD---NKTINF 120 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC---Cceeee
Confidence 4568999999999999999888888764443 123334578999999999999999999999987655 245778
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec-CCCceEEee
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD-DYMTARVGD 784 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~-~~~~~kl~D 784 (949)
|+|.+..|+|..|.++ .+.++......|++||++||.|||++ .|+|+|||||-+||+|+ ..|.|||+|
T Consensus 121 iTEL~TSGtLr~Y~kk----------~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGD 189 (632)
T KOG0584|consen 121 ITELFTSGTLREYRKK----------HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGD 189 (632)
T ss_pred eeecccCCcHHHHHHH----------hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecc
Confidence 9999999999999973 45678889999999999999999999 89999999999999997 568999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCc
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
+|+|......... .+.|||.|||||+.. ..|++.+||||||+++.||+|+.+||.........+.+-.....|..
T Consensus 190 LGLAtl~r~s~ak----svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~s 264 (632)
T KOG0584|consen 190 LGLATLLRKSHAK----SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAA 264 (632)
T ss_pred hhHHHHhhccccc----eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHH
Confidence 9999987654432 367999999999987 68999999999999999999999999644322211111111111111
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
+..+- -+++.++|.+|+.. ..+|||+.|++.
T Consensus 265 l~kV~------------------------------dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 265 LSKVK------------------------------DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred hhccC------------------------------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 11111 23578999999999 999999999975
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=309.87 Aligned_cols=257 Identities=26% Similarity=0.410 Sum_probs=201.4
Q ss_pred CeeeeecCceEEEEEEcCC---CEEEEEEEEecCCCcc-hHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEe
Q 039533 632 NLVGVGSFGSVYKGIIDEG---RTTIAVKVFNLQHHGA-SRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVY 707 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 707 (949)
+.||+|+||.||+|..... +..||+|+++...... .+.+.+|++.+++++|+||+++++++... ...++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEE-----EPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCC-----CceEEEE
Confidence 4799999999999999865 8899999997654433 57889999999999999999999997653 3789999
Q ss_pred eeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccc
Q 039533 708 EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGL 787 (949)
Q Consensus 708 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~ 787 (949)
||+++++|.+++....... .......+++.++..++.|++.|++|||++ +++||||||+||++++++.+||+|||.
T Consensus 76 e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~ 151 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVF-PSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGL 151 (262)
T ss_pred EeccCCcHHHHHhhccccc-cccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccc
Confidence 9999999999997321110 001136689999999999999999999976 999999999999999999999999999
Q ss_pred ceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCCchh
Q 039533 788 ARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPDDVM 866 (949)
Q Consensus 788 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 866 (949)
+................++..|+|||......++.++||||+|+++|||++ |..||...... ....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~----------- 218 (262)
T cd00192 152 SRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE--EVLE----------- 218 (262)
T ss_pred ccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH--HHHH-----------
Confidence 987765432222223457889999999988889999999999999999999 69998643111 0000
Q ss_pred hhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 039533 867 DIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQ 929 (949)
Q Consensus 867 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 929 (949)
.+.+.... ......+.++.+++.+|++.+|++|||+.|+++.|+
T Consensus 219 ~~~~~~~~-------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 219 YLRKGYRL-------------------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHcCCCC-------------------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 00000000 001133567889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=310.15 Aligned_cols=250 Identities=25% Similarity=0.346 Sum_probs=197.5
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcc---------hHHHHHHHHHHHhcCCCcceeEEeeeecccc
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGA---------SRSFIAECKALKSIRHRNLVKVLTACLGADY 697 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 697 (949)
+|.+.+.||+|++|.||+|.+..+++.||+|++....... .+.+.+|+.++++++||||+++++++...+
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD- 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-
Confidence 4788899999999999999998888999999986443221 246788999999999999999999976544
Q ss_pred cCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCC
Q 039533 698 RGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDY 777 (949)
Q Consensus 698 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~ 777 (949)
..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||+|+||+++++
T Consensus 80 ----~~~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~ 142 (267)
T cd06628 80 ----HLNIFLEYVPGGSVAALLNN----------YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNK 142 (267)
T ss_pred ----ccEEEEEecCCCCHHHHHHh----------ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCC
Confidence 78999999999999999962 24578889999999999999999977 89999999999999999
Q ss_pred CceEEeecccceecCCCCCcc----ccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchh
Q 039533 778 MTARVGDFGLARILSPDHTQT----SSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINL 853 (949)
Q Consensus 778 ~~~kl~DfG~a~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~ 853 (949)
+.+||+|||.++......... ......|+..|+|||.+.+..++.++||||+||++|||++|+.||....... ..
T Consensus 143 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~ 221 (267)
T cd06628 143 GGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-AI 221 (267)
T ss_pred CCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-HH
Confidence 999999999998765322111 1112347889999999988889999999999999999999999996431110 00
Q ss_pred hhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 854 HNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 854 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
........... ....+..+.+++.+||+.||++||++.||++
T Consensus 222 ------------~~~~~~~~~~~-------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 222 ------------FKIGENASPEI-------------------PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ------------HHHhccCCCcC-------------------CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00000000000 0123456788999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=309.12 Aligned_cols=250 Identities=23% Similarity=0.333 Sum_probs=201.8
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
++|++.+.||+|+||.||+|....+++.||+|.++.... .+++.+|++++++++||||+++++++.... ..++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~l 75 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNT-----DLWI 75 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCC-----cEEE
Confidence 578999999999999999999988789999999875432 578999999999999999999999976544 7899
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
++||+++++|.+++.. ....+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.+||+||
T Consensus 76 ~~e~~~~~~L~~~l~~---------~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~df 143 (256)
T cd06612 76 VMEYCGAGSVSDIMKI---------TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADF 143 (256)
T ss_pred EEecCCCCcHHHHHHh---------CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEccc
Confidence 9999999999999862 235689999999999999999999977 8999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCch
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDV 865 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 865 (949)
|.+......... .....++..|+|||++.+..++.++||||||+++|||++|+.||...........
T Consensus 144 g~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~----------- 210 (256)
T cd06612 144 GVSGQLTDTMAK--RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM----------- 210 (256)
T ss_pred ccchhcccCccc--cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-----------
Confidence 999876543321 1134488999999999988899999999999999999999999864322110000
Q ss_pred hhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 866 MDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 866 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
....... .+.........+.+++.+|++.+|++|||+.||++
T Consensus 211 ---~~~~~~~----------------~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 211 ---IPNKPPP----------------TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred ---hccCCCC----------------CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 0000000 00011123456889999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=310.69 Aligned_cols=258 Identities=25% Similarity=0.367 Sum_probs=194.2
Q ss_pred CeeeeecCceEEEEEEcCCCE--EEEEEEEecCC-CcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCCccceeEe
Q 039533 632 NLVGVGSFGSVYKGIIDEGRT--TIAVKVFNLQH-HGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGNDFKASVY 707 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 707 (949)
+.||+|+||.||+|++..++. .+|+|.++... ....+.+.+|+++++++ +||||+++++++...+ ..++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-----~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-----YLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCC-----CceEEE
Confidence 468999999999999976664 46888876432 23346788999999999 7999999999976544 689999
Q ss_pred eeccCCChhhhcCCCCCCCc------cccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 708 EFMHYGSLEEWLHPFTGEDE------IDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 708 e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
||+++|+|.+++........ .......+++.++..++.|++.|++|||+. +++||||||+||++++++.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEE
Confidence 99999999999974321100 011234588999999999999999999976 999999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhcccc
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
|+|||++....... .......+..|+|||++.+..++.++|||||||++|||++ |+.||......+ .
T Consensus 153 l~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~------- 220 (270)
T cd05047 153 IADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--L------- 220 (270)
T ss_pred ECCCCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH--H-------
Confidence 99999986322111 1111224567999999988889999999999999999997 999985321110 0
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhH
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIK 932 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 932 (949)
.+.+...... +.....+..+.+++.+|++.+|.+|||+.|++..|+++.
T Consensus 221 -----~~~~~~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 221 -----YEKLPQGYRL------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -----HHHHhCCCCC------------------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0000000000 000123346789999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=308.23 Aligned_cols=253 Identities=26% Similarity=0.412 Sum_probs=197.9
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
++|.+.+.||+|++|.||+|.+.. +..||+|++.... ...+.+.+|++++++++|+|++++++++.. ...++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~ 77 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNG-TTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE------EPIYI 77 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcC-CceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC------CCcEE
Confidence 468889999999999999999874 4569999876433 234678899999999999999999987632 25789
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
||||+++++|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+||
T Consensus 78 v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~df 146 (260)
T cd05069 78 VTEFMGKGSLLDFLKEG--------DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADF 146 (260)
T ss_pred EEEcCCCCCHHHHHhhC--------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCC
Confidence 99999999999999631 223478999999999999999999976 8999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCCc
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
|.+......... ......++..|+|||+..+..++.++||||||+++|||++ |+.||....... ....
T Consensus 147 g~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~-------- 215 (260)
T cd05069 147 GLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQ-------- 215 (260)
T ss_pred ccceEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH--------
Confidence 999876443221 1112346778999999988889999999999999999999 899986332110 0000
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQS 930 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 930 (949)
+...... +.....+..+.+++.+|++.+|++||++++|.+.|++
T Consensus 216 ----~~~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 216 ----VERGYRM------------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ----HHcCCCC------------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0000000 0001335668899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=315.36 Aligned_cols=252 Identities=22% Similarity=0.272 Sum_probs=196.9
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC---cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH---GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
.|+..+.||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.++++++|++|+++++.+...+ ..
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-----~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKD-----AL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC-----EE
Confidence 36778899999999999999999999999999864322 22345778999999999999999998875444 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++||||+++++|.+++... ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.++|+
T Consensus 76 ~lv~e~~~g~~L~~~l~~~--------~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~ 144 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHM--------GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRIS 144 (285)
T ss_pred EEEEEecCCCcHHHHHHHh--------cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEe
Confidence 9999999999999988521 123588999999999999999999976 99999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCC
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
|||++.......... ...|+..|+|||++.+..++.++||||+||++|||++|+.||....... ...
T Consensus 145 Dfg~~~~~~~~~~~~---~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~~~--------- 211 (285)
T cd05630 145 DLGLAVHVPEGQTIK---GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KRE--------- 211 (285)
T ss_pred eccceeecCCCcccc---CCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-hHH---------
Confidence 999997654332211 3458999999999998899999999999999999999999996431110 000
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC-----HHHHHH
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTN-----MTNVVH 926 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~~ 926 (949)
......+... . .........+.+++..|++.||++||| ++|+++
T Consensus 212 ~~~~~~~~~~-~------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 212 EVERLVKEVQ-E------------------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred HHHhhhhhhh-h------------------hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0000000000 0 000122345789999999999999999 888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=316.93 Aligned_cols=251 Identities=24% Similarity=0.263 Sum_probs=204.9
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc---chHHHHHHHHHHHhcC-CCcceeEEeeeecccccCC
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG---ASRSFIAECKALKSIR-HRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~ 700 (949)
...|.+.+.||+|.||.||+++.+.+|+.+|+|++.+.... ....+.+|+.+|+++. |||||.+++++....
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~---- 109 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD---- 109 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC----
Confidence 45688889999999999999999999999999999755443 3368999999999998 999999999965544
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC----
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD---- 776 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~---- 776 (949)
..++|||++.||.|.+.+... .+++.++..++.|++.|++|||+. ||+|||+||+|+|+..
T Consensus 110 -~~~lvmEL~~GGeLfd~i~~~-----------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~ 174 (382)
T KOG0032|consen 110 -SVYLVMELCEGGELFDRIVKK-----------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEG 174 (382)
T ss_pred -eEEEEEEecCCchHHHHHHHc-----------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCC
Confidence 899999999999999999621 389999999999999999999976 9999999999999963
Q ss_pred CCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhh
Q 039533 777 YMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNF 856 (949)
Q Consensus 777 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~ 856 (949)
++.+|++|||+|........ .....||+.|+|||++.+..|+..+||||+||++|.|++|.+||....+.....
T Consensus 175 ~~~ik~~DFGla~~~~~~~~---~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~--- 248 (382)
T KOG0032|consen 175 SGRIKLIDFGLAKFIKPGER---LHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL--- 248 (382)
T ss_pred CCcEEEeeCCCceEccCCce---EeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH---
Confidence 35799999999998877222 225679999999999999999999999999999999999999996443222111
Q ss_pred ccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 857 GRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 857 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.+....... ... .+........+++..|+..||.+|+|+.++++
T Consensus 249 ----------~i~~~~~~f-------------~~~---~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 249 ----------AILRGDFDF-------------TSE---PWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred ----------HHHcCCCCC-------------CCC---CccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 111110000 001 11244566789999999999999999999998
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=313.39 Aligned_cols=251 Identities=22% Similarity=0.265 Sum_probs=195.0
Q ss_pred CCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC---cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH---GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 628 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
|+..+.||+|+||+||+|.+..+++.||+|++..... .....+.+|++++++++|+||+++.+++...+ ..+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-----~~~ 76 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKD-----ALC 76 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCC-----EEE
Confidence 6677899999999999999998999999999864432 22345778999999999999999998865443 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|
T Consensus 77 lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~D 145 (285)
T cd05632 77 LVLTIMNGGDLKFHIYNM--------GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISD 145 (285)
T ss_pred EEEEeccCccHHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEec
Confidence 999999999999888521 223589999999999999999999977 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCc
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
||++......... ....|+..|+|||++.+..++.++|||||||++|||++|+.||....... .... ........
T Consensus 146 fg~~~~~~~~~~~---~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-~~~~-~~~~~~~~ 220 (285)
T cd05632 146 LGLAVKIPEGESI---RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-KREE-VDRRVLET 220 (285)
T ss_pred CCcceecCCCCcc---cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHHhhhcc
Confidence 9999765433221 13458999999999988889999999999999999999999996321110 0000 00000000
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC-----HHHHHH
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTN-----MTNVVH 926 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~~ 926 (949)
. .. .....+..+.+++..|++.||++||+ +.|+++
T Consensus 221 -------~-~~-------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 221 -------E-EV-------------------YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred -------c-cc-------------------cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 0 00 00123445788999999999999999 666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=313.15 Aligned_cols=271 Identities=22% Similarity=0.295 Sum_probs=200.2
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
++|++.+.||+|++|.||+|.+..+++.||+|++..... ...+.+.+|+.++++++|||++++++++.... ..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKR-----KL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC-----EE
Confidence 468899999999999999999998899999999864332 23356789999999999999999999976544 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++||||++++.+..++. ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+
T Consensus 76 ~~v~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~ 142 (286)
T cd07847 76 HLVFEYCDHTVLNELEK----------NPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLC 142 (286)
T ss_pred EEEEeccCccHHHHHHh----------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEEC
Confidence 99999999998888765 234589999999999999999999977 99999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCch--hhhhcccc
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDIN--LHNFGRKA 860 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~--~~~~~~~~ 860 (949)
|||.+.......... ....++..|+|||++.+ ..++.++||||||+++|||++|+.||......+.. ........
T Consensus 143 dfg~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 220 (286)
T cd07847 143 DFGFARILTGPGDDY--TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDL 220 (286)
T ss_pred ccccceecCCCcccc--cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 999998765433211 12347889999999876 45789999999999999999999999643321111 00000000
Q ss_pred CCCchhhhcc------cCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 861 LPDDVMDIVD------SSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 861 ~~~~~~~~~d------~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.+ ...+..+ ....+.+.. ...........+..+.+++.+|++.+|++||++.|++.
T Consensus 221 ~~-~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 221 IP-RHQQIFSTNQFFKGLSIPEPET---------REPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred Ch-HHhhhcccccccccccCCCccc---------ccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00 0000000 000000000 00000011133567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=309.19 Aligned_cols=254 Identities=24% Similarity=0.389 Sum_probs=191.7
Q ss_pred CeeeeecCceEEEEEEcC---CCEEEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEe
Q 039533 632 NLVGVGSFGSVYKGIIDE---GRTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVY 707 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 707 (949)
+.||+|+||.||+|.+.. ....||+|++.... ....+.+.+|+.+++.++||||+++++++...+ ...++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE----GSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC----CCcEEEE
Confidence 468999999999998642 34679999885332 234567889999999999999999999775322 3578999
Q ss_pred eeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccc
Q 039533 708 EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGL 787 (949)
Q Consensus 708 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~ 787 (949)
||+.+++|.+++... ....++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||+
T Consensus 77 e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~ 144 (262)
T cd05058 77 PYMKHGDLRNFIRSE---------THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGL 144 (262)
T ss_pred ecCCCCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccc
Confidence 999999999999621 23467778899999999999999976 999999999999999999999999999
Q ss_pred ceecCCCCCc--cccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhC-CCCCccccccCchhhhhccccCCCc
Q 039533 788 ARILSPDHTQ--TSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIG-KKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 788 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
++........ .......++..|+|||++.+..++.++|||||||++|||++| .+||...... ......
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~--~~~~~~------- 215 (262)
T cd05058 145 ARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF--DITVYL------- 215 (262)
T ss_pred cccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH-------
Confidence 9765432211 111123467789999999888899999999999999999995 5566422110 010000
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHH
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKN 933 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 933 (949)
........ ....+..+.+++.+||+.+|++||++.||++.|+++..
T Consensus 216 ----~~~~~~~~-------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 216 ----LQGRRLLQ-------------------PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ----hcCCCCCC-------------------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 00000000 01224568899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=346.96 Aligned_cols=261 Identities=18% Similarity=0.250 Sum_probs=199.9
Q ss_pred HHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccC
Q 039533 622 YNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRG 699 (949)
Q Consensus 622 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 699 (949)
....++|.+.+.||+|+||+||+|.+..++..||+|++.... ......+..|+.++++++||||++++++|....
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~--- 85 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA--- 85 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC---
Confidence 345678999999999999999999999899999999987442 223467889999999999999999999875432
Q ss_pred CccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCC----CCCeEecCCCCCCeeec
Q 039533 700 NDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDC----QPVTAHCDLKPSNVLLD 775 (949)
Q Consensus 700 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~----~~~ivHrDlkp~NIll~ 775 (949)
....++||||+++|+|.+++.... .....+++..++.|+.||+.||+|||+.. ..+||||||||+|||++
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~------~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~ 159 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCY------KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS 159 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHh------hccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEee
Confidence 346899999999999999986321 12346899999999999999999999742 13599999999999996
Q ss_pred C-----------------CCceEEeecccceecCCCCCccccccccCccCccCccccCC--CccCCccchHHHHHHHHHH
Q 039533 776 D-----------------YMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG--CEVSTNGDVYSYGILLLEL 836 (949)
Q Consensus 776 ~-----------------~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlGvvl~el 836 (949)
. .+.+||+|||++......... ....||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 160 s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~---~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYEL 236 (1021)
T PTZ00266 160 TGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMA---HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236 (1021)
T ss_pred cCccccccccccccccCCCCceEEccCCccccccccccc---cccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHH
Confidence 4 345899999999876433221 13458999999999864 4588999999999999999
Q ss_pred HhCCCCCccccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCC
Q 039533 837 VIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQ 916 (949)
Q Consensus 837 ltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~ 916 (949)
+||+.||...... .... ..+...... + ....+..+.+++..||+.+|+
T Consensus 237 LTGk~PF~~~~~~----~qli---------~~lk~~p~l-p------------------i~~~S~eL~dLI~~~L~~dPe 284 (1021)
T PTZ00266 237 CSGKTPFHKANNF----SQLI---------SELKRGPDL-P------------------IKGKSKELNILIKNLLNLSAK 284 (1021)
T ss_pred HHCCCCCCcCCcH----HHHH---------HHHhcCCCC-C------------------cCCCCHHHHHHHHHHhcCChh
Confidence 9999999632111 0000 000000000 0 001245678999999999999
Q ss_pred CCCCHHHHHH
Q 039533 917 DRTNMTNVVH 926 (949)
Q Consensus 917 ~RPs~~ev~~ 926 (949)
+||++.|++.
T Consensus 285 eRPSa~QlL~ 294 (1021)
T PTZ00266 285 ERPSALQCLG 294 (1021)
T ss_pred HCcCHHHHhc
Confidence 9999999984
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=315.41 Aligned_cols=254 Identities=24% Similarity=0.307 Sum_probs=200.1
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.++|++.+.||.|+||.||+|.+..++..||+|+++.......+.+.+|++++++++||||+++++++.... ..+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN-----KLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC-----eEE
Confidence 457899999999999999999998889999999998665555678889999999999999999999976544 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++++|.+++.. ....+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.++|+|
T Consensus 79 lv~e~~~~~~L~~~~~~---------~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d 146 (280)
T cd06611 79 ILIEFCDGGALDSIMLE---------LERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLAD 146 (280)
T ss_pred EEeeccCCCcHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEcc
Confidence 99999999999999862 234589999999999999999999977 899999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccC-----CCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGV-----GCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
||.+.......... ....++..|+|||++. +..++.++||||||+++|||++|+.||....... ....
T Consensus 147 ~g~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-~~~~---- 219 (280)
T cd06611 147 FGVSAKNKSTLQKR--DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-VLLK---- 219 (280)
T ss_pred Cccchhhccccccc--ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-HHHH----
Confidence 99987654332211 1345899999999874 3457789999999999999999999986431110 0000
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
+... ..+. .......+..+.+++..|++.+|++||++.+|++.
T Consensus 220 --------~~~~-~~~~----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 220 --------ILKS-EPPT----------------LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred --------HhcC-CCCC----------------cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0000 0000 00001233457889999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=307.86 Aligned_cols=240 Identities=20% Similarity=0.343 Sum_probs=185.3
Q ss_pred CeeeeecCceEEEEEEcC------------CCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccC
Q 039533 632 NLVGVGSFGSVYKGIIDE------------GRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRG 699 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 699 (949)
+.||+|+||.||+|+... ....||+|++..........+.+|+.++++++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~--- 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV--- 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence 468999999999998642 23368999987655555567889999999999999999999976544
Q ss_pred CccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCc
Q 039533 700 NDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMT 779 (949)
Q Consensus 700 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~ 779 (949)
..++||||+++++|..++.. ....+++..+..++.|+++|++|||+. +|+||||||+||+++.++.
T Consensus 78 --~~~lv~e~~~~~~l~~~~~~---------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~ 143 (262)
T cd05077 78 --ENIMVEEFVEFGPLDLFMHR---------KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGI 143 (262)
T ss_pred --CCEEEEecccCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCc
Confidence 67999999999999998862 224588999999999999999999977 9999999999999986654
Q ss_pred -------eEEeecccceecCCCCCccccccccCccCccCccccC-CCccCCccchHHHHHHHHHHH-hCCCCCccccccC
Q 039533 780 -------ARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGV-GCEVSTNGDVYSYGILLLELV-IGKKPIDIMFEGD 850 (949)
Q Consensus 780 -------~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwSlGvvl~ell-tg~~Pf~~~~~~~ 850 (949)
++++|||.+....... ...++..|+|||++. +..++.++|||||||++|||+ +|+.||.......
T Consensus 144 ~~~~~~~~~l~d~g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~ 217 (262)
T cd05077 144 DGECGPFIKLSDPGIPITVLSRQ------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE 217 (262)
T ss_pred cCCCCceeEeCCCCCCccccCcc------cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH
Confidence 8999999987543221 234788999999887 456889999999999999998 5888875321100
Q ss_pred chhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 039533 851 INLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHEL 928 (949)
Q Consensus 851 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 928 (949)
. ........... ......+.+++.+||+.||++||++.|+++.+
T Consensus 218 --~------------~~~~~~~~~~~--------------------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 218 --K------------ERFYEGQCMLV--------------------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred --H------------HHHHhcCccCC--------------------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0 00000000000 01134578899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=308.26 Aligned_cols=255 Identities=27% Similarity=0.456 Sum_probs=201.0
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
-++|++.++||+|+||.||+|... +++.||||.+..... ..+++.+|+.++++++|+||+++++++.... ..+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 77 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEE-----PIY 77 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCC-----ceE
Confidence 467899999999999999999986 567899999874432 3467899999999999999999999865433 689
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++++|.+++... ....+++.++..++.|++.|++|||+. +++||||||+||++++++.+||+|
T Consensus 78 ~v~e~~~~~~L~~~i~~~--------~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d 146 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSG--------EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIAD 146 (261)
T ss_pred EEEeccCCCCHHHHHhcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECc
Confidence 999999999999999631 224589999999999999999999977 899999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCC
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
||.++......... .....++..|+|||...+..++.++||||+|+++||+++ |+.||....... ...
T Consensus 147 ~g~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~~--------- 215 (261)
T cd05034 147 FGLARLIEDDEYTA-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-VLE--------- 215 (261)
T ss_pred cccceeccchhhhh-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHH---------
Confidence 99998765432211 112235678999999998889999999999999999999 999985321110 000
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQS 930 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 930 (949)
.+....-.+.+ .+.+..+.+++.+|++.+|++||+++|+.+.|+.
T Consensus 216 ---~~~~~~~~~~~-------------------~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 216 ---QVERGYRMPRP-------------------PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---HHHcCCCCCCC-------------------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00000000000 1224568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=322.36 Aligned_cols=289 Identities=19% Similarity=0.227 Sum_probs=206.6
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
+++|++.+.||+|+||.||+|.+..+++.||+|+++... ......+.+|+.++++++||||+++++++....+......
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 578999999999999999999998889999999986432 2334668889999999999999999998876665555678
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++|+||++ +++.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 84 ~lv~e~~~-~~l~~~~~-----------~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~ 148 (336)
T cd07849 84 YIVQELME-TDLYKLIK-----------TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKIC 148 (336)
T ss_pred EEEehhcc-cCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEC
Confidence 99999996 48887775 23588999999999999999999977 89999999999999999999999
Q ss_pred ecccceecCCCCCcc-ccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCc--hhhhhccc
Q 039533 784 DFGLARILSPDHTQT-SSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDI--NLHNFGRK 859 (949)
Q Consensus 784 DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~--~~~~~~~~ 859 (949)
|||++.......... ......|+..|+|||++.+ ..++.++||||+||++|||++|+.||........ ........
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~ 228 (336)
T cd07849 149 DFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT 228 (336)
T ss_pred cccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 999998764432211 1123458899999998654 4688999999999999999999999953211100 00000000
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH--HHHhH
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE--LQSIK 932 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~--L~~i~ 932 (949)
..++....+.+.. ..+......................++.+++.+|++.+|++|||+.|+++. ++...
T Consensus 229 ~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 229 PSQEDLNCIISLR----ARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred CCHHHHHHhhchh----hhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0111111111100 000000000000000000111235678999999999999999999999886 55443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=317.22 Aligned_cols=285 Identities=19% Similarity=0.253 Sum_probs=201.5
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
.++|.+.+.||+|+||.||+|.+..+++.||+|.++... ......+.+|+.++++++||||+++++++.... ..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~-----~~ 79 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK-----SL 79 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCC-----eE
Confidence 357899999999999999999998889999999987443 233456788999999999999999999976444 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++||||++ ++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+
T Consensus 80 ~lv~e~~~-~~l~~~l~~---------~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 146 (301)
T cd07873 80 TLVFEYLD-KDLKQYLDD---------CGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLA 146 (301)
T ss_pred EEEEeccc-cCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEEC
Confidence 99999997 589888862 234578899999999999999999977 99999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCch--hhhhcccc
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDIN--LHNFGRKA 860 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~--~~~~~~~~ 860 (949)
|||++.......... ....++..|+|||++.+. .++.++|||||||++|||++|++||......+.. ........
T Consensus 147 dfg~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~ 224 (301)
T cd07873 147 DFGLARAKSIPTKTY--SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTP 224 (301)
T ss_pred cCcchhccCCCCCcc--cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 999997644322211 123478899999987654 4788999999999999999999999643221100 00000000
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH--HHHHhHHh
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH--ELQSIKNI 934 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~--~L~~i~~~ 934 (949)
..+.+..+.+........ ................+..+.+++.+|++.||++|||++|+++ .++.+.+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~ 295 (301)
T cd07873 225 TEETWPGILSNEEFKSYN-----YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGER 295 (301)
T ss_pred Chhhchhhhccccccccc-----cCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccch
Confidence 000011111000000000 0000000000001123456789999999999999999999987 44444433
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=310.18 Aligned_cols=249 Identities=23% Similarity=0.335 Sum_probs=200.7
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
++|++.+.||.|++|.||+|.+..+++.||+|++.... ......+.+|++++++++|+||+++++++.+.. ..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS-----KLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC-----eEE
Confidence 46888999999999999999999889999999987543 333467889999999999999999999876543 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+|+||+++++|.+++.. ..+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++|+|
T Consensus 76 ~v~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d 141 (274)
T cd06609 76 IIMEYCGGGSCLDLLKP-----------GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLAD 141 (274)
T ss_pred EEEEeeCCCcHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcc
Confidence 99999999999999862 2688999999999999999999977 899999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCc
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
||.++......... ....++..|+|||+..+..++.++|||||||++|||+||+.||....... ..
T Consensus 142 ~g~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--~~---------- 207 (274)
T cd06609 142 FGVSGQLTSTMSKR--NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--VL---------- 207 (274)
T ss_pred cccceeeccccccc--ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--HH----------
Confidence 99998876442211 13458889999999998889999999999999999999999996432110 00
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
..+.....+... . ...+..+.+++.+|+..+|++|||++++++
T Consensus 208 --~~~~~~~~~~~~----------------~-~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 208 --FLIPKNNPPSLE----------------G-NKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred --HHhhhcCCCCCc----------------c-cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 000000000000 0 013446788999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=316.29 Aligned_cols=206 Identities=21% Similarity=0.319 Sum_probs=163.2
Q ss_pred CCeeeeecCceEEEEEEc--CCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEee
Q 039533 631 ANLVGVGSFGSVYKGIID--EGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYE 708 (949)
Q Consensus 631 ~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 708 (949)
.++||+|+||.||+|++. .+++.||+|++.... ......+|++++++++||||+++++++.... ....++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHA---DRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCC---CcEEEEEEe
Confidence 468999999999999975 356889999986432 2356789999999999999999999875332 346789999
Q ss_pred eccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeee----cCCCceEEee
Q 039533 709 FMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL----DDYMTARVGD 784 (949)
Q Consensus 709 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll----~~~~~~kl~D 784 (949)
|+. ++|.+++....... .......+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|
T Consensus 81 ~~~-~~l~~~~~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07868 81 YAE-HDLWHIIKFHRASK-ANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred ccC-CCHHHHHHhccccc-ccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEee
Confidence 986 58888875322111 111234589999999999999999999977 89999999999999 4667999999
Q ss_pred cccceecCCCCCc-cccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccc
Q 039533 785 FGLARILSPDHTQ-TSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIM 846 (949)
Q Consensus 785 fG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~ 846 (949)
||+|+........ .......||+.|+|||++.+. .++.++||||+||++|||++|++||...
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 9999876543221 112235689999999998774 5889999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=305.75 Aligned_cols=251 Identities=21% Similarity=0.312 Sum_probs=201.9
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
+|++.+.||.|+||.||.++...+++.+++|.+.... ....+++.+|++++++++|+||+++++++.+.+ ..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDN-----TLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCC-----eEE
Confidence 5888999999999999999999889999999987543 334467889999999999999999999976544 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++++|.+++... ....+++.++..++.|++.|++|||+. +++||||+|+||++++++.+||+|
T Consensus 76 ~~~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d 144 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQ--------KGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGD 144 (256)
T ss_pred EEEEecCCCcHHHHHHhc--------cccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECc
Confidence 999999999999999621 134588999999999999999999977 899999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCc
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
||.+......... .....|+..|+|||+..+..++.++||||||+++|||++|+.||+...... .
T Consensus 145 ~~~~~~~~~~~~~--~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-----~-------- 209 (256)
T cd08221 145 FGISKILGSEYSM--AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN-----L-------- 209 (256)
T ss_pred CcceEEccccccc--ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH-----H--------
Confidence 9999876544321 123458999999999988888999999999999999999999986321110 0
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
...+........ ....+..+.+++.+|++.+|++||++.|+++.
T Consensus 210 ~~~~~~~~~~~~-------------------~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 210 VVKIVQGNYTPV-------------------VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HHHHHcCCCCCC-------------------ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 001111000000 01334567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=306.68 Aligned_cols=252 Identities=23% Similarity=0.303 Sum_probs=199.1
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
+|++.+.||+|++|.||+|.+..+++.||+|++..... ...+.+.+|++++++++|+|++++++.+... ....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE----DGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC----CCEEE
Confidence 58899999999999999999988889999999864332 3345788999999999999999998875322 23578
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++++|.+++... ....+++.++..++.|++.|++|||+. +++||||||+||+++.++.++|+|
T Consensus 77 lv~e~~~~~~l~~~l~~~--------~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~d 145 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQ--------KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGD 145 (257)
T ss_pred EEecccCCCcHHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEec
Confidence 999999999999998621 234588999999999999999999977 899999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCc
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
||.+.......... ....+++.|+|||+..+..++.++||||||+++|||++|+.||+...... ..
T Consensus 146 f~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-----~~------- 211 (257)
T cd08223 146 LGIARVLENQCDMA--STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS-----LV------- 211 (257)
T ss_pred ccceEEecccCCcc--ccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-----HH-------
Confidence 99998764432211 13458899999999999889999999999999999999999986321110 00
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
..+....... . ....+..+.+++.+|++.+|++||++.|+++.
T Consensus 212 -~~~~~~~~~~-~------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 212 -YRIIEGKLPP-M------------------PKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -HHHHhcCCCC-C------------------ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000000 0 01234568899999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=314.00 Aligned_cols=203 Identities=27% Similarity=0.425 Sum_probs=168.5
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
++.+|.+.+.||+|+||.||+|....+++.||+|+++.... .....+.+|+.++++++|+||+++++++...+ .
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-----~ 77 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKE-----T 77 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCC-----e
Confidence 46789999999999999999999988899999999875432 23356789999999999999999999975443 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+. +++.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 78 ~~lv~e~~~-~~l~~~~~~---------~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l 144 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQ---------HPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKL 144 (291)
T ss_pred EEEEEeccc-CCHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEE
Confidence 899999996 677777642 123467888899999999999999977 8999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccc
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIM 846 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~ 846 (949)
+|||.++......... ....++..|+|||++.+. .++.++|||||||++|||++|+.||+..
T Consensus 145 ~Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 145 ADFGLARAKSIPSQTY--SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred eccccccccCCCCCCC--CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 9999987643322111 133478999999998764 5788999999999999999999999744
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=314.97 Aligned_cols=263 Identities=23% Similarity=0.307 Sum_probs=203.6
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
.++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+.+.+|+++++.++||||+++++++.... ..
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~ 78 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNEN-----NI 78 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCC-----EE
Confidence 356888899999999999999999889999999987543 233567899999999999999999999986554 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++||||+++++|.+++.. .+.+++..+..++.|++.|+.|||+.+ +++||||||+||++++++.++|+
T Consensus 79 ~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~ 146 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKK----------GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLC 146 (284)
T ss_pred EEEEecCCCCCHHHHHHh----------ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEc
Confidence 999999999999998862 245889999999999999999999632 79999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCC
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
|||++........ ....|+..|+|||++.+..++.++|||||||++||+++|+.||+........ ...+.
T Consensus 147 d~gl~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~------~~~~~ 216 (284)
T cd06620 147 DFGVSGELINSIA----DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG------QDDPM 216 (284)
T ss_pred cCCcccchhhhcc----CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhh------hhhhh
Confidence 9999875432221 1345899999999998888999999999999999999999999744321100 00000
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHEL 928 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 928 (949)
.+.+.+........ ..++ ..+.+..+.+++.+|++.||++|||+.||++..
T Consensus 217 ~~~~~~~~~~~~~~-------------~~~~-~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 217 GILDLLQQIVQEPP-------------PRLP-SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred HHHHHHHHHhhccC-------------CCCC-chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 11111111110000 0000 012456788999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=311.48 Aligned_cols=256 Identities=26% Similarity=0.420 Sum_probs=195.8
Q ss_pred CeeeeecCceEEEEEEcCCC------EEEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 632 NLVGVGSFGSVYKGIIDEGR------TTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
+.||+|+||.||+|+..... +.||+|.+.... ......+.+|+.++++++||||+++++++...+ ..+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE-----PQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC-----CeE
Confidence 46899999999999986433 689999886433 234567889999999999999999999976544 689
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC-----c
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM-----T 779 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~-----~ 779 (949)
+||||+++++|.+++....... .....+++.+++.++.|++.|++|||+. +++||||||+||+++.++ .
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~ 149 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVER---FGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRV 149 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcc---cCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcc
Confidence 9999999999999996322111 1234578999999999999999999976 899999999999999877 8
Q ss_pred eEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhcc
Q 039533 780 ARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGR 858 (949)
Q Consensus 780 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~ 858 (949)
++++|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||...... ....
T Consensus 150 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~~~--- 224 (269)
T cd05044 150 VKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVLQ--- 224 (269)
T ss_pred eEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HHHH---
Confidence 99999999976543322221122345788999999998899999999999999999998 99998532111 0100
Q ss_pred ccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 039533 859 KALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQS 930 (949)
Q Consensus 859 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 930 (949)
.++... ++......+..+.+++.+|+..+|++||++++|.+.|++
T Consensus 225 ---------~~~~~~------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 225 ---------HVTAGG------------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ---------HHhcCC------------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 000000 000011345678899999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=305.57 Aligned_cols=248 Identities=22% Similarity=0.310 Sum_probs=203.5
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc--chHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG--ASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
.-|...+.||+|.|+.|-+|++--+|++||||++.+.... ....+.+|++.|+.++|||||++|++.. .....
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViD-----TQTKl 92 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVID-----TQTKL 92 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhc-----ccceE
Confidence 4577889999999999999999999999999999765433 3457889999999999999999999843 34479
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeee-cCCCceEE
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL-DDYMTARV 782 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll-~~~~~~kl 782 (949)
|+|+|.-++|+|++|+.. ....+.+.-+.+++.||+.|+.|+|.- .+|||||||+||.+ ..-|-+||
T Consensus 93 yLiLELGD~GDl~DyImK---------He~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKL 160 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMK---------HEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKL 160 (864)
T ss_pred EEEEEecCCchHHHHHHh---------hhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEe
Confidence 999999999999999973 345588999999999999999999955 79999999999977 46689999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCccC-CccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVS-TNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
+|||++-.+.++.... ...|+..|.|||++.|..|+ +++||||+|||+|.+++|++||+...+.+
T Consensus 161 TDFGFSNkf~PG~kL~---TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE----------- 226 (864)
T KOG4717|consen 161 TDFGFSNKFQPGKKLT---TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE----------- 226 (864)
T ss_pred eeccccccCCCcchhh---cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-----------
Confidence 9999998887776543 34599999999999998886 78999999999999999999997543221
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
-+..++|-... .+.-...+..+++..|+..||++|.+.+||+.
T Consensus 227 --TLTmImDCKYt--------------------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 227 --TLTMIMDCKYT--------------------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred --hhhhhhccccc--------------------CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 11222221111 11234566789999999999999999999874
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=328.18 Aligned_cols=197 Identities=24% Similarity=0.284 Sum_probs=167.6
Q ss_pred cCCCCCCeeeeecCceEEEEEEcC--CCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDE--GRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
.+|.+.+.||+|+||.||+|.... .++.||+|.+... +...+|++++++++||||+++++++.... ..
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~-----~~ 161 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKS-----TV 161 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCC-----EE
Confidence 579999999999999999998643 4578999987532 34568999999999999999998865433 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++|||++. ++|.+++. ....+++.+++.|+.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 162 ~lv~e~~~-~~l~~~l~----------~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~ 227 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVD----------RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLG 227 (392)
T ss_pred EEEehhcC-CCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEc
Confidence 99999995 68888884 234689999999999999999999977 99999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccc
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIM 846 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~ 846 (949)
|||+++...............||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 228 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 228 DFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred cCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 999998765543333333456999999999999989999999999999999999999999543
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=320.75 Aligned_cols=198 Identities=30% Similarity=0.345 Sum_probs=169.9
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcC-C-----CcceeEEeeeecccccCC
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIR-H-----RNLVKVLTACLGADYRGN 700 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~~~~~~~~~~~~ 700 (949)
+|.+.++||+|.||.|-+|.+..+++.||||+++... .-..+...|+.+|+.++ | -|+|+++++|....
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~---- 261 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN---- 261 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc----
Confidence 7899999999999999999999999999999997543 23466778999999996 3 38999999976555
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCC--C
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDY--M 778 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~--~ 778 (949)
+.|+|+|.++ .+|+++++.. .-..++...++.++.||+.||.+||.. +|||+||||+|||+.+. .
T Consensus 262 -HlciVfELL~-~NLYellK~n--------~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~ 328 (586)
T KOG0667|consen 262 -HLCIVFELLS-TNLYELLKNN--------KFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRS 328 (586)
T ss_pred -ceeeeehhhh-hhHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcC
Confidence 9999999996 5999999843 234589999999999999999999976 99999999999999633 4
Q ss_pred ceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCcccc
Q 039533 779 TARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMF 847 (949)
Q Consensus 779 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~ 847 (949)
.+||+|||.|........ ...-+..|+|||++.|.+|+.+.||||||||++||++|.+.|....
T Consensus 329 ~vKVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 329 RIKVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred ceeEEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 799999999987654432 2346789999999999999999999999999999999988886443
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=308.76 Aligned_cols=249 Identities=23% Similarity=0.340 Sum_probs=200.5
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
..|+..+.||.|+||.||+|.+..++..||+|++.... ......+.+|+.+++++.||||+++++++.... ..+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 78 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT-----KLW 78 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-----EEE
Confidence 35778899999999999999998889999999987543 234567889999999999999999999976544 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++++|.+++.. ..+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|
T Consensus 79 lv~e~~~~~~L~~~i~~-----------~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~d 144 (277)
T cd06640 79 IIMEYLGGGSALDLLRA-----------GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLAD 144 (277)
T ss_pred EEEecCCCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcc
Confidence 99999999999999861 3478889999999999999999977 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCc
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
||.+.......... ....++..|+|||++.+..++.++|+|||||++|||++|+.||........
T Consensus 145 fg~~~~~~~~~~~~--~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------------- 209 (277)
T cd06640 145 FGVAGQLTDTQIKR--NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV------------- 209 (277)
T ss_pred cccceeccCCcccc--ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-------------
Confidence 99997764433211 123578899999999888899999999999999999999999864321100
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
...+.....+ ......+..+.+++.+||+.+|++||++.|+++.
T Consensus 210 -~~~~~~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 210 -LFLIPKNNPP------------------TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred -hhhhhcCCCC------------------CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 0000000000 0012445678899999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=311.37 Aligned_cols=240 Identities=20% Similarity=0.322 Sum_probs=184.1
Q ss_pred eeeeecCceEEEEEEcC------------------------CCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeE
Q 039533 633 LVGVGSFGSVYKGIIDE------------------------GRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKV 688 (949)
Q Consensus 633 ~lg~G~~g~Vy~~~~~~------------------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 688 (949)
.||+|+||.||+|.... ....||+|++..........+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 68999999999998531 124589999875544445678899999999999999999
Q ss_pred EeeeecccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 039533 689 LTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLK 768 (949)
Q Consensus 689 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlk 768 (949)
++++.... ..++||||+++|+|..++.. ....+++..+..++.|+++||+|||++ +|+|||||
T Consensus 82 ~~~~~~~~-----~~~lv~ey~~~g~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlk 144 (274)
T cd05076 82 HGVCVRGS-----ENIMVEEFVEHGPLDVCLRK---------EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVC 144 (274)
T ss_pred EEEEEeCC-----ceEEEEecCCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCC
Confidence 99987554 78999999999999999862 234578999999999999999999977 89999999
Q ss_pred CCCeeecCCC-------ceEEeecccceecCCCCCccccccccCccCccCccccCC-CccCCccchHHHHHHHHHHH-hC
Q 039533 769 PSNVLLDDYM-------TARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELV-IG 839 (949)
Q Consensus 769 p~NIll~~~~-------~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~ell-tg 839 (949)
|+||+++..+ .+|++|||.+....... ...++..|+|||.+.+ ..++.++|||||||++||++ +|
T Consensus 145 p~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g 218 (274)
T cd05076 145 AKNILLARLGLAEGTSPFIKLSDPGVSFTALSRE------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDG 218 (274)
T ss_pred cccEEEeccCcccCccceeeecCCcccccccccc------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 9999997543 48999999886543221 2347888999998875 56899999999999999995 69
Q ss_pred CCCCccccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC
Q 039533 840 KKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRT 919 (949)
Q Consensus 840 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 919 (949)
+.||....... .....+..... + ......+.+++.+||+.+|++||
T Consensus 219 ~~p~~~~~~~~--------------~~~~~~~~~~~-~-------------------~~~~~~~~~li~~cl~~~p~~Rp 264 (274)
T cd05076 219 EVPLKERTPSE--------------KERFYEKKHRL-P-------------------EPSCKELATLISQCLTYEPTQRP 264 (274)
T ss_pred CCCccccChHH--------------HHHHHHhccCC-C-------------------CCCChHHHHHHHHHcccChhhCc
Confidence 99986332111 00011000000 0 01123578899999999999999
Q ss_pred CHHHHHHHHH
Q 039533 920 NMTNVVHELQ 929 (949)
Q Consensus 920 s~~ev~~~L~ 929 (949)
|+.||++.|+
T Consensus 265 s~~~il~~L~ 274 (274)
T cd05076 265 SFRTILRDLT 274 (274)
T ss_pred CHHHHHHhhC
Confidence 9999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=312.20 Aligned_cols=276 Identities=22% Similarity=0.281 Sum_probs=197.3
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
+|++.+.||+|++|.||+|+...+++.||+|+++... ....+.+.+|+.++++++||||+++++++...+ ..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQES-----RLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCC-----eEE
Confidence 5788899999999999999998889999999986443 223467889999999999999999999976544 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||++ ++|.+++.... ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|
T Consensus 76 ~v~e~~~-~~l~~~~~~~~-------~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d 144 (285)
T cd07861 76 LIFEFLS-MDLKKYLDSLP-------KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLAD 144 (285)
T ss_pred EEEecCC-CCHHHHHhcCC-------CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECc
Confidence 9999997 68988886321 224689999999999999999999977 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCchhh--hhccccC
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLH--NFGRKAL 861 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~--~~~~~~~ 861 (949)
||++......... .....++..|+|||++.+. .++.++|||||||++|||+||+.||......+.... .......
T Consensus 145 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~ 222 (285)
T cd07861 145 FGLARAFGIPVRV--YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPT 222 (285)
T ss_pred ccceeecCCCccc--ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9999765433221 1123478899999987654 478999999999999999999999964322111000 0000000
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
........+ ..+...... ..............+.++.+++.+|++.||++|||+.||++
T Consensus 223 ~~~~~~~~~---~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 223 EDVWPGVTS---LPDYKNTFP---KWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhhhhcchh---hHHHHhhcc---ccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000 000000000 00000000001124566789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=304.78 Aligned_cols=247 Identities=26% Similarity=0.377 Sum_probs=192.6
Q ss_pred CeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc-chHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEeeec
Q 039533 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG-ASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFM 710 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 710 (949)
++||+|+||.||+|... +++.||+|+++..... ....+.+|++++++++||||+++++++...+ ..++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ-----PIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC-----ccEEEEECC
Confidence 47899999999999876 6789999998654322 2346889999999999999999999976544 789999999
Q ss_pred cCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccccee
Q 039533 711 HYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARI 790 (949)
Q Consensus 711 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~ 790 (949)
++++|.+++.. ....+++..+..++.|++.||.|+|++ +++||||||+||++++++.+||+|||++..
T Consensus 75 ~~~~L~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 142 (250)
T cd05085 75 PGGDFLSFLRK---------KKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQ 142 (250)
T ss_pred CCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCcccee
Confidence 99999999862 123478999999999999999999977 999999999999999999999999999976
Q ss_pred cCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCCchhhhc
Q 039533 791 LSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPDDVMDIV 869 (949)
Q Consensus 791 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 869 (949)
......... ....++..|+|||+..+..++.++||||||+++||+++ |..||....... .... +
T Consensus 143 ~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--~~~~------------~ 207 (250)
T cd05085 143 EDDGIYSSS-GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--AREQ------------V 207 (250)
T ss_pred ccccccccC-CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHH------------H
Confidence 443222111 11234678999999988889999999999999999998 999986332111 0000 0
Q ss_pred ccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 039533 870 DSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQ 929 (949)
Q Consensus 870 d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 929 (949)
....... ....++..+.+++.+|++.+|++||++.|++++|.
T Consensus 208 ~~~~~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 208 EKGYRMS------------------CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HcCCCCC------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 0000000 00123456889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=311.83 Aligned_cols=240 Identities=23% Similarity=0.387 Sum_probs=185.6
Q ss_pred CeeeeecCceEEEEEEcCCCE-------EEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 632 NLVGVGSFGSVYKGIIDEGRT-------TIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
+.||+|+||.||+|.....+. .||+|++........+.+.+|+.++++++||||+++++++...+ ..+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~-----~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD-----ESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC-----CcE
Confidence 468999999999999864443 48889886554445567889999999999999999999986544 689
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCc-----
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMT----- 779 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~----- 779 (949)
+||||+++|+|.+++.. ....+++..++.++.|++.|++|||+. +|+||||||+||+++.++.
T Consensus 76 lv~e~~~~g~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~ 143 (258)
T cd05078 76 MVQEYVKFGSLDTYLKK---------NKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGN 143 (258)
T ss_pred EEEecCCCCcHHHHHhc---------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCC
Confidence 99999999999999972 123578999999999999999999977 9999999999999987765
Q ss_pred ---eEEeecccceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCC-CCCccccccCchhh
Q 039533 780 ---ARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGK-KPIDIMFEGDINLH 854 (949)
Q Consensus 780 ---~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~-~Pf~~~~~~~~~~~ 854 (949)
++++|||.+....... ...++..|+|||++.+. .++.++|||||||++|||++|. .||....... .
T Consensus 144 ~~~~~l~d~g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--~- 214 (258)
T cd05078 144 PPFIKLSDPGISITVLPKE------ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--K- 214 (258)
T ss_pred CceEEecccccccccCCch------hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--H-
Confidence 6999999887554321 23478899999998874 5789999999999999999985 5553211100 0
Q ss_pred hhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 039533 855 NFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHEL 928 (949)
Q Consensus 855 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 928 (949)
......... .+ ......+.+++.+|++.+|++|||++|+++.|
T Consensus 215 -----------~~~~~~~~~-~~-------------------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 215 -----------LQFYEDRHQ-LP-------------------APKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred -----------HHHHHcccc-CC-------------------CCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 000000000 00 01124578999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=312.05 Aligned_cols=252 Identities=21% Similarity=0.280 Sum_probs=194.5
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEec--CCCcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNL--QHHGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 702 (949)
..|++.+.||+||.+.||++... +.+.+|+|.+.. .+......|.+|+..|.++ .|.+||++++|-...+ .
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~-----~ 434 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG-----Y 434 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc-----e
Confidence 45888999999999999999987 456677776642 2334457899999999999 4999999999966544 8
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.|+||||=+ .+|..+|.... .....-.++.+..|++.|+.++|.+ ||||.||||.|+++-. |.+||
T Consensus 435 lYmvmE~Gd-~DL~kiL~k~~---------~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKL 500 (677)
T KOG0596|consen 435 LYMVMECGD-IDLNKILKKKK---------SIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKL 500 (677)
T ss_pred EEEEeeccc-ccHHHHHHhcc---------CCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEe
Confidence 999999875 49999997432 2223227888999999999999977 9999999999999976 79999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCC-----------ccCCccchHHHHHHHHHHHhCCCCCccccccCc
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-----------EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDI 851 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~ 851 (949)
+|||+|..+..+.+.......+||+.||+||.+... +.+.++||||+|||+|+|+.|+.||........
T Consensus 501 IDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~a 580 (677)
T KOG0596|consen 501 IDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIA 580 (677)
T ss_pred eeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHH
Confidence 999999999888887777778899999999986532 367899999999999999999999964321111
Q ss_pred hhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 852 NLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 852 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.+..+.++.-.-+.. .. ....++.++++.|+++||.+|||..|+++
T Consensus 581 ------------Kl~aI~~P~~~Iefp----------------~~-~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 581 ------------KLHAITDPNHEIEFP----------------DI-PENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ------------HHHhhcCCCcccccc----------------CC-CCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 112222221110000 00 00123889999999999999999999975
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=311.97 Aligned_cols=266 Identities=22% Similarity=0.273 Sum_probs=204.9
Q ss_pred cCHHHHHHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhc-CCCcceeEEeeeec
Q 039533 616 LSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSI-RHRNLVKVLTACLG 694 (949)
Q Consensus 616 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 694 (949)
.++.++....+.|++.+.||+|+||.||+|++..+++.||+|++.... .....+..|+.+++++ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 355666677889999999999999999999998889999999986543 2345688899999998 69999999999864
Q ss_pred ccc-cCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCee
Q 039533 695 ADY-RGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVL 773 (949)
Q Consensus 695 ~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIl 773 (949)
... ......++||||+++|+|.+++... ....+++..+..++.|++.|++|||+. +|+||||||+||+
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nil 153 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNT--------KGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVL 153 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHc--------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEE
Confidence 321 2345789999999999999998632 123477888999999999999999977 8999999999999
Q ss_pred ecCCCceEEeecccceecCCCCCccccccccCccCccCccccC-----CCccCCccchHHHHHHHHHHHhCCCCCccccc
Q 039533 774 LDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGV-----GCEVSTNGDVYSYGILLLELVIGKKPIDIMFE 848 (949)
Q Consensus 774 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~ 848 (949)
+++++.++|+|||.+......... .....|+..|+|||++. +..++.++|||||||++|||++|+.||.....
T Consensus 154 i~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~ 231 (282)
T cd06636 154 LTENAEVKLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP 231 (282)
T ss_pred ECCCCCEEEeeCcchhhhhccccC--CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH
Confidence 999999999999998765332211 12345899999999875 34578899999999999999999999853311
Q ss_pred cCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 849 GDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 849 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.... ........ ... ....++..+.+++.+||+.||.+||++.|+++
T Consensus 232 ~~~~-------------~~~~~~~~-~~~-----------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 232 MRAL-------------FLIPRNPP-PKL-----------------KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred Hhhh-------------hhHhhCCC-CCC-----------------cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 1000 00000000 000 00133456899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=319.68 Aligned_cols=202 Identities=24% Similarity=0.293 Sum_probs=171.4
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecC---CCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ---HHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
++|++.+.||+|+||.||+|+...+++.||+|++... .....+.+.+|+.++..++|+||+++++++...+ .
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDEN-----N 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC-----e
Confidence 4789999999999999999999988999999999642 2223456889999999999999999999876444 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl 143 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSK---------FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRL 143 (331)
T ss_pred EEEEEecCCCCcHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEE
Confidence 8999999999999999862 134588899999999999999999977 8999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCC-----CccCCccchHHHHHHHHHHHhCCCCCcc
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-----CEVSTNGDVYSYGILLLELVIGKKPIDI 845 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwSlGvvl~elltg~~Pf~~ 845 (949)
+|||++........... ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 144 ~Dfg~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 144 ADFGSCLRLLADGTVQS-NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred EECCceeecCCCCCccc-cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 99999977654332211 12458999999999863 4578899999999999999999999953
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=307.02 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=196.5
Q ss_pred CeeeeecCceEEEEEEcC-CC--EEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEe
Q 039533 632 NLVGVGSFGSVYKGIIDE-GR--TTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVY 707 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~-~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 707 (949)
++||+|++|.||+|.+.. ++ ..||+|+++.... ...+.+.+|+.++++++||||+++++++.. ...++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence 468999999999999864 23 3699999976555 456789999999999999999999998754 3789999
Q ss_pred eeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccc
Q 039533 708 EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGL 787 (949)
Q Consensus 708 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~ 787 (949)
||+++++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.
T Consensus 75 e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~ 143 (257)
T cd05040 75 ELAPLGSLLDRLRKDA--------LGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGL 143 (257)
T ss_pred EecCCCcHHHHHHhcc--------cccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccc
Confidence 9999999999997311 14589999999999999999999977 999999999999999999999999999
Q ss_pred ceecCCCCC-ccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCCch
Q 039533 788 ARILSPDHT-QTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPDDV 865 (949)
Q Consensus 788 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 865 (949)
++....... ........++..|+|||++.+..++.++|||||||++|||++ |+.||......+ .......
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~------ 215 (257)
T cd05040 144 MRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILKKIDK------ 215 (257)
T ss_pred cccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHh------
Confidence 987654322 111113447789999999998899999999999999999999 999985331111 0000000
Q ss_pred hhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 039533 866 MDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQ 929 (949)
Q Consensus 866 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 929 (949)
.... .......+..+.+++.+|++.+|++||++.||++.|.
T Consensus 216 ----~~~~-------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 216 ----EGER-------------------LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ----cCCc-------------------CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0000 0001133557889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=304.50 Aligned_cols=248 Identities=27% Similarity=0.409 Sum_probs=194.7
Q ss_pred CeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc-chHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEeeec
Q 039533 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG-ASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFM 710 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 710 (949)
++||+|+||.||+|.+.. ++.||+|+++..... ....+.+|++++++++|+||+++++++.... ..++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ-----PIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCC-----CeEEEEEcC
Confidence 478999999999999986 899999998755433 4467899999999999999999999876544 789999999
Q ss_pred cCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccccee
Q 039533 711 HYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARI 790 (949)
Q Consensus 711 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~ 790 (949)
++++|.+++.. ....+++..+..++.|++.|++|||++ +++||||||+||+++.++.+||+|||.++.
T Consensus 75 ~~~~l~~~l~~---------~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~ 142 (251)
T cd05041 75 PGGSLLTFLRK---------KKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRE 142 (251)
T ss_pred CCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeecccccc
Confidence 99999999862 123578889999999999999999977 899999999999999999999999999986
Q ss_pred cCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCCchhhhc
Q 039533 791 LSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPDDVMDIV 869 (949)
Q Consensus 791 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 869 (949)
..............++..|+|||.+.+..++.++|||||||++|||+| |..||....... ..+.+
T Consensus 143 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--------------~~~~~ 208 (251)
T cd05041 143 EEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--------------TRERI 208 (251)
T ss_pred ccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--------------HHHHH
Confidence 543222111111224567999999988889999999999999999999 888885332110 00111
Q ss_pred ccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 039533 870 DSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQ 929 (949)
Q Consensus 870 d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 929 (949)
....... .....+..+.+++.+|+..+|++|||+.||++.|+
T Consensus 209 ~~~~~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 209 ESGYRMP------------------APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred hcCCCCC------------------CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 1000000 00123457899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=309.04 Aligned_cols=257 Identities=21% Similarity=0.307 Sum_probs=185.8
Q ss_pred CeeeeecCceEEEEEEcC--CCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEee
Q 039533 632 NLVGVGSFGSVYKGIIDE--GRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYE 708 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 708 (949)
+.||+|+||.||+|.... ....+|+|.+..... .....+.+|++.++.++||||+++++++...+ ..++|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~-----~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI-----PYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCC-----ceEEEEE
Confidence 368999999999997642 345788888754332 23456889999999999999999999976544 7899999
Q ss_pred eccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecccc
Q 039533 709 FMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLA 788 (949)
Q Consensus 709 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a 788 (949)
|+++|+|.+++...... .....++.....++.|++.|++|||+. +|+||||||+||++++++.+||+|||++
T Consensus 76 ~~~~g~L~~~l~~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~ 147 (269)
T cd05042 76 FCPLGDLKNYLRSNRGM-----VAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLA 147 (269)
T ss_pred eCCCCcHHHHHHhcccc-----ccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccc
Confidence 99999999999743211 123356778899999999999999977 8999999999999999999999999998
Q ss_pred eecCCCCCccccccccCccCccCccccC-------CCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhcccc
Q 039533 789 RILSPDHTQTSSFSVKGSLGYIAPEYGV-------GCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 789 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
................++..|+|||+.. ...++.++|||||||++|||++ |..||......+ ......
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~--- 223 (269)
T cd05042 148 LEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVV--- 223 (269)
T ss_pred cccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHh---
Confidence 7643332221122334677899999864 2356889999999999999999 788885432111 000000
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQ 929 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 929 (949)
.....++.++... ...+..+.+++..|+ .||++|||++||++.|.
T Consensus 224 -~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 224 -REQDIKLPKPQLD----------------------LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred -hccCccCCCCccc----------------------ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 0000000011000 123345667788888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=325.57 Aligned_cols=193 Identities=22% Similarity=0.339 Sum_probs=163.8
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
...+|.+.+.||+|+||.||+|++..+++.||+|+.... ....|+.++++++||||+++++++.... ..
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 132 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGA-----IT 132 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCC-----ee
Confidence 346899999999999999999999988899999975322 2356999999999999999999976544 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++||||+. ++|.+++.. ....+++..+..|+.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 133 ~lv~e~~~-~~l~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~ 199 (357)
T PHA03209 133 CMVLPHYS-SDLYTYLTK---------RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIG 199 (357)
T ss_pred EEEEEccC-CcHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEe
Confidence 99999995 688888852 234689999999999999999999977 89999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCC
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPI 843 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf 843 (949)
|||.++....... .....||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 200 DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 200 DLGAAQFPVVAPA---FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cCccccccccCcc---cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 9999975332221 12345899999999999989999999999999999999865554
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=315.73 Aligned_cols=244 Identities=25% Similarity=0.346 Sum_probs=195.2
Q ss_pred CCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc---chHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG---ASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 628 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
|.-.+.||.|+||.||-|++..+.+.||||.+...... .-.++..|+..|.+++|||++.+-|+|.... ..|
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~-----TaW 102 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH-----TAW 102 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccc-----hHH
Confidence 44457899999999999999999999999999754332 2357889999999999999999999976433 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+|||||- |+-.|.+. ...+++.+.++..|+.+.+.||+|||+. +.||||||..|||+++.|.|||+|
T Consensus 103 LVMEYCl-GSAsDlle---------VhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaD 169 (948)
T KOG0577|consen 103 LVMEYCL-GSASDLLE---------VHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLAD 169 (948)
T ss_pred HHHHHHh-ccHHHHHH---------HHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeecc
Confidence 9999995 57777775 2346688899999999999999999988 899999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccC---CCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGV---GCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
||.|....+.. .++||+.|||||++. .+.|+-|+||||+|++..|+.-.++|+-.+......+ ..+..
T Consensus 170 FGSAsi~~PAn------sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY-HIAQN-- 240 (948)
T KOG0577|consen 170 FGSASIMAPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQN-- 240 (948)
T ss_pred ccchhhcCchh------cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH-HHHhc--
Confidence 99998876654 467999999999855 4679999999999999999999999975331110000 00000
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
+ .+.+. ..+....+.+++..|++.-|++|||.+++++
T Consensus 241 --e-----sPtLq---------------------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 241 --E-----SPTLQ---------------------SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred --C-----CCCCC---------------------CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 0 00010 1244667889999999999999999998864
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=306.70 Aligned_cols=253 Identities=21% Similarity=0.288 Sum_probs=194.0
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-----cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-----GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
.+|+..+.||+|+||.||+|.+..+++.||+|+++.... ...+.+.+|+.++++++||||+++++++... ..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CC
Confidence 478999999999999999999988899999999864321 2235688899999999999999999987532 23
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
...+++|||+++++|.+++. ....+++.....++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~----------~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~ 145 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLK----------AYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNV 145 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCE
Confidence 36789999999999999986 223478889999999999999999977 89999999999999999999
Q ss_pred EEeecccceecCCCCCc-cccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 781 RVGDFGLARILSPDHTQ-TSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++|+.||....... .
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~-~------- 217 (266)
T cd06651 146 KLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA-A------- 217 (266)
T ss_pred EEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH-H-------
Confidence 99999999765432111 11112448899999999998889999999999999999999999986331110 0
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
..........+.. .....+.+.+++ .|+..+|++||+++||++
T Consensus 218 -----~~~~~~~~~~~~~------------------~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 218 -----IFKIATQPTNPQL------------------PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -----HHHHhcCCCCCCC------------------chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0000000000000 012233455666 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=309.02 Aligned_cols=265 Identities=24% Similarity=0.397 Sum_probs=200.3
Q ss_pred CCCCCeeeeecCceEEEEEEcC---CCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC-c
Q 039533 628 FSSANLVGVGSFGSVYKGIIDE---GRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN-D 701 (949)
Q Consensus 628 y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~-~ 701 (949)
|.+.+.||+|+||.||+|.+.. +++.||||++.... ....+++.+|++++++++||||+++++++......+. .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 6678899999999999998643 46899999987543 2334678899999999999999999998765432211 2
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++++||+++|+|.+++...... .....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~----~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~k 153 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIG----EEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVC 153 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhccc----CCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEE
Confidence 347889999999999887521111 1223578999999999999999999977 899999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhcccc
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
|+|||.++...............++..|++||......++.++|||||||++|||++ |++||...... .......
T Consensus 154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~--~~~~~~~-- 229 (273)
T cd05074 154 VADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--EIYNYLI-- 229 (273)
T ss_pred ECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--HHHHHHH--
Confidence 999999987644332222222345678999999988889999999999999999999 88888533211 1100000
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHh
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSI 931 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 931 (949)
....... ....+..+.+++.+|++.+|++||++.|+++.|+++
T Consensus 230 ---------~~~~~~~-------------------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 ---------KGNRLKQ-------------------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---------cCCcCCC-------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000000 012345688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=309.74 Aligned_cols=262 Identities=22% Similarity=0.311 Sum_probs=203.8
Q ss_pred HHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhc-CCCcceeEEeeeecccc-cCC
Q 039533 623 NATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSI-RHRNLVKVLTACLGADY-RGN 700 (949)
Q Consensus 623 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~-~~~ 700 (949)
.++++|++.+.||+|++|.||+|.+..+++.+++|++..... ..+.+.+|+.+++++ +|+||+++++++..... ...
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 356899999999999999999999988889999999875543 346789999999999 79999999999876543 234
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
...++||||+++++|.+++.... .....+++..+..++.|++.||+|||+. +++||||+|+||++++++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~ 152 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLR------KKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEV 152 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHh------hcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeE
Confidence 56899999999999999986321 1235688999999999999999999977 89999999999999999999
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCC-----CccCCccchHHHHHHHHHHHhCCCCCccccccCchhhh
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-----CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHN 855 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~ 855 (949)
||+|||.+......... .....|+..|+|||++.. ..++.++|||||||++|||++|+.||....... ...
T Consensus 153 ~l~d~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~- 228 (275)
T cd06608 153 KLVDFGVSAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-ALF- 228 (275)
T ss_pred EECCCccceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HHH-
Confidence 99999999865433221 123458899999998753 346789999999999999999999996321110 000
Q ss_pred hccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 856 FGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 856 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.+..... . ........+..+.+++.+|+..||++|||+.|+++
T Consensus 229 -----------~~~~~~~-~----------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 229 -----------KIPRNPP-P----------------TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -----------HhhccCC-C----------------CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0000000 0 00011134557889999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=305.80 Aligned_cols=250 Identities=21% Similarity=0.285 Sum_probs=199.5
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
+|++.+.||+|+||.||++....+++.||+|++.... ....+++.+|+.++++++||||+++++++...+ ..+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENG-----NLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCC-----eEE
Confidence 5888999999999999999999889999999987432 233467899999999999999999999875443 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++++|.+++... ....+++.+++.++.|++.|++|||++ +++|+||+|+||+++.++.++|+|
T Consensus 76 lv~e~~~~~~l~~~~~~~--------~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d 144 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQ--------RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGD 144 (256)
T ss_pred EEEecCCCCcHHHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEee
Confidence 999999999999998621 123578899999999999999999977 899999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCc
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
||.+.......... ....|+..|+|||+..+..++.++|||||||++|+|++|+.||...... ..
T Consensus 145 ~~~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~-------- 209 (256)
T cd08218 145 FGIARVLNSTVELA--RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK-----NL-------- 209 (256)
T ss_pred ccceeecCcchhhh--hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH-----HH--------
Confidence 99998764432211 1345888999999998888999999999999999999999998532110 00
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
...+....... .....+..+.+++.+|++.+|++||++.||++
T Consensus 210 ~~~~~~~~~~~-------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 210 VLKIIRGSYPP-------------------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred HHHHhcCCCCC-------------------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 00111000000 01133456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=307.78 Aligned_cols=255 Identities=21% Similarity=0.300 Sum_probs=195.6
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc----------chHHHHHHHHHHHhcCCCcceeEEeeeeccc
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG----------ASRSFIAECKALKSIRHRNLVKVLTACLGAD 696 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 696 (949)
+|.+.+.||+|+||.||+|....+++.||+|.++..... ..+.+..|+.++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477889999999999999999888999999998632110 1245788999999999999999999875443
Q ss_pred ccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC
Q 039533 697 YRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD 776 (949)
Q Consensus 697 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~ 776 (949)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||+++.
T Consensus 82 -----~~~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~ 143 (272)
T cd06629 82 -----YLSIFLEYVPGGSIGSCLRT----------YGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDA 143 (272)
T ss_pred -----ceEEEEecCCCCcHHHHHhh----------ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcC
Confidence 78999999999999999862 24588889999999999999999977 8999999999999999
Q ss_pred CCceEEeecccceecCCCCCccccccccCccCccCccccCCCc--cCCccchHHHHHHHHHHHhCCCCCccccccCchhh
Q 039533 777 YMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCE--VSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLH 854 (949)
Q Consensus 777 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~ 854 (949)
++.++++|||.++...............|+..|+|||...... ++.++|+||||+++||+++|..||....... ...
T Consensus 144 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~ 222 (272)
T cd06629 144 DGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA-AMF 222 (272)
T ss_pred CCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH-HHH
Confidence 9999999999997654322221122345889999999987654 7899999999999999999999985321110 000
Q ss_pred hhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 855 NFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 855 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
+........... .....+.+..+.+++.+|+..+|++||+++||++
T Consensus 223 ------------~~~~~~~~~~~~--------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 223 ------------KLGNKRSAPPIP--------------PDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred ------------HhhccccCCcCC--------------ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 000000000000 0000133567889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=311.47 Aligned_cols=248 Identities=23% Similarity=0.331 Sum_probs=197.6
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
.|+..+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|++++++++||||+++++++.... ..++
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l 79 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT-----KLWI 79 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC-----ceEE
Confidence 3556688999999999999998889999999987443 233467889999999999999999999875443 7899
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
||||+++++|.+++. ...+++..+..++.|+++|+.|||++ +++|+||+|+||++++++.++++||
T Consensus 80 v~e~~~~~~L~~~~~-----------~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~df 145 (277)
T cd06642 80 IMEYLGGGSALDLLK-----------PGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADF 145 (277)
T ss_pred EEEccCCCcHHHHhh-----------cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccc
Confidence 999999999999985 23478899999999999999999976 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCch
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDV 865 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 865 (949)
|.+.......... ....|+..|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 146 g~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------------- 210 (277)
T cd06642 146 GVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL------------- 210 (277)
T ss_pred cccccccCcchhh--hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH-------------
Confidence 9997665432211 1245788999999999888999999999999999999999998633211100
Q ss_pred hhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 866 MDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 866 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
..+.....+.. ....+..+.+++.+|++.+|++||++.||++.
T Consensus 211 -~~~~~~~~~~~------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 211 -FLIPKNSPPTL------------------EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred -hhhhcCCCCCC------------------CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 00000000000 01234567899999999999999999999873
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=313.21 Aligned_cols=271 Identities=21% Similarity=0.283 Sum_probs=195.4
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
+|++.+.||+|+||.||+|++..+|+.||+|+++.... .....+.+|++++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD-----KKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC-----CceE
Confidence 47888999999999999999998899999999875422 2235678899999999999999999986544 3789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+|+||++ ++|.+++.. ....+++..++.++.||++||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 76 lv~e~~~-~~l~~~~~~---------~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d 142 (284)
T cd07839 76 LVFEYCD-QDLKKYFDS---------CNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLAD 142 (284)
T ss_pred EEEecCC-CCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECc
Confidence 9999997 588887752 234589999999999999999999977 899999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCc-cCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC-
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCE-VSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP- 862 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~- 862 (949)
||.++......... ....++..|+|||++.+.. ++.++|||||||++|||+||+.||.........+....+..-.
T Consensus 143 fg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~ 220 (284)
T cd07839 143 FGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 220 (284)
T ss_pred cchhhccCCCCCCc--CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCC
Confidence 99998654332211 1234788999999887654 6899999999999999999999864322111111110000000
Q ss_pred -Cc----hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 863 -DD----VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 863 -~~----~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
+. ..+..+........ ...............+.+++.+|++.||++|||++|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 221 TEESWPGVSKLPDYKPYPMYP---------ATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ChHHhHHhhhcccccccCCCC---------CcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00 00000000000000 000000011123567789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=311.90 Aligned_cols=202 Identities=26% Similarity=0.391 Sum_probs=168.8
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
.++|++.+.||+|++|.||+|....+++.||+|.+..... .....+.+|++++++++|+||+++++++...+ ..
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~ 78 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKK-----TL 78 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCC-----eE
Confidence 3678999999999999999999988899999999875432 23356778999999999999999999976444 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++||||+.+ +|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 79 ~lv~e~~~~-~L~~~~~~---------~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~ 145 (291)
T cd07844 79 TLVFEYLDT-DLKQYMDD---------CGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLA 145 (291)
T ss_pred EEEEecCCC-CHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEEC
Confidence 999999975 99998862 223578999999999999999999977 89999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccc
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIM 846 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~ 846 (949)
|||.++......... ....++..|+|||+..+ ..++.++||||+|+++|||++|+.||...
T Consensus 146 dfg~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 207 (291)
T cd07844 146 DFGLARAKSVPSKTY--SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS 207 (291)
T ss_pred ccccccccCCCCccc--cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999987543221111 12346889999998875 45789999999999999999999999643
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=307.95 Aligned_cols=264 Identities=22% Similarity=0.256 Sum_probs=200.8
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
++|...+.||.|++|.||+|.+..+++.+|+|++..... ....++.+|++++++++||||+++++++.... ....+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDES---SSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC---CCeEE
Confidence 467888999999999999999988899999999875433 34567899999999999999999999875432 33679
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++++|.+++.... .....++...+..++.|++.||+|||+. +++||||+|+||++++++.++|+|
T Consensus 78 lv~e~~~~~~L~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d 148 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVK------KRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCD 148 (287)
T ss_pred EEEEecCCCCHHHHHHHHH------hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEee
Confidence 9999999999999875211 1234578899999999999999999977 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCc
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
||++......... ...++..|+|||.+.+..++.++||||+||++|||++|+.||+..........+.
T Consensus 149 fg~~~~~~~~~~~----~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------- 216 (287)
T cd06621 149 FGVSGELVNSLAG----TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIEL-------- 216 (287)
T ss_pred ccccccccccccc----cccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHH--------
Confidence 9998765432221 2347889999999988889999999999999999999999997442110000000
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
...+...-.....+ ........+..+.+++.+|++.+|++|||+.||++
T Consensus 217 -~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 217 -LSYIVNMPNPELKD------------EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred -HHHHhcCCchhhcc------------CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 00000000000000 00000022456889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=314.46 Aligned_cols=271 Identities=23% Similarity=0.303 Sum_probs=199.0
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|++++++++||||+++++++... ...
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRK-----KRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccC-----CeE
Confidence 468899999999999999999988899999999864332 2345788999999999999999999997543 378
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++||||++++++.++.. ....+++.++..++.|++.||+|||+. +++||||+|+||++++++.++|+
T Consensus 76 ~lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~ 142 (286)
T cd07846 76 YLVFEFVDHTVLDDLEK----------YPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLC 142 (286)
T ss_pred EEEEecCCccHHHHHHh----------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEE
Confidence 99999999999988765 223488999999999999999999977 89999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCc--hhhhhcccc
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDI--NLHNFGRKA 860 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~--~~~~~~~~~ 860 (949)
|||++......... .....++..|+|||+..+ ..++.++||||||+++|||++|++||......+. ...... ..
T Consensus 143 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~-~~ 219 (286)
T cd07846 143 DFGFARTLAAPGEV--YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCL-GN 219 (286)
T ss_pred eeeeeeeccCCccc--cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHh-CC
Confidence 99999876443321 112457899999998875 3478899999999999999999999863321100 000000 00
Q ss_pred CCCchhhhcc------cCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 861 LPDDVMDIVD------SSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 861 ~~~~~~~~~d------~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
..+...+..+ ....+... ............+..+.+++.+|++.+|++||+++|+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 220 LIPRHQEIFQKNPLFAGMRLPEVK---------EIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred CchhhHHHhccchHhhcccccccc---------CcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 1111111100 00000000 000000011234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=304.85 Aligned_cols=252 Identities=24% Similarity=0.390 Sum_probs=197.1
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
..+|++.+.||+|+||.||+|.+. .++.+|+|+++... .....+.+|++++++++|||++++++++.... ..+
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~ 75 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERS-----PIC 75 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCC-----ceE
Confidence 356888999999999999999986 46789999886433 23467899999999999999999999875444 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++++|.+++.. ....+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|
T Consensus 76 ~v~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d 143 (256)
T cd05112 76 LVFEFMEHGCLSDYLRA---------QRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSD 143 (256)
T ss_pred EEEEcCCCCcHHHHHHh---------CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECC
Confidence 99999999999999862 123578899999999999999999977 899999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCC
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
||.++......... .....++..|+|||+..+..++.++||||||+++|||++ |+.||...... ......
T Consensus 144 ~g~~~~~~~~~~~~-~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~~------ 214 (256)
T cd05112 144 FGMTRFVLDDQYTS-STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--EVVETI------ 214 (256)
T ss_pred CcceeecccCcccc-cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHH------
Confidence 99998664332211 112235678999999988889999999999999999998 99998632211 000000
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHEL 928 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 928 (949)
........ ....+..+.+++.+|++.+|++|||+.||++.|
T Consensus 215 ------~~~~~~~~------------------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 215 ------NAGFRLYK------------------PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred ------hCCCCCCC------------------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 00000000 001235688999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=305.35 Aligned_cols=251 Identities=24% Similarity=0.332 Sum_probs=195.2
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC------cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH------GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
+|++.+.||+|+||.||+|... +++.+|+|.++.... ...+.+.+|++++++++|+||+++++++.+.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 75 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDN---- 75 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCC----
Confidence 5888999999999999999875 678999999864321 12256889999999999999999999976544
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
..++||||+++++|.+++.. ...+++..+..++.|++.|++|||+. +|+|+||+|+||+++.++.+
T Consensus 76 -~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~ 141 (265)
T cd06631 76 -TISIFMEFVPGGSISSILNR----------FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGII 141 (265)
T ss_pred -eEEEEEecCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeE
Confidence 78999999999999999962 23578889999999999999999977 89999999999999999999
Q ss_pred EEeecccceecCCCCC----ccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhh
Q 039533 781 RVGDFGLARILSPDHT----QTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNF 856 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~ 856 (949)
+|+|||.+........ ........|+..|+|||+..+..++.++|||||||++|||++|+.||........ ....
T Consensus 142 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-~~~~ 220 (265)
T cd06631 142 KLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-MFYI 220 (265)
T ss_pred EeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-HHHh
Confidence 9999999876532111 1111234588999999999988899999999999999999999999963311100 0000
Q ss_pred ccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 857 GRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 857 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.. ... ..+.. ....+..+.+++.+|++.+|++||++.|+++
T Consensus 221 ~~---~~~----~~~~~----------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 221 GA---HRG----LMPRL----------------------PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred hh---ccC----CCCCC----------------------CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 000 00000 0123456789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=315.85 Aligned_cols=250 Identities=25% Similarity=0.364 Sum_probs=204.7
Q ss_pred CCCeeeeecCceEEEEEEcCC---CEEEEEEEEecCCCc-chHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 630 SANLVGVGSFGSVYKGIIDEG---RTTIAVKVFNLQHHG-ASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 630 ~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
..+.||+|.||.|++|.|... ...||||.++..... ...+|.+|+.+|.+++|+|++++||...+. ...+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~q------p~mM 187 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQ------PAMM 187 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccc------hhhH
Confidence 457899999999999999642 246999999866544 568999999999999999999999997642 5789
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
|||.++.|+|.+.|+. .....+-......++.|||.|+.||.++ +.|||||..+|+++-....+||+||
T Consensus 188 V~ELaplGSLldrLrk--------a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DF 256 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRK--------AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDF 256 (1039)
T ss_pred HhhhcccchHHHHHhh--------ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecc
Confidence 9999999999999973 1345677888899999999999999988 8999999999999998899999999
Q ss_pred ccceecCCCCCcc-ccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCC
Q 039533 786 GLARILSPDHTQT-SSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 786 G~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
|+.+.++...... ......-.+.|+|||.+...+++.++|||+|||++|||+| |+.||......
T Consensus 257 GLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~-------------- 322 (1039)
T KOG0199|consen 257 GLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI-------------- 322 (1039)
T ss_pred cceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH--------------
Confidence 9999887665532 2223445678999999999999999999999999999999 88887422110
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHEL 928 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 928 (949)
.+.+.+| ..++.+....|++.+++++..||..+|++|||+..+.+.+
T Consensus 323 qIL~~iD------------------~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 323 QILKNID------------------AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HHHHhcc------------------ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 1112222 2234445568899999999999999999999999997544
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=310.45 Aligned_cols=254 Identities=22% Similarity=0.291 Sum_probs=197.3
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
++|++.+.||+|+||.||+|.+..+++.||+|.++... ......+.+|+.++++++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEG-----AVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCC-----eEE
Confidence 46889999999999999999998889999999987542 223467889999999999999999999876544 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++++|.+++.... ....+++..+..++.|++.|+.|||+.+ +|+||||||+||+++.++.+||+|
T Consensus 76 lv~e~~~~~~l~~~~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d 146 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGGV-------ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCD 146 (286)
T ss_pred EEEeecCCCCHHHHHHhcc-------ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEee
Confidence 9999999999999986210 1246899999999999999999999643 899999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCC------ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcc
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC------EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGR 858 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~ 858 (949)
||.+......... ...++..|+|||++.+. .++.++|||||||++|||++|+.||....... ....
T Consensus 147 fg~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~-- 218 (286)
T cd06622 147 FGVSGNLVASLAK----TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--IFAQ-- 218 (286)
T ss_pred cCCcccccCCccc----cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--HHHH--
Confidence 9998765432221 23478899999997654 35889999999999999999999996321110 0000
Q ss_pred ccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 859 KALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 859 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
...+.+..... ...+.+..+.+++.+|++.+|++||+++|++.
T Consensus 219 ------~~~~~~~~~~~-------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 219 ------LSAIVDGDPPT-------------------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred ------HHHHhhcCCCC-------------------CCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 00011100000 01134566789999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=316.31 Aligned_cols=201 Identities=20% Similarity=0.215 Sum_probs=164.5
Q ss_pred CCCeeeee--cCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 630 SANLVGVG--SFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 630 ~~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
+.++||+| +|++||++....+++.||+|+++.... ...+.+.+|+++++.++||||+++++++...+ ..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-----~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN-----ELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC-----EEEE
Confidence 45789999 678999999999999999999875432 23456778999999999999999999986554 7899
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
||||+++|+|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.++++||
T Consensus 77 v~e~~~~~~l~~~~~~~--------~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~ 145 (327)
T cd08227 77 VTSFMAYGSAKDLICTH--------FMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGL 145 (327)
T ss_pred EEeccCCCcHHHHHHhh--------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEccc
Confidence 99999999999998621 123488999999999999999999977 8999999999999999999999999
Q ss_pred ccceecCCCCC-c----cccccccCccCccCccccCC--CccCCccchHHHHHHHHHHHhCCCCCccc
Q 039533 786 GLARILSPDHT-Q----TSSFSVKGSLGYIAPEYGVG--CEVSTNGDVYSYGILLLELVIGKKPIDIM 846 (949)
Q Consensus 786 G~a~~~~~~~~-~----~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlGvvl~elltg~~Pf~~~ 846 (949)
+.+........ . .......++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 146 RSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred chhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 86544321111 0 00112346788999999876 45889999999999999999999999643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=318.94 Aligned_cols=202 Identities=23% Similarity=0.300 Sum_probs=172.0
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecC---CCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ---HHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
++|.+.+.||+|+||.||+|++..+++.||+|++... .......+.+|..++..++|++|+++++++...+ .
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~-----~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDEN-----Y 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-----E
Confidence 4789999999999999999999988999999998642 1223356788999999999999999999876444 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~---------~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl 143 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSK---------FEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRL 143 (331)
T ss_pred EEEEEeCCCCCcHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEE
Confidence 8999999999999999962 124578889999999999999999977 9999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCC-----CccCCccchHHHHHHHHHHHhCCCCCcc
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-----CEVSTNGDVYSYGILLLELVIGKKPIDI 845 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwSlGvvl~elltg~~Pf~~ 845 (949)
+|||+++.......... ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 144 ~DfG~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 144 ADFGSCLKMNQDGTVQS-SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred EeccceeeccCCCceee-ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 99999987654433221 13459999999998875 4678999999999999999999999953
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=304.07 Aligned_cols=254 Identities=24% Similarity=0.387 Sum_probs=199.1
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.++|++.+.||+|+||.||+|.+. ++..+|+|.+.... ...+.+.+|++++++++|+||+++++++.. ...+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~ 76 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIY 76 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeE
Confidence 357899999999999999999876 55679999886432 234678899999999999999999988654 2679
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
++|||+++++|.+++... ....+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|
T Consensus 77 ~v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d 145 (260)
T cd05073 77 IITEFMAKGSLLDFLKSD--------EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIAD 145 (260)
T ss_pred EEEEeCCCCcHHHHHHhC--------CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECC
Confidence 999999999999999631 234578889999999999999999977 899999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCC
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
||.+.......... .....++..|+|||++.+..++.++|||||||++|++++ |+.||...... .....
T Consensus 146 ~~~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~------- 215 (260)
T cd05073 146 FGLARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRA------- 215 (260)
T ss_pred CcceeeccCCCccc-ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHHH-------
Confidence 99998664332211 112335678999999988889999999999999999999 99998632111 01000
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQS 930 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 930 (949)
+...... +.....+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus 216 -----~~~~~~~------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 216 -----LERGYRM------------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -----HhCCCCC------------------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0000000 0001234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=304.50 Aligned_cols=253 Identities=21% Similarity=0.251 Sum_probs=194.5
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-----cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-----GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
.+|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.. .
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM---E 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC---C
Confidence 578999999999999999999998899999999864321 22357888999999999999999999865432 2
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
...++||||+++++|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~ 145 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKS----------YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNV 145 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCE
Confidence 357899999999999999862 23478888999999999999999977 89999999999999999999
Q ss_pred EEeecccceecCCCCC-ccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 781 RVGDFGLARILSPDHT-QTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
+|+|||.++....... ........|+..|+|||++.+..++.++|||||||++|||++|+.||....... ..
T Consensus 146 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~------ 218 (265)
T cd06652 146 KLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-AI------ 218 (265)
T ss_pred EECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-HH------
Confidence 9999999986543211 111123458899999999988889999999999999999999999985321110 00
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.+.......+ .........+.+++.+|+. +|++||+++||++
T Consensus 219 ------~~~~~~~~~~------------------~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 219 ------FKIATQPTNP------------------VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ------HHHhcCCCCC------------------CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0000000000 0011334456778888884 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=304.40 Aligned_cols=247 Identities=27% Similarity=0.422 Sum_probs=195.3
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
++|++.+.||+|+||.||+|.. .++.||+|+++... ....+.+|+.++++++|||++++++++... ..++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~~~~ 75 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN------GLYI 75 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC------CcEE
Confidence 4688999999999999999975 47789999986432 346788999999999999999999987532 3689
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
||||+++++|.+++... ....+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+||
T Consensus 76 v~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Df 144 (254)
T cd05083 76 VMELMSKGNLVNFLRTR--------GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDF 144 (254)
T ss_pred EEECCCCCCHHHHHHhc--------CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCC
Confidence 99999999999999631 223578999999999999999999976 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCCc
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
|.+........ ....+..|+|||++.+..++.++|||||||++|||++ |+.||.......
T Consensus 145 g~~~~~~~~~~-----~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------------- 205 (254)
T cd05083 145 GLARVGSMGVD-----NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-------------- 205 (254)
T ss_pred ccceeccccCC-----CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--------------
Confidence 99976433211 1234678999999988889999999999999999998 999985332110
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQS 930 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 930 (949)
..+.+.......+ ....+..+.+++.+|++.+|++||+++++++.|++
T Consensus 206 ~~~~~~~~~~~~~------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 206 VKECVEKGYRMEP------------------PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHHHhCCCCCCC------------------CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0011111100000 01334567899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=303.95 Aligned_cols=256 Identities=21% Similarity=0.304 Sum_probs=183.8
Q ss_pred CeeeeecCceEEEEEEcCC--CEEEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEee
Q 039533 632 NLVGVGSFGSVYKGIIDEG--RTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYE 708 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 708 (949)
+.||+|+||.||+|+...+ ...+++|.++... ....+.+.+|+.+++.++||||+++++++.... ..++|||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-----~~~lv~e 75 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI-----PYLLVFE 75 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCC-----ccEEEEe
Confidence 3689999999999976433 2356677765433 234568999999999999999999999976544 7899999
Q ss_pred eccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecccc
Q 039533 709 FMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLA 788 (949)
Q Consensus 709 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a 788 (949)
|+++|+|.++++.... .....++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||.+
T Consensus 76 ~~~~~~L~~~l~~~~~------~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~ 146 (268)
T cd05086 76 YCELGDLKSYLSQEQW------HRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIG 146 (268)
T ss_pred cCCCCcHHHHHHhhhc------ccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccc
Confidence 9999999999973211 123466778889999999999999977 8999999999999999999999999998
Q ss_pred eecCCCCCccccccccCccCccCccccCC-------CccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhcccc
Q 039533 789 RILSPDHTQTSSFSVKGSLGYIAPEYGVG-------CEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 789 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
................++..|+|||++.. ..++.++|||||||++|||++ |..||....... .....
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-----~~~~~ 221 (268)
T cd05086 147 PSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE-----VLNHV 221 (268)
T ss_pred cccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHH
Confidence 64322211111123457889999998753 245789999999999999997 567875321110 00010
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQ 929 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 929 (949)
..+......++.+.. .....+.+++..|| .+|++||+++||++.|.
T Consensus 222 ~~~~~~~~~~~~~~~----------------------~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 222 IKDQQVKLFKPQLEL----------------------PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HhhcccccCCCccCC----------------------CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 111111111211111 12235677888899 67999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=307.76 Aligned_cols=263 Identities=23% Similarity=0.366 Sum_probs=201.1
Q ss_pred cCCCCCCeeeeecCceEEEEEEcC-----CCEEEEEEEEecCCCc-chHHHHHHHHHHHhcCCCcceeEEeeeecccccC
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDE-----GRTTIAVKVFNLQHHG-ASRSFIAECKALKSIRHRNLVKVLTACLGADYRG 699 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 699 (949)
++|++.+.||+|+||.||+|+... +.+.|++|.+...... ..+.+.+|++++++++|+||+++++++.+.+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE--- 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC---
Confidence 578899999999999999999753 3467999998654433 3467999999999999999999999975544
Q ss_pred CccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCc
Q 039533 700 NDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMT 779 (949)
Q Consensus 700 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~ 779 (949)
..++||||+++|+|.+++........ ......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 82 --~~~lv~e~~~~~~L~~~i~~~~~~~~-~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~ 155 (275)
T cd05046 82 --PHYMILEYTDLGDLKQFLRATKSKDE-KLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQRE 155 (275)
T ss_pred --cceEEEEecCCCcHHHHHHhcccccc-cccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCc
Confidence 78999999999999999974321111 11223689999999999999999999977 8999999999999999999
Q ss_pred eEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhcc
Q 039533 780 ARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGR 858 (949)
Q Consensus 780 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~ 858 (949)
++++|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ......
T Consensus 156 ~~l~~~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~--~~~~~~ 232 (275)
T cd05046 156 VKVSLLSLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE--VLNRLQ 232 (275)
T ss_pred EEEcccccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH--HHHHHH
Confidence 999999998754322211 1112346778999999988888999999999999999999 888885322111 110000
Q ss_pred ccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 039533 859 KALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQ 929 (949)
Q Consensus 859 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 929 (949)
..... +......+..+.+++.+|++.+|++||++.|+++.|+
T Consensus 233 -----------~~~~~------------------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 233 -----------AGKLE------------------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -----------cCCcC------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00000 0000123457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=308.13 Aligned_cols=254 Identities=22% Similarity=0.252 Sum_probs=192.7
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-cchHHHHHHHHH-HHhcCCCcceeEEeeeecccccCCccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECKA-LKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
++|++.+.||+|+||.||+|++..+++.||+|+++.... ....++..|+.. ++..+||||+++++++.... ..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~-----~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREG-----DV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCC-----cE
Confidence 478899999999999999999998899999999875432 233456666665 55668999999999976544 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++||||++ |+|.+++.... .....+++..+..++.|++.|++|||+++ +++||||||+||+++.++.+||+
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~ 146 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVY------DKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLC 146 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhc------cCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEe
Confidence 99999997 68888875321 12346899999999999999999999643 89999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCC----CccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG----CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
|||.+......... ....|+..|+|||++.+ ..++.++|+|||||++|||++|+.||..........
T Consensus 147 dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------ 217 (283)
T cd06617 147 DFGISGYLVDSVAK---TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQL------ 217 (283)
T ss_pred eccccccccccccc---ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHH------
Confidence 99999865432221 12358889999998765 456889999999999999999999986321110000
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
...........+. ...+..+.+++.+|+..+|++||++.|+++
T Consensus 218 ------~~~~~~~~~~~~~------------------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 218 ------KQVVEEPSPQLPA------------------EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ------HHHHhcCCCCCCc------------------cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111000000000 123456889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=303.09 Aligned_cols=239 Identities=24% Similarity=0.452 Sum_probs=187.9
Q ss_pred CeeeeecCceEEEEEEcCCC----------EEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 632 NLVGVGSFGSVYKGIIDEGR----------TTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
+.||+|+||.||+|.+..++ ..|++|++...... ...+.+|+.++++++||||+++++++.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~----- 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-D----- 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-C-----
Confidence 46899999999999997655 35888887644433 5788999999999999999999999765 3
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC---
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM--- 778 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~--- 778 (949)
..++||||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~ 141 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHR---------EKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNE 141 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHh---------hccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCcccc
Confidence 57999999999999999972 122588999999999999999999977 999999999999999887
Q ss_pred ----ceEEeecccceecCCCCCccccccccCccCccCccccCCC--ccCCccchHHHHHHHHHHHh-CCCCCccccccCc
Q 039533 779 ----TARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC--EVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDI 851 (949)
Q Consensus 779 ----~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~ 851 (949)
.+||+|||++....... ...++..|+|||++.+. .++.++|||||||++|||++ |..||.......
T Consensus 142 ~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~- 214 (259)
T cd05037 142 GYVPFIKLSDPGIPITVLSRE------ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE- 214 (259)
T ss_pred CCceeEEeCCCCccccccccc------ccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh-
Confidence 79999999998654311 23467889999998876 78999999999999999999 577775332110
Q ss_pred hhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 039533 852 NLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQ 929 (949)
Q Consensus 852 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 929 (949)
...+. ......+.+ ....+.+++.+|+..+|++|||+.||++.|+
T Consensus 215 -~~~~~-----------~~~~~~~~~---------------------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 215 -KERFY-----------QDQHRLPMP---------------------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -HHHHH-----------hcCCCCCCC---------------------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000 000000000 0146789999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=308.97 Aligned_cols=252 Identities=21% Similarity=0.303 Sum_probs=201.7
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.++|.+.+.||+|+||.||+|....++..||+|.+........+.+.+|+.++++++||||+++++++...+ ..+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-----~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD-----ELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCC-----cEE
Confidence 367899999999999999999988788999999987555555577899999999999999999999876544 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+|+||+++++|.+++.. ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|
T Consensus 93 lv~e~~~~~~L~~~~~~-----------~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~d 158 (293)
T cd06647 93 VVMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTD 158 (293)
T ss_pred EEEecCCCCcHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEcc
Confidence 99999999999999862 3478889999999999999999977 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCc
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
||.+.......... ....|+..|+|||...+..++.++|||||||++||+++|+.||.......... ....
T Consensus 159 fg~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-~~~~------ 229 (293)
T cd06647 159 FGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIAT------ 229 (293)
T ss_pred Ccceeccccccccc--ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-ehhc------
Confidence 99987655433221 13458889999999988889999999999999999999999996432111000 0000
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
... + .+......+..+.+++.+||+.+|++||++.|++..
T Consensus 230 -----~~~--~----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 230 -----NGT--P----------------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -----CCC--C----------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0 000011234567889999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=317.47 Aligned_cols=202 Identities=23% Similarity=0.286 Sum_probs=170.4
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
++|++.++||+|+||.||+++...+++.||+|++.... ......+.+|+.++..++|++|+++++++...+ .
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDEN-----N 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC-----E
Confidence 47899999999999999999999889999999986321 222345788999999999999999998875444 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~ey~~~g~L~~~l~~---------~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL 143 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSK---------FEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRL 143 (332)
T ss_pred EEEEEeccCCCcHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEE
Confidence 8999999999999999962 124588889999999999999999977 9999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccC-----CCccCCccchHHHHHHHHHHHhCCCCCcc
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGV-----GCEVSTNGDVYSYGILLLELVIGKKPIDI 845 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlGvvl~elltg~~Pf~~ 845 (949)
+|||++.......... .....||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 144 ~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 144 ADFGSCLKLMEDGTVQ-SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred eecchheecccCCcce-ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 9999997654332211 11345999999999876 34578999999999999999999999963
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=312.71 Aligned_cols=249 Identities=22% Similarity=0.275 Sum_probs=196.2
Q ss_pred CCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEe
Q 039533 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVY 707 (949)
Q Consensus 628 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 707 (949)
|.....||+|+||.||+|....++..||||++........+.+.+|+.++++++|+||+++++.+...+ ..++||
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~-----~~~lv~ 98 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD-----ELWVVM 98 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC-----eEEEEE
Confidence 333467999999999999998889999999987655555667889999999999999999999876544 789999
Q ss_pred eeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccc
Q 039533 708 EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGL 787 (949)
Q Consensus 708 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~ 787 (949)
||+++++|.+++. ...+++.++..++.|++.|++|||+. +|+||||||+||++++++.++|+|||+
T Consensus 99 e~~~~~~L~~~~~-----------~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~ 164 (292)
T cd06658 99 EFLEGGALTDIVT-----------HTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGF 164 (292)
T ss_pred eCCCCCcHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcc
Confidence 9999999999885 13478899999999999999999977 899999999999999999999999999
Q ss_pred ceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhh
Q 039533 788 ARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMD 867 (949)
Q Consensus 788 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 867 (949)
+.......... ....|+..|+|||+..+..++.++||||||+++|||++|+.||...... ....... .
T Consensus 165 ~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~--------~ 232 (292)
T cd06658 165 CAQVSKEVPKR--KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--QAMRRIR--------D 232 (292)
T ss_pred hhhcccccccC--ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHH--------h
Confidence 87654332211 1345889999999998888999999999999999999999998532110 0000000 0
Q ss_pred hcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 868 IVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 868 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
........ .......+.+++.+|+..||++|||++|+++.
T Consensus 233 ~~~~~~~~--------------------~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 233 NLPPRVKD--------------------SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cCCCcccc--------------------ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00000000 01223457789999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=304.11 Aligned_cols=257 Identities=21% Similarity=0.299 Sum_probs=201.6
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
+|++.+.||.|+||.||+|.+..+++.||+|++.... ....+++..|++++++++||||+++++++... .....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR---SNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC---CCCEEE
Confidence 5888999999999999999998889999999987433 23345788999999999999999999887532 234678
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeEecCCCCCCeeecCCCceEE
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDC--QPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~--~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
++|||+++++|.+++.... .....+++..++.++.|++.||+|||..+ ..+++||||||+||++++++.+||
T Consensus 78 ~~~e~~~~~~L~~~l~~~~------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl 151 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCK------KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKL 151 (265)
T ss_pred EEehhccCCCHHHHHHHHh------hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEE
Confidence 9999999999999986321 12356899999999999999999999322 238999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
+|||.+.......... ....++..|+|||++.+..++.++||||||+++|+|++|+.||...... .....
T Consensus 152 ~d~g~~~~~~~~~~~~--~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~------ 221 (265)
T cd08217 152 GDFGLAKILGHDSSFA--KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL--QLASK------ 221 (265)
T ss_pred ecccccccccCCcccc--cccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH--HHHHH------
Confidence 9999998765443211 1345899999999999888999999999999999999999998643211 11000
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
+.....+. .....+..+.+++.+|++.+|++||++.||++
T Consensus 222 ------~~~~~~~~------------------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 222 ------IKEGKFRR------------------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ------HhcCCCCC------------------CccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00000000 00133456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=321.84 Aligned_cols=192 Identities=25% Similarity=0.301 Sum_probs=159.4
Q ss_pred eeeecCceEEEEEEcCCCEEEEEEEEecCCC---cchHHHHHHHHHHHhc---CCCcceeEEeeeecccccCCccceeEe
Q 039533 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH---GASRSFIAECKALKSI---RHRNLVKVLTACLGADYRGNDFKASVY 707 (949)
Q Consensus 634 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~~~lv~ 707 (949)
||+|+||+||+|++..+++.||||++..... ........|..++.+. +||||+++++++...+ ..++||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~-----~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDS-----DLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCC-----eEEEEE
Confidence 6999999999999998899999999864321 2223455666777665 6999999998865544 789999
Q ss_pred eeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccc
Q 039533 708 EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGL 787 (949)
Q Consensus 708 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~ 787 (949)
||+++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~g~L~~~l~----------~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~ 142 (330)
T cd05586 76 DYMSGGELFWHLQ----------KEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGL 142 (330)
T ss_pred cCCCCChHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCc
Confidence 9999999999886 234588999999999999999999977 999999999999999999999999999
Q ss_pred ceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCcc
Q 039533 788 ARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDI 845 (949)
Q Consensus 788 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~ 845 (949)
++........ .....||..|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus 143 a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~ 199 (330)
T cd05586 143 SKANLTDNKT--TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA 199 (330)
T ss_pred CcCCCCCCCC--ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC
Confidence 8754322221 1234599999999998765 478999999999999999999999853
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=305.79 Aligned_cols=256 Identities=23% Similarity=0.375 Sum_probs=198.3
Q ss_pred CCCCCCeeeeecCceEEEEEEcC-CCEEEEEEEEecCC----------CcchHHHHHHHHHHHh-cCCCcceeEEeeeec
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDE-GRTTIAVKVFNLQH----------HGASRSFIAECKALKS-IRHRNLVKVLTACLG 694 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~ 694 (949)
+|++.+.||+|+||.||+|.+.. +++.+|+|.+.... .....++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999986 57899999986332 1123457788888875 699999999999765
Q ss_pred ccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeee
Q 039533 695 ADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL 774 (949)
Q Consensus 695 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll 774 (949)
.+ ..++||||+++++|.+++.... .....+++..++.++.|++.|+.|||+. .+++||||+|+||++
T Consensus 81 ~~-----~~~lv~e~~~~~~l~~~l~~~~------~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~ 147 (269)
T cd08528 81 ND-----RLYIVMDLIEGAPLGEHFNSLK------EKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIML 147 (269)
T ss_pred CC-----eEEEEEecCCCCcHHHHHHHHH------hccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEE
Confidence 44 7899999999999999885211 1234688999999999999999999963 279999999999999
Q ss_pred cCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhh
Q 039533 775 DDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLH 854 (949)
Q Consensus 775 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~ 854 (949)
+.++.+||+|||.+........ .....|+..|+|||+..+..++.++||||||+++|||++|+.||.......
T Consensus 148 ~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~---- 220 (269)
T cd08528 148 GEDDKVTITDFGLAKQKQPESK---LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS---- 220 (269)
T ss_pred CCCCcEEEecccceeecccccc---cccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH----
Confidence 9999999999999987654431 123458999999999998889999999999999999999999985321110
Q ss_pred hhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 039533 855 NFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQ 929 (949)
Q Consensus 855 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 929 (949)
. ...+.+....+... ...+..+.+++.+|++.||++||++.||..+++
T Consensus 221 -~--------~~~~~~~~~~~~~~------------------~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 221 -L--------ATKIVEAVYEPLPE------------------GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -H--------HHHHhhccCCcCCc------------------ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0 00011110000000 022356789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=302.37 Aligned_cols=249 Identities=24% Similarity=0.387 Sum_probs=197.7
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
+|+..+.||+|++|.||+|....+++.+|+|++.... ....+.+.+|++++++++||||+++++.+... ...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED-----KALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC-----CEEE
Confidence 5788899999999999999998889999999987543 23346788999999999999999999886543 3789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCC-CceEEe
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDY-MTARVG 783 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~-~~~kl~ 783 (949)
+||||+++++|.+++... ....+++..+..++.|++.|++|||++ +++||||||+||+++++ +.+||+
T Consensus 76 lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~ 144 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKR--------CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIG 144 (256)
T ss_pred EEEecCCCCCHHHHHHHh--------cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEc
Confidence 999999999999999631 134578999999999999999999977 99999999999999854 468999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCC
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
|||.+......... ....|+..|+|||.+.+..++.++||||||+++|+|++|+.||+...... .
T Consensus 145 d~~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--~---------- 209 (256)
T cd08220 145 DFGISKILSSKSKA---YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA--L---------- 209 (256)
T ss_pred cCCCceecCCCccc---cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH--H----------
Confidence 99999876543321 12458899999999998888999999999999999999999986321110 0
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
............ ....+..+.+++.+||+.+|++|||+.|+++
T Consensus 210 -~~~~~~~~~~~~-------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 210 -VLKIMSGTFAPI-------------------SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred -HHHHHhcCCCCC-------------------CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 001110000000 0123456789999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=313.04 Aligned_cols=206 Identities=21% Similarity=0.326 Sum_probs=162.7
Q ss_pred CCeeeeecCceEEEEEEcC--CCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEee
Q 039533 631 ANLVGVGSFGSVYKGIIDE--GRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYE 708 (949)
Q Consensus 631 ~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 708 (949)
..+||+|+||.||+|+... +++.||+|.++... ....+.+|++++++++||||+++++++... .....++|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSH---SDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEecc---CCCeEEEEEe
Confidence 4689999999999999753 45789999986432 235678999999999999999999987542 2346789999
Q ss_pred eccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeee----cCCCceEEee
Q 039533 709 FMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL----DDYMTARVGD 784 (949)
Q Consensus 709 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll----~~~~~~kl~D 784 (949)
|+++ +|.+++....... .......+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|
T Consensus 81 ~~~~-~l~~~~~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07867 81 YAEH-DLWHIIKFHRASK-ANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred eeCC-cHHHHHHhhhccc-cCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEee
Confidence 9864 7877775321111 111234588999999999999999999977 89999999999999 5667999999
Q ss_pred cccceecCCCCCc-cccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccc
Q 039533 785 FGLARILSPDHTQ-TSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIM 846 (949)
Q Consensus 785 fG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~ 846 (949)
||+++........ .......||..|+|||++.+. .++.++|||||||++|||+||++||...
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 9999876543321 111234589999999998764 5789999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=302.44 Aligned_cols=248 Identities=26% Similarity=0.326 Sum_probs=197.1
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-----cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-----GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
+|+..+.||+|++|.||+|....+++.|++|++..... ...+.+.+|++++++++|+||+++++++....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----- 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREED----- 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCC-----
Confidence 47888999999999999999988899999999875432 23467889999999999999999999875444
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++++|.+++.. ...+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+|
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~k 142 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKK----------YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVK 142 (258)
T ss_pred eEEEEEEecCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence 78999999999999999862 23578899999999999999999977 899999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCc-cCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCE-VSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
|+|||.+........ .....|+..|+|||...... ++.++|+|||||++|+|++|+.||........ ......
T Consensus 143 l~d~~~~~~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~-- 216 (258)
T cd06632 143 LADFGMAKQVVEFSF---AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA-VFKIGR-- 216 (258)
T ss_pred EccCccceecccccc---ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH-HHHHHh--
Confidence 999999887544331 12345889999999987766 89999999999999999999999964321100 000000
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
. ..... ........+.+++.+|++.+|++||++.|+++
T Consensus 217 -~--------~~~~~-------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 217 -S--------KELPP-------------------IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -c--------ccCCC-------------------cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0 00000 00122456788999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=307.70 Aligned_cols=254 Identities=22% Similarity=0.299 Sum_probs=200.6
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
++|+..+.||+|++|.||+|.+..+++.||+|++..... ...+++.+|++++++++||||+++++++.... ..+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~ 75 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNG-----DIS 75 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCC-----EEE
Confidence 367888999999999999999998899999999875532 34467889999999999999999999876543 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHH-DCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
+|+||+++++|.+++... ...++...+..++.|++.|++|||+ . +++||||||+||++++++.++|+
T Consensus 76 lv~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~ 143 (265)
T cd06605 76 ICMEYMDGGSLDKILKEV---------QGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLC 143 (265)
T ss_pred EEEEecCCCcHHHHHHHc---------cCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEe
Confidence 999999999999998621 2568889999999999999999997 5 99999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCC
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
|||.+......... ...++..|+|||+..+..++.++||||||+++|+|++|+.||...............
T Consensus 144 d~g~~~~~~~~~~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----- 214 (265)
T cd06605 144 DFGVSGQLVNSLAK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQ----- 214 (265)
T ss_pred ecccchhhHHHHhh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHH-----
Confidence 99998765432221 145889999999999889999999999999999999999999643221111111110
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
..........+ ....+..+.+++.+|+..+|++|||+.|++.
T Consensus 215 ---~~~~~~~~~~~------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 215 ---YIVNEPPPRLP------------------SGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred ---HHhcCCCCCCC------------------hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 00000000000 0014556889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=302.35 Aligned_cols=252 Identities=28% Similarity=0.479 Sum_probs=198.6
Q ss_pred CCCCCeeeeecCceEEEEEEcCCC----EEEEEEEEecCCCc-chHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 628 FSSANLVGVGSFGSVYKGIIDEGR----TTIAVKVFNLQHHG-ASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 628 y~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
+++.+.||.|+||.||+|++...+ ..||+|+++..... ..+.+..|++.+++++|+||+++++++...+ .
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEE-----P 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC-----e
Confidence 457789999999999999998655 88999999755433 4578999999999999999999999976543 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.+++|||+++++|.+++... ....+++.++..++.|++.|++|||+. +++||||||+||++++++.++|
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~--------~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l 144 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKN--------RPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKI 144 (258)
T ss_pred eEEEEeccCCCCHHHHHHhh--------hhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEE
Confidence 89999999999999999621 111289999999999999999999977 9999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
+|||.++........... ...++..|+|||...+..++.++||||+|+++|||++ |..||...... ......
T Consensus 145 ~dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~--~~~~~~---- 217 (258)
T smart00219 145 SDFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE--EVLEYL---- 217 (258)
T ss_pred cccCCceecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH----
Confidence 999999877654332211 2236789999999988889999999999999999998 78887532110 000000
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHEL 928 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 928 (949)
....... .....+.++.+++.+|+..+|++|||+.|+++.|
T Consensus 218 -------~~~~~~~-------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 218 -------KKGYRLP-------------------KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -------hcCCCCC-------------------CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0000000 0012355688999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=317.14 Aligned_cols=290 Identities=20% Similarity=0.214 Sum_probs=206.2
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecC--CCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ--HHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
..+|.+.+.||+|+||+||+|++..+++.||||.++.. .......+.+|+.++++++|+||+++++++..........
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45799999999999999999999989999999998643 2233456788999999999999999999876544333346
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+. ++|.+++. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||
T Consensus 84 ~~lv~e~~~-~~L~~~~~----------~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL 149 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR----------SSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKI 149 (337)
T ss_pred EEEEEeCCC-CCHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEE
Confidence 899999996 68988885 234589999999999999999999977 8999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccC-ch-hhhhccc
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD-IN-LHNFGRK 859 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~-~~-~~~~~~~ 859 (949)
+|||+++........ .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....... .. .......
T Consensus 150 ~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 227 (337)
T cd07858 150 CDFGLARTTSEKGDF--MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGS 227 (337)
T ss_pred CcCccccccCCCccc--ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC
Confidence 999999876443211 123457889999998765 468899999999999999999999996431100 00 0000000
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH--HHHhHHh
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE--LQSIKNI 934 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~--L~~i~~~ 934 (949)
..++....+.+... .....................++..+.+++.+|++.+|++|||++|+++. +..+...
T Consensus 228 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 228 PSEEDLGFIRNEKA----RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300 (337)
T ss_pred CChHHhhhcCchhh----hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence 00000000000000 00000000000000001112346678999999999999999999999877 6655443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=311.48 Aligned_cols=257 Identities=22% Similarity=0.235 Sum_probs=197.7
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC---cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH---GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+++++.++||||+++++.+... +.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETK-----RH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC-----CE
Confidence 468899999999999999999998899999999875432 2345778999999999999999999886543 37
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++++|.+++. ....+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||
T Consensus 76 ~~lv~e~~~g~~L~~~l~----------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l 142 (305)
T cd05609 76 LCMVMEYVEGGDCATLLK----------NIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKL 142 (305)
T ss_pred EEEEEecCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEE
Confidence 899999999999999996 224588899999999999999999977 8999999999999999999999
Q ss_pred eecccceecCCCCC-------------ccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCcccccc
Q 039533 783 GDFGLARILSPDHT-------------QTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEG 849 (949)
Q Consensus 783 ~DfG~a~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~ 849 (949)
+|||.++....... ........++..|+|||.+.+..++.++|||||||++||+++|+.||......
T Consensus 143 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~ 222 (305)
T cd05609 143 TDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE 222 (305)
T ss_pred eeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999874211110 00011234788999999998888999999999999999999999998532111
Q ss_pred CchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 039533 850 DINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQ 929 (949)
Q Consensus 850 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 929 (949)
. ... ....... ..+. .....+..+.+++.+|++.+|++||++.++.+.++
T Consensus 223 ~-----~~~--------~~~~~~~-~~~~----------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 223 E-----LFG--------QVISDDI-EWPE----------------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred H-----HHH--------HHHhccc-CCCC----------------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 0 000 0000000 0000 00023456789999999999999999776666665
Q ss_pred H
Q 039533 930 S 930 (949)
Q Consensus 930 ~ 930 (949)
.
T Consensus 273 ~ 273 (305)
T cd05609 273 H 273 (305)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=311.97 Aligned_cols=248 Identities=23% Similarity=0.282 Sum_probs=196.3
Q ss_pred CCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEee
Q 039533 629 SSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYE 708 (949)
Q Consensus 629 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 708 (949)
.....||+|+||.||+|.+..+++.||+|++........+.+.+|+.+++.++||||+++++++...+ ..++|||
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-----~~~iv~e 98 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGE-----ELWVLME 98 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCC-----eEEEEEe
Confidence 33457999999999999998889999999997655555677889999999999999999999876544 7899999
Q ss_pred eccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecccc
Q 039533 709 FMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLA 788 (949)
Q Consensus 709 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a 788 (949)
|+++++|.+++. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus 99 ~~~~~~L~~~~~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~ 164 (297)
T cd06659 99 FLQGGALTDIVS-----------QTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFC 164 (297)
T ss_pred cCCCCCHHHHHh-----------hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhH
Confidence 999999999875 23478999999999999999999977 8999999999999999999999999998
Q ss_pred eecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhhh
Q 039533 789 RILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDI 868 (949)
Q Consensus 789 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 868 (949)
.......... ....|+..|+|||++.+..++.++|||||||++|||++|+.||...... ............
T Consensus 165 ~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~----- 235 (297)
T cd06659 165 AQISKDVPKR--KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMKRLRDSPPP----- 235 (297)
T ss_pred hhcccccccc--cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhccCCC-----
Confidence 7654332211 2345899999999999888999999999999999999999998532111 000000000000
Q ss_pred cccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 869 VDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 869 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
... .....+..+.+++.+|++.+|++||+++|+++.
T Consensus 236 ---~~~--------------------~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 236 ---KLK--------------------NAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ---Ccc--------------------ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000 001223457889999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=302.97 Aligned_cols=253 Identities=26% Similarity=0.345 Sum_probs=204.1
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
++|++.+.||+|++|.||+|++..+++.||+|++..... ...+.+.+|+..+.+++|+|++++++++.... ..+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~ 75 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEG-----EIS 75 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCC-----eEE
Confidence 468889999999999999999998899999999876543 34578999999999999999999999976544 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHH-DCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
+||||+++++|.+++.. ...+++..+..++.|+++|++|||+ . +++||||+|+||+++.++.++|+
T Consensus 76 lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~ 142 (264)
T cd06623 76 IVLEYMDGGSLADLLKK----------VGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIA 142 (264)
T ss_pred EEEEecCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEc
Confidence 99999999999999962 2568999999999999999999997 6 99999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCC
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
|||.+.......... ....++..|+|||.+.+..++.++||||||+++|||++|+.||...... .....
T Consensus 143 df~~~~~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~------- 211 (264)
T cd06623 143 DFGISKVLENTLDQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--SFFEL------- 211 (264)
T ss_pred cCccceecccCCCcc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--CHHHH-------
Confidence 999998765443322 1234789999999999888999999999999999999999999644320 00000
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHH-HHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIE-CLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
...+........+ .. .+..+.+++.+|++.+|++||++.|+++.
T Consensus 212 -~~~~~~~~~~~~~-------------------~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 212 -MQAICDGPPPSLP-------------------AEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -HHHHhcCCCCCCC-------------------cccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0011110000000 11 45678999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=315.51 Aligned_cols=251 Identities=23% Similarity=0.282 Sum_probs=201.4
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeE
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASV 706 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 706 (949)
-|.++..||.|+||.||+|..+.++-..|.|++.........+|.-|+++|...+||+||++++.|+... ..+|+
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en-----kLwil 107 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN-----KLWIL 107 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC-----ceEEE
Confidence 3667788999999999999999888888999998887778889999999999999999999998865333 78999
Q ss_pred eeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecc
Q 039533 707 YEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFG 786 (949)
Q Consensus 707 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG 786 (949)
.|||.||..+..+- +-+..+++.++..+++|++.||.|||++ .|||||||..|||++-+|.++|+|||
T Consensus 108 iEFC~GGAVDaiml---------EL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFG 175 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIML---------ELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFG 175 (1187)
T ss_pred EeecCCchHhHHHH---------HhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeeccc
Confidence 99999999988875 2356799999999999999999999988 89999999999999999999999999
Q ss_pred cceecCCCCCccccccccCccCccCccccC-----CCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 787 LARILSPDHTQTSSFSVKGSLGYIAPEYGV-----GCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 787 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
.+...... ......+.||+.|||||+.. ..+|++++||||||+++.||..+.+|....... .
T Consensus 176 VSAKn~~t--~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM-----R------ 242 (1187)
T KOG0579|consen 176 VSAKNKST--RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM-----R------ 242 (1187)
T ss_pred ccccchhH--HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH-----H------
Confidence 88643222 22233677999999999854 467999999999999999999999996432111 0
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
++-.....+| ...-.+......+.+++.+|+..||..||+++++++
T Consensus 243 ------VllKiaKSeP-------------PTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 243 ------VLLKIAKSEP-------------PTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ------HHHHHhhcCC-------------CcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 0000000111 011112244556889999999999999999999864
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=306.48 Aligned_cols=274 Identities=22% Similarity=0.270 Sum_probs=199.7
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
+|++.+.||+|++|.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.... ..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGS-----GFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCC-----eeE
Confidence 5888999999999999999998889999999997544 233467899999999999999999999976543 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+ +++|.+++.. ....+++.+++.++.|+++||+|||+. +++|+||||+||+++.++.++|+|
T Consensus 76 ~v~e~~-~~~L~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~d 142 (286)
T cd07832 76 LVMEYM-PSDLSEVLRD---------EERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIAD 142 (286)
T ss_pred EEeccc-CCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEee
Confidence 999999 9999999862 224589999999999999999999977 899999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhc---ccc
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFG---RKA 860 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~---~~~ 860 (949)
||.+........ .......|+..|+|||++.+. .++.++||||+|+++|||++|++||....... .+.... ...
T Consensus 143 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~ 220 (286)
T cd07832 143 FGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE-QLAIVFRTLGTP 220 (286)
T ss_pred eeecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH-HHHHHHHHcCCC
Confidence 999987654332 111134589999999998654 46899999999999999999988875332111 000000 000
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhh-hhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARI-NSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.+....+..+ ..+....... ......+ ....+....+.+++.+|++.+|++|||++++++
T Consensus 221 ~~~~~~~~~~---~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 221 NEETWPGLTS---LPDYNKITFP---ESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred ChHHHhhccC---cchhhcccCC---CCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000000000 0000000000 0000000 001133477899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=308.22 Aligned_cols=274 Identities=21% Similarity=0.233 Sum_probs=197.6
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc-----chHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG-----ASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
+|++.+.||+|++|.||+|.+..+++.||||+++..... ....+..|++++++++|+||+++++++.+. +
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK-----S 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecC-----C
Confidence 478889999999999999999888999999999754322 235677899999999999999999997653 3
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+ +++|.+++.. ....+++..+..++.|+++||+|||++ +|+||||||+||+++.++.++
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~---------~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~ 142 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKD---------KSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLK 142 (298)
T ss_pred EEEEEEccc-CCCHHHHHhc---------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEE
Confidence 789999999 8999999962 112589999999999999999999977 899999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
|+|||.++......... ....++..|+|||.+.+ ..++.++|||||||++|||++|.+||......+ .+..... .
T Consensus 143 l~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~-~ 218 (298)
T cd07841 143 LADFGLARSFGSPNRKM--THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFE-A 218 (298)
T ss_pred EccceeeeeccCCCccc--cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHH-H
Confidence 99999998765432211 12346788999998765 457899999999999999999988775322111 0100000 0
Q ss_pred CCCc-hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 861 LPDD-VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 861 ~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.... .....+........ .. ..................+.+++.+|++.+|++|||++||++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~--~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 219 LGTPTEENWPGVTSLPDYV--EF--KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cCCCchhhhhhcccccccc--cc--cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0000 00000000000000 00 000000000011234567899999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=301.59 Aligned_cols=253 Identities=25% Similarity=0.357 Sum_probs=199.4
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc--chHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG--ASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
+|++.+.||+|+||.||+|....+++.||+|+++..... ..+.+..|+.++++++|+||+++++++...+ ..+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHRE-----KVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCC-----EEE
Confidence 588899999999999999999888999999999865543 5578999999999999999999999865444 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+|+||+++++|.+++. ....+++..+..++.|+++|++|||+. +++||||+|+||++++++.+||+|
T Consensus 76 lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d 142 (264)
T cd06626 76 IFMEYCSGGTLEELLE----------HGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGD 142 (264)
T ss_pred EEEecCCCCcHHHHHh----------hcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcc
Confidence 9999999999999986 223478889999999999999999977 899999999999999999999999
Q ss_pred cccceecCCCCCccc--cccccCccCccCccccCCCc---cCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 785 FGLARILSPDHTQTS--SFSVKGSLGYIAPEYGVGCE---VSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 785 fG~a~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
||.+........... .....++..|+|||++.+.. ++.++||||||+++||+++|+.||....... ........
T Consensus 143 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-~~~~~~~~ 221 (264)
T cd06626 143 FGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-QIMFHVGA 221 (264)
T ss_pred cccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-HHHHHHhc
Confidence 999987654433211 11245788999999988766 8899999999999999999999996332110 00000000
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
. ..+. .+........+.+++.+|++.+|++||++.|++.
T Consensus 222 ---~-----~~~~--------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 222 ---G-----HKPP--------------------IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ---C-----CCCC--------------------CCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 0000 0001123456778999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=302.31 Aligned_cols=259 Identities=22% Similarity=0.303 Sum_probs=202.3
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
++|++.+.||.|+||+||+|....++..+|+|++.... ....+.+.+|++.++.++|+||+++++.+...+ ..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGD-----ELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC-----EEE
Confidence 47899999999999999999998888999999986433 224578899999999999999999998875544 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++++|.+++.... ....+++..+..++.|++.|++|||+. +++||||||+||++++++.++|+|
T Consensus 76 iv~e~~~~~~l~~~~~~~~-------~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~d 145 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSY-------PRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIAD 145 (267)
T ss_pred EEEeccCCCcHHHHHHHhc-------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcc
Confidence 9999999999999996211 124588999999999999999999977 999999999999999999999999
Q ss_pred cccceecCCCCCcc--ccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 785 FGLARILSPDHTQT--SSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 785 fG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
||.+..+....... ......|+..|+|||++... .++.++|+|||||++|||++|+.||....... .+.......
T Consensus 146 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~- 223 (267)
T cd06610 146 FGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQND- 223 (267)
T ss_pred cchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhcCC-
Confidence 99998765543321 12234588999999998876 78999999999999999999999996432211 011100000
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.+...... .....+..+.+++.+|++.||++||++.|+++
T Consensus 224 --------~~~~~~~~-----------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 224 --------PPSLETGA-----------------DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred --------CCCcCCcc-----------------ccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000000 01134566789999999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=308.13 Aligned_cols=278 Identities=21% Similarity=0.252 Sum_probs=200.6
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
++|++.+.||+|++|.||+|.+..+++.||+|+++... ....+.+.+|++++++++|+||+++++++...+ ..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG-----RL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECC-----EE
Confidence 36889999999999999999999889999999987432 233467899999999999999999999976543 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++||||++++.+..+.. ....+++.++..++.|++.|++|||+. +++||||+|+||++++++.+||+
T Consensus 76 ~iv~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~ 142 (288)
T cd07833 76 YLVFEYVERTLLELLEA----------SPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLC 142 (288)
T ss_pred EEEEecCCCCHHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEE
Confidence 99999999877776654 234478999999999999999999977 89999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCchhh-hhccccC
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLH-NFGRKAL 861 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~-~~~~~~~ 861 (949)
|||.+.......... .....++..|+|||++.+. .++.++||||||+++|+|++|+.||......+.... .......
T Consensus 143 d~g~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 221 (288)
T cd07833 143 DFGFARALRARPASP-LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPL 221 (288)
T ss_pred eeecccccCCCcccc-ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999998765443211 1234578899999999887 789999999999999999999999864321110000 0000000
Q ss_pred CCchhhhcc--cCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 862 PDDVMDIVD--SSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 862 ~~~~~~~~d--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
+........ ...... +............++ ....+..+.+++.+|+..+|++||+++++++
T Consensus 222 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 222 PPSHQELFSSNPRFAGV--AFPEPSQPESLERRY--PGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CHHHhhhcccCcccccc--ccCCCCCcHHHHHhc--CCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000000000 000000 000000000000000 0123677899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=306.62 Aligned_cols=275 Identities=25% Similarity=0.310 Sum_probs=195.8
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
+|+..+.||+|++|.||+|++..+++.||||+++.... .....+.+|++++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-----NKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC-----CcEE
Confidence 48889999999999999999988899999999864432 2235788999999999999999999986543 3789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+. ++|.+++... ....+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|
T Consensus 76 ~v~e~~~-~~l~~~~~~~--------~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~d 143 (284)
T cd07860 76 LVFEFLH-QDLKKFMDAS--------PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLAD 143 (284)
T ss_pred EEeeccc-cCHHHHHHhC--------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEee
Confidence 9999996 6898888621 234588999999999999999999977 899999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCc-cCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc-CC
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCE-VSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA-LP 862 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~-~~ 862 (949)
||.++........ .....++..|+|||+..+.. ++.++|||||||++|||+||+.||........ ........ .+
T Consensus 144 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~-~~~~~~~~~~~ 220 (284)
T cd07860 144 FGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-LFRIFRTLGTP 220 (284)
T ss_pred ccchhhcccCccc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCC
Confidence 9998765433221 11234688999999887654 58899999999999999999999964321111 11000000 00
Q ss_pred Cc-hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 863 DD-VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 863 ~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.. ....+... +.... ...+................+.+++.+|++.||++|||++|+++
T Consensus 221 ~~~~~~~~~~~--~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 221 DEVVWPGVTSL--PDYKP---SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred ChhhhhhhhHH--HHHHh---hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00 00000000 00000 00000000000001123456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=304.93 Aligned_cols=249 Identities=22% Similarity=0.288 Sum_probs=197.6
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeE
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASV 706 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 706 (949)
.|...+.||+|++|.||+|.+..+++.||+|+++.......+.+.+|+.++++++||||+++++++...+ ..++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~-----~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD-----ELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCC-----eEEEE
Confidence 3555689999999999999998889999999987555445567889999999999999999999876544 78999
Q ss_pred eeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecc
Q 039533 707 YEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFG 786 (949)
Q Consensus 707 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG 786 (949)
+||+++++|.+++.. ..+++.++..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||
T Consensus 95 ~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g 160 (285)
T cd06648 95 MEFLEGGALTDIVTH-----------TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG 160 (285)
T ss_pred EeccCCCCHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccc
Confidence 999999999999861 3478899999999999999999977 89999999999999999999999999
Q ss_pred cceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchh
Q 039533 787 LARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVM 866 (949)
Q Consensus 787 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 866 (949)
.+.......... ....|+..|+|||...+..++.++|||||||++|||++|+.||...... ..........+
T Consensus 161 ~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~--~~~~~~~~~~~---- 232 (285)
T cd06648 161 FCAQVSKEVPRR--KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL--QAMKRIRDNLP---- 232 (285)
T ss_pred cchhhccCCccc--ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH--HHHHHHHhcCC----
Confidence 887554332211 1345889999999998888999999999999999999999998532110 00000000000
Q ss_pred hhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 867 DIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 867 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
+... .....+..+.+++.+|++.+|++||++.|+++
T Consensus 233 ----~~~~--------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 233 ----PKLK--------------------NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ----CCCc--------------------ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 0000 00123456899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=314.13 Aligned_cols=284 Identities=19% Similarity=0.223 Sum_probs=202.2
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
.++|++.+.||+|++|.||+|....+++.||+|++..... ...+.+.+|+.++++++||||+++++++.... .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence 3689999999999999999999998899999999875422 33467788999999999999999998865443 23446
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+. ++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||
T Consensus 83 ~~lv~e~~~-~~l~~~~~----------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl 148 (334)
T cd07855 83 VYVVMDLME-SDLHHIIH----------SDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRI 148 (334)
T ss_pred EEEEEehhh-hhHHHHhc----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEe
Confidence 899999996 68999886 234489999999999999999999977 8999999999999999999999
Q ss_pred eecccceecCCCCCcc--ccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 783 GDFGLARILSPDHTQT--SSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
+|||.++......... ......|+..|+|||++.+ ..++.++|||||||++|||++|+.||....... .......
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~--~~~~~~~ 226 (334)
T cd07855 149 GDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH--QLKLILS 226 (334)
T ss_pred cccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH--HHHHHHH
Confidence 9999998764332211 1113458899999998765 458899999999999999999999996432110 0000000
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhh-hHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARIN-SIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.......+..+.............. .......+. .....+..+.+++.+|++.+|++||+++|++.
T Consensus 227 ~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 227 VLGSPSEEVLNRIGSDRVRKYIQNL-PRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred HhCCChhHhhhhhchhhHHHHHhhc-ccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0000000111000000000000000 000000000 11234677899999999999999999999887
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=302.28 Aligned_cols=254 Identities=22% Similarity=0.329 Sum_probs=198.1
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC------cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH------GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
+|+..+.||+|++|.||+|....+++.||+|+++.... ...+.+.+|++++++++|+||+++++++.+.+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 76 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS---- 76 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC----
Confidence 47888999999999999999988899999999874331 12467889999999999999999999976544
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC-c
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM-T 779 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~-~ 779 (949)
..++||||+++++|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++ .
T Consensus 77 -~~~~v~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~ 142 (268)
T cd06630 77 -HFNLFVEWMAGGSVSHLLSK----------YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQR 142 (268)
T ss_pred -eEEEEEeccCCCcHHHHHHH----------hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCE
Confidence 78999999999999999862 24578899999999999999999977 999999999999998775 5
Q ss_pred eEEeecccceecCCCCCcc--ccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhc
Q 039533 780 ARVGDFGLARILSPDHTQT--SSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFG 857 (949)
Q Consensus 780 ~kl~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~ 857 (949)
+||+|||.+.......... ......|+..|+|||++.+..++.++||||+|+++|+|++|+.||........ . ..
T Consensus 143 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~-~~- 219 (268)
T cd06630 143 LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-L-AL- 219 (268)
T ss_pred EEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-H-HH-
Confidence 9999999998765432211 11134578999999999888899999999999999999999999853211100 0 00
Q ss_pred cccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 858 RKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 858 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
..+.......+. ........+.+++.+|+..+|++||++.|+++
T Consensus 220 -------~~~~~~~~~~~~------------------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 220 -------IFKIASATTAPS------------------IPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -------HHHHhccCCCCC------------------CchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 000000000000 01134566888999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=306.81 Aligned_cols=244 Identities=22% Similarity=0.232 Sum_probs=196.2
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
++|++.+.||+|++|.||+|.+..+++.||+|+++... ....+.+.+|++++++++||||+++++++.... .
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS-----N 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC-----e
Confidence 47889999999999999999999889999999986432 233467889999999999999999999875444 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++++|.+++. ....++...+..++.|++.||+|||+. +++||||+|+||+++.++.+||
T Consensus 76 ~~~v~e~~~~~~L~~~~~----------~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl 142 (290)
T cd05580 76 LYLVMEYVPGGELFSHLR----------KSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKI 142 (290)
T ss_pred EEEEEecCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEE
Confidence 899999999999999986 234688999999999999999999977 9999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
+|||+++...... ....|++.|+|||.+.+...+.++||||||+++|+|++|+.||...... ..
T Consensus 143 ~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~--------- 206 (290)
T cd05580 143 TDFGFAKRVKGRT-----YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI--QI--------- 206 (290)
T ss_pred eeCCCccccCCCC-----CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--HH---------
Confidence 9999998765441 1345889999999998888899999999999999999999998633210 00
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRT-----NMTNVV 925 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~ 925 (949)
...+..... .. .......+.+++.+|+..||++|| +++|++
T Consensus 207 --~~~~~~~~~-~~-------------------~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 207 --YEKILEGKV-RF-------------------PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred --HHHHhcCCc-cC-------------------CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 000000000 00 001245678899999999999999 555554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=301.24 Aligned_cols=248 Identities=24% Similarity=0.338 Sum_probs=197.8
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
-|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++...+ ..++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~l 79 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT-----KLWI 79 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC-----eEEE
Confidence 3677899999999999999998889999999986433 233467889999999999999999999976544 7899
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
||||+++++|.+++. ...+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+||
T Consensus 80 v~e~~~~~~l~~~i~-----------~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~df 145 (277)
T cd06641 80 IMEYLGGGSALDLLE-----------PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADF 145 (277)
T ss_pred EEEeCCCCcHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeec
Confidence 999999999999985 23478999999999999999999977 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCch
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDV 865 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 865 (949)
|.+.......... ....++..|+|||...+..++.++|||||||++|+|++|..||....... ..
T Consensus 146 g~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~----------- 210 (277)
T cd06641 146 GVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK--VL----------- 210 (277)
T ss_pred ccceecccchhhh--ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH--HH-----------
Confidence 9987664332211 12457889999999988888999999999999999999999986322110 00
Q ss_pred hhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 866 MDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 866 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
..+.....+.. ....+..+.+++.+|++.+|++||++.|+++.
T Consensus 211 -~~~~~~~~~~~------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 211 -FLIPKNNPPTL------------------EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -HHHhcCCCCCC------------------CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000000000 01234567889999999999999999999883
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=313.97 Aligned_cols=286 Identities=24% Similarity=0.257 Sum_probs=204.7
Q ss_pred CCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeeccc-ccCCcccee
Q 039533 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGAD-YRGNDFKAS 705 (949)
Q Consensus 628 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~~l 705 (949)
|...+.||+|+||.||+|+++.+|+.||||.++... ....++..+|++++++++|+|||++++.-.+.. +-..+...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 455689999999999999999999999999997543 344577889999999999999999987733221 111456789
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec--CCC--ceE
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD--DYM--TAR 781 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~--~~~--~~k 781 (949)
|||||.+|||+..+... +....+++.+.+.+..+++.||.|||++ +||||||||.||++- ++| ..|
T Consensus 95 vmEyC~gGsL~~~L~~P-------EN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyK 164 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSP-------ENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYK 164 (732)
T ss_pred EEeecCCCcHHHHhcCc-------ccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEe
Confidence 99999999999999732 3456799999999999999999999977 999999999999983 333 579
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
|+|||.|+..+++... ...+||..|.+||+... ..|+..+|.|||||++|+..||..||...... .+..+.++..
T Consensus 165 LtDfG~Arel~d~s~~---~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p-k~~~~~~~~~ 240 (732)
T KOG4250|consen 165 LTDFGAARELDDNSLF---TSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP-KNNKEIMWHI 240 (732)
T ss_pred eecccccccCCCCCee---eeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc-cccchhhhhh
Confidence 9999999998876633 36789999999999995 78899999999999999999999999643222 1111111111
Q ss_pred C---CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC--CHHHHHHHHHHhHH
Q 039533 861 L---PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRT--NMTNVVHELQSIKN 933 (949)
Q Consensus 861 ~---~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP--s~~ev~~~L~~i~~ 933 (949)
. +..+.-..++...+... .-....+ ...........+...+..++..+|++|- ...+....+..|..
T Consensus 241 ~tkkp~~v~i~~~~~eNgpv~-~s~~lP~-----p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 241 ITKKPSGVAIGAQEEENGPVE-WSSTLPQ-----PNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred hccCCCceeEeeecccCCcee-eeccCCC-----cccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 1 11111111111111000 0000000 0011123344566667778888899988 77777777766644
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=301.84 Aligned_cols=248 Identities=22% Similarity=0.312 Sum_probs=196.5
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC-CcchHHHHHHHHHHHhcC---CCcceeEEeeeecccccCCcc
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-HGASRSFIAECKALKSIR---HRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~ 702 (949)
.|++.+.||+|+||.||+|.+..+++.||+|+++... .....++.+|+.++++++ |||++++++++.... .
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~-----~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGP-----R 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCC-----E
Confidence 4778899999999999999998889999999987543 233467889999999996 999999999876443 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++++|.+++.. ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|
T Consensus 77 ~~lv~e~~~~~~L~~~~~~-----------~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l 142 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKA-----------GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKL 142 (277)
T ss_pred EEEEEecCCCCcHHHHHHc-----------cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEE
Confidence 8999999999999999851 2588999999999999999999977 9999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
+|||.+.......... ....|+..|+|||+..+. .++.++|||||||++|+|++|+.||........ ....
T Consensus 143 ~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~---- 214 (277)
T cd06917 143 CDFGVAALLNQNSSKR--STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA--MMLI---- 214 (277)
T ss_pred ccCCceeecCCCcccc--ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh--hhcc----
Confidence 9999998775543221 234588999999987654 468999999999999999999999964321100 0000
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.. ...+.+.. ...+..+.+++.+|++.||++||++.|+++
T Consensus 215 ~~----~~~~~~~~---------------------~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 215 PK----SKPPRLED---------------------NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred cc----CCCCCCCc---------------------ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 00 00000000 013456789999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=304.99 Aligned_cols=248 Identities=26% Similarity=0.334 Sum_probs=194.2
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC---cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH---GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
..+|...+.||+|+||.||+|+...+++.||+|++..... ...+.+.+|+++++.++||||+++++++...+
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~----- 88 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH----- 88 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC-----
Confidence 3568889999999999999999988899999999864332 22356889999999999999999999986544
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||++ |++.+++.. ....+++..+..++.|++.||.|||+. +|+||||+|+||++++++.++
T Consensus 89 ~~~lv~e~~~-g~l~~~~~~---------~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~k 155 (307)
T cd06607 89 TAWLVMEYCL-GSASDILEV---------HKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVK 155 (307)
T ss_pred eEEEEHHhhC-CCHHHHHHH---------cccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEE
Confidence 7899999997 577776641 123588999999999999999999977 899999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccC---CCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcc
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGV---GCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGR 858 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~ 858 (949)
|+|||.+....... ...++..|+|||++. ...++.++||||||+++|||++|+.||.........
T Consensus 156 L~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~------ 223 (307)
T cd06607 156 LADFGSASLVSPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------ 223 (307)
T ss_pred EeecCcceecCCCC------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH------
Confidence 99999997654332 234788999999874 356889999999999999999999998532111000
Q ss_pred ccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 859 KALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 859 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
..+..... +.. .....+..+.+++.+||+.+|++||++.+|+..
T Consensus 224 -------~~~~~~~~-~~~-----------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 224 -------YHIAQNDS-PTL-----------------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -------HHHhcCCC-CCC-----------------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000 000 001245568999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=298.23 Aligned_cols=248 Identities=23% Similarity=0.274 Sum_probs=198.6
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
+.|+.-++||+||||.||-++.+.+|+.+|.|.+.+.. ........+|-.++++++.+.||.+-.+| +..+.
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf-----eTkd~ 259 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF-----ETKDA 259 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee-----cCCCc
Confidence 56888899999999999999999999999999885332 23345677899999999999999886664 45559
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.|+|+..|.||+|.-++... ..+.+++..++-++.+|+.||++||.. +||.||+||+|||+|+.|+++|
T Consensus 260 LClVLtlMNGGDLkfHiyn~--------g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRI 328 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNH--------GNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRI 328 (591)
T ss_pred eEEEEEeecCCceeEEeecc--------CCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEe
Confidence 99999999999999998742 235699999999999999999999977 9999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
+|.|+|..+....... ..+||.+|||||++....|+...|.||+||++|||+.|+.||....+..
T Consensus 329 SDLGLAvei~~g~~~~---~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv------------ 393 (591)
T KOG0986|consen 329 SDLGLAVEIPEGKPIR---GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV------------ 393 (591)
T ss_pred eccceEEecCCCCccc---cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh------------
Confidence 9999999987766544 3479999999999999999999999999999999999999995321110
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNM 921 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 921 (949)
-.+-+|++...++.+ -.....++..++.+..++.||++|-..
T Consensus 394 --k~eEvdrr~~~~~~e---------------y~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 394 --KREEVDRRTLEDPEE---------------YSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred --hHHHHHHHHhcchhh---------------cccccCHHHHHHHHHHHccCHHHhccC
Confidence 111223332222210 012334556777888889999988643
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=305.96 Aligned_cols=203 Identities=24% Similarity=0.340 Sum_probs=170.2
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
.++|++.+.||+|+||.||+|.+..+++.||+|.++.... .....+.+|+.++++++||||+++++++...+ ...
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~ 80 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDK 80 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCc
Confidence 3578999999999999999999998899999999974432 22345778999999999999999999876542 247
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||++ ++|.+++.. ....+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||
T Consensus 81 ~~lv~e~~~-~~L~~~~~~---------~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l 147 (293)
T cd07843 81 IYMVMEYVE-HDLKSLMET---------MKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKI 147 (293)
T ss_pred EEEEehhcC-cCHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEE
Confidence 899999997 499988862 123589999999999999999999977 8999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCc-cCCccchHHHHHHHHHHHhCCCCCcc
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCE-VSTNGDVYSYGILLLELVIGKKPIDI 845 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlGvvl~elltg~~Pf~~ 845 (949)
+|||.+.......... ....++..|+|||.+.+.. ++.++||||+|+++|||++|+.||..
T Consensus 148 ~d~g~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~ 209 (293)
T cd07843 148 CDFGLAREYGSPLKPY--TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPG 209 (293)
T ss_pred eecCceeeccCCcccc--ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999998765442211 1234788999999887654 68999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=282.62 Aligned_cols=259 Identities=20% Similarity=0.219 Sum_probs=203.6
Q ss_pred HHhcCCCCC-CeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCC
Q 039533 623 NATSGFSSA-NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 623 ~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 700 (949)
..+++|++. ++||-|-.|.|-.+..+.+++.+|+|++.. ....++|++.--.. .|||||.+++++.. .+.+.
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeN-s~~~r 131 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYEN-SYQGR 131 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhh-hccCc
Confidence 346677764 689999999999999999999999999842 24566888876555 69999999999754 35677
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec---CC
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD---DY 777 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~---~~ 777 (949)
....+|||.|+||.|...++.. ....+++.++-.|+.||+.|+.|||+. +|.||||||+|+|.. .+
T Consensus 132 kcLLiVmE~meGGeLfsriq~~--------g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~n 200 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDR--------GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPN 200 (400)
T ss_pred eeeEeeeecccchHHHHHHHHc--------ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCC
Confidence 7889999999999999999732 345699999999999999999999976 999999999999996 45
Q ss_pred CceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhc
Q 039533 778 MTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFG 857 (949)
Q Consensus 778 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~ 857 (949)
-.+||+|||+|+.-....... ...-|+.|.|||++...+|+..+|+||+||++|-|++|.+||-....
T Consensus 201 a~lKLtDfGFAK~t~~~~~L~---TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg--------- 268 (400)
T KOG0604|consen 201 APLKLTDFGFAKETQEPGDLM---TPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--------- 268 (400)
T ss_pred cceEecccccccccCCCcccc---CCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC---------
Confidence 579999999999755332211 23479999999999999999999999999999999999999953311
Q ss_pred cccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 858 RKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 858 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
..+++++...+...- -.-+ .+++.+.++...++++.++..+|.+|-|+.|++.
T Consensus 269 -~aispgMk~rI~~gq------------y~FP---~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 269 -LAISPGMKRRIRTGQ------------YEFP---EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred -ccCChhHHhHhhccC------------ccCC---ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 122233222221111 1111 1345577888899999999999999999999875
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=300.43 Aligned_cols=250 Identities=21% Similarity=0.293 Sum_probs=197.5
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
+|++.+.||+|+||.||+|....++..||+|.+.... ....+.+.+|++++++++|+||+++++.+...+ ..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~-----~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENG-----RLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCC-----eEE
Confidence 5788899999999999999999889999999987532 223457889999999999999999999875443 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC-ceEEe
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM-TARVG 783 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kl~ 783 (949)
+|+||+++++|.+++... ....+++..+..++.|+++|++|||+. +++||||||+||++++++ .+||+
T Consensus 76 lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~ 144 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQ--------RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLG 144 (257)
T ss_pred EEEecCCCCcHHHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEec
Confidence 999999999999998631 223578999999999999999999977 899999999999999875 56999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCC
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
|||.+.......... ....|+..|+|||+..+..++.++||||||+++|||++|+.||...... ....
T Consensus 145 d~~~~~~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~----- 212 (257)
T cd08225 145 DFGIARQLNDSMELA--YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH-----QLVL----- 212 (257)
T ss_pred ccccchhccCCcccc--cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-----HHHH-----
Confidence 999998765433221 1235889999999998888999999999999999999999998532111 1111
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
........... ...+..+.+++.+|+..+|++|||+.|+++
T Consensus 213 ---~~~~~~~~~~~-------------------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 213 ---KICQGYFAPIS-------------------PNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ---HHhcccCCCCC-------------------CCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 11111110000 022346789999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=317.41 Aligned_cols=256 Identities=27% Similarity=0.426 Sum_probs=209.5
Q ss_pred CCCCeeeeecCceEEEEEEcCCC----EEEEEEEEecC-CCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 629 SSANLVGVGSFGSVYKGIIDEGR----TTIAVKVFNLQ-HHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 629 ~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
...++||.|+||+||+|.+-..+ .+||+|++... ......++..|+.+|.+++|||+++++|+|.... .
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~------~ 772 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST------L 772 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch------H
Confidence 44689999999999999995444 36899998643 3445678999999999999999999999997554 7
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
.+|++||+.|.|.+|++. .+..+.....+.|..|||+|+.|||.+ ++|||||-.+||||....++||.
T Consensus 773 qlvtq~mP~G~LlDyvr~---------hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkit 840 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVRE---------HRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKIT 840 (1177)
T ss_pred HHHHHhcccchHHHHHHH---------hhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEE
Confidence 899999999999999984 345578889999999999999999977 99999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCC
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
|||+|+...++..........-.+.|||=|.+....++.++|||||||++||++| |..|++.....+
T Consensus 841 dfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e------------ 908 (1177)
T KOG1025|consen 841 DFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE------------ 908 (1177)
T ss_pred ecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH------------
Confidence 9999999887765433323334577999999999999999999999999999999 999987543221
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHh
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNI 934 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 934 (949)
+.++++. +.|.+.+.-+...+..++.+||..|++.||+++|+..++.+....
T Consensus 909 --I~dlle~------------------geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 909 --IPDLLEK------------------GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred --hhHHHhc------------------cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 2222211 112233346777899999999999999999999999999886543
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=302.59 Aligned_cols=254 Identities=23% Similarity=0.325 Sum_probs=202.7
Q ss_pred HHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 623 NATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 623 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
..++.|++.+.||+|++|.||+|.+..++..||+|++..... ..+.+.+|++.+++++|+|++++++++...+ .
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~ 89 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGD-----E 89 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECC-----E
Confidence 356678889999999999999999988889999999976544 4567889999999999999999999976554 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++|+||+++++|.+++... ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~---------~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l 157 (286)
T cd06614 90 LWVVMEYMDGGSLTDIITQN---------FVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKL 157 (286)
T ss_pred EEEEEeccCCCcHHHHHHHh---------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEE
Confidence 89999999999999999721 13689999999999999999999976 9999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
+|||.+......... .....++..|+|||++.+..++.++|||||||++|+|++|+.||....... ...
T Consensus 158 ~d~~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-~~~-------- 226 (286)
T cd06614 158 ADFGFAAQLTKEKSK--RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-ALF-------- 226 (286)
T ss_pred Cccchhhhhccchhh--hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-HHH--------
Confidence 999998765433221 112347889999999988889999999999999999999999985321110 000
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.+....... ......++..+.+++.+|++.+|.+||++.|+++
T Consensus 227 ----~~~~~~~~~-----------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 227 ----LITTKGIPP-----------------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ----HHHhcCCCC-----------------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 000000000 0001124556889999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=307.67 Aligned_cols=254 Identities=22% Similarity=0.264 Sum_probs=198.6
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc---chHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG---ASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
++|++.+.||+|++|.||+|....+++.||+|.+...... ..+.+..|++++++++|+||+++++.+.... .
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTET-----Y 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC-----E
Confidence 3688899999999999999999988999999999754322 3457889999999999999999999865443 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+.+++|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~--------~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l 144 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQ--------PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIML 144 (316)
T ss_pred EEEEEEecCCCCHHHHHHhC--------CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEE
Confidence 89999999999999998621 124588999999999999999999977 8999999999999999999999
Q ss_pred eecccceecCCCCCcc---------------------------ccccccCccCccCccccCCCccCCccchHHHHHHHHH
Q 039533 783 GDFGLARILSPDHTQT---------------------------SSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLE 835 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~e 835 (949)
+|||++.......... ......|+..|+|||++.+..++.++||||||+++|+
T Consensus 145 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~ 224 (316)
T cd05574 145 SDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYE 224 (316)
T ss_pred eecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHH
Confidence 9999987653321100 0112357889999999998889999999999999999
Q ss_pred HHhCCCCCccccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCC
Q 039533 836 LVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELP 915 (949)
Q Consensus 836 lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP 915 (949)
|++|+.||....... . ..++.+.... ++.....+..+.+++.+|++.||
T Consensus 225 l~~g~~pf~~~~~~~-~------------~~~~~~~~~~------------------~~~~~~~~~~~~~li~~~l~~~p 273 (316)
T cd05574 225 MLYGTTPFKGSNRDE-T------------FSNILKKEVT------------------FPGSPPVSSSARDLIRKLLVKDP 273 (316)
T ss_pred HhhCCCCCCCCchHH-H------------HHHHhcCCcc------------------CCCccccCHHHHHHHHHHccCCH
Confidence 999999996332110 0 0111111000 00001245678999999999999
Q ss_pred CCCCC----HHHHHH
Q 039533 916 QDRTN----MTNVVH 926 (949)
Q Consensus 916 ~~RPs----~~ev~~ 926 (949)
++||+ ++|++.
T Consensus 274 ~~R~s~~~~~~~ll~ 288 (316)
T cd05574 274 SKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHCCCchhhHHHHHc
Confidence 99999 555555
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=304.85 Aligned_cols=264 Identities=19% Similarity=0.196 Sum_probs=185.4
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCC---CEEEEEEEEecCCCcch-----------HHHHHHHHHHHhcCCCcceeEEe
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEG---RTTIAVKVFNLQHHGAS-----------RSFIAECKALKSIRHRNLVKVLT 690 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~~~~ 690 (949)
.++|.+.++||+|+||.||+|....+ +..+|+|+......... .....+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 36899999999999999999998766 56778887543322111 11223334455678999999998
Q ss_pred eeecccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 039533 691 ACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPS 770 (949)
Q Consensus 691 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~ 770 (949)
++.... ......++++|++. .++.+.+.. ....++..+..|+.|++.||+|||+. +|+||||||+
T Consensus 91 ~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~----------~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~ 155 (294)
T PHA02882 91 CGSFKR-CRMYYRFILLEKLV-ENTKEIFKR----------IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPE 155 (294)
T ss_pred eeeEec-CCceEEEEEEehhc-cCHHHHHHh----------hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHH
Confidence 765332 11223467777764 356665541 12346778899999999999999977 9999999999
Q ss_pred CeeecCCCceEEeecccceecCCCCCc-----cccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCcc
Q 039533 771 NVLLDDYMTARVGDFGLARILSPDHTQ-----TSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDI 845 (949)
Q Consensus 771 NIll~~~~~~kl~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~ 845 (949)
||+++.++.++|+|||+|+.+...... .......||+.|+|||+..+..++.++|||||||++|||++|+.||..
T Consensus 156 Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~ 235 (294)
T PHA02882 156 NIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKG 235 (294)
T ss_pred HEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCc
Confidence 999999999999999999876432211 111124599999999999999999999999999999999999999964
Q ss_pred ccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHH
Q 039533 846 MFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVV 925 (949)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~ 925 (949)
...... ...... .+.+.....+.. ....++..+.+++..|+..+|++||+++++.
T Consensus 236 ~~~~~~-~~~~~~-------~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~ 290 (294)
T PHA02882 236 FGHNGN-LIHAAK-------CDFIKRLHEGKI-----------------KIKNANKFIYDFIECVTKLSYEEKPDYDALI 290 (294)
T ss_pred cccchH-HHHHhH-------HHHHHHhhhhhh-----------------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHH
Confidence 321110 000000 000000000000 0113356788999999999999999999999
Q ss_pred HHH
Q 039533 926 HEL 928 (949)
Q Consensus 926 ~~L 928 (949)
+.+
T Consensus 291 ~~~ 293 (294)
T PHA02882 291 KIF 293 (294)
T ss_pred Hhh
Confidence 876
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=313.64 Aligned_cols=203 Identities=21% Similarity=0.261 Sum_probs=171.3
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecC--CCcchHHHHHHHHHHHhcCCCcceeEEeeeeccc-ccCC
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ--HHGASRSFIAECKALKSIRHRNLVKVLTACLGAD-YRGN 700 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~ 700 (949)
..++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.++++++||||+++++++.... ..+.
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999999989999999998643 2233456778999999999999999999876432 2233
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
...++||||+. ++|.+++. ..++...+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~------------~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~ 157 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQ------------MDLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTL 157 (353)
T ss_pred CcEEEEEeccC-CCHHHHHh------------hcCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCE
Confidence 46799999996 58888775 1278889999999999999999977 99999999999999999999
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCcc
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDI 845 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~ 845 (949)
||+|||.++....... .....++..|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 158 kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 219 (353)
T cd07850 158 KILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG 219 (353)
T ss_pred EEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999987644322 1123578999999999998999999999999999999999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=310.43 Aligned_cols=285 Identities=19% Similarity=0.213 Sum_probs=199.8
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccc-cCCc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADY-RGND 701 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 701 (949)
.++|.+.+.||+|+||.||+|++..+++.||+|++.... ......+.+|++++++++||||+++++++..... ....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 378999999999999999999998889999999986432 2223568899999999999999999998764432 1223
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++|+||+.. ++.++.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|
T Consensus 94 ~~~lv~e~~~~-~l~~~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~k 157 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG------------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELK 157 (342)
T ss_pred eEEEEeccccc-CHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence 46899999864 6766542 2478899999999999999999977 899999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcc--
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGR-- 858 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~-- 858 (949)
|+|||+++....... ...++..|+|||++.+ ..++.++|||||||++|||++|+.||....... .+.....
T Consensus 158 L~dfg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~~ 231 (342)
T cd07879 158 ILDFGLARHADAEMT-----GYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVT 231 (342)
T ss_pred EeeCCCCcCCCCCCC-----CceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhc
Confidence 999999876432211 2347889999999876 468899999999999999999999996421110 0000000
Q ss_pred ccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH--HHHhHHh
Q 039533 859 KALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE--LQSIKNI 934 (949)
Q Consensus 859 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~--L~~i~~~ 934 (949)
....+...+..+..... ........................+.+++.+|++.||++||+++|++.. ++..+..
T Consensus 232 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 232 GVPGPEFVQKLEDKAAK---SYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred CCCCHHHHHHhcccchH---HHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 00000011111000000 0000000000000000011234567899999999999999999999954 7776653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=307.69 Aligned_cols=208 Identities=22% Similarity=0.337 Sum_probs=169.8
Q ss_pred CCCCCCeeeeecCceEEEEEEcC--CCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDE--GRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
+|++.+.||+|++|.||+|.+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence 47888999999999999999987 78999999997633 33446788999999999999999999998754 124
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC----C
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD----Y 777 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~----~ 777 (949)
..++||||+++ ++.+++..... .....++...+..++.|++.|++|||+. +|+||||||+||+++. +
T Consensus 78 ~~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~ 148 (316)
T cd07842 78 SVYLLFDYAEH-DLWQIIKFHRQ-----AKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPER 148 (316)
T ss_pred eEEEEEeCCCc-CHHHHHHhhcc-----CCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCcc
Confidence 78999999975 67776642211 1124688999999999999999999977 8999999999999999 9
Q ss_pred CceEEeecccceecCCCCC-ccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccc
Q 039533 778 MTARVGDFGLARILSPDHT-QTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIM 846 (949)
Q Consensus 778 ~~~kl~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~ 846 (949)
+.+||+|||+++....... ........++..|+|||++.+. .++.++|||||||++|||++|++||...
T Consensus 149 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 219 (316)
T cd07842 149 GVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR 219 (316)
T ss_pred ceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 9999999999987644332 1112234578899999987764 5789999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=303.58 Aligned_cols=284 Identities=19% Similarity=0.192 Sum_probs=199.2
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcC-CCcceeEEeeeecccccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIR-HRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 702 (949)
++|++.+.||+|+||.||+|.+..+++.||+|+.+.... .....+.+|+.++++++ ||||+++++++...+..+...
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 468899999999999999999998899999999864432 23467889999999995 699999999887655333445
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC-CCceE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD-YMTAR 781 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~-~~~~k 781 (949)
.++||||+++ ++.+++..... .....+++..++.++.||+.||+|||+. +|+||||||+||+++. ++.+|
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~k 151 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGR-----GPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLK 151 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcc-----cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEE
Confidence 7999999985 89888863211 1134589999999999999999999977 9999999999999998 89999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
|+|||.++.+....... ....+++.|+|||++.+ ..++.++||||||+++|||++|..||........ ........
T Consensus 152 l~dfg~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~ 228 (295)
T cd07837 152 IADLGLGRAFSIPVKSY--THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ-LLHIFKLL 228 (295)
T ss_pred EeecccceecCCCcccc--CCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHHh
Confidence 99999998654332211 12346888999998765 4578999999999999999999999864321110 00000000
Q ss_pred -CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 861 -LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 861 -~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.+.. .... ........ ....+..+..........+..+.+++.+|++.||++||++.|++.
T Consensus 229 ~~~~~--~~~~-~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 229 GTPTE--QVWP-GVSKLRDW--HEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CCCCh--hhCc-chhhccch--hhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000 0000 00000000 000000000000011234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=337.84 Aligned_cols=414 Identities=30% Similarity=0.375 Sum_probs=274.0
Q ss_pred EEEEEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCC
Q 039533 67 VTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQN 146 (949)
Q Consensus 67 v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 146 (949)
...||+++|.+. ..|..+..+.+|+.|+++.|.+. ..|.+.+++.+|++|.|.+|.+. ..|.++..+++|++|+++.
T Consensus 47 L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~ 123 (1081)
T KOG0618|consen 47 LKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSF 123 (1081)
T ss_pred eEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccch
Confidence 566777766554 66667777777777777777776 66677777777777777777776 6777777777777777777
Q ss_pred ccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCcccccccc
Q 039533 147 NQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVEN 226 (949)
Q Consensus 147 n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 226 (949)
|++. .+|..+..+..++.+..++|..... ++.. .++.++|..|.+.+.++..+..+.. .|||+.|.+..+
T Consensus 124 N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~----lg~~-~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~~~-- 193 (1081)
T KOG0618|consen 124 NHFG-PIPLVIEVLTAEEELAASNNEKIQR----LGQT-SIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEMEVL-- 193 (1081)
T ss_pred hccC-CCchhHHhhhHHHHHhhhcchhhhh----hccc-cchhhhhhhhhcccchhcchhhhhe--eeecccchhhhh--
Confidence 7765 4445555566666666666622211 2222 2667777777777777777776666 678887776522
Q ss_pred cccCCCCChhhhccccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCccc
Q 039533 227 KLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKI 306 (949)
Q Consensus 227 ~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l 306 (949)
.+..+.+|+.+....|++.... -..++|+.|+.++|.++...+. ..|.+|+++++++|++
T Consensus 194 -------dls~~~~l~~l~c~rn~ls~l~----------~~g~~l~~L~a~~n~l~~~~~~---p~p~nl~~~dis~n~l 253 (1081)
T KOG0618|consen 194 -------DLSNLANLEVLHCERNQLSELE----------ISGPSLTALYADHNPLTTLDVH---PVPLNLQYLDISHNNL 253 (1081)
T ss_pred -------hhhhccchhhhhhhhcccceEE----------ecCcchheeeeccCcceeeccc---cccccceeeecchhhh
Confidence 3556667777777777665321 1235566667777766633222 1234567777777777
Q ss_pred cCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecccccccccCCCCC
Q 039533 307 YGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSL 386 (949)
Q Consensus 307 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 386 (949)
+ .+|++++.+.+|+.|+..+|+|+ .+|..+...++|+.|+..+|.++ .+|+....++.|++|+|..|+|. ..|+.|
T Consensus 254 ~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~ 329 (1081)
T KOG0618|consen 254 S-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNF 329 (1081)
T ss_pred h-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHH
Confidence 6 45566777777777777777775 56666666666777777777766 56666666677777777776665 333321
Q ss_pred --------------------------CCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccc
Q 039533 387 --------------------------GQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKI 440 (949)
Q Consensus 387 --------------------------~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~ 440 (949)
..++.|+.|++.+|.|+...-+.+-....| +.|+|++|+|.......+.++..
T Consensus 330 l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hL-KVLhLsyNrL~~fpas~~~kle~ 408 (1081)
T KOG0618|consen 330 LAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHL-KVLHLSYNRLNSFPASKLRKLEE 408 (1081)
T ss_pred HhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccce-eeeeecccccccCCHHHHhchHH
Confidence 123456777777777776666666666777 67777777777444455677777
Q ss_pred cceeeeccccccccCCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCC-cCcccccCCccceEeCCC
Q 039533 441 LEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSG-EIPKFLAGLSLNNLNLSY 519 (949)
Q Consensus 441 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~~~L~~l~ls~ 519 (949)
|+.|+||+|+|+ .+|.++.++..|+.|...+|++. ..| .+..++.|+.+|+|.|+|+. .+|......+|++|||++
T Consensus 409 LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSG 485 (1081)
T KOG0618|consen 409 LEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSG 485 (1081)
T ss_pred hHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccC
Confidence 777777777777 67777777777777777777777 555 77778888888888888863 445444444588888888
Q ss_pred Cc
Q 039533 520 ND 521 (949)
Q Consensus 520 N~ 521 (949)
|.
T Consensus 486 N~ 487 (1081)
T KOG0618|consen 486 NT 487 (1081)
T ss_pred Cc
Confidence 76
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=296.42 Aligned_cols=251 Identities=20% Similarity=0.243 Sum_probs=193.2
Q ss_pred HHHHHHHhcCCCCCCee--eeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhc-CCCcceeEEeeeec
Q 039533 618 YQDLYNATSGFSSANLV--GVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSI-RHRNLVKVLTACLG 694 (949)
Q Consensus 618 ~~~l~~~~~~y~~~~~l--g~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 694 (949)
..+.....++|.+.+.+ |+|+||.||+++...+++.+|+|++........ |+.....+ +||||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec
Confidence 34555566788888877 999999999999998999999999865432211 22222222 79999999999765
Q ss_pred ccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeee
Q 039533 695 ADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL 774 (949)
Q Consensus 695 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll 774 (949)
.+ ..++||||+++++|.+++.. ...+++.++..++.|+++|++|||+. +++||||||+||++
T Consensus 81 ~~-----~~~iv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~ 142 (267)
T PHA03390 81 LK-----GHVLIMDYIKDGDLFDLLKK----------EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLY 142 (267)
T ss_pred CC-----eeEEEEEcCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEE
Confidence 44 78999999999999999962 23689999999999999999999977 89999999999999
Q ss_pred cCCC-ceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchh
Q 039533 775 DDYM-TARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINL 853 (949)
Q Consensus 775 ~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~ 853 (949)
+.++ .++|+|||.++...... ...|+..|+|||++.+..++.++||||+|+++|||++|+.||..........
T Consensus 143 ~~~~~~~~l~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~ 216 (267)
T PHA03390 143 DRAKDRIYLCDYGLCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL 216 (267)
T ss_pred eCCCCeEEEecCccceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhH
Confidence 9888 99999999998664332 2348899999999998889999999999999999999999997433222111
Q ss_pred hhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC-HHHHHH
Q 039533 854 HNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTN-MTNVVH 926 (949)
Q Consensus 854 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~ev~~ 926 (949)
..+.... .... ......+..+.+++.+|++.+|++||+ ++|+++
T Consensus 217 ~~~~~~~---------~~~~--------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 217 ESLLKRQ---------QKKL--------------------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHhh---------cccC--------------------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 1111100 0000 001134556889999999999999996 588763
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=301.37 Aligned_cols=248 Identities=24% Similarity=0.281 Sum_probs=197.7
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC---cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH---GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
+|++.+.||.|+||.||+|.+..+++.||+|++..... ...+.+.+|++++++++||||+++++++.+. ...
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDE-----ENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCC-----CeE
Confidence 58889999999999999999988899999999974432 3457889999999999999999999886543 479
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++|+||+++++|.+++.. ...+++.++..++.|+++||+|||+. +++|+||+|+||++++++.++|+
T Consensus 76 ~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~ 142 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQ----------KVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHIT 142 (258)
T ss_pred EEEEeCCCCCCHHHHHHh----------cCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEe
Confidence 999999999999999962 24688999999999999999999977 89999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCC
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
|||.+......... ....|+..|+|||+..+..++.++|+||||+++|+|++|+.||....... ..
T Consensus 143 d~~~~~~~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~--------- 208 (258)
T cd05578 143 DFNIATKVTPDTLT---TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI--RD--------- 208 (258)
T ss_pred ecccccccCCCccc---cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH--HH---------
Confidence 99998876543221 23458889999999988889999999999999999999999986432110 00
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCH--HHHH
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNM--TNVV 925 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~--~ev~ 925 (949)
........... ..+...+..+.+++.+|++.||.+||++ +|++
T Consensus 209 ~~~~~~~~~~~-------------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 209 QIRAKQETADV-------------------LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred HHHHHhccccc-------------------cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 00000000000 0011234678899999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=294.41 Aligned_cols=250 Identities=26% Similarity=0.335 Sum_probs=201.6
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeE
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASV 706 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 706 (949)
+|+..+.||+|++|.||+|.+..+++.+++|++........+.+.+|++.+++++|++++++++++.... ..+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKD-----ELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-----eEEEE
Confidence 4788899999999999999998889999999997655445678999999999999999999999876543 78999
Q ss_pred eeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecc
Q 039533 707 YEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFG 786 (949)
Q Consensus 707 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG 786 (949)
+||+++++|.+++.. ....+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||
T Consensus 76 ~e~~~~~~L~~~~~~---------~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~ 143 (253)
T cd05122 76 MEFCSGGSLKDLLKS---------TNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFG 143 (253)
T ss_pred EecCCCCcHHHHHhh---------cCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecc
Confidence 999999999999862 124689999999999999999999976 99999999999999999999999999
Q ss_pred cceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchh
Q 039533 787 LARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVM 866 (949)
Q Consensus 787 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 866 (949)
.+........ .....++..|+|||+..+..++.++||||||+++|+|++|+.||.......... .... ....
T Consensus 144 ~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~---~~~~ 215 (253)
T cd05122 144 LSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF--KIAT---NGPP 215 (253)
T ss_pred cccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH--HHHh---cCCC
Confidence 9987665432 123458899999999988889999999999999999999999986331110000 0000 0000
Q ss_pred hhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 867 DIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 867 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
. . ......+..+.+++.+|++.||++|||+.|+++
T Consensus 216 ~-----~--------------------~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 216 G-----L--------------------RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred C-----c--------------------CcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 0 000112456889999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=304.42 Aligned_cols=210 Identities=22% Similarity=0.324 Sum_probs=170.4
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeeccccc---
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYR--- 698 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--- 698 (949)
..++|++.+.||+|+||.||+|....+++.||||++..... .....+.+|++++++++||||+++++++...+..
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 34679999999999999999999998899999999864432 2234567899999999999999999998654321
Q ss_pred CCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC
Q 039533 699 GNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM 778 (949)
Q Consensus 699 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~ 778 (949)
.....++||||+. +++.+++.. ....+++.++..++.|++.||+|||++ +++||||||+||+++.++
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~---------~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~ 156 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSN---------KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDG 156 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCC
Confidence 2235699999996 488887752 223589999999999999999999977 899999999999999999
Q ss_pred ceEEeecccceecCCCCCc--cccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccc
Q 039533 779 TARVGDFGLARILSPDHTQ--TSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIM 846 (949)
Q Consensus 779 ~~kl~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~ 846 (949)
.+||+|||.+......... .......++..|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~ 227 (310)
T cd07865 157 ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN 227 (310)
T ss_pred cEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999866433221 111133478899999987765 3688999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=302.10 Aligned_cols=274 Identities=24% Similarity=0.291 Sum_probs=195.8
Q ss_pred CCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 628 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
|++.+.||.|++|.||+|.+..+++.||+|++.... ......+.+|++++++++|||++++++++...+ ..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~-----~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN-----KLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC-----eEEE
Confidence 677899999999999999998889999999987543 223357889999999999999999999976543 7899
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
||||++ ++|.+++... ....+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+||
T Consensus 76 v~e~~~-~~l~~~~~~~--------~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df 143 (283)
T cd07835 76 VFEFLD-LDLKKYMDSS--------PLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADF 143 (283)
T ss_pred EEeccC-cCHHHHHhhC--------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeec
Confidence 999995 6899998621 113589999999999999999999977 8999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC-CC
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL-PD 863 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~ 863 (949)
|.++......... ....++..|+|||++.+. .++.++||||||+++|||++|+.||....... ......+... +.
T Consensus 144 ~~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~ 220 (283)
T cd07835 144 GLARAFGVPVRTY--THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTLGTPD 220 (283)
T ss_pred ccccccCCCcccc--CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCC
Confidence 9997654322111 123468899999987664 46899999999999999999999996432211 0111111000 00
Q ss_pred c-hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 864 D-VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 864 ~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
. ...... ..++.......... ..........+..+.+++.+|++.+|++|||++|+++
T Consensus 221 ~~~~~~~~--~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 221 EDVWPGVT--SLPDYKPTFPKWAR---QDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hHHhhhhh--hchhhhhhcccccc---cchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 000000 00000000000000 0000001123457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=299.75 Aligned_cols=243 Identities=22% Similarity=0.241 Sum_probs=184.0
Q ss_pred eeeeecCceEEEEEEcCCCEEEEEEEEecCCC---cchHHHHHHHHHHHh---cCCCcceeEEeeeecccccCCccceeE
Q 039533 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH---GASRSFIAECKALKS---IRHRNLVKVLTACLGADYRGNDFKASV 706 (949)
Q Consensus 633 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~---l~h~niv~~~~~~~~~~~~~~~~~~lv 706 (949)
.||+|+||.||+|.+..+++.||+|.+..... .....+.+|..+++. .+||+|+.+++++...+ ..++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-----~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPD-----KLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC-----eEEEE
Confidence 48999999999999988899999999864322 112334455544443 37999999998875443 78999
Q ss_pred eeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecc
Q 039533 707 YEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFG 786 (949)
Q Consensus 707 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG 786 (949)
|||+++++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||
T Consensus 76 ~e~~~~~~L~~~i~----------~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg 142 (279)
T cd05633 76 LDLMNGGDLHYHLS----------QHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLG 142 (279)
T ss_pred EecCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCC
Confidence 99999999999886 234589999999999999999999977 89999999999999999999999999
Q ss_pred cceecCCCCCccccccccCccCccCccccC-CCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCch
Q 039533 787 LARILSPDHTQTSSFSVKGSLGYIAPEYGV-GCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDV 865 (949)
Q Consensus 787 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 865 (949)
++........ ....|+..|+|||... +..++.++||||+||++|||++|+.||................
T Consensus 143 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~------ 212 (279)
T cd05633 143 LACDFSKKKP----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL------ 212 (279)
T ss_pred cceeccccCc----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh------
Confidence 9876543222 1235899999999886 4568899999999999999999999996432111000000000
Q ss_pred hhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHHH
Q 039533 866 MDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRT-----NMTNVVHE 927 (949)
Q Consensus 866 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~~ 927 (949)
.....+ ....+..+.+++.+|+..||++|| |++|+++.
T Consensus 213 --~~~~~~----------------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 213 --TVNVEL----------------------PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred --cCCcCC----------------------ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 000000 112345678999999999999999 59888774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=300.49 Aligned_cols=276 Identities=20% Similarity=0.273 Sum_probs=199.0
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
+|++.+.||.|++|.||+|++..+++.||||+++.... ...+.+.+|++++++++|+||+++++++...+ ..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN-----KLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC-----cEEE
Confidence 58889999999999999999998899999999975433 23466788999999999999999999976554 7899
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
||||+++ +|.+++.... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+||
T Consensus 76 v~e~~~~-~l~~~~~~~~-------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~ 144 (284)
T cd07836 76 VFEYMDK-DLKKYMDTHG-------VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADF 144 (284)
T ss_pred EEecCCc-cHHHHHHhcC-------CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeec
Confidence 9999985 8888876221 124589999999999999999999977 8999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCc--hhhhhccccCC
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDI--NLHNFGRKALP 862 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~--~~~~~~~~~~~ 862 (949)
|.+......... .....++..|+|||++.+. .++.++|||||||++|||++|+.||......+. ...........
T Consensus 145 g~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (284)
T cd07836 145 GLARAFGIPVNT--FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTE 222 (284)
T ss_pred chhhhhcCCccc--cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Confidence 999765432211 1123478899999987664 468999999999999999999999964322110 00000000001
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.....+.+. +...... ...............+..+.+++.+|++.||++||+++|+++
T Consensus 223 ~~~~~~~~~---~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 223 STWPGISQL---PEYKPTF---PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhHHHHhcC---chhcccc---cCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 001111100 0000000 000000000111234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=309.05 Aligned_cols=290 Identities=19% Similarity=0.222 Sum_probs=208.4
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
+|++.+.||.|++|.||+|+...+++.||+|++.... ....+.+.+|+.++++++|+||+++++++...........+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999998889999999987543 33456889999999999999999999987655433344689
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||++ ++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|
T Consensus 81 lv~e~~~-~~l~~~l~----------~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~d 146 (330)
T cd07834 81 IVTELME-TDLHKVIK----------SPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICD 146 (330)
T ss_pred EEecchh-hhHHHHHh----------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcc
Confidence 9999997 48988886 223689999999999999999999977 899999999999999999999999
Q ss_pred cccceecCCCCCc-cccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCc--hhhhhcccc
Q 039533 785 FGLARILSPDHTQ-TSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDI--NLHNFGRKA 860 (949)
Q Consensus 785 fG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~--~~~~~~~~~ 860 (949)
||.+......... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||........ .........
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 226 (330)
T cd07834 147 FGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTP 226 (330)
T ss_pred cCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCC
Confidence 9999887654310 111234578899999999887 789999999999999999999999964422110 000000000
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH--HHHhHHh
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE--LQSIKNI 934 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~--L~~i~~~ 934 (949)
.++.... .. .....+.+................+.+..+.+++.+||+.+|++||+++++++. +++++..
T Consensus 227 ~~~~~~~-~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 227 SEEDLKF-IT---SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred ChhHhhh-cc---ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 0000000 00 000000000000000000001112345678999999999999999999999974 6555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=294.52 Aligned_cols=254 Identities=25% Similarity=0.318 Sum_probs=202.9
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
+|+..+.||+|++|.||+|.+..+++.|++|++..... ...+.+.+|++.+++++||||+++++.+.... ....+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 47888999999999999999998899999999875543 34578899999999999999999999876541 24789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+|+||+++++|.+++.. ...+++.++..++.|+++|++|||+. +++||||+|+||+++.++.++|+|
T Consensus 78 lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d 144 (260)
T cd06606 78 IFLEYVSGGSLSSLLKK----------FGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLAD 144 (260)
T ss_pred EEEEecCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcc
Confidence 99999999999999862 23689999999999999999999976 899999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCc
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
||.+................++..|+|||...+...+.++||||||+++|+|++|..||....... ..
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~-------- 212 (260)
T cd06606 145 FGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM----AA-------- 212 (260)
T ss_pred cccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH----HH--------
Confidence 999987765543111223458899999999988889999999999999999999999986432000 00
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
............ .....+..+.+++.+|++.+|++||++.|+++
T Consensus 213 ~~~~~~~~~~~~------------------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 213 LYKIGSSGEPPE------------------IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred HHhccccCCCcC------------------CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 000000000000 00122567889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=328.71 Aligned_cols=258 Identities=24% Similarity=0.318 Sum_probs=188.2
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccC----
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRG---- 699 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~---- 699 (949)
..+|...+.||+||||.||+++.+-+|+.+|||++.... ........+|+..+++++|||||+++..+.+...+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 456777899999999999999999999999999997543 233457889999999999999999995443221000
Q ss_pred --------------------------------------------------------------------------------
Q 039533 700 -------------------------------------------------------------------------------- 699 (949)
Q Consensus 700 -------------------------------------------------------------------------------- 699 (949)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred ----------------------C--------ccceeEeeeccCCChhhhcCCCCCCCccccCCCCC-CHHHHHHHHHHHH
Q 039533 700 ----------------------N--------DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNL-NLLQRLNIAIDIA 748 (949)
Q Consensus 700 ----------------------~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l-~~~~~~~i~~qi~ 748 (949)
+ ...||=||||+.-++++++... ... .....++++++|+
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N----------~~~~~~d~~wrLFreIl 707 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN----------HFNSQRDEAWRLFREIL 707 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc----------ccchhhHHHHHHHHHHH
Confidence 0 1246677888877777777521 111 3567889999999
Q ss_pred HHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecccceecC----------------CCCCccccccccCccCccCc
Q 039533 749 YALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILS----------------PDHTQTSSFSVKGSLGYIAP 812 (949)
Q Consensus 749 ~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~----------------~~~~~~~~~~~~gt~~y~aP 812 (949)
+||+|+|++ |||||||||.||++|++..+||+|||+|+... ........+..+||.-|+||
T Consensus 708 EGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAP 784 (1351)
T KOG1035|consen 708 EGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAP 784 (1351)
T ss_pred HHHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecH
Confidence 999999977 89999999999999999999999999998721 00011123356799999999
Q ss_pred cccCCC---ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhh
Q 039533 813 EYGVGC---EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQK 889 (949)
Q Consensus 813 E~~~~~---~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~ 889 (949)
|++.+. .|+.|+|+||+|||++||+. ||....+....+.......+|.. .++.+
T Consensus 785 Ell~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-~~f~~------------------- 841 (1351)
T KOG1035|consen 785 ELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-ADFFD------------------- 841 (1351)
T ss_pred HHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-ccccc-------------------
Confidence 998765 49999999999999999996 57644332222222111112221 11111
Q ss_pred hhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 890 QARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 890 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
...+.=.+++.++++.||.+||||.|++.
T Consensus 842 --------~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 842 --------PEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred --------ccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 11223367899999999999999999874
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=300.12 Aligned_cols=272 Identities=18% Similarity=0.189 Sum_probs=194.0
Q ss_pred CCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcC-CCcceeEEeeeecccccCCcccee
Q 039533 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECKALKSIR-HRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 628 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
|++.+.||+|+||.||+|+...+++.||+|+++.... .......+|+..+.++. |+|++++++++.+.. .+..++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~---~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK---TGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC---CCcEEE
Confidence 6778899999999999999988899999999875422 22234557888999885 999999999986541 237899
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
||||++ +++.+++.. ....+++.++..++.|++.||+|||+. +++||||||+||+++. +.+||+||
T Consensus 78 v~e~~~-~~l~~~l~~---------~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~df 143 (282)
T cd07831 78 VFELMD-MNLYELIKG---------RKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADF 143 (282)
T ss_pred EEecCC-ccHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEec
Confidence 999997 588888752 124589999999999999999999977 8999999999999999 99999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCC-
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPD- 863 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~- 863 (949)
|.++......... ...++..|+|||++.. ..++.++||||+||++|||++|+.||......+ ...........
T Consensus 144 g~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~--~~~~~~~~~~~~ 218 (282)
T cd07831 144 GSCRGIYSKPPYT---EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD--QIAKIHDVLGTP 218 (282)
T ss_pred ccccccccCCCcC---CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH--HHHHHHHHcCCC
Confidence 9998764433221 2347889999997654 457899999999999999999999996432111 11111111110
Q ss_pred --chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 864 --DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 864 --~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.+............. ................+..+.+++.+|++.+|++||+++|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 219 DAEVLKKFRKSRHMNYN-----FPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred CHHHHHhhccccccccc-----CcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 010000000000000 0000000000111244678999999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=310.83 Aligned_cols=282 Identities=21% Similarity=0.269 Sum_probs=199.1
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecC--CCcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCC
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ--HHGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 700 (949)
..++|++.+.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+++++ +||||+++++++...+ .
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~---~ 81 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN---D 81 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCC---C
Confidence 356789999999999999999999888999999988532 222335677899999999 9999999999875422 3
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
...++||||++ ++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~-----------~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~ 146 (337)
T cd07852 82 KDIYLVFEYME-TDLHAVIRA-----------NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRV 146 (337)
T ss_pred ceEEEEecccc-cCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcE
Confidence 35799999997 599988851 2578889999999999999999977 99999999999999999999
Q ss_pred EEeecccceecCCCCCc---cccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhh
Q 039533 781 RVGDFGLARILSPDHTQ---TSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNF 856 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~ 856 (949)
||+|||.++........ .......|+..|+|||++.+ ..++.++||||||+++|||++|+.||........ ....
T Consensus 147 kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~ 225 (337)
T cd07852 147 KLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKI 225 (337)
T ss_pred EEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHH
Confidence 99999999866443221 12223458999999998765 4578999999999999999999999964322110 0000
Q ss_pred c--cccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 857 G--RKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 857 ~--~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
. ...........+.... ..+....................+..+.+++.+|++.+|++|||+.++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 226 IEVIGPPSAEDIESIKSPF---AATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHhCCCCHHHHHHHHhhh---HHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0 0000000000000000 000000000000000000111245678999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=304.47 Aligned_cols=258 Identities=23% Similarity=0.265 Sum_probs=192.1
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcC-CCcceeEEeeeecccccCCccce
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECKALKSIR-HRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
+|...+.||+|+||.||++.+..+++.||+|.+..... .....+.+|+.++.++. |+||+++++++.... ..+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~-----~~~ 79 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG-----DCW 79 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC-----cEE
Confidence 45667899999999999999998899999999875432 33467889999999996 999999999876443 678
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
++|||+.. ++.++..... ......+++..+..++.|++.||+|||+.. +++||||||+||+++.++.+||+|
T Consensus 80 ~~~e~~~~-~l~~l~~~~~-----~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~d 151 (288)
T cd06616 80 ICMELMDI-SLDKFYKYVY-----EVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCD 151 (288)
T ss_pred EEEecccC-CHHHHHHHHH-----HhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEee
Confidence 99999864 5544332100 012356899999999999999999999643 899999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCC---ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC---EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
||+++......... ...|+..|+|||++.+. .++.++|||||||++|||++|+.||..... .........
T Consensus 152 fg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~ 224 (288)
T cd06616 152 FGISGQLVDSIAKT---RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VFDQLTQVV 224 (288)
T ss_pred cchhHHhccCCccc---cccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----HHHHHhhhc
Confidence 99997654332211 23488999999998776 688999999999999999999999863321 000000000
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
.... +.+... .....+..+.+++.+|++.+|++|||+.||++.
T Consensus 225 ~~~~-----~~~~~~------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 225 KGDP-----PILSNS------------------EEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCC-----CcCCCc------------------CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 000000 001245578999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=299.84 Aligned_cols=276 Identities=21% Similarity=0.255 Sum_probs=199.0
Q ss_pred CCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 628 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
|++.+.||+|++|.||+|+...+++.+|+|++.... ......+.+|++++++++|+|++++++++...+ ....++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence 677899999999999999999889999999998653 333467889999999999999999999976541 247899
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
||||+++ +|.+++.. ....+++..++.++.|+++||+|||+. +++|+||||+||++++++.+||+||
T Consensus 78 v~e~~~~-~l~~~~~~---------~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~ 144 (287)
T cd07840 78 VFEYMDH-DLTGLLDS---------PEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADF 144 (287)
T ss_pred Eeccccc-cHHHHHhc---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccc
Confidence 9999975 89888862 124689999999999999999999977 8999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhc---cccC
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFG---RKAL 861 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~---~~~~ 861 (949)
|.+.......... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||+...... ...... ....
T Consensus 145 g~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~-~~~~~~~~~~~~~ 222 (287)
T cd07840 145 GLARPYTKRNSAD-YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE-QLEKIFELCGSPT 222 (287)
T ss_pred cceeeccCCCccc-ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCc
Confidence 9998765543211 123347889999998765 457899999999999999999999996432211 011000 0000
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHH-HHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIE-CLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
........+.. ..+.... .........+.... ++..+.+++.+|++.+|++||+++|+++
T Consensus 223 ~~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 223 DENWPGVSKLP----WFENLKP-KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhccccccch----hhhhccc-cccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000000000 0000000 00000000011112 2678899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=303.98 Aligned_cols=280 Identities=24% Similarity=0.259 Sum_probs=197.6
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.... .....+.+|+.++++++|+||+++++++.+.. .+.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH---LDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC---CCe
Confidence 4689999999999999999999998899999999875432 22345678999999999999999999976432 235
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++ +|.+++.. ....+++.++..++.|++.|++|||+. +++||||||+||++++++.+||
T Consensus 83 ~~lv~e~~~~-~l~~~l~~---------~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL 149 (309)
T cd07845 83 IFLVMEYCEQ-DLASLLDN---------MPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKI 149 (309)
T ss_pred EEEEEecCCC-CHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence 7999999974 88888762 124589999999999999999999977 8999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
+|||.+.......... ....++..|+|||++.+ ..++.++||||+||++|||++|+.||....... .+. ......
T Consensus 150 ~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~-~~~-~~~~~~ 225 (309)
T cd07845 150 ADFGLARTYGLPAKPM--TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE-QLD-LIIQLL 225 (309)
T ss_pred CccceeeecCCccCCC--CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHH-HHHHhc
Confidence 9999998765432211 12335788999999875 457899999999999999999999996432211 000 000000
Q ss_pred CCchhhhcccCCCCCc-hhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 862 PDDVMDIVDSSLLPDD-EDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
......... ....-+ ............ ..........+.+.+++.+|++.||++|||+.|+++
T Consensus 226 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 226 GTPNESIWP-GFSDLPLVGKFTLPKQPYN-NLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred CCCChhhch-hhhcccccccccccCCCCC-chHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000 000000 000000000000 000001123556789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=334.79 Aligned_cols=255 Identities=24% Similarity=0.291 Sum_probs=199.4
Q ss_pred HHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 623 NATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 623 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
..+-+|+-...||.|.||.||.|....+|...|+|.++.+.. ...+...+|..++..++|||+|++||+-...+
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe---- 1307 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE---- 1307 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH----
Confidence 334577888999999999999999999999999999875433 33467889999999999999999999855444
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
..+|.||||++|+|.+.+. .++..++.....+..|++.|++|||++ |||||||||.||+++.+|.+
T Consensus 1308 -kv~IFMEyC~~GsLa~ll~----------~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~i 1373 (1509)
T KOG4645|consen 1308 -KVYIFMEYCEGGSLASLLE----------HGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLI 1373 (1509)
T ss_pred -HHHHHHHHhccCcHHHHHH----------hcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcE
Confidence 7899999999999999997 334466667778999999999999988 99999999999999999999
Q ss_pred EEeecccceecCCCCC--ccccccccCccCccCccccCCCc---cCCccchHHHHHHHHHHHhCCCCCccccccCchhhh
Q 039533 781 RVGDFGLARILSPDHT--QTSSFSVKGSLGYIAPEYGVGCE---VSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHN 855 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~ 855 (949)
|++|||.|..+..... ...-....||+.|||||++.+.. ..-++||||+|||+.||.||++||.........+..
T Consensus 1374 K~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~ 1453 (1509)
T KOG4645|consen 1374 KYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYH 1453 (1509)
T ss_pred EeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhH
Confidence 9999999998766532 12222467999999999988643 567899999999999999999999643222111100
Q ss_pred hccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 856 FGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 856 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
-+.. ..... +.....+=.+++..|+..||++|.++.|+++
T Consensus 1454 V~~g------------h~Pq~-------------------P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1454 VAAG------------HKPQI-------------------PERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred Hhcc------------CCCCC-------------------chhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 0000 00000 1123445578899999999999988876554
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=275.27 Aligned_cols=251 Identities=21% Similarity=0.240 Sum_probs=193.1
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC-CcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCCccce
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-HGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
+.+....||.|..|.||+++.+.+|..+|||.+.... .++.+++...+.++.+- ++|+||+.+|||.... ..+
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~-----dV~ 167 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT-----DVF 167 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc-----hHH
Confidence 3455678999999999999999999999999997543 34457788888877766 4899999999987655 678
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+.||.|.. -++.++.. ...++++.-+-++...++.||.||.+++ +|+|||+||+|||+|+.|++|+||
T Consensus 168 IcMelMs~-C~ekLlkr---------ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCD 235 (391)
T KOG0983|consen 168 ICMELMST-CAEKLLKR---------IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCD 235 (391)
T ss_pred HHHHHHHH-HHHHHHHH---------hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeec
Confidence 88998843 44555542 2345777788889999999999999876 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCC---CccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG---CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
||++..+.+...... ..|-+.|||||.+.- .+|+.++||||||++++|+.||+.||.....+...+..... ..
T Consensus 236 FGIsGrlvdSkAhtr---sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~e 311 (391)
T KOG0983|consen 236 FGISGRLVDSKAHTR---SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EE 311 (391)
T ss_pred ccccceeeccccccc---ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cC
Confidence 999988877665443 458999999998764 36899999999999999999999999754322211111111 00
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
+ +.+.+ .......+.+++..|+..|+.+||...++++
T Consensus 312 P--------P~L~~--------------------~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 312 P--------PLLPG--------------------HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred C--------CCCCc--------------------ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 1 11111 0123456789999999999999999988764
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=307.21 Aligned_cols=282 Identities=21% Similarity=0.242 Sum_probs=200.1
Q ss_pred HHHHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccc
Q 039533 620 DLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADY 697 (949)
Q Consensus 620 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 697 (949)
++...+++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-- 81 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP-- 81 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC--
Confidence 44567889999999999999999999999899999999885432 22346788999999999999999999987532
Q ss_pred cCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCC
Q 039533 698 RGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDY 777 (949)
Q Consensus 698 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~ 777 (949)
....++||||+ +++|.+++. ...+++..+..++.|++.||+|||+. +|+||||+|+||+++++
T Consensus 82 --~~~~~lv~e~~-~~~L~~~~~-----------~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~ 144 (328)
T cd07856 82 --LEDIYFVTELL-GTDLHRLLT-----------SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINEN 144 (328)
T ss_pred --CCcEEEEeehh-ccCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCC
Confidence 23678999998 568988875 23467888889999999999999977 89999999999999999
Q ss_pred CceEEeecccceecCCCCCccccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhh
Q 039533 778 MTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNF 856 (949)
Q Consensus 778 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~ 856 (949)
+.++|+|||.+....... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||....... ....
T Consensus 145 ~~~~l~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~--~~~~ 217 (328)
T cd07856 145 CDLKICDFGLARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN--QFSI 217 (328)
T ss_pred CCEEeCccccccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH
Confidence 999999999987543321 12347889999998765 568999999999999999999999996432110 0000
Q ss_pred ccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 857 GRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 857 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
..........++.+........+.........+..........+..+.+++.+|++.+|++||++.|++..
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 218 ITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000011111100000000000000000000000111235678999999999999999999998654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=301.36 Aligned_cols=244 Identities=23% Similarity=0.304 Sum_probs=194.2
Q ss_pred CeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEeeecc
Q 039533 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMH 711 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~ 711 (949)
.+||+|+||.||+|....+++.||||++..........+.+|+.++++++|+||+++++++...+ ..++||||++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~ 100 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-----ELWVVMEFLE 100 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCC-----EEEEEEecCC
Confidence 67999999999999998889999999986544445567889999999999999999999976544 7899999999
Q ss_pred CCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecccceec
Q 039533 712 YGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARIL 791 (949)
Q Consensus 712 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~ 791 (949)
+++|.+++. ...+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.+...
T Consensus 101 ~~~L~~~~~-----------~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~ 166 (292)
T cd06657 101 GGALTDIVT-----------HTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 166 (292)
T ss_pred CCcHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceec
Confidence 999999875 13478899999999999999999977 8999999999999999999999999998765
Q ss_pred CCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhhhccc
Q 039533 792 SPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDS 871 (949)
Q Consensus 792 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 871 (949)
....... ....|+..|+|||+..+..++.++||||+|+++|||++|+.||...... ..........+.
T Consensus 167 ~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~~~~~~~~~~-------- 234 (292)
T cd06657 167 SKEVPRR--KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNLPP-------- 234 (292)
T ss_pred ccccccc--cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhhCCc--------
Confidence 4332211 2345889999999988888899999999999999999999998532111 000000000000
Q ss_pred CCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 872 SLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 872 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.+ ......+..+.+++.+|++.+|.+||++.|+++
T Consensus 235 ~~--------------------~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 235 KL--------------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred cc--------------------CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 00 001123445788999999999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=307.16 Aligned_cols=292 Identities=17% Similarity=0.195 Sum_probs=203.8
Q ss_pred HHHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeeccccc
Q 039533 621 LYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADYR 698 (949)
Q Consensus 621 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 698 (949)
+....++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++......
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3445678999999999999999999998889999999985432 22235688999999999999999999987643311
Q ss_pred -CCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCC
Q 039533 699 -GNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDY 777 (949)
Q Consensus 699 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~ 777 (949)
.....++||||+ +++|.+++. ...+++..++.++.|+++||+|||+. +|+||||||+||+++.+
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~ 154 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMK-----------HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNED 154 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence 112468999998 779988875 23588999999999999999999977 89999999999999999
Q ss_pred CceEEeecccceecCCCCCccccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhh
Q 039533 778 MTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNF 856 (949)
Q Consensus 778 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~ 856 (949)
+.+||+|||.+........ ...++..|+|||++.+ ..++.++||||+||++|++++|+.||....... .....
T Consensus 155 ~~~kl~dfg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~~ 228 (343)
T cd07880 155 CELKILDFGLARQTDSEMT-----GYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD-QLMEI 228 (343)
T ss_pred CCEEEeecccccccccCcc-----ccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH
Confidence 9999999999986543221 2347889999998876 458899999999999999999999996332110 01000
Q ss_pred ccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHH--HHHHHhHHh
Q 039533 857 GRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVV--HELQSIKNI 934 (949)
Q Consensus 857 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~--~~L~~i~~~ 934 (949)
... ......++.+................................+.+++.+|++.||++|||+.+++ ..++.....
T Consensus 229 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~ 307 (343)
T cd07880 229 MKV-TGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307 (343)
T ss_pred HHh-cCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence 000 00000010000000000000000000000000001123345688999999999999999999998 445554443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=302.23 Aligned_cols=247 Identities=26% Similarity=0.329 Sum_probs=193.3
Q ss_pred CCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC---cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH---GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 628 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
|...+.||+|+||.||+|++..++..||+|++..... .....+.+|++++++++|||++++++++.... ..+
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 101 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH-----TAW 101 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC-----eEE
Confidence 6778899999999999999988899999999874322 22357889999999999999999999976544 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+. |++.+.+.. ....+++.++..++.|++.|+.|||+. +|+||||+|+||+++.++.+||+|
T Consensus 102 lv~e~~~-g~l~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~d 168 (317)
T cd06635 102 LVMEYCL-GSASDLLEV---------HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLAD 168 (317)
T ss_pred EEEeCCC-CCHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEec
Confidence 9999997 477777642 234588999999999999999999977 899999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccC---CCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGV---GCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
||.+....... ...|+..|+|||++. ...++.++|||||||++|||++|+.||....... ..
T Consensus 169 fg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~-------- 233 (317)
T cd06635 169 FGSASIASPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-AL-------- 233 (317)
T ss_pred CCCccccCCcc------cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-HH--------
Confidence 99987644322 234888999999874 4568899999999999999999999985321110 00
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQ 929 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 929 (949)
..+........ .....+..+.+++.+|++.+|++||++.||++...
T Consensus 234 ----~~~~~~~~~~~------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 234 ----YHIAQNESPTL------------------QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred ----HHHHhccCCCC------------------CCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 00100000000 00123456889999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=293.18 Aligned_cols=253 Identities=21% Similarity=0.250 Sum_probs=195.6
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC-----CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-----HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
.+|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++|+||+++++++...+ .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~---~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE---E 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC---C
Confidence 57899999999999999999998889999999985321 223457889999999999999999999875432 2
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
...++|+||+++++|.+++.. ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~----------~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~ 145 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKA----------YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNV 145 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCE
Confidence 357899999999999999862 23478889999999999999999977 89999999999999999999
Q ss_pred EEeecccceecCCCCC-ccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 781 RVGDFGLARILSPDHT-QTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
+|+|||.++....... ........|+..|+|||++.+..++.++|||||||++||+++|+.||....... ..
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~------ 218 (264)
T cd06653 146 KLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA-AI------ 218 (264)
T ss_pred EECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH-HH------
Confidence 9999999986532211 111113458899999999998889999999999999999999999986321110 00
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.........+. .+......+.+++.+|+. +|..||++.+++.
T Consensus 219 ------~~~~~~~~~~~------------------~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 219 ------FKIATQPTKPM------------------LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ------HHHHcCCCCCC------------------CCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 00000000000 011234567899999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=292.61 Aligned_cols=252 Identities=22% Similarity=0.341 Sum_probs=202.2
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
+|++.+.||+|++|.||+|.+..++..||+|++..... ...+.+.+|++++++++|+|++++++.+... ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-----~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-----GKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-----CEEE
Confidence 57888999999999999999998899999999975543 4456788999999999999999999987654 3789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+|+||+++++|.+++.... .....+++.++..++.|++.|++|||+. +++|+||+|+||++++++.++|+|
T Consensus 76 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d 146 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQK------KEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGD 146 (258)
T ss_pred EEEEecCCCcHHHHHHHhh------ccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECC
Confidence 9999999999999997321 1235689999999999999999999977 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCc
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
||.+.......... ....|++.|+|||...+..++.++||||+|+++|+|++|+.||+...... ..
T Consensus 147 ~~~~~~~~~~~~~~--~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~------- 212 (258)
T cd08215 147 FGISKVLSSTVDLA--KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE-----LA------- 212 (258)
T ss_pred ccceeecccCccee--cceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH-----HH-------
Confidence 99998765543211 13458889999999988889999999999999999999999986332110 00
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
...........+ ...+..+.+++.+|+..+|++|||+.|+++
T Consensus 213 -~~~~~~~~~~~~-------------------~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 213 -LKILKGQYPPIP-------------------SQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred -HHHhcCCCCCCC-------------------CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 001110000000 023456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=295.34 Aligned_cols=278 Identities=22% Similarity=0.247 Sum_probs=198.9
Q ss_pred CCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhc---CCCcceeEEeeeecccccCCcc
Q 039533 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSI---RHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 628 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~ 702 (949)
|++.+.||+|+||.||+|++..+++.||+|+++.... .....+.+|+.+++++ +|+|++++++++...+......
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6778899999999999999988899999999974332 2234566788877766 5999999999988766444445
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.+++|||+. ++|.+++... ....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~--------~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l 148 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKC--------PKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKI 148 (287)
T ss_pred eEEEehhcc-cCHHHHHHHc--------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEE
Confidence 899999997 4898888621 123589999999999999999999977 8999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
+|||.+.......... ...++..|+|||++.+..++.++|||||||++|||++|++||+.....+ .+.........
T Consensus 149 ~dfg~~~~~~~~~~~~---~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~~~ 224 (287)
T cd07838 149 ADFGLARIYSFEMALT---SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD-QLDKIFDVIGL 224 (287)
T ss_pred eccCcceeccCCcccc---cccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH-HHHHHHHHcCC
Confidence 9999998765443221 2347889999999998889999999999999999999999986432211 11111110000
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.......... ........ ............+....+.+++.+|++.||++||++.|+++
T Consensus 225 ~~~~~~~~~~--~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 225 PSEEEWPRNV--SLPRSSFP---SYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CChHhcCCCc--ccchhhcc---cccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000000 00000000 00000001112244567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=301.92 Aligned_cols=251 Identities=23% Similarity=0.278 Sum_probs=201.9
Q ss_pred HHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcc--hHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 623 NATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGA--SRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 623 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
.-...|.+.+.||+|.|+.|.+|++..++..||||.++...... ...+.+|+++|+.++|||||+++.+....
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~----- 127 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE----- 127 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec-----
Confidence 34567999999999999999999999999999999997654333 24588999999999999999999996544
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
...|+||||+.+|.+++|+.. ........+..++.|+++|++|+|++ .|||||||++||+++.+.++
T Consensus 128 ~~lylV~eya~~ge~~~yl~~----------~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mni 194 (596)
T KOG0586|consen 128 ATLYLVMEYASGGELFDYLVK----------HGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNI 194 (596)
T ss_pred ceeEEEEEeccCchhHHHHHh----------cccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccce
Confidence 489999999999999999972 34455688999999999999999988 89999999999999999999
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCCCcc-CCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEV-STNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
||+|||++.++....... ...|++.|.|||++.+.+| ++++|+||+|+++|-|+.|..||+...-..
T Consensus 195 kIaDfgfS~~~~~~~~lq---t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~--------- 262 (596)
T KOG0586|consen 195 KIADFGFSTFFDYGLMLQ---TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE--------- 262 (596)
T ss_pred eeeccccceeeccccccc---ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc---------
Confidence 999999999987554322 3569999999999999876 589999999999999999999997431110
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
+-++.+.+.. +++. -......+++++++..+|.+|++++++++.
T Consensus 263 --------Lr~rvl~gk~--------------rIp~--~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 263 --------LRPRVLRGKY--------------RIPF--YMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred --------ccchheeeee--------------cccc--eeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 0000000000 0000 112235678889999999999999999764
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=296.50 Aligned_cols=274 Identities=20% Similarity=0.213 Sum_probs=199.7
Q ss_pred CCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc--chHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG--ASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 628 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
|++.+.||+|++|.||+|....+++.+++|+++..... ....+.+|++++++++|+||+++++++... ...++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-----GDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC-----CCEEE
Confidence 67788999999999999999888999999998754332 346788999999999999999999986544 47899
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
||||+++ ++.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||++++++.++|+||
T Consensus 76 v~e~~~~-~l~~~l~~---------~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df 142 (283)
T cd05118 76 VFEFMDT-DLYKLIKD---------RQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADF 142 (283)
T ss_pred EEeccCC-CHHHHHHh---------hcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeee
Confidence 9999975 88888762 224689999999999999999999977 8999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCch--hhhhccccCC
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDIN--LHNFGRKALP 862 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~--~~~~~~~~~~ 862 (949)
|.+........ ......++..|+|||.+.+. .++.++||||+|+++|+|+||+.||......+.. .........+
T Consensus 143 ~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (283)
T cd05118 143 GLARSFGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDP 220 (283)
T ss_pred eeeEecCCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCch
Confidence 99987765431 11134578899999998776 7899999999999999999999998643221100 0000000000
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.......+ .... .. ................+.+.++.+++.+|++.||.+||++.|++.
T Consensus 221 ~~~~~~~~-~~~~-~~---~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 221 EVWPKFTS-LARN-YK---FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred Hhcccchh-hhhh-hh---hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000000 0000 00 000000000001112345678999999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=303.61 Aligned_cols=286 Identities=20% Similarity=0.262 Sum_probs=195.3
Q ss_pred Ceeeee--cCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEe
Q 039533 632 NLVGVG--SFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVY 707 (949)
Q Consensus 632 ~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 707 (949)
..||+| +||+||+|++..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+ ..++||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~-----~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS-----WLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC-----ceEEEE
Confidence 356666 899999999988999999999875432 23467889999999999999999999976544 789999
Q ss_pred eeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccc
Q 039533 708 EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGL 787 (949)
Q Consensus 708 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~ 787 (949)
||+.++++.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.
T Consensus 79 e~~~~~~l~~~l~~~--------~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~ 147 (328)
T cd08226 79 PFMAYGSANSLLKTY--------FPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSH 147 (328)
T ss_pred ecccCCCHHHHHHhh--------cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHH
Confidence 999999999998732 123478899999999999999999977 899999999999999999999999986
Q ss_pred ceecCCCCCcc-----ccccccCccCccCccccCCC--ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 788 ARILSPDHTQT-----SSFSVKGSLGYIAPEYGVGC--EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 788 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
+.......... ......++..|+|||++.+. .++.++|||||||++|||++|+.||.................
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 227 (328)
T cd08226 148 LYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPP 227 (328)
T ss_pred HhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCC
Confidence 54332211100 00012256779999998763 478999999999999999999999965432211111000000
Q ss_pred C--------CCchhhhcccCCCCC--chh-hhh---hhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 861 L--------PDDVMDIVDSSLLPD--DED-LIL---TGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 861 ~--------~~~~~~~~d~~l~~~--~~~-~~~---~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
+ +.......+.....+ ..+ .+. .........+.+....+...+.+++.+|++.||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 228 YSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred CCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0 000000000000000 000 000 00000011112223356678899999999999999999999964
Q ss_pred --HHHHhHH
Q 039533 927 --ELQSIKN 933 (949)
Q Consensus 927 --~L~~i~~ 933 (949)
.+..+++
T Consensus 308 ~~~~~~~~~ 316 (328)
T cd08226 308 HAFFKQVKE 316 (328)
T ss_pred CHHHHHHHH
Confidence 4444444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=300.60 Aligned_cols=284 Identities=21% Similarity=0.255 Sum_probs=200.4
Q ss_pred HHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeeccc----
Q 039533 623 NATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGAD---- 696 (949)
Q Consensus 623 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 696 (949)
.+.++|++.+.||+|+||.||+|.+..+++.||+|+++.... .....+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 456789999999999999999999998899999999975432 23356788999999999999999999876533
Q ss_pred -ccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec
Q 039533 697 -YRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD 775 (949)
Q Consensus 697 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~ 775 (949)
..+....++|+||+++ ++.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~ 150 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES---------GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLN 150 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc---------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 1123378999999976 77777652 124589999999999999999999977 999999999999999
Q ss_pred CCCceEEeecccceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCchhh
Q 039533 776 DYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLH 854 (949)
Q Consensus 776 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~ 854 (949)
+++.+||+|||.+.......... .....++..|+|||++.+. .++.++|||||||++|||++|++||...... ..+.
T Consensus 151 ~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-~~~~ 228 (302)
T cd07864 151 NKGQIKLADFGLARLYNSEESRP-YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-AQLE 228 (302)
T ss_pred CCCcEEeCcccccccccCCcccc-cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHH
Confidence 99999999999998765433211 1123467889999987653 5789999999999999999999999643211 0110
Q ss_pred hh---ccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 855 NF---GRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 855 ~~---~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.. .....+....++.......... .......... ......+..+.+++.+|++.+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 229 LISRLCGSPCPAVWPDVIKLPYFNTMK--PKKQYRRRLR---EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHHHhCCCChhhcccccccccccccc--cccccccchh---hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 0000010011110000000000 0000000000 011123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=279.95 Aligned_cols=208 Identities=23% Similarity=0.339 Sum_probs=173.6
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCC----EEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeeccccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGR----TTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYR 698 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 698 (949)
...|..+..||+|.||.||+|....+. +.+|+|.++.... +......+|+..++.++|||++.+..++...
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~--- 99 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH--- 99 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc---
Confidence 456889999999999999999665332 2689999975533 3446788999999999999999999887653
Q ss_pred CCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCC-
Q 039533 699 GNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDY- 777 (949)
Q Consensus 699 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~- 777 (949)
+...++++||.+. +|...++..+.. ..+.++...+..|+.||+.|+.|||++ =|+||||||.|||+..+
T Consensus 100 -d~~v~l~fdYAEh-DL~~II~fHr~~-----~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdg 169 (438)
T KOG0666|consen 100 -DKKVWLLFDYAEH-DLWHIIKFHRAS-----KAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDG 169 (438)
T ss_pred -CceEEEEehhhhh-hHHHHHHHhccc-----hhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccC
Confidence 3478999999987 899998754332 235789999999999999999999988 79999999999999877
Q ss_pred ---CceEEeecccceecCCCCC-ccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCcc
Q 039533 778 ---MTARVGDFGLARILSPDHT-QTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDI 845 (949)
Q Consensus 778 ---~~~kl~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~ 845 (949)
|.+||+|||+|+.+...-. ......++-|..|+|||.+.|. .|+.+.||||.|||+.||+|-++.|..
T Consensus 170 perG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 170 PERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred CccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 9999999999998865543 2234467789999999998886 489999999999999999999998853
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=306.00 Aligned_cols=285 Identities=19% Similarity=0.221 Sum_probs=202.0
Q ss_pred HHHHHHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecc
Q 039533 618 YQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGA 695 (949)
Q Consensus 618 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 695 (949)
..++...+++|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 4567778899999999999999999999998889999999986432 22245678899999999999999999987543
Q ss_pred cc-cCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeee
Q 039533 696 DY-RGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL 774 (949)
Q Consensus 696 ~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll 774 (949)
.. ......+++++++ +++|.+++. ...+++..+..++.|+++||+|||+. +|+||||||+||++
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll 153 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVK-----------CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAV 153 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEE
Confidence 21 2223467788876 789988875 23488999999999999999999977 89999999999999
Q ss_pred cCCCceEEeecccceecCCCCCccccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCchh
Q 039533 775 DDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINL 853 (949)
Q Consensus 775 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~ 853 (949)
++++.+||+|||+++...... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||....... ..
T Consensus 154 ~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~ 227 (345)
T cd07877 154 NEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QL 227 (345)
T ss_pred cCCCCEEEecccccccccccc-----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HH
Confidence 999999999999987643321 13457899999998766 467899999999999999999999995322110 11
Q ss_pred hhhcccc--CCCchhhhcccCCCCCchhhhhhhchhhhhhhh-hhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 854 HNFGRKA--LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARI-NSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 854 ~~~~~~~--~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
....+.. .++.....+. ..............+...+ .........+.+++.+|++.||++||++.|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 228 KLILRLVGTPGAELLKKIS----SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHHHhCCCCHHHHhhcc----cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 1100000 0000000000 0000000000000000000 0001234567899999999999999999998764
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=294.26 Aligned_cols=244 Identities=20% Similarity=0.230 Sum_probs=186.2
Q ss_pred CeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc---chHHHHHHHHHH-HhcCCCcceeEEeeeecccccCCccceeEe
Q 039533 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG---ASRSFIAECKAL-KSIRHRNLVKVLTACLGADYRGNDFKASVY 707 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 707 (949)
+.||+|+||.||+|.+..+++.||+|+++..... ....+..|..++ ...+|+|++++++++...+ ..++||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKD-----YLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCC-----eEEEEE
Confidence 5789999999999999888999999998644321 123344555444 4458999999999976444 789999
Q ss_pred eeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccc
Q 039533 708 EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGL 787 (949)
Q Consensus 708 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~ 787 (949)
||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||.
T Consensus 77 e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 143 (260)
T cd05611 77 EYLNGGDCASLIKT----------LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGL 143 (260)
T ss_pred eccCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeeccc
Confidence 99999999999862 24578899999999999999999977 899999999999999999999999999
Q ss_pred ceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhh
Q 039533 788 ARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMD 867 (949)
Q Consensus 788 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 867 (949)
++..... ....|+..|+|||...+..++.++||||||+++|||++|..||....... ... .
T Consensus 144 ~~~~~~~------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~------------~ 204 (260)
T cd05611 144 SRNGLEN------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-VFD------------N 204 (260)
T ss_pred ceecccc------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-HHH------------H
Confidence 8764331 12348889999999988888999999999999999999999996332110 000 0
Q ss_pred hcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 039533 868 IVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHEL 928 (949)
Q Consensus 868 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 928 (949)
+....... +. .....++..+.+++.+|++.+|++||++.++.+.+
T Consensus 205 ~~~~~~~~-~~---------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 205 ILSRRINW-PE---------------EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred HHhcccCC-CC---------------cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 00000000 00 00012356688999999999999999887665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=304.90 Aligned_cols=282 Identities=19% Similarity=0.163 Sum_probs=195.0
Q ss_pred CCCCCCeeeeecCceEEEEEEcCC--CEEEEEEEEecCCC--cchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCCc
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEG--RTTIAVKVFNLQHH--GASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 701 (949)
+|++.+.||+|+||.||+|++... +..||+|++..... ...+.+.+|+++++++ +||||+++++++.... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence 478889999999999999999877 88999999864322 2245788899999999 5999999998754321 2334
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++++||+. ++|.+++. ....+++..++.++.|++.||+|||+. +|+||||||+||++++++.+|
T Consensus 80 ~~~~~~e~~~-~~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~k 145 (332)
T cd07857 80 ELYLYEELME-ADLHQIIR----------SGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELK 145 (332)
T ss_pred cEEEEEeccc-CCHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEE
Confidence 5788889886 68998885 234588999999999999999999977 899999999999999999999
Q ss_pred EeecccceecCCCCCc--cccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcc
Q 039533 782 VGDFGLARILSPDHTQ--TSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGR 858 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~ 858 (949)
|+|||.++........ .......|+..|+|||+..+ ..++.++||||+||++|+|++|+.||...... .......
T Consensus 146 l~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~--~~~~~~~ 223 (332)
T cd07857 146 ICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV--DQLNQIL 223 (332)
T ss_pred eCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH--HHHHHHH
Confidence 9999999876533221 11123458999999998765 46889999999999999999999998643211 0000000
Q ss_pred ccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhh-HHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 859 KALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINS-IIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 859 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
........+.+......... .........+...+.. .......+.+++.+|++.||++|||+.|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 224 QVLGTPDEETLSRIGSPKAQ-NYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHhCCCCHHHHHhhhhhhHH-HHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000000000000 0000000000000000 0122457889999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=298.33 Aligned_cols=277 Identities=23% Similarity=0.246 Sum_probs=194.2
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
++|++.+.||+|++|.||+|.+..+++.||+|+++.... ...+.+.+|++++++++||||+++++++.... ..
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK-----RL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCC-----eE
Confidence 578999999999999999999988899999999864432 23457889999999999999999999976544 79
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC-CCceEE
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD-YMTARV 782 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~-~~~~kl 782 (949)
++||||++ +++.+++... ....+++..+..++.|++.||+|||++ +++||||+|+||+++. ++.+||
T Consensus 77 ~lv~e~~~-~~l~~~~~~~--------~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl 144 (294)
T PLN00009 77 YLVFEYLD-LDLKKHMDSS--------PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKL 144 (294)
T ss_pred EEEEeccc-ccHHHHHHhC--------CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEE
Confidence 99999996 5888877521 123357888889999999999999977 8999999999999985 567999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
+|||++.......... ....++..|+|||++.+. .++.++||||+||++|+|+||+.||......+. ...... ..
T Consensus 145 ~dfg~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~-~~~~~~-~~ 220 (294)
T PLN00009 145 ADFGLARAFGIPVRTF--THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE-LFKIFR-IL 220 (294)
T ss_pred cccccccccCCCcccc--ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH-Hh
Confidence 9999997654332111 123478899999987664 578999999999999999999999964322111 000000 00
Q ss_pred CCchhhhcccCC-CCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 862 PDDVMDIVDSSL-LPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 862 ~~~~~~~~d~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
........+... .++.. ..................+.++.+++.+|++.+|++||++.|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 221 GTPNEETWPGVTSLPDYK---SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred CCCChhhccccccchhhh---hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000000000 00000 000000000000001123456889999999999999999999986
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=290.53 Aligned_cols=248 Identities=25% Similarity=0.331 Sum_probs=199.8
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
+|++.+.||+|++|.||+|++..+++.||+|.+..... ...+.+.+|++++++++|+|++++++++.... ..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSD-----SLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCC-----EEE
Confidence 57889999999999999999988889999999976543 34567899999999999999999999876543 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++++|.+++.. ...+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.++|+|
T Consensus 76 ~v~e~~~~~~L~~~~~~----------~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d 142 (254)
T cd06627 76 IILEYAENGSLRQIIKK----------FGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLAD 142 (254)
T ss_pred EEEecCCCCcHHHHHHh----------ccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEec
Confidence 99999999999999862 24689999999999999999999977 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCc
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
||.+.......... ....++..|+|||...+..++.++||||+|+++|+|++|+.||....... ...
T Consensus 143 ~~~~~~~~~~~~~~--~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~----~~~------- 209 (254)
T cd06627 143 FGVATKLNDVSKDD--ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA----ALF------- 209 (254)
T ss_pred cccceecCCCcccc--cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH----HHH-------
Confidence 99998765543321 23458899999999888788999999999999999999999986332110 000
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
....... ... ....+..+.+++.+|+..+|++||++.|++.
T Consensus 210 --~~~~~~~-~~~------------------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 210 --RIVQDDH-PPL------------------PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred --HHhccCC-CCC------------------CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0000000 000 0122456789999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=291.96 Aligned_cols=243 Identities=23% Similarity=0.298 Sum_probs=191.3
Q ss_pred eeeecCceEEEEEEcCCCEEEEEEEEecCCC---cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEeeec
Q 039533 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH---GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFM 710 (949)
Q Consensus 634 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 710 (949)
||.|++|.||+|++..+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.. ..++||||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKK-----YIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCC-----ccEEEEecC
Confidence 6899999999999998899999999874332 33467899999999999999999999875443 789999999
Q ss_pred cCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccccee
Q 039533 711 HYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARI 790 (949)
Q Consensus 711 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~ 790 (949)
++++|.+++.. ...++...+..++.|++.||+|||++ +++|+||+|+||+++.++.++|+|||.++.
T Consensus 76 ~~~~L~~~l~~----------~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~ 142 (262)
T cd05572 76 LGGELWTILRD----------RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKK 142 (262)
T ss_pred CCCcHHHHHhh----------cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccc
Confidence 99999999962 23478899999999999999999977 999999999999999999999999999987
Q ss_pred cCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhhhcc
Q 039533 791 LSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVD 870 (949)
Q Consensus 791 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d 870 (949)
...... .....++..|+|||.+.+..++.++|+||+|+++|||++|+.||.......... ...+.+
T Consensus 143 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-----------~~~~~~ 208 (262)
T cd05572 143 LKSGQK---TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEI-----------YNDILK 208 (262)
T ss_pred cCcccc---cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHH-----------HHHHhc
Confidence 654321 123458899999999888889999999999999999999999996432111000 001110
Q ss_pred cCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC-----HHHHHH
Q 039533 871 SSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTN-----MTNVVH 926 (949)
Q Consensus 871 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~~ 926 (949)
...... .....+..+.+++.+||+.+|++||+ ++|+++
T Consensus 209 ~~~~~~------------------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 209 GNGKLE------------------FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCCCCC------------------CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 000000 00122456899999999999999999 555544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=307.14 Aligned_cols=284 Identities=19% Similarity=0.226 Sum_probs=197.6
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeeccccc------
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYR------ 698 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~------ 698 (949)
..+|.+.+.||.|+||.||+|.+..+++.||+|++........+.+.+|++++++++||||+++++++......
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 36899999999999999999999988999999999766655667789999999999999999999876543211
Q ss_pred ---CCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec
Q 039533 699 ---GNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD 775 (949)
Q Consensus 699 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~ 775 (949)
.....++||||++ ++|.+++. ...+++..++.++.|++.||.|||+. +|+||||||+||+++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~-----------~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~ 148 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE-----------QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFIN 148 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH-----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEc
Confidence 1235789999997 58988874 23478899999999999999999977 899999999999997
Q ss_pred -CCCceEEeecccceecCCCCCcc-ccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCch
Q 039533 776 -DYMTARVGDFGLARILSPDHTQT-SSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDIN 852 (949)
Q Consensus 776 -~~~~~kl~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~ 852 (949)
+++.+|++|||.++......... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~- 227 (342)
T cd07854 149 TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ- 227 (342)
T ss_pred CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 55678999999998654322211 1112347889999997654 4678899999999999999999999964322110
Q ss_pred hhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 853 LHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 853 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
....... .+....+.........+ +......................++.+++.+|++.||++|||+.|+++
T Consensus 228 ~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 228 MQLILES-VPVVREEDRNELLNVIP-SFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHHHHh-cCCCChHHhhhhhhhhh-hhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000000 00000000000000000 000000000000000001123456889999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=292.76 Aligned_cols=250 Identities=24% Similarity=0.311 Sum_probs=200.1
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
+|++.+.||+|++|.||+|.+..+++.+|+|++.... ......+.+|++++++++|+||+++++++... ...+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-----NKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-----CEEE
Confidence 5888999999999999999998889999999987543 23345778899999999999999999886544 4789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++++|.+++.... .....+++..+..++.|++.|++|||+. +++||||+|+||++++++.+||+|
T Consensus 76 ~v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d 146 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRK------KKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGD 146 (256)
T ss_pred EEehhcCCCCHHHHHHHHH------hhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEee
Confidence 9999999999999986311 1235688999999999999999999977 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCc
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
||.++........ ...++..|+|||.+.+..++.++|+||+|+++|||++|+.||...... .+...
T Consensus 147 ~g~~~~~~~~~~~----~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~~-------- 212 (256)
T cd08530 147 LGISKVLKKNMAK----TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLRYK-------- 212 (256)
T ss_pred ccchhhhccCCcc----cccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH--------
Confidence 9999876554211 234788999999999888999999999999999999999998633211 00000
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
+.....+. .....+..+.+++.+|++.+|++||++.|+++
T Consensus 213 ----~~~~~~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 213 ----VQRGKYPP------------------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred ----HhcCCCCC------------------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000000 01134556899999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=295.22 Aligned_cols=245 Identities=23% Similarity=0.246 Sum_probs=188.6
Q ss_pred eeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEeeec
Q 039533 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFM 710 (949)
Q Consensus 634 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 710 (949)
||+|+||+||+|.+..+++.||+|++.... ......+.+|++++++++||||+++++++...+ ..++||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKD-----DLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCC-----eEEEEEecC
Confidence 689999999999998889999999986432 222345678999999999999999998865443 789999999
Q ss_pred cCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccccee
Q 039533 711 HYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARI 790 (949)
Q Consensus 711 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~ 790 (949)
++++|.+++... ....+++.++..++.|++.|+.|||+. +++||||+|+||++++++.+||+|||.+..
T Consensus 76 ~~~~L~~~l~~~--------~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~ 144 (277)
T cd05577 76 NGGDLKYHIYNV--------GEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVE 144 (277)
T ss_pred CCCcHHHHHHHc--------CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhh
Confidence 999999998621 123588999999999999999999977 999999999999999999999999999876
Q ss_pred cCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhhhcc
Q 039533 791 LSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVD 870 (949)
Q Consensus 791 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d 870 (949)
....... ....++..|+|||++.+..++.++||||+||++|+|++|+.||....... .... +.....
T Consensus 145 ~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~---------~~~~~~ 211 (277)
T cd05577 145 LKGGKKI---KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-EKEE---------LKRRTL 211 (277)
T ss_pred hccCCcc---ccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-cHHH---------HHhccc
Confidence 5432221 13457889999999988889999999999999999999999996432110 0000 000000
Q ss_pred cCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 039533 871 SSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRT-----NMTNVVH 926 (949)
Q Consensus 871 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~ 926 (949)
.... ......+..+.+++.+|++.+|++|| ++.++++
T Consensus 212 ~~~~-------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 212 EMAV-------------------EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred cccc-------------------cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 0000 00012245678999999999999999 5555543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=298.25 Aligned_cols=270 Identities=20% Similarity=0.214 Sum_probs=186.3
Q ss_pred cCceEEEEEEcCCCEEEEEEEEecC--CCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEeeeccCCCh
Q 039533 638 SFGSVYKGIIDEGRTTIAVKVFNLQ--HHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSL 715 (949)
Q Consensus 638 ~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL 715 (949)
++|.||.++...+++.||||+++.. .....+.+.+|++++++++|+||+++++++...+ ..+++|||+++++|
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~-----~~~~~~e~~~~~~l 86 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS-----ELYVVSPLMAYGSC 86 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCC-----eEEEEEeccCCCCH
Confidence 4455666666667899999999754 2334568999999999999999999999876544 78999999999999
Q ss_pred hhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecccceecCCCC
Q 039533 716 EEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDH 795 (949)
Q Consensus 716 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 795 (949)
.+++... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+.......
T Consensus 87 ~~~l~~~--------~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~ 155 (314)
T cd08216 87 EDLLKTH--------FPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHG 155 (314)
T ss_pred HHHHHHh--------cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccc
Confidence 9998632 123478889999999999999999977 89999999999999999999999999887653221
Q ss_pred C-----ccccccccCccCccCccccCC--CccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC----Cc
Q 039533 796 T-----QTSSFSVKGSLGYIAPEYGVG--CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP----DD 864 (949)
Q Consensus 796 ~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~----~~ 864 (949)
. ........++..|+|||++.+ ..++.++|||||||++|||++|+.||.......... .......+ ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~ 234 (314)
T cd08216 156 KRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL-EKVRGTVPCLLDKS 234 (314)
T ss_pred ccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhccCccccccC
Confidence 1 111123347788999999876 358899999999999999999999997432211111 00000000 00
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
................ ....................+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 235 TYPLYEDSMSQSRSSN--EHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred chhhhcCCcCcccccc--cccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0000000000000000 00000000001111233457889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=300.71 Aligned_cols=284 Identities=19% Similarity=0.218 Sum_probs=197.4
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccc---cC
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADY---RG 699 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~ 699 (949)
.++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+|++++++++||||+++++++..... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 5789999999999999999999998899999999864432 223467889999999999999999988754331 12
Q ss_pred CccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCc
Q 039533 700 NDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMT 779 (949)
Q Consensus 700 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~ 779 (949)
....++||||+.+ ++.+.+.. ....+++.++..++.|+++||+|||+. +|+||||||+||++++++.
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~---------~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~ 153 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN---------PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGI 153 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc---------cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCC
Confidence 3457899999965 67776652 234589999999999999999999977 8999999999999999999
Q ss_pred eEEeecccceecCCCCCcc---------ccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCcccccc
Q 039533 780 ARVGDFGLARILSPDHTQT---------SSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEG 849 (949)
Q Consensus 780 ~kl~DfG~a~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~ 849 (949)
+||+|||+++......... ......++..|+|||++.+. .++.++|||||||++|||++|++||......
T Consensus 154 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~ 233 (311)
T cd07866 154 LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233 (311)
T ss_pred EEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999997654332211 11233578889999987654 5789999999999999999999999643221
Q ss_pred Cc--hhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 850 DI--NLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 850 ~~--~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.. ..........+...... +. +.................. ........+.+++.+|++.||++|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 234 DQLHLIFKLCGTPTEETWPGW-RS-LPGCEGVHSFTNYPRTLEE---RFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHHHHHhCCCChhhchhh-hh-cccccccccCCCCCccHHH---HcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 10 00000000000000000 00 0000000000000000000 11122356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=306.39 Aligned_cols=280 Identities=18% Similarity=0.202 Sum_probs=199.3
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccc-cCC
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADY-RGN 700 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~ 700 (949)
..++|++.+.||+|++|.||+|++..+++.||+|++.... ....+.+.+|+.++++++|||++++++++...+. ...
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999999889999999986432 2233567789999999999999999887654432 222
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
...++|+||+ +++|.+++. ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~-----------~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~ 157 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVK-----------CQKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCEL 157 (343)
T ss_pred ccEEEEEecC-CCCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCE
Confidence 3479999998 679999886 13589999999999999999999977 89999999999999999999
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
||+|||.+....... ....++..|+|||.+.+ ..++.++|||||||++||+++|+.||....... .+... ..
T Consensus 158 kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~~i-~~ 230 (343)
T cd07851 158 KILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-QLKRI-MN 230 (343)
T ss_pred EEccccccccccccc-----cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHH-HH
Confidence 999999998654331 12357889999998765 367899999999999999999999996332110 00000 00
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhh-hHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARIN-SIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.......++.......... .............+. ........+.+++.+|++.+|++|||+.||++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 231 LVGTPDEELLQKISSESAR-NYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hcCCCCHHHHhhccchhHH-HHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0000000111100000000 000000000000111 11123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=291.87 Aligned_cols=242 Identities=21% Similarity=0.221 Sum_probs=183.2
Q ss_pred eeeeecCceEEEEEEcCCCEEEEEEEEecCCCc---chHHHHHHHHH---HHhcCCCcceeEEeeeecccccCCccceeE
Q 039533 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG---ASRSFIAECKA---LKSIRHRNLVKVLTACLGADYRGNDFKASV 706 (949)
Q Consensus 633 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~---l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 706 (949)
.||+|+||.||+|.+..+++.||+|.+...... ....+..|..+ ++...||+|+++++++...+ ..++|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-----~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD-----KLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC-----EEEEE
Confidence 489999999999999888999999998754221 12233444443 44457999999998865444 78999
Q ss_pred eeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecc
Q 039533 707 YEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFG 786 (949)
Q Consensus 707 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG 786 (949)
|||+++++|.+++. ....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~e~~~g~~L~~~l~----------~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg 142 (278)
T cd05606 76 LDLMNGGDLHYHLS----------QHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLG 142 (278)
T ss_pred EecCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCc
Confidence 99999999999885 234589999999999999999999977 89999999999999999999999999
Q ss_pred cceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCch
Q 039533 787 LARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDV 865 (949)
Q Consensus 787 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 865 (949)
.+........ ....|+..|+|||++.+. .++.++||||+||++|||++|+.||..............
T Consensus 143 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~-------- 210 (278)
T cd05606 143 LACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-------- 210 (278)
T ss_pred CccccCccCC----cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH--------
Confidence 9876543222 123589999999998754 688999999999999999999999964321110000000
Q ss_pred hhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 039533 866 MDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRT-----NMTNVVH 926 (949)
Q Consensus 866 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~ 926 (949)
....+..+ ....+..+.+++.+|+..+|++|| ++.|+++
T Consensus 211 ~~~~~~~~----------------------~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 211 TLTMAVEL----------------------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred hhccCCCC----------------------CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 00000000 012245678999999999999999 9999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=296.54 Aligned_cols=254 Identities=21% Similarity=0.245 Sum_probs=192.3
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-cchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCCcc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 702 (949)
.++|++.+.||+|++|.||+|.+..+++.||||+++.... .....+..|+.++.+. .||||+++++++.... .
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~ 88 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS-----D 88 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCC-----e
Confidence 4678899999999999999999988899999999975432 2335566777777676 4999999999986544 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+. +++.+++.. ....+++..+..++.|++.|++|||+.. +|+||||+|+||++++++.+||
T Consensus 89 ~~~v~e~~~-~~l~~l~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL 156 (296)
T cd06618 89 VFICMELMS-TCLDKLLKR---------IQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKL 156 (296)
T ss_pred EEEEeeccC-cCHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEE
Confidence 899999985 477776642 1236889999999999999999999632 8999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCc----cCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcc
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCE----VSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGR 858 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~ 858 (949)
+|||.+.......... ...++..|+|||++.+.. ++.++||||||+++|||++|+.||.........+.
T Consensus 157 ~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~---- 229 (296)
T cd06618 157 CDFGISGRLVDSKAKT---RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLT---- 229 (296)
T ss_pred CccccchhccCCCccc---CCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHH----
Confidence 9999987654333221 234788999999987553 78999999999999999999999864211110000
Q ss_pred ccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 859 KALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 859 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
..+.......+ ....++.++.+++.+|++.||++||++.++++.
T Consensus 230 --------~~~~~~~~~~~-----------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 230 --------KILQEEPPSLP-----------------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred --------HHhcCCCCCCC-----------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11110000000 000234568899999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=294.23 Aligned_cols=272 Identities=21% Similarity=0.208 Sum_probs=194.7
Q ss_pred CCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc-chHHHHHHHHHHHhcC-CCcceeEEeeeecccccCCcccee
Q 039533 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG-ASRSFIAECKALKSIR-HRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 628 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
|++.+.||+|++|+||+|+...+++.||||++...... ......+|+..+++++ |+|++++++++... +..++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~-----~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREN-----DELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcC-----CcEEE
Confidence 67789999999999999999888899999998644322 2234567999999998 99999999987553 48899
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
||||+ +|+|.+++... ....+++.++..++.|++.||.|||++ +++|+||+|+||++++++.++|+||
T Consensus 76 v~e~~-~~~l~~~~~~~--------~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~ 143 (283)
T cd07830 76 VFEYM-EGNLYQLMKDR--------KGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADF 143 (283)
T ss_pred EEecC-CCCHHHHHHhc--------ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeec
Confidence 99999 78999988621 124689999999999999999999977 8999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCch--hhhhccccCC
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDIN--LHNFGRKALP 862 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~--~~~~~~~~~~ 862 (949)
|.++......... ...++..|+|||++.+ ..++.++||||||+++|||++|+.||......+.. ..........
T Consensus 144 ~~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (283)
T cd07830 144 GLAREIRSRPPYT---DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTK 220 (283)
T ss_pred ccceeccCCCCcC---CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCCh
Confidence 9998765432221 2447889999998754 45789999999999999999999998543221110 0000000000
Q ss_pred Cchhhh--cccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 863 DDVMDI--VDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 863 ~~~~~~--~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
+...+. .+...... ......... ..........+.+++.+|++.+|++|||++|++.
T Consensus 221 ~~~~~~~~~~~~~~~~----~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 221 QDWPEGYKLASKLGFR----FPQFAPTSL---HQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hhhhhHhhhhcccccc----ccccccccH---HHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000000 00000000 000000000 0001122466889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=293.56 Aligned_cols=247 Identities=22% Similarity=0.296 Sum_probs=192.3
Q ss_pred eeeecCceEEEEEEcCCCEEEEEEEEecCCC---cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEeeec
Q 039533 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH---GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFM 710 (949)
Q Consensus 634 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 710 (949)
||+|+||.||+|++..+++.||+|++..... ...+.+.+|++++++++||||+++++.+.. ....++||||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG-----KKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec-----CcEEEEEEecC
Confidence 6899999999999998899999999865433 344678899999999999999999887643 34789999999
Q ss_pred cCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccccee
Q 039533 711 HYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARI 790 (949)
Q Consensus 711 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~ 790 (949)
++++|.+++.. ...+++..+..++.|+++||+|||+. +++||||+|+||++++++.++|+|||++..
T Consensus 76 ~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~ 142 (265)
T cd05579 76 PGGDLASLLEN----------VGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKV 142 (265)
T ss_pred CCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchh
Confidence 99999999962 23588999999999999999999977 899999999999999999999999999876
Q ss_pred cCCCCCc------cccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCc
Q 039533 791 LSPDHTQ------TSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 791 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
....... .......++..|+|||...+...+.++||||||+++||+++|+.||....... .
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~----------- 209 (265)
T cd05579 143 GLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE--I----------- 209 (265)
T ss_pred cccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--H-----------
Confidence 5433211 11123457889999999988889999999999999999999999986332110 0
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQ 929 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 929 (949)
.......... ++.....+..+.+++.+|++.+|++|||+.+|.+.|+
T Consensus 210 ~~~~~~~~~~------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 210 FQNILNGKIE------------------WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HHHHhcCCcC------------------CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0000000000 0000012456789999999999999999966665553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.8e-33 Score=274.23 Aligned_cols=272 Identities=21% Similarity=0.287 Sum_probs=201.5
Q ss_pred CHHHHHHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhc-CCCcceeEEeeeecc
Q 039533 617 SYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSI-RHRNLVKVLTACLGA 695 (949)
Q Consensus 617 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 695 (949)
.++|+..-| .+.||+|+|+.|-.+....++..+|||++.+.......+..+|++++.+. .|+||++++++|.+.
T Consensus 74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 466776666 36899999999999999989999999999887666678899999999999 599999999996544
Q ss_pred cccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec
Q 039533 696 DYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD 775 (949)
Q Consensus 696 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~ 775 (949)
...|+|||-|.||+|..+++ ....+++.++.++..+|+.||.|||++ ||.|||+||+|||-.
T Consensus 149 -----~~FYLVfEKm~GGplLshI~----------~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~ 210 (463)
T KOG0607|consen 149 -----TRFYLVFEKMRGGPLLSHIQ----------KRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCE 210 (463)
T ss_pred -----ceEEEEEecccCchHHHHHH----------HhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeec
Confidence 48999999999999999997 456789999999999999999999977 999999999999987
Q ss_pred CCC---ceEEeecccceecCCCC-----CccccccccCccCccCccccC---C--CccCCccchHHHHHHHHHHHhCCCC
Q 039533 776 DYM---TARVGDFGLARILSPDH-----TQTSSFSVKGSLGYIAPEYGV---G--CEVSTNGDVYSYGILLLELVIGKKP 842 (949)
Q Consensus 776 ~~~---~~kl~DfG~a~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~---~--~~~~~~sDiwSlGvvl~elltg~~P 842 (949)
... -+||+||.++.-..... ....-...+|+..|||||+.. + ..|+.++|.||+|||+|-|++|.+|
T Consensus 211 ~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpP 290 (463)
T KOG0607|consen 211 SPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPP 290 (463)
T ss_pred CCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCC
Confidence 554 47999998775432111 111222456999999999743 2 3588999999999999999999999
Q ss_pred CccccccCchhhhhccccCCCc-hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCH
Q 039533 843 IDIMFEGDINLHNFGRKALPDD-VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNM 921 (949)
Q Consensus 843 f~~~~~~~~~~~~~~~~~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 921 (949)
|...-..+- -|-+...-+. -..++ +.|..+.-.-+...|. .+..+..+++...+..|+.+|-++
T Consensus 291 FvG~Cg~dC---GWdrGe~Cr~CQ~~LF---------esIQEGkYeFPdkdWa---hIS~eakdlisnLlvrda~~rlsa 355 (463)
T KOG0607|consen 291 FVGHCGADC---GWDRGEVCRVCQNKLF---------ESIQEGKYEFPDKDWA---HISSEAKDLISNLLVRDAKQRLSA 355 (463)
T ss_pred ccCccCCcC---CccCCCccHHHHHHHH---------HHHhccCCcCChhhhH---HhhHHHHHHHHHHHhccHHhhhhh
Confidence 965432211 0111111000 00111 1111111112223333 444556777778888999999999
Q ss_pred HHHHH
Q 039533 922 TNVVH 926 (949)
Q Consensus 922 ~ev~~ 926 (949)
.+++.
T Consensus 356 ~~vln 360 (463)
T KOG0607|consen 356 AQVLN 360 (463)
T ss_pred hhccC
Confidence 98876
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=296.84 Aligned_cols=248 Identities=25% Similarity=0.328 Sum_probs=192.6
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
.|+..+.||+|+||.||+|++..+++.||+|.+.... ....+++.+|++++++++|+|++++++++.... ..
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~ 90 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-----TA 90 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC-----ee
Confidence 4677789999999999999998889999999986432 223356788999999999999999999976544 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++||||+. |++.+++.. ....+++.++..++.|++.|+.|||+. +++||||||+||+++.++.++|+
T Consensus 91 ~lv~e~~~-~~l~~~~~~---------~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~ 157 (308)
T cd06634 91 WLVMEYCL-GSASDLLEV---------HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLG 157 (308)
T ss_pred EEEEEccC-CCHHHHHHH---------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEEC
Confidence 99999996 588777641 224478899999999999999999977 89999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccC---CCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGV---GCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
|||.+....... ...++..|+|||++. ...++.++|||||||++|||++|+.||....... ...
T Consensus 158 dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~------ 224 (308)
T cd06634 158 DFGSASIMAPAN------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALY------ 224 (308)
T ss_pred CcccceeecCcc------cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HHH------
Confidence 999988654322 234788999999874 3467889999999999999999999985321110 000
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQ 929 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 929 (949)
....... +.. .....+..+.+++.+||+.+|++||++.+|++.-.
T Consensus 225 ------~~~~~~~-~~~-----------------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 225 ------HIAQNES-PAL-----------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred ------HHhhcCC-CCc-----------------CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 0000000 000 00133456789999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=318.68 Aligned_cols=205 Identities=19% Similarity=0.215 Sum_probs=157.2
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCC-EEEEEEEEe-----------------cCCCcchHHHHHHHHHHHhcCCCcc
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGR-TTIAVKVFN-----------------LQHHGASRSFIAECKALKSIRHRNL 685 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~-----------------~~~~~~~~~~~~E~~~l~~l~h~ni 685 (949)
..++|++.+.||+|+||+||+|..+... ..+++|.+. .........+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3568999999999999999998764322 112222110 0111223568899999999999999
Q ss_pred eeEEeeeecccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 039533 686 VKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHC 765 (949)
Q Consensus 686 v~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHr 765 (949)
+++++++...+ ..++|+|++. +++.+++..... .........++..|+.|++.||+|||++ +|+||
T Consensus 226 v~l~~~~~~~~-----~~~lv~e~~~-~~l~~~l~~~~~-----~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHr 291 (501)
T PHA03210 226 LKIEEILRSEA-----NTYMITQKYD-FDLYSFMYDEAF-----DWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHR 291 (501)
T ss_pred CcEeEEEEECC-----eeEEEEeccc-cCHHHHHhhccc-----cccccccHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 99999976544 7899999985 577777652111 0112234667788999999999999977 99999
Q ss_pred CCCCCCeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCC
Q 039533 766 DLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPI 843 (949)
Q Consensus 766 Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf 843 (949)
||||+|||++.++.+||+|||+++.+....... .....||..|+|||++.+..++.++|||||||++|||++|..++
T Consensus 292 DLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 292 DIKLENIFLNCDGKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCHHHEEECCCCCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 999999999999999999999998765433221 12356999999999999999999999999999999999987543
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-32 Score=299.88 Aligned_cols=276 Identities=21% Similarity=0.236 Sum_probs=194.6
Q ss_pred hcCCCC-CCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcc--------------hHHHHHHHHHHHhcCCCcceeEE
Q 039533 625 TSGFSS-ANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGA--------------SRSFIAECKALKSIRHRNLVKVL 689 (949)
Q Consensus 625 ~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~~~ 689 (949)
.++|.. .+.||+|+||.||+|.+..+++.||||+++...... ...+.+|++++++++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 356654 577999999999999998889999999986432211 12577899999999999999999
Q ss_pred eeeecccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 039533 690 TACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKP 769 (949)
Q Consensus 690 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp 769 (949)
+++...+ ..++||||++ ++|.+++. ....+++..+..++.|++.||+|||+. +++||||+|
T Consensus 87 ~~~~~~~-----~~~lv~e~~~-~~l~~~l~----------~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~ 147 (335)
T PTZ00024 87 DVYVEGD-----FINLVMDIMA-SDLKKVVD----------RKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSP 147 (335)
T ss_pred EEEecCC-----cEEEEEeccc-cCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccH
Confidence 9976444 7899999997 68999886 234588999999999999999999977 999999999
Q ss_pred CCeeecCCCceEEeecccceecCCCCC------------ccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHH
Q 039533 770 SNVLLDDYMTARVGDFGLARILSPDHT------------QTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLEL 836 (949)
Q Consensus 770 ~NIll~~~~~~kl~DfG~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~el 836 (949)
+||+++.++.+||+|||.++....... ........++..|+|||++.+. .++.++||||+||++|||
T Consensus 148 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el 227 (335)
T PTZ00024 148 ANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAEL 227 (335)
T ss_pred HHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHH
Confidence 999999999999999999987651110 0111123467889999998764 468999999999999999
Q ss_pred HhCCCCCccccccCch--hhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCC
Q 039533 837 VIGKKPIDIMFEGDIN--LHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMEL 914 (949)
Q Consensus 837 ltg~~Pf~~~~~~~~~--~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d 914 (949)
++|+.||......+.. ............+....+.... .+ .....+..........+..+.+++.+|++.+
T Consensus 228 ~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~~------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 300 (335)
T PTZ00024 228 LTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLY-TE------FTPRKPKDLKTIFPNASDDAIDLLQSLLKLN 300 (335)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccc-cc------cCcCCcccHHHhCcCCChHHHHHHHHHcCCC
Confidence 9999999643221100 0000000000000000000000 00 0000000000011123456889999999999
Q ss_pred CCCCCCHHHHHH
Q 039533 915 PQDRTNMTNVVH 926 (949)
Q Consensus 915 P~~RPs~~ev~~ 926 (949)
|++|||++|++.
T Consensus 301 P~~R~s~~~~l~ 312 (335)
T PTZ00024 301 PLERISAKEALK 312 (335)
T ss_pred chhccCHHHHhc
Confidence 999999999986
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-33 Score=277.35 Aligned_cols=201 Identities=24% Similarity=0.293 Sum_probs=172.6
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC---cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH---GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
..++|...++||+|.||.|.+++.+.+++.+|+|++++.-. ........|-++++..+||.+..+-..| ...
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~ 240 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQ 240 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccC
Confidence 34678889999999999999999999999999999985532 2234566789999999999998876554 444
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
++.|+||||..||.|.-++. ..+.+++...+-+-..|+.||.|||++ +||.||+|.+|.|+|.+|++
T Consensus 241 drlCFVMeyanGGeLf~HLs----------rer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHI 307 (516)
T KOG0690|consen 241 DRLCFVMEYANGGELFFHLS----------RERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHI 307 (516)
T ss_pred ceEEEEEEEccCceEeeehh----------hhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCce
Confidence 58999999999999999987 245688888899999999999999987 99999999999999999999
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCc
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPID 844 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~ 844 (949)
||+|||+++.--...... ..+.||+.|.|||++....|+.++|.|.+||++|||++|+.||.
T Consensus 308 KitDFGLCKE~I~~g~t~--kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFy 369 (516)
T KOG0690|consen 308 KITDFGLCKEEIKYGDTT--KTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFY 369 (516)
T ss_pred Eeeecccchhccccccee--ccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccc
Confidence 999999998643322222 24679999999999999999999999999999999999999995
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-35 Score=326.66 Aligned_cols=414 Identities=27% Similarity=0.335 Sum_probs=329.0
Q ss_pred cEEEEEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCC
Q 039533 66 RVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQ 145 (949)
Q Consensus 66 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 145 (949)
+...|+++.|.+. .+|.+++++.+|++|.|..|.+. ..|..+..+++|++||+|.|++. .+|..+..++.+..+..+
T Consensus 69 ~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s 145 (1081)
T KOG0618|consen 69 HLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAAS 145 (1081)
T ss_pred HHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhh
Confidence 5667888888777 67788999999999999999998 89999999999999999999997 999999999999999999
Q ss_pred CccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCccccccc
Q 039533 146 NNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVE 225 (949)
Q Consensus 146 ~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 225 (949)
+|......+... .+.++|..|.+.+.++..+.++.. .|||++|.+. --.+..+.+|+.|....|+++.+.
T Consensus 146 ~N~~~~~lg~~~-----ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~ 215 (1081)
T KOG0618|consen 146 NNEKIQRLGQTS-----IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELE 215 (1081)
T ss_pred cchhhhhhcccc-----chhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEE
Confidence 994332222222 788999999999999988888777 7999999987 234677889999999999988664
Q ss_pred ccccCCCCChhhhccccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCcc
Q 039533 226 NKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNK 305 (949)
Q Consensus 226 ~~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~ 305 (949)
- .-++|+.|+.+.|.+..... .....+|+++++++|++++. |+|+... .+|+.|...+|+
T Consensus 216 ~----------~g~~l~~L~a~~n~l~~~~~--------~p~p~nl~~~dis~n~l~~l-p~wi~~~-~nle~l~~n~N~ 275 (1081)
T KOG0618|consen 216 I----------SGPSLTALYADHNPLTTLDV--------HPVPLNLQYLDISHNNLSNL-PEWIGAC-ANLEALNANHNR 275 (1081)
T ss_pred e----------cCcchheeeeccCcceeecc--------ccccccceeeecchhhhhcc-hHHHHhc-ccceEecccchh
Confidence 2 23567788888888763221 12234678888888888864 4888777 468888888888
Q ss_pred ccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCccc-----------------------
Q 039533 306 IYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSI----------------------- 362 (949)
Q Consensus 306 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----------------------- 362 (949)
++ .+|..+..+++|+.|++.+|.+. -+|+....++.|++|+|..|+|. ..|+.+
T Consensus 276 l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~ 352 (1081)
T KOG0618|consen 276 LV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPS 352 (1081)
T ss_pred HH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhcccccccc
Confidence 85 67777888888888888888887 66777777888888888888877 344322
Q ss_pred ---ccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcc-cCCcccceeeccCCCccCCCCccccccc
Q 039533 363 ---GNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQF-FSLSSLSISLDWSRNKLTGSLPIEVGKL 438 (949)
Q Consensus 363 ---~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~~l~~~L~ls~N~l~~~~p~~~~~l 438 (949)
..++.|+.|++.+|.++...-..+.+.++|+.|+|++|+|. .+|+.. .++..| +.|+||+|+++ .+|..+..+
T Consensus 353 ~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~L-eeL~LSGNkL~-~Lp~tva~~ 429 (1081)
T KOG0618|consen 353 YEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEEL-EELNLSGNKLT-TLPDTVANL 429 (1081)
T ss_pred ccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHh-HHHhcccchhh-hhhHHHHhh
Confidence 13456888999999999888788999999999999999998 777755 456666 89999999999 889999999
Q ss_pred cccceeeeccccccccCCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCcCcccccCCc-cceEeC
Q 039533 439 KILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLS-LNNLNL 517 (949)
Q Consensus 439 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~l~l 517 (949)
+.|++|...+|+|. ..| ++..++.|+.+|+|.|+|+...-..-..-++|++|||++|.-.-..-+.+..++ +...++
T Consensus 430 ~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i 507 (1081)
T KOG0618|consen 430 GRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDI 507 (1081)
T ss_pred hhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcccccchhhhHHhhhhhheec
Confidence 99999999999999 788 899999999999999999854332222228999999999984323333344333 555555
Q ss_pred CCC
Q 039533 518 SYN 520 (949)
Q Consensus 518 s~N 520 (949)
.-|
T Consensus 508 ~~~ 510 (1081)
T KOG0618|consen 508 TLN 510 (1081)
T ss_pred ccC
Confidence 555
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=295.28 Aligned_cols=250 Identities=23% Similarity=0.321 Sum_probs=198.5
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcC-CCcceeEEeeeecccccCCc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIR-HRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 701 (949)
++|.+.+.||+|++|.||+|+...+++.||+|++.... ....+.+.+|++++++++ ||||+++++++... +
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-----~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE-----E 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC-----c
Confidence 47889999999999999999998889999999986432 233467889999999998 99999999886543 3
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++++|.+++. ....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++
T Consensus 76 ~~~lv~e~~~~~~L~~~l~----------~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~ 142 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIR----------KYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIK 142 (280)
T ss_pred eEEEEEcCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEE
Confidence 7899999999999999996 233689999999999999999999977 899999999999999999999
Q ss_pred EeecccceecCCCCCc------------------cccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCC
Q 039533 782 VGDFGLARILSPDHTQ------------------TSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPI 843 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf 843 (949)
++|||.+......... .......++..|+|||+..+..++.++||||||+++|++++|+.||
T Consensus 143 l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 222 (280)
T cd05581 143 ITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF 222 (280)
T ss_pred ecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC
Confidence 9999999876543321 1112345789999999988888999999999999999999999998
Q ss_pred ccccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCH--
Q 039533 844 DIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNM-- 921 (949)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-- 921 (949)
....... .+ ....+... . .....++.+.+++.+|++.+|++||++
T Consensus 223 ~~~~~~~-~~------------~~~~~~~~-~-------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 269 (280)
T cd05581 223 RGSNEYL-TF------------QKILKLEY-S-------------------FPPNFPPDAKDLIEKLLVLDPQDRLGVNE 269 (280)
T ss_pred CCccHHH-HH------------HHHHhcCC-C-------------------CCCccCHHHHHHHHHHhcCCHhhCCCccc
Confidence 6432100 00 00000000 0 001224568899999999999999999
Q ss_pred --HHHHH
Q 039533 922 --TNVVH 926 (949)
Q Consensus 922 --~ev~~ 926 (949)
+|+++
T Consensus 270 ~~~~ll~ 276 (280)
T cd05581 270 GYDELKA 276 (280)
T ss_pred CHHHHhc
Confidence 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=293.55 Aligned_cols=245 Identities=26% Similarity=0.324 Sum_probs=189.9
Q ss_pred CCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC---cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH---GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 628 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
|...+.||+|+||.||+|++..+++.||+|++..... ...+.+.+|++++++++|||++++++++.+.. ..+
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 97 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEH-----TAW 97 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC-----EEE
Confidence 5667889999999999999988899999999874432 22356788999999999999999999976544 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+. |++.+++.. ....+++.++..++.|++.|++|||+. +++||||+|+||+++.++.+||+|
T Consensus 98 lv~e~~~-~~l~~~l~~---------~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~d 164 (313)
T cd06633 98 LVMEYCL-GSASDLLEV---------HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLAD 164 (313)
T ss_pred EEEecCC-CCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEee
Confidence 9999996 577777752 234588999999999999999999977 899999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccC---CCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGV---GCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
||.+....... ...|+..|+|||++. ...++.++|||||||++|||++|..||........ ..
T Consensus 165 fg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~-~~------- 230 (313)
T cd06633 165 FGSASKSSPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LY------- 230 (313)
T ss_pred cCCCcccCCCC------CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HH-------
Confidence 99986432211 245889999999974 45688999999999999999999999853311100 00
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
........... ....+..+.+++.+|++.+|++||++.|+++.
T Consensus 231 -----~~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 231 -----HIAQNDSPTLQ------------------SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -----HHHhcCCCCCC------------------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000000 00123457889999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-32 Score=288.42 Aligned_cols=251 Identities=20% Similarity=0.243 Sum_probs=193.2
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC-----CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-----HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
+|.+.+.||+|+||.||+|.+...+..+++|+.+... .....++..|+.++++++||||+++++++.+.+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD----- 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC-----
Confidence 5888999999999999999998666667777765321 122345778999999999999999998865443
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++++|.+++.... .....+++.+++.++.|++.|+.|||+. +++|+||||+||++++ +.++
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~ 145 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELK------HTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLK 145 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHh------hcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEe
Confidence 7899999999999999886321 1235689999999999999999999977 9999999999999986 5799
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
|+|||.++......... ....|+..|+|||...+..++.++|+||||+++|+|++|..||...... ...
T Consensus 146 l~d~g~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~---- 214 (260)
T cd08222 146 IGDFGVSRLLMGSCDLA--TTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL-----SVV---- 214 (260)
T ss_pred ecccCceeecCCCcccc--cCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-----HHH----
Confidence 99999998764433221 1345888999999988888899999999999999999999998532110 000
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.......... .....+..+.+++.+|+..+|++||++.|+++
T Consensus 215 ----~~~~~~~~~~-------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 215 ----LRIVEGPTPS-------------------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ----HHHHcCCCCC-------------------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 0000000000 01134557889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=293.54 Aligned_cols=257 Identities=21% Similarity=0.235 Sum_probs=195.3
Q ss_pred CCCCCCeeeeecCceEEEEEEc---CCCEEEEEEEEecCC----CcchHHHHHHHHHHHhc-CCCcceeEEeeeeccccc
Q 039533 627 GFSSANLVGVGSFGSVYKGIID---EGRTTIAVKVFNLQH----HGASRSFIAECKALKSI-RHRNLVKVLTACLGADYR 698 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 698 (949)
+|++.+.||+|++|.||+|+.. .+++.||||+++... ....+.+.+|+++++++ +||||+++++.+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~--- 77 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD--- 77 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC---
Confidence 4788899999999999999864 356889999987432 22335688999999999 599999999886443
Q ss_pred CCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC
Q 039533 699 GNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM 778 (949)
Q Consensus 699 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~ 778 (949)
...++||||+++++|.+++.. ...+++..+..++.|+++||+|||+. +++||||||+||+++.++
T Consensus 78 --~~~~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~ 142 (288)
T cd05583 78 --TKLHLILDYVNGGELFTHLYQ----------REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEG 142 (288)
T ss_pred --CEEEEEEecCCCCcHHHHHhh----------cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCC
Confidence 378999999999999999862 24578889999999999999999976 899999999999999999
Q ss_pred ceEEeecccceecCCCCCccccccccCccCccCccccCCCc--cCCccchHHHHHHHHHHHhCCCCCccccccCchhhhh
Q 039533 779 TARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCE--VSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNF 856 (949)
Q Consensus 779 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~ 856 (949)
.++|+|||+++......... .....|+..|+|||...+.. .+.++||||||+++|||++|..||....... .....
T Consensus 143 ~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~ 220 (288)
T cd05583 143 HVVLTDFGLSKEFLAEEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-SQSEI 220 (288)
T ss_pred CEEEEECccccccccccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-hHHHH
Confidence 99999999987654432211 11345889999999987654 7889999999999999999999985221100 00000
Q ss_pred ccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHh
Q 039533 857 GRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSI 931 (949)
Q Consensus 857 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 931 (949)
. ....... .+. .......+.+++.+|++.+|++|||+.+|.+.|+..
T Consensus 221 ~--------~~~~~~~-~~~-------------------~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 221 S--------RRILKSK-PPF-------------------PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred H--------HHHHccC-CCC-------------------CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0 0000000 000 012334678899999999999999999888877654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=290.61 Aligned_cols=273 Identities=22% Similarity=0.272 Sum_probs=197.6
Q ss_pred CCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 628 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
|+..+.||+|++|.||+|+...+++.||+|++.... ....+.+..|+.++++++|+|++++++++.+. ...++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-----RKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-----CceEE
Confidence 567789999999999999999889999999998653 33346788999999999999999999987654 37899
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
||||++ ++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||+|+||++++++.+||+||
T Consensus 76 v~e~~~-~~l~~~i~~---------~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~ 142 (282)
T cd07829 76 VFEYCD-MDLKKYLDK---------RPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADF 142 (282)
T ss_pred EecCcC-cCHHHHHHh---------hccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecC
Confidence 999997 599999972 114589999999999999999999987 8999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCc--hhhhhccccCC
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDI--NLHNFGRKALP 862 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~--~~~~~~~~~~~ 862 (949)
|.++......... ....++..|+|||.+.+. .++.++|||||||++||+++|+.||........ ..........+
T Consensus 143 g~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (282)
T cd07829 143 GLARAFGIPLRTY--THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTE 220 (282)
T ss_pred CcccccCCCcccc--CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcH
Confidence 9998765433211 123367789999998776 789999999999999999999999864321100 00000000000
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.......+.. ................. .......+.+++.+|+..+|++||++.||+.
T Consensus 221 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~---~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 221 ESWPGVTKLP---DYKPTFPKFPPKDLEKV---LPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HHHHhhcccc---cccccccccCccchHHh---cccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000 00000000000000000 1122567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=290.47 Aligned_cols=252 Identities=22% Similarity=0.255 Sum_probs=190.4
Q ss_pred CCCCCCeeeeecCceEEEEEEc---CCCEEEEEEEEecCCC----cchHHHHHHHHHHHhc-CCCcceeEEeeeeccccc
Q 039533 627 GFSSANLVGVGSFGSVYKGIID---EGRTTIAVKVFNLQHH----GASRSFIAECKALKSI-RHRNLVKVLTACLGADYR 698 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 698 (949)
+|++.+.||+|+||.||+|+.. .+++.||+|+++.... ...+.+.+|+++++++ +|++|+++++++...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--- 77 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD--- 77 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC---
Confidence 4788899999999999999874 3678999999874321 2235678899999999 599999999886543
Q ss_pred CCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC
Q 039533 699 GNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM 778 (949)
Q Consensus 699 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~ 778 (949)
...++||||+++++|.+++.. ...+++..+..++.|+++||+|||+. +++||||+|+||++++++
T Consensus 78 --~~~~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~ 142 (290)
T cd05613 78 --TKLHLILDYINGGELFTHLSQ----------RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNG 142 (290)
T ss_pred --CeEEEEEecCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCC
Confidence 378999999999999999862 24578889999999999999999976 999999999999999999
Q ss_pred ceEEeecccceecCCCCCccccccccCccCccCccccCCC--ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhh
Q 039533 779 TARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC--EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNF 856 (949)
Q Consensus 779 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~ 856 (949)
.+||+|||++.......... .....|+..|+|||...+. .++.++||||||+++|+|++|+.||...... ......
T Consensus 143 ~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~~ 220 (290)
T cd05613 143 HVVLTDFGLSKEFHEDEVER-AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQAEI 220 (290)
T ss_pred CEEEeeCccceecccccccc-cccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHHHH
Confidence 99999999998754432211 1234588999999998753 4678999999999999999999998532110 000000
Q ss_pred ccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 039533 857 GRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRT-----NMTNVVH 926 (949)
Q Consensus 857 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~ 926 (949)
.+.+.....+.+ ......+.+++.+|++.||++|| ++.+++.
T Consensus 221 ---------~~~~~~~~~~~~-------------------~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 221 ---------SRRILKSEPPYP-------------------QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ---------HHHhhccCCCCC-------------------ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 000000000000 12345678999999999999997 6666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-33 Score=286.41 Aligned_cols=259 Identities=23% Similarity=0.334 Sum_probs=197.0
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecC--CC-----cchHHHHHHHHHHHhcCCCcceeEEeeeeccccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ--HH-----GASRSFIAECKALKSIRHRNLVKVLTACLGADYR 698 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 698 (949)
++|-..+.||+|||+.||+|.+-...+.||||+-... .. ...+...+|.++-+.++||.||++|+|+.-.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD--- 539 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD--- 539 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec---
Confidence 4577778999999999999999888999999997522 11 1235577899999999999999999998533
Q ss_pred CCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec---
Q 039533 699 GNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD--- 775 (949)
Q Consensus 699 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~--- 775 (949)
.+.+|-|+||++|.+|+-|++ ..+.+++.+++.|+.||+.||.||... +++|||-||||.|||+.
T Consensus 540 -tdsFCTVLEYceGNDLDFYLK----------QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~Gt 607 (775)
T KOG1151|consen 540 -TDSFCTVLEYCEGNDLDFYLK----------QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGT 607 (775)
T ss_pred -cccceeeeeecCCCchhHHHH----------hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCc
Confidence 347899999999999999997 456689999999999999999999988 89999999999999994
Q ss_pred CCCceEEeecccceecCCCCCc-----cccccccCccCccCccccCCC----ccCCccchHHHHHHHHHHHhCCCCCccc
Q 039533 776 DYMTARVGDFGLARILSPDHTQ-----TSSFSVKGSLGYIAPEYGVGC----EVSTNGDVYSYGILLLELVIGKKPIDIM 846 (949)
Q Consensus 776 ~~~~~kl~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~sDiwSlGvvl~elltg~~Pf~~~ 846 (949)
.-|.+||+|||+++.+..+... .......||++|.+||.+.-+ +.+.|+||||.|||+|..+.|+.||...
T Consensus 608 acGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 608 ACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred ccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 5588999999999998765432 122245699999999986533 5789999999999999999999999644
Q ss_pred cccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 847 FEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 847 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
......+ .... +...-.-.+.+. .....+...++++|+++--++|....+++.
T Consensus 688 qsQQdIL-qeNT------IlkAtEVqFP~K--------------------PvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 688 QSQQDIL-QENT------ILKATEVQFPPK--------------------PVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hhHHHHH-hhhc------hhcceeccCCCC--------------------CccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 2221111 0000 000000001111 122344567888999988888887777653
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=312.98 Aligned_cols=267 Identities=25% Similarity=0.390 Sum_probs=207.6
Q ss_pred cCCCCCCeeeeecCceEEEEEEcC-------CCEEEEEEEEecCCC-cchHHHHHHHHHHHhc-CCCcceeEEeeeeccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDE-------GRTTIAVKVFNLQHH-GASRSFIAECKALKSI-RHRNLVKVLTACLGAD 696 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 696 (949)
++..+.+.+|+|.||.||+|.... ....||||..+.... .+.+.+..|+++|+.+ +|+||+.++|+|...+
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 344566799999999999998641 146799999874433 3457899999999999 6999999999997633
Q ss_pred ccCCccceeEeeeccCCChhhhcCCCCCCCccccCC------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 039533 697 YRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAP------RNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPS 770 (949)
Q Consensus 697 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~------~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~ 770 (949)
..++|+||++.|+|.+|++..+........+ ..++..+.+.++.|||.|++||++. ++|||||-.+
T Consensus 376 -----~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaR 447 (609)
T KOG0200|consen 376 -----PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAAR 447 (609)
T ss_pred -----ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhh
Confidence 7899999999999999998655111111111 3489999999999999999999977 8999999999
Q ss_pred CeeecCCCceEEeecccceecCCCCCccccccccC--ccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCcccc
Q 039533 771 NVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKG--SLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMF 847 (949)
Q Consensus 771 NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~ 847 (949)
|||+.++..+||+|||+|+............ ..| ...|||||.+....++.|+|||||||++|||+| |..||....
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~-~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKS-SAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecC-CCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 9999999999999999999766554433221 112 345999999999999999999999999999999 899986421
Q ss_pred ccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 848 EGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 848 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
.. +++.+.+. .+.+.+.+..|..++.++++.||+.+|++||++.|+.+.
T Consensus 527 ~~-------------~~l~~~l~------------------~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~ 575 (609)
T KOG0200|consen 527 PT-------------EELLEFLK------------------EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEF 575 (609)
T ss_pred cH-------------HHHHHHHh------------------cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 00 01111111 122223334667789999999999999999999999999
Q ss_pred HHHhH
Q 039533 928 LQSIK 932 (949)
Q Consensus 928 L~~i~ 932 (949)
++...
T Consensus 576 ~~~~l 580 (609)
T KOG0200|consen 576 FEKHL 580 (609)
T ss_pred HHHHH
Confidence 99954
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-34 Score=275.01 Aligned_cols=253 Identities=25% Similarity=0.275 Sum_probs=191.5
Q ss_pred CeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-cchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCCccceeEeee
Q 039533 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGNDFKASVYEF 709 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 709 (949)
..||.|.||+|++-.++..|+..|||+++.... ...+++..|.+...+- +.||||++||++...+ ..|+-||.
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG-----dcWiCMEL 144 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG-----DCWICMEL 144 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC-----ceeeeHHH
Confidence 579999999999999999999999999986554 5567888998876665 6899999999986544 68999999
Q ss_pred ccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecccce
Q 039533 710 MHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLAR 789 (949)
Q Consensus 710 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~ 789 (949)
|. .|++.+.+.- .......+++.-.-+|....+.||.||.... .|+|||+||+|||++..|.+||||||++.
T Consensus 145 Md-~SlDklYk~v-----y~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcG 216 (361)
T KOG1006|consen 145 MD-ISLDKLYKRV-----YSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICG 216 (361)
T ss_pred Hh-hhHHHHHHHH-----HHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchH
Confidence 95 4776655311 1123456788888889999999999999865 89999999999999999999999999997
Q ss_pred ecCCCCCccccccccCccCccCccccCCC--ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhh
Q 039533 790 ILSPDHTQTSSFSVKGSLGYIAPEYGVGC--EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMD 867 (949)
Q Consensus 790 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 867 (949)
.+..+-..+ ...|-..|||||.+... .|+.+|||||+|+++||+.||+.||..+......+...+. .+..
T Consensus 217 qLv~SiAkT---~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~----gdpp- 288 (361)
T KOG1006|consen 217 QLVDSIAKT---VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI----GDPP- 288 (361)
T ss_pred hHHHHHHhh---hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc----CCCC-
Confidence 665443322 34588999999987643 4899999999999999999999999754221111111110 0000
Q ss_pred hcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 868 IVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 868 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.+..+. ...+....+.+++..|+.+|-.+||...++.+
T Consensus 289 ----~l~~~~-----------------~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 289 ----ILLFDK-----------------ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ----eecCcc-----------------cccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 000000 01234567899999999999999999998765
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=317.57 Aligned_cols=147 Identities=27% Similarity=0.357 Sum_probs=129.6
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC---cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH---GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
.++|.+.++||+|+||.||+|++..+++.||||+++.... .....+..|+.+++.++||||+++++++...+
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~----- 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN----- 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC-----
Confidence 3679999999999999999999998899999999975432 22367889999999999999999998865444
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++++|.+++.. ...+++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+|
T Consensus 78 ~~~lVmEy~~g~~L~~li~~----------~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vk 144 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHI----------YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIK 144 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEE
Confidence 78999999999999999862 23578889999999999999999977 999999999999999999999
Q ss_pred Eeecccce
Q 039533 782 VGDFGLAR 789 (949)
Q Consensus 782 l~DfG~a~ 789 (949)
|+|||+++
T Consensus 145 L~DFGls~ 152 (669)
T cd05610 145 LTDFGLSK 152 (669)
T ss_pred EEeCCCCc
Confidence 99999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=285.90 Aligned_cols=195 Identities=28% Similarity=0.416 Sum_probs=167.4
Q ss_pred CCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEee
Q 039533 631 ANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYE 708 (949)
Q Consensus 631 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 708 (949)
.++||.|.||+||-|+++.+|+.||||++.+.. .....++++|+++++++.||.||.+.-.|...+ ..++|||
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~e-----rvFVVME 643 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPE-----RVFVVME 643 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCc-----eEEEEeh
Confidence 479999999999999999999999999997432 234478999999999999999999987765444 8999999
Q ss_pred eccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec---CCCceEEeec
Q 039533 709 FMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD---DYMTARVGDF 785 (949)
Q Consensus 709 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~---~~~~~kl~Df 785 (949)
-+.| +..+.+-. ...+++++....-++.||+.||.|||.+ +|+|+||||+|||+. .-.++||+||
T Consensus 644 Kl~G-DMLEMILS--------sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDF 711 (888)
T KOG4236|consen 644 KLHG-DMLEMILS--------SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDF 711 (888)
T ss_pred hhcc-hHHHHHHH--------hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccc
Confidence 9965 55554431 2346688888888999999999999977 999999999999995 3458999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCcc
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDI 845 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~ 845 (949)
|+|++++...... .++||+.|.|||++....|...-|+||.||++|--++|..||.+
T Consensus 712 GfARiIgEksFRr---sVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE 768 (888)
T KOG4236|consen 712 GFARIIGEKSFRR---SVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE 768 (888)
T ss_pred cceeecchhhhhh---hhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence 9999987655433 57899999999999999999999999999999999999999964
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=312.51 Aligned_cols=207 Identities=26% Similarity=0.336 Sum_probs=179.6
Q ss_pred HHHHHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecC---CCcchHHHHHHHHHHHhcCCCcceeEEeeeecc
Q 039533 619 QDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ---HHGASRSFIAECKALKSIRHRNLVKVLTACLGA 695 (949)
Q Consensus 619 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 695 (949)
.++.-..++|.+.++||+|+||.|..++++.+++.+|+|++.+. ......-|..|-.+|.--+.+=|+.+.-+|.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ-- 145 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ-- 145 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc--
Confidence 45666778999999999999999999999999999999999753 3445567889999999888899999877654
Q ss_pred cccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec
Q 039533 696 DYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD 775 (949)
Q Consensus 696 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~ 775 (949)
++.+.|+|||||+||+|-.++..+ ..+++..++-++..|+-||..+|+- |+|||||||+|||+|
T Consensus 146 ---D~~~LYlVMdY~pGGDlltLlSk~----------~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld 209 (1317)
T KOG0612|consen 146 ---DERYLYLVMDYMPGGDLLTLLSKF----------DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLD 209 (1317)
T ss_pred ---CccceEEEEecccCchHHHHHhhc----------CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEec
Confidence 445899999999999999999732 2589999999999999999999955 999999999999999
Q ss_pred CCCceEEeecccceecCCCCCccccccccCccCccCccccC----C-CccCCccchHHHHHHHHHHHhCCCCCc
Q 039533 776 DYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGV----G-CEVSTNGDVYSYGILLLELVIGKKPID 844 (949)
Q Consensus 776 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDiwSlGvvl~elltg~~Pf~ 844 (949)
..|++||+|||.+-.+..+..... ...+|||.|.+||++. + +.|++.+|.||+||++|||+.|..||.
T Consensus 210 ~~GHikLADFGsClkm~~dG~V~s-~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY 282 (1317)
T KOG0612|consen 210 KSGHIKLADFGSCLKMDADGTVRS-SVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY 282 (1317)
T ss_pred ccCcEeeccchhHHhcCCCCcEEe-ccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence 999999999999988876655333 3567999999999866 2 568999999999999999999999995
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=243.38 Aligned_cols=199 Identities=25% Similarity=0.390 Sum_probs=169.3
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.|...++||+|.||+||+|+...+++.||+|+++..+ ++......+|+-+++.++|.|||++++.... +....
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs-----dkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc-----CceeE
Confidence 4666789999999999999999999999999998543 4455788999999999999999999988543 34789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+|+||++. +|..|... -.+.++.+.++.++.|+++||.++|++ .+.|||+||.|.+|+.+|+.|++|
T Consensus 78 lvfe~cdq-dlkkyfds---------lng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelklad 144 (292)
T KOG0662|consen 78 LVFEFCDQ-DLKKYFDS---------LNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLAD 144 (292)
T ss_pred EeHHHhhH-HHHHHHHh---------cCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecc
Confidence 99999964 88888863 345689999999999999999999988 899999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCc-cCCccchHHHHHHHHHHHh-CCCCCcc
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCE-VSTNGDVYSYGILLLELVI-GKKPIDI 845 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlGvvl~ellt-g~~Pf~~ 845 (949)
||+|+.++-+..... ..+-|..|++|+++.+.+ |++..|+||-||++.|+.. |++.|..
T Consensus 145 fglarafgipvrcys--aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg 205 (292)
T KOG0662|consen 145 FGLARAFGIPVRCYS--AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_pred cchhhhcCCceEeee--ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC
Confidence 999998765543221 344789999999998876 8899999999999999997 6655643
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-33 Score=266.46 Aligned_cols=210 Identities=23% Similarity=0.349 Sum_probs=172.4
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecC--CCcchHHHHHHHHHHHhcCCCcceeEEeeeeccc---ccCC
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ--HHGASRSFIAECKALKSIRHRNLVKVLTACLGAD---YRGN 700 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~ 700 (949)
+.|....+||+|.||.||+|+.+.+++.||+|++-.. ..+-.....+|+++++.++|+|++.+++.|.... .+..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 3456667999999999999999999999999876432 3344456789999999999999999998886533 2233
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
...|+||++++. +|...+.. ....++..++.+++.++..||.|+|.. .|+|||+||.|+||+.+|.+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn---------~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgil 163 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN---------RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGIL 163 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC---------ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceE
Confidence 458999999986 88888852 235688999999999999999999977 89999999999999999999
Q ss_pred EEeecccceecCCCCC--ccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccc
Q 039533 781 RVGDFGLARILSPDHT--QTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFE 848 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~ 848 (949)
||+|||+|+.+..... ....+..+-|..|++||.+.|. .|+++.|||+-|||+.||+||.+-++...+
T Consensus 164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte 234 (376)
T KOG0669|consen 164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE 234 (376)
T ss_pred EeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH
Confidence 9999999987654332 2333455679999999988775 589999999999999999999998865433
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=295.78 Aligned_cols=267 Identities=21% Similarity=0.253 Sum_probs=217.0
Q ss_pred cCHHHHHHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhc-CCCcceeEEeeeec
Q 039533 616 LSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSI-RHRNLVKVLTACLG 694 (949)
Q Consensus 616 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 694 (949)
..++.+..-++.|.+.++||+|.+|.||+++...+++.+|+|+...... ..++...|..+++.. .|||++.++|++.-
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 3444455567789999999999999999999999999999999875543 346788899999988 69999999999988
Q ss_pred ccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeee
Q 039533 695 ADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL 774 (949)
Q Consensus 695 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll 774 (949)
.+...++..|+|||||.+||..|+++... +..+.|.....|++.++.|+.+||.. .++|||||-.|||+
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--------g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLL 156 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK--------GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLL 156 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc--------ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEE
Confidence 88778889999999999999999998543 45689999999999999999999977 89999999999999
Q ss_pred cCCCceEEeecccceecCCCCCccccccccCccCccCccccCCC-----ccCCccchHHHHHHHHHHHhCCCCCcccccc
Q 039533 775 DDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-----EVSTNGDVYSYGILLLELVIGKKPIDIMFEG 849 (949)
Q Consensus 775 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~ 849 (949)
+.++.+|++|||.+..+.... .......||+.|||||++... .|+.++|+||+|++..||--|.+|+.++...
T Consensus 157 T~e~~VKLvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm 234 (953)
T KOG0587|consen 157 TENAEVKLVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM 234 (953)
T ss_pred eccCcEEEeeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh
Confidence 999999999999998765432 223356799999999997643 4778999999999999999999998644322
Q ss_pred CchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 850 DINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 850 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
..- -...+.+......+....+++.+++..|+..|-++||++.++++
T Consensus 235 raL------------------------------F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 235 RAL------------------------------FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred hhh------------------------------ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 100 00111222233334456778899999999999999999998764
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=278.17 Aligned_cols=237 Identities=26% Similarity=0.263 Sum_probs=188.8
Q ss_pred eeeecCceEEEEEEcCCCEEEEEEEEecCCCc---chHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEeeec
Q 039533 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG---ASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFM 710 (949)
Q Consensus 634 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 710 (949)
||+|+||.||++....+++.+|+|+++..... ....+..|+.++++++||||+++++.+.. +...++||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT-----EEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec-----CCeeEEEEecC
Confidence 68999999999999888999999998754322 34578899999999999999999988643 34789999999
Q ss_pred cCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccccee
Q 039533 711 HYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARI 790 (949)
Q Consensus 711 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~ 790 (949)
++++|.+++.. ...+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||.+..
T Consensus 76 ~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 142 (250)
T cd05123 76 PGGELFSHLSK----------EGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKE 142 (250)
T ss_pred CCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCccee
Confidence 99999999962 23588999999999999999999976 999999999999999999999999999987
Q ss_pred cCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhhhcc
Q 039533 791 LSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVD 870 (949)
Q Consensus 791 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d 870 (949)
...... ......++..|+|||...+...+.++|+||||+++||+++|+.||...... ... ..+..
T Consensus 143 ~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~-----------~~~~~ 207 (250)
T cd05123 143 LSSEGS--RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK--EIY-----------EKILK 207 (250)
T ss_pred cccCCC--cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHH-----------HHHhc
Confidence 654321 112345888999999998888899999999999999999999999633210 000 00000
Q ss_pred cCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHH
Q 039533 871 SSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTN 923 (949)
Q Consensus 871 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 923 (949)
..... ....+..+.+++.+|+..||++||++++
T Consensus 208 ~~~~~--------------------~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 208 DPLRF--------------------PEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCC--------------------CCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 00000 0012456788999999999999999955
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=290.77 Aligned_cols=241 Identities=22% Similarity=0.214 Sum_probs=190.7
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCCccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
++.|.....+|.|+|+.|-.+.+..+++..+||++.... .+..+|+.++... +||||+++.+.+.+ ..+.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~-----~~~~ 391 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYED-----GKEI 391 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecC-----Ccee
Confidence 456777888999999999999999999999999987552 2345677666666 79999999998654 4489
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeee-cCCCceEE
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL-DDYMTARV 782 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll-~~~~~~kl 782 (949)
++|||.+.++-+.+.+.. .+... .++..|+.+|+.|+.|||++ ||||||+||+|||+ +..++++|
T Consensus 392 ~~v~e~l~g~ell~ri~~----------~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrl 457 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRS----------KPEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRL 457 (612)
T ss_pred eeeehhccccHHHHHHHh----------cchhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEE
Confidence 999999999988777751 22233 67788999999999999987 99999999999999 68999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
+|||.++....+- ....-|..|.|||+.....|++++||||||++||+|++|+.||.....+ ..+...
T Consensus 458 tyFG~a~~~~~~~-----~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~------ 525 (612)
T KOG0603|consen 458 TYFGFWSELERSC-----DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTR------ 525 (612)
T ss_pred EEechhhhCchhh-----cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHh------
Confidence 9999998776551 1223588999999999999999999999999999999999999754322 111110
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
...+.. ....+....+++..|++.||.+||+|.|+...
T Consensus 526 ---------i~~~~~------------------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 526 ---------IQMPKF------------------SECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ---------hcCCcc------------------ccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 000100 02445567889999999999999999998653
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=271.55 Aligned_cols=276 Identities=23% Similarity=0.347 Sum_probs=219.5
Q ss_pred HHHHHHhcCCCCCCeeeeecCceEEEEEEcCCC-----EEEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeee
Q 039533 619 QDLYNATSGFSSANLVGVGSFGSVYKGIIDEGR-----TTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTAC 692 (949)
Q Consensus 619 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 692 (949)
+++.....+++....+-+|.||.||+|.+.+.. +.|.+|.++... .-....+..|.-.+..+.|||+.++.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 345555567788888999999999999776432 346677665332 22346788898899999999999999998
Q ss_pred ecccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCe
Q 039533 693 LGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNV 772 (949)
Q Consensus 693 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NI 772 (949)
.+. ....++.|.++.-|+|..|+..+++.+. ...+.++..+...++.|++.|++|||++ +|||.||..+|.
T Consensus 357 ie~----~~~P~V~y~~~~~gNLK~FL~~Cr~~~~--~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNC 427 (563)
T KOG1024|consen 357 IED----YATPFVLYPATGVGNLKSFLQICRGDDP--SYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNC 427 (563)
T ss_pred eec----cCcceEEEeccCcchHHHHHHHhccCCC--ccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcc
Confidence 653 3478899999999999999986664432 3456688889999999999999999977 999999999999
Q ss_pred eecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCc
Q 039533 773 LLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDI 851 (949)
Q Consensus 773 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~ 851 (949)
+||+..++||+|=.+++.+-+.....-.........||+||.+....|+.++|||||||++|||+| |+.||.+..+.+
T Consensus 428 vIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE- 506 (563)
T KOG1024|consen 428 VIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE- 506 (563)
T ss_pred eehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-
Confidence 999999999999999998877665444444556788999999999999999999999999999999 999986442221
Q ss_pred hhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHh
Q 039533 852 NLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSI 931 (949)
Q Consensus 852 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 931 (949)
+...+ ..+.|...+..||.++..++..||+.+|++||+++|+..-|.+.
T Consensus 507 -------------m~~yl------------------kdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 507 -------------MEHYL------------------KDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred -------------HHHHH------------------hccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 11110 11223334458899999999999999999999999999999987
Q ss_pred HHhh
Q 039533 932 KNIL 935 (949)
Q Consensus 932 ~~~~ 935 (949)
-..+
T Consensus 556 ~~ql 559 (563)
T KOG1024|consen 556 HTQL 559 (563)
T ss_pred HHHH
Confidence 6554
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=273.89 Aligned_cols=278 Identities=19% Similarity=0.226 Sum_probs=200.5
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcC--CCc----ceeEEeeeeccccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIR--HRN----LVKVLTACLGADYR 698 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~n----iv~~~~~~~~~~~~ 698 (949)
+.+|.+...+|+|.||.|-++.+...+..||||+++.... ..+..+-|+++++++. .|+ +|.+.++| +
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-----d 161 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWF-----D 161 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-----h
Confidence 6789999999999999999999998899999999874432 2345678999999993 232 66666664 3
Q ss_pred CCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec---
Q 039533 699 GNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD--- 775 (949)
Q Consensus 699 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~--- 775 (949)
...+.|+|+|.+ |.|+++++... ...+++...++.++.|++++++|||+. +++|-||||+||++.
T Consensus 162 yrghiCivfell-G~S~~dFlk~N--------~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~ 229 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKEN--------NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSE 229 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccC--------CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccc
Confidence 445899999998 66999999732 345688999999999999999999977 999999999999983
Q ss_pred -----------------CCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh
Q 039533 776 -----------------DYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI 838 (949)
Q Consensus 776 -----------------~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt 838 (949)
.+..+|++|||.|+....... ..+.|..|+|||++.+-.++.++||||+||||+|+.|
T Consensus 230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs-----~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Elyt 304 (415)
T KOG0671|consen 230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHS-----TIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYT 304 (415)
T ss_pred eEEEeccCCccceeccCCCcceEEEecCCcceeccCcc-----eeeeccccCCchheeccCcCCccCceeeeeEEEEeec
Confidence 134689999999987654442 4568999999999999999999999999999999999
Q ss_pred CCCCCccccccC-chhhhhccccCCCchh------hhcccCCCCCchhhhhhh------chhhhhhh-hhhHHHHHHHHH
Q 039533 839 GKKPIDIMFEGD-INLHNFGRKALPDDVM------DIVDSSLLPDDEDLILTG------NQRQKQAR-INSIIECLISMV 904 (949)
Q Consensus 839 g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~------~~~d~~l~~~~~~~~~~~------~~~~~~~~-~~~~~~~~~~l~ 904 (949)
|...|+.....+ ..+++.+-..+|..+. +.+... .-++.+....+ ....+... ...-..+...+.
T Consensus 305 G~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~Lf 383 (415)
T KOG0671|consen 305 GETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRG-RLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLF 383 (415)
T ss_pred cceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcc-cccCccccccccchhhhcCCccHHHHhccCcHHHhHHH
Confidence 999997554211 1222222222222211 111111 11111100000 00000000 011124456799
Q ss_pred HHhhccccCCCCCCCCHHHHHH
Q 039533 905 RIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 905 ~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
+++.+|+..||.+|+|+.|++.
T Consensus 384 DLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 384 DLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred HHHHHHHccCccccccHHHHhc
Confidence 9999999999999999999875
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=274.43 Aligned_cols=202 Identities=25% Similarity=0.301 Sum_probs=170.9
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC---cchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCC
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH---GASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 700 (949)
..+|....+||+|+||.|.+|+.+.+.+.+|||+++..-. .+.+--+.|-++|..- +-|.++++..+|...+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD---- 423 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD---- 423 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh----
Confidence 3578889999999999999999998889999999975421 2233445677777766 5788999888866555
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
..|+||||+.||+|-..++ +-+.+.+..+.-+|.+||-||-+||++ ||+.||||.+|||+|.+|++
T Consensus 424 -RLyFVMEyvnGGDLMyhiQ----------Q~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHi 489 (683)
T KOG0696|consen 424 -RLYFVMEYVNGGDLMYHIQ----------QVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHI 489 (683)
T ss_pred -heeeEEEEecCchhhhHHH----------HhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCce
Confidence 8999999999999998887 334566778889999999999999977 99999999999999999999
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccc
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIM 846 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~ 846 (949)
||+|||+++.--.+...+. ...||+.|+|||++..++|+..+|.|||||++|||+.|++||+..
T Consensus 490 Ki~DFGmcKEni~~~~TTk--TFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe 553 (683)
T KOG0696|consen 490 KIADFGMCKENIFDGVTTK--TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 553 (683)
T ss_pred EeeecccccccccCCccee--eecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999986443333222 467999999999999999999999999999999999999999754
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=249.53 Aligned_cols=210 Identities=22% Similarity=0.256 Sum_probs=171.7
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC-CcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCCcc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-HGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 702 (949)
.++...+..||+|+||.|-+-++..+|...|+|.++..- ....++..+|+.+..+- .+|.+|++||..... ..
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re-----gd 119 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE-----GD 119 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc-----cc
Confidence 344455678999999999999999999999999997543 34456788888876665 799999999975433 37
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++.||.|. .||+.+.. +.-..+..+++...-+||..+++||.|||++. .++|||+||+|||++.+|++|+
T Consensus 120 vwIcME~M~-tSldkfy~------~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKi 190 (282)
T KOG0984|consen 120 VWICMELMD-TSLDKFYR------KVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKI 190 (282)
T ss_pred EEEeHHHhh-hhHHHHHH------HHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEE
Confidence 899999996 48887764 22235667888889999999999999999875 9999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCC----CccCCccchHHHHHHHHHHHhCCCCCccccccCc
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG----CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDI 851 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~ 851 (949)
||||++-.+.++...+. ..|-..|||||.+.. ..|+.|+||||+|+++.||.+++.||+.+.....
T Consensus 191 CDFGIsG~L~dSiAkt~---daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~ 260 (282)
T KOG0984|consen 191 CDFGISGYLVDSIAKTM---DAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQ 260 (282)
T ss_pred cccccceeehhhhHHHH---hcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHH
Confidence 99999988766554332 348889999998654 3699999999999999999999999987654433
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=274.37 Aligned_cols=223 Identities=19% Similarity=0.131 Sum_probs=175.0
Q ss_pred ecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEeeeccCCChh
Q 039533 637 GSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLE 716 (949)
Q Consensus 637 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~ 716 (949)
|.+|.||+|++..+++.||+|+++... .+.+|...+....||||+++++++...+ ..++||||+++|+|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSED-----SVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCC-----eEEEEEecCCCCCHH
Confidence 899999999999999999999986543 2334555555667999999999875443 789999999999999
Q ss_pred hhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecccceecCCCCC
Q 039533 717 EWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHT 796 (949)
Q Consensus 717 ~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 796 (949)
+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+........
T Consensus 74 ~~l~~----------~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~ 140 (237)
T cd05576 74 SHISK----------FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCD 140 (237)
T ss_pred HHHHH----------hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccccc
Confidence 99862 23488999999999999999999976 999999999999999999999999998866543221
Q ss_pred ccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhhhcccCCCCC
Q 039533 797 QTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPD 876 (949)
Q Consensus 797 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 876 (949)
...++..|+|||...+..++.++||||+|+++|||++|+.|++..... ........+
T Consensus 141 -----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---------------~~~~~~~~~--- 197 (237)
T cd05576 141 -----GEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG---------------INTHTTLNI--- 197 (237)
T ss_pred -----cCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---------------cccccccCC---
Confidence 233677899999998888999999999999999999999887422100 000000000
Q ss_pred chhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHH
Q 039533 877 DEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNV 924 (949)
Q Consensus 877 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev 924 (949)
.......+.+++.+|++.||++||++.+.
T Consensus 198 -------------------~~~~~~~~~~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 198 -------------------PEWVSEEARSLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred -------------------cccCCHHHHHHHHHHccCCHHHhcCCCcc
Confidence 01223457889999999999999997443
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=298.20 Aligned_cols=280 Identities=15% Similarity=0.129 Sum_probs=172.2
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCC----CEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeeccc-cc
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEG----RTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGAD-YR 698 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~ 698 (949)
..++|.+.+.||+|+||.||+|++..+ +..||+|++..... .+....| .+....+.++..++..+.... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 567899999999999999999999887 89999998753221 1111111 112222233333222211111 13
Q ss_pred CCccceeEeeeccCCChhhhcCCCCCCCcc----------ccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 039533 699 GNDFKASVYEFMHYGSLEEWLHPFTGEDEI----------DEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLK 768 (949)
Q Consensus 699 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~----------~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlk 768 (949)
.....++||||+++++|.+++......... ...........+..++.|++.||+|||++ +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 445789999999999999998632100000 00011122345668999999999999977 89999999
Q ss_pred CCCeeecC-CCceEEeecccceecCCCCCccccccccCccCccCccccCCC----------------------ccCCccc
Q 039533 769 PSNVLLDD-YMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC----------------------EVSTNGD 825 (949)
Q Consensus 769 p~NIll~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sD 825 (949)
|+|||+++ ++.+||+|||+|+......... .....+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~-~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccC-CcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 5899999999998654332211 1235689999999965322 2345679
Q ss_pred hHHHHHHHHHHHhCCCCCccccccCchhhhhccc-cCC-CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHH
Q 039533 826 VYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK-ALP-DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISM 903 (949)
Q Consensus 826 iwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~-~~~-~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 903 (949)
||||||++|||+++..|++.... .+...... ... ..+...+.+....+. ...++.........
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~---~~~~~l~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~d~~~~~~ 426 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLI---QFNRQLKRNDYDLVAWRKLVEPRASPDL------------RRGFEVLDLDGGAG 426 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHH---HHHHHHHhcCCcHHHHHHhhccccchhh------------hhhhhhccccchHH
Confidence 99999999999998777542210 00000000 000 001111111100000 00000011112345
Q ss_pred HHHhhccccCCCCCCCCHHHHHH
Q 039533 904 VRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 904 ~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.+++.+|++.||++|||++|+++
T Consensus 427 ~dLi~~mL~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 427 WELLKSMMRFKGRQRISAKAALA 449 (566)
T ss_pred HHHHHHHccCCcccCCCHHHHhC
Confidence 68999999999999999999986
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=264.32 Aligned_cols=203 Identities=24% Similarity=0.317 Sum_probs=170.2
Q ss_pred CCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecC--CCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ--HHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 628 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
.+..+.||.|+||.||.+++..+|+.||.|++... .-...+++.+|++++.-++|.|+...++.......+--++.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 45568999999999999999999999999998632 2334578999999999999999999887755443333345788
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
++|.|. .+|.+.+- .+..++...+.-+.+||++||+|||+. +|.||||||.|.+++.+..+||+||
T Consensus 135 ~TELmQ-SDLHKIIV----------SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDF 200 (449)
T KOG0664|consen 135 LTELMQ-SDLHKIIV----------SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDF 200 (449)
T ss_pred HHHHHH-hhhhheec----------cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccc
Confidence 899985 47887775 567788889999999999999999987 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCcc
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDI 845 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~ 845 (949)
|+|+.-..+...... ..+-|..|+|||+++|. .|+.+.||||.||++.|++..+..|+.
T Consensus 201 GLARvee~d~~~hMT-qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA 260 (449)
T KOG0664|consen 201 GLARTWDQRDRLNMT-HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA 260 (449)
T ss_pred ccccccchhhhhhhH-HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc
Confidence 999987665543332 34468899999999986 489999999999999999999988864
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=247.55 Aligned_cols=269 Identities=19% Similarity=0.258 Sum_probs=205.0
Q ss_pred HHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcC-CCcceeEEeeeecccccCCc
Q 039533 623 NATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIR-HRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 623 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 701 (949)
...++|++.+++|+|.|+.||.|....+.++++||++++.. .+.+.+|+.+++.+. ||||+++++...++. ..
T Consensus 35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~---Sk 108 (338)
T KOG0668|consen 35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPE---SK 108 (338)
T ss_pred cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCcc---cc
Confidence 34578999999999999999999988889999999997554 467889999999996 999999999877654 34
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC-CCce
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD-YMTA 780 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~-~~~~ 780 (949)
...+++||+.+.+...... .++..+++.++.+++.||.|+|+. ||+|||+||.|+++|. ...+
T Consensus 109 tpaLiFE~v~n~Dfk~ly~-------------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkL 172 (338)
T KOG0668|consen 109 TPSLIFEYVNNTDFKQLYP-------------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKL 172 (338)
T ss_pred CchhHhhhhccccHHHHhh-------------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhcee
Confidence 6789999999988776653 477778999999999999999977 9999999999999994 4579
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
+|+|+|+|.++-+...... .+.+..|.-||.+..- .|+..-|+|||||++..|+..+.||-........++..+.-
T Consensus 173 rlIDWGLAEFYHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakV 249 (338)
T KOG0668|consen 173 RLIDWGLAEFYHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKV 249 (338)
T ss_pred eeeecchHhhcCCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHH
Confidence 9999999999888776543 3467889999988764 58899999999999999999999995443332333322211
Q ss_pred c---------------CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHH
Q 039533 860 A---------------LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNV 924 (949)
Q Consensus 860 ~---------------~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev 924 (949)
. ++++..+++...-...+...+....+. -..++..+++.+.+..|-++||||+|.
T Consensus 250 LGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~h----------l~~peaiDlldklLrYDHqeRlTakEa 319 (338)
T KOG0668|consen 250 LGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQH----------LVSPEAIDLLDKLLRYDHQERLTAKEA 319 (338)
T ss_pred hChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccc----------cCChHHHHHHHHHHhhccccccchHHH
Confidence 1 222333333333222222222211111 112456788999999999999999998
Q ss_pred HH
Q 039533 925 VH 926 (949)
Q Consensus 925 ~~ 926 (949)
+.
T Consensus 320 m~ 321 (338)
T KOG0668|consen 320 MA 321 (338)
T ss_pred hc
Confidence 75
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-30 Score=267.21 Aligned_cols=136 Identities=25% Similarity=0.381 Sum_probs=117.8
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcC-----C---CcceeEEeeeecccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIR-----H---RNLVKVLTACLGADY 697 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~~~~~~~~~~~ 697 (949)
.+|.+.++||-|.|++||+|.+..+.+.||+|+.+... ...+....||++|++++ | .+||++++.|...+
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG- 155 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG- 155 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC-
Confidence 67999999999999999999999999999999997543 34567789999999993 3 37999999998776
Q ss_pred cCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeee
Q 039533 698 RGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL 774 (949)
Q Consensus 698 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll 774 (949)
.++.+.|+|+|++ |.+|-.++... ..+.++...+.+|++||+.||.|||.+| +|||-||||+|||+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s--------~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYS--------NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHh--------CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 4566899999999 67898888632 3456899999999999999999999998 99999999999999
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=284.05 Aligned_cols=279 Identities=15% Similarity=0.164 Sum_probs=183.3
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEc----------------CCCEEEEEEEEecCCCcchH--------------HHHHH
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIID----------------EGRTTIAVKVFNLQHHGASR--------------SFIAE 673 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~~~~~~--------------~~~~E 673 (949)
..++|.+.++||+|+||.||+|... ..++.||||++........+ ....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4678999999999999999999752 24568999998654332222 23457
Q ss_pred HHHHHhcCCCcc-----eeEEeeeeccccc---CCccceeEeeeccCCChhhhcCCCCCCC------------c--cccC
Q 039533 674 CKALKSIRHRNL-----VKVLTACLGADYR---GNDFKASVYEFMHYGSLEEWLHPFTGED------------E--IDEA 731 (949)
Q Consensus 674 ~~~l~~l~h~ni-----v~~~~~~~~~~~~---~~~~~~lv~e~~~~gsL~~~l~~~~~~~------------~--~~~~ 731 (949)
+.++.+++|.++ ++++++|.....+ .....++||||+++++|.++++...+.. . ....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766544 6777777543211 2346799999999999999997422110 0 0011
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecccceecCCCCCccccccccCccCccC
Q 039533 732 PRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIA 811 (949)
Q Consensus 732 ~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~a 811 (949)
...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......... ....+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNP-LYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCc-cccCCCcceeC
Confidence 23467888999999999999999977 899999999999999999999999999976543322111 12235789999
Q ss_pred ccccCCCc--------------------c--CCccchHHHHHHHHHHHhCCC-CCccccccCchhhhhccccCCCchhhh
Q 039533 812 PEYGVGCE--------------------V--STNGDVYSYGILLLELVIGKK-PIDIMFEGDINLHNFGRKALPDDVMDI 868 (949)
Q Consensus 812 PE~~~~~~--------------------~--~~~sDiwSlGvvl~elltg~~-Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 868 (949)
||.+.... + ..+.||||+||++|||++|.. ||............ .......+
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~-----~~~~~~~~ 453 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQ-----YDNDLNRW 453 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhh-----ccchHHHH
Confidence 99875422 1 234799999999999999885 66432111111000 00000000
Q ss_pred cccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCC---CCCCCHHHHHH
Q 039533 869 VDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELP---QDRTNMTNVVH 926 (949)
Q Consensus 869 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP---~~RPs~~ev~~ 926 (949)
...... ...++..........+++.+++..+| .+|+|++|+++
T Consensus 454 -r~~~~~--------------~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 454 -RMYKGQ--------------KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred -Hhhccc--------------CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 000000 00011112334567888889998766 68999999975
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=264.34 Aligned_cols=239 Identities=27% Similarity=0.334 Sum_probs=190.2
Q ss_pred cCceEEEEEEcCCCEEEEEEEEecCCCcc-hHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEeeeccCCChh
Q 039533 638 SFGSVYKGIIDEGRTTIAVKVFNLQHHGA-SRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLE 716 (949)
Q Consensus 638 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~ 716 (949)
+||.||+|+...+++.+|+|++....... .+.+.+|++.+++++|+|++++++++.... ..+++|||+++++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDED-----KLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCC-----EEEEEEeCCCCCCHH
Confidence 58999999998888999999997655444 678999999999999999999999876543 789999999999999
Q ss_pred hhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecccceecCCCCC
Q 039533 717 EWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHT 796 (949)
Q Consensus 717 ~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 796 (949)
+++.. ...+++..+..++.+++.++.|||+. +++|+||+|+||++++++.++|+|||.+........
T Consensus 76 ~~~~~----------~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~ 142 (244)
T smart00220 76 DLLKK----------RGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGL 142 (244)
T ss_pred HHHHh----------ccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeeccccc
Confidence 99862 12278899999999999999999977 999999999999999999999999999987765431
Q ss_pred ccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhhhcccCCCCC
Q 039533 797 QTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPD 876 (949)
Q Consensus 797 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 876 (949)
.....++..|+|||...+..++.++||||||+++|++++|..||....... .. .+.........
T Consensus 143 ---~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~-~~------------~~~~~~~~~~~ 206 (244)
T smart00220 143 ---LTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL-EL------------FKKIGKPKPPF 206 (244)
T ss_pred ---cccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HH------------HHHHhccCCCC
Confidence 113458889999999988888999999999999999999999986421110 00 01110000000
Q ss_pred chhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 877 DEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 877 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.. .....+..+.+++.+|+..+|++||++.++++
T Consensus 207 ~~----------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 207 PP----------------PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred cc----------------ccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 00 00003457889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-31 Score=275.19 Aligned_cols=201 Identities=24% Similarity=0.338 Sum_probs=174.6
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC---cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH---GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
.+++.++..||-|+||.|-++..+.....+|+|++++.+. ...+....|-.+|...+.|.||++|-.| ++..
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~k 493 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSK 493 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccch
Confidence 3566777889999999999999886555689999875543 2335677899999999999999999874 4555
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
+.|++||.|-||.++..+. ..+.++..+++-++..+++|++|||++ +||.|||||+|.++|.+|-+|
T Consensus 494 yvYmLmEaClGGElWTiLr----------dRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~K 560 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILR----------DRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLK 560 (732)
T ss_pred hhhhhHHhhcCchhhhhhh----------hcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceE
Confidence 8999999999999999997 456788889999999999999999977 999999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccc
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIM 846 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~ 846 (949)
|.|||+|+.+..+.... .+.||+.|.|||++.....+.++|.||+|+++||+++|++||...
T Consensus 561 LVDFGFAKki~~g~KTw---TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~ 622 (732)
T KOG0614|consen 561 LVDFGFAKKIGSGRKTW---TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV 622 (732)
T ss_pred EeehhhHHHhccCCcee---eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999987665422 467999999999999999999999999999999999999999643
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=251.62 Aligned_cols=202 Identities=25% Similarity=0.317 Sum_probs=174.8
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecC---CCcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCC
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ---HHGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 700 (949)
.++|...++||+|+|+.|..+++..+.+.+|+|++++. ..+..+-.+.|-.+..+. +||.+|-+..+|....
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes---- 324 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES---- 324 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc----
Confidence 35788999999999999999999999999999999754 334455677788888777 6999999988865444
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
..++|.||++||+|--+++ ..+.++++.++-+..+|.-||.|||++ ||+.||+|.+|+|+|..|++
T Consensus 325 -rlffvieyv~ggdlmfhmq----------rqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghi 390 (593)
T KOG0695|consen 325 -RLFFVIEYVNGGDLMFHMQ----------RQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHI 390 (593)
T ss_pred -eEEEEEEEecCcceeeehh----------hhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCce
Confidence 8999999999999988876 346689999999999999999999987 99999999999999999999
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccc
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIM 846 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~ 846 (949)
|++|||.++.--.+...+. .+.||+.|.|||++.+..|...+|.|++||+++||+.|+.||+..
T Consensus 391 kltdygmcke~l~~gd~ts--tfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv 454 (593)
T KOG0695|consen 391 KLTDYGMCKEGLGPGDTTS--TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV 454 (593)
T ss_pred eecccchhhcCCCCCcccc--cccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence 9999999986443333222 467999999999999999999999999999999999999999743
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-30 Score=286.79 Aligned_cols=243 Identities=24% Similarity=0.343 Sum_probs=183.9
Q ss_pred CCeeeeecCc-eEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCCccceeEee
Q 039533 631 ANLVGVGSFG-SVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGNDFKASVYE 708 (949)
Q Consensus 631 ~~~lg~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e 708 (949)
.+++|.|+.| .||+|... ++.||||++-.. ..+...+|+..++.- +|||||++++. ..++++.||..|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~-----E~d~qF~YIalE 583 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE--GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCS-----EQDRQFLYIALE 583 (903)
T ss_pred HHHcccCCCCcEEEEEeeC--CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEee-----ccCCceEEEEeh
Confidence 3578999988 58999996 899999987432 235677999999998 59999999866 344568999999
Q ss_pred eccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC-----CCceEEe
Q 039533 709 FMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD-----YMTARVG 783 (949)
Q Consensus 709 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~-----~~~~kl~ 783 (949)
.|.. +|++++... +.+ . ........+.+..|++.||++||+- +||||||||.||||+. ..+++|+
T Consensus 584 LC~~-sL~dlie~~-~~d-~----~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iS 653 (903)
T KOG1027|consen 584 LCAC-SLQDLIESS-GLD-V----EMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKIS 653 (903)
T ss_pred Hhhh-hHHHHHhcc-ccc-h----hhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEec
Confidence 9965 999999742 111 0 1111145677899999999999975 9999999999999974 3579999
Q ss_pred ecccceecCCCCCc-cccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhC-CCCCccccccCchhhhhccccC
Q 039533 784 DFGLARILSPDHTQ-TSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIG-KKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 784 DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg-~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
|||+++.+..+... .......||-+|+|||++....-+.++||||+||++|+.++| ++||....+.+.++..-..
T Consensus 654 DfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~--- 730 (903)
T KOG1027|consen 654 DFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNY--- 730 (903)
T ss_pred ccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCcc---
Confidence 99999998776552 223356699999999999998888999999999999999995 9999765443333221110
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVV 925 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~ 925 (949)
.++ .+.+.. ++ +..+++.+|++++|..||+|.+|+
T Consensus 731 -----~L~--~L~~~~--------------------d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 731 -----TLV--HLEPLP--------------------DC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred -----cee--eeccCc--------------------hH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 000 011111 11 567899999999999999999995
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-29 Score=267.20 Aligned_cols=207 Identities=23% Similarity=0.276 Sum_probs=171.5
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC---cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH---GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
+-|..++.||-|+||.|.++.-.++...+|+|.+++.+. ......+.|-.||...+.+-||++|-.|.+.+ .
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd-----n 703 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-----N 703 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC-----c
Confidence 457778899999999999999988888899999875542 22345778999999999999999997765444 8
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.|+||||++||++-.+|- .-+.+.+..++-++.++..|+++.| +.|+|||||||+|||||.+|++||
T Consensus 704 LYFVMdYIPGGDmMSLLI----------rmgIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKL 770 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLI----------RMGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKL 770 (1034)
T ss_pred eEEEEeccCCccHHHHHH----------HhccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceee
Confidence 999999999999999886 2355788889999999999999999 459999999999999999999999
Q ss_pred eecccceecCC---------CCC-------------------------------ccccccccCccCccCccccCCCccCC
Q 039533 783 GDFGLARILSP---------DHT-------------------------------QTSSFSVKGSLGYIAPEYGVGCEVST 822 (949)
Q Consensus 783 ~DfG~a~~~~~---------~~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ 822 (949)
+|||++.-+.. +.. .......+||+.|+|||++....++.
T Consensus 771 TDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q 850 (1034)
T KOG0608|consen 771 TDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQ 850 (1034)
T ss_pred eeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccc
Confidence 99999864311 000 00001346999999999999999999
Q ss_pred ccchHHHHHHHHHHHhCCCCCccccccC
Q 039533 823 NGDVYSYGILLLELVIGKKPIDIMFEGD 850 (949)
Q Consensus 823 ~sDiwSlGvvl~elltg~~Pf~~~~~~~ 850 (949)
-+|.||.|||||||+.|++||-....++
T Consensus 851 ~cdwws~gvil~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 851 LCDWWSVGVILYEMLVGQPPFLADTPGE 878 (1034)
T ss_pred cchhhHhhHHHHHHhhCCCCccCCCCCc
Confidence 9999999999999999999996554443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=262.81 Aligned_cols=200 Identities=22% Similarity=0.288 Sum_probs=170.4
Q ss_pred HHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--------cchHHHHHHHHHHHhcC---CCcceeEEee
Q 039533 623 NATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--------GASRSFIAECKALKSIR---HRNLVKVLTA 691 (949)
Q Consensus 623 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---h~niv~~~~~ 691 (949)
....+|+..+.+|+|+||.|+.|.++.+...|+||.+.+... ...-..-.|+++|..++ |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 345679999999999999999999998889999999864421 11123557999999996 9999999999
Q ss_pred eecccccCCccceeEeeec-cCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 039533 692 CLGADYRGNDFKASVYEFM-HYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPS 770 (949)
Q Consensus 692 ~~~~~~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~ 770 (949)
|.+.+ ++|++||-. ++.+|.+++. ..+.+++.++..|++||+.|+++||++ +|||||||-+
T Consensus 638 FEddd-----~yyl~te~hg~gIDLFd~IE----------~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikde 699 (772)
T KOG1152|consen 638 FEDDD-----YYYLETEVHGEGIDLFDFIE----------FKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDE 699 (772)
T ss_pred eecCC-----eeEEEecCCCCCcchhhhhh----------ccCccchHHHHHHHHHHHhcccccccc---Cceecccccc
Confidence 65544 899999876 6679999996 356789999999999999999999988 9999999999
Q ss_pred CeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCcc-CCccchHHHHHHHHHHHhCCCCCc
Q 039533 771 NVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEV-STNGDVYSYGILLLELVIGKKPID 844 (949)
Q Consensus 771 NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlGvvl~elltg~~Pf~ 844 (949)
|+.++.+|-+||+|||.|.....+.. ..++||..|.|||++.|.+| +...|||++|+++|.++...-||.
T Consensus 700 nvivd~~g~~klidfgsaa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 700 NVIVDSNGFVKLIDFGSAAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cEEEecCCeEEEeeccchhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999999999999999976544332 24679999999999999887 577899999999999999988874
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-28 Score=243.07 Aligned_cols=200 Identities=23% Similarity=0.279 Sum_probs=168.3
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecC--CCcchHHHHHHHHHHHhcCCCcceeEEeeeecccc-cCCc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ--HHGASRSFIAECKALKSIRHRNLVKVLTACLGADY-RGND 701 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 701 (949)
..+|.-.+.+|.|.- .|..|.+.-.++.||+|.+... .....++..+|...+..+.|+||++++.++..... ....
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 356777788999988 8888888888999999998633 23345788899999999999999999998864332 2234
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..|+|||+|. .+|...++ ..++-.+...|..|++.|++|||+. +|+||||||+||++..+..+|
T Consensus 95 e~y~v~e~m~-~nl~~vi~------------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lK 158 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVIL------------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLK 158 (369)
T ss_pred hHHHHHHhhh-hHHHHHHH------------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhhee
Confidence 5799999996 58888876 2367788999999999999999977 999999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCc
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPID 844 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~ 844 (949)
|.|||+|+.-..+ ......+.|..|+|||++.+..+.+.+||||.||++.||++|+.-|.
T Consensus 159 i~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~ 218 (369)
T KOG0665|consen 159 ILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP 218 (369)
T ss_pred eccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec
Confidence 9999999875554 12234668999999999999899999999999999999999999885
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=233.62 Aligned_cols=255 Identities=18% Similarity=0.238 Sum_probs=189.3
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCCccce
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
+.|.+.+.+|+|.||.+-+++++.+++.+|+|.+.... ...++|.+|...--.+ .|.||+.-|+.. ++..+.++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~va----Fqt~d~Yv 98 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVA----FQTSDAYV 98 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHH----hhcCceEE
Confidence 45888999999999999999999999999999986433 3457899998765555 589999887654 44455889
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec--CCCceEE
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD--DYMTARV 782 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~--~~~~~kl 782 (949)
+++||++.|+|.+-+. ...+.+....+++.|++.|+.|||++ ++||||||.+||||- +..++|+
T Consensus 99 F~qE~aP~gdL~snv~-----------~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKl 164 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVE-----------AAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKL 164 (378)
T ss_pred EeeccCccchhhhhcC-----------cccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEe
Confidence 9999999999998875 24477788899999999999999987 999999999999993 4458999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCC---C--ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhc
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG---C--EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFG 857 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~ 857 (949)
||||.++..+.... ...-+..|.|||.... + ...+.+|||.||+++|.++||..||+.....+..+.+|.
T Consensus 165 cDFG~t~k~g~tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~ 239 (378)
T KOG1345|consen 165 CDFGLTRKVGTTVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWE 239 (378)
T ss_pred eecccccccCceeh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHH
Confidence 99999876543322 1235678999997442 2 457889999999999999999999986555555554443
Q ss_pred cccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 039533 858 RKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQ 929 (949)
Q Consensus 858 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 929 (949)
...- .....-| .......+.+.++.++-+.++|++|--..++.+...
T Consensus 240 ~w~~---------rk~~~~P----------------~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 240 QWLK---------RKNPALP----------------KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred HHhc---------ccCccCc----------------hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 2110 0000000 001122345677888889999999955555554443
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-29 Score=255.85 Aligned_cols=300 Identities=23% Similarity=0.266 Sum_probs=185.9
Q ss_pred EEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCC-cc
Q 039533 70 LDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQN-NQ 148 (949)
Q Consensus 70 l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~-n~ 148 (949)
+|-++.+|+ .+|..+. ..-..++|..|+|+...|.+|+.+++||.||||+|+|+..-|+.|.++.+|..|-+-+ |+
T Consensus 51 VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~Nk 127 (498)
T KOG4237|consen 51 VDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNK 127 (498)
T ss_pred EEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCc
Confidence 344455555 4554333 3456788889999866677899999999999999999888888898888887765544 88
Q ss_pred ccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCcccccc----
Q 039533 149 LVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVV---- 224 (949)
Q Consensus 149 l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---- 224 (949)
|+....+.|.+|..|+.|.+.-|++.-.....|..+++|..|.|..|.+..+--..|..+.+++++.+..|.+-..
T Consensus 128 I~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~ 207 (498)
T KOG4237|consen 128 ITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLP 207 (498)
T ss_pred hhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccc
Confidence 9888888899999999999999999877778888899999999999988833334888888999998888873211
Q ss_pred --cccccCCCCChhhhccccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCc-hhhcccccccEEEc
Q 039533 225 --ENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPG-CISNLSKTIKTLFL 301 (949)
Q Consensus 225 --~~~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~-~~~~l~~~L~~L~L 301 (949)
...+....-.++..+-..-..+.++++...... .|.+.+ ..+..-..+.....+..|. +|..+ ++|+.|+|
T Consensus 208 wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~--kf~c~~---esl~s~~~~~d~~d~~cP~~cf~~L-~~L~~lnl 281 (498)
T KOG4237|consen 208 WLADDLAMNPIETSGARCVSPYRLYYKRINQEDAR--KFLCSL---ESLPSRLSSEDFPDSICPAKCFKKL-PNLRKLNL 281 (498)
T ss_pred hhhhHHhhchhhcccceecchHHHHHHHhcccchh--hhhhhH---HhHHHhhccccCcCCcChHHHHhhc-ccceEecc
Confidence 000000011122233333334444444332211 112221 1111111222333333333 34444 34666666
Q ss_pred cCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecccccc
Q 039533 302 NNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFL 378 (949)
Q Consensus 302 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 378 (949)
++|+|+++-+.+|..+..+++|.|..|+|...-...|.++..|+.|+|++|+|+...|.+|..+.+|.+|+|-.|.+
T Consensus 282 snN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~ 358 (498)
T KOG4237|consen 282 SNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPF 358 (498)
T ss_pred CCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcc
Confidence 66666655566666666666666666666544445555666666666666666655556666666666666555543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-28 Score=263.84 Aligned_cols=254 Identities=22% Similarity=0.274 Sum_probs=201.1
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.++|...+++|.|.||.||+|++..+++..|+|+++..........++|+-+++..+||||+.++|-+.. .+..+
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr-----~dklw 88 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR-----RDKLW 88 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhh-----hcCcE
Confidence 3578889999999999999999999999999999998877777888899999999999999999988543 44899
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+.|||+.+|+|++..+ ....+++.+....++...+|++|||+. +=+|||||-.||++++.|.+|++|
T Consensus 89 icMEycgggslQdiy~----------~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaD 155 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYH----------VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLAD 155 (829)
T ss_pred EEEEecCCCcccceee----------ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecc
Confidence 9999999999999887 456789999999999999999999977 889999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccC---CCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGV---GCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
||.+-.+...... ...+.||+.|||||+.. .+.|..++|||+.|+...|+---++|..........+. +.
T Consensus 156 fgvsaqitati~K--rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~L--mT--- 228 (829)
T KOG0576|consen 156 FGVSAQITATIAK--RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFL--MT--- 228 (829)
T ss_pred cCchhhhhhhhhh--hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHH--hh---
Confidence 9998766543322 23567999999999854 45689999999999999999888887432211110000 00
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
...+++.-..++. ...+.+-++++.|+..+|++||+++..++
T Consensus 229 ----kS~~qpp~lkDk~-------------------kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 229 ----KSGFQPPTLKDKT-------------------KWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ----ccCCCCCcccCCc-------------------cchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 0011111111111 22345788999999999999999987754
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-27 Score=246.75 Aligned_cols=282 Identities=23% Similarity=0.280 Sum_probs=199.5
Q ss_pred HHHHhcCCCCCCeeeeecCceEEEEEEcC---CCEEEEEEEEecCCCcchHHHHHHHHHHHhc-CCCcceeEEeeeeccc
Q 039533 621 LYNATSGFSSANLVGVGSFGSVYKGIIDE---GRTTIAVKVFNLQHHGASRSFIAECKALKSI-RHRNLVKVLTACLGAD 696 (949)
Q Consensus 621 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 696 (949)
+....+.|..+++||+|.|++||+|.+.. ..+.||+|.+.... ...+..+|++.|..+ .+.||+++.+++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~---- 104 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCF---- 104 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhh----
Confidence 33445678999999999999999999876 67899999986443 346789999999999 589999999885
Q ss_pred ccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec-
Q 039533 697 YRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD- 775 (949)
Q Consensus 697 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~- 775 (949)
+.++...+|+||++.....++.. .++..++..+++.+..||+++|++ |||||||||+|++.+
T Consensus 105 -rnnd~v~ivlp~~~H~~f~~l~~-------------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~ 167 (418)
T KOG1167|consen 105 -RNNDQVAIVLPYFEHDRFRDLYR-------------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNR 167 (418)
T ss_pred -ccCCeeEEEecccCccCHHHHHh-------------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCcccccccc
Confidence 44558999999999999988875 367889999999999999999977 999999999999997
Q ss_pred CCCceEEeecccceecCCCC------------------------------------------CccccccccCccCccCcc
Q 039533 776 DYMTARVGDFGLARILSPDH------------------------------------------TQTSSFSVKGSLGYIAPE 813 (949)
Q Consensus 776 ~~~~~kl~DfG~a~~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE 813 (949)
..+.-.|+|||+|..+.... .........||++|+|||
T Consensus 168 ~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPE 247 (418)
T KOG1167|consen 168 RTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPE 247 (418)
T ss_pred ccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchH
Confidence 56788999999998321000 000112356999999999
Q ss_pred ccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCc---hhhhccc------CCCCCchh----
Q 039533 814 YGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDD---VMDIVDS------SLLPDDED---- 879 (949)
Q Consensus 814 ~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~d~------~l~~~~~~---- 879 (949)
++... ..++++||||.||++.-+++++.||-....+-..+.+.+...-+.. .....+. .-.+...+
T Consensus 248 vL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~ 327 (418)
T KOG1167|consen 248 VLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVN 327 (418)
T ss_pred HHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhc
Confidence 98765 4789999999999999999999999654443333322211100000 0000000 00000000
Q ss_pred ---h-hhhhchhhhh--hhhhhHH-HHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 880 ---L-ILTGNQRQKQ--ARINSII-ECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 880 ---~-~~~~~~~~~~--~~~~~~~-~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
. +..... ... ....... ..+..+.+++.+|+..||.+|.|++|.++
T Consensus 328 f~s~~~~~~~~-~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 328 FETLHIESIYK-SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred hhccChhhccc-ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 0 000000 000 0111112 23447899999999999999999999874
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-26 Score=234.04 Aligned_cols=211 Identities=28% Similarity=0.452 Sum_probs=180.6
Q ss_pred eeeecCceEEEEEEcCCCEEEEEEEEecCCCc-chHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEeeeccC
Q 039533 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG-ASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHY 712 (949)
Q Consensus 634 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~ 712 (949)
||+|++|.||++....+++.+++|++...... ..+.+.+|++.++.++|++++++++++... ...+++|||+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE-----NHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-----CeEEEEEecCCC
Confidence 68999999999999877899999999755432 346799999999999999999999997654 378999999999
Q ss_pred CChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC-CCceEEeecccceec
Q 039533 713 GSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD-YMTARVGDFGLARIL 791 (949)
Q Consensus 713 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DfG~a~~~ 791 (949)
++|.+++... ...+++..+..++.+++++++|||+. +++|+||+|.||+++. ++.++|+|||.+...
T Consensus 76 ~~l~~~~~~~---------~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~ 143 (215)
T cd00180 76 GSLKDLLKEN---------EGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLL 143 (215)
T ss_pred CcHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEc
Confidence 9999998621 13588999999999999999999977 9999999999999999 899999999999876
Q ss_pred CCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhhhcc
Q 039533 792 SPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVD 870 (949)
Q Consensus 792 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d 870 (949)
..... ......+...|++||..... ..+.++|+|++|++++++
T Consensus 144 ~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------- 187 (215)
T cd00180 144 TSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------- 187 (215)
T ss_pred cCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------
Confidence 55431 11134478899999998877 788999999999999999
Q ss_pred cCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 871 SSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 871 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
..+.+++..|++.+|++||++.++++.
T Consensus 188 ------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 236788999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-27 Score=248.46 Aligned_cols=202 Identities=22% Similarity=0.263 Sum_probs=167.1
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcC------CCcceeEEeeeecccc
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIR------HRNLVKVLTACLGADY 697 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~ 697 (949)
--++|.+....|+|-|++|.+|.+..-+..||||+++.... -.+.=+.|+++|+++. --|+++++-.|.
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~---- 504 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK---- 504 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh----
Confidence 34679999999999999999999988889999999974432 2244568999999994 347888877644
Q ss_pred cCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCC
Q 039533 698 RGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDY 777 (949)
Q Consensus 698 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~ 777 (949)
..++.|+|+|-+. .+|.+.++.+. ..-.+....+..++.|+.-||..|... +|+|.||||+||||++.
T Consensus 505 -hknHLClVFE~Ls-lNLRevLKKyG-------~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 505 -HKNHLCLVFEPLS-LNLREVLKKYG-------RNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNES 572 (752)
T ss_pred -hcceeEEEehhhh-chHHHHHHHhC-------cccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccC
Confidence 4459999999985 59999998542 234578889999999999999999966 99999999999999865
Q ss_pred -CceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccc
Q 039533 778 -MTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIM 846 (949)
Q Consensus 778 -~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~ 846 (949)
..+||||||.|...+.....+ ..-+..|.|||++.|..|+...|+||.||+|||+.||+..|...
T Consensus 573 k~iLKLCDfGSA~~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred cceeeeccCccccccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 468999999998877655432 22466899999999999999999999999999999999988643
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=233.58 Aligned_cols=200 Identities=31% Similarity=0.409 Sum_probs=170.7
Q ss_pred CCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc-chHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeE
Q 039533 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG-ASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASV 706 (949)
Q Consensus 628 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 706 (949)
|++.+.||.|++|.||+|....+++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++.... ..+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~-----~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPE-----PLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCC-----ceEEE
Confidence 56778999999999999999877899999999865544 5678999999999999999999999876543 78999
Q ss_pred eeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecc
Q 039533 707 YEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFG 786 (949)
Q Consensus 707 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG 786 (949)
+||+++++|.+++... ...+++..+..++.+++.++.|||+. +++|+|++|+||+++.++.++|+|||
T Consensus 76 ~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g 143 (225)
T smart00221 76 MEYCEGGDLFDYLRKK---------GGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFG 143 (225)
T ss_pred EeccCCCCHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCc
Confidence 9999999999998621 11178899999999999999999977 99999999999999999999999999
Q ss_pred cceecCCCCCccccccccCccCccCcccc-CCCccCCccchHHHHHHHHHHHhCCCCCcc
Q 039533 787 LARILSPDHTQTSSFSVKGSLGYIAPEYG-VGCEVSTNGDVYSYGILLLELVIGKKPIDI 845 (949)
Q Consensus 787 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDiwSlGvvl~elltg~~Pf~~ 845 (949)
.+......... ......++..|++||.. ....++.++|||+||++++||++|+.||+.
T Consensus 144 ~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 144 LARFIHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eeeEecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 99877554311 11134578899999998 666788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.4e-27 Score=238.67 Aligned_cols=412 Identities=19% Similarity=0.200 Sum_probs=297.2
Q ss_pred eEEeCCC---------CcEEEEEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeecc-ccccC
Q 039533 58 VTCSRRH---------QRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNN-NSICG 127 (949)
Q Consensus 58 v~C~~~~---------~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~ 127 (949)
|.|+..+ ...+.++|..|+|+...+.+|..++.|+.||||+|+|+-+-|++|.++.+|..|-+-+ |+|+.
T Consensus 51 VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~ 130 (498)
T KOG4237|consen 51 VDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITD 130 (498)
T ss_pred EEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhh
Confidence 7887643 3578999999999988888999999999999999999999999999999988777666 99995
Q ss_pred cCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECCCCCCCCCCCC-CcCCCCCccEEecccccc---------
Q 039533 128 EIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPS-SLGNLSSIHTISLAYNNL--------- 197 (949)
Q Consensus 128 ~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l--------- 197 (949)
.--..|++|+.|+.|.+.-|++.-+..+.|..|++|..|.|-+|.+. .++. +|..+..++.+.+..|.+
T Consensus 131 l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL~wl 209 (498)
T KOG4237|consen 131 LPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNLPWL 209 (498)
T ss_pred hhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccccchh
Confidence 44457999999999999999999999999999999999999999999 5554 899999999999999983
Q ss_pred ---CCCCCCcccCCCccccccccCcccccccccccCCCCChhhhccccccccccCCCCCCCCCCcchhccccccCcccEE
Q 039533 198 ---DGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWM 274 (949)
Q Consensus 198 ---~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L 274 (949)
....|..++++.-..-..|.++++..++..-+.. .+.++..--.+...... ..-...|..+++|+.|
T Consensus 210 a~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c-----~~esl~s~~~~~d~~d~-----~cP~~cf~~L~~L~~l 279 (498)
T KOG4237|consen 210 ADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLC-----SLESLPSRLSSEDFPDS-----ICPAKCFKKLPNLRKL 279 (498)
T ss_pred hhHHhhchhhcccceecchHHHHHHHhcccchhhhhh-----hHHhHHHhhccccCcCC-----cChHHHHhhcccceEe
Confidence 2344555666666666666666655443221111 11111111111111211 1223348899999999
Q ss_pred EccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCccc
Q 039533 275 HINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKL 354 (949)
Q Consensus 275 ~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 354 (949)
+|++|+++.+-+++|..+. .++.|+|..|+|...-...|.++..|+.|+|.+|+|+...|.+|..+..|.+|+|-.|.+
T Consensus 280 nlsnN~i~~i~~~aFe~~a-~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~ 358 (498)
T KOG4237|consen 280 NLSNNKITRIEDGAFEGAA-ELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPF 358 (498)
T ss_pred ccCCCccchhhhhhhcchh-hhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcc
Confidence 9999999999999999885 599999999999977788899999999999999999999999999999999999999887
Q ss_pred cccc-CcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCcccc---CCCCCccc---------CCcccceeec
Q 039533 355 SGNI-PPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLS---GTIPPQFF---------SLSSLSISLD 421 (949)
Q Consensus 355 ~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~---~~~p~~~~---------~l~~l~~~L~ 421 (949)
.-.- -.+++. +|..+.-.|..|- +.-..++.+.++.+.+. -.-|+..+ .++-+-+...
T Consensus 359 ~CnC~l~wl~~-------Wlr~~~~~~~~~C--q~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvR 429 (498)
T KOG4237|consen 359 NCNCRLAWLGE-------WLRKKSVVGNPRC--QSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVR 429 (498)
T ss_pred cCccchHHHHH-------HHhhCCCCCCCCC--CCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHh
Confidence 5210 011111 1222221211111 11123444444444332 11122111 1222323344
Q ss_pred cCCCccCCCCccccccccccceeeeccccccccCCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCC
Q 039533 422 WSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQN 497 (949)
Q Consensus 422 ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N 497 (949)
-|++.++ .+|..+ ...-+.|++.+|.++ .+|.+ .+.+| .+|+++|+++..--..|.++++|.+|-||+|
T Consensus 430 cSnk~lk-~lp~~i--P~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 430 CSNKLLK-LLPRGI--PVDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred hcccchh-hcCCCC--CchhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 5555555 444332 234567889999998 77877 67788 8999999998888888999999999999887
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=267.06 Aligned_cols=337 Identities=21% Similarity=0.267 Sum_probs=208.5
Q ss_pred CCCCCCCCCceeeccCce------eccccCCcccCcc-cCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccc
Q 039533 83 HFIGNLSFLKQLYLQVNS------FTHEIPSEIGGLR-RLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILS 155 (949)
Q Consensus 83 ~~l~~l~~L~~L~L~~n~------l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~ 155 (949)
.+|..+++|+.|.+..+. +...+|..|..++ +|+.|++.+|.+. .+|..| ...+|+.|++++|++.. .+.
T Consensus 552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~~-L~~ 628 (1153)
T PLN03210 552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLEK-LWD 628 (1153)
T ss_pred HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCccccc-ccc
Confidence 467889999999886653 3446788787764 6999999999887 788877 57889999999988874 455
Q ss_pred cccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCcc-cccccccccCCCCC
Q 039533 156 RFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANN-LSVVENKLTGEVPS 234 (949)
Q Consensus 156 ~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~l~~~~~~ 234 (949)
.+..+++|+.|+|++|...+.+| .++.+++|++|+|++|.....+|..++++++|+.|++++|. ++. +|.
T Consensus 629 ~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~--------Lp~ 699 (1153)
T PLN03210 629 GVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEI--------LPT 699 (1153)
T ss_pred ccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCc--------cCC
Confidence 67888889999998876555666 47788889999998887666888888888888888888753 322 222
Q ss_pred hhhhccccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCC
Q 039533 235 LEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGI 314 (949)
Q Consensus 235 l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~ 314 (949)
-.+ +++|+.|++++|.....+|. .+.+|++|+|++|.+. .+|..+
T Consensus 700 ~i~------------------------------l~sL~~L~Lsgc~~L~~~p~----~~~nL~~L~L~~n~i~-~lP~~~ 744 (1153)
T PLN03210 700 GIN------------------------------LKSLYRLNLSGCSRLKSFPD----ISTNISWLDLDETAIE-EFPSNL 744 (1153)
T ss_pred cCC------------------------------CCCCCEEeCCCCCCcccccc----ccCCcCeeecCCCccc-cccccc
Confidence 112 34455555555543333332 1235667777777765 455444
Q ss_pred CCCCcccEEEeecceec-------ccCCCcccccCCCCEEecCCcccccccCcccccccccceeecccccccccCCCCCC
Q 039533 315 GNFVNLQRLDMWNNQLS-------GTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLG 387 (949)
Q Consensus 315 ~~l~~L~~L~L~~N~l~-------~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 387 (949)
.+++|++|++.++... ...+..+...++|+.|+|++|...+.+|.+++++++|+.|++++|...+.+|..+
T Consensus 745 -~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~- 822 (1153)
T PLN03210 745 -RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI- 822 (1153)
T ss_pred -cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-
Confidence 4566666666653321 1111112223456666666665555556556666666666665554333445443
Q ss_pred CCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccCCcccccccchhh
Q 039533 388 QCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQ 467 (949)
Q Consensus 388 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 467 (949)
++++|+.|++++|..-..+|.. ..+|+.|+|++|.++ .+|.++..+++|+.
T Consensus 823 ~L~sL~~L~Ls~c~~L~~~p~~----------------------------~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~ 873 (1153)
T PLN03210 823 NLESLESLDLSGCSRLRTFPDI----------------------------STNISDLNLSRTGIE-EVPWWIEKFSNLSF 873 (1153)
T ss_pred CccccCEEECCCCCcccccccc----------------------------ccccCEeECCCCCCc-cChHHHhcCCCCCE
Confidence 4555555555554433233321 234555556666555 45555666666666
Q ss_pred cccCc-cccccccCCCcCCCCCCCEEECCCCc
Q 039533 468 LGMGG-NLFQGPISSSLGSLRGLRVLDLSQNN 498 (949)
Q Consensus 468 L~l~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~ 498 (949)
|+|++ |++. .+|..+..+++|+.|+++++.
T Consensus 874 L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 874 LDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred EECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 66655 3343 355556666666666666663
|
syringae 6; Provisional |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.5e-24 Score=249.24 Aligned_cols=265 Identities=29% Similarity=0.357 Sum_probs=153.4
Q ss_pred CCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCcccccccccccCCCCChhhhcc
Q 039533 161 SKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQR 240 (949)
Q Consensus 161 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~ 240 (949)
.+-..|+|++|.|+ .+|..+. ++|+.|++++|+|+ .+|.. +++|++|+|++|+|+.++.. .++
T Consensus 201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~LtsLP~l----------p~s 263 (788)
T PRK15387 201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLTSLPVL----------PPG 263 (788)
T ss_pred CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccCcccCc----------ccc
Confidence 34567888888888 6777665 37888888888888 45542 46778888887777654310 123
Q ss_pred ccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcc
Q 039533 241 LQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNL 320 (949)
Q Consensus 241 L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L 320 (949)
|++|++++| .++. +|. ++..|+.|+|++|+|+ .+|. .+++|
T Consensus 264 L~~L~Ls~N------------------------------~L~~-Lp~----lp~~L~~L~Ls~N~Lt-~LP~---~p~~L 304 (788)
T PRK15387 264 LLELSIFSN------------------------------PLTH-LPA----LPSGLCKLWIFGNQLT-SLPV---LPPGL 304 (788)
T ss_pred cceeeccCC------------------------------chhh-hhh----chhhcCEEECcCCccc-cccc---ccccc
Confidence 344444444 3332 111 2234555566666555 2333 12456
Q ss_pred cEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCc
Q 039533 321 QRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNN 400 (949)
Q Consensus 321 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 400 (949)
++|+|++|+|++ +|... .+|+.|++++|+|++ +|.. ..+|+.|+|++|+|++ +|.. ..+|+.|++++|
T Consensus 305 ~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N 372 (788)
T PRK15387 305 QELSVSDNQLAS-LPALP---SELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNN 372 (788)
T ss_pred ceeECCCCcccc-CCCCc---ccccccccccCcccc-cccc---ccccceEecCCCccCC-CCCC---Ccccceehhhcc
Confidence 666666666653 33321 235555666666652 3321 1345566666666652 3332 234555666666
Q ss_pred cccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccCCcccccccchhhcccCccccccccC
Q 039533 401 NLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPIS 480 (949)
Q Consensus 401 ~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~ 480 (949)
+|+ .+|... .+| ..|++++|+|++ +|.. .++|+.|++++|+|+ .+|..+ .+|+.|++++|+|+ .+|
T Consensus 373 ~L~-~LP~l~---~~L-~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP 438 (788)
T PRK15387 373 RLT-SLPALP---SGL-KELIVSGNRLTS-LPVL---PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLP 438 (788)
T ss_pred ccc-cCcccc---ccc-ceEEecCCcccC-CCCc---ccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccC
Confidence 665 355432 233 456666666663 4432 245777777777777 355432 35677777777777 567
Q ss_pred CCcCCCCCCCEEECCCCcCCCcCcccc
Q 039533 481 SSLGSLRGLRVLDLSQNNLSGEIPKFL 507 (949)
Q Consensus 481 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 507 (949)
..++.+++|+.|+|++|+|++.+|..+
T Consensus 439 ~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 439 ESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred hHHhhccCCCeEECCCCCCCchHHHHH
Confidence 777777777777777777777666655
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-24 Score=250.58 Aligned_cols=83 Identities=30% Similarity=0.356 Sum_probs=44.0
Q ss_pred CCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccCCcccccccchhhccc
Q 039533 391 SLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGM 470 (949)
Q Consensus 391 ~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 470 (949)
+|+.|++++|+|+ .+|... +++ +.|++++|+|++ +|.. ..+|+.|+|++|+|+ .+|..++++++|+.|+|
T Consensus 383 ~L~~LdLs~N~Lt-~LP~l~---s~L-~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdL 452 (788)
T PRK15387 383 GLKELIVSGNRLT-SLPVLP---SEL-KELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNL 452 (788)
T ss_pred ccceEEecCCccc-CCCCcc---cCC-CEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEEC
Confidence 3445555555554 233322 222 345555555552 3432 234555666666666 56666666666666666
Q ss_pred CccccccccCCCc
Q 039533 471 GGNLFQGPISSSL 483 (949)
Q Consensus 471 ~~N~l~~~~~~~~ 483 (949)
++|.|++.++..+
T Consensus 453 s~N~Ls~~~~~~L 465 (788)
T PRK15387 453 EGNPLSERTLQAL 465 (788)
T ss_pred CCCCCCchHHHHH
Confidence 6666666655544
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.6e-24 Score=211.81 Aligned_cols=169 Identities=22% Similarity=0.245 Sum_probs=126.0
Q ss_pred CChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecccceecC
Q 039533 713 GSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILS 792 (949)
Q Consensus 713 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~ 792 (949)
|+|.+++.. ....+++.+++.|+.|++.||+|||++ + ||+||+++.++.+|+ ||.++...
T Consensus 1 GsL~~~l~~---------~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~ 60 (176)
T smart00750 1 VSLADILEV---------RGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKT 60 (176)
T ss_pred CcHHHHHHH---------hCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeec
Confidence 678888862 234589999999999999999999977 4 999999999999999 99998765
Q ss_pred CCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhhhcccC
Q 039533 793 PDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSS 872 (949)
Q Consensus 793 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 872 (949)
... ..||+.|+|||++.+..++.++|||||||++|||+||+.||.........+.. +....
T Consensus 61 ~~~-------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~------------~~~~~ 121 (176)
T smart00750 61 PEQ-------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEI------------LLNGM 121 (176)
T ss_pred ccc-------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHH------------HHHHh
Confidence 432 24889999999999999999999999999999999999998543221111111 11111
Q ss_pred CCCCchhhhhhhchhhhhhhhhhHHHHH--HHHHHHhhccccCCCCCCCCHHHHHHHHHHhHH
Q 039533 873 LLPDDEDLILTGNQRQKQARINSIIECL--ISMVRIGVACSMELPQDRTNMTNVVHELQSIKN 933 (949)
Q Consensus 873 l~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 933 (949)
....+.++ ....... ..+.+++.+|+..+|++||++.|+++.+..+..
T Consensus 122 ~~~~~~~~-------------~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 122 PADDPRDR-------------SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred ccCCcccc-------------ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 00000000 0001222 368999999999999999999999999887654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-23 Score=262.22 Aligned_cols=315 Identities=19% Similarity=0.261 Sum_probs=192.5
Q ss_pred ccccccCCC-CCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCcccccccccccCC
Q 039533 153 ILSRFSSLS-KTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGE 231 (949)
Q Consensus 153 ~~~~~~~L~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~ 231 (949)
+|..|..++ +|+.|++.+|.+. .+|..| ...+|++|+|++|++. .+|..+..+++|++|+|++|.. .+.
T Consensus 580 lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~-------l~~ 649 (1153)
T PLN03210 580 LPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKN-------LKE 649 (1153)
T ss_pred cCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCC-------cCc
Confidence 344454443 4677777777776 566665 4567777777777776 5666667777777777765431 122
Q ss_pred CCChhhhccccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCC
Q 039533 232 VPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIP 311 (949)
Q Consensus 232 ~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~ 311 (949)
+|.+..+++|++|+|++ |.....+|..+..+. +|+.|++++|..-+.+|
T Consensus 650 ip~ls~l~~Le~L~L~~------------------------------c~~L~~lp~si~~L~-~L~~L~L~~c~~L~~Lp 698 (1153)
T PLN03210 650 IPDLSMATNLETLKLSD------------------------------CSSLVELPSSIQYLN-KLEDLDMSRCENLEILP 698 (1153)
T ss_pred CCccccCCcccEEEecC------------------------------CCCccccchhhhccC-CCCEEeCCCCCCcCccC
Confidence 33333334444444433 333333444444432 35555555443223344
Q ss_pred CCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecccccc-------cccCCC
Q 039533 312 AGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFL-------EVSIPS 384 (949)
Q Consensus 312 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l-------~~~~p~ 384 (949)
..+ ++++|++|+|++|...+.+|.. ..+|+.|+|++|.+. .+|..+ .+++|+.|++.++.. ....+.
T Consensus 699 ~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~ 772 (1153)
T PLN03210 699 TGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPL 772 (1153)
T ss_pred CcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchh
Confidence 433 4455555555555433334432 234555555555554 344433 345555555544221 111122
Q ss_pred CCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccCCcccccccc
Q 039533 385 SLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIR 464 (949)
Q Consensus 385 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 464 (949)
.+...++|+.|+|++|...+.+|..+.++++| +.|++++|..-+.+|..+ .+++|+.|+|++|..-..+|.. ..+
T Consensus 773 ~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L-~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~n 847 (1153)
T PLN03210 773 MTMLSPSLTRLFLSDIPSLVELPSSIQNLHKL-EHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STN 847 (1153)
T ss_pred hhhccccchheeCCCCCCccccChhhhCCCCC-CEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccc
Confidence 23334678888888887777788888888877 678888765444677665 6889999999998655566654 367
Q ss_pred hhhcccCccccccccCCCcCCCCCCCEEECCC-CcCCCcCcccccCCc-cceEeCCCCc
Q 039533 465 LEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQ-NNLSGEIPKFLAGLS-LNNLNLSYND 521 (949)
Q Consensus 465 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~~~-L~~l~ls~N~ 521 (949)
|+.|+|++|.++ .+|.++..+++|+.|+|++ |+|+ .+|.....++ |+.++++++.
T Consensus 848 L~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 848 ISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred cCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 999999999998 6899999999999999999 5666 4666666665 9999999874
|
syringae 6; Provisional |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-24 Score=263.60 Aligned_cols=201 Identities=18% Similarity=0.246 Sum_probs=136.9
Q ss_pred hcCC-CcceeEEeeeecccccC--CccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHh
Q 039533 679 SIRH-RNLVKVLTACLGADYRG--NDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLH 755 (949)
Q Consensus 679 ~l~h-~niv~~~~~~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH 755 (949)
.++| +||.+++++|.....++ ....+.++||+ +++|.+++.. ....+++.+++.++.||++||+|||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~al~~lH 97 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---------PDRSVDAFECFHVFRQIVEIVNAAH 97 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---------ccccccHHHHHHHHHHHHHHHHHHH
Confidence 3455 57888888763322111 22466778887 5699999962 2345899999999999999999999
Q ss_pred hCCCCCeEecCCCCCCeeecC-------------------CCceEEeecccceecCCCCC--------------cccccc
Q 039533 756 HDCQPVTAHCDLKPSNVLLDD-------------------YMTARVGDFGLARILSPDHT--------------QTSSFS 802 (949)
Q Consensus 756 ~~~~~~ivHrDlkp~NIll~~-------------------~~~~kl~DfG~a~~~~~~~~--------------~~~~~~ 802 (949)
++ +|+||||||+|||++. ++.+|++|||+++....... ......
T Consensus 98 ~~---gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (793)
T PLN00181 98 SQ---GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQIL 174 (793)
T ss_pred hC---CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccc
Confidence 77 9999999999999954 44566666666654211000 000011
Q ss_pred ccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhhhcccCCCCCchhhhh
Q 039533 803 VKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLIL 882 (949)
Q Consensus 803 ~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 882 (949)
..||+.|||||++.+..++.++|||||||++|||++|.+|+..... ........ ...+.
T Consensus 175 ~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~~~------------~~~~~------ 233 (793)
T PLN00181 175 AMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLRHR------------VLPPQ------ 233 (793)
T ss_pred cCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHHHh------------hcChh------
Confidence 3478899999999999999999999999999999999888642110 00000000 00000
Q ss_pred hhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 883 TGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
..........++.+|++++|.+||+|.||++
T Consensus 234 -------------~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 234 -------------ILLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred -------------hhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 0011223457788999999999999999975
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-23 Score=245.83 Aligned_cols=367 Identities=22% Similarity=0.291 Sum_probs=181.4
Q ss_pred hhcCCCChhhHHHHHHHHhccCCCCCCCccC----ccCCCCcceeee----------------eEEeCCCCcEEEEEcCC
Q 039533 15 LVAGTGNETDRVALLEFKSKSTYDPVGVLGT----WNESIHFCKWYG----------------VTCSRRHQRVTLLDLRS 74 (949)
Q Consensus 15 ~~~~~~~~~~~~aLl~~k~~~~~~~~~~l~s----W~~~~~~C~w~g----------------v~C~~~~~~v~~l~l~~ 74 (949)
+..++...+|.+.+++..+.+.+. +.+.+ |++.+++|.=.. |.|.. +.||.+..-+
T Consensus 55 ~~~~~~~~~~~~~~~~~~~~l~~p--~~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~~--~~vt~l~~~g 130 (754)
T PRK15370 55 HPPETASPEEIKSKFECLRMLAFP--AYADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGGG--KSVTYTRVTE 130 (754)
T ss_pred CCCCCCCHHHHHHHHHHHHHhcCC--chhhccccccCCCCcccccCCcchhhheeeecCCceEEecCC--Cccccccccc
Confidence 456667789999999998877433 34555 998899995443 66754 3566666554
Q ss_pred CCCCccccCCCCCCCCCceeec----cCceeccc----------cCCcccCcccCcEEeeccccccCcCCCCCCCCccce
Q 039533 75 LKLAGSVSHFIGNLSFLKQLYL----QVNSFTHE----------IPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLI 140 (949)
Q Consensus 75 ~~l~g~~~~~l~~l~~L~~L~L----~~n~l~~~----------~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 140 (949)
...+.....+ -..-.+... ..+.-.+. +..+ -..+.+.|+|+++.++ .+|..+. +.|+
T Consensus 131 ~~~~~~~~~~---~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~C--l~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~ 202 (754)
T PRK15370 131 SEQASSASGS---KDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDC--LKNNKTELRLKILGLT-TIPACIP--EQIT 202 (754)
T ss_pred ccccccCCCC---CChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhh--cccCceEEEeCCCCcC-cCCcccc--cCCc
Confidence 3222211110 000000000 00000000 0111 1245677888887777 5665543 2455
Q ss_pred eecCCCccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCcc
Q 039533 141 PIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANN 220 (949)
Q Consensus 141 ~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 220 (949)
.|++++|+|+..+...+ ++|+.|+|++|+|+ .+|..+. .+|+.|+|++|+++ .+|..+. ++|++|+|++|+
T Consensus 203 ~L~Ls~N~LtsLP~~l~---~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~ 273 (754)
T PRK15370 203 TLILDNNELKSLPENLQ---GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNK 273 (754)
T ss_pred EEEecCCCCCcCChhhc---cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCc
Confidence 55555555543322221 24455555555554 3343332 23445555555444 3333322 233444444333
Q ss_pred cccccccccCCCCChhhhccccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEE
Q 039533 221 LSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLF 300 (949)
Q Consensus 221 l~~~~~~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~ 300 (949)
|+. +|..+ +.+|+.|+
T Consensus 274 L~~-------------------------------------------------------------LP~~l---~~sL~~L~ 289 (754)
T PRK15370 274 ISC-------------------------------------------------------------LPENL---PEELRYLS 289 (754)
T ss_pred cCc-------------------------------------------------------------ccccc---CCCCcEEE
Confidence 322 22211 12344555
Q ss_pred ccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecccccccc
Q 039533 301 LNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEV 380 (949)
Q Consensus 301 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 380 (949)
|++|+|++ +|..+. ++|+.|++++|+++. +|..+. ++|+.|++++|.+++ +|..+. ++|+.|++++|+|+
T Consensus 290 Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~- 359 (754)
T PRK15370 290 VYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT- 359 (754)
T ss_pred CCCCcccc-Ccccch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-
Confidence 55555542 333221 245555555555552 333222 355556666666553 444332 45666666666665
Q ss_pred cCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccc----cccccccceeeeccccccccCC
Q 039533 381 SIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIE----VGKLKILEFLYVYENRLEGEIP 456 (949)
Q Consensus 381 ~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~~~~p 456 (949)
.+|..+. ++|+.|+|++|+|+ .+|..+.. .+ +.|++++|+|+ .+|.. .+.++.+..|++.+|.++
T Consensus 360 ~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~~--sL-~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls---- 428 (754)
T PRK15370 360 VLPETLP--PTITTLDVSRNALT-NLPENLPA--AL-QIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS---- 428 (754)
T ss_pred cCChhhc--CCcCEEECCCCcCC-CCCHhHHH--HH-HHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc----
Confidence 3444432 46777777777776 45554432 33 56777777776 44443 334467788888888876
Q ss_pred cccccccchhhcccCccccccc-cCCCcCCCCCCC
Q 039533 457 STFGNCIRLEQLGMGGNLFQGP-ISSSLGSLRGLR 490 (949)
Q Consensus 457 ~~~~~l~~L~~L~l~~N~l~~~-~~~~~~~l~~L~ 490 (949)
...+.+|+.| ++.+.+.|. ++..++.+.+++
T Consensus 429 --~~tl~~L~~L-l~s~~~~gp~i~~~~~~~~~l~ 460 (754)
T PRK15370 429 --ERTIQNMQRL-MSSVGYQGPRVLFAMGDFSIVR 460 (754)
T ss_pred --HHHHHHHHHh-hhcccccCCccccccccccccc
Confidence 2455666666 444554442 333333333333
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=218.91 Aligned_cols=168 Identities=23% Similarity=0.137 Sum_probs=130.6
Q ss_pred HHhcCCCCCCeeeeecCceEEEEEEcC-CCEEEEEEEEecCC-----CcchHHHHHHHHHHHhcCCCcceeEEeeeeccc
Q 039533 623 NATSGFSSANLVGVGSFGSVYKGIIDE-GRTTIAVKVFNLQH-----HGASRSFIAECKALKSIRHRNLVKVLTACLGAD 696 (949)
Q Consensus 623 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 696 (949)
...++|.+.+.||+|+||+||+|++.. +++.||||+..... ....+.+.+|++++++++|+|+++.+..+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 445789999999999999999998875 67888999875321 12245689999999999999998533221
Q ss_pred ccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC-CCCCeeec
Q 039533 697 YRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDL-KPSNVLLD 775 (949)
Q Consensus 697 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDl-kp~NIll~ 775 (949)
...++||||+++++|... .. . . ...++.|+++||+|||++ ||+|||| ||+||+++
T Consensus 91 ----~~~~LVmE~~~G~~L~~~-~~---------~-~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~ 146 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLHLA-RP---------H-G------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMG 146 (365)
T ss_pred ----CCcEEEEEccCCCCHHHh-Cc---------c-c------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEc
Confidence 146999999999999632 10 0 0 146789999999999977 9999999 99999999
Q ss_pred CCCceEEeecccceecCCCCCccc------cccccCccCccCccccCCC
Q 039533 776 DYMTARVGDFGLARILSPDHTQTS------SFSVKGSLGYIAPEYGVGC 818 (949)
Q Consensus 776 ~~~~~kl~DfG~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 818 (949)
.++.+||+|||+|+.+........ -....+++.|+|||++...
T Consensus 147 ~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 147 PDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999999999999998765443111 1245688999999987754
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8e-22 Score=198.26 Aligned_cols=265 Identities=16% Similarity=0.183 Sum_probs=204.3
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcC-CCcceeEEeeeecccccCCcccee
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIR-HRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
.|.++++||+|.||.++.|+.--++++||||.-....+ ..++..|.+..+.+. .+.|..+|-+..+.. +-.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~-----~NiL 101 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGK-----YNIL 101 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccc-----hhhh
Confidence 68999999999999999999988899999998654433 457888999999884 689999886643333 6789
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCC-----Cce
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDY-----MTA 780 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~-----~~~ 780 (949)
|+|.+ |.||+|++. -.++.++..++..||.|+..-++|+|++ .+|.|||||+|+||... ..+
T Consensus 102 VidLL-GPSLEDLFD---------~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~I 168 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFD---------LCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVI 168 (449)
T ss_pred hhhhh-CcCHHHHHH---------HhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceE
Confidence 99998 789999886 2457799999999999999999999988 89999999999999643 358
Q ss_pred EEeecccceecCCCCC-----ccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCcccccc--Cchh
Q 039533 781 RVGDFGLARILSPDHT-----QTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEG--DINL 853 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~--~~~~ 853 (949)
.++|||+|+.+.+..+ ........||.+||+-....+...+.+.|+=|+|-++.+.+-|..||+..... ...+
T Consensus 169 hiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kY 248 (449)
T KOG1165|consen 169 HIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKY 248 (449)
T ss_pred EEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHH
Confidence 9999999999877655 22233456999999999988999999999999999999999999999744221 1111
Q ss_pred hhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHH
Q 039533 854 HNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKN 933 (949)
Q Consensus 854 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 933 (949)
.....+.....+. .-+...|+++.+-+...-..+-++-|..+-+...+..+.+
T Consensus 249 eKIGe~Kr~T~i~---------------------------~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld 301 (449)
T KOG1165|consen 249 EKIGETKRSTPIE---------------------------VLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD 301 (449)
T ss_pred HHhccccccCCHH---------------------------HHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 1111111010111 1123445566666666667788999999988888888877
Q ss_pred hhccC
Q 039533 934 ILLGV 938 (949)
Q Consensus 934 ~~~~~ 938 (949)
....+
T Consensus 302 r~g~t 306 (449)
T KOG1165|consen 302 RLGET 306 (449)
T ss_pred hcCCc
Confidence 76655
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-21 Score=214.62 Aligned_cols=274 Identities=23% Similarity=0.209 Sum_probs=200.4
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCC-EEEEEEEEecCCCcchHHHHHHHHHHHhcCC----CcceeEEeeeecccccCCc
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGR-TTIAVKVFNLQHHGASRSFIAECKALKSIRH----RNLVKVLTACLGADYRGND 701 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~~~~~~~~~~~~ 701 (949)
+|.+.+.||+|+||.||.|.+..++ ..+|+|+...........+..|..++..+.. +++.++++... ....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence 7999999999999999999997654 6799998875543333378889999999863 68888887753 2344
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCC----
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDY---- 777 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~---- 777 (949)
+.++||+.+ |.+|.++.... ..+.++..++..|+.|++.+|+++|+. |++||||||+|+++...
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~--------~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~ 162 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRN--------PPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSE 162 (322)
T ss_pred eeEEEEecc-CccHHHHHHhC--------CCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcc
Confidence 789999988 78999987521 146799999999999999999999977 99999999999999854
Q ss_pred -CceEEeecccce--ecCCCCC----cc-c-cccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccc
Q 039533 778 -MTARVGDFGLAR--ILSPDHT----QT-S-SFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFE 848 (949)
Q Consensus 778 -~~~kl~DfG~a~--~~~~~~~----~~-~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~ 848 (949)
..+.+.|||+|+ .+..... .. . .....||..|+++....+...+.+.|+||++.++.|++.|..||.....
T Consensus 163 ~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 163 VRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred cceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 469999999998 3322221 11 1 1235599999999999999999999999999999999999999854322
Q ss_pred cCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 039533 849 GDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHEL 928 (949)
Q Consensus 849 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 928 (949)
... .... ........... .....+..+.++...+-..+..++|....+...+
T Consensus 243 ~~~-~~~~---------~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l 294 (322)
T KOG1164|consen 243 TDL-KSKF---------EKDPRKLLTDR------------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELL 294 (322)
T ss_pred cch-HHHH---------HHHhhhhcccc------------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHH
Confidence 111 0000 00000000000 0011234456666666668999999999999999
Q ss_pred HHhHHhhccCCCCCCc
Q 039533 929 QSIKNILLGVELCPPC 944 (949)
Q Consensus 929 ~~i~~~~~~~~~~~~~ 944 (949)
++...........|+.
T Consensus 295 ~~~~~~~~~~~~~~~d 310 (322)
T KOG1164|consen 295 KDVFDSEGSKEDSPFD 310 (322)
T ss_pred HHHHHhcCCCCCCCCc
Confidence 8887775444445543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-22 Score=193.14 Aligned_cols=265 Identities=18% Similarity=0.229 Sum_probs=194.1
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCC-CcceeEEeeeecccccCCccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRH-RNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~ 703 (949)
.+.|.++++||.|+||.+|.|..-.+|+.||||+-+.... ..++..|..+...+++ ..|.++..|..+.. +.
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~-----yn 86 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKD-----YN 86 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccc-----cc
Confidence 4679999999999999999999999999999999754332 3467889999999875 56777766644443 77
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec---CCCce
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD---DYMTA 780 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~---~~~~~ 780 (949)
.+||+.+ |.+|++.+.- ..+.++..+++-++.|++.-++|+|.+ +++||||||+|+|.. ....+
T Consensus 87 vlVMdLL-GPsLEdLfnf---------C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl 153 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNF---------CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKL 153 (341)
T ss_pred eeeeecc-CccHHHHHHH---------HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceE
Confidence 9999998 7899998863 345689999999999999999999977 899999999999996 33468
Q ss_pred EEeecccceecCCCCC-----ccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhh
Q 039533 781 RVGDFGLARILSPDHT-----QTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHN 855 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~ 855 (949)
.++|||+|+.+.+..+ ........||.+|.+-....+...+.+.|+=|+|.++.+.--|..||+........
T Consensus 154 ~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~--- 230 (341)
T KOG1163|consen 154 YLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK--- 230 (341)
T ss_pred EEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH---
Confidence 9999999998765443 22233456999999988888888899999999999999999999999754322100
Q ss_pred hccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHh
Q 039533 856 FGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNI 934 (949)
Q Consensus 856 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 934 (949)
+....+.+..+....+ .-+...|.++.-.+..|-..--++-|...-+.+.+.-+...
T Consensus 231 -------QKyEkI~EkK~s~~ie---------------~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ 287 (341)
T KOG1163|consen 231 -------QKYEKISEKKMSTPIE---------------VLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRT 287 (341)
T ss_pred -------HHHHHHHHhhcCCCHH---------------HHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhh
Confidence 0011111111111000 01123344556666677777777777777666666555433
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.9e-23 Score=200.78 Aligned_cols=250 Identities=22% Similarity=0.315 Sum_probs=186.4
Q ss_pred CCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeE
Q 039533 629 SSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASV 706 (949)
Q Consensus 629 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 706 (949)
....+|.+...|..|+|++. |..+++|++....- ...++|..|.-.++-+.||||.++++.|..+. ...++
T Consensus 193 nl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp-----nlv~i 265 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP-----NLVII 265 (448)
T ss_pred hhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC-----CceEe
Confidence 34467889999999999997 55688888764432 23468999999999999999999999997665 78999
Q ss_pred eeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecc
Q 039533 707 YEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFG 786 (949)
Q Consensus 707 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG 786 (949)
..||+.|+|+..++.. ..-..+..++.+++.++|+|++|||+- .+-|.---+.+..+++|++.+++|+= +
T Consensus 266 sq~mp~gslynvlhe~--------t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-a 335 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQ--------TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-A 335 (448)
T ss_pred eeeccchHHHHHHhcC--------ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-c
Confidence 9999999999999843 233467779999999999999999987 44455557899999999999988751 1
Q ss_pred cceecCCCCCccccccccCccCccCccccCCCccC---CccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCC
Q 039533 787 LARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVS---TNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 787 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
-+++. .......-.+.||+||.++..+.+ .++|+|||++++||+-|...||.+....+... +.
T Consensus 336 d~kfs------fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm-----ki--- 401 (448)
T KOG0195|consen 336 DTKFS------FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM-----KI--- 401 (448)
T ss_pred cceee------eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh-----hh---
Confidence 11111 001122246889999998876533 67999999999999999999997543321110 00
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhH
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIK 932 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 932 (949)
..+-++..+ +......+.+++.-|+..||.+||.+..|+-.|+++.
T Consensus 402 -aleglrv~i----------------------ppgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 402 -ALEGLRVHI----------------------PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred -hhccccccC----------------------CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 001111111 1244567889999999999999999999999998764
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=9e-22 Score=232.58 Aligned_cols=255 Identities=26% Similarity=0.440 Sum_probs=131.1
Q ss_pred eeeeEEeCCCCcEEEEEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCC
Q 039533 55 WYGVTCSRRHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNIS 134 (949)
Q Consensus 55 w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 134 (949)
|.-..|-.. .++.|++++++++ .+|..+. ++|+.|+|++|+++ .+|..+. ++|++|+|++|+|+ .+|..+.
T Consensus 170 ~r~~~Cl~~--~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~ 240 (754)
T PRK15370 170 QRMRDCLKN--NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP 240 (754)
T ss_pred HHHHhhccc--CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh
Confidence 333456433 4677888887777 3555443 46778888888877 5665543 47778888887776 5565432
Q ss_pred CCccceeecCCCccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccc
Q 039533 135 RCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFL 214 (949)
Q Consensus 135 ~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 214 (949)
.+| +.|+|++|.++ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|++|
T Consensus 241 --~~L------------------------~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L 288 (754)
T PRK15370 241 --DTI------------------------QEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYL 288 (754)
T ss_pred --ccc------------------------cEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEE
Confidence 234 45555555554 3444332 34555555555555 3444332 345555
Q ss_pred cccCcccccccccccCCCCChhhhccccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccc
Q 039533 215 SLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSK 294 (949)
Q Consensus 215 ~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~ 294 (949)
+|++|+|+.++.. +| ++|++|++++|+++.. |..+ ++
T Consensus 289 ~Ls~N~Lt~LP~~----lp-----~sL~~L~Ls~N~Lt~L-------------------------------P~~l---~~ 325 (754)
T PRK15370 289 SVYDNSIRTLPAH----LP-----SGITHLNVQSNSLTAL-------------------------------PETL---PP 325 (754)
T ss_pred ECCCCccccCccc----ch-----hhHHHHHhcCCccccC-------------------------------Cccc---cc
Confidence 5555555433211 11 1233444444433321 1111 12
Q ss_pred cccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecc
Q 039533 295 TIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLN 374 (949)
Q Consensus 295 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 374 (949)
+|+.|++++|.+++ +|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ..|+.|+++
T Consensus 326 sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs 396 (754)
T PRK15370 326 GLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--AALQIMQAS 396 (754)
T ss_pred cceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhc
Confidence 34455555555542 333332 45556666666555 3444332 45666666666666 3444332 245566666
Q ss_pred cccccccCCCC----CCCCCCCcEEEeeCcccc
Q 039533 375 DNFLEVSIPSS----LGQCESLIEINLSNNNLS 403 (949)
Q Consensus 375 ~N~l~~~~p~~----~~~l~~L~~L~l~~N~l~ 403 (949)
+|+|+ .+|.. +..++++..|++.+|.++
T Consensus 397 ~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 397 RNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred cCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 66655 33332 233455666666666654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.4e-22 Score=231.17 Aligned_cols=254 Identities=21% Similarity=0.262 Sum_probs=188.0
Q ss_pred CCCeeeeecCceEEEEEEcCCCEEEEEEEEecC--CCcc----hHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 630 SANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ--HHGA----SRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 630 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
...++|.|.+|.|+.+......+..+.|.++.. .... ...+..|+-+-..++|+|++..+..+.+.. ..
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~-----~~ 396 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID-----GI 396 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc-----cc
Confidence 457899999999988888766666666655421 1111 122556777778889999988776654433 33
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
.-+|||+++ +|..++.. ...++..++..++.|+..|++|+|+. ||.|||+|++|++++.+|.+||+
T Consensus 397 ~~~mE~~~~-Dlf~~~~~----------~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~ 462 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMS----------NGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKII 462 (601)
T ss_pred hhhhhcccH-HHHHHHhc----------ccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEe
Confidence 334999999 99999862 24578889999999999999999977 99999999999999999999999
Q ss_pred ecccceecCCCCCc--cccccccCccCccCccccCCCccC-CccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 784 DFGLARILSPDHTQ--TSSFSVKGSLGYIAPEYGVGCEVS-TNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 784 DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~-~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
|||.+.....+... .......|+..|+|||++.+..|+ ...||||.|++++.|.+|+.||......+..+.. ..
T Consensus 463 Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~---~~ 539 (601)
T KOG0590|consen 463 DFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT---NN 539 (601)
T ss_pred ecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh---hc
Confidence 99999876544443 344467799999999999999887 4689999999999999999999755444332200 00
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
...+ ..............+.+...++.++++.||.+|.|+++|++
T Consensus 540 ~~~~---------------------~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 540 YSDQ---------------------RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccc---------------------cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0000 00000111123456677888999999999999999999986
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.8e-21 Score=192.49 Aligned_cols=175 Identities=13% Similarity=0.092 Sum_probs=134.7
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHH---------HHHHHHHHHhcCCCcceeEEeeeecc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRS---------FIAECKALKSIRHRNLVKVLTACLGA 695 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~niv~~~~~~~~~ 695 (949)
.++|++.+++|.|+||.||.+.. ++..+|+|+++.......+. +.+|+..+.++.|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 47899999999999999999766 36689999997554433322 67999999999999999999886644
Q ss_pred ccc---CCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCe
Q 039533 696 DYR---GNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNV 772 (949)
Q Consensus 696 ~~~---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NI 772 (949)
++. .....++||||++|.+|.++.. ++. ....+++.++..+|.. |++|||+||+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Ni 166 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNF 166 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh--------------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHE
Confidence 321 1345789999999999988742 222 2466999999999977 999999999999
Q ss_pred eecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHH
Q 039533 773 LLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELV 837 (949)
Q Consensus 773 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ell 837 (949)
+++.++ ++++|||.......+..... +.....+..++||||||+++....
T Consensus 167 li~~~g-i~liDfg~~~~~~e~~a~d~--------------~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 167 IVSKNG-LRIIDLSGKRCTAQRKAKDR--------------IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEeCCC-EEEEECCCcccccchhhHHH--------------HHHHhHhcccccccceeEeehHHH
Confidence 999988 99999998876533222111 233345667999999999977543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.1e-19 Score=199.78 Aligned_cols=260 Identities=27% Similarity=0.329 Sum_probs=192.8
Q ss_pred CCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc---chHHHHHHHHHHHhcCCC-cceeEEeeeecccccCCccc
Q 039533 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG---ASRSFIAECKALKSIRHR-NLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 628 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~ 703 (949)
|.+.+.||.|+||.||++.+. ..+++|.+...... ....+.+|+..++.+.|+ +++++++++.... ..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEG-----SL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCC-----EE
Confidence 677889999999999999987 78899998755433 357899999999999988 7999999874332 47
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC-ceEE
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM-TARV 782 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kl 782 (949)
+++++++.++++.+++...... ..++......++.|++.+++|+|+. +++|||+||+||+++..+ .+++
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l 143 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRK-------GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKL 143 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccc-------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEE
Confidence 9999999999999777521100 3688899999999999999999977 899999999999999888 7999
Q ss_pred eecccceecCCCCCcc----ccccccCccCccCccccCC---CccCCccchHHHHHHHHHHHhCCCCCcccccc--Cchh
Q 039533 783 GDFGLARILSPDHTQT----SSFSVKGSLGYIAPEYGVG---CEVSTNGDVYSYGILLLELVIGKKPIDIMFEG--DINL 853 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~--~~~~ 853 (949)
+|||.++......... ......|+..|+|||...+ ..++...|+||+|++++++++|..||...... ....
T Consensus 144 ~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~ 223 (384)
T COG0515 144 IDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT 223 (384)
T ss_pred eccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHH
Confidence 9999998665443221 1235669999999999987 57889999999999999999999997543221 0011
Q ss_pred hhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 854 HNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 854 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
.......... ........ ... ......+.+++..|+..+|..|.++.+....
T Consensus 224 ~~~~~~~~~~--------~~~~~~~~------------~~~--~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 224 LKIILELPTP--------SLASPLSP------------SNP--ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHHhcCCc--------ccccccCc------------ccc--chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1110000000 00000000 000 1223467788889999999999999987765
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.3e-20 Score=183.43 Aligned_cols=141 Identities=15% Similarity=0.099 Sum_probs=108.1
Q ss_pred CCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc--c-------hHH-----------------HHHHHHHHHhcCCCc
Q 039533 631 ANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG--A-------SRS-----------------FIAECKALKSIRHRN 684 (949)
Q Consensus 631 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~h~n 684 (949)
...||+|++|.||+|.+. +|+.||||+++..... . ..+ ...|++.+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999997 8999999999754211 1 112 234999999998877
Q ss_pred ceeEEeeeecccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeE
Q 039533 685 LVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYL-HHDCQPVTA 763 (949)
Q Consensus 685 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~L-H~~~~~~iv 763 (949)
+.....+.. ...++||||++++++..... ....++..++..++.|++.+|+|+ |+. +|+
T Consensus 81 v~~p~~~~~-------~~~~iVmE~i~g~~l~~~~~----------~~~~~~~~~~~~i~~qi~~~L~~l~H~~---gii 140 (190)
T cd05147 81 IPCPEPILL-------KSHVLVMEFIGDDGWAAPRL----------KDAPLSESKARELYLQVIQIMRILYQDC---RLV 140 (190)
T ss_pred CCCCcEEEe-------cCCEEEEEEeCCCCCcchhh----------hcCCCCHHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 643332211 12489999999877654432 123578899999999999999999 666 899
Q ss_pred ecCCCCCCeeecCCCceEEeecccceecCC
Q 039533 764 HCDLKPSNVLLDDYMTARVGDFGLARILSP 793 (949)
Q Consensus 764 HrDlkp~NIll~~~~~~kl~DfG~a~~~~~ 793 (949)
||||||+||++++ +.++|+|||+|.....
T Consensus 141 HrDlkP~NIli~~-~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 141 HADLSEYNLLYHD-GKLYIIDVSQSVEHDH 169 (190)
T ss_pred cCCCCHHHEEEEC-CcEEEEEccccccCCC
Confidence 9999999999984 7899999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.3e-20 Score=212.92 Aligned_cols=250 Identities=20% Similarity=0.244 Sum_probs=176.4
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc-chHHHH---HHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG-ASRSFI---AECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~---~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
+|...+.||.+.|=.|.+|+++ .|. |+||++-..... ..+.+. .|++ ...++|||++++.-+- .....
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHH
Confidence 5777899999999999999998 344 999999765532 233343 4444 4555899999987552 23346
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.|+|-+|+.+ +|+|.+. .++-+...+.+.|+.|++.|+..+|.. ||+|||||.+||||+.-.-+.|
T Consensus 96 AylvRqyvkh-nLyDRlS----------TRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~L 161 (1431)
T KOG1240|consen 96 AYLVRQYVKH-NLYDRLS----------TRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYL 161 (1431)
T ss_pred HHHHHHHHhh-hhhhhhc----------cchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhh
Confidence 7888888865 8999986 456678889999999999999999977 9999999999999999999999
Q ss_pred eecccceec--CCCCCcc---ccccccCccCccCccccCCC----------c-cCCccchHHHHHHHHHHHh-CCCCCcc
Q 039533 783 GDFGLARIL--SPDHTQT---SSFSVKGSLGYIAPEYGVGC----------E-VSTNGDVYSYGILLLELVI-GKKPIDI 845 (949)
Q Consensus 783 ~DfG~a~~~--~~~~~~~---~~~~~~gt~~y~aPE~~~~~----------~-~~~~sDiwSlGvvl~ellt-g~~Pf~~ 845 (949)
+||..-+.. +.+.... .......-..|.|||.+... . .+++.||||+||++.|+++ |++||+-
T Consensus 162 tDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L 241 (1431)
T KOG1240|consen 162 TDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL 241 (1431)
T ss_pred hcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence 999876543 2222111 11122344679999975431 1 5678999999999999998 7888852
Q ss_pred ccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHH
Q 039533 846 MFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVV 925 (949)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~ 925 (949)
. .+..+.+.. ......+++ .++ ...+..++..|++.||++|-+|++++
T Consensus 242 S-----QL~aYr~~~-~~~~e~~Le------------------------~Ie--d~~~Rnlil~Mi~rdPs~RlSAedyL 289 (1431)
T KOG1240|consen 242 S-----QLLAYRSGN-ADDPEQLLE------------------------KIE--DVSLRNLILSMIQRDPSKRLSAEDYL 289 (1431)
T ss_pred H-----HHHhHhccC-ccCHHHHHH------------------------hCc--CccHHHHHHHHHccCchhccCHHHHH
Confidence 2 111111100 000111110 000 12467899999999999999999999
Q ss_pred HHHHH
Q 039533 926 HELQS 930 (949)
Q Consensus 926 ~~L~~ 930 (949)
+.-..
T Consensus 290 ~~yrG 294 (1431)
T KOG1240|consen 290 QKYRG 294 (1431)
T ss_pred Hhhhc
Confidence 87443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.4e-19 Score=177.13 Aligned_cols=141 Identities=17% Similarity=0.099 Sum_probs=110.8
Q ss_pred CCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcc--------------------------hHHHHHHHHHHHhcCCCc
Q 039533 631 ANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGA--------------------------SRSFIAECKALKSIRHRN 684 (949)
Q Consensus 631 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~n 684 (949)
...||+|++|.||+|++. +|+.||||+++...... ...+.+|.+.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999987 89999999998543210 112457899999999998
Q ss_pred ceeEEeeeecccccCCccceeEeeeccCCChhhh-cCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCe
Q 039533 685 LVKVLTACLGADYRGNDFKASVYEFMHYGSLEEW-LHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHH-DCQPVT 762 (949)
Q Consensus 685 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~~~~i 762 (949)
+.....+... ..++||||++++++... +. ...++..++..++.|++.++.++|+ . ||
T Consensus 81 i~~p~~~~~~-------~~~lVmE~~~g~~~~~~~l~-----------~~~~~~~~~~~i~~~l~~~l~~lH~~~---gi 139 (190)
T cd05145 81 VPVPEPILLK-------KNVLVMEFIGDDGSPAPRLK-----------DVPLEEEEAEELYEQVVEQMRRLYQEA---GL 139 (190)
T ss_pred CCCceEEEec-------CCEEEEEEecCCCchhhhhh-----------hccCCHHHHHHHHHHHHHHHHHHHHhC---CE
Confidence 7544333211 24899999998755333 32 2346778899999999999999998 6 99
Q ss_pred EecCCCCCCeeecCCCceEEeecccceecCCC
Q 039533 763 AHCDLKPSNVLLDDYMTARVGDFGLARILSPD 794 (949)
Q Consensus 763 vHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~ 794 (949)
+||||||+||+++ ++.++|+|||+|+.....
T Consensus 140 vHrDlkP~NIll~-~~~~~liDFG~a~~~~~~ 170 (190)
T cd05145 140 VHGDLSEYNILYH-DGKPYIIDVSQAVELDHP 170 (190)
T ss_pred ecCCCChhhEEEE-CCCEEEEEcccceecCCC
Confidence 9999999999999 789999999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-19 Score=188.39 Aligned_cols=241 Identities=19% Similarity=0.212 Sum_probs=149.8
Q ss_pred CCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc---chHHHHHHHHHHHhcCC----------CcceeEEeeeecc
Q 039533 629 SSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG---ASRSFIAECKALKSIRH----------RNLVKVLTACLGA 695 (949)
Q Consensus 629 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h----------~niv~~~~~~~~~ 695 (949)
...+.||.|+++.||.+++..+++.+|||++...... ..+++.+|.-....+.+ -.++-.++.....
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 3457899999999999999999999999999744422 23566666655544322 1122111111100
Q ss_pred c----c---cCCc-----cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 039533 696 D----Y---RGND-----FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTA 763 (949)
Q Consensus 696 ~----~---~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~iv 763 (949)
. + .+.. ..+++|+-+ .++|.+++.-..... .....+....++.+..|+++.+++||+. |++
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~---~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlV 167 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRA---QTHSPLAFAARLSLTVQMIRLVANLHSY---GLV 167 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHT---TTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcc---cccchhHHHHHHHHHHHHHHHHHHHhhc---ceE
Confidence 0 0 0001 235677777 458888764111100 0122345566778889999999999988 999
Q ss_pred ecCCCCCCeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCC--------CccCCccchHHHHHHHHH
Q 039533 764 HCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG--------CEVSTNGDVYSYGILLLE 835 (949)
Q Consensus 764 HrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDiwSlGvvl~e 835 (949)
|+||||+|++++++|.++|+||+.....+..... ...+..|.|||.... ..++.+.|.|++|+++|.
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 9999999999999999999999988765432221 225678999997533 257889999999999999
Q ss_pred HHhCCCCCccccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCC
Q 039533 836 LVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELP 915 (949)
Q Consensus 836 lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP 915 (949)
|++|..||+.......... .+..+.+.++.+.+++..+++++|
T Consensus 243 lWC~~lPf~~~~~~~~~~~-------------------------------------~f~~C~~~Pe~v~~LI~~lL~~~~ 285 (288)
T PF14531_consen 243 LWCGRLPFGLSSPEADPEW-------------------------------------DFSRCRDMPEPVQFLIRGLLQRNP 285 (288)
T ss_dssp HHHSS-STCCCGGGSTSGG-------------------------------------GGTTSS---HHHHHHHHHHT-SSG
T ss_pred HHHccCCCCCCCccccccc-------------------------------------cchhcCCcCHHHHHHHHHHccCCc
Confidence 9999999974422211000 111222557789999999999999
Q ss_pred CCC
Q 039533 916 QDR 918 (949)
Q Consensus 916 ~~R 918 (949)
++|
T Consensus 286 ~~R 288 (288)
T PF14531_consen 286 EDR 288 (288)
T ss_dssp GGS
T ss_pred ccC
Confidence 988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.9e-19 Score=183.74 Aligned_cols=203 Identities=21% Similarity=0.203 Sum_probs=139.7
Q ss_pred CCCcceeEEeeeeccc----------------------ccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHH
Q 039533 681 RHRNLVKVLTACLGAD----------------------YRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLL 738 (949)
Q Consensus 681 ~h~niv~~~~~~~~~~----------------------~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~ 738 (949)
+|||||++.++|.+.- +......|+||..++. +|.+|+. ....+..
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~-----------~~~~s~r 341 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLW-----------TRHRSYR 341 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHh-----------cCCCchH
Confidence 5999999998875431 1223456888887764 8999885 2345667
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec--CCC--ceEEeecccceecCCCC---C-ccccccccCccCcc
Q 039533 739 QRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD--DYM--TARVGDFGLARILSPDH---T-QTSSFSVKGSLGYI 810 (949)
Q Consensus 739 ~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~--~~~--~~kl~DfG~a~~~~~~~---~-~~~~~~~~gt~~y~ 810 (949)
...-++.|+++|+.|||.+ ||.|||+|++|||+. +|+ .++|+|||++-...... . ........|...-|
T Consensus 342 ~~~~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lm 418 (598)
T KOG4158|consen 342 TGRVILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLM 418 (598)
T ss_pred HHHHHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceec
Confidence 7888999999999999977 999999999999993 443 57899999985432211 1 11111234777899
Q ss_pred CccccCCCc------cCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhh
Q 039533 811 APEYGVGCE------VSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTG 884 (949)
Q Consensus 811 aPE~~~~~~------~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 884 (949)
|||+....+ --.|+|.|+.|.+.||+++..-||..-.+...+... +.+ ..+.
T Consensus 419 APEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-----Yqe-------~qLP---------- 476 (598)
T KOG4158|consen 419 APEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-----YQE-------SQLP---------- 476 (598)
T ss_pred chhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh-----hhh-------hhCC----------
Confidence 999866421 236899999999999999999999531111111111 000 0111
Q ss_pred chhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 039533 885 NQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQ 929 (949)
Q Consensus 885 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 929 (949)
..++.++..+.+++...++.||.+|++..-...+|.
T Consensus 477 ---------alp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 477 ---------ALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred ---------CCcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 112355677889999999999999999876665553
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.1e-21 Score=173.21 Aligned_cols=166 Identities=34% Similarity=0.580 Sum_probs=127.4
Q ss_pred CCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecccccccccCCCCCCCCCCCc
Q 039533 314 IGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLI 393 (949)
Q Consensus 314 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 393 (949)
+.++.+.+.|.||+|+++ .+|+.+..+.+|+.|++++|+|+ .+|.+++.+++|+.|+++-|++. ..|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 345566667777777776 66666777777777777777776 66777777777777777777776 6777777777788
Q ss_pred EEEeeCcccc-CCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccCCcccccccchhhcccCc
Q 039533 394 EINLSNNNLS-GTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGG 472 (949)
Q Consensus 394 ~L~l~~N~l~-~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 472 (949)
.|||.+|++. ..+|..|+.+..+ ..|+|+.|.+. .+|..++++++|+.|.+..|.+- .+|.+++.+++|++|.+.+
T Consensus 106 vldltynnl~e~~lpgnff~m~tl-ralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqg 182 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTL-RALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQG 182 (264)
T ss_pred hhhccccccccccCCcchhHHHHH-HHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccc
Confidence 8888877775 4578888888877 67888888887 78888888888888888888888 7888888888888888888
Q ss_pred cccccccCCCcCCC
Q 039533 473 NLFQGPISSSLGSL 486 (949)
Q Consensus 473 N~l~~~~~~~~~~l 486 (949)
|+++ .+|..++++
T Consensus 183 nrl~-vlppel~~l 195 (264)
T KOG0617|consen 183 NRLT-VLPPELANL 195 (264)
T ss_pred ceee-ecChhhhhh
Confidence 8888 666665553
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-18 Score=170.43 Aligned_cols=186 Identities=16% Similarity=0.044 Sum_probs=139.3
Q ss_pred CCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc----chHHHHHHHHHHHhcC-CCcceeEEeeeecccccCCccc
Q 039533 629 SSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG----ASRSFIAECKALKSIR-HRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 629 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 703 (949)
.+...|++|+||+||.+.. .+.+++.+.+.....- ....+.+|+++++++. |+++++++++ + ..
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~-----~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----D-----GR 73 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----c-----CE
Confidence 4568999999999997776 5788887777533221 1125789999999995 5889999876 1 46
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC-CCCCeeecCCCceEE
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDL-KPSNVLLDDYMTARV 782 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDl-kp~NIll~~~~~~kl 782 (949)
+++|||++|.+|.+.... ....++.|++++++++|++ ||+|||| ||+||+++.++.++|
T Consensus 74 ~lvmeyI~G~~L~~~~~~-----------------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~L 133 (218)
T PRK12274 74 HLDRSYLAGAAMYQRPPR-----------------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAV 133 (218)
T ss_pred EEEEeeecCccHHhhhhh-----------------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEE
Confidence 899999999998654320 1134788999999999987 9999999 799999999999999
Q ss_pred eecccceecCCCCCc----cc-------cccccCccCccCccccCCC-ccC-CccchHHHHHHHHHHHhCCCCCcc
Q 039533 783 GDFGLARILSPDHTQ----TS-------SFSVKGSLGYIAPEYGVGC-EVS-TNGDVYSYGILLLELVIGKKPIDI 845 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~----~~-------~~~~~gt~~y~aPE~~~~~-~~~-~~sDiwSlGvvl~elltg~~Pf~~ 845 (949)
+|||+|....+.... .. ......++.|++|+...-- ..+ .+.+.++-|.-+|.++|+..|+-.
T Consensus 134 IDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 134 IDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred EECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 999999865543321 00 1112357777888753322 233 567999999999999999998643
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.6e-18 Score=204.25 Aligned_cols=201 Identities=19% Similarity=0.216 Sum_probs=158.3
Q ss_pred HHHHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcC---CCcceeEEeeeeccc
Q 039533 620 DLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIR---HRNLVKVLTACLGAD 696 (949)
Q Consensus 620 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~ 696 (949)
+.+.....|.|.+.+|+|+||+||+|.... |+.||+|+-+... ..+|.--.+++.+++ -+.|+++..++...+
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~---~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPN---PWEFYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCC---ceeeeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 334455678889999999999999999985 9999999976443 233333344455554 234555544433333
Q ss_pred ccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec-
Q 039533 697 YRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD- 775 (949)
Q Consensus 697 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~- 775 (949)
..++|+||.+.|+|.+++. ..+.+++.-++.++.|+++.+++||.. +||||||||+|+|+.
T Consensus 768 -----~S~lv~ey~~~Gtlld~~N----------~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~ 829 (974)
T KOG1166|consen 768 -----ASVLVSEYSPYGTLLDLIN----------TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRR 829 (974)
T ss_pred -----cceeeeeccccccHHHhhc----------cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeec
Confidence 6789999999999999997 346688999999999999999999977 999999999999994
Q ss_pred ------CCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCC
Q 039533 776 ------DYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842 (949)
Q Consensus 776 ------~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~P 842 (949)
+..-++|+|||.+..+..-........+++|-.+-.+|+..|..+++.+|.|.++.+++-|+.|++-
T Consensus 830 ~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 830 EICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 3346899999999766433333333356789999999999999999999999999999999999863
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.2e-20 Score=172.08 Aligned_cols=157 Identities=32% Similarity=0.474 Sum_probs=113.5
Q ss_pred ccccCCCCEEecCCcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccc
Q 039533 338 IGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLS 417 (949)
Q Consensus 338 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~ 417 (949)
+.++.+++.|.||+|+++ .+|+.+..+.+|+.|++++|+|+ .+|..++.+++|+.|+++-|++. .+|..|++++.+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l- 104 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL- 104 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh-
Confidence 345678888999999998 77888999999999999999998 68888889999999999988887 777777777777
Q ss_pred eeeccCCCccCC-CCccccccccccceeeeccccccccCCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCC
Q 039533 418 ISLDWSRNKLTG-SLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQ 496 (949)
Q Consensus 418 ~~L~ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 496 (949)
+.|||++|++.. .+|..|..++.|+.|+|+.|.+. .+|+.++++++|+.|.+.+|.+- ..|..++.+..|+.|.+.+
T Consensus 105 evldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqg 182 (264)
T KOG0617|consen 105 EVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQG 182 (264)
T ss_pred hhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccc
Confidence 667777777764 35555555666666666666665 55555666666666666655555 4555555555555555555
Q ss_pred CcCC
Q 039533 497 NNLS 500 (949)
Q Consensus 497 N~l~ 500 (949)
|+++
T Consensus 183 nrl~ 186 (264)
T KOG0617|consen 183 NRLT 186 (264)
T ss_pred ceee
Confidence 5555
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.5e-18 Score=189.96 Aligned_cols=218 Identities=25% Similarity=0.396 Sum_probs=160.3
Q ss_pred HHhcCCCcceeEEeeeecccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 039533 677 LKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHH 756 (949)
Q Consensus 677 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~ 756 (949)
|+.+.|.|+.+++|.+.+.. ..++|++|+..|+|.+.+.. ....+++.....+.++++.||+|+|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~-----~~~~i~~~c~rGsl~D~i~~---------~~~~~d~~F~~s~~rdi~~Gl~ylh~ 66 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGP-----EMIVIWEYCSRGSLLDILSN---------EDIKLDYFFILSFIRDISKGLAYLHN 66 (484)
T ss_pred CcccchhhhhhheeeEecCC-----ceEEEEeeecCccHHhHHhc---------cccCccHHHHHHHHHHHHHHHHHHhc
Confidence 35678999999999998764 78999999999999999972 34668999999999999999999997
Q ss_pred CCCCCeEecCCCCCCeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCc-------cCCccchHHH
Q 039533 757 DCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCE-------VSTNGDVYSY 829 (949)
Q Consensus 757 ~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDiwSl 829 (949)
. . ...|+.++++|.++|..+.+|++|||+.................-..-|.|||.+.+.. .+.+.|||||
T Consensus 67 s-~-i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~ 144 (484)
T KOG1023|consen 67 S-P-IGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSF 144 (484)
T ss_pred C-c-ceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehH
Confidence 6 2 23999999999999999999999999988764311111111222456799999977631 4678999999
Q ss_pred HHHHHHHHhCCCCCccccccCc--hhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHh
Q 039533 830 GILLLELVIGKKPIDIMFEGDI--NLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIG 907 (949)
Q Consensus 830 Gvvl~elltg~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 907 (949)
|++++|+++.+.||+....... ........ . -.+...++. ....+.++.+..++
T Consensus 145 ~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~----~----~~~~~rP~i----------------~~~~e~~~~l~~l~ 200 (484)
T KOG1023|consen 145 GIIMYEILFRSGPFDLRNLVEDPDEIILRVKK----G----GSNPFRPSI----------------ELLNELPPELLLLV 200 (484)
T ss_pred HHHHHHHHhccCccccccccCChHHHHHHHHh----c----CCCCcCcch----------------hhhhhcchHHHHHH
Confidence 9999999999999975422211 11111100 0 000011111 00113445788999
Q ss_pred hccccCCCCCCCCHHHHHHHHHHhHHh
Q 039533 908 VACSMELPQDRTNMTNVVHELQSIKNI 934 (949)
Q Consensus 908 ~~cl~~dP~~RPs~~ev~~~L~~i~~~ 934 (949)
..||..+|++||++++|-..++.+...
T Consensus 201 ~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 201 ARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred HHhcccChhhCccHHHHHhhhhhhccc
Confidence 999999999999999999998877553
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-17 Score=167.76 Aligned_cols=140 Identities=16% Similarity=0.194 Sum_probs=107.1
Q ss_pred CCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhc-----CCCcceeEEeeeecccccCCcc
Q 039533 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSI-----RHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 628 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~ 702 (949)
+.-.+.||+|+||.||. +..++.. +||+.........+.+.+|+.+++++ .||||++++|++.... +...
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~ 78 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGY 78 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeE
Confidence 34568999999999995 5545555 69998765555567899999999999 5799999999986542 1123
Q ss_pred -ceeEeee--ccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHH-HHHhhCCCCCeEecCCCCCCeeecC--
Q 039533 703 -KASVYEF--MHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYAL-NYLHHDCQPVTAHCDLKPSNVLLDD-- 776 (949)
Q Consensus 703 -~~lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL-~~LH~~~~~~ivHrDlkp~NIll~~-- 776 (949)
..+|+|| +.+++|.+++.. ..+++. ..++.|++.++ +|||++ +|+||||||+||+++.
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~-----------~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~ 142 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQ-----------CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRIS 142 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHc-----------ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccC
Confidence 3478999 567999999962 124444 35678888887 999987 8999999999999973
Q ss_pred --CCceEEeecccc
Q 039533 777 --YMTARVGDFGLA 788 (949)
Q Consensus 777 --~~~~kl~DfG~a 788 (949)
++.++|+||+.+
T Consensus 143 ~~~~~~~LiDg~G~ 156 (210)
T PRK10345 143 ESEVIPVVCDNIGE 156 (210)
T ss_pred CCCCcEEEEECCCC
Confidence 348999995444
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.4e-20 Score=203.81 Aligned_cols=134 Identities=23% Similarity=0.267 Sum_probs=62.0
Q ss_pred EEcCCCCCCc-cccCCCCCCCCCceeeccCceecc----ccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecC
Q 039533 70 LDLRSLKLAG-SVSHFIGNLSFLKQLYLQVNSFTH----EIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHP 144 (949)
Q Consensus 70 l~l~~~~l~g-~~~~~l~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 144 (949)
|+|.++.+++ .....+..+..|++|+|+++.++. .++..+...++|++|+++++.+.+ .+..+
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~-~~~~~----------- 70 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGR-IPRGL----------- 70 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCC-cchHH-----------
Confidence 4455555542 223334444445555555555532 133344444555555555554431 01000
Q ss_pred CCccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCC---ccEEeccccccCC----CCCCcccCC-Cccccccc
Q 039533 145 QNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSS---IHTISLAYNNLDG----TIPNSFGWF-ENLVFLSL 216 (949)
Q Consensus 145 ~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~L 216 (949)
..++..|..+++|+.|+|++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|+|
T Consensus 71 ------~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L 144 (319)
T cd00116 71 ------QSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVL 144 (319)
T ss_pred ------HHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEc
Confidence 122344555566666666666665444444444443 6666666666552 112223333 44555555
Q ss_pred cCccc
Q 039533 217 AANNL 221 (949)
Q Consensus 217 s~N~l 221 (949)
++|.+
T Consensus 145 ~~n~l 149 (319)
T cd00116 145 GRNRL 149 (319)
T ss_pred CCCcC
Confidence 54444
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.6e-20 Score=205.57 Aligned_cols=156 Identities=22% Similarity=0.251 Sum_probs=100.7
Q ss_pred cEEEEEcCCCCCCcc----ccCCCCCCCCCceeeccCceecc------ccCCcccCcccCcEEeeccccccCcCCCCCCC
Q 039533 66 RVTLLDLRSLKLAGS----VSHFIGNLSFLKQLYLQVNSFTH------EIPSEIGGLRRLKVLALNNNSICGEIPTNISR 135 (949)
Q Consensus 66 ~v~~l~l~~~~l~g~----~~~~l~~l~~L~~L~L~~n~l~~------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 135 (949)
.++.++++++.++.. ++..+...+.|++|+++++.+.+ .++..+..+++|++|+|++|.+.+..+..+..
T Consensus 24 ~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~ 103 (319)
T cd00116 24 CLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLES 103 (319)
T ss_pred hccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHH
Confidence 378899999998553 56677888999999999998872 34556778889999999999998666655555
Q ss_pred Ccc---ceeecCCCccccc----cccccccCC-CCCcEEECCCCCCCCC----CCCCcCCCCCccEEeccccccCCC---
Q 039533 136 CST---LIPIHPQNNQLVG----KILSRFSSL-SKTEILNLGSNHLTGS----IPSSLGNLSSIHTISLAYNNLDGT--- 200 (949)
Q Consensus 136 l~~---L~~L~l~~n~l~~----~~~~~~~~L-~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~--- 200 (949)
+.+ |++|++++|++.+ .+...+..+ ++|+.|+|++|.+++. ++..+..+.+|++|+|++|.+++.
T Consensus 104 l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~ 183 (319)
T cd00116 104 LLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIR 183 (319)
T ss_pred HhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHH
Confidence 544 7777777777653 223344555 6667777777766632 223344555666666666666531
Q ss_pred -CCCcccCCCccccccccCccc
Q 039533 201 -IPNSFGWFENLVFLSLAANNL 221 (949)
Q Consensus 201 -~p~~~~~l~~L~~L~Ls~N~l 221 (949)
++..+..+++|++|+|++|.+
T Consensus 184 ~l~~~l~~~~~L~~L~L~~n~i 205 (319)
T cd00116 184 ALAEGLKANCNLEVLDLNNNGL 205 (319)
T ss_pred HHHHHHHhCCCCCEEeccCCcc
Confidence 122233334455555554443
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=5e-17 Score=168.62 Aligned_cols=148 Identities=17% Similarity=0.108 Sum_probs=113.7
Q ss_pred HHhcCCCCCCeeeeecCceEEEEE-EcCCCEEEEEEEEecCCCc------------------------chHHHHHHHHHH
Q 039533 623 NATSGFSSANLVGVGSFGSVYKGI-IDEGRTTIAVKVFNLQHHG------------------------ASRSFIAECKAL 677 (949)
Q Consensus 623 ~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l 677 (949)
.....|.+.+.||+|++|.||+|. +..+|+.||+|+++..... ....+.+|+..+
T Consensus 25 ~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L 104 (237)
T smart00090 25 NRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL 104 (237)
T ss_pred hcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH
Confidence 333458889999999999999998 5568999999999754210 012356899999
Q ss_pred HhcCCC--cceeEEeeeecccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHh
Q 039533 678 KSIRHR--NLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLH 755 (949)
Q Consensus 678 ~~l~h~--niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH 755 (949)
+++.+. .+++++++ . ..++||||++++++..+.. ........++..++.|++.++++||
T Consensus 105 ~~L~~~~i~~p~~~~~----~-----~~~lV~E~~~g~~L~~~~~----------~~~~~~~~~~~~i~~qi~~~l~~LH 165 (237)
T smart00090 105 QRLYEAGVPVPKPIAW----R-----RNVLVMEFIGGDGLPAPRL----------KDVEPEEEEEFELYDDILEEMRKLY 165 (237)
T ss_pred HHHHhcCCCCCeeeEe----c-----CceEEEEEecCCccccccc----------ccCCcchHHHHHHHHHHHHHHHHHH
Confidence 999753 34444432 1 3489999999988876542 1123455667899999999999999
Q ss_pred hCCCCC-eEecCCCCCCeeecCCCceEEeecccceecCC
Q 039533 756 HDCQPV-TAHCDLKPSNVLLDDYMTARVGDFGLARILSP 793 (949)
Q Consensus 756 ~~~~~~-ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~ 793 (949)
++ + |+||||||+||+++ ++.++|+|||.|.....
T Consensus 166 ~~---g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 166 KE---GELVHGDLSEYNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hc---CCEEeCCCChhhEEEE-CCCEEEEEChhhhccCC
Confidence 77 8 99999999999999 78999999999875443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.7e-18 Score=188.81 Aligned_cols=187 Identities=26% Similarity=0.261 Sum_probs=151.6
Q ss_pred eeeeecCceEEEEEE---cCCCEEEEEEEEecCCCc--chHHHHHHHHHHHhcC-CCcceeEEeeeecccccCCccceeE
Q 039533 633 LVGVGSFGSVYKGII---DEGRTTIAVKVFNLQHHG--ASRSFIAECKALKSIR-HRNLVKVLTACLGADYRGNDFKASV 706 (949)
Q Consensus 633 ~lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv 706 (949)
++|+|.||.|+++.- ...+..+|+|+.+..... .......|..++..++ ||.++++...+.... ..+++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~-----kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDG-----KLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecccc-----chhHh
Confidence 378999999987543 334677899988644321 1125566788888886 999999987755443 78999
Q ss_pred eeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecc
Q 039533 707 YEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFG 786 (949)
Q Consensus 707 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG 786 (949)
++|..+|.+...+. ....++......+...++-|++++|+. +|+|||+|++||+++.+|++++.|||
T Consensus 76 ld~~rgg~lft~l~----------~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfg 142 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLS----------KEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFG 142 (612)
T ss_pred hhhcccchhhhccc----------cCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCch
Confidence 99999999988886 234567778888999999999999976 99999999999999999999999999
Q ss_pred cceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCcc
Q 039533 787 LARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDI 845 (949)
Q Consensus 787 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~ 845 (949)
.++..-..... .||..|||||+.. ....++|.||||++++||+||..||..
T Consensus 143 lske~v~~~~~------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 143 LSKEAVKEKIA------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hhhHhHhhhhc------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 99875443322 4899999999988 567889999999999999999999964
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.69 E-value=9.3e-18 Score=181.12 Aligned_cols=129 Identities=31% Similarity=0.452 Sum_probs=108.5
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
+.+|.|++++..+|.+|+.+.. .....++.....++.|++.|++| + +.+|||+||.||+...+..+|
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~-------~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~k 396 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR-------TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLK 396 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC-------cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhh
Confidence 5789999999999999996321 23346778889999999999999 4 899999999999999999999
Q ss_pred EeecccceecCCCC----CccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCC
Q 039533 782 VGDFGLARILSPDH----TQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPI 843 (949)
Q Consensus 782 l~DfG~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf 843 (949)
|.|||+........ .......-+||..||+||.+.+..|+.|+||||+|++++|+++ -..+|
T Consensus 397 IgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~ 463 (516)
T KOG1033|consen 397 IGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF 463 (516)
T ss_pred hhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH
Confidence 99999998776555 1223335569999999999999999999999999999999998 44443
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.7e-16 Score=186.11 Aligned_cols=152 Identities=25% Similarity=0.365 Sum_probs=108.8
Q ss_pred cCCCChhhHHHHHHHHhccCCCCCCCccCccCCCCcc----eeeeeEEeCC--C--CcEEEEEcCCCCCCccccCCCCCC
Q 039533 17 AGTGNETDRVALLEFKSKSTYDPVGVLGTWNESIHFC----KWYGVTCSRR--H--QRVTLLDLRSLKLAGSVSHFIGNL 88 (949)
Q Consensus 17 ~~~~~~~~~~aLl~~k~~~~~~~~~~l~sW~~~~~~C----~w~gv~C~~~--~--~~v~~l~l~~~~l~g~~~~~l~~l 88 (949)
.....+.|..||++||+++. ++.. .+|+. ..|| .|.||+|+.. + .+|+.|+|+++++.|.+|+.++.|
T Consensus 366 ~~~t~~~~~~aL~~~k~~~~-~~~~--~~W~g-~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L 441 (623)
T PLN03150 366 ESKTLLEEVSALQTLKSSLG-LPLR--FGWNG-DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKL 441 (623)
T ss_pred ccccCchHHHHHHHHHHhcC-Cccc--CCCCC-CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCC
Confidence 34456789999999998863 4332 48964 2442 7999999632 2 258889999999988888888888
Q ss_pred CCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCC-CCCcEEE
Q 039533 89 SFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSL-SKTEILN 167 (949)
Q Consensus 89 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L-~~L~~L~ 167 (949)
++|+.|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|..+++|++|+.|+|++|++++.+|..+..+ .++..++
T Consensus 442 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~ 521 (623)
T PLN03150 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFN 521 (623)
T ss_pred CCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEE
Confidence 888888888888888888888888888888888888888888877777666555555555554444444332 2333444
Q ss_pred CCCCC
Q 039533 168 LGSNH 172 (949)
Q Consensus 168 Ls~N~ 172 (949)
+++|.
T Consensus 522 ~~~N~ 526 (623)
T PLN03150 522 FTDNA 526 (623)
T ss_pred ecCCc
Confidence 44443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.9e-16 Score=156.17 Aligned_cols=146 Identities=20% Similarity=0.132 Sum_probs=112.7
Q ss_pred HHHHHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc----------------------chHHHHHHHHH
Q 039533 619 QDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG----------------------ASRSFIAECKA 676 (949)
Q Consensus 619 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~ 676 (949)
+++.....-|.+.+.||+|+||.||+|... +++.||||+++..... .......|+.+
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 86 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAA 86 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHH
Confidence 344444445888999999999999999886 7899999997643210 01236778999
Q ss_pred HHhcCCC--cceeEEeeeecccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHH
Q 039533 677 LKSIRHR--NLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYL 754 (949)
Q Consensus 677 l~~l~h~--niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~L 754 (949)
+.++.|+ .+++.++. ...++||||+++++|.+.... .....++.+++.++.++
T Consensus 87 l~~l~~~~i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~----------------~~~~~~~~~i~~~l~~l 141 (198)
T cd05144 87 LKALYEEGFPVPKPIDW---------NRHAVVMEYIDGVELYRVRVL----------------EDPEEVLDEILEEIVKA 141 (198)
T ss_pred HHHHHHcCCCCCceeec---------CCceEEEEEeCCcchhhcccc----------------ccHHHHHHHHHHHHHHH
Confidence 9999877 44444432 145899999999998765420 23467899999999999
Q ss_pred hhCCCCCeEecCCCCCCeeecCCCceEEeecccceecCC
Q 039533 755 HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSP 793 (949)
Q Consensus 755 H~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~ 793 (949)
|+. +|+||||||+||++++++.++|+|||.+.....
T Consensus 142 h~~---gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 142 YKH---GIIHGDLSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred HHC---CCCcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence 976 999999999999999999999999999965544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.2e-15 Score=157.36 Aligned_cols=134 Identities=19% Similarity=0.215 Sum_probs=109.1
Q ss_pred CeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc--------chHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG--------ASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
+.||+|++|.||+|.+ .+..|++|+....... ...++.+|++++..+.|++++....++...+ ..
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE-----NF 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC-----CC
Confidence 5799999999999988 4678999986543221 1235778999999999998876666654333 67
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++||||++|++|.+++.. ... ++..++.+++.+|.++|+. +++|||++|+||+++ ++.++++
T Consensus 75 ~lv~e~~~G~~L~~~~~~-------------~~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~li 136 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINS-------------NGM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLI 136 (211)
T ss_pred EEEEEEeCCcCHHHHHHh-------------ccH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEE
Confidence 899999999999999851 111 7788999999999999977 899999999999999 7899999
Q ss_pred eccccee
Q 039533 784 DFGLARI 790 (949)
Q Consensus 784 DfG~a~~ 790 (949)
|||.+..
T Consensus 137 Df~~a~~ 143 (211)
T PRK14879 137 DFGLAEF 143 (211)
T ss_pred ECCcccC
Confidence 9998864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.3e-16 Score=183.73 Aligned_cols=168 Identities=27% Similarity=0.364 Sum_probs=121.6
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
..++|..++.|..|+||.||.++++.+.+.+|+|+-+ +. .+.+- ++.....|.
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~-----lilRn--ilt~a~npf------------------- 133 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QN-----LILRN--ILTFAGNPF------------------- 133 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcccc-cc-----hhhhc--cccccCCcc-------------------
Confidence 3468999999999999999999999888899996532 11 01110 111112222
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
.| |+-...++. .+.++.. ++.+++|+|+. +|+|||+||+|.+|+.-|++|++
T Consensus 134 -vv------gDc~tllk~----------~g~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlT 185 (1205)
T KOG0606|consen 134 -VV------GDCATLLKN----------IGPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLT 185 (1205)
T ss_pred -ee------chhhhhccc----------CCCCcch--------hhHHhHhhccC---CeecCCCCCCcceeeeccccccc
Confidence 22 333333331 1122222 27899999977 99999999999999999999999
Q ss_pred ecccceecCCCCC-------------ccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccc
Q 039533 784 DFGLARILSPDHT-------------QTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIM 846 (949)
Q Consensus 784 DfG~a~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~ 846 (949)
|||+++......+ ......+.||+.|.|||++....|...+|+|++|+++||.+.|..||...
T Consensus 186 DfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd 261 (1205)
T KOG0606|consen 186 DFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 261 (1205)
T ss_pred chhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence 9999976432111 11112457999999999999999999999999999999999999999643
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.9e-15 Score=177.32 Aligned_cols=144 Identities=19% Similarity=0.191 Sum_probs=112.2
Q ss_pred HHHHHHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecC--CC------cchHHHHHHHHHHHhcCCCcceeEE
Q 039533 618 YQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ--HH------GASRSFIAECKALKSIRHRNLVKVL 689 (949)
Q Consensus 618 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~------~~~~~~~~E~~~l~~l~h~niv~~~ 689 (949)
+.........|...+.||+|+||.||+|.+.. ..+++|+.... .. ...+++.+|++++++++|++++...
T Consensus 325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~ 402 (535)
T PRK09605 325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPV 402 (535)
T ss_pred eccccccccccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeE
Confidence 33333444566778999999999999998863 34455443211 11 1124688999999999999998877
Q ss_pred eeeecccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 039533 690 TACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKP 769 (949)
Q Consensus 690 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp 769 (949)
.++.... ..++||||+++++|.+++. ....++.|+++++.|||+. +++|||+||
T Consensus 403 ~~~~~~~-----~~~lv~E~~~g~~L~~~l~------------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp 456 (535)
T PRK09605 403 IYDVDPE-----EKTIVMEYIGGKDLKDVLE------------------GNPELVRKVGEIVAKLHKA---GIVHGDLTT 456 (535)
T ss_pred EEEEeCC-----CCEEEEEecCCCcHHHHHH------------------HHHHHHHHHHHHHHHHHhC---CCccCCCCh
Confidence 6654433 5689999999999998874 3567999999999999977 999999999
Q ss_pred CCeeecCCCceEEeeccccee
Q 039533 770 SNVLLDDYMTARVGDFGLARI 790 (949)
Q Consensus 770 ~NIll~~~~~~kl~DfG~a~~ 790 (949)
+||++ +++.++|+|||+++.
T Consensus 457 ~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 457 SNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred HHEEE-ECCcEEEEeCccccc
Confidence 99999 577999999999875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.61 E-value=3e-15 Score=152.72 Aligned_cols=130 Identities=19% Similarity=0.209 Sum_probs=102.1
Q ss_pred eeeeecCceEEEEEEcCCCEEEEEEEEecCCCc--------chHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG--------ASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 633 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.||+|++|.||+|.+. +..|++|+....... ...++.+|++++..+.|+++.....++...+ ..+
T Consensus 1 ~ig~G~~~~vy~~~~~--~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL--GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD-----NKT 73 (199)
T ss_pred CCCCCceEEEEEeecC--CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC-----CCE
Confidence 4799999999999964 678999986532211 1256778999999998876554443433222 568
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||++|++|.+++.. .. ..++.+++.+++++|+. +++|||++|+||+++ ++.++++|
T Consensus 74 lv~e~~~g~~l~~~~~~----------~~-------~~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liD 132 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEE----------GN-------DELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLID 132 (199)
T ss_pred EEEEEECCccHHHHHhh----------cH-------HHHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEE
Confidence 99999999999988751 00 07899999999999977 999999999999999 78999999
Q ss_pred ccccee
Q 039533 785 FGLARI 790 (949)
Q Consensus 785 fG~a~~ 790 (949)
||.+..
T Consensus 133 fg~a~~ 138 (199)
T TIGR03724 133 FGLGKY 138 (199)
T ss_pred CCCCcC
Confidence 999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.8e-14 Score=143.96 Aligned_cols=137 Identities=19% Similarity=0.169 Sum_probs=98.4
Q ss_pred CCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcc--hHH----------------------HHHHHHHHHhcCCC--c
Q 039533 631 ANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGA--SRS----------------------FIAECKALKSIRHR--N 684 (949)
Q Consensus 631 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~h~--n 684 (949)
.+.||+|+||+||+|.+. +++.||||+++...... ... ...|...+.++.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 578999999999999987 78999999987532211 111 13566666666443 2
Q ss_pred ceeEEeeeecccccCCccceeEeeeccCCChhhh-cCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCe
Q 039533 685 LVKVLTACLGADYRGNDFKASVYEFMHYGSLEEW-LHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHH-DCQPVT 762 (949)
Q Consensus 685 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~~~~i 762 (949)
+.+.+++ ...++||||++++++... +.. .... .++..++.+++.++.++|+ . +|
T Consensus 81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~-----------~~~~-~~~~~~~~~~~~~l~~lh~~~---~i 136 (187)
T cd05119 81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKD-----------VRLL-EDPEELYDQILELMRKLYREA---GL 136 (187)
T ss_pred CCceEec---------CCCEEEEEEeCCCCccChhhhh-----------hhhc-ccHHHHHHHHHHHHHHHhhcc---Cc
Confidence 4444433 135899999998654321 110 0001 5678899999999999997 5 89
Q ss_pred EecCCCCCCeeecCCCceEEeecccceecCC
Q 039533 763 AHCDLKPSNVLLDDYMTARVGDFGLARILSP 793 (949)
Q Consensus 763 vHrDlkp~NIll~~~~~~kl~DfG~a~~~~~ 793 (949)
+||||||+||+++ ++.++++|||.+.....
T Consensus 137 vH~Dl~p~Nili~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 137 VHGDLSEYNILVD-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CcCCCChhhEEEE-CCcEEEEECcccccccC
Confidence 9999999999999 89999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.7e-15 Score=176.32 Aligned_cols=257 Identities=23% Similarity=0.233 Sum_probs=187.8
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCC-CEEEEEEEEecCC--CcchHHHHHHHHHHHhcC-CCcceeEEeeeecccccCC
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEG-RTTIAVKVFNLQH--HGASRSFIAECKALKSIR-HRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~ 700 (949)
...|.+.+.||+|.|+.|-.+....+ ...+|+|.+.... .........|..+-+.+. |+|++++++... ..
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~-----~~ 93 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSS-----SP 93 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccC-----CC
Confidence 34577888899999999998887433 3456667665332 222345556777777776 999999998844 44
Q ss_pred ccceeEeeeccCCChhhhc-CCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeEecCCCCCCeeecCCC
Q 039533 701 DFKASVYEFMHYGSLEEWL-HPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLH-HDCQPVTAHCDLKPSNVLLDDYM 778 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l-~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH-~~~~~~ivHrDlkp~NIll~~~~ 778 (949)
+..+++.+|..++++.+.+ +. .....+...+..++.|+..++.|+| .. ++.|||+||+|.+++..+
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~~~---------~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~ 161 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKISHP---------DSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESG 161 (601)
T ss_pred cccccccCcccccccccccccC---------CccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCC
Confidence 4889999999999998888 41 1113555667789999999999999 66 899999999999999999
Q ss_pred -ceEEeecccceecCC-CCCccccccccC-ccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCchhh
Q 039533 779 -TARVGDFGLARILSP-DHTQTSSFSVKG-SLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLH 854 (949)
Q Consensus 779 -~~kl~DfG~a~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~ 854 (949)
..+++|||+|..+.. ...........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++.....+..+.
T Consensus 162 ~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~ 241 (601)
T KOG0590|consen 162 SALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS 241 (601)
T ss_pred CcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce
Confidence 999999999998877 444444445568 9999999998885 456889999999999999999999986655544433
Q ss_pred hhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 855 NFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 855 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.|....... ...+ .........++..+++..+|..|.+.+++..
T Consensus 242 ~~~~~~~~~----------~~~~------------------~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 242 SWKSNKGRF----------TQLP------------------WNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred eeccccccc----------ccCc------------------cccCChhhhhcccccccCCchhccccccccc
Confidence 333221000 0000 0122234566777888888999988877643
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.1e-13 Score=143.96 Aligned_cols=141 Identities=17% Similarity=0.101 Sum_probs=106.2
Q ss_pred CCeee-eecCceEEEEEEcCCCEEEEEEEEecCC-------------CcchHHHHHHHHHHHhcCCCcc--eeEEeeeec
Q 039533 631 ANLVG-VGSFGSVYKGIIDEGRTTIAVKVFNLQH-------------HGASRSFIAECKALKSIRHRNL--VKVLTACLG 694 (949)
Q Consensus 631 ~~~lg-~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~ 694 (949)
...|| .||.|+||.+... +..+|||.+.... .....++.+|++++.++.|++| ++.+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 46788 8999999999885 6789999885321 1123567889999999998775 667766432
Q ss_pred ccccCCccceeEeeeccC-CChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCee
Q 039533 695 ADYRGNDFKASVYEFMHY-GSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVL 773 (949)
Q Consensus 695 ~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIl 773 (949)
.. ......++|||++++ .+|.+++.. ..++.. .+.+++.++.+||+. ||+||||||+|||
T Consensus 114 ~~-~~~~~~~lV~e~l~G~~~L~~~l~~-----------~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NIL 174 (239)
T PRK01723 114 RH-GLFYRADILIERIEGARDLVALLQE-----------APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNIL 174 (239)
T ss_pred ec-CcceeeeEEEEecCCCCCHHHHHhc-----------CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEE
Confidence 21 111123599999997 689988752 123332 367899999999977 9999999999999
Q ss_pred ecCCCceEEeecccceecC
Q 039533 774 LDDYMTARVGDFGLARILS 792 (949)
Q Consensus 774 l~~~~~~kl~DfG~a~~~~ 792 (949)
++.++.++|+|||.+....
T Consensus 175 v~~~~~v~LIDfg~~~~~~ 193 (239)
T PRK01723 175 LDPDGKFWLIDFDRGELRT 193 (239)
T ss_pred EcCCCCEEEEECCCcccCC
Confidence 9998899999999987643
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.2e-13 Score=134.17 Aligned_cols=135 Identities=23% Similarity=0.208 Sum_probs=110.7
Q ss_pred CCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCC--CcceeEEeeeecccccCCccceeEe
Q 039533 630 SANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRH--RNLVKVLTACLGADYRGNDFKASVY 707 (949)
Q Consensus 630 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~ 707 (949)
+.+.+|+|.++.||++... +..+++|+...... ...+.+|+..++.++| .++++++++.... +..+++|
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~-----~~~~~v~ 72 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESD-----GWSYLLM 72 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-----CccEEEE
Confidence 4578999999999999986 37899999864433 4578899999999976 5888888775433 4689999
Q ss_pred eeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccc
Q 039533 708 EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGL 787 (949)
Q Consensus 708 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~ 787 (949)
||++++.+..+ +......++.+++++++++|.....+++|||++|+||++++.+.++++|||.
T Consensus 73 e~~~g~~~~~~-----------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~ 135 (155)
T cd05120 73 EWIEGETLDEV-----------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEY 135 (155)
T ss_pred EecCCeecccC-----------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccc
Confidence 99988766433 3456678999999999999976445799999999999999989999999998
Q ss_pred cee
Q 039533 788 ARI 790 (949)
Q Consensus 788 a~~ 790 (949)
+..
T Consensus 136 ~~~ 138 (155)
T cd05120 136 AGY 138 (155)
T ss_pred ccC
Confidence 864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.1e-15 Score=164.93 Aligned_cols=179 Identities=31% Similarity=0.429 Sum_probs=135.7
Q ss_pred CCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEE
Q 039533 316 NFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEI 395 (949)
Q Consensus 316 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 395 (949)
.++.-...||+.|++. .+|..+..+..|+.+.|++|.|. .+|..++++..|+.|+|+.|+++ ..|..++.|+ |+.|
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl 148 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL 148 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence 3445566788888887 77777777777888888888887 77778888888888888888887 6777777665 7888
Q ss_pred EeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccCCcccccccchhhcccCcccc
Q 039533 396 NLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLF 475 (949)
Q Consensus 396 ~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 475 (949)
-+++|+++ .+|+.++.+..+ ..||.+.|.+. .+|..++.+.+|+.|.+..|++. .+|.+++ .-.|..||+|.|++
T Consensus 149 i~sNNkl~-~lp~~ig~~~tl-~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~-~LpLi~lDfScNki 223 (722)
T KOG0532|consen 149 IVSNNKLT-SLPEEIGLLPTL-AHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELC-SLPLIRLDFSCNKI 223 (722)
T ss_pred EEecCccc-cCCcccccchhH-HHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHh-CCceeeeecccCce
Confidence 88888887 777777766666 57788888877 67777778888888888888877 6777777 33477788888888
Q ss_pred ccccCCCcCCCCCCCEEECCCCcCCCcCcc
Q 039533 476 QGPISSSLGSLRGLRVLDLSQNNLSGEIPK 505 (949)
Q Consensus 476 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 505 (949)
+ .||-.|.+|+.|++|-|.+|.|+ .+|.
T Consensus 224 s-~iPv~fr~m~~Lq~l~LenNPLq-SPPA 251 (722)
T KOG0532|consen 224 S-YLPVDFRKMRHLQVLQLENNPLQ-SPPA 251 (722)
T ss_pred e-ecchhhhhhhhheeeeeccCCCC-CChH
Confidence 7 67778888888888888888887 4443
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.6e-15 Score=163.47 Aligned_cols=194 Identities=32% Similarity=0.436 Sum_probs=170.0
Q ss_pred EEeecceecccCCC--cccccCCCCEEecCCcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCc
Q 039533 323 LDMWNNQLSGTIPP--AIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNN 400 (949)
Q Consensus 323 L~L~~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 400 (949)
|.|++-++. ..|. +-..+..-...||+.|++. .+|..+..+..|+.+.|.+|.+. .+|..++++..|++|||+.|
T Consensus 55 l~Ls~rrlk-~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~N 131 (722)
T KOG0532|consen 55 LLLSGRRLK-EFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSN 131 (722)
T ss_pred cccccchhh-cCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccc
Confidence 444554554 3332 1134566678899999999 89999999999999999999998 89999999999999999999
Q ss_pred cccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccCCcccccccchhhcccCccccccccC
Q 039533 401 NLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPIS 480 (949)
Q Consensus 401 ~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~ 480 (949)
+++ .+|..++.++ | +.|-+++|+++ .+|..++.+..|..||.+.|++. .+|..++++.+|+.|+++.|++. .+|
T Consensus 132 qlS-~lp~~lC~lp-L-kvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp 205 (722)
T KOG0532|consen 132 QLS-HLPDGLCDLP-L-KVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLP 205 (722)
T ss_pred hhh-cCChhhhcCc-c-eeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCC
Confidence 999 8999999886 3 57899999999 89999999999999999999999 89999999999999999999999 678
Q ss_pred CCcCCCCCCCEEECCCCcCCCcCcccccCCc-cceEeCCCCcCcCccc
Q 039533 481 SSLGSLRGLRVLDLSQNNLSGEIPKFLAGLS-LNNLNLSYNDLEGMVT 527 (949)
Q Consensus 481 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~l~ls~N~l~~~~~ 527 (949)
..++.| .|..||+|.|+++ .||-.|..++ |++|-|.+|+|...+-
T Consensus 206 ~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSPPA 251 (722)
T KOG0532|consen 206 EELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSPPA 251 (722)
T ss_pred HHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCChH
Confidence 888866 6899999999999 8999999888 9999999999998543
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.3e-13 Score=163.43 Aligned_cols=111 Identities=35% Similarity=0.531 Sum_probs=63.3
Q ss_pred cceeeeccccccccCCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCcCcccccCCc-cceEeCCC
Q 039533 441 LEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLS-LNNLNLSY 519 (949)
Q Consensus 441 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~l~ls~ 519 (949)
++.|+|++|.++|.+|..++.+++|+.|+|++|+|+|.+|..++.+++|+.|||++|+|+|.+|..+..+. |+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 44555555555555555555555555555555555555555555555555555555555555555555544 55555555
Q ss_pred CcCcCccccc--ccccccccccccCCCCCCCCCC
Q 039533 520 NDLEGMVTTE--GVFKNASATRILGNSKLCGGIS 551 (949)
Q Consensus 520 N~l~~~~~~~--~~~~~~~~~~~~gn~~~c~~~~ 551 (949)
|+++|.+|.. ..+.....+.+.+|+.+|+.+.
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~ 533 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG 533 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCccccCCCC
Confidence 5555555542 1122334567788889998653
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.9e-13 Score=138.32 Aligned_cols=160 Identities=23% Similarity=0.326 Sum_probs=124.4
Q ss_pred HHHHHhcCCCcceeEEeeeecccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHH
Q 039533 674 CKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNY 753 (949)
Q Consensus 674 ~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~ 753 (949)
...+-++.|.|+|++..|+.+..+.+.....++.|||..|++..+|++.+ .....+......+|+.||..||.|
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~------~~~~a~~~~~wkkw~tqIlsal~y 191 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTK------KNQKALFQKAWKKWCTQILSALSY 191 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHH------HhhhhhhHHHHHHHHHHHHhhhhh
Confidence 34455567999999999998888777778899999999999999997432 234567888899999999999999
Q ss_pred HhhCCCCCeEecCCCCCCeeecCCCceEEeecccceecCCCCC---ccccccccCccCccCccccCCCccCCccchHHHH
Q 039533 754 LHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHT---QTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYG 830 (949)
Q Consensus 754 LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG 830 (949)
||+. .|+|+|+++.-+-|++..+|-+|+.--.-.. ..+... ........+-++|.|||.-.....+.++|||+||
T Consensus 192 Lhs~-~PpiihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fg 269 (458)
T KOG1266|consen 192 LHSC-DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFG 269 (458)
T ss_pred hhcc-CCccccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhh
Confidence 9988 8999999999999999999888875211111 000000 0111122367899999997777788899999999
Q ss_pred HHHHHHHhCCC
Q 039533 831 ILLLELVIGKK 841 (949)
Q Consensus 831 vvl~elltg~~ 841 (949)
+...||..|..
T Consensus 270 mcAlemailEi 280 (458)
T KOG1266|consen 270 MCALEMAILEI 280 (458)
T ss_pred HHHHHHHHhee
Confidence 99999988775
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.5e-13 Score=154.28 Aligned_cols=202 Identities=39% Similarity=0.526 Sum_probs=125.1
Q ss_pred EEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccC-CCCEEecCCcccccccCcccccccccceeecccc
Q 039533 298 TLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQ-NLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDN 376 (949)
Q Consensus 298 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 376 (949)
.+.++.|.+.. ....+..++.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..++++++|+.|++++|
T Consensus 97 ~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 35555555532 2223344456666666666666 4555555553 6666666666666 45555666666666666666
Q ss_pred cccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccCC
Q 039533 377 FLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIP 456 (949)
Q Consensus 377 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 456 (949)
+++ .+|...+.+++|+.|++++|+++ .+|........+ .+|.+++|.+. ..+..+..+.++..+.+++|++. .++
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L-~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~ 248 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSAL-EELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLP 248 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhh-hhhhhcCCcce-ecchhhhhcccccccccCCceee-ecc
Confidence 666 44544445666777777777776 555554444444 45666666433 45556667777777777777776 446
Q ss_pred cccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCcCcccccC
Q 039533 457 STFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAG 509 (949)
Q Consensus 457 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 509 (949)
..++.+++|+.|++++|+++.. +. ++.+.+|+.||+++|.++..+|.....
T Consensus 249 ~~~~~l~~l~~L~~s~n~i~~i-~~-~~~~~~l~~L~~s~n~~~~~~~~~~~~ 299 (394)
T COG4886 249 ESIGNLSNLETLDLSNNQISSI-SS-LGSLTNLRELDLSGNSLSNALPLIALL 299 (394)
T ss_pred chhccccccceecccccccccc-cc-ccccCccCEEeccCccccccchhhhcc
Confidence 6677777777777777777733 33 777777777777777777666654443
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.1e-11 Score=129.93 Aligned_cols=290 Identities=15% Similarity=0.137 Sum_probs=179.2
Q ss_pred CCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhc-CCCcceeEEeeeecc--cccCCcccee
Q 039533 629 SSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSI-RHRNLVKVLTACLGA--DYRGNDFKAS 705 (949)
Q Consensus 629 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~~~~~~~l 705 (949)
.....||+|+-+.+|-.-.- +..+.|++......... +.++.|.+. .||-+-.-+.+-... +-+......+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCCccccCCccceeeecchh---hchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 45678999999999976443 33577888755443322 223334444 566443312111110 1112223567
Q ss_pred EeeeccCC-ChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 706 VYEFMHYG-SLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 706 v~e~~~~g-sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+|+.+.+. ....++.. +.....-...+|...++.++.+|.+.+.||+. |.+-||+.++|+|+++++.+.|+|
T Consensus 88 lmP~v~g~~pI~~~y~p----~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVd 160 (637)
T COG4248 88 LMPKVSGKEPIHMIYSP----ATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVD 160 (637)
T ss_pred ecccCCCccchhhhcCc----hhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEc
Confidence 77777653 23333332 22223455688999999999999999999988 899999999999999999999998
Q ss_pred cccceecCCCCCccccccccCccCccCccccC-----CCccCCccchHHHHHHHHHHHhC-CCCCccccccCchhhhhcc
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGV-----GCEVSTNGDVYSYGILLLELVIG-KKPIDIMFEGDINLHNFGR 858 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlGvvl~elltg-~~Pf~~~~~~~~~~~~~~~ 858 (949)
-..-.....+ ......+|...|.+||... +...+...|-|.+||++++++.| ++||..+......-.
T Consensus 161 sDsfqi~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~---- 233 (637)
T COG4248 161 SDSFQINANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPN---- 233 (637)
T ss_pred ccceeeccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCC----
Confidence 6544433222 2223566999999999744 45677889999999999999986 999975532211000
Q ss_pred ccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccC--CCCCCCCHHHHHHHHHHhHHhhc
Q 039533 859 KALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSME--LPQDRTNMTNVVHELQSIKNILL 936 (949)
Q Consensus 859 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~--dP~~RPs~~ev~~~L~~i~~~~~ 936 (949)
... .++.......... ....+.+..+.....-.+..+..+..+|+.. .+.-|||++.++..|.++.+.+.
T Consensus 234 -p~E---~~Ia~g~f~ya~~----~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 234 -PLE---TDIAHGRFAYASD----QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred -cch---hhhhcceeeechh----ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 000 0000000000000 0000000111111233455667777788765 35689999999999999999998
Q ss_pred cC------------CCCCCccc
Q 039533 937 GV------------ELCPPCKV 946 (949)
Q Consensus 937 ~~------------~~~~~~~~ 946 (949)
+| -.||||.-
T Consensus 306 ~C~v~a~H~y~~hl~~CPwCa~ 327 (637)
T COG4248 306 KCTVSAMHVYPVHLTDCPWCAL 327 (637)
T ss_pred hhhhcccccccCCCCCCchhhh
Confidence 88 57999974
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.34 E-value=9.5e-13 Score=149.58 Aligned_cols=199 Identities=38% Similarity=0.515 Sum_probs=171.1
Q ss_pred cEEEeecceecccCCCcccccCCCCEEecCCcccccccCccccccc-ccceeecccccccccCCCCCCCCCCCcEEEeeC
Q 039533 321 QRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLK-MLLNLFLNDNFLEVSIPSSLGQCESLIEINLSN 399 (949)
Q Consensus 321 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 399 (949)
..|+++.|.+. ..+..+..++.++.|++.+|.++ .+|.....++ +|+.|++++|.+. .+|..+..+++|+.|++++
T Consensus 96 ~~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~ 172 (394)
T COG4886 96 PSLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF 172 (394)
T ss_pred ceeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCC
Confidence 46899999985 23445566789999999999999 7788788885 9999999999998 6777889999999999999
Q ss_pred ccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccCCcccccccchhhcccCcccccccc
Q 039533 400 NNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPI 479 (949)
Q Consensus 400 N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 479 (949)
|+++ .+|......+.+ ..|++++|+++ .+|.....+..|++|++++|++. ..+..+.++.++..|.+++|++. .+
T Consensus 173 N~l~-~l~~~~~~~~~L-~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~ 247 (394)
T COG4886 173 NDLS-DLPKLLSNLSNL-NNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DL 247 (394)
T ss_pred chhh-hhhhhhhhhhhh-hheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-ec
Confidence 9999 788877778888 78999999999 78887778888999999999765 68888999999999999999998 44
Q ss_pred CCCcCCCCCCCEEECCCCcCCCcCcccccCC-ccceEeCCCCcCcCccccc
Q 039533 480 SSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL-SLNNLNLSYNDLEGMVTTE 529 (949)
Q Consensus 480 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~l~ls~N~l~~~~~~~ 529 (949)
+..++.+++|+.|++++|+++. ++. +..+ .++.|++++|.+...+|..
T Consensus 248 ~~~~~~l~~l~~L~~s~n~i~~-i~~-~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 248 PESIGNLSNLETLDLSNNQISS-ISS-LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred cchhccccccceeccccccccc-ccc-ccccCccCEEeccCccccccchhh
Confidence 7889999999999999999994 444 4444 4999999999999887754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.32 E-value=6.7e-12 Score=142.16 Aligned_cols=143 Identities=20% Similarity=0.157 Sum_probs=99.8
Q ss_pred CCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcch----------------------------------------HHH
Q 039533 631 ANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGAS----------------------------------------RSF 670 (949)
Q Consensus 631 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~ 670 (949)
.+.||.|++|.||+|+.. +|+.||||+.+....... -++
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 368999999999999987 789999999864321100 025
Q ss_pred HHHHHHHHhcC----CCcceeEEeeeecccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHH
Q 039533 671 IAECKALKSIR----HRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAID 746 (949)
Q Consensus 671 ~~E~~~l~~l~----h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~q 746 (949)
.+|++.+.++. |.+-+.+-..+.+ .....++||||++|++|.++.... .... ...+++.+
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~----~~~~~vLvmE~i~G~~L~~~~~~~---------~~~~---~~~~ia~~ 264 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWD----RTSERVLTMEWIDGIPLSDIAALD---------EAGL---DRKALAEN 264 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehh----hcCCceEEEEeECCcccccHHHHH---------hcCC---CHHHHHHH
Confidence 55666666662 3322333223221 122469999999999998876410 0111 23456666
Q ss_pred HHH-HHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecccceecCC
Q 039533 747 IAY-ALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSP 793 (949)
Q Consensus 747 i~~-gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~ 793 (949)
++. .+..+|.. |++|+|+||.||++++++.++++|||++..+.+
T Consensus 265 ~~~~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 265 LARSFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 666 46788866 999999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.7e-11 Score=136.03 Aligned_cols=198 Identities=27% Similarity=0.305 Sum_probs=153.3
Q ss_pred CCCCCCeeee--ecCceEEEEEE--cCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhc-CCCcceeEEeeeecccccC
Q 039533 627 GFSSANLVGV--GSFGSVYKGII--DEGRTTIAVKVFNLQHH--GASRSFIAECKALKSI-RHRNLVKVLTACLGADYRG 699 (949)
Q Consensus 627 ~y~~~~~lg~--G~~g~Vy~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 699 (949)
.|.+.+.+|. |.+|.||.+.. ..++..+|+|.-+.... ....+-.+|+...+++ .|++.++.+..+ ++
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~-----e~ 189 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW-----EG 189 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-----cc
Confidence 4566788999 99999999998 77888999998543322 3334455677777777 499999866664 34
Q ss_pred CccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHH----HHHHHhhCCCCCeEecCCCCCCeeec
Q 039533 700 NDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAY----ALNYLHHDCQPVTAHCDLKPSNVLLD 775 (949)
Q Consensus 700 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~----gL~~LH~~~~~~ivHrDlkp~NIll~ 775 (949)
.+..++-+|++. .++.++.+. ....++....+.+..+..+ |+.++|+. +++|-|+||.||+..
T Consensus 190 ~~~lfiqtE~~~-~sl~~~~~~---------~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~ 256 (524)
T KOG0601|consen 190 SGILFIQTELCG-ESLQSYCHT---------PCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTT 256 (524)
T ss_pred CCcceeeecccc-chhHHhhhc---------ccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecc
Confidence 447888888884 788888762 2233666677778888888 99999977 899999999999999
Q ss_pred CC-CceEEeecccceecCCCCCccc---cccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCC
Q 039533 776 DY-MTARVGDFGLARILSPDHTQTS---SFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPI 843 (949)
Q Consensus 776 ~~-~~~kl~DfG~a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf 843 (949)
.+ ...+++|||+...+.+...... .....|...|++||...+ .++.++|||++|.++.+..++..+.
T Consensus 257 ~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 257 SDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred cccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccc
Confidence 88 8899999999988876653221 112247788999999765 6788999999999999999988765
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.20 E-value=6.7e-11 Score=117.26 Aligned_cols=131 Identities=19% Similarity=0.098 Sum_probs=96.0
Q ss_pred CCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcc-eeEEeeeecccccCCccceeEeee
Q 039533 631 ANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNL-VKVLTACLGADYRGNDFKASVYEF 709 (949)
Q Consensus 631 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~ 709 (949)
.+.++.|.++.||+++.. +..|++|+...... ....+.+|+.+++.+.+.++ ++++.+.. ...++||||
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~-------~~~~lv~e~ 72 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP-------ETGVLITEF 72 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC-------CCCeEEEEe
Confidence 467899999999999875 77899999754322 12356789999999865544 44554321 135799999
Q ss_pred ccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeEecCCCCCCeeecCCCceEEeeccc
Q 039533 710 MHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDC--QPVTAHCDLKPSNVLLDDYMTARVGDFGL 787 (949)
Q Consensus 710 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~--~~~ivHrDlkp~NIll~~~~~~kl~DfG~ 787 (949)
+++.++.+.-. ....++.+++++++.||+.. ..+++|||++|.||+++ ++.++++|||.
T Consensus 73 i~G~~l~~~~~------------------~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~ 133 (170)
T cd05151 73 IEGSELLTEDF------------------SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEY 133 (170)
T ss_pred cCCCccccccc------------------cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccc
Confidence 99987754310 11346789999999999762 22369999999999999 66899999998
Q ss_pred cee
Q 039533 788 ARI 790 (949)
Q Consensus 788 a~~ 790 (949)
+..
T Consensus 134 a~~ 136 (170)
T cd05151 134 AGM 136 (170)
T ss_pred ccC
Confidence 764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.6e-10 Score=112.94 Aligned_cols=139 Identities=18% Similarity=0.118 Sum_probs=100.3
Q ss_pred CCeeeeecCceEEEEEEcC------CCEEEEEEEEecCCC----------------------cchHHHH----HHHHHHH
Q 039533 631 ANLVGVGSFGSVYKGIIDE------GRTTIAVKVFNLQHH----------------------GASRSFI----AECKALK 678 (949)
Q Consensus 631 ~~~lg~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~----------------------~~~~~~~----~E~~~l~ 678 (949)
...||.|--+.||.|.... .+..+|||+++.... ...+.+. +|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998653 247899999862210 0012233 8999999
Q ss_pred hcC--CCcceeEEeeeecccccCCccceeEeeeccCCChhh-hcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHH-
Q 039533 679 SIR--HRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEE-WLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYL- 754 (949)
Q Consensus 679 ~l~--h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~L- 754 (949)
++. .-++++.+++ . ..++||||+.+..+.. .++ ...++..+...+..+++.++.++
T Consensus 82 rl~~~Gv~vP~pi~~----~-----~~~lvME~Ig~~~~~~~~Lk-----------d~~~~~~~~~~i~~~i~~~l~~l~ 141 (197)
T cd05146 82 RMQKAGIPCPEVVVL----K-----KHVLVMSFIGDDQVPAPKLK-----------DAKLNDEEMKNAYYQVLSMMKQLY 141 (197)
T ss_pred HHHHcCCCCCeEEEe----c-----CCEEEEEEcCCCCccchhhh-----------ccccCHHHHHHHHHHHHHHHHHHH
Confidence 985 3567777754 1 4689999997653321 121 11244556677889999999999
Q ss_pred hhCCCCCeEecCCCCCCeeecCCCceEEeecccceecCC
Q 039533 755 HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSP 793 (949)
Q Consensus 755 H~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~ 793 (949)
|.. ++||||+++.||++++ +.++|+|||.|.....
T Consensus 142 H~~---glVHGDLs~~NIL~~~-~~v~iIDF~qav~~~h 176 (197)
T cd05146 142 KEC---NLVHADLSEYNMLWHD-GKVWFIDVSQSVEPTH 176 (197)
T ss_pred HhC---CeecCCCCHHHEEEEC-CcEEEEECCCceeCCC
Confidence 755 9999999999999974 6899999999876544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.19 E-value=5e-11 Score=136.19 Aligned_cols=150 Identities=15% Similarity=0.106 Sum_probs=97.3
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcc----------------------------------h----
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGA----------------------------------S---- 667 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----------------------------------~---- 667 (949)
..|.. +.||.|++|.||+|+.+.+|+.||||+.++..... .
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45665 78999999999999998669999999997442100 0
Q ss_pred --HHHHHHHHHHHhcC----CCcceeEEeeeecccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHH
Q 039533 668 --RSFIAECKALKSIR----HRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRL 741 (949)
Q Consensus 668 --~~~~~E~~~l~~l~----h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~ 741 (949)
-++.+|+..+.+++ +...+.+-.++.+ .....++||||++|+.+.++-.-. .. ......+....+.
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d----~st~~VLvmE~i~G~~l~d~~~l~-~~---g~d~~~la~~~v~ 270 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWD----YCSETVMVMERMYGIPVSDVAALR-AA---GTDMKLLAERGVE 270 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecc----cCCCceEEEeeecCccHHhHHHHH-hc---CCCHHHHHHHHHH
Confidence 12455666666552 3333332222211 123578999999999998742100 00 0001123333344
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC----ceEEeecccceecCCC
Q 039533 742 NIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM----TARVGDFGLARILSPD 794 (949)
Q Consensus 742 ~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~----~~kl~DfG~a~~~~~~ 794 (949)
.++.|+. .. |++|+|+||.||+++.++ +++++|||++..+++.
T Consensus 271 ~~~~Qif-------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 271 VFFTQVF-------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHHHHHH-------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 4445543 23 899999999999999888 9999999999887553
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.5e-10 Score=129.42 Aligned_cols=171 Identities=22% Similarity=0.211 Sum_probs=129.9
Q ss_pred EEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEeeeccCCChhhhcCCCC
Q 039533 644 KGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFT 723 (949)
Q Consensus 644 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~ 723 (949)
.|..+.++.+|.|.+++...........+-++.++.++||||+++++.+... ...|+|+|.+. .|..++..
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~-----~~~ylvTErV~--Pl~~~lk~-- 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEE-----GTLYLVTERVR--PLETVLKE-- 100 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhccc-----CceEEEeeccc--cHHHHHHH--
Confidence 4666778899999999866655556678889999999999999999885443 38999999985 57777752
Q ss_pred CCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecccceecCCCCCccccccc
Q 039533 724 GEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSV 803 (949)
Q Consensus 724 ~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 803 (949)
++...+...+.||+.||.|||+.+ +++|++|.-+-|+|++.|+.||++|.++........... ..
T Consensus 101 -----------l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~--~~ 165 (690)
T KOG1243|consen 101 -----------LGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAK--SL 165 (690)
T ss_pred -----------hHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccc--cc
Confidence 335567778999999999999876 999999999999999999999999998765432221000 11
Q ss_pred cCccCccCccccCCCccCCccchHHHHHHHHHHHhCC
Q 039533 804 KGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGK 840 (949)
Q Consensus 804 ~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~ 840 (949)
.--..|..|+.+.... -..|.|.|||+++|++.|.
T Consensus 166 ~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 166 YLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred hhhhcccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence 1223456666543322 3469999999999999993
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.15 E-value=5.6e-12 Score=125.84 Aligned_cols=133 Identities=26% Similarity=0.277 Sum_probs=93.4
Q ss_pred CCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccCCcccccccchhhc
Q 039533 389 CESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQL 468 (949)
Q Consensus 389 l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 468 (949)
+..|+++|||+|.|+ .+.++..-++.+ +.|++|+|.++ .+ ..+..+++|+.||||+|.++ .+-.+-..+.+++.|
T Consensus 283 Wq~LtelDLS~N~I~-~iDESvKL~Pki-r~L~lS~N~i~-~v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL 357 (490)
T KOG1259|consen 283 WQELTELDLSGNLIT-QIDESVKLAPKL-RRLILSQNRIR-TV-QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTL 357 (490)
T ss_pred Hhhhhhccccccchh-hhhhhhhhccce-eEEecccccee-ee-hhhhhcccceEeecccchhH-hhhhhHhhhcCEeee
Confidence 445666666666666 555555555555 56666666665 22 23667788888888888887 566666677888888
Q ss_pred ccCccccccccCCCcCCCCCCCEEECCCCcCCCcC-cccccCCc-cceEeCCCCcCcCcccc
Q 039533 469 GMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEI-PKFLAGLS-LNNLNLSYNDLEGMVTT 528 (949)
Q Consensus 469 ~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~~~-L~~l~ls~N~l~~~~~~ 528 (949)
.|++|.|... +.++.|-+|..||+++|+|.... -..++.++ |+.+.|.+|++.+.+..
T Consensus 358 ~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vdY 417 (490)
T KOG1259|consen 358 KLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVDY 417 (490)
T ss_pred ehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccchH
Confidence 8888888733 45777888889999999887321 23455666 89999999999988654
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.3e-11 Score=140.37 Aligned_cols=266 Identities=26% Similarity=0.317 Sum_probs=142.0
Q ss_pred CCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEEC
Q 039533 89 SFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNL 168 (949)
Q Consensus 89 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~L 168 (949)
+.++.++..++.+.+.--. ...+..++.+++..|.+. .+-..+..+++|..|++.+|+|..+... +..+++|++|+|
T Consensus 49 ~~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~i~~~-l~~~~~L~~L~l 125 (414)
T KOG0531|consen 49 SDLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIEKIENL-LSSLVNLQVLDL 125 (414)
T ss_pred chhhhhcchhccccchhhh-HHHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchhhcccc-hhhhhcchheec
Confidence 3344555555444321111 145667777778888776 3444466667777777777776543321 555666677777
Q ss_pred CCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCcccccccccccCCCCChhhhcccccccccc
Q 039533 169 GSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITS 248 (949)
Q Consensus 169 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~ 248 (949)
++|.|+... .+..++.|+.|++++|.|+. + ..+..+.+|+.+++++|.+..+++. + +..+.+++.+.+.+
T Consensus 126 s~N~I~~i~--~l~~l~~L~~L~l~~N~i~~-~-~~~~~l~~L~~l~l~~n~i~~ie~~-----~-~~~~~~l~~l~l~~ 195 (414)
T KOG0531|consen 126 SFNKITKLE--GLSTLTLLKELNLSGNLISD-I-SGLESLKSLKLLDLSYNRIVDIEND-----E-LSELISLEELDLGG 195 (414)
T ss_pred ccccccccc--chhhccchhhheeccCcchh-c-cCCccchhhhcccCCcchhhhhhhh-----h-hhhccchHHHhccC
Confidence 777666332 34455556666666666652 2 2344466666666666666554421 1 23444455555555
Q ss_pred CCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCC--cccEEEee
Q 039533 249 NSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFV--NLQRLDMW 326 (949)
Q Consensus 249 N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~L~ 326 (949)
|.+... -.-... ..+..+++..|+++..-+ +..+. .|+.++++
T Consensus 196 n~i~~i------------------------------~~~~~~---~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~ 240 (414)
T KOG0531|consen 196 NSIREI------------------------------EGLDLL---KKLVLLSLLDNKISKLEG--LNELVMLHLRELYLS 240 (414)
T ss_pred Cchhcc------------------------------cchHHH---HHHHHhhcccccceeccC--cccchhHHHHHHhcc
Confidence 544321 111000 123334556666652221 12222 36777777
Q ss_pred cceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeeccccccccc---CCCC-CCCCCCCcEEEeeCccc
Q 039533 327 NNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVS---IPSS-LGQCESLIEINLSNNNL 402 (949)
Q Consensus 327 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~---~p~~-~~~l~~L~~L~l~~N~l 402 (949)
+|.+. ..+..+..+.++..|+++.|++... ..+.....+..+.+..|.+... .... ....+.++.+.+..|.+
T Consensus 241 ~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (414)
T KOG0531|consen 241 GNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPI 317 (414)
T ss_pred cCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCcc
Confidence 77776 3445566667777777777777632 2244555666666666665421 1111 34455566666666666
Q ss_pred cCC
Q 039533 403 SGT 405 (949)
Q Consensus 403 ~~~ 405 (949)
...
T Consensus 318 ~~~ 320 (414)
T KOG0531|consen 318 RKI 320 (414)
T ss_pred ccc
Confidence 543
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.09 E-value=5e-11 Score=115.66 Aligned_cols=127 Identities=24% Similarity=0.278 Sum_probs=40.9
Q ss_pred CCCCCCCceeeccCceeccccCCccc-CcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCC
Q 039533 85 IGNLSFLKQLYLQVNSFTHEIPSEIG-GLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKT 163 (949)
Q Consensus 85 l~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L 163 (949)
+.+...+++|+|++|.|+. |. .++ .+.+|+.||||+|.|+ .++ .+..++.|++|++++|+|+.........+++|
T Consensus 15 ~~n~~~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L 90 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNL 90 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT-
T ss_pred ccccccccccccccccccc-cc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCccccchHHhCCcC
Confidence 3455567888888888873 32 455 5778888888888887 343 46667777777777777775543333456777
Q ss_pred cEEECCCCCCCCCCC-CCcCCCCCccEEeccccccCCCCCC----cccCCCccccccc
Q 039533 164 EILNLGSNHLTGSIP-SSLGNLSSIHTISLAYNNLDGTIPN----SFGWFENLVFLSL 216 (949)
Q Consensus 164 ~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~L 216 (949)
++|+|++|+|...-- ..+..+++|++|+|.+|.++.. +. .+..+++|+.||-
T Consensus 91 ~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 91 QELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp -EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEETT
T ss_pred CEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeCC
Confidence 777777777763221 3455666777777777766632 22 2444555555553
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1e-10 Score=85.21 Aligned_cols=41 Identities=51% Similarity=0.941 Sum_probs=31.7
Q ss_pred ChhhHHHHHHHHhccCCCCCCCccCccCC--CCcceeeeeEEe
Q 039533 21 NETDRVALLEFKSKSTYDPVGVLGTWNES--IHFCKWYGVTCS 61 (949)
Q Consensus 21 ~~~~~~aLl~~k~~~~~~~~~~l~sW~~~--~~~C~w~gv~C~ 61 (949)
+++|++||++||+++..+|.+.+.+|+.+ .+||+|.||+|+
T Consensus 1 ~~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 1 PNQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp -HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred CcHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 36899999999999987888999999977 799999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.06 E-value=4.7e-11 Score=119.37 Aligned_cols=131 Identities=27% Similarity=0.288 Sum_probs=76.7
Q ss_pred cccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceee
Q 039533 366 KMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLY 445 (949)
Q Consensus 366 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ 445 (949)
..|++++|++|.|+ .+.++..-.+.++.|++|+|.|. .+.. +..+++| +.||||+|.++ .+..+-..+.+.+.|.
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L-~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQL-QLLDLSGNLLA-ECVGWHLKLGNIKTLK 358 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEecccccee-eehh-hhhcccc-eEeecccchhH-hhhhhHhhhcCEeeee
Confidence 34445555555544 34444444455555555555554 2222 4444444 45555555555 3334444566667777
Q ss_pred eccccccccCCcccccccchhhcccCccccccc-cCCCcCCCCCCCEEECCCCcCCCcC
Q 039533 446 VYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGP-ISSSLGSLRGLRVLDLSQNNLSGEI 503 (949)
Q Consensus 446 Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~ 503 (949)
|+.|.|.. -+.++.+-+|..||+++|+|+.. --..+++|+-|+.|.|.+|.|.+.+
T Consensus 359 La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 359 LAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred hhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 77776652 23366677778888888887632 2356888999999999999998543
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.2e-11 Score=138.51 Aligned_cols=271 Identities=23% Similarity=0.239 Sum_probs=119.8
Q ss_pred cCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEecc
Q 039533 114 RLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLA 193 (949)
Q Consensus 114 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 193 (949)
.++.++..++.+.+.--. ...+..++.+++..|.|.. +...+..+++|+.|++.+|+|.. +...+..+++|++|+|+
T Consensus 50 ~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls 126 (414)
T KOG0531|consen 50 DLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLS 126 (414)
T ss_pred hhhhhcchhccccchhhh-HHHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheecc
Confidence 444555555544311111 1344455555555555543 22334455555555555555552 22224445555555555
Q ss_pred ccccCCCCCCcccCCCccccccccCcccccccccccCCCCChhhhccccccccccCCCCCCCCCCcchhccccccCcccE
Q 039533 194 YNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTW 273 (949)
Q Consensus 194 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~ 273 (949)
+|+|+...+ +..++.|+.|++++|.|+.+. .+..++.|+.
T Consensus 127 ~N~I~~i~~--l~~l~~L~~L~l~~N~i~~~~--------------------------------------~~~~l~~L~~ 166 (414)
T KOG0531|consen 127 FNKITKLEG--LSTLTLLKELNLSGNLISDIS--------------------------------------GLESLKSLKL 166 (414)
T ss_pred ccccccccc--hhhccchhhheeccCcchhcc--------------------------------------CCccchhhhc
Confidence 555543222 333444444444444444322 2222444445
Q ss_pred EEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccC--CCCEEecCC
Q 039533 274 MHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQ--NLKILGLNR 351 (949)
Q Consensus 274 L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~Ls~ 351 (949)
+++++|++...-+.....+ ..++.+++.+|.+.. ...+..+..+..+++..|.++..-+ +..+. +|+.+++++
T Consensus 167 l~l~~n~i~~ie~~~~~~~-~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~ 241 (414)
T KOG0531|consen 167 LDLSYNRIVDIENDELSEL-ISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSG 241 (414)
T ss_pred ccCCcchhhhhhhhhhhhc-cchHHHhccCCchhc--ccchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhccc
Confidence 5555555443322101122 235555666666542 2223333444444555555552211 11111 255555555
Q ss_pred cccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCC
Q 039533 352 NKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSL 431 (949)
Q Consensus 352 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~ 431 (949)
|++. ..+..+..+..+..|++.+|++...- .+.....+..+.+..|.+... . ...
T Consensus 242 n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~--~~~~~~~~~~~~~~~~~~~~~-~---------------------~~~ 296 (414)
T KOG0531|consen 242 NRIS-RSPEGLENLKNLPVLDLSSNRISNLE--GLERLPKLSELWLNDNKLALS-E---------------------AIS 296 (414)
T ss_pred Cccc-cccccccccccccccchhhccccccc--cccccchHHHhccCcchhcch-h---------------------hhh
Confidence 5555 23334444455555555555544211 122223333333333333210 0 011
Q ss_pred ccc-cccccccceeeeccccccccCCc
Q 039533 432 PIE-VGKLKILEFLYVYENRLEGEIPS 457 (949)
Q Consensus 432 p~~-~~~l~~L~~L~Ls~N~l~~~~p~ 457 (949)
... ......++.+++..|.+....+.
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (414)
T KOG0531|consen 297 QEYITSAAPTLVTLTLELNPIRKISSL 323 (414)
T ss_pred ccccccccccccccccccCcccccccc
Confidence 111 45667788888888888765553
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.6e-09 Score=102.81 Aligned_cols=131 Identities=20% Similarity=0.192 Sum_probs=96.2
Q ss_pred CeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcc--------hHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGA--------SRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
..+++|+-+.||.+.+. |..+++|.-.+..... ..+..+|++++.+++--.|...+-+..+.+ ..
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~-----~~ 74 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPD-----NG 74 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCC-----CC
Confidence 45789999999999875 4557777643222111 146778999999986443333222333333 56
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
.++|||++|..|.+++.. . ...++..+-+-+.-||.. ||+|+|+.++||++..+. +.++
T Consensus 75 ~I~me~I~G~~lkd~l~~----------~-------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~I 133 (204)
T COG3642 75 LIVMEYIEGELLKDALEE----------A-------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFI 133 (204)
T ss_pred EEEEEEeCChhHHHHHHh----------c-------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEE
Confidence 899999999999988862 1 245778888888999977 999999999999998864 9999
Q ss_pred eccccee
Q 039533 784 DFGLARI 790 (949)
Q Consensus 784 DfG~a~~ 790 (949)
|||++..
T Consensus 134 DfGLg~~ 140 (204)
T COG3642 134 DFGLGEF 140 (204)
T ss_pred ECCcccc
Confidence 9999874
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.03 E-value=3e-11 Score=127.38 Aligned_cols=64 Identities=22% Similarity=0.247 Sum_probs=41.6
Q ss_pred cCCCCCcEEECCCCCCCCCCC--CCcCCCCCccEEeccccccCCCCC--CcccCCCccccccccCcccc
Q 039533 158 SSLSKTEILNLGSNHLTGSIP--SSLGNLSSIHTISLAYNNLDGTIP--NSFGWFENLVFLSLAANNLS 222 (949)
Q Consensus 158 ~~L~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~ 222 (949)
+++++|+...|.+.... ..+ .....+++++.||||.|-+....| .....|++|+.|+|+.|++.
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~ 185 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLS 185 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhccccccccc
Confidence 46777888888888776 333 355677778888888887763222 23345666777777766654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.2e-10 Score=127.32 Aligned_cols=249 Identities=18% Similarity=0.129 Sum_probs=169.3
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEc-CCCEEEEEEEEecCCCcchH--HHHHHHHHHHhc-CCCcceeEEeeeecccccC
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIID-EGRTTIAVKVFNLQHHGASR--SFIAECKALKSI-RHRNLVKVLTACLGADYRG 699 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 699 (949)
-..+|..+..||.|.|+.|+....+ .++..+++|........... .-..|+.+...+ .|.++++.+..+...+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r--- 339 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR--- 339 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc---
Confidence 3457888899999999999998765 67888999987643322221 223455555555 5888888765544332
Q ss_pred CccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCC-C
Q 039533 700 NDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDY-M 778 (949)
Q Consensus 700 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~-~ 778 (949)
..++--||+++++...... ....++...++++..|++.++.++|+. .++|+|+||+||++..+ +
T Consensus 340 --~~~ip~e~~~~~s~~l~~~----------~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~ 404 (524)
T KOG0601|consen 340 --QGYIPLEFCEGGSSSLRSV----------TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGF 404 (524)
T ss_pred --cccCchhhhcCcchhhhhH----------HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchh
Confidence 5568889999998876652 234567778899999999999999955 89999999999999876 8
Q ss_pred ceEEeecccceecCCCCCccccccccCccCcc--CccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhh
Q 039533 779 TARVGDFGLARILSPDHTQTSSFSVKGSLGYI--APEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNF 856 (949)
Q Consensus 779 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~ 856 (949)
..++.|||++..+.-... ...+..+++ +|+......+..+.|+||||..+.|..+|..--... ..|
T Consensus 405 ~~~~~~~~~~t~~~~~~~-----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-------~~~ 472 (524)
T KOG0601|consen 405 FSKLGDFGCWTRLAFSSG-----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-------VQS 472 (524)
T ss_pred hhhccccccccccceecc-----cccccccccccchhhccccccccccccccccccccccccCcccCccc-------ccc
Confidence 889999999875322211 111333444 555566667889999999999999999987532110 001
Q ss_pred ccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHh
Q 039533 857 GRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSI 931 (949)
Q Consensus 857 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 931 (949)
. .+..... +.. ......+..+...+...++..||.+.+.....+-.
T Consensus 473 ~---------~i~~~~~-p~~-------------------~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 473 L---------TIRSGDT-PNL-------------------PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred e---------eeecccc-cCC-------------------CchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 0 0000000 000 01123456677788889999999988876655443
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=5.4e-12 Score=129.51 Aligned_cols=259 Identities=19% Similarity=0.237 Sum_probs=130.6
Q ss_pred CCCCCCCCCceeeccCceecc----ccCCcccCcccCcEEeecccc---ccCcCCCCCCCCccceeecCCCccccccccc
Q 039533 83 HFIGNLSFLKQLYLQVNSFTH----EIPSEIGGLRRLKVLALNNNS---ICGEIPTNISRCSTLIPIHPQNNQLVGKILS 155 (949)
Q Consensus 83 ~~l~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~N~---l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~ 155 (949)
+.+.....++.|+||+|.|.. .+...+.+.++|+..++|+=- +..++|+.+. ....
T Consensus 24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~-----------------~l~~ 86 (382)
T KOG1909|consen 24 EELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALK-----------------MLSK 86 (382)
T ss_pred HHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHH-----------------HHHH
Confidence 345556667777777777753 234445566677777666531 2223443321 1123
Q ss_pred cccCCCCCcEEECCCCCCCCCCCCC----cCCCCCccEEeccccccCCCCCCcccCCCccccccccCcccccccccccCC
Q 039533 156 RFSSLSKTEILNLGSNHLTGSIPSS----LGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGE 231 (949)
Q Consensus 156 ~~~~L~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~ 231 (949)
++...++|++||||+|-|.-..+.. +.++..|++|.|.+|.+.-.--..++ ..|..|. .|+.
T Consensus 87 aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~--~al~~l~--~~kk---------- 152 (382)
T KOG1909|consen 87 ALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLG--RALFELA--VNKK---------- 152 (382)
T ss_pred HHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHH--HHHHHHH--HHhc----------
Confidence 3444456666666666665333322 23456666677766665411111111 0111111 0000
Q ss_pred CCChhhhccccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCC----chhhcccccccEEEccCcccc
Q 039533 232 VPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLP----GCISNLSKTIKTLFLNNNKIY 307 (949)
Q Consensus 232 ~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p----~~~~~l~~~L~~L~L~~N~l~ 307 (949)
..+-+.|+.+...+|++...+...+ ...+...+.|+.+.++.|.+...-- ..+... ++|+.|||.+|-++
T Consensus 153 ---~~~~~~Lrv~i~~rNrlen~ga~~~--A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~-~~LevLdl~DNtft 226 (382)
T KOG1909|consen 153 ---AASKPKLRVFICGRNRLENGGATAL--AEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHC-PHLEVLDLRDNTFT 226 (382)
T ss_pred ---cCCCcceEEEEeeccccccccHHHH--HHHHHhccccceEEEecccccCchhHHHHHHHHhC-Ccceeeecccchhh
Confidence 0111234444444444444332211 1223334455555555555442111 122222 35666666666665
Q ss_pred CC----CCCCCCCCCcccEEEeecceecccCCCcc-----cccCCCCEEecCCccccc----ccCcccccccccceeecc
Q 039533 308 GS----IPAGIGNFVNLQRLDMWNNQLSGTIPPAI-----GELQNLKILGLNRNKLSG----NIPPSIGNLKMLLNLFLN 374 (949)
Q Consensus 308 ~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~ 374 (949)
.. +...+..+++|+.|+++++.+...-..+| ...++|+.|.|.+|.++. .+-..+...+.|..|+|+
T Consensus 227 ~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLn 306 (382)
T KOG1909|consen 227 LEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLN 306 (382)
T ss_pred hHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCC
Confidence 32 33456667778888888887764333222 125778888888888763 223345567788888888
Q ss_pred cccc
Q 039533 375 DNFL 378 (949)
Q Consensus 375 ~N~l 378 (949)
+|.+
T Consensus 307 gN~l 310 (382)
T KOG1909|consen 307 GNRL 310 (382)
T ss_pred cccc
Confidence 8887
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=3.3e-12 Score=131.03 Aligned_cols=256 Identities=18% Similarity=0.248 Sum_probs=116.0
Q ss_pred cccccCCCCCcEEECCCCCCCC----CCCCCcCCCCCccEEeccccccCC----CCCCc-------ccCCCccccccccC
Q 039533 154 LSRFSSLSKTEILNLGSNHLTG----SIPSSLGNLSSIHTISLAYNNLDG----TIPNS-------FGWFENLVFLSLAA 218 (949)
Q Consensus 154 ~~~~~~L~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~----~~p~~-------~~~l~~L~~L~Ls~ 218 (949)
......+..++.|+||+|.|.. .+...+.+.++|+..++|+= ++| .+|.. +...++|++||||+
T Consensus 23 ~~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~-ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSD 101 (382)
T KOG1909|consen 23 EEELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDM-FTGRLKDEIPEALKMLSKALLGCPKLQKLDLSD 101 (382)
T ss_pred HHHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhh-hcCCcHHHHHHHHHHHHHHHhcCCceeEeeccc
Confidence 3445667778888888888862 23445666777888777642 332 23332 22334555555555
Q ss_pred cccccccccccCCCCChhhhccccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccE
Q 039533 219 NNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKT 298 (949)
Q Consensus 219 N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~ 298 (949)
|.+.. ....+.-.-+.++..|++|.|.+|.++..+...+.- .|..|+ .|+.. .-+..|++
T Consensus 102 NA~G~--~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--------al~~l~--~~kk~--------~~~~~Lrv 161 (382)
T KOG1909|consen 102 NAFGP--KGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--------ALFELA--VNKKA--------ASKPKLRV 161 (382)
T ss_pred cccCc--cchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--------HHHHHH--HHhcc--------CCCcceEE
Confidence 55431 110000001233444444444444443322211100 000000 00000 00123555
Q ss_pred EEccCccccCC----CCCCCCCCCcccEEEeecceecc----cCCCcccccCCCCEEecCCcccccc----cCccccccc
Q 039533 299 LFLNNNKIYGS----IPAGIGNFVNLQRLDMWNNQLSG----TIPPAIGELQNLKILGLNRNKLSGN----IPPSIGNLK 366 (949)
Q Consensus 299 L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~ 366 (949)
+..++|++... +...|...+.|+.+.++.|.|.. .+-..|..+++|+.|||..|-|+.. +...+..++
T Consensus 162 ~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~ 241 (382)
T KOG1909|consen 162 FICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWP 241 (382)
T ss_pred EEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccc
Confidence 55555555421 11224444556666666665541 1112345556666666666655521 223344455
Q ss_pred ccceeecccccccccCCCCC-----CCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCcccccccccc
Q 039533 367 MLLNLFLNDNFLEVSIPSSL-----GQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKIL 441 (949)
Q Consensus 367 ~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L 441 (949)
+|+.|+++++.+...-..+| ...++|++|.|.+|.++..-- ..+..++...+.|
T Consensus 242 ~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~---------------------~~la~~~~ek~dL 300 (382)
T KOG1909|consen 242 HLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAA---------------------LALAACMAEKPDL 300 (382)
T ss_pred hheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHH---------------------HHHHHHHhcchhh
Confidence 55555555555543221111 113455555555555541000 0122334456667
Q ss_pred ceeeeccccc
Q 039533 442 EFLYVYENRL 451 (949)
Q Consensus 442 ~~L~Ls~N~l 451 (949)
+.|+|++|++
T Consensus 301 ~kLnLngN~l 310 (382)
T KOG1909|consen 301 EKLNLNGNRL 310 (382)
T ss_pred HHhcCCcccc
Confidence 7777777777
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.98 E-value=5.6e-09 Score=108.52 Aligned_cols=145 Identities=21% Similarity=0.181 Sum_probs=108.6
Q ss_pred CeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCC--cceeEEeeeecccccCCccceeEee
Q 039533 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHR--NLVKVLTACLGADYRGNDFKASVYE 708 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~~~~~~lv~e 708 (949)
+.++.|..+.||+++.. +|+.+++|+...... .....+.+|+++++.+.+. .+.+++.+..... .....++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEE
Confidence 57899999999999886 357899999764332 1345788999999999753 4577776654321 1124689999
Q ss_pred eccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCC------------------------------
Q 039533 709 FMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDC------------------------------ 758 (949)
Q Consensus 709 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~------------------------------ 758 (949)
|++|.++.+.+. ...++..+...++.+++++|++||+..
T Consensus 81 ~i~G~~l~~~~~-----------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (223)
T cd05154 81 RVDGRVLRDRLL-----------RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDAS 149 (223)
T ss_pred EeCCEecCCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhh
Confidence 999988877653 023667777788888888888888421
Q ss_pred -----------------------CCCeEecCCCCCCeeecC--CCceEEeeccccee
Q 039533 759 -----------------------QPVTAHCDLKPSNVLLDD--YMTARVGDFGLARI 790 (949)
Q Consensus 759 -----------------------~~~ivHrDlkp~NIll~~--~~~~kl~DfG~a~~ 790 (949)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 150 RTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.1e-08 Score=110.87 Aligned_cols=181 Identities=18% Similarity=0.177 Sum_probs=137.7
Q ss_pred cCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEeeeccC-CChh
Q 039533 638 SFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHY-GSLE 716 (949)
Q Consensus 638 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-gsL~ 716 (949)
...+.|++....+|..|++|+++............-++.++++.|+|||++.+++....+ ++...++||+|.++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF-~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTF-GDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhcc-CcceEEEEEecCCCCchHH
Confidence 446899999999999999999954443334445567889999999999999998874443 34468899999976 5777
Q ss_pred hhcCCCCCCC-----ccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecccceec
Q 039533 717 EWLHPFTGED-----EIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARIL 791 (949)
Q Consensus 717 ~~l~~~~~~~-----~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~ 791 (949)
++.-...... .....+...++...+.++.|+..||.++|+. |..-+-|.|.+|+++.+.+++|+..|.....
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 7543222111 1234556788899999999999999999988 8999999999999999999999988887766
Q ss_pred CCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCC
Q 039533 792 SPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKK 841 (949)
Q Consensus 792 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~ 841 (949)
..+.... +.+ -.+-|.=.||.++..|.||..
T Consensus 444 ~~d~~~~----------------le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 444 QEDPTEP----------------LES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred cCCCCcc----------------hhH---HhhhhHHHHHHHHHHHhhccc
Confidence 5544111 111 135688899999999999954
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.2e-10 Score=112.89 Aligned_cols=109 Identities=25% Similarity=0.354 Sum_probs=26.7
Q ss_pred ccCcccCcEEeeccccccCcCCCCCC-CCccceeecCCCccccccccccccCCCCCcEEECCCCCCCCCCCCCc-CCCCC
Q 039533 109 IGGLRRLKVLALNNNSICGEIPTNIS-RCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSL-GNLSS 186 (949)
Q Consensus 109 ~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~-~~l~~ 186 (949)
+.+..+++.|+|++|.|+ .| +.++ .+.+|+.|++++|.|+... .+..+++|+.|+|++|+|+ .+++.+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~~l~--~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIS-TI-ENLGATLDKLEVLDLSNNQITKLE--GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S--T--T----TT--EEE--SS----S-CHHHHHH-TT
T ss_pred cccccccccccccccccc-cc-cchhhhhcCCCEEECCCCCCcccc--CccChhhhhhcccCCCCCC-ccccchHHhCCc
Confidence 455567788888888886 33 2444 4566666666666665432 3555566666666666665 232223 24556
Q ss_pred ccEEeccccccCCCC-CCcccCCCccccccccCcccc
Q 039533 187 IHTISLAYNNLDGTI-PNSFGWFENLVFLSLAANNLS 222 (949)
Q Consensus 187 L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~ 222 (949)
|++|+|++|+|...- -..+..+++|+.|+|.+|.++
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 666666666655221 123444555555555555544
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.1e-10 Score=123.27 Aligned_cols=216 Identities=20% Similarity=0.183 Sum_probs=126.1
Q ss_pred CCCCCCceeeccCceeccccC--CcccCcccCcEEeeccccccCc--CCCCCCCCccceeecCCCcccccccccc-ccCC
Q 039533 86 GNLSFLKQLYLQVNSFTHEIP--SEIGGLRRLKVLALNNNSICGE--IPTNISRCSTLIPIHPQNNQLVGKILSR-FSSL 160 (949)
Q Consensus 86 ~~l~~L~~L~L~~n~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~l~~n~l~~~~~~~-~~~L 160 (949)
.++..|+.+.|.+..... .+ .....|++++.||||+|-+..- +-.....|++|+.|+++.|++....... -..+
T Consensus 118 sn~kkL~~IsLdn~~V~~-~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVED-AGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCccccc-cchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 356666666666665542 22 2445566777777777665421 1222345666667777777665333222 1255
Q ss_pred CCCcEEECCCCCCCCC-CCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCcccccccccccCCCCChhhhc
Q 039533 161 SKTEILNLGSNHLTGS-IPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQ 239 (949)
Q Consensus 161 ~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~ 239 (949)
++|+.|.|+.|.|+.. +-..+..+++|+.|+|.+|..-+.-.....-++.|++|||++|++-..+ ..+....++
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~-----~~~~~~~l~ 271 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFD-----QGYKVGTLP 271 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccc-----ccccccccc
Confidence 6677777777777621 1122335567777777777533344445555677777777777665433 234455666
Q ss_pred cccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCC-chhhcccccccEEEccCccccC
Q 039533 240 RLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLP-GCISNLSKTIKTLFLNNNKIYG 308 (949)
Q Consensus 240 ~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p-~~~~~l~~~L~~L~L~~N~l~~ 308 (949)
.|..|+++.+.+.+....+....+-....++|++|+++.|++...-. ..+..+ ++|+.|....|.|+.
T Consensus 272 ~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l-~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 272 GLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTL-ENLKHLRITLNYLNK 340 (505)
T ss_pred chhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhcc-chhhhhhcccccccc
Confidence 77777777777766654444444445667788888888888743211 122222 457778887888864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.2e-08 Score=100.96 Aligned_cols=127 Identities=22% Similarity=0.200 Sum_probs=83.8
Q ss_pred eEEEEEEcCCCEEEEEEEEecCCC-------------c-------------chHHHHHHHHHHHhcCCC--cceeEEeee
Q 039533 641 SVYKGIIDEGRTTIAVKVFNLQHH-------------G-------------ASRSFIAECKALKSIRHR--NLVKVLTAC 692 (949)
Q Consensus 641 ~Vy~~~~~~~~~~vavK~~~~~~~-------------~-------------~~~~~~~E~~~l~~l~h~--niv~~~~~~ 692 (949)
.||.|... ++..+|||+++.... . ......+|++.|.++... ++++.+++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 38999986 678999999863210 0 013567899999999755 577777552
Q ss_pred ecccccCCccceeEeeecc--CCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeEecCCCC
Q 039533 693 LGADYRGNDFKASVYEFMH--YGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYL-HHDCQPVTAHCDLKP 769 (949)
Q Consensus 693 ~~~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~L-H~~~~~~ivHrDlkp 769 (949)
...+||||++ |..+..+.. ..++......++.+++..+..+ |.. ||+|||+.+
T Consensus 80 ---------~~~ivME~I~~~G~~~~~l~~------------~~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~ 135 (188)
T PF01163_consen 80 ---------RNVIVMEYIGEDGVPLPRLKD------------VDLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSE 135 (188)
T ss_dssp ---------TTEEEEE--EETTEEGGCHHH------------CGGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-ST
T ss_pred ---------CCEEEEEecCCCccchhhHHh------------ccccchhHHHHHHHHHHHHHHHHHhc---CceecCCCh
Confidence 4589999998 655544432 1111234566788888866664 554 999999999
Q ss_pred CCeeecCCCceEEeecccceecCC
Q 039533 770 SNVLLDDYMTARVGDFGLARILSP 793 (949)
Q Consensus 770 ~NIll~~~~~~kl~DfG~a~~~~~ 793 (949)
.||+++++ .+.++|||.+.....
T Consensus 136 ~NIlv~~~-~~~iIDf~qav~~~~ 158 (188)
T PF01163_consen 136 YNILVDDG-KVYIIDFGQAVDSSH 158 (188)
T ss_dssp TSEEEETT-CEEE--GTTEEETTS
T ss_pred hhEEeecc-eEEEEecCcceecCC
Confidence 99999987 999999999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.89 E-value=4e-10 Score=131.16 Aligned_cols=207 Identities=22% Similarity=0.265 Sum_probs=145.1
Q ss_pred HHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc---chHHHHHHHHHHHhcCCCcceeEEeeeecccccC
Q 039533 623 NATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG---ASRSFIAECKALKSIRHRNLVKVLTACLGADYRG 699 (949)
Q Consensus 623 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 699 (949)
...+++.+.+-+-.|.++.++.+.-...+...+.|+......- ..+....+-.+.-...||-+++...- +.-
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s-----~~~ 875 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS-----FPC 875 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC-----CCC
Confidence 4556788888899999999998887766655556554322211 11112222222222234555543322 223
Q ss_pred CccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCc
Q 039533 700 NDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMT 779 (949)
Q Consensus 700 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~ 779 (949)
....++|++|+.+++|...++.. +..+.+.++.....++.+.+|||+. .+.|||++|.|++...+++
T Consensus 876 rsP~~L~~~~~~~~~~~Skl~~~----------~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh 942 (1205)
T KOG0606|consen 876 RSPLPLVGHYLNGGDLPSKLHNS----------GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGH 942 (1205)
T ss_pred CCCcchhhHHhccCCchhhhhcC----------CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCC
Confidence 34678999999999999998732 2345555666778889999999976 6899999999999999999
Q ss_pred eEEeecccceecCCC---------------------C--------CccccccccCccCccCccccCCCccCCccchHHHH
Q 039533 780 ARVGDFGLARILSPD---------------------H--------TQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYG 830 (949)
Q Consensus 780 ~kl~DfG~a~~~~~~---------------------~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG 830 (949)
.+++|||.....+-- . .........||+.|.|||...+......+|+|+.|
T Consensus 943 ~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g 1022 (1205)
T KOG0606|consen 943 RPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSG 1022 (1205)
T ss_pred cccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhh
Confidence 999999843322100 0 00112345699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCcccc
Q 039533 831 ILLLELVIGKKPIDIMF 847 (949)
Q Consensus 831 vvl~elltg~~Pf~~~~ 847 (949)
++++|.++|.+||....
T Consensus 1023 ~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 1023 VCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred hhhhhhhcCCCCCCCcc
Confidence 99999999999997543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.4e-08 Score=95.88 Aligned_cols=143 Identities=19% Similarity=0.180 Sum_probs=98.2
Q ss_pred CCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC-Cc-------chHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 630 SANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-HG-------ASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 630 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
....+-+|+-+.|+++.+. |+..+||.--... .. ..++..+|++.+.++.--.|.-..-++.+..
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~----- 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY----- 83 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC-----
Confidence 5678999999999999986 6777777532211 11 1257789999999985333222222222222
Q ss_pred cceeEeeeccC-CChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC--
Q 039533 702 FKASVYEFMHY-GSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM-- 778 (949)
Q Consensus 702 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~-- 778 (949)
.-.++|||+++ .++.+++..... ...........+.+|-+.+.-||.. +|+||||..+||++..++
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~--------~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~ 152 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTME--------DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQ 152 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHcc--------CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCc
Confidence 45899999987 477777752211 1112223367899999999999977 899999999999996554
Q ss_pred -ceEEeeccccee
Q 039533 779 -TARVGDFGLARI 790 (949)
Q Consensus 779 -~~kl~DfG~a~~ 790 (949)
.+.++|||++..
T Consensus 153 ~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 153 ITPILIDFGLSSV 165 (229)
T ss_pred CceEEEeecchhc
Confidence 458999999864
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.1e-09 Score=130.16 Aligned_cols=126 Identities=21% Similarity=0.270 Sum_probs=60.5
Q ss_pred CCCceeeccCceeccccCCcccCcccCcEEeecccc--ccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEE
Q 039533 89 SFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNS--ICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEIL 166 (949)
Q Consensus 89 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~--l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L 166 (949)
...+...+-+|.+. .++.... +++|+.|-+..|. +.-..++.|..++.|+.|||++|.=.+..|..++.|-+|++|
T Consensus 523 ~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL 600 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL 600 (889)
T ss_pred hheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence 44455555555544 2222221 2245555555553 221112224445555555555444444445555555555555
Q ss_pred ECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCcccccccc
Q 039533 167 NLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLA 217 (949)
Q Consensus 167 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 217 (949)
+|++..++ .+|..+++|..|.+|++.++.-...+|.....+++|++|.+-
T Consensus 601 ~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~ 650 (889)
T KOG4658|consen 601 DLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLP 650 (889)
T ss_pred cccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEee
Confidence 55555555 555555555555555555554443444444455555555554
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.79 E-value=4.8e-09 Score=83.64 Aligned_cols=14 Identities=50% Similarity=0.717 Sum_probs=5.0
Q ss_pred cCCCCEEecCCccc
Q 039533 341 LQNLKILGLNRNKL 354 (949)
Q Consensus 341 l~~L~~L~Ls~N~l 354 (949)
+++|++|++++|++
T Consensus 24 l~~L~~L~l~~N~l 37 (61)
T PF13855_consen 24 LPNLETLDLSNNNL 37 (61)
T ss_dssp GTTESEEEETSSSE
T ss_pred CCCCCEeEccCCcc
Confidence 33333333333333
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.79 E-value=5.8e-09 Score=83.14 Aligned_cols=61 Identities=39% Similarity=0.451 Sum_probs=55.4
Q ss_pred CCCCEEecCCcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccc
Q 039533 342 QNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNL 402 (949)
Q Consensus 342 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 402 (949)
++|++|++++|+|+...+..|.++++|++|++++|.++...|++|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5789999999999977778899999999999999999988889999999999999999975
|
... |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.77 E-value=5.5e-09 Score=126.65 Aligned_cols=294 Identities=24% Similarity=0.237 Sum_probs=160.5
Q ss_pred CCceeeccCce--eccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEE
Q 039533 90 FLKQLYLQVNS--FTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILN 167 (949)
Q Consensus 90 ~L~~L~L~~n~--l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~ 167 (949)
.|++|-+..|. +....++.|..++.|++||||+|.=-+.+|..++.|-+|++|++++..+. ..|..+.+|.+|.+|+
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln 624 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN 624 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence 57777777775 44333344677888888888877655678888888888888888888876 6677788888888888
Q ss_pred CCCCCCCCCCCCCcCCCCCccEEeccccccC--CCCCCcccCCCccccccccCcccccccccccCCCCChhhhcccc---
Q 039533 168 LGSNHLTGSIPSSLGNLSSIHTISLAYNNLD--GTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQ--- 242 (949)
Q Consensus 168 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~--- 242 (949)
+..+.-...+|..+..+++|++|.|..-... ...-..+.++.+|+.+.........+. .+..+..|.
T Consensus 625 l~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~~~~e--------~l~~~~~L~~~~ 696 (889)
T KOG4658|consen 625 LEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSVLLLE--------DLLGMTRLRSLL 696 (889)
T ss_pred cccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchhHhHh--------hhhhhHHHHHHh
Confidence 8877766566666666888888877665422 222233344444444444322210000 011111111
Q ss_pred -ccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhccc-----ccccEEEccCccccCCCCCCCCC
Q 039533 243 -HFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLS-----KTIKTLFLNNNKIYGSIPAGIGN 316 (949)
Q Consensus 243 -~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~-----~~L~~L~L~~N~l~~~~~~~~~~ 316 (949)
.+.+..+.. -....++..+.+|+.|.+.++.+......+..... +++..+...++... ..+.+.-.
T Consensus 697 ~~l~~~~~~~-------~~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~-r~l~~~~f 768 (889)
T KOG4658|consen 697 QSLSIEGCSK-------RTLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHML-RDLTWLLF 768 (889)
T ss_pred Hhhhhccccc-------ceeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccc-cccchhhc
Confidence 222211111 11233455666777777777766533222211100 01111111111111 12333344
Q ss_pred CCcccEEEeecceecccCCCcccccCCCCEEecCCcccccc-cCcccccccccceeecccccccccCCC---CCCCCCCC
Q 039533 317 FVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGN-IPPSIGNLKMLLNLFLNDNFLEVSIPS---SLGQCESL 392 (949)
Q Consensus 317 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~---~~~~l~~L 392 (949)
.++|+.|.+........+.+....+..++.+-+..+.+.+. .-...+.++++..+.+..=.+....-+ ..+.+|.+
T Consensus 769 ~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~l~~~~l~~~~ve~~p~l~~~P~~ 848 (889)
T KOG4658|consen 769 APHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWLPLSFLKLEELIVEECPKLGKLPLL 848 (889)
T ss_pred cCcccEEEEecccccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEecccCccchhheehhcCcccccCccc
Confidence 57888888887776656666666666677677777777765 344455555555555544333211111 13445666
Q ss_pred cEEEeeCc
Q 039533 393 IEINLSNN 400 (949)
Q Consensus 393 ~~L~l~~N 400 (949)
..+.+.++
T Consensus 849 ~~~~i~~~ 856 (889)
T KOG4658|consen 849 STLTIVGC 856 (889)
T ss_pred cccceecc
Confidence 66666664
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.8e-07 Score=98.37 Aligned_cols=147 Identities=12% Similarity=0.014 Sum_probs=101.7
Q ss_pred CCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc-----------chHHHHHHHHHHHhcCCCc--ceeEEeeeecccc
Q 039533 631 ANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG-----------ASRSFIAECKALKSIRHRN--LVKVLTACLGADY 697 (949)
Q Consensus 631 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~ 697 (949)
.+.+-+.....|++++.. |+.+.||+....... ....+.+|...+.++...+ +++.+++......
T Consensus 27 ~e~v~~~~~rrvvr~~~~--g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~ 104 (268)
T PRK15123 27 GEVFRELEGRRTLRFELA--GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSN 104 (268)
T ss_pred CcEEecCCCceEEEEEEC--CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCC
Confidence 355555555567787664 788999987433211 1124789999998884333 3344445422111
Q ss_pred cCCccceeEeeeccCC-ChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC
Q 039533 698 RGNDFKASVYEFMHYG-SLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD 776 (949)
Q Consensus 698 ~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~ 776 (949)
......++|||++++. +|.+++.... ....+...+..++.+++..++-||.. ||+|||++++|||++.
T Consensus 105 ~~~~~s~LVte~l~~~~sL~~~~~~~~--------~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~ 173 (268)
T PRK15123 105 PATRTSFIITEDLAPTISLEDYCADWA--------TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHL 173 (268)
T ss_pred CccceeEEEEeeCCCCccHHHHHHhhc--------ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEec
Confidence 1123468999999886 8988874210 12345667788999999999999987 9999999999999975
Q ss_pred -------CCceEEeeccccee
Q 039533 777 -------YMTARVGDFGLARI 790 (949)
Q Consensus 777 -------~~~~kl~DfG~a~~ 790 (949)
++.+.++||+.++.
T Consensus 174 ~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 174 PFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred cccCCCCCceEEEEECCcccc
Confidence 46899999998754
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.2e-07 Score=95.66 Aligned_cols=137 Identities=21% Similarity=0.153 Sum_probs=97.2
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC------------------c----chHHHHHHHHHHHhcCCC-
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH------------------G----ASRSFIAECKALKSIRHR- 683 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~----~~~~~~~E~~~l~~l~h~- 683 (949)
=+.+++.||.|--+.||.|.+. .|.++|||.-+.... . ......+|.++|+++...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 3566789999999999999987 688999998642110 0 013467899999999654
Q ss_pred -cceeEEeeeecccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 039533 684 -NLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVT 762 (949)
Q Consensus 684 -niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~i 762 (949)
.|++.+++ +...+||||++|-.|...- ++......|+..|++-+..+-.. ||
T Consensus 171 ~~VP~P~~~---------nRHaVvMe~ieG~eL~~~r---------------~~~en~~~il~~il~~~~~~~~~---Gi 223 (304)
T COG0478 171 VKVPKPIAW---------NRHAVVMEYIEGVELYRLR---------------LDVENPDEILDKILEEVRKAYRR---GI 223 (304)
T ss_pred CCCCCcccc---------ccceeeeehcccceeeccc---------------CcccCHHHHHHHHHHHHHHHHHc---Cc
Confidence 67776654 2568999999986664332 12223334444444444444433 89
Q ss_pred EecCCCCCCeeecCCCceEEeecccceec
Q 039533 763 AHCDLKPSNVLLDDYMTARVGDFGLARIL 791 (949)
Q Consensus 763 vHrDlkp~NIll~~~~~~kl~DfG~a~~~ 791 (949)
||+|+++-||+++++|.+.++||-.+...
T Consensus 224 VHGDlSefNIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 224 VHGDLSEFNILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred cccCCchheEEEecCCCEEEEeCcccccC
Confidence 99999999999999999999999766543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.46 E-value=4.9e-08 Score=110.13 Aligned_cols=151 Identities=17% Similarity=0.245 Sum_probs=100.7
Q ss_pred HHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecccceecCCCCCccc-------cccccCccCccCccccC
Q 039533 744 AIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTS-------SFSVKGSLGYIAPEYGV 816 (949)
Q Consensus 744 ~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~ 816 (949)
+.+++.|+.|+|... ++||++|.|++|.++..+..||+.|+++........... ..-......|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 334558999999764 999999999999999999999999998876544222110 01122567899999999
Q ss_pred CCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhh
Q 039533 817 GCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINS 895 (949)
Q Consensus 817 ~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~ 895 (949)
+...+.++|+||+||.+|.+.. |+.-++.. .....+ ...+. ..+. ..+..
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~-~~~~~~-~~~~~--~~~~-------------------------~~~~~ 233 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAAN-GGLLSY-SFSRN--LLNA-------------------------GAFGY 233 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhcc-CCcchh-hhhhc--cccc-------------------------ccccc
Confidence 9888999999999999999994 55444321 111000 00000 0000 00001
Q ss_pred HHHHHHHHHHHhhccccCCCCCCCCHHHHH
Q 039533 896 IIECLISMVRIGVACSMELPQDRTNMTNVV 925 (949)
Q Consensus 896 ~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~ 925 (949)
..+.+.++.+-+.+.+..++.-||++.++.
T Consensus 234 s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 234 SNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred cccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 124566777778888888888999776663
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.9e-06 Score=87.85 Aligned_cols=111 Identities=21% Similarity=0.161 Sum_probs=83.8
Q ss_pred HHHHHHHHHHHhcCC--CcceeEEeeeecccccCCccceeEeeeccCC-ChhhhcCCCCCCCccccCCCCCCHHHHHHHH
Q 039533 668 RSFIAECKALKSIRH--RNLVKVLTACLGADYRGNDFKASVYEFMHYG-SLEEWLHPFTGEDEIDEAPRNLNLLQRLNIA 744 (949)
Q Consensus 668 ~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~ 744 (949)
.+..+|...+.++.. =.+++.+++..... ......++|+|++++. +|.+++.. ....+......++
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~-~~~~~s~lite~l~~~~~L~~~~~~----------~~~~~~~~~~~ll 124 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRK-GGGYRSYLITEALPGAQDLRDLLQQ----------WEQLDPSQRRELL 124 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcC-CCceeEEEEEEeCCCcccHHHHHHh----------hcccchhhHHHHH
Confidence 467888888888743 33555566544322 1123458999999874 79998862 1125566788899
Q ss_pred HHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC---ceEEeecccceecC
Q 039533 745 IDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM---TARVGDFGLARILS 792 (949)
Q Consensus 745 ~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~---~~kl~DfG~a~~~~ 792 (949)
.+++..++-||.. ||+|+|+++.|||++.+. .+.++||+-++...
T Consensus 125 ~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 125 RALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 9999999999988 999999999999999876 89999999887643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.39 E-value=4.3e-06 Score=83.08 Aligned_cols=156 Identities=13% Similarity=0.055 Sum_probs=108.3
Q ss_pred HHHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC------CcchHHHHHHHHHHHhcCC--CcceeEEeee
Q 039533 621 LYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH------HGASRSFIAECKALKSIRH--RNLVKVLTAC 692 (949)
Q Consensus 621 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h--~niv~~~~~~ 692 (949)
+-....++...---|+||.+.|++.... |..+-+|+-.... .-....|.+|+..+.++.. -.+++++ ++
T Consensus 13 ~w~~~~~wve~pN~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~ 89 (216)
T PRK09902 13 WWATEGDWVEEPNYRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FG 89 (216)
T ss_pred HHhCCCceecCCCcCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-ee
Confidence 3333334443344577999999998876 4468888764111 2234689999999999852 2355555 33
Q ss_pred ecccccCCccceeEeeeccC-CChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCC
Q 039533 693 LGADYRGNDFKASVYEFMHY-GSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSN 771 (949)
Q Consensus 693 ~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~N 771 (949)
...........++|+|-+++ .+|.+++... ...+.+...+..+..+++..++-||+. |+.|+|+.+.|
T Consensus 90 ~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~--------~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~kh 158 (216)
T PRK09902 90 EAVKIEGEWRALLVTEDMAGFISIADWYAQH--------AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRH 158 (216)
T ss_pred eeeccCCceEEEEEEEeCCCCccHHHHHhcC--------CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhh
Confidence 22211223346789997753 5888887521 123457778889999999999999977 99999999999
Q ss_pred eeecCCCc--eEEeeccccee
Q 039533 772 VLLDDYMT--ARVGDFGLARI 790 (949)
Q Consensus 772 Ill~~~~~--~kl~DfG~a~~ 790 (949)
|+++.++. ++++||.-++.
T Consensus 159 Ill~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 159 IYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred eeecCCCCeeEEEEEhhccch
Confidence 99986666 99999987764
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.38 E-value=5.8e-06 Score=83.05 Aligned_cols=155 Identities=19% Similarity=0.131 Sum_probs=104.6
Q ss_pred cCHHHHHHHhcCCCCCCeeee---ecCceEEEEEEcCCCEEEEEEEEecCCCcc-------------------h-----H
Q 039533 616 LSYQDLYNATSGFSSANLVGV---GSFGSVYKGIIDEGRTTIAVKVFNLQHHGA-------------------S-----R 668 (949)
Q Consensus 616 ~~~~~l~~~~~~y~~~~~lg~---G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------------------~-----~ 668 (949)
.+...+....++..+....|. |--+.||+|... ++..+|||+++.....- . .
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~ 113 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA 113 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence 345566667777777766554 555689999875 68999999997432110 0 1
Q ss_pred HHHHHHHHHHhcC--CCcceeEEeeeecccccCCccceeEeeeccCCC-hhhhcCCCCCCCccccCCCCCCHHHHHHHHH
Q 039533 669 SFIAECKALKSIR--HRNLVKVLTACLGADYRGNDFKASVYEFMHYGS-LEEWLHPFTGEDEIDEAPRNLNLLQRLNIAI 745 (949)
Q Consensus 669 ~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~ 745 (949)
-..+|+..|.++. +=.+++-+++. .-.+||||+.... -.-.| ....+...++..+..
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~~---------~nVLvMEfIg~~g~pAP~L-----------kDv~~e~~e~~~~~~ 173 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAFR---------NNVLVMEFIGDDGLPAPRL-----------KDVPLELEEAEGLYE 173 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceeec---------CCeEEEEeccCCCCCCCCc-----------ccCCcCchhHHHHHH
Confidence 1346788888874 44455555542 4589999995431 11111 112233336777888
Q ss_pred HHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecccceecCCC
Q 039533 746 DIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPD 794 (949)
Q Consensus 746 qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~ 794 (949)
++++.+.-|-..+ ++||+||+.=|||+. ++.+.|+|||.|.....+
T Consensus 174 ~~v~~~~~l~~~a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 174 DVVEYMRRLYKEA--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred HHHHHHHHHHHhc--CcccccchhhheEEE-CCeEEEEECccccccCCC
Confidence 8888888888633 999999999999999 789999999998766543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.37 E-value=3.2e-06 Score=84.13 Aligned_cols=142 Identities=17% Similarity=0.132 Sum_probs=94.6
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHH---------HHHHHHHHHhcC---CCcceeEEeee
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRS---------FIAECKALKSIR---HRNLVKVLTAC 692 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~---h~niv~~~~~~ 692 (949)
..+|.+.+++-......|.+.... +..+++|..+.......+. ..+++..+.+++ -.....++.+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei~--~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEID--GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEEC--CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 367888888888888888877764 7889999987544333222 233444444443 22333333332
Q ss_pred ecccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCe
Q 039533 693 LGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNV 772 (949)
Q Consensus 693 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NI 772 (949)
.-..++-....+++|||++|..|.+... ++. .++..+++++.-+|.. |+.|+|..|+|+
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNF 166 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED--------------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNF 166 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh--------------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcE
Confidence 2222222234568999999988876543 222 3556788889999977 999999999999
Q ss_pred eecCCCceEEeeccccee
Q 039533 773 LLDDYMTARVGDFGLARI 790 (949)
Q Consensus 773 ll~~~~~~kl~DfG~a~~ 790 (949)
+++++ .++++||+..+.
T Consensus 167 lv~~~-~i~iID~~~k~~ 183 (229)
T PF06176_consen 167 LVSNN-GIRIIDTQGKRM 183 (229)
T ss_pred EEECC-cEEEEECccccc
Confidence 99965 599999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.7e-08 Score=112.75 Aligned_cols=185 Identities=24% Similarity=0.248 Sum_probs=86.4
Q ss_pred CCCcCCCCCccEEeccccccCCCCCCcccCC-CccccccccCcccccccccc---cCCCCChhhhccccccccccCCCCC
Q 039533 178 PSSLGNLSSIHTISLAYNNLDGTIPNSFGWF-ENLVFLSLAANNLSVVENKL---TGEVPSLEKLQRLQHFTITSNSLGS 253 (949)
Q Consensus 178 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~~~l---~~~~~~l~~l~~L~~L~l~~N~l~~ 253 (949)
|-.+..+.+|++|.|.++.|+. .- .+..+ ..|++|-. .|.+..+..-+ .|.+.+-...-.|...+.++|++..
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~-~~-GL~~lr~qLe~LIC-~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~~ 178 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST-AK-GLQELRHQLEKLIC-HNSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLVL 178 (1096)
T ss_pred CceeccccceeeEEecCcchhh-hh-hhHHHHHhhhhhhh-hccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHHh
Confidence 4456677778888888777762 11 11111 23444432 23333222111 1222221222344555555555542
Q ss_pred CCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCC-CCCCCcccEEEeecceecc
Q 039533 254 GGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAG-IGNFVNLQRLDMWNNQLSG 332 (949)
Q Consensus 254 ~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~ 332 (949)
. -.++.-++.|+.|+|++|+++..- .+..++ .|++|||+.|.+. .+|.. ...+ .|+.|.|++|.++.
T Consensus 179 m-------D~SLqll~ale~LnLshNk~~~v~--~Lr~l~-~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~lrnN~l~t 246 (1096)
T KOG1859|consen 179 M-------DESLQLLPALESLNLSHNKFTKVD--NLRRLP-KLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNLRNNALTT 246 (1096)
T ss_pred H-------HHHHHHHHHhhhhccchhhhhhhH--HHHhcc-cccccccccchhc-cccccchhhh-hheeeeecccHHHh
Confidence 1 123344445555555555555432 333443 3555666666555 23321 1122 35666666666552
Q ss_pred cCCCcccccCCCCEEecCCcccccccC-cccccccccceeeccccccc
Q 039533 333 TIPPAIGELQNLKILGLNRNKLSGNIP-PSIGNLKMLLNLFLNDNFLE 379 (949)
Q Consensus 333 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~ 379 (949)
. ..+.+|.+|+.|||++|-|.+.-. ..++.|..|+.|+|.+|.+.
T Consensus 247 L--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 247 L--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred h--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 1 234455566666666666554211 12445555666666666553
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.6e-08 Score=90.22 Aligned_cols=87 Identities=18% Similarity=0.177 Sum_probs=54.4
Q ss_pred cccceeeeccccccccCCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCcCcccc-cCCccceEeC
Q 039533 439 KILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFL-AGLSLNNLNL 517 (949)
Q Consensus 439 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~~~L~~l~l 517 (949)
+.++.|+|++|+|+ .+|.++..++.|+.|+++.|.|. ..|..+..|.+|..||..+|.+. ++|..+ ..-..-..++
T Consensus 77 ~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~l 153 (177)
T KOG4579|consen 77 PTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKL 153 (177)
T ss_pred chhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHh
Confidence 35566666666666 66666777777777777777776 55666666777777777777776 444332 2212334455
Q ss_pred CCCcCcCcccc
Q 039533 518 SYNDLEGMVTT 528 (949)
Q Consensus 518 s~N~l~~~~~~ 528 (949)
.++++.+..+.
T Consensus 154 gnepl~~~~~~ 164 (177)
T KOG4579|consen 154 GNEPLGDETKK 164 (177)
T ss_pred cCCcccccCcc
Confidence 77777776554
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 949 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-32 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-31 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-26 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-26 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-21 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-21 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-20 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-20 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 8e-20 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 9e-09 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-19 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-19 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-13 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-12 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-11 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 9e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-09 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-09 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-09 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 8e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-07 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 9e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-06 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-06 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-06 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-06 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-06 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-06 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-06 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-06 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 8e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-05 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-05 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-05 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-05 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-05 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-05 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-05 | ||
| 4fmz_A | 347 | Crystal Structure Of An Internalin (Inlf) From List | 2e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-05 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-05 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-05 | ||
| 1xku_A | 330 | Crystal Structure Of The Dimeric Protein Core Of De | 3e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-05 | ||
| 1xcd_A | 329 | Dimeric Bovine Tissue-Extracted Decorin, Crystal Fo | 3e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-05 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-05 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-05 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-05 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 5e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-05 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-05 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-05 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-05 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 8e-05 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 9e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-05 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 1e-04 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-04 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-04 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-04 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 1e-04 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 1e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-04 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-04 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-04 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-04 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-04 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 2e-04 | ||
| 3rfj_A | 279 | Design Of A Binding Scaffold Based On Variable Lymp | 2e-04 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 2e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-04 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 3e-04 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-04 | ||
| 3cig_A | 697 | Crystal Structure Of Mouse Tlr3 Ectodomain Length = | 3e-04 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-04 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-04 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-04 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 4e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-04 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 4e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-04 | ||
| 3zyj_A | 440 | Netring1 In Complex With Ngl1 Length = 440 | 5e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-04 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-04 | ||
| 2wfh_A | 193 | The Human Slit 2 Dimerization Domain D4 Length = 19 | 6e-04 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-04 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-04 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-04 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4FMZ|A Chain A, Crystal Structure Of An Internalin (Inlf) From Listeria Monocytogenes Str. 4b F2365 At 1.91 A Resolution Length = 347 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1XKU|A Chain A, Crystal Structure Of The Dimeric Protein Core Of Decorin, The Archetypal Small Leucine-Rich Repeat Proteoglycan Length = 330 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1XCD|A Chain A, Dimeric Bovine Tissue-Extracted Decorin, Crystal Form 1 Length = 329 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3CIG|A Chain A, Crystal Structure Of Mouse Tlr3 Ectodomain Length = 697 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3ZYJ|A Chain A, Netring1 In Complex With Ngl1 Length = 440 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2WFH|A Chain A, The Human Slit 2 Dimerization Domain D4 Length = 193 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 949 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-125 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-122 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-108 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-73 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 5e-21 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-09 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 8e-97 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 5e-73 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 7e-85 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 6e-67 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 3e-43 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 7e-37 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-33 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-14 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 2e-78 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-77 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 7e-72 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-71 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 5e-66 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-49 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-44 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-12 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 5e-05 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 5e-71 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 3e-69 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 4e-53 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-47 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-40 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 4e-70 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-66 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-62 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-55 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 7e-40 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-28 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-12 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 5e-65 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-63 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 3e-54 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 4e-34 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 7e-06 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 1e-57 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 3e-56 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-53 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 3e-49 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-42 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-31 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-50 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-48 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-44 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-42 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 9e-24 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 3e-48 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 1e-47 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 7e-46 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-45 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-43 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-41 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-36 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-26 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-10 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-45 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 4e-45 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-43 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-42 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 3e-35 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-32 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-21 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 7e-45 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 9e-44 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 7e-41 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 5e-40 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 6e-24 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 2e-43 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-42 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-42 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-42 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 7e-38 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 4e-33 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-24 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 5e-24 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-41 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 3e-38 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 4e-34 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 4e-22 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 2e-41 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 3e-41 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 3e-41 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-40 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-38 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 7e-22 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 9e-41 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-40 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-35 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-32 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-29 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-19 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-40 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 3e-40 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 9e-40 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-39 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-32 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 5e-32 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 3e-31 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 9e-26 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-25 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 2e-37 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-36 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-35 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 3e-35 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 5e-35 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-21 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-34 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-33 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-31 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 5e-20 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-12 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 4e-34 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-30 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 2e-30 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 7e-30 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 2e-25 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 2e-13 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 4e-34 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 8e-29 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 1e-28 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 1e-27 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-31 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 3e-29 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-26 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 5e-19 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-16 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 5e-14 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 9e-09 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 3e-31 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 4e-30 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-27 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 3e-21 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 3e-15 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 9e-10 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 6e-31 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 4e-27 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 3e-23 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 3e-30 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 4e-30 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 4e-27 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-20 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 5e-20 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 4e-17 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 1e-29 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 5e-29 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 5e-29 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 5e-26 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 7e-22 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 6e-29 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-25 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-23 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 5e-10 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 8e-10 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 6e-29 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 6e-28 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 7e-26 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 9e-24 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 8e-29 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-21 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 8e-14 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 4e-13 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-28 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 5e-28 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 6e-28 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-27 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 1e-27 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-27 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 2e-27 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 4e-27 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 6e-27 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 1e-26 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 2e-26 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-26 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 3e-26 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 3e-26 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 4e-26 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 4e-26 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 5e-26 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 5e-26 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 6e-26 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 7e-26 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 2e-23 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 8e-22 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 7e-21 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 3e-13 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 8e-26 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 1e-25 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 1e-25 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 1e-25 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-25 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 2e-25 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 2e-25 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 3e-25 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 3e-25 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 3e-25 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 5e-25 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 5e-25 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 6e-25 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 6e-25 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 7e-25 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 1e-24 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 1e-24 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 1e-24 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-24 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 2e-24 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 2e-24 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 2e-24 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 3e-24 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 3e-24 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 3e-24 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 3e-24 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 3e-21 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 2e-20 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 4e-19 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 8e-07 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 3e-24 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 4e-24 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 4e-24 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 6e-24 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 7e-24 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 8e-24 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 1e-23 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-23 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 2e-23 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 2e-23 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 2e-23 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 2e-23 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 5e-22 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 5e-22 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-21 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-20 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 8e-20 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-11 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 1e-06 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 2e-23 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-23 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 3e-23 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 3e-23 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 4e-23 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-21 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 1e-19 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-19 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 1e-18 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 3e-14 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 6e-06 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 5e-23 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 5e-23 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 5e-23 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 7e-23 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 7e-23 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 1e-22 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 1e-22 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 1e-22 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 1e-22 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 2e-22 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 3e-22 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 3e-22 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 4e-22 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 9e-22 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 1e-21 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 3e-21 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 5e-17 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 1e-08 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 2e-21 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 2e-20 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 2e-19 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 2e-14 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 4e-07 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-21 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 3e-21 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 7e-21 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 7e-21 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 4e-20 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 4e-20 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 4e-20 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 8e-20 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 8e-20 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 1e-19 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 1e-19 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 2e-19 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 6e-16 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 5e-12 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-11 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 3e-19 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 3e-19 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 5e-19 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 5e-19 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 6e-19 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 1e-15 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 6e-19 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 2e-18 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 2e-08 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 1e-18 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 7e-18 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-12 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 6e-08 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 2e-18 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 3e-18 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 4e-18 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 8e-18 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 8e-18 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-11 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 5e-10 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 6e-09 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 8e-18 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-17 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-17 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-14 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-11 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-17 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 4e-14 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 8e-10 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 8e-06 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 9e-06 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 2e-17 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 3e-17 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 3e-15 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 7e-13 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 2e-12 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 5e-09 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 4e-05 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 4e-17 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 4e-17 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 4e-17 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 6e-17 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 6e-17 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 7e-17 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 1e-16 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 5e-16 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 6e-13 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 3e-08 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 3e-16 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 5e-16 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 5e-16 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 1e-15 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 1e-15 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 2e-12 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-15 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 4e-15 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 8e-07 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 6e-05 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 4e-04 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 2e-15 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-15 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-15 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 2e-15 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 3e-15 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 4e-15 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 5e-15 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 6e-15 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 7e-15 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 9e-15 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 1e-14 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 1e-11 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 8e-10 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-08 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-06 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 1e-14 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 1e-14 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 1e-14 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 1e-14 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 1e-14 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-14 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 2e-14 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-14 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 2e-14 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 2e-14 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-14 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 2e-14 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 2e-14 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 2e-14 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 4e-14 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 4e-14 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 4e-14 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 4e-14 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 4e-14 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 6e-14 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 6e-14 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 7e-14 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 7e-14 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 7e-14 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 7e-14 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 8e-14 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 9e-14 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-13 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 1e-13 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 2e-13 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 2e-13 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-13 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 7e-13 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 7e-11 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 4e-10 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-09 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 9e-09 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 3e-13 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 4e-13 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 4e-13 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 6e-13 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 7e-13 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 1e-12 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-12 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 2e-12 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 3e-12 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 3e-12 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 3e-12 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 4e-12 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 4e-12 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 5e-12 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 6e-11 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 5e-09 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 3e-07 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 7e-07 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-05 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 4e-05 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 5e-12 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 5e-12 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 9e-12 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 9e-12 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 1e-11 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 1e-11 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 1e-11 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-11 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 2e-11 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 2e-11 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 2e-11 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 3e-11 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 3e-11 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 2e-09 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 3e-09 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 2e-06 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 1e-04 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 4e-11 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 5e-11 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 1e-10 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 6e-08 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 3e-07 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 1e-06 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-06 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 5e-05 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 7e-11 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 7e-11 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 7e-11 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 7e-11 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 9e-11 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 1e-10 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 1e-10 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 2e-10 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 2e-10 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 3e-10 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 6e-06 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 3e-10 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 3e-10 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 4e-10 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 4e-10 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 4e-10 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 5e-10 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 2e-08 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 1e-07 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 5e-10 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 7e-10 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 7e-10 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-08 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 9e-10 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 1e-09 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 2e-09 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 2e-09 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 4e-09 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 5e-09 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 7e-08 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-05 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 6e-05 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 1e-08 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 4e-06 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 1e-05 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 2e-05 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 1e-08 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 2e-08 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-07 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-04 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 2e-04 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 4e-04 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 3e-08 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 3e-08 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 4e-07 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 3e-05 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 4e-08 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 4e-08 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 5e-08 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 6e-05 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 1e-07 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-07 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 2e-07 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 2e-07 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 2e-07 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-07 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 3e-07 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 3e-07 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 4e-07 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 4e-07 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 4e-07 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 2e-06 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 3e-05 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 5e-07 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 5e-07 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 7e-05 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 6e-07 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 1e-06 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 4e-04 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 1e-06 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 2e-06 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 2e-06 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 3e-06 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 4e-06 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-06 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-05 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-04 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 5e-06 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 4e-05 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 8e-04 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 7e-06 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-04 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-04 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 6e-04 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 3e-05 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 3e-05 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 398 bits (1024), Expect = e-125
Identities = 148/519 (28%), Positives = 238/519 (45%), Gaps = 37/519 (7%)
Query: 20 GNETDRVALLEFKSKSTYDPVGVLGTWNESIHFCKWYGVTCSRRHQRVTLLDLRSLKLA- 78
+ L+ FK D +L W+ + + C + GVTC +VT +DL S L
Sbjct: 9 SLYREIHQLISFKDVLP-DK-NLLPDWSSNKNPCTFDGVTCR--DDKVTSIDLSSKPLNV 64
Query: 79 --GSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPT--NIS 134
+VS + +L+ L+ L+L + + L L L+ NS+ G + T ++
Sbjct: 65 GFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLG 123
Query: 135 RCSTLIPIHPQNNQLVGKI-LSRFSSLSKTEILNLGSNHLTGSIPSSL---GNLSSIHTI 190
CS L ++ +N L +S L+ E+L+L +N ++G+ + +
Sbjct: 124 SCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHL 183
Query: 191 SLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNS 250
+++ N + G + NL FL +++NN S +P L LQH I+ N
Sbjct: 184 AISGNKISGDVD--VSRCVNLEFLDVSSNNFS-------TGIPFLGDCSALQHLDISGNK 234
Query: 251 LGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSI 310
L SG F +++ T L ++I+SN F G +P L ++ L L NK G I
Sbjct: 235 L-SG-----DFSRAISTCTELKLLNISSNQFVGPIPP--LPLKS-LQYLSLAENKFTGEI 285
Query: 311 PAGI-GNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPP-SIGNLKML 368
P + G L LD+ N G +PP G L+ L L+ N SG +P ++ ++ L
Sbjct: 286 PDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGL 345
Query: 369 LNLFLNDNFLEVSIPSSLGQC-ESLIEINLSNNNLSGTIPPQFFSLSSLSIS-LDWSRNK 426
L L+ N +P SL SL+ ++LS+NN SG I P ++ L N
Sbjct: 346 KVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNG 405
Query: 427 LTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSL 486
TG +P + L L++ N L G IPS+ G+ +L L + N+ +G I L +
Sbjct: 406 FTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYV 465
Query: 487 RGLRVLDLSQNNLSGEIPKFLAGL-SLNNLNLSYNDLEG 524
+ L L L N+L+GEIP L+ +LN ++LS N L G
Sbjct: 466 KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTG 504
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 387 bits (997), Expect = e-122
Identities = 141/500 (28%), Positives = 218/500 (43%), Gaps = 32/500 (6%)
Query: 68 TLLDLRSLKLAGSVSHFI-GNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSIC 126
L L K G + F+ G L L L N F +P G L+ LAL++N+
Sbjct: 272 QYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFS 331
Query: 127 GEIPTN-ISRCSTLIPIHPQNNQLVGKILSRFSSLSKT-EILNLGSNHLTGSIPSSLGN- 183
GE+P + + + L + N+ G++ ++LS + L+L SN+ +G I +L
Sbjct: 332 GELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQN 391
Query: 184 -LSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVP-SLEKLQRL 241
+++ + L N G IP + LV L L+ N LS G +P SL L +L
Sbjct: 392 PKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLS-------GTIPSSLGSLSKL 444
Query: 242 QHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFL 301
+ + N L G L L + ++ N+ G +P +SN + + + L
Sbjct: 445 RDLKLWLNML-EG-----EIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTN-LNWISL 497
Query: 302 NNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPS 361
+NN++ G IP IG NL L + NN SG IP +G+ ++L L LN N +G IP +
Sbjct: 498 SNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAA 557
Query: 362 IGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNN--NLSGTIPPQFFSLSSLSIS 419
+ + NF+ + E + + N G Q LS+ +
Sbjct: 558 MFKQSGKIA----ANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNP- 612
Query: 420 LDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPI 479
+ + G + FL + N L G IP G+ L L +G N G I
Sbjct: 613 CNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSI 672
Query: 480 SSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL-SLNNLNLSYNDLEGMVTTEGVFKNASAT 538
+G LRGL +LDLS N L G IP+ ++ L L ++LS N+L G + G F+
Sbjct: 673 PDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPA 732
Query: 539 RILGNSKLCGGISEFKLPTC 558
+ L N LCG + LP C
Sbjct: 733 KFLNNPGLCG----YPLPRC 748
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 351 bits (902), Expect = e-108
Identities = 141/473 (29%), Positives = 217/473 (45%), Gaps = 33/473 (6%)
Query: 66 RVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSI 125
+ L + K++G V + L+ L + N+F+ IP +G L+ L ++ N +
Sbjct: 179 ELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKL 235
Query: 126 CGEIPTNISRCSTLIPIHPQNNQLVGKI-LSRFSSLSKTEILNLGSNHLTGSIPSSL-GN 183
G+ IS C+ L ++ +NQ VG I SL + L+L N TG IP L G
Sbjct: 236 SGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSL---QYLSLAENKFTGEIPDFLSGA 292
Query: 184 LSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVP--SLEKLQRL 241
++ + L+ N+ G +P FG L L+L++NN S GE+P +L K++ L
Sbjct: 293 CDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFS-------GELPMDTLLKMRGL 345
Query: 242 QHFTITSNSLGSGGNDDLSFLCSLTNAT-RLTWMHINSNNFGGLLPGCISNLSKT-IKTL 299
+ ++ N SG SLTN + L + ++SNNF G + + K ++ L
Sbjct: 346 KVLDLSFNEF-SG-----ELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQEL 399
Query: 300 FLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIP 359
+L NN G IP + N L L + N LSGTIP ++G L L+ L L N L G IP
Sbjct: 400 YLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIP 459
Query: 360 PSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSIS 419
+ +K L L L+ N L IPS L C +L I+LSNN L+G IP L +L+I
Sbjct: 460 QELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAI- 518
Query: 420 LDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPI 479
L S N +G++P E+G + L +L + N G IP+ + N G
Sbjct: 519 LKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKR 574
Query: 480 SSSLGSLRGLRVLDLSQN--NLSGEIPKFLAGLS-LNNLNLSYNDLEGMVTTE 529
+ + + + N G + L LS N N++ G +
Sbjct: 575 YVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPT 627
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 255 bits (655), Expect = 3e-73
Identities = 103/371 (27%), Positives = 170/371 (45%), Gaps = 51/371 (13%)
Query: 166 LNLGSNHLT---GSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLS 222
++L S L ++ SSL +L+ + ++ L+ ++++G++ F +L L L+ N+LS
Sbjct: 55 IDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLS 113
Query: 223 VVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFG 282
G V +L SL + + L +++++SN
Sbjct: 114 -------GPVTTLT---------------------------SLGSCSGLKFLNVSSNTLD 139
Query: 283 GLLPGCISNLSKTIKTLFLNNNKIYGSIPAGI---GNFVNLQRLDMWNNQLSGTIPPAIG 339
+++ L L+ N I G+ G L+ L + N++SG + +
Sbjct: 140 FPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VS 197
Query: 340 ELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSN 399
NL+ L ++ N S I P +G+ L +L ++ N L ++ C L +N+S+
Sbjct: 198 RCVNLEFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISS 256
Query: 400 NNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEV-GKLKILEFLYVYENRLEGEIPST 458
N G IPP L SL L + NK TG +P + G L L + N G +P
Sbjct: 257 NQFVGPIPP--LPLKSLQY-LSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPF 313
Query: 459 FGNCIRLEQLGMGGNLFQGPI-SSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLS--LNNL 515
FG+C LE L + N F G + +L +RGL+VLDLS N SGE+P+ L LS L L
Sbjct: 314 FGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTL 373
Query: 516 NLSYNDLEGMV 526
+LS N+ G +
Sbjct: 374 DLSSNNFSGPI 384
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 5e-21
Identities = 42/153 (27%), Positives = 56/153 (36%), Gaps = 25/153 (16%)
Query: 67 VTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSIC 126
++ S G S N + L + N + IP EIG + L +L L +N I
Sbjct: 610 RNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDIS 669
Query: 127 GEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSS 186
G IP L IL+L SN L G IP ++ L+
Sbjct: 670 GSIPDE------------------------VGDLRGLNILDLSSNKLDGRIPQAMSALTM 705
Query: 187 IHTISLAYNNLDGTIPNSFGWFENLVFLSLAAN 219
+ I L+ NNL G IP G FE N
Sbjct: 706 LTEIDLSNNNLSGPIPEM-GQFETFPPAKFLNN 737
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 3e-09
Identities = 27/79 (34%), Positives = 40/79 (50%)
Query: 463 IRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLSLNNLNLSYNDL 522
++ N+ +SSSL SL GL L LS ++++G + F SL +L+LS N L
Sbjct: 53 TSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSL 112
Query: 523 EGMVTTEGVFKNASATRIL 541
G VTT + S + L
Sbjct: 113 SGPVTTLTSLGSCSGLKFL 131
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 306 bits (786), Expect = 8e-97
Identities = 90/308 (29%), Positives = 141/308 (45%), Gaps = 15/308 (4%)
Query: 259 LSFLCSLTNATRL-TW---MHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGS--IPA 312
L L N T L +W + + G+L + + + L L+ + IP+
Sbjct: 12 LQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYR-VNNLDLSGLNLPKPYPIPS 70
Query: 313 GIGNFVNLQRLDMWN-NQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNL 371
+ N L L + N L G IPPAI +L L L + +SG IP + +K L+ L
Sbjct: 71 SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130
Query: 372 FLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSL 431
+ N L ++P S+ +L+ I N +SG IP + S S L S+ SRN+LTG +
Sbjct: 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKI 190
Query: 432 PIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRV 491
P L L F+ + N LEG+ FG+ +++ + N + +G + L
Sbjct: 191 PPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNG 248
Query: 492 LDLSQNNLSGEIPKFLAGL-SLNNLNLSYNDLEGMVTTEGVFKNASATRILGNSKLCGGI 550
LDL N + G +P+ L L L++LN+S+N+L G + G + + N LCG
Sbjct: 249 LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308
Query: 551 SEFKLPTC 558
LP C
Sbjct: 309 ----LPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 5e-73
Identities = 94/350 (26%), Positives = 143/350 (40%), Gaps = 51/350 (14%)
Query: 21 NETDRVALLEFKSKSTYDPVGVLGTWNESIHFC--KWYGVTCSRRHQ--RVTLLDLRSLK 76
N D+ ALL+ K L +W + C W GV C Q RV LDL L
Sbjct: 4 NPQDKQALLQIKKDLGNPTT--LSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLN 61
Query: 77 LAGS--VSHFIGNLSFLKQLYLQ-VNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNI 133
L + + NL +L LY+ +N+ IP I L +L L + + ++ G IP +
Sbjct: 62 LPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFL 121
Query: 134 SRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHT-ISL 192
S+ TL+ + N L G + SSL + N ++G+IP S G+ S + T +++
Sbjct: 122 SQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTI 181
Query: 193 AYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLG 252
+ N L G IP +F NL F+ L+ N L G+
Sbjct: 182 SRNRLTGKIPPTFANL-NLAFVDLS-------RNMLEGDASV------------------ 215
Query: 253 SGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPA 312
+ +H+ N+ L + K + L L NN+IYG++P
Sbjct: 216 -----------LFGSDKNTQKIHLAKNSLAFDLGK-VGLS-KNLNGLDLRNNRIYGTLPQ 262
Query: 313 GIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNK-LSGNIPPS 361
G+ L L++ N L G I P G LQ + NK L G+ P+
Sbjct: 263 GLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKCLCGSPLPA 311
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 285 bits (730), Expect = 7e-85
Identities = 95/531 (17%), Positives = 172/531 (32%), Gaps = 56/531 (10%)
Query: 43 LGTWNESIHFCKWY---GVTCSRRHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVN 99
WN + W GV+ + RVT L L +G V IG L+ L+ L L +
Sbjct: 57 GANWNFNKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSH 115
Query: 100 SFTH----EIPSEIGGLRRLKVLALNNNSICGEIPTNISR--CSTLIPIHPQNNQLVGKI 153
P I + R S LI ++ I
Sbjct: 116 GEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSI 175
Query: 154 LSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVF 213
K + SN++T + ++ L+ + + + EN +
Sbjct: 176 KKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY 234
Query: 214 LSLAAN------------NLSVVENKLTGEVP-SLEKLQRLQHFTITSNSLGSGG--NDD 258
++ V ++P L+ L +Q + N SG DD
Sbjct: 235 AQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDD 294
Query: 259 LSFLCSLTNATRLTWMHINSNNFGGL-LPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNF 317
L ++ ++I NN + + + K + L N++ G +PA G+
Sbjct: 295 WQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKK-LGMLECLYNQLEGKLPA-FGSE 352
Query: 318 VNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPP--SIGNLKMLLNLFLND 375
+ L L++ NQ++ G + ++ L NKL IP ++ ++ + +
Sbjct: 353 IKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSY 411
Query: 376 NFLE-------VSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLT 428
N + + + + ++ INLSNN +S F + S LS ++ N LT
Sbjct: 412 NEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSS-INLMGNMLT 470
Query: 429 G-------SLPIEVGKLKILEFLYVYENRLEGEIPS-TFGNCIRLEQLGMGGNLFQGPIS 480
+L + + N+L L + + N F
Sbjct: 471 EIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FP 529
Query: 481 SSLGSLRGLRVL------DLSQNNLSGEIPKFLAGL-SLNNLNLSYNDLEG 524
+ + L+ D N E P+ + SL L + ND+
Sbjct: 530 TQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK 580
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 6e-67
Identities = 77/478 (16%), Positives = 148/478 (30%), Gaps = 71/478 (14%)
Query: 70 LDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEI 129
+ S + VS + L+ L+Q Y+ + F E E +
Sbjct: 188 IGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT-----E 241
Query: 130 PTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLT--------GSIPSSL 181
L + N + K+ + +L + +++N+ N +
Sbjct: 242 DLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADA 301
Query: 182 GNLSSIHTISLAYNNL-DGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQR 240
I I + YNNL + S + L L N+L G++P+ +
Sbjct: 302 PVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECL-------YNQLEGKLPAFGSEIK 354
Query: 241 LQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPG-CISNLSKTIKTL 299
L + N + + F ++ + N + ++S + +
Sbjct: 355 LASLNLAYNQITEIPANFCGFT------EQVENLSFAHNKLKYIPNIFDAKSVSV-MSAI 407
Query: 300 FLNNNKIYG-------SIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRN 352
+ N+I + +N+ +++ NNQ+S L + L N
Sbjct: 408 DFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGN 467
Query: 353 KLSG-------NIPPSIGNLKMLLNLFLNDNFLEVSIPSSL--GQCESLIEINLSNNNLS 403
L+ + + N +L ++ L N L + L+ I+LS N+ S
Sbjct: 468 MLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFS 526
Query: 404 GTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCI 463
P Q + S+L I NR E P C
Sbjct: 527 K-FPTQPLNSSTLK-------------------GFGIRNQRDAQGNRTLREWPEGITLCP 566
Query: 464 RLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLA-GLSLNNLNLSYN 520
L QL +G N + ++ + + VLD+ N ++ + L Y+
Sbjct: 567 SLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYD 621
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 3e-43
Identities = 53/347 (15%), Positives = 111/347 (31%), Gaps = 19/347 (5%)
Query: 69 LLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTH-EIPSEIGGLRRLKVLALNNNSICG 127
+ LK ++ +Y+ N+ + + + +++L +L N + G
Sbjct: 285 GISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG 344
Query: 128 EIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSL--GNLS 185
++P L ++ NQ+ + + E L+ N L IP+ ++S
Sbjct: 345 KLPA-FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVS 402
Query: 186 SIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPS-LEKLQRLQHF 244
+ I +YN + +F + F + +++++ N+++ L
Sbjct: 403 VMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSI 462
Query: 245 TITSNSLGS-GGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPG-CISNLSKTIKTLFLN 302
+ N L N + N LT + + N L + L + + L+
Sbjct: 463 NLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPY-LVGIDLS 521
Query: 303 NNKIYGSIPAGIGNFVNLQRLDMWN------NQLSGTIPPAIGELQNLKILGLNRNKLSG 356
N P N L+ + N N+ P I +L L + N +
Sbjct: 522 YNSF-SKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK 580
Query: 357 NIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLS 403
+ I + L + DN S + L +
Sbjct: 581 -VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 7e-37
Identities = 33/237 (13%), Positives = 75/237 (31%), Gaps = 14/237 (5%)
Query: 314 IGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGN----IPPSIGNLKMLL 369
+ + + L + SG +P AIG+L L++L L + N P I
Sbjct: 77 LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136
Query: 370 NLFLNDNFLEVSIPSSLGQCE--SLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKL 427
+ + + + LI+ ++++ +I + + N +
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT-QIGQLSNNI 195
Query: 428 TGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLR 487
T + V +L L Y+ + E E +L+
Sbjct: 196 T-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT-----EDLKWDNLK 249
Query: 488 GLRVLDLSQNNLSGEIPKFLAGL-SLNNLNLSYNDLEGMVTTEGVFKNASATRILGN 543
L +++ ++P FL L + +N++ N + ++ + +
Sbjct: 250 DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK 306
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-33
Identities = 55/326 (16%), Positives = 100/326 (30%), Gaps = 47/326 (14%)
Query: 68 TLLDLRSLKLA-GSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSIC 126
++ + L V + + L L N G +L L L N I
Sbjct: 308 QIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLE-GKLPAFGSEIKLASLNLAYNQI- 365
Query: 127 GEIPTNI-SRCSTLIPIHPQNNQLVGKILSRFS--SLSKTEILNLGSNHLTG-------S 176
EIP N + + +N+L I + F S+S ++ N +
Sbjct: 366 TEIPANFCGFTEQVENLSFAHNKL-KYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDP 424
Query: 177 IPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLS-VVENKLTGEVPSL 235
+ + ++ +I+L+ N + F L ++L N L+ + +N L E +
Sbjct: 425 LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENF 484
Query: 236 EKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSK- 294
+ L + N L + +DD +L L + ++ N+F P N S
Sbjct: 485 KNTYLLTSIDLRFNKL-TKLSDDFRA-TTLPY---LVGIDLSYNSFSKF-PTQPLNSSTL 538
Query: 295 ----TIKTLFLNNNKIYGSIPAGIGN---------------------FVNLQRLDMWNNQ 329
N+ P GI N+ LD+ +N
Sbjct: 539 KGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPNISVLDIKDNP 598
Query: 330 LSGTIPPAIGELQNLKILGLNRNKLS 355
+ + L +K
Sbjct: 599 NISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-14
Identities = 24/150 (16%), Positives = 48/150 (32%), Gaps = 13/150 (8%)
Query: 85 IGNLSFLKQLYLQVNSFTHEIPSEI--GGLRRLKVLALNNNSICGEIPTNISRCSTLIPI 142
N L + L+ N T ++ + L L + L+ NS + PT STL
Sbjct: 484 FKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSF-SKFPTQPLNSSTLKGF 541
Query: 143 HPQN------NQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNN 196
+N N+ + + + L +GSN + + + +I + + N
Sbjct: 542 GIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNP 598
Query: 197 LDGTIPNSFGWFENLVFLSLAANNLSVVEN 226
+ + L + +
Sbjct: 599 NISIDLSYVCPYIEAGMYMLFYDKTQDIRG 628
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 2e-78
Identities = 100/336 (29%), Positives = 167/336 (49%), Gaps = 36/336 (10%)
Query: 600 IKEKENPSSSIYSLLYLSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVF 659
+ +E+P + L S ++L A+ FS+ N++G G FG VYKG + +G T +AVK
Sbjct: 4 VPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADG-TLVAVKRL 62
Query: 660 NLQ-HHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEW 718
+ G F E + + HRNL+++ C+ R VY +M GS+
Sbjct: 63 KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER-----LLVYPYMANGSVASC 117
Query: 719 LHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM 778
L E E+ L+ +R IA+ A L YLH C P H D+K +N+LLD+
Sbjct: 118 LR------ERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 171
Query: 779 TARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI 838
A VGDFGLA+++ T ++ +V+G++G+IAPEY + S DV+ YG++LLEL+
Sbjct: 172 EAVVGDFGLAKLMDYKDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 230
Query: 839 GKKPIDIMF---EGDINLHNFGRKALPD-DVMDIVDSSLLPDDEDLILTGNQRQKQARIN 894
G++ D+ + D+ L ++ + L + + +VD L + N
Sbjct: 231 GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDL------------------QGN 272
Query: 895 SIIECLISMVRIGVACSMELPQDRTNMTNVVHELQS 930
E + ++++ + C+ P +R M+ VV L+
Sbjct: 273 YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 266 bits (682), Expect = 1e-77
Identities = 90/477 (18%), Positives = 173/477 (36%), Gaps = 28/477 (5%)
Query: 67 VTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSIC 126
+T+L+L +L + S L L + N+ + P L LKVL L +N +
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 127 GEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSS 186
+ C+ L +H +N + + F L+L N L+ + + L +
Sbjct: 87 QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLEN 146
Query: 187 IHTISLAYNNLDGTIPNSFGWFEN--LVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHF 244
+ + L+ N + F N L L L++N + + RL
Sbjct: 147 LQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSP------GCFHAIGRLFGL 200
Query: 245 TITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKT-IKTLFLNN 303
+ + LG + L + T+ + + ++++ L T + L L+
Sbjct: 201 FLNNVQLGPSLTEKLCLELANTS---IRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSY 257
Query: 304 NKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRN---------KL 354
N + L+ + N + ++ L N++ L L R+ L
Sbjct: 258 NNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASL 317
Query: 355 SGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPP--QFFS 412
S LK L +L + DN + + +L ++LSN+ S F S
Sbjct: 318 PKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVS 377
Query: 413 LSSLSI-SLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIP-STFGNCIRLEQLGM 470
L+ + L+ ++NK++ L LE L + N + E+ + + ++ +
Sbjct: 378 LAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYL 437
Query: 471 GGNLFQGPISSSLGSLRGLRVLDLSQNNLSG--EIPKFLAGL-SLNNLNLSYNDLEG 524
N + +S + L+ L L + L P L +L L+LS N++
Sbjct: 438 SYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIAN 494
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 250 bits (640), Expect = 7e-72
Identities = 108/480 (22%), Positives = 183/480 (38%), Gaps = 30/480 (6%)
Query: 70 LDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIG--GLRRLKVLALNNNSICG 127
LDL L+ + L L++L L N E+ LK L L++N I
Sbjct: 126 LDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKE 185
Query: 128 EIPTNISRCSTLIPIHPQNNQLVGKI---LSRFSSLSKTEILNLGSNHLTGSIPSSLGNL 184
P L + N QL + L + + L+L ++ L+ + ++ L
Sbjct: 186 FSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGL 245
Query: 185 --SSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQ 242
+++ + L+YNNL+ +SF W L + L NN+ + + + ++ L +
Sbjct: 246 KWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKR 305
Query: 243 HFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLN 302
FT S SL S D L L +++ N+ G+ + L +K L L+
Sbjct: 306 SFTKQSISLASLPKIDDFSFQWLKC---LEHLNMEDNDIPGIKSNMFTGLIN-LKYLSLS 361
Query: 303 NNKIYGSIPAGIGNFVN-----LQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGN 357
N+ FV+ L L++ N++S A L +L++L L N++
Sbjct: 362 NSFT-SLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQE 420
Query: 358 IPPS-IGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSG--TIPPQFFSLS 414
+ L+ + ++L+ N +S SL + L L + P F L
Sbjct: 421 LTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLR 480
Query: 415 SLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLE--------GEIPSTFGNCIRLE 466
+L+I LD S N + + L+ LE L + N L G L
Sbjct: 481 NLTI-LDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLH 539
Query: 467 QLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL-SLNNLNLSYNDLEGM 525
L + N F L L+++DL NNL+ SL +LNL N + +
Sbjct: 540 ILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSV 599
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 248 bits (636), Expect = 3e-71
Identities = 101/486 (20%), Positives = 182/486 (37%), Gaps = 33/486 (6%)
Query: 65 QRVTLLDLRSLKLAGSVSHFIG--NLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNN 122
+ + L L + K+ S + S LK+L L N P + RL L LNN
Sbjct: 145 ENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNN 204
Query: 123 NSICGEIPTNIS---RCSTLIPIHPQNNQLVGKILSRFSSLSKT--EILNLGSNHLTGSI 177
+ + + +++ + N+QL + F L T +L+L N+L
Sbjct: 205 VQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVG 264
Query: 178 PSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAAN--NLSVVENKLTGEVP-S 234
S L + L YNN+ +S N+ +L+L + S+ L S
Sbjct: 265 NDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFS 324
Query: 235 LEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSN--NFGGLLPGCISNL 292
+ L+ L+H + N + ++ T L ++ ++++ + L +L
Sbjct: 325 FQWLKCLEHLNMEDNDIPGIKSN------MFTGLINLKYLSLSNSFTSLRTLTNETFVSL 378
Query: 293 SKT-IKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPP-AIGELQNLKILGLN 350
+ + + L L NKI +L+ LD+ N++ + L+N+ + L+
Sbjct: 379 AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLS 438
Query: 351 RNKLSGNIPPSIGNLKMLLNLFLNDNFLE--VSIPSSLGQCESLIEINLSNNNLSGTIPP 408
NK S + L L L L+ S PS +L ++LSNNN++
Sbjct: 439 YNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDD 498
Query: 409 QFFSLSSLSISLDWSRNKLT--------GSLPIEVGKLKILEFLYVYENRLEGEIPSTFG 460
L L I LD N L G + L L L + N + F
Sbjct: 499 MLEGLEKLEI-LDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFK 557
Query: 461 NCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL--SLNNLNLS 518
+ L+ + +G N +S + L+ L+L +N ++ K +L L++
Sbjct: 558 DLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMR 617
Query: 519 YNDLEG 524
+N +
Sbjct: 618 FNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 5e-66
Identities = 94/454 (20%), Positives = 178/454 (39%), Gaps = 41/454 (9%)
Query: 91 LKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLV 150
+ T ++P ++ + VL L +N + N +R S L + N +
Sbjct: 6 HEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62
Query: 151 GKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFEN 210
L ++LNL N L+ + +++ + L N++ N F +N
Sbjct: 63 KLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKN 122
Query: 211 LVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATR 270
L+ L L+ N LS + + +L+ LQ +++N + + +++L + +
Sbjct: 123 LITLDLSHNGLSSTKL------GTQVQLENLQELLLSNNKIQALKSEELDIFAN----SS 172
Query: 271 LTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVN---LQRLDMWN 327
L + ++SN PGC + + + LFLNN ++ S+ + + ++ L + N
Sbjct: 173 LKKLELSSNQIKEFSPGCFHAIGR-LFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSN 231
Query: 328 NQLSGTIPPAIGELQ--NLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSS 385
+QLS T L+ NL +L L+ N L+ S L L FL N ++ S
Sbjct: 232 SQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHS 291
Query: 386 LGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLY 445
L ++ +NL + S L LK LE L
Sbjct: 292 LHGLFNVRYLNLKRSFT----------------KQSISLASLPKIDDFSFQWLKCLEHLN 335
Query: 446 VYENRLEGEIPSTFGNCIRLEQLGMGGNLFQ--GPISSSLGSL--RGLRVLDLSQNNLSG 501
+ +N + G + F I L+ L + + + + SL L +L+L++N +S
Sbjct: 336 MEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISK 395
Query: 502 EIPKFLAGL-SLNNLNLSYNDLEGMVTTEGVFKN 534
+ L L L+L N++ + T ++
Sbjct: 396 IESDAFSWLGHLEVLDLGLNEIGQEL-TGQEWRG 428
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 3e-49
Identities = 72/391 (18%), Positives = 133/391 (34%), Gaps = 41/391 (10%)
Query: 68 TLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNN---- 123
T+LDL L + L L+ +L+ N+ H + GL ++ L L +
Sbjct: 251 TMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQ 310
Query: 124 -----SICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIP 178
S+ + L ++ ++N + G + F+ L + L+L ++ +
Sbjct: 311 SISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTL 370
Query: 179 SSLG----NLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVP- 233
++ S +H ++L N + ++F W +L L L N++ E+
Sbjct: 371 TNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLG-------LNEIGQELTG 423
Query: 234 -SLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGL--LPGCIS 290
L+ + ++ N S L + + + P
Sbjct: 424 QEWRGLENIFEIYLSYNKY------LQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQ 477
Query: 291 NLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLS--------GTIPPAIGELQ 342
L + L L+NN I + L+ LD+ +N L+ G + L
Sbjct: 478 PLRN-LTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLS 536
Query: 343 NLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNL 402
+L IL L N +L L + L N L S SL +NL N +
Sbjct: 537 HLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLI 596
Query: 403 SGTIPPQFF-SLSSLSISLDWSRNKLTGSLP 432
+ F + +L+ LD N +
Sbjct: 597 TSVEKKVFGPAFRNLTE-LDMRFNPFDCTCE 626
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 2e-44
Identities = 63/260 (24%), Positives = 102/260 (39%), Gaps = 11/260 (4%)
Query: 290 SNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGL 349
+L I L L +N++ A + L LD+ N +S P +L LK+L L
Sbjct: 21 DDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNL 80
Query: 350 NRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQ 409
N+LS + L L L N ++ + + ++LI ++LS+N LS T
Sbjct: 81 QHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGT 140
Query: 410 FFSLSSLSISLDWSRNKLTGSLP--IEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQ 467
L +L L S NK+ +++ L+ L + N+++ P F RL
Sbjct: 141 QVQLENLQ-ELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFG 199
Query: 468 LGMGGNLFQGPISSSLG---SLRGLRVLDLSQNNLSGEIPKFLAGL---SLNNLNLSYND 521
L + ++ L + +R L LS + LS GL +L L+LSYN+
Sbjct: 200 LFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNN 259
Query: 522 LEGMVTTEGVFKNASATRIL 541
L F
Sbjct: 260 LNV--VGNDSFAWLPQLEYF 277
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-12
Identities = 33/181 (18%), Positives = 60/181 (33%), Gaps = 28/181 (15%)
Query: 69 LLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGE 128
L L G +F+ LS L L L+ N F L LK++ L N++
Sbjct: 516 LARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTL 575
Query: 129 IPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLG-NLSSI 187
S F++ + LNL N +T G ++
Sbjct: 576 PA------------------------SVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNL 611
Query: 188 HTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTIT 247
+ + +N D T + WF + +++ N+ + + P ++ F +
Sbjct: 612 TELDMRFNPFDCTCES-IAWF--VNWINETHTNIPELSSHYLCNTPPHYHGFPVRLFDTS 668
Query: 248 S 248
S
Sbjct: 669 S 669
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 5e-05
Identities = 22/137 (16%), Positives = 36/137 (26%), Gaps = 23/137 (16%)
Query: 65 QRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNS 124
+ +L+L S +L LK + L +N+ S LK L L N
Sbjct: 536 SHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNL 595
Query: 125 ICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNL 184
I F +L L++ N + S +
Sbjct: 596 ITSVEKKVFG--------------------PAFRNL---TELDMRFNPFDCTCESIAWFV 632
Query: 185 SSIHTISLAYNNLDGTI 201
+ I+ L
Sbjct: 633 NWINETHTNIPELSSHY 649
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 246 bits (629), Expect = 5e-71
Identities = 96/508 (18%), Positives = 163/508 (32%), Gaps = 55/508 (10%)
Query: 67 VTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSIC 126
LDL L S+ + L+ L L L L L L N I
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 127 GEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTG-SIPSSLGNLS 185
S S+L + L L + LN+ N + +P NL+
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 186 SIHTISLAYNNLDGTIPNSFGWFENL----VFLSLAANNLSVVE---------------- 225
++ + L+ N + + + L L+ N ++ ++
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRN 209
Query: 226 NKLTGEVP--SLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNN--- 280
N + V ++ L L+ + + GN + +L LT
Sbjct: 210 NFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDY 269
Query: 281 FGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLS--------- 331
+ + + L+ + + L + I Q L++ N +
Sbjct: 270 YLDDIIDLFNCLTN-VSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKS 326
Query: 332 ----------GTIPPAIGELQNLKILGLNRNKLS--GNIPPSIGNLKMLLNLFLNDNFLE 379
G + +L +L+ L L+RN LS G S L L L+ N +
Sbjct: 327 LKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 386
Query: 380 VSIPSSLGQCESLIEINLSNNNLSGTIPPQFF-SLSSLSISLDWSRNKLTGSLPIEVGKL 438
++ S+ E L ++ ++NL F SL +L I LD S + L
Sbjct: 387 -TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL-IYLDISHTHTRVAFNGIFNGL 444
Query: 439 KILEFLYVYENRLEGEI-PSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQN 497
LE L + N + P F L L + + ++ SL L+VL++S N
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN 504
Query: 498 NLSGEIPKFLAGL-SLNNLNLSYNDLEG 524
N L SL L+ S N +
Sbjct: 505 NFFSLDTFPYKCLNSLQVLDYSLNHIMT 532
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 241 bits (616), Expect = 3e-69
Identities = 95/472 (20%), Positives = 177/472 (37%), Gaps = 32/472 (6%)
Query: 68 TLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTH-EIPSEIGGLRRLKVLALNNNSIC 126
L LA + IG+L LK+L + N ++P L L+ L L++N I
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 127 GEIPTNISRCSTLIPIHP----QNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPS-SL 181
T++ + ++ N + F + L L +N + ++ +
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCI 221
Query: 182 GNLSSIHTISLAYNNLDGTI---PNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKL 238
L+ + L E L L++ L+ ++ L + L
Sbjct: 222 QGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCL 281
Query: 239 QRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKT 298
+ F++ S ++ + + + + + FG + +L K
Sbjct: 282 TNVSSFSLVSVTI--------ERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSL----KR 329
Query: 299 LFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLS--GTIPPAIGELQNLKILGLNRNKLSG 356
L +NK + + +L+ LD+ N LS G + +LK L L+ N +
Sbjct: 330 LTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT 387
Query: 357 NIPPSIGNLKMLLNLFLNDNFLEVSIPSS-LGQCESLIEINLSNNNLSGTIPPQFFSLSS 415
+ + L+ L +L + L+ S +LI +++S+ + F LSS
Sbjct: 388 -MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 446
Query: 416 LSISLDWSRNKLTGSLPIEV-GKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNL 474
L + L + N + ++ +L+ L FL + + +LE P+ F + L+ L M N
Sbjct: 447 LEV-LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN 505
Query: 475 FQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL--SLNNLNLSYNDLEG 524
F + L L+VLD S N++ + L SL LNL+ ND
Sbjct: 506 FFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 4e-53
Identities = 84/429 (19%), Positives = 152/429 (35%), Gaps = 38/429 (8%)
Query: 128 EIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSI 187
+IP N+ + + N L F S + ++L+L + + +LS +
Sbjct: 21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 188 HTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTIT 247
T+ L N + +F +L L NL+ +EN + L+ L+ +
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLEN------FPIGHLKTLKELNVA 132
Query: 248 SNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSK---TIKTLFLNNN 304
N + S + +N T L + ++SN + + L + +L L+ N
Sbjct: 133 HNLIQSFKLPE-----YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187
Query: 305 KIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPP-AIGELQNLKILGL------NRNKLSGN 357
+ I G + L +L + NN S + I L L++ L N L
Sbjct: 188 PM-NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246
Query: 358 IPPSIGNLKMLLNLFLNDNFLEVS---IPSSLGQCESLIEINLSNNNLSGTIPPQFFSLS 414
++ L L +L+ I ++ +L + + FS +
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD---FSYN 303
Query: 415 SLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGN- 473
L+ K +++ LK L F +G + + LE L + N
Sbjct: 304 FGWQHLELVNCKFGQFPTLKLKSLKRLTF-----TSNKGGNAFSEVDLPSLEFLDLSRNG 358
Query: 474 -LFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLSLNNLNLSYNDLEGMVTTEGVF 532
F+G S S L+ LDLS N + FL L +L+ +++L+ M VF
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMS-EFSVF 417
Query: 533 KNASATRIL 541
+ L
Sbjct: 418 LSLRNLIYL 426
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 2e-47
Identities = 70/413 (16%), Positives = 139/413 (33%), Gaps = 33/413 (7%)
Query: 63 RHQRVTLLDLRSLKLAGSV-SHFIGNLSFLKQLYLQVNSFTHE------IPSEIGGLRRL 115
+ R+ L LR+ + +V I L+ L+ L + F +E S + GL L
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 116 KVLALNNNSI---CGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNH 172
+ + +I + + + + + + FS + L L +
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCK 315
Query: 173 LTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEV 232
L +L L + + G S +L FL L+ N LS G
Sbjct: 316 FGQFPTLKLKSLKR-----LTFTSNKGGNAFSEVDLPSLEFLDLSRNGLS-----FKGCC 365
Query: 233 P-SLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISN 291
S L++ ++ N + ++ + +L + +N + +
Sbjct: 366 SQSDFGTTSLKYLDLSFNGV-------ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418
Query: 292 LSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPP-AIGELQNLKILGLN 350
+ + L +++ + +L+ L M N P EL+NL L L+
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478
Query: 351 RNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQF 410
+ +L P + +L L L ++ N SL ++ S N++ + +
Sbjct: 479 QCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQEL 538
Query: 411 FSLSSLSISLDWSRNKLTGSLPIE--VGKLKILEFLYVYENRLEGEIPSTFGN 461
S L+ ++N + + + +K L V R+E PS
Sbjct: 539 QHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQG 591
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-40
Identities = 75/394 (19%), Positives = 133/394 (33%), Gaps = 57/394 (14%)
Query: 70 LDLRSLKLAGSVSHF-IGNLSFLKQLYLQVNSFTH------EIPSEIGGLRRLKVLALNN 122
L L + G++ F L L L ++ + +I L + +L +
Sbjct: 232 LVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVS 291
Query: 123 NSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLG 182
+I E + S + N + +F +L + L G S
Sbjct: 292 VTI--ERVKDFSYNFGWQHLELVNCKF-----GQFPTLKLKSLKRLTFTSNKGGNAFSEV 344
Query: 183 NLSSIHTISLAYNNLD--GTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQR 240
+L S+ + L+ N L G S +L +L L+ N + + + L++
Sbjct: 345 DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMS-------SNFLGLEQ 397
Query: 241 LQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLF 300
L+H ++L + S SL N L ++ I+ + G + LS ++ L
Sbjct: 398 LEHLDFQHSNLK--QMSEFSVFLSLRN---LIYLDISHTHTRVAFNGIFNGLSS-LEVLK 451
Query: 301 LNNNKIYGSIPAGI-GNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIP 359
+ N + I NL LD+ QL P A L +L++L ++ N
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 511
Query: 360 PSIGNLKMLLNLFLNDNFLEVSIPSSLGQCE-SLIEINLSNNNLSGT------------- 405
L L L + N + S L SL +NL+ N+ + T
Sbjct: 512 FPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQ 571
Query: 406 -------------IPPQFFSLSSLSISLDWSRNK 426
P + LS+++ NK
Sbjct: 572 RQLLVEVERMECATPSDKQGMPVLSLNITCQMNK 605
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 4e-70
Identities = 88/331 (26%), Positives = 147/331 (44%), Gaps = 37/331 (11%)
Query: 604 ENPSSSIYSLLYLSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH 663
+ + + DL AT+ F L+G G FG VYKG++ +G +A+K +
Sbjct: 17 SSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG-AKVALKRRTPES 75
Query: 664 HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFT 723
F E + L RH +LV ++ C + +Y++M G+L+ L+
Sbjct: 76 SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM-----ILIYKYMENGNLKRHLY--- 127
Query: 724 GEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783
D +++ QRL I I A L+YLH H D+K N+LLD+ ++
Sbjct: 128 ---GSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKIT 181
Query: 784 DFGLARI-LSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
DFG+++ D T S+ VKG+LGYI PEY + ++ DVYS+G++L E++ +
Sbjct: 182 DFGISKKGTELDQTHLST-VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
Query: 843 IDIMF-EGDINLHNFGRKALPD-DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECL 900
I +NL + ++ + + IVD +L +I E L
Sbjct: 241 IVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL----------------ADKIRP--ESL 282
Query: 901 ISMVRIGVACSMELPQDRTNMTNVVHELQSI 931
V C +DR +M +V+ +L+
Sbjct: 283 RKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 2e-66
Identities = 85/487 (17%), Positives = 153/487 (31%), Gaps = 36/487 (7%)
Query: 67 VTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSIC 126
L+ L + L L L L RL L L N +
Sbjct: 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94
Query: 127 GEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSS 186
T +S L + + + E L LGSNH++
Sbjct: 95 FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEK 154
Query: 187 IHTISLAYNNLDGTIPNSFGWFENL--VFLSLAANNLSVVE----------------NKL 228
+ + N + + + L+L N+++ +E +
Sbjct: 155 LKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQN 214
Query: 229 TGEVP---SLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLL 285
+ +Q L T LC ++ + +++ + F +
Sbjct: 215 LLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMS----VESINLQKHYFFNIS 270
Query: 286 PGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLK 345
S ++ L L + +P+G+ L++L + N+ + +L
Sbjct: 271 SNTFHCFSG-LQELDLTATHL-SELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLT 328
Query: 346 ILGLNRNKLSGNIPP-SIGNLKMLLNLFLNDNFLEVS--IPSSLGQCESLIEINLSNNNL 402
L + N + + NL+ L L L+ + +E S L L +NLS N
Sbjct: 329 HLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEP 388
Query: 403 SGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEV-GKLKILEFLYVYENRLEGEIPSTFGN 461
F L + LD + +L L +L+ L + + L+ F
Sbjct: 389 LSLKTEAFKECPQLEL-LDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDG 447
Query: 462 CIRLEQLGMGGNLFQGPISSSLGSLRG---LRVLDLSQNNLSGEIPKFLAGL-SLNNLNL 517
L+ L + GN F SL+ L +L LS +LS L +N+++L
Sbjct: 448 LPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDL 507
Query: 518 SYNDLEG 524
S+N L
Sbjct: 508 SHNRLTS 514
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 1e-62
Identities = 95/512 (18%), Positives = 161/512 (31%), Gaps = 42/512 (8%)
Query: 59 TCSRRHQRVTLLDLRSLKLAGSVSHFIGNL-SFLKQLYLQVNSFTHEIPSEIGGLRRLKV 117
C + T + +L L + G L + + L N + L L
Sbjct: 7 KCIEKEVNKTY-NCENLGL----NEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTF 61
Query: 118 LALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSI 177
L L I L + N L+ + S + L ++
Sbjct: 62 LDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSID 121
Query: 178 PSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVE------------ 225
L N ++ ++ L N++ E L L N + +
Sbjct: 122 FIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATN 181
Query: 226 -------NKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINS 278
N + G P Q L L
Sbjct: 182 LSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNS----TIQSLWLGTFED 237
Query: 279 NNFGGLLPGCISNLSK-TIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPA 337
+ + P L + +++++ L + + F LQ LD+ LS +P
Sbjct: 238 MDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSG 296
Query: 338 IGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPS-SLGQCESLIEIN 396
+ L LK L L+ NK S N L +L + N + + + L E+L E++
Sbjct: 297 LVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELD 356
Query: 397 LSNNNL--SGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEG- 453
LS++++ S Q +LS L SL+ S N+ + LE L + RL+
Sbjct: 357 LSHDDIETSDCCNLQLRNLSHLQ-SLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVK 415
Query: 454 EIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEI---PKFLAGL 510
+ S F N L+ L + +L L L+ L+L N+ L L
Sbjct: 416 DAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTL 475
Query: 511 -SLNNLNLSYNDLEGMVTTEGVFKNASATRIL 541
L L LS+ DL + + F + +
Sbjct: 476 GRLEILVLSFCDLSSI--DQHAFTSLKMMNHV 505
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 1e-55
Identities = 98/466 (21%), Positives = 169/466 (36%), Gaps = 49/466 (10%)
Query: 70 LDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKV--LALNNNSICG 127
L L S ++ LK L Q N+ + ++ L++ L LN N I
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI-A 192
Query: 128 EIPTNISRCSTLIPIHPQNNQLVGKILS--RFSSLSKTEILNLGSNHLTGSIPSSLGNLS 185
I + ++ Q + I + S++ + P+ L
Sbjct: 193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC 252
Query: 186 --SIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQH 243
S+ +I+L + N+F F L L L A +LS + + L G L L+
Sbjct: 253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVG-------LSTLKK 305
Query: 244 FTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNF-GGLLPGCISNLSKTIKTLFLN 302
+++N + S +N LT + I N L GC+ NL ++ L L+
Sbjct: 306 LVLSANKFENLCQI------SASNFPSLTHLSIKGNTKRLELGTGCLENLEN-LRELDLS 358
Query: 303 NNKIYGS--IPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPP 360
++ I S + N +LQ L++ N+ A E L++L L +L
Sbjct: 359 HDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQ 418
Query: 361 SI-GNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSIS 419
S NL +L L L+ + L++S +L +NL N+ + SL +L
Sbjct: 419 SPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGR- 477
Query: 420 LDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPI 479
LE L + L F + + + + N
Sbjct: 478 ---------------------LEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSS 516
Query: 480 SSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL-SLNNLNLSYNDLEG 524
+L L+G+ L+L+ N++S +P L L +NL N L+
Sbjct: 517 IEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 7e-40
Identities = 60/355 (16%), Positives = 127/355 (35%), Gaps = 22/355 (6%)
Query: 65 QRVTLLDLRSLKLAGSVSHFIGNLSF--LKQLYLQVNSFTHEIPSEIGGLRRLKVLALNN 122
Q + L + L ++ + LQ + F + + L+ L L
Sbjct: 228 QSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTA 287
Query: 123 NSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPS-SL 181
+ E+P+ + STL + N+ S+ L++ N + + L
Sbjct: 288 THL-SELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCL 346
Query: 182 GNLSSIHTISLAYNNLD--GTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQ 239
NL ++ + L++++++ +L L+L+ N ++ + + ++
Sbjct: 347 ENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTE------AFKECP 400
Query: 240 RLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTL 299
+L+ + L D S +L L ++++ + L ++ L
Sbjct: 401 QLELLDLAFTRLK--VKDAQSPFQNLHL---LKVLNLSHSLLDISSEQLFDGLPA-LQHL 454
Query: 300 FLNNNKIYGSIPAGIGNFVN---LQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSG 356
L N + L+ L + LS A L+ + + L+ N+L+
Sbjct: 455 NLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTS 514
Query: 357 NIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFF 411
+ ++ +LK + L L N + + +PS L INL N L T +F
Sbjct: 515 SSIEALSHLK-GIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIYF 568
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-28
Identities = 39/261 (14%), Positives = 74/261 (28%), Gaps = 30/261 (11%)
Query: 288 CISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKIL 347
+ KT N + IP + + + L+ N L L NL L
Sbjct: 6 QKCIEKEVNKTYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFL 62
Query: 348 GLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIP 407
L R ++ + + L L L N L ++L ++L + +S
Sbjct: 63 DLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDF 122
Query: 408 PQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQ 467
+ +L E LY+ N + +L+
Sbjct: 123 IPLHNQKTL-------------------------ESLYLGSNHISSIKLPKGFPTEKLKV 157
Query: 468 LGMGGNLFQGPISSSLGSLRGLRV--LDLSQNNLSGEIPKFLAGLSLNNLNLSYNDLEGM 525
L N + SL+ L+L+ N+++G P +LN +
Sbjct: 158 LDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLV 217
Query: 526 VTTEGVFKNASATRILGNSKL 546
+ + + +
Sbjct: 218 IFKGLKNSTIQSLWLGTFEDM 238
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 3e-12
Identities = 49/183 (26%), Positives = 73/183 (39%), Gaps = 9/183 (4%)
Query: 68 TLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIG---GLRRLKVLALNNNS 124
+L+L L S L L+ L LQ N F + L RL++L L+
Sbjct: 428 KVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCD 487
Query: 125 ICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNL 184
+ + + + +N+L + S L LNL SNH++ +PS L L
Sbjct: 488 LSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKG-IYLNLASNHISIILPSLLPIL 546
Query: 185 SSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHF 244
S TI+L N LD T N +F L + L E+ E P L + RL
Sbjct: 547 SQQRTINLRQNPLDCTCSNI--YF--LEWYKENMQKLEDTED-TLCENPPLLRGVRLSDV 601
Query: 245 TIT 247
T++
Sbjct: 602 TLS 604
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 5e-65
Identities = 88/342 (25%), Positives = 140/342 (40%), Gaps = 50/342 (14%)
Query: 602 EKENPSSSIYSLLYLSYQDLYNATSGFSS------ANLVGVGSFGSVYKGIIDEGRTTIA 655
E ++ S S+ +L N T+ F N +G G FG VYKG ++ TT+A
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN--TTVA 58
Query: 656 VKVFNLQHHGAS----RSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMH 711
VK + + F E K + +H NLV++L D VY +M
Sbjct: 59 VKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDL-----CLVYVYMP 113
Query: 712 YGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSN 771
GSL + L P L+ R IA A +N+LH + H D+K +N
Sbjct: 114 NGSLLDRLS-----CLDGTPP--LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSAN 163
Query: 772 VLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGI 831
+LLD+ TA++ DFGLAR + + G+ Y+APE G E++ D+YS+G+
Sbjct: 164 ILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGV 222
Query: 832 LLLELVIGKKPIDIMFEGDINLHNFGRKALPD--DVMDIVDSSLLPDDEDLILTGNQRQK 889
+LLE++ G +D E L + + + + D +D + +
Sbjct: 223 VLLEIITGLPAVDEHRE-PQLLLDIKEEIEDEEKTIEDYIDKKM----------NDADST 271
Query: 890 QARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSI 931
+M + C E R ++ V LQ +
Sbjct: 272 SVE---------AMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 1e-63
Identities = 76/550 (13%), Positives = 147/550 (26%), Gaps = 100/550 (18%)
Query: 11 VRASLVAGTGNETDRVALLEFKSK----------STYDPVGVLGTWNESIHFCKWYGVTC 60
V L D AL T + WN + W
Sbjct: 257 VPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPG 316
Query: 61 SRRHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLAL 120
+ N + L L +P IG L LKVL+
Sbjct: 317 V----------------------DLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSF 354
Query: 121 NNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSS 180
+S T + ++ + + +
Sbjct: 355 GTHSETVSGRLFGDEELTPDMSEERKHR-----------------IRMHYKKMFLDYDQR 397
Query: 181 LGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQR 240
L + ++ N I +SL + + N++T ++++L +
Sbjct: 398 LNLSDLLQD-AINRNPEMKPIK-------KDSRISLKDTQIGNLTNRITFISKAIQRLTK 449
Query: 241 LQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLF 300
LQ ++ A + + SNL + +
Sbjct: 450 LQIIYFANSPFT-----------YDNIAVDWEDANSDYAKQYENEELSWSNLKD-LTDVE 497
Query: 301 LNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSG---------TIPPAIGELQNLKILGLNR 351
L N +P + + LQ L++ N+ + ++I +
Sbjct: 498 LYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGY 557
Query: 352 NKLSGNIPPS--IGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQ 409
N L P S + + L L N + + G L ++ L N + IP
Sbjct: 558 NNLEE-FPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIE-EIPED 613
Query: 410 FFSLSSLSISLDWSRNKLTGSLP--IEVGKLKILEFLYVYENRLEGEIPSTFG-----NC 462
F + + L +S NKL +P + ++ + N++ E +
Sbjct: 614 FCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKG 672
Query: 463 IRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLS-------GEIPKFLAGL-SLNN 514
I + + N Q + + + + LS N ++ L
Sbjct: 673 INASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTT 732
Query: 515 LNLSYNDLEG 524
++L +N L
Sbjct: 733 IDLRFNKLTS 742
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 3e-54
Identities = 69/482 (14%), Positives = 135/482 (28%), Gaps = 91/482 (18%)
Query: 69 LLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGE 128
L L+ + A S + + L+ L + L N +
Sbjct: 447 LTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQ 506
Query: 129 IPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTG---------SIPS 179
+P + L + LN+ N +
Sbjct: 507 LPDFLYDLPEL------------------------QSLNIACNRGISAAQLKADWTRLAD 542
Query: 180 SLGNLSSIHTISLAYNNLDG-TIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKL 238
I + YNNL+ S L L N + + +
Sbjct: 543 DEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--------HLEAFGTN 594
Query: 239 QRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGC-ISNLSKTIK 297
+L + N + D C+ T+ + + + N + ++ +
Sbjct: 595 VKLTDLKLDYNQIEEIPED----FCAFTDQ--VEGLGFSHNKLKYIPNIFNAKSVYV-MG 647
Query: 298 TLFLNNNKIYGSIPAGIG------NFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNR 351
++ + NKI GS I +N + + N++ + + L+
Sbjct: 648 SVDFSYNKI-GSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSN 706
Query: 352 NKLS-------GNIPPSIGNLKMLLNLFLNDNFLEVSIPSSL--GQCESLIEINLSNNNL 402
N ++ + N +L + L N L S+ L +++S N
Sbjct: 707 NLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCF 765
Query: 403 SGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNC 462
S + P Q + S L + NR+ + P+ C
Sbjct: 766 S-SFPTQPLNSSQLKA-FGIRHQRDAEG------------------NRILRQWPTGITTC 805
Query: 463 IRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNL-SGEIPKFLAGLSLNNLNLSYND 521
L QL +G N + + L L +LD++ N S ++ + L Y+
Sbjct: 806 PSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDK 862
Query: 522 LE 523
+
Sbjct: 863 TQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-34
Identities = 46/355 (12%), Positives = 106/355 (29%), Gaps = 52/355 (14%)
Query: 215 SLAANNLSVVENKLTGE----VPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATR 270
S+ + +V++NKLT + + E + ++ + + + + N T
Sbjct: 238 SVRGESFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTI 297
Query: 271 L--TWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNN 328
W + G PG + + + L L G +P IG L+ L +
Sbjct: 298 HSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTH 357
Query: 329 QLSGTIPPAIGELQNLKILGLNRNKLSGNIP-----------------------PSIGNL 365
+ + E + ++++ + P + +
Sbjct: 358 SETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPI 417
Query: 366 KMLLNLFLNDNFLEV------SIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSIS 419
K + L D + I ++ + L I +N+ +
Sbjct: 418 KKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVD------WED 471
Query: 420 LDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGP- 478
+ K + + LK L + +Y ++P + L+ L + N
Sbjct: 472 ANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAA 531
Query: 479 --------ISSSLGSLRGLRVLDLSQNNLSG-EIPKFLAGL-SLNNLNLSYNDLE 523
++ + +++ + NNL L + L L+ +N +
Sbjct: 532 QLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR 586
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 7e-06
Identities = 14/106 (13%), Positives = 35/106 (33%), Gaps = 8/106 (7%)
Query: 449 NRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKF-- 506
+ + N R+ L + G +G + ++G L L+VL ++ + F
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 507 ------LAGLSLNNLNLSYNDLEGMVTTEGVFKNASATRILGNSKL 546
++ + + + Y + + I N ++
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEM 414
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 1e-57
Identities = 69/345 (20%), Positives = 129/345 (37%), Gaps = 47/345 (13%)
Query: 602 EKENPSSSIYSLLYLSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNL 661
+ SS + L ++LY + + G FG V+K + +AVK+F +
Sbjct: 4 HHHHHSSG----VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLN--EYVAVKIFPI 57
Query: 662 QHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS---VYEFMHYGSLEEW 718
Q S E +L ++H N+++ +GA+ RG + F GSL ++
Sbjct: 58 QDK-QSWQNEYEVYSLPGMKHENILQ----FIGAEKRGTSVDVDLWLITAFHEKGSLSDF 112
Query: 719 LHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHD-------CQPVTAHCDLKPSN 771
L ++ + +IA +A L YLH D +P +H D+K N
Sbjct: 113 LKA-----------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKN 161
Query: 772 VLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEY-----GVGCEVSTNGDV 826
VLL + +TA + DFGLA + + G+ Y+APE + D+
Sbjct: 162 VLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDM 221
Query: 827 YSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQ 886
Y+ G++L EL D + + F + ++ + ++ + +L
Sbjct: 222 YAMGLVLWELASRCTAADGPVDE--YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYW 279
Query: 887 RQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSI 931
++ + + C + R + V + +
Sbjct: 280 QKH--------AGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 3e-56
Identities = 101/509 (19%), Positives = 164/509 (32%), Gaps = 50/509 (9%)
Query: 67 VTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSIC 126
+DL L S+ N S L+ L L GL L L L N I
Sbjct: 34 TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93
Query: 127 GEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTG-SIPSSLGNLS 185
P + S ++L + +L L + LN+ N + +P+ NL+
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLT 153
Query: 186 SIHTISLAYNNLDGTIPNSFGWFENL----VFLSLAANNLSVVE---------------- 225
++ + L+YN + N + + L ++ N + ++
Sbjct: 154 NLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRG 213
Query: 226 NKLTGEVP--------SLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHIN 277
N + + L + + +L + LC + + +
Sbjct: 214 NFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDV----TIDEFRLT 269
Query: 278 SNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPA 337
N L+ + + L I + +F Q L + QL P
Sbjct: 270 YTNDFSDDIVKFHCLAN-VSAMSLAGVSI-KYLEDVPKHF-KWQSLSIIRCQLK-QFPTL 325
Query: 338 IGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQ--CESLIEI 395
+L LK L L NK S I L L L L+ N L S S SL +
Sbjct: 326 --DLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHL 381
Query: 396 NLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEV-GKLKILEFLYVYENRLEGE 454
+LS N + F L L LD+ + L L+ L +L + + +
Sbjct: 382 DLSFNGAI-IMSANFMGLEELQH-LDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKID 439
Query: 455 IPSTFGNCIRLEQLGMGGNLFQGPI-SSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL-SL 512
F L L M GN F+ S+ + L LDLS+ L L L
Sbjct: 440 FDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRL 499
Query: 513 NNLNLSYNDLEGMVTTEGVFKNASATRIL 541
LN+S+N+L + + + L
Sbjct: 500 QLLNMSHNNLLFL--DSSHYNQLYSLSTL 526
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 1e-53
Identities = 95/470 (20%), Positives = 157/470 (33%), Gaps = 34/470 (7%)
Query: 68 TLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTH-EIPSEIGGLRRLKVLALNNNSIC 126
L KLA S IG L LK+L + N ++P+ L L + L+ N I
Sbjct: 107 ENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQ 166
Query: 127 GEIPTNISR----CSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPS-SL 181
++ + + N + F + L L N + +I L
Sbjct: 167 TITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIK-LHELTLRGNFNSSNIMKTCL 225
Query: 182 GNLSSIHTISLAYNNLDGTIPNSF---GWFENLVFLSLAANNLSVVENKLTGEVP-SLEK 237
NL+ +H L E L +++ L+ +
Sbjct: 226 QNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLT--YTNDFSDDIVKFHC 283
Query: 238 LQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIK 297
L + ++ S+ +L + + + I + L K
Sbjct: 284 LANVSAMSLAGVSI--------KYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFL----K 331
Query: 298 TLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQ--NLKILGLNRNKLS 355
+L L NK SI +L LD+ N LS + + +L +L+ L L+ N
Sbjct: 332 SLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI 389
Query: 356 GNIPPSIGNLKMLLNLFLNDNFLEVSIP-SSLGQCESLIEINLSNNNLSGTIPPQFFSLS 414
+ + L+ L +L + L+ S+ E L+ +++S N F L+
Sbjct: 390 I-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLT 448
Query: 415 SLSISLDWSRNKLTGSLPIEV-GKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGN 473
SL+ L + N + V L FL + + +LE F RL+ L M N
Sbjct: 449 SLNT-LKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHN 507
Query: 474 LFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL-SLNNLNLSYNDL 522
SS L L LD S N + SL NL+ N +
Sbjct: 508 NLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 3e-49
Identities = 82/455 (18%), Positives = 149/455 (32%), Gaps = 46/455 (10%)
Query: 69 LLDLRSLKLAG------SVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLK----VL 118
L+ L+ L +A + + NL+ L + L N +++ LR L
Sbjct: 127 LITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSL 186
Query: 119 ALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSR-FSSLSKTEILNL------GSN 171
++ N I I + L + + N I+ +L+ + L
Sbjct: 187 DMSLNPI-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDER 245
Query: 172 HLTGSIPSSLGNLSSIHT--ISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLT 229
+L PS + L + L Y N F N+ +SLA ++
Sbjct: 246 NLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK------- 298
Query: 230 GEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCI 289
+ + K + Q +I L DL FL SL + N
Sbjct: 299 -YLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSL---------TLTMNKGSISFK--K 346
Query: 290 SNLSKTIKTLFLNNNKIYGSIPA--GIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKIL 347
L + L L+ N + S +L+ LD+ N + L+ L+ L
Sbjct: 347 VALPS-LSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHL 404
Query: 348 GLNRNKLSGNIPPS-IGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTI 406
+ L S +L+ LL L ++ ++ SL + ++ N+
Sbjct: 405 DFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNT 464
Query: 407 PPQFFS-LSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRL 465
F+ ++L+ LD S+ +L L L+ L + N L S + L
Sbjct: 465 LSNVFANTTNLTF-LDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSL 523
Query: 466 EQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLS 500
L N + + L +L+ N+++
Sbjct: 524 STLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-42
Identities = 78/490 (15%), Positives = 130/490 (26%), Gaps = 84/490 (17%)
Query: 68 TLLDLRSLKLAGSVSHFIGNL-SFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSIC 126
KL S ++ S K + L N L+ L L+ I
Sbjct: 14 ITYQCMDQKL----SKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIE 69
Query: 127 GEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSS 186
L + N + FS L+ E L L +G L +
Sbjct: 70 TIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLIT 129
Query: 187 IHTISLAYNNLDG-TIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFT 245
+ +++A+N + +P F NLV + L+ N +
Sbjct: 130 LKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQ----------------------- 166
Query: 246 ITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNK 305
I N+ L + +L ++ N
Sbjct: 167 -----------------------------TITVNDLQFL-----RENPQVNLSLDMSLNP 192
Query: 306 IYGSIPAGIGNFVNLQRLDMWNNQLSGTIPP-AIGELQNLKILGLNRNKLSGNIPPSIGN 364
I I + L L + N S I + L L + L + I
Sbjct: 193 I-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFE 251
Query: 365 LKML--------LNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSL 416
++ L ++ ++L+ ++
Sbjct: 252 PSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKW 309
Query: 417 SISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQ 476
SL R +L L L+ L + N+ I L L + N
Sbjct: 310 Q-SLSIIRCQLKQ---FPTLDLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALS 363
Query: 477 --GPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLSLNNLNLSYNDLEGMVTTEGVFKN 534
G S S LR LDLS N F+ L +L+ ++ L+ + T F +
Sbjct: 364 FSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRV-TEFSAFLS 422
Query: 535 ASATRILGNS 544
L S
Sbjct: 423 LEKLLYLDIS 432
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-31
Identities = 50/313 (15%), Positives = 103/313 (32%), Gaps = 21/313 (6%)
Query: 66 RVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSI 125
+ L L+ + + L S + ++ + + L++ +
Sbjct: 262 TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQL 319
Query: 126 CGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNL- 184
++ +L N+ I + +L L+L N L+ S S +L
Sbjct: 320 KQFPTLDLPFLKSL---TLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLG 374
Query: 185 -SSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQH 243
+S+ + L++N + +F E L L + L V E + L++L +
Sbjct: 375 TNSLRHLDLSFNGA-IIMSANFMGLEELQHLDFQHSTLKRVT-----EFSAFLSLEKLLY 428
Query: 244 FTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNN 303
I+ + F T L + + N+F + + + L L+
Sbjct: 429 LDISYTNTKI------DFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSK 482
Query: 304 NKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIG 363
++ LQ L+M +N L +L +L L + N++ +
Sbjct: 483 CQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQH 542
Query: 364 NLKMLLNLFLNDN 376
K L L +N
Sbjct: 543 FPKSLAFFNLTNN 555
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 2e-50
Identities = 95/438 (21%), Positives = 171/438 (39%), Gaps = 47/438 (10%)
Query: 85 IGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHP 144
L+ + L + T + L ++ L + I + + + L I+
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINF 75
Query: 145 QNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNS 204
NNQL ++ +L+K + + +N + P L NL+++ ++L N + P
Sbjct: 76 SNNQLTD--ITPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP-- 129
Query: 205 FGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCS 264
NL L L++N +S ++ +L L LQ + + ++ L
Sbjct: 130 LKNLTNLNRLELSSNTIS--------DISALSGLTSLQQLSFGNQ---------VTDLKP 172
Query: 265 LTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLD 324
L N T L + I+SN + ++ L+ +++L NN+I P +G NL L
Sbjct: 173 LANLTTLERLDISSNKVSDISV--LAKLTN-LESLIATNNQISDITP--LGILTNLDELS 227
Query: 325 MWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPS 384
+ NQL + L NL L L N++S P + L L L L N + P
Sbjct: 228 LNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP- 282
Query: 385 SLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFL 444
L +L + L+ N L P +L +L+ L N ++ P+ L L+ L
Sbjct: 283 -LAGLTALTNLELNENQLEDISP--ISNLKNLTY-LTLYFNNISDISPV--SSLTKLQRL 336
Query: 445 YVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIP 504
+ Y N++ S+ N + L G N + L +L + L L+ +
Sbjct: 337 FFYNNKVSD--VSSLANLTNINWLSAGHNQISDL--TPLANLTRITQLGLNDQAWTNAPV 392
Query: 505 KFLAGLSLNNLNLSYNDL 522
+ A +S+ N +
Sbjct: 393 NYKANVSIPNTVKNVTGA 410
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 1e-48
Identities = 100/419 (23%), Positives = 171/419 (40%), Gaps = 48/419 (11%)
Query: 107 SEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEIL 166
L L ++ + + + + + K + L+ +
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQI 73
Query: 167 NLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVEN 226
N +N LT P L NL+ + I + N + P NL L+L N ++
Sbjct: 74 NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQIT---- 125
Query: 227 KLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLP 286
++ L+ L L ++SN++ D+S L LT+ +L+ N L P
Sbjct: 126 ----DIDPLKNLTNLNRLELSSNTIS-----DISALSGLTSLQQLS----FGNQVTDLKP 172
Query: 287 GCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKI 346
++NL+ ++ L +++NK+ S + + NL+ L NNQ+S P +G L NL
Sbjct: 173 --LANLTT-LERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDE 225
Query: 347 LGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTI 406
L LN N+L ++ +L L +L L +N + P L L E+ L N +S
Sbjct: 226 LSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS 281
Query: 407 PPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLE 466
P L++L+ +L+ + N+L PI LK L +L +Y N + P + +L+
Sbjct: 282 P--LAGLTALT-NLELNENQLEDISPI--SNLKNLTYLTLYFNNISDISP--VSSLTKLQ 334
Query: 467 QLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL-SLNNLNLSYNDLEG 524
+L N SSL +L + L N +S P LA L + L L+
Sbjct: 335 RLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-44
Identities = 99/461 (21%), Positives = 172/461 (37%), Gaps = 47/461 (10%)
Query: 67 VTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSIC 126
VT L L + S+ + L+ L Q+ N T P + L +L + +NNN I
Sbjct: 48 VTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI- 102
Query: 127 GEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSS 186
T ++ + L + NNQ+ + +L+ L L SN ++ S+L L+S
Sbjct: 103 -ADITPLANLTNLTGLTLFNNQI--TDIDPLKNLTNLNRLELSSNTISD--ISALSGLTS 157
Query: 187 IHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTI 246
+ +S N + P L L +++N +S ++ L KL L+
Sbjct: 158 LQQLSF-GNQVTDLKP--LANLTTLERLDISSNKVS--------DISVLAKLTNLESLIA 206
Query: 247 TSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKI 306
T+N + D++ L LTN L + +N N + +++L+ + L L NN+I
Sbjct: 207 TNNQI-----SDITPLGILTN---LDELSLNGNQLKDIGT--LASLTN-LTDLDLANNQI 255
Query: 307 YGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLK 366
P + L L + NQ+S P + L L L LN N+L I NLK
Sbjct: 256 SNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLK 309
Query: 367 MLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNK 426
L L L N + P + L + NN +S +L++++ L N+
Sbjct: 310 NLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNIN-WLSAGHNQ 364
Query: 427 LTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSL 486
++ P+ L + L + + + N + P +++
Sbjct: 365 ISDLTPL--ANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAP--ATISDG 420
Query: 487 RGLRVLDLSQNNLSGEIPKFLAGLSLNNLNLSYNDLEGMVT 527
D++ N S + G VT
Sbjct: 421 GSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-42
Identities = 85/395 (21%), Positives = 161/395 (40%), Gaps = 52/395 (13%)
Query: 145 QNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNS 204
Q+ + + ++L++ LG ++T ++ +L + T+ + +
Sbjct: 10 QDTPI--NQIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDG 63
Query: 205 FGWFENLVFLSLAANNLSVVE---------------NKLTGEVPSLEKLQRLQHFTITSN 249
+ NL ++ + N L+ + N++ + L L L T+ +N
Sbjct: 64 VEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIAD-ITPLANLTNLTGLTLFNN 122
Query: 250 SLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGS 309
+ D+ L +LTN L + ++SN + +S L+ ++ L N +
Sbjct: 123 QIT-----DIDPLKNLTN---LNRLELSSNTISDISA--LSGLTS-LQQLSFGNQV---T 168
Query: 310 IPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLL 369
+ N L+RLD+ +N++S + +L NL+ L N++S P +G L L
Sbjct: 169 DLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLD 224
Query: 370 NLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTG 429
L LN N L +L +L +++L+NN +S P L+ L+ L N+++
Sbjct: 225 ELSLNGNQL--KDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTE-LKLGANQISN 279
Query: 430 SLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGL 489
P+ L L L + EN+LE P N L L + N S + SL L
Sbjct: 280 ISPL--AGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISD--ISPVSSLTKL 333
Query: 490 RVLDLSQNNLSGEIPKFLAGLSLNNLNLSYNDLEG 524
+ L N +S + ++N L+ +N +
Sbjct: 334 QRLFFYNNKVSD-VSSLANLTNINWLSAGHNQISD 367
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-24
Identities = 45/229 (19%), Positives = 83/229 (36%), Gaps = 21/229 (9%)
Query: 297 KTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSG 356
+ I + + ++ T+ +L + L +R +
Sbjct: 5 SATITQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK- 59
Query: 357 NIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSL 416
+ L L + ++N L P L L++I ++NN ++ P +L++L
Sbjct: 60 -SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNL 114
Query: 417 SISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQ 476
+ L N++T P+ L L L + N + S L+QL G +
Sbjct: 115 T-GLTLFNNQITDIDPL--KNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD 169
Query: 477 GPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL-SLNNLNLSYNDLEG 524
L +L L LD+S N +S LA L +L +L + N +
Sbjct: 170 ---LKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD 213
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 3e-48
Identities = 67/350 (19%), Positives = 123/350 (35%), Gaps = 46/350 (13%)
Query: 616 LSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECK 675
+ + L+G G +G+VYKG +DE +AVKVF+ + ++FI E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDE--RPVAVKVFSFANR---QNFINEKN 57
Query: 676 --ALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPR 733
+ + H N+ + + G V E+ GSL ++L
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----------H 106
Query: 734 NLNLLQRLNIAIDIAYALNYLHHD------CQPVTAHCDLKPSNVLLDDYMTARVGDFGL 787
+ + +A + L YLH + +P +H DL NVL+ + T + DFGL
Sbjct: 107 TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166
Query: 788 ARILS------PDHTQTSSFSVKGSLGYIAPEY-------GVGCEVSTNGDVYSYGILLL 834
+ L+ P ++ S G++ Y+APE D+Y+ G++
Sbjct: 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYW 226
Query: 835 ELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQK-QARI 893
E+ + D+ + + + + D + L+ QR K
Sbjct: 227 EIFMRCT--DLFPGESVPEYQ-----MAFQTEVGNHPTFE-DMQVLVSREKQRPKFPEAW 278
Query: 894 NSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILLGVELCPP 943
+ S+ C + + R + + I + P
Sbjct: 279 KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSP 328
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-47
Identities = 68/211 (32%), Positives = 106/211 (50%), Gaps = 19/211 (9%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGAS--RSFIAECKALKSIRHRNLVKVLTA 691
+G GSFG+V++ + +AVK+ Q A F+ E +K +RH N+V + A
Sbjct: 45 IGAGSFGTVHRAEWHG--SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 692 CLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYAL 751
+ V E++ GSL LH A L+ +RL++A D+A +
Sbjct: 103 VTQPPNL-----SIVTEYLSRGSLYRLLHK-------SGAREQLDERRRLSMAYDVAKGM 150
Query: 752 NYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIA 811
NYLH+ P H +LK N+L+D T +V DFGL+R+ + T SS S G+ ++A
Sbjct: 151 NYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA--STFLSSKSAAGTPEWMA 207
Query: 812 PEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
PE + DVYS+G++L EL ++P
Sbjct: 208 PEVLRDEPSNEKSDVYSFGVILWELATLQQP 238
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 7e-46
Identities = 52/217 (23%), Positives = 87/217 (40%), Gaps = 32/217 (14%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGA--SRSFIAECKALKSIRHRNLVKVLTA 691
+ G ++KG I VKV ++ SR F EC L+ H N++ VL A
Sbjct: 18 LNENHSGELWKGRWQG--NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 692 CLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYAL 751
C + +M YGSL LH + ++ Q + A+D+A +
Sbjct: 76 CQSPP---APHPTLITHWMPYGSLYNVLH--------EGTNFVVDQSQAVKFALDMARGM 124
Query: 752 NYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIA 811
+LH +P+ L +V++D+ MTAR+ + S + ++A
Sbjct: 125 AFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVA 176
Query: 812 PE------YGVGCEVSTNGDVYSYGILLLELVIGKKP 842
PE + D++S+ +LL ELV + P
Sbjct: 177 PEALQKKPEDTNRRSA---DMWSFAVLLWELVTREVP 210
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-45
Identities = 107/487 (21%), Positives = 163/487 (33%), Gaps = 41/487 (8%)
Query: 67 VTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSIC 126
LDL L S+ + L+ L L L L L L N I
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 127 GEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLT-GSIPSSLGNLS 185
S S+L + L L + LN+ N + +P NL+
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 186 SIHTISLAYNNLDGTIPNSFGWFENL----VFLSLAANNLSVVE---------------- 225
++ + L+ N + + + L L+ N ++ ++
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRN 209
Query: 226 NKLTGEVPS--LEKLQRLQHFTITSNSLGSGGND---DLSFLCSLTNATRLTWMHINSNN 280
N + V ++ L L+ + + GN D S L L N T + + +
Sbjct: 210 NFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT-IEEFRLAYLD 268
Query: 281 FGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGE 340
+ + N + + L + I + NF Q L++ N + P +
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTI-ERVKDFSYNF-GWQHLELVNCKFGQ-FPT--LK 323
Query: 341 LQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVS--IPSSLGQCESLIEINLS 398
L++LK L NK S +L L L L+ N L S SL ++LS
Sbjct: 324 LKSLKRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 399 NNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEV-GKLKILEFLYVYENRLEGEIPS 457
N + T+ F L L LD+ + L V L+ L +L +
Sbjct: 382 FNGVI-TMSSNFLGLEQLEH-LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439
Query: 458 TFGNCIRLEQLGMGGNLFQGPISS-SLGSLRGLRVLDLSQNNLSGEIPKFLAGL-SLNNL 515
F LE L M GN FQ LR L LDLSQ L P L SL L
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499
Query: 516 NLSYNDL 522
N++ N L
Sbjct: 500 NMASNQL 506
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 3e-43
Identities = 88/465 (18%), Positives = 160/465 (34%), Gaps = 23/465 (4%)
Query: 68 TLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSI-C 126
+ L L + LS L++L + IG L+ LK L + +N I
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 127 GEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEI----LNLGSNHLTGSIPSSLG 182
++P S + L + +N++ + L + + L+L N + I
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAF 197
Query: 183 NLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQ 242
+H ++L N + + + L L + L N+ E L+ L
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTC--IQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLC 255
Query: 243 HFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLN 302
+ TI L + T ++ + S + + + ++ +
Sbjct: 256 NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCK 315
Query: 303 NNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLS--GNIPP 360
+ +L+RL +N+ + +L +L+ L L+RN LS G
Sbjct: 316 FGQF------PTLKLKSLKRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNGLSFKGCCSQ 367
Query: 361 SIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFF-SLSSLSIS 419
S L L L+ N + ++ S+ E L ++ ++NL F SL +L
Sbjct: 368 SDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY- 425
Query: 420 LDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPS-TFGNCIRLEQLGMGGNLFQGP 478
LD S + L LE L + N + F L L + +
Sbjct: 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL 485
Query: 479 ISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL-SLNNLNLSYNDL 522
++ SL L+VL+++ N L L SL + L N
Sbjct: 486 SPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-41
Identities = 84/447 (18%), Positives = 166/447 (37%), Gaps = 32/447 (7%)
Query: 68 TLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTH-EIPSEIGGLRRLKVLALNNNSIC 126
L LA + IG+L LK+L + N ++P L L+ L L++N I
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 127 GEIPTNISRCSTLIPIHP----QNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPS-SL 181
T++ + ++ N + F + L L +N + ++ +
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCI 221
Query: 182 GNLSSIHTISLAYNNLDGT---IPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKL 238
L+ + L E L L++ L+ ++ L + L
Sbjct: 222 QGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCL 281
Query: 239 QRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKT 298
+ F++ S ++ + + + + + FG + +L K
Sbjct: 282 TNVSSFSLVSVTI--------ERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSL----KR 329
Query: 299 LFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLS--GTIPPAIGELQNLKILGLNRNKLSG 356
L +NK G+ + + + +L+ LD+ N LS G + +LK L L+ N +
Sbjct: 330 LTFTSNKG-GNAFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI- 386
Query: 357 NIPPSIGNLKMLLNLFLNDNFLEVSIPSS-LGQCESLIEINLSNNNLSGTIPPQFFS-LS 414
+ + L+ L +L + L+ S +LI +++S+ + F+ LS
Sbjct: 387 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLS 445
Query: 415 SLSISLDWSRNKLTGSLPIEV-GKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGN 473
SL + L + N + ++ +L+ L FL + + +LE P+ F + L+ L M N
Sbjct: 446 SLEV-LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN 504
Query: 474 LFQGPISSSLGSLRGLRVLDLSQNNLS 500
+ L L+ + L N
Sbjct: 505 QLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-36
Identities = 79/422 (18%), Positives = 150/422 (35%), Gaps = 38/422 (9%)
Query: 128 EIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSI 187
+IP N+ + + N L F S + ++L+L + + +LS +
Sbjct: 21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 188 HTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTIT 247
T+ L N + +F +L L NL+ +EN + L+ L+ +
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF------PIGHLKTLKELNVA 132
Query: 248 SNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSK---TIKTLFLNNN 304
N + S + +N T L + ++SN + + L + +L L+ N
Sbjct: 133 HNLIQSFKLPE-----YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187
Query: 305 KIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPP-AIGELQNLKILGLNRNK---------L 354
+ I G + L +L + NN S + I L L++ L +
Sbjct: 188 PM-NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246
Query: 355 SGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLS 414
+ + NL + ++ I ++ +L + + + ++
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFG 305
Query: 415 SLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNL 474
L+ K KLK L+ L N+ + + LE L + N
Sbjct: 306 --WQHLELVNCKFGQ---FPTLKLKSLKRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNG 358
Query: 475 --FQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLSLNNLNLSYNDLEGMVTTEGVF 532
F+G S S L+ LDLS N + FL L +L+ +++L+ M + VF
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQM-SEFSVF 417
Query: 533 KN 534
+
Sbjct: 418 LS 419
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-26
Identities = 61/356 (17%), Positives = 118/356 (33%), Gaps = 29/356 (8%)
Query: 63 RHQRVTLLDLRSLKLAGSV-SHFIGNLSFLKQLYLQVNSF------THEIPSEIGGLRRL 115
+ R+ L LR+ + +V I L+ L+ L + F S + GL L
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 116 KVLALNNNSI---CGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNH 172
+ + +I + + + + + + + FS + L L +
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI--ERVKDFSYNFGWQHLELVNCK 315
Query: 173 LTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEV 232
L +L + N S +L FL L+ N LS
Sbjct: 316 FGQFPTLKLKSLKRLT---FTSNKG--GNAFSEVDLPSLEFLDLSRNGLSFKGCCSQ--- 367
Query: 233 PSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNL 292
S L++ ++ N + ++ + +L + +N + +
Sbjct: 368 -SDFGTTSLKYLDLSFNGV-------ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 419
Query: 293 SKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAI-GELQNLKILGLNR 351
+ + L +++ + +L+ L M N P I EL+NL L L++
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 479
Query: 352 NKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIP 407
+L P + +L L L + N L+ + SL +I L N + P
Sbjct: 480 CQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 6e-10
Identities = 34/138 (24%), Positives = 50/138 (36%), Gaps = 2/138 (1%)
Query: 68 TLLDLRSLKLAG-SVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSIC 126
LD + L S +L L L + GL L+VL + NS
Sbjct: 399 EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 458
Query: 127 GEIPTNI-SRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLS 185
+I + L + QL + F+SLS ++LN+ SN L L+
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLT 518
Query: 186 SIHTISLAYNNLDGTIPN 203
S+ I L N D + P
Sbjct: 519 SLQKIWLHTNPWDCSCPR 536
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-45
Identities = 68/410 (16%), Positives = 136/410 (33%), Gaps = 65/410 (15%)
Query: 91 LKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLV 150
L P L L S+ +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT-------------------- 39
Query: 151 GKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFEN 210
L L + + SI + L+++ ++L N + P
Sbjct: 40 ------QEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVK 89
Query: 211 LVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATR 270
L L + N ++ ++ +L+ L L+ + +++ D+S L +LT
Sbjct: 90 LTNLYIGTNKIT--------DISALQNLTNLRELYLNEDNI-----SDISPLANLTK--- 133
Query: 271 LTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQL 330
+ +++ +N+ L +SN++ + L + +K+ P I N +L L + NQ+
Sbjct: 134 MYSLNLGANHNLSDLSP-LSNMTG-LNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQI 189
Query: 331 SGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCE 390
+ L +L N+++ P + N+ L +L + +N + P L
Sbjct: 190 ED--ISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLS 243
Query: 391 SLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENR 450
L + + N +S L+ L L+ N+++ + L L L++ N+
Sbjct: 244 QLTWLEIGTNQISD--INAVKDLTKLK-MLNVGSNQISDISVL--NNLSQLNSLFLNNNQ 298
Query: 451 LEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLS 500
L E G L L + N L SL + D + +
Sbjct: 299 LGNEDMEVIGGLTNLTTLFLSQNHITD--IRPLASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 4e-45
Identities = 81/371 (21%), Positives = 152/371 (40%), Gaps = 40/371 (10%)
Query: 154 LSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVF 213
+ + L++ L +T + L SI + +A + + NL +
Sbjct: 15 IFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV--ASIQGIEYLTNLEY 70
Query: 214 LSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTW 273
L+L N ++ ++ L L +L + I +N + D+S L +LTN L
Sbjct: 71 LNLNGNQIT--------DISPLSNLVKLTNLYIGTNKI-----TDISALQNLTN---LRE 114
Query: 274 MHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGT 333
+++N +N + P ++NL+K + +L L N S + + N L L + +++
Sbjct: 115 LYLNEDNISDISP--LANLTK-MYSLNLGANHN-LSDLSPLSNMTGLNYLTVTESKVKD- 169
Query: 334 IPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLI 393
I L +L L LN N++ P + +L L N + P + L
Sbjct: 170 -VTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLN 224
Query: 394 EINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEG 453
+ + NN ++ P +LS L+ L+ N+++ V L L+ L V N++
Sbjct: 225 SLKIGNNKITDLSP--LANLSQLT-WLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD 279
Query: 454 EIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL-SL 512
S N +L L + N +G L L L LSQN+++ P LA L +
Sbjct: 280 --ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKM 335
Query: 513 NNLNLSYNDLE 523
++ + + ++
Sbjct: 336 DSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-43
Identities = 78/360 (21%), Positives = 144/360 (40%), Gaps = 40/360 (11%)
Query: 166 LNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVE 225
L + P +L+ L ++ + E++ L +A ++
Sbjct: 5 LATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA--- 57
Query: 226 NKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLL 285
+ +E L L++ + N + D+S L +L LT ++I +N +
Sbjct: 58 -----SIQGIEYLTNLEYLNLNGNQI-----TDISPLSNLVK---LTNLYIGTNKITDIS 104
Query: 286 PGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLK 345
+ NL+ ++ L+LN + I P + N + L++ N + + + L
Sbjct: 105 A--LQNLTN-LRELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLN 158
Query: 346 ILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGT 405
L + +K+ ++ P I NL L +L LN N +E P L SL N ++
Sbjct: 159 YLTVTESKVK-DVTP-IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDI 214
Query: 406 IPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRL 465
P +++ L+ L NK+T P+ L L +L + N++ + + +L
Sbjct: 215 TP--VANMTRLNS-LKIGNNKITDLSPL--ANLSQLTWLEIGTNQISD--INAVKDLTKL 267
Query: 466 EQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL-SLNNLNLSYNDLEG 524
+ L +G N S L +L L L L+ N L E + + GL +L L LS N +
Sbjct: 268 KMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-42
Identities = 81/364 (22%), Positives = 154/364 (42%), Gaps = 39/364 (10%)
Query: 65 QRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNS 124
L+ + V+ L + +L + I L L+ L LN N
Sbjct: 22 AEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQ 77
Query: 125 ICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNL 184
I P +S L ++ N++ +S +L+ L L ++++ P L NL
Sbjct: 78 ITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISP--LANL 131
Query: 185 SSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHF 244
+ +++++L N+ + + L +L++ + + +V + L L
Sbjct: 132 TKMYSLNLGANHN-LSDLSPLSNMTGLNYLTVTESKVK--------DVTPIANLTDLYSL 182
Query: 245 TITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNN 304
++ N + D+S L SLT+ L + N + P ++N+++ + +L + NN
Sbjct: 183 SLNYNQIE-----DISPLASLTS---LHYFTAYVNQITDITP--VANMTR-LNSLKIGNN 231
Query: 305 KIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGN 364
KI P + N L L++ NQ+S A+ +L LK+L + N++S + N
Sbjct: 232 KITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNN 285
Query: 365 LKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSR 424
L L +LFLN+N L +G +L + LS N+++ P SLS + S D++
Sbjct: 286 LSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMD-SADFAN 342
Query: 425 NKLT 428
+
Sbjct: 343 QVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-35
Identities = 67/306 (21%), Positives = 118/306 (38%), Gaps = 31/306 (10%)
Query: 220 NLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSN 279
L+ + + ++ L + S+ D+ L + +T + +
Sbjct: 4 TLATLPAPIN-QIFPDADLAEGIRAVLQKASV-----TDVVTQEELES---ITKLVVAGE 54
Query: 280 NFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIG 339
+ I L+ ++ L LN N+I P + N V L L + N++ T A+
Sbjct: 55 KVASIQG--IEYLTN-LEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQ 107
Query: 340 ELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSN 399
L NL+ L LN + +S + NL + +L L N +S S L L + ++
Sbjct: 108 NLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHN-LSDLSPLSNMTGLNYLTVTE 164
Query: 400 NNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTF 459
+ + P +L+ L SL + N++ P+ L L + Y N++ P
Sbjct: 165 SKVKDVTP--IANLTDL-YSLSLNYNQIEDISPL--ASLTSLHYFTAYVNQITDITP--V 217
Query: 460 GNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL-SLNNLNLS 518
N RL L +G N S L +L L L++ N +S + L L LN+
Sbjct: 218 ANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVG 273
Query: 519 YNDLEG 524
N +
Sbjct: 274 SNQISD 279
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-32
Identities = 56/269 (20%), Positives = 103/269 (38%), Gaps = 25/269 (9%)
Query: 258 DLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNF 317
+ L R + + ++ L I L + K+ SI GI
Sbjct: 14 QIFPDADLAEGIRA---VLQKASVTDVVT--QEELES-ITKLVVAGEKV-ASIQ-GIEYL 65
Query: 318 VNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNF 377
NL+ L++ NQ++ P + L L L + NK++ ++ NL L L+LN++
Sbjct: 66 TNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDN 121
Query: 378 LEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGK 437
+ P L + +NL N+ + P +++ L+ L + +K+ PI
Sbjct: 122 ISDISP--LANLTKMYSLNLGANHNLSDLSP-LSNMTGLN-YLTVTESKVKDVTPI--AN 175
Query: 438 LKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQN 497
L L L + N++E P + L N + + ++ L L + N
Sbjct: 176 LTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNN 231
Query: 498 NLSGEIPKFLAGL-SLNNLNLSYNDLEGM 525
++ P LA L L L + N + +
Sbjct: 232 KITDLSP--LANLSQLTWLEIGTNQISDI 258
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 2e-21
Identities = 42/230 (18%), Positives = 82/230 (35%), Gaps = 41/230 (17%)
Query: 297 KTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSG 356
TL I P + R + ++ + EL+++ L + K++
Sbjct: 3 ATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS 58
Query: 357 NIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSL 416
I L L L LN N + P L L + + N + T +L++L
Sbjct: 59 --IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNL 112
Query: 417 SISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQ 476
L + + ++ P+ L + L + N ++
Sbjct: 113 R-ELYLNEDNISDISPL--ANLTKMYSLNLGANHNLSDL--------------------- 148
Query: 477 GPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL-SLNNLNLSYNDLEGM 525
S L ++ GL L ++++ + P +A L L +L+L+YN +E +
Sbjct: 149 ----SPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDI 192
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 7e-45
Identities = 72/308 (23%), Positives = 114/308 (37%), Gaps = 56/308 (18%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACL 693
VG G+FG V K +A+K + ++FI E + L + H N+VK+ ACL
Sbjct: 16 VGRGAFGVVCKAKWRA--KDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 694 GADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNY 753
V E+ GSL LH E ++ + + + Y
Sbjct: 72 NPVC-------LVMEYAEGGSLYNVLH-------GAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 754 LHHDCQPVTAHCDLKPSNVLLD-DYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAP 812
LH H DLKP N+LL ++ DFG A + T + KGS ++AP
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT-----NNKGSAAWMAP 172
Query: 813 EYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSS 872
E G S DV+S+GI+L E++ +KP F+ +M V +
Sbjct: 173 EVFEGSNYSEKCDVFSWGIILWEVITRRKP----FD--------EIGGPAFRIMWAVHNG 220
Query: 873 LLPDDEDLILTGNQRQKQARINSIIE-CLISMVRIGVACSMELPQDRTNMTNVVHELQSI 931
P +I+ + + C + P R +M +V + +
Sbjct: 221 TRPP-------------------LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261
Query: 932 KNILLGVE 939
G +
Sbjct: 262 MRYFPGAD 269
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 9e-44
Identities = 97/496 (19%), Positives = 184/496 (37%), Gaps = 45/496 (9%)
Query: 67 VTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEI-GGLRRLKVLALNNNSI 125
L L + + L L+ L L I E L L++L L ++ I
Sbjct: 26 TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKI 85
Query: 126 CGEIPTNI-SRCSTLIPIHPQNNQLVGKILSR--FSSLSKTEILNLGSNHLTG-SIPSSL 181
+ + L + L +L F +L L+L N + + S
Sbjct: 86 -YFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSF 144
Query: 182 GNLSSIHTISLAYNNLDGTIPNSFGWFE--NLVFLSLAANNLSVVENKLTGEVPSLEKLQ 239
G L+S+ +I + N + + + L F SLAAN+L + G+ + +
Sbjct: 145 GKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNM 204
Query: 240 RLQHFTITSNSLGSGGNDDL------SFLCSLTNATRLTWMHINSNNFGGLLPGCISNLS 293
L+ ++ N + S SL A + +N + L+
Sbjct: 205 VLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLA 264
Query: 294 KT-IKTLFLNNNKIYGSIPAGI-GNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNR 351
++ ++ L L++ ++ S+ + + +L+ L++ N+++ A L NL++L L+
Sbjct: 265 RSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSY 323
Query: 352 NKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLS-------- 403
N L + L + + L N + + + E L ++L +N L+
Sbjct: 324 NLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSI 383
Query: 404 ----------GTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEG 453
T+P + + + +S + N ++ L+ L + +NR
Sbjct: 384 PDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFL---LRVPHLQILILNQNRFSS 440
Query: 454 -EIPSTFGNCIRLEQLGMGGNLFQGPISSSL-----GSLRGLRVLDLSQNNLSGEIPKFL 507
T LEQL +G N+ Q + L L L+VL L+ N L+ P
Sbjct: 441 CSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVF 500
Query: 508 AGL-SLNNLNLSYNDL 522
+ L +L L+L+ N L
Sbjct: 501 SHLTALRGLSLNSNRL 516
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 7e-41
Identities = 83/471 (17%), Positives = 164/471 (34%), Gaps = 59/471 (12%)
Query: 59 TCSRRHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVL 118
+CS + + R L + L+ ++L L N S L +L++L
Sbjct: 1 SCSFDGR---IAFYRFCNL----TQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLL 53
Query: 119 ALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIP 178
L + I F +L IL+LGS+ + P
Sbjct: 54 ELGSQYTPLTIDKEA-----------------------FRNLPNLRILDLGSSKIYFLHP 90
Query: 179 SSLGNLSSIHTISLAYNNLDGTI--PNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLE 236
+ L + + L + L + F + L L L+ N + + PS
Sbjct: 91 DAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLY-----LHPSFG 145
Query: 237 KLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTI 296
KL L+ +SN + +L L T L++ + +N+ +
Sbjct: 146 KLNSLKSIDFSSNQIFLVCEHELEPLQGKT----LSFFSLAANSLYSRVSVDWGKCMNPF 201
Query: 297 KTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSG 356
+ + L + GN + ++N +S + ++ ++ G + +
Sbjct: 202 RNMVLEILDVS-------GNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKD 254
Query: 357 NIPPSIGNLKM--LLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLS 414
+ L + +L L+ F+ + L +NL+ N ++ F+ L
Sbjct: 255 PDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLD 314
Query: 415 SLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNL 474
+L L+ S N L L + ++ + +N + TF +L+ L + N
Sbjct: 315 NLQ-VLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNA 373
Query: 475 FQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLSLNNLNLSYNDLEGM 525
+++ + + + LS N L +PK L+ N ++LS N LE +
Sbjct: 374 L-----TTIHFIPSIPDIFLSGNKLV-TLPKI--NLTANLIHLSENRLENL 416
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 5e-40
Identities = 101/528 (19%), Positives = 173/528 (32%), Gaps = 65/528 (12%)
Query: 68 TLLDLRSLKLAGSV-SHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSIC 126
LL+L S ++ NL L+ L L + P GL L L L +
Sbjct: 51 QLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLS 110
Query: 127 GEI--PTNISRCSTLIPIHPQNNQLVGKILSR-FSSLSKTEILNLGSNHLTGSIPSSLGN 183
+ L + NQ+ L F L+ + ++ SN + L
Sbjct: 111 DAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEP 170
Query: 184 LSSIH--TISLAYNNLDGTIPNSF-GWFENLVFLSLAANNLSVVENKLTGEVP------- 233
L SLA N+L + + + L ++S N T ++
Sbjct: 171 LQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVS--GNGWTVDITGNFSNAI 228
Query: 234 ------SLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPG 287
SL + +++ + + L + + + ++ L
Sbjct: 229 SKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSS----VRHLDLSHGFVFSLNSR 284
Query: 288 CISNLSKTIKTLFLNNNKIYGSIPAGI-GNFVNLQRLDMWNNQLSGTIPPAIGELQNLKI 346
L +K L L NKI I NLQ L++ N L L +
Sbjct: 285 VFETLKD-LKVLNLAYNKI-NKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAY 342
Query: 347 LGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTI 406
+ L +N ++ + L+ L L L DN L +++ S+ +I LS N L T+
Sbjct: 343 IDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLV-TL 396
Query: 407 PPQFFSLSSLSIS---------------------LDWSRNKLTGSLPIEV-GKLKILEFL 444
P + + + +S L ++N+ + + + LE L
Sbjct: 397 PKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQL 456
Query: 445 YVYENRLEGEI-----PSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNL 499
++ EN L+ F L+ L + N L LR L L+ N L
Sbjct: 457 FLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL 516
Query: 500 SGEIPKFLAGLSLNNLNLSYNDLEGMVTTEGVFKNASATRILGNSKLC 547
+ + +L L++S N L VF + S I N +C
Sbjct: 517 T-VLSHNDLPANLEILDISRNQLLAP--NPDVFVSLSVLDITHNKFIC 561
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-24
Identities = 72/386 (18%), Positives = 129/386 (33%), Gaps = 80/386 (20%)
Query: 65 QRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNS 124
+ + +L+L K+ L L+ L L N S GL ++ + L N
Sbjct: 290 KDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNH 349
Query: 125 ICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNL 184
I I + F L K + L+L N LT ++ +
Sbjct: 350 I-----AIIQDQT-------------------FKFLEKLQTLDLRDNALT-----TIHFI 380
Query: 185 SSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHF 244
SI I L+ N L L ++L AN + + EN+L
Sbjct: 381 PSIPDIFLSGNKL-----------VTLPKINLTANLIHLSENRLE--------------- 414
Query: 245 TITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNN 304
D L FL + + L + +N N F + + +++ LFL N
Sbjct: 415 ----------NLDILYFLLRVPH---LQILILNQNRFSSCSGDQTPSENPSLEQLFLGEN 461
Query: 305 KIYGSIPAGI-----GNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIP 359
+ + + +LQ L + +N L+ P L L+ L LN N+L+ +
Sbjct: 462 MLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLS 520
Query: 360 PSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFS--LSSLS 417
+ L L ++ N L P SL +++++N F L+ +
Sbjct: 521 HND-LPANLEILDISRNQLLAPNPDVF---VSLSVLDITHNKFICECELSTFINWLNHTN 576
Query: 418 ISLDWSRNKLTGSLPIEVGKLKILEF 443
+++ + P + +
Sbjct: 577 VTIAGPPADIYCVYPDSFSGVSLFSL 602
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-43
Identities = 50/223 (22%), Positives = 91/223 (40%), Gaps = 36/223 (16%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGAS-------RSFIAECKALKSIRHRNLV 686
+G G FG V+KG + + ++ +A+K L + F E + ++ H N+V
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 687 KVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAID 746
K+ V EF+ G L L + + +L + +D
Sbjct: 87 KLYGLMHNPPR-------MVMEFVPCGDLYHRLL---------DKAHPIKWSVKLRLMLD 130
Query: 747 IAYALNYLHHDCQPVTAHCDLKPSNVLLDDY-----MTARVGDFGLARILSPDHTQTSSF 801
IA + Y+ + P H DL+ N+ L + A+V DFGL++ + S
Sbjct: 131 IALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVS 184
Query: 802 SVKGSLGYIAPE--YGVGCEVSTNGDVYSYGILLLELVIGKKP 842
+ G+ ++APE + D YS+ ++L ++ G+ P
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-42
Identities = 60/221 (27%), Positives = 90/221 (40%), Gaps = 34/221 (15%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQH----HGASRSFIAECKALKSIRHRNLVKVL 689
+G+G FG VY+ +AVK + E K ++H N++ +
Sbjct: 15 IGIGGFGKVYRAFWIG--DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 690 TACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAY 749
CL V EF G L L + + +N A+ IA
Sbjct: 73 GVCLKEPNL-----CLVMEFARGGPLNRVLSG-----------KRIPPDILVNWAVQIAR 116
Query: 750 ALNYLHHDCQPVTAHCDLKPSNVLLDDYM--------TARVGDFGLARILSPDHTQTSSF 801
+NYLH + H DLK SN+L+ + ++ DFGLAR +T+
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH----RTTKM 172
Query: 802 SVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
S G+ ++APE S DV+SYG+LL EL+ G+ P
Sbjct: 173 SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-42
Identities = 72/303 (23%), Positives = 128/303 (42%), Gaps = 53/303 (17%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGAS--RSFIAECKALKSIRHRNLVKVLTA 691
+G GSFG+VYKG +AVK+ N+ ++F E L+ RH N++ +
Sbjct: 32 IGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 692 CLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYAL 751
A V ++ SL LH + + + ++IA A +
Sbjct: 89 STAPQL------AIVTQWCEGSSLYHHLH---------ASETKFEMKKLIDIARQTARGM 133
Query: 752 NYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIA 811
+YLH + + H DLK +N+ L + T ++GDFGLA S + GS+ ++A
Sbjct: 134 DYLH--AKSII-HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190
Query: 812 PE---YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDI 868
PE S DVY++GI+L EL+ G+ P + ++N D ++++
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP----YSN---INN------RDQIIEM 237
Query: 869 VDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHEL 928
V G+ +++ S C M R+ C + +R + ++ E+
Sbjct: 238 VGR------------GSLSPDLSKVRS--NCPKRMKRLMAECLKKKRDERPSFPRILAEI 283
Query: 929 QSI 931
+ +
Sbjct: 284 EEL 286
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 2e-42
Identities = 61/391 (15%), Positives = 115/391 (29%), Gaps = 37/391 (9%)
Query: 157 FSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSL 216
+ ++ +I + + L ++ S + ++ + L+ N L F L L+L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 217 AANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHI 276
++N L E LE L L+ + +N + L + +H
Sbjct: 66 SSNVLY--------ETLDLESLSTLRTLDLNNNYVQ-----------ELLVGPSIETLHA 106
Query: 277 NSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPP 336
+NN + K ++L NNKI G +Q LD+ N++
Sbjct: 107 ANNNISRVSCSRGQGK----KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA 162
Query: 337 A-IGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEI 395
L+ L L N + ++ + L L L+ N L + + I
Sbjct: 163 ELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWI 219
Query: 396 NLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEI 455
+L NN L I +L D N + K V + ++
Sbjct: 220 SLRNNKLV-LIEKALRFSQNLE-HFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLT 276
Query: 456 PSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPK-----FLAGL 510
C G + + L L+ + + + G +
Sbjct: 277 GQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQA 336
Query: 511 SLNNLNLSYNDLEGMVTTEGVFKNASATRIL 541
++ + V A L
Sbjct: 337 RQREIDALKEQYR--TVIDQVTLRKQAKITL 365
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 7e-38
Identities = 67/449 (14%), Positives = 141/449 (31%), Gaps = 33/449 (7%)
Query: 80 SVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTL 139
++ N + K + +S + S +K L L+ N + +++ + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 140 IPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDG 199
++ +N L SLS L+L +N++ L SI T+ A NN+
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-S 112
Query: 200 TIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDL 259
+ + + LA N ++++ + R+Q+ + N + + +
Sbjct: 113 RVS--CSRGQGKKNIYLANNKITMLRDL------DEGCRSRVQYLDLKLNEIDT-----V 159
Query: 260 SFLCSLTNATRLTWMHINSNNFGGLLPG-CISNLSKTIKTLFLNNNKIYGSIPAGIGNFV 318
+F ++ L +++ N + + L KTL L++NK+ + +
Sbjct: 160 NFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKL----KTLDLSSNKL-AFMGPEFQSAA 214
Query: 319 NLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLS-GNIPPSIGNLKMLLNLFLNDN- 376
+ + + NN+L I A+ QNL+ L N G + + + +
Sbjct: 215 GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273
Query: 377 FLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVG 436
L +L + +L +L + T L E
Sbjct: 274 KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERE 333
Query: 437 KLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPIS---SSLGSLRGLRVLD 493
+ + + I L +S + L G
Sbjct: 334 NQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQA 393
Query: 494 LSQNNLSGEIPKFLAGLSLNNLNLSYNDL 522
+ Q L + L + Y ++
Sbjct: 394 VGQIELQHATEEQSPLQLLRAIVKRYEEM 422
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-33
Identities = 52/280 (18%), Positives = 95/280 (33%), Gaps = 18/280 (6%)
Query: 267 NATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMW 326
N R + ++ L + +K L L+ N + A + F L+ L++
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWN-VKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 327 NNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSL 386
+N L + L L+ L LN N + + + L +N + + S
Sbjct: 67 SNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR 118
Query: 387 GQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTG-SLPIEVGKLKILEFLY 445
GQ I L+NN ++ S + LD N++ + LE L
Sbjct: 119 GQ--GKKNIYLANNKITMLRDLDEGCRSRV-QYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 446 VYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPK 505
+ N + ++ +L+ L + N + S G+ + L N L I K
Sbjct: 176 LQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEK 231
Query: 506 FLAGL-SLNNLNLSYNDLEGMVTTEGVFKNASATRILGNS 544
L +L + +L N + KN + +
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT 271
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 59/361 (16%), Positives = 105/361 (29%), Gaps = 17/361 (4%)
Query: 86 GNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICG-EIPTNISRCSTLIPIHP 144
K +YL N T + G R++ L L N I + TL ++
Sbjct: 117 SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 145 QNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNS 204
Q N + + +K + L+L SN L + + + + ISL N L I +
Sbjct: 177 QYNFI--YDVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKA 232
Query: 205 FGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCS 264
+ +NL L N + K QR+Q + +G N++ C+
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLR-----DFFSKNQRVQTVAKQTVKKLTGQNEEE---CT 284
Query: 265 LTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLD 324
+ I+ K L ++ + N + +D
Sbjct: 285 VPTLGHYGAYCCEDLP-APFADRLIALKRKEHALLSGQGSET-ERLECERENQARQREID 342
Query: 325 MWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPS 384
Q I Q L + L + L +
Sbjct: 343 ALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHA 402
Query: 385 SLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFL 444
+ Q + + + Q +++ D ++K T L E +LK L
Sbjct: 403 TEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIR-DWDMYQHKET-QLAEENARLKKLNGE 460
Query: 445 Y 445
Sbjct: 461 A 461
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-24
Identities = 40/216 (18%), Positives = 79/216 (36%), Gaps = 13/216 (6%)
Query: 309 SIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKML 368
+I N + + ++ L + N+K L L+ N LS + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 369 LNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLT 428
L L+ N L L +L ++L+NN + + S+ +L + N ++
Sbjct: 61 ELLNLSSNVL--YETLDLESLSTLRTLDLNNNYVQ-ELLV----GPSI-ETLHAANNNIS 112
Query: 429 GSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQG-PISSSLGSLR 487
+ + + + +Y+ N++ G R++ L + N + S
Sbjct: 113 R---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 488 GLRVLDLSQNNLSGEIPKFLAGLSLNNLNLSYNDLE 523
L L+L N + ++ + L L+LS N L
Sbjct: 170 TLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLA 204
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-41
Identities = 87/479 (18%), Positives = 165/479 (34%), Gaps = 98/479 (20%)
Query: 85 IGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHP 144
+ +FL++ ++ T E+P E ++ + P +
Sbjct: 7 NVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRL 65
Query: 145 QNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNS 204
++ + L L + L+ S+P +L S+ + N+L +P
Sbjct: 66 RDC-----------LDRQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPEL 109
Query: 205 FGWFENLVFLSLAANNLSVVENKLT---------GEVPSLEKLQRLQHFTITSNSLGSGG 255
++L+ + LS + L ++P L+ L+ + +NSL
Sbjct: 110 PQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK--- 166
Query: 256 NDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIG 315
+ L ++ +N L + NL + ++ +NN + +P
Sbjct: 167 ----KLPDLPPS---LEFIAAGNNQLEELPE--LQNLPF-LTAIYADNNSL-KKLPDLPL 215
Query: 316 NFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLND 375
+L+ + NN L P + L L + + N L +P +L+ L + D
Sbjct: 216 ---SLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLE---ALNVRD 266
Query: 376 NFLEVSIPSSLGQC-----------------ESLIEINLSNNNLSGTIPPQFFSLSSLSI 418
N+L +P +L +N S+N + ++ SL L++
Sbjct: 267 NYLT-DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIR-SLCDLPPSLEELNV 324
Query: 419 SLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQG- 477
S NKL LP +L+ L N L E+P N L+QL + N +
Sbjct: 325 ----SNNKLI-ELPALPPRLER---LIASFNHLA-EVPELPQN---LKQLHVEYNPLREF 372
Query: 478 -PISSSLGSLR-------------GLRVLDLSQNNLSGEIPKFLAGLSLNNLNLSYNDL 522
I S+ LR L+ L + N L E P S+ +L ++ +
Sbjct: 373 PDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPE--SVEDLRMNSERV 428
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-38
Identities = 86/451 (19%), Positives = 151/451 (33%), Gaps = 79/451 (17%)
Query: 63 RHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNN 122
++ L+L +L L S+ +L + L NS T E+P L+ L V N
Sbjct: 69 LDRQAHELELNNLGL-SSLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNL 123
Query: 123 NSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLG 182
++ P L + NNQL + L + S +I+++ +N L +P
Sbjct: 124 KALSDLPPL-------LEYLGVSNNQL--EKLPELQNSSFLKIIDVDNNSLK-KLPDLPP 173
Query: 183 NLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVV-------------ENKLT 229
+L I N L L + N+L + N L
Sbjct: 174 SLEFIA---AGNNQL--EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILE 228
Query: 230 GEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCI 289
E+P L+ L L +N L + + L +++ N L P
Sbjct: 229 -ELPELQNLPFLTTIYADNNLLKT-------LPDLPPS---LEALNVRDNYLTDL-PELP 276
Query: 290 SNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGL 349
+L + + + P NL L+ +N++ ++ +L+ L +
Sbjct: 277 QSL-TFLDVSENIFSGLSELPP-------NLYYLNASSNEIR-SLC---DLPPSLEELNV 324
Query: 350 NRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQ 409
+ NKL +P L+ L + N L +P + L ++ N L P
Sbjct: 325 SNNKLI-ELPALPPRLE---RLIASFNHLA-EVPELPQNLKQL---HVEYNPLR-EFPDI 375
Query: 410 FFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLG 469
S+ L ++ + L +P LK L +V N L E P + +E L
Sbjct: 376 PESVEDLRMN-----SHLA-EVPELPQNLKQL---HVETNPLR-EFPDIPES---VEDLR 422
Query: 470 MGGNLFQGPISSSLGSLRGLRVLDLSQNNLS 500
M P + + L ++
Sbjct: 423 MNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-34
Identities = 77/384 (20%), Positives = 137/384 (35%), Gaps = 61/384 (15%)
Query: 159 SLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAA 218
S + + S++LT +P N+ S A++ + P G + L
Sbjct: 9 SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD 67
Query: 219 N------NLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLT 272
L + L+ +P L L+ + NSL + L
Sbjct: 68 CLDRQAHELELNNLGLS-SLPEL--PPHLESLVASCNSLT-------ELPELPQSLKSLL 117
Query: 273 WMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSG 332
+ N +S+L ++ L ++NN++ +P + N L+ +D+ NN L
Sbjct: 118 VDNNNLKA--------LSDLPPLLEYLGVSNNQL-EKLPE-LQNSSFLKIIDVDNNSLK- 166
Query: 333 TIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESL 392
+P +L+ + N+L P + NL L ++ ++N L+ +P ES+
Sbjct: 167 KLPD---LPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK-KLPDLPLSLESI 220
Query: 393 IEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLE 452
NN L P+ +L L+ ++ N L +LP L+ L V +N L
Sbjct: 221 ---VAGNNIL--EELPELQNLPFLT-TIYADNNLLK-TLPDLPPSLEA---LNVRDNYLT 270
Query: 453 GEIPSTFGNCIRLEQLGMGGN-------------LFQGPISSSLGSLRGLRVLDLSQNNL 499
++P + L+ + I S L L++S N L
Sbjct: 271 -DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL 329
Query: 500 SGEIPKFLAGLSLNNLNLSYNDLE 523
E+P L L S+N L
Sbjct: 330 I-ELPALPP--RLERLIASFNHLA 350
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-22
Identities = 48/213 (22%), Positives = 75/213 (35%), Gaps = 31/213 (14%)
Query: 311 PAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLN 370
P + N LQ ++ L+ +P +++ ++ N PP G + +
Sbjct: 5 PRNVSN-TFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62
Query: 371 LFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGS 430
L D E+ L+N LS ++P L SL S N LT
Sbjct: 63 SRLRDCL-----------DRQAHELELNNLGLS-SLPELPPHLESLVA----SCNSLT-E 105
Query: 431 LPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLR 490
LP LK L L P LE LG+ N + L + L+
Sbjct: 106 LPELPQSLKSLLVDNNNLKALSDLPPL-------LEYLGVSNNQLEK--LPELQNSSFLK 156
Query: 491 VLDLSQNNLSGEIPKFLAGLSLNNLNLSYNDLE 523
++D+ N+L ++P SL + N LE
Sbjct: 157 IIDVDNNSLK-KLPDLPP--SLEFIAAGNNQLE 186
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 51/235 (21%), Positives = 94/235 (40%), Gaps = 38/235 (16%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECK--ALKSIRHRNLVKVL 689
VG G +G V++G +AVK+F+ + +S+ E + +RH N++
Sbjct: 14 ECVGKGRYGEVWRGSWQG--ENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILG-- 66
Query: 690 TACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAID 746
+ +D ++ + GSL ++L L+ + L I +
Sbjct: 67 --FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-----------TTLDTVSCLRIVLS 113
Query: 747 IAYALNYLHHD-----CQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHT--QTS 799
IA L +LH + +P AH DLK N+L+ + D GLA + S
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG 173
Query: 800 SFSVKGSLGYIAPE------YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFE 848
+ G+ Y+APE + D++++G++L E+ I+ +
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-41
Identities = 66/320 (20%), Positives = 109/320 (34%), Gaps = 49/320 (15%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECK--ALKSIRHRNLVKVL 689
+G G +G V+ G +AVKVF S+ E + +RH N++
Sbjct: 43 KQIGKGRYGEVWMGKWRG--EKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILG-- 95
Query: 690 TACLGADYRGNDFKAS---VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAID 746
+ AD +G + ++ GSL ++L L+ L +A
Sbjct: 96 --FIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-----------TTLDAKSMLKLAYS 142
Query: 747 IAYALNYLH-----HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSP--DHTQTS 799
L +LH +P AH DLK N+L+ T + D GLA +
Sbjct: 143 SVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIP 202
Query: 800 SFSVKGSLGYIAPE------YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINL 853
+ G+ Y+ PE + D+YS+G++L E+ I+ E +
Sbjct: 203 PNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262
Query: 854 HNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSME 913
H+ + M +++ R S ECL M ++ C
Sbjct: 263 HDLVPSDPSYEDM-----------REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAH 311
Query: 914 LPQDRTNMTNVVHELQSIKN 933
P R V L +
Sbjct: 312 NPASRLTALRVKKTLAKMSE 331
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-41
Identities = 51/309 (16%), Positives = 96/309 (31%), Gaps = 28/309 (9%)
Query: 226 NKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLL 285
L L + QR + + N+ + +
Sbjct: 23 TALRPYHDVLSQWQRHYNA----------DRNRWHSAWRQANSNNPQ-IETRTGRALKAT 71
Query: 286 PGCISNL-SKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNL 344
+ + L L + + P +LQ + + L +P + + L
Sbjct: 72 ADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGL 129
Query: 345 KILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCE---------SLIEI 395
+ L L RN L +P SI +L L L + +P L + +L +
Sbjct: 130 ETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSL 188
Query: 396 NLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEI 455
L + ++P +L +L L + L+ +L + L LE L +
Sbjct: 189 RLEWTGIR-SLPASIANLQNLKS-LKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNY 245
Query: 456 PSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL-SLNN 514
P FG L++L + + + L L LDL +P +A L +
Sbjct: 246 PPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCI 305
Query: 515 LNLSYNDLE 523
+ + +
Sbjct: 306 ILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-40
Identities = 66/347 (19%), Positives = 116/347 (33%), Gaps = 30/347 (8%)
Query: 79 GSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCST 138
GS H + S + LY Q ++ + +R + + + +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNA---DRNRW-HSAWRQANSNN 57
Query: 139 LIPIHPQNNQLVGKILS-RFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNL 197
L ++ L L S L P LS + +++ L
Sbjct: 58 PQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL 116
Query: 198 DGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVP-SLEKLQRLQHFTITS-NSLGS-- 253
+P++ F L L+LA N L +P S+ L RL+ +I + L
Sbjct: 117 M-ELPDTMQQFAGLETLTLARNPLR--------ALPASIASLNRLRELSIRACPELTELP 167
Query: 254 ---GGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSI 310
D L N L + + LP I+NL +K+L + N+ + ++
Sbjct: 168 EPLASTDASGEHQGLVN---LQSLRLEWTGIRS-LPASIANLQN-LKSLKIRNSPL-SAL 221
Query: 311 PAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGL-NRNKLSGNIPPSIGNLKMLL 369
I + L+ LD+ PP G LK L L + + L +P I L L
Sbjct: 222 GPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLE 280
Query: 370 NLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSL 416
L L +PS + Q + I + + + + + +
Sbjct: 281 KLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-38
Identities = 62/339 (18%), Positives = 111/339 (32%), Gaps = 37/339 (10%)
Query: 160 LSKTEILNL-GSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAA 218
S E L GS L L + N D +S N +
Sbjct: 11 SSGRENLYFQGSTALR-PYHDVLSQWQR-------HYNADRNRWHSAWRQANSNNPQIET 62
Query: 219 NNLSVVENKLTGEVPSLEKLQR--LQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHI 276
L LE + + S L F + L M I
Sbjct: 63 RTG----RALKATADLLEDATQPGRVALELRSVPLPQ-------FPDQAFRLSHLQHMTI 111
Query: 277 NSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPP 336
++ L P + + ++TL L N + ++PA I + L+ L + +P
Sbjct: 112 DAAGLMEL-PDTMQQFAG-LETLTLARNPL-RALPASIASLNRLRELSIRACPELTELPE 168
Query: 337 AIG---------ELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLG 387
+ L NL+ L L + ++P SI NL+ L +L + ++ L ++ ++
Sbjct: 169 PLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIH 226
Query: 388 QCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVY 447
L E++L PP F + L + + L +LP+++ +L LE L +
Sbjct: 227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLR 285
Query: 448 ENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSL 486
+PS + + +L +
Sbjct: 286 GCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 7e-22
Identities = 31/203 (15%), Positives = 60/203 (29%), Gaps = 19/203 (9%)
Query: 332 GTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCES 391
G+ + L + + + N N +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNN 57
Query: 392 LIEINLSNNNLSGTIPPQFFSLSSLS-ISLDWSRNKLTGSLPIEVGKLKILEFLYVYENR 450
+ L + ++L+ L P + +L L+ + +
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 451 LEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL 510
L E+P T LE L + N + + +S+ SL LR L + E+P+ LA
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 511 ----------SLNNLNLSYNDLE 523
+L +L L + +
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIR 196
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-40
Identities = 86/477 (18%), Positives = 168/477 (35%), Gaps = 30/477 (6%)
Query: 62 RRHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALN 121
R + +L L+S ++ +L L+ L L N + S G L LK L L
Sbjct: 47 RACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLM 106
Query: 122 NNSI-CGEIPTNISRCSTLIPIHPQNNQLVGKILSR-FSSLSKTEILNLGSNHLTGSIPS 179
N + + + L + N + +I F+ L+ L + + L
Sbjct: 107 GNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQ 166
Query: 180 SLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQ 239
SL ++ IH ++L + + ++ +L L NL+ + +P E
Sbjct: 167 SLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQ---FSPLPVDEVSS 223
Query: 240 RLQHFTITSNSLGSGGNDDL-SFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSK---- 294
++ + L ++L L + + + + N G P +S+
Sbjct: 224 PMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKV 283
Query: 295 ---TIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNR 351
TI+ L + ++ + ++R+ + N+++ L++L+ L L+
Sbjct: 284 ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSE 343
Query: 352 NKLSGNIPPS---IGNLKMLLNLFLNDNFLEV--SIPSSLGQCESLIEINLSNNNLSGTI 406
N + + G L L L+ N L L ++L +++S N +
Sbjct: 344 NLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PM 402
Query: 407 PPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLE 466
P + L+ S + + + + LE L V N L+ L+
Sbjct: 403 PDSCQWPEKMRF-LNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSLFLPR---LQ 454
Query: 467 QLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL-SLNNLNLSYNDL 522
+L + N + +SL L V+ +S+N L L SL + L N
Sbjct: 455 ELYISRNKLKTLPDASL--FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-35
Identities = 85/463 (18%), Positives = 152/463 (32%), Gaps = 66/463 (14%)
Query: 86 GNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQ 145
G + +K L L N T+ ++ L+VL L ++ I I +
Sbjct: 23 GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI-NTIEGDA------------ 69
Query: 146 NNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDG-TIPNS 204
F SL E L+L NHL+ S G LSS+ ++L N + +
Sbjct: 70 -----------FYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSL 118
Query: 205 FGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCS 264
F NL L + ++ L L I + SL + + L +
Sbjct: 119 FPNLTNLQTLRIGNVETFSEIRRID-----FAGLTSLNELEIKALSLRNYQSQSLKSI-- 171
Query: 265 LTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLD 324
+ + ++ + LL LS ++ L L + + + + +
Sbjct: 172 ----RDIHHLTLHLSESAFLLEIFADILSS-VRYLELRDTNLARFQFSPLPVDEVSSPMK 226
Query: 325 MWNNQLSG----------TIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLK-------- 366
+ S + I EL ++ N L P +
Sbjct: 227 KLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETV 286
Query: 367 MLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFS-LSSLSISLDWSRN 425
+ L + +L + + E + I + N+ + +P F L SL LD S N
Sbjct: 287 TIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEF-LDLSEN 344
Query: 426 KLTGSL---PIEVGKLKILEFLYVYENRLE--GEIPSTFGNCIRLEQLGMGGNLFQGPIS 480
+ G L+ L + +N L + L L + N F P+
Sbjct: 345 LMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMP 403
Query: 481 SSLGSLRGLRVLDLSQNNLSGEIPKFLAGLSLNNLNLSYNDLE 523
S +R L+LS + + + +L L++S N+L+
Sbjct: 404 DSCQWPEKMRFLNLSSTGIR-VVKTCIP-QTLEVLDVSNNNLD 444
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-32
Identities = 57/380 (15%), Positives = 135/380 (35%), Gaps = 24/380 (6%)
Query: 160 LSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAAN 219
+ + L+L N +T L +++ + L + ++ ++F +L L L+ N
Sbjct: 25 TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDN 84
Query: 220 NLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSN 279
+LS + + L L++ + N + G L N T L + I +
Sbjct: 85 HLSSLSSSW------FGPLSSLKYLNLMGNPYQTLGVTSL-----FPNLTNLQTLRIGNV 133
Query: 280 N-FGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAI 338
F + + L+ + L + + + + ++ L + ++ + +
Sbjct: 134 ETFSEIRRIDFAGLTS-LNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFA 192
Query: 339 GELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLS 398
L +++ L L L+ + ++ + V S + L+ L
Sbjct: 193 DILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILE 252
Query: 399 NNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPST 458
+ + F + + D++ ++ + + + L++ + L ++ +
Sbjct: 253 LSEVE------FDDCTLNGL-GDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTV 305
Query: 459 FGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPK---FLAGL-SLNN 514
+ +++++ + + S L+ L LDLS+N + E K SL
Sbjct: 306 YSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQT 365
Query: 515 LNLSYNDLEGMVTTEGVFKN 534
L LS N L M T +
Sbjct: 366 LVLSQNHLRSMQKTGEILLT 385
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-29
Identities = 62/380 (16%), Positives = 131/380 (34%), Gaps = 26/380 (6%)
Query: 159 SLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAA 218
S + + + S T SIPS L +++ ++ L++N + NL L L +
Sbjct: 3 SCDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 219 NNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINS 278
+ ++ +E + L L+H ++ N L S + L + L ++++
Sbjct: 60 SRINTIEGD------AFYSLGSLEHLDLSDNHLSSLSSSWFGPL------SSLKYLNLMG 107
Query: 279 NNFGGL-LPGCISNLSKTIKTLFLNNNKIYGSIPAG-IGNFVNLQRLDMWNNQLSGTIPP 336
N + L + NL+ ++TL + N + + I +L L++ L
Sbjct: 108 NPYQTLGVTSLFPNLTN-LQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQ 166
Query: 337 AIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEIN 396
++ ++++ L L+ ++ + + L + L L D L S L E +
Sbjct: 167 SLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMK 226
Query: 397 LSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIP 456
S F L L + +E + + +
Sbjct: 227 KLAFRGSVLTDESFNELLKLL-------RYILELSEVEFDDCTLNGLGDFNPSESDVVSE 279
Query: 457 STFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL-SLNNL 515
+ + +L + +S+ L ++ + + + + F L SL L
Sbjct: 280 LGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFL 339
Query: 516 NLSYNDLEGMVTTEGVFKNA 535
+LS N + K A
Sbjct: 340 DLSENLMVEEYLKNSACKGA 359
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-19
Identities = 45/248 (18%), Positives = 86/248 (34%), Gaps = 16/248 (6%)
Query: 309 SIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSI-GNLKM 367
SIP+G+ ++ LD+ N+++ + NL++L L ++++ I +L
Sbjct: 19 SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGS 75
Query: 368 LLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFS-LSSLSISLDWSRNK 426
L +L L+DN L S G SL +NL N F L++L +L +
Sbjct: 76 LEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQ-TLRIGNVE 134
Query: 427 LTGSLPIEV-GKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGS 485
+ L L L + L + + + L + + +
Sbjct: 135 TFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADI 194
Query: 486 LRGLRVLDLSQNNLSG---------EIPKFLAGLSLNNLNLSYNDLEGMVTTEGVFKNAS 536
L +R L+L NL+ E+ + L+ L+ ++ S
Sbjct: 195 LSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELS 254
Query: 537 ATRILGNS 544
+
Sbjct: 255 EVEFDDCT 262
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-40
Identities = 61/315 (19%), Positives = 113/315 (35%), Gaps = 66/315 (20%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGAS--RSFIAECKALKSIRHRNLVKVL 689
L+G G FG VY G +A+++ +++ ++F E A + RH N+V +
Sbjct: 39 ELIGKGRFGQVYHGRW---HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 690 TACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAY 749
AC+ + A + +L + +A L++ + IA +I
Sbjct: 96 GACMSPPHL-----AIITSLCKGRTLYSVVR---------DAKIVLDVNKTRQIAQEIVK 141
Query: 750 ALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILS---PDHTQTSSFSVKGS 806
+ YLH + + H DLK NV D+ + DFGL I + G
Sbjct: 142 GMGYLH--AKGIL-HKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGW 197
Query: 807 LGYIAPE---------YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFG 857
L ++APE S + DV++ G + EL + P F+
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP----FKT-QP----- 247
Query: 858 RKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQD 917
+ ++ + + + P+ S I + I + C ++
Sbjct: 248 ----AEAIIWQMGTGMKPNL-----------------SQIGMGKEISDILLFCWAFEQEE 286
Query: 918 RTNMTNVVHELQSIK 932
R T ++ L+ +
Sbjct: 287 RPTFTKLMDMLEKLP 301
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 9e-40
Identities = 54/233 (23%), Positives = 93/233 (39%), Gaps = 38/233 (16%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECK--ALKSIRHRNLVKVL 689
+G G FG V++G +AVK+F+ + RS+ E + +RH N++
Sbjct: 48 ESIGKGRFGEVWRGKWRG--EEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILG-- 100
Query: 690 TACLGADYRGNDFKAS---VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAID 746
+ AD + N V ++ +GSL ++L+ + + + +A+
Sbjct: 101 --FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----------YTVTVEGMIKLALS 147
Query: 747 IAYALNYLHHD-----CQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSP--DHTQTS 799
A L +LH + +P AH DLK N+L+ T + D GLA D +
Sbjct: 148 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 207
Query: 800 SFSVKGSLGYIAPE------YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIM 846
G+ Y+APE E D+Y+ G++ E+ I
Sbjct: 208 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 1e-39
Identities = 58/345 (16%), Positives = 107/345 (31%), Gaps = 35/345 (10%)
Query: 157 FSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSL 216
+ ++ +I + + L ++ S + ++ + L+ N L F L L+L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 217 AANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHI 276
++N L E LE L L+ + +N + L + +H
Sbjct: 66 SSNVLY--------ETLDLESLSTLRTLDLNNNYVQ-----------ELLVGPSIETLHA 106
Query: 277 NSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPP 336
+NN + K ++L NNKI G +Q LD+ N++
Sbjct: 107 ANNNISRVSCSRGQGK----KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA 162
Query: 337 A-IGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEI 395
L+ L L N + ++ + L L L+ N L + + I
Sbjct: 163 ELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWI 219
Query: 396 NLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEI 455
+L NN L I +L D N + K V + ++
Sbjct: 220 SLRNNKLV-LIEKALRFSQNLE-HFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLT 276
Query: 456 PSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLS 500
C G L + R++ L ++
Sbjct: 277 GQNEEECTVPTLGHYGAYCC-----EDLPAPFADRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 43/288 (14%), Positives = 103/288 (35%), Gaps = 21/288 (7%)
Query: 238 LQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIK 297
R + +T +SL +A + + ++ N + ++ +K ++
Sbjct: 9 GNRYKIEKVTDSSLKQALAS------LRQSAWNVKELDLSGNPLSQISAADLAPFTK-LE 61
Query: 298 TLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGN 357
L L++N +Y + + L+ LD+ NN + + +++ L N +S
Sbjct: 62 LLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-R 113
Query: 358 IPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLS 417
+ S G N++L +N + + G + ++L N + + + S
Sbjct: 114 VSCSRGQG--KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 418 ISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQG 477
L+ N + + +V L+ L + N+L + F + + + + N
Sbjct: 172 EHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL 228
Query: 478 PISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLSLNNLNLSYNDLEGM 525
I +L + L DL N + + ++ ++ +
Sbjct: 229 -IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKL 275
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 68/391 (17%), Positives = 128/391 (32%), Gaps = 81/391 (20%)
Query: 80 SVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTL 139
++ N + K + +S + S +K L L+ N + +I
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPL-SQISAAD------ 53
Query: 140 IPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDG 199
+ +K E+LNL SN L L +LS++ T+ L N +
Sbjct: 54 -----------------LAPFTKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-- 92
Query: 200 TIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDL 259
++ L A NN+S V + + +
Sbjct: 93 ---QELLVGPSIETLHAANNNISRV------SCSRGQGKKNI------------------ 125
Query: 260 SFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYG-SIPAGIGNFV 318
++ +N L S+ ++ L L N+I + +
Sbjct: 126 ---------------YLANNKITMLRDLDEGCRSR-VQYLDLKLNEIDTVNFAELAASSD 169
Query: 319 NLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFL 378
L+ L++ N + + + LK L L+ NKL+ + P + + + L +N L
Sbjct: 170 TLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
Query: 379 EVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKL 438
I +L ++L +L N FFS + ++ K L + +
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK---KLTGQNEEE 282
Query: 439 KILEFLYVYENRLEGEIPSTFGNCIRLEQLG 469
+ L Y ++P+ F + RL LG
Sbjct: 283 CTVPTLGHYGAYCCEDLPAPFAD--RLIALG 311
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 45/238 (18%), Positives = 96/238 (40%), Gaps = 19/238 (7%)
Query: 289 ISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILG 348
N ++ K + ++ + ++ + + N++ LD+ N LS + L++L
Sbjct: 6 KQNGNR-YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 349 LNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPP 408
L+ N L + +L L L LN+N++ L S+ ++ +NNN+S +
Sbjct: 65 LSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSC 116
Query: 409 QFF-SLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEG-EIPSTFGNCIRLE 466
++ + + NK+T ++ G +++L + N ++ + LE
Sbjct: 117 SRGQGKKNIYL----ANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLE 172
Query: 467 QLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL-SLNNLNLSYNDLE 523
L + N + + L+ LDLS N L+ + + ++L N L
Sbjct: 173 HLNLQYNFIYD-VKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 41/216 (18%), Positives = 80/216 (37%), Gaps = 13/216 (6%)
Query: 309 SIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKML 368
+I N + + ++ L + N+K L L+ N LS + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 369 LNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLT 428
L L+ N L L +L ++L+NN + + S+ +L + N ++
Sbjct: 61 ELLNLSSNVL--YETLDLESLSTLRTLDLNNNYVQ-ELLV----GPSI-ETLHAANNNIS 112
Query: 429 GSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGN-LFQGPISSSLGSLR 487
+ G+ + +Y+ N++ G R++ L + N + + S
Sbjct: 113 -RVSCSRGQG--KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 488 GLRVLDLSQNNLSGEIPKFLAGLSLNNLNLSYNDLE 523
L L+L N + ++ + L L+LS N L
Sbjct: 170 TLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLA 204
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 49/322 (15%), Positives = 98/322 (30%), Gaps = 54/322 (16%)
Query: 68 TLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICG 127
LDL L+ + + + L+ L L N ++ L L+ L LNNN +
Sbjct: 37 KELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-- 92
Query: 128 EIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSI 187
+ ++ +H NN + SR + + L +N +T G S +
Sbjct: 93 ---QELLVGPSIETLHAANNNISRVSCSRGQGK---KNIYLANNKITMLRDLDEGCRSRV 146
Query: 188 HTISLAYNNLDG-TIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTI 246
+ L N +D + L L+L N + +V +L+ +
Sbjct: 147 QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY--------DVKGQVVFAKLKTLDL 198
Query: 247 TSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKI 306
+SN L + + + + + L NNK+
Sbjct: 199 SSNKLAF-------------------------------MGPEFQSAAG-VTWISLRNNKL 226
Query: 307 YGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLK 366
I + NL+ D+ N +N ++ + + + +
Sbjct: 227 -VLIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVK-KLTGQNEEEC 283
Query: 367 MLLNLFLNDNFLEVSIPSSLGQ 388
+ L + +P+
Sbjct: 284 TVPTLGHYGAYCCEDLPAPFAD 305
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 58/249 (23%), Positives = 99/249 (39%), Gaps = 37/249 (14%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGAS--RSFIAECKALKSIRHRNLVKVLTA 691
+G G FG K E T + + L R+F+ E K ++ + H N++K +
Sbjct: 18 LGKGCFGQAIKVTHRE--TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 692 CLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYAL 751
Y+ + E++ G+L + QR++ A DIA +
Sbjct: 76 L----YKDKRLNF-ITEYIKGGTLRGIIK---------SMDSQYPWSQRVSFAKDIASGM 121
Query: 752 NYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQT------------S 799
YLH + H DL N L+ + V DFGLAR++ + TQ
Sbjct: 122 AYLH--SMNII-HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178
Query: 800 SFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMF----EGDINLHN 855
++V G+ ++APE G DV+S+GI+L E++ + +N+
Sbjct: 179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG 238
Query: 856 FGRKALPDD 864
F + P +
Sbjct: 239 FLDRYCPPN 247
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-36
Identities = 71/432 (16%), Positives = 147/432 (34%), Gaps = 60/432 (13%)
Query: 129 IPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIH 188
I +N+ +H +L+ +I+ ++ + + L + +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 189 TISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITS 248
++L ++ +F + + L + N + + +
Sbjct: 73 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHV-------------------- 112
Query: 249 NSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYG 308
N LT + + N+ L G N K + TL ++NN +
Sbjct: 113 ----------------FQNVPLLTVLVLERNDLSSLPRGIFHNTPK-LTTLSMSNNNL-E 154
Query: 309 SIPAGI-GNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKM 367
I +LQ L + +N+L+ + + +L ++ N LS ++
Sbjct: 155 RIEDDTFQATTSLQNLQLSSNRLT-HVDL--SLIPSLFHANVSYNLLS-----TLAIPIA 206
Query: 368 LLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKL 427
+ L + N + + L + L +NNL T + L + +D S N+L
Sbjct: 207 VEELDASHNSIN-VVRG--PVNVELTILKLQHNNL--TDTAWLLNYPGL-VEVDLSYNEL 260
Query: 428 TGSLPIEV-GKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSL 486
+ K++ LE LY+ NRL + L+ L + N + +
Sbjct: 261 E-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQF 317
Query: 487 RGLRVLDLSQNNLSGEIPKFLAGLSLNNLNLSYNDLEGMVTTEGVFKNASATRILGNSKL 546
L L L N++ + +L NL LS+ND + + +F+N + + +
Sbjct: 318 DRLENLYLDHNSIV-TLK-LSTHHTLKNLTLSHNDWDC-NSLRALFRNVARPAVDDADQH 374
Query: 547 CGGISEFKLPTC 558
C + + C
Sbjct: 375 CKIDYQLEHGLC 386
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-35
Identities = 72/361 (19%), Positives = 146/361 (40%), Gaps = 38/361 (10%)
Query: 87 NLSFLKQLYLQVNSFTHEIPSEI-GGLRRLKVLALNNNSICGEIPTNI-SRCSTLIPIHP 144
L+ K + + ++ +P+ + R++++L LN+ I EI T + T+ ++
Sbjct: 43 TLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQI-EEIDTYAFAYAHTIQKLYM 100
Query: 145 QNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNS 204
N + F ++ +L L N L+ N + T+S++ NNL+ ++
Sbjct: 101 GFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDT 160
Query: 205 FGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCS 264
F +L L L++N L+ V L + L H ++ N L +
Sbjct: 161 FQATTSLQNLQLSSNRLTHV---------DLSLIPSLFHANVSYNLLS-----------T 200
Query: 265 LTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLD 324
L + + + N+ + L L L +N + + N+ L +D
Sbjct: 201 LAIPIAVEELDASHNSINVVRGPVNVEL----TILKLQHNNL-TDTAW-LLNYPGLVEVD 254
Query: 325 MWNNQLSGTIPP-AIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIP 383
+ N+L I ++Q L+ L ++ N+L + + L L L+ N L +
Sbjct: 255 LSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVE 311
Query: 384 SSLGQCESLIEINLSNNNLSGTIPPQ-FFSLSSLSIS-LDWSRNKLTGSLPIEVGKLKIL 441
+ Q + L + L +N++ T+ +L +L++S DW N L +L V + +
Sbjct: 312 RNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVD 369
Query: 442 E 442
+
Sbjct: 370 D 370
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-35
Identities = 68/414 (16%), Positives = 145/414 (35%), Gaps = 58/414 (14%)
Query: 87 NLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQN 146
+++ + + E L K++ N+++ ++P +
Sbjct: 19 YDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAAL------------- 64
Query: 147 NQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFG 206
S + E+LNL + + +I + + +N + P+ F
Sbjct: 65 ----------LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQ 114
Query: 207 WFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLT 266
L L L N+LS + + +L ++++N+L +D +
Sbjct: 115 NVPLLTVLVLERNDLSSLPRGI------FHNTPKLTTLSMSNNNLERIEDD------TFQ 162
Query: 267 NATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMW 326
T L + ++SN + I +L ++ N + ++ I ++ LD
Sbjct: 163 ATTSLQNLQLSSNRLTHVDLSLIPSL----FHANVSYNLL-STLAIPI----AVEELDAS 213
Query: 327 NNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSL 386
+N ++ + + L IL L N L+ + N L+ + L+ N LE +
Sbjct: 214 HNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPF 268
Query: 387 GQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYV 446
+ + L + +SNN L + + +L + LD S N L + + LE LY+
Sbjct: 269 VKMQRLERLYISNNRLV-ALNLYGQPIPTLKV-LDLSHNHLL-HVERNQPQFDRLENLYL 325
Query: 447 YENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLS 500
N + + L+ L + N + +S R + + +
Sbjct: 326 DHNSIV-TLK--LSTHHTLKNLTLSHNDWDC--NSLRALFRNVARPAVDDADQH 374
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 5e-35
Identities = 68/352 (19%), Positives = 131/352 (37%), Gaps = 36/352 (10%)
Query: 176 SIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSL 235
I S+L + + + D N ++ + + + L L
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAAL------L 65
Query: 236 EKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKT 295
+ ++++ + + + A + +++ N L P N+
Sbjct: 66 DSFRQVELLNLNDLQIEEIDTY------AFAYAHTIQKLYMGFNAIRYLPPHVFQNVPL- 118
Query: 296 IKTLFLNNNKIYGSIPAGI-GNFVNLQRLDMWNNQLSGTIPPAI-GELQNLKILGLNRNK 353
+ L L N + S+P GI N L L M NN L I +L+ L L+ N+
Sbjct: 119 LTVLVLERNDL-SSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNR 176
Query: 354 LSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFF-S 412
L+ ++ + L + ++ N L S+L ++ E++ S+N+++ +
Sbjct: 177 LT-HVDL--SLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPVNVE 227
Query: 413 LSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGG 472
L+ L + N LT + L + + N LE + F RLE+L +
Sbjct: 228 LTILKL----QHNNLT-DTAWLLN-YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN 281
Query: 473 NLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL-SLNNLNLSYNDLE 523
N ++ + L+VLDLS N+L + + L NL L +N +
Sbjct: 282 NRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 331
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 56/325 (17%), Positives = 106/325 (32%), Gaps = 59/325 (18%)
Query: 65 QRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEI-GGLRRLKVLALNNN 123
+T+L L L+ N L L + N+ I + L+ L L++N
Sbjct: 117 PLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSN 175
Query: 124 SICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGN 183
+ T + LS SL N+ N L+ +L
Sbjct: 176 RL------------THVD------------LSLIPSL---FHANVSYNLLS-----TLAI 203
Query: 184 LSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQH 243
++ + ++N+++ + L L L NNL+ + L L
Sbjct: 204 PIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT--------DTAWLLNYPGLVE 252
Query: 244 FTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNN 303
++ N L RL ++I++N L + +K L L++
Sbjct: 253 VDLSYNELEKIMYH------PFVKMQRLERLYISNNRLVA-LNLYGQPIPT-LKVLDLSH 304
Query: 304 NKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIG 363
N + + F L+ L + +N + T+ + LK L L+ N N ++
Sbjct: 305 NHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLKNLTLSHNDWDCNSLRAL- 359
Query: 364 NLKMLLNLFLNDNFLEVSIPSSLGQ 388
+ + ++D I L
Sbjct: 360 -FRNVARPAVDDADQHCKIDYQLEH 383
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-34
Identities = 68/393 (17%), Positives = 141/393 (35%), Gaps = 36/393 (9%)
Query: 109 IGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNL 168
+GG +R V C I +N+ +H +L+ +I+
Sbjct: 1 VGGQQRYNVKPRQPEYKC--IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTF 58
Query: 169 GSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKL 228
++ + + L + + ++L ++ +F + + L + N + + +
Sbjct: 59 KNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHV 118
Query: 229 TGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGC 288
+ + L + N L S N +LT + +++NN +
Sbjct: 119 ------FQNVPLLTVLVLERNDLSSLPRG------IFHNTPKLTTLSMSNNNLERIEDDT 166
Query: 289 ISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILG 348
+ ++ L L++N++ + + +L ++ N LS + ++ L
Sbjct: 167 FQATTS-LQNLQLSSNRL-THVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELD 217
Query: 349 LNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPP 408
+ N ++ + + L L L N L + + L L+E++LS N L I
Sbjct: 218 ASHNSIN-VVRGPV--NVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELE-KIMY 271
Query: 409 QFFS-LSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQ 467
F + L L S N+L +L + + L+ L + N L + RLE
Sbjct: 272 HPFVKMQRLE-RLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLEN 328
Query: 468 LGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLS 500
L + N + L + L+ L LS N+
Sbjct: 329 LYLDHNSIV---TLKLSTHHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-33
Identities = 72/361 (19%), Positives = 147/361 (40%), Gaps = 38/361 (10%)
Query: 87 NLSFLKQLYLQVNSFTHEIPSEI-GGLRRLKVLALNNNSICGEIPTNI-SRCSTLIPIHP 144
L+ K + + ++ +P+ + R++++L LN+ I EI T + T+ ++
Sbjct: 49 TLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQI-EEIDTYAFAYAHTIQKLYM 106
Query: 145 QNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNS 204
N + F ++ +L L N L+ N + T+S++ NNL+ ++
Sbjct: 107 GFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDT 166
Query: 205 FGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCS 264
F +L L L++N L+ V+ L + L H ++ N L +
Sbjct: 167 FQATTSLQNLQLSSNRLTHVDLSL---------IPSLFHANVSYNLLS-----------T 206
Query: 265 LTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLD 324
L + + + N+ + L L L +N + + N+ L +D
Sbjct: 207 LAIPIAVEELDASHNSINVVRGPVNVEL----TILKLQHNNL-TDTAW-LLNYPGLVEVD 260
Query: 325 MWNNQLSGTIPP-AIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIP 383
+ N+L I ++Q L+ L ++ N+L + + L L L+ N L +
Sbjct: 261 LSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVE 317
Query: 384 SSLGQCESLIEINLSNNNLSGTIPPQ-FFSLSSLSIS-LDWSRNKLTGSLPIEVGKLKIL 441
+ Q + L + L +N++ T+ +L +L++S DW N L +L V + +
Sbjct: 318 RNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVD 375
Query: 442 E 442
+
Sbjct: 376 D 376
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-31
Identities = 69/418 (16%), Positives = 147/418 (35%), Gaps = 58/418 (13%)
Query: 87 NLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQN 146
+++ + + E L K++ N+++ ++P +
Sbjct: 25 YDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAAL------------- 70
Query: 147 NQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFG 206
S + E+LNL + + +I + + +N + P+ F
Sbjct: 71 ----------LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQ 120
Query: 207 WFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLT 266
L L L N+LS + + +L ++++N+L +D +
Sbjct: 121 NVPLLTVLVLERNDLSSLPRGI------FHNTPKLTTLSMSNNNLERIEDD------TFQ 168
Query: 267 NATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMW 326
T L + ++SN + I +L ++ N + ++ I ++ LD
Sbjct: 169 ATTSLQNLQLSSNRLTHVDLSLIPSL----FHANVSYNLL-STLAIPI----AVEELDAS 219
Query: 327 NNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSL 386
+N ++ + + L IL L N L+ + N L+ + L+ N LE +
Sbjct: 220 HNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPF 274
Query: 387 GQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYV 446
+ + L + +SNN L + + +L + LD S N L + + LE LY+
Sbjct: 275 VKMQRLERLYISNNRLV-ALNLYGQPIPTLKV-LDLSHNHLL-HVERNQPQFDRLENLYL 331
Query: 447 YENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIP 504
N + + L+ L + N + +S R + + + +I
Sbjct: 332 DHNSIV-TLK--LSTHHTLKNLTLSHNDWDC--NSLRALFRNVARPAVDDADQHCKID 384
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 5e-20
Identities = 67/441 (15%), Positives = 134/441 (30%), Gaps = 98/441 (22%)
Query: 65 QRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEI-GGLRRLKVLALNNN 123
+T+L L L+ N L L + N+ I + L+ L L++N
Sbjct: 123 PLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSN 181
Query: 124 SICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGN 183
+ T + S + N+ N L+ +L
Sbjct: 182 RL------------THVD---------------LSLIPSLFHANVSYNLLS-----TLAI 209
Query: 184 LSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQH 243
++ + ++N+++ + L L L NNL+ + L L
Sbjct: 210 PIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT--------DTAWLLNYPGLVE 258
Query: 244 FTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNN 303
++ N L I + F + L + L+++N
Sbjct: 259 VDLSYNEL----------------------EKIMYHPFVKM-----QRL----ERLYISN 287
Query: 304 NKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIG 363
N++ ++ L+ LD+ +N L + + L+ L L+ N + +
Sbjct: 288 NRL-VALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL--S 342
Query: 364 NLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWS 423
L NL L+ N + + S ++ + + + I Q S
Sbjct: 343 THHTLKNLTLSHNDWDCN--SLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPY 400
Query: 424 RNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSL 483
++L L+ + V E ++ G C + + +L
Sbjct: 401 LDRL----------LQYIALTSVVE-----KVQRAQGRCSATDTINSVQSLSHYITQQGG 445
Query: 484 GSLRGLRVLDLSQNNLSGEIP 504
L+G L+ N L E+
Sbjct: 446 VPLQGNEQLEAEVNELRAEVQ 466
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 2e-12
Identities = 53/409 (12%), Positives = 125/409 (30%), Gaps = 29/409 (7%)
Query: 68 TLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICG 127
+ L ++ ++ + +++L NS + + L +L L +N++
Sbjct: 190 LIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHNNL-T 245
Query: 128 EIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSI 187
+ + L+ + N+L + F + + E L + +N L ++ + ++
Sbjct: 246 DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTL 303
Query: 188 HTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTIT 247
+ L++N+L + + F+ L L L N++ + L L++ T++
Sbjct: 304 KVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL---------KLSTHHTLKNLTLS 353
Query: 248 SNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPG-CISNLSKTIKTL---FLNN 303
N + L L + + L G C K ++
Sbjct: 354 HNDW---DCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIAL 410
Query: 304 NKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNI----P 359
+ + G ++ + LQ + L N+L +
Sbjct: 411 TSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTN 470
Query: 360 PSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSIS 419
I ++L L + + N + Q F L
Sbjct: 471 EQIQQEQLLQGLHAEIDTNLRRYRLPKDGLARSSD--NLNKVFTHLKERQAFKLRETQAR 528
Query: 420 LDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQL 468
+ K + +E + + + L + T +++QL
Sbjct: 529 RTEADAKQKETEDLEQENIALEKQLDNKRAKQAELRQETSLKRQKVKQL 577
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-34
Identities = 79/367 (21%), Positives = 136/367 (37%), Gaps = 50/367 (13%)
Query: 161 SKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANN 220
++ + ++P + + + L N + + F F +L L L N
Sbjct: 11 AQDRAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENI 67
Query: 221 LSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNN 280
+S VE + L L+ + SN L I
Sbjct: 68 VSAVEPG------AFNNLFNLRTLGLRSNRLKL----------------------IPLGV 99
Query: 281 FGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGI-GNFVNLQRLDMWNNQLSGTIPP-AI 338
F GL SNL L ++ NKI + + + NL+ L++ +N L I A
Sbjct: 100 FTGL-----SNL----TKLDISENKI-VILLDYMFQDLYNLKSLEVGDNDLV-YISHRAF 148
Query: 339 GELQNLKILGLNRNKLSGNIPP-SIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINL 397
L +L+ L L + L+ +IP ++ +L L+ L L + S + L + +
Sbjct: 149 SGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEI 207
Query: 398 SNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEV-GKLKILEFLYVYENRLEGEIP 456
S+ T+ P +L+ SL + LT ++P L L FL + N +
Sbjct: 208 SHWPYLDTMTPNCLYGLNLT-SLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEG 265
Query: 457 STFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL-SLNNL 515
S +RL+++ + G + L LRVL++S N L+ + +L L
Sbjct: 266 SMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETL 325
Query: 516 NLSYNDL 522
L N L
Sbjct: 326 ILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-30
Identities = 66/291 (22%), Positives = 109/291 (37%), Gaps = 21/291 (7%)
Query: 240 RLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTL 299
+ + N + + D+ + L + +N N + PG +NL ++TL
Sbjct: 33 ETRLLDLGKNRIKTLNQDEFASF------PHLEELELNENIVSAVEPGAFNNLFN-LRTL 85
Query: 300 FLNNNKIYGSIPAGI-GNFVNLQRLDMWNNQLSGTIPPAI-GELQNLKILGLNRNKLSGN 357
L +N++ IP G+ NL +LD+ N++ + + +L NLK L + N L
Sbjct: 86 GLRSNRL-KLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-Y 142
Query: 358 IPPSI-GNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFS-LSS 415
I L L L L L +L LI + L + N++ I F L
Sbjct: 143 ISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYR 201
Query: 416 LSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPS-TFGNCIRLEQLGMGGNL 474
L L+ S ++ L L + L +P + + L L + N
Sbjct: 202 LK-VLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNP 259
Query: 475 FQGPISSSLGSLRGLRVLDLSQNNLSGEIPKF-LAGL-SLNNLNLSYNDLE 523
S L L L+ + L L+ + + GL L LN+S N L
Sbjct: 260 ISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT 309
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-30
Identities = 72/328 (21%), Positives = 126/328 (38%), Gaps = 24/328 (7%)
Query: 128 EIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSI 187
+P I + + N++ F+S E L L N ++ P + NL ++
Sbjct: 25 AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL 82
Query: 188 HTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTIT 247
T+ L N L F NL L ++ N + ++ + + + L L+ +
Sbjct: 83 RTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYM------FQDLYNLKSLEVG 136
Query: 248 SNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIY 307
N L + S L L + + N + +S+L + L L + I
Sbjct: 137 DNDLVYISHRAFSGL------NSLEQLTLEKCNLTSIPTEALSHLHG-LIVLRLRHLNIN 189
Query: 308 GSIPAGI-GNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPP-SIGNL 365
+I L+ L++ + T+ P NL L + L+ +P ++ +L
Sbjct: 190 -AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHL 247
Query: 366 KMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQ-FFSLSSLSISLDWSR 424
L L L+ N + S L + L EI L L+ + P F L+ L + L+ S
Sbjct: 248 VYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRV-LNVSG 305
Query: 425 NKLTGSLPIEV-GKLKILEFLYVYENRL 451
N+LT +L V + LE L + N L
Sbjct: 306 NQLT-TLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-30
Identities = 59/319 (18%), Positives = 122/319 (38%), Gaps = 21/319 (6%)
Query: 89 SFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNI-SRCSTLIPIHPQNN 147
+ + L L N E L+ L LN N + + + L + ++N
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV-SAVEPGAFNNLFNLRTLGLRSN 90
Query: 148 QLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGW 207
+L L F+ LS L++ N + + +L ++ ++ + N+L +F
Sbjct: 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSG 150
Query: 208 FENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTN 267
+L L+L NL+ + + +L L L + ++ + + L
Sbjct: 151 LNSLEQLTLEKCNLTSIPTE------ALSHLHGLIVLRLRHLNINAIRDYSFKRL----- 199
Query: 268 ATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAG-IGNFVNLQRLDMW 326
RL + I+ + + + +L + + + ++P + + V L+ L++
Sbjct: 200 -YRLKVLEISHWPYLDTMTPNCLYGL-NLTSLSITHCNL-TAVPYLAVRHLVYLRFLNLS 256
Query: 327 NNQLSGTIPP-AIGELQNLKILGLNRNKLSGNIPPSI-GNLKMLLNLFLNDNFLEVSIPS 384
N +S TI + EL L+ + L +L+ + P L L L ++ N L S
Sbjct: 257 YNPIS-TIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEES 314
Query: 385 SLGQCESLIEINLSNNNLS 403
+L + L +N L+
Sbjct: 315 VFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 54/250 (21%), Positives = 100/250 (40%), Gaps = 36/250 (14%)
Query: 290 SNLSKTIKTLFLNNNKIYGSIPAGI-GNFVNLQRLDMWNNQLSGTIPP-AIGELQNLKIL 347
+ + L L N+I ++ +F +L+ L++ N +S + P A L NL+ L
Sbjct: 28 EGIPTETRLLDLGKNRI-KTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTL 85
Query: 348 GLNRNKLSGNIPPSI-GNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTI 406
GL N+L IP + L L L +++N + + + +L + + +N+L I
Sbjct: 86 GLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YI 143
Query: 407 PPQFFS-LSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRL 465
+ FS L+SL L + LT S+P + L
Sbjct: 144 SHRAFSGLNSLEQ-LTLEKCNLT-SIP-----------------------TEALSHLHGL 178
Query: 466 EQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEI-PKFLAGLSLNNLNLSYNDLEG 524
L + S L L+VL++S + P L GL+L +L++++ +L
Sbjct: 179 IVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA 238
Query: 525 MVTTEGVFKN 534
+ ++
Sbjct: 239 V--PYLAVRH 246
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-13
Identities = 46/222 (20%), Positives = 87/222 (39%), Gaps = 25/222 (11%)
Query: 69 LLDLRSLKLAG------SVSHFIGNLSFLKQLYLQVNSFTHEIPSEI-GGLRRLKVLALN 121
L +L+SL++ S F G L+ L+QL L+ + T IP+E L L VL L
Sbjct: 127 LYNLKSLEVGDNDLVYISHRAFSG-LNSLEQLTLEKCNLTS-IPTEALSHLHGLIVLRLR 184
Query: 122 NNSICGEIPTNI-SRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPS- 179
+ +I I R L + + + + L++ +LT ++P
Sbjct: 185 HLNI-NAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYL 242
Query: 180 SLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQ 239
++ +L + ++L+YN + + L + L L+VVE + L
Sbjct: 243 AVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPY------AFRGLN 296
Query: 240 RLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNF 281
L+ ++ N L + + +L + ++SN
Sbjct: 297 YLRVLNVSGNQLTTLEESVFHSVGNLET------LILDSNPL 332
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-34
Identities = 81/367 (22%), Positives = 133/367 (36%), Gaps = 57/367 (15%)
Query: 160 LSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAAN 219
+ +LN+G + LT ++P L I T+ + NNL ++P L L ++ N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPP---ELRTLEVSGN 91
Query: 220 NLSVVENKLTGEVP-SLEKLQRLQHFTITSNSLGS----------GGNDDLSFLCSLTNA 268
L+ +P L L F+ L + GN S
Sbjct: 92 QLT--------SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVLPPG- 142
Query: 269 TRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNN 328
L + ++ N L P S L K L+ NN++ S+P LQ L + +N
Sbjct: 143 --LQELSVSDNQLASL-PALPSELCK----LWAYNNQL-TSLPMLPSG---LQELSVSDN 191
Query: 329 QLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQ 388
QL+ ++P EL L N+L+ ++P LK L ++ N L S+P +
Sbjct: 192 QLA-SLPTLPSELYKLWAYN---NRLT-SLPALPSGLK---ELIVSGNRLT-SLPVLPSE 242
Query: 389 CESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYE 448
L E+ +S N L+ ++P L SLS+ RN+LT LP + L + +
Sbjct: 243 ---LKELMVSGNRLT-SLPMLPSGLLSLSVY----RNQLT-RLPESLIHLSSETTVNLEG 293
Query: 449 NRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLA 508
N L E I G + +S L + + +
Sbjct: 294 NPLS-ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAP 352
Query: 509 GLSLNNL 515
+
Sbjct: 353 ADRWHMF 359
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 8e-29
Identities = 68/378 (17%), Positives = 125/378 (33%), Gaps = 62/378 (16%)
Query: 68 TLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICG 127
+L++ L ++ + + L + N+ T +P+ LR L ++ N +
Sbjct: 43 AVLNVGESGLT-TLPDCLPAH--ITTLVIPDNNLT-SLPALPPELR---TLEVSGNQL-T 94
Query: 128 EIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSI 187
+P L L + S L + N LT S+P L +
Sbjct: 95 SLPVLPPGLLELSIFSNPLTHLP-------ALPSGLCKLWIFGNQLT-SLPVLPPGLQEL 146
Query: 188 HTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTIT 247
++ N L ++P L L N L+ +P L LQ +++
Sbjct: 147 S---VSDNQLA-SLPALPS---ELCKLWAYNNQLT--------SLPML--PSGLQELSVS 189
Query: 248 SNSLGSGGNDDLSFLCSLTNA-TRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKI 306
N L SL + L + +N L P S L K L ++ N++
Sbjct: 190 DNQL-----------ASLPTLPSELYKLWAYNNRLTSL-PALPSGL----KELIVSGNRL 233
Query: 307 YGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLK 366
S+P L+ L + N+L+ ++P L L + RN+L+ +P S+ +L
Sbjct: 234 -TSLPVLPSE---LKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLS 284
Query: 367 MLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNK 426
+ L N L +L + S + +L ++ +
Sbjct: 285 SETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAA---ADW 341
Query: 427 LTGSLPIEVGKLKILEFL 444
L + E
Sbjct: 342 LVPAREGEPAPADRWHMF 359
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 1e-28
Identities = 61/255 (23%), Positives = 102/255 (40%), Gaps = 41/255 (16%)
Query: 269 TRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNN 328
+T + I NN L P L +TL ++ N++ S+P + L
Sbjct: 61 AHITTLVIPDNNLTSL-PALPPEL----RTLEVSGNQLT-SLPVLPPGLLELSIFSNPLT 114
Query: 329 QLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQ 388
L L L + N+L+ ++P L+ L ++DN L S+P+ +
Sbjct: 115 HLPA-------LPSGLCKLWIFGNQLT-SLPVLPPGLQ---ELSVSDNQLA-SLPALPSE 162
Query: 389 CESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYE 448
L NN L+ ++P L LS+S N+L SLP +L L + Y
Sbjct: 163 LCKL---WAYNNQLT-SLPMLPSGLQELSVS----DNQLA-SLPTLPSELYKL---WAYN 210
Query: 449 NRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLA 508
NRL +P+ L++L + GN + L+ L +S N L+ +P +
Sbjct: 211 NRLT-SLPALPSG---LKELIVSGNRLTS-LPVLPSELK---ELMVSGNRLT-SLPMLPS 261
Query: 509 GLSLNNLNLSYNDLE 523
L +L++ N L
Sbjct: 262 --GLLSLSVYRNQLT 274
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-27
Identities = 64/261 (24%), Positives = 103/261 (39%), Gaps = 43/261 (16%)
Query: 263 CSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQR 322
C L ++ + L P L I TL + +N + S+PA L+
Sbjct: 37 CLNNGNAVL---NVGESGLTTL-P---DCLPAHITTLVIPDNNL-TSLPALPPE---LRT 85
Query: 323 LDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSI 382
L++ NQL+ ++P L L I L P L L++ N L S+
Sbjct: 86 LEVSGNQLT-SLPVLPPGLLELSIFSNPLTHL----PALPSGLC---KLWIFGNQLT-SL 136
Query: 383 PSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILE 442
P + L ++S+N L+ ++P L L N+LT SLP+ L+ L
Sbjct: 137 PVLPPGLQEL---SVSDNQLA-SLPALPSELCKLWAY----NNQLT-SLPMLPSGLQEL- 186
Query: 443 FLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGE 502
V +N+L +P+ L +L N ++S GL+ L +S N L+
Sbjct: 187 --SVSDNQLA-SLPTLPSE---LYKLWAYNN----RLTSLPALPSGLKELIVSGNRLT-S 235
Query: 503 IPKFLAGLSLNNLNLSYNDLE 523
+P + L L +S N L
Sbjct: 236 LPVLPS--ELKELMVSGNRLT 254
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-31
Identities = 80/396 (20%), Positives = 145/396 (36%), Gaps = 38/396 (9%)
Query: 53 CKWYGVTCSRRH--------QRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHE 104
Y C R V +DL +A L L+ L ++ +
Sbjct: 10 VIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLV 69
Query: 105 IPSEI-GGLRRLKVLALNNNSICGEIPTNI-SRCSTLIPIHPQNNQLVGKILSR--FSSL 160
I + GL L +L L+ N ++ T + + L + L G +LS F L
Sbjct: 70 IRNNTFRGLSSLIILKLDYNQF-LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPL 128
Query: 161 SKTEILNLGSNHLTGSIPSSL-GNLSSIHTISLAYNNLDGTIPNSFGWFE--NLVFLSLA 217
+ E+L L N++ P+S N+ H + L +N + F+ + L L+
Sbjct: 129 TSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLS 188
Query: 218 ANNLSVVENKLTGEVP--SLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMH 275
+ L + G + K + ++ N + T L +
Sbjct: 189 SITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSL-ILS 247
Query: 276 INSNNFGGLLPGCISNLSK---------TIKTLFLNNNKIYGSIPAGI-GNFVNLQRLDM 325
+ N + +KT L+ +KI ++ + +F +L++L +
Sbjct: 248 NSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKI-FALLKSVFSHFTDLEQLTL 306
Query: 326 WNNQLSGTIPP-AIGELQNLKILGLNRNKLSGNIPPSI-GNLKMLLNLFLNDNFLEVSIP 383
N+++ I A L +L L L++N L +I + NL L L L+ N + ++
Sbjct: 307 AQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALG 363
Query: 384 S-SLGQCESLIEINLSNNNLSGTIPPQFF-SLSSLS 417
S +L E+ L N L ++P F L+SL
Sbjct: 364 DQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQ 398
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-29
Identities = 72/391 (18%), Positives = 130/391 (33%), Gaps = 48/391 (12%)
Query: 163 TEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIP-NSFGWFENLVFLSLAANNL 221
++L N + +S L + + + I N+F +L+ L L N
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 222 SVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNF 281
+E L L+ T+T +L F T L + + NN
Sbjct: 92 LQLETGA------FNGLANLEVLTLTQCNLDGAVLSGNFF----KPLTSLEMLVLRDNNI 141
Query: 282 GGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGI---GNFVNLQRLDMWNNQL-------- 330
+ P + L L NK+ SI + L + + L
Sbjct: 142 KKIQPASFFLNMRRFHVLDLTFNKV-KSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWL 200
Query: 331 SGTIPPAIGELQNLKILGLNRNKLSGNIPPSI---GNLKMLLNLFLNDNFLEVSIPSSLG 387
+ ++ L L+ N ++ + +L L++++ S
Sbjct: 201 GWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGS------ 254
Query: 388 QCESLIEINLSNNNLSGTIPPQFFSLSSLSI-SLDWSRNKLTGSLPIEV-GKLKILEFLY 445
+ + N F L + + + D S++K+ +L V LE L
Sbjct: 255 --------SFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLT 305
Query: 446 VYENRLEGEIPS-TFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIP 504
+ +N + +I F L +L + N S +L L VLDLS N++
Sbjct: 306 LAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGD 364
Query: 505 KFLAGL-SLNNLNLSYNDLEGMVTTEGVFKN 534
+ GL +L L L N L+ + +G+F
Sbjct: 365 QSFLGLPNLKELALDTNQLKSV--PDGIFDR 393
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-26
Identities = 78/414 (18%), Positives = 147/414 (35%), Gaps = 65/414 (15%)
Query: 91 LKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLV 150
+ + L +NS + L+ L+ L + + I N
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNT----------------- 74
Query: 151 GKILSRFSSLSKTEILNLGSNHLTGSIPSS-LGNLSSIHTISLAYNNLDGTI--PNSFGW 207
F LS IL L N + + L+++ ++L NLDG + N F
Sbjct: 75 ------FRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKP 127
Query: 208 FENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTN 267
+L L L NN+ ++ ++R +T N + S +DL
Sbjct: 128 LTSLEMLVLRDNNIKKIQPA-----SFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGK-- 180
Query: 268 ATRLTWMHINSNNFGGLLPGCISNLS-------KTIKTLFLNNNKIYGSIPAGIGNFVN- 319
T + ++S + + +I TL L+ N S+ + +
Sbjct: 181 --HFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAG 238
Query: 320 --LQRLDMWNNQLSGTIPPAIG------------ELQNLKILGLNRNKLSGNIPPSI-GN 364
+Q L + N+ G+ E +K L+++K+ + S+ +
Sbjct: 239 TKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSH 297
Query: 365 LKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFF-SLSSLSISLDWS 423
L L L N + ++ L+++NLS N L +I + F +L L + LD S
Sbjct: 298 FTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEV-LDLS 355
Query: 424 RNKLTGSLPIEV-GKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQ 476
N + +L + L L+ L + N+L+ F L+++ + N +
Sbjct: 356 YNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 5e-19
Identities = 49/284 (17%), Positives = 87/284 (30%), Gaps = 39/284 (13%)
Query: 291 NLSKTIKTLFLNNNKIYGSIPAG-IGNFVNLQRLDMWNNQLSGTIPP-AIGELQNLKILG 348
L + + L+ N I + +LQ L + I L +L IL
Sbjct: 27 ELPAHVNYVDLSLNSI-AELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85
Query: 349 LNRNKLSGNIPPSI-GNLKMLLNLFLNDNFLEVSI--PSSLGQCESLIEINLSNNNLSGT 405
L+ N+ + L L L L L+ ++ + SL + L +NN+
Sbjct: 86 LDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-K 143
Query: 406 IPPQ--FFSLSSLSISLDWSRNKLT----------GSLPIEVGKLKILEFLYVYENRLEG 453
I P F ++ + LD + NK+ + +L + + E L
Sbjct: 144 IQPASFFLNMRRFHV-LDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGW 202
Query: 454 EIPSTFGNCIRLEQLGMGGN---------LFQGPISSSLGSLR----GLRVLDLSQNNLS 500
E + L + GN F + + SL N
Sbjct: 203 EKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFK 262
Query: 501 GEIPKFLAGLSLNN---LNLSYNDLEGMVTTEGVFKNASATRIL 541
GL + +LS + + + + VF + + L
Sbjct: 263 DPDNFTFKGLEASGVKTCDLSKSKIFAL--LKSVFSHFTDLEQL 304
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 56/316 (17%), Positives = 105/316 (33%), Gaps = 62/316 (19%)
Query: 72 LRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPT 131
++ ++ A F N+ L L N ++ + L +SI
Sbjct: 141 IKKIQPAS----FFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSI------ 190
Query: 132 NISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTI- 190
TL ++ L + + L+L N S+ + + I
Sbjct: 191 ------TLQDMNE--YWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQ 242
Query: 191 ----SLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVE---NKLTGEVPSLEKLQRLQH 243
S +YN +F +N F L A+ + + +K+
Sbjct: 243 SLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-------------- 288
Query: 244 FTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNN 303
+L ++ T L + + N + L+ + L L+
Sbjct: 289 ------ALLKS---------VFSHFTDLEQLTLAQNEINKIDDNAFWGLTH-LLKLNLSQ 332
Query: 304 NKIYGSIPAGI-GNFVNLQRLDMWNNQLSGTIPP-AIGELQNLKILGLNRNKLSGNIPPS 361
N + GSI + + N L+ LD+ N + + + L NLK L L+ N+L ++P
Sbjct: 333 NFL-GSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDG 389
Query: 362 I-GNLKMLLNLFLNDN 376
I L L ++L+ N
Sbjct: 390 IFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 5e-14
Identities = 44/253 (17%), Positives = 81/253 (32%), Gaps = 27/253 (10%)
Query: 309 SIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSI-GNLKM 367
+PA ++ +D+ N ++ + LQ+L+ L + + I + L
Sbjct: 27 ELPA------HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80
Query: 368 LLNLFLNDNFLEVSIPSS-LGQCESLIEINLSNNNL-SGTIPPQFFS-LSSLSISLDWSR 424
L+ L L+ N + + +L + L+ NL + FF L+SL L
Sbjct: 81 LIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLE-MLVLRD 138
Query: 425 NKLTGSLPIEV-GKLKILEFLYVYENRLEGEIPSTFGNCIRLEQ----------LGMGGN 473
N + P ++ L + N+++ N M
Sbjct: 139 NNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEY 198
Query: 474 LFQGPISSSLGSLRGLRVLDLSQNNL----SGEIPKFLAGLSLNNLNLSYNDLEGMVTTE 529
+ + LDLS N + +AG + +L LS + G
Sbjct: 199 WLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGH 258
Query: 530 GVFKNASATRILG 542
FK+ G
Sbjct: 259 TNFKDPDNFTFKG 271
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 9e-09
Identities = 41/235 (17%), Positives = 77/235 (32%), Gaps = 29/235 (12%)
Query: 63 RHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLK-----V 117
R +TL D+ L + + L L N F + +
Sbjct: 186 RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLI 245
Query: 118 LALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSR----------FSSLSKTEILN 167
L+ + N TN + + + LS+ FS + E L
Sbjct: 246 LSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLT 305
Query: 168 LGSNHLTGSIPS-SLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVEN 226
L N + I + L+ + ++L+ N L F + L L L+ N++ + +
Sbjct: 306 LAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGD 364
Query: 227 KLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNF 281
+ S L L+ + +N L S + L T L + +++N +
Sbjct: 365 Q------SFLGLPNLKELALDTNQLKSVPDGIFDRL------TSLQKIWLHTNPW 407
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-31
Identities = 88/425 (20%), Positives = 148/425 (34%), Gaps = 31/425 (7%)
Query: 68 TLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTH-EIPSEIGGLRRLKVLALNNNSIC 126
LDL KL LK L L N+F I E G + +LK L L+ +
Sbjct: 72 EYLDLSHNKLV---KISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE 128
Query: 127 GEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSS 186
I+ + + K L +L T + ++S
Sbjct: 129 KSSVLPIAHLNISKVLLVLGETYGEKE--DPEGLQDFNTESLHIVFPTNKEFHFILDVSV 186
Query: 187 IHTISLAYNNLDGT---------IPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEK 237
+L +N+ + N +L NN+ N + L
Sbjct: 187 KTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFI-RILQLVW 245
Query: 238 LQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSK-TI 296
+ +F+I++ L + S T+ L+ + S+ FG S I
Sbjct: 246 HTTVWYFSISNVKLQGQLDFRDFDY-SGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNI 304
Query: 297 KTLFLNNNKIYGSIPAGI-GNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLS 355
K ++ + + LD NN L+ T+ G L L+ L L N+L
Sbjct: 305 KNFTVSGTR---MVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361
Query: 356 GNIPPSIG---NLKMLLNLFLNDNFLEVSIPSSL-GQCESLIEINLSNNNLSGTIPPQFF 411
+ +K L L ++ N + +SL+ +N+S+N L+ TI F
Sbjct: 362 -ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTI---FR 417
Query: 412 SLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMG 471
L LD NK+ S+P +V KL+ L+ L V N+L+ F L+++ +
Sbjct: 418 CLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLH 476
Query: 472 GNLFQ 476
N +
Sbjct: 477 TNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-30
Identities = 87/454 (19%), Positives = 158/454 (34%), Gaps = 42/454 (9%)
Query: 91 LKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLV 150
L + N + S+I L +L++L +++N I + L + +N+L
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL- 81
Query: 151 GKILSRFSSLSKTEILNLGSNHLTGSIPSS--LGNLSSIHTISLAYNNLDGTIPNSFGWF 208
+S + L+L N ++P GN+S + + L+ +L+
Sbjct: 82 -VKIS-CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEK------SSV 132
Query: 209 ENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFL--CSLT 266
+ L+++ L + E E P LQ F S + N + F+ S+
Sbjct: 133 LPIAHLNISKVLLVLGETYGEKEDPEG-----LQDFNTESLHIVFPTNKEFHFILDVSVK 187
Query: 267 NATRLTWMHINSNNFGGLLPGCISNLSK-----TIKTLFLNNNKIYGSIPAGIGNFV--- 318
L +I +S L+K + L LNN + + I V
Sbjct: 188 TVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHT 247
Query: 319 NLQRLDMWNNQLSG-----TIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFL 373
+ + N +L G + L+ L I + + +
Sbjct: 248 TVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNF 307
Query: 374 NDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPI 433
+ + + + ++ SNN L+ T+ L+ L L N+L L
Sbjct: 308 TVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELET-LILQMNQLK-ELSK 365
Query: 434 EVG---KLKILEFLYVYENRLE-GEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGL 489
++K L+ L + +N + E L L M N+ I L +
Sbjct: 366 IAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRI 423
Query: 490 RVLDLSQNNLSGEIPKFLAGL-SLNNLNLSYNDL 522
+VLDL N + IPK + L +L LN++ N L
Sbjct: 424 KVLDLHSNKIK-SIPKQVVKLEALQELNVASNQL 456
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-27
Identities = 73/426 (17%), Positives = 143/426 (33%), Gaps = 25/426 (5%)
Query: 87 NLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSI-CGEIPTNISRCSTLIPIHPQ 145
L+ L L N I LK L L+ N+ I S L +
Sbjct: 67 FNQELEYLDLSHNKLVK-ISC--HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLS 123
Query: 146 NNQLVGKILSRFSSLSKTEI-LNLGSNHLTGSIPSSLGNL--SSIHTISLAYNNLDGTIP 202
L + + L+ +++ L LG + P L + S+H + +
Sbjct: 124 TTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILD 183
Query: 203 NSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFL 262
S NL ++ + + L+ +L + T+ + + +
Sbjct: 184 VSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTW---NSFIRI 240
Query: 263 CSLTNATRLTWMHINSNNFGGLLPGCISNLS----KTIKTLFLNNNKIYGSIPAGIGNFV 318
L T + + I++ G L + S K + + ++ F
Sbjct: 241 LQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFS 300
Query: 319 NLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFL 378
N+ + + ++ L + N L+ + + G+L L L L N L
Sbjct: 301 NMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL 360
Query: 379 EVSIPSSLG---QCESLIEINLSNNNLSGTIPPQFFS-LSSLSISLDWSRNKLTGSLPIE 434
+ + Q +SL ++++S N++S S SL L+ S N LT ++
Sbjct: 361 K-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLS-LNMSSNILTDTIF-- 416
Query: 435 VGKLKI-LEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLD 493
L ++ L ++ N+++ IP L++L + N + L L+ +
Sbjct: 417 -RCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIW 474
Query: 494 LSQNNL 499
L N
Sbjct: 475 LHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 3e-21
Identities = 71/403 (17%), Positives = 143/403 (35%), Gaps = 38/403 (9%)
Query: 161 SKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANN 220
KT ILN+ N+++ S + +LS + + +++N + + F + + L +L L+ N
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 221 LSVV--------------ENKLT--GEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCS 264
L + N + +L+ +++ L ++ L
Sbjct: 81 LVKISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNI 140
Query: 265 LTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLD 324
L + + GL +L T + + S+ ++ +
Sbjct: 141 SKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCV 200
Query: 325 MWNNQLSGTIPPAIGELQN--LKILGLNRNKLSGNIPPSIGNLKM--------LLNLFLN 374
+ +N+ S + N L L LN + + N I L + N+ L
Sbjct: 201 LEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQ 260
Query: 375 DNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSI-SLDWSRNKLTGSLPI 433
S ++L + ++ + S+++I + S ++ L
Sbjct: 261 GQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCP 320
Query: 434 EVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQ--GPISSSLGSLRGLRV 491
K+ L N L + G+ LE L + N + I+ ++ L+
Sbjct: 321 --SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQ 378
Query: 492 LDLSQNNLSGEIPK--FLAGLSLNNLNLSYNDLEGMVTTEGVF 532
LD+SQN++S + K SL +LN+S N L T+ +F
Sbjct: 379 LDISQNSVSYDEKKGDCSWTKSLLSLNMSSNIL-----TDTIF 416
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 3e-15
Identities = 42/252 (16%), Positives = 81/252 (32%), Gaps = 22/252 (8%)
Query: 290 SNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGL 349
+LS+ L ++ N I + I + L+ L + +N++ Q L+ L L
Sbjct: 17 KDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDL 76
Query: 350 NRNKLSGNIPPSIGNLKMLLNLFLNDNFL-EVSIPSSLGQCESLIEINLSNNNLSGTIPP 408
+ NKL I L +L L+ N + I G L + LS +L +
Sbjct: 77 SHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVL 133
Query: 409 QFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPS-----TFGNCI 463
L+ + L + L+ ++ + +
Sbjct: 134 PIAHLNISKVLLVLGETYG---EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVA 190
Query: 464 RLEQLGMGGNLFQG------PISSSLGSLRGLRVLDLSQNNLSG----EIPKFLAGLSLN 513
LE + L I + L + L L L+ + I + + ++
Sbjct: 191 NLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVW 250
Query: 514 NLNLSYNDLEGM 525
++S L+G
Sbjct: 251 YFSISNVKLQGQ 262
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 9e-10
Identities = 37/193 (19%), Positives = 63/193 (32%), Gaps = 22/193 (11%)
Query: 67 VTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSIC 126
+ + + +S L N T + G L L+ L L N +
Sbjct: 302 MNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL- 360
Query: 127 GEIPTNISRCSTLIPIHPQ-------NNQL-VGKILSRFSSLSKTEILNLGSNHLTGSIP 178
+S+ + + N + + S LN+ SN LT +I
Sbjct: 361 ----KELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIF 416
Query: 179 SSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKL 238
L I + L N + +IP E L L++A+N L V + ++L
Sbjct: 417 RCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPD------GIFDRL 467
Query: 239 QRLQHFTITSNSL 251
LQ + +N
Sbjct: 468 TSLQKIWLHTNPW 480
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-31
Identities = 63/322 (19%), Positives = 131/322 (40%), Gaps = 34/322 (10%)
Query: 115 LKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLT 174
L+V+ ++ + ++P ++ + L+ + QNN++ F +L L L +N ++
Sbjct: 33 LRVVQCSDLGL-EKVPKDLPPDTALLDL--QNNKITEIKDGDFKNLKNLHTLILINNKIS 89
Query: 175 GSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPS 234
P + L + + L+ N L +P + L L + N ++ V + +
Sbjct: 90 KISPGAFAPLVKLERLYLSKNQLK-ELPE--KMPKTLQELRVHENEITKVRKSVFNGLNQ 146
Query: 235 LEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSK 294
+ + L N L S G ++ +F +L+++ I N + G +L
Sbjct: 147 MIVV-ELGT-----NPLKSSGIENGAF----QGMKKLSYIRIADTNITTIPQGLPPSL-- 194
Query: 295 TIKTLFLNNNKIYGSIPAGI-GNFVNLQRLDMWNNQLSGTIPP-AIGELQNLKILGLNRN 352
L L+ NKI + A NL +L + N +S + ++ +L+ L LN N
Sbjct: 195 --TELHLDGNKI-TKVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNN 250
Query: 353 KLSGNIPPSIGNLKMLLNLFLNDNFLE------VSIPSSLGQCESLIEINLSNNNLSGT- 405
KL +P + + K + ++L++N + P + S ++L +N +
Sbjct: 251 KLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWE 309
Query: 406 IPPQ-FFSLSSLSISLDWSRNK 426
I P F + + ++ K
Sbjct: 310 IQPSTFRCVYVRA-AVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 51/288 (17%), Positives = 103/288 (35%), Gaps = 44/288 (15%)
Query: 264 SLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRL 323
N L + + +N + PG + L K ++ L+L+ N++ +P + LQ L
Sbjct: 71 DFKNLKNLHTLILINNKISKISPGAFAPLVK-LERLYLSKNQLK-ELPEKM--PKTLQEL 126
Query: 324 DMWNNQLSGTIPPAI-GELQNLKILGLNRNKL-SGNIPPSI-GNLKMLLNLFLNDNFLEV 380
+ N+++ + ++ L + ++ L N L S I +K L + + D +
Sbjct: 127 RVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT- 184
Query: 381 SIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKI 440
+IP L SL E++L N ++ + L
Sbjct: 185 TIPQGL--PPSLTELHLDGNKIT-KVDAASLK------------------------GLNN 217
Query: 441 LEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLS 500
L L + N + + N L +L + N + L + ++V+ L NN+S
Sbjct: 218 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNIS 276
Query: 501 G------EIPKFLAGL-SLNNLNLSYNDLEGMVTTEGVFKNASATRIL 541
P + S + ++L N ++ F+ +
Sbjct: 277 AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAV 324
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 70/340 (20%), Positives = 125/340 (36%), Gaps = 67/340 (19%)
Query: 58 VTCSRRH---------QRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSE 108
V CS LLDL++ K+ NL L L L N + P
Sbjct: 36 VQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 95
Query: 109 IGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSR-FSSLSKTEILN 167
L +L+ L L+ N + E+P + + TL + N++ K+ F+ L++ ++
Sbjct: 96 FAPLVKLERLYLSKNQL-KELPEKMPK--TLQELRVHENEIT-KVRKSVFNGLNQMIVVE 151
Query: 168 LGSNHLTGSI--PSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVE 225
LG+N L S + + + I +A N+ TIP G +L L L N ++ V+
Sbjct: 152 LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVD 208
Query: 226 NKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLL 285
SL L + ++ N+ +
Sbjct: 209 AA------------------------------------SLKGLNNLAKLGLSFNSISAVD 232
Query: 286 PGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPP-------AI 338
G ++N ++ L LNNNK+ +P G+ + +Q + + NN +S I
Sbjct: 233 NGSLANTPH-LRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYN 289
Query: 339 GELQNLKILGLNRNKLS-GNIPPSI-GNLKMLLNLFLNDN 376
+ + + L N + I PS + + + L +
Sbjct: 290 TKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 51/217 (23%), Positives = 93/217 (42%), Gaps = 28/217 (12%)
Query: 633 LVGVGSFGSVYKGI-IDEGRTTIAVKVFNLQHHGAS--RSFIAECKALKSIRHRNLVKVL 689
+G GSF +VYKG+ + +A + S + F E + LK ++H N+V+
Sbjct: 33 EIGRGSFKTVYKGLDTETTV-EVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR-- 89
Query: 690 TACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAID 746
+ K + E M G+L+ +L F + + + +
Sbjct: 90 --FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF----------KVMKIKVLRSWCRQ 137
Query: 747 IAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM-TARVGDFGLARILSPDHTQTSSFSVKG 805
I L +L H P H DLK N+ + + ++GD GLA + + + +V G
Sbjct: 138 ILKGLQFL-HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIG 192
Query: 806 SLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
+ ++APE + + DVY++G+ +LE+ + P
Sbjct: 193 TPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYP 228
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-29
Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 27/213 (12%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLG 694
G G +G VY+G+ + T+AVK + F+ E +K I+H NLV++L C
Sbjct: 229 GGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 287
Query: 695 ADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYAL 751
Y EFM YG+L ++L + + ++ + L +A I+ A+
Sbjct: 288 EPP--------FYIITEFMTYGNLLDYLR--------ECNRQEVSAVVLLYMATQISSAM 331
Query: 752 NYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYI 810
YL + H +L N L+ + +V DFGL+R+++ T T+ K + +
Sbjct: 332 EYLEKKNF----IHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWT 386
Query: 811 APEYGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
APE + S DV+++G+LL E+ G P
Sbjct: 387 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 63/323 (19%), Positives = 126/323 (39%), Gaps = 37/323 (11%)
Query: 115 LKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLT 174
L+V+ ++ + +P IS + QNN + F L L L +N ++
Sbjct: 35 LRVVQCSDLGL-KAVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS 91
Query: 175 GSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPS 234
+ L + + ++ N+L IP +LV L + N + V + + +
Sbjct: 92 KIHEKAFSPLRKLQKLYISKNHLV-EIPP--NLPSSLVELRIHDNRIRKVPKGVFSGLRN 148
Query: 235 LEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSK 294
+ + + + ++ G D L L ++ I+ G+ L
Sbjct: 149 MNCI-EMGGNPLENSGFEPGAFDGLK----------LNYLRISEAKLTGIPKDLPETL-- 195
Query: 295 TIKTLFLNNNKIYGSIPAGI-GNFVNLQRLDMWNNQLSGTIPP-AIGELQNLKILGLNRN 352
L L++NKI +I + L RL + +NQ+ I ++ L L+ L L+ N
Sbjct: 196 --NELHLDHNKI-QAIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNN 251
Query: 353 KLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSS-------LGQCESLIEINLSNNNLS-G 404
KLS +P + +LK+L ++L+ N + + + + I+L NN +
Sbjct: 252 KLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYW 309
Query: 405 TIPPQ-FFSLSSLSISLDWSRNK 426
+ P F ++ ++ + K
Sbjct: 310 EVQPATFRCVTDRL-AIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 53/285 (18%), Positives = 104/285 (36%), Gaps = 25/285 (8%)
Query: 269 TRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGI-GNFVNLQRLDMWN 327
T + + +N+ L L + L L NNKI I LQ+L +
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQH-LYALVLVNNKI-SKIHEKAFSPLRKLQKLYISK 111
Query: 328 NQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSI-GNLKMLLNLFLNDNFL-EVSIPSS 385
N L IPP + +L L ++ N++ +P + L+ + + + N L
Sbjct: 112 NHLV-EIPPNL--PSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPG 167
Query: 386 LGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEV-GKLKILEFL 444
L + +S L+ IP +L+ L NK+ ++ +E + L L
Sbjct: 168 AFDGLKLNYLRISEAKLT-GIPKDLPE--TLN-ELHLDHNKIQ-AIELEDLLRYSKLYRL 222
Query: 445 YVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIP 504
+ N++ + L +L + N + + L L+ L+V+ L NN++ ++
Sbjct: 223 GLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNIT-KVG 280
Query: 505 K--------FLAGLSLNNLNLSYNDLEGMVTTEGVFKNASATRIL 541
+ N ++L N + F+ + +
Sbjct: 281 VNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAI 325
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 7e-22
Identities = 64/365 (17%), Positives = 118/365 (32%), Gaps = 94/365 (25%)
Query: 58 VTCSRRH---------QRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSE 108
V CS TLLDL++ ++ L L L L N +
Sbjct: 38 VQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKA 97
Query: 109 IGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNL 168
LR+L+ L ++ N + EIP N+ SSL L +
Sbjct: 98 FSPLRKLQKLYISKNHL-VEIPPNL-----------------------PSSL---VELRI 130
Query: 169 GSNHLTGSIPSSLGNLSSIHTISLAYNNL-DGTIPNSFGWFE--NLVFLSLAANNLSVVE 225
N + L +++ I + N L + G F+ L +L ++ L+ +
Sbjct: 131 HDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEP--GAFDGLKLNYLRISEAKLTGIP 188
Query: 226 NKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLL 285
L L +H++ N +
Sbjct: 189 KDLP---------------------------------------ETLNELHLDHNKIQAIE 209
Query: 286 PGCISNLSKTIKTLFLNNNKIYGSIPAGI-GNFVNLQRLDMWNNQLSGTIPPAIGELQNL 344
+ SK + L L +N+I I G L+ L + NN+LS +P + +L+ L
Sbjct: 210 LEDLLRYSK-LYRLGLGHNQI-RMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLL 266
Query: 345 KILGLNRNKLSGNIPPSI-------GNLKMLLNLFLNDNFLE-VSIPSSLGQC-ESLIEI 395
+++ L+ N ++ + + + L +N + + + +C + I
Sbjct: 267 QVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAI 325
Query: 396 NLSNN 400
N
Sbjct: 326 QFGNY 330
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-29
Identities = 69/403 (17%), Positives = 150/403 (37%), Gaps = 22/403 (5%)
Query: 86 GNLSFLKQLYLQVNSFTH-EIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHP 144
++ L+ L L N F + E G L +L L L+ ++ +
Sbjct: 118 CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLD 177
Query: 145 QNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNS 204
+ + + + T +L+L + + +++++ + L+ L+
Sbjct: 178 LVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQR 237
Query: 205 FGWFENLVFLSLAANNLSVVENKLTG----EVPSLEKLQRLQHFTITSNSLGSGGNDDLS 260
F + + N+++ + T ++ + +++ I + ++ + +
Sbjct: 238 LMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEF 297
Query: 261 FLCSLTNATRLTWMHINSNNFGGLLPGCISNLSK-TIKTLFLNNNKIYGSIPAGIGNFVN 319
+ L H+ + F S ++ IK L +++ + +
Sbjct: 298 TYSETALKS-LMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPS--PSS 354
Query: 320 LQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLE 379
L+ N + ++ L+ L+ L L RN L N K + +L D L
Sbjct: 355 FTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLN 413
Query: 380 VSIPSSLGQC-----ESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIE 434
S+ S ES++ +NLS+N L+G++ F L LD N++ S+P +
Sbjct: 414 -SLNSHAYDRTCAWAESILVLNLSSNMLTGSV---FRCLPPKVKVLDLHNNRIM-SIPKD 468
Query: 435 VGKLKILEFLYVYENRLEGEIP-STFGNCIRLEQLGMGGNLFQ 476
V L+ L+ L V N+L+ +P F L+ + + N +
Sbjct: 469 VTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWD 510
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-25
Identities = 79/487 (16%), Positives = 156/487 (32%), Gaps = 35/487 (7%)
Query: 52 FCKWYGVTCSRRHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGG 111
G ++ +++D + L V K L L NS + +I
Sbjct: 18 LALIVGSMTPFSNELESMVDYSNRNLT-HV--PKDLPPRTKALSLSQNSISELRMPDISF 74
Query: 112 LRRLKVLALNNNSICGEIPTNI-SRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGS 170
L L+VL L++N I + ++ L + +N+L + +S ++ L+L
Sbjct: 75 LSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHNRL--QNIS-CCPMASLRHLDLSF 130
Query: 171 NHLTGSIPSS--LGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKL 228
N +P GNL+ + + L+ +L + + +S
Sbjct: 131 NDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQ---LDLLPVAHLHLSCILLDLVSYHIKGG 186
Query: 229 TGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGC 288
E + L ++ N ++ L L + + N L
Sbjct: 187 ETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQL-SNIKLNDENCQRLMTFLSEL 245
Query: 289 ISNLSKTIKTLFLNNNKIYGSIPAGIGNFVN---LQRLDMWNNQLSGTIPPAIG-----E 340
T+ + L + + + F ++ L+++N ++ I
Sbjct: 246 TRGP--TLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETA 303
Query: 341 LQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNN 400
L++L I + + + L+ + S +N + N
Sbjct: 304 LKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQN 363
Query: 401 NLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRL----EGEIP 456
+ ++ +L L L RN L + K + L + L
Sbjct: 364 VFTDSVFQGCSTLKRLQT-LILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYD 421
Query: 457 STFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL-SLNNL 515
T + L + N+ G + L ++VLDL N + IPK + L +L L
Sbjct: 422 RTCAWAESILVLNLSSNMLTGSVFRCLPPK--VKVLDLHNNRIM-SIPKDVTHLQALQEL 478
Query: 516 NLSYNDL 522
N++ N L
Sbjct: 479 NVASNQL 485
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-23
Identities = 69/426 (16%), Positives = 137/426 (32%), Gaps = 29/426 (6%)
Query: 87 NLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSI-CGEIPTNISRCSTLIPIHPQ 145
L+ L + N + I + L+ L L+ N + + L +
Sbjct: 98 FNQDLEYLDVSHNRLQN-ISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLS 154
Query: 146 NNQLVGKILSRFSSLS-KTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNS 204
+ L + L +L+L S H+ G SL ++ + L ++
Sbjct: 155 AAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTT-VLHLVFHPNSLFSVQV 213
Query: 205 FGWFENLVFLSLAANNLSVVE-NKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLC 263
L L L+ L+ +L + L + L + T+ L
Sbjct: 214 NMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTW---KCSVKLF 270
Query: 264 SLTNATRLTWMHINSNNFGGLLPGCISNLS----KTIKTLFLNNNKIYGSIPAGIGNFVN 319
+ +++I + + S K++ + N S A F
Sbjct: 271 QFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAE 330
Query: 320 LQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLE 379
+ + + + L +N + ++ LK L L L N L+
Sbjct: 331 MNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390
Query: 380 VSIPS---SLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTG----SLP 432
+ SL +++S N+L+ + + + + L+ S N LTG LP
Sbjct: 391 -NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP 449
Query: 433 IEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVL 492
+ ++ L ++ NR+ IP + L++L + N + L L+ +
Sbjct: 450 PK------VKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYI 502
Query: 493 DLSQNN 498
L N
Sbjct: 503 WLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 5e-10
Identities = 43/294 (14%), Positives = 83/294 (28%), Gaps = 87/294 (29%)
Query: 60 CSRRHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLA 119
+ + + +++ S + + L ++ L
Sbjct: 300 SETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLN 359
Query: 120 LNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPS 179
N + S+L + + L L N L
Sbjct: 360 FT------------------------QNVFTDSVFQGCSTLKRLQTLILQRNGLK----- 390
Query: 180 SLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQ 239
+N+
Sbjct: 391 --------------------NFFKVALMTKNM---------------------------S 403
Query: 240 RLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTL 299
L+ ++ NSL S D C+ + ++++SN G + C L +K L
Sbjct: 404 SLETLDVSLNSLNSHAYD---RTCAWA--ESILVLNLSSNMLTGSVFRC---LPPKVKVL 455
Query: 300 FLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPP-AIGELQNLKILGLNRN 352
L+NN+I SIP + + LQ L++ +NQL ++P L +L+ + L+ N
Sbjct: 456 DLHNNRI-MSIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 8e-10
Identities = 43/225 (19%), Positives = 90/225 (40%), Gaps = 12/225 (5%)
Query: 309 SIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSI-GNLKM 367
+P + + L + N +S P I L L++L L+ N++ ++ + +
Sbjct: 45 HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQD 101
Query: 368 LLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNL-SGTIPPQFFSLSSLSISLDWSRNK 426
L L ++ N L+ +I SL ++LS N+ + +F +L+ L+ L S K
Sbjct: 102 LEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTF-LGLSAAK 157
Query: 427 LTGSLPIEVGKLKILE-FLYVYENRLEGEIPSTF--GNCIRLEQLGMGGNLFQGPISSSL 483
+ V L + L + ++G + N L + +LF ++ S+
Sbjct: 158 FRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSV 217
Query: 484 GSLRGLRVLDLSQNNLSGEIPKFLAGLSLNNLNLSYNDLEGMVTT 528
+L L++ ++ N+ + + L L+ + TT
Sbjct: 218 NALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETT 262
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 122 bits (306), Expect = 6e-29
Identities = 58/265 (21%), Positives = 98/265 (36%), Gaps = 33/265 (12%)
Query: 260 SFLCSLTNATRLTWMHINSNNFGGLLPGCI-SNLSKTIKTLFLNNNKIYGSIPAGIGNFV 318
+ + + N N LL C+ + L LN + S+P +
Sbjct: 28 DYFSAWDKWEKQALPGENRNEAVSLLKECLINQF----SELQLNRLNL-SSLPDNLPP-- 80
Query: 319 NLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFL 378
+ L++ N L ++P L+ L N+LS +P +LK +L +++N L
Sbjct: 81 QITVLEITQNALI-SLPELPASLEYLD---ACDNRLS-TLPELPASLK---HLDVDNNQL 132
Query: 379 EVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKL 438
+P E + N NN L+ +P SL LS+ N+LT LP L
Sbjct: 133 T-MLPELPALLEYI---NADNNQLT-MLPELPTSLEVLSVR----NNQLT-FLPELPESL 182
Query: 439 KILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISS---SLGSLRGLRVLDLS 495
+ L V N LE +P+ E+ + + I+ ++ SL + L
Sbjct: 183 EAL---DVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRITHIPENILSLDPTCTIILE 238
Query: 496 QNNLSGEIPKFLAGLSLNNLNLSYN 520
N LS I + L+ +
Sbjct: 239 DNPLSSRIRESLSQQTAQPDYHGPR 263
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 6e-28
Identities = 56/338 (16%), Positives = 121/338 (35%), Gaps = 43/338 (12%)
Query: 176 SIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSL 235
SI + N S+ + + YN + GT + F ++ +L N N+ +
Sbjct: 2 SIMLPINNNFSL-SQNSFYNTISGTYADYFSAWDKWEKQALPGENR----NEAV-SLLKE 55
Query: 236 EKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKT 295
+ + + +L S ++T + I N L P ++L
Sbjct: 56 CLINQFSELQLNRLNLSS---------LPDNLPPQITVLEITQNALISL-PELPASL--- 102
Query: 296 IKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLS 355
+ L +N++ ++P + L+ LD+ NNQL+ +P L+ + + N+L+
Sbjct: 103 -EYLDACDNRL-STLPELPAS---LKHLDVDNNQLT-MLPELPA---LLEYINADNNQLT 153
Query: 356 GNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSS 415
+P +L++L + +N L +P SL +++S N L ++P
Sbjct: 154 -MLPELPTSLEVL---SVRNNQLT-FLPELPE---SLEALDVSTNLLE-SLPAVPVRNHH 204
Query: 416 LS---ISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGG 472
I N++T +P + L + + +N L + + G
Sbjct: 205 SEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLS-SRIRESLSQQTAQPDYHGP 262
Query: 473 NLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL 510
++ +S + + D ++ +
Sbjct: 263 RIYF-SMSDGQQNTLHRPLADAVTAWFPENKQSDVSQI 299
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-26
Identities = 55/322 (17%), Positives = 107/322 (33%), Gaps = 70/322 (21%)
Query: 105 IPSEIGGLRRLKVLALNNN--SICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSK 162
I I L + N + + + N+ V + + +++
Sbjct: 3 IMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLL--KECLINQ 60
Query: 163 TEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLS 222
L L +L+ S+P +L I + + N L ++P +L +L N LS
Sbjct: 61 FSELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPA---SLEYLDACDNRLS 113
Query: 223 VVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFG 282
+P L L+H + +N +LT
Sbjct: 114 --------TLPEL--PASLKHLDVDNN--------------------QLTM--------- 134
Query: 283 GLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQ 342
LP + L + + +NN++ +P + L+ L + NNQL+ +P +
Sbjct: 135 --LPELPALL----EYINADNNQL-TMLPELPTS---LEVLSVRNNQLT-FLPE---LPE 180
Query: 343 NLKILGLNRNKLSGNIPPSIGNLKMLLN----LFLNDNFLEVSIPSSLGQCESLIEINLS 398
+L+ L ++ N L ++P +N + IP ++ + I L
Sbjct: 181 SLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILE 238
Query: 399 NNNLSGTIPPQFFSLSSLSISL 420
+N LS I ++
Sbjct: 239 DNPLSSRIRESLSQQTAQPDYH 260
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-24
Identities = 54/218 (24%), Positives = 87/218 (39%), Gaps = 29/218 (13%)
Query: 309 SIPAGIGNFVNLQRLDMWNNQLSGT---IPPAIGELQNLKILGLNRNKLSGNIPPSIGNL 365
SI I N +L + + N +SGT A + + + G NRN+ + + +
Sbjct: 2 SIMLPINNNFSLS-QNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--I 58
Query: 366 KMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRN 425
L LN L S+P +L + + ++ N L ++P SL L N
Sbjct: 59 NQFSELQLNRLNLS-SLPDNLPP--QITVLEITQNALI-SLPELPASLEYLDAC----DN 110
Query: 426 KLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGS 485
+L+ +LP LK L V N+L +P LE + N ++
Sbjct: 111 RLS-TLPELPASLKHL---DVDNNQLT-MLPELPAL---LEYINADNNQ----LTMLPEL 158
Query: 486 LRGLRVLDLSQNNLSGEIPKFLAGLSLNNLNLSYNDLE 523
L VL + N L+ +P+ SL L++S N LE
Sbjct: 159 PTSLEVLSVRNNQLT-FLPELPE--SLEALDVSTNLLE 193
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-29
Identities = 76/433 (17%), Positives = 139/433 (32%), Gaps = 56/433 (12%)
Query: 91 LKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLV 150
L L L +N+SI T I + + L + +N +
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSI--TDMTGIEKLTGLTKLICTSNNI- 76
Query: 151 GKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFEN 210
L S + L SN LT ++ + L+ + ++ N L
Sbjct: 77 -TTLD-LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKL---TKLDVSQNPL 128
Query: 211 LVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATR 270
L +L+ A N L+ ++ + +L N + +T T+
Sbjct: 129 LTYLNCARNTLTEID---------VSHNTQLTELDCHLNKKIT--------KLDVTPQTQ 171
Query: 271 LTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQL 330
LT + + N L +S + L + N I + + + L LD +N+L
Sbjct: 172 LTTLDCSFNKITEL---DVSQNKL-LNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKL 224
Query: 331 SGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCE 390
+ I + L L + N L+ + S L L L L I L
Sbjct: 225 T-EID--VTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLL-EID--LTHNT 275
Query: 391 SLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENR 450
LI + + L LD +T +++ + L +LY+
Sbjct: 276 QLIYFQAEGCRKIKELD--VTHNTQLY-LLDCQAAGIT---ELDLSQNPKLVYLYLNNTE 329
Query: 451 LEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL 510
L E+ + +L+ L Q SS+G + L ++ +PK
Sbjct: 330 LT-ELD--VSHNTKLKSLSCVNAHIQD--FSSVGKIPALNNNFEAEGQTI-TMPKETLTN 383
Query: 511 SLNNLNLSYNDLE 523
+ + +S + L+
Sbjct: 384 NSLTIAVSPDLLD 396
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-21
Identities = 50/345 (14%), Positives = 126/345 (36%), Gaps = 47/345 (13%)
Query: 85 IGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHP 144
+ L+ L L N T ++ L L N++ EI +S + L +
Sbjct: 102 VTPLTKLTYLNCDTNKLTK---LDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDC 155
Query: 145 QNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNS 204
N+ + + ++ L+ N +T + + ++ ++ NN+ + +
Sbjct: 156 HLNKKIT--KLDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLDLN 209
Query: 205 FGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCS 264
L FL ++N L+ ++ + L +L +F + N L
Sbjct: 210 Q--NIQLTFLDCSSNKLTEID---------VTPLTQLTYFDCSVNPLTE---------LD 249
Query: 265 LTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLD 324
++ ++LT +H + + +++ ++ + + + + + L LD
Sbjct: 250 VSTLSKLTTLHCIQTDLLEI---DLTHNTQ-LIYFQAEGCRKIKELD--VTHNTQLYLLD 303
Query: 325 MWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPS 384
++ + + + L L LN +L+ + + + L +L + ++ S
Sbjct: 304 CQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFSS 356
Query: 385 SLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTG 429
+G+ +L + T+P + + +SL+I++ G
Sbjct: 357 -VGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLLDQFG 399
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 8e-14
Identities = 42/206 (20%), Positives = 78/206 (37%), Gaps = 21/206 (10%)
Query: 319 NLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFL 378
N ++ T + +L L L + + ++ ++ I L L L N +
Sbjct: 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNI 76
Query: 379 EVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKL 438
++ L Q +L + +N L+ L+ L+ NKLT ++V +
Sbjct: 77 T-TLD--LSQNTNLTYLACDSNKLTNLDVTPLTKLTYLNC----DTNKLT---KLDVSQN 126
Query: 439 KILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNN 498
+L +L N L EI + +L +L N + + L LD S N
Sbjct: 127 PLLTYLNCARNTLT-EID--VSHNTQLTELDCHLN--KKITKLDVTPQTQLTTLDCSFNK 181
Query: 499 LSGEIPKFLAGL-SLNNLNLSYNDLE 523
++ E+ ++ LN LN N++
Sbjct: 182 IT-ELD--VSQNKLLNRLNCDTNNIT 204
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 4e-13
Identities = 49/341 (14%), Positives = 102/341 (29%), Gaps = 49/341 (14%)
Query: 85 IGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHP 144
+ + + L +L +N ++ + +L L + N I ++S+ L ++
Sbjct: 144 VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKI---TELDVSQNKLLNRLNC 198
Query: 145 QNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNS 204
N + L++ L L+ SN LT I + L+ + + N L + S
Sbjct: 199 DTNNITKLDLNQNIQL---TFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELDVS 251
Query: 205 FGWFENLVFLSLAANNLSVVE---------------NKLTGEVPSLEKLQRLQHFTITSN 249
L L +L ++ K+ + +L +
Sbjct: 252 --TLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIK--ELDVTHNTQLYLLDCQAA 307
Query: 250 SLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGS 309
+ L+ +L ++++N+ L +S+ +K +K+L N I
Sbjct: 308 GITE---------LDLSQNPKLVYLYLNNTELTEL---DVSHNTK-LKSLSCVNAHI-QD 353
Query: 310 IPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGN---IPPSIGNLK 366
+ +G L Q + + + GN I P G +
Sbjct: 354 FSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVY 412
Query: 367 MLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIP 407
+ L P+ S + P
Sbjct: 413 DQATNTITWENLSTDNPAVTYTFTSENGAIVGTVTTPFEAP 453
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 63/224 (28%), Positives = 102/224 (45%), Gaps = 33/224 (14%)
Query: 635 GVGSFGSVYKGI---IDEGRTTIAVKVFNLQHHGASRS----FIAECKALKSIRHRNLVK 687
G G FGSV +G D +AVK ++ +S+ F++E +K H N+++
Sbjct: 43 GEGEFGSVMEGNLKQEDGTSLKVAVKT--MKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 688 VLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDI 747
+L C+ +G + FM YG L +L ++ P+++ L L +DI
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLL----YSRLETGPKHIPLQTLLKFMVDI 156
Query: 748 AYALNYL-HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLAR-ILSPD-HTQTSS--FS 802
A + YL + + H DL N +L D MT V DFGL++ I S D + Q
Sbjct: 157 ALGMEYLSNRNF----LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 212
Query: 803 VKGSLGYIAPE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
VK +IA E V ++ DV+++G+ + E+ G P
Sbjct: 213 VK----WIAIESLADRV---YTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 39/219 (17%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLG 694
G G +G VY+G+ + T+AVK + F+ E +K I+H NLV++L C
Sbjct: 22 GGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 695 ADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYAL 751
Y EFM YG+L ++L + + ++ + L +A I+ A+
Sbjct: 81 EP--------PFYIITEFMTYGNLLDYLR--------ECNRQEVSAVVLLYMATQISSAM 124
Query: 752 NYL-HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSS---FSVKGSL 807
YL + H DL N L+ + +V DFGL+R+++ D + F +K
Sbjct: 125 EYLEKKNF----IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--- 177
Query: 808 GYIAPE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
+ APE Y S DV+++G+LL E+ G P
Sbjct: 178 -WTAPESLAYNK---FSIKSDVWAFGVLLWEIATYGMSP 212
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 56/226 (24%), Positives = 91/226 (40%), Gaps = 36/226 (15%)
Query: 635 GVGSFGSVYKGI---IDEGRTTIAVKVFNLQHHGASR--SFIAECKALKSIRHRNLVKVL 689
G G FGSV + D +AVK+ +S F+ E +K H ++ K++
Sbjct: 32 GKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLV 91
Query: 690 TACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAID 746
L R FM +G L +L I E P NL L + +D
Sbjct: 92 GVSL--RSRAKGRLPIPMVILPFMKHGDLHAFLL----ASRIGENPFNLPLQTLVRFMVD 145
Query: 747 IAYALNYL-HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKG 805
IA + YL + H DL N +L + MT V DFGL+R + + + +G
Sbjct: 146 IACGMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGLSRKI-----YSGDYYRQG 196
Query: 806 SLGYI-----APE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
+ A E + + + DV+++G+ + E++ G+ P
Sbjct: 197 CASKLPVKWLALESLADNL---YTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 55/229 (24%), Positives = 95/229 (41%), Gaps = 42/229 (18%)
Query: 633 LVGVGSFGSVYKGIIDE--GRTTIAVKVFNLQHHG---ASRSFIAECKALKSIRHRNLVK 687
+G G +VY D +A+K + + F E + H+N+V
Sbjct: 18 KLGGGGMSTVYLAE-DTILNIK-VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 688 VLTACLGADYRGNDFKASVYEFMHY---GSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIA 744
++ D + Y M Y +L E++ P L++ +N
Sbjct: 76 MI------DV-DEE-DDCYYLVMEYIEGPTLSEYIE--------SHGP--LSVDTAINFT 117
Query: 745 IDIAYALNYLHHDCQPVTA---HCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSF 801
I + + H H D+KP N+L+D T ++ DFG+A+ LS + + T +
Sbjct: 118 NQILDGIKHAHD------MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTN 170
Query: 802 SVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
V G++ Y +PE G D+YS GI+L E+++G+ P F G+
Sbjct: 171 HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP----FNGE 215
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 65/268 (24%), Positives = 98/268 (36%), Gaps = 46/268 (17%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTA 691
L+G G FG V+K T +K + A R E KAL + H N+V
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVHYNGC 72
Query: 692 CLGADYRGNDFKASVY-----------EFMHYGSLEEWLH-----PFTGEDEIDEAPRNL 735
G DY + EF G+LE+W+ +
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD-KVLA------- 124
Query: 736 NLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDH 795
L + I ++Y+H + DLKPSN+ L D ++GDFGL L D
Sbjct: 125 -----LELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 176
Query: 796 TQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHN 855
+T KG+L Y++PE + D+Y+ G++L EL+ FE +
Sbjct: 177 KRT---RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT---AFETSKFFTD 230
Query: 856 FGRKALPD----DVMDIVDSSLLPDDED 879
+ D ++ L ED
Sbjct: 231 LRDGIISDIFDKKEKTLLQKLLSKKPED 258
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-27
Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 41/219 (18%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLG 694
G G FG V+ + T +AVK + +F+AE +K+++H LVK+
Sbjct: 197 GAGQFGEVWMATYN-KHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT- 253
Query: 695 ADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYAL 751
K +Y EFM GSL ++L + L + ++ + IA +
Sbjct: 254 --------KEPIYIITEFMAKGSLLDFLK--------SDEGSKQPLPKLIDFSAQIAEGM 297
Query: 752 NYL-HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSS---FSVKGSL 807
++ + H DL+ +N+L+ + ++ DFGLAR++ + F +K
Sbjct: 298 AFIEQRNY----IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK--- 350
Query: 808 GYIAPE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
+ APE +G + DV+S+GILL+E+V G+ P
Sbjct: 351 -WTAPEAINFGS---FTIKSDVWSFGILLMEIVTYGRIP 385
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 54/225 (24%), Positives = 98/225 (43%), Gaps = 46/225 (20%)
Query: 635 GVGSFGSVYKGI----IDEGRTTIAVKVFNLQHHGASRS-FIAECKALKSIRHRNLVKVL 689
G G+FG+VYKG+ ++ + +A+K + + E + S+ + ++ ++L
Sbjct: 24 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83
Query: 690 TACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAID 746
CL ++V + M +G L +++ E N+ LN +
Sbjct: 84 GICL---------TSTVQLITQLMPFGCLLDYVR---------EHKDNIGSQYLLNWCVQ 125
Query: 747 IAYALNYL-HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPD----HTQTSSF 801
IA +NYL H DL NVL+ ++ DFGLA++L + H +
Sbjct: 126 IAKGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 802 SVKGSLGYIAPE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
+K ++A E + + + DV+SYG+ + EL+ G KP
Sbjct: 182 PIK----WMALESILHRI---YTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 41/219 (18%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLG 694
G G FG V+ G G T +AVK Q + +F+AE +K ++H+ LV++
Sbjct: 22 GAGQFGEVWMGYY-NGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT- 78
Query: 695 ADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYAL 751
+ +Y E+M GSL ++L + L + + L++A IA +
Sbjct: 79 --------QEPIYIITEYMENGSLVDFLK--------TPSGIKLTINKLLDMAAQIAEGM 122
Query: 752 NYL-HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSS---FSVKGSL 807
++ + H DL+ +N+L+ D ++ ++ DFGLAR++ + F +K
Sbjct: 123 AFIEERNY----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK--- 175
Query: 808 GYIAPE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
+ APE YG + DV+S+GILL E+V G+ P
Sbjct: 176 -WTAPEAINYGT---FTIKSDVWSFGILLTEIVTHGRIP 210
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 38/221 (17%)
Query: 635 GVGSFGSVYKGI----IDEGRTTIAVKVFNLQHHGASRS-FIAECKALKSIRHRNLVKVL 689
G G FG+V+KG+ + + + +KV + S A+ S+ H ++V++L
Sbjct: 22 GSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLL 81
Query: 690 TACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAID 746
C +S+ +++ GSL + + + L LN +
Sbjct: 82 GLCP---------GSSLQLVTQYLPLGSLLDHVR---------QHRGALGPQLLLNWGVQ 123
Query: 747 IAYALNYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKG 805
IA + YL H H +L NVLL +V DFG+A +L PD Q K
Sbjct: 124 IAKGMYYLEEHGM----VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT 179
Query: 806 SLGYIAPE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
+ ++A E +G + DV+SYG+ + EL+ G +P
Sbjct: 180 PIKWMALESIHFGK---YTHQSDVWSYGVTVWELMTFGAEP 217
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-26
Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 35/216 (16%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLG 694
G G FG V+ G G T +A+K + +F+ E + +K +RH LV++
Sbjct: 193 GQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS- 249
Query: 695 ADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYAL 751
+ +Y E+M GSL ++L E + L L Q +++A IA +
Sbjct: 250 --------EEPIYIVTEYMSKGSLLDFLK--------GETGKYLRLPQLVDMAAQIASGM 293
Query: 752 NYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSS---FSVKGSL 807
Y+ + H DL+ +N+L+ + + +V DFGLAR++ + F +K
Sbjct: 294 AYVERMNY----VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK--- 346
Query: 808 GYIAPEYGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
+ APE + + DV+S+GILL EL G+ P
Sbjct: 347 -WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 36/221 (16%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTAC 692
++G G++G VY G + IA+K + S+ E K ++H+N+V+
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ----- 83
Query: 693 LGADYRGNDFKAS-VYEFMHY---GSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIA 748
Y G+ + + FM GSL L G + +E Q L
Sbjct: 84 ----YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILE------ 133
Query: 749 YALNYLHHDCQPVTAHCDLKPSNVLLDDYM-TARVGDFGLARILSPDHTQTSSFSVKGSL 807
L YLH + H D+K NVL++ Y ++ DFG ++ L+ + T +F G+L
Sbjct: 134 -GLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF--TGTL 187
Query: 808 GYIAPE------YGVGCEVSTNGDVYSYGILLLELVIGKKP 842
Y+APE G G D++S G ++E+ GK P
Sbjct: 188 QYMAPEIIDKGPRGYGKAA----DIWSLGCTIIEMATGKPP 224
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 56/224 (25%), Positives = 84/224 (37%), Gaps = 47/224 (20%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRS----FIAECKALKSIRHRNLVKVLT 690
G G+FG V+ G + T +AVK F+ E + LK H N+V+++
Sbjct: 123 GRGNFGEVFSGRLRADNTLVAVKSCR---ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 691 ACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDI 747
C +Y E + G +L L + L + D
Sbjct: 180 VCTQKQ--------PIYIVMELVQGGDFLTFLR---------TEGARLRVKTLLQMVGDA 222
Query: 748 AYALNYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPD----HTQTSSFS 802
A + YL C H DL N L+ + ++ DFG++R +
Sbjct: 223 AAGMEYLESKCC----IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVP 278
Query: 803 VKGSLGYIAPE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
VK + APE YG S+ DV+S+GILL E +G P
Sbjct: 279 VKWT----APEALNYGR---YSSESDVWSFGILLWETFSLGASP 315
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 54/223 (24%), Positives = 88/223 (39%), Gaps = 39/223 (17%)
Query: 635 GVGSFGSVYKGI---IDEGRTTIAVKVFNLQHHGASRS-FIAECKALKSIRHRNLVKVLT 690
G G FG VY G + R A+K + F+ E ++ + H N++ ++
Sbjct: 30 GKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIG 89
Query: 691 ACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYA 750
L + +M +G L +++ RN + ++ + +A
Sbjct: 90 IML----PPEGLPHVLLPYMCHGDLLQFIR---------SPQRNPTVKDLISFGLQVARG 136
Query: 751 LNYL-HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLAR-ILSPDHTQTSS-----FSV 803
+ YL H DL N +LD+ T +V DFGLAR IL ++ V
Sbjct: 137 MEYLAEQKF----VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPV 192
Query: 804 KGSLGYIAPE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
K + A E +T DV+S+G+LL EL+ G P
Sbjct: 193 K----WTALESLQTYR---FTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 57/227 (25%), Positives = 88/227 (38%), Gaps = 47/227 (20%)
Query: 635 GVGSFGSVYKGII----DEGRTTIAVKVFNLQHHG--ASRSFIAECKALKSIRHRNLVKV 688
G G+FGSV D +AVK LQH G R F E + LK++ +VK
Sbjct: 32 GKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 689 LTACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAI 745
G + S+ E++ G L ++L L+ + L +
Sbjct: 90 RGVSYGPGRQ------SLRLVMEYLPSGCLRDFLQ---------RHRARLDASRLLLYSS 134
Query: 746 DIAYALNYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDH-----TQTS 799
I + YL C H DL N+L++ ++ DFGLA++L D +
Sbjct: 135 QICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPG 190
Query: 800 SFSVKGSLGYIAPE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
+ + APE + S DV+S+G++L EL K
Sbjct: 191 QSPIF----WYAPESLSDNI---FSRQSDVWSFGVVLYELFTYCDKS 230
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-26
Identities = 62/216 (28%), Positives = 95/216 (43%), Gaps = 39/216 (18%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLG 694
G G FG V G +AVK +++ +++F+AE + +RH NLV++L +
Sbjct: 202 GKGEFGDVMLGDYRG--NKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV- 256
Query: 695 ADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYAL 751
+ K +Y E+M GSL ++L L L ++D+ A+
Sbjct: 257 ------EEKGGLYIVTEYMAKGSLVDYLR--------SRGRSVLGGDCLLKFSLDVCEAM 302
Query: 752 NYL-HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYI 810
YL ++ H DL NVL+ + A+V DFGL + S VK +
Sbjct: 303 EYLEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-KLPVK----WT 353
Query: 811 APE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
APE ST DV+S+GILL E+ G+ P
Sbjct: 354 APEALREKK---FSTKSDVWSFGILLWEIYSFGRVP 386
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 58/232 (25%), Positives = 96/232 (41%), Gaps = 42/232 (18%)
Query: 633 LVGVGSFGSVYKGIIDE--GRTTIAVKVFNLQHHG---ASRSFIAECKALKSIRHRNLVK 687
++G G V+ D R +AVKV F E + ++ H +V
Sbjct: 19 ILGFGGMSEVHLAR-DLRDHRD-VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 688 VLTACLGADYRGNDFKASVYEF--MHY---GSLEEWLHPFTGEDEIDEAPRNLNLLQRLN 742
V D + A + M Y +L + +H E P + + +
Sbjct: 77 VY------DTGEAETPAGPLPYIVMEYVDGVTLRDIVH--------TEGP--MTPKRAIE 120
Query: 743 IAIDIAYALNYLHHDCQPVTA---HCDLKPSNVLLDDYMTARVGDFGLARILSPD-HTQT 798
+ D ALN+ H H D+KP+N+++ +V DFG+AR ++ ++ T
Sbjct: 121 VIADACQALNFSHQ------NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 799 SSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
+ +V G+ Y++PE G V DVYS G +L E++ G+ P F GD
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-26
Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLG 694
G G FG V+ G + G T +A+K + +F+ E + +K +RH LV++
Sbjct: 276 GQGCFGEVWMGTWN-GTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS- 332
Query: 695 ADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYAL 751
+ +Y E+M GSL ++L E + L L Q +++A IA +
Sbjct: 333 --------EEPIYIVTEYMSKGSLLDFLK--------GETGKYLRLPQLVDMAAQIASGM 376
Query: 752 NYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSS---FSVKGSL 807
Y+ + H DL+ +N+L+ + + +V DFGLAR++ + F +K
Sbjct: 377 AYVERMNY----VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK--- 429
Query: 808 GYIAPEYGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
+ APE + + DV+S+GILL EL G+ P
Sbjct: 430 -WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 54/227 (23%), Positives = 89/227 (39%), Gaps = 38/227 (16%)
Query: 633 LVGVGSFGSVYKGIIDE--GRTTIAVKVFNLQHHGASRSFIA----ECKALKSIRHRNLV 686
LVG G G VY+ D R +A+K+ + + + F E + ++ ++V
Sbjct: 41 LVGRGGMGDVYEAE-DTVRERI-VALKLMS-ETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 687 KVLTACLGADYRGNDFKASVYEFMHY---GSLEEWLHPFTGEDEIDEAPRNLNLLQRLNI 743
+ D+ G +Y M L L + P L + + I
Sbjct: 98 PIH------DF-GEI-DGQLYVDMRLINGVDLAAMLR--------RQGP--LAPPRAVAI 139
Query: 744 AIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSV 803
I AL+ H H D+KP N+L+ A + DFG+A + D T +
Sbjct: 140 VRQIGSALDAAHAA-GAT--HRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNT 195
Query: 804 KGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
G+L Y+APE + D+Y+ +L E + G P ++GD
Sbjct: 196 VGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP----YQGD 238
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 57/230 (24%), Positives = 98/230 (42%), Gaps = 45/230 (19%)
Query: 635 GVGSFGSVYKGII-----DEGRTTIAVKVFNLQHHGASRS----FIAECKALKSIRHRNL 685
G GSFG VY+G+ DE T +A+K N AS F+ E +K ++
Sbjct: 34 GQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKEFNCHHV 90
Query: 686 VKVLTACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLN 742
V++L E M G L+ +L + +L + +
Sbjct: 91 VRLLGVVSQGQ--------PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 743 IAIDIAYALNYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSF 801
+A +IA + YL+ + H DL N ++ + T ++GDFG+ R + + +
Sbjct: 143 MAGEIADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMTRDI-----YETDY 193
Query: 802 SVKGSLGYI-----APE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
KG G + +PE GV +T DV+S+G++L E+ + ++P
Sbjct: 194 YRKGGKGLLPVRWMSPESLKDGV---FTTYSDVWSFGVVLWEIATLAEQP 240
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 57/245 (23%), Positives = 94/245 (38%), Gaps = 16/245 (6%)
Query: 297 KTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLS- 355
+ N+ + S+P GI + RL++ +N+L +L L L L+ N LS
Sbjct: 10 TEIRCNSKGL-TSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 356 -GNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQ--FFS 412
G S L L L+ N + ++ S+ E L ++ ++NL + F S
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLS 124
Query: 413 LSSLSISLDWSRNKLTGSLPIEV-GKLKILEFLYVYENRLEGEIPS-TFGNCIRLEQLGM 470
L +L I LD S + L LE L + N + F L L +
Sbjct: 125 LRNL-IYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 182
Query: 471 GGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL-SLNNLNLSYNDLEGMVTTE 529
+ ++ SL L+VL++S NN L SL L+ S N + +
Sbjct: 183 SQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTS--KK 240
Query: 530 GVFKN 534
++
Sbjct: 241 QELQH 245
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 52/283 (18%), Positives = 99/283 (34%), Gaps = 38/283 (13%)
Query: 269 TRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNF---VNLQRLDM 325
+ T + + SN L G L++ + L L++N + + +L+ LD+
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQ-LTKLSLSSNGLS-FKGCCSQSDFGTTSLKYLDL 85
Query: 326 WNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSI-GNLKMLLNLFLNDNFLEVSIPS 384
N + T+ L+ L+ L + L S+ +L+ L+ L ++ V+
Sbjct: 86 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 144
Query: 385 SLGQCESLIEINLSNNNLSGTIPPQFFS-LSSLSISLDWSRNKLTGSLPIEV-GKLKILE 442
SL + ++ N+ P F+ L +L+ LD S+ +L L L L+
Sbjct: 145 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF-LDLSQCQLE-QLSPTAFNSLSSLQ 202
Query: 443 FLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSL-RGLRVLDLSQNNL-- 499
L + N + L+ L N L L L+L+QN+
Sbjct: 203 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 262
Query: 500 --------------------SGEI----PKFLAGLSLNNLNLS 518
+ P G+ + +LN++
Sbjct: 263 TCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSLNIT 305
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 8e-22
Identities = 53/263 (20%), Positives = 97/263 (36%), Gaps = 27/263 (10%)
Query: 166 LNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVE 225
+ S LT S+P+ + SS + L N L F L LSL++N LS
Sbjct: 12 IRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68
Query: 226 NKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLL 285
S L++ ++ N + + ++ +L + +N +
Sbjct: 69 C----CSQSDFGTTSLKYLDLSFNGVITMSSN-------FLGLEQLEHLDFQHSNLKQMS 117
Query: 286 PGCI-SNLSKTIKTLFLNNNKIYGSIPAGI-GNFVNLQRLDMWNNQLSGTIPP-AIGELQ 342
+ +L + L +++ GI +L+ L M N P EL+
Sbjct: 118 EFSVFLSLRN-LIYLDISHTHT-RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR 175
Query: 343 NLKILGLNRNKLSGNIPPSI-GNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNN 401
NL L L++ +L + P+ +L L L ++ N SL ++ S N+
Sbjct: 176 NLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 234
Query: 402 LSGTIPPQFF-----SLSSLSIS 419
+ T Q SL+ L+++
Sbjct: 235 IM-TSKKQELQHFPSSLAFLNLT 256
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 7e-21
Identities = 48/269 (17%), Positives = 94/269 (34%), Gaps = 41/269 (15%)
Query: 91 LKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLV 150
+L L+ N L +L L+L++N + + Q+
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL------------SFKGCCSQS---- 73
Query: 151 GKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNS-FGWFE 209
+ + L+L N + ++ S+ L + + ++NL S F
Sbjct: 74 ------DFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 126
Query: 210 NLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNAT 269
NL++L ++ + V N + L L+ + NS D+ T
Sbjct: 127 NLIYLDISHTHTRVAFNGI------FNGLSSLEVLKMAGNSFQENFLPDI-----FTELR 175
Query: 270 RLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGI-GNFVNLQRLDMWNN 328
LT++ ++ L P ++LS ++ L +++N S+ +LQ LD N
Sbjct: 176 NLTFLDLSQCQLEQLSPTAFNSLSS-LQVLNMSHNNF-FSLDTFPYKCLNSLQVLDYSLN 233
Query: 329 QLSGTIPPAI--GELQNLKILGLNRNKLS 355
+ T +L L L +N +
Sbjct: 234 HIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 32/222 (14%), Positives = 67/222 (30%), Gaps = 39/222 (17%)
Query: 87 NLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNI-SRCSTLIPIHPQ 145
+ LK L L N + S GL +L+ L ++++ ++ LI +
Sbjct: 76 GTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 134
Query: 146 NNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPS-SLGNLSSIHTISLAYNNLDGTIPNS 204
+ F+ LS E+L + N + L ++ + L+ L+ P +
Sbjct: 135 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 194
Query: 205 FGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCS 264
F +L L+++ NN ++
Sbjct: 195 FNSLSSLQVLNMSHNNFFSLDTF------------------------------------P 218
Query: 265 LTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKI 306
L + + N+ + + ++ L L N
Sbjct: 219 YKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 45/219 (20%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLG 694
G G FG V G +AVK +++ +++F+AE + +RH NLV++L +
Sbjct: 30 GKGEFGDVMLGDYRG--NKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV- 84
Query: 695 ADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYAL 751
+ K +Y E+M GSL ++L L L ++D+ A+
Sbjct: 85 ------EEKGGLYIVTEYMAKGSLVDYLR--------SRGRSVLGGDCLLKFSLDVCEAM 130
Query: 752 NYL-HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSS---FSVKGSL 807
YL ++ H DL NVL+ + A+V DFGL + + + T VK
Sbjct: 131 EYLEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVK--- 179
Query: 808 GYIAPE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
+ APE ST DV+S+GILL E+ G+ P
Sbjct: 180 -WTAPEALREKK---FSTKSDVWSFGILLWEIYSFGRVP 214
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-25
Identities = 47/230 (20%), Positives = 84/230 (36%), Gaps = 49/230 (21%)
Query: 633 LVGVGSFGSVYKGIIDE---GRTTIAVKVFNLQHHG---ASRSFIAECKALKSIRHRNLV 686
+ G G +Y + D GR + +K L H G A +AE + L + H ++V
Sbjct: 87 CIAHGGLGWIYLAL-DRNVNGRP-VVLKG--LVHSGDAEAQAMAMAERQFLAEVVHPSIV 142
Query: 687 KVLTACLGADY---RGNDFKASVYEFMHY---GSLEEWLHPFTGEDEIDEAPRNLNLLQR 740
++ ++ Y M Y SL+ + L + +
Sbjct: 143 QIF------NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------------QKLPVAEA 184
Query: 741 LNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSS 800
+ ++I AL+YLH + + DLKP N++L + ++ D G +
Sbjct: 185 IAYLLEILPALSYLHS--IGL-VYNDLKPENIMLTE-EQLKLIDLGAVSRI----NSFG- 235
Query: 801 FSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
+ G+ G+ APE + D+Y+ G L L + G
Sbjct: 236 -YLYGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPT----RNGR 279
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 46/221 (20%)
Query: 635 GVGSFGSVYKG----IIDEGRTTIAVKVFNLQHHGAS--RSFIAECKALKSIRHRNLVKV 688
G G+FGSV + D +AVK LQH R F E + LKS++H N+VK
Sbjct: 19 GKGNFGSVEMCRYDPLQDNTGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 689 LTACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAI 745
C A R ++ E++ YGSL ++L + ++ ++ L
Sbjct: 77 KGVCYSAGRR------NLKLIMEYLPYGSLRDYLQ---------KHKERIDHIKLLQYTS 121
Query: 746 DIAYALNYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDH-----TQTS 799
I + YL H DL N+L+++ ++GDFGL ++L D +
Sbjct: 122 QICKGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPG 177
Query: 800 SFSVKGSLGYIAPE---YGVGCEVSTNGDVYSYGILLLELV 837
+ + APE S DV+S+G++L EL
Sbjct: 178 ESPIF----WYAPESLTESK---FSVASDVWSFGVVLYELF 211
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 55/226 (24%), Positives = 84/226 (37%), Gaps = 46/226 (20%)
Query: 635 GVGSFGSVYKGI---IDEGRTTIAVKVFN---LQHHGASRSFIAECKALKSIRHRNLVKV 688
G GSFG V +G ++AVK L A FI E A+ S+ HRNL+++
Sbjct: 27 GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRL 86
Query: 689 LTACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAI 745
L + E GSL + L + + L A+
Sbjct: 87 YGVVLTP---------PMKMVTELAPLGSLLDRLR---------KHQGHFLLGTLSRYAV 128
Query: 746 DIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDH-----TQTSS 800
+A + YL + + H DL N+LL ++GDFGL R L + +
Sbjct: 129 QVAEGMGYLE-SKRFI--HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 185
Query: 801 FSVKGSLGYIAPE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
+ APE S D + +G+ L E+ G++P
Sbjct: 186 VPFA----WCAPESLKTRT---FSHASDTWMFGVTLWEMFTYGQEP 224
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 50/226 (22%), Positives = 90/226 (39%), Gaps = 50/226 (22%)
Query: 635 GVGSFGSVYKGI---IDEGRTTIAVKVFNLQHHGAS----RSFIAECKALKSIRHRNLVK 687
G G FG V++GI + +A+K + S F+ E ++ H ++VK
Sbjct: 24 GEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 688 VLTACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIA 744
++ + V+ E G L +L +L+L + A
Sbjct: 81 LIGVIT---------ENPVWIIMELCTLGELRSFLQ---------VRKYSLDLASLILYA 122
Query: 745 IDIAYALNYL-HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSS--- 800
++ AL YL H D+ NVL+ ++GDFGL+R + +S
Sbjct: 123 YQLSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 178
Query: 801 FSVKGSLGYIAPE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
+K ++APE + ++ DV+ +G+ + E++ G KP
Sbjct: 179 LPIK----WMAPESINFRR---FTSASDVWMFGVCMWEILMHGVKP 217
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 65/273 (23%), Positives = 106/273 (38%), Gaps = 51/273 (18%)
Query: 598 RKIKEKENPSSSIYSLLYLSYQDLYNATSGFSSANLV-----GVGSFGSVYKGII----- 647
+ I+ E S + L Y + + F NL G G+FG V +
Sbjct: 17 KIIESYEGNSYTFIDPTQLPYNEKWE----FPRNNLQFGKTLGAGAFGKVVEATAFGLGK 72
Query: 648 DEGRTTIAVKVFNLQHHGASRS-FIAECKALKSI-RHRNLVKVLTACLGAD--YRGNDFK 703
++ +AVK+ H + ++E K + + +H N+V +L AC
Sbjct: 73 EDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVL------ 126
Query: 704 ASVYEFMHYGSLEEWL----HPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYL-HHDC 758
+ E+ YG L +L + A + L+ + +A + +L +C
Sbjct: 127 -VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNC 185
Query: 759 QPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYI-----APE 813
H D+ NVLL + A++GDFGLAR + S + + APE
Sbjct: 186 ----IHRDVAARNVLLTNGHVAKIGDFGLARDI-----MNDSNYIVKGNARLPVKWMAPE 236
Query: 814 ---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
V + DV+SYGILL E+ +G P
Sbjct: 237 SIFDCV---YTVQSDVWSYGILLWEIFSLGLNP 266
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 46/221 (20%)
Query: 635 GVGSFGSVYKG----IIDEGRTTIAVKVFNLQHHGAS--RSFIAECKALKSIRHRNLVKV 688
G G+FGSV + D +AVK LQH R F E + LKS++H N+VK
Sbjct: 50 GKGNFGSVEMCRYDPLQDNTGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 689 LTACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAI 745
C A R ++ E++ YGSL ++L + ++ ++ L
Sbjct: 108 KGVCYSAGRR------NLKLIMEYLPYGSLRDYLQ---------KHKERIDHIKLLQYTS 152
Query: 746 DIAYALNYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDH-----TQTS 799
I + YL H DL N+L+++ ++GDFGL ++L D +
Sbjct: 153 QICKGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPG 208
Query: 800 SFSVKGSLGYIAPE---YGVGCEVSTNGDVYSYGILLLELV 837
+ + APE S DV+S+G++L EL
Sbjct: 209 ESPIF----WYAPESLTESK---FSVASDVWSFGVVLYELF 242
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 58/219 (26%), Positives = 89/219 (40%), Gaps = 41/219 (18%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLG 694
G G FG V G G+ +AVK+ + + F E + + + H LVK C
Sbjct: 17 GSGQFGVVKLGKWK-GQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 695 ADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYAL 751
+Y E++ G L +L + L Q L + D+ +
Sbjct: 75 EY--------PIYIVTEYISNGCLLNYLR---------SHGKGLEPSQLLEMCYDVCEGM 117
Query: 752 NYL-HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSS---FSVKGSL 807
+L H H DL N L+D + +V DFG+ R + D +S F VK
Sbjct: 118 AFLESHQF----IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK--- 170
Query: 808 GYIAPE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
+ APE Y S+ DV+++GIL+ E+ +GK P
Sbjct: 171 -WSAPEVFHYFK---YSSKSDVWAFGILMWEVFSLGKMP 205
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 38/221 (17%)
Query: 635 GVGSFGSVYKGI----IDEGRTTIAVKVFNLQHHGASRS-FIAECKALKSIRHRNLVKVL 689
G G+FG+VYKG+ ++ + +A+K + + E + S+ + ++ ++L
Sbjct: 24 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83
Query: 690 TACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAID 746
CL ++V + M +G L +++ E N+ LN +
Sbjct: 84 GICL---------TSTVQLITQLMPFGCLLDYVR---------EHKDNIGSQYLLNWCVQ 125
Query: 747 IAYALNYL-HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKG 805
IA +NYL H DL NVL+ ++ DFGLA++L + + + K
Sbjct: 126 IAKGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 806 SLGYIAPE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
+ ++A E + + + DV+SYG+ + EL+ G KP
Sbjct: 182 PIKWMALESILHRI---YTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 49/223 (21%), Positives = 96/223 (43%), Gaps = 44/223 (19%)
Query: 635 GVGSFGSVYKGI---IDEGRTTIAVKVFNLQHHGASRS-FIAECKALKSIRHRNLVKVLT 690
G G FG VY+G+ + +AVK ++ F++E +K++ H ++VK++
Sbjct: 21 GEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG 80
Query: 691 ACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDI 747
+ + E YG L +L +L +L + ++ I
Sbjct: 81 IIE---------EEPTWIIMELYPYGELGHYLE---------RNKNSLKVLTLVLYSLQI 122
Query: 748 AYALNYL-HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSS---FSV 803
A+ YL +C H D+ N+L+ ++GDFGL+R + + +S +
Sbjct: 123 CKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPI 178
Query: 804 KGSLGYIAPE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
K +++PE + +T DV+ + + + E++ GK+P
Sbjct: 179 K----WMSPESINFRR---FTTASDVWMFAVCMWEILSFGKQP 214
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 61/279 (21%), Positives = 98/279 (35%), Gaps = 51/279 (18%)
Query: 598 RKIKEKENPSSSIYSLLYLSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVK 657
R++ + S ++ S Y + F + +G GS+G V+K E AVK
Sbjct: 29 RRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVK 88
Query: 658 VFNLQHHGAS--RSFIAECKALKSI-RHRNLVKVLTACLGADYRGNDFKASVYEFMHY-- 712
G +AE + + + +H V++ A + +Y
Sbjct: 89 RSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA-----WEEGG---ILYLQTELCG 140
Query: 713 GSL----EEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLK 768
SL E W E ++ D AL +LH H D+K
Sbjct: 141 PSLQQHCEAWGASLP-EAQV------------WGYLRDTLLALAHLH---SQGLVHLDVK 184
Query: 769 PSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPE-----YGVGCEVSTN 823
P+N+ L ++GDFGL L T + +G Y+APE YG
Sbjct: 185 PANIFLGPRGRCKLGDFGLLVELG---TAGAGEVQEGDPRYMAPELLQGSYGTAA----- 236
Query: 824 GDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862
DV+S G+ +LE+ + G+ + LP
Sbjct: 237 -DVFSLGLTILEVACNMEL---PHGGE-GWQQLRQGYLP 270
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 54/222 (24%), Positives = 92/222 (41%), Gaps = 28/222 (12%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASR-SFIAECKALKSIRHRNLVKVLTA 691
+G G FG V++ A+K L + +R + E KAL + H +V+ A
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 692 CLGADYRGNDFKASVYEF----MHY---GSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIA 744
L + +S + M +L++W++ +E + + L+I
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS-------VCLHIF 124
Query: 745 IDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVK 804
+ IA A+ +LH H DLKPSN+ +VGDFGL + D + + +
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 805 GSLG----------YIAPEYGVGCEVSTNGDVYSYGILLLEL 836
+ Y++PE G S D++S G++L EL
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 55/220 (25%), Positives = 84/220 (38%), Gaps = 43/220 (19%)
Query: 635 GVGSFGSVYKGI----IDEGRTTIAVKVFNLQHHGASRS-FIAECKALKSIRHRNLVKVL 689
G G FG V D +AVK + G + E + L+++ H N+VK
Sbjct: 30 GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYK 89
Query: 690 TACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAID 746
C + EF+ GSL+E+L + +NL Q+L A+
Sbjct: 90 GICTEDGGN------GIKLIMEFLPSGSLKEYLP---------KNKNKINLKQQLKYAVQ 134
Query: 747 IAYALNYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDH-----TQTSS 800
I ++YL H DL NVL++ ++GDFGL + + D
Sbjct: 135 ICKGMDYLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRD 190
Query: 801 FSVKGSLGYIAPE---YGVGCEVSTNGDVYSYGILLLELV 837
V + APE DV+S+G+ L EL+
Sbjct: 191 SPVF----WYAPECLMQSK---FYIASDVWSFGVTLHELL 223
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 53/225 (23%), Positives = 90/225 (40%), Gaps = 47/225 (20%)
Query: 635 GVGSFGSVYKGI--IDEGRTTIAVKVF--NLQHHGASRSFIAECKALKSIRHRNLVKVLT 690
G G+FG+V KG + + T+AVK+ +AE ++ + + +V+++
Sbjct: 26 GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 85
Query: 691 ACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDI 747
C S E G L ++L R++ + + +
Sbjct: 86 ICE---------AESWMLVMEMAELGPLNKYLQ----------QNRHVKDKNIIELVHQV 126
Query: 748 AYALNYL-HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDH-----TQTSSF 801
+ + YL + H DL NVLL A++ DFGL++ L D +
Sbjct: 127 SMGMKYLEESNF----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 182
Query: 802 SVKGSLGYIAPE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
VK + APE Y S+ DV+S+G+L+ E G+KP
Sbjct: 183 PVK----WYAPECINYYK---FSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 55/221 (24%), Positives = 88/221 (39%), Gaps = 45/221 (20%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGAS--RSFIAECKALKSIRHRNLVKVLTAC 692
G G FG V+ G + +A+K GA FI E + + + H LV++ C
Sbjct: 17 GSGQFGLVHLGYW-LNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 693 LGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAY 749
L + EFM +G L ++L L + +D+
Sbjct: 73 LEQA--------PICLVTEFMEHGCLSDYLR---------TQRGLFAAETLLGMCLDVCE 115
Query: 750 ALNYL-HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSS---FSVKG 805
+ YL H DL N L+ + +V DFG+ R + D +S+ F VK
Sbjct: 116 GMAYLEEACV----IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK- 170
Query: 806 SLGYIAPE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
+ +PE + S+ DV+S+G+L+ E+ GK P
Sbjct: 171 ---WASPEVFSFSR---YSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 57/221 (25%), Positives = 91/221 (41%), Gaps = 45/221 (20%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGAS--RSFIAECKALKSIRHRNLVKVLTAC 692
G G FG V G G+ +A+K+ G+ FI E K + ++ H LV++ C
Sbjct: 33 GTGQFGVVKYGKW-RGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 693 LGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAY 749
++ E+M G L +L E Q L + D+
Sbjct: 89 TKQR--------PIFIITEYMANGCLLNYLR---------EMRHRFQTQQLLEMCKDVCE 131
Query: 750 ALNYL-HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSS---FSVKG 805
A+ YL H DL N L++D +V DFGL+R + D +S F V+
Sbjct: 132 AMEYLESKQF----LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR- 186
Query: 806 SLGYIAPE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
+ PE Y S+ D++++G+L+ E+ +GK P
Sbjct: 187 ---WSPPEVLMYSK---FSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 52/227 (22%), Positives = 94/227 (41%), Gaps = 49/227 (21%)
Query: 635 GVGSFGSVYKGII---DEGRTTIAVKVFNLQHHGAS----RSFIAECKALKSIRHRNLVK 687
G G G V G + + +A+K G + R F++E + H N+++
Sbjct: 58 GSGDSGEVCYGRLRVPGQRDVPVAIKALK---AGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 688 VLTACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIA 744
+ E+M GSL+ +L ++Q + +
Sbjct: 115 LEGVVTRGR--------LAMIVTEYMENGSLDTFLR---------THDGQFTIMQLVGML 157
Query: 745 IDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARIL--SPDHTQTSS-- 800
+ + YL D V H DL NVL+D + +V DFGL+R+L PD T++
Sbjct: 158 RGVGAGMRYLS-DLGYV--HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGG 214
Query: 801 -FSVKGSLGYIAPE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
++ + APE + S+ DV+S+G+++ E++ G++P
Sbjct: 215 KIPIR----WTAPEAIAFRT---FSSASDVWSFGVVMWEVLAYGERP 254
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 57/232 (24%), Positives = 90/232 (38%), Gaps = 51/232 (21%)
Query: 632 NLVGVGSFGSVYKGI---IDEGRTTIAVKVFNLQHHGAS----RSFIAECKALKSIRHRN 684
++G G FG VY G D + AVK N F+ E +K H N
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 685 LVKVLTACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRL 741
++ +L CL + S +M +G L ++ N + +
Sbjct: 88 VLSLLGICL-------RSEGSPLVVLPYMKHGDLRNFIR---------NETHNPTVKDLI 131
Query: 742 NIAIDIAYALNYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLAR-ILSPDHTQTS 799
+ +A + YL H DL N +LD+ T +V DFGLAR + ++
Sbjct: 132 GFGLQVAKGMKYLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVH 187
Query: 800 SFS-----VKGSLGYIAPE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
+ + VK ++A E +T DV+S+G+LL EL+ G P
Sbjct: 188 NKTGAKLPVK----WMALESLQTQK---FTTKSDVWSFGVLLWELMTRGAPP 232
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 54/231 (23%), Positives = 86/231 (37%), Gaps = 49/231 (21%)
Query: 632 NLVGVGSFGSVYKGI---IDEGRTTIAVKVFNLQHHGAS----RSFIAECKALKSIRHRN 684
++G G FG VY G D + AVK N F+ E +K H N
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 685 LVKVLTACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRL 741
++ +L CL + S +M +G L ++ N + +
Sbjct: 152 VLSLLGICL-------RSEGSPLVVLPYMKHGDLRNFIR---------NETHNPTVKDLI 195
Query: 742 NIAIDIAYALNYL-HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSS 800
+ +A + +L H DL N +LD+ T +V DFGLAR + + +
Sbjct: 196 GFGLQVAKGMKFLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDM---YDKEFD 248
Query: 801 FSVKGSLGYI-----APE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
+ + A E +T DV+S+G+LL EL+ G P
Sbjct: 249 SVHNKTGAKLPVKWMALESLQTQK---FTTKSDVWSFGVLLWELMTRGAPP 296
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 48/224 (21%), Positives = 94/224 (41%), Gaps = 45/224 (20%)
Query: 635 GVGSFGSVYKGI--IDEGRTTIAVKVFNLQHHGASRS-FIAECKALKSIRHRNLVKVLTA 691
G G+FGSV +G+ + + + +A+KV A + E + + + + +V+++
Sbjct: 19 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 78
Query: 692 CLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIA 748
C ++ E G L ++L + + + ++
Sbjct: 79 CQ---------AEALMLVMEMAGGGPLHKFLV---------GKREEIPVSNVAELLHQVS 120
Query: 749 YALNYL-HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSS-----FS 802
+ YL + H DL NVLL + A++ DFGL++ L D + ++ +
Sbjct: 121 MGMKYLEEKNF----VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 176
Query: 803 VKGSLGYIAPE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
+K + APE + S+ DV+SYG+ + E + G+KP
Sbjct: 177 LK----WYAPECINFRK---FSSRSDVWSYGVTMWEALSYGQKP 213
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 52/244 (21%), Positives = 86/244 (35%), Gaps = 42/244 (17%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIR-HRNLVKVLTA 691
++ G F VY+ A+K +R+ I E +K + H N+V+ +A
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 692 CLGADYRGNDFKASVYEFMHY--GSLEEWL------HPFTGEDEIDEAPRNLNLLQRLNI 743
+ +A G L E+L P + D + L I
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLS-CDTV------------LKI 141
Query: 744 AIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSV 803
A+ ++H +P H DLK N+LL + T ++ DFG A +S + S
Sbjct: 142 FYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 804 K----------GSLGYIAPE----YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEG 849
+ + Y PE Y + D+++ G +L L + P FE
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYS-NFPIGEKQDIWALGCILYLLCFRQHP----FED 255
Query: 850 DINL 853
L
Sbjct: 256 GAKL 259
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 49/229 (21%), Positives = 92/229 (40%), Gaps = 42/229 (18%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGAS--RSFIAECKALKSIRHRNL--VK 687
+G G V++ + ++ + A+K NL+ S+ E L ++ + ++
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 688 VLTACLGADYRGNDFKASVYEFMHY--GSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAI 745
+ + Y +Y M L WL ++++ +R +
Sbjct: 121 LYDYEITDQY--------IYMVMECGNIDLNSWLKKK----------KSIDPWERKSYWK 162
Query: 746 DIAYALNYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVK 804
++ A++ +H H H DLKP+N L+ D ++ DFG+A + PD T S
Sbjct: 163 NMLEAVHTIHQHG----IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQV 217
Query: 805 GSLGYIAPE-----------YGVGCEVSTNGDVYSYGILLLELVIGKKP 842
G++ Y+ PE ++S DV+S G +L + GK P
Sbjct: 218 GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 46/239 (19%), Positives = 78/239 (32%), Gaps = 46/239 (19%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTAC 692
+G G F V A+K E + H N+++
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR----L 91
Query: 693 LGADYRGNDFKASVY---EFMHYGSLEEWL-------HPFTGEDEIDEAPRNLNLLQRLN 742
+ R K + F G+L + + T ED+I L
Sbjct: 92 VAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT-EDQI------------LW 138
Query: 743 IAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSF- 801
+ + I L +H + AH DLKP+N+LL D + D G +
Sbjct: 139 LLLGICRGLEAIHA--KGY-AHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQAL 195
Query: 802 ------SVKGSLGYIAPE----YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
+ + ++ Y APE C + DV+S G +L ++ G+ P ++
Sbjct: 196 TLQDWAAQRCTISYRAPELFSVQS-HCVIDERTDVWSLGCVLYAMMFGEGP----YDMV 249
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 60/232 (25%), Positives = 97/232 (41%), Gaps = 45/232 (19%)
Query: 635 GVGSFGSVYKGII-----DEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVL 689
G G+FG V+ ++ + +AVK A + F E + L ++H+++V+
Sbjct: 50 GEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFF 109
Query: 690 TACLGAD--YRGNDFKASVYEFMHYGSLEEWL-----HPFTGEDEIDEAPRNLNLLQRLN 742
C V+E+M +G L +L D AP L L Q L
Sbjct: 110 GVCTEGRPLL-------MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162
Query: 743 IAIDIAYALNYL--HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLAR-ILSPDHTQTS 799
+A +A + YL H H DL N L+ + ++GDFG++R I S D+ +
Sbjct: 163 VASQVAAGMVYLAGLHFV-----HRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR-- 215
Query: 800 SFSVKGSLGYI-----APE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
G + PE Y +T DV+S+G++L E+ GK+P
Sbjct: 216 ----VGGRTMLPIRWMPPESILYRK---FTTESDVWSFGVVLWEIFTYGKQP 260
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 61/236 (25%), Positives = 92/236 (38%), Gaps = 48/236 (20%)
Query: 635 GVGSFGSVYKGII-----DEGRTTIAVKVFNLQHHGASRS-FIAECKALKSI-RHRNLVK 687
G G+FG V + + T+AVK+ H R ++E K L + H N+V
Sbjct: 32 GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVN 91
Query: 688 VLTACLGADYRGNDFKASVY---EFMHYGSLEEWL--------HPFTGEDEIDEAPRNLN 736
+L AC E+ YG L +L T +++ L+
Sbjct: 92 LLGACTIGG--------PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 737 LLQRLNIAIDIAYALNYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDH 795
L L+ + +A + +L +C H DL N+LL ++ DFGLAR +
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDI---- 195
Query: 796 TQTSSFSVKGSLGYI-----APE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
+ S V + APE V + DV+SYGI L EL +G P
Sbjct: 196 -KNDSNYVVKGNARLPVKWMAPESIFNCV---YTFESDVWSYGIFLWELFSLGSSP 247
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-24
Identities = 55/238 (23%), Positives = 88/238 (36%), Gaps = 33/238 (13%)
Query: 290 SNLSKTIKTLFLNNNKIYGSIPAGI-GNFVNLQRLDMWNNQLSGTIPP-AIGELQNLKIL 347
+ + L L N I I A + +L+ L + N + I A L +L L
Sbjct: 71 QGIPSNTRYLNLMENNI-QMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTL 128
Query: 348 GLNRNKLSGNIPPSI-GNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTI 406
L N L+ IP L L L+L +N +E + + SL+ ++L I
Sbjct: 129 ELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYI 187
Query: 407 PPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLE 466
F L L++L + ++ ++P + LE
Sbjct: 188 SEGAFE------------------------GLFNLKYLNLGMCNIK-DMP-NLTPLVGLE 221
Query: 467 QLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL-SLNNLNLSYNDLE 523
+L M GN F S L L+ L + + +S GL SL LNL++N+L
Sbjct: 222 ELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS 279
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 3e-21
Identities = 52/261 (19%), Positives = 103/261 (39%), Gaps = 26/261 (9%)
Query: 166 LNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVE 225
+ L+ +P + S+ ++L NN+ ++F +L L L N++ +E
Sbjct: 59 VVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIE 115
Query: 226 NKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLL 285
+ L L + N L + +L ++L + + +N +
Sbjct: 116 VG------AFNGLASLNTLELFDNWLTVIPSGAFEYL------SKLRELWLRNNPIESIP 163
Query: 286 PGCISNLSKTIKTLFL-NNNKIYGSIPAGI-GNFVNLQRLDMWNNQLSGTIPPAIGELQN 343
+ + + L L K+ I G NL+ L++ + P + L
Sbjct: 164 SYAFNRVPS-LMRLDLGELKKL-EYISEGAFEGLFNLKYLNLGMCNI--KDMPNLTPLVG 219
Query: 344 LKILGLNRNKLSGNIPP-SIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNL 402
L+ L ++ N I P S L L L++ ++ + + ++ SL+E+NL++NNL
Sbjct: 220 LEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNL 278
Query: 403 SGTIPPQFF-SLSSL-SISLD 421
S ++P F L L + L
Sbjct: 279 S-SLPHDLFTPLRYLVELHLH 298
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-20
Identities = 57/275 (20%), Positives = 102/275 (37%), Gaps = 39/275 (14%)
Query: 113 RRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSR--FSSLSKTEILNLGS 170
+ + + E+P I + + + N + +++ F L E+L LG
Sbjct: 54 NQFSKVVCTRRGL-SEVPQGIPSNTRYLNL--MENNI--QMIQADTFRHLHHLEVLQLGR 108
Query: 171 NHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTG 230
N + + L+S++T+ L N L +F + L L L N + + +
Sbjct: 109 NSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFN 168
Query: 231 EVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNN------FGGL 284
VPSL +L L L + L ++++ N L
Sbjct: 169 RVPSLMRL-DLGEL----KKLEYISEG------AFEGLFNLKYLNLGMCNIKDMPNLTPL 217
Query: 285 LPGCISNLSKTIKTLFLNNNKIYGSIPAG-IGNFVNLQRLDMWNNQLSGTIPP-AIGELQ 342
L + L ++ N I G +L++L + N+Q+S I A L
Sbjct: 218 -----VGL----EELEMSGNHF-PEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLA 266
Query: 343 NLKILGLNRNKLSGNIPPSI-GNLKMLLNLFLNDN 376
+L L L N LS ++P + L+ L+ L L+ N
Sbjct: 267 SLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 4e-19
Identities = 57/286 (19%), Positives = 96/286 (33%), Gaps = 55/286 (19%)
Query: 58 VTCSRRH---------QRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSE 108
V C+RR L+L + + +L L+ L L NS I
Sbjct: 59 VVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQ-IEVG 117
Query: 109 I-GGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILN 167
GL L L L +N + IP+ F LSK L
Sbjct: 118 AFNGLASLNTLELFDNWL-TVIPSGA-----------------------FEYLSKLRELW 153
Query: 168 LGSNHLTGSIPS-SLGNLSSIHTISLAYNNLDGTIP-NSFGWFENLVFLSLAANNLSVVE 225
L +N + SIPS + + S+ + L I +F NL +L+L N+
Sbjct: 154 LRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK--- 209
Query: 226 NKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLL 285
++P+L L L+ ++ N L + L + + ++ +
Sbjct: 210 -----DMPNLTPLVGLEELEMSGNHFPEIRPGSFHGL------SSLKKLWVMNSQVSLIE 258
Query: 286 PGCISNLSKTIKTLFLNNNKIYGSIPAGI-GNFVNLQRLDMWNNQL 330
L+ + L L +N + S+P + L L + +N
Sbjct: 259 RNAFDGLAS-LVELNLAHNNL-SSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 8e-07
Identities = 28/134 (20%), Positives = 45/134 (33%), Gaps = 29/134 (21%)
Query: 69 LLDLRSLKLAG----SVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNS 124
L +L+ L L + + L L++L + N F P GL LK L + N+
Sbjct: 195 LFNLKYLNLGMCNIKDMPNL-TPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQ 253
Query: 125 ICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNL 184
+ I N F L+ LNL N+L+ L
Sbjct: 254 VS-LIERNA-----------------------FDGLASLVELNLAHNNLSSLPHDLFTPL 289
Query: 185 SSIHTISLAYNNLD 198
+ + L +N +
Sbjct: 290 RYLVELHLHHNPWN 303
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 57/222 (25%), Positives = 84/222 (37%), Gaps = 49/222 (22%)
Query: 635 GVGSFGSVYKGII----DEGRTTIAVKVFNLQHHGASRS-FIAECKALKSIRHRNLVKVL 689
G G FG V D +AVK RS + E L+++ H +++K
Sbjct: 40 GEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYK 99
Query: 690 TACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAID 746
C A S+ E++ GSL ++L ++ L Q L A
Sbjct: 100 GCCEDAGAA------SLQLVMEYVPLGSLRDYLPR-----------HSIGLAQLLLFAQQ 142
Query: 747 IAYALNYLHHDCQPVTAHC---DLKPSNVLLDDYMTARVGDFGLARILSPDH-----TQT 798
I + YLH H DL NVLLD+ ++GDFGLA+ + H +
Sbjct: 143 ICEGMAYLH------AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 196
Query: 799 SSFSVKGSLGYIAPE---YGVGCEVSTNGDVYSYGILLLELV 837
V + APE DV+S+G+ L EL+
Sbjct: 197 GDSPVF----WYAPECLKEYK---FYYASDVWSFGVTLYELL 231
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 59/241 (24%), Positives = 91/241 (37%), Gaps = 53/241 (21%)
Query: 635 GVGSFGSVYKGII-----DEGRTTIAVKVFNLQHHGASRS-FIAECKALKSIRHRNLVKV 688
G G FG V K G TT+AVK+ + ++E LK + H +++K+
Sbjct: 32 GEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKL 91
Query: 689 LTACLGADYRGNDFKASVY---EFMHYGSLEEWL--------------HPFTGEDEIDEA 731
AC + E+ YGSL +L
Sbjct: 92 YGACSQDG--------PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 732 PRNLNLLQRLNIAIDIAYALNYL-HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARI 790
R L + ++ A I+ + YL H DL N+L+ + ++ DFGL+R
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 791 LSPDHTQTSSFSVKGSLGYI-----APE---YGVGCEVSTNGDVYSYGILLLELV-IGKK 841
+ VK S G I A E + +T DV+S+G+LL E+V +G
Sbjct: 200 V-----YEEDSYVKRSQGRIPVKWMAIESLFDHI---YTTQSDVWSFGVLLWEIVTLGGN 251
Query: 842 P 842
P
Sbjct: 252 P 252
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 49/229 (21%), Positives = 92/229 (40%), Gaps = 42/229 (18%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGAS--RSFIAECKALKSIRHRNL--VK 687
+G G V++ + ++ + A+K NL+ S+ E L ++ + ++
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73
Query: 688 VLTACLGADYRGNDFKASVYEFMHY--GSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAI 745
+ + Y +Y M L WL ++++ +R +
Sbjct: 74 LYDYEITDQY--------IYMVMECGNIDLNSWLKKK----------KSIDPWERKSYWK 115
Query: 746 DIAYALNYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVK 804
++ A++ +H H H DLKP+N L+ D ++ DFG+A + PD T S
Sbjct: 116 NMLEAVHTIHQHG----IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQV 170
Query: 805 GSLGYIAPE-----------YGVGCEVSTNGDVYSYGILLLELVIGKKP 842
G++ Y+ PE ++S DV+S G +L + GK P
Sbjct: 171 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 56/238 (23%), Positives = 88/238 (36%), Gaps = 51/238 (21%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGAS--RSFIAECKALKSIRHRNLVKVLT 690
+G GS+G K + K + + + ++E L+ ++H N+V+
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 691 ACLGADYRGNDFKASVYEFMHY---GSLEEWL-------HPFTGEDEIDEAPRNLNLLQR 740
+ D ++Y M Y G L + E+ +
Sbjct: 73 RII--DRTNT----TLYIVMEYCEGGDLASVITKGTKERQYLD-EEFV------------ 113
Query: 741 LNIAIDIAYALNYLHHDCQPVTA--HCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQT 798
L + + AL H H DLKP+NV LD ++GDFGLARIL+ D +
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA 173
Query: 799 SSFSVKGSLGYIAPE------YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
+F G+ Y++PE Y D++S G LL EL P F
Sbjct: 174 KTF--VGTPYYMSPEQMNRMSYNEKS------DIWSLGCLLYELCALMPP----FTAF 219
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 49/229 (21%), Positives = 92/229 (40%), Gaps = 42/229 (18%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGAS--RSFIAECKALKSIRHRNL--VK 687
+G G V++ + ++ + A+K NL+ S+ E L ++ + ++
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92
Query: 688 VLTACLGADYRGNDFKASVYEFMHY--GSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAI 745
+ + Y +Y M L WL ++++ +R +
Sbjct: 93 LYDYEITDQY--------IYMVMECGNIDLNSWLKKK----------KSIDPWERKSYWK 134
Query: 746 DIAYALNYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVK 804
++ A++ +H H H DLKP+N L+ D ++ DFG+A + PD T S
Sbjct: 135 NMLEAVHTIHQHG----IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQV 189
Query: 805 GSLGYIAPE-----------YGVGCEVSTNGDVYSYGILLLELVIGKKP 842
G++ Y+ PE ++S DV+S G +L + GK P
Sbjct: 190 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-24
Identities = 54/228 (23%), Positives = 97/228 (42%), Gaps = 50/228 (21%)
Query: 635 GVGSFGSVYKGI----IDEGRTTIAVKVFNLQHHGAS----RSFIAECKALKSIRHRNLV 686
G G FG VYKG+ + +A+K G + F+ E + H N++
Sbjct: 53 GAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 687 KVLTACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNI 743
++ + E+M G+L+++L E ++LQ + +
Sbjct: 110 RLEGVISKYK--------PMMIITEYMENGALDKFLR---------EKDGEFSVLQLVGM 152
Query: 744 AIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPD-----HTQT 798
IA + YL + V H DL N+L++ + +V DFGL+R+L D T
Sbjct: 153 LRGIAAGMKYLA-NMNYV--HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 209
Query: 799 SSFSVKGSLGYIAPE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
++ + APE Y ++ DV+S+GI++ E++ G++P
Sbjct: 210 GKIPIR----WTAPEAISYRK---FTSASDVWSFGIVMWEVMTYGERP 250
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 66/234 (28%), Positives = 100/234 (42%), Gaps = 52/234 (22%)
Query: 635 GVGSFGSVYKGII--DEGRTTIAVKVFNLQHHGASRS----FIAECKALKSI-RHRNLVK 687
G G+FG V K I D R A+K AS+ F E + L + H N++
Sbjct: 34 GEGNFGQVLKARIKKDGLRMDAAIKRMK---EYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 688 VLTACLGADYRGNDFKASVY---EFMHYGSLEEWL------HPFTGEDEIDEAPRNLNLL 738
+L AC Y +Y E+ +G+L ++L + L+
Sbjct: 91 LLGACEHRGY--------LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 739 QRLNIAIDIAYALNYL-HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQ 797
Q L+ A D+A ++YL H DL N+L+ + A++ DFGL+R
Sbjct: 143 QLLHFAADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSR-------- 190
Query: 798 TSSFSVKGSLGYI-----APE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
VK ++G + A E Y V +TN DV+SYG+LL E+V +G P
Sbjct: 191 GQEVYVKKTMGRLPVRWMAIESLNYSV---YTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 56/230 (24%), Positives = 90/230 (39%), Gaps = 44/230 (19%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGAS--RSFIAECKALKSIRHRNLVKVLT 690
+G GSFG E +K N+ + E L +++H N+V+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQ--- 87
Query: 691 ACLGADYRGNDF--KASVYEFMHY---GSLEEWL-----HPFTGEDEIDEAPRNLNLLQR 740
YR + F S+Y M Y G L + + F ED+I
Sbjct: 88 ------YRES-FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQ-EDQI------------ 127
Query: 741 LNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSS 800
L+ + I AL ++H H D+K N+ L T ++GDFG+AR+L+ +
Sbjct: 128 LDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA 184
Query: 801 FSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
G+ Y++PE + D+++ G +L EL K FE
Sbjct: 185 C--IGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA----FEAG 228
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 61/233 (26%), Positives = 100/233 (42%), Gaps = 46/233 (19%)
Query: 635 GVGSFGSVYKGII-----DEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVL 689
G G+FG V+ + + +AVK A + F E + L +++H ++VK
Sbjct: 24 GEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFY 83
Query: 690 TACLGAD--YRGNDFKASVYEFMHYGSLEEWL------HPFTGEDEIDEAPRNLNLLQRL 741
C D V+E+M +G L ++L + + +A L L Q L
Sbjct: 84 GVCGDGDPLI-------MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 136
Query: 742 NIAIDIAYALNYL--HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLAR-ILSPDHTQT 798
+IA IA + YL H H DL N L+ + ++GDFG++R + S D+ +
Sbjct: 137 HIASQIASGMVYLASQHFV-----HRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR- 190
Query: 799 SSFSVKGSLGYI-----APE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
G + PE Y +T DV+S+G++L E+ GK+P
Sbjct: 191 -----VGGHTMLPIRWMPPESIMYRK---FTTESDVWSFGVILWEIFTYGKQP 235
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 34/281 (12%), Positives = 63/281 (22%), Gaps = 48/281 (17%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFN---LQHHGASRSFIAECKALKSIRHRNLVKVL 689
+ VG V+ E A+KVF A + + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 690 T-------------------ACLGADYRGNDFKA--SVYEFMHYGSLEEWLHPFTGEDEI 728
A L + LE D +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFV 184
Query: 729 DEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLA 788
+ +L + + L + + H P N+ + +GD
Sbjct: 185 YVFRGDEGILALHILTAQLIRLAANLQS--KGL-VHGHFTPDNLFIMPDGRLMLGDVSAL 241
Query: 789 RILSPDHTQTSSFSVKGSLGYIAPEY--GVGCEVSTNGDVYSYGILLLELVIGKKPIDIM 846
+ T + + Y E+ + + + G+ + + P
Sbjct: 242 WKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP---- 292
Query: 847 FEGDINLHNFGRKALPDDVMDIVDSSL-----LPDD-EDLI 881
F K V + LPD + LI
Sbjct: 293 FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLI 333
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 52/227 (22%), Positives = 84/227 (37%), Gaps = 35/227 (15%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASR---SFIAECKALKSIRHRNLVKVL 689
+G G F VY+ +A+K + ++ I E LK + H N++K
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK-- 96
Query: 690 TACLGADYRGNDFKA--SVYEFMHY---GSLEEWLHPFTGEDE-IDEAPRNLNLLQRLNI 743
Y + F + + G L + F + I E
Sbjct: 97 -------YYAS-FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPER-------TVWKY 141
Query: 744 AIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSV 803
+ + AL ++H H D+KP+NV + ++GD GL R S T S
Sbjct: 142 FVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-- 196
Query: 804 KGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
G+ Y++PE + D++S G LL E+ + P F GD
Sbjct: 197 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGD 239
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 56/238 (23%), Positives = 88/238 (36%), Gaps = 33/238 (13%)
Query: 290 SNLSKTIKTLFLNNNKIYGSIPAGI-GNFVNLQRLDMWNNQLSGTIPP-AIGELQNLKIL 347
+S + L L+ N+I I + +L+ L + N + TI A L NL L
Sbjct: 60 DGISTNTRLLNLHENQI-QIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTL 117
Query: 348 GLNRNKLSGNIPPSI-GNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTI 406
L N+L+ IP L L L+L +N +E + + SL ++L I
Sbjct: 118 ELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYI 176
Query: 407 PPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLE 466
F L L +L + L EIP I+L+
Sbjct: 177 SEGAFE------------------------GLSNLRYLNLAMCNLR-EIP-NLTPLIKLD 210
Query: 467 QLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL-SLNNLNLSYNDLE 523
+L + GN S L L+ L + Q+ + L SL +NL++N+L
Sbjct: 211 ELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT 268
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 5e-22
Identities = 50/242 (20%), Positives = 95/242 (39%), Gaps = 18/242 (7%)
Query: 163 TEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLS 222
T +LNL N + +S +L + + L+ N++ +F NL L L N L+
Sbjct: 66 TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT 125
Query: 223 VVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNN-F 281
+ N + L +L+ + +N + S + + + L + +
Sbjct: 126 TIPNG------AFVYLSKLKELWLRNNPIESIPSYAFNRI------PSLRRLDLGELKRL 173
Query: 282 GGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGEL 341
+ G LS ++ L L + IP + + L LD+ N LS P + L
Sbjct: 174 SYISEGAFEGLSN-LRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGL 230
Query: 342 QNLKILGLNRNKLSGNIPP-SIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNN 400
+L+ L + ++++ I + NL+ L+ + L N L + L I+L +N
Sbjct: 231 MHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
Query: 401 NL 402
Sbjct: 290 PW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 5e-22
Identities = 54/236 (22%), Positives = 94/236 (39%), Gaps = 13/236 (5%)
Query: 269 TRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGI-GNFVNLQRLDMWN 327
T ++++ N + +L ++ L L+ N I +I G NL L++++
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRH-LEILQLSRNHI-RTIEIGAFNGLANLNTLELFD 121
Query: 328 NQLSGTIPP-AIGELQNLKILGLNRNKLSGNIPPSI-GNLKMLLNLFLND-NFLEVSIPS 384
N+L+ TIP A L LK L L N + +IP + L L L + L
Sbjct: 122 NRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEG 179
Query: 385 SLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEV-GKLKILEF 443
+ +L +NL+ NL P L L LD S N L+ ++ L L+
Sbjct: 180 AFEGLSNLRYLNLAMCNL--REIPNLTPLIKLD-ELDLSGNHLS-AIRPGSFQGLMHLQK 235
Query: 444 LYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNL 499
L++ +++++ + F N L ++ + N L L + L N
Sbjct: 236 LWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 4e-21
Identities = 59/275 (21%), Positives = 110/275 (40%), Gaps = 26/275 (9%)
Query: 155 SRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFL 214
S S ++ + +L +P + ++ ++L N + NSF +L L
Sbjct: 37 SVCSCSNQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEIL 93
Query: 215 SLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWM 274
L+ N++ +E + L L + N L + N +L ++L +
Sbjct: 94 QLSRNHIRTIEIG------AFNGLANLNTLELFDNRLTTIPNGAFVYL------SKLKEL 141
Query: 275 HINSNNFGGLLPGCISNLSKTIKTLFL-NNNKIYGSIPAGI-GNFVNLQRLDMWNNQLSG 332
+ +N + + + ++ L L ++ I G NL+ L++ L
Sbjct: 142 WLRNNPIESIPSYAFNRIPS-LRRLDLGELKRL-SYISEGAFEGLSNLRYLNLAMCNL-- 197
Query: 333 TIPPAIGELQNLKILGLNRNKLSGNIPP-SIGNLKMLLNLFLNDNFLEVSIPSSLGQCES 391
P + L L L L+ N LS I P S L L L++ + ++V ++ +S
Sbjct: 198 REIPNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQS 256
Query: 392 LIEINLSNNNLSGTIPPQFF-SLSSLSISLDWSRN 425
L+EINL++NNL+ +P F L L + N
Sbjct: 257 LVEINLAHNNLT-LLPHDLFTPLHHLE-RIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 4e-20
Identities = 59/254 (23%), Positives = 105/254 (41%), Gaps = 26/254 (10%)
Query: 128 EIPTNISRCSTLIPIHPQNNQLVGKILSR--FSSLSKTEILNLGSNHLTGSIPSSLGNLS 185
E+P IS + L+ + NQ+ +I+ F L EIL L NH+ + L+
Sbjct: 57 EVPDGISTNTRLLNL--HENQI--QIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLA 112
Query: 186 SIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFT 245
+++T+ L N L +F + L L L N + + + +PSL +L L
Sbjct: 113 NLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRL-DLGEL- 170
Query: 246 ITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNK 305
L + + L ++++ N + ++ L K + L L+ N
Sbjct: 171 ---KRLSYISEG------AFEGLSNLRYLNLAMCNLREIPN--LTPLIK-LDELDLSGNH 218
Query: 306 IYGSIPAGI-GNFVNLQRLDMWNNQLSGTIPP-AIGELQNLKILGLNRNKLSGNIPPSI- 362
+ +I G ++LQ+L M +Q+ I A LQ+L + L N L+ +P +
Sbjct: 219 L-SAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHDLF 275
Query: 363 GNLKMLLNLFLNDN 376
L L + L+ N
Sbjct: 276 TPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 8e-20
Identities = 59/286 (20%), Positives = 99/286 (34%), Gaps = 55/286 (19%)
Query: 58 VTCSRRH---------QRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSE 108
V C R++ LL+L ++ + +L L+ L L N I
Sbjct: 48 VICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRT-IEIG 106
Query: 109 I-GGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILN 167
GL L L L +N + IP F LSK + L
Sbjct: 107 AFNGLANLNTLELFDNRL-TTIPNGA-----------------------FVYLSKLKELW 142
Query: 168 LGSNHLTGSIPSSL-GNLSSIHTISLAYNNLDGTIP-NSFGWFENLVFLSLAANNLSVVE 225
L +N + SIPS + S+ + L I +F NL +L+LA NL
Sbjct: 143 LRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR--- 198
Query: 226 NKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLL 285
E+P+L L +L ++ N L + L L + + + +
Sbjct: 199 -----EIPNLTPLIKLDELDLSGNHLSAIRPGSFQGL------MHLQKLWMIQSQIQVIE 247
Query: 286 PGCISNLSKTIKTLFLNNNKIYGSIPAGI-GNFVNLQRLDMWNNQL 330
NL + + L +N + +P + +L+R+ + +N
Sbjct: 248 RNAFDNLQS-LVEINLAHNNL-TLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 4e-11
Identities = 38/159 (23%), Positives = 62/159 (38%), Gaps = 10/159 (6%)
Query: 368 LLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPP-QFFSLSSLSISLDWSRNK 426
+ L +P + + +NL N + I F L L L SRN
Sbjct: 45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQ-IIKVNSFKHLRHLE-ILQLSRNH 99
Query: 427 LTGSLPIEV-GKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGS 485
+ ++ I L L L +++NRL F +L++L + N + S +
Sbjct: 100 IR-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNR 158
Query: 486 LRGLRVLDLSQNNLSGEIPK-FLAGL-SLNNLNLSYNDL 522
+ LR LDL + I + GL +L LNL+ +L
Sbjct: 159 IPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL 197
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 26/113 (23%), Positives = 44/113 (38%), Gaps = 4/113 (3%)
Query: 87 NLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNI-SRCSTLIPIHPQ 145
LS L+ L L + + IP+ + L +L L L+ N + I L +
Sbjct: 183 GLSNLRYLNLAMCNLRE-IPN-LTPLIKLDELDLSGNHL-SAIRPGSFQGLMHLQKLWMI 239
Query: 146 NNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLD 198
+Q+ + F +L +NL N+LT L + I L +N +
Sbjct: 240 QSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 2e-23
Identities = 49/220 (22%), Positives = 94/220 (42%), Gaps = 37/220 (16%)
Query: 635 GVGSFGSVYKGI--IDEGRTTIAVKVFNLQHHGASRS-FIAECKALKSIRHRNLVKVLTA 691
G G+FGSV +G+ + + + +A+KV A + E + + + + +V+++
Sbjct: 345 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 404
Query: 692 CLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIA 748
C ++ E G L ++L + + + ++
Sbjct: 405 CQ---------AEALMLVMEMAGGGPLHKFLV---------GKREEIPVSNVAELLHQVS 446
Query: 749 YALNYL-HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQ-TSSFSVKGS 806
+ YL + H +L NVLL + A++ DFGL++ L D + T+ + K
Sbjct: 447 MGMKYLEEKNF----VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 502
Query: 807 LGYIAPE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
L + APE + S+ DV+SYG+ + E + G+KP
Sbjct: 503 LKWYAPECINFRK---FSSRSDVWSYGVTMWEALSYGQKP 539
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 60/235 (25%), Positives = 94/235 (40%), Gaps = 55/235 (23%)
Query: 635 GVGSFGSVYKGII-----DEGRTTIAVKVFNLQHHGASRS----FIAECKALKSIRHRNL 685
G G+FG VY+G + D +AVK S F+ E + H+N+
Sbjct: 39 GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFNHQNI 95
Query: 686 VKVLTACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLN 742
V+ + L + + E M G L+ +L P +L +L L+
Sbjct: 96 VRCIGVSLQSL--------PRFILMELMAGGDLKSFLRETRPR---PSQPSSLAMLDLLH 144
Query: 743 IAIDIAYALNYL--HHDCQPVTAHCDLKPSNVLLDDY---MTARVGDFGLAR-ILSPDHT 796
+A DIA YL +H H D+ N LL A++GDFG+AR I +
Sbjct: 145 VARDIACGCQYLEENHFI-----HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 199
Query: 797 QTSSFSVKGSLGYI-----APE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
+ KG + PE G+ ++ D +S+G+LL E+ +G P
Sbjct: 200 R------KGGCAMLPVKWMPPEAFMEGI---FTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 55/281 (19%), Positives = 96/281 (34%), Gaps = 53/281 (18%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVK----- 687
++G G+FG V K A+K + ++E L S+ H+ +V+
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 688 VLTACLGADYRGNDFKASVYEFMHY---GSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIA 744
+ K++++ M Y G+L + +H + DE +
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY---------WRLF 122
Query: 745 IDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSF--- 801
I AL+Y+H Q + H DLKP N+ +D+ ++GDFGLA+ +
Sbjct: 123 RQILEALSYIHS--QGI-IHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 802 ---------SVKGSLGYIAPE-------YGVGCEVSTNGDVYSYGILLLELVIG------ 839
S G+ Y+A E Y D+YS GI+ E++
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKI------DMYSLGIIFFEMIYPFSTGME 233
Query: 840 -KKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDED 879
+ + I I+ + D
Sbjct: 234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNK 274
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 59/237 (24%), Positives = 90/237 (37%), Gaps = 51/237 (21%)
Query: 635 GVGSFGSVYKGII-----DEGRTTIAVKVFNLQHHGASRS----FIAECKALKSI-RHRN 684
G G+FG V + T+AVK+ GA+ S ++E K L I H N
Sbjct: 36 GRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHLN 92
Query: 685 LVKVLTACLGADYRGNDFKASVY---EFMHYGSLEEWL------HPFTGEDEIDEAPRNL 735
+V +L AC + EF +G+L +L D L
Sbjct: 93 VVNLLGACTKPG-------GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145
Query: 736 NLLQRLNIAIDIAYALNYL-HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPD 794
L + + +A + +L C H DL N+LL + ++ DFGLAR +
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDI--- 198
Query: 795 HTQTSSFSVKGSLGYI-----APE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
V+ + APE V + DV+S+G+LL E+ +G P
Sbjct: 199 --YKDPDYVRKGDARLPLKWMAPETIFDRV---YTIQSDVWSFGVLLWEIFSLGASP 250
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 56/259 (21%), Positives = 101/259 (38%), Gaps = 21/259 (8%)
Query: 290 SNLSKTIKTLFLNNNKIYGSIPAGI-GNFVNLQRLDMWNNQLSGTIPP-AIGELQNLKIL 347
S L++ +K+L L+NN+I I VNLQ L + +N ++ TI + L +L+ L
Sbjct: 48 SGLTEAVKSLDLSNNRI-TYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHL 105
Query: 348 GLNRNKLSGNIPPSI-GNLKMLLNLFLNDNFLEVSIPSSL-GQCESLIEINLSNNNLSGT 405
L+ N LS N+ S L L L L N + +SL L + + N +
Sbjct: 106 DLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTK 164
Query: 406 IPPQFF-SLSSLSISLDWSRNKLTGSLPIEV-GKLKILEFLYVYENRLEGEIPSTFGNCI 463
I + F L+ L L+ + L S + ++ + L ++ + +
Sbjct: 165 IQRKDFAGLTFLE-ELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTS 222
Query: 464 RLEQLGMGGNLFQGP--------ISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLSLNNL 515
+E L + ++SL R + ++ +L + L L
Sbjct: 223 SVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLEL 282
Query: 516 NLSYNDLEGMVTTEGVFKN 534
S N L+ + +G+F
Sbjct: 283 EFSRNQLKSV--PDGIFDR 299
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 2e-21
Identities = 61/275 (22%), Positives = 106/275 (38%), Gaps = 26/275 (9%)
Query: 91 LKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNI-SRCSTLIPIHPQNNQL 149
+K L L N T+ S++ L+ L L +N I I + S +L + N L
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI-NTIEEDSFSSLGSLEHLDLSYNYL 112
Query: 150 VGKILSR--FSSLSKTEILNLGSNHLTGSIPSSL-GNLSSIHTISLAYNNLDGTIP-NSF 205
LS F LS LNL N +SL +L+ + + + + I F
Sbjct: 113 --SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170
Query: 206 GWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSN---SLGSGGNDDLSFL 262
L L + A++L E K SL+ +Q + H + L D S +
Sbjct: 171 AGLTFLEELEIDASDLQSYEPK------SLKSIQNVSHLILHMKQHILLLEIFVDVTSSV 224
Query: 263 CSLTNATRLTWMHINSNNFGGLLPGCISNLSK--TIKTLFLNNNKIYGSIPAGIGNFVNL 320
L L +++ +F L G ++L K T + + + + ++ + + L
Sbjct: 225 ECL----ELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGL 279
Query: 321 QRLDMWNNQLSGTIPP-AIGELQNLKILGLNRNKL 354
L+ NQL ++P L +L+ + L+ N
Sbjct: 280 LELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-19
Identities = 45/227 (19%), Positives = 85/227 (37%), Gaps = 18/227 (7%)
Query: 309 SIPAGIGNFVNLQRLDMWNNQLSGTIPP-AIGELQNLKILGLNRNKLSGNIPPSI-GNLK 366
SIP+G+ ++ LD+ NN+++ I + NL+ L L N ++ I +L
Sbjct: 45 SIPSGL--TEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLG 100
Query: 367 MLLNLFLNDNFLEVSIPSSL-GQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRN 425
L +L L+ N+L ++ SS SL +NL N FS + L
Sbjct: 101 SLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNM 159
Query: 426 KLTGSLPIEV-GKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLG 484
+ + L LE L + + L+ P + + + L + + +
Sbjct: 160 DTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVD 219
Query: 485 SLRGLRVLDLSQNNL---------SGEIPKFLAGLSLNNLNLSYNDL 522
+ L+L +L +GE + + N+ ++ L
Sbjct: 220 VTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL 266
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-19
Identities = 40/247 (16%), Positives = 78/247 (31%), Gaps = 17/247 (6%)
Query: 265 LTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGI-GNFVNLQRL 323
L L + + SN + S+L ++ L L+ N + ++ + +L L
Sbjct: 72 LQRCVNLQALVLTSNGINTIEEDSFSSLGS-LEHLDLSYNYL-SNLSSSWFKPLSSLTFL 129
Query: 324 DMWNNQLSGTIPPAI--GELQNLKILGLNRNKLSGNIPPSI-GNLKMLLNLFLNDNFLEV 380
++ N T+ L L+IL + I L L L ++ + L+
Sbjct: 130 NLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQS 188
Query: 381 SIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTG----SLPIEV- 435
P SL +++ + L + F ++S L+ L L
Sbjct: 189 YEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGET 247
Query: 436 ---GKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVL 492
K + + + L ++ L +L N + L L+ +
Sbjct: 248 NSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKI 306
Query: 493 DLSQNNL 499
L N
Sbjct: 307 WLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 53/328 (16%), Positives = 113/328 (34%), Gaps = 52/328 (15%)
Query: 159 SLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAA 218
S + I S L SIPS L ++ ++ L+ N + + NL L L +
Sbjct: 29 SCDRNGICKGSSGSLN-SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTS 85
Query: 219 NNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINS 278
N ++ +E S L L+H ++ N L + + + LT++++
Sbjct: 86 NGINTIEED------SFSSLGSLEHLDLSYNYLSNLSSS------WFKPLSSLTFLNLLG 133
Query: 279 NNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGI-GNFVNLQRLDMWNNQLSGTIPPA 337
N + L + + ++ L + N + I L+ L++ + L P +
Sbjct: 134 NPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKS 193
Query: 338 IGELQNLKILGLNRNKLSGNIPPSI-GNLKMLLNLFLNDNFLEV----SIPS----SLGQ 388
+ +QN+ L L+ + + + L L D L+ + + SL +
Sbjct: 194 LKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIK 252
Query: 389 CESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYE 448
+ + +++ +L + +S L L
Sbjct: 253 KFTFRNVKITDESLF-QVMKLLNQISGL-------------------------LELEFSR 286
Query: 449 NRLEGEIPSTFGNCIRLEQLGMGGNLFQ 476
N+L+ F L+++ + N +
Sbjct: 287 NQLKSVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 47/223 (21%), Positives = 86/223 (38%), Gaps = 14/223 (6%)
Query: 87 NLSFLKQLYLQVNSFTHEIPSEI-GGLRRLKVLALNNNSICGEIPTNI-SRCSTLIPIHP 144
+L L+ L L N ++ + S L L L L N T++ S + L +
Sbjct: 98 SLGSLEHLDLSYNYLSN-LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRV 156
Query: 145 QNNQLVGKILSR-FSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPN 203
N KI + F+ L+ E L + ++ L P SL ++ ++ + L +
Sbjct: 157 GNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEI 216
Query: 204 SFGWFENLVFLSLAANNLSVVE-NKL-TGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSF 261
++ L L +L ++L TGE SL K ++ IT SL
Sbjct: 217 FVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL-------FQV 269
Query: 262 LCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNN 304
+ L + L + + N + G L+ ++ ++L+ N
Sbjct: 270 MKLLNQISGLLELEFSRNQLKSVPDGIFDRLTS-LQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 6e-06
Identities = 19/122 (15%), Positives = 41/122 (33%), Gaps = 13/122 (10%)
Query: 87 NLSFLKQLYLQVNSFTHEIPSEI-GGLRRLKVLALNNNSICGEIPTNIS--------RCS 137
++ + L L + + ++ L L + + + +S +
Sbjct: 196 SIQNVSHLILHMKQHIL-LLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKF 254
Query: 138 TLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSS-LGNLSSIHTISLAYNN 196
T + + L +++ + +S L N L S+P L+S+ I L N
Sbjct: 255 TFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNP 312
Query: 197 LD 198
D
Sbjct: 313 WD 314
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 102 bits (254), Expect = 5e-23
Identities = 32/279 (11%), Positives = 73/279 (26%), Gaps = 47/279 (16%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNL-------------------------QHHGAS 667
++G + + E + V V ++ +
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 668 RSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDE 727
+ + ++ K++ L + +Y M +L+ +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSS 203
Query: 728 IDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGL 787
++ L RL + + + L LHH + H L+P +++LD + F
Sbjct: 204 THKS---LVHHARLQLTLQVIRLLASLHH--YGL-VHTYLRPVDIVLDQRGGVFLTGFEH 257
Query: 788 ARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNG-----DVYSYGILLLELVIGKKP 842
+ A + D ++ G+ + + P
Sbjct: 258 LVRDG-ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
Query: 843 IDIMFEGDINLHNF-----GRKALPDDVMDIVDSSLLPD 876
D L K +P V +++ L
Sbjct: 317 ----NTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYP 351
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-23
Identities = 55/227 (24%), Positives = 96/227 (42%), Gaps = 49/227 (21%)
Query: 635 GVGSFGSVYKGII---DEGRTTIAVKVFNLQHHGAS----RSFIAECKALKSIRHRNLVK 687
G G FG V G + + ++A+K G + R F+ E + H N+++
Sbjct: 54 GAGEFGEVCSGRLKLPSKKEISVAIKTLK---VGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 688 VLTACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIA 744
+ + V E+M GSL+ +L + ++Q + +
Sbjct: 111 LEGVVTKSK--------PVMIVTEYMENGSLDSFLRKHDAQ---------FTVIQLVGML 153
Query: 745 IDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPD-----HTQTS 799
IA + YL D V H DL N+L++ + +V DFGL R+L D T+
Sbjct: 154 RGIASGMKYLS-DMGYV--HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGG 210
Query: 800 SFSVKGSLGYIAPE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
++ + +PE Y ++ DV+SYGI+L E++ G++P
Sbjct: 211 KIPIR----WTSPEAIAYRK---FTSASDVWSYGIVLWEVMSYGERP 250
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 5e-23
Identities = 55/234 (23%), Positives = 87/234 (37%), Gaps = 47/234 (20%)
Query: 635 GVGSFGSVYKGII-----DEGRTTIAVKVFNLQHHGASRS-FIAECKALKSIRHRNLVKV 688
G FG VYKG + E +A+K + G R F E ++H N+V +
Sbjct: 18 GEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCL 77
Query: 689 LTACLGADYRGNDFKASVY---EFMHYGSLEEWLH------PFTGEDEIDEAPRNLNLLQ 739
L + + +G L E+L D+ L
Sbjct: 78 LGVVTKDQ--------PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 740 RLNIAIDIAYALNYL--HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQ 797
+++ IA + YL HH H DL NVL+ D + ++ D GL R +
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVV-----HKDLATRNVLVYDKLNVKISDLGLFREV-----Y 179
Query: 798 TSSFSVKGSLGYI-----APE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
+ + + APE YG S + D++SYG++L E+ G +P
Sbjct: 180 AADYYKLLGNSLLPIRWMAPEAIMYGK---FSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 7e-23
Identities = 49/232 (21%), Positives = 92/232 (39%), Gaps = 54/232 (23%)
Query: 635 GVGSFGSVYKGI-------IDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVK 687
G G+F ++KG+ T + +KV + H S SF + + H++LV
Sbjct: 17 GQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVL 76
Query: 688 VLTACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIA 744
C+ D EF+ +GSL+ +L + +N+L +L +A
Sbjct: 77 NYGVCVCGD--------ENILVQEFVKFGSLDTYLK---------KNKNCINILWKLEVA 119
Query: 745 IDIAYALNYL-HHDCQPVTAHCDLKPSNVLLD--------DYMTARVGDFGLAR-ILSPD 794
+A A+++L + H ++ N+LL + ++ D G++ +L D
Sbjct: 120 KQLAAAMHFLEENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175
Query: 795 HTQTSSFSVKGSLGYIAPE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
Q + ++ PE ++ D +S+G L E+ G KP
Sbjct: 176 ILQ---ERIP----WVPPECIENPK--NLNLATDKWSFGTTLWEICSGGDKP 218
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-23
Identities = 58/238 (24%), Positives = 95/238 (39%), Gaps = 47/238 (19%)
Query: 635 GVGSFGSVYKGII-----DEGRTTIAVKVFNLQHHGASRS-FIAECKALKSIRHRNLVKV 688
G G+FG V++ E T +AVK+ + ++ F E + + N+VK+
Sbjct: 56 GEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKL 115
Query: 689 LTACLGADYRGNDFKASVYEFMHYGSLEEWL--------------HPFTGEDEIDEAPRN 734
L C ++E+M YG L E+L T P
Sbjct: 116 LGVCAVGKPM-----CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 735 LNLLQRLNIAIDIAYALNYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSP 793
L+ ++L IA +A + YL V H DL N L+ + M ++ DFGL+R +
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERKF--V--HRDLATRNCLVGENMVVKIADFGLSRNI-- 224
Query: 794 DHTQTSSFSVKGSLGYI-----APE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
++ + I PE Y +T DV++YG++L E+ G +P
Sbjct: 225 ---YSADYYKADGNDAIPIRWMPPESIFYNR---YTTESDVWAYGVVLWEIFSYGLQP 276
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 1e-22
Identities = 50/226 (22%), Positives = 90/226 (39%), Gaps = 50/226 (22%)
Query: 635 GVGSFGSVYKGI---IDEGRTTIAVKVFNLQHHGAS----RSFIAECKALKSIRHRNLVK 687
G G FG V++GI + +A+K + S F+ E ++ H ++VK
Sbjct: 399 GEGQFGDVHQGIYMSPENPAMAVAIKTCK---NCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 688 VLTACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIA 744
++ + V+ E G L +L +L+L + A
Sbjct: 456 LIGVIT---------ENPVWIIMELCTLGELRSFLQ---------VRKFSLDLASLILYA 497
Query: 745 IDIAYALNYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSS--- 800
++ AL YL H D+ NVL+ ++GDFGL+R + +S
Sbjct: 498 YQLSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 553
Query: 801 FSVKGSLGYIAPE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
+K ++APE + ++ DV+ +G+ + E++ G KP
Sbjct: 554 LPIK----WMAPESINFRR---FTSASDVWMFGVCMWEILMHGVKP 592
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 59/232 (25%), Positives = 92/232 (39%), Gaps = 49/232 (21%)
Query: 635 GVGSFGSVYKGII-----DEGRTTIAVKVFNLQHHGASRS-FIAECKALKSIRHRNLVKV 688
G G+FG VY+G + D +AVK F+ E + H+N+V+
Sbjct: 80 GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 139
Query: 689 LTACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAI 745
+ L + + E M G L+ +L P +L +L L++A
Sbjct: 140 IGVSLQSL--------PRFILLELMAGGDLKSFLRETRPR---PSQPSSLAMLDLLHVAR 188
Query: 746 DIAYALNYL--HHDCQPVTAHCDLKPSNVLLDDY---MTARVGDFGLAR-ILSPDHTQTS 799
DIA YL +H H D+ N LL A++GDFG+AR I +
Sbjct: 189 DIACGCQYLEENHFI-----HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY--- 240
Query: 800 SFSVKGSLGYI-----APE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
KG + PE G+ ++ D +S+G+LL E+ +G P
Sbjct: 241 ---RKGGCAMLPVKWMPPEAFMEGI---FTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 57/239 (23%), Positives = 94/239 (39%), Gaps = 54/239 (22%)
Query: 635 GVGSFGSVYKGII-------DEGRTTIAVKVFNLQHHGASRS----FIAECKALKSI-RH 682
G G+FG V T +AVK+ A+ I+E + +K I +H
Sbjct: 78 GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEMEMMKMIGKH 134
Query: 683 RNLVKVLTACLGADYRGNDFKASVY---EFMHYGSLEEWL------HPFTGEDEIDEAPR 733
+N++ +L AC +Y E+ G+L E+L +
Sbjct: 135 KNIINLLGACTQDG--------PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 734 NLNLLQRLNIAIDIAYALNYL-HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILS 792
L+ ++ A +A + YL C H DL NVL+ + ++ DFGLAR +
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDI- 241
Query: 793 PDHTQTSSFSVKGSLGYI-----APE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
+ K + G + APE + + DV+S+G+LL E+ +G P
Sbjct: 242 ----HHIDYYKKTTNGRLPVKWMAPEALFDRI---YTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 55/239 (23%), Positives = 93/239 (38%), Gaps = 54/239 (22%)
Query: 635 GVGSFGSVYKGII-------DEGRTTIAVKVFNLQHHGASRS----FIAECKALKSI-RH 682
G G+FG V + T+AVK+ A+ ++E + +K I +H
Sbjct: 44 GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGKH 100
Query: 683 RNLVKVLTACLGADYRGNDFKASVY---EFMHYGSLEEWL------HPFTGEDEIDEAPR 733
+N++ +L AC +Y E+ G+L E+L D
Sbjct: 101 KNIINLLGACTQDG--------PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 734 NLNLLQRLNIAIDIAYALNYL-HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILS 792
+ ++ +A + YL C H DL NVL+ + ++ DFGLAR +
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDI- 207
Query: 793 PDHTQTSSFSVKGSLGYI-----APE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
+ K + G + APE V + DV+S+G+L+ E+ +G P
Sbjct: 208 ----NNIDYYKKTTNGRLPVKWMAPEALFDRV---YTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-22
Identities = 63/287 (21%), Positives = 103/287 (35%), Gaps = 63/287 (21%)
Query: 592 LVLCLVRKIKEKENPSSSIYSLLYLSYQDLYNATSGFSSANLV-----GVGSFGSVYKGI 646
LV R + P + S L + F L G G FG V
Sbjct: 46 LVRITTRLSSTADTPMLAGVSEYELPEDPKWE----FPRDKLTLGKPLGEGCFGQVVMAE 101
Query: 647 I-------DEGRTTIAVKVFNLQHHGASRS----FIAECKALKSI-RHRNLVKVLTACLG 694
+ T+AVK+ A+ ++E + +K I +H+N++ +L AC
Sbjct: 102 AVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158
Query: 695 ADYRGNDFKASVY---EFMHYGSLEEWL------HPFTGEDEIDEAPRNLNLLQRLNIAI 745
+Y E+ G+L E+L D + ++
Sbjct: 159 DG--------PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY 210
Query: 746 DIAYALNYL-HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVK 804
+A + YL C H DL NVL+ + ++ DFGLAR + + K
Sbjct: 211 QLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDI-----NNIDYYKK 261
Query: 805 GSLGYI-----APE---YGVGCEVSTNGDVYSYGILLLELV-IGKKP 842
+ G + APE V + DV+S+G+L+ E+ +G P
Sbjct: 262 TTNGRLPVKWMAPEALFDRV---YTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 3e-22
Identities = 51/216 (23%), Positives = 79/216 (36%), Gaps = 29/216 (13%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTA 691
VG GSFG V++ + AVK L+ E A + +V
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVP---- 114
Query: 692 CLGADYRGNDFKASVY-EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYA 750
GA G +++ E + GSL + + E +
Sbjct: 115 LYGAVREGPWV--NIFMELLEGGSLGQLIKQMGCLPE--------DRAL--YYLGQALEG 162
Query: 751 LNYLHHDCQPVTAHCDLKPSNVLLDDY-MTARVGDFGLARILSPDH---TQTSSFSVKGS 806
L YLH H D+K NVLL A + DFG A L PD + + + G+
Sbjct: 163 LEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219
Query: 807 LGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
++APE +G D++S ++L ++ G P
Sbjct: 220 ETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 3e-22
Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 28/214 (13%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIA-ECKALKSIRHRNLVKVLTAC 692
+G G+ G V+K +A K+ +L+ A R+ I E + L +V
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG----F 96
Query: 693 LGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAY 749
GA Y + + E M GSL++ L E ++I +
Sbjct: 97 YGAFYSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQILGK----------VSIAVIK 142
Query: 750 ALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGY 809
L YL + + H D+KPSN+L++ ++ DFG++ L + +SF G+ Y
Sbjct: 143 GLTYLREKHKIM--HRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFV--GTRSY 196
Query: 810 IAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPI 843
++PE G S D++S G+ L+E+ +G+ PI
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-22
Identities = 60/241 (24%), Positives = 91/241 (37%), Gaps = 53/241 (21%)
Query: 635 GVGSFGSVYKGII-----DEGRTTIAVKVFNLQHHGASRS-FIAECKALKSI-RHRNLVK 687
G G+FG V +AVK+ + + R ++E K + + H N+V
Sbjct: 54 GSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVN 113
Query: 688 VLTACLGADYRGNDFKASVY---EFMHYGSLEEWL-------------HPFTGEDEIDEA 731
+L AC + +Y E+ YG L +L + E +E
Sbjct: 114 LLGACTLSG--------PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 732 PRNLNLLQRLNIAIDIAYALNYL-HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARI 790
L L A +A + +L C H DL NVL+ ++ DFGLAR
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 791 LSPDHTQTSSFSVKGSLGYI-----APE---YGVGCEVSTNGDVYSYGILLLELV-IGKK 841
+ + S V + APE G+ + DV+SYGILL E+ +G
Sbjct: 222 I-----MSDSNYVVRGNARLPVKWMAPESLFEGI---YTIKSDVWSYGILLWEIFSLGVN 273
Query: 842 P 842
P
Sbjct: 274 P 274
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 97.4 bits (242), Expect = 9e-22
Identities = 38/281 (13%), Positives = 77/281 (27%), Gaps = 50/281 (17%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGAS------RSFIAECKALKSIRH-RNL 685
++G + + E + V V S + + + L+ I++ +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 686 VKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPF--------TGEDEIDE------A 731
L D + K + L F + +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 732 PRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARIL 791
++L RL + + + L LHH + H L+P +++LD + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHH--YGL-VHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 792 SPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNG-----------DVYSYGILLLELVIGK 840
S G+ PE + D ++ G+++ +
Sbjct: 257 GARVV------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 841 KPIDIMFEGDINLHNF-----GRKALPDDVMDIVDSSLLPD 876
P D L K +P V +++ L
Sbjct: 311 LP----ITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYP 347
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 51/265 (19%), Positives = 107/265 (40%), Gaps = 27/265 (10%)
Query: 258 DLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNF 317
+ +L NA ++ +N + ++L I TL + +I G+
Sbjct: 11 VIFPDPALANAIKI---AAGKSNVTDTVT--QADLDG-ITTLSAFGTGV-TTIE-GVQYL 62
Query: 318 VNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNF 377
NL L++ +NQ++ + P + L + L L+ N L N+ I L+ + L L
Sbjct: 63 NNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTST- 117
Query: 378 LEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGK 437
+++ + L +L + L N ++ I P L++L L +++ P+
Sbjct: 118 -QITDVTPLAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQ-YLSIGNAQVSDLTPLA--N 171
Query: 438 LKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPIS--SSLGSLRGLRVLDLS 495
L L L +N++ +I + L ++ + N IS S L + L ++ L+
Sbjct: 172 LSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNN----QISDVSPLANTSNLFIVTLT 225
Query: 496 QNNLSGEIPKFLAGLSLNNLNLSYN 520
++ + + L + N+ +
Sbjct: 226 NQTITNQPVFYNNNLVVPNVVKGPS 250
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 61/295 (20%), Positives = 118/295 (40%), Gaps = 33/295 (11%)
Query: 111 GLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGS 170
L +A +++ + + + + + + L+ L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELKD 72
Query: 171 NHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTG 230
N +T + + L NL+ I + L+ N L ++ +++ L L + ++
Sbjct: 73 NQIT-DL-APLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQIT-------- 120
Query: 231 EVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCIS 290
+V L L LQ + N + ++S L LTN L ++ I + L P ++
Sbjct: 121 DVTPLAGLSNLQVLYLDLNQI-----TNISPLAGLTN---LQYLSIGNAQVSDLTP--LA 170
Query: 291 NLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLN 350
NLSK + TL ++NKI I + + NL + + NNQ+S + P + NL I+ L
Sbjct: 171 NLSK-LTTLKADDNKI-SDIS-PLASLPNLIEVHLKNNQIS-DVSP-LANTSNLFIVTLT 225
Query: 351 RNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGT 405
++ N P N ++ N+ + P+++ + NL+ N S
Sbjct: 226 NQTIT-NQPVFYNNNLVVPNV-VKGPSGAPIAPATISDNGTYASPNLTWNLTSFI 278
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 44/225 (19%), Positives = 87/225 (38%), Gaps = 22/225 (9%)
Query: 301 LNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPP 360
I ++ N ++ + ++ T+ +L + L ++ I
Sbjct: 4 TQPTAI--NVIFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG 58
Query: 361 SIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISL 420
+ L L+ L L DN +++ + L + E+ LS N L + L S+ +L
Sbjct: 59 -VQYLNNLIGLELKDN--QITDLAPLKNLTKITELELSGNPLK-NVSA-IAGLQSI-KTL 112
Query: 421 DWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPIS 480
D + ++T P+ L L+ LY+ N++ I L+ L +G +S
Sbjct: 113 DLTSTQITDVTPLA--GLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNA----QVS 164
Query: 481 --SSLGSLRGLRVLDLSQNNLSGEIPKFLAGLSLNNLNLSYNDLE 523
+ L +L L L N +S +I + +L ++L N +
Sbjct: 165 DLTPLANLSKLTTLKADDNKIS-DISPLASLPNLIEVHLKNNQIS 208
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 46/257 (17%), Positives = 86/257 (33%), Gaps = 56/257 (21%)
Query: 85 IGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHP 144
+ NL+ + +L L N + S I GL+ +K L L + I
Sbjct: 81 LKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQI------------------- 119
Query: 145 QNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNS 204
++ + LS ++L L N +T +I S L L+++ +S+ + P
Sbjct: 120 -------TDVTPLAGLSNLQVLYLDLNQIT-NI-SPLAGLTNLQYLSIGNAQVSDLTP-- 168
Query: 205 FGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCS 264
L L N +S ++ L L L + +N + D+S L +
Sbjct: 169 LANLSKLTTLKADDNKIS--------DISPLASLPNLIEVHLKNNQI-----SDVSPLAN 215
Query: 265 LTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLD 324
+N L + + + I+N + N + G A I
Sbjct: 216 TSN---LFIVTLTNQT--------ITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGT 264
Query: 325 MWNNQLSGTIPPAIGEL 341
+ L+ + I +
Sbjct: 265 YASPNLTWNLTSFINNV 281
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 52/241 (21%), Positives = 98/241 (40%), Gaps = 23/241 (9%)
Query: 166 LNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVE 225
+ L ++P + ++ I L N + SF NL L L +N L+ ++
Sbjct: 16 TSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72
Query: 226 NKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFL--CSLTNATRLTWMHINSNNFGG 283
+ LE+L L N L + + RL +H++
Sbjct: 73 AAAFTGLALLEQL-DLSD------------NAQLRSVDPATFHGLGRLHTLHLDRCGLQE 119
Query: 284 LLPGCISNLSKTIKTLFLNNNKIYGSIPAGI-GNFVNLQRLDMWNNQLSGTIPPAIGELQ 342
L PG L+ ++ L+L +N + ++P + NL L + N++S A L
Sbjct: 120 LGPGLFRGLAA-LQYLYLQDNAL-QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLH 177
Query: 343 NLKILGLNRNKLSGNIPPSI-GNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNN 401
+L L L++N+++ ++ P +L L+ L+L N L +L +L + L++N
Sbjct: 178 SLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNP 236
Query: 402 L 402
Sbjct: 237 W 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 54/219 (24%), Positives = 84/219 (38%), Gaps = 33/219 (15%)
Query: 309 SIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKML 368
++P GI QR+ + N++S + +NL IL L+ N L+ I
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDA-----AAF 76
Query: 369 LNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFS-LSSLSISLDWSRNKL 427
L L +++LS+N ++ P F L L +L R L
Sbjct: 77 TGL------------------ALLEQLDLSDNAQLRSVDPATFHGLGRLH-TLHLDRCGL 117
Query: 428 TGSLPIEV-GKLKILEFLYVYENRLEGEIPS-TFGNCIRLEQLGMGGNLFQGPISSSLGS 485
L + L L++LY+ +N L+ +P TF + L L + GN +
Sbjct: 118 Q-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRG 175
Query: 486 LRGLRVLDLSQNNLSGEIPKFLAGL-SLNNLNLSYNDLE 523
L L L L QN ++ P L L L L N+L
Sbjct: 176 LHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS 214
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 47/228 (20%), Positives = 84/228 (36%), Gaps = 20/228 (8%)
Query: 128 EIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSI 187
+P I + I N++ + F + IL L SN L ++ L+ +
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 188 HTISLAYNNLDGTIP-NSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTI 246
+ L+ N ++ +F L L L L + L L LQ+ +
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGL------FRGLAALQYLYL 136
Query: 247 TSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKI 306
N+L + +D L LT + ++ N + L + L L+ N++
Sbjct: 137 QDNALQALPDDTFRDL------GNLTHLFLHGNRISSVPERAFRGLHS-LDRLLLHQNRV 189
Query: 307 YGSIPAGI-GNFVNLQRLDMWNNQLSGTIPP-AIGELQNLKILGLNRN 352
+ + L L ++ N LS +P A+ L+ L+ L LN N
Sbjct: 190 -AHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 41/237 (17%), Positives = 83/237 (35%), Gaps = 28/237 (11%)
Query: 58 VTCSRRH---------QRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSE 108
+C ++ + L +++ + L L+L N +
Sbjct: 16 TSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75
Query: 109 IGGLRRLKVLALNNNSICGEIPTNI-SRCSTLIPIHPQNNQLVGKILSR--FSSLSKTEI 165
GL L+ L L++N+ + L +H L + L F L+ +
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL--QELGPGLFRGLAALQY 133
Query: 166 LNLGSNHLTGSIPS-SLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVV 224
L L N L ++P + +L ++ + L N + +F +L L L N ++ V
Sbjct: 134 LYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192
Query: 225 ENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNF 281
+ L RL + +N+L + + +L L ++ +N N +
Sbjct: 193 HPH------AFRDLGRLMTLYLFANNLSALPTE------ALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 28/117 (23%), Positives = 50/117 (42%), Gaps = 10/117 (8%)
Query: 87 NLSFLKQLYLQVNSFTHEIPSEI-GGLRRLKVLALNNNSICGEIPTNI-SRCSTLIPIHP 144
L+ L+ LYLQ N+ +P + L L L L+ N I +P +L +
Sbjct: 127 GLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRI-SSVPERAFRGLHSLDRLLL 184
Query: 145 QNNQLVGKILSR--FSSLSKTEILNLGSNHLTGSIPSS-LGNLSSIHTISLAYNNLD 198
N++ + F L + L L +N+L+ ++P+ L L ++ + L N
Sbjct: 185 HQNRV--AHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPWV 238
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 56/229 (24%), Positives = 85/229 (37%), Gaps = 51/229 (22%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFN---LQHHGASRSFIAECKALKSIRHRNLVKVL 689
+G G F ++ + + A K+ L E +S+ H+++V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF- 80
Query: 690 TACLGADYRGNDFKASVY---EFMHYGSLEEWL---HPFTGEDEIDEAPRNLNLLQRLNI 743
+ + V+ E SL E T E E R L Q
Sbjct: 81 -------HGFFEDNDFVFVVLELCRRRSLLELHKRRKALT-EPEA----RYY-LRQ---- 123
Query: 744 AIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPD----HTQTS 799
I YLH V H DLK N+ L++ + ++GDFGLA + D
Sbjct: 124 ---IVLGCQYLHR--NRV-IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--- 174
Query: 800 SFSVKGSLGYIAPE----YGVGCEVSTNGDVYSYGILLLELVIGKKPID 844
+ G+ YIAPE G EV DV+S G ++ L++GK P +
Sbjct: 175 ---LCGTPNYIAPEVLSKKGHSFEV----DVWSIGCIMYTLLVGKPPFE 216
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 98.6 bits (245), Expect = 3e-21
Identities = 62/279 (22%), Positives = 102/279 (36%), Gaps = 39/279 (13%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIA-ECKALKSIRHRNLVKVLTACL 693
G G FG V + I + +A+K + +R E + +K + H N+V
Sbjct: 23 GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS-AREVP 81
Query: 694 --GADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYAL 751
ND E+ G L ++L+ F + E + DI+ AL
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG-------PIRTLLSDISSAL 134
Query: 752 NYLHHDCQPVTAHCDLKPSNVLLD---DYMTARVGDFGLARILSPDHTQTSSFSVKGSLG 808
YLH + + + H DLKP N++L + ++ D G A+ L T G+L
Sbjct: 135 RYLH-ENRII--HRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF---VGTLQ 188
Query: 809 YIAPE------YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862
Y+APE Y V D +S+G L E + G +P F + + K
Sbjct: 189 YLAPELLEQKKYTVTV------DYWSFGTLAFECITGFRP----FLPNWQPVQWHGKVRE 238
Query: 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLI 901
IV D + + ++ I+ +
Sbjct: 239 KSNEHIVVYD---DLTGAVKFSSVLPTPNHLSGILAGKL 274
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 7e-21
Identities = 51/242 (21%), Positives = 88/242 (36%), Gaps = 47/242 (19%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFN-LQHHGASRSFIAECKALKSIRHRNLVKVLTA 691
++G G+ +V++G + A+KVFN + + E + LK + H+N+VK+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF-- 73
Query: 692 CLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIA 748
EF GSL L + + E+ + L + D+
Sbjct: 74 ----AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES-------EFLIVLRDVV 122
Query: 749 YALNYLHHDCQPVTAHCDLKPSNVLL----DDYMTARVGDFGLARILSPDHTQTSSFSVK 804
+N+L + H ++KP N++ D ++ DFG AR L D S +
Sbjct: 123 GGMNHLRE--NGI-VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--- 176
Query: 805 GSLGYIAPE--------------YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
G+ Y+ P+ YG D++S G+ G P
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATV------DLWSIGVTFYHAATGSLPFRPFEGPR 230
Query: 851 IN 852
N
Sbjct: 231 RN 232
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 7e-21
Identities = 57/235 (24%), Positives = 86/235 (36%), Gaps = 55/235 (23%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFN---LQHHGASRSFIAECKALKSIRHRNLVKVL 689
+G G F ++ + + A K+ L E +S+ H+++V
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF- 106
Query: 690 TACLGADYRGNDFKASVY---EFMHYGSLEEWL---HPFTGEDEIDEAPRNLNLLQRLNI 743
+ + V+ E SL E T E E R L Q
Sbjct: 107 -------HGFFEDNDFVFVVLELCRRRSLLELHKRRKALT-EPEA----RYY-LRQ---- 149
Query: 744 AIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPD----HTQTS 799
I YLH + H DLK N+ L++ + ++GDFGLA + D
Sbjct: 150 ---IVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--- 200
Query: 800 SFSVKGSLGYIAPEY----GVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
+ G+ YIAPE G EV DV+S G ++ L++GK P FE
Sbjct: 201 ---LCGTPNYIAPEVLSKKGHSFEV----DVWSIGCIMYTLLVGKPP----FETS 244
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 4e-20
Identities = 55/273 (20%), Positives = 92/273 (33%), Gaps = 73/273 (26%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIA-ECKALKSIRHRNLVKVLTA 691
+G G FG V++ A+K L + +R + E KAL + H +V+ A
Sbjct: 13 CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72
Query: 692 CLGADYRGNDF------------------------------------------------- 702
L
Sbjct: 73 WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132
Query: 703 KASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQ 759
K +Y + +L++W++ ++ + L+I I IA A+ +LH
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDREHG-------VCLHIFIQIAEAVEFLHSKG- 184
Query: 760 PVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVK----------GSLGY 809
H DLKPSN+ +VGDFGL + D + + + G+ Y
Sbjct: 185 --LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 810 IAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
++PE G S D++S G++L EL+
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFST 275
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 4e-20
Identities = 45/231 (19%), Positives = 89/231 (38%), Gaps = 44/231 (19%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALK-SIRHRNLV 686
F +++G G+ G++ + + R +AVK + + E + L+ S H N++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRD-VAVKRILPECFSFADR---EVQLLRESDEHPNVI 81
Query: 687 KVLTACLGADYRGNDFKASVYEFMHY--GSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIA 744
+ + F Y + +L+ + +++ L+ + +
Sbjct: 82 R-----YFCTEKDRQF---QYIAIELCAATLQ---------EYVEQKDFAHLGLEPITLL 124
Query: 745 IDIAYALNYLHHDCQPVTAHCDLKPSNVLL-----DDYMTARVGDFGLARILSPD-HTQT 798
L +LH + H DLKP N+L+ + A + DFGL + L+ H+ +
Sbjct: 125 QQTTSGLAHLHS--LNI-VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFS 181
Query: 799 SSFSVKGSLGYIAPEY-------GVGCEVSTNGDVYSYGILLLELVIGKKP 842
V G+ G+IAPE V D++S G + ++
Sbjct: 182 RRSGVPGTEGWIAPEMLSEDCKENPTYTV----DIFSAGCVFYYVISEGSH 228
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 48/216 (22%), Positives = 95/216 (43%), Gaps = 23/216 (10%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVK 687
++ +G G+ G+VY + +A++ NLQ I E ++ ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 688 VLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFT-GEDEIDEAPRNLNLLQRLNIAID 746
L + G++ V E++ GSL + + E +I + +
Sbjct: 82 ----YLDSYLVGDELWV-VMEYLAGGSLTDVVTETCMDEGQIA------------AVCRE 124
Query: 747 IAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGS 806
AL +LH + H D+K N+LL + ++ DFG ++P+ ++ S+ G+
Sbjct: 125 CLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV--GT 179
Query: 807 LGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
++APE D++S GI+ +E++ G+ P
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 8e-20
Identities = 53/229 (23%), Positives = 91/229 (39%), Gaps = 41/229 (17%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFN-LQHHGASRSFIAECKALKSIRHRNLVKVLTA 691
++G G+ +V++G + A+KVFN + + E + LK + H+N+VK L A
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK-LFA 74
Query: 692 CLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYAL 751
+ K + EF GSL L + + E+ + L + D+ +
Sbjct: 75 IE--EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES-------EFLIVLRDVVGGM 125
Query: 752 NYLHHDCQPVTAHCDLKPSNVLL----DDYMTARVGDFGLARILSPDHTQTSSFSVKGSL 807
N+L + H ++KP N++ D ++ DFG AR L D S+ G+
Sbjct: 126 NHLRE--NGI-VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV---SLYGTE 179
Query: 808 GYIAPE--------------YGVGCEVSTNGDVYSYGILLLELVIGKKP 842
Y+ P+ YG D++S G+ G P
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATV------DLWSIGVTFYHAATGSLP 222
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 91.6 bits (227), Expect = 8e-20
Identities = 42/265 (15%), Positives = 84/265 (31%), Gaps = 30/265 (11%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTT-----IAVKVFNLQHHGASRSFIAECKALKSIRHRNLV 686
+L+G G+F VY+ + +KV + + LK +
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130
Query: 687 KVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAID 746
K +A + + V E YG+L ++ + E + + ++ A+
Sbjct: 131 KFYSA-----HLFQNGSVLVGELYSYGTLLNAINLYKNTPE-----KVMPQGLVISFAMR 180
Query: 747 IAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG-----------DFGLARILSPDH 795
+ Y + +H DC+ + H D+KP N +L + + D G + +
Sbjct: 181 MLYMIEQVH-DCEII--HGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237
Query: 796 TQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLH- 854
T + + G+ E + D + + ++ G G+
Sbjct: 238 KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEG 297
Query: 855 NFGRKALPDDVMDIVDSSLLPDDED 879
F R D + L D
Sbjct: 298 LFRRLPHLDMWNEFFHVMLNIPDCH 322
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 1e-19
Identities = 62/229 (27%), Positives = 92/229 (40%), Gaps = 46/229 (20%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFN---LQHHGASRSFIAECKALKSIRHRNLVKVLTA 691
G GSF VY+ +A+K+ + + G + E K ++H ++++ L
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILE-LYN 78
Query: 692 CLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGE-DEIDEAPRNLNLLQRLNIAIDI 747
D VY E H G + +L E +EA R+ + Q I
Sbjct: 79 YF-ED------SNYVYLVLEMCHNGEMNRYLKNRVKPFSE-NEA-RHF-MHQ-------I 121
Query: 748 AYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHT--QTSSFSVKG 805
+ YLH + H DL SN+LL M ++ DFGLA L H T G
Sbjct: 122 ITGMLYLHS--HGI-LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC----G 174
Query: 806 SLGYIAPE----YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
+ YI+PE G E DV+S G + L+IG+ P F+ D
Sbjct: 175 TPNYISPEIATRSAHGLES----DVWSLGCMFYTLLIGRPP----FDTD 215
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 1e-19
Identities = 63/303 (20%), Positives = 117/303 (38%), Gaps = 55/303 (18%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-HGASRSFIAECKAL-KSIRHRNL 685
S ++G GS G+V +GR +AVK + A E K L +S H N+
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRP-VAVKRMLIDFCDIALM----EIKLLTESDDHPNV 71
Query: 686 VKVLTACLGADYRGNDFKASVYEFMHY--GSLEEWLHPFTGEDEIDEAPRNLNLLQRLNI 743
++ + F +Y + +L++ + ++ DE + +++
Sbjct: 72 IR-----YYCSETTDRF---LYIALELCNLNLQDLV---ESKNVSDENLKLQKEYNPISL 120
Query: 744 AIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD-------------DYMTARVGDFGLARI 790
IA + +LH H DLKP N+L+ + + + DFGL +
Sbjct: 121 LRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177
Query: 791 LSPDHTQTSSF--SVKGSLGYIAPEYGVGCEVSTNG-------DVYSYGILLLE-LVIGK 840
L + + + G+ G+ APE D++S G + L GK
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237
Query: 841 KPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLI---LTGNQRQKQARINSII 897
P + + N+ G +L D++ + D SL+ + DLI + + + R + +
Sbjct: 238 HPFGDKYSRESNIIR-GIFSL-DEMKCLHDRSLIAEATDLISQMIDHDPLK---RP-TAM 291
Query: 898 ECL 900
+ L
Sbjct: 292 KVL 294
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 2e-19
Identities = 47/308 (15%), Positives = 84/308 (27%), Gaps = 67/308 (21%)
Query: 229 TGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGC 288
G+ + K L+ T+ + + S + ++ L + + + G P
Sbjct: 58 LGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGIS---GLQELTLENLEVTGTAPPP 114
Query: 289 ISNLS-KTIKTLFLNNNKIYG--SIPAGIGNFV--NLQRLDMWNNQLSGTIPPAIGELQN 343
+ + + L L N + A + ++ L+ L + +
Sbjct: 115 LLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPA 174
Query: 344 LKILGLNRNKLSGNIPPSI----GNLKMLLNLFLNDNFLE---VSIPSSLGQCESLIEIN 396
L L L+ N G L L L + +E + L ++
Sbjct: 175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLD 234
Query: 397 LSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIP 456
LS+N+L S SL+ S L ++ +P
Sbjct: 235 LSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK---------------------QVPKGLP 273
Query: 457 STFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLSLNNLN 516
+ L VLDLS N L P + NL+
Sbjct: 274 AK------------------------------LSVLDLSYNRLD-RNPSPDELPQVGNLS 302
Query: 517 LSYNDLEG 524
L N
Sbjct: 303 LKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 6e-16
Identities = 47/311 (15%), Positives = 89/311 (28%), Gaps = 62/311 (19%)
Query: 77 LAGSVSHFIGNLSFLKQLYLQVNSFTHEIP-SEIGGLRRLKVLALNNNSICGEIPTNISR 135
L + G L+ L +V++ ++I LK L + I I
Sbjct: 31 LGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFG--- 87
Query: 136 CSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLS---------- 185
R +S + L L + +TG+ P L +
Sbjct: 88 ------------------ALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLR 129
Query: 186 --------------------SIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVE 225
+ +S+A + F L L L+ N
Sbjct: 130 NVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGER 189
Query: 226 NKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLL 285
++ P K LQ + + + + + + L + ++ N+
Sbjct: 190 GLISALCPL--KFPTLQVLALRNAGMETPSGVCSALAAARVQ---LQGLDLSHNSLRDAA 244
Query: 286 PGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLK 345
+ + +L L+ + +P G+ L LD+ N+L P+ EL +
Sbjct: 245 GAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLDRN--PSPDELPQVG 299
Query: 346 ILGLNRNKLSG 356
L L N
Sbjct: 300 NLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 5e-12
Identities = 40/248 (16%), Positives = 73/248 (29%), Gaps = 27/248 (10%)
Query: 288 CISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPA-IGELQNLKI 346
C N S N + + G +L+ L + + I + +LK
Sbjct: 13 CSCNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKR 72
Query: 347 LGLNRNKLSGNIPPS---IGNLKMLLNLFLNDNFLEVSIPSSLGQC--ESLIEINLSNNN 401
L + ++ I + + L L L + + + P L + L +NL N +
Sbjct: 73 LTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVS 132
Query: 402 LSG--TIPPQFFSLSSLSI-SLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPST 458
+ + + L ++ +V L L + +N GE
Sbjct: 133 WATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLI 192
Query: 459 FGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL-SLNNLNL 517
C +L+ L + + SG A L L+L
Sbjct: 193 SALC-----------------PLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDL 235
Query: 518 SYNDLEGM 525
S+N L
Sbjct: 236 SHNSLRDA 243
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 35/210 (16%), Positives = 69/210 (32%), Gaps = 37/210 (17%)
Query: 61 SRRHQRVTLLDLRSLKLAGSVSHFIGNLSF----LKQLYLQVNSFTHEIPSEIGGLRRLK 116
+ +L+LR++ A + + LK L + + ++ L
Sbjct: 117 EATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALS 176
Query: 117 VLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGS 176
L L++N GE + C +F +L + N G +G
Sbjct: 177 TLDLSDNPELGERGLISALC-----------------PLKFPTLQVLALRNAGMETPSGV 219
Query: 177 IPSSLGNLSSIHTISLAYNNLDGTIPN-SFGWFENLVFLSLAANNLSVV----------- 224
+ + + L++N+L S W L L+L+ L V
Sbjct: 220 CSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSVL 279
Query: 225 ---ENKLTGEVPSLEKLQRLQHFTITSNSL 251
N+L PS ++L ++ + ++ N
Sbjct: 280 DLSYNRLD-RNPSPDELPQVGNLSLKGNPF 308
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 50/216 (23%), Positives = 89/216 (41%), Gaps = 23/216 (10%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVK 687
S +G GS G V +AVK+ +L+ E ++ +H N+V+
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 688 VLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFT-GEDEIDEAPRNLNLLQRLNIAID 746
+ G + + EF+ G+L + + E++I +
Sbjct: 107 ----MYKSYLVGEELWV-LMEFLQGGALTDIVSQVRLNEEQIA------------TVCEA 149
Query: 747 IAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGS 806
+ AL YLH H D+K ++LL ++ DFG +S D + S G+
Sbjct: 150 VLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV--GT 204
Query: 807 LGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
++APE +T D++S GI+++E+V G+ P
Sbjct: 205 PYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 47/288 (16%), Positives = 97/288 (33%), Gaps = 72/288 (25%)
Query: 628 FSSANLVGVGSFGSVYKGI-IDEGRTTIAVKVFNLQHHGAS--RSFIAECKALKSI-RHR 683
F +G G FGSV+K + +G A+K G+ ++ + E A + +H
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGC-IYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 684 NLVKVLTACLGADYRGNDFKASVYEFMHY---GSLEEWLHPFTGEDE-IDEAPRNLNLLQ 739
++V+ +A D+ + Y GSL + + EA +
Sbjct: 72 HVVRYFSAWAEDDH--------MLIQNEYCNGGSLADAISENYRIMSYFKEA-------E 116
Query: 740 RLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD-------------------DYMTA 780
++ + + L Y+H H D+KPSN+ + + +
Sbjct: 117 LKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMF 173
Query: 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPE-----YGVGCEVSTNGDVYSYGILLLE 835
++GD G +S + G ++A E Y + D+++ + ++
Sbjct: 174 KIGDLGHVTRISSPQVEE------GDSRFLANEVLQENYTHLPKA----DIFALALTVVC 223
Query: 836 LVIGKKPIDIMFEGDINLHNFGRKALP-------DDVMDIVDSSLLPD 876
+ H + LP + +++ + PD
Sbjct: 224 AAGAEPL----PRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPD 267
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 5e-19
Identities = 48/291 (16%), Positives = 99/291 (34%), Gaps = 71/291 (24%)
Query: 635 GVGSFGSVY---------------KGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKS 679
G F + K ++++ R + F E + +
Sbjct: 40 NQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITD 99
Query: 680 IRHRNLVK---VLTACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPR 733
I++ + ++ + VY E+M S+ ++ F D+
Sbjct: 100 IKNEYCLTCEGII-----TN------YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 734 NLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSP 793
+ +++ I + + +Y+H++ H D+KPSN+L+D ++ DFG + +
Sbjct: 149 PIQVIKC--IIKSVLNSFSYIHNEKNIC--HRDVKPSNILMDKNGRVKLSDFGESEYMVD 204
Query: 794 DHTQTSSFSVKGSLGYIAPE------YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMF 847
+ S +G+ ++ PE G +V D++S GI L + P F
Sbjct: 205 KKIKGS----RGTYEFMPPEFFSNESSYNGAKV----DIWSLGICLYVMFYNVVP----F 252
Query: 848 EGDINL-----------------HNFGRKALPDDVMDIVDSSLLPDDEDLI 881
I+L N L + ++ L +D D +
Sbjct: 253 SLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFL 303
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 90.9 bits (225), Expect = 5e-19
Identities = 50/278 (17%), Positives = 104/278 (37%), Gaps = 37/278 (13%)
Query: 144 PQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPN 203
+ + K + + ++T NL +T ++ L+SI I +++ ++
Sbjct: 6 TVSTPI--KQIFPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG 60
Query: 204 SFGWFENLVFLSLAANNLSVVE---------------NKLTGEVPSLEKLQRLQHFTITS 248
+ N+ L L N L+ ++ NK+ ++ SL+ L++L+ ++
Sbjct: 61 -IQYLPNVTKLFLNGNKLTDIKPLTNLKNLGWLFLDENKIK-DLSSLKDLKKLKSLSLEH 118
Query: 249 NSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYG 308
N + D++ L L L ++ +N + +S L+K + TL L +N+I
Sbjct: 119 NGI-----SDINGLVHLPQLESL---YLGNNKITDITV--LSRLTK-LDTLSLEDNQIS- 166
Query: 309 SIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKML 368
I + LQ L + N +S + + L+NL +L L + NL +
Sbjct: 167 DIV-PLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVP 223
Query: 369 LNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTI 406
+ D L S + + +
Sbjct: 224 NTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEV 261
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 90.9 bits (225), Expect = 6e-19
Identities = 55/331 (16%), Positives = 112/331 (33%), Gaps = 34/331 (10%)
Query: 91 LKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLV 150
+ + P + L S+ + + +++ I N+ +
Sbjct: 1 MGETITVSTPIKQIFPDD--AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI- 55
Query: 151 GKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFEN 210
K + L L L N LT I L NL ++ + L N + + + +
Sbjct: 56 -KSVQGIQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIK-DLSS-LKDLKK 110
Query: 211 LVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATR 270
L LSL N +S + L L +L+ + +N + D++ L LT
Sbjct: 111 LKSLSLEHNGISDING--------LVHLPQLESLYLGNNKI-----TDITVLSRLTK--- 154
Query: 271 LTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQL 330
L + + N ++P ++ L+K ++ L+L+ N I S + NL L++++ +
Sbjct: 155 LDTLSLEDNQISDIVP--LAGLTK-LQNLYLSKNHI--SDLRALAGLKNLDVLELFSQEC 209
Query: 331 SGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCE 390
L + L P I + + + E + S
Sbjct: 210 LNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPEFTNEVSF-IFY 266
Query: 391 SLIEINLSNNNLSGTIPPQFFSLSSLSISLD 421
+ I + G + + ++S +D
Sbjct: 267 QPVTIGKAKARFHGRVTQPLKEVYTVSYDVD 297
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 80.5 bits (198), Expect = 1e-15
Identities = 49/230 (21%), Positives = 82/230 (35%), Gaps = 44/230 (19%)
Query: 296 IKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLS 355
+ + I I F + ++ ++ + EL ++ + N + +
Sbjct: 1 MGETITVSTPI-KQIF-PDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 356 GNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSS 415
++ I L + LFLN N L I L ++L + L N + LSS
Sbjct: 57 -SVQG-IQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIK--------DLSS 104
Query: 416 LSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLF 475
L LK L+ L + N + +I + + +LE L +G N
Sbjct: 105 LK-------------------DLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNN-- 141
Query: 476 QGPIS--SSLGSLRGLRVLDLSQNNLSGEIPKFLAGLSLNNLNLSYNDLE 523
I+ + L L L L L N +S +I L NL LS N +
Sbjct: 142 --KITDITVLSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKNHIS 188
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 6e-19
Identities = 51/218 (23%), Positives = 87/218 (39%), Gaps = 25/218 (11%)
Query: 161 SKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANN 220
S E +N +LT ++P L + L+ N L + + L L+L
Sbjct: 11 SHLE-VNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66
Query: 221 LSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNN 280
L+ ++ L L ++ N L S L L LT + ++ N
Sbjct: 67 LT--------KLQVDGTLPVLGTLDLSHNQLQS-----LPLL--GQTLPALTVLDVSFNR 111
Query: 281 FGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGI-GNFVNLQRLDMWNNQLSGTIPPAI- 338
L G + L + ++ L+L N++ ++P G+ L++L + NN L+ +P +
Sbjct: 112 LTSLPLGALRGLGE-LQELYLKGNEL-KTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLL 168
Query: 339 GELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDN 376
L+NL L L N L IP +L FL+ N
Sbjct: 169 NGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 51/237 (21%), Positives = 84/237 (35%), Gaps = 35/237 (14%)
Query: 286 PGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLK 345
P C + + + + + ++P + + L + N L + L
Sbjct: 2 PICEVSKVASHLEVNCDKRNL-TALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLT 58
Query: 346 ILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGT 405
L L+R +L+ G L +L L L+ N L+ S+P +L +++S N L+ +
Sbjct: 59 QLNLDRAELT--KLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-S 114
Query: 406 IPPQFF-SLSSLSISLDWSRNKLTGSLPIEV-GKLKILEFLYVYENRLEGEIPSTFGNCI 463
+P L L L N+L +LP + LE L + N L E+P+
Sbjct: 115 LPLGALRGLGELQ-ELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPA------ 165
Query: 464 RLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLSLNNLNLSYN 520
L G L L L L +N+L F L L N
Sbjct: 166 ---------GLLNG--------LENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 40/160 (25%), Positives = 59/160 (36%), Gaps = 9/160 (5%)
Query: 68 TLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICG 127
T+L L L + + L QL L T + + G L L L L++N +
Sbjct: 34 TILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD-GTLPVLGTLDLSHNQLQ- 90
Query: 128 EIPTNISRCSTLIPIHPQNNQLVGKILSR--FSSLSKTEILNLGSNHLTGSIPSSL-GNL 184
+P L + N+L L L + + L L N L ++P L
Sbjct: 91 SLPLLGQTLPALTVLDVSFNRL--TSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPT 147
Query: 185 SSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVV 224
+ +SLA NNL ENL L L N+L +
Sbjct: 148 PKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTI 187
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 1e-18
Identities = 47/239 (19%), Positives = 88/239 (36%), Gaps = 16/239 (6%)
Query: 290 SNLSKTIKTLFLNNNKIYGSIPAGI-GNFVNLQRLDMWNNQLSGTIPP-AIGELQNLKIL 347
S+L + L K+ I G F +L+++++ N + I L L +
Sbjct: 26 SDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEI 84
Query: 348 GL-NRNKLSGNIPPSI-GNLKMLLNLFLNDNFLEVSIPS-SLGQCESLIEINLSNNNLSG 404
+ N L I P NL L L +++ ++ +P + +++ +N
Sbjct: 85 RIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIH 142
Query: 405 TIPPQ-FFSLSSLSISLDWSRNKLTGSLPIEV-GKLKILEFLYVYENRLEGEIPS-TFGN 461
TI F LS S+ L ++N + + ++ E N LE E+P+ F
Sbjct: 143 TIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHG 200
Query: 462 CIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLSLNNLNLSYN 520
L + S L +L+ LR ++P ++L +L+Y
Sbjct: 201 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPTLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 7e-18
Identities = 47/245 (19%), Positives = 85/245 (34%), Gaps = 27/245 (11%)
Query: 163 TEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLS----LAA 218
L L + + I ++ N++ I F NL L A
Sbjct: 32 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA--DVFSNLPKLHEIRIEKA 89
Query: 219 NNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINS 278
NNL + + + L LQ+ I++ + D+ + ++ + + I
Sbjct: 90 NNLLYINPEA------FQNLPNLQYLLISNTGIKH--LPDVHKI----HSLQKVLLDIQD 137
Query: 279 NNFGGLLP-GCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLD-MWNNQLSGTIPP 336
N + LS L+LN N I I N L L+ NN L +P
Sbjct: 138 NINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPN 195
Query: 337 -AIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEI 395
IL ++R ++ ++P L+ L L + +P +L + +L+E
Sbjct: 196 DVFHGASGPVILDISRTRIH-SLPS--YGLENLKKLRARSTYNLKKLP-TLEKLVALMEA 251
Query: 396 NLSNN 400
+L+
Sbjct: 252 SLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 40/245 (16%), Positives = 77/245 (31%), Gaps = 27/245 (11%)
Query: 91 LKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIP----TNISRCSTLIPIHPQN 146
+L + G L+ + ++ N + I +N+ + + +
Sbjct: 32 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEI--RIEKA 89
Query: 147 NQLVGKILSRFSSLSKTEILNLGSNHLTGSIPS-SLGNLSSIHTISLAYNNLDGTIP-NS 204
N L+ F +L + L + + + +P + + + N TI NS
Sbjct: 90 NNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNS 148
Query: 205 F-GWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLC 263
F G V L L N + + N + Q + +N+L ND
Sbjct: 149 FVGLSFESVILWLNKNGIQEIHNS------AFNGTQLDELNLSDNNNLEELPND------ 196
Query: 264 SLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRL 323
A+ + I+ L + NL K ++ N K +P + V L
Sbjct: 197 VFHGASGPVILDISRTRIHSLPSYGLENLKK-LRARSTYNLK---KLPT-LEKLVALMEA 251
Query: 324 DMWNN 328
+
Sbjct: 252 SLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 37/183 (20%), Positives = 65/183 (35%), Gaps = 21/183 (11%)
Query: 87 NLSFLKQLYLQVNSFTHEIPSEI-GGLRRLKVLALNNNSICGEIPTNI-SRCSTLIPIHP 144
NL L ++ ++ + I E L L+ L ++N I +P + +
Sbjct: 77 NLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDI 135
Query: 145 QNNQLVGKILSR-FSSLS-KTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIP 202
Q+N + I F LS ++ IL L N + S+ NNL+
Sbjct: 136 QDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPN 195
Query: 203 NSFGWFENLVFLSLAANNLSVVE---------------NKLTGEVPSLEKLQRLQHFTIT 247
+ F V L ++ + + L ++P+LEKL L ++T
Sbjct: 196 DVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK-KLPTLEKLVALMEASLT 254
Query: 248 SNS 250
S
Sbjct: 255 YPS 257
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-18
Identities = 58/249 (23%), Positives = 98/249 (39%), Gaps = 44/249 (17%)
Query: 622 YNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVK-VFNLQHHG-ASRSFIAECKALKS 679
F + G G+FG+V G ++A+K V Q +R + + L
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI--QDPRFRNRE-LQIMQDLAV 75
Query: 680 IRHRNLVKVLTACLGADYRGND--FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNL 737
+ H N+V++ + R + V E++ + LH R
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-----PDTLHRC-----CRNYYRRQVA 125
Query: 738 LQRLNIAIDIAY----ALNYLHHDCQPVTAHCDLKPSNVLLDDYM-TARVGDFGLARILS 792
+ I + + ++ LH V H D+KP NVL+++ T ++ DFG A+ LS
Sbjct: 126 PPPILIKV-FLFQLIRSIGCLHLPSVNV-CHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183
Query: 793 PDHTQTSSFSVKGSLGYI------APEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDI 845
P + YI APE G +T D++S G + E+++G +PI
Sbjct: 184 PSEPNVA---------YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPI-- 231
Query: 846 MFEGDINLH 854
F GD +
Sbjct: 232 -FRGDNSAG 239
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 56/226 (24%), Positives = 92/226 (40%), Gaps = 37/226 (16%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFN---LQHHGASRSFIAECKALKSIRHRNLVKV 688
+G G FG+VY + + +A+KV L+ G E + +RH N++++
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 689 LTACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAI 745
D VY E+ G++ L + DE
Sbjct: 75 YGYF--HD------ATRVYLILEYAPLGTVYRELQKLSKFDE-QRTAT---------YIT 116
Query: 746 DIAYALNYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVK 804
++A AL+Y H H D+KP N+LL ++ DFG + + +P +T
Sbjct: 117 ELANALSYCHSKRVI----HRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLC--- 168
Query: 805 GSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
G+L Y+ PE G D++S G+L E ++GK P FE +
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEAN 210
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 8e-18
Identities = 58/228 (25%), Positives = 89/228 (39%), Gaps = 40/228 (17%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVK 687
+ +G G+FG VYK E A KV + +I E + L + H +VK
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 688 VLTACLGADYRGNDFKAS----VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNI 743
G + + EF G++ + + E R L Q I
Sbjct: 81 ---------LLGAYYHDGKLWIMIEFCPGGAV---------DAIMLELDRGLTEPQ---I 119
Query: 744 AI---DIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSS 800
+ + ALN+LH H DLK NVL+ R+ DFG++ + S
Sbjct: 120 QVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS 176
Query: 801 FSVKGSLGYIAPEYGVGCEVSTNG------DVYSYGILLLELVIGKKP 842
F G+ ++APE V CE + D++S GI L+E+ + P
Sbjct: 177 FI--GTPYWMAPEV-VMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 87.1 bits (215), Expect = 8e-18
Identities = 50/288 (17%), Positives = 107/288 (37%), Gaps = 19/288 (6%)
Query: 129 IPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIH 188
+ + L+ + + + + S + +L + L +P +
Sbjct: 265 LTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTG 324
Query: 189 TISLAYNNLDGTIPNSF----GWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHF 244
+ S L P + E L L+ +V++++L L++L+ +
Sbjct: 325 SDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSEL-ESCKELQELEPENKW 383
Query: 245 TITSNSLGSGGNDDLSF----LCSLTNATRLTWMHINSN----NFGGLLPGCISNLSKTI 296
+ + L D L + L + + M + L + +
Sbjct: 384 CLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADV 443
Query: 297 KTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSG 356
+ L L + + ++ + + + LD+ +N+L +PPA+ L+ L++L + N L
Sbjct: 444 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE- 499
Query: 357 NIPPSIGNLKMLLNLFLNDNFLE-VSIPSSLGQCESLIEINLSNNNLS 403
N+ + NL L L L +N L+ + L C L+ +NL N+L
Sbjct: 500 NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 67.1 bits (163), Expect = 1e-11
Identities = 47/235 (20%), Positives = 83/235 (35%), Gaps = 21/235 (8%)
Query: 272 TWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLS 331
+ S + + L+ K + + + + LQ L+ N
Sbjct: 327 SQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCL 385
Query: 332 GTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSI-----PSSL 386
TI I ++ L L + L LK + + S
Sbjct: 386 LTI---ILLMRALDPLLYEKETLQ-----YFSTLKAVDPMRAAYLDDLRSKFLLENSVLK 437
Query: 387 GQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYV 446
+ + ++L++ +L T+ L ++ LD S N+L +LP + L+ LE L
Sbjct: 438 MEYADVRVLHLAHKDL--TVLCHLEQLLLVT-HLDLSHNRLR-ALPPALAALRCLEVLQA 493
Query: 447 YENRLEGEIPSTFGNCIRLEQLGMGGNLFQG-PISSSLGSLRGLRVLDLSQNNLS 500
+N LE + N RL++L + N Q L S L +L+L N+L
Sbjct: 494 SDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 62.1 bits (150), Expect = 5e-10
Identities = 35/224 (15%), Positives = 70/224 (31%), Gaps = 15/224 (6%)
Query: 303 NNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSI 362
N+++ I + Q+ + + L L+ K + + +
Sbjct: 310 NDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSEL 368
Query: 363 GNLKMLLNLFLNDNFL---EVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSIS 419
+ K L L + + + + +L E + L P +
Sbjct: 369 ESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRA-------AY 421
Query: 420 LDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPI 479
LD R+K + + + L++ L + + + L + N + +
Sbjct: 422 LDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLRA-L 478
Query: 480 SSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLSLNNLNLSYNDLE 523
+L +LR L VL S N L + L L L N L+
Sbjct: 479 PPALAALRCLEVLQASDNALE-NVDGVANLPRLQELLLCNNRLQ 521
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 58.6 bits (141), Expect = 6e-09
Identities = 25/156 (16%), Positives = 52/156 (33%), Gaps = 30/156 (19%)
Query: 43 LGTWNESIHFCKWYGVTCSRRHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFT 102
++ + V +L L L + H + L + L L N
Sbjct: 419 AAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR 476
Query: 103 HEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSK 162
+P + LR L+VL ++N++ + + ++L +
Sbjct: 477 -ALPPALAALRCLEVLQASDNAL--------------------------ENVDGVANLPR 509
Query: 163 TEILNLGSNHLTG-SIPSSLGNLSSIHTISLAYNNL 197
+ L L +N L + L + + ++L N+L
Sbjct: 510 LQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 8e-18
Identities = 54/228 (23%), Positives = 92/228 (40%), Gaps = 33/228 (14%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFI-AECK-ALKSIRHRNLVKVLTA 691
+G G++GSV K + +AVK + + + ++S +V+
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQ---- 85
Query: 692 CLGADYRGNDFKASVYEFMHY--GSLEEWLHPFTGEDE--IDEAPRNLNLLQRLNIAIDI 747
GA +R D + M S +++ + I E +L + I +
Sbjct: 86 FYGALFREGD----CWICMELMSTSFDKFYKYVYSVLDDVIPE-----EILGK--ITLAT 134
Query: 748 AYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSL 807
ALN+L + + H D+KPSN+LLD ++ DFG++ L + + G
Sbjct: 135 VKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLV--DSIAKTRDA-GCR 189
Query: 808 GYIAPE----YGVGCEVSTNGDVYSYGILLLELVIGKKP---IDIMFE 848
Y+APE DV+S GI L EL G+ P + +F+
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD 237
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 51/231 (22%), Positives = 96/231 (41%), Gaps = 23/231 (9%)
Query: 128 EIPTNISRCSTLIPIHPQNNQLVGKILSR-FSSLSKTEILNLGSNHLTGSIPSSL-GNLS 185
+IP N+ + + N L + S F S + ++L+L + +I +LS
Sbjct: 21 KIPDNLP--FSTKNLDLSFNPL-RHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLS 76
Query: 186 SIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFT 245
+ T+ L N + +F +L L NL+ +EN G + +L++L + H
Sbjct: 77 HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL-NVAH-- 133
Query: 246 ITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSK---TIKTLFLN 302
N + S + +LTN L + ++SN + + L + +L L+
Sbjct: 134 ---NLIQSFKLPEY--FSNLTN---LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS 185
Query: 303 NNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPP-AIGELQNLKILGLNRN 352
N + I G + L+ L + NQL ++P L +L+ + L+ N
Sbjct: 186 LNPM-NFIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 49/223 (21%), Positives = 81/223 (36%), Gaps = 38/223 (17%)
Query: 309 SIPAGIGNFVNLQRLDMWNNQLSGTIPP-AIGELQNLKILGLNRNKLSGNIPPSI-GNLK 366
IP + + + LD+ N L + + L++L L+R ++ I +L
Sbjct: 21 KIPDNL--PFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLS 76
Query: 367 MLLNLFLNDNFLEVSIPSSL-GQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRN 425
L L L N ++ S+ SL ++ NL+ ++
Sbjct: 77 HLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPI-------------- 120
Query: 426 KLTGSLPIEVGKLKILEFLYVYENRL-EGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLG 484
G LK L+ L V N + ++P F N LE L + N Q + L
Sbjct: 121 ----------GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 170
Query: 485 SLRGLRV----LDLSQNNLSGEIPKFLAGLSLNNLNLSYNDLE 523
L + + LDLS N ++ P + L L L N L+
Sbjct: 171 VLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLK 213
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 54/234 (23%), Positives = 85/234 (36%), Gaps = 29/234 (12%)
Query: 176 SIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSL 235
IP +L S + L++N L SF F L L L+ + +E+
Sbjct: 21 KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGA------Y 72
Query: 236 EKLQRLQHFTITSN---SLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNL 292
+ L L +T N SL G L + L + N L I +L
Sbjct: 73 QSLSHLSTLILTGNPIQSLALGAFSGL---------SSLQKLVAVETNLASLENFPIGHL 123
Query: 293 SKTIKTLFLNNNKIYGSIPAGI-GNFVNLQRLDMWNNQLSGTIPP-AIGELQNLKI---- 346
K L + +N I N NL+ LD+ +N++ +I + L + +
Sbjct: 124 KTL-KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLS 181
Query: 347 LGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNN 400
L L+ N ++ I P L L L+ N L+ + SL +I L N
Sbjct: 182 LDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 39/187 (20%), Positives = 62/187 (33%), Gaps = 14/187 (7%)
Query: 87 NLSFLKQLYLQVNSFTHEIPSEI-GGLRRLKVLALNNNSICGEIPTNI-SRCSTLIPIHP 144
+ L+ L L I L L L L N I + S S+L +
Sbjct: 50 SFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPI-QSLALGAFSGLSSLQKLVA 107
Query: 145 QNNQLVGKILSR--FSSLSKTEILNLGSNHLTGSIPSS--LGNLSSIHTISLAYNNLDGT 200
L L L + LN+ N + S NL+++ + L+ N + +
Sbjct: 108 VETNL--ASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKI-QS 163
Query: 201 IPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLS 260
I L + L +L + N + P K RL+ + +N L S +
Sbjct: 164 IYC--TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFD 221
Query: 261 FLCSLTN 267
L SL
Sbjct: 222 RLTSLQK 228
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 59/239 (24%), Positives = 94/239 (39%), Gaps = 32/239 (13%)
Query: 146 NNQLVGKILSRFSSLSKTEILNLGSNHLT---GSIPSSLGNLSSIHTISLAYNNLDGTIP 202
N L K S + ++ S LT +IP+ L L N L
Sbjct: 1 NEALCKKDGGVCSCNNNKNSVDCSSKKLTAIPSNIPADTKKLD------LQSNKLSSLPS 54
Query: 203 NSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGS---GGNDDL 259
+F L L L N L + + ++L+ L+ +T N L + G D L
Sbjct: 55 KAFHRLTKLRLLYLNDNKLQTLPAGI------FKELKNLETLWVTDNKLQALPIGVFDQL 108
Query: 260 SFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGI-GNFV 318
L + ++ N L P +L+K + L L N++ S+P G+
Sbjct: 109 ---------VNLAELRLDRNQLKSLPPRVFDSLTK-LTYLSLGYNEL-QSLPKGVFDKLT 157
Query: 319 NLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSI-GNLKMLLNLFLNDN 376
+L+ L ++NNQL A +L LK L L+ N+L +P +L+ L L L +N
Sbjct: 158 SLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 46/156 (29%), Positives = 71/156 (45%), Gaps = 15/156 (9%)
Query: 269 TRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGI-GNFVNLQRLDMWN 327
T+L +++N N L G L +TL++ +NK+ ++P G+ VNL L +
Sbjct: 61 TKLRLLYLNDNKLQTLPAGIFKELKNL-ETLWVTDNKL-QALPIGVFDQLVNLAELRLDR 118
Query: 328 NQLSGTIPPAI-GELQNLKILGLNRNKLSGNIPPSI-GNLKMLLNLFLNDNFLEVSIPS- 384
NQL ++PP + L L L L N+L ++P + L L L L +N L+ +P
Sbjct: 119 NQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEG 175
Query: 385 ---SLGQCESLIEINLSNNNLSGTIPPQFFSLSSLS 417
L + L + L NN L F SL L
Sbjct: 176 AFDKLTE---LKTLKLDNNQLKRVPEGAFDSLEKLK 208
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 8e-10
Identities = 47/184 (25%), Positives = 72/184 (39%), Gaps = 20/184 (10%)
Query: 91 LKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNI-SRCSTLIPIHPQNNQL 149
K+L LQ N + L +L++L LN+N + +P I L + +N+L
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNKL 97
Query: 150 VGKILSR--FSSLSKTEILNLGSNHLTGSIPSSL-GNLSSIHTISLAYNNLDGTIPNSFG 206
+ L F L L L N L S+P + +L+ + +SL YN L ++P G
Sbjct: 98 --QALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPK--G 151
Query: 207 WFENLV---FLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLC 263
F+ L L L N L V +KL L+ + +N L L
Sbjct: 152 VFDKLTSLKELRLYNNQLKRVPEGA------FDKLTELKTLKLDNNQLKRVPEGAFDSLE 205
Query: 264 SLTN 267
L
Sbjct: 206 KLKM 209
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 8e-06
Identities = 30/134 (22%), Positives = 54/134 (40%), Gaps = 6/134 (4%)
Query: 68 TLLDLRSLKLAGSVSHFI-GNLSFLKQLYLQVNSFTHEIPSEI-GGLRRLKVLALNNNSI 125
L + KL ++ + L L +L L N +P + L +L L+L N +
Sbjct: 88 ETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNEL 145
Query: 126 CGEIPTNI-SRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNL 184
+P + + ++L + NNQL F L++ + L L +N L + +L
Sbjct: 146 -QSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSL 204
Query: 185 SSIHTISLAYNNLD 198
+ + L N D
Sbjct: 205 EKLKMLQLQENPWD 218
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 9e-06
Identities = 52/236 (22%), Positives = 78/236 (33%), Gaps = 82/236 (34%)
Query: 309 SIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKML 368
+IP+ I + ++LD+ +N+LS A L L++L LN NKL
Sbjct: 30 AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ------------- 74
Query: 369 LNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLT 428
L I L L + +++N L +P F
Sbjct: 75 --------TLPAGIFKELKN---LETLWVTDNKLQ-ALPIGVFD---------------- 106
Query: 429 GSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRG 488
+L L L + N+L+ +P +F L
Sbjct: 107 --------QLVNLAELRLDRNQLK-SLPP---------------RVFDS--------LTK 134
Query: 489 LRVLDLSQNNLSGEIPK--FLAGL-SLNNLNLSYNDLEGMVTTEGVFKNASATRIL 541
L L L N L +PK F L SL L L N L+ + EG F + + L
Sbjct: 135 LTYLSLGYNELQ-SLPKGVF-DKLTSLKELRLYNNQLKRV--PEGAFDKLTELKTL 186
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 56/221 (25%), Positives = 99/221 (44%), Gaps = 31/221 (14%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFI-AECK-ALKSIRHRNLVKVLTA 691
+G G++G V K +AVK + + + + +++++ V
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVT---- 70
Query: 692 CLGADYRGNDFKASVYEFMHY--GSLEEWLHPFTGEDE-IDEAPRNLNLLQRLNIAIDIA 748
GA +R D V+ M SL+++ + + I E ++L + IA+ I
Sbjct: 71 FYGALFREGD----VWICMELMDTSLDKFYKQVIDKGQTIPE-----DILGK--IAVSIV 119
Query: 749 YALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLG 808
AL +LH + H D+KPSNVL++ ++ DFG++ L D + G
Sbjct: 120 KALEHLHSKLSVI--HRDVKPSNVLINALGQVKMCDFGISGYLV-DDVAKDIDA--GCKP 174
Query: 809 YIAPEYGVGCEVSTNG-----DVYSYGILLLELVIGKKPID 844
Y+APE + E++ G D++S GI ++EL I + P D
Sbjct: 175 YMAPER-INPELNQKGYSVKSDIWSLGITMIELAILRFPYD 214
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-17
Identities = 32/184 (17%), Positives = 65/184 (35%), Gaps = 13/184 (7%)
Query: 246 ITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNK 305
+ LG +++ LT++ + + N L I IK L +NN
Sbjct: 25 YLNGLLGQSSTANITE----AQMNSLTYITLANINVTDLTG--IEYAHN-IKDLTINNIH 77
Query: 306 IYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNL 365
+ I NL+RL + ++ P + L +L +L ++ + +I I L
Sbjct: 78 A--TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135
Query: 366 KMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRN 425
+ ++ L+ N ++ L L +N+ + + L+ L
Sbjct: 136 PKVNSIDLSYNGA-ITDIMPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLN-QLYAFSQ 191
Query: 426 KLTG 429
+ G
Sbjct: 192 TIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-15
Identities = 31/209 (14%), Positives = 63/209 (30%), Gaps = 56/209 (26%)
Query: 294 KTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNK 353
++ + L N + + GI N++ L + N + P I L NL+ L +
Sbjct: 44 NSLTYITLANINV-TDLT-GIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKD 99
Query: 354 LSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSL 413
++ + P++ L L L ++ + + SI + + + I+LS N I P
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP----- 154
Query: 414 SSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGN 473
+ L L+ L + + +
Sbjct: 155 ---------------------LKTLPELKSLNIQFDGVHD-------------------- 173
Query: 474 LFQGPISSSLGSLRGLRVLDLSQNNLSGE 502
+ L L + G+
Sbjct: 174 ------YRGIEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 7e-13
Identities = 30/198 (15%), Positives = 61/198 (30%), Gaps = 22/198 (11%)
Query: 87 NLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQN 146
L +S + L + L N ++ T I + + N
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINV--TDLTGIEYAHNIKDLTINN 75
Query: 147 NQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFG 206
+ S LS E L + +T +L L+S+ + ++++ D +I
Sbjct: 76 IHA--TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 207 WFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLT 266
+ + L+ N ++ L+ L L+ I + + D +
Sbjct: 134 TLPKVNSIDLSYNG-------AITDIMPLKTLPELKSLNIQFDGV-----HDYRGIEDFP 181
Query: 267 NATRLTWMHINSNNFGGL 284
L ++ S GG
Sbjct: 182 K---LNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 34/163 (20%), Positives = 57/163 (34%), Gaps = 20/163 (12%)
Query: 364 NLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLS-----I 418
K LN L + + Q SL I L+N N++ L+ +
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT--------DLTGIEYAHNIK 69
Query: 419 SLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGP 478
L + T PI L LE L + + + L L + +
Sbjct: 70 DLTINNIHATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDS 127
Query: 479 ISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL-SLNNLNLSYN 520
I + + +L + +DLS N +I L L L +LN+ ++
Sbjct: 128 ILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFD 169
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 5e-09
Identities = 19/114 (16%), Positives = 45/114 (39%), Gaps = 3/114 (2%)
Query: 84 FIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIH 143
I LS L++L + T + + GL L +L +++++ I T I+ + I
Sbjct: 83 PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSID 142
Query: 144 PQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNL 197
N + I +L + + LN+ + + + + ++ + +
Sbjct: 143 LSYNGAITDI-MPLKTLPELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 16/108 (14%), Positives = 36/108 (33%), Gaps = 3/108 (2%)
Query: 68 TLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICG 127
L + + + L+ L L + ++ I ++I L ++ + L+ N
Sbjct: 91 ERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT 150
Query: 128 EIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTG 175
+I + L ++ Q + + K L S + G
Sbjct: 151 DI-MPLKTLPELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQTIGG 195
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 4e-17
Identities = 44/228 (19%), Positives = 70/228 (30%), Gaps = 47/228 (20%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASR--SFIAECKALKSIRHRNLVKVLTAC 692
G +V + V+ NL+ E K H N+V
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP----- 90
Query: 693 LGADYRGNDFKAS----VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAI--- 745
YR + V FM YGS ++ + D ++E IA
Sbjct: 91 ----YRATFIADNELWVVTSFMAYGSAKDLICT-HFMDGMNEL----------AIAYILQ 135
Query: 746 DIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVK- 804
+ AL+Y+HH H +K S++L+ + + +
Sbjct: 136 GVLKALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFP 192
Query: 805 ----GSLGYIAPE------YGVGCEVSTNGDVYSYGILLLELVIGKKP 842
L +++PE G + D+YS GI EL G P
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKS----DIYSVGITACELANGHVP 236
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-17
Identities = 58/218 (26%), Positives = 87/218 (39%), Gaps = 31/218 (14%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIA-ECKAL-KSIRHRNLVKVLTA 691
+G G+ G V+K + IAVK + I + + KS +V+
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQ---- 88
Query: 692 CLGADYRGNDFKASVYEFMHY--GSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAY 749
C G D V+ M E+ G I E +L + + + I
Sbjct: 89 CFGTFITNTD----VFIAMELMGTCAEKLKKRMQGP--IPE-----RILGK--MTVAIVK 135
Query: 750 ALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGY 809
AL YL + H D+KPSN+LLD+ ++ DFG++ L D + S G Y
Sbjct: 136 ALYYLKEKHGVI--HRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA---GCAAY 190
Query: 810 IAPE-----YGVGCEVSTNGDVYSYGILLLELVIGKKP 842
+APE + DV+S GI L+EL G+ P
Sbjct: 191 MAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 59/229 (25%), Positives = 98/229 (42%), Gaps = 48/229 (20%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFI-AECKALKSIRHRNLV 686
F+ +G GSFG V+KGI + + +A+K+ +L+ I E L +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 687 KVLTACLGADYRGNDFKAS----VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLN 742
K Y G+ K + + E++ GS + L P L
Sbjct: 84 K---------YYGSYLKDTKLWIIMEYLGGGSALDLLEP--------------GPLDETQ 120
Query: 743 IAI---DIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTS 799
IA +I L+YLH + + H D+K +NVLL ++ ++ DFG+A L+ + +
Sbjct: 121 IATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 177
Query: 800 SFSVKGSLGYIAPE------YGVGCEVSTNGDVYSYGILLLELVIGKKP 842
+F G+ ++APE Y D++S GI +EL G+ P
Sbjct: 178 TFV--GTPFWMAPEVIKQSAYDSKA------DIWSLGITAIELARGEPP 218
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 51/227 (22%), Positives = 88/227 (38%), Gaps = 41/227 (18%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIA-ECKALKSIRHRNLVKVLTAC 692
+G G+ V + +A+K NL+ S + E +A+ H N+V
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVS----- 77
Query: 693 LGADYRGNDFKAS----VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAI--- 745
Y + V + + GS+ + + + E L IA
Sbjct: 78 ----YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV-----LDESTIATILR 128
Query: 746 DIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKG 805
++ L YLH + Q H D+K N+LL + + ++ DFG++ L+ T + K
Sbjct: 129 EVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 806 SLG---YIAPE-------YGVGCEVSTNGDVYSYGILLLELVIGKKP 842
+G ++APE Y D++S+GI +EL G P
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFKA------DIWSFGITAIELATGAAP 226
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 6e-17
Identities = 63/246 (25%), Positives = 100/246 (40%), Gaps = 37/246 (15%)
Query: 612 SLLYLSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFI 671
SL + L + F LVG G++G VYKG + A+KV ++
Sbjct: 10 SLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIK 68
Query: 672 AECKALKSI-RHRNLVKVLTACLGADYRGNDFKAS-----VYEFMHYGSLEEWLHPFTGE 725
E LK HRN+ GA + N V EF GS+ + + G
Sbjct: 69 QEINMLKKYSHHRNIAT----YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG- 123
Query: 726 DEIDEAPRNLNLLQRLNIAI---DIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782
N L+ IA +I L++LH H D+K NVLL + ++
Sbjct: 124 ----------NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKL 170
Query: 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNG------DVYSYGILLLEL 836
DFG++ L + ++F G+ ++APE + C+ + + D++S GI +E+
Sbjct: 171 VDFGVSAQLDRTVGRRNTFI--GTPYWMAPEV-IACDENPDATYDFKSDLWSLGITAIEM 227
Query: 837 VIGKKP 842
G P
Sbjct: 228 AEGAPP 233
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 7e-17
Identities = 60/266 (22%), Positives = 106/266 (39%), Gaps = 55/266 (20%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVK----VFNLQHHGASRSFIAECKALKSIRHR 683
+ + +G G+ G V +A+K F Q H A R++ E +K + H+
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH-AKRAY-RELVLMKCVNHK 84
Query: 684 NLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNI 743
N++ +L +F+ VY M ++ L + E L L Q L
Sbjct: 85 NIIGLLNV-FTPQKSLEEFQ-DVYIVMEL--MDANLCQVIQMELDHERMSYL-LYQMLC- 138
Query: 744 AIDIAYALNYLHHDCQPVTA---HCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSS 800
+ +LH +A H DLKPSN+++ T ++ DFGLAR T
Sbjct: 139 ------GIKHLH------SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT-- 184
Query: 801 FSVKGSLGYI------APEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLH 854
Y+ APE +G N D++S G ++ E++ G ++F G ++
Sbjct: 185 -------PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG----VLFPGTDHID 233
Query: 855 NFGRKALPDDVMDIVDSSLLPDDEDL 880
+ + V++ + + P E +
Sbjct: 234 QWNK------VIEQLGT---PCPEFM 250
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 57/239 (23%), Positives = 100/239 (41%), Gaps = 24/239 (10%)
Query: 289 ISNLS--KTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKI 346
I + L + ++ ++ ++ N+ + ++ I L N+
Sbjct: 17 IFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTK 72
Query: 347 LGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTI 406
L LN NKL+ +I P + NLK L LFL++N +V SSL + L ++L +N +S I
Sbjct: 73 LFLNGNKLT-DIKP-LANLKNLGWLFLDEN--KVKDLSSLKDLKKLKSLSLEHNGIS-DI 127
Query: 407 PPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLE 466
L L SL NK+T + +L L+ L + +N++ +I +L+
Sbjct: 128 NG-LVHLPQLE-SLYLGNNKITDITVLS--RLTKLDTLSLEDNQIS-DIVP-LAGLTKLQ 181
Query: 467 QLGMGGNLFQGPIS--SSLGSLRGLRVLDLSQNNLSGEIPKFLAGLS-LNNLNLSYNDL 522
L + N IS +L L+ L VL+L + + L N + + L
Sbjct: 182 NLYLSKN----HISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 51/263 (19%), Positives = 102/263 (38%), Gaps = 37/263 (14%)
Query: 158 SSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLA 217
+ ++T NL +T + L+SI I +++ ++ + N+ L L
Sbjct: 21 DAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLN 76
Query: 218 ANN---------------LSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFL 262
N L + ENK+ ++ SL+ L++L+ ++ N + D++ L
Sbjct: 77 GNKLTDIKPLANLKNLGWLFLDENKVK-DLSSLKDLKKLKSLSLEHNGI-----SDINGL 130
Query: 263 CSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQR 322
L L +++ +N + +S L+K + TL L +N+I I + LQ
Sbjct: 131 VHLPQ---LESLYLGNNKITDITV--LSRLTK-LDTLSLEDNQIS-DIV-PLAGLTKLQN 182
Query: 323 LDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSI 382
L + N +S + + L+NL +L L + NL + + D +
Sbjct: 183 LYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDG--SLVT 238
Query: 383 PSSLGQCESLIEINLSNNNLSGT 405
P + + N+ + T
Sbjct: 239 PEIISDDGDYEKPNVKWHLPEFT 261
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 49/229 (21%), Positives = 79/229 (34%), Gaps = 44/229 (19%)
Query: 297 KTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSG 356
I I F + ++ ++ + EL ++ + N + +
Sbjct: 5 SETITVPTPI-KQIF-SDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK- 59
Query: 357 NIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSL 416
++ I L + LFLN N L I L ++L + L N + LSSL
Sbjct: 60 SVQG-IQYLPNVTKLFLNGNKLT-DI-KPLANLKNLGWLFLDENKVK--------DLSSL 108
Query: 417 SISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQ 476
LK L+ L + N + +I + +LE L +G N
Sbjct: 109 K-------------------DLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNN--- 144
Query: 477 GPIS--SSLGSLRGLRVLDLSQNNLSGEIPKFLAGLSLNNLNLSYNDLE 523
I+ + L L L L L N +S +I L NL LS N +
Sbjct: 145 -KITDITVLSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKNHIS 191
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 37/183 (20%), Positives = 73/183 (39%), Gaps = 18/183 (9%)
Query: 85 IGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHP 144
I L + +L+L N T + L+ L L L+ N + + +++ L +
Sbjct: 64 IQYLPNVTKLFLNGNKLTDI--KPLANLKNLGWLFLDENKV--KDLSSLKDLKKLKSLSL 119
Query: 145 QNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNS 204
++N + ++ L + E L LG+N +T + L L+ + T+SL N + +
Sbjct: 120 EHNGI--SDINGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQI--SDIVP 173
Query: 205 FGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCS 264
L L L+ N++S ++ +L L+ L + S + + S L
Sbjct: 174 LAGLTKLQNLYLSKNHIS--------DLRALAGLKNLDVLELFSQECLNKPINHQSNLVV 225
Query: 265 LTN 267
Sbjct: 226 PNT 228
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 3e-16
Identities = 68/300 (22%), Positives = 115/300 (38%), Gaps = 58/300 (19%)
Query: 597 VRKIKEKENPSSSIYSLLYLSYQ---DLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTT 653
V I + N S S + S + + + + +G G+ G V
Sbjct: 30 VSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN 89
Query: 654 IAVK----VFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEF 709
+A+K F Q H A R++ E +K + H+N++ +L +F+ VY
Sbjct: 90 VAIKKLSRPFQNQTH-AKRAY-RELVLMKCVNHKNIISLLNV-FTPQKTLEEFQ-DVYLV 145
Query: 710 MHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTA---HCD 766
M ++ L + E L L Q L + +LH +A H D
Sbjct: 146 MEL--MDANLCQVIQMELDHERMSYL-LYQMLC-------GIKHLH------SAGIIHRD 189
Query: 767 LKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYI------APEYGVGCEV 820
LKPSN+++ T ++ DFGLAR T Y+ APE +G
Sbjct: 190 LKPSNIVVKSDCTLKILDFGLARTAGTSFMMT---------PYVVTRYYRAPEVILGMGY 240
Query: 821 STNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDL 880
N D++S G ++ E+V K I+F G + + + V++ + + P E +
Sbjct: 241 KENVDIWSVGCIMGEMVRHK----ILFPGRDYIDQWNK------VIEQLGT---PCPEFM 287
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 59/228 (25%), Positives = 93/228 (40%), Gaps = 47/228 (20%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVK 687
F +G GS+GSVYK I E +A+K ++ + I E ++ ++VK
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVK 88
Query: 688 VLTACLGADYRGNDFKAS----VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNI 743
Y G+ FK + V E+ GS+ D I + L + I
Sbjct: 89 ---------YYGSYFKNTDLWIVMEYCGAGSV---------SDIIRLRNKTLTEDE---I 127
Query: 744 AI---DIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSS 800
A L YLH H D+K N+LL+ A++ DFG+A L+ + ++
Sbjct: 128 ATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT 184
Query: 801 FSVKGSLGYIAPE------YGVGCEVSTNGDVYSYGILLLELVIGKKP 842
G+ ++APE Y D++S GI +E+ GK P
Sbjct: 185 VI--GTPFWMAPEVIQEIGYNCVA------DIWSLGITAIEMAEGKPP 224
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 5e-16
Identities = 52/225 (23%), Positives = 87/225 (38%), Gaps = 37/225 (16%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFN---LQHHGASRSFIAECKALKSIRHRNLVKVL 689
+G G FG+VY + + +A+KV L+ G E + +RH N++++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 690 TACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAID 746
D + +Y EF G L + L DE + +
Sbjct: 81 NYF--HD------RKRIYLMLEFAPRGELYKELQKHGRFDE-QRSAT---------FMEE 122
Query: 747 IAYALNYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKG 805
+A AL+Y H H D+KP N+L+ ++ DFG + +T G
Sbjct: 123 LADALHYCHERKV----IHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC----G 174
Query: 806 SLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
+L Y+ PE G D++ G+L E ++G P F+
Sbjct: 175 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP----FDSP 215
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 1e-15
Identities = 58/236 (24%), Positives = 96/236 (40%), Gaps = 48/236 (20%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACL 693
+G GSFG VY+ + + +A+K +R E + ++ + H N+V+ L
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR-LRYFF 116
Query: 694 GADYRGNDFKA--SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAY-- 749
+ D V +++ E ++ R L + + + Y
Sbjct: 117 YSSGEKKDEVYLNLVLDYV-----PETVYRV-----ARHYSRAKQTLPVIYVKL-YMYQL 165
Query: 750 --ALNYLH-HDCQPVTAHCDLKPSNVLLD-DYMTARVGDFGLARILSPDHTQTSSFSVKG 805
+L Y+H H D+KP N+LLD D ++ DFG A+ L S
Sbjct: 166 FRSLAYIHSFGI----CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS------ 215
Query: 806 SLGYI------APEYGVGCEV-STNGDVYSYGILLLELVIGKKPIDIMFEGDINLH 854
YI APE G +++ DV+S G +L EL++G +PI F GD +
Sbjct: 216 ---YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI---FPGDSGVD 264
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-15
Identities = 84/499 (16%), Positives = 166/499 (33%), Gaps = 105/499 (21%)
Query: 91 LKQLYLQVNSFTHEIPSEIG-GLRRLKVLALNNNSI----CGEIPTNISRCSTLIPIHPQ 145
++ L +Q + +E+ L++ +V+ L++ + C +I + + L ++ +
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 146 NNQL----VGKILSRFSSLSKT-EILNLGSNHLT----GSIPSSLGNLSSIHTISLAYNN 196
+N+L V +L + S + L+L + LT G + S+L L ++ + L+ N
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124
Query: 197 LDGT----------IPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTI 246
L P L L L +LS + V L + T+
Sbjct: 125 LGDAGLQLLCEGLLDPQC-----RLEKLQLEYCSLSAASCEPLASV--LRAKPDFKELTV 177
Query: 247 TSNSLGSGGNDDLSFLCSL--TNATRLTWMHINSNNFGGLLPGCISNLS------KTIKT 298
++N + G + LC + +L + + S +L +++
Sbjct: 178 SNNDINEAG---VRVLCQGLKDSPCQLEALKLESCGVT---SDNCRDLCGIVASKASLRE 231
Query: 299 LFLNNNKIYGS-----IPAGIGNFVNLQRLDMWNNQLS----GTIPPAIGELQNLKILGL 349
L L +NK+ P + L+ L +W ++ G + + ++LK L L
Sbjct: 232 LALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSL 291
Query: 350 NRNKLSGNIPPSIGNL-----KMLLNLFLNDNFLE----VSIPSSLGQCESLIEINLSNN 400
N+L + L +L++ S L Q L+E+ +SNN
Sbjct: 292 AGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNN 351
Query: 401 NLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFG 460
L + L L + L L++ + +
Sbjct: 352 RLEDA------GVRELCQGLGQPGSVL--------------RVLWLADCDVSDS------ 385
Query: 461 NCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLA-GLSLNNLNLSY 519
++++L + LR LDLS N L L + L
Sbjct: 386 --------SCSS------LAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 431
Query: 520 NDLEG-MVTTEGVFKNASA 537
L + E + +
Sbjct: 432 LVLYDIYWSEEMEDRLQAL 450
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-12
Identities = 61/350 (17%), Positives = 100/350 (28%), Gaps = 63/350 (18%)
Query: 209 ENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNA 268
++ L + LS L LQ+ Q + L D+S L
Sbjct: 3 LDIQSLDIQCEELSD-----ARWAELLPLLQQCQVVRLDDCGLTEARCKDISSA--LRVN 55
Query: 269 TRLTWMHINSNNFGG----LLPGCISNLSKTIKTLFLNNNKI----YGSIPAGIGNFVNL 320
L +++ SN G + + S I+ L L N + G + + + L
Sbjct: 56 PALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTL 115
Query: 321 QRLDMWNNQLSGTIPPAIGELQ-----NLKILGLNRNKLSGNIPPSIGNLKMLLNLFLND 375
Q L + +N L + E L+ L L LS +
Sbjct: 116 QELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA------------ 163
Query: 376 NFLEVSIPSSLGQCESLIEINLSNNNLSGT----IPPQFFSLSSLSISLDWSRNKLT--- 428
S L E+ +SNN+++ + +L +T
Sbjct: 164 --------SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDN 215
Query: 429 -GSLPIEVGKLKILEFLYVYENRLEGE-----IPSTFGNCIRLEQLGMGGNLFQGP---- 478
L V L L + N+L P RL L +
Sbjct: 216 CRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGD 275
Query: 479 ISSSLGSLRGLRVLDLSQNNLSGEIPKFLA------GLSLNNLNLSYNDL 522
+ L + L+ L L+ N L E + L G L +L +
Sbjct: 276 LCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSF 325
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 43/261 (16%), Positives = 93/261 (35%), Gaps = 32/261 (12%)
Query: 145 QNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNS 204
+ + + L+ NLG +T S LS + + +N+ ++
Sbjct: 5 RPTPI--NQVFPDPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQ-SLAG- 58
Query: 205 FGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCS 264
+F NL L L+ N +S + L+ L +L+ ++ N L +L+ + S
Sbjct: 59 MQFFTNLKELHLSHNQISDLSP--------LKDLTKLEELSVNRNRL-----KNLNGIPS 105
Query: 265 LTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLD 324
L+ + +++N + +L ++ L + NNK+ +G L+ LD
Sbjct: 106 AC----LSRLFLDNNELRDTDS--LIHLKN-LEILSIRNNKL--KSIVMLGFLSKLEVLD 156
Query: 325 MWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPS 384
+ N+++ + L+ + + L K L + + D P
Sbjct: 157 LHGNEIT-NTGG-LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDG--RWISPY 212
Query: 385 SLGQCESLIEINLSNNNLSGT 405
+ S ++ + T
Sbjct: 213 YISNGGSYVDGCVLWELPVYT 233
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 44/219 (20%), Positives = 81/219 (36%), Gaps = 22/219 (10%)
Query: 299 LFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNI 358
I P N + ++ ++ + EL ++ + + + ++
Sbjct: 2 SIQRPTPINQVFP--DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL 56
Query: 359 PPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSI 418
+ L L L+ N ++S S L L E++++ N L LS L +
Sbjct: 57 AG-MQFFTNLKELHLSHN--QISDLSPLKDLTKLEELSVNRNRLKNLNGIPSACLSRLFL 113
Query: 419 SLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGP 478
N+L + + LK LE L + N+L+ I G +LE L + GN
Sbjct: 114 D----NNELRDTDSLI--HLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGN----E 161
Query: 479 IS--SSLGSLRGLRVLDLSQNNLSGEIPKFLAGLSLNNL 515
I+ L L+ + +DL+ E K+ L + N
Sbjct: 162 ITNTGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNT 200
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 8e-07
Identities = 41/224 (18%), Positives = 80/224 (35%), Gaps = 29/224 (12%)
Query: 85 IGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHP 144
LS ++ ++ + + LK L L++N I ++ + + + L +
Sbjct: 37 QKELSGVQNFNGDNSNIQS--LAGMQFFTNLKELHLSHNQI-SDL-SPLKDLTKLEELSV 92
Query: 145 QNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNS 204
N+L K L+ S + L L +N L SL +L ++ +S+ N L +I
Sbjct: 93 NRNRL--KNLNGIPSACLSR-LFLDNNELRD--TDSLIHLKNLEILSIRNNKLK-SIVM- 145
Query: 205 FGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCS 264
G+ L L L N ++ L +L+++ +T +
Sbjct: 146 LGFLSKLEVLDLHGNEITNTGG--------LTRLKKVNWIDLTGQKCVN---------EP 188
Query: 265 LTNATRLTWMHINSNNFGGLL-PGCISNLSKTIKTLFLNNNKIY 307
+ L + + G + P ISN + L +Y
Sbjct: 189 VKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPVY 232
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 23/142 (16%), Positives = 55/142 (38%), Gaps = 15/142 (10%)
Query: 384 SSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEF 443
+ ++ NL +++ + LS + + + + + ++ L+
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQ-NFNGDNSNIQSLAGMQ--FFTNLKE 67
Query: 444 LYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISS-SLGSLRGLRVLDLSQNNLSGE 502
L++ N++ ++ S + +LE+L + N + + + L L L N L
Sbjct: 68 LHLSHNQIS-DL-SPLKDLTKLEELSVNRN----RLKNLNGIPSACLSRLFLDNNELRD- 120
Query: 503 IPKFLAGL-SLNNLNLSYNDLE 523
L L +L L++ N L+
Sbjct: 121 -TDSLIHLKNLEILSIRNNKLK 141
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 22/131 (16%), Positives = 49/131 (37%), Gaps = 19/131 (14%)
Query: 397 LSNNNLSGTIPPQFFSLSSLS--ISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGE 454
++ Q F L+ + + + +T + + +L ++ + ++
Sbjct: 4 QRPTPIN-----QVFPDPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQ-S 55
Query: 455 IPSTFGNCIRLEQLGMGGNLFQGPIS--SSLGSLRGLRVLDLSQNNLSGEIPKFLAGLSL 512
+ + L++L + N IS S L L L L +++N L + + L
Sbjct: 56 L-AGMQFFTNLKELHLSHN----QISDLSPLKDLTKLEELSVNRNRLK-NLN-GIPSACL 108
Query: 513 NNLNLSYNDLE 523
+ L L N+L
Sbjct: 109 SRLFLDNNELR 119
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 2e-15
Identities = 56/234 (23%), Positives = 92/234 (39%), Gaps = 40/234 (17%)
Query: 634 VGVGSFGSVYKGIIDEGRT--TIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTA 691
VG G++G VYK +G+ A+K G S S E L+ ++H N++ +
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGISMSACREIALLRELKHPNVISLQKV 86
Query: 692 CLGA---------DYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLN 742
L DY +D + +F + + ++L L Q L+
Sbjct: 87 FLSHADRKVWLLFDYAEHDLW-HIIKFHRASKANKKPVQLP-RGMV----KSL-LYQILD 139
Query: 743 IAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR----VGDFGLARIL-SPDHTQ 797
++YLH + H DLKP+N+L+ R + D G AR+ SP
Sbjct: 140 -------GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 189
Query: 798 TSSFSVKGSLGYIAPEYGVGCEV-STNGDVYSYGILLLELVIGKKPIDIMFEGD 850
V + Y APE +G + D+++ G + EL + +PI F
Sbjct: 190 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL-LTSEPI---FHCR 239
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 61/268 (22%), Positives = 106/268 (39%), Gaps = 57/268 (21%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVK----VFNLQHHGASRSFIAECKALKSIRHRNLVKVL 689
VG G++G+V + +A+K F + A R++ E + LK +RH N++ +L
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF-AKRAY-RELRLLKHMRHENVIGLL 90
Query: 690 TACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAY 749
D +DF Y M + + L +++ E + Q L
Sbjct: 91 DV-FTPDETLDDFT-DFYLVMPF--MGTDLGKLMKHEKLGEDRIQFLVYQMLK------- 139
Query: 750 ALNYLHHDCQPVTA---HCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGS 806
L Y+H A H DLKP N+ +++ ++ DFGLAR + T
Sbjct: 140 GLRYIH------AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT---------- 183
Query: 807 LGYI------APEYGVGCEVSTNG-DVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859
GY+ APE + T D++S G ++ E++ GK +F+G +L
Sbjct: 184 -GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK----TLFKGSDHLDQLKE- 237
Query: 860 ALPDDVMDIVDSSLLPDDEDLILTGNQR 887
+M + + P E + +
Sbjct: 238 -----IMKVTGT---PPAEFVQRLQSDE 257
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 2e-15
Identities = 53/224 (23%), Positives = 94/224 (41%), Gaps = 34/224 (15%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTA 691
+G G++G+V+K E +A+K L G S + E LK ++H+N+V++
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 692 CLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIA 748
+ EF L+++ + ++D L Q L
Sbjct: 70 LHS--------DKKLTLVFEFCDQ-DLKKYFD--SCNGDLDPEIVKSFLFQLLK------ 112
Query: 749 YALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILS-PDHTQTSSFSVKGSL 807
L + H H DLKP N+L++ ++ +FGLAR P ++ +L
Sbjct: 113 -GLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV---TL 165
Query: 808 GYIAPEYGVGCEV-STNGDVYSYGILLLELVIGKKPIDIMFEGD 850
Y P+ G ++ ST+ D++S G + EL +P+ F G+
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL---FPGN 206
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 61/281 (21%), Positives = 108/281 (38%), Gaps = 58/281 (20%)
Query: 621 LYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVK----VFNLQHHGASRSFIAECKA 676
+ + S VG G++GSV I +A+K F + A R++ E
Sbjct: 19 AWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIF-AKRAY-RELLL 76
Query: 677 LKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLN 736
LK ++H N++ +L +F Y M + ++ L G +E + L
Sbjct: 77 LKHMQHENVIGLLDV-FTPASSLRNFY-DFYLVMPF--MQTDLQKIMGLKFSEEKIQYL- 131
Query: 737 LLQRLNIAIDIAYALNYLHHDCQPVTA---HCDLKPSNVLLDDYMTARVGDFGLARILSP 793
+ Q L L Y+H +A H DLKP N+ +++ ++ DFGLAR
Sbjct: 132 VYQMLK-------GLKYIH------SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178
Query: 794 DHTQTSSFSVKGSLGYI------APEYGVGCEVSTNG-DVYSYGILLLELVIGKKPIDIM 846
+ T GY+ APE + D++S G ++ E++ GK +
Sbjct: 179 EMT-----------GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK----TL 223
Query: 847 FEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQR 887
F+G L + ++ + P E + ++
Sbjct: 224 FKGKDYLDQLTQ------ILKVTGV---PGTEFVQKLNDKA 255
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 57/262 (21%), Positives = 98/262 (37%), Gaps = 46/262 (17%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIA-ECKALKSIRHRNLVK---V 688
+G G++G V + +AVK+ +++ I E K + H N+VK
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 689 LTACLGADYRGNDFKASVYEFMHY---GSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAI 745
Y F+ Y G L + + P G E +A R +L +
Sbjct: 74 RRE-----------GNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQR---FFHQLMAGV 118
Query: 746 DIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKG 805
YLH + H D+KP N+LLD+ ++ DFGLA + ++ + + G
Sbjct: 119 V------YLHG--IGI-THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 806 SLGYIAPE------YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859
+L Y+APE + V DV+S GI+L ++ G+ P ++ +
Sbjct: 170 TLPYVAPELLKRREF-HAEPV----DVWSCGIVLTAMLAGELP----WDQPSDSCQEYSD 220
Query: 860 ALPDDVMDIVDSSLLPDDEDLI 881
+ L+
Sbjct: 221 WKEKKTYLNPWKKIDSAPLALL 242
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 4e-15
Identities = 58/229 (25%), Positives = 98/229 (42%), Gaps = 35/229 (15%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACL 693
+G GSFG V++ + E +A+K +R E + ++ ++H N+V L A
Sbjct: 48 IGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNR----ELQIMRIVKHPNVVD-LKAFF 101
Query: 694 GADYRGNDFKA--SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAY-- 749
++ D V E++ E ++ + + L I + Y
Sbjct: 102 YSNGDKKDEVFLNLVLEYV-----PETVYRA-----SRHYAKLKQTMPMLLIKL-YMYQL 150
Query: 750 --ALNYLHHDCQPVTAHCDLKPSNVLLD-DYMTARVGDFGLARILSPDHTQTSSFSVKGS 806
+L Y+H + H D+KP N+LLD ++ DFG A+IL S S
Sbjct: 151 LRSLAYIH--SIGI-CHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC---S 204
Query: 807 LGYIAPEYGVGCEV-STNGDVYSYGILLLELVIGKKPIDIMFEGDINLH 854
Y APE G +TN D++S G ++ EL+ G +P+ F G+ +
Sbjct: 205 RYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG-QPL---FPGESGID 249
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 65/248 (26%), Positives = 100/248 (40%), Gaps = 56/248 (22%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFN---LQHHGASRSFIA-ECKALKSIRHRNLVK- 687
L+G GS+G V + + E AVK+ L+ + + E + L+ +RH+N+++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 688 --VLTACLGADYRGNDFKASVYEFMHY---GSLEEWLHPFTGEDEIDEAPRNLNLLQRLN 742
VL N+ K +Y M Y G E + +A +L
Sbjct: 72 VDVLY---------NEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHG---YFCQL- 118
Query: 743 IAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSP----DHTQT 798
ID L YLH H D+KP N+LL T ++ G+A L P D +T
Sbjct: 119 --ID---GLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 799 SSFSVKGSLGYIAPE-------YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDI 851
S GS + PE + G +V D++S G+ L + G P FEGD
Sbjct: 171 SQ----GSPAFQPPEIANGLDTF-SGFKV----DIWSAGVTLYNITTGLYP----FEGD- 216
Query: 852 NLHNFGRK 859
N++
Sbjct: 217 NIYKLFEN 224
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 6e-15
Identities = 59/233 (25%), Positives = 98/233 (42%), Gaps = 41/233 (17%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTT---IAVKVFNLQH--HGASRSFIAECKALKSIR---HR 683
+G G++G V+K + + +A+K +Q G S I E L+ + H
Sbjct: 17 AEIGEGAYGKVFKAR--DLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHP 74
Query: 684 NLVKVLTACLGADYRGNDFKASVY---EFMHY---GSLEEWLHPFTGEDEIDEAPRNLNL 737
N+V++ C D + + E + L++ P + I +++ +
Sbjct: 75 NVVRLFDVCTV---SRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI----KDM-M 126
Query: 738 LQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQ 797
Q L L++LH H DLKP N+L+ ++ DFGLARI S
Sbjct: 127 FQLLR-------GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL 176
Query: 798 TSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
TS V +L Y APE + +T D++S G + E+ +KP+ F G
Sbjct: 177 TSVV-V--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL---FRGS 222
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 7e-15
Identities = 55/268 (20%), Positives = 85/268 (31%), Gaps = 63/268 (23%)
Query: 635 GVGSFGSVYKGII-----DEGRTTIAVKVFNLQHHGASRS-FIAECKALKSI-RHRNLVK 687
G G+FG V + T+AVK+ + ++E K L I H N+V
Sbjct: 31 GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90
Query: 688 VLTACLGADY----------RGN----------------DFKASVYEFMHYGSLEE---- 717
+L AC GN A + Y
Sbjct: 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLK 150
Query: 718 ----------------------WLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLH 755
E D L L + + +A + +L
Sbjct: 151 RRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA 210
Query: 756 HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYG 815
+ H DL N+LL + ++ DFGLAR + D + L ++APE
Sbjct: 211 --SRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 267
Query: 816 VGCEVSTNGDVYSYGILLLELV-IGKKP 842
+ DV+S+G+LL E+ +G P
Sbjct: 268 FDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 9e-15
Identities = 59/234 (25%), Positives = 93/234 (39%), Gaps = 56/234 (23%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGAS---RSFIAECKALKSIRHRN 684
FS +G GSFG+VY +A+K + ++ + I E + L+ +RH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 685 LVKVLTACLGADYRGNDFKAS----VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQR 740
++ YRG + V E+ GS D ++ + L ++
Sbjct: 116 TIQ---------YRGCYLREHTAWLVMEYCL-GSA---------SDLLEVHKKPLQEVE- 155
Query: 741 LNIAI---DIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQ 797
IA L YLH H D+K N+LL + ++GDFG A I++P ++
Sbjct: 156 --IAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS- 209
Query: 798 TSSFSVKGSLGYIAPE---------YGVGCEVSTNGDVYSYGILLLELVIGKKP 842
G+ ++APE Y DV+S GI +EL K P
Sbjct: 210 -----FVGTPYWMAPEVILAMDEGQYDGKV------DVWSLGITCIELAERKPP 252
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 1e-14
Identities = 43/173 (24%), Positives = 71/173 (41%), Gaps = 17/173 (9%)
Query: 290 SNLSKTIKTLFLNNNKIYGSIPAGI--GNFVNLQRLDMWNNQLSGTIPP-AIGELQNLKI 346
+L L L++N + + A NL L + +N L+ I A + NL+
Sbjct: 35 QSLPSYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRY 92
Query: 347 LGLNRNKLSGNIPPSI-GNLKMLLNLFLNDNFLEVSIPS-SLGQCESLIEINLSNNNLSG 404
L L+ N L + + +L+ L L L +N + + + L ++ LS N +S
Sbjct: 93 LDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS- 149
Query: 405 TIPPQFF----SLSSLSISLDWSRNKLTGSLPIEVGKLKIL--EFLYVYENRL 451
P + L L + LD S NKL ++ KL LY++ N L
Sbjct: 150 RFPVELIKDGNKLPKLML-LDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 43/219 (19%), Positives = 71/219 (32%), Gaps = 58/219 (26%)
Query: 309 SIPAGIGNFVNLQRLDMWNNQLSGTIPP--AIGELQNLKILGLNRNKLSGNIPPSIGNLK 366
++P + LD+ +N LS + L NL L L+ N L+ I
Sbjct: 32 NVPQSL--PSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSE----- 82
Query: 367 MLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFS-LSSLSISLDWSRN 425
+ +L ++LS+N+L T+ FS L +L + L N
Sbjct: 83 ------------------AFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEV-LLLYNN 122
Query: 426 KLTGSLPIEV-GKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLG 484
+ + + L+ LY+ +N++ +
Sbjct: 123 HIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKD---------------------GN 160
Query: 485 SLRGLRVLDLSQNNLS---GEIPKFLAGLSLNNLNLSYN 520
L L +LDLS N L + L N L L N
Sbjct: 161 KLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 8e-10
Identities = 36/181 (19%), Positives = 74/181 (40%), Gaps = 17/181 (9%)
Query: 128 EIPTNISRCSTLIPIHPQNNQLVGKILSR--FSSLSKTEILNLGSNHLTGSIPS-SLGNL 184
+P ++ + L+ + +N L ++ + + L+ L L NHL I S + +
Sbjct: 32 NVPQSLPSYTALLDL--SHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPV 87
Query: 185 SSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHF 244
++ + L+ N+L F + L L L N++ VV+ + E + +LQ
Sbjct: 88 PNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRN------AFEDMAQLQKL 141
Query: 245 TITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSK-TIKTLFLNN 303
++ N + + + L +L + ++SN L + L L+L+N
Sbjct: 142 YLSQNQISRFPVELIKDGNKLP---KLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
Query: 304 N 304
N
Sbjct: 199 N 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 37/194 (19%), Positives = 68/194 (35%), Gaps = 36/194 (18%)
Query: 91 LKQLYLQVNSFTHEIPSEI--GGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQ 148
L L N+ + + +E L L L L++N + I +
Sbjct: 41 TALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHL-NFISSEA--------------- 83
Query: 149 LVGKILSRFSSLSKTEILNLGSNHLTGSIPS-SLGNLSSIHTISLAYNNLDGTIPNSFGW 207
F + L+L SNHL ++ +L ++ + L N++ N+F
Sbjct: 84 --------FVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFED 134
Query: 208 FENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTN 267
L L L+ N +S + KL +L ++SN L DL L +
Sbjct: 135 MAQLQKLYLSQNQISRFPV---ELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVK 191
Query: 268 ATRLTWMHINSNNF 281
+++++N
Sbjct: 192 NG----LYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 35/133 (26%), Positives = 49/133 (36%), Gaps = 12/133 (9%)
Query: 396 NLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEV--GKLKILEFLYVYENRLEG 453
+ S L +P SL S + LD S N L+ L E +L L L + N L
Sbjct: 24 SCSKQQLP-NVPQ---SLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN- 77
Query: 454 EIPS-TFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKF-LAGL- 510
I S F L L + N L+ L VL L N++ + + +
Sbjct: 78 FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMA 136
Query: 511 SLNNLNLSYNDLE 523
L L LS N +
Sbjct: 137 QLQKLYLSQNQIS 149
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 60/237 (25%), Positives = 92/237 (38%), Gaps = 47/237 (19%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFN---LQHHGASRSFIAECKALKSIRHRNLVKVLTA 691
G G+F V +A+K+ + L + F E + +K + H N+VK+
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVKL--- 79
Query: 692 CLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGE--DEIDEAPRNLNLLQRLNIAIDIAY 749
+ + + ++Y M Y S GE D + R + + + I
Sbjct: 80 -----FEVIETEKTLYLIMEYAS--------GGEVFDYLVAHGR-MKEKEARSKFRQIVS 125
Query: 750 ALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHT-QTSSFSVKGSLG 808
A+ Y H H DLK N+LLD M ++ DFG + + G+
Sbjct: 126 AVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC----GAPP 178
Query: 809 YIAPE------YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859
Y APE Y G EV DV+S G++L LV G P F+G NL +
Sbjct: 179 YAAPELFQGKKY-DGPEV----DVWSLGVILYTLVSGSLP----FDGQ-NLKELRER 225
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 66/261 (25%), Positives = 106/261 (40%), Gaps = 48/261 (18%)
Query: 600 IKEKENPSSSIYSLLYLSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVF 659
+ + SS +L + + Y VG G++G VYK +GR +A+K
Sbjct: 1 MHHHHHHSSGRENLYFQGLMEKYQKL------EKVGEGTYGVVYKAKDSQGRI-VALKRI 53
Query: 660 NLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVY---EFMHY-- 712
L G + I E LK + H N+V ++ + + EFM
Sbjct: 54 RLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS--------ERCLTLVFEFMEKDL 105
Query: 713 -GSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSN 771
L+E + +I + L Q L + + H H DLKP N
Sbjct: 106 KKVLDENKTGLQ-DSQI----KIY-LYQLLR-------GVAHCHQHR---ILHRDLKPQN 149
Query: 772 VLLDDYMTARVGDFGLARILS-PDHTQTSSFSVKGSLGYIAPEYGVGCEV-STNGDVYSY 829
+L++ ++ DFGLAR P + T V +L Y AP+ +G + ST+ D++S
Sbjct: 150 LLINSDGALKLADFGLARAFGIPVRSYTHEV-V--TLWYRAPDVLMGSKKYSTSVDIWSI 206
Query: 830 GILLLELVIGKKPIDIMFEGD 850
G + E++ G KP+ F G
Sbjct: 207 GCIFAEMITG-KPL---FPGV 223
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 1e-14
Identities = 53/221 (23%), Positives = 80/221 (36%), Gaps = 43/221 (19%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASR--SFIAECKALKSIRHRNLVKVLTAC 692
G G++G V A+K+ S + E LK + H N++K+
Sbjct: 46 GSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF- 104
Query: 693 LGADYRGNDFKASVYEFMHYGSLEEWL---HPFTGEDEIDEAPRNLNLLQRLNIAIDIAY 749
+ V E G L + + F E+D A I +
Sbjct: 105 ----FEDKRNYYLVMECYKGGELFDEIIHRMKFN---EVDAA----------VIIKQVLS 147
Query: 750 ALNYLHHDCQPVTAHCDLKPSNVLL---DDYMTARVGDFGLARILSPDHTQTSSFSVKGS 806
+ YLH + H DLKP N+LL + ++ DFGL+ + G+
Sbjct: 148 GVTYLHK--HNI-VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL---GT 201
Query: 807 LGYIAPE-----YGVGCEVSTNGDVYSYGILLLELVIGKKP 842
YIAPE Y C DV+S G++L L+ G P
Sbjct: 202 AYYIAPEVLRKKYDEKC------DVWSIGVILFILLAGYPP 236
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 61/227 (26%), Positives = 95/227 (41%), Gaps = 37/227 (16%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVL 689
LVG GS+G V K + +A+K F + + E K LK +RH NLV +L
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 690 TACLGADYRGNDFKASVYEFMH---YGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAID 746
C + V+EF+ LE + + + + L Q +N
Sbjct: 91 EVC-----KKKKRWYLVFEFVDHTILDDLELFPNGLD-YQVV----QKY-LFQIIN---- 135
Query: 747 IAYALNYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILS-PDHTQTSSFSVK 804
+ + H H+ H D+KP N+L+ ++ DFG AR L+ P +
Sbjct: 136 ---GIGFCHSHNI----IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-- 186
Query: 805 GSLGYIAPEYGVGCEV-STNGDVYSYGILLLELVIGKKPIDIMFEGD 850
+ Y APE VG DV++ G L+ E+ +G +P+ F GD
Sbjct: 187 -TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG-EPL---FPGD 228
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 1e-14
Identities = 59/286 (20%), Positives = 95/286 (33%), Gaps = 55/286 (19%)
Query: 607 SSSIYSLLYLSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFN-----L 661
SS LY L + +G GS+G V I ++ R A+K+ N
Sbjct: 7 HSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ 66
Query: 662 QHHGASRSFIAECKALKSIRHRNLVK-------------VLTACLGAD------YRGNDF 702
+ E + +K + H N+ + V+ C G +D
Sbjct: 67 INPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDS 126
Query: 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLN------IAIDIAYALNYLHH 756
+ + +L I I AL+YLH+
Sbjct: 127 TGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN 186
Query: 757 DCQPVTAHCDLKPSNVLL--DDYMTARVGDFGLARILSPDHTQTSSF--SVKGSLGYIAP 812
Q + H D+KP N L + ++ DFGL++ + + G+ ++AP
Sbjct: 187 --QGI-CHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243
Query: 813 E--------YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
E YG C D +S G+LL L++G P F G
Sbjct: 244 EVLNTTNESYGPKC------DAWSAGVLLHLLLMGAVP----FPGV 279
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 34/229 (14%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLV 686
+ + +G G++ +VYKG +A+K L+H GA + I E LK ++H N+V
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 63
Query: 687 KVLTACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNI 743
+ + S+ E++ L+++L + I+ L L Q L
Sbjct: 64 TLHDIIHT--------EKSLTLVFEYLDK-DLKQYLD--DCGNIINMHNVKLFLFQLLR- 111
Query: 744 AIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILS-PDHTQTSSFS 802
L Y H H DLKP N+L+++ ++ DFGLAR S P T +
Sbjct: 112 ------GLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN--E 160
Query: 803 VKGSLGYIAPEYGVGCEV-STNGDVYSYGILLLELVIGKKPIDIMFEGD 850
V +L Y P+ +G ST D++ G + E+ G +P+ F G
Sbjct: 161 VV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG-RPL---FPGS 204
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-14
Identities = 59/230 (25%), Positives = 86/230 (37%), Gaps = 48/230 (20%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFN---LQHHGASRSFIAECKALKSIRHRNLVKVLTA 691
G GSFG V AVKV + ++ S + E + LK + H N++K+
Sbjct: 35 GKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF 94
Query: 692 CLGADYRGNDFKASVYEFMHYGSLEEWL---HPFTGEDEIDEAPRNLNLLQRLNIAIDIA 748
+ + V E G L + + F+ E+D A I +
Sbjct: 95 -----FEDKGYFYLVGEVYTGGELFDEIISRKRFS---EVDAA----------RIIRQVL 136
Query: 749 YALNYLHHDCQPVTAHCDLKPSNVLL---DDYMTARVGDFGLARILSPDHTQTSSFSVKG 805
+ Y+H + H DLKP N+LL R+ DFGL+ G
Sbjct: 137 SGITYMHK--NKI-VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI---G 190
Query: 806 SLGYIAPE-----YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
+ YIAPE Y C DV+S G++L L+ G P F G
Sbjct: 191 TAYYIAPEVLHGTYDEKC------DVWSTGVILYILLSGCPP----FNGA 230
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 69/237 (29%), Positives = 103/237 (43%), Gaps = 46/237 (19%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFN---LQHHGASRSFIAECKALKSIRHRNLVKVLTA 691
GVG+FG V G +AVK+ N ++ E + LK RH +++K+
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL--- 76
Query: 692 CLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGE--DEIDEAPRNLNLLQRLNIAIDIAY 749
Y+ + M Y S GE D I + R + ++ + I
Sbjct: 77 -----YQVISTPTDFFMVMEYVS--------GGELFDYICKHGR-VEEMEARRLFQQILS 122
Query: 750 ALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHT-QTSSFSVKGSLG 808
A++Y H H DLKP NVLLD +M A++ DFGL+ ++S +TS GS
Sbjct: 123 AVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----GSPN 175
Query: 809 YIAPE------YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859
Y APE Y G EV D++S G++L L+ G P D D ++ +K
Sbjct: 176 YAAPEVISGRLY-AGPEV----DIWSCGVILYALLCGTLPFD-----DEHVPTLFKK 222
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 57/262 (21%), Positives = 98/262 (37%), Gaps = 46/262 (17%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIA-ECKALKSIRHRNLVK---V 688
+G G++G V + +AVK+ +++ I E K + H N+VK
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 689 LTACLGADYRGNDFKASVYEFMHY---GSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAI 745
Y F+ Y G L + + P G E +A R +L +
Sbjct: 74 RRE-----------GNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQR---FFHQLMAGV 118
Query: 746 DIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKG 805
YLH + H D+KP N+LLD+ ++ DFGLA + ++ + + G
Sbjct: 119 V------YLHG--IGI-THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 806 SLGYIAPE------YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859
+L Y+APE + V DV+S GI+L ++ G+ P ++ +
Sbjct: 170 TLPYVAPELLKRREF-HAEPV----DVWSCGIVLTAMLAGELP----WDQPSDSCQEYSD 220
Query: 860 ALPDDVMDIVDSSLLPDDEDLI 881
+ L+
Sbjct: 221 WKEKKTYLNPWKKIDSAPLALL 242
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 56/268 (20%), Positives = 91/268 (33%), Gaps = 64/268 (23%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFN---LQHHGASRSFIA-----ECKALKSIRHRNLV 686
G G+FG V+ + E + VK + E L + H N++
Sbjct: 33 GSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92
Query: 687 KVLTACLGADYRGNDFKASVYEFMH-----YGSLEEWLHPFTGE--DEIDEAPRNLNLLQ 739
KV + +E H + ID PR L+
Sbjct: 93 KV------------------LDIFENQGFFQLVME--KHGSGLDLFAFIDRHPR-LDEPL 131
Query: 740 RLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHT-QT 798
I + A+ YL H D+K N+++ + T ++ DFG A L T
Sbjct: 132 ASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT 188
Query: 799 SSFSVKGSLGYIAPE------YGVGCEVSTNGDVYSYGILLLELVIGKKPID----IMFE 848
G++ Y APE Y G E+ +++S G+ L LV + P + E
Sbjct: 189 FC----GTIEYCAPEVLMGNPY-RGPEL----EMWSLGVTLYTLVFEENPFCELEETV-E 238
Query: 849 GDINLHNFGRKALPDDVMDIVDSSLLPD 876
I+ + ++M +V L P
Sbjct: 239 AAIHPPYL----VSKELMSLVSGLLQPV 262
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 27/227 (11%), Positives = 55/227 (24%), Gaps = 68/227 (29%)
Query: 633 LVGVGSFGSVYKGIIDE--GRTTIAVKVFNLQHHGASRS---FIAECKALKSIRHRNLVK 687
G ++ + D R +A+ + Q ++ L I +
Sbjct: 38 FHGGVPPLQFWQAL-DTALDRQ-VALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA- 94
Query: 688 VLTACLGADYRGNDFKASVYEFMHYGSLE----EWLHPFTGEDEIDEAPRNLNLLQRLNI 743
V + +H + EW+ G + A + + + +
Sbjct: 95 -----------------RVLDVVHTRAGGLVVAEWIR---GGSLQEVADTSPSPVGAIRA 134
Query: 744 AIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSV 803
+A A + H V A PS V + + + + Q
Sbjct: 135 MQSLAAAADAAHR--AGV-ALSIDHPSRVRVSIDGDVVLAYPA---TMPDANPQD----- 183
Query: 804 KGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
D+ G L L++ + P
Sbjct: 184 ---------------------DIRGIGASLYALLVNRWP----LPEA 205
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 61/268 (22%), Positives = 107/268 (39%), Gaps = 57/268 (21%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVK----VFNLQHHGASRSFIAECKALKSIRHRNLVKVL 689
VG G++GSV + +AVK F H A R++ E + LK ++H N++ +L
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTY-RELRLLKHMKHENVIGLL 94
Query: 690 TACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAY 749
+F VY H + L+ ++ + + Q L
Sbjct: 95 DV-FTPARSLEEFN-DVYLVTHL--MGADLNNIVKCQKLTDDHVQFLIYQILR------- 143
Query: 750 ALNYLHHDCQPVTA---HCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGS 806
L Y+H +A H DLKPSN+ +++ ++ DFGLAR + + T
Sbjct: 144 GLKYIH------SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT---------- 187
Query: 807 LGYI------APEYGVGCEVSTNG-DVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859
GY+ APE + D++S G ++ EL+ G+ +F G ++
Sbjct: 188 -GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR----TLFPGTDHIDQLKL- 241
Query: 860 ALPDDVMDIVDSSLLPDDEDLILTGNQR 887
++ +V + P E L ++
Sbjct: 242 -----ILRLVGT---PGAELLKKISSES 261
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 52/263 (19%), Positives = 92/263 (34%), Gaps = 70/263 (26%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVL---- 689
+G GSFG V + E A+K +R E +K + H N++K++
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVNIIKLVDYFY 70
Query: 690 --TACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQ-------- 739
+ D + + + LN++
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKY-----LNVIMEYVPDTLH 125
Query: 740 -------RLNIAIDIAY----------ALNYLHHDCQPVTA---HCDLKPSNVLLD-DYM 778
R +I + A+ ++H + H D+KP N+L++
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH------SLGICHRDIKPQNLLVNSKDN 179
Query: 779 TARVGDFGLARILSPDHTQTSSFSVKGSLGYI------APEYGVGCEVSTNG-DVYSYGI 831
T ++ DFG A+ L P + YI APE +G T D++S G
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVA---------YICSRFYRAPELMLGATEYTPSIDLWSIGC 230
Query: 832 LLLELVIGKKPIDIMFEGDINLH 854
+ EL++G KP+ F G+ ++
Sbjct: 231 VFGELILG-KPL---FSGETSID 249
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 57/278 (20%), Positives = 103/278 (37%), Gaps = 60/278 (21%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVK--VFNLQHHGASRSFIAECKALKSIRHRNLVKVLTA 691
+G G G V+ + ++ +A+K V + E K ++ + H N+VKV
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQS-VKHAL-REIKIIRRLDHDNIVKVFEI 76
Query: 692 CLGADYRGNDFKAS---------VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLN 742
+ + D S V E+M E L + + E L + Q L
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLLEEHARLFMYQLLR 131
Query: 743 IAIDIAYALNYLHHDCQPVTA---HCDLKPSNVLLDDY-MTARVGDFGLARILSPDHTQT 798
L Y+H +A H DLKP+N+ ++ + ++GDFGLARI+ P ++
Sbjct: 132 -------GLKYIH------SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178
Query: 799 SSFSVKGSLGYI------APEYGVGCEVSTNG-DVYSYGILLLELVIGKKPIDIMFEGDI 851
S + +P + T D+++ G + E++ GK +F G
Sbjct: 179 GHLS-----EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK----TLFAGAH 229
Query: 852 NLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQK 889
L +++ + +ED +
Sbjct: 230 ELEQMQL------ILESIPV---VHEEDRQELLSVIPV 258
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 66/237 (27%), Positives = 99/237 (41%), Gaps = 47/237 (19%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFN---LQHHGASRSFIAECKALKSIRHRNLVKVLTA 691
G GSFG V + + +A+K + L+ E LK +RH +++K+
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL--- 74
Query: 692 CLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGE--DEIDEAPRNLNLLQRLNIAIDIAY 749
Y + + Y GE D I E R + + I
Sbjct: 75 -----YDVITTPTDIVMVIEYAG---------GELFDYIVEKKR-MTEDEGRRFFQQIIC 119
Query: 750 ALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHT-QTSSFSVKGSLG 808
A+ Y H H DLKP N+LLDD + ++ DFGL+ I++ + +TS GS
Sbjct: 120 AIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC----GSPN 172
Query: 809 YIAPE------YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859
Y APE Y G EV DV+S GI+L +++G+ P D D + N +K
Sbjct: 173 YAAPEVINGKLY-AGPEV----DVWSCGIVLYVMLVGRLPFD-----DEFIPNLFKK 219
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 4e-14
Identities = 56/222 (25%), Positives = 93/222 (41%), Gaps = 31/222 (13%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTA 691
+G GS+G V+K + +A+K F + + E + LK ++H NLV +L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 692 CLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYAL 751
R V+E+ + T E+D R + +I A+
Sbjct: 71 F-----RRKRRLHLVFEYCDH----------TVLHELDRYQRGVPEHLVKSITWQTLQAV 115
Query: 752 NYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARIL-SPDHTQTSSFSVKGSLGY 809
N+ H H+C H D+KP N+L+ + ++ DFG AR+L P + + Y
Sbjct: 116 NFCHKHNC----IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA---TRWY 168
Query: 810 IAPEYGVGCEV-STNGDVYSYGILLLELVIGKKPIDIMFEGD 850
+PE VG DV++ G + EL+ G P+ + G
Sbjct: 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSG-VPL---WPGK 206
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 4e-14
Identities = 56/232 (24%), Positives = 87/232 (37%), Gaps = 48/232 (20%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFN-LQHHGASRSFIAECKALKSIRHRNLVKVLTAC 692
+G G+FG V+ +K N + AE + LKS+ H N++K+
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 693 LGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLL---QRLNIAID 746
+ ++Y E G L + I A L +
Sbjct: 90 --------EDYHNMYIVMETCEGGEL------L---ERIVSAQARGKALSEGYVAELMKQ 132
Query: 747 IAYALNYLHHDCQPVTAHCDLKPSNVLL---DDYMTARVGDFGLARILSPDHTQTSSFSV 803
+ AL Y H Q V H DLKP N+L + ++ DFGLA + D T++
Sbjct: 133 MMNALAYFHS--QHV-VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA-- 187
Query: 804 KGSLGYIAPE-----YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
G+ Y+APE C D++S G+++ L+ G P F G
Sbjct: 188 -GTALYMAPEVFKRDVTFKC------DIWSAGVVMYFLLTGCLP----FTGT 228
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 4e-14
Identities = 40/205 (19%), Positives = 73/205 (35%), Gaps = 30/205 (14%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLG 694
G G+FG V++ + K N + + E + + H L+ L
Sbjct: 60 GSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN-----LH 114
Query: 695 ADYRGNDFKASVYEFMHYGSLEEWL----HPFTGEDEIDEAPRNLNLLQRLNIAIDIAYA 750
+ + EF+ G L + + + + E + N
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMS---EAEVI----------NYMRQACEG 161
Query: 751 LNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV--GDFGLARILSPDHTQTSSFSVKGSLG 808
L ++H + H D+KP N++ + + V DFGLA L+PD + +
Sbjct: 162 LKHMHE--HSI-VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAE 215
Query: 809 YIAPEYGVGCEVSTNGDVYSYGILL 833
+ APE V D+++ G+L
Sbjct: 216 FAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 6e-14
Identities = 60/234 (25%), Positives = 105/234 (44%), Gaps = 35/234 (14%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTA 691
+G G+FG V+K + +A+K +++ G + + E K L+ ++H N+V ++
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 692 CLGADYRGNDFKASVY---EFMHY---GSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAI 745
C N K S+Y +F + G L L FT EI + + + LN
Sbjct: 85 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFT-LSEI----KRV-MQMLLN--- 135
Query: 746 DIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILS-PDHTQTSSFS-- 802
L Y+H + H D+K +NVL+ ++ DFGLAR S ++Q + ++
Sbjct: 136 ----GLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 188
Query: 803 -VKGSLGYIAPEYGVGCEV-STNGDVYSYGILLLELVIGKKPIDIMFEGDINLH 854
V +L Y PE +G D++ G ++ E+ + PI +G+ H
Sbjct: 189 VV--TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI---MQGNTEQH 236
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 6e-14
Identities = 61/233 (26%), Positives = 102/233 (43%), Gaps = 39/233 (16%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSF-------IAECKALKSIRHR 683
+GVG++G+VYK +A+K + + G +A + L++ H
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 684 NLVKVLTACLGADYRGNDFKASVY---EFMHY---GSLEEWLHPFTGEDEIDEAPRNLNL 737
N+V+++ C D + V E + L++ P + I ++L +
Sbjct: 75 NVVRLMDVCAT---SRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETI----KDL-M 126
Query: 738 LQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQ 797
Q L L++LH +C H DLKP N+L+ T ++ DFGLARI S
Sbjct: 127 RQFLR-------GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL 176
Query: 798 TSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
T V +L Y APE + +T D++S G + E+ +KP+ F G+
Sbjct: 177 TPVV-V--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL---FCGN 222
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 7e-14
Identities = 55/223 (24%), Positives = 82/223 (36%), Gaps = 47/223 (21%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACL 693
+G GS+G V + R A K F E + +KS+ H N++++
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF- 75
Query: 694 GADYRGNDFKASVY---EFMHYGSLEEWL---HPFTGEDEIDEAPRNLNLLQRLNIAIDI 747
+ +Y E G L E + F E D A I D+
Sbjct: 76 -------EDNTDIYLVMELCTGGELFERVVHKRVFR---ESDAA----------RIMKDV 115
Query: 748 AYALNYLHHDCQPVTAHCDLKPSNVLL---DDYMTARVGDFGLARILSPDHTQTSSFSVK 804
A+ Y H V AH DLKP N L ++ DFGLA P +
Sbjct: 116 LSAVAYCHK--LNV-AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV--- 169
Query: 805 GSLGYIAPE-----YGVGCEVSTNGDVYSYGILLLELVIGKKP 842
G+ Y++P+ YG C D +S G+++ L+ G P
Sbjct: 170 GTPYYVSPQVLEGLYGPEC------DEWSAGVMMYVLLCGYPP 206
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 7e-14
Identities = 58/293 (19%), Positives = 107/293 (36%), Gaps = 56/293 (19%)
Query: 615 YLSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNL-QHHGASRSFIAE 673
Y S+ + + +G G + V++ I + VK+ + R E
Sbjct: 25 YESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR----E 80
Query: 674 CKALKSIR-HRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAP 732
K L+++R N++ L + A V+E ++ ++ T D
Sbjct: 81 IKILENLRGGPNIIT-LADIVKDPVSRTP--ALVFEHVNNTDFKQLYQTLTDYD------ 131
Query: 733 RNLNLLQRLNIAIDIAY-------ALNYLHHDCQPVTA---HCDLKPSNVLLD-DYMTAR 781
I + AL+Y H + H D+KP NV++D ++ R
Sbjct: 132 --------------IRFYMYEILKALDYCH------SMGIMHRDVKPHNVMIDHEHRKLR 171
Query: 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEV-STNGDVYSYGILLLELVIGK 840
+ D+GLA P + S + PE V ++ + D++S G +L ++ K
Sbjct: 172 LIDWGLAEFYHPGQEYNVRVA---SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 228
Query: 841 KPIDIMFEGDINLHNFGR--KAL-PDDVMDIVDSSLLPDDEDLILTGNQRQKQ 890
+P F G N R K L +D+ D +D + D + ++
Sbjct: 229 EPF---FHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRK 278
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 7e-14
Identities = 62/279 (22%), Positives = 102/279 (36%), Gaps = 59/279 (21%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFN----LQHHGASRSFIA------------------ 672
G GS+G V + T A+KV + ++ G R
Sbjct: 22 GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81
Query: 673 ----ECKALKSIRHRNLVK---VLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGE 725
E LK + H N+VK VL D D V+E ++ G +
Sbjct: 82 QVYQEIAILKKLDHPNVVKLVEVL------DDPNEDHLYMVFELVNQGPV------M--- 126
Query: 726 DEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785
E+ L+ Q D+ + YLH+ Q + H D+KPSN+L+ + ++ DF
Sbjct: 127 -EVPTLKP-LSEDQARFYFQDLIKGIEYLHY--QKI-IHRDIKPSNLLVGEDGHIKIADF 181
Query: 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNG---DVYSYGILLLELVIGKKP 842
G++ S+ G+ ++APE +G DV++ G+ L V G+ P
Sbjct: 182 GVSNEFKGSDALLSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
Query: 843 IDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLI 881
F + + K + + D +DLI
Sbjct: 240 ----FMDE-RIMCLHSKIKSQALEFPDQPDIAEDLKDLI 273
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 7e-14
Identities = 69/248 (27%), Positives = 105/248 (42%), Gaps = 68/248 (27%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFN---LQHHGASRSFIAECKALKSIRHRNLVKVLTA 691
GVG+FG V G + +AVK+ N ++ E + LK RH +++K+
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL--- 81
Query: 692 CLGADYRGNDFKASVYEFMHY-------------GSLEEWLHPFTGEDEIDEAPRNLNLL 738
Y+ + ++ M Y G L+E E+ R L
Sbjct: 82 -----YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDE-----------KESRR---LF 122
Query: 739 QRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHT-Q 797
Q++ +D Y H H DLKP NVLLD +M A++ DFGL+ ++S +
Sbjct: 123 QQILSGVD------YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR 173
Query: 798 TSSFSVKGSLGYIAPE------YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDI 851
TS GS Y APE Y G EV D++S G++L L+ G P F+ D
Sbjct: 174 TSC----GSPNYAAPEVISGRLY-AGPEV----DIWSSGVILYALLCGTLP----FDDD- 219
Query: 852 NLHNFGRK 859
++ +K
Sbjct: 220 HVPTLFKK 227
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 8e-14
Identities = 65/279 (23%), Positives = 110/279 (39%), Gaps = 49/279 (17%)
Query: 621 LYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVK-VFNLQHHG-ASRSFIAECKALK 678
+++ +++ + +G G++G V + + +A+K + +H R+ E K L
Sbjct: 22 VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILL 80
Query: 679 SIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLL 738
RH N++ + K VY +E L+ + L
Sbjct: 81 RFRHENIIGINDIIRAPTIE--QMK-DVYIVQDL--METDLYKLLKTQHLSNDHICYFLY 135
Query: 739 QRLNIAIDIAYALNYLHHDCQPVTA---HCDLKPSNVLLDDYMTARVGDFGLARILSPDH 795
Q L L Y+H +A H DLKPSN+LL+ ++ DFGLAR+ PDH
Sbjct: 136 QILR-------GLKYIH------SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182
Query: 796 TQTSSFSVKGSLGYI------APEYGVGCEVSTNG-DVYSYGILLLELVIGKKPIDIMFE 848
T + Y+ APE + + T D++S G +L E++ + +F
Sbjct: 183 DHTGFLT-----EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR----PIFP 233
Query: 849 GDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQR 887
G L ++ I+ S P EDL N +
Sbjct: 234 GKHYLDQLNH------ILGILGS---PSQEDLNCIINLK 263
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 9e-14
Identities = 64/224 (28%), Positives = 96/224 (42%), Gaps = 36/224 (16%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTA 691
+G G++G VYK + G T A+K L+ G + I E LK ++H N+VK+
Sbjct: 10 IGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 692 CLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIA 748
K + E + L++ L E ++ LLQ LN
Sbjct: 69 IHT--------KKRLVLVFEHLDQ-DLKKLLD--VCEGGLESVTAKSFLLQLLN------ 111
Query: 749 YALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILS-PDHTQTSSFSVKGSL 807
+ Y H H DLKP N+L++ ++ DFGLAR P T V +L
Sbjct: 112 -GIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI-V--TL 164
Query: 808 GYIAPEYGVGCEV-STNGDVYSYGILLLELVIGKKPIDIMFEGD 850
Y AP+ +G + ST D++S G + E+V G P+ F G
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG-TPL---FPGV 204
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-13
Identities = 59/229 (25%), Positives = 86/229 (37%), Gaps = 47/229 (20%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGAS--RSFIAECKALKSIRHRNLVKVLTAC 692
G GSFG V K + AVKV N + + E + LK + H N++K+
Sbjct: 31 GKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI- 89
Query: 693 LGADYRGNDFKASVYEFMHYGSLEEWL---HPFTGEDEIDEAPRNLNLLQRLNIAIDIAY 749
+ V E G L + + F+ E D A I +
Sbjct: 90 ----LEDSSSFYIVGELYTGGELFDEIIKRKRFS---EHDAA----------RIIKQVFS 132
Query: 750 ALNYLHHDCQPVTAHCDLKPSNVLL---DDYMTARVGDFGLARILSPDHTQTSSFSVKGS 806
+ Y+H + H DLKP N+LL + ++ DFGL+ + G+
Sbjct: 133 GITYMHK--HNI-VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GT 186
Query: 807 LGYIAPE-----YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
YIAPE Y C DV+S G++L L+ G P F G
Sbjct: 187 AYYIAPEVLRGTYDEKC------DVWSAGVILYILLSGTPP----FYGK 225
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 50/225 (22%), Positives = 84/225 (37%), Gaps = 38/225 (16%)
Query: 619 QDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALK 678
Y S ++G G FG V+K +A K+ + E +
Sbjct: 86 NSFYT----VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMN 141
Query: 679 SIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWL----HPFTGEDEIDEAPRN 734
+ H NL+++ A + + V E++ G L + + + T E+D
Sbjct: 142 QLDHANLIQLYDA-----FESKNDIVLVMEYVDGGELFDRIIDESYNLT---ELDTI--- 190
Query: 735 LNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV--GDFGLARILS 792
I + ++H + H DLKP N+L + ++ DFGLAR
Sbjct: 191 -------LFMKQICEGIRHMHQ--MYI-LHLDLKPENILCVNRDAKQIKIIDFGLARRYK 240
Query: 793 PDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYG----ILL 833
P +F G+ ++APE VS D++S G +LL
Sbjct: 241 PREKLKVNF---GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-13
Identities = 62/237 (26%), Positives = 89/237 (37%), Gaps = 52/237 (21%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKV-------------FNLQHHGASRSFIAECKALKSIR 681
G G++G V G + A+KV N E LKS+
Sbjct: 45 GSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD 104
Query: 682 HRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRL 741
H N++K+ + + V EF G L E + DE D A
Sbjct: 105 HPNIIKLFDV-----FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA---------- 149
Query: 742 NIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL---DDYMTARVGDFGLARILSPDHTQT 798
NI I + YLH + H D+KP N+LL + + ++ DFGL+ S D+
Sbjct: 150 NIMKQILSGICYLHK--HNI-VHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR 206
Query: 799 SSFSVKGSLGYIAPE-----YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
G+ YIAPE Y C DV+S G+++ L+ G P F G
Sbjct: 207 DRL---GTAYYIAPEVLKKKYNEKC------DVWSCGVIMYILLCGYPP----FGGQ 250
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 41/212 (19%), Positives = 77/212 (36%), Gaps = 17/212 (8%)
Query: 319 NLQRLDMWNNQLSGTIPP-AIGELQNLKILGLNRNKLSGNIPPSI-GNLKMLLNLFLNDN 376
+ Q L + L TIP A L N+ + ++ + + NL + ++ + +
Sbjct: 32 STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90
Query: 377 FLEVSIPSS-LGQCESLIEINLSNNNLSGTIPPQ-FFSLSSLSISLDWSRNKLTGSLPIE 434
I L + L + + N L P + + L+ + N S+P+
Sbjct: 91 RNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149
Query: 435 V--GKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSL--GSLRGLR 490
G L +Y N + N +L+ + + N + I G G
Sbjct: 150 AFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPS 208
Query: 491 VLDLSQNNLSGEIP-KFLAGL----SLNNLNL 517
+LD+SQ +++ +P K L L + N L
Sbjct: 209 LLDVSQTSVT-ALPSKGLEHLKELIARNTWTL 239
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 7e-13
Identities = 37/245 (15%), Positives = 78/245 (31%), Gaps = 62/245 (25%)
Query: 289 ISNLSKTIKTLFLNNNKIYGSIPAGI-GNFVNLQRLDM-WNNQLSGTIPP-AIGELQNLK 345
I +L + +TL L + +IP+ N N+ R+ + + L + + L +
Sbjct: 26 IPSLPPSTQTLKLIETHL-RTIPSHAFSNLPNISRIYVSIDVTLQ-QLESHSFYNLSKVT 83
Query: 346 ILGLNRNKLSGNIPPSI-GNLKMLLNLFLNDNFLEVSIP--SSLGQCESLIEINLSNNNL 402
+ + + I P L +L L + + L+ P + + + + +++N
Sbjct: 84 HIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPY 142
Query: 403 SGTIPPQFFS-LSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGN 461
+IP F L + +++L N T +
Sbjct: 143 MTSIPVNAFQGLCNETLTLKLYNNGFT-------------------------SVQG---- 173
Query: 462 CIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKF-LAGL--SLNNLNLS 518
F G L + L++N I K G+ + L++S
Sbjct: 174 -----------YAFNGTK---------LDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVS 213
Query: 519 YNDLE 523
+
Sbjct: 214 QTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 7e-11
Identities = 33/163 (20%), Positives = 60/163 (36%), Gaps = 15/163 (9%)
Query: 87 NLSFLKQLYLQVNSFTHEIPSEI-GGLRRLKVLALNNNSICGEIP--TNISRCSTLIPIH 143
NLS + + ++ I + L LK L + N + P T + +
Sbjct: 78 NLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGL-KMFPDLTKVYSTDIFFILE 136
Query: 144 PQNNQLVGKILSR-FSSLSK-TEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTI 201
+N + I F L T L L +N T S+ N + + + L N I
Sbjct: 137 ITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVI 195
Query: 202 P-NSF-GWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQ 242
++F G + L ++ +++ + +K LE L+ L
Sbjct: 196 DKDAFGGVYSGPSLLDVSQTSVTALPSKG------LEHLKELI 232
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 38/210 (18%), Positives = 65/210 (30%), Gaps = 40/210 (19%)
Query: 319 NLQRLDMWNNQLSG--TIPPAIGELQNLKILGLNRNKLSGNIPP-SIGNLKMLLNLFLND 375
+ + + ++PP + + L L L IP + NL + ++++
Sbjct: 12 QEEDFRVTCKDIQRIPSLPP------STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSI 64
Query: 376 NFLEVSIPS-SLGQCESLIEINLSNNNLSGTIPPQFFS-LSSLSISLDWSRNKLTGSLP- 432
+ + S S + I + N I P L L L L P
Sbjct: 65 DVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLK-FLGIFNTGLK-MFPD 122
Query: 433 -IEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRV 491
+V I L + +N IP N FQG L +
Sbjct: 123 LTKVYSTDIFFILEITDNPYMTSIPV---------------NAFQG-----LCNE--TLT 160
Query: 492 LDLSQNNLSGEIPKF-LAGLSLNNLNLSYN 520
L L N + + + G L+ + L+ N
Sbjct: 161 LKLYNNGFT-SVQGYAFNGTKLDAVYLNKN 189
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 42/269 (15%), Positives = 75/269 (27%), Gaps = 66/269 (24%)
Query: 154 LSRFSSLSK-TEILNLGSNHLTGSIPS-SLGNLSSIHTISLAYNNLDGTIP-NSFGWFEN 210
+ R SL T+ L L HL +IPS + NL +I I ++ + + +SF
Sbjct: 23 IQRIPSLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSK 81
Query: 211 LVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATR 270
+ + + L + L
Sbjct: 82 VTHIEIRNTR----------------NLTYIDPDA-------------------LKELPL 106
Query: 271 LTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQL 330
L ++ I + + L + +N SIP F L
Sbjct: 107 LKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNA--FQGLCNE------- 157
Query: 331 SGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSL--GQ 388
L L N + ++ N L ++LN N I G
Sbjct: 158 -------------TLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGV 203
Query: 389 CESLIEINLSNNNLSGTIPPQFF-SLSSL 416
+++S +++ +P + L L
Sbjct: 204 YSGPSLLDVSQTSVT-ALPSKGLEHLKEL 231
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 9e-09
Identities = 37/268 (13%), Positives = 79/268 (29%), Gaps = 70/268 (26%)
Query: 67 VTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEI-GGLRRLKVLALNNNSI 125
L L L SH NL + ++Y+ ++ ++ S L ++ + + N
Sbjct: 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92
Query: 126 CGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIP--SSLGN 183
I + L + L + + L P + + +
Sbjct: 93 LTYIDPDA-----------------------LKELPLLKFLGIFNTGLK-MFPDLTKVYS 128
Query: 184 LSSIHTISLAYNNLDGTIP-NSFGWFEN-LVFLSLAANNLSVVENKLTGEVPSLEKLQRL 241
+ + N +IP N+F N + L L N + V+
Sbjct: 129 TDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGY-------------- 174
Query: 242 QHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNF-GGLLPGCISNLSKTIKTLF 300
+F N T+L +++N N + + + L
Sbjct: 175 ------------------AF-----NGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLD 211
Query: 301 LNNNKIYGSIPAGIGNFVNLQRLDMWNN 328
++ + ++P+ +L+ L N
Sbjct: 212 VSQTSV-TALPSKG--LEHLKELIARNT 236
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 29/223 (13%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTAC 692
+G G++ +VYKG+ +A+K L G + I E +K ++H N+V++
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 693 LGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAY 749
+ + EFM L++++ + PR L L +
Sbjct: 73 HT--------ENKLTLVFEFMDN-DLKKYMD----SRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 750 ALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILS-PDHTQTSSFSVKGSLG 808
L + H + H DLKP N+L++ ++GDFGLAR P +T +S V +L
Sbjct: 120 GLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEV-V--TLW 173
Query: 809 YIAPEYGVGCEV-STNGDVYSYGILLLELVIGKKPIDIMFEGD 850
Y AP+ +G ST+ D++S G +L E++ G KP+ F G
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITG-KPL---FPGT 212
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 4e-13
Identities = 60/331 (18%), Positives = 109/331 (32%), Gaps = 66/331 (19%)
Query: 602 EKENPSSSIYSLLYLSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVK---- 657
+ SS LY + + +L+G GS+G VY +A+K
Sbjct: 2 HHHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR 61
Query: 658 VFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA--SVYEFMHYGSL 715
+F R E L ++ ++++ + D F V E
Sbjct: 62 MFEDLID-CKRIL-REITILNRLKSDYIIRLYDLIIPDDLL--KFDELYIVLEIA----- 112
Query: 716 EEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTA---HCDLKPSNV 772
+ L ++ + P L I ++ N++H + H DLKP+N
Sbjct: 113 DSDLK------KLFKTPIFLTEEHIKTILYNLLLGENFIH------ESGIIHRDLKPANC 160
Query: 773 LLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLG--------------------YIAP 812
LL+ + +V DFGLAR ++ + ++ + Y AP
Sbjct: 161 LLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAP 220
Query: 813 EYGVGCEVSTNG-DVYSYGILLLELVIGKKPID-------IMFEGDINLH-NFGRKALPD 863
E + E T D++S G + EL+ + +F G + R +
Sbjct: 221 ELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKV 280
Query: 864 DVMDIVD-----SSLL--PDDEDLILTGNQR 887
D +++ P ++DL
Sbjct: 281 HEKSNRDQLNIIFNIIGTPTEDDLKNINKPE 311
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 41/229 (17%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTA 691
+G G++G VYK I T+A+K L+H G + I E LK ++HRN++++ +
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 692 CLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIA 748
++ E+ L++++ + L Q +N
Sbjct: 102 IHH--------NHRLHLIFEYAEN-DLKKYMDKNPD---VSMRVIKSFLYQLIN------ 143
Query: 749 YALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG-----DFGLARILS-PDHTQTSSFS 802
+N+ H + H DLKP N+LL + DFGLAR P T
Sbjct: 144 -GVNFCHS--RRCL-HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEI- 198
Query: 803 VKGSLGYIAPEYGVGCEV-STNGDVYSYGILLLELVIGKKPIDIMFEGD 850
+ +L Y PE +G ST+ D++S + E+++ P+ F GD
Sbjct: 199 I--TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK-TPL---FPGD 241
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 6e-13
Identities = 53/293 (18%), Positives = 99/293 (33%), Gaps = 64/293 (21%)
Query: 618 YQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVK--VFNLQHHGASRSF----- 670
+L+ S ++ + GS+G+V G+ D +A+K +
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFL 72
Query: 671 ----IAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPF--TG 724
+ E + L H N++ + + + +Y + L
Sbjct: 73 CKRVLREIRLLNHFHHPNILGLRDIFVHFEEP--AMH-KLYLVTEL--MRTDLAQVIHDQ 127
Query: 725 EDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTA---HCDLKPSNVLLDDYMTAR 781
I + L L+ LH A H DL P N+LL D
Sbjct: 128 RIVISPQHIQYFMYHILL-------GLHVLH------EAGVVHRDLHPGNILLADNNDIT 174
Query: 782 VGDFGLARILSPDHTQTSSFSVKGSLGYI------APEYGVGCEVSTNG-DVYSYGILLL 834
+ DF LAR + D +T Y+ APE + + T D++S G ++
Sbjct: 175 ICDFNLAREDTADANKT---------HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMA 225
Query: 835 ELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQR 887
E+ K +F G + + ++++V + P ED+++ +
Sbjct: 226 EMFNRK----ALFRGSTFYNQLNK------IVEVVGT---PKIEDVVMFSSPS 265
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 7e-13
Identities = 50/219 (22%), Positives = 87/219 (39%), Gaps = 26/219 (11%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACL 693
+G G+FG V++ A K H + E + + +RH LV + A
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-- 222
Query: 694 GADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNY 753
+ ++ +YEFM G L F +++ + ++ + + + L +
Sbjct: 223 ---FEDDNEMVMIYEFMSGGEL------F---EKVADEHNKMSEDEAVEYMRQVCKGLCH 270
Query: 754 LHHDCQPVTAHCDLKPSNVLLDDYMTARV--GDFGLARILSPDHTQTSSFSVKGSLGYIA 811
+H H DLKP N++ + + DFGL L P + + G+ + A
Sbjct: 271 MHE--NNY-VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAA 324
Query: 812 PEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
PE G V D++S G+L L+ G P F G+
Sbjct: 325 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSP----FGGE 359
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 51/229 (22%), Positives = 80/229 (34%), Gaps = 65/229 (28%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFN---------LQHHGASRSFIAECKALKSI-RHRN 684
G G V + I AVK+ + + + + E L+ + H N
Sbjct: 26 GRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPN 85
Query: 685 LVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEI--------DEAPRNLN 736
+++ L Y N F V++ M G L F D + E +
Sbjct: 86 IIQ-----LKDTYETNTFFFLVFDLMKKGEL------F---DYLTEKVTLSEKETRK--- 128
Query: 737 LLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHT 796
I + + LH + H DLKP N+LLDD M ++ DFG + L P
Sbjct: 129 ------IMRALLEVICALHK--LNI-VHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK 179
Query: 797 QTSSFSVKGSLGYIAPE------------YGVGCEVSTNGDVYSYGILL 833
G+ Y+APE YG D++S G+++
Sbjct: 180 LREVC---GTPSYLAPEIIECSMNDNHPGYGKEV------DMWSTGVIM 219
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 33/103 (32%), Positives = 55/103 (53%), Gaps = 17/103 (16%)
Query: 747 IAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGS 806
+ AL+YL + Q + H D+KP N+LLD++ + DF +A +L + TQ ++ + G+
Sbjct: 124 LVMALDYLQN--QRI-IHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITTMA--GT 177
Query: 807 LGYIAPE-------YGVGCEVSTNGDVYSYGILLLELVIGKKP 842
Y+APE G V D +S G+ EL+ G++P
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRP 216
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-12
Identities = 56/236 (23%), Positives = 92/236 (38%), Gaps = 39/236 (16%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVK---VFNLQHHGASRSFIAECKALKSIRHRNLVKVLT 690
+G G++G V +A+K F+ A R+ E K LK +H N++ +
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLF-ALRTL-REIKILKHFKHENIITIFN 76
Query: 691 ACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYA 750
+ +F VY ++ LH + + + Q L A
Sbjct: 77 IQRPDSFE--NFN-EVYIIQEL--MQTDLHRVISTQMLSDDHIQYFIYQTLR-------A 124
Query: 751 LNYLHHDCQPVTA---HCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSL 807
+ LH + H DLKPSN+L++ +V DFGLARI+ S + + S
Sbjct: 125 VKVLH------GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 808 --GYI------APEYGVGCEVSTNG-DVYSYGILLLELVIGKKPIDIMFEGDINLH 854
++ APE + + DV+S G +L EL + + +F G H
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR----PIFPGRDYRH 230
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 47/238 (19%), Positives = 96/238 (40%), Gaps = 45/238 (18%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVF-NLQHHGASRSFIAECKALKSIR---------- 681
+G G F +V+ T +A+K+ + + + E K L+ +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT--EAAEDEIKLLQRVNDADNTKEDSM 83
Query: 682 -HRNLVKVLTACLGADYRGNDFK--ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLL 738
+++K+L +++G + V+E + +L + + + L +
Sbjct: 84 GANHILKLLDH---FNHKGPNGVHVVMVFEVLGE-NLLALIKKY------EHRGIPLIYV 133
Query: 739 QRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD------YMTARVGDFGLARILS 792
++ I+ + L+Y+H C + H D+KP NVL++ + ++ D G A
Sbjct: 134 KQ--ISKQLLLGLDYMHRRCGII--HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 189
Query: 793 PDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
+T + + Y +PE +G D++S L+ EL+ G D +FE D
Sbjct: 190 EHYTNSIQ-----TREYRSPEVLLGAPWGCGADIWSTACLIFELITG----DFLFEPD 238
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 50/219 (22%), Positives = 75/219 (34%), Gaps = 55/219 (25%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLG 694
G G+F V+ A+K S E LK I+H N+V +
Sbjct: 18 GSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY-- 75
Query: 695 ADYRGNDFKASVYEFMHY---GSLEEWL---HPFTGEDEIDEAPRNLNLLQRLNIAIDIA 748
+ Y M G L + + +T E D + + +
Sbjct: 76 ------ESTTHYYLVMQLVSGGELFDRILERGVYT---EKDAS----------LVIQQVL 116
Query: 749 YALNYLH-HDCQPVTAHCDLKPSNVLL---DDYMTARVGDFGLARILSPDHTQTSSFSVK 804
A+ YLH + H DLKP N+L ++ + DFGL+++ T
Sbjct: 117 SAVKYLHENG----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST----AC 168
Query: 805 GSLGYIAPE------YGVGCEVSTNGDVYSYG----ILL 833
G+ GY+APE Y D +S G ILL
Sbjct: 169 GTPGYVAPEVLAQKPYSKAV------DCWSIGVITYILL 201
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 60/232 (25%), Positives = 88/232 (37%), Gaps = 53/232 (22%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGAS--RSFIAECKALKSIRHRNLVKVLTAC 692
G GSFG V K + AVKV N + + E + LK + H N++K+
Sbjct: 31 GKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL 90
Query: 693 LGADYRGNDFKASVY---EFMHYGSLEEWL---HPFTGEDEIDEAPRNLNLLQRLNIAID 746
+ +S Y E G L + + F+ E D A I
Sbjct: 91 --------EDSSSFYIVGELYTGGELFDEIIKRKRFS---EHDAA----------RIIKQ 129
Query: 747 IAYALNYLHHDCQPVTAHCDLKPSNVLL---DDYMTARVGDFGLARILSPDHTQTSSFSV 803
+ + Y+H + H DLKP N+LL + ++ DFGL+ +
Sbjct: 130 VFSGITYMHK--HNI-VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK---DR 183
Query: 804 KGSLGYIAPE-----YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
G+ YIAPE Y C DV+S G++L L+ G P F G
Sbjct: 184 IGTAYYIAPEVLRGTYDEKC------DVWSAGVILYILLSGTPP----FYGK 225
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 53/238 (22%), Positives = 91/238 (38%), Gaps = 51/238 (21%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVF--NLQHHGASRSFIAECKALKSIRHR------N 684
++G GSFG V K + +A+K+ + H + E + L+ +R + N
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE---EIRILEHLRKQDKDNTMN 160
Query: 685 LVKVLTACLGADYRGNDF------KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLL 738
++ +L +R + ++YE + F +L L+
Sbjct: 161 VIHMLEN---FTFRNHICMTFELLSMNLYELIKKNKF----QGF-----------SLPLV 202
Query: 739 QRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA--RVGDFGLARILSPDHT 796
++ A I L+ LH + + HCDLKP N+LL + +V DFG +
Sbjct: 203 RK--FAHSILQCLDALH-KNRII--HCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY 257
Query: 797 QTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLH 854
S Y APE +G D++S G +L EL+ G + G+
Sbjct: 258 TYIQ-----SRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY----PLLPGEDEGD 306
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 46/203 (22%), Positives = 85/203 (41%), Gaps = 25/203 (12%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIA-ECKALKSIRHRNLVKVLTAC 692
+G G FG V++ + + T K + G + + E L RHRN++ + +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKV--KGTDQVLVKKEISILNIARHRNILHLHES- 69
Query: 693 LGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALN 752
+ + ++EF+ + F + I+ + LN + ++ + AL
Sbjct: 70 ----FESMEELVMIFEFISGLDI------F---ERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 753 YLHHDCQPVTAHCDLKPSNVLLDDYMTARV--GDFGLARILSPDHTQTSSFSVKGSLGYI 810
+LH + H D++P N++ ++ + +FG AR L P F + Y
Sbjct: 117 FLHS--HNI-GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPEYY 170
Query: 811 APEYGVGCEVSTNGDVYSYGILL 833
APE VST D++S G L+
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLV 193
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 5e-12
Identities = 32/136 (23%), Positives = 58/136 (42%), Gaps = 15/136 (11%)
Query: 290 SNLSKTIKTLFLNNNKIYGSIPAGI-GNFVNLQRLDMWNNQLSGTIPP-AIGELQNLKIL 347
++ + L LNNN+ GI L++++ NN+++ I A + +
Sbjct: 28 EHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEI 86
Query: 348 GLNRNKLSGNIPPSI-GNLKMLLNLFLNDNFLEVSIPS----SLGQCESLIEINLSNNNL 402
L N+L N+ + L+ L L L N + + + L L +L +N +
Sbjct: 87 LLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLL---SLYDNQI 141
Query: 403 SGTIPPQFF-SLSSLS 417
+ T+ P F +L SLS
Sbjct: 142 T-TVAPGAFDTLHSLS 156
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 6e-11
Identities = 33/145 (22%), Positives = 59/145 (40%), Gaps = 23/145 (15%)
Query: 266 TNATRLTWMHINSNNFGGLLP-GCISNLSKTIKTLFLNNNKIYGSIPAGIGNF---VNLQ 321
L +N+N F L G L + ++ + +NNKI I G F +
Sbjct: 32 QYTAEL---RLNNNEFTVLEATGIFKKLPQ-LRKINFSNNKI-TDIEEGA--FEGASGVN 84
Query: 322 RLDMWNNQLSGTIPPAI-GELQNLKILGLNRNKLSGNIPPSI-GNLKMLLNLFLNDNFLE 379
+ + +N+L + + L++LK L L N+++ + L + L L DN +
Sbjct: 85 EILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT 142
Query: 380 VSIP----SSLGQCESLIEINLSNN 400
++ +L SL +NL N
Sbjct: 143 -TVAPGAFDTLH---SLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 33/171 (19%), Positives = 58/171 (33%), Gaps = 32/171 (18%)
Query: 309 SIPAGIGNFVNLQRLDMWNNQLSGTIPPAI-GELQNLKILGLNRNKLSGNIPPSI-GNLK 366
IP I L + NN+ + I +L L+ + + NK++ +I
Sbjct: 25 KIPEHI--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGAS 81
Query: 367 MLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNK 426
+ + L N LE ++ + F L SL L N+
Sbjct: 82 GVNEILLTSNRLE-NVQHKM-----------------------FKGLESLKT-LMLRSNR 116
Query: 427 LTGSLPIEV-GKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQ 476
+T + + L + L +Y+N++ P F L L + N F
Sbjct: 117 IT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 27/147 (18%), Positives = 53/147 (36%), Gaps = 22/147 (14%)
Query: 163 TEILNLGSNHLTGSIPSS--LGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANN 220
T L L +N T + ++ L + I+ + N + +F + + L +N
Sbjct: 34 TAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNR 92
Query: 221 LSVVENKLTGEVPSLEKLQRLQHFTITSNSLGS---GGNDDLSFLCSLTNATRLTWMHIN 277
L V++K+ + L+ L+ + SN + L + + + +
Sbjct: 93 LENVQHKM------FKGLESLKTLMLRSNRITCVGNDSFIGL---------SSVRLLSLY 137
Query: 278 SNNFGGLLPGCISNLSKTIKTLFLNNN 304
N + PG L + TL L N
Sbjct: 138 DNQITTVAPGAFDTLHS-LSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 7e-07
Identities = 32/132 (24%), Positives = 53/132 (40%), Gaps = 9/132 (6%)
Query: 394 EINLSNNNLSGTIPPQ--FFSLSSLSISLDWSRNKLTGSLPIEV-GKLKILEFLYVYENR 450
E+ L+NN + + F L L +++S NK+T + + + + NR
Sbjct: 36 ELRLNNNEFT-VLEATGIFKKLPQLR-KINFSNNKIT-DIEEGAFEGASGVNEILLTSNR 92
Query: 451 LEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPK--FLA 508
LE F L+ L + N + S L +R+L L N ++ + F
Sbjct: 93 LENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDT 151
Query: 509 GLSLNNLNLSYN 520
SL+ LNL N
Sbjct: 152 LHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 36/127 (28%), Positives = 55/127 (43%), Gaps = 8/127 (6%)
Query: 92 KQLYLQVNSFTHEIPSEI-GGLRRLKVLALNNNSICGEIPTNI-SRCSTLIPIHPQNNQL 149
+L L N FT + I L +L+ + +NN I +I S + I +N+L
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI-TDIEEGAFEGASGVNEILLTSNRL 93
Query: 150 VGKILSRFSSLSKTEILNLGSNHLTGSIPS-SLGNLSSIHTISLAYNNLDGTIPNSFGWF 208
F L + L L SN +T + + S LSS+ +SL N + T+ G F
Sbjct: 94 ENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQI-TTVAP--GAF 149
Query: 209 ENLVFLS 215
+ L LS
Sbjct: 150 DTLHSLS 156
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 28/159 (17%), Positives = 62/159 (38%), Gaps = 16/159 (10%)
Query: 53 CKWYGVTCS-RRHQRV--------TLLDLRSLKLAG-SVSHFIGNLSFLKQLYLQVNSFT 102
C+ V CS ++ ++ L L + + + L L+++ N T
Sbjct: 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT 70
Query: 103 HEIPSEI-GGLRRLKVLALNNNSICGEIPTNI-SRCSTLIPIHPQNNQLVGKILSRFSSL 160
+I G + + L +N + + + +L + ++N++ F L
Sbjct: 71 -DIEEGAFEGASGVNEILLTSNRL-ENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGL 128
Query: 161 SKTEILNLGSNHLTGSIP-SSLGNLSSIHTISLAYNNLD 198
S +L+L N +T ++ + L S+ T++L N +
Sbjct: 129 SSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPFN 166
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 5e-12
Identities = 49/216 (22%), Positives = 78/216 (36%), Gaps = 42/216 (19%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKV-----FNLQHHGASRSFIAECKALKSIRHRNLVKVL 689
G G F V + I E AVK+ F ++ E ++H ++V++L
Sbjct: 33 GKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELL 92
Query: 690 TACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLL---QRLNIAID 746
Y + V+EFM L EI + + +
Sbjct: 93 ET-----YSSDGMLYMVFEFMDGADL------C---FEIVKRADAGFVYSEAVASHYMRQ 138
Query: 747 IAYALNYLHHDCQPVTAHCDLKPSNVLL---DDYMTARVGDFGLARILSPDHTQTSSFSV 803
I AL Y H + H D+KP VLL ++ ++G FG+A L +
Sbjct: 139 ILEALRYCHD--NNI-IHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--GLVAGGR 193
Query: 804 KGSLGYIAPE------YGVGCEVSTNGDVYSYGILL 833
G+ ++APE YG DV+ G++L
Sbjct: 194 VGTPHFMAPEVVKREPYGKPV------DVWGCGVIL 223
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 5e-12
Identities = 46/222 (20%), Positives = 80/222 (36%), Gaps = 58/222 (26%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGAS--RSFIAECKALKSIRHRNLVKVLTAC 692
G G+F V + + A K+ N + A + E + + ++H N+V+
Sbjct: 15 GKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR----- 69
Query: 693 LGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEI--------DEAPRNLNLLQRLNIA 744
L + F V++ + G L F ++I +A
Sbjct: 70 LHDSIQEESFHYLVFDLVTGGEL------F---EDIVAREFYSEADASH---------CI 111
Query: 745 IDIAYALNYLHHDCQPVTAHCDLKPSNVLL---DDYMTARVGDFGLARILSPDHTQTSSF 801
I ++ Y H + H +LKP N+LL ++ DFGLA ++
Sbjct: 112 QQILESIAYCHS--NGI-VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA 168
Query: 802 SVKGSLGYIAPE------YGVGCEVSTNGDVYSYG----ILL 833
G+ GY++PE Y D+++ G ILL
Sbjct: 169 ---GTPGYLSPEVLKKDPYSKPV------DIWACGVILYILL 201
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 9e-12
Identities = 51/213 (23%), Positives = 82/213 (38%), Gaps = 47/213 (22%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKAL-KSIRHRNLVKVLTACL 693
GVGS+ + I AVK+ + + E + L + +H N++ L
Sbjct: 31 GVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHPNIIT-----L 81
Query: 694 GADYRGNDFKASVYEFMHYGSLEEWLH---PFTGEDEIDEAPRNLNLLQRLNIAIDIAYA 750
Y + V E M G L + + F+ E + + + I
Sbjct: 82 KDVYDDGKYVYVVTELMKGGELLDKILRQKFFS---EREAS----------AVLFTITKT 128
Query: 751 LNYLHHDCQPVTAHCDLKPSNVLL----DDYMTARVGDFGLARILSPDHTQTSSFSVKGS 806
+ YLH Q V H DLKPSN+L + + R+ DFG A+ L + + +
Sbjct: 129 VEYLH--AQGV-VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE--NGLLMTPCYT 183
Query: 807 LGYIAPE------YGVGCEVSTNGDVYSYGILL 833
++APE Y C D++S G+LL
Sbjct: 184 ANFVAPEVLERQGYDAAC------DIWSLGVLL 210
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 9e-12
Identities = 47/219 (21%), Positives = 80/219 (36%), Gaps = 48/219 (21%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFN--------LQHHGASRSFIAECKALKSIRHRNLV 686
G G+ G V + +A+++ + + + + E + LK + H ++
Sbjct: 144 GSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII 203
Query: 687 KVLTACLGADYRGNDFKASVYEFMHYGSLEEWL--HPFTGEDEIDEAPRNLNLLQRLNIA 744
K+ DY V E M G L + + + E
Sbjct: 204 KIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEATC------------KLYF 245
Query: 745 IDIAYALNYLHHDCQPVTAHCDLKPSNVLL---DDYMTARVGDFGLARILSPDHTQTSSF 801
+ A+ YLH + H DLKP NVLL ++ ++ DFG ++IL +
Sbjct: 246 YQMLLAVQYLHE--NGII-HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 302
Query: 802 SVKGSLGYIAPE-------YGVGCEVSTNGDVYSYGILL 833
G+ Y+APE G V D +S G++L
Sbjct: 303 ---GTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVIL 334
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 48/217 (22%), Positives = 77/217 (35%), Gaps = 53/217 (24%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSI-RHRNLVKVLTACL 693
G+G G V + A+K+ A + E ++V +L
Sbjct: 38 GLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQ----EVDHHWQASGGPHIVCILDVYE 92
Query: 694 GADYRGNDFKASVY---EFMHYGSL-----EEWLHPFTGEDEIDEAPRNLNLLQRLNIAI 745
+ K + E M G L E FT E + A I
Sbjct: 93 NMHHG----KRCLLIIMECMEGGELFSRIQERGDQAFT---EREAA----------EIMR 135
Query: 746 DIAYALNYLHHDCQPVTAHCDLKPSNVLL---DDYMTARVGDFGLARILSPDHTQTSSFS 802
DI A+ +LH + AH D+KP N+L + ++ DFG A+ + + QT
Sbjct: 136 DIGTAIQFLHS--HNI-AHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT---- 188
Query: 803 VKGSLGYIAPE------YGVGCEVSTNGDVYSYGILL 833
+ Y+APE Y C D++S G+++
Sbjct: 189 PCYTPYYVAPEVLGPEKYDKSC------DMWSLGVIM 219
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-11
Identities = 45/217 (20%), Positives = 83/217 (38%), Gaps = 47/217 (21%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTAC 692
G G+F V + + A + N + + E + + ++H N+V++ +
Sbjct: 20 GKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS- 78
Query: 693 LGADYRGNDFKASVYEFMHYGSLEEWL---HPFTGEDEIDEAPRNLNLLQRLNIAIDIAY 749
+++ + G L E + ++ E D + + I
Sbjct: 79 ----ISEEGHHYLIFDLVTGGELFEDIVAREYYS---EADAS----------HCIQQILE 121
Query: 750 ALNYLHHDCQPVTAHCDLKPSNVLL---DDYMTARVGDFGLARILSPDHTQTSSFSVKGS 806
A+ + H V H +LKP N+LL ++ DFGLA + + Q + F G+
Sbjct: 122 AVLHCHQ--MGV-VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAWFGFAGT 176
Query: 807 LGYIAPE------YGVGCEVSTNGDVYSYG----ILL 833
GY++PE YG D+++ G ILL
Sbjct: 177 PGYLSPEVLRKDPYGKPV------DLWACGVILYILL 207
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 1e-11
Identities = 59/230 (25%), Positives = 93/230 (40%), Gaps = 31/230 (13%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTT---IAVKVFN----LQHHGASRSFIAECKALKSI 680
F ++G G FG V+ + + T A K N + G + E K L +
Sbjct: 187 FLDFRVLGRGGFGEVFAC---QMKATGKLYACKKLNKKRLKKRKGYQ-GAMVEKKILAKV 242
Query: 681 RHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQR 740
R +V L + V M+ G + ++ ++ + PR
Sbjct: 243 HSRFIV-----SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPR-----AI 292
Query: 741 LNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSS 800
A I L +LH Q + DLKP NVLLDD R+ D GLA L T+T
Sbjct: 293 FYTA-QIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG 348
Query: 801 FSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
++ G+ G++APE +G E + D ++ G+ L E++ + P F
Sbjct: 349 YA--GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP----FRAR 392
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 48/228 (21%), Positives = 80/228 (35%), Gaps = 66/228 (28%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFN--------LQHHGASRSFIAECKALKSIRHRNLV 686
G G+ G V + +A+K+ + + + + E + LK + H ++
Sbjct: 19 GSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII 78
Query: 687 KVLTACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEI--------DEAPRNL 735
K+ + D Y E M G L F D++
Sbjct: 79 KIKNF-----FDAED----YYIVLELMEGGEL------F---DKVVGNKRLKEATCKL-- 118
Query: 736 NLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL---DDYMTARVGDFGLARILS 792
+ A+ YLH + H DLKP NVLL ++ ++ DFG ++IL
Sbjct: 119 -------YFYQMLLAVQYLHE--NGII-HRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168
Query: 793 PDHTQTSSFSVKGSLGYIAPE-------YGVGCEVSTNGDVYSYGILL 833
+ G+ Y+APE G V D +S G++L
Sbjct: 169 ETSLMRTLC---GTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVIL 209
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 2e-11
Identities = 59/230 (25%), Positives = 91/230 (39%), Gaps = 34/230 (14%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTT---IAVKVFN----LQHHGASRSFIAECKALKSI 680
F ++G G FG V + R T A K + G + E + L+ +
Sbjct: 186 FRQYRVLGKGGFGEVCAC---QVRATGKMYACKKLEKKRIKKRKGE-AMALNEKQILEKV 241
Query: 681 RHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQR 740
R +V L Y D V M+ G L+ ++ G+ E R
Sbjct: 242 NSRFVV-----SLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGQAGFPE-AR-----AV 289
Query: 741 LNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSS 800
A +I L LH + + DLKP N+LLDD+ R+ D GLA + T
Sbjct: 290 FYAA-EICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKG 344
Query: 801 FSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
G++GY+APE + + D ++ G LL E++ G+ P F+
Sbjct: 345 RV--GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP----FQQR 388
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 49/236 (20%), Positives = 82/236 (34%), Gaps = 74/236 (31%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNL--------QHHGASRSFIAECKALKSIR-HRN 684
+G G V + + AVK+ + Q + E L+ + H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 685 LVKVLTACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEI--------DEAPR 733
++ ++ + + + ++ + M G L F D + E
Sbjct: 162 IITLIDSY--------ESSSFMFLVFDLMRKGEL------F---DYLTEKVALSEKETRS 204
Query: 734 NLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSP 793
I + A+++LH + H DLKP N+LLDD M R+ DFG + L P
Sbjct: 205 ---------IMRSLLEAVSFLH--ANNI-VHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252
Query: 794 DHTQTSSFSVKGSLGYIAPE------------YGVGCEVSTNGDVYSYG----ILL 833
G+ GY+APE YG D+++ G LL
Sbjct: 253 GEKLRELC---GTPGYLAPEILKCSMDETHPGYGKEV------DLWACGVILFTLL 299
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 52/235 (22%), Positives = 81/235 (34%), Gaps = 49/235 (20%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFN---LQHHGASRSFIA---ECKALKSIRHR--N 684
L+G G FGSVY GI +A+K + G + E LK +
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 685 LVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGE--DEIDEAPRNLNLLQRLN 742
++++L + S + + D I E L +
Sbjct: 110 VIRLLDWF--------ERPDSFVLILERPEP-------VQDLFDFITERGA-LQEELARS 153
Query: 743 IAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD-DYMTARVGDFGLARILSPDHTQTSSF 801
+ A+ + H+ H D+K N+L+D + ++ DFG +L
Sbjct: 154 FFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD- 209
Query: 802 SVKGSLGYIAPE------YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
G+ Y PE Y G V+S GILL ++V G P FE D
Sbjct: 210 ---GTRVYSPPEWIRYHRYH-GRSA----AVWSLGILLYDMVCGDIP----FEHD 252
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 60/244 (24%), Positives = 86/244 (35%), Gaps = 58/244 (23%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIA-ECKALKSIRHRNLVK----VL 689
G G+FG + +AVK + E +S+RH N+V+ +L
Sbjct: 29 GSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN--VQREIINHRSLRHPNIVRFKEVIL 86
Query: 690 TACLGADYRGNDFKASVYEFMHY---GSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAID 746
T + M Y G L E + E DEA Q+L +
Sbjct: 87 T------------PTHLAIIMEYASGGELYERICNAGRFSE-DEARF---FFQQLLSGVS 130
Query: 747 IAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR--VGDFGLARILSPDHT-QTSSFSV 803
Y H H DLK N LLD R + DFG ++ +++
Sbjct: 131 ------YCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--- 178
Query: 804 KGSLGYIAPE------YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFG 857
G+ YIAPE Y G DV+S G+ L +++G P FE D
Sbjct: 179 -GTPAYIAPEVLLRQEY-DGKIA----DVWSCGVTLYVMLVGAYP----FE-DPEEPRDY 227
Query: 858 RKAL 861
RK +
Sbjct: 228 RKTI 231
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 44/171 (25%), Positives = 76/171 (44%), Gaps = 15/171 (8%)
Query: 309 SIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSI-GNLKM 367
S+P+GI + ++LD+ + L+ L L L L+ N+L + + +L
Sbjct: 28 SVPSGI--PADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTE 84
Query: 368 LLNLFLNDN---FLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFF-SLSSLSISLDWS 423
L L L +N L + + L Q L ++ L N L ++P F L+ L L +
Sbjct: 85 LGTLGLANNQLASLPLGVFDHLTQ---LDKLYLGGNQLK-SLPSGVFDRLTKLKE-LRLN 139
Query: 424 RNKLTGSLPIEV-GKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGN 473
N+L S+P KL L+ L + N+L+ F +L+ + + GN
Sbjct: 140 TNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 49/218 (22%), Positives = 78/218 (35%), Gaps = 69/218 (31%)
Query: 163 TEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLS 222
TE L+L S L ++ +F L +L+L N L
Sbjct: 37 TEKLDLQSTGLA-TLS-----------------------DATFRGLTKLTWLNLDYNQLQ 72
Query: 223 VVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFG 282
+L +G DDL T L + + +N
Sbjct: 73 ---------------------------TLSAGVFDDL---------TELGTLGLANNQLA 96
Query: 283 GLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNF---VNLQRLDMWNNQLSGTIPP-AI 338
L G +L++ L+L N++ S+P+G+ F L+ L + NQL +IP A
Sbjct: 97 SLPLGVFDHLTQL-DKLYLGGNQL-KSLPSGV--FDRLTKLKELRLNTNQLQ-SIPAGAF 151
Query: 339 GELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDN 376
+L NL+ L L+ N+L + L L + L N
Sbjct: 152 DKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 47/168 (27%), Positives = 78/168 (46%), Gaps = 17/168 (10%)
Query: 290 SNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAI-GELQNLKILG 348
S + + L L + + A L L++ NQL T+ + +L L LG
Sbjct: 31 SGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLG 89
Query: 349 LNRNKLSGNIPPSI-GNLKMLLNLFLNDNFLEVSIPS----SLGQCESLIEINLSNNNLS 403
L N+L+ ++P + +L L L+L N L+ S+PS L + L E+ L+ N L
Sbjct: 90 LANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTK---LKELRLNTNQLQ 144
Query: 404 GTIPPQFF-SLSSLSISLDWSRNKLTGSLPIEV-GKLKILEFLYVYEN 449
+IP F L++L L S N+L S+P +L L+ + ++ N
Sbjct: 145 -SIPAGAFDKLTNLQT-LSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 46/166 (27%), Positives = 69/166 (41%), Gaps = 22/166 (13%)
Query: 92 KQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNI-SRCSTLIPIHPQNNQLV 150
++L LQ + GL +L L L+ N + + + + L + NNQL
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQL- 95
Query: 151 GKILSR--FSSLSKTEILNLGSNHLTGSIPS----SLGNLSSIHTISLAYNNLDGTIPNS 204
L F L++ + L LG N L S+PS L L + L N L +IP
Sbjct: 96 -ASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKL---KELRLNTNQL-QSIPAG 149
Query: 205 -FGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSN 249
F NL LSL+ N L V + + ++L +LQ T+ N
Sbjct: 150 AFDKLTNLQTLSLSTNQLQSVPHG------AFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 48/172 (27%), Positives = 73/172 (42%), Gaps = 22/172 (12%)
Query: 58 VTC-SRRHQRV--------TLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSE 108
V C + V LDL+S LA L+ L L L N + +
Sbjct: 19 VDCQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAG 77
Query: 109 I-GGLRRLKVLALNNNSICGEIPTNI-SRCSTLIPIHPQNNQLVGKILSR--FSSLSKTE 164
+ L L L L NN + +P + + L ++ NQL K L F L+K +
Sbjct: 78 VFDDLTELGTLGLANNQL-ASLPLGVFDHLTQLDKLYLGGNQL--KSLPSGVFDRLTKLK 134
Query: 165 ILNLGSNHLTGSIPSSL-GNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLS 215
L L +N L SIP+ L+++ T+SL+ N L ++P+ G F+ L L
Sbjct: 135 ELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ-SVPH--GAFDRLGKLQ 182
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 4e-11
Identities = 52/222 (23%), Positives = 87/222 (39%), Gaps = 50/222 (22%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIR-HRNLVKVLTACL 693
G G+ V I AVK+ Q E + L + HRN+++ L
Sbjct: 22 GEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLE-----L 76
Query: 694 GADYRGNDFKASVYEFMHYGSLEEWLH---PFTGEDEIDEAPRNLNLLQRLNIAIDIAYA 750
+ D V+E M GS+ +H F E++ + + D+A A
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFN---ELEAS----------VVVQDVASA 123
Query: 751 LNYLHHDCQPVTAHCDLKPSNVLL---DDYMTARVGDFGLARILSPDHTQTSSFSVK--- 804
L++LH+ + + AH DLKP N+L + ++ DF L + + + + +
Sbjct: 124 LDFLHN--KGI-AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180
Query: 805 --GSLGYIAPE-----------YGVGCEVSTNGDVYSYGILL 833
GS Y+APE Y C D++S G++L
Sbjct: 181 PCGSAEYMAPEVVEAFSEEASIYDKRC------DLWSLGVIL 216
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 33/146 (22%), Positives = 65/146 (44%), Gaps = 13/146 (8%)
Query: 309 SIPAGIGNFVNLQRLDMWNNQLSGTIPP-AIGELQNLKILGLNRNKLSGNIPPSI-GNLK 366
IP + + + + N + IPP A + L+ + L+ N++S + P L+
Sbjct: 25 EIPTNL--PETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLR 80
Query: 367 MLLNLFLNDNFLEVSIPSSL-GQCESLIEINLSNNNLSGTIPPQFF-SLSSLSISLDWSR 424
L +L L N + +P SL SL + L+ N ++ + F L +L+ L
Sbjct: 81 SLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLN-LLSLYD 137
Query: 425 NKLTGSLPIEV-GKLKILEFLYVYEN 449
NKL ++ L+ ++ +++ +N
Sbjct: 138 NKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 46/232 (19%), Positives = 77/232 (33%), Gaps = 73/232 (31%)
Query: 290 SNLSKTIKTLFLNNNKIYGSIPAGI-GNFVNLQRLDMWNNQLSGTIPPAI-GELQNLKIL 347
+NL +TI + L N I IP G + L+R+D+ NNQ+S + P L++L L
Sbjct: 28 TNLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSL 85
Query: 348 GLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIP 407
L NK++ +P S+ F L L + L+ N ++ +
Sbjct: 86 VLYGNKIT-ELPKSL--------------F------EGLFS---LQLLLLNANKIN-CLR 120
Query: 408 PQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQ 467
F L L L +Y+N+L+ TF ++
Sbjct: 121 VDAFQ------------------------DLHNLNLLSLYDNKLQTIAKGTFSPLRAIQT 156
Query: 468 LGMGGNLF--------------------QGPISSSLGSLRGLRVLDLSQNNL 499
+ + N F G +S L R+ +
Sbjct: 157 MHLAQNPFICDCHLKWLADYLHTNPIETSGARCTSPRRLANKRIGQIKSKKF 208
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 29/145 (20%), Positives = 49/145 (33%), Gaps = 19/145 (13%)
Query: 163 TEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLS 222
+ L N + P + + I L+ N + P++F +L L L N ++
Sbjct: 34 ITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT 93
Query: 223 VVENKLTGEVPSLEKLQRLQHFTITSNSLGS---GGNDDLSFLCSLTNATRLTWMHINSN 279
+ L E L LQ + +N + DL L + + N
Sbjct: 94 ELPKSL------FEGLFSLQLLLLNANKINCLRVDAFQDL---------HNLNLLSLYDN 138
Query: 280 NFGGLLPGCISNLSKTIKTLFLNNN 304
+ G S L I+T+ L N
Sbjct: 139 KLQTIAKGTFSPLRA-IQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 32/130 (24%), Positives = 52/130 (40%), Gaps = 6/130 (4%)
Query: 394 EINLSNNNLSGTIPPQFF-SLSSLSISLDWSRNKLTGSLPIEV-GKLKILEFLYVYENRL 451
EI L N + IPP F L +D S N+++ L + L+ L L +Y N++
Sbjct: 36 EIRLEQNTIK-VIPPGAFSPYKKLR-RIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKI 92
Query: 452 EGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL- 510
S F L+ L + N + L L +L L N L + L
Sbjct: 93 TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR 152
Query: 511 SLNNLNLSYN 520
++ ++L+ N
Sbjct: 153 AIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 35/184 (19%), Positives = 60/184 (32%), Gaps = 42/184 (22%)
Query: 170 SNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLT 229
LT IP++L +I I L N + P +F ++ L + L+ N +S
Sbjct: 20 GKGLT-EIPTNL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS------- 69
Query: 230 GEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCI 289
L L L + + N L
Sbjct: 70 --------------------ELAPDAFQGL---------RSLNSLVLYGNKITELPKSLF 100
Query: 290 SNLSKTIKTLFLNNNKIYGSIPAGI-GNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILG 348
L ++ L LN NKI + + NL L +++N+L L+ ++ +
Sbjct: 101 EGLFS-LQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMH 158
Query: 349 LNRN 352
L +N
Sbjct: 159 LAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 33/152 (21%), Positives = 55/152 (36%), Gaps = 29/152 (19%)
Query: 92 KQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVG 151
++ L+ N+ P ++L+ + L+NN I E+ +
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-SELAPDA------------------ 75
Query: 152 KILSRFSSLSKTEILNLGSNHLTGSIPSSL-GNLSSIHTISLAYNNLDGTIPNSFGWFEN 210
F L L L N +T +P SL L S+ + L N ++ ++F N
Sbjct: 76 -----FQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHN 129
Query: 211 LVFLSLAANNLSVVENKLTGEVPSLEKLQRLQ 242
L LSL N L + G L +Q +
Sbjct: 130 LNLLSLYDNKLQTIAK---GTFSPLRAIQTMH 158
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 29/116 (25%), Positives = 47/116 (40%), Gaps = 8/116 (6%)
Query: 87 NLSFLKQLYLQVNSFTHEIPSEI-GGLRRLKVLALNNNSICGEIPTNI-SRCSTLIPIHP 144
L+++ L N + E+ + GLR L L L N I E+P ++ +L +
Sbjct: 54 PYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKI-TELPKSLFEGLFSLQLLLL 111
Query: 145 QNNQLVGKILSR--FSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLD 198
N++ L F L +L+L N L + L +I T+ LA N
Sbjct: 112 NANKI--NCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 7e-11
Identities = 46/222 (20%), Positives = 81/222 (36%), Gaps = 58/222 (26%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGAS--RSFIAECKALKSIRHRNLVKVLTAC 692
G G+F V + + A K+ N + A + E + + ++H N+V+
Sbjct: 38 GKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR----- 92
Query: 693 LGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEI--------DEAPRNLNLLQRLNIA 744
L + F V++ + G L F ++I +A +
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGEL------F---EDIVAREFYSEADAS---------HCI 134
Query: 745 IDIAYALNYLHHDCQPVTAHCDLKPSNVLL---DDYMTARVGDFGLARILSPDHTQTSSF 801
I ++ Y H + H +LKP N+LL ++ DFGLA ++
Sbjct: 135 QQILESIAYCHS--NGI-VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA 191
Query: 802 SVKGSLGYIAPE------YGVGCEVSTNGDVYSYG----ILL 833
G+ GY++PE Y D+++ G ILL
Sbjct: 192 ---GTPGYLSPEVLKKDPYSKPV------DIWACGVILYILL 224
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 7e-11
Identities = 59/304 (19%), Positives = 96/304 (31%), Gaps = 68/304 (22%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVK-VFNLQHHG--ASRSFIAECKALKSIRHRNLVKVLT 690
+G GS+G V + + +A+K + + R E L + H ++VKVL
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL-REIAILNRLNHDHVVKVLD 119
Query: 691 ACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYA 750
+ D D V E ++ P L L + ++
Sbjct: 120 IVIPKDVEKFDELYVVLEIADSD-----FK------KLFRTPVYLTELHIKTLLYNLLVG 168
Query: 751 LNYLHHDCQPVTA---HCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSL 807
+ Y+H +A H DLKP+N L++ + +V DFGLAR + S +
Sbjct: 169 VKYVH------SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222
Query: 808 G-------------------------YIAPEYGVGCEVSTNG-DVYSYGILLLELV---- 837
Y APE + E T DV+S G + EL+
Sbjct: 223 DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282
Query: 838 ------IGKKPI----DIMFEGDINLHNFGRKALPDDVMD----IVDSSLLPDDEDLILT 883
+ P+ K D I + P +ED+
Sbjct: 283 ENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEAL 342
Query: 884 GNQR 887
+
Sbjct: 343 EKED 346
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 7e-11
Identities = 39/140 (27%), Positives = 66/140 (47%), Gaps = 18/140 (12%)
Query: 747 IAYALNYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKG 805
I AL YLH H DLKP N+LL++ M ++ DFG A++LSP+ Q + S G
Sbjct: 139 IVSALEYLHGKGI----IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 194
Query: 806 SLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP-----IDIMFE----GDINLHNF 856
+ Y++PE + D+++ G ++ +LV G P ++F+ + +
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK 254
Query: 857 GRKALPDDVMDIVDSSLLPD 876
D+V+ L+ D
Sbjct: 255 ----FFPKARDLVEKLLVLD 270
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 7e-11
Identities = 50/222 (22%), Positives = 81/222 (36%), Gaps = 65/222 (29%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLG 694
G GSF K + + AVK+ + + ++ I K + H N+VK+
Sbjct: 20 GEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEG--HPNIVKLHEVF-- 75
Query: 695 ADYRGNDFKASVYEFMHY--GSLEEWLHPFTGEDEIDEAPRNLNLLQRL----------- 741
+ + M G GE L +R+
Sbjct: 76 ------HDQLHTFLVMELLNG----------GE-----------LFERIKKKKHFSETEA 108
Query: 742 -NIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL---DDYMTARVGDFGLARILSPDHTQ 797
I + A++++H V H DLKP N+L +D + ++ DFG AR+ PD
Sbjct: 109 SYIMRKLVSAVSHMHD--VGV-VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--N 163
Query: 798 TSSFSVKGSLGYIAPE------YGVGCEVSTNGDVYSYGILL 833
+ +L Y APE Y C D++S G++L
Sbjct: 164 QPLKTPCFTLHYAAPELLNQNGYDESC------DLWSLGVIL 199
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 9e-11
Identities = 49/216 (22%), Positives = 80/216 (37%), Gaps = 45/216 (20%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIA------ECKALKSIRHRNLVKV 688
G G F V K A K + ASR ++ E L+ + H N++
Sbjct: 21 GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT- 79
Query: 689 LTACLGADYRGNDFKASVYEFMHYGSLEEWL---HPFTGEDEIDEAPRNLNLLQRLNIAI 745
L Y + E + G L ++L + E + +
Sbjct: 80 ----LHDVYENRTDVVLILELVSGGELFDFLAQKESLS---EEEAT----------SFIK 122
Query: 746 DIAYALNYLHHDCQPVTAHCDLKPSNVLL----DDYMTARVGDFGLARILSPDHTQTSSF 801
I +NYLH + + AH DLKP N++L ++ DFGLA + + F
Sbjct: 123 QILDGVNYLHT--KKI-AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 802 SVKGSLGYIAPE----YGVGCEVSTNGDVYSYGILL 833
G+ ++APE +G E D++S G++
Sbjct: 180 ---GTPEFVAPEIVNYEPLGLEA----DMWSIGVIT 208
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 1e-10
Identities = 34/99 (34%), Positives = 49/99 (49%), Gaps = 12/99 (12%)
Query: 747 IAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGS 806
I L ++H + DLKP+N+LLD++ R+ D GLA S S G+
Sbjct: 301 IILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GT 353
Query: 807 LGYIAPE---YGVGCEVSTNGDVYSYGILLLELVIGKKP 842
GY+APE GV + S D +S G +L +L+ G P
Sbjct: 354 HGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLRGHSP 390
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 49/216 (22%), Positives = 79/216 (36%), Gaps = 45/216 (20%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIA------ECKALKSIRHRNLVKV 688
G G F V K A K + ASR + E L+ + H N++
Sbjct: 21 GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT- 79
Query: 689 LTACLGADYRGNDFKASVYEFMHYGSLEEWL---HPFTGEDEIDEAPRNLNLLQRLNIAI 745
L Y + E + G L ++L + E + +
Sbjct: 80 ----LHDVYENRTDVVLILELVSGGELFDFLAQKESLS---EEEAT----------SFIK 122
Query: 746 DIAYALNYLHHDCQPVTAHCDLKPSNVLL----DDYMTARVGDFGLARILSPDHTQTSSF 801
I +NYLH + + AH DLKP N++L ++ DFGLA + + F
Sbjct: 123 QILDGVNYLHT--KKI-AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 802 SVKGSLGYIAPE----YGVGCEVSTNGDVYSYGILL 833
G+ ++APE +G E D++S G++
Sbjct: 180 ---GTPEFVAPEIVNYEPLGLEA----DMWSIGVIT 208
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 2e-10
Identities = 61/230 (26%), Positives = 97/230 (42%), Gaps = 44/230 (19%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-----GASRSFIAECKALKSIRHRNLVKV 688
+G G F +VYK +A+K L H G +R+ + E K L+ + H N++ +
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 689 LTACLGADYRGNDFKASVY---EFMHY---GSLEEWLHPFTGEDEIDEAPRNLNLLQRLN 742
L A K+++ +FM +++ T I + +L L
Sbjct: 78 LDAFGH--------KSNISLVFDFMETDLEVIIKDNSLVLT-PSHI----KAY-MLMTLQ 123
Query: 743 IAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARIL-SPDHTQTSSF 801
L YLH H DLKP+N+LLD+ ++ DFGLA+ SP+ T
Sbjct: 124 -------GLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV 173
Query: 802 SVKGSLGYIAPEYGVGCEV-STNGDVYSYGILLLELVIGKKPIDIMFEGD 850
V + Y APE G + D+++ G +L EL++ P GD
Sbjct: 174 -V--TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR-VPF---LPGD 216
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 50/218 (22%), Positives = 80/218 (36%), Gaps = 50/218 (22%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTAC 692
+G G+ VY+ + A+KV + E L + H N++K+
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 693 LGADYRGNDFKASVY---EFMHYGSLEEWL---HPFTGEDEIDEAPRNLNLLQRLNIAID 746
+ + E + G L + + ++ E D A +
Sbjct: 118 --------ETPTEISLVLELVTGGELFDRIVEKGYYS---ERDAA----------DAVKQ 156
Query: 747 IAYALNYLHHDCQPVTAHCDLKPSNVLL---DDYMTARVGDFGLARILSPDHTQTSSFSV 803
I A+ YLH + H DLKP N+L ++ DFGL++I+ +
Sbjct: 157 ILEAVAYLHE--NGI-VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC-- 211
Query: 804 KGSLGYIAPE----YGVGCEVSTNGDVYSYG----ILL 833
G+ GY APE G EV D++S G ILL
Sbjct: 212 -GTPGYCAPEILRGCAYGPEV----DMWSVGIITYILL 244
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 50/384 (13%), Positives = 119/384 (30%), Gaps = 80/384 (20%)
Query: 181 LGNLSSIHTISLAYNNLDG----TIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLE 236
+ S I SL + + ++ +++ + L+ N + + E +
Sbjct: 1 MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSEN--IA 57
Query: 237 KLQRLQHFTITSNSLGSGGNDDL----SFLCSLTNATRLTWMHINSNNFGGLLPGCISNL 292
+ L+ + G ++ L +L +L + ++ N FG + +
Sbjct: 58 SKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDF 117
Query: 293 ---SKTIKTLFLNNNKI-------------YGSIPAGIGNFVNLQRLDMWNNQLSGTIPP 336
++ L+L+NN + ++ N L+ + N+L
Sbjct: 118 LSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMK 177
Query: 337 AIGEL----QNLKILGLNRNKL-----SGNIPPSIGNLKMLLNLFLNDNFLE----VSIP 383
+ + L + + +N + + + + L L L DN ++
Sbjct: 178 EWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 237
Query: 384 SSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEF 443
+L +L E+ L++ LS +++ + N L+
Sbjct: 238 IALKSWPNLRELGLNDCLLSAR------GAAAVVDAFSKLENIG-------------LQT 278
Query: 444 LYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLS--G 501
L + N +E + T I + L L+L+ N S
Sbjct: 279 LRLQYNEIELDAVRTLKTVID-------------------EKMPDLLFLELNGNRFSEED 319
Query: 502 EIPKFLAGLSLNNLNLSYNDLEGM 525
++ + + ++L+ M
Sbjct: 320 DVVDEIREVFSTRGRGELDELDDM 343
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 6e-06
Identities = 35/272 (12%), Positives = 73/272 (26%), Gaps = 40/272 (14%)
Query: 62 RRHQRVTLLDLRSLKL----------AGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGG 111
+ + + + + + + L + L N+F +
Sbjct: 57 ASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLID 116
Query: 112 L----RRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILN 167
L+ L L+NN + + I L + L +
Sbjct: 117 FLSKHTPLEHLYLHNNGLGPQAGAKI--ARALQELAVNKKAKNAPPL---------RSII 165
Query: 168 LGSNHLTG----SIPSSLGNLSSIHTISLAYNNL-----DGTIPNSFGWFENLVFLSLAA 218
G N L + + +HT+ + N + + + + + L L L
Sbjct: 166 CGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQD 225
Query: 219 NNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINS 278
N + + + L+ L+ + L + G + S L + +
Sbjct: 226 NTFTHLGSSALAIA--LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQY 283
Query: 279 NNFGG----LLPGCISNLSKTIKTLFLNNNKI 306
N L I + L LN N+
Sbjct: 284 NEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 54/237 (22%), Positives = 85/237 (35%), Gaps = 51/237 (21%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFN---LQHHGASRSFIA---ECKALKSIR----H 682
L+G G FG+V+ G R +A+KV + + E L + H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 683 RNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRL- 741
++++L D+ + F LE P +D D L +
Sbjct: 98 PGVIRLL-----------DWFETQEGF--MLVLE---RPLPAQDLFDYITEKGPLGEGPS 141
Query: 742 -NIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD-DYMTARVGDFGLARILSPDHTQTS 799
+ A+ + H + V H D+K N+L+D A++ DFG +L +
Sbjct: 142 RCFFGQVVAAIQHCHS--RGV-VHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF 198
Query: 800 SFSVKGSLGYIAPE------YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
G+ Y PE Y V+S GILL ++V G P FE D
Sbjct: 199 D----GTRVYSPPEWISRHQYH-ALPA----TVWSLGILLYDMVCGDIP----FERD 242
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 41/216 (18%), Positives = 67/216 (31%), Gaps = 47/216 (21%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGAS--RSFIAECKALKSIRHR-NLVKVLTA 691
G G F V + I A K + G + E L+ + ++
Sbjct: 38 GRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN---- 93
Query: 692 CLGADYRGNDFKASVYEFMHYGSL-----EEWLHPFTGEDEIDEAPRNLNLLQRLNIAID 746
L Y + E+ G + E + E D +
Sbjct: 94 -LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVS---ENDVI----------RLIKQ 139
Query: 747 IAYALNYLHHDCQPVTAHCDLKPSNVLL---DDYMTARVGDFGLARILSPDHTQTSSFSV 803
I + YLH + H DLKP N+LL ++ DFG++R +
Sbjct: 140 ILEGVYYLHQ--NNI-VHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM-- 194
Query: 804 KGSLGYIAPE------YGVGCEVSTNGDVYSYGILL 833
G+ Y+APE D+++ GI+
Sbjct: 195 -GTPEYLAPEILNYDPITTAT------DMWNIGIIA 223
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-10
Identities = 68/293 (23%), Positives = 113/293 (38%), Gaps = 86/293 (29%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVK----VFNLQHHGASRSFIAECKALKSIR-HRNLVKV 688
+G G++G V+K I +AVK F A R+F E L + H N+V +
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTD-AQRTF-REIMILTELSGHENIVNL 74
Query: 689 LTACLGADYRGNDFKA--SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAID 746
L R ++ + V+++M E D L+ + R NI
Sbjct: 75 LNV-----LRADNDRDVYLVFDYM----------------ETD-----LHAVIRANILEP 108
Query: 747 -----IAY----ALNYLHHDCQPVTA---HCDLKPSNVLLDDYMTARVGDFGLARILSPD 794
+ Y + YLH + H D+KPSN+LL+ +V DFGL+R
Sbjct: 109 VHKQYVVYQLIKVIKYLH------SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162
Query: 795 HTQTSSFSVKGSLG-------------------YIAPEYGVGCEVSTNG-DVYSYGILLL 834
T++ + + Y APE +G T G D++S G +L
Sbjct: 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILG 222
Query: 835 ELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQR 887
E++ GK +F G ++ R ++ ++D P +ED+ +
Sbjct: 223 EILCGK----PIFPGSSTMNQLER------IIGVIDF---PSNEDVESIQSPF 262
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 50/215 (23%), Positives = 79/215 (36%), Gaps = 43/215 (20%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIA------ECKALKSIRHRNLVKV 688
G G F V K A K + +SR ++ E LK I+H N++
Sbjct: 20 GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT- 78
Query: 689 LTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIA 748
L Y + E + G L F D + E +L + I
Sbjct: 79 ----LHEVYENKTDVILILELVAGGEL------F---DFLAEK-ESLTEEEATEFLKQIL 124
Query: 749 YALNYLHHDCQPVTAHCDLKPSNVLL----DDYMTARVGDFGLARILSPDHTQTSSFSVK 804
+ YLH + AH DLKP N++L ++ DFGLA + + + F
Sbjct: 125 NGVYYLHS--LQI-AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--- 178
Query: 805 GSLGYIAPE------YGVGCEVSTNGDVYSYGILL 833
G+ ++APE G+ D++S G++
Sbjct: 179 GTPEFVAPEIVNYEPLGLEA------DMWSIGVIT 207
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 54/241 (22%), Positives = 95/241 (39%), Gaps = 53/241 (21%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVF--NLQHHGASRSFIAECKALKSIRHR------ 683
+L+G GSFG V K + +A+K+ ++ E + L+ +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI---EVRLLELMNKHDTEMKY 116
Query: 684 NLVKVLTA-------CLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLN 736
+V + CL V+E + Y +L + L + +LN
Sbjct: 117 YIVHLKRHFMFRNHLCL------------VFEMLSY-NLYDLL------RNTNFRGVSLN 157
Query: 737 LLQRLNIAIDIAYALNYLH-HDCQPVTAHCDLKPSNVLLDDYMTA--RVGDFGLARILSP 793
L ++ A + AL +L + + HCDLKP N+LL + + ++ DFG + L
Sbjct: 158 LTRK--FAQQMCTALLFLATPELSII--HCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 213
Query: 794 DHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINL 853
Q S Y +PE +G D++S G +L+E+ G+ +F G +
Sbjct: 214 RIYQYIQ-----SRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE----PLFSGANEV 264
Query: 854 H 854
Sbjct: 265 D 265
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 44/202 (21%), Positives = 72/202 (35%), Gaps = 19/202 (9%)
Query: 303 NNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSI 362
+ I P F + ++ ++ L ++ + N + + I
Sbjct: 6 STPIKQIFPDDA--FAETIKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIKS--VQGI 59
Query: 363 GNLKMLLNLFLNDNFLEVSIPSSLGQCESLIE---INLSNNNLSGTIPPQFF-SLSSLSI 418
L + L L N L + + L + L+ N L ++P F L++L
Sbjct: 60 QYLPNVRYLALGGNKL-----HDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKE 113
Query: 419 SLDWSRNKLTGSLPIEV-GKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQG 477
L N+L SLP V KL L +L + N+L+ F L +L + N Q
Sbjct: 114 -LVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS 171
Query: 478 PISSSLGSLRGLRVLDLSQNNL 499
L L+ L L QN L
Sbjct: 172 LPEGVFDKLTQLKDLRLYQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 53/200 (26%), Positives = 83/200 (41%), Gaps = 44/200 (22%)
Query: 259 LSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNF- 317
++ + + + N+++ + G I L + L L NK+ I
Sbjct: 31 VTDAVTQNELNSIDQIIANNSDIK-SVQG-IQYLPNV-RYLALGGNKL-----HDISALK 82
Query: 318 --VNLQRLDMWNNQLSGTIPPAI-GELQNLKILGLNRNKLSGNIPPSIGN-LKMLLNLFL 373
NL L + NQL ++P + +L NLK L L N+L ++P + + L L L L
Sbjct: 83 ELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNL 140
Query: 374 NDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFF-SLSSLSISLDWSRNKLTGSLP 432
N Q +SL P F L++L+ LD S N+L SLP
Sbjct: 141 AHN-----------QLQSL--------------PKGVFDKLTNLTE-LDLSYNQLQ-SLP 173
Query: 433 IEV-GKLKILEFLYVYENRL 451
V KL L+ L +Y+N+L
Sbjct: 174 EGVFDKLTQLKDLRLYQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 53/263 (20%), Positives = 86/263 (32%), Gaps = 71/263 (26%)
Query: 92 KQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVG 151
+ L+ S T ++ L + + NN+ I I + + N+L
Sbjct: 22 IKANLKKKSVTD-AVTQNE-LNSIDQIIANNSDIKSVQG--IQYLPNVRYLALGGNKL-- 75
Query: 152 KILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENL 211
+S L+ L L N L S+P F NL
Sbjct: 76 HDISALKELTNLTYLILTGNQLQ-SLP-----------------------NGVFDKLTNL 111
Query: 212 VFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRL 271
L L N L SL G D L T L
Sbjct: 112 KELVLVENQLQ---------------------------SLPDGVFDKL---------TNL 135
Query: 272 TWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGI-GNFVNLQRLDMWNNQL 330
T++++ N L G L+ + L L+ N++ S+P G+ L+ L ++ NQL
Sbjct: 136 TYLNLAHNQLQSLPKGVFDKLTN-LTELDLSYNQL-QSLPEGVFDKLTQLKDLRLYQNQL 193
Query: 331 SGTIPP-AIGELQNLKILGLNRN 352
++P L +L+ + L+ N
Sbjct: 194 K-SVPDGVFDRLTSLQYIWLHDN 215
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 44/218 (20%), Positives = 80/218 (36%), Gaps = 54/218 (24%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSI-RHRNLVKVLTACL 693
G+G G V + + A+K+ A R E + + ++V+++
Sbjct: 71 GLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDV-- 123
Query: 694 GADYR-GNDFKASVY---EFMHYGSL-----EEWLHPFTGEDEIDEAPRNLNLLQRLNIA 744
Y + + E + G L + FT E + + I
Sbjct: 124 ---YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT---EREAS----------EIM 167
Query: 745 IDIAYALNYLHHDCQPVTAHCDLKPSNVLL---DDYMTARVGDFGLARILSPDHTQTSSF 801
I A+ YLH + AH D+KP N+L ++ DFG A+ + ++ T
Sbjct: 168 KSIGEAIQYLHS--INI-AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT--- 221
Query: 802 SVKGSLGYIAPE------YGVGCEVSTNGDVYSYGILL 833
+ + Y+APE Y C D++S G+++
Sbjct: 222 TPCYTPYYVAPEVLGPEKYDKSC------DMWSLGVIM 253
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 7e-10
Identities = 53/221 (23%), Positives = 84/221 (38%), Gaps = 51/221 (23%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIA------ECKALKSIRHRNLVKV 688
G G F V K A K + +SR ++ E L+ IRH N++ +
Sbjct: 14 GSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITL 73
Query: 689 LTACLGADYRGNDFKASVYEFMHY--GSLEEWLHPFTGE--DEIDEAPRNLNLLQRLNIA 744
+ K V + G GE D + E +L +
Sbjct: 74 HDIF--------ENKTDVVLILELVSG----------GELFDFLAEK-ESLTEDEATQFL 114
Query: 745 IDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA----RVGDFGLARILSPDHTQTSS 800
I ++YLH + + AH DLKP N++L D ++ DFG+A + + +
Sbjct: 115 KQILDGVHYLHS--KRI-AHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI 171
Query: 801 FSVKGSLGYIAPE----YGVGCEVSTNGDVYSYG----ILL 833
F G+ ++APE +G E D++S G ILL
Sbjct: 172 F---GTPEFVAPEIVNYEPLGLEA----DMWSIGVITYILL 205
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 62.2 bits (150), Expect = 7e-10
Identities = 76/646 (11%), Positives = 169/646 (26%), Gaps = 228/646 (35%)
Query: 311 PAGIGNFVNLQRLDMWNN-----QLSGTIPPAIGELQNLKILGLNRNK---LSGNIPPSI 362
P+ + QR ++N+ + + + +L+ +L L K + G
Sbjct: 105 PSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQ-ALLELRPAKNVLIDG--VLGS 161
Query: 363 GNLK-MLLNLFLNDNFLEVSIPS-----SLGQC---ESLIEINLSNNNLSGTIPPQFFSL 413
G K + ++ + +L C E+++E+ L I P + S
Sbjct: 162 G--KTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEML---QKLLYQIDPNWTSR 216
Query: 414 SSLSISLDWSRNKLTGSLPIEVGKLKILEFLY--VYENRL-------EGEIPSTFG-NCI 463
S S ++ L I + ++ L YEN L + + F +C
Sbjct: 217 SDHSSNI---------KLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSC- 266
Query: 464 RLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNN-----LSGEIPKFLAGLSLNNLNLS 518
++L ++ LS + SL++ +++
Sbjct: 267 --------------------------KILLTTRFKQVTDFLSAATTTHI---SLDHHSMT 297
Query: 519 YNDLEGMVTTEGVFKNASATRILGNSKLCGGISEFKLPTCVSKKSKRRRLTFVPTLVIAI 578
E + + LP V + P
Sbjct: 298 LTPDE----VKSLLLK------------YLDCRPQDLPREVLTTN--------P------ 327
Query: 579 VFRLLGLALALFGLVLCLVRKIKEKENPSSSIY---------------SLLYLS---YQD 620
L++ + ++ ++ SL L Y+
Sbjct: 328 ------RRLSIIAESI--------RDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRK 373
Query: 621 LYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNL----QH--------HGASR 668
+++ S F + + ++ +I + K+ +
Sbjct: 374 MFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYL 433
Query: 669 SFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEI 728
+ + ++ HR++V HY + + +
Sbjct: 434 ELKVKLENEYAL-HRSIVD-----------------------HYNIPKTFDSDDLIPPYL 469
Query: 729 DEAPRNLNLLQRLNIAIDIAYALNYL-HHDCQPVTAHCDLKPSNVLLD-DYMTARVGDFG 786
D+ Y +++ HH V LD ++ ++
Sbjct: 470 DQ------------------YFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKI---- 507
Query: 787 LARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIM 846
R H T+ + L +T + Y + P
Sbjct: 508 --R-----HDSTAWNASGSIL-------------NTLQQLKFYK----PYICDNDPKYER 543
Query: 847 FEGDI--NLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQ 890
I L + D++ +L+ +DE + + +Q Q
Sbjct: 544 LVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEEAH-KQVQ 588
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.8 bits (136), Expect = 3e-08
Identities = 86/550 (15%), Positives = 160/550 (29%), Gaps = 162/550 (29%)
Query: 7 EFLWVRASLVAGTGNETDRVALLEFKSKSTYDPVGVLGTWNESIHFCKWYGVTCSRRHQR 66
+FL E + +++ D +N++ F K Y V+ R Q
Sbjct: 92 KFLMSPIK------TEQRQPSMMTRMYIEQRDR-----LYNDNQVFAK-YNVS---RLQP 136
Query: 67 VTLLD--LRSLKLAGSVS-HFIGNLSFLKQ-LYLQV---NSFTHEIPSEI-----GGLRR 114
L L L+ A +V G L K + L V ++ +I
Sbjct: 137 YLKLRQALLELRPAKNVLID--GVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNS 194
Query: 115 LKVLALNNNSICGEI-PTNISRCSTLIPIHPQNNQLVGKILSRF-------SSL------ 160
+ + + +I P SR I + L R + L
Sbjct: 195 PETVLEMLQKLLYQIDPNWTSRSDHSSNI-KLRIHSIQAELRRLLKSKPYENCLLVLLNV 253
Query: 161 --SKT-EILNLGSNHL--T--GSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVF 213
+K NL L T + L ++ H ISL ++++ T
Sbjct: 254 QNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTH-ISLDHHSMTLTPDEV--------- 303
Query: 214 LSLAANNLSVVENKLTGEV----PSLEKL--QRLQHFTITSNSLGSGGNDDLSFLCSLTN 267
SL L L EV P + + ++ T +
Sbjct: 304 KSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWD------------------ 345
Query: 268 ATRLTWMHINSNNFGGLLPGCISNLSKTIK-------TLFLNNNKI---------YGSIP 311
W H+N + ++ ++ L ++F + I + I
Sbjct: 346 ----NWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIK 401
Query: 312 AGIGNFVN-LQR---LDMWNNQLSGTIP-------PAIGELQNL--KILG---LNRNKLS 355
+ + VN L + ++ + + +IP + L I+ + + S
Sbjct: 402 SDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDS 461
Query: 356 GNIPPS---------IG----------NLKMLLNLFLNDNFLEVSIPSSLGQCESLIEIN 396
++ P IG + + +FL+ FLE I
Sbjct: 462 DDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKI-------------- 507
Query: 397 LSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLK-ILEFLYVYENRLEGEI 455
T S+ + L + + + + P + IL+FL E L I
Sbjct: 508 ----RHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENL---I 560
Query: 456 PSTFGNCIRL 465
S + + +R+
Sbjct: 561 CSKYTDLLRI 570
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 9e-10
Identities = 31/107 (28%), Positives = 52/107 (48%), Gaps = 9/107 (8%)
Query: 747 IAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGS 806
I AL+YLH + V + DLK N++LD ++ DFGL + D +F G+
Sbjct: 257 IVSALDYLHSEKNVV--YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC--GT 312
Query: 807 LGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP-----IDIMFE 848
Y+APE + D + G+++ E++ G+ P + +FE
Sbjct: 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 359
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 55/238 (23%), Positives = 87/238 (36%), Gaps = 42/238 (17%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRN 684
F ++G G+F V + + A+K+ N G F E L + R
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 685 LVKVLTACLGADYRGNDFKAS-----VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQ 739
+ ++ A F+ V E+ G L L F + I +
Sbjct: 123 ITQLHFA----------FQDENYLYLVMEYYVGGDLLTLLSKF--GERIPAE------MA 164
Query: 740 RLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTS 799
R +A +I A++ +H + H D+KP N+LLD R+ DFG L D T S
Sbjct: 165 RFYLA-EIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS 220
Query: 800 SFSVKGSLGYIAPEYGVGCEVSTNGDVY-------SYGILLLELVIGKKPIDIMFEGD 850
+V G+ Y++PE Y + G+ E+ G+ P F D
Sbjct: 221 LVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP----FYAD 273
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 59.5 bits (143), Expect = 2e-09
Identities = 34/200 (17%), Positives = 59/200 (29%), Gaps = 41/200 (20%)
Query: 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKV--------FNLQHHGASRSFIAECK 675
T +G G FG V++ I D T +A+K+ N H + E
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 676 ALKSI---------RHRNLVKVLTACLGADYRGNDFKASVYEFMHY----GSLEEWLHPF 722
K + R + + + +G+ + + HY GS + F
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHC---VQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132
Query: 723 T-------------GEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKP 769
G D + +L +I + +L + H DL
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFE--HRDLHW 190
Query: 770 SNVLLDDYMTARVGDFGLAR 789
NVLL ++ +
Sbjct: 191 GNVLLKKTSLKKLHYTLNGK 210
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 34/116 (29%), Positives = 52/116 (44%), Gaps = 27/116 (23%)
Query: 747 IAYALNYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKG 805
+ A++ +H H D+KP N+L+D R+ DFG L D T SS +V G
Sbjct: 184 MVIAIDSVHQLH----YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-G 238
Query: 806 SLGYIAPE-----------YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
+ YI+PE YG C D +S G+ + E++ G+ P F +
Sbjct: 239 TPDYISPEILQAMEGGKGRYGPEC------DWWSLGVCMYEMLYGETP----FYAE 284
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 4e-09
Identities = 55/273 (20%), Positives = 95/273 (34%), Gaps = 74/273 (27%)
Query: 597 VRKIKEKENPSSSIYSLLYLSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAV 656
+ + + + L + +D + ++G G+FG V R A+
Sbjct: 47 IDNFLSRYKDTINKIRDLRMKAED-------YEVVKVIGRGAFGEVQLVRHKSTRKVYAM 99
Query: 657 KVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS-----VYE 708
K+ + S F E + +V++ A F+ V E
Sbjct: 100 KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA----------FQDDRYLYMVME 149
Query: 709 FMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIA--Y------ALNYLH-HDCQ 759
+M G L +NL+ ++ A Y AL+ +H
Sbjct: 150 YMPGGDL-------------------VNLMSNYDVPEKWARFYTAEVVLALDAIHSMGF- 189
Query: 760 PVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPE------ 813
H D+KP N+LLD ++ DFG ++ + +V G+ YI+PE
Sbjct: 190 ---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQG 245
Query: 814 ----YGVGCEVSTNGDVYSYGILLLELVIGKKP 842
YG C D +S G+ L E+++G P
Sbjct: 246 GDGYYGREC------DWWSVGVFLYEMLVGDTP 272
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 58.2 bits (140), Expect = 5e-09
Identities = 21/103 (20%), Positives = 36/103 (34%), Gaps = 3/103 (2%)
Query: 327 NNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPP-SIGNLKMLLNLFLNDNFLEVSIPSS 385
+ + +NL L + + ++ + L L NL + + L P +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 386 LGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLT 428
L +NLS N L ++ + SL L S N L
Sbjct: 76 FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQ-ELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.7 bits (131), Expect = 7e-08
Identities = 27/119 (22%), Positives = 42/119 (35%), Gaps = 8/119 (6%)
Query: 286 PGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPP-AIGELQNL 344
C + S ++ + NL L + N Q + + L L
Sbjct: 3 DACCPHGSSGLRCTRDGAL----DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGEL 58
Query: 345 KILGLNRNKLSGNIPPSI-GNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNL 402
+ L + ++ L + P L L L+ N LE S+ Q SL E+ LS N L
Sbjct: 59 RNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 16/100 (16%), Positives = 33/100 (33%), Gaps = 8/100 (8%)
Query: 153 ILSRFSSLSKTEILNLGSNHLTGSIPS-SLGNLSSIHTISLAYNNLDGTIPNSFGWFENL 211
L L + + + L L + +++ + L P++F + L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 212 VFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSL 251
L+L+ N L + + LQ ++ N L
Sbjct: 83 SRLNLSFNALESLS-------WKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 6e-05
Identities = 23/105 (21%), Positives = 36/105 (34%), Gaps = 2/105 (1%)
Query: 419 SLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPS-TFGNCIRLEQLGMGGNLFQG 477
L +R+ + + L LY+ + + L L + + +
Sbjct: 12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF 70
Query: 478 PISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLSLNNLNLSYNDL 522
+ L L+LS N L K + GLSL L LS N L
Sbjct: 71 VAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 28/114 (24%), Positives = 53/114 (46%), Gaps = 7/114 (6%)
Query: 290 SNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAI-GELQNLKILG 348
+ + + L+L+ N+ +P + N+ +L +D+ NN++S T+ + L L
Sbjct: 27 KGIPRDVTELYLDGNQF-TLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLI 84
Query: 349 LNRNKLSGNIPPSI-GNLKMLLNLFLNDNFLEVSIP-SSLGQCESLIEINLSNN 400
L+ N+L IPP LK L L L+ N + +P + +L + + N
Sbjct: 85 LSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 32/107 (29%), Positives = 50/107 (46%), Gaps = 8/107 (7%)
Query: 370 NLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFF-SLSSLSISLDWSRNKLT 428
L+L+ N +P L + L I+LSNN +S T+ Q F +++ L L S N+L
Sbjct: 35 ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLT-LILSYNRLR 91
Query: 429 GSLPIEV-GKLKILEFLYVYENRLEGEIP-STFGNCIRLEQLGMGGN 473
+P LK L L ++ N + +P F + L L +G N
Sbjct: 92 -CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 22/86 (25%), Positives = 40/86 (46%), Gaps = 5/86 (5%)
Query: 269 TRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGI-GNFVNLQRLDMWN 327
LT + +++N L SN+++ + TL L+ N++ IP +L+ L +
Sbjct: 54 KHLTLIDLSNNRISTLSNQSFSNMTQ-LLTLILSYNRL-RCIPPRTFDGLKSLRLLSLHG 111
Query: 328 NQLSGTIPP-AIGELQNLKILGLNRN 352
N +S +P A +L L L + N
Sbjct: 112 NDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 27/111 (24%), Positives = 53/111 (47%), Gaps = 9/111 (8%)
Query: 92 KQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNI-SRCSTLIPIHPQNNQLV 150
+LYL N FT +P E+ + L ++ L+NN I + S + L+ + N+L
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRI-STLSNQSFSNMTQLLTLILSYNRL- 90
Query: 151 GKILSR--FSSLSKTEILNLGSNHLTGSIP-SSLGNLSSIHTISLAYNNLD 198
+ + F L +L+L N ++ +P + +LS++ +++ N L
Sbjct: 91 -RCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPLY 139
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 26/114 (22%), Positives = 44/114 (38%), Gaps = 9/114 (7%)
Query: 266 TNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGI-GNFVNLQRLD 324
+ T L +N N G + + + L L N++ I ++Q L
Sbjct: 29 LHTTEL---LLNDNELGRISSDGLFGRLPHLVKLELKRNQL-TGIEPNAFEGASHIQELQ 84
Query: 325 MWNNQLSGTIPPAI-GELQNLKILGLNRNKLSGNIPPSI-GNLKMLLNLFLNDN 376
+ N++ I + L LK L L N++S + P +L L +L L N
Sbjct: 85 LGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 33/166 (19%), Positives = 65/166 (39%), Gaps = 19/166 (11%)
Query: 285 LPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNL 344
+ +S L K L L+ N I I + + NL+ L + N + I L
Sbjct: 40 MDATLSTLKA-CKHLALSTNNI-EKI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTL 95
Query: 345 KILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFL-EVSIPSSLGQCESLIEINLSNNNLS 403
+ L ++ N+++ ++ I L L L++++N + L + L ++ L+ N L
Sbjct: 96 EELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153
Query: 404 GTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYEN 449
+ + R ++ LP LK L+ + V +
Sbjct: 154 NDYKE--------NNATSEYRIEVVKRLP----NLKKLDGMPVDVD 187
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 23/105 (21%), Positives = 45/105 (42%), Gaps = 6/105 (5%)
Query: 299 LFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNI 358
L I + A + + L + N + I + ++NL+IL L RN + I
Sbjct: 30 LHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLIK-KI 85
Query: 359 PPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLS 403
L L+++ N + S+ S + + +L + +SNN ++
Sbjct: 86 ENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKIT 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 29/173 (16%), Positives = 64/173 (36%), Gaps = 46/173 (26%)
Query: 191 SLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNS 250
++ + + + L+L+ NN+ + + L ++ L+ ++ N
Sbjct: 31 HGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISS--------LSGMENLRILSLGRNL 81
Query: 251 LGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSI 310
+ N + ++ T++ L+++ N+I +
Sbjct: 82 IKKIEN--------------------------------LDAVADTLEELWISYNQI--AS 107
Query: 311 PAGIGNFVNLQRLDMWNNQLS--GTIPPAIGELQNLKILGLNRNKLSGNIPPS 361
+GI VNL+ L M NN+++ G I + L L+ L L N L + +
Sbjct: 108 LSGIEKLVNLRVLYMSNNKITNWGEIDK-LAALDKLEDLLLAGNPLYNDYKEN 159
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 29/157 (18%), Positives = 60/157 (38%), Gaps = 35/157 (22%)
Query: 93 QLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGK 152
+L+ + ++ + + L+ K LAL+ N NI + S+L
Sbjct: 29 ELHGMIPPIE-KMDATLSTLKACKHLALSTN--------NIEKISSL------------- 66
Query: 153 ILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLV 212
S + IL+LG N + I + ++ + ++YN + ++ NL
Sbjct: 67 -----SGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLR 118
Query: 213 FLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSN 249
L ++ N ++ E+ L L +L+ + N
Sbjct: 119 VLYMSNNKITNWG-----EIDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 38/158 (24%), Positives = 64/158 (40%), Gaps = 39/158 (24%)
Query: 368 LLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKL 427
+ L +E + ++L ++ + LS NN+ +SSLS
Sbjct: 27 KVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE--------KISSLS---------- 67
Query: 428 TGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPIS--SSLGS 485
++ L L + N ++ +I + LE+L + N I+ S +
Sbjct: 68 ---------GMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQ----IASLSGIEK 113
Query: 486 LRGLRVLDLSQNNLS--GEIPKFLAGL-SLNNLNLSYN 520
L LRVL +S N ++ GEI LA L L +L L+ N
Sbjct: 114 LVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGN 150
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 3e-08
Identities = 54/255 (21%), Positives = 93/255 (36%), Gaps = 63/255 (24%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVF--NLQHHGASRSFIAECKALKSIRHR-----NL 685
+G G+FG V + + AVKV ++ +++ E LK I++ N+
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI---EADILKKIQNDDINNNNI 98
Query: 686 VKVLTACLGADYRGN------DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQ 739
VK Y + S+YE + + + F ++ ++
Sbjct: 99 VK-YHGKF--MYYDHMCLIFEPLGPSLYEIITRNNY----NGF-----------HIEDIK 140
Query: 740 RLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD--YMTARVGDFGLARILSPDHTQ 797
I+I ALNYL H DLKP N+LLDD + + + + +
Sbjct: 141 L--YCIEILKALNYLR-KMSLT--HTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYR 195
Query: 798 TSSFSVK----GS--------LGYI------APEYGVGCEVSTNGDVYSYGILLLELVIG 839
T S +K G I APE + + D++S+G +L EL G
Sbjct: 196 TKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255
Query: 840 KKPIDIMFEGDINLH 854
++F ++
Sbjct: 256 ----SLLFRTHEHME 266
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 49/172 (28%), Positives = 69/172 (40%), Gaps = 30/172 (17%)
Query: 303 NNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSI 362
+K + S+PAGI N Q L + +NQ++ P L NLK L L N+L
Sbjct: 27 RSKRHASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG------- 77
Query: 363 GNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFF-SLSSLSISLD 421
L V + SL Q L ++L N L+ +P F L L L
Sbjct: 78 --------------ALPVGVFDSLTQ---LTVLDLGTNQLT-VLPSAVFDRLVHLKE-LF 118
Query: 422 WSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGN 473
NKLT LP + +L L L + +N+L+ F L + GN
Sbjct: 119 MCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 45/194 (23%), Positives = 66/194 (34%), Gaps = 42/194 (21%)
Query: 159 SLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAA 218
S S T + + S S+P+ G ++ + L N + P F NL L L +
Sbjct: 18 SCSGTTV-DCRSKRHA-SVPA--GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGS 73
Query: 219 NNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINS 278
N L +L G D L T+LT + + +
Sbjct: 74 NQLG---------------------------ALPVGVFDSL---------TQLTVLDLGT 97
Query: 279 NNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAI 338
N L L +K LF+ NK+ +P GI +L L + NQL A
Sbjct: 98 NQLTVLPSAVFDRLVH-LKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLKSIPHGAF 155
Query: 339 GELQNLKILGLNRN 352
L +L L N
Sbjct: 156 DRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 36/127 (28%), Positives = 56/127 (44%), Gaps = 10/127 (7%)
Query: 92 KQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNI-SRCSTLIPIHPQNNQLV 150
+ LYL N T P L LK L L +N + G +P + + L + NQL
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQL- 100
Query: 151 GKILSR--FSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWF 208
+L F L + L + N LT +P + L+ + ++L N L +IP+ G F
Sbjct: 101 -TVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPH--GAF 155
Query: 209 ENLVFLS 215
+ L L+
Sbjct: 156 DRLSSLT 162
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 56.2 bits (135), Expect = 4e-08
Identities = 34/107 (31%), Positives = 53/107 (49%), Gaps = 9/107 (8%)
Query: 744 AIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSV 803
A +IA L +L + DLK NV+LD ++ DFG+ + D T +F
Sbjct: 448 AAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC- 503
Query: 804 KGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
G+ YIAPE + D +++G+LL E++ G+ P FEG+
Sbjct: 504 -GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP----FEGE 545
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 4e-08
Identities = 32/112 (28%), Positives = 50/112 (44%), Gaps = 22/112 (19%)
Query: 747 IAYALNYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLA-RILSPDHTQTSSFSVK 804
I AL +LH + D+K N+LLD + DFGL+ ++ + + F
Sbjct: 168 IVLALEHLHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-- 221
Query: 805 GSLGYIAPE------YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
G++ Y+AP+ G V D +S G+L+ EL+ G P F D
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASP----FTVD 265
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 47/364 (12%), Positives = 109/364 (29%), Gaps = 69/364 (18%)
Query: 210 NLVFLSLAANNLSVVENKLTGEVPSLEKL-QRLQHFTITSNSLGSGGNDDLSFLCSLTNA 268
+ L L+ NNL + + + ++ NSLG +D+L + + A
Sbjct: 23 GVTSLDLSLNNLYSISTVELIQA--FANTPASVTSLNLSGNSLGFKNSDELVQILAAIPA 80
Query: 269 TRLTWMHINSNNFGG----LLPGCISNLSKTIKTLFLNNNKIYGS-----IPAGIGNFVN 319
+T ++++ N L ++ + TI L L N A +
Sbjct: 81 N-VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPAS 139
Query: 320 LQRLDMWNNQLSGTIPPAIGEL-----QNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLN 374
+ L++ N L + ++ N+ L L N L+ S L +
Sbjct: 140 ITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA-----SKN-CAELAKFLAS 193
Query: 375 DNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIE 434
S+ ++LS N L S + L+ N +
Sbjct: 194 IP-------------ASVTSLDLSANLLGLK------SYAELAYIFSSIPNHVV------ 228
Query: 435 VGKLKILEFLYVYENRLEGE----IPSTFGNCIRLEQLGMGGNLFQGP-------ISSSL 483
L + N L G + + L+ + + ++ + + ++
Sbjct: 229 --------SLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAF 280
Query: 484 GSLRGLRVLDLSQNNLSGEIPKFLA-GLSLNNLNLSYNDLEGMVTTEGVFKNASATRILG 542
+++ + ++D + + ++ + + L + +
Sbjct: 281 PNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNI 340
Query: 543 NSKL 546
+L
Sbjct: 341 PDEL 344
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 6e-05
Identities = 51/366 (13%), Positives = 124/366 (33%), Gaps = 63/366 (17%)
Query: 78 AGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIG-GLRR----LKVLALNNNSICGEIPTN 132
+ V F + L L +N+ E+ + L L+ NS+ +
Sbjct: 11 SNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDE 70
Query: 133 ISR-----CSTLIPIHPQNNQL----VGKILSRFSSLSKT-EILNLGSNHLTGSIPSSLG 182
+ + + + ++ N L +++ +++ T +L+LG N + S
Sbjct: 71 LVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFK 130
Query: 183 NLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQ-RL 241
+ + ++ L+L N+L + + ++ L + +
Sbjct: 131 Q-------AFSNLPA------------SITSLNLRGNDLGIKSSDELIQI--LAAIPANV 169
Query: 242 QHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGG----LLPGCISNLSKTIK 297
+ N+L S +L+ + A+ +T + +++N G L S++ +
Sbjct: 170 NSLNLRGNNLASKNCAELAKFLASIPAS-VTSLDLSANLLGLKSYAELAYIFSSIPNHVV 228
Query: 298 TLFLNNNKIYGS----IPAGIGNFVNLQRLDMWNNQLSGT-------IPPAIGELQNLKI 346
+L L N ++G + + +LQ + + + + + A +Q + +
Sbjct: 229 SLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIIL 288
Query: 347 LGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFL----------EVSIPSSLGQCESLIEIN 396
+ N ++ + I NL L+ + L + L + L E
Sbjct: 289 VDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESI 348
Query: 397 LSNNNL 402
+ L
Sbjct: 349 QTCKPL 354
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 1e-07
Identities = 33/111 (29%), Positives = 55/111 (49%), Gaps = 23/111 (20%)
Query: 747 IAYALNYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKG 805
+A AL++LH + DLKP N+LLD+ ++ DFGL++ + SF G
Sbjct: 135 LALALDHLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC--G 188
Query: 806 SLGYIAPE------YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
++ Y+APE + D +S+G+L+ E++ G P F+G
Sbjct: 189 TVEYMAPEVVNRRGHTQSA------DWWSFGVLMFEMLTGTLP----FQGK 229
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 1e-07
Identities = 32/111 (28%), Positives = 52/111 (46%), Gaps = 23/111 (20%)
Query: 747 IAYALNYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKG 805
I+ AL +LH + DLKP N++L+ ++ DFGL + D T T +F G
Sbjct: 130 ISMALGHLHQKG----IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC--G 183
Query: 806 SLGYIAPE------YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
++ Y+APE + D +S G L+ +++ G P F G+
Sbjct: 184 TIEYMAPEILMRSGHNRAV------DWWSLGALMYDMLTGAPP----FTGE 224
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 2e-07
Identities = 31/111 (27%), Positives = 48/111 (43%), Gaps = 23/111 (20%)
Query: 747 IAYALNYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKG 805
I AL YLH D + D+K N++LD ++ DFGL + D +F G
Sbjct: 114 IVSALEYLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC--G 167
Query: 806 SLGYIAPE------YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
+ Y+APE YG D + G+++ E++ G+ P F
Sbjct: 168 TPEYLAPEVLEDNDYGRAV------DWWGLGVVMYEMMCGRLP----FYNQ 208
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 2e-07
Identities = 33/104 (31%), Positives = 51/104 (49%), Gaps = 9/104 (8%)
Query: 747 IAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGS 806
IA L +L + DLK NV+LD ++ DFG+ + D T +F G+
Sbjct: 130 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC--GT 184
Query: 807 LGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
YIAPE + D +++G+LL E++ G+ P FEG+
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP----FEGE 224
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 53/256 (20%), Positives = 94/256 (36%), Gaps = 69/256 (26%)
Query: 633 LVGVGSFGSVYKGI-IDEGRTTIAVKVF--NLQHHGASRSFIAECKALKSIRHR------ 683
+G G+FG V + + G++ +A+K+ ++ A+R E LK I+ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL---EINVLKKIKEKDKENKF 82
Query: 684 NLVKVLTACLGADYRGNDF------KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNL 737
V + ++ G+ + +EF+ + P+ L
Sbjct: 83 LCVLMSDW---FNFHGHMCIAFELLGKNTFEFLKENNF----QPY-----------PLPH 124
Query: 738 LQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA----------------- 780
++ +A + +AL +LH + Q H DLKP N+L +
Sbjct: 125 VRH--MAYQLCHALRFLH-ENQLT--HTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT 179
Query: 781 --RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI 838
RV DFG A HT ++ + Y PE + + DV+S G +L E
Sbjct: 180 SIRVADFGSATFDHEHHT-----TIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234
Query: 839 GKKPIDIMFEGDINLH 854
G +F+ N
Sbjct: 235 GF----TLFQTHENRE 246
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 51/274 (18%), Positives = 92/274 (33%), Gaps = 87/274 (31%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIR-----HRNLVKV 688
+G G F +V+ +G+ +A+KV H + E + LKS+R N V
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD-EIRLLKSVRNSDPNDPNREMV 103
Query: 689 LTACLGADYRGNDFKAS---------VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQ 739
+ +DFK S V+E + + L +W+ + L ++
Sbjct: 104 VQLL-------DDFKISGVNGTHICMVFEVLGH-HLLKWIIKS------NYQGLPLPCVK 149
Query: 740 RLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL------------------------- 774
+ I + L+YLH C+ + H D+KP N+LL
Sbjct: 150 K--IIQQVLQGLDYLHTKCRII--HTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPP 205
Query: 775 ------------------------DDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYI 810
+ + ++ D G A + T+ + Y
Sbjct: 206 SGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ-----TRQYR 260
Query: 811 APEYGVGCEVSTNGDVYSYGILLLELVIGKKPID 844
+ E +G +T D++S + EL G +
Sbjct: 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFE 294
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 3e-07
Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 5/96 (5%)
Query: 747 IAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGS 806
I+ ALNYLH + + DLK NVLLD ++ D+G+ + TS+F G+
Sbjct: 119 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC--GT 173
Query: 807 LGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
YIAPE G + + D ++ G+L+ E++ G+ P
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 3e-07
Identities = 34/105 (32%), Positives = 55/105 (52%), Gaps = 11/105 (10%)
Query: 747 IAYALNYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKG 805
I L +LH + DLK N+LLD ++ DFG+ + +T++F G
Sbjct: 127 IILGLQFLHSKG----IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC--G 180
Query: 806 SLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
+ YIAPE +G + + + D +S+G+LL E++IG+ P F G
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP----FHGQ 221
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 4e-07
Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 5/96 (5%)
Query: 747 IAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGS 806
I+ ALNYLH + + DLK NVLLD ++ D+G+ + TS+F G+
Sbjct: 162 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC--GT 216
Query: 807 LGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
YIAPE G + + D ++ G+L+ E++ G+ P
Sbjct: 217 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 4e-07
Identities = 35/108 (32%), Positives = 51/108 (47%), Gaps = 17/108 (15%)
Query: 747 IAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGS 806
I AL +LH + DLK NVLLD ++ DFG+ + + T++F G+
Sbjct: 133 IISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC--GT 187
Query: 807 LGYIAPE----YGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
YIAPE G V D ++ G+LL E++ G P FE +
Sbjct: 188 PDYIAPEILQEMLYGPAV----DWWAMGVLLYEMLCGHAP----FEAE 227
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 35/135 (25%), Positives = 59/135 (43%), Gaps = 14/135 (10%)
Query: 290 SNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAI-GELQNLKILG 348
+ + L L N + +L +L + N+L ++P + +L +L L
Sbjct: 24 TGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLN 82
Query: 349 LNRNKLSGNIPPSI-GNLKMLLNLFLNDNFLEVSIPS----SLGQCESLIEINLSNNNLS 403
L+ N+L ++P + L L L LN N L+ S+P L Q L ++ L N L
Sbjct: 83 LSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQ---LKDLRLYQNQLK 137
Query: 404 GTIPPQFF-SLSSLS 417
++P F L+SL
Sbjct: 138 -SVPDGVFDRLTSLQ 151
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 46/154 (29%), Positives = 74/154 (48%), Gaps = 17/154 (11%)
Query: 303 NNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSI 362
++ S+P GI LD+ N L EL +L L L NKL ++P +
Sbjct: 15 YSQGRTSVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGV 71
Query: 363 GN-LKMLLNLFLNDNFLEVSIPS----SLGQCESLIEINLSNNNLSGTIPPQFF-SLSSL 416
N L L L L+ N L+ S+P+ L Q L E+ L+ N L ++P F L+ L
Sbjct: 72 FNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQ---LKELALNTNQLQ-SLPDGVFDKLTQL 126
Query: 417 SISLDWSRNKLTGSLPIEV-GKLKILEFLYVYEN 449
L +N+L S+P V +L L+++++++N
Sbjct: 127 K-DLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 45/195 (23%), Positives = 74/195 (37%), Gaps = 43/195 (22%)
Query: 159 SLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAA 218
S S T + S T S+P+ G + + L N+L F +L L L
Sbjct: 6 SCSGTTV-ECYSQGRT-SVPT--GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGG 61
Query: 219 NNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINS 278
N L SL +G + L T LT++++++
Sbjct: 62 NKLQ---------------------------SLPNGVFNKL---------TSLTYLNLST 85
Query: 279 NNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGI-GNFVNLQRLDMWNNQLSGTIPPA 337
N L G L++ +K L LN N++ S+P G+ L+ L ++ NQL
Sbjct: 86 NQLQSLPNGVFDKLTQ-LKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQLKSVPDGV 143
Query: 338 IGELQNLKILGLNRN 352
L +L+ + L+ N
Sbjct: 144 FDRLTSLQYIWLHDN 158
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 5e-07
Identities = 31/101 (30%), Positives = 45/101 (44%), Gaps = 18/101 (17%)
Query: 747 IAYALNYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKG 805
I YLH D + DLKP N+L+D +V DFG A+ + T T + G
Sbjct: 150 IVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWT----LCG 200
Query: 806 SLGYIAPE----YGVGCEVSTNGDVYSYGILLLELVIGKKP 842
+ +APE G V D ++ G+L+ E+ G P
Sbjct: 201 TPEALAPEIILSKGYNKAV----DWWALGVLIYEMAAGYPP 237
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 5e-07
Identities = 33/114 (28%), Positives = 55/114 (48%), Gaps = 12/114 (10%)
Query: 309 SIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSI-GNLKM 367
S+P GI + RL++ +N+L +L L L L++N++ ++P + L
Sbjct: 21 SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTK 77
Query: 368 LLNLFLNDNFLEVSIPS----SLGQCESLIEINLSNNNLSGTIPPQFFSLSSLS 417
L L+L++N L+ S+P+ L Q L E+ L N L F L+SL
Sbjct: 78 LTILYLHENKLQ-SLPNGVFDKLTQ---LKELALDTNQLKSVPDGIFDRLTSLQ 127
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 7e-05
Identities = 24/85 (28%), Positives = 41/85 (48%), Gaps = 3/85 (3%)
Query: 269 TRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGI-GNFVNLQRLDMWN 327
T+LT + ++ N L G L+K + L+L+ NK+ S+P G+ L+ L +
Sbjct: 52 TQLTKLSLSQNQIQSLPDGVFDKLTK-LTILYLHENKL-QSLPNGVFDKLTQLKELALDT 109
Query: 328 NQLSGTIPPAIGELQNLKILGLNRN 352
NQL L +L+ + L+ N
Sbjct: 110 NQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 6e-07
Identities = 34/105 (32%), Positives = 48/105 (45%), Gaps = 11/105 (10%)
Query: 747 IAYALNYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKG 805
IA AL YLH + + DLKP N+LLD + DFGL + ++ TS+F G
Sbjct: 148 IASALGYLHSLN----IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC--G 201
Query: 806 SLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
+ Y+APE D + G +L E++ G P F
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP----FYSR 242
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 22/107 (20%), Positives = 39/107 (36%), Gaps = 9/107 (8%)
Query: 299 LFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLS--G 356
+ L I + A N V + LD+ ++ I L + + N++
Sbjct: 2 VKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLD 58
Query: 357 NIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLS 403
P L+ L L +N+N + L E+ L+NN+L
Sbjct: 59 GFP----LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 23/132 (17%), Positives = 50/132 (37%), Gaps = 9/132 (6%)
Query: 112 LRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSN 171
R + L L I I + I +N++ + L F L + + L + +N
Sbjct: 18 AVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVNNN 74
Query: 172 HLTGSIPSSLGNLSSIHTISLAYNNLD--GTIPNSFGWFENLVFLSLAANNLSVVEN--- 226
+ L + + L N+L G + + ++L +L + N ++ ++
Sbjct: 75 RICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRNPVTNKKHYRL 133
Query: 227 KLTGEVPSLEKL 238
+ +VP + L
Sbjct: 134 YVIYKVPQVRVL 145
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 50.2 bits (121), Expect = 1e-06
Identities = 33/101 (32%), Positives = 47/101 (46%), Gaps = 18/101 (17%)
Query: 747 IAYALNYLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKG 805
+ AL YLH D + DLKP N+LLD ++ DFG A+ T + G
Sbjct: 115 VCLALEYLHSKD----IIYRDLKPENILLDKNGHIKITDFGFAKY---VPDVTYTLC--G 165
Query: 806 SLGYIAPE----YGVGCEVSTNGDVYSYGILLLELVIGKKP 842
+ YIAPE + D +S+GIL+ E++ G P
Sbjct: 166 TPDYIAPEVVSTKPYNKSI----DWWSFGILIYEMLAGYTP 202
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 290 SNLSKTIKTLFLNNNKIYGSIPAGI-GNFVNLQRLDMWNNQLSGTIPPAI-GELQNLKIL 347
+ + T + L+L +N+I + G+ L RLD+ NNQL+ +P + +L L L
Sbjct: 26 TGIPTTTQVLYLYDNQI-TKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQL 83
Query: 348 GLNRNKLSGNIPPSI-GNLKMLLNLFLNDN 376
LN N+L +IP NLK L +++L +N
Sbjct: 84 SLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 2e-06
Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 6/90 (6%)
Query: 290 SNLSKTIKTLFLNNNKIYGSIPAGI-GNFVNLQRLDMWNNQLSGTIPPAI-GELQNLKIL 347
+ + + L+LNNN+I + G+ + VNLQ+L +N+L+ IP + +L L L
Sbjct: 29 AGIPTDKQRLWLNNNQI-TKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQL 86
Query: 348 GLNRNKLSGNIPPSI-GNLKMLLNLFLNDN 376
LN N L +IP NLK L +++L +N
Sbjct: 87 DLNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 42/233 (18%), Positives = 79/233 (33%), Gaps = 37/233 (15%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFN---LQHHGASRSFIAECKALKSIRHRNLVKVL 689
+G G FG +Y ++ ++ ++ F E K + ++
Sbjct: 42 PIGQGGFGCIYLADMNSS-ESVGSDAPCVVKVEPSDNGPLFT-ELKFYQRAAKPEQIQKW 99
Query: 690 TACLGADYRG---------NDFKASVYEFM---HYG-SLEEWLHPFTGEDEIDEAPRNLN 736
Y G +D Y FM +G L + + + +
Sbjct: 100 IRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDL---------QKIYEANAKRFS 150
Query: 737 LLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV--GDFGLARILSPD 794
L +++ I L Y+H H D+K SN+LL+ +V D+GLA P+
Sbjct: 151 RKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPE 207
Query: 795 HTQT-----SSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
G++ + + + G S GD+ G +++ + G P
Sbjct: 208 GVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 4e-06
Identities = 55/256 (21%), Positives = 95/256 (37%), Gaps = 69/256 (26%)
Query: 633 LVGVGSFGSVYKGI-IDEGRTTIAVKVF--NLQHHGASRSFIAECKALKSIRHR------ 683
+G G+FG V + I G +AVK+ ++ A+RS E + L+ +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS---EIQVLEHLNTTDPNSTF 77
Query: 684 NLVKVLTACLGADYRGNDF------KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNL 737
V++L ++ G+ S Y+F+ E P L+
Sbjct: 78 RCVQMLEW---FEHHGHICIVFELLGLSTYDFI---------------KENGFLPFRLDH 119
Query: 738 LQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA----------------- 780
+++ +A I ++N+LH + H DLKP N+L
Sbjct: 120 IRK--MAYQICKSVNFLH-SNKLT--HTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174
Query: 781 --RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI 838
+V DFG A H+ ++ + Y APE + S DV+S G +L+E +
Sbjct: 175 DIKVVDFGSATYDDEHHS-----TLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 229
Query: 839 GKKPIDIMFEGDINLH 854
G +F +
Sbjct: 230 GF----TVFPTHDSKE 241
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-06
Identities = 24/111 (21%), Positives = 39/111 (35%), Gaps = 27/111 (24%)
Query: 294 KTIKTLFLNNNKI-YGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRN 352
+K L L+N++ G + F L+ L N L+ + NL
Sbjct: 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT--------SIANLP------- 61
Query: 353 KLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLS 403
L L L L+DN + + +C +L +NLS N +
Sbjct: 62 -----------KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 25/129 (19%), Positives = 51/129 (39%), Gaps = 7/129 (5%)
Query: 115 LKVLALNNNSI-CGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHL 173
+K L L+N+ G++ L + N L ++ L+K + L L N +
Sbjct: 19 VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL--TSIANLPKLNKLKKLELSDNRV 76
Query: 174 TGSIPSSLGNLSSIHTISLAYNNL-DGTIPNSFGWFENLVFLSLAANNLSVVEN---KLT 229
+G + ++ ++L+ N + D + ENL L L ++ + + +
Sbjct: 77 SGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVF 136
Query: 230 GEVPSLEKL 238
+P L L
Sbjct: 137 KLLPQLTYL 145
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 27/136 (19%), Positives = 48/136 (35%), Gaps = 29/136 (21%)
Query: 364 NLKMLLNLFLNDN-FLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDW 422
+ L L+++ E + + E L ++ N L+ S+++L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT--------SIANLP----- 61
Query: 423 SRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPIS-S 481
KL L+ L + +NR+ G + C L L + GN + +
Sbjct: 62 --------------KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIE 107
Query: 482 SLGSLRGLRVLDLSQN 497
L L L+ LDL
Sbjct: 108 PLKKLENLKSLDLFNC 123
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 48.8 bits (115), Expect = 5e-06
Identities = 28/170 (16%), Positives = 61/170 (35%), Gaps = 14/170 (8%)
Query: 170 SNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLS--VVENK 227
S + L + ++ + + N NL L + + L VVE+
Sbjct: 157 SWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPR---PNLKSLEIISGGLPDSVVEDI 213
Query: 228 LTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPG 287
L ++P+LE +L + + G + L S L W+ I ++
Sbjct: 214 LGSDLPNLE---KLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVE 270
Query: 288 CI--SNLSKTIKTLFLNNNKIYGS----IPAGIGNFVNLQRLDMWNNQLS 331
S++ ++T+ ++ + + + +L+ ++M N LS
Sbjct: 271 MFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 46.1 bits (108), Expect = 4e-05
Identities = 22/152 (14%), Positives = 55/152 (36%), Gaps = 16/152 (10%)
Query: 234 SLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGG------LLPG 287
+ L+ I S L +D+ L N +L +++ ++G P
Sbjct: 188 GKKPRPNLKSLEIISGGLPDSVVEDIL-GSDLPNLEKLV-LYVGVEDYGFDGDMNVFRPL 245
Query: 288 CISNLSKTIKTLFLNNNKIYGSIPAGIGNFV---NLQRLDMWNNQLSGT----IPPAIGE 340
+ +K L + + + + L+ +D+ L+ + + +
Sbjct: 246 FSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDK 305
Query: 341 LQNLKILGLNRNKLSGNIPPSIGN-LKMLLNL 371
+++LK + + N LS + + L M +++
Sbjct: 306 IKHLKFINMKYNYLSDEMKKELQKSLPMKIDV 337
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 41.9 bits (97), Expect = 8e-04
Identities = 30/160 (18%), Positives = 47/160 (29%), Gaps = 23/160 (14%)
Query: 382 IPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWS-----RNKLTGSLPIEVG 436
+ L L + + N +L SL I + L LP
Sbjct: 164 LSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLP---- 219
Query: 437 KLKILEFLYVYENRLEGEIPSTF------GNCIRLEQLGMGGNLFQGPISSSLGS---LR 487
L+ L E+ + F L+ LG+ Q + L
Sbjct: 220 NLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILP 279
Query: 488 GLRVLDLSQNNLSGEIPKFLAGL-----SLNNLNLSYNDL 522
L +D+S L+ E + L L +N+ YN L
Sbjct: 280 QLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 7e-06
Identities = 26/110 (23%), Positives = 39/110 (35%), Gaps = 27/110 (24%)
Query: 295 TIKTLFLNNNKIY-GSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNK 353
++ L L+N K G I FVNL+ L + N L + NL
Sbjct: 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--------SVSNLP-------- 68
Query: 354 LSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLS 403
L L L L++N + + + +L +NLS N L
Sbjct: 69 ----------KLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 27/130 (20%), Positives = 49/130 (37%), Gaps = 9/130 (6%)
Query: 115 LKVLALNNNSIC-GEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHL 173
++ L L+N G+I + L + N L +S L K + L L N +
Sbjct: 26 VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL--ISVSNLPKLPKLKKLELSENRI 83
Query: 174 TGSIPSSLGNLSSIHTISLAYNNLD--GTIPNSFGWFENLVFLSLAANNLSVVEN---KL 228
G + L ++ ++L+ N L T+ E L L L ++ + + +
Sbjct: 84 FGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNCEVTNLNDYRESV 142
Query: 229 TGEVPSLEKL 238
+P L L
Sbjct: 143 FKLLPQLTYL 152
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 4e-04
Identities = 28/127 (22%), Positives = 50/127 (39%), Gaps = 19/127 (14%)
Query: 183 NLSSIHTISLAYNNLD-GTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRL 241
+++ + L + G I F NL FLSL L V N L KL +L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSN--------LPKLPKL 73
Query: 242 QHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLS--KTIKTL 299
+ ++ N + G + L LT ++++ N + + L + +K+L
Sbjct: 74 KKLELSENRIFGGLDMLAEKL------PNLTHLNLSGNKLKDI--STLEPLKKLECLKSL 125
Query: 300 FLNNNKI 306
L N ++
Sbjct: 126 DLFNCEV 132
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 6e-04
Identities = 29/136 (21%), Positives = 45/136 (33%), Gaps = 29/136 (21%)
Query: 364 NLKMLLNLFL-NDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDW 422
+ L L N + I + +L ++L N L S+S+L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--------SVSNLP----- 68
Query: 423 SRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPIS-S 481
KL L+ L + ENR+ G + L L + GN + +
Sbjct: 69 --------------KLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLE 114
Query: 482 SLGSLRGLRVLDLSQN 497
L L L+ LDL
Sbjct: 115 PLKKLECLKSLDLFNC 130
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 37/180 (20%), Positives = 61/180 (33%), Gaps = 29/180 (16%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTAC 692
+G G FG +Y A V +++ F E K + + ++ +K
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFS-ELKFYQRVAKKDCIKKWIER 102
Query: 693 LGADYRG---------NDFKASVYEFM---HYG-SLEEWLHPFTGEDEIDEAPRNLNLLQ 739
DY G +FK Y FM G L++
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKIS----------GQNGTFKKST 152
Query: 740 RLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV--GDFGLARILSPDHTQ 797
L + I + L Y+H + H D+K +N+LL +V D+GL+ P+
Sbjct: 153 VLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 32/167 (19%), Positives = 56/167 (33%), Gaps = 39/167 (23%)
Query: 635 GVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSI-RHRNLVKVLTACL 693
G+G G V + + A+K+ E + + ++V+++
Sbjct: 27 GLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDV-- 79
Query: 694 GADYR-GNDFKASVY---EFMHYGSL-----EEWLHPFTGEDEIDEAPRNLNLLQRLNIA 744
Y + + E + G L + FT E + + I
Sbjct: 80 ---YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT---EREAS----------EIM 123
Query: 745 IDIAYALNYLHHDCQPVTAHCDLKPSNVLL---DDYMTARVGDFGLA 788
I A+ YLH + AH D+KP N+L ++ DFG A
Sbjct: 124 KSIGEAIQYLH--SINI-AHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 949 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.91 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.88 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.85 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.85 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.84 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.84 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.82 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.8 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.8 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.79 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.79 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.79 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.78 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.78 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.78 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.78 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.77 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.77 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.77 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.76 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.74 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.74 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.74 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.73 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.73 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.72 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.72 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.7 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.68 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.66 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.65 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.65 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.63 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.63 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.61 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.6 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.59 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.58 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.58 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.57 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.55 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.52 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.52 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.52 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.49 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.47 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.46 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.45 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.44 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.31 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.29 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.26 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.24 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.22 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.2 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.17 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.96 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.94 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.89 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.89 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.87 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.85 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.83 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.78 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.48 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.45 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.39 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.35 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.34 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.3 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.28 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.12 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.0 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.84 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.72 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.66 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.62 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.47 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.46 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.43 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.23 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.18 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.07 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.05 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.01 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.93 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.67 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.65 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.61 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.5 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.34 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.34 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.28 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.84 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.45 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.36 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.95 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 84.25 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-74 Score=706.73 Aligned_cols=535 Identities=30% Similarity=0.464 Sum_probs=390.9
Q ss_pred hcCCCChhhHHHHHHHHhccCCCCCCCccCccCCCCcceeeeeEEeCCCCcEEEEEcCCCCCCcc---cc----------
Q 039533 16 VAGTGNETDRVALLEFKSKSTYDPVGVLGTWNESIHFCKWYGVTCSRRHQRVTLLDLRSLKLAGS---VS---------- 82 (949)
Q Consensus 16 ~~~~~~~~~~~aLl~~k~~~~~~~~~~l~sW~~~~~~C~w~gv~C~~~~~~v~~l~l~~~~l~g~---~~---------- 82 (949)
+++.+.++|++|||+||+++. ||. .+++|+.++|||+|.||+|+ ++||+.|||+++++.|. ++
T Consensus 5 ~~~~~~~~~~~all~~k~~~~-~~~-~l~~W~~~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~ 80 (768)
T 3rgz_A 5 SPSQSLYREIHQLISFKDVLP-DKN-LLPDWSSNKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLE 80 (768)
T ss_dssp ---CCHHHHHHHHHHHHTTCS-CTT-SSTTCCTTSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCC
T ss_pred ccccCCHHHHHHHHHHHhhCC-Ccc-cccCCCCCCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCccc
Confidence 455567899999999999986 888 99999988899999999999 68999999999999987 44
Q ss_pred -------------CCCCCCCCCceeeccCceeccccCC--cccCcccCcEEeeccccccCcCCCCC-CCCccceeecCCC
Q 039533 83 -------------HFIGNLSFLKQLYLQVNSFTHEIPS--EIGGLRRLKVLALNNNSICGEIPTNI-SRCSTLIPIHPQN 146 (949)
Q Consensus 83 -------------~~l~~l~~L~~L~L~~n~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~l~~ 146 (949)
+.++++++|++|+|++|.++|.+|. .|+++++|++|+|++|.+++.+|..+ +++++|++|++++
T Consensus 81 ~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~ 160 (768)
T 3rgz_A 81 SLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSA 160 (768)
T ss_dssp EEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCS
T ss_pred ccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCC
Confidence 5788899999999999999999998 89999999999999999988888765 6666666666666
Q ss_pred cccccccccc-------------------------ccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCC
Q 039533 147 NQLVGKILSR-------------------------FSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTI 201 (949)
Q Consensus 147 n~l~~~~~~~-------------------------~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 201 (949)
|++++..+.. +..+++|++|+|++|.+++.+|. ++++++|++|+|++|++++.+
T Consensus 161 n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~ 239 (768)
T 3rgz_A 161 NSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDF 239 (768)
T ss_dssp SCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCH
T ss_pred CccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcc
Confidence 6665544332 13555666666666666665554 666666666666666666666
Q ss_pred CCcccCCCccccccccCcccccc---------------cccccCCC-------------------------C-Chhhhcc
Q 039533 202 PNSFGWFENLVFLSLAANNLSVV---------------ENKLTGEV-------------------------P-SLEKLQR 240 (949)
Q Consensus 202 p~~~~~l~~L~~L~Ls~N~l~~~---------------~~~l~~~~-------------------------~-~l~~l~~ 240 (949)
|..|+.+++|++|+|++|.++.. .+.+.|.+ | .+..+++
T Consensus 240 ~~~l~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~ 319 (768)
T 3rgz_A 240 SRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSL 319 (768)
T ss_dssp HHHTTTCSSCCEEECCSSCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTT
T ss_pred cHHHhcCCCCCEEECCCCcccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCC
Confidence 66666666666666655554311 01111111 1 1233333
Q ss_pred ccccccccCCCC-------------------------CCCCCCcchh-------------------ccccc--cCcccEE
Q 039533 241 LQHFTITSNSLG-------------------------SGGNDDLSFL-------------------CSLTN--ATRLTWM 274 (949)
Q Consensus 241 L~~L~l~~N~l~-------------------------~~~~~~~~~~-------------------~~l~~--~~~L~~L 274 (949)
|++|++++|++. ...+..+... ..+.. +++|++|
T Consensus 320 L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L 399 (768)
T 3rgz_A 320 LESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQEL 399 (768)
T ss_dssp CCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEE
T ss_pred ccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEE
Confidence 333333333332 1111111000 00001 3345555
Q ss_pred EccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCccc
Q 039533 275 HINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKL 354 (949)
Q Consensus 275 ~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 354 (949)
++++|++++.+|..+..+ ++|++|+|++|++++.+|..++.+++|++|+|++|.+++.+|..+..+++|+.|+|++|++
T Consensus 400 ~L~~n~l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l 478 (768)
T 3rgz_A 400 YLQNNGFTGKIPPTLSNC-SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDL 478 (768)
T ss_dssp ECCSSEEEEECCGGGGGC-TTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCC
T ss_pred ECCCCccccccCHHHhcC-CCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcc
Confidence 555555555555555555 3466666666666666666666666666666666666666666666777777777777777
Q ss_pred ccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccc
Q 039533 355 SGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIE 434 (949)
Q Consensus 355 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~ 434 (949)
++.+|..+.++++|++|+|++|++++.+|.+|+.+++|++|+|++|+++|.+|..+..+++| +.|++++|+++|.+|..
T Consensus 479 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L-~~L~Ls~N~l~g~ip~~ 557 (768)
T 3rgz_A 479 TGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSL-IWLDLNTNLFNGTIPAA 557 (768)
T ss_dssp CSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTC-CEEECCSSEEESBCCGG
T ss_pred cCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCC-CEEECCCCccCCcCChH
Confidence 77777777777777777777777777777777777777777777777777777777777777 67777777777766654
Q ss_pred c----------------------------------------------------------------------cccccccee
Q 039533 435 V----------------------------------------------------------------------GKLKILEFL 444 (949)
Q Consensus 435 ~----------------------------------------------------------------------~~l~~L~~L 444 (949)
+ +.+++|++|
T Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~L 637 (768)
T 3rgz_A 558 MFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFL 637 (768)
T ss_dssp GGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEE
T ss_pred HhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEE
Confidence 3 335678899
Q ss_pred eeccccccccCCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCcCcccccCCc-cceEeCCCCcCc
Q 039533 445 YVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLS-LNNLNLSYNDLE 523 (949)
Q Consensus 445 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~l~ls~N~l~ 523 (949)
||++|+++|.+|.+|+++++|+.|+|++|+++|.+|..|+.+++|+.||||+|+++|.+|..+..++ |++||+++|+|+
T Consensus 638 dLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~ 717 (768)
T 3rgz_A 638 DMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLS 717 (768)
T ss_dssp ECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEE
T ss_pred ECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999887 999999999999
Q ss_pred CcccccccccccccccccCCCCCCCCCCCCCCCccccc
Q 039533 524 GMVTTEGVFKNASATRILGNSKLCGGISEFKLPTCVSK 561 (949)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~gn~~~c~~~~~~~~~~c~~~ 561 (949)
|.||..++|..++..+|.||+++||.|.. .|...
T Consensus 718 g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~----~C~~~ 751 (768)
T 3rgz_A 718 GPIPEMGQFETFPPAKFLNNPGLCGYPLP----RCDPS 751 (768)
T ss_dssp EECCSSSSGGGSCGGGGCSCTEEESTTSC----CCCSC
T ss_pred ccCCCchhhccCCHHHhcCCchhcCCCCc----CCCCC
Confidence 99999999999999999999999998753 56543
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-59 Score=564.72 Aligned_cols=480 Identities=20% Similarity=0.229 Sum_probs=410.3
Q ss_pred CCChhhHHHHHHHHhccCCCCCC-------CccCccCCCCccee---eeeEEeCCCCcEEEEEcCCCCCCccccCCCCCC
Q 039533 19 TGNETDRVALLEFKSKSTYDPVG-------VLGTWNESIHFCKW---YGVTCSRRHQRVTLLDLRSLKLAGSVSHFIGNL 88 (949)
Q Consensus 19 ~~~~~~~~aLl~~k~~~~~~~~~-------~l~sW~~~~~~C~w---~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l 88 (949)
+....|++||.+||.+...+++. ...+|+.+++||.| .||+|+.. +||+.|+|++++++|.+|+++++|
T Consensus 26 ~~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~~L 104 (636)
T 4eco_A 26 AEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQL 104 (636)
T ss_dssp CHHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGGGC
T ss_pred hhHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHhcC
Confidence 34467999999999986443333 23489988999999 99999875 899999999999999999999999
Q ss_pred CCCceeeccCcee------cc------ccCCcccCcccCcEEeeccccccCcCCCCCCCC-cc-----------------
Q 039533 89 SFLKQLYLQVNSF------TH------EIPSEIGGLRRLKVLALNNNSICGEIPTNISRC-ST----------------- 138 (949)
Q Consensus 89 ~~L~~L~L~~n~l------~~------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~----------------- 138 (949)
++|++|+|++|++ .| .+|... +.+|+ +++++|.+.+.+|..++.+ ..
T Consensus 105 ~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~ 181 (636)
T 4eco_A 105 TELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRI 181 (636)
T ss_dssp TTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCC
T ss_pred ccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCcccccccccccc
Confidence 9999999999987 33 455444 67888 9999999999888877632 12
Q ss_pred -ceeecCC--CccccccccccccCCCCCcEEECCCCCCCCC-----------------CCCCcC--CCCCccEEeccccc
Q 039533 139 -LIPIHPQ--NNQLVGKILSRFSSLSKTEILNLGSNHLTGS-----------------IPSSLG--NLSSIHTISLAYNN 196 (949)
Q Consensus 139 -L~~L~l~--~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~-----------------~p~~~~--~l~~L~~L~L~~N~ 196 (949)
++.+.+. +|++++ +|..|+++++|++|+|++|.|+|. +|..++ ++++|++|+|++|+
T Consensus 182 ~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~ 260 (636)
T 4eco_A 182 TLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCP 260 (636)
T ss_dssp CCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCT
T ss_pred chhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCc
Confidence 2222222 689999 899999999999999999999986 999999 99999999999999
Q ss_pred cCCCCCCcccCCCccccccccCcc-cccccccccCCCC-Chhhh------ccccccccccCCCCCCCCCCcchhc--ccc
Q 039533 197 LDGTIPNSFGWFENLVFLSLAANN-LSVVENKLTGEVP-SLEKL------QRLQHFTITSNSLGSGGNDDLSFLC--SLT 266 (949)
Q Consensus 197 l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~l~~~~~-~l~~l------~~L~~L~l~~N~l~~~~~~~~~~~~--~l~ 266 (949)
+.+.+|..|+++++|++|+|++|+ ++.. .+| .+.++ ++|++|++++|+++.. +. .+.
T Consensus 261 l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~------~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~i-------p~~~~l~ 327 (636)
T 4eco_A 261 NLTKLPTFLKALPEMQLINVACNRGISGE------QLKDDWQALADAPVGEKIQIIYIGYNNLKTF-------PVETSLQ 327 (636)
T ss_dssp TCSSCCTTTTTCSSCCEEECTTCTTSCHH------HHHHHHHHHHHSGGGGTCCEEECCSSCCSSC-------CCHHHHT
T ss_pred CCccChHHHhcCCCCCEEECcCCCCCccc------cchHHHHhhhccccCCCCCEEECCCCcCCcc-------Cchhhhc
Confidence 999999999999999999999997 6520 233 24454 8999999999999742 33 577
Q ss_pred ccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCc-ccEEEeecceecccCCCcccccC--C
Q 039533 267 NATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVN-LQRLDMWNNQLSGTIPPAIGELQ--N 343 (949)
Q Consensus 267 ~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~--~ 343 (949)
++++|++|++++|+++|.+| .+..+ ++|++|+|++|+++ .+|..+..+++ |++|+|++|.++ .+|..+..+. +
T Consensus 328 ~l~~L~~L~L~~N~l~g~ip-~~~~l-~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~ 403 (636)
T 4eco_A 328 KMKKLGMLECLYNQLEGKLP-AFGSE-IKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSV 403 (636)
T ss_dssp TCTTCCEEECCSCCCEEECC-CCEEE-EEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSC
T ss_pred cCCCCCEEeCcCCcCccchh-hhCCC-CCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCc
Confidence 88999999999999999999 77777 46999999999999 88999999999 999999999999 7888888765 8
Q ss_pred CCEEecCCcccccccCcccc-------cccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCc--
Q 039533 344 LKILGLNRNKLSGNIPPSIG-------NLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLS-- 414 (949)
Q Consensus 344 L~~L~Ls~N~l~~~~p~~~~-------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~-- 414 (949)
|+.|+|++|++++.+|..+. .+++|+.|+|++|.++...+..+..+++|++|+|++|+++ .+|..++...
T Consensus 404 L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~ 482 (636)
T 4eco_A 404 MSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENE 482 (636)
T ss_dssp EEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTE
T ss_pred cCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccc
Confidence 99999999999999999888 8889999999999999444444566899999999999999 7888766543
Q ss_pred ------ccceeeccCCCccCCCCccccc--cccccceeeeccccccccCCcccccccchhhccc------CccccccccC
Q 039533 415 ------SLSISLDWSRNKLTGSLPIEVG--KLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGM------GGNLFQGPIS 480 (949)
Q Consensus 415 ------~l~~~L~ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l------~~N~l~~~~~ 480 (949)
+| +.|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..++.+++|+.|+| ++|++.+.+|
T Consensus 483 ~~~~l~~L-~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p 559 (636)
T 4eco_A 483 NFKNTYLL-TSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWP 559 (636)
T ss_dssp ECTTGGGC-CEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCC
T ss_pred cccccCCc-cEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccCh
Confidence 67 78999999999 7888887 99999999999999997 8999999999999999 5688899999
Q ss_pred CCcCCCCCCCEEECCCCcCCCcCcccccCCccceEeCCCCcCcCcc
Q 039533 481 SSLGSLRGLRVLDLSQNNLSGEIPKFLAGLSLNNLNLSYNDLEGMV 526 (949)
Q Consensus 481 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~ls~N~l~~~~ 526 (949)
..++.+++|+.|+|++|+| +.+|..+. .+|+.|++++|++....
T Consensus 560 ~~l~~l~~L~~L~Ls~N~l-~~ip~~~~-~~L~~L~Ls~N~l~~~~ 603 (636)
T 4eco_A 560 EGITLCPSLTQLQIGSNDI-RKVNEKIT-PNISVLDIKDNPNISID 603 (636)
T ss_dssp TTGGGCSSCCEEECCSSCC-CBCCSCCC-TTCCEEECCSCTTCEEE
T ss_pred HHHhcCCCCCEEECCCCcC-CccCHhHh-CcCCEEECcCCCCcccc
Confidence 9999999999999999999 57887765 35999999999887653
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-57 Score=558.24 Aligned_cols=449 Identities=31% Similarity=0.483 Sum_probs=367.4
Q ss_pred CcEEEEEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecC
Q 039533 65 QRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHP 144 (949)
Q Consensus 65 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 144 (949)
.+++.|+|++|.+++.++. ++++++|++|+|++|.+++.+|..|+++++|++|+|++|.+++.+|.. .+++|++|++
T Consensus 200 ~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L 276 (768)
T 3rgz_A 200 VNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSL 276 (768)
T ss_dssp TTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEEC
T ss_pred CcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEEC
Confidence 3566777777777776665 777777777777777777777777777777777777777777666654 6677777777
Q ss_pred CCccccccccccccCC-CCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCc-ccCCCccccccccCcccc
Q 039533 145 QNNQLVGKILSRFSSL-SKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNS-FGWFENLVFLSLAANNLS 222 (949)
Q Consensus 145 ~~n~l~~~~~~~~~~L-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~ 222 (949)
++|++++.+|..+..+ ++|++|+|++|++++.+|..|+++++|++|+|++|+++|.+|.. |+.+++|++|+|++|+++
T Consensus 277 ~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~ 356 (768)
T 3rgz_A 277 AENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFS 356 (768)
T ss_dssp CSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEE
T ss_pred cCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccC
Confidence 7777776666666554 77777777777777777777777777777777777777666654 777777777777777654
Q ss_pred cccccccCCCC-Chhhhc-cccccccccCCCCCCCCCCc--------------------chhccccccCcccEEEccCCC
Q 039533 223 VVENKLTGEVP-SLEKLQ-RLQHFTITSNSLGSGGNDDL--------------------SFLCSLTNATRLTWMHINSNN 280 (949)
Q Consensus 223 ~~~~~l~~~~~-~l~~l~-~L~~L~l~~N~l~~~~~~~~--------------------~~~~~l~~~~~L~~L~L~~N~ 280 (949)
+.+| .+..++ +|++|++++|++....+..+ ..+..+.++++|++|++++|+
T Consensus 357 -------~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~ 429 (768)
T 3rgz_A 357 -------GELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNY 429 (768)
T ss_dssp -------ECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSE
T ss_pred -------ccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCc
Confidence 2222 244444 55555555555432111110 234467889999999999999
Q ss_pred CCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCc
Q 039533 281 FGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPP 360 (949)
Q Consensus 281 l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 360 (949)
+++.+|..+..++ +|++|+|++|++++.+|..+..+++|++|+|++|++++.+|..+.++++|++|+|++|++++.+|.
T Consensus 430 l~~~~p~~l~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~ 508 (768)
T 3rgz_A 430 LSGTIPSSLGSLS-KLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPK 508 (768)
T ss_dssp EESCCCGGGGGCT-TCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCG
T ss_pred ccCcccHHHhcCC-CCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCCh
Confidence 9999999999985 699999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccC----------------------------
Q 039533 361 SIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFS---------------------------- 412 (949)
Q Consensus 361 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~---------------------------- 412 (949)
+++++++|++|+|++|++++.+|..+.++++|++|++++|+++|.+|..++.
T Consensus 509 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (768)
T 3rgz_A 509 WIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECH 588 (768)
T ss_dssp GGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCC
T ss_pred HHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccccccc
Confidence 9999999999999999999999999999999999999999999999876644
Q ss_pred ------------------------------------------CcccceeeccCCCccCCCCccccccccccceeeecccc
Q 039533 413 ------------------------------------------LSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENR 450 (949)
Q Consensus 413 ------------------------------------------l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 450 (949)
++++ +.|||++|+++|.+|..++.++.|+.|+|++|+
T Consensus 589 ~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L-~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~ 667 (768)
T 3rgz_A 589 GAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSM-MFLDMSYNMLSGYIPKEIGSMPYLFILNLGHND 667 (768)
T ss_dssp SSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCC-CEEECCSSCCBSCCCGGGGGCTTCCEEECCSSC
T ss_pred ccccccccccccchhhhccccccccccccceecccCchhhhccccc-cEEECcCCcccccCCHHHhccccCCEEeCcCCc
Confidence 2345 679999999999999999999999999999999
Q ss_pred ccccCCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCcCcccccCCccceEeCCCCc-CcCc
Q 039533 451 LEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLSLNNLNLSYND-LEGM 525 (949)
Q Consensus 451 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~ls~N~-l~~~ 525 (949)
++|.+|..|+++++|+.|||++|+++|.+|..++.+++|++||||+|+|+|.||......++....+.+|+ |+|.
T Consensus 668 l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~ 743 (768)
T 3rgz_A 668 ISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGY 743 (768)
T ss_dssp CCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEEST
T ss_pred cCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCC
Confidence 99999999999999999999999999999999999999999999999999999986443346666677775 6664
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-57 Score=552.44 Aligned_cols=463 Identities=19% Similarity=0.221 Sum_probs=326.3
Q ss_pred cCCCChhhHHHHHHHHhccCCCCCCCccCccCCC-----Cc--cee------------eeeEEeCCCCcEEEEEcCCCCC
Q 039533 17 AGTGNETDRVALLEFKSKSTYDPVGVLGTWNESI-----HF--CKW------------YGVTCSRRHQRVTLLDLRSLKL 77 (949)
Q Consensus 17 ~~~~~~~~~~aLl~~k~~~~~~~~~~l~sW~~~~-----~~--C~w------------~gv~C~~~~~~v~~l~l~~~~l 77 (949)
++++..+|++||++||+++ .+| +|+.+. +| |+| .||+|+. ++||+.|+|+++++
T Consensus 263 ~~~~~~~d~~ALl~~k~~l-~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L 335 (876)
T 4ecn_A 263 ETAEYIKDYKALKAIWEAL-DGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGA 335 (876)
T ss_dssp CCCHHHHHHHHHHHHHHHT-TGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCC
T ss_pred ccccchHHHHHHHHHHHHc-CCC-----CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCC
Confidence 3445578999999999987 355 786544 55 999 9999987 58999999999999
Q ss_pred CccccCCCCCCCCCceeec-cCceeccccCCcc-----------------------------------------------
Q 039533 78 AGSVSHFIGNLSFLKQLYL-QVNSFTHEIPSEI----------------------------------------------- 109 (949)
Q Consensus 78 ~g~~~~~l~~l~~L~~L~L-~~n~l~~~~p~~~----------------------------------------------- 109 (949)
+|.+|++|++|++|++|+| ++|.++|..|-..
T Consensus 336 ~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~ 415 (876)
T 4ecn_A 336 KGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMK 415 (876)
T ss_dssp EEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSC
T ss_pred CCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccc
Confidence 9999999999999999999 8999988744221
Q ss_pred ----cCcccCcEEeecc--ccccCcCCCCCCCCccceeecCCCccccc-----------------ccccccc--CCCCCc
Q 039533 110 ----GGLRRLKVLALNN--NSICGEIPTNISRCSTLIPIHPQNNQLVG-----------------KILSRFS--SLSKTE 164 (949)
Q Consensus 110 ----~~l~~L~~L~Ls~--N~l~~~~p~~~~~l~~L~~L~l~~n~l~~-----------------~~~~~~~--~L~~L~ 164 (949)
.....++.+.++. |+++| +|..|+++++|++|+|++|.+++ .+|..++ ++++|+
T Consensus 416 ~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~ 494 (876)
T 4ecn_A 416 PIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLT 494 (876)
T ss_dssp CCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCC
T ss_pred ccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCC
Confidence 1122334444443 88887 89999999999999999999988 3777776 999999
Q ss_pred EEECCCCCCCCCCCCCcCCCCCccEEeccccc-cCC-CCCCcccCCC-------ccccccccCcccccccccccCCCCCh
Q 039533 165 ILNLGSNHLTGSIPSSLGNLSSIHTISLAYNN-LDG-TIPNSFGWFE-------NLVFLSLAANNLSVVENKLTGEVPSL 235 (949)
Q Consensus 165 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~p~~~~~l~-------~L~~L~Ls~N~l~~~~~~l~~~~~~l 235 (949)
+|+|++|.+.+.+|..|+++++|++|+|++|+ ++| .+|..++.++ +|++|+|++|+++.++. ...+
T Consensus 495 ~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~-----~~~l 569 (876)
T 4ecn_A 495 DVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPA-----SASL 569 (876)
T ss_dssp EEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCC-----HHHH
T ss_pred EEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCC-----hhhh
Confidence 99999999999999999999999999999998 888 7887776665 99999999998764432 0025
Q ss_pred hhhccccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCC
Q 039533 236 EKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIG 315 (949)
Q Consensus 236 ~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~ 315 (949)
.++++|++|+|++|+++..+ .+.++++|+.|+|++|+++ .+|..+..++.+|++|+|++|+|+ .+|..+.
T Consensus 570 ~~L~~L~~L~Ls~N~l~~lp--------~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~ 639 (876)
T 4ecn_A 570 QKMVKLGLLDCVHNKVRHLE--------AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFN 639 (876)
T ss_dssp TTCTTCCEEECTTSCCCBCC--------CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCC
T ss_pred hcCCCCCEEECCCCCcccch--------hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhh
Confidence 56667777777777665211 4556666777777777766 566666666433777777777766 5666665
Q ss_pred CCCc--ccEEEeecceecccCCCcc---c--ccCCCCEEecCCcccccccCccc-ccccccceeecccccccccCCCCCC
Q 039533 316 NFVN--LQRLDMWNNQLSGTIPPAI---G--ELQNLKILGLNRNKLSGNIPPSI-GNLKMLLNLFLNDNFLEVSIPSSLG 387 (949)
Q Consensus 316 ~l~~--L~~L~L~~N~l~~~~p~~~---~--~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~~~ 387 (949)
.++. |+.|+|++|++++.+|... . .+++|+.|+|++|+|+ .+|..+ ..+++|+.|+|++|+++ .+|..+.
T Consensus 640 ~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~ 717 (876)
T 4ecn_A 640 AKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSL 717 (876)
T ss_dssp TTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSS
T ss_pred ccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHh
Confidence 5543 7777777777766554322 2 2336667777777766 444443 35666666666666666 4444332
Q ss_pred CC--------CCCcEEEeeCccccCCCCCccc--CCcccceeeccCCCccCCCCccccccccccceeeeccccccccCCc
Q 039533 388 QC--------ESLIEINLSNNNLSGTIPPQFF--SLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPS 457 (949)
Q Consensus 388 ~l--------~~L~~L~l~~N~l~~~~p~~~~--~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 457 (949)
.. ++|+.|+|++|+|+ .+|..++ .+++| +.|+|++|++++ +|..+..+++|+.|+|++|+
T Consensus 718 ~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L-~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~------- 787 (876)
T 4ecn_A 718 KPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYL-SNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQR------- 787 (876)
T ss_dssp SCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTC-CEEECCSSCCSS-CCCGGGGCTTCCEEECCCCB-------
T ss_pred ccccccccccCCccEEECCCCCCc-cchHHhhhccCCCc-CEEEeCCCCCCc-cchhhhcCCCCCEEECCCCC-------
Confidence 21 26666666666666 5666655 56666 556666666664 55566666666666665543
Q ss_pred ccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCcCcccccCCccceEeCCCCcCcCccc
Q 039533 458 TFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLSLNNLNLSYNDLEGMVT 527 (949)
Q Consensus 458 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~ls~N~l~~~~~ 527 (949)
++++|++.+.+|..|..+++|+.|+|++|+| +.+|..+. .+|+.|+|++|++....+
T Consensus 788 -----------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~-~~L~~LdLs~N~l~~i~~ 844 (876)
T 4ecn_A 788 -----------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT-PQLYILDIADNPNISIDV 844 (876)
T ss_dssp -----------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC-SSSCEEECCSCTTCEEEC
T ss_pred -----------CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc-CCCCEEECCCCCCCccCh
Confidence 3345777777777777777788888888877 56776654 257778888887766543
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-55 Score=524.72 Aligned_cols=484 Identities=18% Similarity=0.173 Sum_probs=429.9
Q ss_pred eeeeEEeCC---------CCcEEEEEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccc
Q 039533 55 WYGVTCSRR---------HQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSI 125 (949)
Q Consensus 55 w~gv~C~~~---------~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l 125 (949)
+..|.|... ...++.|||++|.+++..+..|+++++|++|+|++|.+++..|.+|+++++|++|+|++|++
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 345778643 24689999999999988899999999999999999999999999999999999999999999
Q ss_pred cCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcc
Q 039533 126 CGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSF 205 (949)
Q Consensus 126 ~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 205 (949)
++..|..|+++++|++|++++|++++..+..|.++++|++|+|++|++++..+..+..+++|++|+|++|++++..|..|
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 173 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM 173 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHH
T ss_pred cccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhh
Confidence 98899999999999999999999999989999999999999999999997554555569999999999999998889999
Q ss_pred cCCCccc--cccccCcccccccccccCCC-----------------------------------------C--Chhhhc-
Q 039533 206 GWFENLV--FLSLAANNLSVVENKLTGEV-----------------------------------------P--SLEKLQ- 239 (949)
Q Consensus 206 ~~l~~L~--~L~Ls~N~l~~~~~~l~~~~-----------------------------------------~--~l~~l~- 239 (949)
+.+++|+ +|++++|.++.++....... + .+..+.
T Consensus 174 ~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~ 253 (606)
T 3t6q_A 174 SSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCE 253 (606)
T ss_dssp HTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGG
T ss_pred hhhcccceeEEecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhc
Confidence 9999999 89999999987665433211 0 011121
Q ss_pred -cccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCC
Q 039533 240 -RLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFV 318 (949)
Q Consensus 240 -~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~ 318 (949)
+|++|++++|.++..+.. .+.++++|++|++++|+++ .+|..+..+ ++|++|++++|++++..|..+..++
T Consensus 254 ~~L~~L~l~~n~l~~~~~~------~~~~l~~L~~L~l~~n~l~-~lp~~l~~l-~~L~~L~l~~n~l~~~~~~~~~~l~ 325 (606)
T 3t6q_A 254 MSVESINLQKHYFFNISSN------TFHCFSGLQELDLTATHLS-ELPSGLVGL-STLKKLVLSANKFENLCQISASNFP 325 (606)
T ss_dssp SEEEEEECTTCCCSSCCTT------TTTTCTTCSEEECTTSCCS-CCCSSCCSC-TTCCEEECTTCCCSBGGGGCGGGCT
T ss_pred CceeEEEeecCccCccCHH------HhccccCCCEEeccCCccC-CCChhhccc-ccCCEEECccCCcCcCchhhhhccC
Confidence 688899999988765433 3667899999999999999 677778877 4699999999999988898999999
Q ss_pred cccEEEeecceecccCCC-cccccCCCCEEecCCccccccc--CcccccccccceeecccccccccCCCCCCCCCCCcEE
Q 039533 319 NLQRLDMWNNQLSGTIPP-AIGELQNLKILGLNRNKLSGNI--PPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEI 395 (949)
Q Consensus 319 ~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 395 (949)
+|++|++++|.+.+.+|. .+.++++|++|+|++|++++.. |..+.++++|++|++++|.+++..|..|..+++|++|
T Consensus 326 ~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 405 (606)
T 3t6q_A 326 SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELL 405 (606)
T ss_dssp TCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEE
T ss_pred cCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeE
Confidence 999999999999877765 5999999999999999999776 8889999999999999999999999999999999999
Q ss_pred EeeCccccCCCCCc-ccCCcccceeeccCCCccCCCCccccccccccceeeecccccccc---CCcccccccchhhcccC
Q 039533 396 NLSNNNLSGTIPPQ-FFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGE---IPSTFGNCIRLEQLGMG 471 (949)
Q Consensus 396 ~l~~N~l~~~~p~~-~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~l~ 471 (949)
++++|++++..|.. +..+++| +.|++++|.+++..|..++.+++|++|++++|++++. .+..+..+++|+.|+|+
T Consensus 406 ~l~~n~l~~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls 484 (606)
T 3t6q_A 406 DLAFTRLKVKDAQSPFQNLHLL-KVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLS 484 (606)
T ss_dssp ECTTCCEECCTTCCTTTTCTTC-CEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECT
T ss_pred ECCCCcCCCcccchhhhCcccC-CEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECC
Confidence 99999999877665 7888998 8999999999999999999999999999999999873 34679999999999999
Q ss_pred ccccccccCCCcCCCCCCCEEECCCCcCCCcCcccccCCc-cceEeCCCCcCcCccccc-ccccccccccccCCCCCCC
Q 039533 472 GNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLS-LNNLNLSYNDLEGMVTTE-GVFKNASATRILGNSKLCG 548 (949)
Q Consensus 472 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~l~ls~N~l~~~~~~~-~~~~~~~~~~~~gn~~~c~ 548 (949)
+|++++..|..|+.+++|+.|+|++|++++.+|..+..++ | .|++++|++++.+|.. ..+..+..+.+.|||+.|.
T Consensus 485 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 562 (606)
T 3t6q_A 485 FCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562 (606)
T ss_dssp TSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECS
T ss_pred CCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCcccc
Confidence 9999999999999999999999999999999999999887 8 9999999999988764 5677888999999999984
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-53 Score=517.35 Aligned_cols=489 Identities=21% Similarity=0.250 Sum_probs=385.4
Q ss_pred ceeeeeEEeCC---------CCcEEEEEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeeccc
Q 039533 53 CKWYGVTCSRR---------HQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNN 123 (949)
Q Consensus 53 C~w~gv~C~~~---------~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N 123 (949)
|.+.-|.|+.. ..+++.|||++|++++..+..++++++|++|+|++|.+++..|..|+++++|++|+|++|
T Consensus 4 ~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 4 VSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred eECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 44455666532 247999999999999888888999999999999999999999999999999999999999
Q ss_pred cccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCC
Q 039533 124 SICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPN 203 (949)
Q Consensus 124 ~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 203 (949)
.+++..+..|+++++|++|++++|++++..+..|.++++|++|+|++|.+++..|..++++++|++|+|++|++++..+.
T Consensus 84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 163 (680)
T 1ziw_A 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 163 (680)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHH
T ss_pred ccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHH
Confidence 99955555799999999999999999999999999999999999999999999999999999999999999999988777
Q ss_pred ccc--CCCccccccccCcccccccccccCCCC---------------------------------------------Chh
Q 039533 204 SFG--WFENLVFLSLAANNLSVVENKLTGEVP---------------------------------------------SLE 236 (949)
Q Consensus 204 ~~~--~l~~L~~L~Ls~N~l~~~~~~l~~~~~---------------------------------------------~l~ 236 (949)
.++ .+++|++|++++|+++.+.....+.++ .+.
T Consensus 164 ~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~ 243 (680)
T 1ziw_A 164 ELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL 243 (680)
T ss_dssp HHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTG
T ss_pred HhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhh
Confidence 664 458999999999988765543222211 133
Q ss_pred hhcc--ccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcc----------------------
Q 039533 237 KLQR--LQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNL---------------------- 292 (949)
Q Consensus 237 ~l~~--L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l---------------------- 292 (949)
.++. |++|++++|+++...+ ..+..+++|++|++++|++++..|..+..+
T Consensus 244 ~l~~~~L~~L~Ls~n~l~~~~~------~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~l 317 (680)
T 1ziw_A 244 GLKWTNLTMLDLSYNNLNVVGN------DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASL 317 (680)
T ss_dssp GGGGSCCCEEECTTSCCCEECT------TTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------C
T ss_pred ccCcCCCCEEECCCCCcCccCc------ccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccc
Confidence 3333 6666666666654322 234556677777777777766655443322
Q ss_pred ----------cccccEEEccCccccCCCCCCCCCCCcccEEEee----------------------------cceecccC
Q 039533 293 ----------SKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMW----------------------------NNQLSGTI 334 (949)
Q Consensus 293 ----------~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~----------------------------~N~l~~~~ 334 (949)
.++|++|++++|++++..+..|..+++|++|+++ +|++++..
T Consensus 318 p~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~ 397 (680)
T 1ziw_A 318 PKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIE 397 (680)
T ss_dssp CEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEEC
T ss_pred cccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEC
Confidence 1346666666666666666666665555555544 44455555
Q ss_pred CCcccccCCCCEEecCCcccccccC-cccccccccceeecccccccccCCCCCCCCCCCcEEEeeCcccc--CCCCCccc
Q 039533 335 PPAIGELQNLKILGLNRNKLSGNIP-PSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLS--GTIPPQFF 411 (949)
Q Consensus 335 p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~--~~~p~~~~ 411 (949)
|.+|..+++|+.|+|++|++++.+| ..|.++++|++|++++|++++..+..|..+++|+.|++++|.++ +.+|..+.
T Consensus 398 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~ 477 (680)
T 1ziw_A 398 SDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQ 477 (680)
T ss_dssp TTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTT
T ss_pred hhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccc
Confidence 6677777777777777777776555 56777777777777777777777777777788888888888776 56788889
Q ss_pred CCcccceeeccCCCccCCCCccccccccccceeeeccccccccCC--------cccccccchhhcccCccccccccCCCc
Q 039533 412 SLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIP--------STFGNCIRLEQLGMGGNLFQGPISSSL 483 (949)
Q Consensus 412 ~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~l~~N~l~~~~~~~~ 483 (949)
.+++| +.|++++|++++..|..+.++++|++|+|++|++++..+ ..|+++++|+.|+|++|+++...+..|
T Consensus 478 ~l~~L-~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~ 556 (680)
T 1ziw_A 478 PLRNL-TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVF 556 (680)
T ss_dssp TCTTC-CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred cCCCC-CEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHc
Confidence 99999 789999999998888889999999999999999986422 247899999999999999996666679
Q ss_pred CCCCCCCEEECCCCcCCCcCcccccCCc-cceEeCCCCcCcCccccc-c-cccccccccccCCCCCCC
Q 039533 484 GSLRGLRVLDLSQNNLSGEIPKFLAGLS-LNNLNLSYNDLEGMVTTE-G-VFKNASATRILGNSKLCG 548 (949)
Q Consensus 484 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~l~ls~N~l~~~~~~~-~-~~~~~~~~~~~gn~~~c~ 548 (949)
.++++|+.|||++|+|++.++..+..++ |+.|+|++|.|++.++.. . .+..+..+.+.||||.|.
T Consensus 557 ~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~ 624 (680)
T 1ziw_A 557 KDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT 624 (680)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBC
T ss_pred ccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccC
Confidence 9999999999999999987777777766 999999999999987753 2 577888999999999995
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-53 Score=508.83 Aligned_cols=483 Identities=20% Similarity=0.185 Sum_probs=419.1
Q ss_pred Ccceee----eeEEeCC---------CCcEEEEEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccCcE
Q 039533 51 HFCKWY----GVTCSRR---------HQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKV 117 (949)
Q Consensus 51 ~~C~w~----gv~C~~~---------~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 117 (949)
++|.|. .|.|+.. ..+++.|||++|.+++..+..|.++++|++|+|++|.+++..|.+|+++++|++
T Consensus 5 ~~c~~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~ 84 (606)
T 3vq2_A 5 NPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSN 84 (606)
T ss_dssp -CCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCE
T ss_pred CCceecCCCCceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCE
Confidence 456664 5777642 257899999999999888889999999999999999999888999999999999
Q ss_pred EeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECCCCCCCC-CCCCCcCCCCCccEEeccccc
Q 039533 118 LALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTG-SIPSSLGNLSSIHTISLAYNN 196 (949)
Q Consensus 118 L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~ 196 (949)
|+|++|.+++..|..|+++++|++|++++|++++..+..|+++++|++|+|++|.+++ .+|..|+++++|++|+|++|+
T Consensus 85 L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~ 164 (606)
T 3vq2_A 85 LILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNY 164 (606)
T ss_dssp EECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSC
T ss_pred eECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCc
Confidence 9999999998889999999999999999999999998999999999999999999986 579999999999999999999
Q ss_pred cCCCCCCcccCCCccc----cccccCcccccccccccCCCCChhhhccccccccccCCCCC-------------------
Q 039533 197 LDGTIPNSFGWFENLV----FLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGS------------------- 253 (949)
Q Consensus 197 l~~~~p~~~~~l~~L~----~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N~l~~------------------- 253 (949)
+++..|..|+.+++|+ +|++++|.++.++... ....+|++|++++|.+..
T Consensus 165 l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~-------~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~ 237 (606)
T 3vq2_A 165 IQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQA-------FQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLI 237 (606)
T ss_dssp CCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTT-------TTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEE
T ss_pred ceecChhhhhhhhccccccceeeccCCCcceeCccc-------ccCceeeeeeccCCccchhHHHHHhcccccccccccc
Confidence 9998899898888776 7999999998766432 223378888888887641
Q ss_pred --------------------------------CCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEc
Q 039533 254 --------------------------------GGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFL 301 (949)
Q Consensus 254 --------------------------------~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L 301 (949)
....-......+..+++|+.|++++|.+.. +| .+..+ ++|++|++
T Consensus 238 ~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~-l~-~l~~~-~~L~~L~l 314 (606)
T 3vq2_A 238 LGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY-LE-DVPKH-FKWQSLSI 314 (606)
T ss_dssp EECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEESCCCCC-CC-CCCTT-CCCSEEEE
T ss_pred ccccccCCcccccChHHhhhhhhccHhheeccccccccccccccccCCCCCEEEecCccchh-hh-hcccc-ccCCEEEc
Confidence 000111112236778899999999999975 44 56665 46999999
Q ss_pred cCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccc--cCcccccccccceeeccccccc
Q 039533 302 NNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGN--IPPSIGNLKMLLNLFLNDNFLE 379 (949)
Q Consensus 302 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~ 379 (949)
++|++ +.+| .+ .+++|++|++++|...+.+ .+..+++|+.|+|++|++++. +|..+..+++|++|++++|.++
T Consensus 315 ~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~ 389 (606)
T 3vq2_A 315 IRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI 389 (606)
T ss_dssp ESCCC-SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEE
T ss_pred ccccC-cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccc
Confidence 99999 5788 45 8999999999999665444 677999999999999999976 4889999999999999999998
Q ss_pred ccCCCCCCCCCCCcEEEeeCccccCCCC-CcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccc-cCCc
Q 039533 380 VSIPSSLGQCESLIEINLSNNNLSGTIP-PQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEG-EIPS 457 (949)
Q Consensus 380 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~ 457 (949)
+ +|..|..+++|++|++++|++++..| ..+..+++| +.|++++|.+++..|..++.+++|++|++++|++++ .+|.
T Consensus 390 ~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 467 (606)
T 3vq2_A 390 I-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKL-LYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSN 467 (606)
T ss_dssp E-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTC-CEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECS
T ss_pred c-chhhccCCCCCCeeECCCCccCCccChhhhhccccC-CEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHH
Confidence 5 67899999999999999999998887 688899999 899999999999999999999999999999999998 4899
Q ss_pred ccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCcCcccccCCc-cceEeCCCCcCcCccccccccc-cc
Q 039533 458 TFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLS-LNNLNLSYNDLEGMVTTEGVFK-NA 535 (949)
Q Consensus 458 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~l~ls~N~l~~~~~~~~~~~-~~ 535 (949)
.|+.+++|+.|+|++|++++.+|..|+.+++|+.|+|++|++++.+|..+..++ |+.|++++|++++.++....+. ++
T Consensus 468 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L 547 (606)
T 3vq2_A 468 VFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSL 547 (606)
T ss_dssp CCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTC
T ss_pred hhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccC
Confidence 999999999999999999999999999999999999999999999999998887 9999999999997665544554 47
Q ss_pred ccccccCCCCCCCCC
Q 039533 536 SATRILGNSKLCGGI 550 (949)
Q Consensus 536 ~~~~~~gn~~~c~~~ 550 (949)
..+.+.+||+.|.-+
T Consensus 548 ~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 548 AFFNLTNNSVACICE 562 (606)
T ss_dssp CEEECCSCCCCCSST
T ss_pred cEEEccCCCcccCCc
Confidence 888999999999644
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-53 Score=526.61 Aligned_cols=483 Identities=22% Similarity=0.197 Sum_probs=400.4
Q ss_pred ceeeeeEEeCCCCcEEEEEcCCCCCCccccCCCCCCCCCceeeccCceecccc-CCcccCcccCcEEeeccccccCcCCC
Q 039533 53 CKWYGVTCSRRHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEI-PSEIGGLRRLKVLALNNNSICGEIPT 131 (949)
Q Consensus 53 C~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~ 131 (949)
|+|.+|.+ -..+++.|||++|.+++..+..|.++++|++|+|++|.+.+.+ |.+|+++++|++|+|++|.+++..|.
T Consensus 14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~ 91 (844)
T 3j0a_A 14 CNLTQVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD 91 (844)
T ss_dssp CCSSCCCS--SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred CCCCCCCC--CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence 56778877 3468999999999999988999999999999999999777777 78899999999999999999988999
Q ss_pred CCCCCccceeecCCCcccccccccc--ccCCCCCcEEECCCCCCCCCCC-CCcCCCCCccEEeccccccCCCCCCcccCC
Q 039533 132 NISRCSTLIPIHPQNNQLVGKILSR--FSSLSKTEILNLGSNHLTGSIP-SSLGNLSSIHTISLAYNNLDGTIPNSFGWF 208 (949)
Q Consensus 132 ~~~~l~~L~~L~l~~n~l~~~~~~~--~~~L~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 208 (949)
.|+++++|++|+|++|.+++..+.. |.++++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++..|..|+.+
T Consensus 92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l 171 (844)
T 3j0a_A 92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL 171 (844)
T ss_dssp SSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHH
T ss_pred HccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccc
Confidence 9999999999999999999866554 9999999999999999997765 579999999999999999999999999888
Q ss_pred --CccccccccCcccccccccccCCCCChhhhccccccccccCCCCCCCCCCcchh------------------------
Q 039533 209 --ENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFL------------------------ 262 (949)
Q Consensus 209 --~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~------------------------ 262 (949)
++|++|+|++|.+......-.+..+..-...+|++|++++|.++......+...
T Consensus 172 ~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~ 251 (844)
T 3j0a_A 172 QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHN 251 (844)
T ss_dssp HHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSS
T ss_pred cCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccc
Confidence 899999999998875332222222221122259999999998765433222110
Q ss_pred ------ccccc--cCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeecceecccC
Q 039533 263 ------CSLTN--ATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTI 334 (949)
Q Consensus 263 ------~~l~~--~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 334 (949)
..+.+ .++|+.|++++|.+.+..|..+..++ +|++|+|++|+|++..|..|..+++|++|+|++|.+++..
T Consensus 252 l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 330 (844)
T 3j0a_A 252 IKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLK-DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELY 330 (844)
T ss_dssp STTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCC-CCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCC
T ss_pred cCCCChhhhhccccCCccEEECCCCcccccChhhhhcCC-CCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccC
Confidence 01111 26789999999999988888888774 6999999999999888888999999999999999998888
Q ss_pred CCcccccCCCCEEecCCcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCc-----
Q 039533 335 PPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQ----- 409 (949)
Q Consensus 335 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~----- 409 (949)
|..|.++++|+.|+|++|++++..+..|.++++|+.|+|++|.+++. ..+++|+.|++++|+++ .+|..
T Consensus 331 ~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-----~~~~~L~~L~l~~N~l~-~l~~~~~~l~ 404 (844)
T 3j0a_A 331 SSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-----HFIPSIPDIFLSGNKLV-TLPKINLTAN 404 (844)
T ss_dssp SCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-----SSCCSCSEEEEESCCCC-CCCCCCTTCC
T ss_pred HHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-----cCCCCcchhccCCCCcc-cccccccccc
Confidence 88999999999999999999887778899999999999999998742 23667777777777776 45543
Q ss_pred -----------------ccCCcccceeeccCCCccCCCCcc-ccccccccceeeecccccc-----ccCCcccccccchh
Q 039533 410 -----------------FFSLSSLSISLDWSRNKLTGSLPI-EVGKLKILEFLYVYENRLE-----GEIPSTFGNCIRLE 466 (949)
Q Consensus 410 -----------------~~~l~~l~~~L~ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~ 466 (949)
+..+++| +.|+|++|++++..+. .+..+++|+.|+|++|.++ +..|..|.++++|+
T Consensus 405 ~L~ls~N~l~~l~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~ 483 (844)
T 3j0a_A 405 LIHLSENRLENLDILYFLLRVPHL-QILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQ 483 (844)
T ss_dssp EEECCSCCCCSSTTHHHHTTCTTC-CEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEE
T ss_pred eeecccCccccCchhhhhhcCCcc-ceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCccccc
Confidence 2356667 6788888888865443 4566788999999999887 45557789999999
Q ss_pred hcccCccccccccCCCcCCCCCCCEEECCCCcCCCcCcccccCCccceEeCCCCcCcCcccccccccccccccccCCCCC
Q 039533 467 QLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLSLNNLNLSYNDLEGMVTTEGVFKNASATRILGNSKL 546 (949)
Q Consensus 467 ~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~ls~N~l~~~~~~~~~~~~~~~~~~~gn~~~ 546 (949)
.|+|++|+|++.+|..|..+++|+.|+|++|+|++.+|..+. .+|+.|+|++|+|++.+|. .|..+..+.+.|||+.
T Consensus 484 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~-~~L~~L~Ls~N~l~~~~~~--~~~~L~~l~l~~Np~~ 560 (844)
T 3j0a_A 484 VLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP-ANLEILDISRNQLLAPNPD--VFVSLSVLDITHNKFI 560 (844)
T ss_dssp CCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC-SCCCEEEEEEECCCCCCSC--CCSSCCEEEEEEECCC
T ss_pred EEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh-ccccEEECCCCcCCCCChh--HhCCcCEEEecCCCcc
Confidence 999999999999999999999999999999999988887776 4699999999999999885 3668888999999999
Q ss_pred CC
Q 039533 547 CG 548 (949)
Q Consensus 547 c~ 548 (949)
|.
T Consensus 561 C~ 562 (844)
T 3j0a_A 561 CE 562 (844)
T ss_dssp CS
T ss_pred cc
Confidence 84
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=494.73 Aligned_cols=448 Identities=20% Similarity=0.218 Sum_probs=402.3
Q ss_pred CcEEEEEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecC
Q 039533 65 QRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHP 144 (949)
Q Consensus 65 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 144 (949)
.+++.|||++|++++..+.+|+++++|++|+|++|.+++..|..|+++++|++|+|++|.+++..|..|+++++|++|++
T Consensus 57 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L 136 (606)
T 3t6q_A 57 INLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYL 136 (606)
T ss_dssp TTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEEC
T ss_pred ccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEEC
Confidence 46889999999999988999999999999999999999999999999999999999999999777889999999999999
Q ss_pred CCccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCcc--EEeccccccCCCCCCcccCC--------------
Q 039533 145 QNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIH--TISLAYNNLDGTIPNSFGWF-------------- 208 (949)
Q Consensus 145 ~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~--~L~L~~N~l~~~~p~~~~~l-------------- 208 (949)
++|++.+.....+..+++|++|+|++|.+++..|..|+.+++|+ +|++++|++++..|..|...
T Consensus 137 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~ 216 (606)
T 3t6q_A 137 GSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLL 216 (606)
T ss_dssp CSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHH
T ss_pred CCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhhccccccccCCchhHH
Confidence 99999987766666799999999999999988888899999999 99999999998888776542
Q ss_pred -------------------------------------CccccccccCcccccccccccCCCCChhhhccccccccccCCC
Q 039533 209 -------------------------------------ENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSL 251 (949)
Q Consensus 209 -------------------------------------~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N~l 251 (949)
.+|++|++++|.++.++.. .+..+++|++|++++|++
T Consensus 217 ~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~------~~~~l~~L~~L~l~~n~l 290 (606)
T 3t6q_A 217 VIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSN------TFHCFSGLQELDLTATHL 290 (606)
T ss_dssp HHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTT------TTTTCTTCSEEECTTSCC
T ss_pred HHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHH------HhccccCCCEEeccCCcc
Confidence 0455555555555433321 277889999999999999
Q ss_pred CCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCC-CCCCCcccEEEeeccee
Q 039533 252 GSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAG-IGNFVNLQRLDMWNNQL 330 (949)
Q Consensus 252 ~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~N~l 330 (949)
+.. +..+.++++|++|++++|.+++..|..+..++ +|++|++++|.+.+.+|.. +..+++|++|++++|.+
T Consensus 291 ~~l-------p~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l 362 (606)
T 3t6q_A 291 SEL-------PSGLVGLSTLKKLVLSANKFENLCQISASNFP-SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDI 362 (606)
T ss_dssp SCC-------CSSCCSCTTCCEEECTTCCCSBGGGGCGGGCT-TCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCC
T ss_pred CCC-------ChhhcccccCCEEECccCCcCcCchhhhhccC-cCCEEECCCCCcccccchhhhhccCcCCEEECCCCcc
Confidence 854 33577889999999999999999888888885 6999999999999777654 89999999999999999
Q ss_pred cccC--CCcccccCCCCEEecCCcccccccCcccccccccceeecccccccccCCC-CCCCCCCCcEEEeeCccccCCCC
Q 039533 331 SGTI--PPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPS-SLGQCESLIEINLSNNNLSGTIP 407 (949)
Q Consensus 331 ~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p 407 (949)
++.. |..+.++++|++|+|++|++++..|..|.++++|+.|++++|.+++..|. .|..+++|++|++++|.+++..|
T Consensus 363 ~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 442 (606)
T 3t6q_A 363 ETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSE 442 (606)
T ss_dssp CEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCT
T ss_pred ccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCH
Confidence 9776 88899999999999999999999999999999999999999999987765 49999999999999999999899
Q ss_pred CcccCCcccceeeccCCCccCCC---CccccccccccceeeeccccccccCCcccccccchhhcccCccccccccCCCcC
Q 039533 408 PQFFSLSSLSISLDWSRNKLTGS---LPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLG 484 (949)
Q Consensus 408 ~~~~~l~~l~~~L~ls~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 484 (949)
..+..+++| +.|++++|++++. .+..+..+++|++|++++|++++..|..|+.+++|+.|+|++|++++.+|..|.
T Consensus 443 ~~~~~l~~L-~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~ 521 (606)
T 3t6q_A 443 QLFDGLPAL-QHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALS 521 (606)
T ss_dssp TTTTTCTTC-CEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGT
T ss_pred HHHhCCCCC-CEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhC
Confidence 999999999 8999999999873 346799999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCEEECCCCcCCCcCcccccCCc-cceEeCCCCcCcCcccc
Q 039533 485 SLRGLRVLDLSQNNLSGEIPKFLAGLS-LNNLNLSYNDLEGMVTT 528 (949)
Q Consensus 485 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~l~ls~N~l~~~~~~ 528 (949)
.+++| .|+|++|++++.+|..+..++ |+.|++++|++++..+.
T Consensus 522 ~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 565 (606)
T 3t6q_A 522 HLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSN 565 (606)
T ss_dssp TCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGG
T ss_pred ccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCc
Confidence 99999 999999999999998888776 99999999999987664
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=443.21 Aligned_cols=263 Identities=27% Similarity=0.407 Sum_probs=202.9
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
+++.+.++||+|+||+||+|++. ..||||+++.... ...+.|.+|++++++++|||||++++++.. +..
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~------~~~ 106 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK------DNL 106 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SSC
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC------CeE
Confidence 56788899999999999999875 3599999875432 334689999999999999999999998743 257
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++||||+++|+|.++++. ....+++.++..|+.|||+||+|||++ +||||||||+|||+++++++||+
T Consensus 107 ~iVmEy~~gGsL~~~l~~---------~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~ 174 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHV---------QETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIG 174 (307)
T ss_dssp EEEEECCSSCBHHHHHHT---------SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEEC
T ss_pred EEEEEcCCCCCHHHHHhh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEe
Confidence 999999999999999962 234699999999999999999999987 89999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCC---CccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG---CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
|||+|+...............||+.|||||++.+ ..|+.++|||||||++|||+||+.||........ ........
T Consensus 175 DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~-~~~~~~~~ 253 (307)
T 3omv_A 175 DFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ-IIFMVGRG 253 (307)
T ss_dssp CCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHHHHTT
T ss_pred eccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH-HHHHHhcC
Confidence 9999987654433333335679999999999864 3589999999999999999999999964321111 11111000
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhhc
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILL 936 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~ 936 (949)
. ..+.+... ..+++..+.+++.+||+.||++||||+||++.|+.++..+.
T Consensus 254 ~-------~~p~~~~~-------------------~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 254 Y-------ASPDLSKL-------------------YKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp C-------CCCCSTTS-------------------CTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred C-------CCCCcccc-------------------cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 0 00000000 11345678899999999999999999999999999887654
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=485.60 Aligned_cols=447 Identities=21% Similarity=0.197 Sum_probs=402.4
Q ss_pred CcEEEEEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecC
Q 039533 65 QRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHP 144 (949)
Q Consensus 65 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 144 (949)
.+++.|||++|.+++..+.+|+++++|++|+|++|.+++..|..|+++++|++|+|++|.+++..|..|+++++|++|++
T Consensus 56 ~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 135 (606)
T 3vq2_A 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNV 135 (606)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEEC
T ss_pred ccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeC
Confidence 47899999999999888899999999999999999999888999999999999999999999777789999999999999
Q ss_pred CCccccc-cccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCcc----EEeccccccCCCCCCcccCCCccccccccCc
Q 039533 145 QNNQLVG-KILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIH----TISLAYNNLDGTIPNSFGWFENLVFLSLAAN 219 (949)
Q Consensus 145 ~~n~l~~-~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 219 (949)
++|++.+ .+|..|.++++|++|+|++|++++..|..|+.+++|+ +|++++|++++..+..+... +|++|++++|
T Consensus 136 ~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n 214 (606)
T 3vq2_A 136 AHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGN 214 (606)
T ss_dssp CSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESC
T ss_pred CCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCC
Confidence 9999987 5699999999999999999999998888888887765 89999999997777666655 8999999999
Q ss_pred cccc---------------------------------------------------ccccccCCCCChhhhcccccccccc
Q 039533 220 NLSV---------------------------------------------------VENKLTGEVPSLEKLQRLQHFTITS 248 (949)
Q Consensus 220 ~l~~---------------------------------------------------~~~~l~~~~~~l~~l~~L~~L~l~~ 248 (949)
.++. ..+.+.+.+|.+..+++|++|++++
T Consensus 215 ~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~ 294 (606)
T 3vq2_A 215 FNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAG 294 (606)
T ss_dssp CSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEES
T ss_pred ccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccccccCCCCCEEEecC
Confidence 8641 2345566777788999999999999
Q ss_pred CCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeecc
Q 039533 249 NSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNN 328 (949)
Q Consensus 249 N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 328 (949)
|.+...+ .+..+++|++|++++|.+ +.+|. + .+ ++|++|++++|+..+.+ .+..+++|++|++++|
T Consensus 295 ~~~~~l~--------~l~~~~~L~~L~l~~n~l-~~lp~-~-~l-~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n 360 (606)
T 3vq2_A 295 VSIKYLE--------DVPKHFKWQSLSIIRCQL-KQFPT-L-DL-PFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRN 360 (606)
T ss_dssp CCCCCCC--------CCCTTCCCSEEEEESCCC-SSCCC-C-CC-SSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSS
T ss_pred ccchhhh--------hccccccCCEEEcccccC-ccccc-C-CC-CccceeeccCCcCccch--hhccCCCCCEEECcCC
Confidence 9987543 567788999999999999 67774 4 55 57999999999765444 6789999999999999
Q ss_pred eeccc--CCCcccccCCCCEEecCCcccccccCcccccccccceeecccccccccCC-CCCCCCCCCcEEEeeCccccCC
Q 039533 329 QLSGT--IPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIP-SSLGQCESLIEINLSNNNLSGT 405 (949)
Q Consensus 329 ~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~ 405 (949)
.+++. +|..+..+++|+.|+|++|++++ +|..+.++++|+.|++++|.+.+..| ..|..+++|++|++++|++++.
T Consensus 361 ~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~ 439 (606)
T 3vq2_A 361 ALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKID 439 (606)
T ss_dssp CEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEEC
T ss_pred ccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCcc
Confidence 99976 48889999999999999999995 67889999999999999999998888 7899999999999999999999
Q ss_pred CCCcccCCcccceeeccCCCccCC-CCccccccccccceeeeccccccccCCcccccccchhhcccCccccccccCCCcC
Q 039533 406 IPPQFFSLSSLSISLDWSRNKLTG-SLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLG 484 (949)
Q Consensus 406 ~p~~~~~l~~l~~~L~ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 484 (949)
.|..+..+++| +.|++++|++++ .+|..++.+++|++|+|++|++++..|..|+++++|+.|+|++|++++.+|..|+
T Consensus 440 ~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 518 (606)
T 3vq2_A 440 FDGIFLGLTSL-NTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYN 518 (606)
T ss_dssp CTTTTTTCTTC-CEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTT
T ss_pred chhhhcCCCCC-CEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHcc
Confidence 99999999999 899999999998 4799999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCEEECCCCcCCCcCcccccCCc--cceEeCCCCcCcCccccc
Q 039533 485 SLRGLRVLDLSQNNLSGEIPKFLAGLS--LNNLNLSYNDLEGMVTTE 529 (949)
Q Consensus 485 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~--L~~l~ls~N~l~~~~~~~ 529 (949)
.+++|+.|||++|+|+ .+|..+..+. |++|++++|++.+..+..
T Consensus 519 ~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~ 564 (606)
T 3vq2_A 519 QLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEHQ 564 (606)
T ss_dssp TCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTTH
T ss_pred CCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCccH
Confidence 9999999999999999 5666677663 999999999999876643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=448.67 Aligned_cols=269 Identities=24% Similarity=0.375 Sum_probs=206.0
Q ss_pred cCCCCCCeeeeecCceEEEEEEc-----CCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 626 SGFSSANLVGVGSFGSVYKGIID-----EGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
++|.+.++||+|+||+||+|++. .+++.||||+++.......++|.+|++++++++|||||+++|+|.+.+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~---- 116 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR---- 116 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS----
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC----
Confidence 45667789999999999999875 357899999998666556678999999999999999999999987554
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCc-----cccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDE-----IDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD 775 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~-----~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~ 775 (949)
..++||||+++|+|.++++....... .......+++.+++.|+.|||+||+|||++ +||||||||+|||++
T Consensus 117 -~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 117 -PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVG 192 (329)
T ss_dssp -SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEE
T ss_pred -EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEEC
Confidence 78999999999999999975432211 112345799999999999999999999987 899999999999999
Q ss_pred CCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhh
Q 039533 776 DYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLH 854 (949)
Q Consensus 776 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~ 854 (949)
+++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||......+ ..
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~ 270 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE--AI 270 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH--HH
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH--HH
Confidence 999999999999997755444333335669999999999999999999999999999999999 899996432111 11
Q ss_pred hhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHh
Q 039533 855 NFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNI 934 (949)
Q Consensus 855 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 934 (949)
.. +.+..-.+ .+..+++.+.+++.+||+.||++||||+||++.|+.+.+.
T Consensus 271 ~~-----------i~~g~~~~-------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 271 DC-----------ITQGRELE-------------------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HH-----------HHHTCCCC-------------------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HH-----------HHcCCCCC-------------------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 00 00000000 0113456789999999999999999999999999998764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-52 Score=446.11 Aligned_cols=269 Identities=24% Similarity=0.390 Sum_probs=213.1
Q ss_pred cCCCCCCeeeeecCceEEEEEEc-----CCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 626 SGFSSANLVGVGSFGSVYKGIID-----EGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
++|.+.+.||+|+||+||+|++. .+++.||||+++.......++|.+|++++++++|||||+++|+|.+.+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~---- 88 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD---- 88 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS----
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC----
Confidence 46778899999999999999874 357899999998666556678999999999999999999999987554
Q ss_pred ccceeEeeeccCCChhhhcCCCCCC---CccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCC
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGE---DEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDY 777 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~---~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~ 777 (949)
..++||||+++|+|.++++..... .........+++.+++.|+.|||+||+|||++ +|+||||||+|||++++
T Consensus 89 -~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 89 -PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN 164 (299)
T ss_dssp -SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred -EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCC
Confidence 789999999999999999732100 00012345799999999999999999999987 89999999999999999
Q ss_pred CceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhh
Q 039533 778 MTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNF 856 (949)
Q Consensus 778 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~ 856 (949)
+.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||......+ ...
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~~- 241 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIE- 241 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHH-
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHH-
Confidence 9999999999987655444333334568999999999999999999999999999999999 899996432111 110
Q ss_pred ccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHh
Q 039533 857 GRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNI 934 (949)
Q Consensus 857 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 934 (949)
.+.+....+.+ ..++.++.+++.+||+.||++||||+||.+.|+++.+.
T Consensus 242 ----------~i~~~~~~~~p-------------------~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 242 ----------CITQGRVLQRP-------------------RTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp ----------HHHHTCCCCCC-------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------HHHcCCCCCCC-------------------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 01110100111 13456789999999999999999999999999998765
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=481.07 Aligned_cols=469 Identities=19% Similarity=0.172 Sum_probs=362.0
Q ss_pred EEEEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCc
Q 039533 68 TLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNN 147 (949)
Q Consensus 68 ~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n 147 (949)
..+|.++++++ .+|..+. +++++|+|++|++++..+..|+++++|++|+|++|.+++..|..|+++++|++|++++|
T Consensus 7 ~~~~cs~~~L~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 7 EVADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp SEEECCSSCCS-SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred CeeECCCCCcc-ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 35899999997 5777665 79999999999999877788999999999999999999989999999999999999999
Q ss_pred cccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCccccccccc
Q 039533 148 QLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENK 227 (949)
Q Consensus 148 ~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 227 (949)
.+++..+..|.++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|.++.+...
T Consensus 84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 163 (680)
T 1ziw_A 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 163 (680)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHH
T ss_pred ccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHH
Confidence 99998888999999999999999999988888999999999999999999999999999999999999999988755422
Q ss_pred ccCCCCChhhhccccccccccCCCCCCCCCCcchhcccc---------------------ccCcccEEEccCCCCCccCC
Q 039533 228 LTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLT---------------------NATRLTWMHINSNNFGGLLP 286 (949)
Q Consensus 228 l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~---------------------~~~~L~~L~L~~N~l~~~~p 286 (949)
.. ....+++|++|++++|+++...+..+.....+. ..++|+.|++++|.+++..|
T Consensus 164 ~~----~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~ 239 (680)
T 1ziw_A 164 EL----DIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSN 239 (680)
T ss_dssp HH----GGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECT
T ss_pred Hh----hccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccCh
Confidence 11 122457899999999999876655443322221 22678999999999999999
Q ss_pred chhhccc-ccccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCccccc-----ccCc
Q 039533 287 GCISNLS-KTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSG-----NIPP 360 (949)
Q Consensus 287 ~~~~~l~-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-----~~p~ 360 (949)
..+..+. .+|++|+|++|++++..|..|+.+++|++|+|++|++++..|..|.++++|+.|+|++|...+ .+|.
T Consensus 240 ~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~ 319 (680)
T 1ziw_A 240 TTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPK 319 (680)
T ss_dssp TTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCE
T ss_pred hHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccc
Confidence 8888775 359999999999998888999999999999999999999889899999999999998876553 2332
Q ss_pred ----ccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCC-CCC-cccCC--cccceeeccCCCccCCCCc
Q 039533 361 ----SIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGT-IPP-QFFSL--SSLSISLDWSRNKLTGSLP 432 (949)
Q Consensus 361 ----~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~p~-~~~~l--~~l~~~L~ls~N~l~~~~p 432 (949)
.|..+++|++|++++|.+++..|..|.++++|++|++++|.+++. ++. .|..+ +++ +.|++++|++++..|
T Consensus 320 i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L-~~L~L~~n~l~~~~~ 398 (680)
T 1ziw_A 320 IDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPL-HILNLTKNKISKIES 398 (680)
T ss_dssp ECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCC-CEEECTTSCCCEECT
T ss_pred cChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcC-ceEECCCCCCCeECh
Confidence 678888899999999998888888888888888888887765322 121 22222 344 566777777776666
Q ss_pred cccccccccceeeeccccccccCC-cccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCC--CcCcccccC
Q 039533 433 IEVGKLKILEFLYVYENRLEGEIP-STFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLS--GEIPKFLAG 509 (949)
Q Consensus 433 ~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~ 509 (949)
..+..+++|+.|+|++|++++.+| ..|.++++|+.|++++|++++..+..|..+++|+.|++++|.++ +.+|..+..
T Consensus 399 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~ 478 (680)
T 1ziw_A 399 DAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQP 478 (680)
T ss_dssp TTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTT
T ss_pred hhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCccccc
Confidence 666677777777777777665554 46666667777777777666666666666666666666666655 345555555
Q ss_pred Cc-cceEeCCCCcCcCcccc-cccccccccccccCCC
Q 039533 510 LS-LNNLNLSYNDLEGMVTT-EGVFKNASATRILGNS 544 (949)
Q Consensus 510 ~~-L~~l~ls~N~l~~~~~~-~~~~~~~~~~~~~gn~ 544 (949)
++ |+.|++++|.+++.++. ...+..+..+.+.+|.
T Consensus 479 l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~ 515 (680)
T 1ziw_A 479 LRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNN 515 (680)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCC
Confidence 54 66666666666655443 2334444555555553
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-51 Score=439.65 Aligned_cols=265 Identities=21% Similarity=0.311 Sum_probs=208.4
Q ss_pred CCCCCCeeeeecCceEEEEEEc-----CCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 627 GFSSANLVGVGSFGSVYKGIID-----EGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
++++.+.||+|+||+||+|++. .+++.||||+++.... ...++|.+|+.++++++|||||+++|+|...+
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~---- 102 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ---- 102 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS----
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC----
Confidence 4566789999999999999974 3568999999975433 33578999999999999999999999987554
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCc------cccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeee
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDE------IDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL 774 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll 774 (949)
..++||||+++|+|.+++........ .......+++.+++.|+.|||+||+|||++ +||||||||+|||+
T Consensus 103 -~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl 178 (308)
T 4gt4_A 103 -PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLV 178 (308)
T ss_dssp -SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred -EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEE
Confidence 78999999999999999964321110 011235699999999999999999999987 89999999999999
Q ss_pred cCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchh
Q 039533 775 DDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINL 853 (949)
Q Consensus 775 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~ 853 (949)
++++++||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||...... .+
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~--~~ 256 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DV 256 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH--HH
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH--HH
Confidence 9999999999999987654433333334569999999999999999999999999999999999 89999643221 11
Q ss_pred hhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHh
Q 039533 854 HNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSI 931 (949)
Q Consensus 854 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 931 (949)
...+ .+....+.+ .+++..+.+++.+||+.||++||||+||++.|+++
T Consensus 257 ~~~i-----------~~~~~~~~p-------------------~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 257 VEMI-----------RNRQVLPCP-------------------DDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHH-----------HTTCCCCCC-------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHH-----------HcCCCCCCc-------------------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1111 111111111 24566789999999999999999999999999865
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=471.84 Aligned_cols=449 Identities=20% Similarity=0.191 Sum_probs=382.7
Q ss_pred CcEEEEEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecC
Q 039533 65 QRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHP 144 (949)
Q Consensus 65 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 144 (949)
.+++.|||++|++++..+.+|.++++|++|+|++|++++..|..|+++++|++|+|++|.+++..|..|+++++|++|++
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 46889999999999888889999999999999999999888889999999999999999999888899999999999999
Q ss_pred CCccccccccccccCCCCCcEEECCCCCCCC-CCCCCcCCCCCccEEeccccccCCCCCCcccCCCcc----ccccccCc
Q 039533 145 QNNQLVGKILSRFSSLSKTEILNLGSNHLTG-SIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENL----VFLSLAAN 219 (949)
Q Consensus 145 ~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L----~~L~Ls~N 219 (949)
++|++++..+..|+++++|++|+|++|.+++ .+|..|+++++|++|++++|++++..|..|+.+++| +.|++++|
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n 187 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCC
Confidence 9999998888789999999999999999997 479999999999999999999998888899999888 88999999
Q ss_pred ccccccccccCCCCChhhhccccccccccCCCCCC-------------------------------CCCCc---------
Q 039533 220 NLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSG-------------------------------GNDDL--------- 259 (949)
Q Consensus 220 ~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N~l~~~-------------------------------~~~~~--------- 259 (949)
.++.++... +.. .+|++|++++|..... ....+
T Consensus 188 ~l~~~~~~~------~~~-~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~ 260 (570)
T 2z63_A 188 PMNFIQPGA------FKE-IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260 (570)
T ss_dssp CCCEECTTT------TTT-CEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEE
T ss_pred CceecCHHH------hcc-CcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchh
Confidence 988765432 222 2577777776632110 00000
Q ss_pred ------------chhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeec
Q 039533 260 ------------SFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWN 327 (949)
Q Consensus 260 ------------~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 327 (949)
..+..+..+++|+.|++++|.++ .+|..+..+ +|++|++++|.+. .+|. ..+++|++|++++
T Consensus 261 ~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~--~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~ 334 (570)
T 2z63_A 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF--GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTS 334 (570)
T ss_dssp EEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC--CCSEEEEESCBCS-SCCB--CBCSSCCEEEEES
T ss_pred hhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC--CccEEeeccCccc-ccCc--ccccccCEEeCcC
Confidence 01233556788889999999888 477777766 6899999999988 5554 4778899999999
Q ss_pred ceecccCCCcccccCCCCEEecCCccccccc--CcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCC
Q 039533 328 NQLSGTIPPAIGELQNLKILGLNRNKLSGNI--PPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGT 405 (949)
Q Consensus 328 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 405 (949)
|.+.+..+. ..+++|+.|+|++|++++.. |..+.++++|++|++++|.+++..+. +..+++|++|++++|++++.
T Consensus 335 n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~ 411 (570)
T 2z63_A 335 NKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQM 411 (570)
T ss_dssp CBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESC
T ss_pred Ccccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccc
Confidence 998866665 78899999999999998654 77889999999999999999876555 88999999999999999977
Q ss_pred CC-CcccCCcccceeeccCCCccCCCCccccccccccceeeecccccc-ccCCcccccccchhhcccCccccccccCCCc
Q 039533 406 IP-PQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLE-GEIPSTFGNCIRLEQLGMGGNLFQGPISSSL 483 (949)
Q Consensus 406 ~p-~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~ 483 (949)
.| ..+..+++| +.|++++|.+++..|..+.++++|++|++++|+++ +.+|..|+.+++|+.|+|++|++++..|..|
T Consensus 412 ~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~ 490 (570)
T 2z63_A 412 SEFSVFLSLRNL-IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 490 (570)
T ss_dssp TTSCTTTTCTTC-CEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTT
T ss_pred cchhhhhcCCCC-CEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhh
Confidence 66 467788888 78999999999989999999999999999999998 6789999999999999999999999889999
Q ss_pred CCCCCCCEEECCCCcCCCcCcccccCCc-cceEeCCCCcCcCcccccc
Q 039533 484 GSLRGLRVLDLSQNNLSGEIPKFLAGLS-LNNLNLSYNDLEGMVTTEG 530 (949)
Q Consensus 484 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~l~ls~N~l~~~~~~~~ 530 (949)
+.+++|+.|+|++|++++.+|..+..++ |+.|++++|++++.+|...
T Consensus 491 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~ 538 (570)
T 2z63_A 491 NSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 538 (570)
T ss_dssp TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred hcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchH
Confidence 9999999999999999988888887776 9999999999999887643
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=437.56 Aligned_cols=250 Identities=22% Similarity=0.293 Sum_probs=207.2
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
+.|++.++||+|+||+||+|++..+|+.||||+++.......+.+.+|++++++++|||||++++++.+.+ ..|+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-----~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-----ELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----EEEE
Confidence 46888999999999999999999999999999998666666677899999999999999999999976554 7999
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
||||+++|+|.+++. ...+++.++..|+.||+.||+|||++ +||||||||+|||++.++++||+||
T Consensus 149 vmEy~~gg~L~~~l~-----------~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DF 214 (346)
T 4fih_A 149 VMEFLEGGALTDIVT-----------HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDF 214 (346)
T ss_dssp EECCCTTEEHHHHHH-----------HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCC
T ss_pred EEeCCCCCcHHHHHH-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecC
Confidence 999999999999986 23589999999999999999999988 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCch
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDV 865 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 865 (949)
|+|+.+....... ....||+.|||||++.+..|+.++||||+||++|||++|+.||...... ..........+.
T Consensus 215 Gla~~~~~~~~~~--~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~i~~~~~~-- 288 (346)
T 4fih_A 215 GFCAQVSKEVPRR--KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNLPP-- 288 (346)
T ss_dssp TTCEECCSSSCCB--CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSSCC--
T ss_pred cCceecCCCCCcc--cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHcCCCC--
Confidence 9999876543322 2467999999999999999999999999999999999999999632111 111111100000
Q ss_pred hhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 866 MDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 866 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.. . .....+..+.+++.+||+.||++|||++|+++
T Consensus 289 ------~~-~-------------------~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 289 ------RL-K-------------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp ------CC-S-------------------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------CC-C-------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 0 01133456789999999999999999999875
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=483.78 Aligned_cols=460 Identities=22% Similarity=0.220 Sum_probs=385.2
Q ss_pred EEEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcC-CCCCCCCccceeecCCCc
Q 039533 69 LLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEI-PTNISRCSTLIPIHPQNN 147 (949)
Q Consensus 69 ~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~l~~n 147 (949)
..|.++++++ .+|. ..++|++|+|++|.+++..|..|.++++|++|+|++|.+.+.+ |..|+++++|++|+|++|
T Consensus 8 ~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N 83 (844)
T 3j0a_A 8 IAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS 83 (844)
T ss_dssp EEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTC
T ss_pred EEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCC
Confidence 4567788888 4555 4589999999999999999999999999999999999777777 788999999999999999
Q ss_pred cccccccccccCCCCCcEEECCCCCCCCCCCCC--cCCCCCccEEeccccccCCCCC-CcccCCCccccccccCcccccc
Q 039533 148 QLVGKILSRFSSLSKTEILNLGSNHLTGSIPSS--LGNLSSIHTISLAYNNLDGTIP-NSFGWFENLVFLSLAANNLSVV 224 (949)
Q Consensus 148 ~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~ 224 (949)
.+.+..|..|.++++|++|+|++|.+++.+|.. |+++++|++|+|++|.+++..+ ..|+++++|++|+|++|.++.+
T Consensus 84 ~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~ 163 (844)
T 3j0a_A 84 KIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV 163 (844)
T ss_dssp CCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCC
T ss_pred cCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCee
Confidence 999999999999999999999999999877765 9999999999999999997765 5799999999999999988654
Q ss_pred cccccCCCCChhhh--ccccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcc----------
Q 039533 225 ENKLTGEVPSLEKL--QRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNL---------- 292 (949)
Q Consensus 225 ~~~l~~~~~~l~~l--~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l---------- 292 (949)
.. ..+..+ ++|+.|++++|.+....+..+...........|+.|++++|++++..|..+...
T Consensus 164 ~~------~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~ 237 (844)
T 3j0a_A 164 CE------HELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLI 237 (844)
T ss_dssp CS------GGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEE
T ss_pred CH------HHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCccccccee
Confidence 21 235555 789999999999987544332221111112359999999999888777655432
Q ss_pred ---------------------------cccccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCC
Q 039533 293 ---------------------------SKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLK 345 (949)
Q Consensus 293 ---------------------------~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 345 (949)
+.+|+.|+|++|.+.+..|..|..+++|+.|+|++|++++..|..|.++++|+
T Consensus 238 l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 317 (844)
T 3j0a_A 238 LAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQ 317 (844)
T ss_dssp CCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCC
T ss_pred cccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCC
Confidence 24699999999999999999999999999999999999999999999999999
Q ss_pred EEecCCcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCC
Q 039533 346 ILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRN 425 (949)
Q Consensus 346 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N 425 (949)
.|+|++|++++..|..|.++++|+.|++++|.+++..+..|.++++|++|+|++|.+++ ++. ++++ ..|++++|
T Consensus 318 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~~----~~~L-~~L~l~~N 391 (844)
T 3j0a_A 318 VLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT-IHF----IPSI-PDIFLSGN 391 (844)
T ss_dssp EEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC-CSS----CCSC-SEEEEESC
T ss_pred EEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc-ccC----CCCc-chhccCCC
Confidence 99999999998889999999999999999999998888899999999999999999983 433 3344 44555555
Q ss_pred ccC--------------------CCC-ccccccccccceeeeccccccccCCc-ccccccchhhcccCccccc-----cc
Q 039533 426 KLT--------------------GSL-PIEVGKLKILEFLYVYENRLEGEIPS-TFGNCIRLEQLGMGGNLFQ-----GP 478 (949)
Q Consensus 426 ~l~--------------------~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~-----~~ 478 (949)
+++ +.. +..+..+++|+.|+|++|++++..+. .+..+++|+.|+|++|.++ +.
T Consensus 392 ~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~ 471 (844)
T 3j0a_A 392 KLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETEL 471 (844)
T ss_dssp CCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCC
T ss_pred CcccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCcccccccccc
Confidence 544 321 12345789999999999999965544 4667899999999999997 55
Q ss_pred cCCCcCCCCCCCEEECCCCcCCCcCcccccCCc-cceEeCCCCcCcCcccccccccccccccccCCCC
Q 039533 479 ISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLS-LNNLNLSYNDLEGMVTTEGVFKNASATRILGNSK 545 (949)
Q Consensus 479 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~l~ls~N~l~~~~~~~~~~~~~~~~~~~gn~~ 545 (949)
.+..|..+++|+.|+|++|+|++.+|..+..++ |+.|+|++|+|++.++.... .++..+.+.+|..
T Consensus 472 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~-~~L~~L~Ls~N~l 538 (844)
T 3j0a_A 472 CWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP-ANLEILDISRNQL 538 (844)
T ss_dssp CSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC-SCCCEEEEEEECC
T ss_pred chhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh-ccccEEECCCCcC
Confidence 567899999999999999999999999888877 99999999999998765433 5667777777754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=438.82 Aligned_cols=252 Identities=21% Similarity=0.289 Sum_probs=199.8
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
.++|++.+.||+|+||+||+|++..+++.||||+++.... ...+.+.+|++++++++|||||++++++.+.+ .
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-----~ 97 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENG-----S 97 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----E
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECC-----E
Confidence 3689999999999999999999999999999999975532 23467899999999999999999999976544 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.|+||||++||+|.+++... ....+++.+++.|+.||+.||+|||++ +||||||||+|||++.++.+||
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~--------~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl 166 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQ--------KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQL 166 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHT--------TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEE
T ss_pred EEEEEeCCCCCcHHHHHHHc--------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEE
Confidence 99999999999999999621 234578999999999999999999988 9999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
+|||+|+....... ......||+.|||||++.+..|+.++|||||||++|||+||+.||......+ .
T Consensus 167 ~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-----~------ 233 (350)
T 4b9d_A 167 GDFGIARVLNSTVE--LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-----L------ 233 (350)
T ss_dssp CSTTEESCCCHHHH--HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----H------
T ss_pred cccccceeecCCcc--cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-----H------
Confidence 99999987643221 1224569999999999999999999999999999999999999996432111 0
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
+..+......+.+ ...+..+.+++.+||+.||++|||++|+++
T Consensus 234 --~~~i~~~~~~~~~-------------------~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 234 --VLKIISGSFPPVS-------------------LHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp --HHHHHHTCCCCCC-------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHHHHcCCCCCCC-------------------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111111111100 123456789999999999999999999976
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=431.21 Aligned_cols=258 Identities=22% Similarity=0.217 Sum_probs=206.2
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
+.|.+.++||+|+||.||+|++..+|+.||||+++.... ..+|+.++++++|||||++++++.+.+ ..|+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~-----~~~i 127 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGP-----WVNI 127 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETT-----EEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECC-----EEEE
Confidence 457778899999999999999999999999999975432 247999999999999999999976544 7899
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC-ceEEee
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM-TARVGD 784 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kl~D 784 (949)
||||++||+|.++++ ....+++.++..|+.||+.||+|||++ +||||||||+|||++.++ ++||+|
T Consensus 128 vmEy~~gg~L~~~l~----------~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~D 194 (336)
T 4g3f_A 128 FMELLEGGSLGQLIK----------QMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCD 194 (336)
T ss_dssp EECCCTTCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECC
T ss_pred EEeccCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEee
Confidence 999999999999996 235699999999999999999999977 999999999999999887 699999
Q ss_pred cccceecCCCCCc---cccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 785 FGLARILSPDHTQ---TSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 785 fG~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
||+|+........ .......||+.|||||++.+..|+.++|||||||++|||+||+.||.........
T Consensus 195 FGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--------- 265 (336)
T 4g3f_A 195 FGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC--------- 265 (336)
T ss_dssp CTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH---------
T ss_pred CCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH---------
Confidence 9999987654321 1222456999999999999999999999999999999999999999643322111
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhhc
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILL 936 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~ 936 (949)
..+..... +. ......++..+.+++.+||+.||++|||+.|+++.|........
T Consensus 266 ----~~i~~~~~---~~--------------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 266 ----LKIASEPP---PI--------------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp ----HHHHHSCC---GG--------------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred ----HHHHcCCC---Cc--------------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 00100000 00 00011345568899999999999999999999999988776544
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=428.69 Aligned_cols=281 Identities=21% Similarity=0.264 Sum_probs=205.8
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
.+|.+.++||+|+||+||+|++. |+.||||+++.... ....+..|+..+.+++|||||+++++|...+ ......++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEE
Confidence 35677899999999999999985 89999999964432 1223345666667889999999999987543 12235799
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhC-----CCCCeEecCCCCCCeeecCCCce
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHD-----CQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~-----~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
||||+++|+|.++++ ...+++..+.+|+.|+++||+|||++ +.++|+||||||+|||++.++++
T Consensus 79 V~Ey~~~gsL~~~l~-----------~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~ 147 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLN-----------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 147 (303)
T ss_dssp EEECCTTCBHHHHHH-----------HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred EecCCCCCcHHHHHH-----------hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCE
Confidence 999999999999996 23589999999999999999999975 24589999999999999999999
Q ss_pred EEeecccceecCCCCCcc--ccccccCccCccCccccCCC------ccCCccchHHHHHHHHHHHhCCCCCccccccCch
Q 039533 781 RVGDFGLARILSPDHTQT--SSFSVKGSLGYIAPEYGVGC------EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDIN 852 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~ 852 (949)
||+|||+|+......... ......||+.|||||++.+. .++.++|||||||++|||+||++||.........
T Consensus 148 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p 227 (303)
T 3hmm_A 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp EECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred EEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc
Confidence 999999998875543321 22245699999999998754 4788999999999999999999988643322211
Q ss_pred hhhhccccCC-Cch-hhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 039533 853 LHNFGRKALP-DDV-MDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQS 930 (949)
Q Consensus 853 ~~~~~~~~~~-~~~-~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 930 (949)
+......... +.. ..+.+..+.+...+. ....+++..+.+++.+||+.||++||||+||++.|++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~-------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 294 (303)
T 3hmm_A 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNR-------------WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGG-------------GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred chhcccccchHHHHHHHHhcccCCCCCCcc-------------ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 1111100000 001 111222222211100 0112556788999999999999999999999999999
Q ss_pred hHHh
Q 039533 931 IKNI 934 (949)
Q Consensus 931 i~~~ 934 (949)
|.+.
T Consensus 295 l~~~ 298 (303)
T 3hmm_A 295 LSQQ 298 (303)
T ss_dssp HHHC
T ss_pred HHHH
Confidence 8764
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-49 Score=466.36 Aligned_cols=476 Identities=17% Similarity=0.184 Sum_probs=322.5
Q ss_pred cceeeeeEEeCCC-----------CcEEEEEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccCcEEee
Q 039533 52 FCKWYGVTCSRRH-----------QRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLAL 120 (949)
Q Consensus 52 ~C~w~gv~C~~~~-----------~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 120 (949)
.|.|.|| |+... .+++.|||++|++++..+..++++++|++|+|++|++++..|..|+++++|++|+|
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 5999999 97431 36888999999998888888899999999999999998888888999999999999
Q ss_pred ccccccCcCCCCCCCCccceeecCCCcccccc-ccccccCCCCCcEEECCCCCCCCCCC-CCcCCCCCccEEeccccccC
Q 039533 121 NNNSICGEIPTNISRCSTLIPIHPQNNQLVGK-ILSRFSSLSKTEILNLGSNHLTGSIP-SSLGNLSSIHTISLAYNNLD 198 (949)
Q Consensus 121 s~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~L~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~ 198 (949)
++|++++..|..|+++++|++|++++|.+++. .+..|.++++|++|+|++|.+.+.+| ..|+++++|++|+|++|+++
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~ 161 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccc
Confidence 99999877777788999999999999998874 56788899999999999998554554 67888999999999999998
Q ss_pred CCCCCcccCCCccccccccCcccccccccccCCCCChhhhccccccccccCCCCCCCCCCcchhccccccCcccEEEccC
Q 039533 199 GTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINS 278 (949)
Q Consensus 199 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~ 278 (949)
+..|..++.+++|++|++++|.+..++..+ +..+++|++|++++|+++........ ....+++|+.|++++
T Consensus 162 ~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~------~~~l~~L~~L~L~~n~l~~~~~~~~~---~~~~~~~L~~L~l~~ 232 (549)
T 2z81_A 162 NYQSQSLKSIRDIHHLTLHLSESAFLLEIF------ADILSSVRYLELRDTNLARFQFSPLP---VDEVSSPMKKLAFRG 232 (549)
T ss_dssp EECTTTTTTCSEEEEEEEECSBSTTHHHHH------HHSTTTBSEEEEESCBCTTCCCCCCS---SCCCCCCCCEEEEES
T ss_pred ccChhhhhccccCceEecccCcccccchhh------HhhcccccEEEccCCccccccccccc---hhhhhhcccceeccc
Confidence 888889999999999999988876544321 24577889999999988765322211 123467788888888
Q ss_pred CCCCccCCchhhcc---cccccEEEccCccccCCC------CCCCCCCCcccEEEeecceecccC-----CCcccccCCC
Q 039533 279 NNFGGLLPGCISNL---SKTIKTLFLNNNKIYGSI------PAGIGNFVNLQRLDMWNNQLSGTI-----PPAIGELQNL 344 (949)
Q Consensus 279 N~l~~~~p~~~~~l---~~~L~~L~L~~N~l~~~~------~~~~~~l~~L~~L~L~~N~l~~~~-----p~~~~~l~~L 344 (949)
|.+++..+..+... ..+|+.|++++|.+.+.. ...+..+++|+.|++++|.+.... +..+..+.+|
T Consensus 233 n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L 312 (549)
T 2z81_A 233 SVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKV 312 (549)
T ss_dssp CEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTC
T ss_pred cccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccc
Confidence 88876555443321 245788888888876532 122445556666666666554211 1112223456
Q ss_pred CEEecCCcccccccCccc-ccccccceeecccccccccC---CCCCCCCCCCcEEEeeCccccCCCC--CcccCCcccce
Q 039533 345 KILGLNRNKLSGNIPPSI-GNLKMLLNLFLNDNFLEVSI---PSSLGQCESLIEINLSNNNLSGTIP--PQFFSLSSLSI 418 (949)
Q Consensus 345 ~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~---p~~~~~l~~L~~L~l~~N~l~~~~p--~~~~~l~~l~~ 418 (949)
+.|++++|+++ .+|..+ .++++|++|++++|++++.+ +..++.+++|++|++++|++++..+ ..+..+++| +
T Consensus 313 ~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L-~ 390 (549)
T 2z81_A 313 KRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNL-T 390 (549)
T ss_dssp CEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTC-C
T ss_pred eEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCC-C
Confidence 66666666665 455544 35666666666666666554 2345566666666666666653221 335556666 5
Q ss_pred eeccCCCccCCCCccccccccccceeeeccccccccCCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCc
Q 039533 419 SLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNN 498 (949)
Q Consensus 419 ~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 498 (949)
.|++++|+++ .+|..+..+++|++|++++|+++ .+|..+. ++|+.|+|++|+|++.+ ..+++|+.|+|++|+
T Consensus 391 ~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~ 462 (549)
T 2z81_A 391 SLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQELYISRNK 462 (549)
T ss_dssp EEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSC--TTCSEEECCSSCCSCCC----CCCTTCCEEECCSSC
T ss_pred EEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhc--CCceEEECCCCChhhhc----ccCChhcEEECCCCc
Confidence 6666666666 45666666666666666666666 3343332 45666666666666532 356666666666666
Q ss_pred CCCcCcccccCCccceEeCCCCcCcCcccc-cccccccccccccCCCCCCC
Q 039533 499 LSGEIPKFLAGLSLNNLNLSYNDLEGMVTT-EGVFKNASATRILGNSKLCG 548 (949)
Q Consensus 499 l~~~~p~~~~~~~L~~l~ls~N~l~~~~~~-~~~~~~~~~~~~~gn~~~c~ 548 (949)
|+ .+|.......|+.|+|++|++++.+|. ...+..+..+.+.+|++.|.
T Consensus 463 l~-~ip~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 512 (549)
T 2z81_A 463 LK-TLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 512 (549)
T ss_dssp CS-SCCCGGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCC
T ss_pred cC-cCCCcccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCC
Confidence 66 455432222366666666666666554 24455556666666666553
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-50 Score=427.86 Aligned_cols=249 Identities=21% Similarity=0.284 Sum_probs=206.5
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecC---CCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ---HHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
++|++.+.||+|+||+||+|++..+++.||||+++.. .....+.+.+|++++++++|||||++++++.+.+ .
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE-----K 106 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----E
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-----E
Confidence 5799999999999999999999999999999999743 2334578999999999999999999999976544 8
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.|+||||++||+|.+++. ..+.+++.+++.|+.||+.||+|||++ +|+||||||+|||++.++.+||
T Consensus 107 ~yivmEy~~gG~L~~~i~----------~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl 173 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIR----------KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQI 173 (311)
T ss_dssp EEEEECCCTTEEHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEE
T ss_pred EEEEEecCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEE
Confidence 999999999999999996 335699999999999999999999988 9999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
+|||+|+.+.............||+.|||||++.+..|+.++||||+||++|||+||+.||....... ..
T Consensus 174 ~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--~~-------- 243 (311)
T 4aw0_A 174 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL--IF-------- 243 (311)
T ss_dssp CCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH--------
T ss_pred EEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HH--------
Confidence 99999998865544444445679999999999999999999999999999999999999996432110 00
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVV 925 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~ 925 (949)
..+...... .+ ...+.++.+++.+|++.||++|||++|+.
T Consensus 244 ---~~i~~~~~~-~p-------------------~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 244 ---AKIIKLEYD-FP-------------------EKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ---HHHHHTCCC-CC-------------------TTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ---HHHHcCCCC-CC-------------------cccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 011110000 00 01234578999999999999999999874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=419.29 Aligned_cols=251 Identities=23% Similarity=0.356 Sum_probs=197.2
Q ss_pred CCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeE
Q 039533 629 SSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASV 706 (949)
Q Consensus 629 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 706 (949)
.+.++||+|+||+||+|.+..+++.||+|++..... ...+++.+|++++++++|||||++++++.... .++...++|
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~lv 107 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEEE
Confidence 556789999999999999999999999999975432 23467999999999999999999999986432 233468999
Q ss_pred eeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec-CCCceEEeec
Q 039533 707 YEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD-DYMTARVGDF 785 (949)
Q Consensus 707 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~-~~~~~kl~Df 785 (949)
|||+++|+|.+++. ....+++..+..|+.||+.||+|||++ .++|+||||||+|||++ .++.+||+||
T Consensus 108 mEy~~gg~L~~~l~----------~~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DF 176 (290)
T 3fpq_A 108 TELMTSGTLKTYLK----------RFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDL 176 (290)
T ss_dssp EECCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCT
T ss_pred EeCCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeC
Confidence 99999999999996 235689999999999999999999987 33499999999999998 4799999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCch
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDV 865 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 865 (949)
|+|+...... .....||+.|||||++.+ +|+.++|||||||++|||+||+.||........ +
T Consensus 177 Gla~~~~~~~----~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~-~------------ 238 (290)
T 3fpq_A 177 GLATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-I------------ 238 (290)
T ss_dssp TGGGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-H------------
T ss_pred cCCEeCCCCc----cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH-H------------
Confidence 9998643322 124579999999999875 699999999999999999999999963211110 0
Q ss_pred hhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 866 MDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 866 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
...+.....+.. + ....++++.+++.+||+.||++|||++|+++
T Consensus 239 ~~~i~~~~~~~~---------------~--~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 239 YRRVTSGVKPAS---------------F--DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHTTTCCCGG---------------G--GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHcCCCCCC---------------C--CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000100000000 0 0012345788999999999999999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=438.73 Aligned_cols=250 Identities=22% Similarity=0.291 Sum_probs=207.6
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
+.|++.+.||+|+||.||+|++..+|+.||||++........+.+.+|+.+|++++|||||++++++...+ ..|+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-----~~~i 225 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-----ELWV 225 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECC-----EEEE
Confidence 46999999999999999999999999999999998766666678999999999999999999999976554 7999
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
|||||+||+|.+++. ...+++.++..|+.||+.||+|||++ +||||||||+|||++.+|.+||+||
T Consensus 226 VmEy~~gG~L~~~i~-----------~~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DF 291 (423)
T 4fie_A 226 VMEFLEGGALTDIVT-----------HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDF 291 (423)
T ss_dssp EEECCTTEEHHHHHH-----------HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCC
T ss_pred EEeCCCCCcHHHHHh-----------ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecC
Confidence 999999999999986 23589999999999999999999988 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCch
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDV 865 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 865 (949)
|+|+.+....... ...+||+.|||||++.+..|+.++|||||||++|||++|+.||...... ..........+.
T Consensus 292 Gla~~~~~~~~~~--~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~i~~~~~~-- 365 (423)
T 4fie_A 292 GFCAQVSKEVPRR--KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNLPP-- 365 (423)
T ss_dssp TTCEECCSSCCCB--CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCCC--
T ss_pred ccceECCCCCccc--cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHcCCCC--
Confidence 9999876544322 2467999999999999999999999999999999999999999632111 111111110000
Q ss_pred hhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 866 MDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 866 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.+. ....++..+.+++.+||+.||++|||++|+++
T Consensus 366 ------~~~--------------------~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 366 ------RLK--------------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp ------CCS--------------------CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------CCc--------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000 00123456789999999999999999999875
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=457.09 Aligned_cols=454 Identities=22% Similarity=0.238 Sum_probs=387.4
Q ss_pred EEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccc
Q 039533 70 LDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQL 149 (949)
Q Consensus 70 l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l 149 (949)
++.++.+++ .+|..+. +++++|+|++|++++..+..|.++++|++|+|++|++++..|..|+++++|++|++++|++
T Consensus 12 ~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 88 (570)
T 2z63_A 12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88 (570)
T ss_dssp EECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcC
Confidence 455555665 4565543 5799999999999988888999999999999999999987788999999999999999999
Q ss_pred cccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCC-CCCCcccCCCccccccccCcccccccccc
Q 039533 150 VGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDG-TIPNSFGWFENLVFLSLAANNLSVVENKL 228 (949)
Q Consensus 150 ~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l 228 (949)
++..+..|.++++|++|+|++|.+++..+..++++++|++|+|++|.+++ .+|..|+++++|++|++++|+++.+..
T Consensus 89 ~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~-- 166 (570)
T 2z63_A 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC-- 166 (570)
T ss_dssp CEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECG--
T ss_pred CccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecH--
Confidence 99999999999999999999999997666689999999999999999997 479999999999999999999876542
Q ss_pred cCCCCChhhhccc----cccccccCCCCCCCCCCcchhccccccCcccEEEccCC-------------------------
Q 039533 229 TGEVPSLEKLQRL----QHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSN------------------------- 279 (949)
Q Consensus 229 ~~~~~~l~~l~~L----~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N------------------------- 279 (949)
..+..+++| +++++++|.+....+..+. . .+|+.|++++|
T Consensus 167 ----~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~------~-~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~ 235 (570)
T 2z63_A 167 ----TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK------E-IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLG 235 (570)
T ss_dssp ----GGGHHHHTCTTCCCEEECTTCCCCEECTTTTT------T-CEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEE
T ss_pred ----HHccchhccchhhhhcccCCCCceecCHHHhc------c-CcceeEecccccccccchhhhhcCccccceeeeccc
Confidence 246677777 8899999999876544322 1 24666666655
Q ss_pred ---------------------------------CCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEEEee
Q 039533 280 ---------------------------------NFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMW 326 (949)
Q Consensus 280 ---------------------------------~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 326 (949)
.+.+.+|..+..+ ++|++|++++|.++ .+|..+..+ +|++|+++
T Consensus 236 ~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l-~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~ 312 (570)
T 2z63_A 236 EFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCL-TNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELV 312 (570)
T ss_dssp ECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGG-TTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEE
T ss_pred cccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCc-CcccEEEecCccch-hhhhhhccC-CccEEeec
Confidence 3445556666665 46888999988888 577778888 88999999
Q ss_pred cceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecccccccccC--CCCCCCCCCCcEEEeeCccccC
Q 039533 327 NNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSI--PSSLGQCESLIEINLSNNNLSG 404 (949)
Q Consensus 327 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~l~~N~l~~ 404 (949)
+|.+. .+|. ..+++|+.|++++|.+.+..+. ..+++|++|++++|.+++.. |..+..+++|++|++++|++++
T Consensus 313 ~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~ 387 (570)
T 2z63_A 313 NCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT 387 (570)
T ss_dssp SCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEE
T ss_pred cCccc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccc
Confidence 99888 5554 4678899999999988876665 78999999999999998654 6778899999999999999995
Q ss_pred CCCCcccCCcccceeeccCCCccCCCCc-cccccccccceeeeccccccccCCcccccccchhhcccCccccc-cccCCC
Q 039533 405 TIPPQFFSLSSLSISLDWSRNKLTGSLP-IEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQ-GPISSS 482 (949)
Q Consensus 405 ~~p~~~~~l~~l~~~L~ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-~~~~~~ 482 (949)
+|..+..+++| +.|++++|.+++..| ..+..+++|++|++++|++.+..|..|.++++|+.|+|++|.++ +.+|..
T Consensus 388 -~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~ 465 (570)
T 2z63_A 388 -MSSNFLGLEQL-EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 465 (570)
T ss_dssp -EEEEEETCTTC-CEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSC
T ss_pred -ccccccccCCC-CEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhh
Confidence 55558899999 899999999998766 57899999999999999999999999999999999999999998 689999
Q ss_pred cCCCCCCCEEECCCCcCCCcCcccccCCc-cceEeCCCCcCcCccccc-ccccccccccccCCCCCCCC
Q 039533 483 LGSLRGLRVLDLSQNNLSGEIPKFLAGLS-LNNLNLSYNDLEGMVTTE-GVFKNASATRILGNSKLCGG 549 (949)
Q Consensus 483 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~l~ls~N~l~~~~~~~-~~~~~~~~~~~~gn~~~c~~ 549 (949)
+..+++|+.|+|++|++++.+|..+..++ |++|++++|++++.+|.. ..+..+..+.+.+|++.|.-
T Consensus 466 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 534 (570)
T 2z63_A 466 FTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 534 (570)
T ss_dssp CTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred hhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCC
Confidence 99999999999999999999899988877 999999999999987753 56677888999999998853
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-49 Score=413.61 Aligned_cols=247 Identities=22% Similarity=0.299 Sum_probs=188.5
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
.++|++.+.||+|+||+||+|++..+++.||||+++... ....+++.+|++++++++|||||++++++.+.+
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~----- 86 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD----- 86 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC-----
Confidence 368999999999999999999999899999999997543 233467999999999999999999999976544
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+ +|+|.+++. ....+++.++..++.||+.||+|||++ +|+||||||+|||+++++++|
T Consensus 87 ~~~ivmEy~-~g~L~~~l~----------~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vk 152 (275)
T 3hyh_A 87 EIIMVIEYA-GNELFDYIV----------QRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVK 152 (275)
T ss_dssp EEEEEEECC-CEEHHHHHH----------HSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEE
T ss_pred EEEEEEeCC-CCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEE
Confidence 899999999 679999986 235699999999999999999999988 999999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCcc-CCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEV-STNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
|+|||+|+........ ....||+.|||||++.+..+ +.++||||+||++|||+||+.||...... ....
T Consensus 153 l~DFGla~~~~~~~~~---~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~--~~~~----- 222 (275)
T 3hyh_A 153 IADFGLSNIMTDGNFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP--VLFK----- 222 (275)
T ss_dssp ECCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH-----
T ss_pred EeecCCCeecCCCCcc---CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH--HHHH-----
Confidence 9999999876543322 23569999999999998876 58999999999999999999999632111 0000
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.+..... ..+ ...+..+.+++.+|++.||++|||++|+++
T Consensus 223 ------~i~~~~~-~~p-------------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 223 ------NISNGVY-TLP-------------------KFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ------HHHHTCC-CCC-------------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ------HHHcCCC-CCC-------------------CCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0000000 000 012345789999999999999999999976
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-48 Score=469.21 Aligned_cols=415 Identities=19% Similarity=0.239 Sum_probs=333.7
Q ss_pred CCCceeeccCceeccccCCcccCcccCcEEee-ccccccCcCCCCC----------------------------------
Q 039533 89 SFLKQLYLQVNSFTHEIPSEIGGLRRLKVLAL-NNNSICGEIPTNI---------------------------------- 133 (949)
Q Consensus 89 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L-s~N~l~~~~p~~~---------------------------------- 133 (949)
..++.|+|++|+++|.+|++|++|++|++|+| ++|.++|..|..-
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 57899999999999999999999999999999 9999888744321
Q ss_pred -----------------CCCccceeecCCC--ccccccccccccCCCCCcEEECCCCCCCC-----------------CC
Q 039533 134 -----------------SRCSTLIPIHPQN--NQLVGKILSRFSSLSKTEILNLGSNHLTG-----------------SI 177 (949)
Q Consensus 134 -----------------~~l~~L~~L~l~~--n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~-----------------~~ 177 (949)
.....++.+.+.. |++++ +|..|.+|++|++|+|++|+|+| .+
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i 481 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence 1122344444443 88888 78889999999999999999998 38
Q ss_pred CCCcC--CCCCccEEeccccccCCCCCCcccCCCccccccccCcc-ccc--ccccccCCCCChhhhccccccccccCCCC
Q 039533 178 PSSLG--NLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANN-LSV--VENKLTGEVPSLEKLQRLQHFTITSNSLG 252 (949)
Q Consensus 178 p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~--~~~~l~~~~~~l~~l~~L~~L~l~~N~l~ 252 (949)
|..++ ++++|++|+|++|++.+.+|..|+++++|++|+|++|+ ++. ++.. +..++
T Consensus 482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~-------i~~L~------------- 541 (876)
T 4ecn_A 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKAD-------WTRLA------------- 541 (876)
T ss_dssp TSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHH-------HHHHH-------------
T ss_pred ChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHH-------HHhhh-------------
Confidence 88887 99999999999999999999999999999999999887 652 2211 22221
Q ss_pred CCCCCCcchhccccccCcccEEEccCCCCCccCCc--hhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeeccee
Q 039533 253 SGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPG--CISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQL 330 (949)
Q Consensus 253 ~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~--~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 330 (949)
..+..+++|++|+|++|+++ .+|. .+.+++ +|++|+|++|+|+ .+| .|+.+++|++|+|++|++
T Consensus 542 ----------~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~-~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l 607 (876)
T 4ecn_A 542 ----------DDEDTGPKIQIFYMGYNNLE-EFPASASLQKMV-KLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQI 607 (876)
T ss_dssp ----------HCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCT-TCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCC
T ss_pred ----------hcccccCCccEEEeeCCcCC-ccCChhhhhcCC-CCCEEECCCCCcc-cch-hhcCCCcceEEECcCCcc
Confidence 02334567888888888888 6777 777774 6888899888888 777 888888899999999988
Q ss_pred cccCCCcccccCC-CCEEecCCcccccccCcccccccc--cceeecccccccccCCCCC---C--CCCCCcEEEeeCccc
Q 039533 331 SGTIPPAIGELQN-LKILGLNRNKLSGNIPPSIGNLKM--LLNLFLNDNFLEVSIPSSL---G--QCESLIEINLSNNNL 402 (949)
Q Consensus 331 ~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~L~~N~l~~~~p~~~---~--~l~~L~~L~l~~N~l 402 (949)
+ .+|..+.++++ |+.|+|++|+|+ .+|..+..++. |+.|+|++|++++.+|... . .+++|+.|+|++|++
T Consensus 608 ~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L 685 (876)
T 4ecn_A 608 E-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEI 685 (876)
T ss_dssp S-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCC
T ss_pred c-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcC
Confidence 8 78888888888 999999999888 77887777654 8899999998887766433 2 345788999999999
Q ss_pred cCCCCCccc-CCcccceeeccCCCccCCCCcccccc--------ccccceeeeccccccccCCcccc--cccchhhcccC
Q 039533 403 SGTIPPQFF-SLSSLSISLDWSRNKLTGSLPIEVGK--------LKILEFLYVYENRLEGEIPSTFG--NCIRLEQLGMG 471 (949)
Q Consensus 403 ~~~~p~~~~-~l~~l~~~L~ls~N~l~~~~p~~~~~--------l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~l~ 471 (949)
+ .+|..++ .+++| +.|+|++|+++ .+|..+.. +++|+.|+|++|+|+ .+|..+. .+++|+.|+|+
T Consensus 686 ~-~lp~~~~~~l~~L-~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls 761 (876)
T 4ecn_A 686 Q-KFPTELFATGSPI-STIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVS 761 (876)
T ss_dssp C-SCCHHHHHTTCCC-SEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECC
T ss_pred C-ccCHHHHccCCCC-CEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeC
Confidence 8 6777665 67777 78999999988 55554433 338999999999999 7888887 89999999999
Q ss_pred ccccccccCCCcCCCCCCCEEECCC------CcCCCcCcccccCCc-cceEeCCCCcCcCcccccccccccccccccCCC
Q 039533 472 GNLFQGPISSSLGSLRGLRVLDLSQ------NNLSGEIPKFLAGLS-LNNLNLSYNDLEGMVTTEGVFKNASATRILGNS 544 (949)
Q Consensus 472 ~N~l~~~~~~~~~~l~~L~~L~Ls~------N~l~~~~p~~~~~~~-L~~l~ls~N~l~~~~~~~~~~~~~~~~~~~gn~ 544 (949)
+|+|++ +|..+..+++|+.|+|++ |++.+.+|..+..++ |+.|+|++|++ +.+|.. .+..+..+.+.+|+
T Consensus 762 ~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~-l~~~L~~LdLs~N~ 838 (876)
T 4ecn_A 762 YNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEK-LTPQLYILDIADNP 838 (876)
T ss_dssp SSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-CCSSSCEEECCSCT
T ss_pred CCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHh-hcCCCCEEECCCCC
Confidence 999997 788999999999999976 889999999998887 99999999999 666654 34678888999998
Q ss_pred CCC
Q 039533 545 KLC 547 (949)
Q Consensus 545 ~~c 547 (949)
...
T Consensus 839 l~~ 841 (876)
T 4ecn_A 839 NIS 841 (876)
T ss_dssp TCE
T ss_pred CCc
Confidence 654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-49 Score=430.90 Aligned_cols=275 Identities=23% Similarity=0.297 Sum_probs=215.1
Q ss_pred HHHhcCCCCCCeeeeecCceEEEEEEcCC-----CEEEEEEEEecCCC-cchHHHHHHHHHHHhcCC-CcceeEEeeeec
Q 039533 622 YNATSGFSSANLVGVGSFGSVYKGIIDEG-----RTTIAVKVFNLQHH-GASRSFIAECKALKSIRH-RNLVKVLTACLG 694 (949)
Q Consensus 622 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~ 694 (949)
+...++|++.+.||+|+||+||+|++... ++.||||+++.... ...+.+.+|++++++++| ||||+++|+|..
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 34457899999999999999999998643 36899999975443 334679999999999965 899999999854
Q ss_pred ccccCCccceeEeeeccCCChhhhcCCCCCCC------ccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 039533 695 ADYRGNDFKASVYEFMHYGSLEEWLHPFTGED------EIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLK 768 (949)
Q Consensus 695 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlk 768 (949)
.+ ...++|||||++|+|.++++...... ........+++.+++.|+.|||+||+|||++ +|||||||
T Consensus 140 ~~----~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK 212 (353)
T 4ase_A 140 PG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 212 (353)
T ss_dssp TT----SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred cC----CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccC
Confidence 32 36799999999999999997422110 0011235689999999999999999999988 89999999
Q ss_pred CCCeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCcccc
Q 039533 769 PSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMF 847 (949)
Q Consensus 769 p~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~ 847 (949)
|+|||+++++.+||+|||+|+....+..........||+.|||||++.+..|+.++|||||||++|||+| |+.||....
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999998766554444445669999999999999999999999999999999998 999996432
Q ss_pred ccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 848 EGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 848 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
... .+ ...+...... +.+..++.++.+++.+||+.||++||||+||++.
T Consensus 293 ~~~-~~------------~~~i~~g~~~------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 293 IDE-EF------------CRRLKEGTRM------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp CSH-HH------------HHHHHHTCCC------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHH-HH------------HHHHHcCCCC------------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 111 11 1111110000 0011335568899999999999999999999999
Q ss_pred HHHhHHh
Q 039533 928 LQSIKNI 934 (949)
Q Consensus 928 L~~i~~~ 934 (949)
|+++.++
T Consensus 342 L~~llq~ 348 (353)
T 4ase_A 342 LGNLLQA 348 (353)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9998765
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=468.82 Aligned_cols=434 Identities=20% Similarity=0.266 Sum_probs=371.2
Q ss_pred CCCceeeccCceeccccCCcccCcccCcEEeeccccc------cC------cCCCCCCCCccceeecCCCcccccccccc
Q 039533 89 SFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSI------CG------EIPTNISRCSTLIPIHPQNNQLVGKILSR 156 (949)
Q Consensus 89 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l------~~------~~p~~~~~l~~L~~L~l~~n~l~~~~~~~ 156 (949)
.+++.|+|++|+++|.+|.+|++|++|++|+|++|.+ .| .+|... +..|+ +++++|.+.+.++..
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~ 157 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPRED 157 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGG
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhh
Confidence 4688999999999999999999999999999999987 33 344433 56677 888889888888777
Q ss_pred ccCC-C------------------CCcEEECC--CCCCCCCCCCCcCCCCCccEEeccccccCCC---------------
Q 039533 157 FSSL-S------------------KTEILNLG--SNHLTGSIPSSLGNLSSIHTISLAYNNLDGT--------------- 200 (949)
Q Consensus 157 ~~~L-~------------------~L~~L~Ls--~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--------------- 200 (949)
+..+ . .++.+.+. +|+++| +|..|+++++|++|+|++|+++|.
T Consensus 158 ~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~ 236 (636)
T 4eco_A 158 FSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQ 236 (636)
T ss_dssp SCHHHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHH
T ss_pred HHHHHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhc
Confidence 6622 1 12222222 689998 999999999999999999999986
Q ss_pred --CCCccc--CCCccccccccCcccccccccccCCCC-ChhhhccccccccccCC-CCCCCCCCcchhccccc------c
Q 039533 201 --IPNSFG--WFENLVFLSLAANNLSVVENKLTGEVP-SLEKLQRLQHFTITSNS-LGSGGNDDLSFLCSLTN------A 268 (949)
Q Consensus 201 --~p~~~~--~l~~L~~L~Ls~N~l~~~~~~l~~~~~-~l~~l~~L~~L~l~~N~-l~~~~~~~~~~~~~l~~------~ 268 (949)
+|..++ ++++|++|+|++|++. +.+| .+.++++|++|++++|+ ++. ...+..+.+ +
T Consensus 237 ~~ip~~l~~~~l~~L~~L~L~~n~l~-------~~~p~~l~~l~~L~~L~Ls~n~~l~~-----~~lp~~~~~L~~~~~l 304 (636)
T 4eco_A 237 QYKTEDLKWDNLKDLTDVEVYNCPNL-------TKLPTFLKALPEMQLINVACNRGISG-----EQLKDDWQALADAPVG 304 (636)
T ss_dssp HHTTSCCCGGGCTTCCEEEEECCTTC-------SSCCTTTTTCSSCCEEECTTCTTSCH-----HHHHHHHHHHHHSGGG
T ss_pred ccCchhhhhcccCCCCEEEecCCcCC-------ccChHHHhcCCCCCEEECcCCCCCcc-----ccchHHHHhhhccccC
Confidence 999999 9999999999998764 4555 48899999999999998 753 012334444 4
Q ss_pred CcccEEEccCCCCCccCCc--hhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCC-CC
Q 039533 269 TRLTWMHINSNNFGGLLPG--CISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQN-LK 345 (949)
Q Consensus 269 ~~L~~L~L~~N~l~~~~p~--~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~ 345 (949)
++|++|++++|+++ .+|. .+..++ +|++|+|++|+++|.+| .++.+++|++|+|++|+++ .+|..+.++++ |+
T Consensus 305 ~~L~~L~L~~n~l~-~ip~~~~l~~l~-~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~ 380 (636)
T 4eco_A 305 EKIQIIYIGYNNLK-TFPVETSLQKMK-KLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVE 380 (636)
T ss_dssp GTCCEEECCSSCCS-SCCCHHHHTTCT-TCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCC
T ss_pred CCCCEEECCCCcCC-ccCchhhhccCC-CCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCc
Confidence 99999999999999 7888 888884 69999999999999999 9999999999999999999 88999999999 99
Q ss_pred EEecCCcccccccCccccccc--ccceeecccccccccCCCCCC-------CCCCCcEEEeeCccccCCCCCcccC-Ccc
Q 039533 346 ILGLNRNKLSGNIPPSIGNLK--MLLNLFLNDNFLEVSIPSSLG-------QCESLIEINLSNNNLSGTIPPQFFS-LSS 415 (949)
Q Consensus 346 ~L~Ls~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~p~~~~-------~l~~L~~L~l~~N~l~~~~p~~~~~-l~~ 415 (949)
.|+|++|+++ .+|..+..++ +|+.|++++|.+++.+|..|. .+++|++|+|++|+++ .+|..++. +++
T Consensus 381 ~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~ 458 (636)
T 4eco_A 381 NLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS-KFPKELFSTGSP 458 (636)
T ss_dssp EEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCC-SCCTHHHHTTCC
T ss_pred EEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccC-cCCHHHHccCCC
Confidence 9999999999 7898888765 999999999999999999998 8889999999999999 67776654 788
Q ss_pred cceeeccCCCccCCCCcccc-ccc-------cccceeeeccccccccCCcccc--cccchhhcccCccccccccCCCcCC
Q 039533 416 LSISLDWSRNKLTGSLPIEV-GKL-------KILEFLYVYENRLEGEIPSTFG--NCIRLEQLGMGGNLFQGPISSSLGS 485 (949)
Q Consensus 416 l~~~L~ls~N~l~~~~p~~~-~~l-------~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~l~~N~l~~~~~~~~~~ 485 (949)
| +.|+|++|+++ .+|..+ ... ++|+.|+|++|+++ .+|..+. .+++|+.|+|++|+|++ +|..+..
T Consensus 459 L-~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~ 534 (636)
T 4eco_A 459 L-SSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLN 534 (636)
T ss_dssp C-SEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGG
T ss_pred C-CEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhc
Confidence 8 79999999999 555543 333 39999999999999 7898887 99999999999999998 8999999
Q ss_pred CCCCCEEEC------CCCcCCCcCcccccCCc-cceEeCCCCcCcCcccccccccccccccccCCCCCCCCC
Q 039533 486 LRGLRVLDL------SQNNLSGEIPKFLAGLS-LNNLNLSYNDLEGMVTTEGVFKNASATRILGNSKLCGGI 550 (949)
Q Consensus 486 l~~L~~L~L------s~N~l~~~~p~~~~~~~-L~~l~ls~N~l~~~~~~~~~~~~~~~~~~~gn~~~c~~~ 550 (949)
+++|+.|+| ++|++.+.+|..+..++ |+.|+|++|++ +.+|.. .+..+..+.+.+|+..|-..
T Consensus 535 l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~-~~~~L~~L~Ls~N~l~~~~~ 604 (636)
T 4eco_A 535 SSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEK-ITPNISVLDIKDNPNISIDL 604 (636)
T ss_dssp CSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-CCTTCCEEECCSCTTCEEEC
T ss_pred CCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHh-HhCcCCEEECcCCCCccccH
Confidence 999999999 56889999999998887 99999999999 555554 34778889999999887543
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=450.58 Aligned_cols=442 Identities=19% Similarity=0.173 Sum_probs=279.1
Q ss_pred EEEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCcc
Q 039533 69 LLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQ 148 (949)
Q Consensus 69 ~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~ 148 (949)
.+|+++++++ .+|..+. ++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|+++++|++|++++|+
T Consensus 4 ~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 80 (520)
T 2z7x_B 4 LVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80 (520)
T ss_dssp EEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSC
T ss_pred eEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCc
Confidence 5788888888 5666665 788888888888887767778888888888888888887778888888888888888888
Q ss_pred ccccccccccCCCCCcEEECCCCCCCC-CCCCCcCCCCCccEEeccccccCCCCCCcccCCCcc--ccccccCccc--cc
Q 039533 149 LVGKILSRFSSLSKTEILNLGSNHLTG-SIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENL--VFLSLAANNL--SV 223 (949)
Q Consensus 149 l~~~~~~~~~~L~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~Ls~N~l--~~ 223 (949)
|+.... . .+++|++|+|++|.+++ .+|..|+++++|++|+|++|++++ ..+..+++| ++|+|++|.+ ..
T Consensus 81 l~~lp~-~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~ 154 (520)
T 2z7x_B 81 LVKISC-H--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEK 154 (520)
T ss_dssp CCEEEC-C--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSS
T ss_pred eeecCc-c--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccc
Confidence 875433 3 78888888888888886 467788888888888888888875 456667777 8888888876 21
Q ss_pred ccc------------------cccCCCC--ChhhhccccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCc
Q 039533 224 VEN------------------KLTGEVP--SLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGG 283 (949)
Q Consensus 224 ~~~------------------~l~~~~~--~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~ 283 (949)
... .+.+.++ .+..+++|+.+++++|.-..........+..+..+++|+.|++++|.+++
T Consensus 155 ~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~ 234 (520)
T 2z7x_B 155 EDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTW 234 (520)
T ss_dssp CCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEH
T ss_pred cccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCH
Confidence 111 0111111 13345556666666554110000000112245556666666666666554
Q ss_pred cCCchhhcc--cccccEEEccCccccCCCCCCC-----CCCCcccEEEeecceecccCC-Cccccc---CCCCEEecCCc
Q 039533 284 LLPGCISNL--SKTIKTLFLNNNKIYGSIPAGI-----GNFVNLQRLDMWNNQLSGTIP-PAIGEL---QNLKILGLNRN 352 (949)
Q Consensus 284 ~~p~~~~~l--~~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~p-~~~~~l---~~L~~L~Ls~N 352 (949)
..+..+... .++|++|++++|+++|.+|..+ +.+++|+.+++++|.+ .+| ..+..+ .+|+.|++++|
T Consensus 235 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n 312 (520)
T 2z7x_B 235 NSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGT 312 (520)
T ss_dssp HHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESS
T ss_pred HHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCC
Confidence 322221110 1246666666666666666666 6666666666666666 344 334333 45666666666
Q ss_pred ccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccC--CCCCcccCCcccceeeccCCCccCCC
Q 039533 353 KLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSG--TIPPQFFSLSSLSISLDWSRNKLTGS 430 (949)
Q Consensus 353 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~l~~~L~ls~N~l~~~ 430 (949)
++.+.. .+..+++|++|++++|++++.+|..+..+++|++|++++|++++ .+|..+..+++| +.|++++|++++.
T Consensus 313 ~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L-~~L~Ls~N~l~~~ 389 (520)
T 2z7x_B 313 RMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSL-QQLDISQNSVSYD 389 (520)
T ss_dssp CCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTC-CEEECCSSCCBCC
T ss_pred cccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCC-CEEECCCCcCCcc
Confidence 665321 12466666667777777666666666666677777777776664 444556666666 5667777776664
Q ss_pred Ccc-ccccccccceeeeccccccccCCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCcCcccccC
Q 039533 431 LPI-EVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAG 509 (949)
Q Consensus 431 ~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 509 (949)
+|. .+..+++|+.|++++|++++.+|..+. ++|+.|+|++|+++ .+|..+..+++|+.|+|++|+|++..+..+..
T Consensus 390 l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~ 466 (520)
T 2z7x_B 390 EKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDR 466 (520)
T ss_dssp GGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred cccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhcc
Confidence 444 356666677777777766666655553 56666677777666 55666666666777777777666333333554
Q ss_pred Cc-cceEeCCCCcCcCccc
Q 039533 510 LS-LNNLNLSYNDLEGMVT 527 (949)
Q Consensus 510 ~~-L~~l~ls~N~l~~~~~ 527 (949)
++ |++|++++|++++..+
T Consensus 467 l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 467 LTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp CTTCCEEECCSSCBCCCHH
T ss_pred CCcccEEECcCCCCcccCC
Confidence 44 6667777776666543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=414.71 Aligned_cols=243 Identities=23% Similarity=0.246 Sum_probs=189.8
Q ss_pred cCCCCCCeeeeecCceEEEEEEc---CCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 626 SGFSSANLVGVGSFGSVYKGIID---EGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
++|++.+.||+|+||+||+|++. .+++.||||+++... .....++.+|++++++++|||||++++++.+.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~---- 99 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG---- 99 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT----
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC----
Confidence 57999999999999999999884 357899999997442 223346889999999999999999999976544
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
..|+||||++||+|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+|||++.++++
T Consensus 100 -~~~ivmEy~~gg~L~~~l~----------~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~v 165 (304)
T 3ubd_A 100 -KLYLILDFLRGGDLFTRLS----------KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHI 165 (304)
T ss_dssp -EEEEEECCCTTCEEHHHHH----------HHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCE
T ss_pred -EEEEEEEcCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCE
Confidence 7999999999999999996 235699999999999999999999988 99999999999999999999
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
||+|||+|+......... ....||+.|||||++.+..|+.++||||+||++|||+||+.||......+ ..
T Consensus 166 Kl~DFGla~~~~~~~~~~--~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~--~~------ 235 (304)
T 3ubd_A 166 KLTDFGLSKESIDHEKKA--YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE--TM------ 235 (304)
T ss_dssp EEESSEEEEC-----CCC--CSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH------
T ss_pred EecccccceeccCCCccc--cccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH--HH------
Confidence 999999998754433222 24569999999999999999999999999999999999999996432111 00
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCH
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNM 921 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 921 (949)
..+..... ..+ ...+..+.+++.+||+.||++|||+
T Consensus 236 -----~~i~~~~~-~~p-------------------~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 236 -----TMILKAKL-GMP-------------------QFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp -----HHHHHCCC-CCC-------------------TTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred -----HHHHcCCC-CCC-------------------CcCCHHHHHHHHHHcccCHHHCCCC
Confidence 01111000 000 1234567899999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=407.44 Aligned_cols=257 Identities=23% Similarity=0.347 Sum_probs=190.3
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccc-------
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADY------- 697 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------- 697 (949)
++|++.+.||+|+||+||+|++..+++.||||+++.... ...+++.+|++++++++|||||++++++...+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 468899999999999999999999999999999975543 334678999999999999999999999865431
Q ss_pred cCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCC
Q 039533 698 RGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDY 777 (949)
Q Consensus 698 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~ 777 (949)
......|+||||+++|+|.+++.... .....++..++.|+.||+.||+|||++ +|+||||||+|||++.+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~-------~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~ 154 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRC-------TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMD 154 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCC-------SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcC-------CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCC
Confidence 12234689999999999999997321 122356677899999999999999988 99999999999999999
Q ss_pred CceEEeecccceecCCCCCcc----------ccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCcccc
Q 039533 778 MTARVGDFGLARILSPDHTQT----------SSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMF 847 (949)
Q Consensus 778 ~~~kl~DfG~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~ 847 (949)
+.+||+|||+|+......... ......||+.|||||++.+..|+.++|||||||++|||++ ||....
T Consensus 155 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~ 231 (299)
T 4g31_A 155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM 231 (299)
T ss_dssp CCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc
Confidence 999999999998875543211 1123569999999999999999999999999999999996 774221
Q ss_pred ccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 848 EGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 848 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
+.... +..+.+... .+...+..+...+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~------------~~~~~~~~~-------------------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 232 ERVRT------------LTDVRNLKF-------------------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHH------------HHHHHTTCC-------------------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHH------------HHHHhcCCC-------------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 10000 000000000 0112233445678999999999999999999876
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=443.49 Aligned_cols=432 Identities=20% Similarity=0.239 Sum_probs=348.2
Q ss_pred ceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECCCC
Q 039533 92 KQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSN 171 (949)
Q Consensus 92 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N 171 (949)
++|++++|+++ .+|..+. ++|++|+|++|.+++..|..|.++++|++|++++|++++..|..|.++++|++|+|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 57999999999 6888776 89999999999999877889999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcCCCCCccEEeccccccCC-CCCCcccCCCccccccccCcccccccccccCCCCChhhhccc--ccccccc
Q 039533 172 HLTGSIPSSLGNLSSIHTISLAYNNLDG-TIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRL--QHFTITS 248 (949)
Q Consensus 172 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L--~~L~l~~ 248 (949)
+|+ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|+|++|.|+.. .+..+++| ++|++++
T Consensus 80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~---------~~~~l~~L~L~~L~l~~ 147 (520)
T 2z7x_B 80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKS---------SVLPIAHLNISKVLLVL 147 (520)
T ss_dssp CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGG---------GGGGGTTSCEEEEEEEE
T ss_pred cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccchh---------hccccccceeeEEEeec
Confidence 999 57766 89999999999999997 4789999999999999999998641 34556666 9999999
Q ss_pred CCC--CCCCCCCcchhc--------------------cccccCcccEEEccCCC-------CCccCCchhhcccccccEE
Q 039533 249 NSL--GSGGNDDLSFLC--------------------SLTNATRLTWMHINSNN-------FGGLLPGCISNLSKTIKTL 299 (949)
Q Consensus 249 N~l--~~~~~~~~~~~~--------------------~l~~~~~L~~L~L~~N~-------l~~~~p~~~~~l~~~L~~L 299 (949)
|.+ ....+..+..+. .+.++++|+.+++++|. +.+.+| .+..+ ++|+.|
T Consensus 148 n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l-~~L~~L 225 (520)
T 2z7x_B 148 GETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTN-PKLSNL 225 (520)
T ss_dssp CTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGC-TTCCEE
T ss_pred ccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccc-cchhhc
Confidence 998 443333222211 23345566666666665 444444 34444 346677
Q ss_pred EccCccccCCCCCCCC---CCCcccEEEeecceecccCCCcc-----cccCCCCEEecCCcccccccC-cccccc---cc
Q 039533 300 FLNNNKIYGSIPAGIG---NFVNLQRLDMWNNQLSGTIPPAI-----GELQNLKILGLNRNKLSGNIP-PSIGNL---KM 367 (949)
Q Consensus 300 ~L~~N~l~~~~~~~~~---~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~~~p-~~~~~l---~~ 367 (949)
++++|.+++..+..+. ..++|++|++++|+++|.+|..+ +++++|+.+++++|.+ .+| ..+..+ .+
T Consensus 226 ~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~ 303 (520)
T 2z7x_B 226 TLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMN 303 (520)
T ss_dssp EEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCC
T ss_pred cccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCc
Confidence 7766666543221111 13478888888888888888877 7888888888888888 445 455555 66
Q ss_pred cceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCC--CCccccccccccceee
Q 039533 368 LLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTG--SLPIEVGKLKILEFLY 445 (949)
Q Consensus 368 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~--~~p~~~~~l~~L~~L~ 445 (949)
|+.|++++|.+.... .+..+++|++|++++|++++.+|..+..+++| +.|++++|++++ .+|..++.+++|++|+
T Consensus 304 L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L-~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~ 380 (520)
T 2z7x_B 304 IKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTEL-ETLILQMNQLKELSKIAEMTTQMKSLQQLD 380 (520)
T ss_dssp CSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSC-CEEECCSSCCCBHHHHHHHHTTCTTCCEEE
T ss_pred eeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCC-CEEEccCCccCccccchHHHhhCCCCCEEE
Confidence 888888888876322 23688999999999999999899999999999 899999999997 5678899999999999
Q ss_pred eccccccccCCc-ccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCcCcccccCCc-cceEeCCCCcCc
Q 039533 446 VYENRLEGEIPS-TFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLS-LNNLNLSYNDLE 523 (949)
Q Consensus 446 Ls~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~l~ls~N~l~ 523 (949)
+++|++++.+|. .+..+++|+.|++++|++++.+|..+. ++|+.|+|++|+|+ .+|..+..++ |+.|++++|+++
T Consensus 381 Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~ 457 (520)
T 2z7x_B 381 ISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK 457 (520)
T ss_dssp CCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC
T ss_pred CCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC
Confidence 999999985665 488999999999999999998888775 79999999999999 6776655665 999999999999
Q ss_pred Ccccc-cccccccccccccCCCCCCC
Q 039533 524 GMVTT-EGVFKNASATRILGNSKLCG 548 (949)
Q Consensus 524 ~~~~~-~~~~~~~~~~~~~gn~~~c~ 548 (949)
+.++. ...+..+..+.+.+|++.|.
T Consensus 458 ~l~~~~~~~l~~L~~L~l~~N~~~c~ 483 (520)
T 2z7x_B 458 SVPDGIFDRLTSLQKIWLHTNPWDCS 483 (520)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred ccCHHHhccCCcccEEECcCCCCccc
Confidence 76554 45567788899999999884
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=441.79 Aligned_cols=499 Identities=21% Similarity=0.169 Sum_probs=322.7
Q ss_pred CCCCccCccCCC----Ccceee----eeEEeCCC---------CcEEEEEcCCCCCCccccCCCCCCCCCceeeccCcee
Q 039533 39 PVGVLGTWNESI----HFCKWY----GVTCSRRH---------QRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSF 101 (949)
Q Consensus 39 ~~~~l~sW~~~~----~~C~w~----gv~C~~~~---------~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l 101 (949)
+...+++|+.+. ++|.|. .|.|.... ..++.|||++|+|++..+.+|.++++|++|+|++|+|
T Consensus 9 ~~~~~~~~~~~~p~~~~~c~~~~~~~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i 88 (635)
T 4g8a_A 9 DDDKLAAANSSIPESWEPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI 88 (635)
T ss_dssp ----------------CCSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CcchhhcccCCCCCCCCCccccCCCCEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcC
Confidence 344566665432 345554 35676431 3577888888888876667788888888888888888
Q ss_pred ccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECCCCCCCC-CCCCC
Q 039533 102 THEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTG-SIPSS 180 (949)
Q Consensus 102 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~-~~p~~ 180 (949)
++..|.+|++|++|++|+|++|+|++..|..|+++++|++|++++|++++..+..|+++++|++|+|++|.+++ .+|..
T Consensus 89 ~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~ 168 (635)
T 4g8a_A 89 QTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 168 (635)
T ss_dssp CEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGG
T ss_pred CCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchh
Confidence 87777778888888888888888886555678888888888888888888777788888888888888888875 35677
Q ss_pred cCCCCCccEEeccccccCCCCCCcccCCCccc----cccccCcccccccccccCCCC-----------C-------hhhh
Q 039533 181 LGNLSSIHTISLAYNNLDGTIPNSFGWFENLV----FLSLAANNLSVVENKLTGEVP-----------S-------LEKL 238 (949)
Q Consensus 181 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~----~L~Ls~N~l~~~~~~l~~~~~-----------~-------l~~l 238 (949)
++.+++|++|+|++|+|++..|..|..+.+++ .++++.|.++.++........ . +..+
T Consensus 169 ~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l 248 (635)
T 4g8a_A 169 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGL 248 (635)
T ss_dssp GGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTT
T ss_pred hccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhcccccccccchhhcCC
Confidence 77888888888888888877777776665544 466777777655432221110 0 1112
Q ss_pred ccccccccccCCC------CCCCCCCc---------------------chhccccccCcccEEEccCCCCCccCCchhhc
Q 039533 239 QRLQHFTITSNSL------GSGGNDDL---------------------SFLCSLTNATRLTWMHINSNNFGGLLPGCISN 291 (949)
Q Consensus 239 ~~L~~L~l~~N~l------~~~~~~~~---------------------~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~ 291 (949)
..++...+..+.. .......+ .....+.....++.+++.+|.+....+ +..
T Consensus 249 ~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~--~~~ 326 (635)
T 4g8a_A 249 AGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKD--FSY 326 (635)
T ss_dssp TTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGG--GGS
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccccc--ccc
Confidence 2222222111110 00000000 011123345567777777777665432 222
Q ss_pred ccccccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCccccc--ccCcccccccccc
Q 039533 292 LSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSG--NIPPSIGNLKMLL 369 (949)
Q Consensus 292 l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~ 369 (949)
. ..++.|++.+|++.+..+. .+..|+.+++++|.+... .....+++|+.|++++|.+.. ..+..+..+.+|+
T Consensus 327 ~-~~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~ 400 (635)
T 4g8a_A 327 N-FGWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLK 400 (635)
T ss_dssp C-CCCSEEEEESCEESSCCCC---BCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCC
T ss_pred c-hhhhhhhcccccccCcCcc---cchhhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhh
Confidence 2 3578888888887754432 345677777777776632 234467777778887777753 3455666777777
Q ss_pred eeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCC-cccCCcccceeeccCCCccCCCCccccccccccceeeecc
Q 039533 370 NLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPP-QFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYE 448 (949)
Q Consensus 370 ~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 448 (949)
.|++..|.+.. .+..+..+++|+.+++++|+.....+. .+..+..+ ..+++++|.+++..|..+..++.|+.|+|++
T Consensus 401 ~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l-~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~ 478 (635)
T 4g8a_A 401 YLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL-IYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 478 (635)
T ss_dssp EEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTC-CEEECTTSCCEECCTTTTTTCTTCCEEECTT
T ss_pred hhhcccccccc-ccccccccccccchhhhhcccccccccccccccccc-ccccccccccccccccccccchhhhhhhhhh
Confidence 77777777663 455566777777777777776655443 34455666 6777777777777777777777777777777
Q ss_pred ccc-cccCCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCcCcccccCCc-cceEeCCCCcCcCcc
Q 039533 449 NRL-EGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLS-LNNLNLSYNDLEGMV 526 (949)
Q Consensus 449 N~l-~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~l~ls~N~l~~~~ 526 (949)
|++ .+..|..|..+++|+.|+|++|+|++.+|..|.++++|++|+|++|+|++.+|..+..++ |+.|+|++|+|++.+
T Consensus 479 N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~ 558 (635)
T 4g8a_A 479 NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSK 558 (635)
T ss_dssp CEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCC
T ss_pred cccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCC
Confidence 764 345667777777777777777777777777777777777777777777777777776665 777777777777776
Q ss_pred ccc-ccc-cccccccccCCCCCC
Q 039533 527 TTE-GVF-KNASATRILGNSKLC 547 (949)
Q Consensus 527 ~~~-~~~-~~~~~~~~~gn~~~c 547 (949)
|.. ..+ .++..+.+.+||+.|
T Consensus 559 ~~~l~~l~~~L~~L~L~~Np~~C 581 (635)
T 4g8a_A 559 KQELQHFPSSLAFLNLTQNDFAC 581 (635)
T ss_dssp SSCTTCCCTTCCEEECTTCCBCC
T ss_pred HHHHHhhhCcCCEEEeeCCCCcc
Confidence 653 222 456667777777777
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=413.00 Aligned_cols=285 Identities=19% Similarity=0.194 Sum_probs=203.7
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecc-cccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGA-DYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~~~ 702 (949)
++|++.+.||+|+||+||+|++..+|+.||||+++.... ...+++.+|+++|++++|||||++++++... .+.....
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 579999999999999999999999999999999975432 2346788999999999999999999997653 2345567
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.|+||||++ |+|.+++. ....+++.++..|+.||+.||+|||++ +||||||||+|||++.++.+||
T Consensus 134 ~~ivmE~~~-g~L~~~i~----------~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki 199 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH----------SSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKI 199 (398)
T ss_dssp EEEEEECCS-EEHHHHHT----------SSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEE
T ss_pred EEEEEeCCC-CCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEE
Confidence 899999996 68999996 345699999999999999999999988 9999999999999999999999
Q ss_pred eecccceecCCCCC--ccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 783 GDFGLARILSPDHT--QTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 783 ~DfG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
+|||+|+.+..... ........||+.|||||++.+. .++.++||||+||++|||++|++||......+. +......
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~-l~~I~~~ 278 (398)
T 4b99_A 200 GDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ-LQLIMMV 278 (398)
T ss_dssp CCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHHH
T ss_pred eecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH-HHHHHHh
Confidence 99999987644322 1222346799999999998875 468999999999999999999999964322110 1000000
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
..... .+.............+.......+.............+.+++.+|++.||++|||++|+++
T Consensus 279 ~g~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 279 LGTPS-PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp HCCCC-GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCCC-hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000 0000000000000000000000000000000122456789999999999999999999876
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=425.06 Aligned_cols=469 Identities=21% Similarity=0.194 Sum_probs=369.1
Q ss_pred eeeeEEeCCCCcEEEEEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCC
Q 039533 55 WYGVTCSRRHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNIS 134 (949)
Q Consensus 55 w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 134 (949)
|..-.|.... +..|-++.+|+ .+|+.+. +++++|||++|+|++..|.+|.++++|++|||++|+|++..|..|+
T Consensus 24 ~~~c~~~~~~---~~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~ 97 (635)
T 4g8a_A 24 WEPCVEVVPN---ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQ 97 (635)
T ss_dssp -CCSEEEETT---TEEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTT
T ss_pred CCCccccCCC---CEEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhc
Confidence 6655555432 23577777887 6776553 5799999999999987788999999999999999999977778899
Q ss_pred CCccceeecCCCccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCC-CCCCcccCCCcccc
Q 039533 135 RCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDG-TIPNSFGWFENLVF 213 (949)
Q Consensus 135 ~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~ 213 (949)
+|++|++|+|++|+|++..+..|.+|++|++|+|++|+|++..+..|+++++|++|+|++|++++ ..|..++.+++|++
T Consensus 98 ~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~ 177 (635)
T 4g8a_A 98 SLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEH 177 (635)
T ss_dssp TCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCE
T ss_pred CCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhh
Confidence 99999999999999999999999999999999999999998777889999999999999999986 46888999999999
Q ss_pred ccccCcccccccccccCCCCChhhhcccc----ccccccCCCCCCCCCCcchh------------------ccccccCcc
Q 039533 214 LSLAANNLSVVENKLTGEVPSLEKLQRLQ----HFTITSNSLGSGGNDDLSFL------------------CSLTNATRL 271 (949)
Q Consensus 214 L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~----~L~l~~N~l~~~~~~~~~~~------------------~~l~~~~~L 271 (949)
|+|++|+|+.+... .+..+.+++ .++++.|.++......+... ..+..+..+
T Consensus 178 L~L~~N~l~~~~~~------~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l 251 (635)
T 4g8a_A 178 LDLSSNKIQSIYCT------DLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGL 251 (635)
T ss_dssp EECCSSCCCEECGG------GGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTC
T ss_pred hcccCccccccccc------cccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhcccccccccchhhcCCccc
Confidence 99999999876532 234444333 46677777654432211100 011122222
Q ss_pred cEEEccC------------------------------CCCCc---cCCchhhcccccccEEEccCccccCCCCCCCCCCC
Q 039533 272 TWMHINS------------------------------NNFGG---LLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFV 318 (949)
Q Consensus 272 ~~L~L~~------------------------------N~l~~---~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~ 318 (949)
+...+.. +.... ..+..+.. ..+++.+.+.+|.+.... .+....
T Consensus 252 ~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~-~~~l~~l~~~~~~~~~~~--~~~~~~ 328 (635)
T 4g8a_A 252 EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNC-LTNVSSFSLVSVTIERVK--DFSYNF 328 (635)
T ss_dssp EEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGG-GTTCSEEEEESCEEEECG--GGGSCC
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhh-hccccccccccccccccc--ccccch
Confidence 2222211 11100 01111222 246888999999887543 356678
Q ss_pred cccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecccccccc--cCCCCCCCCCCCcEEE
Q 039533 319 NLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEV--SIPSSLGQCESLIEIN 396 (949)
Q Consensus 319 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~ 396 (949)
+|+.|++++|.+.+..+. .+..|+.+++++|.+.... ...++++|+.|++++|.+.. ..+..+..+.+|+.|+
T Consensus 329 ~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~ 403 (635)
T 4g8a_A 329 GWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLD 403 (635)
T ss_dssp CCSEEEEESCEESSCCCC---BCTTCCEEEEESCCSCCBC--CCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEE
T ss_pred hhhhhhcccccccCcCcc---cchhhhhcccccccCCCCc--ccccccccccchhhccccccccccccchhhhhhhhhhh
Confidence 999999999999865443 4678999999999987433 35689999999999999864 3556667789999999
Q ss_pred eeCccccCCCCCcccCCcccceeeccCCCccCCCCc-cccccccccceeeeccccccccCCcccccccchhhcccCcccc
Q 039533 397 LSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLP-IEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLF 475 (949)
Q Consensus 397 l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 475 (949)
++.|.+. .++..+..+.++ +.+++++|+.....+ ..+..+++++.++++.|.+.+..|..+..+++|+.|+|++|++
T Consensus 404 ~~~~~~~-~~~~~~~~l~~L-~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~ 481 (635)
T 4g8a_A 404 LSFNGVI-TMSSNFLGLEQL-EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 481 (635)
T ss_dssp CCSCSEE-EECSCCTTCTTC-CEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEE
T ss_pred ccccccc-cccccccccccc-cchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhccc
Confidence 9999998 567788899999 789999988776554 5688999999999999999999999999999999999999985
Q ss_pred -ccccCCCcCCCCCCCEEECCCCcCCCcCcccccCCc-cceEeCCCCcCcCccccc-ccccccccccccCCCC
Q 039533 476 -QGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLS-LNNLNLSYNDLEGMVTTE-GVFKNASATRILGNSK 545 (949)
Q Consensus 476 -~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~l~ls~N~l~~~~~~~-~~~~~~~~~~~~gn~~ 545 (949)
.+.+|..|..+++|++|||++|+|++.+|..+..++ |++|+|++|+|++.+|.. ..+..+..+.+.+|.-
T Consensus 482 ~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l 554 (635)
T 4g8a_A 482 QENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 554 (635)
T ss_dssp GGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCC
T ss_pred ccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcC
Confidence 556889999999999999999999999999999887 999999999999987753 4566778888888864
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=439.60 Aligned_cols=446 Identities=19% Similarity=0.205 Sum_probs=371.0
Q ss_pred CcEEEEEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccccC-cCCCCCCCCccceeec
Q 039533 65 QRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICG-EIPTNISRCSTLIPIH 143 (949)
Q Consensus 65 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~ 143 (949)
.+++.|+|++|++++..+.+++++++|++|+|++|.+++..|..|+++++|++|+|++|.+++ .+|..++++++|++|+
T Consensus 50 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~ 129 (549)
T 2z81_A 50 ANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLR 129 (549)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEE
T ss_pred CcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEE
Confidence 478999999999999888999999999999999999998888789999999999999999987 4688999999999999
Q ss_pred CCCccc-cccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCc-ccCCCccccccccCccc
Q 039533 144 PQNNQL-VGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNS-FGWFENLVFLSLAANNL 221 (949)
Q Consensus 144 l~~n~l-~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l 221 (949)
+++|.+ ....+..|.++++|++|+|++|.+++..|..++++++|++|++++|.+. .+|.. ++.+++|++|++++|++
T Consensus 130 L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l 208 (549)
T 2z81_A 130 IGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNL 208 (549)
T ss_dssp EEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBC
T ss_pred CCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCcc
Confidence 999994 4455578999999999999999999999999999999999999999987 44544 46799999999999998
Q ss_pred ccccccccCCCCChhhhccccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCC------chhhccccc
Q 039533 222 SVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLP------GCISNLSKT 295 (949)
Q Consensus 222 ~~~~~~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p------~~~~~l~~~ 295 (949)
+.++. ...+....+++|++|++++|.++..... .+...+..+++|+.+++++|.+.+... ..+..+ .+
T Consensus 209 ~~~~~---~~~~~~~~~~~L~~L~l~~n~l~~~~~~--~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l-~~ 282 (549)
T 2z81_A 209 ARFQF---SPLPVDEVSSPMKKLAFRGSVLTDESFN--ELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSEL-GK 282 (549)
T ss_dssp TTCCC---CCCSSCCCCCCCCEEEEESCEEEHHHHH--HHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCC-TT
T ss_pred ccccc---cccchhhhhhcccceeccccccchhHHH--HHHHHhhhhccccccccccccccccccccccchhhhhhh-cc
Confidence 75431 1222334567899999999987643221 123345677899999999998876421 122333 46
Q ss_pred ccEEEccCccccCCC-----CCCCCCCCcccEEEeecceecccCCCcc-cccCCCCEEecCCcccccccC---ccccccc
Q 039533 296 IKTLFLNNNKIYGSI-----PAGIGNFVNLQRLDMWNNQLSGTIPPAI-GELQNLKILGLNRNKLSGNIP---PSIGNLK 366 (949)
Q Consensus 296 L~~L~L~~N~l~~~~-----~~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~ 366 (949)
++.|++.++.+.... +..+..+++|++|++++|.++ .+|..+ .++++|++|+|++|++++.+| ..++.++
T Consensus 283 L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~ 361 (549)
T 2z81_A 283 VETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWP 361 (549)
T ss_dssp CCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSST
T ss_pred cccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccc
Confidence 899999999876421 111234568999999999998 677665 579999999999999998775 3478899
Q ss_pred ccceeecccccccccCC--CCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCcccccccccccee
Q 039533 367 MLLNLFLNDNFLEVSIP--SSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFL 444 (949)
Q Consensus 367 ~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L 444 (949)
+|++|+|++|++++..+ ..+..+++|++|++++|+++ .+|..+..+++| +.|++++|+++ .+|..+ .++|++|
T Consensus 362 ~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L-~~L~Ls~N~l~-~l~~~~--~~~L~~L 436 (549)
T 2z81_A 362 SLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKM-RFLNLSSTGIR-VVKTCI--PQTLEVL 436 (549)
T ss_dssp TCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTC-CEEECTTSCCS-CCCTTS--CTTCSEE
T ss_pred cCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccc-cEEECCCCCcc-cccchh--cCCceEE
Confidence 99999999999986543 46889999999999999999 799999999999 89999999998 455444 3689999
Q ss_pred eeccccccccCCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCcCcccccCCc-cceEeCCCCcCc
Q 039533 445 YVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLS-LNNLNLSYNDLE 523 (949)
Q Consensus 445 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~l~ls~N~l~ 523 (949)
+|++|+|++.+ ..+++|+.|+|++|+|+ .+|. ...+++|+.|||++|+|++.+|..+..++ |+.|++++|++.
T Consensus 437 ~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 510 (549)
T 2z81_A 437 DVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510 (549)
T ss_dssp ECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBC
T ss_pred ECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCcc
Confidence 99999999743 57899999999999999 6776 57899999999999999999998888777 999999999999
Q ss_pred Cccccc
Q 039533 524 GMVTTE 529 (949)
Q Consensus 524 ~~~~~~ 529 (949)
+.+|..
T Consensus 511 ~~~~~~ 516 (549)
T 2z81_A 511 CSCPRI 516 (549)
T ss_dssp CCHHHH
T ss_pred CCCccH
Confidence 988743
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=430.42 Aligned_cols=442 Identities=19% Similarity=0.153 Sum_probs=300.7
Q ss_pred EEEEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCc
Q 039533 68 TLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNN 147 (949)
Q Consensus 68 ~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n 147 (949)
..+|++++++++ +|..+. ++|++|+|++|.+++..|..|+++++|++|+|++|+|++..|..|+++++|++|++++|
T Consensus 34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 668899999885 776664 78999999999998777788999999999999999999878888999999999999999
Q ss_pred cccccccccccCCCCCcEEECCCCCCCC-CCCCCcCCCCCccEEeccccccCCCCCCcccCCCcc--ccccccCccc--c
Q 039533 148 QLVGKILSRFSSLSKTEILNLGSNHLTG-SIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENL--VFLSLAANNL--S 222 (949)
Q Consensus 148 ~l~~~~~~~~~~L~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~Ls~N~l--~ 222 (949)
+|+..... .+++|++|+|++|++++ .+|..|+++++|++|+|++|++++. .+..+++| ++|+|++|.+ +
T Consensus 111 ~l~~lp~~---~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~ 184 (562)
T 3a79_B 111 RLQNISCC---PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIK 184 (562)
T ss_dssp CCCEECSC---CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCC
T ss_pred cCCccCcc---ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeeccccccc
Confidence 98854433 78899999999999986 3467899999999999999998853 44555555 9999998887 3
Q ss_pred ccccc------------------ccCCCC--ChhhhccccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCC
Q 039533 223 VVENK------------------LTGEVP--SLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFG 282 (949)
Q Consensus 223 ~~~~~------------------l~~~~~--~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~ 282 (949)
..... +.+.++ .+..+++|+.+++++|+.... .....+..+..+++|+.++++++.+.
T Consensus 185 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~--~l~~~~~~l~~l~~L~~L~L~~~~l~ 262 (562)
T 3a79_B 185 GGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQ--RLMTFLSELTRGPTLLNVTLQHIETT 262 (562)
T ss_dssp SSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHH--HHHHHHHHHHSCSSCEEEEEEEEEEC
T ss_pred ccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccc--hHHHHHHHHhccCcceEEEecCCcCc
Confidence 22111 111111 122344444444444431000 00011122344445555555554444
Q ss_pred ccCCchhhc--ccccccEEEccCccccCCCCCCC-----CCCCcccEEEeecceecccCC-Cccccc---CCCCEEecCC
Q 039533 283 GLLPGCISN--LSKTIKTLFLNNNKIYGSIPAGI-----GNFVNLQRLDMWNNQLSGTIP-PAIGEL---QNLKILGLNR 351 (949)
Q Consensus 283 ~~~p~~~~~--l~~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~p-~~~~~l---~~L~~L~Ls~ 351 (949)
+.....+.. ...+|++|++++|+++|.+|..+ ..++.|+.++++.|.+ .+| ..+..+ .+|+.|++++
T Consensus 263 ~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~ 340 (562)
T 3a79_B 263 WKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISD 340 (562)
T ss_dssp HHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEES
T ss_pred HHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEccC
Confidence 321111000 01257777777777777777766 5566666666666665 233 222222 4678888888
Q ss_pred cccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccC--CCCCcccCCcccceeeccCCCccCC
Q 039533 352 NKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSG--TIPPQFFSLSSLSISLDWSRNKLTG 429 (949)
Q Consensus 352 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~l~~~L~ls~N~l~~ 429 (949)
|.+.... ....+++|++|++++|++++.+|..+.++++|++|++++|++++ .+|..+..+++| +.|++++|++++
T Consensus 341 n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L-~~L~l~~N~l~~ 417 (562)
T 3a79_B 341 TPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSL-ETLDVSLNSLNS 417 (562)
T ss_dssp SCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTC-CEEECTTSCCBS
T ss_pred CCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCC-CEEECCCCcCCC
Confidence 8775321 12677788888888888887778888888888888888888875 234567777777 678888888887
Q ss_pred CCcc-ccccccccceeeeccccccccCCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCcCccccc
Q 039533 430 SLPI-EVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLA 508 (949)
Q Consensus 430 ~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 508 (949)
.+|. .+..+++|++|+|++|++++.+|..+. ++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.++..+.
T Consensus 418 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~ 494 (562)
T 3a79_B 418 HAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFD 494 (562)
T ss_dssp CCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTT
T ss_pred ccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHh
Confidence 4444 477778888888888888777766554 67888888888887 5676666888888888888888843333366
Q ss_pred CCc-cceEeCCCCcCcCcccc
Q 039533 509 GLS-LNNLNLSYNDLEGMVTT 528 (949)
Q Consensus 509 ~~~-L~~l~ls~N~l~~~~~~ 528 (949)
.++ |+.|++++|++++..+.
T Consensus 495 ~l~~L~~L~l~~N~~~c~c~~ 515 (562)
T 3a79_B 495 RLTSLQYIWLHDNPWDCTCPG 515 (562)
T ss_dssp TCTTCCCEECCSCCBCCCHHH
T ss_pred cCCCCCEEEecCCCcCCCcch
Confidence 555 88888888888876654
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=397.62 Aligned_cols=198 Identities=31% Similarity=0.573 Sum_probs=160.0
Q ss_pred CCChhhHHHHHHHHhccCCCCCCCccCccCCCCcce--eeeeEEeCCC--CcEEEEEcCCCCCCc--cccCCCCCCCCCc
Q 039533 19 TGNETDRVALLEFKSKSTYDPVGVLGTWNESIHFCK--WYGVTCSRRH--QRVTLLDLRSLKLAG--SVSHFIGNLSFLK 92 (949)
Q Consensus 19 ~~~~~~~~aLl~~k~~~~~~~~~~l~sW~~~~~~C~--w~gv~C~~~~--~~v~~l~l~~~~l~g--~~~~~l~~l~~L~ 92 (949)
.|.++|++||++||+++ .||. .+++|..+++||+ |.||+|+..+ ++|+.|+|++++++| .+|+.++++++|+
T Consensus 2 ~c~~~~~~aL~~~k~~~-~~~~-~l~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~ 79 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDL-GNPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHT-TCCG-GGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHhc-CCcc-cccCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCC
Confidence 58999999999999987 4766 7899988889998 9999998765 799999999999999 8999999999999
Q ss_pred eeeccC-ceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECCCC
Q 039533 93 QLYLQV-NSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSN 171 (949)
Q Consensus 93 ~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N 171 (949)
+|+|++ |++.+.+|..|+++++|++|+|++|++++.+|..|+++++|++|++++|.+++..|..|..+++|++|+|++|
T Consensus 80 ~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 159 (313)
T 1ogq_A 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred eeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCC
Confidence 999995 9999999999999999999999999999888888888888877777777777777777777777777777777
Q ss_pred CCCCCCCCCcCCCC-CccEEeccccccCCCCCCcccCCCccccccccCc
Q 039533 172 HLTGSIPSSLGNLS-SIHTISLAYNNLDGTIPNSFGWFENLVFLSLAAN 219 (949)
Q Consensus 172 ~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 219 (949)
++++.+|..++.++ +|++|+|++|++++.+|..|+.++ |++|+|++|
T Consensus 160 ~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N 207 (313)
T 1ogq_A 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRN 207 (313)
T ss_dssp CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSS
T ss_pred cccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCC
Confidence 77766666666666 666666666666666665554443 444444433
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=396.61 Aligned_cols=199 Identities=24% Similarity=0.325 Sum_probs=169.3
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEc---CCCEEEEEEEEecCCCcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccC
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIID---EGRTTIAVKVFNLQHHGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRG 699 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 699 (949)
..++|++.+.||+|+||+||+|+++ .+++.||||++.... ...++.+|+++++++ +||||+++++++...+
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~--- 93 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND--- 93 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT---
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC---
Confidence 4578999999999999999999875 357899999986443 346788999999998 6999999999976544
Q ss_pred CccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCC-C
Q 039533 700 NDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDY-M 778 (949)
Q Consensus 700 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~-~ 778 (949)
..++||||+++|+|.+++. .+++.+++.++.|++.||+|||++ +|+||||||+|||++.+ +
T Consensus 94 --~~~lvmE~~~g~~L~~~~~-------------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~ 155 (361)
T 4f9c_A 94 --HVVIAMPYLEHESFLDILN-------------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLK 155 (361)
T ss_dssp --EEEEEEECCCCCCHHHHHT-------------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTT
T ss_pred --EEEEEEeCCCcccHHHHHc-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCC
Confidence 8999999999999999984 278999999999999999999988 99999999999999876 7
Q ss_pred ceEEeecccceecCCCCCcc--------------------------ccccccCccCccCccccCCC-ccCCccchHHHHH
Q 039533 779 TARVGDFGLARILSPDHTQT--------------------------SSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGI 831 (949)
Q Consensus 779 ~~kl~DfG~a~~~~~~~~~~--------------------------~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGv 831 (949)
.+||+|||+|+...+..... .....+||+.|+|||++.+. .++.++||||+||
T Consensus 156 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~ 235 (361)
T 4f9c_A 156 KYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGV 235 (361)
T ss_dssp EEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHH
T ss_pred eEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHH
Confidence 99999999998765432110 11234699999999998876 4899999999999
Q ss_pred HHHHHHhCCCCCcc
Q 039533 832 LLLELVIGKKPIDI 845 (949)
Q Consensus 832 vl~elltg~~Pf~~ 845 (949)
++|||+||+.||..
T Consensus 236 il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 236 IFLSLLSGRYPFYK 249 (361)
T ss_dssp HHHHHHHTCSSSSC
T ss_pred HHHHHHHCCCCCCC
Confidence 99999999999953
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=402.22 Aligned_cols=371 Identities=20% Similarity=0.212 Sum_probs=223.2
Q ss_pred CCCceeeccCceeccccCCcccCcccCcEEeeccccccCcC-CCCCCCCccceeecCCCccccccccccccCCCCCcEEE
Q 039533 89 SFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEI-PTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILN 167 (949)
Q Consensus 89 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~ 167 (949)
++|++|+|++|.+++..|..|+++++|++|+|++|.+.+.+ |..|.++++|++|++++|++++..+..|.++++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 55666666666666555666666666666666666665444 34566666666666666666666666666666666666
Q ss_pred CCCCCCCCCCCCC--cCCCCCccEEeccccccCCCCCCc-ccCCCccccccccCcccccccccccCCCCChhhh--cccc
Q 039533 168 LGSNHLTGSIPSS--LGNLSSIHTISLAYNNLDGTIPNS-FGWFENLVFLSLAANNLSVVENKLTGEVPSLEKL--QRLQ 242 (949)
Q Consensus 168 Ls~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l--~~L~ 242 (949)
|++|.+++.+|.. |+++++|++|+|++|++++..|.. |+++++|++|+|++|.++.+... .+..+ .+|+
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~------~l~~l~~~~L~ 183 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEE------DLLNFQGKHFT 183 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTT------TSGGGTTCEEE
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChh------hhhcccccccc
Confidence 6666666533332 666666666666666666555554 56666666666666665533221 12222 4566
Q ss_pred ccccccCCCCCCCCCCcch--hccccccCcccEEEccCCCCCccCCchhhccc--ccccEEEccCccccCCCCCCCCCCC
Q 039533 243 HFTITSNSLGSGGNDDLSF--LCSLTNATRLTWMHINSNNFGGLLPGCISNLS--KTIKTLFLNNNKIYGSIPAGIGNFV 318 (949)
Q Consensus 243 ~L~l~~N~l~~~~~~~~~~--~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~--~~L~~L~L~~N~l~~~~~~~~~~l~ 318 (949)
.|++++|.+...+...+.+ ...+..+++|++|++++|++++..|..+.... .+|+.|++++|.+.+...
T Consensus 184 ~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~------- 256 (455)
T 3v47_A 184 LLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF------- 256 (455)
T ss_dssp EEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCT-------
T ss_pred ccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeecccccccccc-------
Confidence 6666666665544332221 12234567788888888888887777766542 458888888887654211
Q ss_pred cccEEEeecceecccCCCccccc--CCCCEEecCCcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEE
Q 039533 319 NLQRLDMWNNQLSGTIPPAIGEL--QNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEIN 396 (949)
Q Consensus 319 ~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 396 (949)
..+.+.+..+..+..+ ++|+.|+|++|++++..|..++++++|+.|+|++|.+++..|..|.++++|++|+
T Consensus 257 -------~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 329 (455)
T 3v47_A 257 -------GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLN 329 (455)
T ss_dssp -------TCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred -------chhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEE
Confidence 1112222222223222 4566666666666655566666666666666666666655566666666666666
Q ss_pred eeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccCCcccccccchhhcccCccccc
Q 039533 397 LSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQ 476 (949)
Q Consensus 397 l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 476 (949)
|++|++++..|..+..+++| +.|++++|++++..|..+..+++|++|+|++|++++..+..|..+++|+.|+|++|.++
T Consensus 330 Ls~N~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 408 (455)
T 3v47_A 330 LSQNFLGSIDSRMFENLDKL-EVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 408 (455)
T ss_dssp CCSSCCCEECGGGGTTCTTC-CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CCCCccCCcChhHhcCcccC-CEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcc
Confidence 66666665555556666666 56666666666666666666777777777777777555556667777777777777777
Q ss_pred cccC
Q 039533 477 GPIS 480 (949)
Q Consensus 477 ~~~~ 480 (949)
+..|
T Consensus 409 ~~~~ 412 (455)
T 3v47_A 409 CSCP 412 (455)
T ss_dssp CCTT
T ss_pred cCCC
Confidence 6554
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=402.33 Aligned_cols=367 Identities=19% Similarity=0.170 Sum_probs=282.6
Q ss_pred ccCcEEeeccccccCcCCCCCCCCccceeecCCCcccccc-ccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEe
Q 039533 113 RRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGK-ILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTIS 191 (949)
Q Consensus 113 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 191 (949)
++|++|+|++|.+++..|..|+++++|++|++++|.+.+. .+..|.++++|++|+|++|.+++..|..|+++++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 7899999999999988899999999999999999999754 467899999999999999999988899999999999999
Q ss_pred ccccccCCCCCCc--ccCCCccccccccCcccccccccccCCCCChhhhccccccccccCCCCCCCCCCcchhccccccC
Q 039533 192 LAYNNLDGTIPNS--FGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNAT 269 (949)
Q Consensus 192 L~~N~l~~~~p~~--~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~ 269 (949)
|++|++++.+|.. |+.+++|++|+|++|+++.+. |. ..+.+++
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~-------~~----------------------------~~~~~l~ 154 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQ-------PA----------------------------SFFLNMR 154 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCC-------CC----------------------------GGGGGCT
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccC-------cc----------------------------cccCCCC
Confidence 9999999855544 999999999999999886442 11 0133445
Q ss_pred cccEEEccCCCCCccCCchhhccc-ccccEEEccCccccCCCCCC--------CCCCCcccEEEeecceecccCCCcccc
Q 039533 270 RLTWMHINSNNFGGLLPGCISNLS-KTIKTLFLNNNKIYGSIPAG--------IGNFVNLQRLDMWNNQLSGTIPPAIGE 340 (949)
Q Consensus 270 ~L~~L~L~~N~l~~~~p~~~~~l~-~~L~~L~L~~N~l~~~~~~~--------~~~l~~L~~L~L~~N~l~~~~p~~~~~ 340 (949)
+|++|++++|++++..|..+..+. ..|+.|++++|.+.+..+.. +..+++|++|+|++|++++..|..+..
T Consensus 155 ~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~ 234 (455)
T 3v47_A 155 RFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFD 234 (455)
T ss_dssp TCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHH
T ss_pred cccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhc
Confidence 566666666666666665555442 35677777777776544433 235567777777777777766666554
Q ss_pred c---CCCCEEecCCcccccccCcccccccccceeecccccccccCCCCCCCC--CCCcEEEeeCccccCCCCCcccCCcc
Q 039533 341 L---QNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQC--ESLIEINLSNNNLSGTIPPQFFSLSS 415 (949)
Q Consensus 341 l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~l~~N~l~~~~p~~~~~l~~ 415 (949)
+ ++|+.|++++|.+.+... ..+.+....+..+..+ ++|++|++++|++++.+|..+..+++
T Consensus 235 ~~~~~~L~~L~l~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~ 300 (455)
T 3v47_A 235 AIAGTKIQSLILSNSYNMGSSF--------------GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTD 300 (455)
T ss_dssp HTTTCCEEEEECTTCTTTSCCT--------------TCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTT
T ss_pred cccccceeeEeecccccccccc--------------chhhhccCcccccccccccCceEEEecCccccccchhhcccCCC
Confidence 4 677777777776653211 1122222223333332 57888888888888777888888888
Q ss_pred cceeeccCCCccCCCCccccccccccceeeeccccccccCCcccccccchhhcccCccccccccCCCcCCCCCCCEEECC
Q 039533 416 LSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLS 495 (949)
Q Consensus 416 l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls 495 (949)
| +.|++++|++++..|..++.+++|++|+|++|++++..|..|+++++|+.|+|++|++++..|..|..+++|++|+|+
T Consensus 301 L-~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 379 (455)
T 3v47_A 301 L-EQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALD 379 (455)
T ss_dssp C-CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred C-CEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECC
Confidence 7 678888888887778888888888888888888887778888888888888888888888888888888999999999
Q ss_pred CCcCCCcCcccccCCc-cceEeCCCCcCcCccccc
Q 039533 496 QNNLSGEIPKFLAGLS-LNNLNLSYNDLEGMVTTE 529 (949)
Q Consensus 496 ~N~l~~~~p~~~~~~~-L~~l~ls~N~l~~~~~~~ 529 (949)
+|+|++.++..+..++ |+.|++++|++++.+|..
T Consensus 380 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 414 (455)
T 3v47_A 380 TNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 414 (455)
T ss_dssp SSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred CCccccCCHhHhccCCcccEEEccCCCcccCCCcc
Confidence 9999877777777666 889999999998887754
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=411.75 Aligned_cols=430 Identities=20% Similarity=0.234 Sum_probs=335.6
Q ss_pred CCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECC
Q 039533 90 FLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLG 169 (949)
Q Consensus 90 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls 169 (949)
..+++++++|++++ +|..+. ++|++|+|++|.|++..|..|+++++|++|++++|+|++..++.|.++++|++|+|+
T Consensus 32 ~~~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 108 (562)
T 3a79_B 32 LESMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVS 108 (562)
T ss_dssp -CCEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECT
T ss_pred CCcEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECC
Confidence 34899999999994 887664 899999999999998778899999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcCCCCCccEEeccccccCC-CCCCcccCCCccccccccCcccccccccccCCCCChhhhccc--ccccc
Q 039533 170 SNHLTGSIPSSLGNLSSIHTISLAYNNLDG-TIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRL--QHFTI 246 (949)
Q Consensus 170 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L--~~L~l 246 (949)
+|+|+ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|+|++|+++.. .+..+++| ++|++
T Consensus 109 ~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---------~~~~l~~L~L~~L~L 176 (562)
T 3a79_B 109 HNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---------DLLPVAHLHLSCILL 176 (562)
T ss_dssp TSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---------TTGGGTTSCEEEEEE
T ss_pred CCcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---------chhhhhhceeeEEEe
Confidence 99999 67766 89999999999999997 3578999999999999999998642 23344444 99999
Q ss_pred ccCCC--CCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCc--------------------
Q 039533 247 TSNSL--GSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNN-------------------- 304 (949)
Q Consensus 247 ~~N~l--~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N-------------------- 304 (949)
++|++ ....+..+..+ . ...+ .++++.|.+.+.++.....-.++|+.|++++|
T Consensus 177 ~~n~l~~~~~~~~~l~~l---~-~~~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L 251 (562)
T 3a79_B 177 DLVSYHIKGGETESLQIP---N-TTVL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTL 251 (562)
T ss_dssp EESSCCCCSSSCCEEEEC---C-EEEE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSC
T ss_pred ecccccccccCccccccc---C-cceE-EEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcc
Confidence 99998 54433322211 1 0122 44566666655554432222234555555555
Q ss_pred --------cccCC----CCCCCCCCCcccEEEeecceecccCCCcc-----cccCCCCEEecCCcccccccC-cccccc-
Q 039533 305 --------KIYGS----IPAGIGNFVNLQRLDMWNNQLSGTIPPAI-----GELQNLKILGLNRNKLSGNIP-PSIGNL- 365 (949)
Q Consensus 305 --------~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~~~p-~~~~~l- 365 (949)
.+++. ++..+ ..++|++|++++|.++|.+|..+ .+++.|+.++++.|.+ .+| ..+..+
T Consensus 252 ~~L~L~~~~l~~~~~~~~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~ 328 (562)
T 3a79_B 252 LNVTLQHIETTWKCSVKLFQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVF 328 (562)
T ss_dssp EEEEEEEEEECHHHHHHHHHHH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHH
T ss_pred eEEEecCCcCcHHHHHHHHHhh-hcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhh
Confidence 33211 11111 12378888888888887787776 6677777777777776 344 333333
Q ss_pred --cccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCC--Ccccccccccc
Q 039533 366 --KMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGS--LPIEVGKLKIL 441 (949)
Q Consensus 366 --~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~--~p~~~~~l~~L 441 (949)
.+|+.|++++|.+.... ....+++|++|++++|++++.+|..+..+++| +.|++++|++++. +|..++.+++|
T Consensus 329 ~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~~~l~~L 405 (562)
T 3a79_B 329 AEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRL-QTLILQRNGLKNFFKVALMTKNMSSL 405 (562)
T ss_dssp HTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSC-CEEECCSSCCCBTTHHHHTTTTCTTC
T ss_pred ccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCC-CEEECCCCCcCCcccchhhhcCCCCC
Confidence 56899999999875322 22688999999999999999999999999999 8999999999973 45779999999
Q ss_pred ceeeeccccccccCCc-ccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCcCcccccCCc-cceEeCCC
Q 039533 442 EFLYVYENRLEGEIPS-TFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLS-LNNLNLSY 519 (949)
Q Consensus 442 ~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~l~ls~ 519 (949)
++|++++|++++.+|. .+..+++|+.|+|++|++++.+|..+. ++|+.|+|++|+|+ .+|..+..++ |+.|+|++
T Consensus 406 ~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~ 482 (562)
T 3a79_B 406 ETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVAS 482 (562)
T ss_dssp CEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCS
T ss_pred CEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCC
Confidence 9999999999985665 588999999999999999998887765 79999999999999 5666555665 99999999
Q ss_pred CcCcCcccc-cccccccccccccCCCCCCC
Q 039533 520 NDLEGMVTT-EGVFKNASATRILGNSKLCG 548 (949)
Q Consensus 520 N~l~~~~~~-~~~~~~~~~~~~~gn~~~c~ 548 (949)
|++++.++. ...+..+..+.+.+|++.|.
T Consensus 483 N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~ 512 (562)
T 3a79_B 483 NQLKSVPDGVFDRLTSLQYIWLHDNPWDCT 512 (562)
T ss_dssp SCCCCCCTTSTTTCTTCCCEECCSCCBCCC
T ss_pred CCCCCCCHHHHhcCCCCCEEEecCCCcCCC
Confidence 999987665 45667788899999999884
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=411.67 Aligned_cols=253 Identities=21% Similarity=0.294 Sum_probs=206.7
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.++|++.+.||+|+||.||+|++..+|+.||+|++........+.+.+|+.+|++++|||||++++++.+.. ..+
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~~ 230 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN-----EMV 230 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSS-----EEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-----EEE
Confidence 368999999999999999999999999999999998766555678899999999999999999999976544 899
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCC--CceEE
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDY--MTARV 782 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~--~~~kl 782 (949)
+||||++||+|.+++.. ....+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||
T Consensus 231 iv~E~~~gg~L~~~i~~---------~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl 298 (573)
T 3uto_A 231 MIYEFMSGGELFEKVAD---------EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKL 298 (573)
T ss_dssp EEEECCCCCBHHHHHTC---------TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEE
T ss_pred EEEeecCCCcHHHHHHH---------hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEE
Confidence 99999999999999862 234689999999999999999999988 99999999999999854 89999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
+|||+|+.+....... ...||+.|||||++.+..|+.++||||+||++|||++|+.||......+ .+.
T Consensus 299 ~DFG~a~~~~~~~~~~---~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~-~~~-------- 366 (573)
T 3uto_A 299 IDFGLTAHLDPKQSVK---VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-TLR-------- 366 (573)
T ss_dssp CCCSSCEECCTTSEEE---EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHH--------
T ss_pred eeccceeEccCCCcee---eeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHH--------
Confidence 9999999876554322 3569999999999999999999999999999999999999996432111 000
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.+......... . .....+..+.+++.+||+.||++|||+.|+++
T Consensus 367 ----~i~~~~~~~~~-------------~---~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 367 ----NVKSCDWNMDD-------------S---AFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp ----HHHTTCCCCCS-------------G---GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----HHHhCCCCCCc-------------c---cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000000 0 00123445788999999999999999999976
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=406.38 Aligned_cols=250 Identities=21% Similarity=0.246 Sum_probs=197.0
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHH---HHHHHHhcCCCcceeEEeeeeccccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIA---ECKALKSIRHRNLVKVLTACLGADYR 698 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~ 698 (949)
.++|++.++||+|+||.||+|++..+|+.||||+++... ........+ ++.+++.++|||||++++++.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~-- 265 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD-- 265 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS--
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC--
Confidence 468999999999999999999999999999999997432 122233333 456667779999999999976554
Q ss_pred CCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC
Q 039533 699 GNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM 778 (949)
Q Consensus 699 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~ 778 (949)
..|+||||++||+|.+++. ....+++..++.|+.||+.||+|||++ +||||||||+|||++.+|
T Consensus 266 ---~lylVmEy~~GGdL~~~l~----------~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G 329 (689)
T 3v5w_A 266 ---KLSFILDLMNGGDLHYHLS----------QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHG 329 (689)
T ss_dssp ---EEEEEECCCCSCBHHHHHH----------HHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTS
T ss_pred ---EEEEEEecCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCC
Confidence 8999999999999999996 235699999999999999999999977 999999999999999999
Q ss_pred ceEEeecccceecCCCCCccccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhc
Q 039533 779 TARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFG 857 (949)
Q Consensus 779 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~ 857 (949)
++||+|||+|+........ ...||+.|||||++.+ ..|+.++||||+||++|||++|++||......+.. ...
T Consensus 330 ~vKL~DFGlA~~~~~~~~~----t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~--~i~ 403 (689)
T 3v5w_A 330 HVRISDLGLACDFSKKKPH----ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EID 403 (689)
T ss_dssp CEEECCCTTCEECSSCCCC----SCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH--HHH
T ss_pred CEEecccceeeecCCCCCC----CccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH--HHH
Confidence 9999999999987654332 3569999999999874 57999999999999999999999999643221110 000
Q ss_pred cccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC-----HHHHHH
Q 039533 858 RKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTN-----MTNVVH 926 (949)
Q Consensus 858 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~~ 926 (949)
. .+..... ..+ ...+..+.+++.+|++.||++|++ ++||.+
T Consensus 404 ~--------~i~~~~~-~~p-------------------~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 404 R--------MTLTMAV-ELP-------------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp H--------HHHHCCC-CCC-------------------TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred H--------hhcCCCC-CCC-------------------ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 0 0000000 000 122446789999999999999998 677654
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=394.38 Aligned_cols=384 Identities=22% Similarity=0.253 Sum_probs=263.3
Q ss_pred CcEEEEEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccC-------------cEEeeccccccCcCCC
Q 039533 65 QRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRL-------------KVLALNNNSICGEIPT 131 (949)
Q Consensus 65 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-------------~~L~Ls~N~l~~~~p~ 131 (949)
.++..++++++++ |.+|+++++|++|++|+|++|.++|.+|.+++++++| ++|++++|.+++ +|.
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~ 88 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPE 88 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCS
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCC
Confidence 3678899999999 8999999999999999999999999999999998875 999999999984 555
Q ss_pred CCCCCccceeecCCCccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCcc
Q 039533 132 NISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENL 211 (949)
Q Consensus 132 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 211 (949)
. .++|++|++++|++++ +|.. +++|++|++++|++++ +|.. .++|++|+|++|++++ +| .|+++++|
T Consensus 89 ~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L 155 (454)
T 1jl5_A 89 L---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFL 155 (454)
T ss_dssp C---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTC
T ss_pred C---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCC
Confidence 3 3688999999999988 4433 4788999999999985 3322 1689999999999996 77 59999999
Q ss_pred ccccccCcccccccccccCCCCChhhhccccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhc
Q 039533 212 VFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISN 291 (949)
Q Consensus 212 ~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~ 291 (949)
++|++++|+++.++.. ..+|++|++++|+++.. +.+.++++|++|++++|++++ +|..
T Consensus 156 ~~L~l~~N~l~~lp~~----------~~~L~~L~L~~n~l~~l--------~~~~~l~~L~~L~l~~N~l~~-l~~~--- 213 (454)
T 1jl5_A 156 KIIDVDNNSLKKLPDL----------PPSLEFIAAGNNQLEEL--------PELQNLPFLTAIYADNNSLKK-LPDL--- 213 (454)
T ss_dssp CEEECCSSCCSCCCCC----------CTTCCEEECCSSCCSSC--------CCCTTCTTCCEEECCSSCCSS-CCCC---
T ss_pred CEEECCCCcCcccCCC----------cccccEEECcCCcCCcC--------ccccCCCCCCEEECCCCcCCc-CCCC---
Confidence 9999999988765421 24789999999988753 246788889999999999886 3432
Q ss_pred ccccccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCccccccccccee
Q 039533 292 LSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNL 371 (949)
Q Consensus 292 l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 371 (949)
+.+|++|++++|+++ .+|. ++.+++|++|++++|++++ +|.. +++|+.|++++|++++ +|.. .++|+.|
T Consensus 214 -~~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L 282 (454)
T 1jl5_A 214 -PLSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFL 282 (454)
T ss_dssp -CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEE
T ss_pred -cCcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEE
Confidence 246899999999998 5674 8889999999999999985 5543 3788999999999985 5553 3788899
Q ss_pred ecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCC-cccceeeccCCCccCCCCccccccccccceeeecccc
Q 039533 372 FLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSL-SSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENR 450 (949)
Q Consensus 372 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l-~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 450 (949)
++++|++++. |.. .++|++|++++|++++ ++ .+ .++ +.|++++|++++ +|.. +++|++|++++|+
T Consensus 283 ~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~-i~----~~~~~L-~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~ 348 (454)
T 1jl5_A 283 DVSENIFSGL-SEL---PPNLYYLNASSNEIRS-LC----DLPPSL-EELNVSNNKLIE-LPAL---PPRLERLIASFNH 348 (454)
T ss_dssp ECCSSCCSEE-SCC---CTTCCEEECCSSCCSE-EC----CCCTTC-CEEECCSSCCSC-CCCC---CTTCCEEECCSSC
T ss_pred ECcCCccCcc-cCc---CCcCCEEECcCCcCCc-cc----CCcCcC-CEEECCCCcccc-cccc---CCcCCEEECCCCc
Confidence 9999998862 221 2678899999998884 33 22 355 788899999886 5554 5788889999998
Q ss_pred ccccCCcccccccchhhcccCcccccc--ccCCCcCCCCCCCEEECCCCcCCCcCcccccCCccceEeCCCCcCcC
Q 039533 451 LEGEIPSTFGNCIRLEQLGMGGNLFQG--PISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLSLNNLNLSYNDLEG 524 (949)
Q Consensus 451 l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~ls~N~l~~ 524 (949)
++ .+|. .+++|+.|++++|++++ .+|.+++.+ +.|++.|.+|... .+|+.|++++|++++
T Consensus 349 l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L--------~~n~~~~~i~~~~--~~L~~L~ls~N~l~~ 410 (454)
T 1jl5_A 349 LA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVEDL--------RMNSHLAEVPELP--QNLKQLHVETNPLRE 410 (454)
T ss_dssp CS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEE--------ECCC--------------------------
T ss_pred cc-cccc---hhhhccEEECCCCCCCcCCCChHHHHhh--------hhccccccccccc--CcCCEEECCCCcCCc
Confidence 88 4666 46888889999998888 677766543 3455666666532 237777888888776
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=379.71 Aligned_cols=285 Identities=29% Similarity=0.461 Sum_probs=224.9
Q ss_pred CHHHHHHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeeccc
Q 039533 617 SYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGAD 696 (949)
Q Consensus 617 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 696 (949)
++.++..++++|++.+.||+|+||.||+|++. +++.||||++........+.+.+|++++++++||||+++++++...+
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 33455567899999999999999999999975 68899999987666666678999999999999999999999975443
Q ss_pred ccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC
Q 039533 697 YRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD 776 (949)
Q Consensus 697 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~ 776 (949)
..++||||+++|+|.+++.... .....+++.+++.++.|++.||+|||++ +|+||||||+||+++.
T Consensus 109 -----~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~ 174 (321)
T 2qkw_B 109 -----EMILIYKYMENGNLKRHLYGSD------LPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDE 174 (321)
T ss_dssp -----CCEEEEECCTTCBTGGGSSSSC------CCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECT
T ss_pred -----eEEEEEEcCCCCcHHHHHhccC------CCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECC
Confidence 7899999999999999997321 1234589999999999999999999987 9999999999999999
Q ss_pred CCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccC-chhhh
Q 039533 777 YMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD-INLHN 855 (949)
Q Consensus 777 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~-~~~~~ 855 (949)
++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....
T Consensus 175 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~ 254 (321)
T 2qkw_B 175 NFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAE 254 (321)
T ss_dssp TCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHH
T ss_pred CCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHH
Confidence 99999999999987654333222223458999999999988899999999999999999999999997543221 12222
Q ss_pred hccccC-CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHh
Q 039533 856 FGRKAL-PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNI 934 (949)
Q Consensus 856 ~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 934 (949)
+..... .......+++...... ..+++..+.+++.+|++.||++|||++||++.|+.+.+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 255 WAVESHNNGQLEQIVDPNLADKI------------------RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp HTHHHHTTTCCCSSSSSSCTTCS------------------CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HhhhccccccHHHhcChhhcccc------------------CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 211111 1112222222221111 136677899999999999999999999999999998754
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=378.43 Aligned_cols=289 Identities=33% Similarity=0.560 Sum_probs=230.0
Q ss_pred cccccCHHHHHHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEe
Q 039533 612 SLLYLSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLT 690 (949)
Q Consensus 612 ~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~ 690 (949)
....++++++..+.++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++||||+++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 4556888999999999999999999999999999865 688999999875432 23347899999999999999999999
Q ss_pred eeecccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 039533 691 ACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPS 770 (949)
Q Consensus 691 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~ 770 (949)
++...+ ..++||||+++|+|.+++.... .....+++..+..|+.|++.||+|||+++.++|+||||||+
T Consensus 95 ~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~ 163 (326)
T 3uim_A 95 FCMTPT-----ERLLVYPYMANGSVASCLRERP------ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAA 163 (326)
T ss_dssp EECCSS-----CCEEEEECCTTCBHHHHHHCCS------TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGG
T ss_pred EEecCC-----ceEEEEEeccCCCHHHHHHhcc------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchh
Confidence 976544 7899999999999999997322 12345899999999999999999999876668999999999
Q ss_pred CeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCcccc---
Q 039533 771 NVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMF--- 847 (949)
Q Consensus 771 NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~--- 847 (949)
||+++.++.+||+|||+++......... .....||+.|+|||++.+..++.++|||||||++|||++|+.||+...
T Consensus 164 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 242 (326)
T 3uim_A 164 NILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242 (326)
T ss_dssp GEEECTTCCEEECCCSSCEECCSSSSCE-ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTT
T ss_pred hEEECCCCCEEeccCccccccCcccccc-cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccc
Confidence 9999999999999999998775443322 223559999999999988889999999999999999999999996321
Q ss_pred ccCchhhhhccccCCCc-hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 848 EGDINLHNFGRKALPDD-VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 848 ~~~~~~~~~~~~~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
........+........ .....+....... ..+.+..+.+++.+|++.||++|||++||++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 304 (326)
T 3uim_A 243 DDDVMLLDWVKGLLKEKKLEALVDVDLQGNY------------------KDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304 (326)
T ss_dssp TSCSBHHHHHTTTTSSCCSTTSSCTTCTTSC------------------CHHHHHHHHHHHHHHTCSCGGGSCCHHHHHH
T ss_pred ccchhHHHHHHHHhhchhhhhhcChhhcccc------------------CHHHHHHHHHHHHHHhCcCCccCCCHHHHHH
Confidence 12222333333333222 2333333322211 1356778999999999999999999999999
Q ss_pred HHHHh
Q 039533 927 ELQSI 931 (949)
Q Consensus 927 ~L~~i 931 (949)
.|+..
T Consensus 305 ~L~~~ 309 (326)
T 3uim_A 305 MLEGD 309 (326)
T ss_dssp HHHTS
T ss_pred HhcCc
Confidence 99863
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=387.69 Aligned_cols=387 Identities=21% Similarity=0.272 Sum_probs=158.5
Q ss_pred cCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCC
Q 039533 82 SHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLS 161 (949)
Q Consensus 82 ~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~ 161 (949)
.|.-...++|++|++++|++ |.+|.+|+++++|++|+|++|.++|.+|..++++++|+.+++..|.. .
T Consensus 4 ~p~~~~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~ 71 (454)
T 1jl5_A 4 NPRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------R 71 (454)
T ss_dssp -------------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------H
T ss_pred cccccccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------c
Confidence 34444578999999999999 79999999999999999999999999999999999874444443321 2
Q ss_pred CCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCcccccccccccCCCCChhhhccc
Q 039533 162 KTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRL 241 (949)
Q Consensus 162 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L 241 (949)
++++|++++|.+++ +|.. .++|++|++++|++++ +|.. +++|++|++++|+++.++. +| ++|
T Consensus 72 ~l~~L~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l~~-----~~-----~~L 133 (454)
T 1jl5_A 72 QAHELELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKALSD-----LP-----PLL 133 (454)
T ss_dssp TCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCCCS-----CC-----TTC
T ss_pred CCCEEEecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcccC-----CC-----CCC
Confidence 33444444444442 2221 1344444444444443 3322 2444444444444433221 00 344
Q ss_pred cccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCccc
Q 039533 242 QHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQ 321 (949)
Q Consensus 242 ~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 321 (949)
++|++++|+++..+ .+.++++|++|++++|++++ +|..+ .+|++|++++|++++ +| .++.+++|+
T Consensus 134 ~~L~L~~n~l~~lp--------~~~~l~~L~~L~l~~N~l~~-lp~~~----~~L~~L~L~~n~l~~-l~-~~~~l~~L~ 198 (454)
T 1jl5_A 134 EYLGVSNNQLEKLP--------ELQNSSFLKIIDVDNNSLKK-LPDLP----PSLEFIAAGNNQLEE-LP-ELQNLPFLT 198 (454)
T ss_dssp CEEECCSSCCSSCC--------CCTTCTTCCEEECCSSCCSC-CCCCC----TTCCEEECCSSCCSS-CC-CCTTCTTCC
T ss_pred CEEECcCCCCCCCc--------ccCCCCCCCEEECCCCcCcc-cCCCc----ccccEEECcCCcCCc-Cc-cccCCCCCC
Confidence 44444444443211 23444445555555555443 22221 235555555555543 33 345555555
Q ss_pred EEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCcc
Q 039533 322 RLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNN 401 (949)
Q Consensus 322 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 401 (949)
+|++++|++++ +|... ++|+.|++++|+++ .+|. ++++++|++|++++|++++ +|.. +++|++|++++|+
T Consensus 199 ~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~ 268 (454)
T 1jl5_A 199 AIYADNNSLKK-LPDLP---LSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNY 268 (454)
T ss_dssp EEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSC
T ss_pred EEECCCCcCCc-CCCCc---CcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCc
Confidence 55555555543 23221 24555555555554 3342 4455555555555555543 2321 2445555555555
Q ss_pred ccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccCCcccccc-cchhhcccCccccccccC
Q 039533 402 LSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNC-IRLEQLGMGGNLFQGPIS 480 (949)
Q Consensus 402 l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~l~~N~l~~~~~ 480 (949)
+++ +|..+ +++ +.|++++|++++. |.. .++|++|++++|++++ ++ .+ ++|+.|++++|++++ +|
T Consensus 269 l~~-l~~~~---~~L-~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~~-lp 333 (454)
T 1jl5_A 269 LTD-LPELP---QSL-TFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLIE-LP 333 (454)
T ss_dssp CSC-CCCCC---TTC-CEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCSC-CC
T ss_pred ccc-cCccc---CcC-CEEECcCCccCcc-cCc---CCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcccc-cc
Confidence 542 33322 233 3455555555431 110 1344555555555543 11 11 244555555555543 33
Q ss_pred CCcCCCCCCCEEECCCCcCCCcCcccccCCccceEeCCCCcCcC------------------cccccccccccccccccC
Q 039533 481 SSLGSLRGLRVLDLSQNNLSGEIPKFLAGLSLNNLNLSYNDLEG------------------MVTTEGVFKNASATRILG 542 (949)
Q Consensus 481 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~ls~N~l~~------------------~~~~~~~~~~~~~~~~~g 542 (949)
.. +++|+.|++++|++++ +|. ...+|++|++++|++++ .+|.. +.++..+.+.+
T Consensus 334 ~~---~~~L~~L~L~~N~l~~-lp~--~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~--~~~L~~L~ls~ 405 (454)
T 1jl5_A 334 AL---PPRLERLIASFNHLAE-VPE--LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPEL--PQNLKQLHVET 405 (454)
T ss_dssp CC---CTTCCEEECCSSCCSC-CCC--CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC---------------------
T ss_pred cc---CCcCCEEECCCCcccc-ccc--hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccc--cCcCCEEECCC
Confidence 32 3445555555555542 333 11125555555555554 33331 25567777888
Q ss_pred CCCC
Q 039533 543 NSKL 546 (949)
Q Consensus 543 n~~~ 546 (949)
|+..
T Consensus 406 N~l~ 409 (454)
T 1jl5_A 406 NPLR 409 (454)
T ss_dssp ----
T ss_pred CcCC
Confidence 8654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=377.01 Aligned_cols=270 Identities=25% Similarity=0.365 Sum_probs=217.8
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.++|.+.+.||+|+||+||+|++..+++.||+|++........+.+.+|++++++++||||+++++++...+ ..+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~~ 83 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK-----RLN 83 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----EEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC-----eeE
Confidence 357888999999999999999999899999999987665566678999999999999999999999986544 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++|+|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 84 lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~D 151 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKS---------MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVAD 151 (310)
T ss_dssp EEEECCTTCBHHHHHHH---------CCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECC
T ss_pred EEEEecCCCcHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEee
Confidence 99999999999999962 235689999999999999999999988 899999999999999999999999
Q ss_pred cccceecCCCCCcc------------ccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCch
Q 039533 785 FGLARILSPDHTQT------------SSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDIN 852 (949)
Q Consensus 785 fG~a~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~ 852 (949)
||+++......... ......||+.|+|||++.+..++.++|||||||++|||++|..||.........
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~ 231 (310)
T 3s95_A 152 FGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD 231 (310)
T ss_dssp CTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT
T ss_pred cccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH
Confidence 99998765443211 111346999999999999999999999999999999999999998643222111
Q ss_pred hhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhH
Q 039533 853 LHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIK 932 (949)
Q Consensus 853 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 932 (949)
.. .......+.... ..++..+.+++.+||+.||++|||++|+++.|++++
T Consensus 232 ~~--------~~~~~~~~~~~~----------------------~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 232 FG--------LNVRGFLDRYCP----------------------PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp SS--------BCHHHHHHHTCC----------------------TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred Hh--------hhhhccccccCC----------------------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 10 001111111110 123445788999999999999999999999999999
Q ss_pred HhhccCCCC
Q 039533 933 NILLGVELC 941 (949)
Q Consensus 933 ~~~~~~~~~ 941 (949)
.......+.
T Consensus 282 ~~~~~~~~~ 290 (310)
T 3s95_A 282 MHLAGHLPL 290 (310)
T ss_dssp HHHHHCCCC
T ss_pred HhccCcccC
Confidence 887765444
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=362.45 Aligned_cols=285 Identities=30% Similarity=0.470 Sum_probs=225.2
Q ss_pred cccccCHHHHHHHhcCCCCC------CeeeeecCceEEEEEEcCCCEEEEEEEEecCC----CcchHHHHHHHHHHHhcC
Q 039533 612 SLLYLSYQDLYNATSGFSSA------NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH----HGASRSFIAECKALKSIR 681 (949)
Q Consensus 612 ~~~~~~~~~l~~~~~~y~~~------~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~ 681 (949)
....|++.++..++++|... +.||+|+||.||+|.. +++.||||++.... ....+.+.+|+.++++++
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 35678999999999998877 8999999999999987 47899999986432 233567899999999999
Q ss_pred CCcceeEEeeeecccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 039533 682 HRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPV 761 (949)
Q Consensus 682 h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ 761 (949)
||||+++++++...+ ..++||||+++++|.+++... .....+++..+..++.|++.||+|||++ +
T Consensus 89 h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ 153 (307)
T 2nru_A 89 HENLVELLGFSSDGD-----DLCLVYVYMPNGSLLDRLSCL-------DGTPPLSWHMRCKIAQGAANGINFLHEN---H 153 (307)
T ss_dssp CTTBCCEEEEECSSS-----SCEEEEECCTTCBHHHHHHTG-------GGCCCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred CCCeEEEEEEEecCC-----ceEEEEEecCCCcHHHHHHhc-------cCCCCCCHHHHHHHHHHHHHHHHHHhcC---C
Confidence 999999999976543 789999999999999998632 1234589999999999999999999987 9
Q ss_pred eEecCCCCCCeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCC
Q 039533 762 TAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKK 841 (949)
Q Consensus 762 ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~ 841 (949)
|+||||||+||++++++.+||+|||+++...............||+.|+|||++.+ .++.++||||||+++|||++|+.
T Consensus 154 i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~ 232 (307)
T 2nru_A 154 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLP 232 (307)
T ss_dssp EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCC
T ss_pred eecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCC
Confidence 99999999999999999999999999987665443332334569999999998865 58999999999999999999999
Q ss_pred CCccccccCchhhhhccc--cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC
Q 039533 842 PIDIMFEGDINLHNFGRK--ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRT 919 (949)
Q Consensus 842 Pf~~~~~~~~~~~~~~~~--~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 919 (949)
||+....... ...+... .....+.+.+++.+...+ ...+..+.+++.+|++.||++||
T Consensus 233 p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~l~~li~~cl~~~p~~Rp 292 (307)
T 2nru_A 233 AVDEHREPQL-LLDIKEEIEDEEKTIEDYIDKKMNDAD-------------------STSVEAMYSVASQCLHEKKNKRP 292 (307)
T ss_dssp SBCTTBSSSB-TTHHHHHHHTTSCCHHHHSCSSCSCCC-------------------HHHHHHHHHHHHHHTCSSTTTSC
T ss_pred CcccCcchHH-HHHHHHHhhhhhhhhhhhccccccccc-------------------hHHHHHHHHHHHHHcCCCcccCc
Confidence 9975432211 1111110 011123333333332221 25577899999999999999999
Q ss_pred CHHHHHHHHHHhHHh
Q 039533 920 NMTNVVHELQSIKNI 934 (949)
Q Consensus 920 s~~ev~~~L~~i~~~ 934 (949)
|++||++.|++++.+
T Consensus 293 s~~~l~~~L~~l~~s 307 (307)
T 2nru_A 293 DIKKVQQLLQEMTAS 307 (307)
T ss_dssp CHHHHHHHHHHHC--
T ss_pred CHHHHHHHHHHHhcC
Confidence 999999999998653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=367.22 Aligned_cols=251 Identities=20% Similarity=0.283 Sum_probs=206.8
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.++|++.+.||+|+||+||+|.+..+++.||||++........+.+.+|+.++++++||||+++++++...+ ..+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~~ 93 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-----ELW 93 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECC-----EEE
Confidence 468999999999999999999998899999999998766666778999999999999999999999976544 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++|+|.+++. ...+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 94 lv~e~~~~~~L~~~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~D 159 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVT-----------ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTD 159 (297)
T ss_dssp EEEECCTTCBHHHHHH-----------HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECC
T ss_pred EEEECCCCCCHHHHHh-----------hcCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEee
Confidence 9999999999999986 23488999999999999999999988 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCc
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
||++.......... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ......
T Consensus 160 fg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~~---- 232 (297)
T 3fxz_A 160 FGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNG---- 232 (297)
T ss_dssp CTTCEECCSTTCCB--CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-HHHHHC----
T ss_pred CCCceecCCccccc--CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhCC----
Confidence 99998776544322 24569999999999999999999999999999999999999996432111000 000000
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.+.. .. ....+..+.+++.+||+.||++|||++|+++
T Consensus 233 -----~~~~-~~-------------------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 233 -----TPEL-QN-------------------PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp -----SCCC-SC-------------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----CCCC-CC-------------------ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0000 00 0123456789999999999999999999976
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=371.37 Aligned_cols=282 Identities=23% Similarity=0.287 Sum_probs=212.1
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.++|++.++||+|+||+||+|++. ++.||||+++... ........|+.++++++||||+++++++.... ......+
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~~~ 98 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVDVDLW 98 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCCceEE
Confidence 467899999999999999999986 7999999996543 23345667999999999999999999987543 1133579
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhC-------CCCCeEecCCCCCCeeecCC
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHD-------CQPVTAHCDLKPSNVLLDDY 777 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~-------~~~~ivHrDlkp~NIll~~~ 777 (949)
+||||+++|+|.+++. ...+++..+..++.|++.||+|||+. ++++|+||||||+||+++.+
T Consensus 99 lv~e~~~~g~L~~~l~-----------~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~ 167 (322)
T 3soc_A 99 LITAFHEKGSLSDFLK-----------ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN 167 (322)
T ss_dssp EEEECCTTCBHHHHHH-----------HCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTT
T ss_pred EEEecCCCCCHHHHHH-----------hcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCC
Confidence 9999999999999996 23489999999999999999999954 12389999999999999999
Q ss_pred CceEEeecccceecCCCCCccccccccCccCccCccccCC-----CccCCccchHHHHHHHHHHHhCCCCCccccccCch
Q 039533 778 MTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-----CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDIN 852 (949)
Q Consensus 778 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~ 852 (949)
+.+||+|||+++...............||+.|+|||++.+ ..++.++|||||||++|||+||+.||.........
T Consensus 168 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 247 (322)
T 3soc_A 168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247 (322)
T ss_dssp CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred CeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence 9999999999988765544333334569999999999886 35678899999999999999999999754332111
Q ss_pred -hhhhcccc-CCCchhhh-cccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 039533 853 -LHNFGRKA-LPDDVMDI-VDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQ 929 (949)
Q Consensus 853 -~~~~~~~~-~~~~~~~~-~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 929 (949)
+....... ..+...+. ......+...+ . .....++..+.+++.+||+.||++|||++||++.|+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 314 (322)
T 3soc_A 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRD------------Y-WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERIT 314 (322)
T ss_dssp TTHHHHCSSCCHHHHHHHHTTSCCCCCCCG------------G-GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred chhhhhccCCchhhhhhhhhcccCCCCccc------------c-ccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 11000000 00011111 11111111110 0 011245667999999999999999999999999999
Q ss_pred HhHHh
Q 039533 930 SIKNI 934 (949)
Q Consensus 930 ~i~~~ 934 (949)
++++.
T Consensus 315 ~l~~~ 319 (322)
T 3soc_A 315 QMQRL 319 (322)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99875
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=364.31 Aligned_cols=263 Identities=22% Similarity=0.244 Sum_probs=212.4
Q ss_pred ccccCHHHHHHHhcC----------CCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCC
Q 039533 613 LLYLSYQDLYNATSG----------FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRH 682 (949)
Q Consensus 613 ~~~~~~~~l~~~~~~----------y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 682 (949)
...++++++..+++. |...+.||+|+||.||+|++..+++.||||+++.......+.+.+|+.++++++|
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 345788888887764 6667799999999999999988899999999987666666789999999999999
Q ss_pred CcceeEEeeeecccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 039533 683 RNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVT 762 (949)
Q Consensus 683 ~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~i 762 (949)
|||+++++++...+ ..++||||+++++|.+++. ...+++..+..++.|++.||+|||+. +|
T Consensus 102 ~niv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~-----------~~~l~~~~~~~i~~qi~~~L~~LH~~---~i 162 (321)
T 2c30_A 102 FNVVEMYKSYLVGE-----ELWVLMEFLQGGALTDIVS-----------QVRLNEEQIATVCEAVLQALAYLHAQ---GV 162 (321)
T ss_dssp TTBCCEEEEEEETT-----EEEEEECCCCSCBHHHHHT-----------TCCCCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred CCcceEEEEEEECC-----EEEEEEecCCCCCHHHHHH-----------hcCCCHHHHHHHHHHHHHHHHHHHHC---Ce
Confidence 99999999986544 7899999999999999986 23589999999999999999999987 99
Q ss_pred EecCCCCCCeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCC
Q 039533 763 AHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842 (949)
Q Consensus 763 vHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~P 842 (949)
+||||||+||+++.++.+||+|||++.......... ....||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 163 vH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p 240 (321)
T 2c30_A 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240 (321)
T ss_dssp ECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCB--CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred ecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccc--ccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999998765543322 245699999999999999999999999999999999999999
Q ss_pred CccccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHH
Q 039533 843 IDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMT 922 (949)
Q Consensus 843 f~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 922 (949)
|...... ......... ..+.... ....+..+.+++.+|++.||++|||++
T Consensus 241 f~~~~~~--~~~~~~~~~--------~~~~~~~--------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ 290 (321)
T 2c30_A 241 YFSDSPV--QAMKRLRDS--------PPPKLKN--------------------SHKVSPVLRDFLERMLVRDPQERATAQ 290 (321)
T ss_dssp TTTSCHH--HHHHHHHHS--------SCCCCTT--------------------GGGSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCCCHH--HHHHHHhcC--------CCCCcCc--------------------cccCCHHHHHHHHHHccCChhhCcCHH
Confidence 9633111 000000000 0000000 012345678999999999999999999
Q ss_pred HHHH
Q 039533 923 NVVH 926 (949)
Q Consensus 923 ev~~ 926 (949)
|+++
T Consensus 291 ell~ 294 (321)
T 2c30_A 291 ELLD 294 (321)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9986
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=373.57 Aligned_cols=272 Identities=21% Similarity=0.342 Sum_probs=212.4
Q ss_pred hcCCCCCCeeeeecCceEEEEEEc-------CCCEEEEEEEEecCCC-cchHHHHHHHHHHHhc-CCCcceeEEeeeecc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIID-------EGRTTIAVKVFNLQHH-GASRSFIAECKALKSI-RHRNLVKVLTACLGA 695 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 695 (949)
.++|.+.+.||+|+||.||+|++. .++..||||+++.... ...+.+.+|+++++++ +||||+++++++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 367889999999999999999974 3456899999975432 2346789999999999 899999999997654
Q ss_pred cccCCccceeEeeeccCCChhhhcCCCCCCCc------cccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 039533 696 DYRGNDFKASVYEFMHYGSLEEWLHPFTGEDE------IDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKP 769 (949)
Q Consensus 696 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp 769 (949)
+ ..++||||+++|+|.+++........ .......+++.+++.++.||+.||+|||++ +|+||||||
T Consensus 160 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp 231 (370)
T 2psq_A 160 G-----PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 231 (370)
T ss_dssp S-----SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCG
T ss_pred C-----CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccch
Confidence 4 78999999999999999974321100 001234589999999999999999999987 999999999
Q ss_pred CCeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccc
Q 039533 770 SNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFE 848 (949)
Q Consensus 770 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~ 848 (949)
+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 232 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp GGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred hhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999999999999997765443333334457889999999999999999999999999999999 9999964321
Q ss_pred cCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 039533 849 GDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHEL 928 (949)
Q Consensus 849 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 928 (949)
.. +...+........ ...++..+.+++.+||+.||++|||+.|+++.|
T Consensus 312 ~~--------------~~~~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 359 (370)
T 2psq_A 312 EE--------------LFKLLKEGHRMDK------------------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359 (370)
T ss_dssp GG--------------HHHHHHTTCCCCC------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HH--------------HHHHHhcCCCCCC------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 11 1111110000000 013345688999999999999999999999999
Q ss_pred HHhHHhhc
Q 039533 929 QSIKNILL 936 (949)
Q Consensus 929 ~~i~~~~~ 936 (949)
+++.....
T Consensus 360 ~~il~~~~ 367 (370)
T 2psq_A 360 DRILTLTT 367 (370)
T ss_dssp HHHHHHHC
T ss_pred HHHHHHhc
Confidence 99876543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=368.91 Aligned_cols=276 Identities=22% Similarity=0.340 Sum_probs=209.3
Q ss_pred hcCCCCCCeeeeecCceEEEEE----EcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 625 TSGFSSANLVGVGSFGSVYKGI----IDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
.++|++.+.||+|+||+||+|+ ...+++.||||++........+.+.+|++++++++||||+++++++...+ .
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---R 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH---H
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---C
Confidence 3678899999999999999998 45578999999998665555678999999999999999999999976432 2
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
...++||||+++|+|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~ 153 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQK---------HKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRV 153 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHH---------CGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEE
T ss_pred CceEEEEEeCCCCCHHHHHHh---------cccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeE
Confidence 357999999999999999962 234589999999999999999999987 99999999999999999999
Q ss_pred EEeecccceecCCCCCc-cccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 781 RVGDFGLARILSPDHTQ-TSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
||+|||+++........ .......++..|+|||++.+..++.++||||||+++|||+||..||....... ......
T Consensus 154 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~ 230 (295)
T 3ugc_A 154 KIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF---MRMIGN 230 (295)
T ss_dssp EECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHH---HHHHCT
T ss_pred EEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHH---HhhhcC
Confidence 99999999876544321 12223447788999999998899999999999999999999999986432110 000000
Q ss_pred cCCC-----chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHh
Q 039533 860 ALPD-----DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNI 934 (949)
Q Consensus 860 ~~~~-----~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 934 (949)
.... ...+.+... .+.+....++..+.+++.+||+.||++|||++|+++.|+++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 231 DKQGQMIVFHLIELLKNN------------------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp TCCTHHHHHHHHHHHHTT------------------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ccccchhHHHHHHHHhcc------------------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 0000 000011000 01111124456789999999999999999999999999999887
Q ss_pred hc
Q 039533 935 LL 936 (949)
Q Consensus 935 ~~ 936 (949)
+.
T Consensus 293 l~ 294 (295)
T 3ugc_A 293 MA 294 (295)
T ss_dssp --
T ss_pred cc
Confidence 54
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=363.93 Aligned_cols=264 Identities=27% Similarity=0.362 Sum_probs=199.5
Q ss_pred HHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 623 NATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 623 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
...++|++.+.||+|+||+||+|++. ++.||||++..... ...+++.+|++++++++||||+++++++...+
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~---- 107 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP---- 107 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT----
T ss_pred CChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC----
Confidence 34567899999999999999999874 78999999975443 23357889999999999999999999976544
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEecCCCCCCeeecCCC
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPV--TAHCDLKPSNVLLDDYM 778 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~--ivHrDlkp~NIll~~~~ 778 (949)
..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||++ + |+||||||+||+++.++
T Consensus 108 -~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~ 176 (309)
T 3p86_A 108 -NLSIVTEYLSRGSLYRLLHKSG-------AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKY 176 (309)
T ss_dssp -CCEEEEECCTTCBHHHHHHSTT-------HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTC
T ss_pred -ceEEEEecCCCCcHHHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCC
Confidence 7899999999999999997211 123489999999999999999999977 7 99999999999999999
Q ss_pred ceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcc
Q 039533 779 TARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGR 858 (949)
Q Consensus 779 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~ 858 (949)
.+||+|||+++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....
T Consensus 177 ~~kL~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~--~~~~~ 252 (309)
T 3p86_A 177 TVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV--VAAVG 252 (309)
T ss_dssp CEEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH--HHHHH
T ss_pred cEEECCCCCCccccccccc--cccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH
Confidence 9999999999865443221 1235699999999999999999999999999999999999999964321110 00000
Q ss_pred ccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhhc
Q 039533 859 KALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILL 936 (949)
Q Consensus 859 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~ 936 (949)
. ....... ...++..+.+++.+||+.||++|||++|+++.|+.+.+...
T Consensus 253 ~----------~~~~~~~-------------------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 253 F----------KCKRLEI-------------------PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp H----------SCCCCCC-------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred h----------cCCCCCC-------------------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 0 0000000 01234568899999999999999999999999999876643
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=360.77 Aligned_cols=266 Identities=23% Similarity=0.361 Sum_probs=203.1
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHh--cCCCcceeEEeeeecccccCCcc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKS--IRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
.++|++.+.||+|+||+||+|++ +++.||||++... ..+.+..|.+++.. ++||||+++++++.... .....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~ 80 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQ 80 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCce
Confidence 46899999999999999999998 4899999998643 34556677777777 78999999999876543 23446
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeEecCCCCCCeee
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLH--------HDCQPVTAHCDLKPSNVLL 774 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH--------~~~~~~ivHrDlkp~NIll 774 (949)
.++||||+++|+|.++++ ...+++..+..++.|++.||+||| +. +|+||||||+||++
T Consensus 81 ~~lv~e~~~~g~L~~~l~-----------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill 146 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQ-----------LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILV 146 (301)
T ss_dssp EEEEECCCTTCBHHHHHT-----------TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEE
T ss_pred eEEehhhccCCCHHHHHh-----------hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEE
Confidence 899999999999999996 235899999999999999999999 55 99999999999999
Q ss_pred cCCCceEEeecccceecCCCCCcc--ccccccCccCccCccccCCC------ccCCccchHHHHHHHHHHHhC-------
Q 039533 775 DDYMTARVGDFGLARILSPDHTQT--SSFSVKGSLGYIAPEYGVGC------EVSTNGDVYSYGILLLELVIG------- 839 (949)
Q Consensus 775 ~~~~~~kl~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDiwSlGvvl~elltg------- 839 (949)
+.++.+||+|||+|+......... ......||+.|+|||++.+. .++.++|||||||++|||+||
T Consensus 147 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~ 226 (301)
T 3q4u_A 147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226 (301)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccc
Confidence 999999999999998765544321 11234699999999998876 566899999999999999999
Q ss_pred ---CCCCccccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCC
Q 039533 840 ---KKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQ 916 (949)
Q Consensus 840 ---~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~ 916 (949)
+.||................... + ...+... .. .....++..+.+++.+||+.||+
T Consensus 227 ~~~~~pf~~~~~~~~~~~~~~~~~~~-------~-~~~~~~~-----------~~--~~~~~~~~~l~~li~~cl~~dP~ 285 (301)
T 3q4u_A 227 EDYKPPFYDVVPNDPSFEDMRKVVCV-------D-QQRPNIP-----------NR--WFSDPTLTSLAKLMKECWYQNPS 285 (301)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHHHTT-------S-CCCCCCC-----------GG--GGGSHHHHHHHHHHHHHCCSSGG
T ss_pred ccccccccccCCCCcchhhhhHHHhc-------c-CCCCCCC-----------hh--hccCccHHHHHHHHHHHhhcChh
Confidence 66664332222111111100000 0 0000000 00 00124577899999999999999
Q ss_pred CCCCHHHHHHHHHHh
Q 039533 917 DRTNMTNVVHELQSI 931 (949)
Q Consensus 917 ~RPs~~ev~~~L~~i 931 (949)
+|||++||++.|++|
T Consensus 286 ~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 286 ARLTALRIKKTLTKI 300 (301)
T ss_dssp GSCCHHHHHHHHHHH
T ss_pred hCCCHHHHHHHHhcc
Confidence 999999999999986
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=365.78 Aligned_cols=255 Identities=20% Similarity=0.293 Sum_probs=203.1
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
.++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+.++++++||||+++++++...+ ..
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~ 80 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN-----IQ 80 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSS-----EE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCC-----eE
Confidence 3689999999999999999999998999999999975432 23456889999999999999999999976544 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++||||+++|+|.+++. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 81 ~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~ 147 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIE----------PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKIS 147 (323)
T ss_dssp EEEEECCTTEEGGGGSB----------TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEcCCCCcHHHHHh----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEE
Confidence 99999999999999996 234589999999999999999999987 99999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCCcc-CCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEV-STNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
|||+++.+.............||+.|+|||++.+..+ +.++|||||||++|||++|+.||+...........+...
T Consensus 148 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--- 224 (323)
T 3tki_A 148 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--- 224 (323)
T ss_dssp CCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTT---
T ss_pred EeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcc---
Confidence 9999987654433222234569999999999987765 789999999999999999999997543322222111111
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
.....+ ....+..+.+++.+|++.||++|||++|+++.
T Consensus 225 ---------~~~~~~------------------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 225 ---------KTYLNP------------------WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ---------CTTSTT------------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---------cccCCc------------------cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 000000 01234557889999999999999999999763
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=380.35 Aligned_cols=262 Identities=24% Similarity=0.339 Sum_probs=209.5
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
.++|.+.+.||+|+||.||+|++..+++.||||+++.... ...+.+.+|++++++++||||+++++++...+ ..
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~ 187 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ-----PI 187 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS-----SC
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC-----Cc
Confidence 3568888999999999999999988899999999874432 22356889999999999999999999986544 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++||||+++|+|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 188 ~lv~e~~~~g~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~ 255 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRT---------EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKIS 255 (377)
T ss_dssp EEEEECCTTCBHHHHHHH---------HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEcCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEEC
Confidence 999999999999999962 234589999999999999999999988 89999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCC
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
|||+++...............++..|+|||++.+..++.++|||||||++|||+| |+.||.......
T Consensus 256 DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~------------ 323 (377)
T 3cbl_A 256 DFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ------------ 323 (377)
T ss_dssp CGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH------------
T ss_pred cCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------------
Confidence 9999987544322211112235778999999998899999999999999999998 999996432111
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhh
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNIL 935 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~ 935 (949)
..+.+...... +....++..+.+++.+||+.||++|||++||++.|+++++..
T Consensus 324 --~~~~~~~~~~~------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~ 376 (377)
T 3cbl_A 324 --TREFVEKGGRL------------------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376 (377)
T ss_dssp --HHHHHHTTCCC------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --HHHHHHcCCCC------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence 01111110000 000123556889999999999999999999999999998753
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=367.53 Aligned_cols=262 Identities=23% Similarity=0.382 Sum_probs=206.9
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCC---CEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEG---RTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
++|++.+.||+|+||.||+|++..+ +..||||+++.... ...+.+.+|+.++++++||||+++++++....
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----- 123 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR----- 123 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG-----
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-----
Confidence 5688889999999999999999743 45699999975432 33467899999999999999999999976544
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++|+|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~k 191 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRT---------HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCK 191 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHT---------TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEE
T ss_pred ccEEEeeCCCCCcHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEE
Confidence 78999999999999999962 234689999999999999999999987 899999999999999999999
Q ss_pred EeecccceecCCCCCcc-ccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccc
Q 039533 782 VGDFGLARILSPDHTQT-SSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~ 859 (949)
|+|||+++......... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... ....
T Consensus 192 l~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~--- 266 (325)
T 3kul_A 192 VSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD--VISS--- 266 (325)
T ss_dssp ECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHH---
T ss_pred ECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH--HHHH---
Confidence 99999999876543211 1123346788999999998899999999999999999999 999996432111 0000
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhhc
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILL 936 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~ 936 (949)
+......+. ...++..+.+++.+||+.||++|||+.||++.|+++.+...
T Consensus 267 --------~~~~~~~~~-------------------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 267 --------VEEGYRLPA-------------------PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp --------HHTTCCCCC-------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred --------HHcCCCCCC-------------------CCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 000000000 01334568899999999999999999999999999977644
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=366.11 Aligned_cols=250 Identities=20% Similarity=0.277 Sum_probs=203.2
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
..++|++.+.||+|+||.||+|++..+++.||||++..... ...+++.+|++++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----- 87 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK----- 87 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-----
Confidence 45689999999999999999999988999999999975432 33467889999999999999999999976544
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++|+|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 88 ~~~lv~e~~~~~~L~~~l~----------~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~k 154 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLV----------AHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIK 154 (328)
T ss_dssp EEEEEECCCTTCBHHHHHH----------HHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred EEEEEEECCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEE
Confidence 7899999999999999986 234589999999999999999999987 999999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCccC-CccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVS-TNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
|+|||+++........ ....||+.|+|||++.+..++ .++||||+||++|||++|+.||+...... ...
T Consensus 155 l~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~----- 224 (328)
T 3fe3_A 155 IADFGFSNEFTVGGKL---DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE--LRE----- 224 (328)
T ss_dssp ECSTTCCGGGSSSCGG---GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH-----
T ss_pred EeeccCceecCCCCcc---ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH--HHH-----
Confidence 9999999876544332 245699999999999888765 89999999999999999999996432110 000
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
.+..... ..+ ...+..+.+++.+|++.||++|||++|+++.
T Consensus 225 ------~i~~~~~-~~p-------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 225 ------RVLRGKY-RIP-------------------FYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ------HHHHCCC-CCC-------------------TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ------HHHhCCC-CCC-------------------CCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000000 000 0123457889999999999999999999763
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=364.99 Aligned_cols=252 Identities=20% Similarity=0.237 Sum_probs=203.9
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc------chHHHHHHHHHHHhcCCCcceeEEeeeeccccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG------ASRSFIAECKALKSIRHRNLVKVLTACLGADYR 698 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 698 (949)
.++|.+.+.||+|+||.||+|++..+++.||+|+++..... ..+.+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-- 88 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT-- 88 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC--
Confidence 46799999999999999999999989999999999754322 2467899999999999999999999976544
Q ss_pred CCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC
Q 039533 699 GNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM 778 (949)
Q Consensus 699 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~ 778 (949)
..++||||+++|+|.+++. ....+++.++..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 89 ---~~~lv~e~~~gg~L~~~l~----------~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~ 152 (361)
T 2yab_A 89 ---DVVLILELVSGGELFDFLA----------QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKN 152 (361)
T ss_dssp ---EEEEEEECCCSCBHHHHHT----------TCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTT
T ss_pred ---EEEEEEEcCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCC
Confidence 7899999999999999996 234689999999999999999999987 999999999999998776
Q ss_pred ----ceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhh
Q 039533 779 ----TARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLH 854 (949)
Q Consensus 779 ----~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~ 854 (949)
.+||+|||+++......... ...||+.|+|||++.+..++.++||||+||++|+|++|..||....... .+
T Consensus 153 ~~~~~vkl~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~-~~- 227 (361)
T 2yab_A 153 IPIPHIKLIDFGLAHEIEDGVEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TL- 227 (361)
T ss_dssp SSSCCEEECCCSSCEECCTTCCCC---CCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HH-
T ss_pred CCccCEEEEecCCceEcCCCCccc---cCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-HH-
Confidence 79999999998876543322 3569999999999999899999999999999999999999996321110 00
Q ss_pred hhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 855 NFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 855 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
..+......... +.....+..+.+++.+|+..||++|||+.|+++
T Consensus 228 -----------~~i~~~~~~~~~----------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 228 -----------ANITAVSYDFDE----------------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp -----------HHHHTTCCCCCH----------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -----------HHHHhcCCCCCc----------------hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 001110000000 001133456789999999999999999999874
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=360.25 Aligned_cols=252 Identities=21% Similarity=0.294 Sum_probs=205.2
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.++++++||||+++++++...+ ..+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~~ 77 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESME-----ELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT-----EEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC-----EEE
Confidence 468999999999999999999999999999999987443 33467889999999999999999999976544 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC--CCceEE
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD--YMTARV 782 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~--~~~~kl 782 (949)
+||||+++|+|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+||+++. ++.+||
T Consensus 78 lv~e~~~g~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl 145 (321)
T 1tki_A 78 MIFEFISGLDIFERINT---------SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKI 145 (321)
T ss_dssp EEECCCCCCBHHHHHTS---------SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEE
T ss_pred EEEEeCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEE
Confidence 99999999999999962 234689999999999999999999987 9999999999999987 789999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
+|||+++......... ...||+.|+|||++.+..++.++|||||||++|||++|+.||....... .
T Consensus 146 ~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~--------- 211 (321)
T 1tki_A 146 IEFGQARQLKPGDNFR---LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ--I--------- 211 (321)
T ss_dssp CCCTTCEECCTTCEEE---EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--H---------
T ss_pred EECCCCeECCCCCccc---cccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH--H---------
Confidence 9999999876544322 3458999999999999889999999999999999999999996432110 0
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
...+......... ....+.+..+.+++.+|++.||++|||+.|+++
T Consensus 212 --~~~i~~~~~~~~~----------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 212 --IENIMNAEYTFDE----------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp --HHHHHHTCCCCCH----------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --HHHHHcCCCCCCh----------------hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0111111111100 011133566889999999999999999999987
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=358.76 Aligned_cols=263 Identities=21% Similarity=0.318 Sum_probs=205.4
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC---cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH---GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
.++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+.+|+.++++++||||+++++++...+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~----- 84 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD----- 84 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSS-----
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCC-----
Confidence 3579999999999999999999998999999999864432 23467889999999999999999999975444
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++++|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 85 ~~~lv~e~~~g~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~k 151 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIE----------SHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLK 151 (294)
T ss_dssp EEEEEEECCCSCBHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred eEEEEEeCCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence 7899999999999999996 234689999999999999999999987 899999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
|+|||+++......... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..........
T Consensus 152 l~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~-------- 222 (294)
T 4eqm_A 152 IFDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI-------- 222 (294)
T ss_dssp ECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHH--------
T ss_pred EEeCCCccccccccccc-cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH--------
Confidence 99999998765433211 223459999999999999999999999999999999999999996432111000
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-CHHHHHHHHHHhHHh
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRT-NMTNVVHELQSIKNI 934 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~ev~~~L~~i~~~ 934 (949)
..+...... .. .....+.+..+.+++.+|++.||++|| +++++.+.|+++...
T Consensus 223 -----~~~~~~~~~-~~--------------~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 223 -----KHIQDSVPN-VT--------------TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp -----HHHSSCCCC-HH--------------HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred -----HHhhccCCC-cc--------------hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 000000000 00 000013356788999999999999999 999999999887544
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=369.88 Aligned_cols=284 Identities=15% Similarity=0.214 Sum_probs=214.2
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCC-----CEEEEEEEEecCCCcc-----------hHHHHHHHHHHHhcCCCccee
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEG-----RTTIAVKVFNLQHHGA-----------SRSFIAECKALKSIRHRNLVK 687 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~ 687 (949)
..++|++.+.||+|+||.||+|.+..+ ++.||||++....... ......|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 345899999999999999999999754 4789999987543211 123445566677778999999
Q ss_pred EEeeeecccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 039533 688 VLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDL 767 (949)
Q Consensus 688 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDl 767 (949)
+++++.... .+....++||||+ +++|.+++.. ....+++.+++.|+.|++.||+|||++ +|+||||
T Consensus 113 ~~~~~~~~~-~~~~~~~lv~e~~-g~~L~~~~~~---------~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDl 178 (364)
T 3op5_A 113 YWGSGLHDK-NGKSYRFMIMDRF-GSDLQKIYEA---------NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDI 178 (364)
T ss_dssp EEEEEEEEE-TTEEEEEEEEECE-EEEHHHHHHH---------TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred EEeeeeecc-CCcceEEEEEeCC-CCCHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecC
Confidence 999987543 2334689999999 9999999962 235699999999999999999999988 9999999
Q ss_pred CCCCeeec--CCCceEEeecccceecCCCCCcc-----ccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCC
Q 039533 768 KPSNVLLD--DYMTARVGDFGLARILSPDHTQT-----SSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGK 840 (949)
Q Consensus 768 kp~NIll~--~~~~~kl~DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~ 840 (949)
||+||+++ .++.+||+|||+|+.+....... ......||+.|+|||++.+..++.++|||||||++|||+||+
T Consensus 179 kp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~ 258 (364)
T 3op5_A 179 KASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258 (364)
T ss_dssp CGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred CHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999 88999999999998765432211 112345999999999999999999999999999999999999
Q ss_pred CCCccccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC
Q 039533 841 KPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTN 920 (949)
Q Consensus 841 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 920 (949)
.||....... .............+.++++..+.. ..++..+.+++..||+.||++||+
T Consensus 259 ~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~li~~cl~~~p~~RP~ 316 (364)
T 3op5_A 259 LPWEDNLKDP-KYVRDSKIRYRENIASLMDKCFPA---------------------ANAPGEIAKYMETVKLLDYTEKPL 316 (364)
T ss_dssp CTTGGGTTCH-HHHHHHHHHHHHCHHHHHHHHSCT---------------------TCCCHHHHHHHHHHHTCCTTCCCC
T ss_pred CCccccccCH-HHHHHHHHHhhhhHHHHHHHhccc---------------------ccCHHHHHHHHHHHhcCCCCCCCC
Confidence 9997432221 111111111111222222222211 123567899999999999999999
Q ss_pred HHHHHHHHHHhHHhhccCCCCCC
Q 039533 921 MTNVVHELQSIKNILLGVELCPP 943 (949)
Q Consensus 921 ~~ev~~~L~~i~~~~~~~~~~~~ 943 (949)
+++|++.|+++.+........++
T Consensus 317 ~~~l~~~l~~~~~~~~~~~~~~~ 339 (364)
T 3op5_A 317 YENLRDILLQGLKAIGSKDDGKL 339 (364)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCCC
T ss_pred HHHHHHHHHHHHHHcCCCcCCcc
Confidence 99999999999888766654444
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=371.10 Aligned_cols=282 Identities=22% Similarity=0.288 Sum_probs=216.8
Q ss_pred cCHHHHHHHhcCCCCCCeeeeecCceEEEEEE-----cCCCEEEEEEEEecCCC-cchHHHHHHHHHHHhc-CCCcceeE
Q 039533 616 LSYQDLYNATSGFSSANLVGVGSFGSVYKGII-----DEGRTTIAVKVFNLQHH-GASRSFIAECKALKSI-RHRNLVKV 688 (949)
Q Consensus 616 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~ 688 (949)
+...+.....++|.+.+.||+|+||.||+|++ ..+++.||||+++.... ...+.+.+|+++++++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 34455556678999999999999999999994 44668999999975433 2346799999999999 79999999
Q ss_pred EeeeecccccCCccceeEeeeccCCChhhhcCCCCCCCc-----------------------------------------
Q 039533 689 LTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDE----------------------------------------- 727 (949)
Q Consensus 689 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~----------------------------------------- 727 (949)
++++...+ ...++||||+++|+|.+++........
T Consensus 92 ~~~~~~~~----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (359)
T 3vhe_A 92 LGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF 167 (359)
T ss_dssp EEEECSTT----SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred eeeeecCC----CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence 99986433 358999999999999999975322100
Q ss_pred ---------------cccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecccceecC
Q 039533 728 ---------------IDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILS 792 (949)
Q Consensus 728 ---------------~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~ 792 (949)
.......+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 244 (359)
T 3vhe_A 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIY 244 (359)
T ss_dssp ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTT
T ss_pred ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeec
Confidence 000122389999999999999999999988 89999999999999999999999999998765
Q ss_pred CCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCCchhhhccc
Q 039533 793 PDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPDDVMDIVDS 871 (949)
Q Consensus 793 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 871 (949)
............||+.|+|||++.+..++.++|||||||++|||+| |+.||........ .. ..+..
T Consensus 245 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~------------~~~~~ 311 (359)
T 3vhe_A 245 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FC------------RRLKE 311 (359)
T ss_dssp SCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-HH------------HHHHH
T ss_pred ccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH-HH------------HHHHc
Confidence 5444333334568899999999998899999999999999999998 9999964322111 00 00000
Q ss_pred CCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhh
Q 039533 872 SLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNIL 935 (949)
Q Consensus 872 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~ 935 (949)
...... ....+..+.+++.+|++.||++|||++||++.|+++.+..
T Consensus 312 ~~~~~~------------------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 312 GTRMRA------------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp TCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCC------------------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 000000 0022446789999999999999999999999999988753
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=373.74 Aligned_cols=270 Identities=24% Similarity=0.349 Sum_probs=208.7
Q ss_pred hcCCCCCCeeeeecCceEEEEEE-----cCCCEEEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeeccccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGII-----DEGRTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGADYR 698 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 698 (949)
.++|++.+.||+|+||.||+|++ ..+++.||||+++... .....++.+|+.++++++||||+++++++....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-- 147 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL-- 147 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC--
Confidence 35788899999999999999994 4467899999986432 233457889999999999999999999976544
Q ss_pred CCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC
Q 039533 699 GNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM 778 (949)
Q Consensus 699 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~ 778 (949)
..++||||+++|+|.+++...... ......+++.+++.++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 148 ---~~~lv~e~~~~g~L~~~l~~~~~~---~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~ 218 (367)
T 3l9p_A 148 ---PRFILLELMAGGDLKSFLRETRPR---PSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPG 218 (367)
T ss_dssp ---SCEEEEECCTTEEHHHHHHHHSCC---SSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSS
T ss_pred ---CCEEEEEeCCCCCHHHHHHhhccc---cCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCC
Confidence 679999999999999999732211 12335689999999999999999999988 999999999999999554
Q ss_pred ---ceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhh
Q 039533 779 ---TARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLH 854 (949)
Q Consensus 779 ---~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~ 854 (949)
.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++ |..||....... .
T Consensus 219 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~--~- 295 (367)
T 3l9p_A 219 PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--V- 295 (367)
T ss_dssp TTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--H-
T ss_pred CCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--H-
Confidence 599999999986533322222223458999999999988899999999999999999998 999996432111 1
Q ss_pred hhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHh
Q 039533 855 NFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNI 934 (949)
Q Consensus 855 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 934 (949)
.+.+........ ...++..+.+++.+||+.||++|||++||++.|+.+.+.
T Consensus 296 -----------~~~i~~~~~~~~------------------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 296 -----------LEFVTSGGRMDP------------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp -----------HHHHHTTCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -----------HHHHHcCCCCCC------------------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 011110000000 012345688999999999999999999999999998776
Q ss_pred hcc
Q 039533 935 LLG 937 (949)
Q Consensus 935 ~~~ 937 (949)
...
T Consensus 347 ~~~ 349 (367)
T 3l9p_A 347 PDV 349 (367)
T ss_dssp HHH
T ss_pred hhh
Confidence 543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=358.79 Aligned_cols=251 Identities=20% Similarity=0.248 Sum_probs=202.8
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc------chHHHHHHHHHHHhcCCCcceeEEeeeecccccC
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG------ASRSFIAECKALKSIRHRNLVKVLTACLGADYRG 699 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 699 (949)
++|.+.+.||+|+||.||+|.+..+++.||+|+++..... ..+.+.+|+.++++++||||+++++++....
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--- 87 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT--- 87 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS---
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC---
Confidence 4688999999999999999999989999999999754321 3467899999999999999999999976544
Q ss_pred CccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC-
Q 039533 700 NDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM- 778 (949)
Q Consensus 700 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~- 778 (949)
..++||||+++++|.+++. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 88 --~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~ 152 (326)
T 2y0a_A 88 --DVILILELVAGGELFDFLA----------EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNV 152 (326)
T ss_dssp --EEEEEEECCCSCBHHHHHT----------TSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSS
T ss_pred --EEEEEEEcCCCCCHHHHHH----------hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCC
Confidence 7899999999999999996 234689999999999999999999987 999999999999999877
Q ss_pred ---ceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhh
Q 039533 779 ---TARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHN 855 (949)
Q Consensus 779 ---~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~ 855 (949)
.+||+|||+++......... ...||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...
T Consensus 153 ~~~~~kl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~- 227 (326)
T 2y0a_A 153 PKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLA- 227 (326)
T ss_dssp SSCCEEECCCTTCEECCTTSCCC---CCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHH-
T ss_pred CCCCEEEEECCCCeECCCCCccc---cccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHH-
Confidence 89999999998875443222 3459999999999998899999999999999999999999995321110 000
Q ss_pred hccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 856 FGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 856 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.+....... +. ......+..+.+++.+|++.||++|||+.|+++
T Consensus 228 -----------~~~~~~~~~-~~---------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 228 -----------NVSAVNYEF-ED---------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp -----------HHHHTCCCC-CH---------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----------HHHhcCCCc-Cc---------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000000000 00 001133456789999999999999999999986
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=361.24 Aligned_cols=249 Identities=21% Similarity=0.230 Sum_probs=202.4
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecC---CCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ---HHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
.++|++.+.||+|+||.||+|++..+++.||+|+++.. .......+.+|+.++++++||||+++++++...+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~----- 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD----- 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS-----
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC-----
Confidence 46789999999999999999999989999999999753 2334567889999999999999999999976554
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++|+|.+++. ....+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+|
T Consensus 79 ~~~lv~E~~~gg~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vk 145 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLS----------RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIK 145 (337)
T ss_dssp EEEEEEECCTTCBHHHHHH----------HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEE
T ss_pred EEEEEEeCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEE
Confidence 7899999999999999986 234689999999999999999999987 999999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
|+|||+++......... ....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..
T Consensus 146 L~DFG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~------- 214 (337)
T 1o6l_A 146 ITDFGLCKEGISDGATM--KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LF------- 214 (337)
T ss_dssp ECCCTTCBCSCCTTCCB--CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH-------
T ss_pred EeeccchhhcccCCCcc--cccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH--HH-------
Confidence 99999998643332211 24569999999999999999999999999999999999999996321110 00
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRT-----NMTNVVH 926 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~ 926 (949)
..+...... .+ ...+..+.+++.+|++.||++|| +++|+++
T Consensus 215 ----~~i~~~~~~-~p-------------------~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 215 ----ELILMEEIR-FP-------------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ----HHHHHCCCC-CC-------------------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----HHHHcCCCC-CC-------------------CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 000000000 00 02244678999999999999999 8998875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=353.79 Aligned_cols=274 Identities=15% Similarity=0.135 Sum_probs=215.6
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCCccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
.++|++.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+.+++++ +|+|++++++++.... ..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~-----~~ 81 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL-----HN 81 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT-----EE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCc-----ee
Confidence 367999999999999999999998899999999986443 234688999999999 7999999999875444 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCc----
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMT---- 779 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~---- 779 (949)
++||||+ +++|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 82 ~lv~e~~-~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~ 148 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDL---------CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNAN 148 (298)
T ss_dssp EEEEECC-CCBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTT
T ss_pred EEEEEec-CCCHHHHHHH---------hccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCC
Confidence 9999999 9999999962 234589999999999999999999977 9999999999999987776
Q ss_pred -eEEeecccceecCCCCCc-----cccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchh
Q 039533 780 -ARVGDFGLARILSPDHTQ-----TSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINL 853 (949)
Q Consensus 780 -~kl~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~ 853 (949)
+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 149 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 228 (298)
T 1csn_A 149 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ 228 (298)
T ss_dssp CEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH
T ss_pred eEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHH
Confidence 999999999877554321 11234569999999999999899999999999999999999999996432111000
Q ss_pred hhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHH
Q 039533 854 HNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKN 933 (949)
Q Consensus 854 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 933 (949)
. ...+..... ..........++..+.+++.+||+.||++|||++||++.|+++.+
T Consensus 229 --~--------~~~~~~~~~---------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 229 --K--------YERIGEKKQ---------------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp --H--------HHHHHHHHH---------------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred --H--------HHHHHhhcc---------------CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 0 000000000 000000011345678999999999999999999999999999999
Q ss_pred hhccCCCCCC
Q 039533 934 ILLGVELCPP 943 (949)
Q Consensus 934 ~~~~~~~~~~ 943 (949)
........|+
T Consensus 284 ~~~~~~~~~~ 293 (298)
T 1csn_A 284 RLNTTEDENF 293 (298)
T ss_dssp HTTCCSCSCC
T ss_pred hcCCCCCCcc
Confidence 8877665554
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=353.21 Aligned_cols=258 Identities=26% Similarity=0.399 Sum_probs=207.6
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.++|++.+.||+|+||.||+|++. +++.||+|++..... ..+++.+|++++++++||||+++++++.... ..+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 81 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-----PIC 81 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-----SEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-----ceE
Confidence 357888999999999999999997 578899999975433 3467999999999999999999999976544 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 82 lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~D 149 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRT---------QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSD 149 (269)
T ss_dssp EEEECCTTCBHHHHHHT---------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECC
T ss_pred EEEEeCCCCcHHHHHHh---------cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecc
Confidence 99999999999999962 234589999999999999999999987 899999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCC
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
||+++....... .......+|..|+|||++.+..++.++||||+|+++|||++ |+.||....... ...
T Consensus 150 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~--~~~-------- 218 (269)
T 4hcu_A 150 FGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVE-------- 218 (269)
T ss_dssp TTGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHH--------
T ss_pred cccccccccccc-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH--HHH--------
Confidence 999987654322 11223447788999999998889999999999999999999 999996432111 000
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHh
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNI 934 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 934 (949)
.+........+ ...+..+.+++.+|++.||++|||++|+++.|+++.++
T Consensus 219 ---~~~~~~~~~~~-------------------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 219 ---DISTGFRLYKP-------------------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp ---HHHTTCCCCCC-------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---HHhcCccCCCC-------------------CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 00000000000 01234578999999999999999999999999999764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=351.02 Aligned_cols=258 Identities=24% Similarity=0.392 Sum_probs=207.9
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.++|++.+.||+|+||.||+|++. ++..||+|+++.... ..+++.+|++++++++||||+++++++.... ..+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 79 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEY-----PIY 79 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SEE
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-----ceE
Confidence 467889999999999999999887 678899999975443 3467999999999999999999999975443 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++++|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 80 lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~D 147 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRS---------HGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSD 147 (268)
T ss_dssp EEEECCTTCBHHHHHHH---------HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECC
T ss_pred EEEEccCCCcHHHHHHH---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEcc
Confidence 99999999999999962 234589999999999999999999987 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCC
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
||.++......... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||+........
T Consensus 148 fg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~----------- 215 (268)
T 3sxs_A 148 FGMTRYVLDDQYVS-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV----------- 215 (268)
T ss_dssp TTCEEECCTTCEEE-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-----------
T ss_pred Cccceecchhhhhc-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH-----------
Confidence 99998776544322 223446788999999998899999999999999999999 99999643221100
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHh
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNI 934 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 934 (949)
..+........+ ...+..+.+++.+|++.||++|||++|+++.|+++++.
T Consensus 216 --~~~~~~~~~~~~-------------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 216 --LKVSQGHRLYRP-------------------HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp --HHHHTTCCCCCC-------------------TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred --HHHHcCCCCCCC-------------------CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 000000000000 01234578999999999999999999999999998764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=369.10 Aligned_cols=262 Identities=24% Similarity=0.419 Sum_probs=197.2
Q ss_pred hcCCCCCCeeeeecCceEEEEEEc---CCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIID---EGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
.++|++.+.||+|+||.||+|++. .++..||||+++.... ...+.+.+|+.++++++||||+++++++....
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 119 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK---- 119 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS----
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC----
Confidence 357999999999999999999886 4567899999875432 33467999999999999999999999976544
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
..++||||+++|+|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 120 -~~~lv~e~~~~~sL~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~ 186 (373)
T 2qol_A 120 -PVMIVTEYMENGSLDSFLRK---------HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVC 186 (373)
T ss_dssp -SCEEEEECCTTCBHHHHHHT---------TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCE
T ss_pred -ceEEEEeCCCCCcHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCE
Confidence 78999999999999999962 234689999999999999999999987 89999999999999999999
Q ss_pred EEeecccceecCCCCCcc-ccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhcc
Q 039533 781 RVGDFGLARILSPDHTQT-SSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGR 858 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~ 858 (949)
||+|||+++......... ......++..|+|||++.+..++.++|||||||++|||++ |+.||......+
T Consensus 187 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~-------- 258 (373)
T 2qol_A 187 KVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-------- 258 (373)
T ss_dssp EECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH--------
T ss_pred EECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--------
Confidence 999999998765443211 1112235778999999998899999999999999999998 999996432111
Q ss_pred ccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhh
Q 039533 859 KALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNIL 935 (949)
Q Consensus 859 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~ 935 (949)
..+.+...... +....++..+.+++.+||+.||++||++.||++.|+++....
T Consensus 259 ------~~~~i~~~~~~------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 259 ------VIKAVDEGYRL------------------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp ------HHHHHHTTEEC------------------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred ------HHHHHHcCCCC------------------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 01111100000 000133556889999999999999999999999999987653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=359.20 Aligned_cols=266 Identities=18% Similarity=0.208 Sum_probs=210.2
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCCccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
.++|++.+.||+|+||.||+|++..+++.||||++..... .+.+.+|+++++++ +||||+++++++...+ ..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-----~~ 80 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGK-----YN 80 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETT-----EE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCC-----cc
Confidence 3679999999999999999999988999999999875432 34688999999999 9999999999976544 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCc----
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMT---- 779 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~---- 779 (949)
++||||+ +++|.+++.. ....+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 81 ~lv~e~~-~~~L~~~~~~---------~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~ 147 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDL---------CDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQ 147 (330)
T ss_dssp EEEEECC-CCBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTT
T ss_pred EEEEEeC-CCCHHHHHHH---------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCc
Confidence 9999999 9999999962 135689999999999999999999988 9999999999999998887
Q ss_pred -eEEeecccceecCCCCCcc-----ccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchh
Q 039533 780 -ARVGDFGLARILSPDHTQT-----SSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINL 853 (949)
Q Consensus 780 -~kl~DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~ 853 (949)
+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 148 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~-- 225 (330)
T 2izr_A 148 VIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL-- 225 (330)
T ss_dssp SEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH--
T ss_pred eEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH--
Confidence 9999999999765443211 11245699999999999999999999999999999999999999964321110
Q ss_pred hhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhh-HHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhH
Q 039533 854 HNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINS-IIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIK 932 (949)
Q Consensus 854 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 932 (949)
.... ..+.+. ......+. ....+ .+.+++..|++.||++||++++|.+.|+++.
T Consensus 226 ~~~~--------~~i~~~----------------~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 226 KERY--------QKIGDT----------------KRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp HHHH--------HHHHHH----------------HHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred HHHH--------HHHHhh----------------hccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 0000 000000 00000000 01123 7899999999999999999999999999998
Q ss_pred Hhhcc
Q 039533 933 NILLG 937 (949)
Q Consensus 933 ~~~~~ 937 (949)
+....
T Consensus 281 ~~~~~ 285 (330)
T 2izr_A 281 DRKGY 285 (330)
T ss_dssp HHTTC
T ss_pred HHcCC
Confidence 77543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=359.66 Aligned_cols=248 Identities=24% Similarity=0.315 Sum_probs=200.6
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
.++|.+.+.||+|+||.||+|++..+++.||||++.... ......+.+|+.++++++||||+++++++...+
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----- 82 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT----- 82 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-----
Confidence 468999999999999999999998899999999997432 223467899999999999999999999976544
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+ +|+|.+++. ....+++.++..++.|++.||+|||+. +|+||||||+||++++++.+|
T Consensus 83 ~~~lv~E~~-~g~l~~~l~----------~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~k 148 (336)
T 3h4j_B 83 DIVMVIEYA-GGELFDYIV----------EKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVK 148 (336)
T ss_dssp EEEEEECCC-CEEHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEE
T ss_pred EEEEEEECC-CCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEE
Confidence 789999999 689999886 235689999999999999999999988 899999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCcc-CCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEV-STNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
|+|||++.......... ...||+.|+|||++.+..+ +.++|||||||++|||++|+.||+...... ..
T Consensus 149 l~DFG~s~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-----~~--- 217 (336)
T 3h4j_B 149 IADFGLSNIMTDGNFLK---TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN-----LF--- 217 (336)
T ss_dssp ECCSSCTBTTTTSBTTC---CCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT-----CB---
T ss_pred EEEeccceeccCCcccc---cccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH-----HH---
Confidence 99999998765443222 3459999999999998876 689999999999999999999996432111 00
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
..+.......+ ...+..+.+++.+|++.||++|||++|+++.
T Consensus 218 ------~~i~~~~~~~p-------------------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 218 ------KKVNSCVYVMP-------------------DFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp ------CCCCSSCCCCC-------------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred ------HHHHcCCCCCc-------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 00000000000 0123457889999999999999999999763
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=372.17 Aligned_cols=358 Identities=20% Similarity=0.220 Sum_probs=201.5
Q ss_pred cCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCC
Q 039533 82 SHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLS 161 (949)
Q Consensus 82 ~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~ 161 (949)
+..++++++|++|+|++|.+++ +| .|+.+++|++|+|++|++++ +| ++++++|++|++++|++++.. |+.++
T Consensus 35 ~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~~---~~~l~ 106 (457)
T 3bz5_A 35 TISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNLD---VTPLT 106 (457)
T ss_dssp EEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCC---CTTCT
T ss_pred ccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCceee---cCCCC
Confidence 3345556666666666666664 34 46666666666666666664 33 666666666666666666541 56666
Q ss_pred CCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCcccccccccccCCCCChhhhccc
Q 039533 162 KTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRL 241 (949)
Q Consensus 162 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L 241 (949)
+|++|+|++|++++ +| ++++++|++|++++|++++. + ++.+++|++|++++|... +.+ .+..+++|
T Consensus 107 ~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~-------~~~-~~~~l~~L 172 (457)
T 3bz5_A 107 KLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKI-------TKL-DVTPQTQL 172 (457)
T ss_dssp TCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCC-------CCC-CCTTCTTC
T ss_pred cCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCcc-------ccc-ccccCCcC
Confidence 66666666666664 33 56666666666666666643 2 556666666666665311 111 23445555
Q ss_pred cccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCccc
Q 039533 242 QHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQ 321 (949)
Q Consensus 242 ~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 321 (949)
++|++++|+++..+ +..+++|+.|++++|++++. .+..+ ++|++|++++|++++ +| ++.+++|+
T Consensus 173 ~~L~ls~n~l~~l~---------l~~l~~L~~L~l~~N~l~~~---~l~~l-~~L~~L~Ls~N~l~~-ip--~~~l~~L~ 236 (457)
T 3bz5_A 173 TTLDCSFNKITELD---------VSQNKLLNRLNCDTNNITKL---DLNQN-IQLTFLDCSSNKLTE-ID--VTPLTQLT 236 (457)
T ss_dssp CEEECCSSCCCCCC---------CTTCTTCCEEECCSSCCSCC---CCTTC-TTCSEEECCSSCCSC-CC--CTTCTTCS
T ss_pred CEEECCCCccceec---------cccCCCCCEEECcCCcCCee---ccccC-CCCCEEECcCCcccc-cC--ccccCCCC
Confidence 55555555554421 34455566666666666654 13444 346666666666665 34 56666666
Q ss_pred EEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCcc
Q 039533 322 RLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNN 401 (949)
Q Consensus 322 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 401 (949)
+|++++|++++.. ++.+++|+.|++++| +|+.|++++|.+.+.+| ++.+++|+.|++++|.
T Consensus 237 ~L~l~~N~l~~~~---~~~l~~L~~L~l~~n--------------~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~ 297 (457)
T 3bz5_A 237 YFDCSVNPLTELD---VSTLSKLTTLHCIQT--------------DLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNT 297 (457)
T ss_dssp EEECCSSCCSCCC---CTTCTTCCEEECTTC--------------CCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCT
T ss_pred EEEeeCCcCCCcC---HHHCCCCCEEeccCC--------------CCCEEECCCCccCCccc--ccccccCCEEECCCCc
Confidence 6666666666543 234445555555544 23455666666655555 3556666667777666
Q ss_pred ccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccCCcccccccchhhcccCccccccccCC
Q 039533 402 LSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISS 481 (949)
Q Consensus 402 l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~ 481 (949)
+.+.+|... ..+ +.|++++| ++|++|++++|+|++. + ++++++|+.|++++|+|++
T Consensus 298 ~l~~l~~~~---~~L-~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~---- 353 (457)
T 3bz5_A 298 QLYLLDCQA---AGI-TELDLSQN-------------PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD---- 353 (457)
T ss_dssp TCCEEECTT---CCC-SCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB----
T ss_pred ccceeccCC---Ccc-eEechhhc-------------ccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC----
Confidence 665555422 222 23333332 4566666666666652 2 5666666666666666654
Q ss_pred CcCCCCCCCEEECCCCcCCCcCcccccCCccceEeCCCCcCcCcccc
Q 039533 482 SLGSLRGLRVLDLSQNNLSGEIPKFLAGLSLNNLNLSYNDLEGMVTT 528 (949)
Q Consensus 482 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~ls~N~l~~~~~~ 528 (949)
++.|..|++++|+++|. + ....+..+++++|+|+|.+|.
T Consensus 354 ----l~~L~~L~l~~n~l~g~-~---~~~~l~~l~l~~N~l~g~ip~ 392 (457)
T 3bz5_A 354 ----FSSVGKIPALNNNFEAE-G---QTITMPKETLTNNSLTIAVSP 392 (457)
T ss_dssp ----CTTGGGSSGGGTSEEEE-E---EEEECCCBCCBTTBEEEECCT
T ss_pred ----ccccccccccCCcEEec-c---eeeecCccccccCcEEEEcCh
Confidence 13444555666666654 1 111255666666666666654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=364.68 Aligned_cols=283 Identities=22% Similarity=0.291 Sum_probs=212.0
Q ss_pred cCCCCCCeeeeecCceEEEEEE----cCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 626 SGFSSANLVGVGSFGSVYKGII----DEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
++|++.+.||+|+||.||+|++ ..+++.||||++........+.+.+|++++++++||||+++++++... +..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~ 99 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP---GRQ 99 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS---SSC
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC---CCc
Confidence 5788899999999999999994 567899999999866555567799999999999999999999987632 234
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++++|.+++.. ....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~k 167 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQR---------HRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVK 167 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHH---------HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEE
T ss_pred eEEEEEeecCCCCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEE
Confidence 68899999999999999962 234589999999999999999999987 999999999999999999999
Q ss_pred EeecccceecCCCCCc-cccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 782 VGDFGLARILSPDHTQ-TSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
|+|||.++........ .......||..|+|||++.+..++.++|||||||++|||++|+.||.......... .....
T Consensus 168 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~--~~~~~ 245 (327)
T 3lxl_A 168 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM--MGCER 245 (327)
T ss_dssp ECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH--CC---
T ss_pred EcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh--ccccc
Confidence 9999999987654432 12223458888999999998889999999999999999999999986432211000 00000
Q ss_pred CCCc---hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhhcc
Q 039533 861 LPDD---VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILLG 937 (949)
Q Consensus 861 ~~~~---~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~ 937 (949)
.... ..+.+..... .+....++..+.+++.+|++.||++|||++|+++.|+++......
T Consensus 246 ~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 307 (327)
T 3lxl_A 246 DVPALSRLLELLEEGQR------------------LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307 (327)
T ss_dssp -CCHHHHHHHHHHTTCC------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred ccccHHHHHHHhhcccC------------------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence 0000 1111111110 011123456789999999999999999999999999999887776
Q ss_pred CCCCCC
Q 039533 938 VELCPP 943 (949)
Q Consensus 938 ~~~~~~ 943 (949)
+...++
T Consensus 308 ~~~~~~ 313 (327)
T 3lxl_A 308 CETHAF 313 (327)
T ss_dssp ------
T ss_pred cccccc
Confidence 655443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=363.08 Aligned_cols=259 Identities=24% Similarity=0.407 Sum_probs=200.8
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEE----EEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTT----IAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
++|++.+.||+|+||+||+|++..+++. ||+|+++... ....+++.+|+.++++++||||++++++|...
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 89 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 89 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-----
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----
Confidence 5688899999999999999998766654 5777775332 23457899999999999999999999998643
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
..++|+||+++|+|.+++.. ....+++..++.|+.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 90 -~~~~v~e~~~~g~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~ 156 (327)
T 3poz_A 90 -TVQLITQLMPFGCLLDYVRE---------HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 156 (327)
T ss_dssp -SEEEEEECCTTCBHHHHHHH---------STTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEE
T ss_pred -CeEEEEEecCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCE
Confidence 36899999999999999962 235689999999999999999999988 99999999999999999999
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccc
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~ 859 (949)
||+|||+|+...............+|..|+|||++.+..++.++|||||||++|||+| |+.||+......
T Consensus 157 kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------- 227 (327)
T 3poz_A 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------- 227 (327)
T ss_dssp EECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---------
T ss_pred EEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---------
Confidence 9999999998765544333334457889999999999999999999999999999999 999996432211
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHh
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNI 934 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 934 (949)
....+........ ...++..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 228 -----~~~~~~~~~~~~~------------------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 228 -----ISSILEKGERLPQ------------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -----HHHHHHTTCCCCC------------------CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred -----HHHHHHcCCCCCC------------------CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 1111111110000 012345678999999999999999999999999998654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=353.54 Aligned_cols=252 Identities=22% Similarity=0.276 Sum_probs=196.6
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--------------------------cchHHHHHHHHHHH
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--------------------------GASRSFIAECKALK 678 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 678 (949)
.++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 4689999999999999999999998999999999974421 11356889999999
Q ss_pred hcCCCcceeEEeeeecccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 039533 679 SIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDC 758 (949)
Q Consensus 679 ~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ 758 (949)
+++||||+++++++... .....++||||+++++|.+++. ...+++.++..++.|++.||+|||++
T Consensus 92 ~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH~~- 156 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEVPT-----------LKPLSEDQARFYFQDLIKGIEYLHYQ- 156 (298)
T ss_dssp TCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCSSC-----------SSCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred hCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHHhh-----------cCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 99999999999998642 2347899999999999988754 24589999999999999999999988
Q ss_pred CCCeEecCCCCCCeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCc---cCCccchHHHHHHHHH
Q 039533 759 QPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCE---VSTNGDVYSYGILLLE 835 (949)
Q Consensus 759 ~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDiwSlGvvl~e 835 (949)
+|+||||||+||+++.++.+||+|||+++......... ....||+.|+|||++.+.. ++.++|||||||++||
T Consensus 157 --~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~ 232 (298)
T 2zv2_A 157 --KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALL--SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC 232 (298)
T ss_dssp --TEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEE--CCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHH
T ss_pred --CeeccCCCHHHEEECCCCCEEEecCCCccccccccccc--cCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHH
Confidence 99999999999999999999999999998765543322 2356999999999988765 4788999999999999
Q ss_pred HHhCCCCCccccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCC
Q 039533 836 LVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELP 915 (949)
Q Consensus 836 lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP 915 (949)
|++|+.||...... .... .+....... +. ....+..+.+++.+|++.||
T Consensus 233 l~~g~~pf~~~~~~--~~~~-----------~~~~~~~~~-~~-----------------~~~~~~~l~~li~~~l~~dp 281 (298)
T 2zv2_A 233 FVFGQCPFMDERIM--CLHS-----------KIKSQALEF-PD-----------------QPDIAEDLKDLITRMLDKNP 281 (298)
T ss_dssp HHHSSCSSCCSSHH--HHHH-----------HHHHCCCCC-CS-----------------SSCCCHHHHHHHHHHTCSCT
T ss_pred HHHCCCCCCCccHH--HHHH-----------HHhcccCCC-CC-----------------ccccCHHHHHHHHHHhhcCh
Confidence 99999999632111 0000 000000000 00 00224567899999999999
Q ss_pred CCCCCHHHHHH
Q 039533 916 QDRTNMTNVVH 926 (949)
Q Consensus 916 ~~RPs~~ev~~ 926 (949)
++|||+.|+++
T Consensus 282 ~~R~s~~e~l~ 292 (298)
T 2zv2_A 282 ESRIVVPEIKL 292 (298)
T ss_dssp TTSCCHHHHTT
T ss_pred hhCCCHHHHhc
Confidence 99999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=351.20 Aligned_cols=254 Identities=24% Similarity=0.411 Sum_probs=201.8
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcc-------hHHHHHHHHHHHhcCCCcceeEEeeeecccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGA-------SRSFIAECKALKSIRHRNLVKVLTACLGADY 697 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 697 (949)
.++|++.+.||+|+||.||+|++..+++.||+|++....... .+.+.+|++++++++||||+++++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 95 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP-- 95 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT--
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC--
Confidence 367899999999999999999999899999999986543321 16789999999999999999999997432
Q ss_pred cCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEecCCCCCCeeec
Q 039533 698 RGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPV--TAHCDLKPSNVLLD 775 (949)
Q Consensus 698 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~--ivHrDlkp~NIll~ 775 (949)
.++||||+++|+|.+++.. ....+++..+..++.|++.||+|||++ + |+||||||+||+++
T Consensus 96 -----~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~ 158 (287)
T 4f0f_A 96 -----PRMVMEFVPCGDLYHRLLD---------KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQ 158 (287)
T ss_dssp -----TEEEEECCTTCBHHHHHHC---------TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEES
T ss_pred -----CeEEEEecCCCCHHHHHhc---------ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEe
Confidence 3799999999999998862 234689999999999999999999977 7 99999999999998
Q ss_pred CCCc-----eEEeecccceecCCCCCccccccccCccCccCccccC--CCccCCccchHHHHHHHHHHHhCCCCCccccc
Q 039533 776 DYMT-----ARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGV--GCEVSTNGDVYSYGILLLELVIGKKPIDIMFE 848 (949)
Q Consensus 776 ~~~~-----~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~ 848 (949)
.++. +||+|||+++..... .....||+.|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 159 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 233 (287)
T 4f0f_A 159 SLDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY 233 (287)
T ss_dssp CCCTTCSCCEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred ccCCCCceeEEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc
Confidence 7776 999999999854332 12356999999999984 45678999999999999999999999964432
Q ss_pred cCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 039533 849 GDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHEL 928 (949)
Q Consensus 849 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 928 (949)
.......... ........ ...++..+.+++.+||+.||++|||++|+++.|
T Consensus 234 ~~~~~~~~~~-----------~~~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 284 (287)
T 4f0f_A 234 GKIKFINMIR-----------EEGLRPTI------------------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284 (287)
T ss_dssp CHHHHHHHHH-----------HSCCCCCC------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cHHHHHHHHh-----------ccCCCCCC------------------CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 2211111110 00000000 012345688999999999999999999999999
Q ss_pred HHh
Q 039533 929 QSI 931 (949)
Q Consensus 929 ~~i 931 (949)
+++
T Consensus 285 ~~l 287 (287)
T 4f0f_A 285 SEL 287 (287)
T ss_dssp HTC
T ss_pred HhC
Confidence 864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=366.13 Aligned_cols=275 Identities=24% Similarity=0.384 Sum_probs=210.5
Q ss_pred HHhcCCCCCCeeeeecCceEEEEEEcC-----CCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeeccc
Q 039533 623 NATSGFSSANLVGVGSFGSVYKGIIDE-----GRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGAD 696 (949)
Q Consensus 623 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 696 (949)
...++|++.+.||+|+||.||+|++.. +++.||||+++.... ...+.+.+|+.++++++||||+++++++...+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 345789999999999999999999973 458999999975433 23467899999999999999999999976543
Q ss_pred ccCCccceeEeeeccCCChhhhcCCCCCCC--------------ccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 039533 697 YRGNDFKASVYEFMHYGSLEEWLHPFTGED--------------EIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVT 762 (949)
Q Consensus 697 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~i 762 (949)
..++||||+++|+|.+++....... ........+++.+++.++.|++.||+|||++ +|
T Consensus 124 -----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~i 195 (343)
T 1luf_A 124 -----PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 195 (343)
T ss_dssp -----SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred -----ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 7899999999999999997432110 0001125689999999999999999999988 99
Q ss_pred EecCCCCCCeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCC
Q 039533 763 AHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKK 841 (949)
Q Consensus 763 vHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~ 841 (949)
+||||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.
T Consensus 196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999987654332222234458899999999988889999999999999999999 999
Q ss_pred CCccccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCH
Q 039533 842 PIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNM 921 (949)
Q Consensus 842 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 921 (949)
||....... ... .+.+......+ ..++..+.+++.+||+.||++|||+
T Consensus 276 p~~~~~~~~--~~~-----------~~~~~~~~~~~-------------------~~~~~~l~~li~~~l~~~p~~Rps~ 323 (343)
T 1luf_A 276 PYYGMAHEE--VIY-----------YVRDGNILACP-------------------ENCPLELYNLMRLCWSKLPADRPSF 323 (343)
T ss_dssp TTTTSCHHH--HHH-----------HHHTTCCCCCC-------------------TTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred cCCCCChHH--HHH-----------HHhCCCcCCCC-------------------CCCCHHHHHHHHHHcccCcccCCCH
Confidence 996432111 000 00111100000 1234568899999999999999999
Q ss_pred HHHHHHHHHhHHhhcc
Q 039533 922 TNVVHELQSIKNILLG 937 (949)
Q Consensus 922 ~ev~~~L~~i~~~~~~ 937 (949)
.||++.|+++.+.+.+
T Consensus 324 ~~~~~~L~~~~~~~~~ 339 (343)
T 1luf_A 324 CSIHRILQRMCERAEG 339 (343)
T ss_dssp HHHHHHHHHTTC----
T ss_pred HHHHHHHHHHHhhhhh
Confidence 9999999999877654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=357.69 Aligned_cols=270 Identities=23% Similarity=0.363 Sum_probs=211.3
Q ss_pred hcCCCCCCeeeeecCceEEEEEEc-----CCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeeccccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIID-----EGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYR 698 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 698 (949)
.++|.+.+.||+|+||.||+|++. .+++.||||+++.... ...+.+.+|++++++++||||+++++++...+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-- 99 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG-- 99 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS--
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC--
Confidence 467889999999999999999983 3558999999875432 33467899999999999999999999976544
Q ss_pred CCccceeEeeeccCCChhhhcCCCCCCCc--------------cccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 039533 699 GNDFKASVYEFMHYGSLEEWLHPFTGEDE--------------IDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAH 764 (949)
Q Consensus 699 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------------~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH 764 (949)
..++||||+++++|.+++........ .......+++.+++.++.|++.||+|||++ +|+|
T Consensus 100 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH 173 (314)
T 2ivs_A 100 ---PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVH 173 (314)
T ss_dssp ---SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred ---ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcc
Confidence 78999999999999999974321000 001123589999999999999999999987 8999
Q ss_pred cCCCCCCeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCC
Q 039533 765 CDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPI 843 (949)
Q Consensus 765 rDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf 843 (949)
|||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999988765544333334457889999999988889999999999999999999 99999
Q ss_pred ccccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHH
Q 039533 844 DIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTN 923 (949)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 923 (949)
....... ..+.+........ ...++..+.+++.+|++.||++|||+.|
T Consensus 254 ~~~~~~~--------------~~~~~~~~~~~~~------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ 301 (314)
T 2ivs_A 254 PGIPPER--------------LFNLLKTGHRMER------------------PDNCSEEMYRLMLQCWKQEPDKRPVFAD 301 (314)
T ss_dssp TTCCGGG--------------HHHHHHTTCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCHHH--------------HHHHhhcCCcCCC------------------CccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 6432211 1111110000000 0123456889999999999999999999
Q ss_pred HHHHHHHhHHh
Q 039533 924 VVHELQSIKNI 934 (949)
Q Consensus 924 v~~~L~~i~~~ 934 (949)
+++.|+++.+.
T Consensus 302 l~~~l~~~~~~ 312 (314)
T 2ivs_A 302 ISKDLEKMMVK 312 (314)
T ss_dssp HHHHHHHHHHT
T ss_pred HHHHHHHHHhh
Confidence 99999998765
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=360.89 Aligned_cols=255 Identities=21% Similarity=0.236 Sum_probs=202.3
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC-----CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-----HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
++|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|+.++++++||||+++++++...+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---- 99 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDG---- 99 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT----
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC----
Confidence 46899999999999999999999899999999986321 123577999999999999999999999976544
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCc-
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMT- 779 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~- 779 (949)
..++||||+++++|.+++... ......+++..+..++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 100 -~~~lv~e~~~g~~L~~~l~~~------~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~ 169 (351)
T 3c0i_A 100 -MLYMVFEFMDGADLCFEIVKR------ADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENS 169 (351)
T ss_dssp -EEEEEEECCSSCBHHHHHHHH------HHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTT
T ss_pred -EEEEEEeCCCCCCHHHHHHHh------cccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCC
Confidence 789999999999999887521 11234589999999999999999999987 9999999999999986554
Q ss_pred --eEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhc
Q 039533 780 --ARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFG 857 (949)
Q Consensus 780 --~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~ 857 (949)
+||+|||+++......... ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..
T Consensus 170 ~~vkl~Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~---- 240 (351)
T 3c0i_A 170 APVKLGGFGVAIQLGESGLVA--GGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE---RL---- 240 (351)
T ss_dssp CCEEECCCTTCEECCTTSCBC--CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH---HH----
T ss_pred CcEEEecCcceeEecCCCeee--cCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH---HH----
Confidence 9999999998876543221 235699999999999998999999999999999999999999964211 00
Q ss_pred cccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 858 RKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 858 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
...+........+ ......+..+.+++.+|++.||++|||+.|+++
T Consensus 241 -------~~~i~~~~~~~~~----------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 241 -------FEGIIKGKYKMNP----------------RQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp -------HHHHHHTCCCCCH----------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -------HHHHHcCCCCCCc----------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0011111111100 001133556889999999999999999999975
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=370.45 Aligned_cols=253 Identities=18% Similarity=0.203 Sum_probs=201.6
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+ .
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~ 84 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEG-----H 84 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSS-----E
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECC-----E
Confidence 4679999999999999999999999999999999975543 23457889999999999999999999976544 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec---CCCc
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD---DYMT 779 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~---~~~~ 779 (949)
.++||||+++|+|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||+++ .++.
T Consensus 85 ~~lv~E~~~gg~L~~~i~----------~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~ 151 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIV----------AREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAA 151 (444)
T ss_dssp EEEEECCCBCCBHHHHHH----------HCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCC
T ss_pred EEEEEEeCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCc
Confidence 899999999999999986 235689999999999999999999988 999999999999998 5688
Q ss_pred eEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 780 ARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 780 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
+||+|||+|+......... ....||+.|+|||++.+..++.++||||+||++|+|++|+.||....... ....
T Consensus 152 vkL~DFG~a~~~~~~~~~~--~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~--~~~~--- 224 (444)
T 3soa_A 152 VKLADFGLAIEVEGEQQAW--FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR--LYQQ--- 224 (444)
T ss_dssp EEECCCSSCBCCCTTCCBC--CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHH---
T ss_pred EEEccCceeEEecCCCcee--ecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH--HHHH---
Confidence 9999999998765543321 24569999999999999899999999999999999999999995332110 0000
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
+....... +. +.....+..+.+++.+|++.||++|||+.|+++
T Consensus 225 --------i~~~~~~~-~~---------------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 225 --------IKAGAYDF-PS---------------PEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp --------HHHTCCCC-CT---------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --------HHhCCCCC-Cc---------------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000000 00 000123456789999999999999999999986
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=352.57 Aligned_cols=274 Identities=20% Similarity=0.268 Sum_probs=199.9
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
++|++.+.||+|+||+||+|++..+++.||||+++.... ...+.+.+|+.++++++||||+++++++...+ ..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-----KL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----EE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCC-----EE
Confidence 578999999999999999999998999999999975443 23467889999999999999999999976544 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++||||+++ ++.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 77 ~lv~e~~~~-~l~~~~~~---------~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~ 143 (292)
T 3o0g_A 77 TLVFEFCDQ-DLKKYFDS---------CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLA 143 (292)
T ss_dssp EEEEECCSE-EHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred EEEEecCCC-CHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEe
Confidence 999999986 55555531 235689999999999999999999988 99999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCCc-cCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcc---c
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCE-VSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGR---K 859 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~---~ 859 (949)
|||.++......... ....||+.|+|||++.+.. ++.++||||+||++|||++|..||..............+ .
T Consensus 144 Dfg~~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~ 221 (292)
T 3o0g_A 144 NFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 221 (292)
T ss_dssp CCTTCEECCSCCSCC--CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCC
T ss_pred ecccceecCCccccc--cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCC
Confidence 999998765433322 2345899999999988765 799999999999999999998886332211111111111 0
Q ss_pred cCCCchhhhcc-cCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 860 ALPDDVMDIVD-SSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 860 ~~~~~~~~~~d-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
...+......+ +...+.+.. .............+..+.+++.+|++.||++|||++|+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 222 PTEEQWPSMTKLPDYKPYPMY-------PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCTTTCTTGGGSTTCCCCCCC-------CTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CChhhhhhhcccccccccccc-------cCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00000000000 000000000 0000000001123456789999999999999999999875
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=363.86 Aligned_cols=253 Identities=19% Similarity=0.239 Sum_probs=204.5
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+|++++++++||||+++++++.... ..+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----~~~ 124 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY-----EMV 124 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS-----EEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC-----EEE
Confidence 457999999999999999999999899999999998665545567899999999999999999999976544 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec--CCCceEE
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD--DYMTARV 782 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~--~~~~~kl 782 (949)
+||||+++|+|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+||+++ .++.+||
T Consensus 125 lv~E~~~gg~L~~~l~~---------~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL 192 (387)
T 1kob_A 125 LILEFLSGGELFDRIAA---------EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKI 192 (387)
T ss_dssp EEEECCCCCBHHHHTTC---------TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEE
T ss_pred EEEEcCCCCcHHHHHHh---------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEE
Confidence 99999999999999862 234589999999999999999999987 999999999999997 4578999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
+|||+++......... ...||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........
T Consensus 193 ~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-~~~~i~~~--- 265 (387)
T 1kob_A 193 IDFGLATKLNPDEIVK---VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQNVKRC--- 265 (387)
T ss_dssp CCCTTCEECCTTSCEE---EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHC---
T ss_pred EecccceecCCCccee---eeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH-HHHHHHhC---
Confidence 9999999876543322 3459999999999999999999999999999999999999996432110 00000000
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
....... .....+..+.+++.+|++.||++|||+.|+++
T Consensus 266 ---------~~~~~~~----------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 266 ---------DWEFDED----------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp ---------CCCCCSS----------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ---------CCCCCcc----------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0000000 00123456789999999999999999999986
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=369.11 Aligned_cols=346 Identities=26% Similarity=0.385 Sum_probs=201.6
Q ss_pred CCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEE
Q 039533 87 NLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEIL 166 (949)
Q Consensus 87 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L 166 (949)
.+++|+.|++++|.+. .+| .+..+++|++|+|++|.+++..| ++++++|++|++++|.+.+..+ |..+++|++|
T Consensus 44 ~l~~l~~L~l~~~~i~-~l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L 117 (466)
T 1o6v_A 44 DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGL 117 (466)
T ss_dssp HHHTCCEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred HhccccEEecCCCCCc-cCc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEE
Confidence 3566777777777776 355 36777777777777777774433 7777777777777777766555 7777777777
Q ss_pred ECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCcccccccccccCCCCChhhhcccccccc
Q 039533 167 NLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTI 246 (949)
Q Consensus 167 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L~l 246 (949)
+|++|.+++..+ +.++++|++|+|++|++++ ++ .++.+++|++|+++ |.+.. ++.+..+
T Consensus 118 ~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~--------~~~~~~l-------- 176 (466)
T 1o6v_A 118 TLFNNQITDIDP--LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTD--------LKPLANL-------- 176 (466)
T ss_dssp ECCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCC--------CGGGTTC--------
T ss_pred ECCCCCCCCChH--HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccC--------chhhccC--------
Confidence 777777775433 7777777777777777774 33 36777777777765 32221 1123333
Q ss_pred ccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEEEee
Q 039533 247 TSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMW 326 (949)
Q Consensus 247 ~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 326 (949)
++|++|++++|.+++. ..+..+ ++|++|++++|++++..| ++.+++|++|+++
T Consensus 177 ----------------------~~L~~L~l~~n~l~~~--~~l~~l-~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~ 229 (466)
T 1o6v_A 177 ----------------------TTLERLDISSNKVSDI--SVLAKL-TNLESLIATNNQISDITP--LGILTNLDELSLN 229 (466)
T ss_dssp ----------------------TTCCEEECCSSCCCCC--GGGGGC-TTCSEEECCSSCCCCCGG--GGGCTTCCEEECC
T ss_pred ----------------------CCCCEEECcCCcCCCC--hhhccC-CCCCEEEecCCccccccc--ccccCCCCEEECC
Confidence 3444444444444332 123333 245555555555554433 4555566666666
Q ss_pred cceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCC
Q 039533 327 NNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTI 406 (949)
Q Consensus 327 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 406 (949)
+|++++. +.+..+++|+.|++++|++++..| +.++++|+.|++++|.+++..+ +..+++|++|++++|++++..
T Consensus 230 ~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~ 303 (466)
T 1o6v_A 230 GNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDIS 303 (466)
T ss_dssp SSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCG
T ss_pred CCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCch
Confidence 6666532 245556666666666666654433 5556666666666666654333 555666666666666665332
Q ss_pred CCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccCCcccccccchhhcccCccccccccCCCcCCC
Q 039533 407 PPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSL 486 (949)
Q Consensus 407 p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l 486 (949)
| +..+++| +.|++++|++++..| +..+++|+.|++++|++++. ..+.++++|+.|++++|++++..| +..+
T Consensus 304 ~--~~~l~~L-~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l 374 (466)
T 1o6v_A 304 P--ISNLKNL-TYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANL 374 (466)
T ss_dssp G--GGGCTTC-SEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTC
T ss_pred h--hcCCCCC-CEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcC
Confidence 2 4444555 455555555554433 45556666666666666543 345556666666666666655554 5556
Q ss_pred CCCCEEECCCCcCCC
Q 039533 487 RGLRVLDLSQNNLSG 501 (949)
Q Consensus 487 ~~L~~L~Ls~N~l~~ 501 (949)
++|+.|++++|++++
T Consensus 375 ~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 375 TRITQLGLNDQAWTN 389 (466)
T ss_dssp TTCCEEECCCEEEEC
T ss_pred CCCCEEeccCCcccC
Confidence 666666666666654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=360.75 Aligned_cols=274 Identities=24% Similarity=0.384 Sum_probs=195.2
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCE---EEEEEEEecC--CCcchHHHHHHHHHHHhcCCCcceeEEeeeeccccc
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRT---TIAVKVFNLQ--HHGASRSFIAECKALKSIRHRNLVKVLTACLGADYR 698 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 698 (949)
..++|++.+.||+|+||.||+|++..++. .||||+++.. .....+++.+|++++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 45689999999999999999999876554 7999998754 233457899999999999999999999998755421
Q ss_pred C-CccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCC
Q 039533 699 G-NDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDY 777 (949)
Q Consensus 699 ~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~ 777 (949)
+ ....++||||+++|+|.+++..... ......+++.++..++.|++.||+|||++ +|+||||||+||+++++
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRI----GENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAED 173 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC-------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhc----cccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCC
Confidence 1 1123899999999999999862211 11233689999999999999999999988 89999999999999999
Q ss_pred CceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhh
Q 039533 778 MTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNF 856 (949)
Q Consensus 778 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~ 856 (949)
+.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |+.||........ .
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--~-- 249 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI--Y-- 249 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--H--
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH--H--
Confidence 9999999999987655443333334457889999999998889999999999999999999 9999864322110 0
Q ss_pred ccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhhc
Q 039533 857 GRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILL 936 (949)
Q Consensus 857 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~ 936 (949)
..+........+ ..++..+.+++.+|++.||++|||+.|+++.|+++.+...
T Consensus 250 ---------~~~~~~~~~~~~-------------------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 250 ---------NYLIGGNRLKQP-------------------PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp ---------HHHHTTCCCCCC-------------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred ---------HHHhcCCCCCCC-------------------CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 000100000000 1234568899999999999999999999999999876543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=361.41 Aligned_cols=253 Identities=19% Similarity=0.252 Sum_probs=202.5
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+ .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----~ 102 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES-----F 102 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----E
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-----E
Confidence 4679999999999999999999998999999999975433 23467889999999999999999999976544 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCC---Cc
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDY---MT 779 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~---~~ 779 (949)
.++||||+++|+|.+++. ....+++.++..++.||+.||+|||++ +|+||||||+||+++.+ +.
T Consensus 103 ~~lv~e~~~gg~L~~~l~----------~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~ 169 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIV----------AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAA 169 (362)
T ss_dssp EEEEECCCCSCBHHHHHT----------TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCC
T ss_pred EEEEEecCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCC
Confidence 899999999999999986 234589999999999999999999988 99999999999999864 45
Q ss_pred eEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 780 ARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 780 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
+||+|||+++........ ....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....
T Consensus 170 ~kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~--~~~~---- 240 (362)
T 2bdw_A 170 VKLADFGLAIEVNDSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYA---- 240 (362)
T ss_dssp EEECCCTTCBCCTTCCSC---CCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH----
T ss_pred EEEeecCcceEecCCccc---ccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHH----
Confidence 999999999876544322 2356999999999999989999999999999999999999999633111 0000
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
.+....... +. . .....+..+.+++.+|++.||++|||+.|+++.
T Consensus 241 -------~i~~~~~~~-~~------------~---~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 241 -------QIKAGAYDY-PS------------P---EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -------HHHHTCCCC-CT------------T---GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -------HHHhCCCCC-Cc------------c---cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 00 0 001234567899999999999999999998753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=364.62 Aligned_cols=252 Identities=21% Similarity=0.255 Sum_probs=197.1
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCC
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 700 (949)
.++|++.++||+|+||.||+|++..+++.||+|+++... ....+.+.+|..++.++ +||||+++++++...+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~---- 126 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES---- 126 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS----
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC----
Confidence 467999999999999999999999999999999997543 22345688999999887 8999999999976544
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
..++||||+++|+|.+++. ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++++
T Consensus 127 -~~~lV~E~~~gg~L~~~l~----------~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~i 192 (396)
T 4dc2_A 127 -RLFFVIEYVNGGDLMFHMQ----------RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHI 192 (396)
T ss_dssp -EEEEEEECCTTCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCE
T ss_pred -EEEEEEEcCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCE
Confidence 7899999999999999986 235689999999999999999999988 99999999999999999999
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
||+|||+|+........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... .
T Consensus 193 kL~DFGla~~~~~~~~~--~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~-----~ 265 (396)
T 4dc2_A 193 KLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-----N 265 (396)
T ss_dssp EECCCTTCBCCCCTTCC--BCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-----------C
T ss_pred EEeecceeeecccCCCc--cccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch-----h
Confidence 99999999863332221 2245699999999999999999999999999999999999999963321110000 0
Q ss_pred CCCchh-hhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCH
Q 039533 861 LPDDVM-DIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNM 921 (949)
Q Consensus 861 ~~~~~~-~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 921 (949)
..+... .+...... .+ ...+..+.+++.+|++.||++||++
T Consensus 266 ~~~~~~~~i~~~~~~-~p-------------------~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 266 TEDYLFQVILEKQIR-IP-------------------RSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CHHHHHHHHHHCCCC-CC-------------------TTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred hHHHHHHHHhccccC-CC-------------------CcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 000000 01111000 00 1234567899999999999999996
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=352.59 Aligned_cols=261 Identities=28% Similarity=0.431 Sum_probs=193.6
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
.++|++.+.||+|+||.||+|++. ..||||+++.... ...+.+.+|++++++++||||+++++++.. ..
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~ 93 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQ 93 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred ccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC------Cc
Confidence 467999999999999999999875 3599999975443 234678999999999999999999997532 25
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++++|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 94 ~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl 161 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHA---------SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKI 161 (289)
T ss_dssp CEEEEECCCEEEHHHHHTT---------C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEE
T ss_pred cEEEEEecCCCcHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEE
Confidence 7999999999999999962 235589999999999999999999987 8999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccC---CCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGV---GCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
+|||+++...............||+.|+|||++. +..++.++||||||+++|||++|+.||......+.........
T Consensus 162 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 241 (289)
T 3og7_A 162 GDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRG 241 (289)
T ss_dssp CCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHT
T ss_pred ccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhccc
Confidence 9999998665433322223456999999999986 5568889999999999999999999996432211111100010
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHH
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKN 933 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 933 (949)
......... ...++..+.+++.+|++.||++|||++|+++.|+++.+
T Consensus 242 ~~~~~~~~~---------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 242 SLSPDLSKV---------------------------RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp SCCCCTTSS---------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ccCcchhhc---------------------------cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 111000000 01335678999999999999999999999999998754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=353.24 Aligned_cols=284 Identities=19% Similarity=0.204 Sum_probs=210.9
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
++|.+.+.||+|+||+||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++.... ....+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~~~ 85 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHKV 85 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCC---CceEE
Confidence 56889999999999999999999889999999997543 233567889999999999999999999876432 33679
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeee----cCCCce
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL----DDYMTA 780 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll----~~~~~~ 780 (949)
+||||+++++|.+++.... ....+++.+++.++.|++.||+|||++ +|+||||||+||++ +.++.+
T Consensus 86 lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~ 155 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPS-------NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVY 155 (319)
T ss_dssp EEEECCTTCBHHHHHHSGG-------GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEE
T ss_pred EEEeCCCCCCHHHHHHHhc-------cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceE
Confidence 9999999999999997321 223489999999999999999999988 99999999999999 788889
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccC--------CCccCCccchHHHHHHHHHHHhCCCCCccccccCc-
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGV--------GCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDI- 851 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~- 851 (949)
||+|||+++......... ...||..|+|||++. +..++.++|||||||++|||++|+.||........
T Consensus 156 kL~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 232 (319)
T 4euu_A 156 KLTDFGAARELEDDEQFV---SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232 (319)
T ss_dssp EECCCTTCEECCTTCCBC---CCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC
T ss_pred EEccCCCceecCCCCcee---ecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh
Confidence 999999998876544322 345999999999875 56789999999999999999999999964322111
Q ss_pred -hhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 039533 852 -NLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQS 930 (949)
Q Consensus 852 -~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 930 (949)
..........+......+......... ... ...............+.+++.+|++.||++|||++|+++...+
T Consensus 233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~--~~~----~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d 306 (319)
T 4euu_A 233 KEVMYKIITGKPSGAISGVQKAENGPID--WSG----DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (319)
T ss_dssp HHHHHHHHHHCCTTCCEEEECSTTCCEE--EES----SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHhcCCCcccchhhhcccCCccc--cCc----cCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence 111111111111100000000000000 000 0000001124567788999999999999999999999998876
Q ss_pred h
Q 039533 931 I 931 (949)
Q Consensus 931 i 931 (949)
.
T Consensus 307 ~ 307 (319)
T 4euu_A 307 I 307 (319)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=362.55 Aligned_cols=290 Identities=21% Similarity=0.301 Sum_probs=206.5
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHH--HHhcCCCcceeEEeeeecccccCCcc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKA--LKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
.++|++.+.||+|+||.||+|+. +++.||||+++... ...+..|.++ +..++||||+++++++......+...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 46899999999999999999987 47999999997443 2344444444 45589999999998776555555667
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCC------CCCeEecCCCCCCeeecC
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDC------QPVTAHCDLKPSNVLLDD 776 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~------~~~ivHrDlkp~NIll~~ 776 (949)
.++||||+++|+|.+++.. ...++..+..++.|++.||+|||+.+ .++|+||||||+||+++.
T Consensus 87 ~~lv~e~~~~g~L~~~l~~-----------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~ 155 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSL-----------HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKN 155 (336)
T ss_dssp EEEEECCCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECT
T ss_pred EEEEEecCCCCcHHHHHhh-----------cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcC
Confidence 8999999999999999962 33588899999999999999999652 228999999999999999
Q ss_pred CCceEEeecccceecCCCCC------ccccccccCccCccCccccCC-------CccCCccchHHHHHHHHHHHhCCCCC
Q 039533 777 YMTARVGDFGLARILSPDHT------QTSSFSVKGSLGYIAPEYGVG-------CEVSTNGDVYSYGILLLELVIGKKPI 843 (949)
Q Consensus 777 ~~~~kl~DfG~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDiwSlGvvl~elltg~~Pf 843 (949)
++.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||
T Consensus 156 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp TSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred CCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence 99999999999987654321 111223469999999999887 45778999999999999999998776
Q ss_pred ccccccCchhhhhcccc-CCC---chhhhcc-cCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCC
Q 039533 844 DIMFEGDINLHNFGRKA-LPD---DVMDIVD-SSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDR 918 (949)
Q Consensus 844 ~~~~~~~~~~~~~~~~~-~~~---~~~~~~d-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 918 (949)
............+.... ... .....+. ....+.. ...+.....++..+.+++.+||+.||++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~l~~li~~cl~~dP~~R 303 (336)
T 3g2f_A 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKF------------PEAWKENSLAVRSLKETIEDCWDQDAEAR 303 (336)
T ss_dssp STTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCC------------CTTCCCCSHHHHHHHHHHHHHSCSSGGGS
T ss_pred CCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCC------------CcccccccchHHHHHHHHHHHhcCChhhC
Confidence 43221111000000000 000 0000000 0000000 01111112456789999999999999999
Q ss_pred CCHHHHHHHHHHhHHhhccCCCCC
Q 039533 919 TNMTNVVHELQSIKNILLGVELCP 942 (949)
Q Consensus 919 Ps~~ev~~~L~~i~~~~~~~~~~~ 942 (949)
||++||++.|+++...+.+....+
T Consensus 304 ps~~e~l~~L~~ll~~~~~~~~~~ 327 (336)
T 3g2f_A 304 LTAQXAEERMAELMMIWERNKSVS 327 (336)
T ss_dssp CCHHHHHHHHHHHHHCCCC-----
T ss_pred cchHHHHHHHHHHHHHHHhcccCC
Confidence 999999999999999888775443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=363.70 Aligned_cols=250 Identities=24% Similarity=0.284 Sum_probs=197.6
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecC---CCcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccC
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ---HHGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRG 699 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 699 (949)
..++|++.++||+|+||.||+|++..+++.||||+++.. .....+.+.+|..+++++ +||||+++++++...+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~--- 97 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD--- 97 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS---
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC---
Confidence 457899999999999999999999989999999999743 223346788999999998 7999999999976544
Q ss_pred CccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCc
Q 039533 700 NDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMT 779 (949)
Q Consensus 700 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~ 779 (949)
..++||||+++|+|.+++. ....+++..++.++.|++.||+|||++ +|+||||||+|||++.+++
T Consensus 98 --~~~lv~E~~~gg~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ 162 (353)
T 3txo_A 98 --RLFFVMEFVNGGDLMFHIQ----------KSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGH 162 (353)
T ss_dssp --EEEEEEECCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSC
T ss_pred --EEEEEEeCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCC
Confidence 7899999999999999996 235689999999999999999999987 9999999999999999999
Q ss_pred eEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 780 ARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 780 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
+||+|||+|+........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .
T Consensus 163 ikL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--~------ 232 (353)
T 3txo_A 163 CKLADFGMCKEGICNGVT--TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD--L------ 232 (353)
T ss_dssp EEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H------
T ss_pred EEEccccceeecccCCcc--ccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH--H------
Confidence 999999999864333222 224569999999999998889999999999999999999999996432111 0
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCH------HHHHH
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNM------TNVVH 926 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~ev~~ 926 (949)
...+....... + ...+..+.+++.+|++.||++||++ .|+++
T Consensus 233 -----~~~i~~~~~~~-p-------------------~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 233 -----FEAILNDEVVY-P-------------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -----HHHHHHCCCCC-C-------------------TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -----HHHHHcCCCCC-C-------------------CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 00111111000 0 0123457889999999999999998 66654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=361.35 Aligned_cols=251 Identities=22% Similarity=0.314 Sum_probs=201.0
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
.++|.+.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++...+
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----- 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE----- 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-----
Confidence 367899999999999999999999999999999996432 334567889999999999999999999976554
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 89 ~~~lv~e~~~gg~L~~~l~----------~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vk 155 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQ----------QNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVH 155 (384)
T ss_dssp EEEEEECCCTTEEHHHHHH----------TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEE
T ss_pred EEEEEEecCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEE
Confidence 7899999999999999996 234689999999999999999999988 999999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCC---CccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcc
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG---CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGR 858 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~ 858 (949)
|+|||+|+........ ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .
T Consensus 156 L~DFG~a~~~~~~~~~---~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~--~--- 227 (384)
T 4fr4_A 156 ITDFNIAAMLPRETQI---TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK--E--- 227 (384)
T ss_dssp ECCCTTCEECCTTCCB---CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHH--H---
T ss_pred EeccceeeeccCCCce---eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHH--H---
Confidence 9999999887544332 24569999999999874 45899999999999999999999999633211100 0
Q ss_pred ccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC-HHHHHH
Q 039533 859 KALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTN-MTNVVH 926 (949)
Q Consensus 859 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~ev~~ 926 (949)
....+.......+ ...+..+.+++.+|++.||++||+ +++|.+
T Consensus 228 ------~~~~~~~~~~~~p-------------------~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 228 ------IVHTFETTVVTYP-------------------SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ------HHHHHHHCCCCCC-------------------TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ------HHHHHhhcccCCC-------------------CcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0000000000001 122456789999999999999998 666543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=364.54 Aligned_cols=275 Identities=23% Similarity=0.340 Sum_probs=214.7
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcC-------CCEEEEEEEEecCCC-cchHHHHHHHHHHHhc-CCCcceeEEeeeecc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDE-------GRTTIAVKVFNLQHH-GASRSFIAECKALKSI-RHRNLVKVLTACLGA 695 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 695 (949)
.++|.+.+.||+|+||.||+|++.. .+..||||+++.... ...+++.+|+++++++ +||||+++++++...
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 4678889999999999999999742 346899999975433 2346789999999999 899999999997654
Q ss_pred cccCCccceeEeeeccCCChhhhcCCCCCCC------ccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 039533 696 DYRGNDFKASVYEFMHYGSLEEWLHPFTGED------EIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKP 769 (949)
Q Consensus 696 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp 769 (949)
+ ..++||||+++|+|.+++....... ........+++.+++.|+.|++.||+|||++ +|+||||||
T Consensus 148 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp 219 (382)
T 3tt0_A 148 G-----PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA 219 (382)
T ss_dssp S-----SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred C-----ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCc
Confidence 4 7899999999999999997432110 0011234699999999999999999999987 999999999
Q ss_pred CCeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccc
Q 039533 770 SNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFE 848 (949)
Q Consensus 770 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~ 848 (949)
+||+++.++.+||+|||+|+...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~ 299 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987765443333334457899999999999999999999999999999999 9999864321
Q ss_pred cCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 039533 849 GDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHEL 928 (949)
Q Consensus 849 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 928 (949)
.. . .+.+........ ...++..+.+++.+||+.||++|||++||++.|
T Consensus 300 ~~--~------------~~~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 347 (382)
T 3tt0_A 300 EE--L------------FKLLKEGHRMDK------------------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347 (382)
T ss_dssp HH--H------------HHHHHTTCCCCC------------------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HH--H------------HHHHHcCCCCCC------------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 10 1 111111000000 012345688999999999999999999999999
Q ss_pred HHhHHhhccCC
Q 039533 929 QSIKNILLGVE 939 (949)
Q Consensus 929 ~~i~~~~~~~~ 939 (949)
+++.......+
T Consensus 348 ~~~~~~~~~~~ 358 (382)
T 3tt0_A 348 DRIVALTSNQE 358 (382)
T ss_dssp HHHHHHSCSCC
T ss_pred HHHHHHHhcCC
Confidence 99987765543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=354.93 Aligned_cols=282 Identities=22% Similarity=0.301 Sum_probs=190.0
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
..++|++.+.||+|+||.||+|.+..+++.||+|+++.... ...+.+.+|++++++++||||+++++++...+ .
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~ 77 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTEN-----K 77 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTT-----E
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECC-----e
Confidence 35689999999999999999999998899999999975432 34467889999999999999999999976543 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||++ |+|.+++..... ......+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 78 ~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl 149 (317)
T 2pmi_A 78 LTLVFEFMD-NDLKKYMDSRTV----GNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKL 149 (317)
T ss_dssp EEEEEECCC-CBHHHHHHHHHS----SSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEE
T ss_pred EEEEEEecC-CCHHHHHHhccc----cccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEE
Confidence 899999998 599998862211 11234589999999999999999999987 9999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCch--hhhhccc
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDIN--LHNFGRK 859 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~--~~~~~~~ 859 (949)
+|||+++......... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+.. .......
T Consensus 150 ~Dfg~~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~ 227 (317)
T 2pmi_A 150 GDFGLARAFGIPVNTF--SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGT 227 (317)
T ss_dssp CCCSSCEETTSCCCCC--CCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred CcCccceecCCCcccC--CCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 9999998765432221 134589999999998764 5899999999999999999999999643221100 0000000
Q ss_pred cCCCchhhh-----cccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 860 ALPDDVMDI-----VDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 860 ~~~~~~~~~-----~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
......... ..+............. .........+..+.+++.+|++.||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 228 PNESLWPSVTKLPKYNPNIQQRPPRDLRQV------LQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CCTTTCGGGGGCTTCCTTCCCCCCCCSHHH------HGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CChhHhhhhhhhhhcccccccccchhHHHh------hcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000000000 0000000000000000 000000123456889999999999999999999875
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=369.34 Aligned_cols=261 Identities=19% Similarity=0.229 Sum_probs=205.8
Q ss_pred HHHHHHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeec
Q 039533 618 YQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLG 694 (949)
Q Consensus 618 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 694 (949)
+.++....++|.+.++||+|+||.||+|++..+++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3455566789999999999999999999999899999999996421 2233568899999999999999999999765
Q ss_pred ccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeee
Q 039533 695 ADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL 774 (949)
Q Consensus 695 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll 774 (949)
.+ ..++||||+++|+|.+++. ...+++..+..++.|++.||+|||++ +|+||||||+||++
T Consensus 141 ~~-----~~~lV~E~~~gg~L~~~l~-----------~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl 201 (410)
T 3v8s_A 141 DR-----YLYMVMEYMPGGDLVNLMS-----------NYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLL 201 (410)
T ss_dssp SS-----EEEEEECCCTTEEHHHHHH-----------HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred CC-----EEEEEEeCCCCCcHHHHHH-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeE
Confidence 44 7899999999999999986 23488999999999999999999987 99999999999999
Q ss_pred cCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCc----cCCccchHHHHHHHHHHHhCCCCCccccccC
Q 039533 775 DDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCE----VSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850 (949)
Q Consensus 775 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~ 850 (949)
+.++++||+|||+|+........ ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.......
T Consensus 202 ~~~g~ikL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~ 280 (410)
T 3v8s_A 202 DKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 280 (410)
T ss_dssp CTTSCEEECCCTTCEECCTTSEE-ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred CCCCCEEEeccceeEeeccCCcc-cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh
Confidence 99999999999999876554322 122456999999999987655 8899999999999999999999996321110
Q ss_pred chhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCC--CCCHHHHHHH
Q 039533 851 INLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQD--RTNMTNVVHE 927 (949)
Q Consensus 851 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~ev~~~ 927 (949)
.+ ..++... ....++.....+..+.+++.+|++.+|++ ||+++||++.
T Consensus 281 -~~------------~~i~~~~----------------~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 281 -TY------------SKIMNHK----------------NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp -HH------------HHHHTHH----------------HHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred -HH------------HHHHhcc----------------ccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 00 0000000 00000000122456789999999999998 9999999863
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=369.70 Aligned_cols=254 Identities=26% Similarity=0.363 Sum_probs=204.9
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|++++++++||||+++++++...+ ...+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~~ 263 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLY 263 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT----SCEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC----CceE
Confidence 456888899999999999999986 7899999997543 4578999999999999999999999975432 3689
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++|+|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 264 iv~e~~~~g~L~~~l~~~--------~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~D 332 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSR--------GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSD 332 (450)
T ss_dssp EEEECCTTCBHHHHHHHH--------CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEEecCCCcHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEee
Confidence 999999999999999721 123478999999999999999999988 899999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCC
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
||+++....... ...++..|+|||++.+..++.++|||||||++|||+| |+.||......+ .
T Consensus 333 fG~a~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~---------- 395 (450)
T 1k9a_A 333 FGLTKEASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--V---------- 395 (450)
T ss_dssp CTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--H----------
T ss_pred CCCccccccccc-----CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--H----------
Confidence 999986543221 2247889999999999999999999999999999998 999996432211 0
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHh
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNI 934 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 934 (949)
...+...... +.+..++..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 396 --~~~i~~~~~~------------------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 396 --VPRVEKGYKM------------------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp --HHHHHTTCCC------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --HHHHHcCCCC------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 0111000000 00113456788999999999999999999999999998764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=354.68 Aligned_cols=276 Identities=24% Similarity=0.400 Sum_probs=201.6
Q ss_pred HHhcCCCCCCeeeeecCceEEEEEEcC---CCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccc
Q 039533 623 NATSGFSSANLVGVGSFGSVYKGIIDE---GRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADY 697 (949)
Q Consensus 623 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 697 (949)
...++|.+.+.||+|+||.||+|.+.. +++.||+|+++.... ...+.+.+|+.++++++||||+++++++...+.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 345678888999999999999998864 456899999875432 234678999999999999999999999876553
Q ss_pred cCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCC
Q 039533 698 RGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDY 777 (949)
Q Consensus 698 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~ 777 (949)
.+....++||||+++++|.+++..... ......+++..++.++.|++.||.|||++ +|+||||||+||+++.+
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRL----ETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD 183 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTB----TTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTT
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhh----hcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC
Confidence 334456999999999999999842111 12345689999999999999999999977 99999999999999999
Q ss_pred CceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhh
Q 039533 778 MTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNF 856 (949)
Q Consensus 778 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~ 856 (949)
+.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..||....... ...
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~- 260 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE--MYD- 260 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHH-
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH--HHH-
Confidence 9999999999987654433222223457889999999999899999999999999999999 889986432111 000
Q ss_pred ccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhhc
Q 039533 857 GRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILL 936 (949)
Q Consensus 857 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~ 936 (949)
.+........+ ..++..+.+++.+|++.||++|||+.|+++.|+++.+.+.
T Consensus 261 ----------~~~~~~~~~~~-------------------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 261 ----------YLLHGHRLKQP-------------------EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp ----------HHHTTCCCCCB-------------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred ----------HHHcCCCCCCC-------------------ccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 00000000000 1234568899999999999999999999999999988764
Q ss_pred c
Q 039533 937 G 937 (949)
Q Consensus 937 ~ 937 (949)
+
T Consensus 312 ~ 312 (313)
T 3brb_A 312 D 312 (313)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=368.77 Aligned_cols=241 Identities=21% Similarity=0.199 Sum_probs=152.9
Q ss_pred CCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecccccccccCCCCCCCC
Q 039533 310 IPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQC 389 (949)
Q Consensus 310 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 389 (949)
.+..|..+++|++|+|++|.+++..|..|.++++|+.|+|++|++++..+..|.++++|+.|+|++|.+.+..+..|..+
T Consensus 120 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l 199 (477)
T 2id5_A 120 LDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRL 199 (477)
T ss_dssp CTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSC
T ss_pred ChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccC
Confidence 33344444455555555555544444455555555555555555554433445555555555555555555555555566
Q ss_pred CCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccCCcccccccchhhcc
Q 039533 390 ESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLG 469 (949)
Q Consensus 390 ~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 469 (949)
++|++|++++|++.+.+|...+...+| +.|++++|++++..+..+..+++|+.|+|++|++++..+..|..+++|+.|+
T Consensus 200 ~~L~~L~l~~~~~~~~~~~~~~~~~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 278 (477)
T 2id5_A 200 YRLKVLEISHWPYLDTMTPNCLYGLNL-TSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQ 278 (477)
T ss_dssp TTCCEEEEECCTTCCEECTTTTTTCCC-SEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEE
T ss_pred cccceeeCCCCccccccCcccccCccc-cEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEE
Confidence 666666666665555555555555555 5666666666644445677777888888888888777777788888888888
Q ss_pred cCccccccccCCCcCCCCCCCEEECCCCcCCCcCcccccCCc-cceEeCCCCcCcCcccccccccccccccccCCCCCCC
Q 039533 470 MGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLS-LNNLNLSYNDLEGMVTTEGVFKNASATRILGNSKLCG 548 (949)
Q Consensus 470 l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~l~ls~N~l~~~~~~~~~~~~~~~~~~~gn~~~c~ 548 (949)
|++|++++..|..|..+++|+.|+|++|+|++..+..+..++ |+.|+|++|++.+..+....+.......+.++...|.
T Consensus 279 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~ 358 (477)
T 2id5_A 279 LVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCA 358 (477)
T ss_dssp CCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEE
T ss_pred CCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeC
Confidence 888888877788888888888888888888877776766665 8888888888877654433333334455666666675
Q ss_pred CCC
Q 039533 549 GIS 551 (949)
Q Consensus 549 ~~~ 551 (949)
.|.
T Consensus 359 ~p~ 361 (477)
T 2id5_A 359 TPE 361 (477)
T ss_dssp ESG
T ss_pred Cch
Confidence 543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=350.95 Aligned_cols=260 Identities=27% Similarity=0.384 Sum_probs=200.2
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
++|++.+.||+|+||.||+|++. ++.||||++... ...+.+.+|++++++++||||+++++++.+ ..++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------~~~l 76 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN-------PVCL 76 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT-------TTEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-------CcEE
Confidence 56888999999999999999986 789999998533 345789999999999999999999998642 4799
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCc-eEEee
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMT-ARVGD 784 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~-~kl~D 784 (949)
||||+++|+|.+++.... ....+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|
T Consensus 77 v~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~D 149 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAE-------PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICD 149 (307)
T ss_dssp EEECCTTCBHHHHHHCSS-------SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECC
T ss_pred EEEcCCCCCHHHHHhccC-------CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcc
Confidence 999999999999997321 1234788999999999999999999842248999999999999998886 79999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCc
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
||.+........ ...||+.|+|||++.+..++.++||||||+++|||++|+.||+..............
T Consensus 150 fg~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~------ 218 (307)
T 2eva_A 150 FGTACDIQTHMT-----NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH------ 218 (307)
T ss_dssp CCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHH------
T ss_pred cccccccccccc-----cCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHh------
Confidence 999976543221 235899999999999999999999999999999999999999643221111100000
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhhccC
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILLGV 938 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~~ 938 (949)
....... ...++..+.+++.+|++.||++|||++|+++.|+++.......
T Consensus 219 -----~~~~~~~-------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 268 (307)
T 2eva_A 219 -----NGTRPPL-------------------IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA 268 (307)
T ss_dssp -----TTCCCCC-------------------BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCT
T ss_pred -----cCCCCCc-------------------ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCC
Confidence 0000000 0123456789999999999999999999999999998876554
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=367.07 Aligned_cols=349 Identities=28% Similarity=0.388 Sum_probs=291.6
Q ss_pred cCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccE
Q 039533 110 GGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHT 189 (949)
Q Consensus 110 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 189 (949)
..+++|+.|++++|.+. .+|. +..+++|++|++++|.+++..+ |..+++|++|+|++|.+++..| ++++++|++
T Consensus 43 ~~l~~l~~L~l~~~~i~-~l~~-~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~ 116 (466)
T 1o6v_A 43 TDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTG 116 (466)
T ss_dssp HHHHTCCEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred hHhccccEEecCCCCCc-cCcc-hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCE
Confidence 45789999999999998 5664 8889999999999999887765 8889999999999999986555 888899999
Q ss_pred EeccccccCCCCCCcccCCCccccccccCcccccccccccCCCCChhhhccccccccccCCCCCCCCCCcchhccccccC
Q 039533 190 ISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNAT 269 (949)
Q Consensus 190 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~ 269 (949)
|+|++|++++..+ +..+++|++|++++|.++.++ . +..++
T Consensus 117 L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~--------~------------------------------~~~l~ 156 (466)
T 1o6v_A 117 LTLFNNQITDIDP--LKNLTNLNRLELSSNTISDIS--------A------------------------------LSGLT 156 (466)
T ss_dssp EECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCG--------G------------------------------GTTCT
T ss_pred EECCCCCCCCChH--HcCCCCCCEEECCCCccCCCh--------h------------------------------hccCC
Confidence 9999998885533 888888888888888765432 2 33345
Q ss_pred cccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEec
Q 039533 270 RLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGL 349 (949)
Q Consensus 270 ~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 349 (949)
+|+.|+++ |.+.+..+ +..+ ++|++|++++|++++. ..+..+++|++|++++|.+++..| ++.+++|+.|++
T Consensus 157 ~L~~L~l~-~~~~~~~~--~~~l-~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l 228 (466)
T 1o6v_A 157 SLQQLSFG-NQVTDLKP--LANL-TTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSL 228 (466)
T ss_dssp TCSEEEEE-ESCCCCGG--GTTC-TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEEC
T ss_pred cccEeecC-CcccCchh--hccC-CCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEEC
Confidence 55566664 34443322 5555 4699999999999854 348899999999999999997666 788999999999
Q ss_pred CCcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCC
Q 039533 350 NRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTG 429 (949)
Q Consensus 350 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~ 429 (949)
++|++++. +.+..+++|+.|++++|.+++..| +..+++|++|++++|++++..| +..+++| +.|++++|++++
T Consensus 229 ~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L-~~L~L~~n~l~~ 301 (466)
T 1o6v_A 229 NGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTAL-TNLELNENQLED 301 (466)
T ss_dssp CSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTC-SEEECCSSCCSC
T ss_pred CCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCcc-CeEEcCCCcccC
Confidence 99999854 468999999999999999997665 8899999999999999996444 8888999 899999999997
Q ss_pred CCccccccccccceeeeccccccccCCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCcCcccccC
Q 039533 430 SLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAG 509 (949)
Q Consensus 430 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 509 (949)
..| +..+++|+.|+|++|++++..| ++.+++|+.|++++|++++. ..+..+++|+.|++++|++++.+| +..
T Consensus 302 ~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~ 373 (466)
T 1o6v_A 302 ISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LAN 373 (466)
T ss_dssp CGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTT
T ss_pred chh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhc
Confidence 655 8899999999999999997766 88999999999999999976 579999999999999999998888 555
Q ss_pred Cc-cceEeCCCCcCcCccc
Q 039533 510 LS-LNNLNLSYNDLEGMVT 527 (949)
Q Consensus 510 ~~-L~~l~ls~N~l~~~~~ 527 (949)
++ |+.|++++|++++.+.
T Consensus 374 l~~L~~L~l~~n~~~~~p~ 392 (466)
T 1o6v_A 374 LTRITQLGLNDQAWTNAPV 392 (466)
T ss_dssp CTTCCEEECCCEEEECCCB
T ss_pred CCCCCEEeccCCcccCCch
Confidence 55 9999999999999643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=360.55 Aligned_cols=275 Identities=23% Similarity=0.314 Sum_probs=207.9
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEc-----CCCEEEEEEEEecCC-CcchHHHHHHHHHHHhc-CCCcceeEEeeeeccc
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIID-----EGRTTIAVKVFNLQH-HGASRSFIAECKALKSI-RHRNLVKVLTACLGAD 696 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 696 (949)
..++|.+.+.||+|+||.||+|++. .+++.||||+++... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 3468899999999999999999972 356789999997442 23457899999999999 8999999999976544
Q ss_pred ccCCccceeEeeeccCCChhhhcCCCCCCC-------------ccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 039533 697 YRGNDFKASVYEFMHYGSLEEWLHPFTGED-------------EIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTA 763 (949)
Q Consensus 697 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------------~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~iv 763 (949)
..++||||+++|+|.+++....... ........+++..++.++.|++.||+|||++ +|+
T Consensus 123 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv 194 (344)
T 1rjb_A 123 -----PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCV 194 (344)
T ss_dssp -----SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred -----ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 7899999999999999997432110 0001124589999999999999999999987 999
Q ss_pred ecCCCCCCeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCC
Q 039533 764 HCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKP 842 (949)
Q Consensus 764 HrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~P 842 (949)
||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |..|
T Consensus 195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999999987655443333334457889999999988889999999999999999998 9999
Q ss_pred CccccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHH
Q 039533 843 IDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMT 922 (949)
Q Consensus 843 f~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 922 (949)
|....... .. ...+........ ...++..+.+++.+||+.||++|||+.
T Consensus 275 ~~~~~~~~-~~------------~~~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ 323 (344)
T 1rjb_A 275 YPGIPVDA-NF------------YKLIQNGFKMDQ------------------PFYATEEIYIIMQSCWAFDSRKRPSFP 323 (344)
T ss_dssp STTCCCSH-HH------------HHHHHTTCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred cccCCcHH-HH------------HHHHhcCCCCCC------------------CCCCCHHHHHHHHHHcCCCchhCcCHH
Confidence 96432111 11 111111111000 012245688999999999999999999
Q ss_pred HHHHHHHHhHHhhcc
Q 039533 923 NVVHELQSIKNILLG 937 (949)
Q Consensus 923 ev~~~L~~i~~~~~~ 937 (949)
|+++.|+.+.+...+
T Consensus 324 ~l~~~l~~~~~~~~~ 338 (344)
T 1rjb_A 324 NLTSFLGCQLADAEE 338 (344)
T ss_dssp HHHHHHHHHC-----
T ss_pred HHHHHHHHHHHHHHH
Confidence 999999998766543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=360.05 Aligned_cols=259 Identities=24% Similarity=0.359 Sum_probs=202.9
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEE----EEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTT----IAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
++|++.+.||+|+||.||+|++..+++. ||+|++.... ....+.+.+|+.++++++||||+++++++..
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------ 86 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG------ 86 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB------
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC------
Confidence 5788899999999999999999766654 7788775332 2334567889999999999999999998742
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
...++||||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~ 154 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQ---------HRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQV 154 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHS---------SGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCE
T ss_pred CccEEEEEeCCCCCHHHHHHH---------ccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeE
Confidence 257899999999999999962 234588889999999999999999988 89999999999999999999
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccc
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~ 859 (949)
||+|||+++...............||..|+|||++.+..++.++|||||||++|||+| |+.||....... ..
T Consensus 155 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~----- 227 (325)
T 3kex_A 155 QVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--VP----- 227 (325)
T ss_dssp EECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--HH-----
T ss_pred EECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--HH-----
Confidence 9999999998765544333334568889999999998899999999999999999999 999996432111 11
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHh
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNI 934 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 934 (949)
+.+........ ...++..+.+++.+||+.||++|||++|+++.|+++...
T Consensus 228 -------~~~~~~~~~~~------------------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 228 -------DLLEKGERLAQ------------------PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp -------HHHHTTCBCCC------------------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred -------HHHHcCCCCCC------------------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11110000000 001223467899999999999999999999999998654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=346.89 Aligned_cols=254 Identities=27% Similarity=0.404 Sum_probs=192.5
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC----cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH----GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
.++|++.+.||+|+||.||+|.+. ++.||||+++.... ...+.+.+|++++++++||||+++++++...+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 79 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP---- 79 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-----
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC----
Confidence 467889999999999999999986 78999999864432 22467899999999999999999999976544
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC----
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD---- 776 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~---- 776 (949)
..++||||+++++|.+++. ...+++..+..++.|++.||+|||++...+|+||||||+||+++.
T Consensus 80 -~~~lv~e~~~~~~L~~~~~-----------~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~ 147 (271)
T 3dtc_A 80 -NLCLVMEFARGGPLNRVLS-----------GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVEN 147 (271)
T ss_dssp --CEEEEECCTTEEHHHHHT-----------SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSS
T ss_pred -ceEEEEEcCCCCCHHHHhh-----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccc
Confidence 7899999999999999985 245899999999999999999999882223999999999999986
Q ss_pred ----CCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCch
Q 039533 777 ----YMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDIN 852 (949)
Q Consensus 777 ----~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~ 852 (949)
++.+||+|||.++........ ...||+.|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 148 ~~~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 223 (271)
T 3dtc_A 148 GDLSNKILKITDFGLAREWHRTTKM----SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA 223 (271)
T ss_dssp SCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH
T ss_pred ccccCcceEEccCCccccccccccc----CCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 778999999999876543322 345899999999998888999999999999999999999999643211110
Q ss_pred hhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHh
Q 039533 853 LHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSI 931 (949)
Q Consensus 853 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 931 (949)
. ........... ...++..+.+++.+|++.||++|||+.|+++.|++|
T Consensus 224 ~-------------~~~~~~~~~~~------------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 224 Y-------------GVAMNKLALPI------------------PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp H-------------HHHTSCCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred H-------------hhhcCCCCCCC------------------CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0 00000000000 012345688999999999999999999999999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=352.77 Aligned_cols=246 Identities=22% Similarity=0.233 Sum_probs=201.1
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
.++|++.+.||+|+||.||+|+...+++.||+|+++... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~----- 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ----- 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS-----
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCC-----
Confidence 467899999999999999999999899999999997432 233467889999999999999999999976544
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 80 ~~~lv~e~~~gg~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~k 146 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLR----------KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIK 146 (318)
T ss_dssp EEEEEECCCCSCBHHHHHH----------HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEE
T ss_pred EEEEEEeCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEE
Confidence 7899999999999999996 234589999999999999999999977 999999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
|+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .
T Consensus 147 L~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~----- 211 (318)
T 1fot_A 147 ITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-----T----- 211 (318)
T ss_dssp ECCCSSCEECSSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-----H-----
T ss_pred EeecCcceecCCcc-----ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-----H-----
Confidence 99999998754321 23569999999999999999999999999999999999999996321110 0
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRT-----NMTNVVH 926 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~ 926 (949)
...+....... + ...+..+.+++.+|++.||++|| +++|+++
T Consensus 212 ---~~~i~~~~~~~-p-------------------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 212 ---YEKILNAELRF-P-------------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ---HHHHHHCCCCC-C-------------------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ---HHHHHhCCCCC-C-------------------CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 01111111100 0 01234578999999999999999 8888874
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=355.67 Aligned_cols=272 Identities=24% Similarity=0.357 Sum_probs=212.2
Q ss_pred hcCCCCCCeeeeecCceEEEEEE-----cCCCEEEEEEEEecCCC-cchHHHHHHHHHHHhc-CCCcceeEEeeeecccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGII-----DEGRTTIAVKVFNLQHH-GASRSFIAECKALKSI-RHRNLVKVLTACLGADY 697 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 697 (949)
.++|++.+.||+|+||.||+|++ ..+++.||||+++.... ...+.+.+|+.+++++ +||||+++++++...+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~- 100 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG- 100 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC-
Confidence 46788999999999999999986 34678999999975443 2346789999999999 9999999999976544
Q ss_pred cCCccceeEeeeccCCChhhhcCCCCCCC--------ccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 039533 698 RGNDFKASVYEFMHYGSLEEWLHPFTGED--------EIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKP 769 (949)
Q Consensus 698 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp 769 (949)
..++||||+++|+|.+++....... ........+++.+++.++.|++.||+|||++ +|+||||||
T Consensus 101 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp 173 (313)
T 1t46_A 101 ----PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA 173 (313)
T ss_dssp ----SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred ----CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCcc
Confidence 7899999999999999997432110 0011233589999999999999999999987 999999999
Q ss_pred CCeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccc
Q 039533 770 SNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFE 848 (949)
Q Consensus 770 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~ 848 (949)
+||+++.++.+||+|||.++...............||+.|+|||++.+..++.++||||||+++|||+| |+.||.....
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 999999999999999999988765544333334457889999999988889999999999999999999 9999864322
Q ss_pred cCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 039533 849 GDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHEL 928 (949)
Q Consensus 849 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 928 (949)
.. .. ...+........ ....+..+.+++.+|++.||++|||+.|+++.|
T Consensus 254 ~~-~~------------~~~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 302 (313)
T 1t46_A 254 DS-KF------------YKMIKEGFRMLS------------------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302 (313)
T ss_dssp SH-HH------------HHHHHHTCCCCC------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hh-HH------------HHHhccCCCCCC------------------cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 11 01 111111100000 012345688999999999999999999999999
Q ss_pred HHhHHhh
Q 039533 929 QSIKNIL 935 (949)
Q Consensus 929 ~~i~~~~ 935 (949)
+++....
T Consensus 303 ~~~~~~~ 309 (313)
T 1t46_A 303 EKQISES 309 (313)
T ss_dssp HHHHHHT
T ss_pred HHHHHHh
Confidence 9987764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=359.16 Aligned_cols=251 Identities=22% Similarity=0.287 Sum_probs=200.6
Q ss_pred HHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhc-CCCcceeEEeeeecccc
Q 039533 622 YNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSI-RHRNLVKVLTACLGADY 697 (949)
Q Consensus 622 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 697 (949)
....++|.+.+.||+|+||.||+|++..+++.||||+++... ....+.+..|..++.++ +||||+++++++...+
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~- 91 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE- 91 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS-
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC-
Confidence 345678999999999999999999999899999999997532 23446788899999987 8999999999976544
Q ss_pred cCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCC
Q 039533 698 RGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDY 777 (949)
Q Consensus 698 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~ 777 (949)
..++||||+++|+|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 92 ----~~~lv~E~~~gg~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~ 154 (345)
T 1xjd_A 92 ----NLFFVMEYLNGGDLMYHIQ----------SCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKD 154 (345)
T ss_dssp ----EEEEEEECCTTCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTT
T ss_pred ----EEEEEEeCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCC
Confidence 7899999999999999996 234689999999999999999999988 99999999999999999
Q ss_pred CceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhc
Q 039533 778 MTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFG 857 (949)
Q Consensus 778 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~ 857 (949)
+++||+|||+|+........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...
T Consensus 155 g~vkL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~-- 228 (345)
T 1xjd_A 155 GHIKIADFGMCKENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--LFH-- 228 (345)
T ss_dssp SCEEECCCTTCBCCCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH--
T ss_pred CCEEEeEChhhhhcccCCCc--ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH--HHH--
Confidence 99999999999865333222 224569999999999999999999999999999999999999996432110 000
Q ss_pred cccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHH-HHH
Q 039533 858 RKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMT-NVV 925 (949)
Q Consensus 858 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-ev~ 925 (949)
.+..... ..+ ...+..+.+++.+|++.||++||++. |+.
T Consensus 229 ---------~i~~~~~-~~p-------------------~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 229 ---------SIRMDNP-FYP-------------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ---------HHHHCCC-CCC-------------------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ---------HHHhCCC-CCC-------------------cccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 0000000 000 01234578899999999999999997 554
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=349.66 Aligned_cols=258 Identities=24% Similarity=0.371 Sum_probs=204.5
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.++|++.+.||+|+||.||+|.+. ++..||+|+++.... ..+++.+|++++++++||||+++++++.... ..+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 95 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR-----PIF 95 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-----SEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCC-----CeE
Confidence 467888999999999999999987 678899999975433 3467999999999999999999999975443 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++++|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 96 lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~D 163 (283)
T 3gen_A 96 IITEYMANGCLLNYLRE---------MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSD 163 (283)
T ss_dssp EEECCCTTCBHHHHHHC---------GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECS
T ss_pred EEEeccCCCcHHHHHHH---------hccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcc
Confidence 99999999999999962 234589999999999999999999987 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCC
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
||.++....... .......+|+.|+|||++.+..++.++||||+|+++|||+| |+.||....... ...
T Consensus 164 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~--~~~-------- 232 (283)
T 3gen_A 164 FGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAE-------- 232 (283)
T ss_dssp TTGGGGBCCHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHH--------
T ss_pred cccccccccccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH--HHH--------
Confidence 999987644322 11223447788999999998889999999999999999998 999996432111 000
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHh
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNI 934 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 934 (949)
.+........+ ...+..+.+++.+||+.||++|||++|+++.|+++.+.
T Consensus 233 ---~~~~~~~~~~~-------------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 233 ---HIAQGLRLYRP-------------------HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp ---HHHTTCCCCCC-------------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHhcccCCCCC-------------------CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 00000000000 01234678999999999999999999999999998764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=354.56 Aligned_cols=271 Identities=23% Similarity=0.320 Sum_probs=207.1
Q ss_pred cCCCCCCeeeeecCceEEEEE----EcCCCEEEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 626 SGFSSANLVGVGSFGSVYKGI----IDEGRTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
.+|++.+.||+|+||.||+|+ ...+++.||||+++... ....+.+.+|++++++++||||+++++++...+ .
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~ 97 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG---G 97 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC---C
Confidence 457888999999999999999 45578999999997443 234478999999999999999999999987542 2
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
...++||||+++++|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~ 165 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPK---------NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQV 165 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHH---------HTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEE
T ss_pred ceEEEEEEeCCCCcHHHHHHh---------ccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCE
Confidence 467999999999999999952 234589999999999999999999987 99999999999999999999
Q ss_pred EEeecccceecCCCCCc-cccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 781 RVGDFGLARILSPDHTQ-TSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
||+|||+++........ .......||..|+|||++.+..++.++||||+|+++|||++|..|+......... ....
T Consensus 166 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~ 242 (302)
T 4e5w_A 166 KIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLK---MIGP 242 (302)
T ss_dssp EECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH---HHCS
T ss_pred EECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhh---ccCC
Confidence 99999999887655432 2222445888999999999889999999999999999999999987533211000 0000
Q ss_pred cCCC----chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhH
Q 039533 860 ALPD----DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIK 932 (949)
Q Consensus 860 ~~~~----~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 932 (949)
.... .....+.... +.+....++..+.+++.+||+.||++|||++|+++.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 243 THGQMTVTRLVNTLKEGK------------------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp CCGGGHHHHHHHHHHTTC------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccccCHHHHHHHHhccC------------------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 0000 0000010000 00011134567899999999999999999999999999875
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=351.94 Aligned_cols=270 Identities=22% Similarity=0.271 Sum_probs=199.1
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
.++|++.+.||+|+||+||+|++. +++.||+|+++.... ...+.+.+|++++++++||||+++++++.... .
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~ 93 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSER-----C 93 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS-----C
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC-----E
Confidence 478999999999999999999996 589999999974432 23467889999999999999999999975443 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++ +|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 94 ~~lv~e~~~~-~l~~~~~~---------~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl 160 (311)
T 3niz_A 94 LTLVFEFMEK-DLKKVLDE---------NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKL 160 (311)
T ss_dssp EEEEEECCSE-EHHHHHHT---------CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEE
T ss_pred EEEEEcCCCC-CHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEE
Confidence 8999999985 88887752 234589999999999999999999987 9999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCch--hhhhccc
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDIN--LHNFGRK 859 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~--~~~~~~~ 859 (949)
+|||+++......... ....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+.. .......
T Consensus 161 ~Dfg~a~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 238 (311)
T 3niz_A 161 ADFGLARAFGIPVRSY--THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGT 238 (311)
T ss_dssp CCCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCC
T ss_pred ccCcCceecCCCcccc--cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCC
Confidence 9999998865433222 23458999999999876 46899999999999999999999999754332211 0011111
Q ss_pred cCCCchhhh------cccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 860 ALPDDVMDI------VDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 860 ~~~~~~~~~------~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
..+...... .+....... .............++.+++.+|++.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 239 PNPREWPQVQELPLWKQRTFQVFE-----------KKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp CCTTTSGGGTTSHHHHSCCCCCCC-----------CCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CChHHhhhhhccchhhhccccccc-----------CCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 111111000 000000000 00000001123456789999999999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=349.23 Aligned_cols=260 Identities=22% Similarity=0.347 Sum_probs=196.1
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCC---CEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEG---RTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
.++|++.+.||+|+||.||+|.+..+ +..||+|+++.... ...+.+.+|+.++++++||||+++++++.+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------ 87 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------ 87 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc------
Confidence 46788999999999999999998643 46799999865432 234678999999999999999999998632
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
+..++||||+++++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 155 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQV---------RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCV 155 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHH---------TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEE
T ss_pred CccEEEEecCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCE
Confidence 257899999999999999962 234589999999999999999999987 99999999999999999999
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccc
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~ 859 (949)
||+|||+++......... .....+|+.|+|||++.+..++.++||||||+++|||++ |..||......+ ...
T Consensus 156 kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--~~~---- 228 (281)
T 1mp8_A 156 KLGDFGLSRYMEDSTYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIG---- 228 (281)
T ss_dssp EECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHH----
T ss_pred EECccccccccCcccccc-cccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--HHH----
Confidence 999999998765433221 123347789999999988889999999999999999997 999996432211 000
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhh
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNIL 935 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~ 935 (949)
.+......+.+ ..++..+.+++.+|++.||++|||+.|+++.|+++.+..
T Consensus 229 -------~i~~~~~~~~~-------------------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 229 -------RIENGERLPMP-------------------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp -------HHHTTCCCCCC-------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -------HHHcCCCCCCC-------------------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 00000000000 123456889999999999999999999999999987653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=358.09 Aligned_cols=252 Identities=21% Similarity=0.253 Sum_probs=187.5
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
..++|.+.+.||+|+||.||+|++..+++.||||+++... ..+.+.+|++++++++||||+++++++...+ ..
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~ 123 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT-----EI 123 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSS-----EE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCC-----eE
Confidence 3567999999999999999999999889999999997543 3456889999999999999999999986544 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC---CCce
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD---YMTA 780 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~---~~~~ 780 (949)
++||||+++++|.+++. ....+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+
T Consensus 124 ~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~ 190 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIV----------EKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPL 190 (349)
T ss_dssp EEEECCCCSCBHHHHHT----------TCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCE
T ss_pred EEEEEeCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCE
Confidence 99999999999999996 234589999999999999999999987 8999999999999975 8899
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
||+|||+++........ ....||+.|+|||++.+..++.++|||||||++|||++|+.||.............
T Consensus 191 kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i---- 263 (349)
T 2w4o_A 191 KIADFGLSKIVEHQVLM---KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRI---- 263 (349)
T ss_dssp EECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHH----
T ss_pred EEccCccccccCccccc---ccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHH----
Confidence 99999999876543221 23458999999999999899999999999999999999999996432211111111
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
......... +...+.+..+.+++.+|++.||++|||+.|+++
T Consensus 264 --------~~~~~~~~~----------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 264 --------LNCEYYFIS----------------PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp --------HTTCCCCCT----------------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --------HhCCCccCC----------------chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000000 000123456789999999999999999999976
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=354.86 Aligned_cols=266 Identities=21% Similarity=0.320 Sum_probs=198.4
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc---chHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG---ASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
.++|++.+.||+|+||.||+|++..+++.||||+++..... ....+.+|+.++++++||||+++++++.... ....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCCc
Confidence 46799999999999999999999889999999999754322 2357889999999999999999999976544 1122
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++++|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 90 ~~~lv~e~~~g~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~k 156 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVH----------TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVK 156 (311)
T ss_dssp EEEEEEECCCEEEHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEE
T ss_pred ccEEEEecCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEE
Confidence 4599999999999999996 234689999999999999999999988 899999999999999999999
Q ss_pred EeecccceecCCCCCc-cccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 782 VGDFGLARILSPDHTQ-TSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
|+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 157 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~------- 229 (311)
T 3ork_A 157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY------- 229 (311)
T ss_dssp ECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-------
T ss_pred EeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH-------
Confidence 9999999876544321 22223558999999999999999999999999999999999999996432111000
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHH-HHHHHHHhHH
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTN-VVHELQSIKN 933 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e-v~~~L~~i~~ 933 (949)
........+ +. ......+..+.+++.+|++.||++||++.+ +.+.+.++..
T Consensus 230 ------~~~~~~~~~-~~---------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 230 ------QHVREDPIP-PS---------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp ------HHHHCCCCC-HH---------------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred ------HHhcCCCCC-cc---------------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 000000000 00 000123556889999999999999996555 5556655543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=346.71 Aligned_cols=277 Identities=18% Similarity=0.210 Sum_probs=212.2
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
..++|++.+.||+|+||.||+|++..+++.||||++..... .+.+.+|+.++++++|++++..+.++.. ..+..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~ 80 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYN 80 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecC----CCCce
Confidence 45789999999999999999999988999999998764432 2458899999999999888887776643 23467
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeee---cCCCce
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL---DDYMTA 780 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll---~~~~~~ 780 (949)
++||||+ +++|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+||++ +.++.+
T Consensus 81 ~lv~e~~-~~~L~~~~~~---------~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~ 147 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNF---------CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLV 147 (296)
T ss_dssp EEEEECC-CCBHHHHHHH---------TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCE
T ss_pred EEEEEcc-CCCHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeE
Confidence 9999999 9999999862 234589999999999999999999988 89999999999999 788999
Q ss_pred EEeecccceecCCCCCc-----cccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhh
Q 039533 781 RVGDFGLARILSPDHTQ-----TSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHN 855 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~ 855 (949)
||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 148 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--- 224 (296)
T 4hgt_A 148 YIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR--- 224 (296)
T ss_dssp EECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS---
T ss_pred EEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh---
Confidence 99999999876554321 1122456999999999999999999999999999999999999999643221100
Q ss_pred hccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhh
Q 039533 856 FGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNIL 935 (949)
Q Consensus 856 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~ 935 (949)
.....+........ ........+..+.+++.+|++.||++|||++||++.|+++....
T Consensus 225 -------~~~~~~~~~~~~~~---------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 225 -------QKYERISEKKMSTP---------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp -------SHHHHHHHHHHHSC---------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred -------hhhhhhhcccccch---------------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 00000000000000 00000123567899999999999999999999999999999988
Q ss_pred ccCCCCCCc
Q 039533 936 LGVELCPPC 944 (949)
Q Consensus 936 ~~~~~~~~~ 944 (949)
......|+.
T Consensus 283 ~~~~~~~~d 291 (296)
T 4hgt_A 283 GFSYDYVFD 291 (296)
T ss_dssp TCCTTCCCG
T ss_pred CCCccCccc
Confidence 777665543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=344.59 Aligned_cols=251 Identities=22% Similarity=0.277 Sum_probs=204.5
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.++|++.+.||+|+||.||+|.+..++..||+|++........+.+.+|++++++++||||+++++++.... ..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 82 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNT-----DIY 82 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----EEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-----eEE
Confidence 457899999999999999999999889999999998766666788999999999999999999999976544 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeee---cCCCceE
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL---DDYMTAR 781 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll---~~~~~~k 781 (949)
+||||+++++|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||++ +.++.+|
T Consensus 83 lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~ 149 (277)
T 3f3z_A 83 LVMELCTGGELFERVV----------HKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLK 149 (277)
T ss_dssp EEEECCCSCBHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEE
T ss_pred EEEeccCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEE
Confidence 9999999999999886 234589999999999999999999988 89999999999999 7889999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
|+|||.+.......... ...||+.|+|||++.+. ++.++||||||+++|||++|+.||....... .
T Consensus 150 l~Dfg~~~~~~~~~~~~---~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~-------- 215 (277)
T 3f3z_A 150 LIDFGLAARFKPGKMMR---TKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE--V-------- 215 (277)
T ss_dssp ECCCTTCEECCTTSCBC---CCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--H--------
T ss_pred EEecccceeccCccchh---ccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH--H--------
Confidence 99999998776544322 34599999999998764 8999999999999999999999996432111 0
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
...+...... .+. ......+..+.+++.+|++.||++|||+.|+++
T Consensus 216 ---~~~~~~~~~~-~~~---------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 216 ---MLKIREGTFT-FPE---------------KDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ---HHHHHHCCCC-CCH---------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---HHHHHhCCCC-CCc---------------hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0001110000 000 001123557889999999999999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=367.49 Aligned_cols=279 Identities=19% Similarity=0.160 Sum_probs=199.6
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecC--CCcchHHHHHHHHHHHhcCCCcceeEEeeeecccc-cCCc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ--HHGASRSFIAECKALKSIRHRNLVKVLTACLGADY-RGND 701 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 701 (949)
.++|++.+.||+|+||.||+|.+..+++.||||++... .....+++.+|+.++++++||||+++++++..... +...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 47899999999999999999999999999999999754 23345678899999999999999999999865432 2335
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++ ++.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 141 ~~~lv~E~~~~-~l~~~~~------------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~k 204 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLK 204 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred eEEEEEeCCCC-CHHHHHh------------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEE
Confidence 67999999976 4666664 2388999999999999999999988 999999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcc---
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGR--- 858 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~--- 858 (949)
|+|||+|+........ ....||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .+.....
T Consensus 205 l~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~-~~~~i~~~lg 280 (464)
T 3ttj_A 205 ILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLG 280 (464)
T ss_dssp ECCCCCC-----CCCC-------CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHC
T ss_pred EEEEEeeeecCCCccc---CCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcC
Confidence 9999999876543322 23569999999999999999999999999999999999999996432111 0000000
Q ss_pred c-------cCCCchhhhcccCCCCC---chhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 859 K-------ALPDDVMDIVDSSLLPD---DEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 859 ~-------~~~~~~~~~~d~~l~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
. .........++...... ........ ...............+.+++.+|++.||++|||++|+++
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 281 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDS---LFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp SCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGG---GSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHcchhhhhHhhcccccCCCChHHhCccc---ccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 00000111111100000 00000000 000000111233567899999999999999999999976
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=353.39 Aligned_cols=258 Identities=22% Similarity=0.320 Sum_probs=200.3
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccc------
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADY------ 697 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------ 697 (949)
.++|++.+.||+|+||.||+|++..+++.||||+++.... ...+.+.+|++++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 3578899999999999999999998999999999975443 345789999999999999999999999865431
Q ss_pred ----------------------------------------------cCCccceeEeeeccCCChhhhcCCCCCCCccccC
Q 039533 698 ----------------------------------------------RGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEA 731 (949)
Q Consensus 698 ----------------------------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~ 731 (949)
......++||||+++++|.+++.... .
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------~ 157 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-------S 157 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-------S
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-------C
Confidence 11223799999999999999997321 2
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecccceecCCCCCc----------cccc
Q 039533 732 PRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQ----------TSSF 801 (949)
Q Consensus 732 ~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~----------~~~~ 801 (949)
....++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++........ ....
T Consensus 158 ~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T 3qd2_B 158 LEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234 (332)
T ss_dssp GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCC
T ss_pred ccchhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccccc
Confidence 23457778899999999999999987 9999999999999999999999999999987654321 1112
Q ss_pred cccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhhhcccCCCCCchhhh
Q 039533 802 SVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLI 881 (949)
Q Consensus 802 ~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 881 (949)
...||+.|+|||++.+..++.++|||||||++|||++|..|+..... .. ........
T Consensus 235 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~----~~-----------~~~~~~~~-------- 291 (332)
T 3qd2_B 235 GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR----II-----------TDVRNLKF-------- 291 (332)
T ss_dssp SCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH----HH-----------HHHHTTCC--------
T ss_pred ccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH----HH-----------HHhhccCC--------
Confidence 34699999999999999999999999999999999999877532100 00 00000000
Q ss_pred hhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 882 LTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
..........+.+++.+|++.||++|||++|+++
T Consensus 292 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 292 -----------PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp -----------CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred -----------CcccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 0112244556789999999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=343.60 Aligned_cols=254 Identities=20% Similarity=0.289 Sum_probs=204.2
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
.++|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|+.++++++||||+++++++.... ..
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~ 80 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN-----IQ 80 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-----EE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCC-----EE
Confidence 467899999999999999999999889999999997543 234578899999999999999999999976544 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++||||+++++|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 81 ~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~ 147 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIE----------PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKIS 147 (276)
T ss_dssp EEEEECCTTEEGGGGSB----------TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEecCCCcHHHHHh----------hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEe
Confidence 99999999999999986 234589999999999999999999987 99999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCCcc-CCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEV-STNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
|||.+................||..|+|||++.+..+ +.++||||||+++|||++|+.||+...........+...
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--- 224 (276)
T 2yex_A 148 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--- 224 (276)
T ss_dssp CCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT---
T ss_pred eCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc---
Confidence 9999987644332222234568999999999987765 789999999999999999999997543222222111110
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
...... ....+..+.+++.+|++.||++|||++|+++
T Consensus 225 ---------~~~~~~------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 225 ---------KTYLNP------------------WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ---------CTTSTT------------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---------ccccCc------------------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 000000 0123456788999999999999999999875
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=368.47 Aligned_cols=264 Identities=17% Similarity=0.192 Sum_probs=206.8
Q ss_pred CHHHHHHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeee
Q 039533 617 SYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACL 693 (949)
Q Consensus 617 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 693 (949)
.+.++....++|++.++||+|+||+||+|++..+++.||+|+++... ......+.+|+.++.+++||||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34455566789999999999999999999999899999999997422 222345889999999999999999999976
Q ss_pred cccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCee
Q 039533 694 GADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVL 773 (949)
Q Consensus 694 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIl 773 (949)
+.+ ..++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+. +|+||||||+|||
T Consensus 145 ~~~-----~~~lV~Ey~~gg~L~~~l~~---------~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NIL 207 (437)
T 4aw2_A 145 DDN-----NLYLVMDYYVGGDLLTLLSK---------FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNIL 207 (437)
T ss_dssp CSS-----EEEEEECCCTTCBHHHHHHT---------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred eCC-----EEEEEEecCCCCcHHHHHHH---------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHee
Confidence 554 78999999999999999972 134689999999999999999999987 8999999999999
Q ss_pred ecCCCceEEeecccceecCCCCCccccccccCccCccCccccC-----CCccCCccchHHHHHHHHHHHhCCCCCccccc
Q 039533 774 LDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGV-----GCEVSTNGDVYSYGILLLELVIGKKPIDIMFE 848 (949)
Q Consensus 774 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~ 848 (949)
++.++.+||+|||+|+......... .....||+.|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 208 l~~~g~vkL~DFGla~~~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~ 286 (437)
T 4aw2_A 208 MDMNGHIRLADFGSCLKLMEDGTVQ-SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 286 (437)
T ss_dssp ECTTSCEEECCCTTCEECCTTSCEE-CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred EcCCCCEEEcchhhhhhcccCCCcc-cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh
Confidence 9999999999999998765544322 22356999999999986 56789999999999999999999999964321
Q ss_pred cCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCC--CCCHHHHHH
Q 039533 849 GDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQD--RTNMTNVVH 926 (949)
Q Consensus 849 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~ev~~ 926 (949)
.+. +...... . . ....... ....+..+.+++.+|+..+|++ ||+++|+++
T Consensus 287 ~~~-~~~i~~~----~-~---~~~~p~~-------------------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 287 VET-YGKIMNH----K-E---RFQFPTQ-------------------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHH-HHHHHTH----H-H---HCCCCSS-------------------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred hHH-HHhhhhc----c-c---cccCCcc-------------------cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 110 0000000 0 0 0000000 0012445788999999988888 999999876
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=356.11 Aligned_cols=252 Identities=22% Similarity=0.252 Sum_probs=197.3
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC---cchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCC
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH---GASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 700 (949)
.++|++.+.||+|+||.||+|++..+++.||+|+++.... ...+.+.+|..+++++ +||||+++++++...+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~---- 83 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES---- 83 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS----
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC----
Confidence 3578899999999999999999998999999999975432 2345688999999988 8999999999976544
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
..++||||+++|+|.+++. ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++++
T Consensus 84 -~~~lv~e~~~gg~L~~~l~----------~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~ 149 (345)
T 3a8x_A 84 -RLFFVIEYVNGGDLMFHMQ----------RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHI 149 (345)
T ss_dssp -EEEEEECCCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCE
T ss_pred -EEEEEEeCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCE
Confidence 7899999999999999986 234689999999999999999999987 99999999999999999999
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
||+|||+++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||........... .
T Consensus 150 kL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-----~ 222 (345)
T 3a8x_A 150 KLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-----N 222 (345)
T ss_dssp EECCGGGCBCSCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC------------
T ss_pred EEEeccccccccCCCCc--ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc-----c
Confidence 99999999864332221 1245699999999999999999999999999999999999999964211100000 0
Q ss_pred CCCchh-hhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCH
Q 039533 861 LPDDVM-DIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNM 921 (949)
Q Consensus 861 ~~~~~~-~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 921 (949)
...... .+...... .+ ...+..+.+++.+|++.||++||++
T Consensus 223 ~~~~~~~~i~~~~~~-~p-------------------~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 223 TEDYLFQVILEKQIR-IP-------------------RSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp CHHHHHHHHHHCCCC-CC-------------------TTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred cHHHHHHHHHcCCCC-CC-------------------CCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 000000 01110000 00 1234567899999999999999996
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=345.82 Aligned_cols=275 Identities=19% Similarity=0.217 Sum_probs=214.1
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.++|++.+.||+|+||.||+|++..+++.||||++..... .+.+.+|+.++++++|++++..+.++.. .....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~ 81 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNV 81 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccC----CCCceE
Confidence 4689999999999999999999988999999999875432 3568999999999999887777766543 234679
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeee---cCCCceE
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL---DDYMTAR 781 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll---~~~~~~k 781 (949)
+||||+ +++|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+||++ +.++.+|
T Consensus 82 lv~e~~-~~~L~~~~~~---------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~k 148 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNF---------CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVY 148 (296)
T ss_dssp EEEECC-CCBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEE
T ss_pred EEEEec-CCCHHHHHHh---------hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEE
Confidence 999999 8999999862 234589999999999999999999988 99999999999999 4888999
Q ss_pred EeecccceecCCCCCcc-----ccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhh
Q 039533 782 VGDFGLARILSPDHTQT-----SSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNF 856 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~ 856 (949)
|+|||.++......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 149 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---- 224 (296)
T 3uzp_A 149 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR---- 224 (296)
T ss_dssp ECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS----
T ss_pred EeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhh----
Confidence 99999998765543211 112456999999999999999999999999999999999999999743211100
Q ss_pred ccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhhc
Q 039533 857 GRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILL 936 (949)
Q Consensus 857 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~ 936 (949)
+....+....... +. ......++..+.+++.+||+.||++|||++||++.|+++.....
T Consensus 225 ------~~~~~~~~~~~~~-------------~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 225 ------QKYERISEKKMST-------------PI--EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp ------SHHHHHHHHHHHS-------------CH--HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ------hhhhhhcccccCC-------------ch--HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 0000000000000 00 00001335678999999999999999999999999999998877
Q ss_pred cCCCCCC
Q 039533 937 GVELCPP 943 (949)
Q Consensus 937 ~~~~~~~ 943 (949)
.....|+
T Consensus 284 ~~~~~~~ 290 (296)
T 3uzp_A 284 FSYDYVF 290 (296)
T ss_dssp CCSSCCC
T ss_pred Ccccccc
Confidence 7655544
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=357.26 Aligned_cols=278 Identities=22% Similarity=0.299 Sum_probs=210.9
Q ss_pred CCCCCeeeeecCceEEEEEE----cCCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 628 FSSANLVGVGSFGSVYKGII----DEGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 628 y~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
|++.+.||+|+||.||+|.+ ..+++.||||+++.... ...+.+.+|++++++++||||+++++++...+ ...
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~ 109 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG---AAS 109 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT---TTE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC---Cce
Confidence 38889999999999988865 34688999999975432 33467899999999999999999999986432 346
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++|+|.+++.. ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 110 ~~lv~e~~~~~~L~~~l~~-----------~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl 175 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPR-----------HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKI 175 (318)
T ss_dssp EEEEECCCTTCBHHHHGGG-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred EEEEEecccCCcHHHHHhh-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEE
Confidence 7999999999999999962 3489999999999999999999988 8999999999999999999999
Q ss_pred eecccceecCCCCCc-cccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 783 GDFGLARILSPDHTQ-TSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
+|||.++........ .......||..|+|||++.+..++.++||||||+++|||++|+.||............+.....
T Consensus 176 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 255 (318)
T 3lxp_A 176 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM 255 (318)
T ss_dssp CCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHH
T ss_pred CCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccch
Confidence 999999987655432 1222345888899999999889999999999999999999999998643221111100000000
Q ss_pred C-CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhhccCCC
Q 039533 862 P-DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILLGVEL 940 (949)
Q Consensus 862 ~-~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~~ 940 (949)
. ....+.++..... +....++..+.+++.+||+.||++|||++|+++.|+++.+.+....+
T Consensus 256 ~~~~~~~~~~~~~~~------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~p 317 (318)
T 3lxp_A 256 TVLRLTELLERGERL------------------PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP 317 (318)
T ss_dssp HHHHHHHHHHTTCCC------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC---
T ss_pred hHHHHHHHHhcccCC------------------CCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCCC
Confidence 0 0011111111110 11123456789999999999999999999999999999998876543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=355.65 Aligned_cols=274 Identities=21% Similarity=0.339 Sum_probs=210.5
Q ss_pred hcCCCCCCeeeeecCceEEEEEEc-------CCCEEEEEEEEecCCC-cchHHHHHHHHHHHhc-CCCcceeEEeeeecc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIID-------EGRTTIAVKVFNLQHH-GASRSFIAECKALKSI-RHRNLVKVLTACLGA 695 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 695 (949)
.++|++.+.||+|+||.||+|++. .+++.||||+++.... ...+.+.+|+++++++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 467899999999999999999985 3567899999875432 2346789999999999 899999999997654
Q ss_pred cccCCccceeEeeeccCCChhhhcCCCCCCCc------cccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 039533 696 DYRGNDFKASVYEFMHYGSLEEWLHPFTGEDE------IDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKP 769 (949)
Q Consensus 696 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp 769 (949)
+ ..++||||+++|+|.+++........ .......+++.+++.++.|++.||+|||++ +|+||||||
T Consensus 114 ~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp 185 (334)
T 2pvf_A 114 G-----PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 185 (334)
T ss_dssp S-----CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred C-----ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCcc
Confidence 4 78999999999999999974321100 001124589999999999999999999987 999999999
Q ss_pred CCeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccc
Q 039533 770 SNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFE 848 (949)
Q Consensus 770 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~ 848 (949)
+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp GGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 999999999999999999988765543333334457889999999988889999999999999999999 9999864321
Q ss_pred cCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 039533 849 GDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHEL 928 (949)
Q Consensus 849 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 928 (949)
.. .. ..+........ ...++..+.+++.+||+.||++|||+.|+++.|
T Consensus 266 ~~--~~------------~~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 313 (334)
T 2pvf_A 266 EE--LF------------KLLKEGHRMDK------------------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313 (334)
T ss_dssp HH--HH------------HHHHHTCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HH--HH------------HHHhcCCCCCC------------------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 10 00 00000000000 012345688999999999999999999999999
Q ss_pred HHhHHhhccC
Q 039533 929 QSIKNILLGV 938 (949)
Q Consensus 929 ~~i~~~~~~~ 938 (949)
+++.......
T Consensus 314 ~~l~~~~~~~ 323 (334)
T 2pvf_A 314 DRILTLTTNE 323 (334)
T ss_dssp HHHHHHHC--
T ss_pred HHHHhccccC
Confidence 9998776544
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=367.07 Aligned_cols=206 Identities=23% Similarity=0.308 Sum_probs=173.0
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
.++|.+.+.||+|+||.||+|++..+++.||||+++.... ...+++.+|++++++++||||+++++++...++.....
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 4689999999999999999999999999999999975322 33468899999999999999999999987665545567
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||++ ++|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||
T Consensus 105 ~~lv~e~~~-~~L~~~~~----------~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL 170 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK----------TPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKV 170 (432)
T ss_dssp EEEEEECCS-EEHHHHHH----------SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEE
T ss_pred EEEEEecCC-cCHHHHHh----------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEE
Confidence 899999986 59999986 335689999999999999999999988 8999999999999999999999
Q ss_pred eecccceecCCCCCc--------------------cccccccCccCccCcccc-CCCccCCccchHHHHHHHHHHHhCCC
Q 039533 783 GDFGLARILSPDHTQ--------------------TSSFSVKGSLGYIAPEYG-VGCEVSTNGDVYSYGILLLELVIGKK 841 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDiwSlGvvl~elltg~~ 841 (949)
+|||+|+........ .......||+.|+|||++ .+..++.++||||+||++|||++|..
T Consensus 171 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 250 (432)
T 3n9x_A 171 CDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250 (432)
T ss_dssp CCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCT
T ss_pred ccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccc
Confidence 999999986543221 112346699999999985 56679999999999999999999777
Q ss_pred CCc
Q 039533 842 PID 844 (949)
Q Consensus 842 Pf~ 844 (949)
||.
T Consensus 251 p~~ 253 (432)
T 3n9x_A 251 SHI 253 (432)
T ss_dssp TTC
T ss_pred ccc
Confidence 764
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=367.22 Aligned_cols=359 Identities=19% Similarity=0.176 Sum_probs=225.8
Q ss_pred cCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECCCCCCCCC
Q 039533 97 QVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGS 176 (949)
Q Consensus 97 ~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~ 176 (949)
......+..+..++++++|++|+|++|.+++ +| .++.+++|++|++++|++++.. ++.+++|++|+|++|+|++.
T Consensus 26 ~~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~~~---~~~l~~L~~L~Ls~N~l~~~ 100 (457)
T 3bz5_A 26 AAFEMQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITTLD---LSQNTNLTYLACDSNKLTNL 100 (457)
T ss_dssp HHTTCCTTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSCCC---CTTCTTCSEEECCSSCCSCC
T ss_pred HhcCcCcccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCeEc---cccCCCCCEEECcCCCCcee
Confidence 3344455566678999999999999999996 46 6899999999999999998862 88999999999999999964
Q ss_pred CCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCcccccccccccCCCCChhhhccccccccccCCC-CCCC
Q 039533 177 IPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSL-GSGG 255 (949)
Q Consensus 177 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N~l-~~~~ 255 (949)
| ++++++|++|+|++|++++ +| ++.+++|++|++++|+++.++ +..+++|++|++++|+. +..
T Consensus 101 -~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l~---------l~~l~~L~~L~l~~n~~~~~~- 164 (457)
T 3bz5_A 101 -D--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEID---------VSHNTQLTELDCHLNKKITKL- 164 (457)
T ss_dssp -C--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCCC---------CTTCTTCCEEECTTCSCCCCC-
T ss_pred -e--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCccceec---------cccCCcCCEEECCCCCccccc-
Confidence 3 8899999999999999986 44 888999999999988876432 44555666666666632 211
Q ss_pred CCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCC
Q 039533 256 NDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIP 335 (949)
Q Consensus 256 ~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 335 (949)
.+..+++|++|++++|++++. | +..+ ++|+.|++++|++++. .++.+++|++|+|++|++++ +|
T Consensus 165 --------~~~~l~~L~~L~ls~n~l~~l-~--l~~l-~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip 228 (457)
T 3bz5_A 165 --------DVTPQTQLTTLDCSFNKITEL-D--VSQN-KLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID 228 (457)
T ss_dssp --------CCTTCTTCCEEECCSSCCCCC-C--CTTC-TTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC
T ss_pred --------ccccCCcCCEEECCCCcccee-c--cccC-CCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC
Confidence 133344445555555544442 2 2222 2344444444444432 24444444444444444443 22
Q ss_pred CcccccCCCCEEecCCcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcc
Q 039533 336 PAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSS 415 (949)
Q Consensus 336 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 415 (949)
++.+++|+.|++++|++++.. ++.+++|+.|++++| +|+.|++++|.+.+.+| +..+++
T Consensus 229 --~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n--------------~L~~L~l~~n~~~~~~~--~~~l~~ 287 (457)
T 3bz5_A 229 --VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQT--------------DLLEIDLTHNTQLIYFQ--AEGCRK 287 (457)
T ss_dssp --CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTC--------------CCSCCCCTTCTTCCEEE--CTTCTT
T ss_pred --ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCC--------------CCCEEECCCCccCCccc--cccccc
Confidence 344444444444444444321 223334444444333 23344444554444444 233444
Q ss_pred cceeeccCCCccCCCCccccccccccceeeeccccccccCCcccccccchhhcccCccccccccCCCcCCCCCCCEEECC
Q 039533 416 LSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLS 495 (949)
Q Consensus 416 l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls 495 (949)
| +.|++++|.+.+.+|. ....|+.|++ .++++|+.|++++|+|++. .++.+++|+.||++
T Consensus 288 L-~~L~Ls~n~~l~~l~~---~~~~L~~L~l-------------~~~~~L~~L~L~~N~l~~l---~l~~l~~L~~L~l~ 347 (457)
T 3bz5_A 288 I-KELDVTHNTQLYLLDC---QAAGITELDL-------------SQNPKLVYLYLNNTELTEL---DVSHNTKLKSLSCV 347 (457)
T ss_dssp C-CCCCCTTCTTCCEEEC---TTCCCSCCCC-------------TTCTTCCEEECTTCCCSCC---CCTTCTTCSEEECC
T ss_pred C-CEEECCCCcccceecc---CCCcceEech-------------hhcccCCEEECCCCccccc---ccccCCcCcEEECC
Confidence 4 4455555554444442 2233333333 4447899999999999984 39999999999999
Q ss_pred CCcCCCcCcccccCCccceEeCCCCcCcCcccccccccccccccccCCC
Q 039533 496 QNNLSGEIPKFLAGLSLNNLNLSYNDLEGMVTTEGVFKNASATRILGNS 544 (949)
Q Consensus 496 ~N~l~~~~p~~~~~~~L~~l~ls~N~l~~~~~~~~~~~~~~~~~~~gn~ 544 (949)
+|+|++. | .|..|++++|.++|. +.+..+....+..|.
T Consensus 348 ~N~l~~l-~------~L~~L~l~~n~l~g~----~~~~~l~~l~l~~N~ 385 (457)
T 3bz5_A 348 NAHIQDF-S------SVGKIPALNNNFEAE----GQTITMPKETLTNNS 385 (457)
T ss_dssp SSCCCBC-T------TGGGSSGGGTSEEEE----EEEEECCCBCCBTTB
T ss_pred CCCCCCc-c------ccccccccCCcEEec----ceeeecCccccccCc
Confidence 9999972 2 367788999999987 233445555555553
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=358.36 Aligned_cols=247 Identities=22% Similarity=0.259 Sum_probs=195.5
Q ss_pred CCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEeeec
Q 039533 631 ANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFM 710 (949)
Q Consensus 631 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 710 (949)
.+.||+|+||.||+|++..+++.||+|+++.......+.+.+|++++++++||||+++++++...+ ..++||||+
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~~lv~E~~ 168 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKN-----DIVLVMEYV 168 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----EEEEEEECC
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-----EEEEEEeCC
Confidence 568999999999999999899999999998765555678999999999999999999999976544 789999999
Q ss_pred cCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeee--cCCCceEEeecccc
Q 039533 711 HYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL--DDYMTARVGDFGLA 788 (949)
Q Consensus 711 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll--~~~~~~kl~DfG~a 788 (949)
++++|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++
T Consensus 169 ~~~~L~~~l~~---------~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a 236 (373)
T 2x4f_A 169 DGGELFDRIID---------ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLA 236 (373)
T ss_dssp TTCEEHHHHHH---------TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSC
T ss_pred CCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCc
Confidence 99999998852 234589999999999999999999987 89999999999999 57789999999999
Q ss_pred eecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhhh
Q 039533 789 RILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDI 868 (949)
Q Consensus 789 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 868 (949)
+......... ...||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+ ..+
T Consensus 237 ~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~------------~~i 300 (373)
T 2x4f_A 237 RRYKPREKLK---VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE-TL------------NNI 300 (373)
T ss_dssp EECCTTCBCC---CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HH------------HHH
T ss_pred eecCCccccc---cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-HH------------HHH
Confidence 9876544322 3459999999999998899999999999999999999999996432110 01 111
Q ss_pred cccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 869 VDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 869 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.......... .....+..+.+++.+|++.||++|||+.|+++
T Consensus 301 ~~~~~~~~~~----------------~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 301 LACRWDLEDE----------------EFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp HHTCCCSCSG----------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HhccCCCChh----------------hhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1111000000 00123456889999999999999999999987
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=356.03 Aligned_cols=260 Identities=24% Similarity=0.398 Sum_probs=199.6
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEE----EEEEEEecC-CCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccC
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTT----IAVKVFNLQ-HHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRG 699 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 699 (949)
.++|++.+.||+|+||.||+|++..+++. ||+|.+... .....+.+.+|+.++++++||||+++++++...
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---- 89 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---- 89 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS----
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC----
Confidence 36789999999999999999999776664 577776533 234457899999999999999999999998643
Q ss_pred CccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCc
Q 039533 700 NDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMT 779 (949)
Q Consensus 700 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~ 779 (949)
..++|+||+++|+|.+++.. ....+++..++.|+.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 90 --~~~~v~~~~~~g~L~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~ 155 (327)
T 3lzb_A 90 --TVQLITQLMPFGCLLDYVRE---------HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQH 155 (327)
T ss_dssp --SEEEEECCCSSCBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTE
T ss_pred --CceEEEEecCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCC
Confidence 37899999999999999962 234589999999999999999999988 8999999999999999999
Q ss_pred eEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhcc
Q 039533 780 ARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGR 858 (949)
Q Consensus 780 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~ 858 (949)
+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||+......
T Consensus 156 ~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------- 227 (327)
T 3lzb_A 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------- 227 (327)
T ss_dssp EEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------
T ss_pred EEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--------
Confidence 99999999987755444333334457889999999999899999999999999999999 999996432221
Q ss_pred ccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHh
Q 039533 859 KALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNI 934 (949)
Q Consensus 859 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 934 (949)
....+........ ...++..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 228 ------~~~~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 228 ------ISSILEKGERLPQ------------------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ------HHHHHHTTCCCCC------------------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred ------HHHHHHcCCCCCC------------------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1111111100000 012344688999999999999999999999999998754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=350.09 Aligned_cols=252 Identities=20% Similarity=0.229 Sum_probs=203.4
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc------chHHHHHHHHHHHhcCCCcceeEEeeeeccccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG------ASRSFIAECKALKSIRHRNLVKVLTACLGADYR 698 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 698 (949)
.++|++.+.||+|+||.||+|++..+++.||+|+++..... ..+.+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 88 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT-- 88 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC--
Confidence 35689999999999999999999989999999999754322 2467999999999999999999999976544
Q ss_pred CCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC
Q 039533 699 GNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM 778 (949)
Q Consensus 699 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~ 778 (949)
..++||||+++++|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 89 ---~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~ 152 (321)
T 2a2a_A 89 ---DVVLILELVSGGELFDFLA----------QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKN 152 (321)
T ss_dssp ---EEEEEECCCCSCBHHHHHH----------TCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTT
T ss_pred ---EEEEEEEcCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCC
Confidence 7899999999999999996 234588999999999999999999987 999999999999999887
Q ss_pred ----ceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhh
Q 039533 779 ----TARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLH 854 (949)
Q Consensus 779 ----~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~ 854 (949)
.+||+|||+++......... ...||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..
T Consensus 153 ~~~~~~kl~Dfg~~~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~ 227 (321)
T 2a2a_A 153 IPIPHIKLIDFGLAHEIEDGVEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TL 227 (321)
T ss_dssp SSSCCEEECCCTTCEECCTTCCCC---CCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HH
T ss_pred CCcCCEEEccCccceecCcccccc---ccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH--HH
Confidence 79999999998876543322 3459999999999999899999999999999999999999996332110 00
Q ss_pred hhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 855 NFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 855 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
..+....... +. ......+..+.+++.+|++.||++|||+.|+++
T Consensus 228 -----------~~i~~~~~~~-~~---------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 228 -----------ANITSVSYDF-DE---------------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp -----------HHHHTTCCCC-CH---------------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred -----------HHHHhccccc-Ch---------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000000000 00 001123456889999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=372.37 Aligned_cols=202 Identities=24% Similarity=0.314 Sum_probs=160.9
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
.++|.+.+.||+|+||.||+|++..+++.||||++..... ...+++.+|++++++++||||+++++++...+.+....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 3689999999999999999999998999999999864332 23467899999999999999999999987666556668
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+ +++|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||
T Consensus 132 ~~lv~e~~-~~~L~~~~~----------~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl 197 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR----------TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKV 197 (458)
T ss_dssp EEEEECCC-SEEHHHHHH----------SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEE
T ss_pred EEEEEecc-ccchhhhcc----------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEee
Confidence 99999998 468999986 335689999999999999999999988 9999999999999999999999
Q ss_pred eecccceecCCCCCc-------------------------cccccccCccCccCcccc-CCCccCCccchHHHHHHHHHH
Q 039533 783 GDFGLARILSPDHTQ-------------------------TSSFSVKGSLGYIAPEYG-VGCEVSTNGDVYSYGILLLEL 836 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDiwSlGvvl~el 836 (949)
+|||+|+........ .......||+.|+|||++ .+..++.++|||||||++|||
T Consensus 198 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~el 277 (458)
T 3rp9_A 198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277 (458)
T ss_dssp CCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred cccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHH
Confidence 999999876533211 112245689999999976 456799999999999999999
Q ss_pred HhCC
Q 039533 837 VIGK 840 (949)
Q Consensus 837 ltg~ 840 (949)
++|.
T Consensus 278 ltg~ 281 (458)
T 3rp9_A 278 LNMI 281 (458)
T ss_dssp HTTS
T ss_pred HHhc
Confidence 9943
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=374.65 Aligned_cols=258 Identities=25% Similarity=0.420 Sum_probs=209.5
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.++|++.+.||+|+||.||+|++..++..||||+++... ...+.+.+|+.++++++||||++++++|...+ ..+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~ 292 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-----PFY 292 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SCE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCC-----cEE
Confidence 346788899999999999999999889999999987543 34578999999999999999999999986544 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++|+|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 293 lv~E~~~~g~L~~~l~~~--------~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~D 361 (495)
T 1opk_A 293 IITEFMTYGNLLDYLREC--------NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVAD 361 (495)
T ss_dssp EEEECCTTCBHHHHHHHS--------CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECC
T ss_pred EEEEccCCCCHHHHHHhc--------CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEee
Confidence 999999999999999631 234589999999999999999999987 899999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCC
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
||+++....... .......++..|+|||++.+..++.++|||||||++|||+| |+.||.......
T Consensus 362 FG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~------------- 427 (495)
T 1opk_A 362 FGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------------- 427 (495)
T ss_dssp TTCEECCTTCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------------
T ss_pred cccceeccCCce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH-------------
Confidence 999987654332 22223446789999999998899999999999999999999 999986432111
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhH
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIK 932 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 932 (949)
+.+.+....... ....++..+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 428 -~~~~~~~~~~~~------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 428 -VYELLEKDYRME------------------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp -HHHHHHTTCCCC------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred -HHHHHHcCCCCC------------------CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 111111111000 01134567889999999999999999999999999874
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=352.87 Aligned_cols=254 Identities=22% Similarity=0.392 Sum_probs=200.3
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCC-------EEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGR-------TTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADY 697 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 697 (949)
.++|.+.+.||+|+||.||+|++..++ +.||+|++........+.+.+|+.++++++||||+++++++...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 85 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD- 85 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT-
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC-
Confidence 357888999999999999999987655 579999997666666688999999999999999999999976544
Q ss_pred cCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCC
Q 039533 698 RGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDY 777 (949)
Q Consensus 698 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~ 777 (949)
..++||||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 86 ----~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~ 149 (289)
T 4fvq_A 86 ----ENILVQEFVKFGSLDTYLKK---------NKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIRE 149 (289)
T ss_dssp ----CCEEEEECCTTCBHHHHHHH---------TGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEEC
T ss_pred ----CCEEEEECCCCCCHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecC
Confidence 77999999999999999962 233489999999999999999999988 89999999999999988
Q ss_pred Cc--------eEEeecccceecCCCCCccccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccc
Q 039533 778 MT--------ARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFE 848 (949)
Q Consensus 778 ~~--------~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~ 848 (949)
+. +||+|||.+....... ...||..|+|||++.+ ..++.++|||||||++|||++|..|+.....
T Consensus 150 ~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~ 223 (289)
T 4fvq_A 150 EDRKTGNPPFIKLSDPGISITVLPKD------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD 223 (289)
T ss_dssp CBGGGTBCCEEEECCCCSCTTTSCHH------HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred CcccccccceeeeccCcccccccCcc------ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc
Confidence 77 9999999986543221 2347899999999887 6789999999999999999996554422111
Q ss_pred cCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 039533 849 GDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHEL 928 (949)
Q Consensus 849 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 928 (949)
..... .... .....+. ..+..+.+++.+||+.||++|||++|+++.|
T Consensus 224 ~~~~~-~~~~-----------~~~~~~~---------------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 270 (289)
T 4fvq_A 224 SQRKL-QFYE-----------DRHQLPA---------------------PKAAELANLINNCMDYEPDHRPSFRAIIRDL 270 (289)
T ss_dssp HHHHH-HHHH-----------TTCCCCC---------------------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred hHHHH-HHhh-----------ccCCCCC---------------------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 10000 0000 0000000 0123467899999999999999999999999
Q ss_pred HHhHHh
Q 039533 929 QSIKNI 934 (949)
Q Consensus 929 ~~i~~~ 934 (949)
+++...
T Consensus 271 ~~l~~p 276 (289)
T 4fvq_A 271 NSLFTP 276 (289)
T ss_dssp HTCC--
T ss_pred HHhcCC
Confidence 988654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=350.21 Aligned_cols=277 Identities=24% Similarity=0.308 Sum_probs=202.8
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC-----CcchHHHHHHHHHHHhcC---CCcceeEEeeeecc
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-----HGASRSFIAECKALKSIR---HRNLVKVLTACLGA 695 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~ 695 (949)
..++|++.+.||+|+||+||+|++..+++.||||+++... ......+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4578999999999999999999998899999999997432 122356778888877774 99999999998765
Q ss_pred cccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec
Q 039533 696 DYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD 775 (949)
Q Consensus 696 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~ 775 (949)
........++||||+. ++|.+++... ....+++.++..++.|++.||+|||++ +|+||||||+||+++
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--------~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~ 154 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA--------PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVT 154 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC--------CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc--------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEc
Confidence 5333445799999997 5999998732 223489999999999999999999988 899999999999999
Q ss_pred CCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCch--h
Q 039533 776 DYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDIN--L 853 (949)
Q Consensus 776 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~--~ 853 (949)
.++.+||+|||+++......... ...||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .
T Consensus 155 ~~~~~kl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i 231 (308)
T 3g33_A 155 SGGTVKLADFGLARIYSYQMALT---PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 231 (308)
T ss_dssp TTSCEEECSCSCTTTSTTCCCSG---GGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHH
T ss_pred CCCCEEEeeCccccccCCCcccC---CccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999999998765443322 356899999999999999999999999999999999999999644322110 0
Q ss_pred hhhccccCCCchhh---hcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 854 HNFGRKALPDDVMD---IVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 854 ~~~~~~~~~~~~~~---~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
...........+.. ..+....... . ........+.+..+.+++.+|++.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~---~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 232 FDLIGLPPEDDWPRDVSLPRGAFPPRG--------P---RPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHCCCCTTTSCSSCSSCGGGSCCCC--------C---CCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhCCCChhhccchhhccccccCCCC--------C---CcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 00000000000000 0000000000 0 0000001133467889999999999999999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=359.84 Aligned_cols=264 Identities=24% Similarity=0.404 Sum_probs=196.9
Q ss_pred CCCCCCeeeeecCceEEEEEEcCC---CEEEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEG---RTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
.|.+.+.||+|+||.||+|++..+ +..||||+++... ....+++.+|+.++++++||||+++++++... +..
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~----~~~ 165 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGS 165 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC----SSC
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC----CCC
Confidence 355668999999999999997532 2468999986433 33457899999999999999999999987532 236
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++|+|.+++.. ....+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||
T Consensus 166 ~~lv~e~~~~g~L~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL 233 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRN---------ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKV 233 (373)
T ss_dssp CEEEEECCTTCBHHHHHHC---------TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEE
T ss_pred eEEEEECCCCCCHHHHHhh---------cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEE
Confidence 7899999999999999962 234578999999999999999999988 9999999999999999999999
Q ss_pred eecccceecCCCCCc--cccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccc
Q 039533 783 GDFGLARILSPDHTQ--TSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~ 859 (949)
+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||+| |.+||......+. ...
T Consensus 234 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~--~~~--- 308 (373)
T 3c1x_A 234 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVY--- 308 (373)
T ss_dssp CCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH--HHH---
T ss_pred eeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH--HHH---
Confidence 999999876443221 11123457889999999998899999999999999999999 6777754322111 000
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhhccC
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILLGV 938 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~~ 938 (949)
+........+ ..++..+.+++.+||+.||++|||++|+++.|+++...+.+.
T Consensus 309 --------~~~~~~~~~p-------------------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 309 --------LLQGRRLLQP-------------------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp --------HHTTCCCCCC-------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred --------HHcCCCCCCC-------------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 0000000000 123456889999999999999999999999999998887655
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=349.39 Aligned_cols=285 Identities=24% Similarity=0.333 Sum_probs=204.0
Q ss_pred HHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhc--CCCcceeEEeeeecccccC
Q 039533 622 YNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSI--RHRNLVKVLTACLGADYRG 699 (949)
Q Consensus 622 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~~~~ 699 (949)
....++|++.+.||+|+||.||+|++. ++.||||++.... ...+..|.+++... +||||+++++++.... ..
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~ 106 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGT-GS 106 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GG
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CC
Confidence 344578999999999999999999986 8999999986432 34455566666555 8999999999986542 12
Q ss_pred CccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeEecCCCCCCeee
Q 039533 700 NDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDC-----QPVTAHCDLKPSNVLL 774 (949)
Q Consensus 700 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~-----~~~ivHrDlkp~NIll 774 (949)
....++||||+++|+|.++++ ...+++..+..++.|++.||+|||++. .++|+||||||+||++
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~-----------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill 175 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLK-----------STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV 175 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHH-----------HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE
T ss_pred CCceEEEEeccCCCcHHHHhh-----------ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE
Confidence 246899999999999999996 235899999999999999999999641 3389999999999999
Q ss_pred cCCCceEEeecccceecCCCCCcc--ccccccCccCccCccccCCCccCCc------cchHHHHHHHHHHHhCCCCCccc
Q 039533 775 DDYMTARVGDFGLARILSPDHTQT--SSFSVKGSLGYIAPEYGVGCEVSTN------GDVYSYGILLLELVIGKKPIDIM 846 (949)
Q Consensus 775 ~~~~~~kl~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------sDiwSlGvvl~elltg~~Pf~~~ 846 (949)
+.++.+||+|||+++......... ......||+.|+|||++.+...+.+ +|||||||++|||+||..|+...
T Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~ 255 (337)
T 3mdy_A 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255 (337)
T ss_dssp CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence 999999999999998765443321 1123469999999999887766554 99999999999999995554322
Q ss_pred cccCchhhhhccccCC-Cchhhhc-ccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHH
Q 039533 847 FEGDINLHNFGRKALP-DDVMDIV-DSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNV 924 (949)
Q Consensus 847 ~~~~~~~~~~~~~~~~-~~~~~~~-d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev 924 (949)
......+......... ....+.+ .....+.... .....+++..+.+++.+||+.||++|||+.||
T Consensus 256 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 322 (337)
T 3mdy_A 256 EEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPN-------------RWSSDECLRQMGKLMTECWAHNPASRLTALRV 322 (337)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCG-------------GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred ccccccHhhhcCCCCchhhhHHHHhhhccCccccc-------------cchhhHHHHHHHHHHHHhhhhChhhCCCHHHH
Confidence 1111111000000000 0011111 0111111100 00112667889999999999999999999999
Q ss_pred HHHHHHhHHhhc
Q 039533 925 VHELQSIKNILL 936 (949)
Q Consensus 925 ~~~L~~i~~~~~ 936 (949)
++.|+++.++..
T Consensus 323 l~~L~~l~~~~~ 334 (337)
T 3mdy_A 323 KKTLAKMSESQD 334 (337)
T ss_dssp HHHHHHHHHTTT
T ss_pred HHHHHHHHhhcc
Confidence 999999987643
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=359.59 Aligned_cols=269 Identities=17% Similarity=0.237 Sum_probs=201.4
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcC---CCEEEEEEEEecCCCc-----------chHHHHHHHHHHHhcCCCcceeEEe
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDE---GRTTIAVKVFNLQHHG-----------ASRSFIAECKALKSIRHRNLVKVLT 690 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~ 690 (949)
.++|.+.+.||+|+||.||+|++.. ++..||||+....... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 3578899999999999999999976 6788999998754321 1234678888999999999999999
Q ss_pred eeecccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 039533 691 ACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPS 770 (949)
Q Consensus 691 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~ 770 (949)
++.... .+....++||||+ +++|.+++.. ...+++.+++.++.|++.||+|||++ +|+||||||+
T Consensus 116 ~~~~~~-~~~~~~~lv~e~~-~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~ 180 (345)
T 2v62_A 116 SGLTEF-KGRSYRFMVMERL-GIDLQKISGQ----------NGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAA 180 (345)
T ss_dssp EEEEES-SSCEEEEEEEECE-EEEHHHHCBG----------GGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred cccccc-CCCcEEEEEEecc-CCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHH
Confidence 987532 3345789999999 9999999972 23689999999999999999999987 9999999999
Q ss_pred CeeecCCC--ceEEeecccceecCCCCCc-----cccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCC
Q 039533 771 NVLLDDYM--TARVGDFGLARILSPDHTQ-----TSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPI 843 (949)
Q Consensus 771 NIll~~~~--~~kl~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf 843 (949)
||+++.++ .+||+|||+++.+...... .......||..|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 181 NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf 260 (345)
T 2v62_A 181 NLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPW 260 (345)
T ss_dssp GEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred HEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999877 9999999999876533211 1112456999999999999989999999999999999999999999
Q ss_pred ccccccCchhhhhcc---ccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC
Q 039533 844 DIMFEGDINLHNFGR---KALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTN 920 (949)
Q Consensus 844 ~~~~~~~~~~~~~~~---~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 920 (949)
............... ...++...+... ....+..+.+++.+||+.||++|||
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~dp~~Rps 315 (345)
T 2v62_A 261 EQNLKDPVAVQTAKTNLLDELPQSVLKWAP-------------------------SGSSCCEIAQFLVCAHSLAYDEKPN 315 (345)
T ss_dssp GGGTTCHHHHHHHHHHHHHTTTHHHHHHSC-------------------------TTSCCHHHHHHHHHHHTCCTTCCCC
T ss_pred cccccccHHHHHHHHhhcccccHHHHhhcc-------------------------ccccHHHHHHHHHHHhhcCcccCCC
Confidence 643221111111000 000000000000 0033557899999999999999999
Q ss_pred HHHHHHHHHHhHH
Q 039533 921 MTNVVHELQSIKN 933 (949)
Q Consensus 921 ~~ev~~~L~~i~~ 933 (949)
++||++.|+++..
T Consensus 316 ~~~l~~~L~~~~~ 328 (345)
T 2v62_A 316 YQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHCTTCC
T ss_pred HHHHHHHHhccCC
Confidence 9999999988654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=373.07 Aligned_cols=260 Identities=24% Similarity=0.387 Sum_probs=207.7
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.++|.+.+.||+|+||.||+|.+. ++..||||+++... ...+.+.+|+.++++++||||+++++++.. ...+
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~------~~~~ 258 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIY 258 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECS------SSCE
T ss_pred hHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC------CccE
Confidence 456888899999999999999997 57889999997543 346789999999999999999999998742 2579
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++|+|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 259 lv~e~~~~g~L~~~l~~~--------~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~D 327 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSD--------EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIAD 327 (454)
T ss_dssp EEECCCTTCBHHHHHHSH--------HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECS
T ss_pred EEEeecCCCcHHHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEee
Confidence 999999999999999621 123578899999999999999999988 899999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCC
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
||+++....... .......++..|+|||++.+..++.++|||||||++|||+| |+.||......+ ....
T Consensus 328 FG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~--~~~~------- 397 (454)
T 1qcf_A 328 FGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIRA------- 397 (454)
T ss_dssp TTGGGGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHH-------
T ss_pred CCCceEcCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHH-------
Confidence 999987643221 11123346788999999988889999999999999999999 999996432111 0000
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhhc
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILL 936 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~ 936 (949)
+......+. ...++..+.+++.+||+.||++|||+++|++.|+++.....
T Consensus 398 ----i~~~~~~~~-------------------~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~ 447 (454)
T 1qcf_A 398 ----LERGYRMPR-------------------PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE 447 (454)
T ss_dssp ----HHHTCCCCC-------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred ----HHcCCCCCC-------------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence 000000000 11345678899999999999999999999999999865543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=343.69 Aligned_cols=258 Identities=25% Similarity=0.378 Sum_probs=206.9
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.++|++.+.||+|+||.||+|.+. +++.||+|+++.... ..+.+.+|++++++++||||+++++++...+ ..+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 79 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-----PIC 79 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-----SCE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-----CeE
Confidence 357888999999999999999997 678999999975443 3467999999999999999999999976543 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 80 lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~d 147 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRT---------QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSD 147 (267)
T ss_dssp EEECCCTTCBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECC
T ss_pred EEEeCCCCCcHHHHHhh---------CcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcc
Confidence 99999999999999962 234588999999999999999999987 899999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCC
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
||.++....... .......++..|+|||++.+..++.++||||||+++|||++ |+.||....... ....
T Consensus 148 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~------- 217 (267)
T 3t9t_A 148 FGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVED------- 217 (267)
T ss_dssp TTGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHH-------
T ss_pred cccccccccccc-cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH--HHHH-------
Confidence 999987643221 11123447789999999988889999999999999999999 899986432110 0000
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHh
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNI 934 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 934 (949)
+........+ ...+..+.+++.+|++.||++|||++|+++.|+++.++
T Consensus 218 ----i~~~~~~~~~-------------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 218 ----ISTGFRLYKP-------------------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp ----HHTTCCCCCC-------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----HhcCCcCCCC-------------------ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0000000000 01234678999999999999999999999999999764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=353.54 Aligned_cols=270 Identities=18% Similarity=0.203 Sum_probs=209.0
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.++|++.+.||+|+||.||+|++..+++.||||++........+.+.+|++++++++||||+++++++.... ......+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeE
Confidence 357899999999999999999998899999999997665556678999999999999999999999986322 2334678
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++|+|.+++.... .....+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 107 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~d 177 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLK------DKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMD 177 (317)
T ss_dssp EEEECCTTCBHHHHHHHHH------TTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECC
T ss_pred EEEEeCCCCcHHHHHHHHH------hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEe
Confidence 9999999999999986311 1245689999999999999999999988 999999999999999999999999
Q ss_pred cccceecCCCCCcc-------ccccccCccCccCccccCCCc---cCCccchHHHHHHHHHHHhCCCCCccccccCchhh
Q 039533 785 FGLARILSPDHTQT-------SSFSVKGSLGYIAPEYGVGCE---VSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLH 854 (949)
Q Consensus 785 fG~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~ 854 (949)
||.+.......... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||+..........
T Consensus 178 fg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 257 (317)
T 2buj_A 178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257 (317)
T ss_dssp CSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH
T ss_pred cCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh
Confidence 99987654321110 011234799999999987653 68999999999999999999999964322211111
Q ss_pred hhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHh
Q 039533 855 NFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNI 934 (949)
Q Consensus 855 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 934 (949)
... ....... .....+..+.+++.+||+.||++|||++|+++.|+++...
T Consensus 258 ~~~------------~~~~~~~------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 258 LAV------------QNQLSIP------------------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp HHH------------HCC--CC------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred HHh------------hccCCCC------------------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 110 0000000 0012345688999999999999999999999999987543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=354.97 Aligned_cols=246 Identities=20% Similarity=0.215 Sum_probs=201.3
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
.++|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----- 114 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS----- 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC-----
Confidence 367899999999999999999999899999999997432 233467889999999999999999999976544
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++|+|.+++. ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 115 ~~~lv~e~~~gg~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~k 181 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLR----------RIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQ 181 (350)
T ss_dssp EEEEEEECCTTCBHHHHHH----------HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEE
T ss_pred EEEEEEcCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEE
Confidence 7899999999999999996 234589999999999999999999987 999999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
|+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .
T Consensus 182 L~DFg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~-------- 246 (350)
T 1rdq_E 182 VTDFGFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ--I-------- 246 (350)
T ss_dssp ECCCTTCEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H--------
T ss_pred EcccccceeccCCc-----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH--H--------
Confidence 99999998765432 13459999999999999999999999999999999999999996331110 0
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC-----HHHHHH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTN-----MTNVVH 926 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~~ 926 (949)
...+...... .+ ...+..+.+++.+|++.||++||+ ++|+++
T Consensus 247 ---~~~i~~~~~~-~p-------------------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 247 ---YEKIVSGKVR-FP-------------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---HHHHHHCCCC-CC-------------------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---HHHHHcCCCC-CC-------------------CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 0011110000 00 022446789999999999999998 777764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=355.13 Aligned_cols=250 Identities=22% Similarity=0.248 Sum_probs=200.1
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccC
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRG 699 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 699 (949)
..++|++.+.||+|+||.||+|++..+++.||||+++... ....+.+..|..++..+ +||+|+++++++...+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~--- 94 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD--- 94 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS---
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC---
Confidence 4578999999999999999999999889999999997532 23456788999999988 7999999999976544
Q ss_pred CccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCc
Q 039533 700 NDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMT 779 (949)
Q Consensus 700 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~ 779 (949)
..++||||+++|+|.+++. ....+++..++.++.|++.||+|||++ +|+||||||+||+++.+++
T Consensus 95 --~~~lv~E~~~gg~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ 159 (353)
T 2i0e_A 95 --RLYFVMEYVNGGDLMYHIQ----------QVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGH 159 (353)
T ss_dssp --EEEEEEECCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSC
T ss_pred --EEEEEEeCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCc
Confidence 7899999999999999996 234589999999999999999999987 9999999999999999999
Q ss_pred eEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 780 ARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 780 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
+||+|||+++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .
T Consensus 160 vkL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--~------ 229 (353)
T 2i0e_A 160 IKIADFGMCKENIWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--L------ 229 (353)
T ss_dssp EEECCCTTCBCCCCTTCC--BCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H------
T ss_pred EEEEeCCcccccccCCcc--cccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH--H------
Confidence 999999999864332221 224569999999999999999999999999999999999999996331110 0
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC-----HHHHHH
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTN-----MTNVVH 926 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~~ 926 (949)
...+...... .+ ...+..+.+++.+|++.||++||+ ++|+++
T Consensus 230 -----~~~i~~~~~~-~p-------------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 230 -----FQSIMEHNVA-YP-------------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp -----HHHHHHCCCC-CC-------------------TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred -----HHHHHhCCCC-CC-------------------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0011111100 00 022456789999999999999996 456553
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=350.36 Aligned_cols=251 Identities=22% Similarity=0.243 Sum_probs=179.1
Q ss_pred CCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcC-CCcceeEEeeeecccccCCccceeEeee
Q 039533 631 ANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIR-HRNLVKVLTACLGADYRGNDFKASVYEF 709 (949)
Q Consensus 631 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~ 709 (949)
.+.||+|+||.||+|.+..+++.||||++... ....+.+|+.+++++. ||||+++++++.+.. ..++||||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~-----~~~lv~e~ 87 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQL-----HTFLVMEL 87 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-----EEEEEECC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC-----EEEEEEEc
Confidence 47899999999999999989999999998643 3467889999999997 999999999976544 78999999
Q ss_pred ccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC---ceEEeecc
Q 039533 710 MHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM---TARVGDFG 786 (949)
Q Consensus 710 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~---~~kl~DfG 786 (949)
+++|+|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||
T Consensus 88 ~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg 154 (325)
T 3kn6_A 88 LNGGELFERIK----------KKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFG 154 (325)
T ss_dssp CCSCBHHHHHH----------HCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCT
T ss_pred cCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccc
Confidence 99999999996 235689999999999999999999987 999999999999997665 89999999
Q ss_pred cceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchh
Q 039533 787 LARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVM 866 (949)
Q Consensus 787 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 866 (949)
+++......... ....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....
T Consensus 155 ~a~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----------~~~~~ 222 (325)
T 3kn6_A 155 FARLKPPDNQPL--KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT----------CTSAV 222 (325)
T ss_dssp TCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-----------------CCCHH
T ss_pred cceecCCCCCcc--cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc----------cccHH
Confidence 998765443322 134589999999999999999999999999999999999999964322100 00001
Q ss_pred hhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 867 DIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 867 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
++++....... ....+.....+..+.+++.+|++.||++|||++|+++
T Consensus 223 ~~~~~i~~~~~------------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 223 EIMKKIKKGDF------------SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHHHHHTTTCC------------CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred HHHHHHHcCCC------------CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 11110000000 0000111234567899999999999999999999863
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=343.16 Aligned_cols=257 Identities=24% Similarity=0.345 Sum_probs=202.7
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
.++|.+.+.||+|+||.||+|++. ++.||||+++.... ...+.+.+|+.++++++||||+++++++...+ ...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~ 83 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP---APH 83 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT---SSS
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC---CCC
Confidence 357899999999999999999986 78999999975532 33467899999999999999999999986542 247
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++|+|.+++... ....+++.++..++.|++.||+|||++ .++|+||||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~l 154 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEG--------TNFVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARI 154 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSC--------SSCCCCHHHHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTSCEEE
T ss_pred eEeeecccCCCcHHHHHhhc--------ccCCCCHHHHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCcceeE
Confidence 89999999999999999731 223589999999999999999999977 223999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCccCC---ccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVST---NGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
+|||++...... ...||+.|+|||++.+..++. ++|||||||++|||++|+.||..........
T Consensus 155 ~~~~~~~~~~~~-------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------ 221 (271)
T 3kmu_A 155 SMADVKFSFQSP-------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM------ 221 (271)
T ss_dssp EGGGSCCTTSCT-------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH------
T ss_pred Eeccceeeeccc-------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH------
Confidence 999987643221 235899999999988766554 7999999999999999999996432211100
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHH
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKN 933 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 933 (949)
........... ...++..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 222 -------~~~~~~~~~~~------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 222 -------KVALEGLRPTI------------------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp -------HHHHSCCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred -------HHHhcCCCCCC------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 00000000000 01234568899999999999999999999999999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=355.06 Aligned_cols=275 Identities=22% Similarity=0.344 Sum_probs=213.0
Q ss_pred cCCCCCCeeeeecCceEEEEEE----cCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 626 SGFSSANLVGVGSFGSVYKGII----DEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
++|++.+.||+|+||.||+|+. ..+++.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~ 117 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---RR 117 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-------
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC---CC
Confidence 5688899999999999999994 4578999999998766666678999999999999999999999876432 33
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++++|.+++.. ....+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~k 185 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQK---------HKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVK 185 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHH---------STTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEE
T ss_pred ceEEEEECCCCCCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEE
Confidence 67999999999999999962 234589999999999999999999987 999999999999999999999
Q ss_pred EeecccceecCCCCCcc-ccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 782 VGDFGLARILSPDHTQT-SSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
|+|||+++......... ......++..|+|||++.+..++.++||||||+++|||+||..||...... +.......
T Consensus 186 L~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~---~~~~~~~~ 262 (326)
T 2w1i_A 186 IGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGND 262 (326)
T ss_dssp ECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH---HHHHHCTT
T ss_pred EecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH---HHHhhccc
Confidence 99999999876554321 112334778899999998888999999999999999999999998532111 00000000
Q ss_pred CCC-----chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhh
Q 039533 861 LPD-----DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNIL 935 (949)
Q Consensus 861 ~~~-----~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~ 935 (949)
... .+.+.+.... +.+....++..+.+++.+||+.||++|||+.||++.|+++++.+
T Consensus 263 ~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 263 KQGQMIVFHLIELLKNNG------------------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp CCTHHHHHHHHHHHHTTC------------------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cchhhhHHHHHHHhhcCC------------------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 000 0011111100 00011234567899999999999999999999999999998876
Q ss_pred c
Q 039533 936 L 936 (949)
Q Consensus 936 ~ 936 (949)
.
T Consensus 325 ~ 325 (326)
T 2w1i_A 325 A 325 (326)
T ss_dssp H
T ss_pred c
Confidence 4
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=365.04 Aligned_cols=248 Identities=26% Similarity=0.352 Sum_probs=202.4
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
.++|.+.+.||+|+||.||+|++..+++.||||+++... ......+.+|+.++++++||||+++++++...+
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~----- 89 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS----- 89 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----
Confidence 367899999999999999999999899999999997432 223467899999999999999999999976544
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++|+|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 90 ~~~lv~E~~~gg~L~~~l~----------~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vk 156 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYIC----------KNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAK 156 (476)
T ss_dssp EEEEEEECCSSEEHHHHTT----------SSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEE
T ss_pred EEEEEEeCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeE
Confidence 7899999999999999996 234689999999999999999999977 999999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCcc-CCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEV-STNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
|+|||+++......... ...||+.|+|||++.+..+ +.++||||+||++|||++|+.||+..... ..
T Consensus 157 L~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--~~------- 224 (476)
T 2y94_A 157 IADFGLSNMMSDGEFLR---TSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP--TL------- 224 (476)
T ss_dssp ECCCSSCEECCTTCCBC---CCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH--HH-------
T ss_pred EEeccchhhcccccccc---ccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH--HH-------
Confidence 99999999876543222 3459999999999988765 68999999999999999999999643111 00
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
...+.+... ..+ ...+..+.+++.+|++.||++|||++|+++
T Consensus 225 ----~~~i~~~~~-~~p-------------------~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 225 ----FKKICDGIF-YTP-------------------QYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ----HHHHHTTCC-CCC-------------------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----HHHHhcCCc-CCC-------------------ccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 011111110 000 012345788999999999999999999987
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=346.08 Aligned_cols=268 Identities=22% Similarity=0.289 Sum_probs=196.7
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
++|++.+.||+|+||.||+|++. +++.||+|+++.... ...+.+.+|++++++++||||+++++++...+ ..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-----RL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-----CE
T ss_pred ccchhhhhcccCCCEEEEEEEcC-CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCC-----eE
Confidence 57889999999999999999984 789999999975432 23467889999999999999999999976544 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++||||+++ +|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 76 ~lv~e~~~~-~l~~~~~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 142 (288)
T 1ob3_A 76 VLVFEHLDQ-DLKKLLDV---------CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIA 142 (288)
T ss_dssp EEEEECCSE-EHHHHHHT---------STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred EEEEEecCC-CHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEe
Confidence 999999985 99998862 234588999999999999999999987 99999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcc---c
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGR---K 859 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~---~ 859 (949)
|||+++......... ....||+.|+|||++.+. .++.++||||+||++|||++|+.||......+. ...... .
T Consensus 143 Dfg~~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~ 219 (288)
T 1ob3_A 143 DFGLARAFGIPVRKY--THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGT 219 (288)
T ss_dssp CTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCC
T ss_pred ECccccccCcccccc--ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHHCC
Confidence 999998765432211 134589999999998764 589999999999999999999999965422111 111100 0
Q ss_pred cCCCchhhh-----cccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 860 ALPDDVMDI-----VDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 860 ~~~~~~~~~-----~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
......... .++...... +..........+..+.+++.+|++.||++|||++|+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 220 PNSKNWPNVTELPKYDPNFTVYE-----------PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCTTTSTTGGGSTTCCTTCCCCC-----------CCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CChhhchhhhccccccccccccc-----------CccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000000 000000000 00000001123456789999999999999999999875
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=360.40 Aligned_cols=283 Identities=18% Similarity=0.202 Sum_probs=203.8
Q ss_pred HhcCCCCCCeeeee--cCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccC
Q 039533 624 ATSGFSSANLVGVG--SFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRG 699 (949)
Q Consensus 624 ~~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 699 (949)
..++|++.+.||+| +||.||+|++..+++.||||+++.... ...+.+.+|+.++++++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--- 99 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN--- 99 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT---
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC---
Confidence 35679999999999 999999999998999999999975432 23467888999999999999999999986544
Q ss_pred CccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCc
Q 039533 700 NDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMT 779 (949)
Q Consensus 700 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~ 779 (949)
..++||||+++|+|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 100 --~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~ 166 (389)
T 3gni_B 100 --ELWVVTSFMAYGSAKDLICTH--------FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGK 166 (389)
T ss_dssp --EEEEEEECCTTCBHHHHHHHT--------CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCC
T ss_pred --EEEEEEEccCCCCHHHHHhhh--------cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCC
Confidence 789999999999999999621 124589999999999999999999988 8999999999999999999
Q ss_pred eEEeecccceecCCCCC-----ccccccccCccCccCccccCC--CccCCccchHHHHHHHHHHHhCCCCCccccccCch
Q 039533 780 ARVGDFGLARILSPDHT-----QTSSFSVKGSLGYIAPEYGVG--CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDIN 852 (949)
Q Consensus 780 ~kl~DfG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~ 852 (949)
+||+|||.+........ ........||..|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 246 (389)
T 3gni_B 167 VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML 246 (389)
T ss_dssp EEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH
T ss_pred EEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 99999999875432211 111112458999999999887 57899999999999999999999999654322211
Q ss_pred hhhhccccCCCchhhhcccCCCC---------------Cchhhhhhhc---hhhhhhhhhhHHHHHHHHHHHhhccccCC
Q 039533 853 LHNFGRKALPDDVMDIVDSSLLP---------------DDEDLILTGN---QRQKQARINSIIECLISMVRIGVACSMEL 914 (949)
Q Consensus 853 ~~~~~~~~~~~~~~~~~d~~l~~---------------~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~l~~~cl~~d 914 (949)
. .......+ .+.+....+ ...+...... ........+.....+..+.+++.+||+.|
T Consensus 247 ~-~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 321 (389)
T 3gni_B 247 L-EKLNGTVP----CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRN 321 (389)
T ss_dssp H-HC------------------------------------------------------------CCHHHHHHHHHHTCSC
T ss_pred H-HHhcCCCC----ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcC
Confidence 1 11111000 000000000 0000000000 00000001112334567899999999999
Q ss_pred CCCCCCHHHHHHH
Q 039533 915 PQDRTNMTNVVHE 927 (949)
Q Consensus 915 P~~RPs~~ev~~~ 927 (949)
|++|||++|+++.
T Consensus 322 P~~Rpta~ell~h 334 (389)
T 3gni_B 322 PDARPSASTLLNH 334 (389)
T ss_dssp TTTSCCHHHHTTS
T ss_pred cccCCCHHHHhcC
Confidence 9999999999853
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=349.05 Aligned_cols=270 Identities=21% Similarity=0.270 Sum_probs=200.6
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
.++|++.+.||+|+||.||+|.+..+++.||||+++... ......+.+|+.++++++||||+++++++...+
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----- 105 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN----- 105 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-----
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-----
Confidence 357899999999999999999998889999999997532 223467889999999999999999999987544
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++++|.+++... ......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~k 176 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHF------KKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVK 176 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHH------HHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred cEEEEEecCCCCCHHHHHHHh------cccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEE
Confidence 789999999999999998621 11235689999999999999999999987 999999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
|+|||+++......... ....|+..|+|||++.+..++.++||||||+++|||++|+.||..............
T Consensus 177 l~Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---- 250 (310)
T 2wqm_A 177 LGDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI---- 250 (310)
T ss_dssp ECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHH----
T ss_pred EEeccceeeecCCCccc--cccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHh----
Confidence 99999998765433221 134589999999999998999999999999999999999999853221111111000
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhhccCC
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILLGVE 939 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~ 939 (949)
.......... ...+..+.+++.+||+.||++|||++||++.|++++.....+.
T Consensus 251 -------~~~~~~~~~~------------------~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 251 -------EQCDYPPLPS------------------DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp -------HTTCSCCCCT------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred -------hcccCCCCcc------------------cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 0000000000 1234568899999999999999999999999999988866553
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=346.57 Aligned_cols=264 Identities=25% Similarity=0.399 Sum_probs=203.5
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCC---CEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEG---RTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
.+|++.+.||+|+||.||+|++..+ ...||+|++..... ...+.+.+|+.++++++||||+++++++... +.
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~ 100 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EG 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----SS
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC----CC
Confidence 4578889999999999999997533 34689999875332 3346789999999999999999999986432 34
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++|+|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~k 168 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRN---------ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVK 168 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHC---------TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEE
T ss_pred ceEEEEeCCCCCCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEE
Confidence 67999999999999999962 234578999999999999999999987 999999999999999999999
Q ss_pred EeecccceecCCCCC--ccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhcc
Q 039533 782 VGDFGLARILSPDHT--QTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGR 858 (949)
Q Consensus 782 l~DfG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~ 858 (949)
|+|||.++....... ........||+.|+|||.+.+..++.++||||||+++|||++ |.+||......+.. .
T Consensus 169 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~--~--- 243 (298)
T 3f66_A 169 VADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT--V--- 243 (298)
T ss_dssp ECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH--H---
T ss_pred ECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH--H---
Confidence 999999987654332 111223457889999999988889999999999999999999 55565432211110 0
Q ss_pred ccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhhcc
Q 039533 859 KALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILLG 937 (949)
Q Consensus 859 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~ 937 (949)
..........+ ..++..+.+++.+|++.||++|||++|+++.|+++...+.+
T Consensus 244 --------~~~~~~~~~~~-------------------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 244 --------YLLQGRRLLQP-------------------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp --------HHHTTCCCCCC-------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred --------HHhcCCCCCCC-------------------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 00000000000 02234688999999999999999999999999999887654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=343.16 Aligned_cols=252 Identities=19% Similarity=0.236 Sum_probs=202.3
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.++++++||||+++++++.... .
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~ 79 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES-----F 79 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----E
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCC-----E
Confidence 4689999999999999999999998999999999975432 23467889999999999999999999976544 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCc---
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMT--- 779 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~--- 779 (949)
.++||||+++++|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 80 ~~~v~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~ 146 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIV----------AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAA 146 (284)
T ss_dssp EEEEECCCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCC
T ss_pred EEEEEecCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCc
Confidence 899999999999999886 235689999999999999999999988 8999999999999986655
Q ss_pred eEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 780 ARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 780 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
+||+|||.+.......... ...||+.|+|||++.+..++.++||||+|+++|+|++|+.||....... .....
T Consensus 147 ~kl~Dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~-- 219 (284)
T 3kk8_A 147 VKLADFGLAIEVNDSEAWH---GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--LYAQI-- 219 (284)
T ss_dssp EEECCCTTCEECCSSCBCC---CSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH--
T ss_pred EEEeeceeeEEcccCcccc---CCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH--HHHHH--
Confidence 9999999998766543322 3569999999999999999999999999999999999999995432111 00000
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
....... +. +.....+..+.+++.+|++.||++|||++|+++
T Consensus 220 ---------~~~~~~~-~~---------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 220 ---------KAGAYDY-PS---------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp ---------HHTCCCC-CT---------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---------HhccccC-Cc---------------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000000 00 000123456789999999999999999999987
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=362.16 Aligned_cols=262 Identities=19% Similarity=0.225 Sum_probs=204.7
Q ss_pred CHHHHHHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeee
Q 039533 617 SYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACL 693 (949)
Q Consensus 617 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 693 (949)
.+.+.....++|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|..++.+++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34455566789999999999999999999999899999999997432 223345889999999999999999999976
Q ss_pred cccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCee
Q 039533 694 GADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVL 773 (949)
Q Consensus 694 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIl 773 (949)
+.+ ..++||||+++|+|.+++.. ....+++..++.++.||+.||+|||++ +|+||||||+|||
T Consensus 132 ~~~-----~~~lVmE~~~gg~L~~~l~~---------~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NIL 194 (412)
T 2vd5_A 132 DEN-----YLYLVMEYYVGGDLLTLLSK---------FGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNIL 194 (412)
T ss_dssp CSS-----EEEEEECCCCSCBHHHHHHH---------HSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred eCC-----EEEEEEcCCCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHee
Confidence 544 78999999999999999962 124689999999999999999999987 9999999999999
Q ss_pred ecCCCceEEeecccceecCCCCCccccccccCccCccCccccC-------CCccCCccchHHHHHHHHHHHhCCCCCccc
Q 039533 774 LDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGV-------GCEVSTNGDVYSYGILLLELVIGKKPIDIM 846 (949)
Q Consensus 774 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDiwSlGvvl~elltg~~Pf~~~ 846 (949)
++.++++||+|||+++......... .....||+.|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 195 ld~~g~vkL~DFGla~~~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 273 (412)
T 2vd5_A 195 LDRCGHIRLADFGSCLKLRADGTVR-SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD 273 (412)
T ss_dssp ECTTSCEEECCCTTCEECCTTSCEE-CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ecCCCCEEEeechhheeccCCCccc-cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC
Confidence 9999999999999998876543322 22356999999999987 457899999999999999999999999643
Q ss_pred cccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhh-HHHHHHHHHHHhhccccCCCCCC---CCHH
Q 039533 847 FEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINS-IIECLISMVRIGVACSMELPQDR---TNMT 922 (949)
Q Consensus 847 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~R---Ps~~ 922 (949)
.... .+. .++... ....++. ....+..+.+++.+|++ +|++| |+++
T Consensus 274 ~~~~-~~~------------~i~~~~----------------~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ 323 (412)
T 2vd5_A 274 STAE-TYG------------KIVHYK----------------EHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAG 323 (412)
T ss_dssp SHHH-HHH------------HHHTHH----------------HHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHH
T ss_pred CHHH-HHH------------HHHhcc----------------cCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHH
Confidence 2111 000 000000 0000000 01234568899999999 99998 5888
Q ss_pred HHHH
Q 039533 923 NVVH 926 (949)
Q Consensus 923 ev~~ 926 (949)
|+++
T Consensus 324 ei~~ 327 (412)
T 2vd5_A 324 DFRT 327 (412)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 8864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=341.50 Aligned_cols=262 Identities=25% Similarity=0.402 Sum_probs=207.9
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.++|++.+.||+|+||.||+|.+. +++.||||+++... ...+.+.+|++++++++||||+++++++.. +..+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~ 83 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EPIY 83 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC------CCcE
Confidence 467888999999999999999987 67889999997543 345789999999999999999999998642 2578
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++++|.+++... ....+++.++..++.|++.||+|||++ +|+||||||+||++++++.+||+|
T Consensus 84 ~v~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~D 152 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTP--------SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIAD 152 (279)
T ss_dssp EEEECCTTCBHHHHTTSH--------HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECC
T ss_pred EEEecCCCCCHHHHHhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECC
Confidence 999999999999999621 123589999999999999999999987 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCC
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
||.++......... .....++..|+|||++.+..++.++||||||+++|||++ |+.||....... ....
T Consensus 153 fg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~------- 222 (279)
T 1qpc_A 153 FGLARLIEDNEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQN------- 222 (279)
T ss_dssp CTTCEECSSSCEEC-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHH-------
T ss_pred CcccccccCccccc-ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH--HHHH-------
Confidence 99998876543221 123447889999999988889999999999999999999 999986432111 0000
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhhccC
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILLGV 938 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~~ 938 (949)
+........ ...++..+.+++.+|++.||++|||++|+++.|+++.......
T Consensus 223 -----~~~~~~~~~------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 274 (279)
T 1qpc_A 223 -----LERGYRMVR------------------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 274 (279)
T ss_dssp -----HHTTCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC---
T ss_pred -----HhcccCCCC------------------cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCC
Confidence 000000000 0123456889999999999999999999999999998775543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=358.48 Aligned_cols=254 Identities=21% Similarity=0.225 Sum_probs=192.4
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.++|++.+.||+|+||+||+|++..+++.||||++..... ..+.+.+|+.++++++||||+++++++...+ ..+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~~ 92 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLA 92 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----EEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCC-----EEE
Confidence 4689999999999999999999998999999999975432 3467889999999999999999999986544 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCc--eEE
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMT--ARV 782 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~--~kl 782 (949)
+||||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||
T Consensus 93 lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl 159 (361)
T 3uc3_A 93 IIMEYASGGELYERIC----------NAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKI 159 (361)
T ss_dssp EEEECCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEE
T ss_pred EEEEeCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEE
Confidence 9999999999999986 234689999999999999999999987 8999999999999987765 999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCccCCc-cchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTN-GDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
+|||+++........ ....||+.|+|||++.+..++.+ +||||+||++|||++|+.||........ .....
T Consensus 160 ~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~~~---- 231 (361)
T 3uc3_A 160 CDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTI---- 231 (361)
T ss_dssp CCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-HHHHH----
T ss_pred eecCccccccccCCC---CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-HHHHH----
Confidence 999999754332221 23459999999999988877655 8999999999999999999964322111 11100
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
..+......... ....+..+.+++.+|++.||++|||+.|+++.
T Consensus 232 ----~~~~~~~~~~~~------------------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 232 ----QRILSVKYSIPD------------------DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ----HHHHTTCCCCCT------------------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ----HHHhcCCCCCCC------------------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 001110000000 00123467899999999999999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=352.47 Aligned_cols=243 Identities=23% Similarity=0.324 Sum_probs=200.9
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc--------chHHHHHHHHHHHhcCCCcceeEEeeeeccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG--------ASRSFIAECKALKSIRHRNLVKVLTACLGAD 696 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 696 (949)
.++|++.+.||+|+||.||+|++..+++.||||+++..... ..+.+.+|+.++++++||||+++++++...+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 46799999999999999999999999999999999754321 2346778999999999999999999976544
Q ss_pred ccCCccceeEeeeccCC-ChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec
Q 039533 697 YRGNDFKASVYEFMHYG-SLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD 775 (949)
Q Consensus 697 ~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~ 775 (949)
..++||||+.+| +|.+++. ....+++..+..|+.|++.||+|||++ +|+||||||+||+++
T Consensus 103 -----~~~lv~e~~~~g~~l~~~~~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~ 164 (335)
T 3dls_A 103 -----FFQLVMEKHGSGLDLFAFID----------RHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIA 164 (335)
T ss_dssp -----EEEEEEECCTTSCBHHHHHH----------TCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred -----EEEEEEEeCCCCccHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEc
Confidence 789999999777 9999986 234589999999999999999999988 999999999999999
Q ss_pred CCCceEEeecccceecCCCCCccccccccCccCccCccccCCCcc-CCccchHHHHHHHHHHHhCCCCCccccccCchhh
Q 039533 776 DYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEV-STNGDVYSYGILLLELVIGKKPIDIMFEGDINLH 854 (949)
Q Consensus 776 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~ 854 (949)
.++.+||+|||+++......... ...||+.|+|||++.+..+ +.++|||||||++|||++|+.||......
T Consensus 165 ~~~~~kL~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----- 236 (335)
T 3dls_A 165 EDFTIKLIDFGSAAYLERGKLFY---TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----- 236 (335)
T ss_dssp TTSCEEECCCTTCEECCTTCCBC---EECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----
T ss_pred CCCcEEEeecccceECCCCCcee---ccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----
Confidence 99999999999998876544322 3459999999999988776 78999999999999999999999632110
Q ss_pred hhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 855 NFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 855 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
....... +. ..+..+.+++.+|++.||++|||++|+++.
T Consensus 237 --------------~~~~~~~-~~-------------------~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 --------------VEAAIHP-PY-------------------LVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp --------------TTTCCCC-SS-------------------CCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred --------------HhhccCC-Cc-------------------ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 00 123457899999999999999999999874
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=352.52 Aligned_cols=283 Identities=22% Similarity=0.280 Sum_probs=216.3
Q ss_pred cCHHHHHHHhcCCCCCCeeeeecCceEEEEEEc-----CCCEEEEEEEEecCCC-cchHHHHHHHHHHHhc-CCCcceeE
Q 039533 616 LSYQDLYNATSGFSSANLVGVGSFGSVYKGIID-----EGRTTIAVKVFNLQHH-GASRSFIAECKALKSI-RHRNLVKV 688 (949)
Q Consensus 616 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~ 688 (949)
+...+.....++|++.+.||+|+||.||+|++. .+++.||||+++.... ...+.+.+|+.+++++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 344455556688999999999999999999863 4668999999975433 2346789999999999 79999999
Q ss_pred EeeeecccccCCccceeEeeeccCCChhhhcCCCCCCCc------cccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 039533 689 LTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDE------IDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVT 762 (949)
Q Consensus 689 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~i 762 (949)
++++...+ ...++||||+++++|.+++........ .......+++..+..++.|++.||+|||++ +|
T Consensus 97 ~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i 169 (316)
T 2xir_A 97 LGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KC 169 (316)
T ss_dssp EEEECCTT----SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred EEEEecCC----CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 99975432 358999999999999999974321100 000123388999999999999999999987 99
Q ss_pred EecCCCCCCeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCC
Q 039533 763 AHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKK 841 (949)
Q Consensus 763 vHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~ 841 (949)
+||||||+||+++.++.+||+|||.++...............||+.|+|||++.+..++.++|||||||++|||+| |+.
T Consensus 170 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~ 249 (316)
T 2xir_A 170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249 (316)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999987655444333334557899999999988889999999999999999998 999
Q ss_pred CCccccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCH
Q 039533 842 PIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNM 921 (949)
Q Consensus 842 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 921 (949)
||........ .. ..+........ ....+..+.+++.+||+.||++|||+
T Consensus 250 p~~~~~~~~~-~~------------~~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~ 298 (316)
T 2xir_A 250 PYPGVKIDEE-FC------------RRLKEGTRMRA------------------PDYTTPEMYQTMLDCWHGEPSQRPTF 298 (316)
T ss_dssp SSTTCCCSHH-HH------------HHHHHTCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCcccchhHH-HH------------HHhccCccCCC------------------CCCCCHHHHHHHHHHcCCChhhCcCH
Confidence 9964321111 10 00000000000 00124467899999999999999999
Q ss_pred HHHHHHHHHhHHhhc
Q 039533 922 TNVVHELQSIKNILL 936 (949)
Q Consensus 922 ~ev~~~L~~i~~~~~ 936 (949)
.||++.|+++.+...
T Consensus 299 ~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 299 SELVEHLGNLLQANA 313 (316)
T ss_dssp HHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHhhhc
Confidence 999999999987643
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=346.57 Aligned_cols=262 Identities=25% Similarity=0.408 Sum_probs=212.4
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|++++++++||||+++++++.... ..
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~ 84 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-----PF 84 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-----CE
Confidence 4567889999999999999999999889999999997433 34578999999999999999999999975443 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++||||+++++|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~ 153 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLREC--------NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVA 153 (288)
T ss_dssp EEEEECCTTEEHHHHHHHC--------CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEEEEcCCCCcHHHHHHhc--------ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEc
Confidence 9999999999999999621 234589999999999999999999988 89999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCC
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
|||.+.......... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 154 Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~------------ 220 (288)
T 3kfa_A 154 DFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------------ 220 (288)
T ss_dssp CCCGGGTSCSSSSEE-ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG------------
T ss_pred cCccceeccCCcccc-ccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------------
Confidence 999998765443322 223447889999999998889999999999999999999 999986432111
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhh
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNIL 935 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~ 935 (949)
..+.+........ ...++..+.+++.+|++.||++|||++|+++.|+++....
T Consensus 221 --~~~~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 221 --VYELLEKDYRMER------------------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp --HHHHHHTTCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --HHHHHhccCCCCC------------------CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1111111110000 0123456889999999999999999999999999987654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=351.18 Aligned_cols=272 Identities=22% Similarity=0.282 Sum_probs=198.3
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc--chHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG--ASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+.+|++++++++||||+++++++...+ ..
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~ 77 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR-----RL 77 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCC-----eE
Confidence 5789999999999999999999988999999998654332 2456889999999999999999999976544 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++||||+++++|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 78 ~lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~ 144 (311)
T 4agu_A 78 HLVFEYCDHTVLHELDR----------YQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLC 144 (311)
T ss_dssp EEEEECCSEEHHHHHHH----------TSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred EEEEEeCCCchHHHHHh----------hhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEe
Confidence 99999999999999876 234589999999999999999999987 99999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCch--hhhhcccc
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDIN--LHNFGRKA 860 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~--~~~~~~~~ 860 (949)
|||.++......... ....||..|+|||++.+ ..++.++||||+|+++|||++|+.||......+.. ........
T Consensus 145 Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 222 (311)
T 4agu_A 145 DFGFARLLTGPSDYY--DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDL 222 (311)
T ss_dssp CCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred eCCCchhccCccccc--CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccc
Confidence 999998765433221 13458999999999876 56899999999999999999999999644322110 00000000
Q ss_pred CCCchh-----hhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 861 LPDDVM-----DIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 861 ~~~~~~-----~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.+.... ........+++.+. ..........+..+.+++.+|++.||++|||++|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 223 IPRHQQVFSTNQYFSGVKIPDPEDM---------EPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp CHHHHHHHHTCGGGTTCCCCCCSSC---------CCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccccccccccccccCcCCCcccc---------chhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000 00000000000000 0000001134556889999999999999999999975
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=361.03 Aligned_cols=275 Identities=20% Similarity=0.327 Sum_probs=211.2
Q ss_pred HHHHHhcCCCCCCeeeeecCceEEEEEEc-----CCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeee
Q 039533 620 DLYNATSGFSSANLVGVGSFGSVYKGIID-----EGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACL 693 (949)
Q Consensus 620 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 693 (949)
+.+...++|++.+.||+|+||.||+|++. .+++.||||++..... .....+.+|+.++++++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 44456678999999999999999999876 3468899999874432 23456889999999999999999999975
Q ss_pred cccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCee
Q 039533 694 GADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVL 773 (949)
Q Consensus 694 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIl 773 (949)
..+ ..++||||+++|+|.+++...............+++..++.++.|++.||+|||++ +|+||||||+||+
T Consensus 99 ~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIl 170 (322)
T 1p4o_A 99 QGQ-----PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM 170 (322)
T ss_dssp SSS-----SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEE
T ss_pred cCC-----ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEE
Confidence 443 78999999999999999963210000001124578999999999999999999988 9999999999999
Q ss_pred ecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCch
Q 039533 774 LDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDIN 852 (949)
Q Consensus 774 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~ 852 (949)
++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||.......
T Consensus 171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-- 248 (322)
T 1p4o_A 171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-- 248 (322)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--
T ss_pred EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH--
Confidence 99999999999999986654333222223457889999999988889999999999999999999 899986432111
Q ss_pred hhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhH
Q 039533 853 LHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIK 932 (949)
Q Consensus 853 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~ 932 (949)
... .+........+ ..++..+.+++.+|++.||++|||+.|+++.|+++.
T Consensus 249 ~~~-----------~~~~~~~~~~~-------------------~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 249 VLR-----------FVMEGGLLDKP-------------------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp HHH-----------HHHTTCCCCCC-------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHH-----------HHHcCCcCCCC-------------------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 000 00111110100 123456889999999999999999999999998875
Q ss_pred Hh
Q 039533 933 NI 934 (949)
Q Consensus 933 ~~ 934 (949)
..
T Consensus 299 ~~ 300 (322)
T 1p4o_A 299 EP 300 (322)
T ss_dssp CT
T ss_pred cc
Confidence 43
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=352.73 Aligned_cols=351 Identities=18% Similarity=0.152 Sum_probs=233.6
Q ss_pred CccCccCCCCcce-eeeeEEeCCCCcEEEEEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccCcEEee
Q 039533 42 VLGTWNESIHFCK-WYGVTCSRRHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLAL 120 (949)
Q Consensus 42 ~l~sW~~~~~~C~-w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 120 (949)
.+++|..+.+||. |.+..|.....+ +............-..+++++.|++++|.++...+..|.++++|++|+|
T Consensus 2 ~~~~~~~~~~C~~~~~~~~c~~~~~~-----i~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L 76 (390)
T 3o6n_A 2 NVKPRQPEYKCIDSNLQYDCVFYDVH-----IDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNL 76 (390)
T ss_dssp -----CCEECBCC------EEEESCE-----ECSSCCCCEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEEC
T ss_pred CcCCCCCccceehhhhhhccceeeee-----eecccccccccccccccCCceEEEecCCchhhCChhHhcccccCcEEEC
Confidence 3678988888885 555555432211 2222222222333346799999999999998544445799999999999
Q ss_pred ccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCC
Q 039533 121 NNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGT 200 (949)
Q Consensus 121 s~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 200 (949)
++|.+++..|..|+++++|++|++++|.+.+..+..|..+++|++|+|++|.++...+..|+++++|++|+|++|++++.
T Consensus 77 ~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~ 156 (390)
T 3o6n_A 77 NDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERI 156 (390)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBC
T ss_pred CCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCcc
Confidence 99999977778999999999999999999999999999999999999999999955555579999999999999999988
Q ss_pred CCCcccCCCccccccccCcccccccccccCCCCChhhhccccccccccCCCCCCCCCCcchhccccccCcccEEEccCCC
Q 039533 201 IPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNN 280 (949)
Q Consensus 201 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~ 280 (949)
.|..|+.+++|++|++++|+++.++ +..+++ |+.|++++|.
T Consensus 157 ~~~~~~~l~~L~~L~l~~n~l~~~~---------~~~l~~------------------------------L~~L~l~~n~ 197 (390)
T 3o6n_A 157 EDDTFQATTSLQNLQLSSNRLTHVD---------LSLIPS------------------------------LFHANVSYNL 197 (390)
T ss_dssp CTTTTSSCTTCCEEECCSSCCSBCC---------GGGCTT------------------------------CSEEECCSSC
T ss_pred ChhhccCCCCCCEEECCCCcCCccc---------cccccc------------------------------cceeeccccc
Confidence 8888999999999999999876442 223333 4444444444
Q ss_pred CCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCc
Q 039533 281 FGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPP 360 (949)
Q Consensus 281 l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 360 (949)
+++.. .+..|++|++++|+++.. |.. ..++|++|+|++|.+++. ..+..+++|+.|+|++|++++..|.
T Consensus 198 l~~~~------~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~ 266 (390)
T 3o6n_A 198 LSTLA------IPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYH 266 (390)
T ss_dssp CSEEE------CCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESG
T ss_pred ccccC------CCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChh
Confidence 44321 123466666666666533 322 235666777777776642 4566666777777777777666666
Q ss_pred ccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccc
Q 039533 361 SIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKI 440 (949)
Q Consensus 361 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~ 440 (949)
.|.++++|+.|+|++|++++ +|..+..+++|++|+|++|+++ .+| ..+..+++
T Consensus 267 ~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~-------------------------~~~~~l~~ 319 (390)
T 3o6n_A 267 PFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVE-------------------------RNQPQFDR 319 (390)
T ss_dssp GGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCG-------------------------GGHHHHTT
T ss_pred HccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecC-------------------------ccccccCc
Confidence 66666666666666666663 3444555666666666666665 333 34444555
Q ss_pred cceeeeccccccccCCcccccccchhhcccCcccccc
Q 039533 441 LEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQG 477 (949)
Q Consensus 441 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 477 (949)
|+.|+|++|+++.. | +..+++|+.|++++|.++.
T Consensus 320 L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~ 353 (390)
T 3o6n_A 320 LENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDC 353 (390)
T ss_dssp CSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEH
T ss_pred CCEEECCCCcccee-C--chhhccCCEEEcCCCCccc
Confidence 55555555555532 2 4455566666666666654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=344.36 Aligned_cols=266 Identities=23% Similarity=0.343 Sum_probs=205.4
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCC---EEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGR---TTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
.|.+.++||+|+||+||+|++..++ ..||+|++..... ...+.+.+|+.++++++||||+++++++...+ ..
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~ 97 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE----GL 97 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----SC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC----CC
Confidence 3555689999999999999975443 3799999875433 33467899999999999999999999975433 34
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+.+|+|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 98 ~~~v~e~~~~~~L~~~~~~---------~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl 165 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRS---------PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKV 165 (298)
T ss_dssp CEEEECCCTTCBHHHHHHC---------TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEE
T ss_pred cEEEEecccCCCHHHHHhc---------cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEe
Confidence 5899999999999999962 235588999999999999999999988 8999999999999999999999
Q ss_pred eecccceecCCCCC--ccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 783 GDFGLARILSPDHT--QTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 783 ~DfG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
+|||+++....... ........++..|+|||.+.+..++.++||||||+++|||++|..|+....... ...
T Consensus 166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~-~~~------ 238 (298)
T 3pls_A 166 ADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF-DLT------ 238 (298)
T ss_dssp CCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG-GHH------
T ss_pred CcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH-HHH------
Confidence 99999986544321 111223457899999999999999999999999999999999665543211110 111
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhhccCC
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILLGVE 939 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~ 939 (949)
..+........ ...++..+.+++.+|++.||++|||++|+++.|+++.+.+....
T Consensus 239 ------~~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 239 ------HFLAQGRRLPQ------------------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp ------HHHHTTCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred ------HHhhcCCCCCC------------------CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 11100000000 01224568899999999999999999999999999998876553
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=360.51 Aligned_cols=288 Identities=19% Similarity=0.204 Sum_probs=213.0
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
++|.+.++||+|+||.||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++...+ ....+
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~~~~~ 85 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHKV 85 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC---CCeeE
Confidence 56889999999999999999999889999999997543 233567889999999999999999999976432 33679
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeee----cCCCce
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL----DDYMTA 780 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll----~~~~~~ 780 (949)
+||||+++|+|.+++.... ....+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+
T Consensus 86 lv~e~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~ 155 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPS-------NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVY 155 (396)
T ss_dssp EEECCCTTEEHHHHTTSGG-------GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEE
T ss_pred EEEecCCCCCHHHHHHhhh-------cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeE
Confidence 9999999999999997321 223489999999999999999999988 89999999999999 778889
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCC--------CccCCccchHHHHHHHHHHHhCCCCCccccccCch
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG--------CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDIN 852 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~ 852 (949)
||+|||+++........ ....||..|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 156 kL~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~ 232 (396)
T 4eut_A 156 KLTDFGAARELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232 (396)
T ss_dssp EECCGGGCEECCCGGGS---SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC
T ss_pred EEecCCCceEccCCCcc---ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch
Confidence 99999999876554322 23569999999998764 56788999999999999999999999643221111
Q ss_pred --hhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 039533 853 --LHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQS 930 (949)
Q Consensus 853 --~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 930 (949)
.........+......+......... .... ..............+.+++.+|++.||++||+++|+++.+++
T Consensus 233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~--~~~~----~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~ 306 (396)
T 4eut_A 233 KEVMYKIITGKPSGAISGVQKAENGPID--WSGD----MPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (396)
T ss_dssp HHHHHHHHHSCCTTCCEEEECSTTCCEE--EESS----CCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHhcCCCcccchhheeccCCCcc--cCcc----CCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence 11101111111100000000000000 0000 000001124667788999999999999999999999999998
Q ss_pred hHHhh
Q 039533 931 IKNIL 935 (949)
Q Consensus 931 i~~~~ 935 (949)
+....
T Consensus 307 il~~~ 311 (396)
T 4eut_A 307 ILHRM 311 (396)
T ss_dssp HHTCE
T ss_pred Hhhce
Confidence 86653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=341.28 Aligned_cols=250 Identities=24% Similarity=0.366 Sum_probs=181.8
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
.++|.+.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|+.++++++||||+++++++...+
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 84 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN----- 84 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS-----
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC-----
Confidence 467999999999999999999998889999999996432 223467899999999999999999999976544
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++++|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~k 152 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKN---------RVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIK 152 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHT---------CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEE
T ss_pred eEEEEEecCCCCcHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEE
Confidence 78999999999999999962 234689999999999999999999988 999999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
|+|||.+.......... ....||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 153 l~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---------- 220 (278)
T 3cok_A 153 IADFGLATQLKMPHEKH--YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT---------- 220 (278)
T ss_dssp ECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------
T ss_pred EEeecceeeccCCCCcc--eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH----------
Confidence 99999998765433221 234589999999999988899999999999999999999999964321110
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
......... ..+ ...+..+.+++.+|++.||++|||++|+++
T Consensus 221 ---~~~~~~~~~-~~~-------------------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 221 ---LNKVVLADY-EMP-------------------SFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ------CCSSCC-CCC-------------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---HHHHhhccc-CCc-------------------cccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 000000000 000 012345789999999999999999999976
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=353.78 Aligned_cols=270 Identities=20% Similarity=0.266 Sum_probs=202.9
Q ss_pred HHHHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecC-----CCcchHHHHHHHHHHHhcCCCcceeEEeeeec
Q 039533 620 DLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ-----HHGASRSFIAECKALKSIRHRNLVKVLTACLG 694 (949)
Q Consensus 620 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 694 (949)
++....++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|++++++++||||+++++++..
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 3456677899999999999999999999989999999999643 23445789999999999999999999999865
Q ss_pred ccccCCccceeEeeeccCCChhhhcCCCCCCCc------------------------------cccCCCCCCHHHHHHHH
Q 039533 695 ADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDE------------------------------IDEAPRNLNLLQRLNIA 744 (949)
Q Consensus 695 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------------------------------~~~~~~~l~~~~~~~i~ 744 (949)
.+ ..++||||+++|+|.+++........ .......+++..+..++
T Consensus 100 ~~-----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 174 (345)
T 3hko_A 100 EQ-----YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIM 174 (345)
T ss_dssp SS-----EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHH
T ss_pred CC-----eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHH
Confidence 44 78999999999999999852111000 00012234677888999
Q ss_pred HHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC--ceEEeecccceecCCCCC--ccccccccCccCccCccccCC--C
Q 039533 745 IDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM--TARVGDFGLARILSPDHT--QTSSFSVKGSLGYIAPEYGVG--C 818 (949)
Q Consensus 745 ~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~--~~kl~DfG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~ 818 (949)
.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+++....... ........||+.|+|||++.+ .
T Consensus 175 ~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 251 (345)
T 3hko_A 175 RQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE 251 (345)
T ss_dssp HHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSS
T ss_pred HHHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCC
Confidence 9999999999988 899999999999998766 899999999987643222 111224569999999999875 5
Q ss_pred ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHH
Q 039533 819 EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIE 898 (949)
Q Consensus 819 ~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 898 (949)
.++.++|||||||++|||++|+.||......+. ...+......... +....
T Consensus 252 ~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-------------~~~~~~~~~~~~~----------------~~~~~ 302 (345)
T 3hko_A 252 SYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADT-------------ISQVLNKKLCFEN----------------PNYNV 302 (345)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------------HHHHHHCCCCTTS----------------GGGGG
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHH-------------HHHHHhcccccCC----------------ccccc
Confidence 788999999999999999999999964322110 1111111111000 00112
Q ss_pred HHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 899 CLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 899 ~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.+..+.+++.+|++.||++|||+.|+++
T Consensus 303 ~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 303 LSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp SCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 3456889999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=347.89 Aligned_cols=264 Identities=18% Similarity=0.180 Sum_probs=198.5
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc---chHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG---ASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
..++|.+.+.||+|+||.||+|++..+++.||+|++...... ..+.+.+|+.++++++||||+++++++...+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~---- 107 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG---- 107 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT----
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC----
Confidence 357899999999999999999999989999999998754322 2367889999999999999999999976544
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
..++||||+++++|.+++. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 108 -~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~ 173 (309)
T 2h34_A 108 -QLYVDMRLINGVDLAAMLR----------RQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFA 173 (309)
T ss_dssp -EEEEEEECCCCEEHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCE
T ss_pred -eEEEEEEecCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCE
Confidence 7899999999999999996 234589999999999999999999987 89999999999999999999
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
||+|||++.......... .....|++.|+|||++.+..++.++||||||+++|||++|+.||...... .........
T Consensus 174 kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~ 250 (309)
T 2h34_A 174 YLVDFGIASATTDEKLTQ-LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQA 250 (309)
T ss_dssp EECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSC
T ss_pred EEecCccCcccccccccc-ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccC
Confidence 999999998765433211 12345899999999999989999999999999999999999999643211 010000000
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-CHHHHHHHHHHhHHhhc
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRT-NMTNVVHELQSIKNILL 936 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~ev~~~L~~i~~~~~ 936 (949)
.+ .+. ......+..+.+++.+|++.||++|| +++++++.|+++.+...
T Consensus 251 ~~-------------~~~---------------~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 251 IP-------------RPS---------------TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp CC-------------CGG---------------GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred CC-------------Ccc---------------ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 00 000 00012344678999999999999999 99999999998765543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=355.56 Aligned_cols=275 Identities=23% Similarity=0.338 Sum_probs=211.1
Q ss_pred HHhcCCCCCCeeeeecCceEEEEEEcCCC-----EEEEEEEEecCCC-cchHHHHHHHHHHHhc-CCCcceeEEeeeecc
Q 039533 623 NATSGFSSANLVGVGSFGSVYKGIIDEGR-----TTIAVKVFNLQHH-GASRSFIAECKALKSI-RHRNLVKVLTACLGA 695 (949)
Q Consensus 623 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 695 (949)
...++|.+.+.||+|+||.||+|.+..++ +.||+|+++.... ...+.+.+|+.+++++ +||||+++++++...
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 34578899999999999999999987544 4799999975433 2346789999999999 899999999997654
Q ss_pred cccCCccceeEeeeccCCChhhhcCCCCC----CCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCC
Q 039533 696 DYRGNDFKASVYEFMHYGSLEEWLHPFTG----EDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSN 771 (949)
Q Consensus 696 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~N 771 (949)
+ ..++||||+++|+|.+++..... ..........+++..+..++.|++.||+|||++ +|+||||||+|
T Consensus 123 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~N 194 (333)
T 2i1m_A 123 G-----PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARN 194 (333)
T ss_dssp S-----SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred C-----ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccce
Confidence 4 78999999999999999863110 000001134589999999999999999999987 99999999999
Q ss_pred eeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccC
Q 039533 772 VLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGD 850 (949)
Q Consensus 772 Ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~ 850 (949)
|+++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |..||.......
T Consensus 195 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 274 (333)
T 2i1m_A 195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS 274 (333)
T ss_dssp CEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred EEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence 9999999999999999987654433322233457889999999988889999999999999999999 999986432111
Q ss_pred chhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 039533 851 INLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQS 930 (949)
Q Consensus 851 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 930 (949)
. ....+........ ...++..+.+++.+||+.||++|||+.||++.|++
T Consensus 275 -~------------~~~~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 323 (333)
T 2i1m_A 275 -K------------FYKLVKDGYQMAQ------------------PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323 (333)
T ss_dssp -H------------HHHHHHHTCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -H------------HHHHHhcCCCCCC------------------CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence 0 1111111100000 00124567899999999999999999999999999
Q ss_pred hHHhhc
Q 039533 931 IKNILL 936 (949)
Q Consensus 931 i~~~~~ 936 (949)
+.....
T Consensus 324 ~~~~~~ 329 (333)
T 2i1m_A 324 QAQEDR 329 (333)
T ss_dssp HHHHHH
T ss_pred HHHhhh
Confidence 876543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=357.63 Aligned_cols=212 Identities=28% Similarity=0.325 Sum_probs=181.0
Q ss_pred cccccCHHHHHHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcC-----CCcce
Q 039533 612 SLLYLSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIR-----HRNLV 686 (949)
Q Consensus 612 ~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv 686 (949)
....+++.+.....++|.+.++||+|+||.||+|++..+++.||||+++.. ....+.+..|+.+++++. ||||+
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 344555556566678999999999999999999999889999999998632 233466788999999996 99999
Q ss_pred eEEeeeecccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 039533 687 KVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCD 766 (949)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrD 766 (949)
++++++...+ ..++||||+ +++|.+++... ....+++.++..++.|++.||+|||++ +|+|||
T Consensus 100 ~~~~~~~~~~-----~~~lv~e~~-~~~L~~~~~~~--------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrD 162 (360)
T 3llt_A 100 KYHGKFMYYD-----HMCLIFEPL-GPSLYEIITRN--------NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTD 162 (360)
T ss_dssp CEEEEEEETT-----EEEEEECCC-CCBHHHHHHHT--------TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred cccceeeECC-----eeEEEEcCC-CCCHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCC
Confidence 9999986554 789999999 89999999631 223589999999999999999999987 999999
Q ss_pred CCCCCeeecC-------------------------CCceEEeecccceecCCCCCccccccccCccCccCccccCCCccC
Q 039533 767 LKPSNVLLDD-------------------------YMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVS 821 (949)
Q Consensus 767 lkp~NIll~~-------------------------~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 821 (949)
|||+||+++. ++.+||+|||+|+....... ...||+.|+|||++.+..++
T Consensus 163 lkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~ 237 (360)
T 3llt_A 163 LKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHG-----SIINTRQYRAPEVILNLGWD 237 (360)
T ss_dssp CSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCC-----SCCSCGGGCCHHHHTTCCCC
T ss_pred CCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCCc-----CccCcccccCcHHHcCCCCC
Confidence 9999999975 78999999999987544322 34589999999999999999
Q ss_pred CccchHHHHHHHHHHHhCCCCCccc
Q 039533 822 TNGDVYSYGILLLELVIGKKPIDIM 846 (949)
Q Consensus 822 ~~sDiwSlGvvl~elltg~~Pf~~~ 846 (949)
.++|||||||++|||++|+.||...
T Consensus 238 ~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 238 VSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp TTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CccchHHHHHHHHHHHHCCCCCCCC
Confidence 9999999999999999999999643
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=345.13 Aligned_cols=261 Identities=22% Similarity=0.367 Sum_probs=203.6
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcC---CCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccC
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDE---GRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRG 699 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 699 (949)
..++|.+.+.||+|+||.||+|++.. .+..||+|+++.... ...+.+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---- 85 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE---- 85 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS----
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC----
Confidence 34678999999999999999999753 235699999875432 3456789999999999999999999986432
Q ss_pred CccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCc
Q 039533 700 NDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMT 779 (949)
Q Consensus 700 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~ 779 (949)
..++||||+++++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 86 --~~~~v~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 151 (281)
T 3cc6_A 86 --PTWIIMELYPYGELGHYLER---------NKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPEC 151 (281)
T ss_dssp --SCEEEEECCTTCBHHHHHHH---------HTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTE
T ss_pred --CCEEEEecCCCCCHHHHHHh---------ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCc
Confidence 46899999999999999962 234589999999999999999999987 9999999999999999999
Q ss_pred eEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhcc
Q 039533 780 ARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGR 858 (949)
Q Consensus 780 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~ 858 (949)
+||+|||.++......... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||....... ......
T Consensus 152 ~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--~~~~~~ 228 (281)
T 3cc6_A 152 VKLGDFGLSRYIEDEDYYK-ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--VIGVLE 228 (281)
T ss_dssp EEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--HHHHHH
T ss_pred EEeCccCCCcccccccccc-cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--HHHHHh
Confidence 9999999998765433221 123447889999999988889999999999999999998 999996332211 000000
Q ss_pred ccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhh
Q 039533 859 KALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNIL 935 (949)
Q Consensus 859 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~ 935 (949)
.....+.+ ..++..+.+++.+|++.||++|||+.|+++.|+++.+..
T Consensus 229 -----------~~~~~~~~-------------------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 229 -----------KGDRLPKP-------------------DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp -----------HTCCCCCC-------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----------cCCCCCCC-------------------CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 00000000 123456889999999999999999999999999987654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=340.21 Aligned_cols=259 Identities=20% Similarity=0.254 Sum_probs=204.0
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC------cchHHHHHHHHHHHhcCCCcceeEEeeeecccccC
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH------GASRSFIAECKALKSIRHRNLVKVLTACLGADYRG 699 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 699 (949)
++|++.+.||+|+||.||+|++..+++.||+|+++.... ...+.+.+|+.++++++||||+++++++....
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--- 81 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT--- 81 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS---
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC---
Confidence 468899999999999999999998899999999975432 13567999999999999999999999976544
Q ss_pred CccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC-
Q 039533 700 NDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM- 778 (949)
Q Consensus 700 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~- 778 (949)
..++||||+++++|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 82 --~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~ 146 (283)
T 3bhy_A 82 --DVVLILELVSGGELFDFLA----------EKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNV 146 (283)
T ss_dssp --EEEEEEECCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSS
T ss_pred --eEEEEEeecCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCC
Confidence 7899999999999999996 234689999999999999999999987 999999999999998877
Q ss_pred ---ceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhh
Q 039533 779 ---TARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHN 855 (949)
Q Consensus 779 ---~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~ 855 (949)
.+||+|||.+.......... ...|++.|+|||++.+..++.++||||||+++|||++|+.||....... ..
T Consensus 147 ~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~-- 220 (283)
T 3bhy_A 147 PNPRIKLIDFGIAHKIEAGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-TL-- 220 (283)
T ss_dssp SSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HH--
T ss_pred CCCceEEEecccceeccCCCccc---ccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-HH--
Confidence 89999999998765443222 3458999999999998899999999999999999999999996432110 00
Q ss_pred hccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH--HHHHhHH
Q 039533 856 FGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH--ELQSIKN 933 (949)
Q Consensus 856 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~--~L~~i~~ 933 (949)
..+....... +. ......+..+.+++.+|++.||++|||+.|+++ .++.++.
T Consensus 221 ----------~~~~~~~~~~-~~---------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 221 ----------TNISAVNYDF-DE---------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp ----------HHHHTTCCCC-CH---------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred ----------HHhHhcccCC-cc---------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 0000000000 00 011133456889999999999999999999997 4555544
Q ss_pred h
Q 039533 934 I 934 (949)
Q Consensus 934 ~ 934 (949)
.
T Consensus 275 ~ 275 (283)
T 3bhy_A 275 R 275 (283)
T ss_dssp C
T ss_pred H
Confidence 3
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=359.57 Aligned_cols=254 Identities=20% Similarity=0.240 Sum_probs=192.9
Q ss_pred HHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--------cchHHHHHHHHHHHhcCCCcceeEEeeeec
Q 039533 623 NATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--------GASRSFIAECKALKSIRHRNLVKVLTACLG 694 (949)
Q Consensus 623 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 694 (949)
...++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 345789999999999999999999999999999999974321 112357899999999999999999998642
Q ss_pred ccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeee
Q 039533 695 ADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL 774 (949)
Q Consensus 695 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll 774 (949)
. ..++||||+++|+|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||++
T Consensus 212 ~------~~~lv~e~~~~g~L~~~l~----------~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll 272 (419)
T 3i6u_A 212 E------DYYIVLELMEGGELFDKVV----------GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLL 272 (419)
T ss_dssp S------EEEEEEECCTTCBGGGGTS----------SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred C------ceEEEEEcCCCCcHHHHHh----------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEE
Confidence 2 4689999999999999986 235689999999999999999999987 89999999999999
Q ss_pred cCC---CceEEeecccceecCCCCCccccccccCccCccCccccCC---CccCCccchHHHHHHHHHHHhCCCCCccccc
Q 039533 775 DDY---MTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG---CEVSTNGDVYSYGILLLELVIGKKPIDIMFE 848 (949)
Q Consensus 775 ~~~---~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~ 848 (949)
+.+ +.+||+|||+|+........ ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 273 ~~~~~~~~~kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~ 349 (419)
T 3i6u_A 273 SSQEEDCLIKITDFGHSKILGETSLM---RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349 (419)
T ss_dssp SSSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS
T ss_pred ecCCCcceEEEeecccceecCCCccc---cccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc
Confidence 754 45999999999876543322 23569999999999864 5678899999999999999999999964322
Q ss_pred cCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 849 GDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 849 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
... ..+.+......... +.....+..+.+++.+|++.||++|||++|+++
T Consensus 350 ~~~-------------~~~~i~~~~~~~~~---------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 350 QVS-------------LKDQITSGKYNFIP---------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp SCC-------------HHHHHHTTCCCCCH---------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hHH-------------HHHHHhcCCCCCCc---------------hhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 111 11111100000000 011133567889999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=348.06 Aligned_cols=277 Identities=22% Similarity=0.313 Sum_probs=210.7
Q ss_pred HHHHHHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHh--cCCCcceeEEeeeecc
Q 039533 618 YQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKS--IRHRNLVKVLTACLGA 695 (949)
Q Consensus 618 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~ 695 (949)
...-....++|.+.+.||+|+||.||+|++. ++.||||+++.. ..+.+.+|++++.. ++||||+++++++...
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 3333445678999999999999999999985 899999998643 34677889999888 6899999999997654
Q ss_pred cccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeEecCC
Q 039533 696 DYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLH--------HDCQPVTAHCDL 767 (949)
Q Consensus 696 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH--------~~~~~~ivHrDl 767 (949)
. ......++||||+++|+|.+++. ...+++.+++.++.|++.||+||| +. +|+||||
T Consensus 109 ~-~~~~~~~lv~e~~~~g~L~~~l~-----------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dl 173 (342)
T 1b6c_B 109 N-GTWTQLWLVSDYHEHGSLFDYLN-----------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDL 173 (342)
T ss_dssp C-SSCCCEEEEECCCTTCBHHHHHH-----------HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCC
T ss_pred C-CccceeEEEEeecCCCcHHHHHh-----------ccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCC
Confidence 3 12236899999999999999996 235899999999999999999999 55 8999999
Q ss_pred CCCCeeecCCCceEEeecccceecCCCCCcc--ccccccCccCccCccccCCC------ccCCccchHHHHHHHHHHHhC
Q 039533 768 KPSNVLLDDYMTARVGDFGLARILSPDHTQT--SSFSVKGSLGYIAPEYGVGC------EVSTNGDVYSYGILLLELVIG 839 (949)
Q Consensus 768 kp~NIll~~~~~~kl~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDiwSlGvvl~elltg 839 (949)
||+||+++.++.+||+|||+++......... ......||+.|+|||++.+. .++.++|||||||++|||+||
T Consensus 174 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg 253 (342)
T 1b6c_B 174 KSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253 (342)
T ss_dssp SGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence 9999999999999999999998775544321 12244699999999998765 344789999999999999999
Q ss_pred ----------CCCCccccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhc
Q 039533 840 ----------KKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVA 909 (949)
Q Consensus 840 ----------~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 909 (949)
+.||............+.. .+......+...+ ++ ...+++..+.+++.+
T Consensus 254 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~------------~~-~~~~~~~~l~~li~~ 312 (342)
T 1b6c_B 254 CSIGGIHEDYQLPYYDLVPSDPSVEEMRK--------VVCEQKLRPNIPN------------RW-QSCEALRVMAKIMRE 312 (342)
T ss_dssp BCBTTBCCCCCCTTTTTSCSSCCHHHHHH--------HHTTSCCCCCCCG------------GG-GTSHHHHHHHHHHHH
T ss_pred cCcCCcccccccCccccCcCcccHHHHHH--------HHHHHHhCCCCcc------------cc-cchhHHHHHHHHHHH
Confidence 5666433222111111110 1111111111110 00 012567789999999
Q ss_pred cccCCCCCCCCHHHHHHHHHHhHHhh
Q 039533 910 CSMELPQDRTNMTNVVHELQSIKNIL 935 (949)
Q Consensus 910 cl~~dP~~RPs~~ev~~~L~~i~~~~ 935 (949)
||+.||++|||+.||++.|+++.+..
T Consensus 313 cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 313 CWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp HCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred HhccChhhCCCHHHHHHHHHHHHHHh
Confidence 99999999999999999999998764
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=351.38 Aligned_cols=263 Identities=23% Similarity=0.419 Sum_probs=200.3
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCC----CEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEG----RTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
++|++.+.||+|+||.||+|.+..+ +..||||+++.... .....+.+|+.++++++||||+++++++...+
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 119 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK---- 119 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS----
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC----
Confidence 4677789999999999999998644 34699999975433 23457889999999999999999999975443
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
..++||||+++++|.+++.. ....+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 120 -~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~ 186 (333)
T 1mqb_A 120 -PMMIITEYMENGALDKFLRE---------KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVC 186 (333)
T ss_dssp -SEEEEEECCTTEEHHHHHHH---------TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCE
T ss_pred -CcEEEEeCCCCCcHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcE
Confidence 78999999999999999962 234689999999999999999999988 89999999999999999999
Q ss_pred EEeecccceecCCCCCcc-ccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhcc
Q 039533 781 RVGDFGLARILSPDHTQT-SSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGR 858 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~ 858 (949)
||+|||.++......... ......+|..|+|||++.+..++.++|||||||++|||++ |+.||....... ...
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~~--- 261 (333)
T 1mqb_A 187 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMK--- 261 (333)
T ss_dssp EECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHH---
T ss_pred EECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH--HHH---
Confidence 999999998765443211 1112346788999999998899999999999999999999 999995332110 000
Q ss_pred ccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhhcc
Q 039533 859 KALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILLG 937 (949)
Q Consensus 859 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~ 937 (949)
.+.+....+.+ ..++..+.+++.+||+.||++||++.|+++.|+++......
T Consensus 262 --------~~~~~~~~~~~-------------------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 262 --------AINDGFRLPTP-------------------MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313 (333)
T ss_dssp --------HHHTTCCCCCC-------------------TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred --------HHHCCCcCCCc-------------------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 00000000000 12345688999999999999999999999999998766544
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=361.69 Aligned_cols=206 Identities=24% Similarity=0.340 Sum_probs=165.1
Q ss_pred HHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcC-CCcceeEEeeeecccccC
Q 039533 623 NATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIR-HRNLVKVLTACLGADYRG 699 (949)
Q Consensus 623 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 699 (949)
...++|++.+.||+|+||.||+|.+..+++.||||++.... ....+++.+|+.+++++. ||||+++++++... +
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~ 82 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---N 82 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---T
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---C
Confidence 34578999999999999999999999999999999986432 233467889999999997 99999999998643 2
Q ss_pred CccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCc
Q 039533 700 NDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMT 779 (949)
Q Consensus 700 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~ 779 (949)
....++||||++ ++|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 83 ~~~~~lv~e~~~-~~L~~~~~-----------~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~ 147 (388)
T 3oz6_A 83 DRDVYLVFDYME-TDLHAVIR-----------ANILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECH 147 (388)
T ss_dssp SSCEEEEEECCS-EEHHHHHH-----------HTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCC
T ss_pred CCEEEEEecccC-cCHHHHHH-----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCC
Confidence 346899999997 58999886 23588999999999999999999988 9999999999999999999
Q ss_pred eEEeecccceecCCCCC-------------------ccccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhC
Q 039533 780 ARVGDFGLARILSPDHT-------------------QTSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIG 839 (949)
Q Consensus 780 ~kl~DfG~a~~~~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg 839 (949)
+||+|||+|+....... ........||+.|+|||++.+ ..++.++||||+||++|||++|
T Consensus 148 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g 227 (388)
T 3oz6_A 148 VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227 (388)
T ss_dssp EEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHS
T ss_pred EEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhC
Confidence 99999999987643111 111123569999999999876 5789999999999999999999
Q ss_pred CCCCccc
Q 039533 840 KKPIDIM 846 (949)
Q Consensus 840 ~~Pf~~~ 846 (949)
++||...
T Consensus 228 ~~pf~~~ 234 (388)
T 3oz6_A 228 KPIFPGS 234 (388)
T ss_dssp SCSCCCS
T ss_pred CCCCCCC
Confidence 9999643
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=349.60 Aligned_cols=265 Identities=22% Similarity=0.272 Sum_probs=197.7
Q ss_pred cCCCCC-CeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCCccc
Q 039533 626 SGFSSA-NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 626 ~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
+.|.+. +.||+|+||.||+|++..+++.||||+++.......+.+.+|++++.++ +||||+++++++...+ ..
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~-----~~ 86 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEED-----RF 86 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-----EE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC-----EE
Confidence 567774 7899999999999999888999999999876655667899999999995 7999999999976544 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCc---e
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMT---A 780 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~---~ 780 (949)
++||||+++++|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++. +
T Consensus 87 ~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~ 153 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIH----------KRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPV 153 (316)
T ss_dssp EEEEECCTTCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSE
T ss_pred EEEEEcCCCCcHHHHHh----------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCce
Confidence 99999999999999996 234689999999999999999999988 9999999999999998776 9
Q ss_pred EEeecccceecCCCCC-----ccccccccCccCccCccccCC-----CccCCccchHHHHHHHHHHHhCCCCCccccccC
Q 039533 781 RVGDFGLARILSPDHT-----QTSSFSVKGSLGYIAPEYGVG-----CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~ 850 (949)
||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+
T Consensus 154 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 233 (316)
T 2ac3_A 154 KICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD 233 (316)
T ss_dssp EECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSC
T ss_pred EEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccc
Confidence 9999999976543221 111123459999999999875 468899999999999999999999997543222
Q ss_pred chhhhhccccC-C---CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 851 INLHNFGRKAL-P---DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 851 ~~~~~~~~~~~-~---~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
... ..... + ....+.+.......+ . ......+..+.+++.+|++.||++|||++|+++
T Consensus 234 ~~~---~~~~~~~~~~~~~~~~i~~~~~~~~------------~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 234 CGW---DRGEACPACQNMLFESIQEGKYEFP------------D---KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp SCC-------CCHHHHHHHHHHHHHCCCCCC------------H---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccc---cccccchhHHHHHHHHHhccCcccC------------c---hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 110 00000 0 000000000000000 0 001134567899999999999999999999987
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=341.65 Aligned_cols=264 Identities=22% Similarity=0.354 Sum_probs=209.1
Q ss_pred cCCCCCC-eeeeecCceEEEEEEc--CCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 626 SGFSSAN-LVGVGSFGSVYKGIID--EGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 626 ~~y~~~~-~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
++|.+.+ .||+|+||.||+|.+. .+++.||||+++.... ...+.+.+|++++++++||||+++++++.. +
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~ 82 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------E 82 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------S
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC------C
Confidence 4555665 8999999999999863 4678899999976432 345678999999999999999999999732 2
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~k 150 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVG---------KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAK 150 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTT---------CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEE
T ss_pred CcEEEEEeCCCCCHHHHHHh---------CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEE
Confidence 58999999999999999962 234589999999999999999999987 999999999999999999999
Q ss_pred EeecccceecCCCCCcc-ccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccc
Q 039533 782 VGDFGLARILSPDHTQT-SSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~ 859 (949)
|+|||+++......... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... .....
T Consensus 151 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~--- 225 (287)
T 1u59_A 151 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAF--- 225 (287)
T ss_dssp ECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHH---
T ss_pred ECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HHHHH---
Confidence 99999999876543321 1223346889999999988889999999999999999998 99999643211 11111
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhhccCC
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILLGVE 939 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~ 939 (949)
+........ ...++..+.+++.+||+.||++||++.|+++.|+++..+.....
T Consensus 226 ---------i~~~~~~~~------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 278 (287)
T 1u59_A 226 ---------IEQGKRMEC------------------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278 (287)
T ss_dssp ---------HHTTCCCCC------------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred ---------HhcCCcCCC------------------CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence 000000000 01334578899999999999999999999999999988866553
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=346.55 Aligned_cols=245 Identities=23% Similarity=0.223 Sum_probs=191.4
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc--chHHHHHHHHHHHhc-CCCcceeEEeeeecccccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG--ASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 702 (949)
++|++.++||+|+||+||+|++..+++.||||++...... ...+...|+..+.++ +||||+++++++...+ .
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~-----~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG-----I 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----E
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC-----E
Confidence 4689999999999999999999989999999998654332 233455666666665 8999999999986544 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+ +++|.+++.. ....+++..+..|+.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 132 ~~lv~e~~-~~~L~~~~~~---------~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl 198 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEA---------WGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKL 198 (311)
T ss_dssp EEEEEECC-CCBHHHHHHH---------HCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEE
T ss_pred EEEEEecc-CCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEE
Confidence 89999999 6799998862 234699999999999999999999987 8999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
+|||+++........ ....||+.|+|||++.+ .++.++|||||||++|||++|..|+.... ...
T Consensus 199 ~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----~~~-------- 262 (311)
T 3p1a_A 199 GDFGLLVELGTAGAG---EVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----GWQ-------- 262 (311)
T ss_dssp CCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----HHH--------
T ss_pred ccceeeeecccCCCC---cccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHH--------
Confidence 999999876544322 23459999999999876 78999999999999999999977653210 000
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.+...... . ......+..+.+++.+|++.||++|||++|+++
T Consensus 263 ----~~~~~~~~---~---------------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 263 ----QLRQGYLP---P---------------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ----HHTTTCCC---H---------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----HHhccCCC---c---------------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 00000000 0 001133567899999999999999999999985
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=343.33 Aligned_cols=249 Identities=21% Similarity=0.301 Sum_probs=199.3
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++...+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 82 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT---- 82 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS----
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC----
Confidence 3567999999999999999999999999999999986432 223467889999999999999999999976544
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
..++||||+++++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 83 -~~~lv~e~~~~~~l~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~ 148 (279)
T 3fdn_A 83 -RVYLILEYAPLGTVYRELQ----------KLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGEL 148 (279)
T ss_dssp -EEEEEECCCTTEEHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCE
T ss_pred -EEEEEEecCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCE
Confidence 7899999999999999986 234589999999999999999999977 99999999999999999999
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
||+|||++........ ....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ..
T Consensus 149 ~l~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~------ 216 (279)
T 3fdn_A 149 KIADFGWSVHAPSSRR----TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--TY------ 216 (279)
T ss_dssp EECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HH------
T ss_pred EEEeccccccCCcccc----cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH--HH------
Confidence 9999999865443322 23458999999999999899999999999999999999999996331110 00
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
..+..... ..+ ...+..+.+++.+|++.||++|||++|+++.
T Consensus 217 -----~~~~~~~~-~~~-------------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 217 -----KRISRVEF-TFP-------------------DFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -----HHHHHTCC-CCC-------------------TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -----HHHHhCCC-CCC-------------------CcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000 000 0123457889999999999999999999974
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=372.68 Aligned_cols=352 Identities=18% Similarity=0.161 Sum_probs=242.1
Q ss_pred CCCCccCccCCCCcce----eeeeEEeCCCCcEEEEEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCccc
Q 039533 39 PVGVLGTWNESIHFCK----WYGVTCSRRHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRR 114 (949)
Q Consensus 39 ~~~~l~sW~~~~~~C~----w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~ 114 (949)
....+++|.++.+||. |.++.|+. + ++-..... .....-..+++++.|++++|.+.+..+..|+++++
T Consensus 5 ~~~~l~~~~~~~~C~~~~~~~~c~~~~~---~---i~~~~~~~--~~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~ 76 (597)
T 3oja_B 5 QRYNVKPRQPEYKCIDSNLQYDCVFYDV---H---IDMQTQDV--YFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQ 76 (597)
T ss_dssp ------CCCSEECCCCC--CCSEEECSC---E---ECSSCCCC--EESCSSGGGCCCSEEEESSCEESEECTHHHHHCCC
T ss_pred ccccccCCCCCCcCcccCcCceeEecCc---e---eccccccc--ccCcccccCCCceEEEeeCCCCCCcCHHHHccCCC
Confidence 3446789988888884 66665541 1 22222111 11222335789999999999998666666899999
Q ss_pred CcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccc
Q 039533 115 LKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAY 194 (949)
Q Consensus 115 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 194 (949)
|++|+|++|.|++..|..|+++++|++|+|++|.+++.++..|+++++|++|+|++|.|++..+..|+++++|++|+|++
T Consensus 77 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~ 156 (597)
T 3oja_B 77 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSN 156 (597)
T ss_dssp CSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeC
Confidence 99999999999988888999999999999999999999999999999999999999999966666789999999999999
Q ss_pred cccCCCCCCcccCCCccccccccCcccccccccccCCCCChhhhccccccccccCCCCCCCCCCcchhccccccCcccEE
Q 039533 195 NNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWM 274 (949)
Q Consensus 195 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L 274 (949)
|.+++..|..|+.+++|++|+|++|.++.++ +..++ +|+.|
T Consensus 157 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---------~~~l~------------------------------~L~~L 197 (597)
T 3oja_B 157 NNLERIEDDTFQATTSLQNLQLSSNRLTHVD---------LSLIP------------------------------SLFHA 197 (597)
T ss_dssp SCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---------GGGCT------------------------------TCSEE
T ss_pred CcCCCCChhhhhcCCcCcEEECcCCCCCCcC---------hhhhh------------------------------hhhhh
Confidence 9999999999999999999999999876442 22233 34444
Q ss_pred EccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCccc
Q 039533 275 HINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKL 354 (949)
Q Consensus 275 ~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 354 (949)
++++|.+++.. .+.+|+.|++++|.++...+ .+ .++|+.|+|++|.+++ +..+..+++|+.|+|++|.+
T Consensus 198 ~l~~n~l~~l~------~~~~L~~L~ls~n~l~~~~~-~~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l 266 (597)
T 3oja_B 198 NVSYNLLSTLA------IPIAVEELDASHNSINVVRG-PV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNEL 266 (597)
T ss_dssp ECCSSCCSEEE------CCTTCSEEECCSSCCCEEEC-SC--CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCC
T ss_pred hcccCcccccc------CCchhheeeccCCccccccc-cc--CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCcc
Confidence 44444444321 12346666666666653222 21 2456666666666664 34566666666666666666
Q ss_pred ccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccc
Q 039533 355 SGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIE 434 (949)
Q Consensus 355 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~ 434 (949)
++..|..|+++++|+.|+|++|.+++ +|..+..+++|+.|+|++|+++ .+|..
T Consensus 267 ~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~--------------------------~i~~~ 319 (597)
T 3oja_B 267 EKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL--------------------------HVERN 319 (597)
T ss_dssp CEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC--------------------------CCGGG
T ss_pred CCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC--------------------------ccCcc
Confidence 66666666666666666666666654 3444555556665555555554 34455
Q ss_pred cccccccceeeeccccccccCCcccccccchhhcccCccccccc
Q 039533 435 VGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGP 478 (949)
Q Consensus 435 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 478 (949)
++.+++|+.|+|++|+|++. | +..+++|+.|+|++|.+++.
T Consensus 320 ~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 320 QPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp HHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHH
T ss_pred cccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCCh
Confidence 55666666777777776643 2 55667777777777777754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=350.06 Aligned_cols=249 Identities=20% Similarity=0.214 Sum_probs=190.0
Q ss_pred hcCCCCCCeeeeecCceEEEEEEc---CCCEEEEEEEEecCC----CcchHHHHHHHHHHHhcCCCcceeEEeeeecccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIID---EGRTTIAVKVFNLQH----HGASRSFIAECKALKSIRHRNLVKVLTACLGADY 697 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 697 (949)
.++|++.+.||+|+||.||+|+.. .+++.||+|+++... ......+.+|+.++++++||||+++++++...+
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 94 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG- 94 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC-
Confidence 467999999999999999999984 578999999997542 223456789999999999999999999976544
Q ss_pred cCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCC
Q 039533 698 RGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDY 777 (949)
Q Consensus 698 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~ 777 (949)
..++||||+++++|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 95 ----~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~ 157 (327)
T 3a62_A 95 ----KLYLILEYLSGGELFMQLE----------REGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQ 157 (327)
T ss_dssp ----CEEEEEECCTTEEHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTT
T ss_pred ----EEEEEEeCCCCCcHHHHHH----------hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCC
Confidence 7899999999999999986 234588999999999999999999988 99999999999999999
Q ss_pred CceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhc
Q 039533 778 MTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFG 857 (949)
Q Consensus 778 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~ 857 (949)
+.+||+|||+++......... ....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~---- 229 (327)
T 3a62_A 158 GHVKLTDFGLCKESIHDGTVT--HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK--T---- 229 (327)
T ss_dssp SCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--H----
T ss_pred CcEEEEeCCcccccccCCccc--cccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH--H----
Confidence 999999999998654332211 23569999999999999899999999999999999999999996432110 0
Q ss_pred cccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 039533 858 RKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRT-----NMTNVVH 926 (949)
Q Consensus 858 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~ 926 (949)
...+...... .+ ...+..+.+++.+|++.||++|| ++.|+++
T Consensus 230 -------~~~i~~~~~~-~p-------------------~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 230 -------IDKILKCKLN-LP-------------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -------HHHHHHTCCC-CC-------------------TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -------HHHHHhCCCC-CC-------------------CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 0011110000 00 02234678999999999999999 6777764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=358.69 Aligned_cols=251 Identities=24% Similarity=0.259 Sum_probs=192.1
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC---cchHHHHHHHHH-HHhcCCCcceeEEeeeecccccCC
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH---GASRSFIAECKA-LKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
.++|++.+.||+|+||.||+|++..+++.||||+++.... .....+.+|..+ ++.++||||+++++++...+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~---- 112 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD---- 112 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS----
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC----
Confidence 4578999999999999999999998999999999975432 233456677776 56789999999999976544
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
..++||||+++|+|.+++. ....+++..++.++.||+.||+|||++ +|+||||||+||+++.++++
T Consensus 113 -~~~lv~E~~~gg~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~i 178 (373)
T 2r5t_A 113 -KLYFVLDYINGGELFYHLQ----------RERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHI 178 (373)
T ss_dssp -EEEEEEECCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred -EEEEEEeCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCE
Confidence 7899999999999999996 234688999999999999999999987 99999999999999999999
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
||+|||+++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .
T Consensus 179 kL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-----~---- 247 (373)
T 2r5t_A 179 VLTDFGLCKENIEHNST--TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-----M---- 247 (373)
T ss_dssp EECCCCBCGGGBCCCCC--CCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH-----H----
T ss_pred EEeeCccccccccCCCc--cccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-----H----
Confidence 99999999864332221 124569999999999999999999999999999999999999996331110 0
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHEL 928 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 928 (949)
...++....... ...+..+.+++.+|++.||++||++.+.++++
T Consensus 248 ----~~~i~~~~~~~~--------------------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 248 ----YDNILNKPLQLK--------------------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp ----HHHHHHSCCCCC--------------------SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred ----HHHHHhcccCCC--------------------CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 011111111000 01234578899999999999999986544443
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=346.98 Aligned_cols=264 Identities=22% Similarity=0.339 Sum_probs=206.8
Q ss_pred HhcCCCCCC-eeeeecCceEEEEEE--cCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeeccccc
Q 039533 624 ATSGFSSAN-LVGVGSFGSVYKGII--DEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYR 698 (949)
Q Consensus 624 ~~~~y~~~~-~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 698 (949)
..++|.+.+ .||+|+||.||+|.+ ..+++.||||+++.... ...+++.+|++++++++||||+++++++. .
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~--- 89 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-A--- 89 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-S---
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC-C---
Confidence 346778777 999999999999965 45678999999975432 23467999999999999999999999973 2
Q ss_pred CCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC
Q 039533 699 GNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM 778 (949)
Q Consensus 699 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~ 778 (949)
+..++||||+++++|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 90 --~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~ 154 (291)
T 1xbb_A 90 --ESWMLVMEMAELGPLNKYLQ----------QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQH 154 (291)
T ss_dssp --SSEEEEEECCTTEEHHHHHH----------HCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred --CCcEEEEEeCCCCCHHHHHH----------hCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCC
Confidence 25789999999999999996 234589999999999999999999988 999999999999999999
Q ss_pred ceEEeecccceecCCCCCcc-ccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhh
Q 039533 779 TARVGDFGLARILSPDHTQT-SSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNF 856 (949)
Q Consensus 779 ~~kl~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~ 856 (949)
.+||+|||+++......... ......++..|+|||++.+..++.++||||||+++|||++ |+.||....... ..
T Consensus 155 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~-- 230 (291)
T 1xbb_A 155 YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VT-- 230 (291)
T ss_dssp EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HH--
T ss_pred cEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HH--
Confidence 99999999998876544321 1122346789999999988889999999999999999999 999996432111 10
Q ss_pred ccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhhc
Q 039533 857 GRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILL 936 (949)
Q Consensus 857 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~ 936 (949)
+.+........ ...++..+.+++.+||+.||++|||+.||++.|+++.....
T Consensus 231 ----------~~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 231 ----------AMLEKGERMGC------------------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp ----------HHHHTTCCCCC------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred ----------HHHHcCCCCCC------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 01100000000 01234568899999999999999999999999999977765
Q ss_pred cC
Q 039533 937 GV 938 (949)
Q Consensus 937 ~~ 938 (949)
+.
T Consensus 283 ~~ 284 (291)
T 1xbb_A 283 NE 284 (291)
T ss_dssp HH
T ss_pred hc
Confidence 43
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=355.48 Aligned_cols=285 Identities=20% Similarity=0.242 Sum_probs=206.1
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|++++++++||||+++++++...........
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 4689999999999999999999998999999999974432 234678899999999999999999999876655555678
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++||||++ ++|.+++. ...+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 106 ~iv~e~~~-~~L~~~l~-----------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~ 170 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLK-----------TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKIC 170 (364)
T ss_dssp EEEEECCS-EEHHHHHH-----------HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred EEEEcccC-cCHHHHHH-----------hCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEE
Confidence 99999997 59999885 23589999999999999999999988 99999999999999999999999
Q ss_pred ecccceecCCCCCcc-ccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 784 DFGLARILSPDHTQT-SSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 784 DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
|||.++......... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||......+. +..... ..
T Consensus 171 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~-~~ 248 (364)
T 3qyz_A 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILG-IL 248 (364)
T ss_dssp CCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH-HHHHHH-HH
T ss_pred eCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH-HHHHHH-Hh
Confidence 999998765433211 11235699999999986654 589999999999999999999999964422211 110000 00
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.....+.+..............................+..+.+++.+|++.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 249 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000000000000000000000000000001123456889999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=352.44 Aligned_cols=275 Identities=22% Similarity=0.240 Sum_probs=198.0
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcC-CCcceeEEeeeecccc---cCC
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIR-HRNLVKVLTACLGADY---RGN 700 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~---~~~ 700 (949)
..+|++.+.||+|+||.||+|++..+++.||||++........+.+.+|+.+++++. ||||+++++++..... ...
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 357889999999999999999998889999999997666555678899999999996 9999999999853321 334
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
...++||||+. |+|.+++... .....+++.+++.++.|++.||+|||++ .++|+||||||+||+++.++.+
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~-------~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKM-------ESRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHH-------HTTCSCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCCCCCGGGCEECTTSCE
T ss_pred ceEEEEEEecC-CCHHHHHHHh-------hccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEEccCCcccEEECCCCCE
Confidence 45799999996 7999988521 1234589999999999999999999977 1229999999999999999999
Q ss_pred EEeecccceecCCCCCcc----------ccccccCccCccCcccc---CCCccCCccchHHHHHHHHHHHhCCCCCcccc
Q 039533 781 RVGDFGLARILSPDHTQT----------SSFSVKGSLGYIAPEYG---VGCEVSTNGDVYSYGILLLELVIGKKPIDIMF 847 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~ 847 (949)
||+|||+++......... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||....
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 999999998765433211 11134589999999998 56678999999999999999999999996432
Q ss_pred ccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 848 EGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 848 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
... +.......... ...+..+.+++.+||+.||++|||+.|+++.
T Consensus 258 ~~~-----------------~~~~~~~~~~~------------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 302 (337)
T 3ll6_A 258 KLR-----------------IVNGKYSIPPH------------------DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ 302 (337)
T ss_dssp -------------------------CCCCTT------------------CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHH-----------------hhcCcccCCcc------------------cccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 110 00000000000 0112236789999999999999999999999
Q ss_pred HHHhHHhhccCCCCCC
Q 039533 928 LQSIKNILLGVELCPP 943 (949)
Q Consensus 928 L~~i~~~~~~~~~~~~ 943 (949)
|+++..........|.
T Consensus 303 l~~~~~~~~~~~~~~~ 318 (337)
T 3ll6_A 303 LQEIAAARNVNPKSPI 318 (337)
T ss_dssp HHHHHHHTTCCTTSCC
T ss_pred HHHHHhccCCCCCccH
Confidence 9999887655544443
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=356.14 Aligned_cols=279 Identities=19% Similarity=0.229 Sum_probs=196.5
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccc-cCCc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADY-RGND 701 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 701 (949)
.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+++.+|++++++++||||+++++++..... ....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 4678999999999999999999998999999999864322 234678899999999999999999999865431 2234
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+ +++|.+++. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 104 ~~~lv~e~~-~~~L~~~~~-----------~~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~k 168 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMK-----------HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELK 168 (367)
T ss_dssp CCEEEEECC-SEEHHHHHH-----------HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEE
T ss_pred eEEEEEecC-CCCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEE
Confidence 569999999 889999986 13588999999999999999999988 999999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
|+|||+++....... ...||..|+|||++.+ ..++.++||||+||++|||++|+.||......+ .+..... .
T Consensus 169 l~Dfg~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~-~ 241 (367)
T 1cm8_A 169 ILDFGLARQADSEMT-----GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMK-V 241 (367)
T ss_dssp ECCCTTCEECCSSCC-----SSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH-H
T ss_pred EEeeecccccccccC-----cCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-h
Confidence 999999987654322 3468999999999877 679999999999999999999999996432111 0000000 0
Q ss_pred CCCchhhhcccCCCCCchhhhhhh-chhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTG-NQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
......+.+... ........... ...............+..+.+++.+|++.||++|||++|+++
T Consensus 242 ~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 242 TGTPPAEFVQRL-QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HCCCCHHHHHTC-SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cCCCCHHHHHHh-hhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 000000000000 00000000000 000000000001123456889999999999999999999987
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=358.41 Aligned_cols=276 Identities=15% Similarity=0.163 Sum_probs=209.8
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcC--------CCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCccee---------
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDE--------GRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVK--------- 687 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 687 (949)
.++|++.+.||+|+||.||+|++.. .++.||||++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3678999999999999999999986 3789999998743 46889999999999999998
Q ss_pred ------EEeeeecccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 039533 688 ------VLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPV 761 (949)
Q Consensus 688 ------~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ 761 (949)
+++++.. .....++||||+ +++|.+++... ....+++.+++.++.|++.||+|||++ +
T Consensus 116 ~~~i~~~~~~~~~----~~~~~~lv~e~~-~~~L~~~l~~~--------~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ 179 (352)
T 2jii_A 116 LLAIPTCMGFGVH----QDKYRFLVLPSL-GRSLQSALDVS--------PKHVLSERSVLQVACRLLDALEFLHEN---E 179 (352)
T ss_dssp TCSCCCCCEEEEE----TTTEEEEEEECC-CEEHHHHHHHS--------GGGCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred ccCccchhhcccc----CCcEEEEEecCC-CcCHHHHHHhC--------CcCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 4445432 234789999999 99999999721 135699999999999999999999988 9
Q ss_pred eEecCCCCCCeeecCCC--ceEEeecccceecCCCCCc-----cccccccCccCccCccccCCCccCCccchHHHHHHHH
Q 039533 762 TAHCDLKPSNVLLDDYM--TARVGDFGLARILSPDHTQ-----TSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLL 834 (949)
Q Consensus 762 ivHrDlkp~NIll~~~~--~~kl~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ 834 (949)
|+||||||+||+++.++ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|
T Consensus 180 ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 259 (352)
T 2jii_A 180 YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCML 259 (352)
T ss_dssp CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHH
Confidence 99999999999999998 9999999999876543211 1112346999999999999989999999999999999
Q ss_pred HHHhCCCCCccccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCC
Q 039533 835 ELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMEL 914 (949)
Q Consensus 835 elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d 914 (949)
||++|+.||................. ......+.+.... ....+..+.+++.+|++.|
T Consensus 260 el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~---------------------~~~~~~~l~~li~~~l~~d 317 (352)
T 2jii_A 260 KWLYGFLPWTNCLPNTEDIMKQKQKF-VDKPGPFVGPCGH---------------------WIRPSETLQKYLKVVMALT 317 (352)
T ss_dssp HHHHSCCTTGGGTTCHHHHHHHHHHH-HHSCCCEECTTSC---------------------EECCCHHHHHHHHHHHTCC
T ss_pred HHHhCCCCcccCCcCHHHHHHHHHhc-cCChhhhhhhccc---------------------cCCCcHHHHHHHHHHHhCC
Confidence 99999999975432211111111000 0000000000000 0012456889999999999
Q ss_pred CCCCCCHHHHHHHHHHhHHhhccCCCCCC
Q 039533 915 PQDRTNMTNVVHELQSIKNILLGVELCPP 943 (949)
Q Consensus 915 P~~RPs~~ev~~~L~~i~~~~~~~~~~~~ 943 (949)
|++|||++||++.|+++.+........|+
T Consensus 318 p~~Rps~~~l~~~L~~~~~~~~~~~~~~~ 346 (352)
T 2jii_A 318 YEEKPPYAMLRNNLEALLQDLRVSPYDPI 346 (352)
T ss_dssp TTCCCCHHHHHHHHHHHHHHTTCCTTSCC
T ss_pred hhhCCCHHHHHHHHHHHHHhcCCCcCccc
Confidence 99999999999999999988877655544
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=354.12 Aligned_cols=258 Identities=14% Similarity=0.125 Sum_probs=203.4
Q ss_pred HhcCCCCCCeeeeecCceEEEEE-----EcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcC---CCcceeEEeeeecc
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGI-----IDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIR---HRNLVKVLTACLGA 695 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~ 695 (949)
..++|.+.+.||+|+||+||+|. ...+++.||||+++.. ...++..|++++++++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 34678899999999999999994 5567889999998643 3467888888888886 99999999997655
Q ss_pred cccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec
Q 039533 696 DYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD 775 (949)
Q Consensus 696 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~ 775 (949)
+ ..++||||+++|+|.+++..... .....+++..++.|+.|++.||+|||++ +|+||||||+|||++
T Consensus 140 ~-----~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~ 206 (365)
T 3e7e_A 140 N-----GSVLVGELYSYGTLLNAINLYKN-----TPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILG 206 (365)
T ss_dssp S-----CEEEEECCCCSCBHHHHHHHHHT-----STTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEEC
T ss_pred C-----CcEEEEeccCCCcHHHHHHHhhc-----ccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEec
Confidence 4 78999999999999999963211 1235699999999999999999999977 899999999999999
Q ss_pred C-----------CCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCc
Q 039533 776 D-----------YMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPID 844 (949)
Q Consensus 776 ~-----------~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~ 844 (949)
. ++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 207 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 286 (365)
T 3e7e_A 207 NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV 286 (365)
T ss_dssp GGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred ccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccc
Confidence 8 89999999999987643333233335669999999999999999999999999999999999999985
Q ss_pred cccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCC-CCHHH
Q 039533 845 IMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDR-TNMTN 923 (949)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R-Ps~~e 923 (949)
....+... .+......+ ..+.+.+++..|++.+|.+| |++++
T Consensus 287 ~~~~~~~~----------------~~~~~~~~~---------------------~~~~~~~~~~~~l~~~p~~r~~~~~~ 329 (365)
T 3e7e_A 287 KNEGGECK----------------PEGLFRRLP---------------------HLDMWNEFFHVMLNIPDCHHLPSLDL 329 (365)
T ss_dssp EEETTEEE----------------ECSCCTTCS---------------------SHHHHHHHHHHHHCCCCTTCCCCHHH
T ss_pred cCCCCcee----------------echhccccC---------------------cHHHHHHHHHHHcCCCCCCcchHHHH
Confidence 43221100 000010000 12346678889999999998 58889
Q ss_pred HHHHHHHhHHh
Q 039533 924 VVHELQSIKNI 934 (949)
Q Consensus 924 v~~~L~~i~~~ 934 (949)
+.+.|+++...
T Consensus 330 l~~~l~~~l~~ 340 (365)
T 3e7e_A 330 LRQKLKKVFQQ 340 (365)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99988887665
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=366.64 Aligned_cols=260 Identities=26% Similarity=0.412 Sum_probs=202.4
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.++|++.+.||+|+||.||+|.+. ++..||||+++... ...+.+.+|++++++++||||+++++++.. ...+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~~ 254 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY 254 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred hhHceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------CceE
Confidence 356788899999999999999997 45789999997544 235689999999999999999999999753 2579
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++|+|.+++... ....+++.++..++.|++.||+|||++ +|+||||||+||++++++.+||+|
T Consensus 255 iv~e~~~~gsL~~~l~~~--------~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~D 323 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGE--------TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVAD 323 (452)
T ss_dssp EEECCCTTCBHHHHHSHH--------HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred EEehhhcCCCHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECC
Confidence 999999999999999621 224589999999999999999999987 899999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCC
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||......+ ..
T Consensus 324 fG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~--------- 391 (452)
T 1fmk_A 324 FGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VL--------- 391 (452)
T ss_dssp CCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HH---------
T ss_pred CccceecCCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH--HH---------
Confidence 9999876543221 1123447889999999988899999999999999999999 999996432111 00
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhhc
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILL 936 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~ 936 (949)
+.+...... +....++..+.+++.+||+.||++|||++++++.|+++.....
T Consensus 392 ---~~i~~~~~~------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 392 ---DQVERGYRM------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp ---HHHHTTCCC------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred ---HHHHcCCCC------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 000000000 0011345678899999999999999999999999999865533
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=353.39 Aligned_cols=252 Identities=21% Similarity=0.326 Sum_probs=191.6
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc--chHHHHHHHHHHHhcCC--CcceeEEeeeecccccCC
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG--ASRSFIAECKALKSIRH--RNLVKVLTACLGADYRGN 700 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~ 700 (949)
.++|++.+.||+|+||.||+|.+. +++.||||++...... ..+.+.+|+.++++++| |||+++++++....
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~---- 82 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ---- 82 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS----
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC----
Confidence 356899999999999999999986 6889999999754332 34678999999999976 99999999976544
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
..++||| +.+++|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||+++ ++.+
T Consensus 83 -~~~lv~e-~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~ 146 (343)
T 3dbq_A 83 -YIYMVME-CGNIDLNSWLK----------KKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGML 146 (343)
T ss_dssp -EEEEEEC-CCSEEHHHHHH----------HSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEE
T ss_pred -EEEEEEe-CCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcE
Confidence 7899999 46789999996 235689999999999999999999987 899999999999997 5789
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCC-----------CccCCccchHHHHHHHHHHHhCCCCCcccccc
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-----------CEVSTNGDVYSYGILLLELVIGKKPIDIMFEG 849 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~ 849 (949)
||+|||+++...............||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 147 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 226 (343)
T 3dbq_A 147 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 226 (343)
T ss_dssp EECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred EEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH
Confidence 9999999987765443333334569999999999754 57889999999999999999999999643221
Q ss_pred CchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 850 DINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 850 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
.... ...++........ ...+..+.+++.+||+.||++|||+.|+++.
T Consensus 227 ~~~~------------~~~~~~~~~~~~~------------------~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 227 ISKL------------HAIIDPNHEIEFP------------------DIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHHH------------HHHHCTTSCCCCC------------------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHH------------HHHhcCCcccCCc------------------ccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1111 1111111111000 0112457899999999999999999999764
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=342.02 Aligned_cols=254 Identities=27% Similarity=0.358 Sum_probs=197.4
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.++|++.+.||+|+||.||+|++. ++.||||+++... ..+.+.+|++++++++||||+++++++... ....+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~~ 91 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLY 91 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCE
T ss_pred hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----CCceE
Confidence 467899999999999999999885 7899999986432 457899999999999999999999986532 23689
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++++|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 92 lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~D 160 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSR--------GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSD 160 (278)
T ss_dssp EEECCCTTEEHHHHHHHH--------HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECC
T ss_pred EEEecCCCCCHHHHHHhc--------ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEee
Confidence 999999999999999621 122378899999999999999999987 899999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCC
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
||+++....... ...++..|+|||++.+..++.++||||||+++|||++ |+.||......+ ..
T Consensus 161 fg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~--------- 224 (278)
T 1byg_A 161 FGLTKEASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VV--------- 224 (278)
T ss_dssp CCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HH---------
T ss_pred cccccccccccc-----CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HH---------
Confidence 999986543322 2347889999999988889999999999999999998 999986432111 00
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHh
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNI 934 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 934 (949)
..+........ ...++..+.+++.+|++.||++|||+.|+++.|++++..
T Consensus 225 ---~~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 225 ---PRVEKGYKMDA------------------PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp ---HHHTTTCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHHhcCCCCCC------------------cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 00000000000 012345688999999999999999999999999999765
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=351.94 Aligned_cols=268 Identities=25% Similarity=0.352 Sum_probs=203.0
Q ss_pred hcCCCCCCeeeeecCceEEEEE-----EcCCCEEEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeeccccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGI-----IDEGRTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGADYR 698 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 698 (949)
.++|++.+.||+|+||.||+|+ ...+++.||||++.... .....++.+|+.++++++||||+++++++...+
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 106 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL-- 106 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC--
Confidence 4679999999999999999999 44567889999986443 234467889999999999999999999976544
Q ss_pred CCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC--
Q 039533 699 GNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD-- 776 (949)
Q Consensus 699 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~-- 776 (949)
..++||||+++++|.+++...... ......+++.+++.++.|++.||+|||++ +|+||||||+||+++.
T Consensus 107 ---~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~ 177 (327)
T 2yfx_A 107 ---PRFILMELMAGGDLKSFLRETRPR---PSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPG 177 (327)
T ss_dssp ---SCEEEEECCTTEEHHHHHHHTSCC---SSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSS
T ss_pred ---CcEEEEecCCCCcHHHHHHhhccc---ccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCC
Confidence 689999999999999999743211 12235689999999999999999999987 9999999999999984
Q ss_pred -CCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhh
Q 039533 777 -YMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLH 854 (949)
Q Consensus 777 -~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~ 854 (949)
+..+||+|||.++...............||+.|+|||++.+..++.++||||||+++|||+| |+.||...... ...
T Consensus 178 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~ 255 (327)
T 2yfx_A 178 PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVL 255 (327)
T ss_dssp TTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHH
T ss_pred CcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--HHH
Confidence 45699999999986544333222234458899999999988889999999999999999998 99998643211 011
Q ss_pred hhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHh
Q 039533 855 NFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNI 934 (949)
Q Consensus 855 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 934 (949)
.. +........ ...++..+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 256 ~~------------~~~~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 256 EF------------VTSGGRMDP------------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp HH------------HHTTCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HH------------HhcCCCCCC------------------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 00 000000000 012345678999999999999999999999999998765
Q ss_pred h
Q 039533 935 L 935 (949)
Q Consensus 935 ~ 935 (949)
.
T Consensus 306 ~ 306 (327)
T 2yfx_A 306 P 306 (327)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=340.78 Aligned_cols=253 Identities=22% Similarity=0.339 Sum_probs=198.4
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.|.+.+.||+|+||.||+|.+..++..||+|++.... ....+.+.+|+.++++++||||+++++++.... .+....+
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~ 105 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIV 105 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCceEE
Confidence 3677789999999999999999899999999997543 233467899999999999999999999876532 3345689
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec-CCCceEEe
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD-DYMTARVG 783 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~-~~~~~kl~ 783 (949)
+||||+++++|.+++. ....+++..+..++.|++.||+|||+. .++|+||||||+||+++ +++.+||+
T Consensus 106 lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~kl~ 174 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLK----------RFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIG 174 (290)
T ss_dssp EEEECCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred EEEEecCCCCHHHHHH----------HccCCCHHHHHHHHHHHHHHHHHHHcC-CCCEEECCCCHHHEEEECCCCCEEEe
Confidence 9999999999999996 235689999999999999999999987 22399999999999998 78999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCC
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
|||++........ ....||+.|+|||++.+ .++.++||||+||++|+|++|+.||.............
T Consensus 175 Dfg~~~~~~~~~~----~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~------- 242 (290)
T 1t4h_A 175 DLGLATLKRASFA----KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV------- 242 (290)
T ss_dssp CTTGGGGCCTTSB----EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH-------
T ss_pred eCCCccccccccc----ccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHH-------
Confidence 9999976543322 13459999999998875 58999999999999999999999996432211111000
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.....+... ....+..+.+++.+|++.||++|||++|+++
T Consensus 243 ------~~~~~~~~~-----------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 243 ------TSGVKPASF-----------------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ------TTTCCCGGG-----------------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------hccCCcccc-----------------CCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 000000000 0012345789999999999999999999985
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=343.58 Aligned_cols=259 Identities=26% Similarity=0.357 Sum_probs=207.0
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccc-------
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADY------- 697 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------- 697 (949)
..+|++.+.||+|+||.||+|++..+++.||+|+++... +.+.+|++++++++||||+++++++...++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 356889999999999999999999889999999997543 356789999999999999999998764322
Q ss_pred ----cCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCee
Q 039533 698 ----RGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVL 773 (949)
Q Consensus 698 ----~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIl 773 (949)
......++||||+++++|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+||+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil 154 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKR--------RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIF 154 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHG--------GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhc--------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEE
Confidence 1234579999999999999999621 234689999999999999999999987 9999999999999
Q ss_pred ecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchh
Q 039533 774 LDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINL 853 (949)
Q Consensus 774 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~ 853 (949)
++.++.+||+|||.++......... ...||+.|+|||++.+..++.++||||||+++|||++|..||..... .
T Consensus 155 ~~~~~~~kl~Dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----~ 227 (284)
T 2a19_B 155 LVDTKQVKIGDFGLVTSLKNDGKRT---RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK----F 227 (284)
T ss_dssp EEETTEEEECCCTTCEESSCCSCCC---CCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH----H
T ss_pred EcCCCCEEECcchhheecccccccc---ccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH----H
Confidence 9999999999999998876543322 34589999999999998999999999999999999999998742110 0
Q ss_pred hhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHH
Q 039533 854 HNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKN 933 (949)
Q Consensus 854 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 933 (949)
...+.+..... ..+..+.+++.+|++.||++|||+.|+++.|+.+++
T Consensus 228 -----------~~~~~~~~~~~----------------------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 228 -----------FTDLRDGIISD----------------------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp -----------HHHHHTTCCCT----------------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred -----------HHHhhcccccc----------------------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 00000101100 123456789999999999999999999999999987
Q ss_pred hhccC
Q 039533 934 ILLGV 938 (949)
Q Consensus 934 ~~~~~ 938 (949)
+....
T Consensus 275 ~~~~~ 279 (284)
T 2a19_B 275 SPEKN 279 (284)
T ss_dssp -----
T ss_pred CCCcc
Confidence 75543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=368.10 Aligned_cols=249 Identities=21% Similarity=0.226 Sum_probs=192.6
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecC---CCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ---HHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
.++|++.+.||+|+||.||+|++..+++.||||+++.. .......+.+|+.++++++||||+++++++...+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~----- 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD----- 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT-----
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC-----
Confidence 46799999999999999999999999999999999743 2333456788999999999999999999986554
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecCCCCCCeeecCCCce
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHH-DCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
..++||||+++|+|.+++. ....+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+
T Consensus 222 ~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~ 288 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLS----------RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHI 288 (446)
T ss_dssp EEEEEECCCSSCBHHHHHH----------HHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCE
T ss_pred EEEEEEeeCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCE
Confidence 7899999999999999986 23568999999999999999999997 6 89999999999999999999
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
||+|||+|+........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...
T Consensus 289 kl~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~----- 359 (446)
T 4ejn_A 289 KITDFGLCKEGIKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFE----- 359 (446)
T ss_dssp EECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH-----
T ss_pred EEccCCCceeccCCCcc--cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--HHH-----
Confidence 99999999864333222 124569999999999999999999999999999999999999996331110 000
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRT-----NMTNVVH 926 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~ 926 (949)
.+...... .+ ...+..+.+++.+|++.||++|| +++|+++
T Consensus 360 ------~i~~~~~~-~p-------------------~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 360 ------LILMEEIR-FP-------------------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ------HHHHCCCC-CC-------------------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ------HHHhCCCC-CC-------------------ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 00000000 00 02234678999999999999999 9999975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=350.99 Aligned_cols=252 Identities=21% Similarity=0.263 Sum_probs=196.6
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCCccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
.++|++.+.||+|+||.||+|.+..+++.||||+++.... ...+|++++.++ +||||+++++++.+.+ ..
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~-----~~ 91 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGK-----YV 91 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSS-----EE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCC-----EE
Confidence 4579999999999999999999999999999999975543 235688888888 7999999999976544 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCC----Cc
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDY----MT 779 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~----~~ 779 (949)
++||||+++|+|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||++.++ +.
T Consensus 92 ~lv~E~~~gg~L~~~i~----------~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~ 158 (342)
T 2qr7_A 92 YVVTELMKGGELLDKIL----------RQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPES 158 (342)
T ss_dssp EEEECCCCSCBHHHHHH----------TCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGG
T ss_pred EEEEeCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCe
Confidence 99999999999999986 234589999999999999999999988 99999999999998533 35
Q ss_pred eEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 780 ARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 780 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
+||+|||+++......... ....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....
T Consensus 159 ~kl~Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~-- 232 (342)
T 2qr7_A 159 IRICDFGFAKQLRAENGLL--MTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT--PEEIL-- 232 (342)
T ss_dssp EEECCCTTCEECBCTTCCB--CCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC--HHHHH--
T ss_pred EEEEECCCcccCcCCCCce--eccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC--HHHHH--
Confidence 9999999998765443222 23468999999999988889999999999999999999999996421111 00000
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
..+......... . .....+..+.+++.+|++.||++|||+.|+++
T Consensus 233 ------~~i~~~~~~~~~-------------~---~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 233 ------ARIGSGKFSLSG-------------G---YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ------HHHHHCCCCCCS-------------T---TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ------HHHccCCcccCc-------------c---ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000000000000 0 00123456789999999999999999999876
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=374.74 Aligned_cols=261 Identities=22% Similarity=0.345 Sum_probs=204.4
Q ss_pred eeeeecCceEEEEEEc--CCCEEEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEeee
Q 039533 633 LVGVGSFGSVYKGIID--EGRTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEF 709 (949)
Q Consensus 633 ~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 709 (949)
.||+|+||.||+|.+. .++..||||+++... ....+.+.+|++++++++||||+++++++.. +..++||||
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~~~~lv~E~ 416 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------EALMLVMEM 416 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------SSEEEEEEC
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------CCeEEEEEe
Confidence 7999999999999875 346789999997543 2345789999999999999999999999853 258999999
Q ss_pred ccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecccce
Q 039533 710 MHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLAR 789 (949)
Q Consensus 710 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~ 789 (949)
+++|+|.+++.. ....+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 417 ~~~g~L~~~l~~---------~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~ 484 (613)
T 2ozo_A 417 AGGGPLHKFLVG---------KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSK 484 (613)
T ss_dssp CTTCBHHHHHTT---------CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTT
T ss_pred CCCCcHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcc
Confidence 999999999962 234589999999999999999999988 89999999999999999999999999998
Q ss_pred ecCCCCC-ccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCCchhh
Q 039533 790 ILSPDHT-QTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPDDVMD 867 (949)
Q Consensus 790 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 867 (949)
....... ........+++.|+|||++.+..++.++|||||||++|||++ |+.||......+ .. +
T Consensus 485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~------------~ 550 (613)
T 2ozo_A 485 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VM------------A 550 (613)
T ss_dssp TCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--HH------------H
T ss_pred cccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HH------------H
Confidence 7654332 111112336689999999998899999999999999999998 999996432211 11 1
Q ss_pred hcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhhccCCCCCC
Q 039533 868 IVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILLGVELCPP 943 (949)
Q Consensus 868 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~~~~~ 943 (949)
.+...... +....++..+.+++..||+.||++||++.||++.|+.+..+.....+-+.
T Consensus 551 ~i~~~~~~------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~~~s 608 (613)
T 2ozo_A 551 FIEQGKRM------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGGS 608 (613)
T ss_dssp HHHTTCCC------------------CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCCCSS
T ss_pred HHHcCCCC------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccCCcc
Confidence 11100000 00113456789999999999999999999999999999888777655443
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=354.87 Aligned_cols=257 Identities=18% Similarity=0.208 Sum_probs=192.5
Q ss_pred hcCCCCC-CeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCCcc
Q 039533 625 TSGFSSA-NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 625 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 702 (949)
.++|.+. ++||+|+||+||+|.+..+++.||||+++. ...+.+|++++.+. +||||+++++++... +.+...
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~-~~~~~~ 133 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC 133 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeec-ccCCcE
Confidence 3456665 689999999999999998999999999863 24677888887554 899999999987542 123447
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC---CCc
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD---YMT 779 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~---~~~ 779 (949)
.++||||+++|+|.+++... ....+++.++..|+.||+.||+|||+. +|+||||||+||+++. ++.
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~--------~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~ 202 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDR--------GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAI 202 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC-----------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCC
T ss_pred EEEEEEeCCCCcHHHHHHHh--------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCcc
Confidence 89999999999999999731 124589999999999999999999987 9999999999999997 789
Q ss_pred eEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 780 ARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 780 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
+||+|||+++........ ....||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 203 ~kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-------- 271 (400)
T 1nxk_A 203 LKLTDFGFAKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-------- 271 (400)
T ss_dssp EEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSS--------
T ss_pred EEEEecccccccCCCCcc---ccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccc--------
Confidence 999999999876543322 234589999999999999999999999999999999999999964322110
Q ss_pred cCCCchh-hhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 860 ALPDDVM-DIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 860 ~~~~~~~-~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
..... .+....... + . +....++..+.+++.+||+.||++|||+.|+++.
T Consensus 272 --~~~~~~~i~~~~~~~-~------------~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 272 --SPGMKTRIRMGQYEF-P------------N---PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp --CCSHHHHHHHTCCCC-C------------T---TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --cHHHHHHHHcCcccC-C------------C---cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000 000000000 0 0 0001234568899999999999999999999874
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=342.01 Aligned_cols=253 Identities=22% Similarity=0.260 Sum_probs=195.4
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
++|.+.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++.... ..+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~~ 96 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH-----NMY 96 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----EEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCC-----eEE
Confidence 56889999999999999999999899999999997543 234578999999999999999999999976544 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeee---cCCCceE
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL---DDYMTAR 781 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll---~~~~~~k 781 (949)
+||||+++|+|.+++... ......+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+|
T Consensus 97 lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~k 167 (285)
T 3is5_A 97 IVMETCEGGELLERIVSA------QARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIK 167 (285)
T ss_dssp EEECCCSCCBHHHHHHHH------HHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEE
T ss_pred EEEEeCCCCcHHHHHHhh------hhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEE
Confidence 999999999999988521 11235689999999999999999999987 99999999999999 4568899
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
|+|||+++........ ....||+.|+|||++. ..++.++||||||+++|||++|+.||......... .....
T Consensus 168 l~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~--~~~~~-- 239 (285)
T 3is5_A 168 IIDFGLAELFKSDEHS---TNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ--QKATY-- 239 (285)
T ss_dssp ECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHH--
T ss_pred EEeeecceecCCcccC---cCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHH--hhhcc--
Confidence 9999999876543322 2345899999999876 46889999999999999999999999643211100 00000
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
......... ...+..+.+++.+|++.||++|||++|+++
T Consensus 240 -------~~~~~~~~~-------------------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 240 -------KEPNYAVEC-------------------RPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -------CCCCCCC---------------------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -------CCccccccc-------------------CcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000000 012345788999999999999999999975
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=366.71 Aligned_cols=254 Identities=22% Similarity=0.270 Sum_probs=203.5
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
.++|.+.++||+|+||.||+|++..+++.||||++.... ......+.+|+.++++++||||+++++++...+
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----- 257 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD----- 257 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC-----
Confidence 467899999999999999999999899999999997432 233467889999999999999999999976544
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++|+|.+++... ....+++..++.++.||+.||+|||++ +|+||||||+||+++.++++|
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~--------~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vK 326 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHM--------GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIR 326 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSS--------SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeE
Confidence 789999999999999998631 123489999999999999999999988 999999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
|+|||+|+......... ...||+.|+|||++.+..++.++|||||||++|||++|+.||......... .
T Consensus 327 L~DFGla~~~~~~~~~~---~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~-~------- 395 (576)
T 2acx_A 327 ISDLGLAVHVPEGQTIK---GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-E------- 395 (576)
T ss_dssp ECCCTTCEECCTTCCEE---CCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH-H-------
T ss_pred EEecccceecccCcccc---ccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH-H-------
Confidence 99999998876543322 346999999999999999999999999999999999999999643211100 0
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRT-----NMTNVVH 926 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~ 926 (949)
.+...+.......+ ...+..+.+++.+|++.||++|| +++||++
T Consensus 396 --~i~~~i~~~~~~~p-------------------~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 396 --EVERLVKEVPEEYS-------------------ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp --HHHHHHHHCCCCCC-------------------TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred --HHHHHhhcccccCC-------------------ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 00010000000000 12245678999999999999999 7788864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=355.36 Aligned_cols=279 Identities=19% Similarity=0.211 Sum_probs=186.1
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeeccc-ccCCc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGAD-YRGND 701 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~ 701 (949)
.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+++.+|++++++++||||+++++++.... .....
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 4689999999999999999999998999999999864322 33467889999999999999999999986532 22334
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+ +++|.+++. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+|
T Consensus 108 ~~~lv~e~~-~~~L~~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~k 172 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVK-----------CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELK 172 (367)
T ss_dssp CCEEEEECC-CEECC----------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred eEEEEeccc-CCCHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEE
Confidence 679999999 689988885 24589999999999999999999987 999999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
|+|||+++...... ....||..|+|||++.+ ..++.++||||+||++|||++|+.||......+ .+.... ..
T Consensus 173 L~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~-~~ 245 (367)
T 2fst_X 173 ILDFGLARHTADEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLIL-RL 245 (367)
T ss_dssp ECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHH-HH
T ss_pred EeeccccccccccC-----CCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH-HH
Confidence 99999998754332 23468999999999877 678999999999999999999999996432211 010000 00
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhh-hHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARIN-SIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
......+.+...........+.. ....+...+. .....+..+.+++.+|++.||++|||+.|+++
T Consensus 246 ~g~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 246 VGTPGAELLKKISSESARNYIQS-LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HCSCCHHHHTTCCCHHHHHHHHT-SCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hCCCCHHHHHHhhhHHHHHHHhc-cCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 00000000000000000000000 0000000000 01123456889999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=348.72 Aligned_cols=271 Identities=24% Similarity=0.332 Sum_probs=206.8
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEE--EEEEEecCC-CcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCC
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTI--AVKVFNLQH-HGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~v--avK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 700 (949)
.++|++.+.||+|+||.||+|++..++..+ |+|+++... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~---- 99 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG---- 99 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT----
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC----
Confidence 367899999999999999999998778755 999987432 23446789999999999 8999999999976544
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCC------ccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeee
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGED------EIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL 774 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll 774 (949)
..++||||+++++|.+++....... ........+++.+++.++.|++.||+|||++ +|+||||||+||++
T Consensus 100 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~ 175 (327)
T 1fvr_A 100 -YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILV 175 (327)
T ss_dssp -EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred -ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEE
Confidence 7899999999999999997321000 0001234689999999999999999999987 99999999999999
Q ss_pred cCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchh
Q 039533 775 DDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINL 853 (949)
Q Consensus 775 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~ 853 (949)
+.++.+||+|||+++....... .....++..|+|||++.+..++.++|||||||++|||++ |+.||....... .
T Consensus 176 ~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~ 250 (327)
T 1fvr_A 176 GENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--L 250 (327)
T ss_dssp CGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--H
T ss_pred cCCCeEEEcccCcCcccccccc---ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH--H
Confidence 9999999999999975332211 112347889999999988889999999999999999998 999996432111 0
Q ss_pred hhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHH
Q 039533 854 HNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKN 933 (949)
Q Consensus 854 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 933 (949)
.. .+........ ...++..+.+++.+|++.||++|||++|+++.|+++.+
T Consensus 251 ~~------------~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 251 YE------------KLPQGYRLEK------------------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp HH------------HGGGTCCCCC------------------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH------------HhhcCCCCCC------------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 00 0000000000 01234568899999999999999999999999999887
Q ss_pred hhccC
Q 039533 934 ILLGV 938 (949)
Q Consensus 934 ~~~~~ 938 (949)
.....
T Consensus 301 ~~~~~ 305 (327)
T 1fvr_A 301 ERKTY 305 (327)
T ss_dssp SSSCS
T ss_pred hhcCc
Confidence 65443
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=347.54 Aligned_cols=267 Identities=19% Similarity=0.211 Sum_probs=202.2
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcC-CCcceeEEeeeecccccCCccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIR-HRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 703 (949)
.++|++.+.||+|+||.||+|++..+++.||||+++.. ..+.+.+|+.++++++ ||||+++++++.... ....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~---~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPV---SRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT---TCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCC---CCce
Confidence 36789999999999999999999889999999998643 3467899999999997 999999999986422 3468
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC-ceEE
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM-TARV 782 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kl 782 (949)
++||||+++++|.+++. .+++.++..++.|++.||+|||++ +|+||||||+||+++.++ .+||
T Consensus 109 ~lv~e~~~~~~l~~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl 172 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ-------------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRL 172 (330)
T ss_dssp EEEEECCCCCCHHHHGG-------------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEE
T ss_pred EEEEeccCchhHHHHHH-------------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEE
Confidence 99999999999999885 278889999999999999999987 899999999999999776 8999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
+|||+++......... ...||..|+|||++.+ ..++.++|||||||++|||++|+.||.........+.......-
T Consensus 173 ~Dfg~a~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~ 249 (330)
T 3nsz_A 173 IDWGLAEFYHPGQEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 249 (330)
T ss_dssp CCCTTCEECCTTCCCC---SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHC
T ss_pred EeCCCceEcCCCCccc---cccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcC
Confidence 9999998776544322 3458999999999877 56899999999999999999999999543222111111111100
Q ss_pred CCc---------------hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 862 PDD---------------VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 862 ~~~---------------~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.+. ..+...........+. .........+..+.+++.+|++.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 250 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERF----------VHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGG----------CCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CchhhhHHHHhccccccchhhhhhhccccchhhh----------ccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111 1111111111100000 000001123567899999999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=349.71 Aligned_cols=277 Identities=22% Similarity=0.278 Sum_probs=193.1
Q ss_pred HHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 623 NATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 623 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
...++|++.+.||+|+||+||+|++..+++.||||+++.... ...+.+.+|+.++++++||||+++++++...+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 106 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH---- 106 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETT----
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCC----
Confidence 345789999999999999999999999999999999974432 22456789999999999999999999976544
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeee-----c
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL-----D 775 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll-----~ 775 (949)
..++||||+++ +|.+++. ....+++..+..|+.|++.||+|||++ +|+||||||+||++ +
T Consensus 107 -~~~lv~e~~~~-~L~~~~~----------~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~ 171 (329)
T 3gbz_A 107 -RLHLIFEYAEN-DLKKYMD----------KNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDAS 171 (329)
T ss_dssp -EEEEEEECCSE-EHHHHHH----------HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC----
T ss_pred -EEEEEEecCCC-CHHHHHh----------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCC
Confidence 78999999984 9999986 234589999999999999999999987 99999999999999 4
Q ss_pred CCCceEEeecccceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCchhh
Q 039533 776 DYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLH 854 (949)
Q Consensus 776 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~ 854 (949)
+++.+||+|||+++......... ....||..|+|||++.+. .++.++|||||||++|||++|+.||......+....
T Consensus 172 ~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 249 (329)
T 3gbz_A 172 ETPVLKIGDFGLARAFGIPIRQF--THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFK 249 (329)
T ss_dssp -CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred ccceEEECcCCCccccCCccccc--CCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHH
Confidence 55569999999998765433221 234589999999998875 489999999999999999999999964422211100
Q ss_pred hhccccCCCc--hhhhcc-cCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 855 NFGRKALPDD--VMDIVD-SSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 855 ~~~~~~~~~~--~~~~~d-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.......+.. ...... +....... ..... .............+.+++.+|++.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 250 IFEVLGLPDDTTWPGVTALPDWKQSFP----KFRGK--TLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp HHHHHCCCCTTTSTTGGGSTTCCTTCC----CCCCC--CHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHhCCCchhhhhhhhhhhhhhhhhh----hhccc--cHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000000000 000000 00000000 00000 0000000113456789999999999999999999975
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=341.53 Aligned_cols=250 Identities=21% Similarity=0.272 Sum_probs=203.2
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
.++|.+.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++...+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 88 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND----- 88 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC-----
Confidence 357889999999999999999999889999999997543 223467889999999999999999999976544
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++++|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 89 ~~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~k 155 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHK----------RRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVK 155 (294)
T ss_dssp EEEEEEECCTTCBHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEE
T ss_pred EEEEEEecCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEE
Confidence 7899999999999999886 234689999999999999999999987 999999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
|+|||.++......... ....||+.|+|||++.+..++.++||||||+++|||++|+.||......+. .
T Consensus 156 l~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~-------- 224 (294)
T 2rku_A 156 IGDFGLATKVEYDGERK--KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-Y-------- 224 (294)
T ss_dssp ECCCTTCEECCSTTCCB--CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-H--------
T ss_pred EEeccCceecccCcccc--ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-H--------
Confidence 99999998765433222 234589999999999998899999999999999999999999964321110 0
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
..+..... ..+ ...+..+.+++.+|++.||++|||++|+++.
T Consensus 225 ----~~~~~~~~-~~~-------------------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 225 ----LRIKKNEY-SIP-------------------KHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp ----HHHHTTCC-CCC-------------------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ----HHHhhccC-CCc-------------------cccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000000 000 0123457889999999999999999999874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=343.64 Aligned_cols=251 Identities=21% Similarity=0.223 Sum_probs=199.2
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.++|.+.+.||+|+||.||+|++..+++.||+|+++.......+.+.+|+.++++++||||+++++++...+ ..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 82 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTT-----HYY 82 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSS-----EEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCC-----EEE
Confidence 357889999999999999999999899999999998655445567899999999999999999999976544 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeee---cCCCceE
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL---DDYMTAR 781 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll---~~~~~~k 781 (949)
+||||+++++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+|
T Consensus 83 lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~k 149 (304)
T 2jam_A 83 LVMQLVSGGELFDRIL----------ERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIM 149 (304)
T ss_dssp EEECCCCSCBHHHHHH----------HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEE
T ss_pred EEEEcCCCccHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEE
Confidence 9999999999999986 234589999999999999999999987 99999999999999 7889999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
|+|||.++....... ....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....
T Consensus 150 l~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~----- 218 (304)
T 2jam_A 150 ITDFGLSKMEQNGIM----STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK--LFEK----- 218 (304)
T ss_dssp BCSCSTTCCCCCBTT----HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHH-----
T ss_pred EccCCcceecCCCcc----ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--HHHH-----
Confidence 999999976443221 12358999999999999899999999999999999999999996432110 0000
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
+......... +.....+..+.+++.+|++.||++|||++|+++
T Consensus 219 ------i~~~~~~~~~----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 219 ------IKEGYYEFES----------------PFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp ------HHHCCCCCCT----------------TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ------HHcCCCCCCc----------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0000000000 000123456889999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=349.22 Aligned_cols=257 Identities=20% Similarity=0.302 Sum_probs=203.5
Q ss_pred HHHHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc--------chHHHHHHHHHHHhc-CCCcceeEEe
Q 039533 620 DLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG--------ASRSFIAECKALKSI-RHRNLVKVLT 690 (949)
Q Consensus 620 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~h~niv~~~~ 690 (949)
......++|.+.+.||+|+||.||+|++..+|+.||||+++..... ..+.+.+|+.+++++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 3344557899999999999999999999888999999999754421 135678999999999 7999999999
Q ss_pred eeecccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 039533 691 ACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPS 770 (949)
Q Consensus 691 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~ 770 (949)
++.... ..++||||+++++|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+
T Consensus 168 ~~~~~~-----~~~lv~e~~~g~~L~~~l~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~ 229 (365)
T 2y7j_A 168 SYESSS-----FMFLVFDLMRKGELFDYLT----------EKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPE 229 (365)
T ss_dssp EEEBSS-----EEEEEECCCTTCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred EEeeCC-----EEEEEEEeCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHH
Confidence 976544 7899999999999999986 234689999999999999999999987 9999999999
Q ss_pred CeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCC------CccCCccchHHHHHHHHHHHhCCCCCc
Q 039533 771 NVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG------CEVSTNGDVYSYGILLLELVIGKKPID 844 (949)
Q Consensus 771 NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDiwSlGvvl~elltg~~Pf~ 844 (949)
||+++.++.+||+|||++.......... ...||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 230 NIl~~~~~~ikl~DfG~~~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 306 (365)
T 2y7j_A 230 NILLDDNMQIRLSDFGFSCHLEPGEKLR---ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFW 306 (365)
T ss_dssp GEEECTTCCEEECCCTTCEECCTTCCBC---CCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred HEEECCCCCEEEEecCcccccCCCcccc---cCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCC
Confidence 9999999999999999998876543322 3569999999998753 358899999999999999999999995
Q ss_pred cccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHH
Q 039533 845 IMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNV 924 (949)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev 924 (949)
..... ... ..+........ .+.....+..+.+++.+|++.||++|||+.|+
T Consensus 307 ~~~~~--~~~-----------~~i~~~~~~~~----------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~el 357 (365)
T 2y7j_A 307 HRRQI--LML-----------RMIMEGQYQFS----------------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQA 357 (365)
T ss_dssp CSSHH--HHH-----------HHHHHTCCCCC----------------HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCHH--HHH-----------HHHHhCCCCCC----------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 32111 000 00000000000 00011234568899999999999999999999
Q ss_pred HH
Q 039533 925 VH 926 (949)
Q Consensus 925 ~~ 926 (949)
++
T Consensus 358 l~ 359 (365)
T 2y7j_A 358 LQ 359 (365)
T ss_dssp HH
T ss_pred hc
Confidence 86
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=352.36 Aligned_cols=283 Identities=19% Similarity=0.251 Sum_probs=197.1
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc-chHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG-ASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
++|.+.+.||+|+||+||+|++..+++.||||+++..... ....+.+|++++++++||||+++++++...+ ..+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK-----SLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSS-----CEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCC-----EEE
Confidence 5789999999999999999999989999999999744322 2234567999999999999999999976544 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||++ |+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 77 lv~e~~~-~~l~~~~~~---------~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~D 143 (324)
T 3mtl_A 77 LVFEYLD-KDLKQYLDD---------CGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLAD 143 (324)
T ss_dssp EEEECCS-EEHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECS
T ss_pred EEecccc-cCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEcc
Confidence 9999997 589888862 234589999999999999999999987 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCch--hhhhccccC
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDIN--LHNFGRKAL 861 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~--~~~~~~~~~ 861 (949)
||+++......... ....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+.. .........
T Consensus 144 fg~a~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 221 (324)
T 3mtl_A 144 FGLARAKSIPTKTY--DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPT 221 (324)
T ss_dssp SSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred CcccccccCCcccc--ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99998654332221 13458999999999876 56899999999999999999999999644221110 000000000
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH--HHHHhHH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH--ELQSIKN 933 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~--~L~~i~~ 933 (949)
++.+....... ... ......................+.+++.+|++.||++|||++|+++ .+.++.+
T Consensus 222 ~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 222 EETWPGILSNE----EFK-TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp TTTSTTGGGCH----HHH-HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred hHhchhhhcch----hhc-ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 11011100000 000 0000000000001111133456789999999999999999999987 4444433
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=355.35 Aligned_cols=251 Identities=21% Similarity=0.322 Sum_probs=191.7
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcC--CCcceeEEeeeecccccCCc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIR--HRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~ 701 (949)
.+|++.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|++++++++ ||||+++++++...+
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~----- 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ----- 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-----
T ss_pred CceEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC-----
Confidence 45899999999999999999987 488999999975432 23467899999999996 599999999976554
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||| +.+++|.+++. ....+++.++..++.||+.||+|||++ +|+||||||+||+++ ++.+|
T Consensus 130 ~~~lv~E-~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~k 194 (390)
T 2zmd_A 130 YIYMVME-CGNIDLNSWLK----------KKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLK 194 (390)
T ss_dssp EEEEEEE-CCSEEHHHHHH----------HCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEE
T ss_pred EEEEEEe-cCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEE
Confidence 6899999 56889999996 234688999999999999999999977 999999999999996 57999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCC-----------CccCCccchHHHHHHHHHHHhCCCCCccccccC
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-----------CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~ 850 (949)
|+|||+++...............||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 195 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~ 274 (390)
T 2zmd_A 195 LIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 274 (390)
T ss_dssp ECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH
T ss_pred EEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH
Confidence 999999987755443322234569999999999865 368899999999999999999999996432111
Q ss_pred chhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 851 INLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 851 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
.. ...+++........ ...+..+.+++.+||+.||++|||+.|+++.
T Consensus 275 ~~------------~~~~~~~~~~~~~~------------------~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 275 SK------------LHAIIDPNHEIEFP------------------DIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HH------------HHHHHCTTSCCCCC------------------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HH------------HHHHhCccccCCCC------------------ccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11 11111111111000 0113457889999999999999999999753
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=357.25 Aligned_cols=317 Identities=22% Similarity=0.180 Sum_probs=223.4
Q ss_pred cCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccc
Q 039533 72 LRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVG 151 (949)
Q Consensus 72 l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~ 151 (949)
.++++++ .+|..+. ++++.|+|++|++++..|..|.++++|++|+|++|.+++..|..|+++++|++|+|++|+++.
T Consensus 18 c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~ 94 (477)
T 2id5_A 18 CHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKL 94 (477)
T ss_dssp CCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCS
T ss_pred eCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCc
Confidence 3344454 4555443 588999999999998888899999999999999999998888889999999888888888888
Q ss_pred cccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCcccccccccccCC
Q 039533 152 KILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGE 231 (949)
Q Consensus 152 ~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~ 231 (949)
..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|+++.++
T Consensus 95 ~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~------ 168 (477)
T 2id5_A 95 IPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIP------ 168 (477)
T ss_dssp CCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCC------
T ss_pred cCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccC------
Confidence 87788888888888888888888777888888888888888888888777777777777777777776654332
Q ss_pred CCChhhhccccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCC
Q 039533 232 VPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIP 311 (949)
Q Consensus 232 ~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~ 311 (949)
+..+..+ ++|+.|+|++|.+.+..+
T Consensus 169 ------------------------------------------------------~~~l~~l-~~L~~L~l~~n~i~~~~~ 193 (477)
T 2id5_A 169 ------------------------------------------------------TEALSHL-HGLIVLRLRHLNINAIRD 193 (477)
T ss_dssp ------------------------------------------------------HHHHTTC-TTCCEEEEESCCCCEECT
T ss_pred ------------------------------------------------------hhHhccc-CCCcEEeCCCCcCcEeCh
Confidence 1222222 235555555555555555
Q ss_pred CCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecccccccccCCCCCCCCCC
Q 039533 312 AGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCES 391 (949)
Q Consensus 312 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 391 (949)
..|..+++|++|++++|.+.+.+|..+....+|+.|+|++|++++..+..|.++++|+.|+|++|.+++..+..|.++++
T Consensus 194 ~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 273 (477)
T 2id5_A 194 YSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLR 273 (477)
T ss_dssp TCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTT
T ss_pred hhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhcccccc
Confidence 55666666666666666655555555555556666666666666433345666666666666666666666666666666
Q ss_pred CcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccc
Q 039533 392 LIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEG 453 (949)
Q Consensus 392 L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 453 (949)
|++|+|++|++++..|..|..+++| +.|++++|++++..+..|..+++|+.|+|++|.+..
T Consensus 274 L~~L~L~~n~l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c 334 (477)
T 2id5_A 274 LQEIQLVGGQLAVVEPYAFRGLNYL-RVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLAC 334 (477)
T ss_dssp CCEEECCSSCCSEECTTTBTTCTTC-CEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEEC
T ss_pred CCEEECCCCccceECHHHhcCcccC-CEEECCCCcCceeCHhHcCCCcccCEEEccCCCccC
Confidence 6666666666665556666666666 556666666665555566666777777777777663
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=349.98 Aligned_cols=247 Identities=26% Similarity=0.341 Sum_probs=196.5
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc---chHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG---ASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
+.|...+.||+|+||.||+|++..+++.||||++...... ..+.+.+|++++++++||||+++++++...+ .
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~ 128 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-----T 128 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----E
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-----e
Confidence 4588889999999999999999889999999999754322 2357889999999999999999999986544 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||++ |++.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 129 ~~lv~e~~~-g~l~~~l~~---------~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL 195 (348)
T 1u5q_A 129 AWLVMEYCL-GSASDLLEV---------HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKL 195 (348)
T ss_dssp EEEEEECCS-EEHHHHHHH---------HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEE
T ss_pred EEEEEecCC-CCHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEE
Confidence 899999997 688887751 235689999999999999999999988 8999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccC---CCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGV---GCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
+|||+++...... ...||+.|+|||++. +..++.++|||||||++|||++|+.||........ .......
T Consensus 196 ~DfG~a~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-~~~~~~~ 268 (348)
T 1u5q_A 196 GDFGSASIMAPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQN 268 (348)
T ss_dssp CCCTTCBSSSSBC------CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHS
T ss_pred eeccCceecCCCC------cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhc
Confidence 9999998754322 345999999999874 56789999999999999999999999864321110 0000000
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
. .+.... ...+..+.+++.+||+.||++|||++|+++.
T Consensus 269 ~---------~~~~~~---------------------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 269 E---------SPALQS---------------------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp C---------CCCCCC---------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred C---------CCCCCC---------------------CCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 000000 0123457889999999999999999999753
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=348.42 Aligned_cols=280 Identities=18% Similarity=0.162 Sum_probs=195.7
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeeccc-ccCCc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGAD-YRGND 701 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~ 701 (949)
.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.++++++||||+++++++...+ .....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 3679999999999999999999998999999999975432 33467889999999999999999999986543 12334
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++ +|.+++. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 104 ~~~lv~e~~~~-~l~~~~~------------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~k 167 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLK 167 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred ceEEEEEcCCC-CHHHHHh------------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEE
Confidence 67999999975 7888775 2378899999999999999999988 999999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc-
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA- 860 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~- 860 (949)
|+|||+++........ ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+.......
T Consensus 168 l~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~ 243 (371)
T 2xrw_A 168 ILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLG 243 (371)
T ss_dssp ECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHC-CC
T ss_pred EEEeeccccccccccc---CCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhC
Confidence 9999999876543221 23458999999999999899999999999999999999999996432211 000000000
Q ss_pred ---------CCCchhhhcccC--CCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 861 ---------LPDDVMDIVDSS--LLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 861 ---------~~~~~~~~~d~~--l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
........+... ......+.... ..............+..+.+++.+|++.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 244 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFP--DVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp CCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSC--GGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHhhhHHHHHHhhCccccccchhhhcc--cccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 000000000000 00000000000 00000001112344677899999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=338.05 Aligned_cols=253 Identities=23% Similarity=0.289 Sum_probs=196.5
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeE
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASV 706 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 706 (949)
+|.....||+|+||.||+|++..+++.||||++........+.+.+|+.++++++||||+++++++...+ ..++|
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv 97 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG-----FIKIF 97 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETT-----EEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC-----cEEEE
Confidence 3555569999999999999999899999999998766666678999999999999999999999986544 78999
Q ss_pred eeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC-CCceEEeec
Q 039533 707 YEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD-YMTARVGDF 785 (949)
Q Consensus 707 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~-~~~~kl~Df 785 (949)
|||+++++|.+++.... ....+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||+||
T Consensus 98 ~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Df 167 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKW-------GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDF 167 (295)
T ss_dssp EECCSEEEHHHHHHHTT-------CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCT
T ss_pred EEeCCCCCHHHHHHhhc-------cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeec
Confidence 99999999999996321 123467889999999999999999987 9999999999999987 899999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCCc--cCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCC
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCE--VSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
|.++......... ....||+.|+|||++.+.. ++.++||||||+++|||++|+.||................
T Consensus 168 g~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---- 241 (295)
T 2clq_A 168 GTSKRLAGINPCT--ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF---- 241 (295)
T ss_dssp TTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH----
T ss_pred ccccccCCCCCcc--cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc----
Confidence 9998765432211 2345899999999987643 7899999999999999999999996432111100000000
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
...+.+. ...+..+.+++.+|++.||++|||+.|+++
T Consensus 242 ----~~~~~~~----------------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 242 ----KVHPEIP----------------------ESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp ----CCCCCCC----------------------TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ----ccccccc----------------------ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000000 123456789999999999999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=356.94 Aligned_cols=268 Identities=19% Similarity=0.246 Sum_probs=206.9
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCC-cceeEEeeeecccccCCccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHR-NLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~ 703 (949)
.++|.+.++||+|+||.||+|++..+++.||||++..... ..++.+|+++++.++|+ ++..+..++.. .+..
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~-----~~~~ 78 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVE-----GDYN 78 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEE-----TTEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEee-----CCEE
Confidence 4689999999999999999999988999999999875433 34588999999999875 45455444332 3377
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeee---cCCCce
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL---DDYMTA 780 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll---~~~~~~ 780 (949)
++||||+ +++|.+++.. ....+++.+++.|+.||+.||+|||++ +|+||||||+|||+ +.++.+
T Consensus 79 ~lvme~~-g~sL~~ll~~---------~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~v 145 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNF---------CSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQV 145 (483)
T ss_dssp EEEEECC-CCBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCE
T ss_pred EEEEECC-CCCHHHHHHh---------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeE
Confidence 9999999 9999999962 234689999999999999999999987 99999999999999 688999
Q ss_pred EEeecccceecCCCCCcc-----ccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhh
Q 039533 781 RVGDFGLARILSPDHTQT-----SSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHN 855 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~ 855 (949)
||+|||+++.+....... ......||..|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~-- 223 (483)
T 3sv0_A 146 YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ-- 223 (483)
T ss_dssp EECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHH--
T ss_pred EEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHH--
Confidence 999999998876543311 1124569999999999999999999999999999999999999997432211000
Q ss_pred hccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhh
Q 039533 856 FGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNIL 935 (949)
Q Consensus 856 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~ 935 (949)
. ...+.+..... ........++.++.+++..||+.+|++||++.+|++.|+++....
T Consensus 224 ~--------~~~i~~~~~~~---------------~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 224 K--------YEKISEKKVAT---------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp H--------HHHHHHHHHHS---------------CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred H--------HHHHhhccccc---------------cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 0 00000000000 000011234567899999999999999999999999999997765
Q ss_pred cc
Q 039533 936 LG 937 (949)
Q Consensus 936 ~~ 937 (949)
..
T Consensus 281 ~~ 282 (483)
T 3sv0_A 281 GF 282 (483)
T ss_dssp TC
T ss_pred CC
Confidence 43
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=347.74 Aligned_cols=250 Identities=21% Similarity=0.263 Sum_probs=203.0
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
.++|.+.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----- 114 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND----- 114 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC-----
Confidence 357888999999999999999999899999999997542 233467889999999999999999999976544
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++++|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 115 ~~~lv~e~~~~~~L~~~~~----------~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~k 181 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHK----------RRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVK 181 (335)
T ss_dssp EEEEEECCCTTCBHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEE
T ss_pred eEEEEEecCCCCCHHHHHh----------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEE
Confidence 7899999999999999886 235689999999999999999999987 999999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
|+|||+++......... ....||..|+|||++.+..++.++||||||+++|||++|+.||......+. ..
T Consensus 182 l~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~------- 251 (335)
T 2owb_A 182 IGDFGLATKVEYDGERK--KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-YL------- 251 (335)
T ss_dssp ECCCTTCEECCSTTCCB--CCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HH-------
T ss_pred EeeccCceecccCcccc--cccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH-HH-------
Confidence 99999998765433222 234589999999999998899999999999999999999999964321110 00
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
.+...... .+ ......+.+++.+|++.||++|||++|+++.
T Consensus 252 -----~~~~~~~~-~~-------------------~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 252 -----RIKKNEYS-IP-------------------KHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp -----HHHHTCCC-CC-------------------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -----HHhcCCCC-CC-------------------ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000 00 0123457889999999999999999999873
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=337.69 Aligned_cols=247 Identities=21% Similarity=0.283 Sum_probs=201.7
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
.++|.+.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++...+
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 87 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK----- 87 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC-----
Confidence 367899999999999999999999899999999996432 233467899999999999999999999976544
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++++|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 88 ~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~k 154 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQ----------KHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELK 154 (284)
T ss_dssp EEEEEECCCTTEEHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEE
T ss_pred EEEEEEEeCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEE
Confidence 7899999999999999986 234589999999999999999999977 999999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
|+|||.+........ ....|++.|+|||++.+..++.++||||||+++|||++|+.||+....... .
T Consensus 155 l~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~-------- 221 (284)
T 2vgo_A 155 IADFGWSVHAPSLRR----RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET-H-------- 221 (284)
T ss_dssp ECCCTTCEECSSSCB----CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-H--------
T ss_pred EecccccccCccccc----ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH-H--------
Confidence 999999976543322 234589999999999998999999999999999999999999964321110 0
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
..+...... .+ ...+..+.+++.+|++.||++|||++|+++
T Consensus 222 ----~~~~~~~~~-~~-------------------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 222 ----RRIVNVDLK-FP-------------------PFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp ----HHHHTTCCC-CC-------------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----HHHhccccC-CC-------------------CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 001000000 00 012345789999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=362.48 Aligned_cols=252 Identities=23% Similarity=0.270 Sum_probs=200.7
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
.++|.+.++||+|+||.||+|++..+++.||+|++.... ......+.+|+.++++++||||+++++++...+
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----- 258 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT----- 258 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC-----
Confidence 367888999999999999999999899999999997432 233467889999999999999999999976544
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++|+|.+++.... .....+++..++.++.||+.||+|||++ +|+||||||+||+++.++++|
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~------~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vk 329 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVD------EDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVR 329 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSS------TTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEE
T ss_pred EEEEEEEeccCCCHHHHHHHhh------cccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEE
Confidence 7899999999999999986321 1234689999999999999999999987 999999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
|+|||+++......... ....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....
T Consensus 330 L~DFGla~~~~~~~~~~--~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~-~~~~~---- 402 (543)
T 3c4z_A 330 ISDLGLAVELKAGQTKT--KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELK---- 402 (543)
T ss_dssp ECCCTTCEECCTTCCCB--CCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC-HHHHH----
T ss_pred EeecceeeeccCCCccc--ccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh-HHHHH----
Confidence 99999999876544322 234699999999999999999999999999999999999999964321110 00000
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNM 921 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 921 (949)
..+...... .+ ...+..+.+++.+|++.||++||++
T Consensus 403 ----~~i~~~~~~-~p-------------------~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 403 ----QRVLEQAVT-YP-------------------DKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp ----HHHHHCCCC-CC-------------------TTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred ----HHHhhcccC-CC-------------------cccCHHHHHHHHHhccCCHhHCCCC
Confidence 001111000 00 1234567889999999999999975
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=340.12 Aligned_cols=250 Identities=24% Similarity=0.334 Sum_probs=203.9
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
.+.|.+.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|+.++++++||||+++++++.... ..
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~ 95 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT-----KL 95 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-----eE
Confidence 356888999999999999999998889999999997554 334578999999999999999999999976544 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++||||+++++|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 96 ~lv~e~~~~~~L~~~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~ 161 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLE-----------PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLA 161 (303)
T ss_dssp EEEEECCTTEEHHHHHT-----------TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred EEEEEeCCCCcHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEe
Confidence 99999999999999986 24589999999999999999999987 99999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCC
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
|||.+.......... ....||+.|+|||++.+..++.++||||||+++|||++|+.||....... .........
T Consensus 162 Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~-- 235 (303)
T 3a7i_A 162 DFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK--VLFLIPKNN-- 235 (303)
T ss_dssp CCTTCEECBTTBCCB--CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSC--
T ss_pred ecccceecCcccccc--CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH--HHHHhhcCC--
Confidence 999998765433221 23568999999999999999999999999999999999999996432111 000000000
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
.+... ...+..+.+++.+|++.||++|||+.|+++.
T Consensus 236 ------~~~~~----------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 236 ------PPTLE----------------------GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp ------CCCCC----------------------SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ------CCCCc----------------------cccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000 0223457899999999999999999999874
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=344.93 Aligned_cols=257 Identities=18% Similarity=0.213 Sum_probs=199.6
Q ss_pred HHHhcCCCCC-CeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhc-CCCcceeEEeeeecccc
Q 039533 622 YNATSGFSSA-NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSI-RHRNLVKVLTACLGADY 697 (949)
Q Consensus 622 ~~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 697 (949)
+.-.++|.+. +.||+|+||.||+|++..+++.||+|+++.... .....+.+|+.+++++ .||||+++++++...+
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~- 102 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS- 102 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC-
Confidence 3445567776 889999999999999998999999999975432 3356889999999999 4699999999976544
Q ss_pred cCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC-
Q 039533 698 RGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD- 776 (949)
Q Consensus 698 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~- 776 (949)
..++||||+++|+|.+++... ....+++.+++.++.|++.||+|||++ +|+||||||+||+++.
T Consensus 103 ----~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~ 167 (327)
T 3lm5_A 103 ----EIILILEYAAGGEIFSLCLPE--------LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSI 167 (327)
T ss_dssp ----EEEEEEECCTTEEGGGGGSSC--------C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCB
T ss_pred ----eEEEEEEecCCCcHHHHHHHh--------cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecC
Confidence 789999999999999998621 235689999999999999999999988 9999999999999987
Q ss_pred --CCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhh
Q 039533 777 --YMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLH 854 (949)
Q Consensus 777 --~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~ 854 (949)
++.+||+|||+++......... ...||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..
T Consensus 168 ~~~~~~kL~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~ 243 (327)
T 3lm5_A 168 YPLGDIKIVDFGMSRKIGHACELR---EIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET-YL 243 (327)
T ss_dssp TTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HH
T ss_pred CCCCcEEEeeCccccccCCccccc---cccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-HH
Confidence 7899999999998775443222 34699999999999999999999999999999999999999964321110 00
Q ss_pred hhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 855 NFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 855 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
. +....... +. +.....+..+.+++.+|++.||++|||++|+++
T Consensus 244 ~------------i~~~~~~~-~~---------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 244 N------------ISQVNVDY-SE---------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp H------------HHHTCCCC-CT---------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred H------------HHhccccc-Cc---------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 0 00000000 00 000123456789999999999999999999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=363.34 Aligned_cols=252 Identities=23% Similarity=0.272 Sum_probs=200.2
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecC--CCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ--HHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
.++|++.++||+|+||+||+|++..+++.||||++... .......+.+|++++++++||||+++++++.... .
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~ 95 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS-----S 95 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----E
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCC-----E
Confidence 45799999999999999999999989999999999643 2234578899999999999999999999976544 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec---CCCc
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD---DYMT 779 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~---~~~~ 779 (949)
.++||||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++ .++.
T Consensus 96 ~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 162 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEII----------KRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCD 162 (486)
T ss_dssp EEEEECCCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCC
T ss_pred EEEEEEcCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCC
Confidence 899999999999999886 235689999999999999999999988 999999999999995 5668
Q ss_pred eEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 780 ARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 780 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
+||+|||+++........ ....||+.|+|||++.+ .++.++||||+||++|+|++|+.||......+ ..
T Consensus 163 ~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~----- 231 (486)
T 3mwu_A 163 IKIIDFGLSTCFQQNTKM---KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--IL----- 231 (486)
T ss_dssp EEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH-----
T ss_pred EEEEECCcCeECCCCCcc---CCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HH-----
Confidence 999999999876544322 23469999999999876 58999999999999999999999996432111 00
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
..+........ .+.....+..+.+++.+|++.||++|||+.|+++.
T Consensus 232 ------~~i~~~~~~~~----------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 232 ------KRVETGKYAFD----------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ------HHHHHTCCCSC----------------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ------HHHHhCCCCCC----------------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000000 00111334567899999999999999999999873
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=340.53 Aligned_cols=258 Identities=22% Similarity=0.287 Sum_probs=202.1
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
.++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+.+|+.++++++||||+++++++... ....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CCce
Confidence 4678999999999999999999998999999999975432 3346789999999999999999999987532 2346
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC-----eEecCCCCCCeeecCC
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPV-----TAHCDLKPSNVLLDDY 777 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~-----ivHrDlkp~NIll~~~ 777 (949)
.++||||+++++|.+++... ......+++..++.++.|++.||+|||+. + |+||||||+||+++.+
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~ 152 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKG------TKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGK 152 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHH------HHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSS
T ss_pred EEEEEeCCCCCCHHHHHHhh------cccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCC
Confidence 89999999999999999621 11234589999999999999999999987 6 9999999999999999
Q ss_pred CceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhc
Q 039533 778 MTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFG 857 (949)
Q Consensus 778 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~ 857 (949)
+.+||+|||.++......... ....||..|+|||++.+..++.++||||||+++|||++|+.||...... .....
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~- 227 (279)
T 2w5a_A 153 QNVKLGDFGLARILNHDTSFA--KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAGK- 227 (279)
T ss_dssp SCEEECCCCHHHHC---CHHH--HHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH-
T ss_pred CCEEEecCchheeeccccccc--cccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH--HHHHH-
Confidence 999999999998765443211 1345899999999999888999999999999999999999999643211 00000
Q ss_pred cccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 039533 858 RKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHEL 928 (949)
Q Consensus 858 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 928 (949)
+........+ ...+..+.+++.+||+.||++|||+.||++.+
T Consensus 228 ----------i~~~~~~~~~-------------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 228 ----------IREGKFRRIP-------------------YRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp ----------HHHTCCCCCC-------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred ----------HhhcccccCC-------------------cccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 0000000000 02345688999999999999999999999865
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=361.27 Aligned_cols=260 Identities=15% Similarity=0.117 Sum_probs=192.2
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecC---CCcchHHHHHHHH---HHHhcCCCcceeEE-------ee
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ---HHGASRSFIAECK---ALKSIRHRNLVKVL-------TA 691 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~---~l~~l~h~niv~~~-------~~ 691 (949)
.++|.+.+.||+|+||.||+|++..+++.||||++... .....+.+.+|+. .+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 45788899999999999999999888999999999743 3334578899994 55555899999998 44
Q ss_pred eecccc-------cCCc-----cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 039533 692 CLGADY-------RGND-----FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQ 759 (949)
Q Consensus 692 ~~~~~~-------~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~ 759 (949)
+...+. .+.. ..++||||+ +|+|.+++.... ........+++..+..|+.|++.||+|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~---~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-- 225 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLL---SHSSTHKSLVHHARLQLTLQVIRLLASLHHY-- 225 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHH---HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcc---ccccccccccHHHHHHHHHHHHHHHHHHHhC--
Confidence 332210 0111 268999999 689999997321 1111123455688889999999999999988
Q ss_pred CCeEecCCCCCCeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCC-----------ccCCccchHH
Q 039533 760 PVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-----------EVSTNGDVYS 828 (949)
Q Consensus 760 ~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDiwS 828 (949)
+|+||||||+|||++.++.+||+|||+|+..... .....| +.|+|||++.+. .++.++||||
T Consensus 226 -~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwS 298 (377)
T 3byv_A 226 -GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR-----VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298 (377)
T ss_dssp -TEECSCCCGGGEEECTTCCEEECCGGGCEETTCE-----EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHH
T ss_pred -CeecCCCCHHHEEEcCCCCEEEEechhheecCCc-----ccCCCC-cCccChhhhcccccccccccccccCChhhhHHH
Confidence 8999999999999999999999999999864331 123457 999999999887 7999999999
Q ss_pred HHHHHHHHHhCCCCCccccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhh
Q 039533 829 YGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGV 908 (949)
Q Consensus 829 lGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 908 (949)
|||++|||++|+.||........ ...+.. .. ...+..+.+++.
T Consensus 299 lG~il~elltg~~Pf~~~~~~~~-------------~~~~~~-~~-----------------------~~~~~~~~~li~ 341 (377)
T 3byv_A 299 LGLVIYWIWCADLPITKDAALGG-------------SEWIFR-SC-----------------------KNIPQPVRALLE 341 (377)
T ss_dssp HHHHHHHHHHSSCCC------CC-------------SGGGGS-SC-----------------------CCCCHHHHHHHH
T ss_pred HHHHHHHHHHCCCCCcccccccc-------------hhhhhh-hc-----------------------cCCCHHHHHHHH
Confidence 99999999999999964321110 000000 00 022346789999
Q ss_pred ccccCCCCCCCCHHHHHH--HHHHhHHh
Q 039533 909 ACSMELPQDRTNMTNVVH--ELQSIKNI 934 (949)
Q Consensus 909 ~cl~~dP~~RPs~~ev~~--~L~~i~~~ 934 (949)
+||+.||++|||+.|+++ .++++++.
T Consensus 342 ~~L~~dp~~Rpt~~e~l~hp~f~~~~~~ 369 (377)
T 3byv_A 342 GFLRYPKEDRLLPLQAMETPEYEQLRTE 369 (377)
T ss_dssp HHTCSSGGGCCCHHHHHTSHHHHHHHHH
T ss_pred HHcCCCchhCCCHHHHhhChHHHHHHHH
Confidence 999999999999999986 55555443
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=365.64 Aligned_cols=250 Identities=23% Similarity=0.301 Sum_probs=202.3
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|+.++++++||||+++++++.... .
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~ 100 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG-----Y 100 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----E
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-----E
Confidence 56889999999999999999999899999999997543 234578999999999999999999999976544 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeee---cCCCc
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL---DDYMT 779 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll---~~~~~ 779 (949)
.++||||+.+|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.
T Consensus 101 ~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 167 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEII----------SRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDAN 167 (484)
T ss_dssp EEEEECCCCSCBHHHHHH----------TCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCC
T ss_pred EEEEEecCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCc
Confidence 899999999999999986 234689999999999999999999988 89999999999999 56789
Q ss_pred eEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 780 ARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 780 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
+||+|||+++......... ...||+.|+|||++.+ .++.++||||+||++|+|++|++||....... ...
T Consensus 168 ~kl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~---- 237 (484)
T 3nyv_A 168 IRIIDFGLSTHFEASKKMK---DKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD--ILK---- 237 (484)
T ss_dssp EEECCTTHHHHBCCCCSHH---HHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH----
T ss_pred EEEEeeeeeEEcccccccc---cCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH--HHH----
Confidence 9999999998776554322 3459999999999876 68999999999999999999999996432111 000
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.+........ .+.....+..+.+++.+|++.||++|||+.|+++
T Consensus 238 -------~i~~~~~~~~----------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 238 -------KVEKGKYTFE----------------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp -------HHHHCCCCCC----------------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------HHHcCCCCCC----------------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0000000000 0011133456789999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=362.76 Aligned_cols=251 Identities=23% Similarity=0.298 Sum_probs=199.3
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-------------cchHHHHHHHHHHHhcCCCcceeEEee
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-------------GASRSFIAECKALKSIRHRNLVKVLTA 691 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~~~ 691 (949)
.++|.+.++||+|+||+||+|++..+++.||||++..... ...+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 5679999999999999999999998999999999974431 234678999999999999999999999
Q ss_pred eecccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCC
Q 039533 692 CLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSN 771 (949)
Q Consensus 692 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~N 771 (949)
+.... ..++||||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|
T Consensus 115 ~~~~~-----~~~lv~e~~~gg~L~~~l~----------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~N 176 (504)
T 3q5i_A 115 FEDKK-----YFYLVTEFYEGGELFEQII----------NRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPEN 176 (504)
T ss_dssp EECSS-----EEEEEEECCTTCBHHHHHH----------HHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred EEcCC-----EEEEEEecCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHH
Confidence 76544 7899999999999999986 235689999999999999999999987 99999999999
Q ss_pred eeecCCC---ceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccc
Q 039533 772 VLLDDYM---TARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFE 848 (949)
Q Consensus 772 Ill~~~~---~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~ 848 (949)
|+++.++ .+||+|||+++......... ...||+.|+|||++.+ .++.++||||+||++|+|++|+.||.....
T Consensus 177 il~~~~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 252 (504)
T 3q5i_A 177 ILLENKNSLLNIKIVDFGLSSFFSKDYKLR---DRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND 252 (504)
T ss_dssp EEESSTTCCSSEEECCCTTCEECCTTSCBC---CCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEEecCCCCccEEEEECCCCEEcCCCCccc---cccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9998765 69999999998876543322 3459999999999874 689999999999999999999999964321
Q ss_pred cCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 849 GDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 849 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.. .. ..+........ .+.....+..+.+++.+|++.||++|||++|+++
T Consensus 253 ~~--~~-----------~~i~~~~~~~~----------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 253 QD--II-----------KKVEKGKYYFD----------------FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HH--HH-----------HHHHHCCCCCC----------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HH--HH-----------HHHHcCCCCCC----------------ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 10 00 00111000000 0111234566889999999999999999999975
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=350.52 Aligned_cols=272 Identities=23% Similarity=0.297 Sum_probs=198.7
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc--chHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG--ASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
.++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+.+|+.++++++||||+++++++...+ .
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~ 98 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK-----R 98 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----E
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC-----E
Confidence 46789999999999999999999988999999998754432 2356789999999999999999999976544 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++++|.++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 99 ~~lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl 165 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLEL----------FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKL 165 (331)
T ss_dssp EEEEEECCSEEHHHHHHH----------STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEE
T ss_pred EEEEEecCCcchHHHHHh----------hccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEE
Confidence 899999999999998865 234589999999999999999999988 9999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCchh--hhhccc
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINL--HNFGRK 859 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~--~~~~~~ 859 (949)
+|||.++......... ....||..|+|||++.+. .++.++|||||||++|||++|+.||......+... ......
T Consensus 166 ~Dfg~~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 243 (331)
T 4aaa_A 166 CDFGFARTLAAPGEVY--DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGN 243 (331)
T ss_dssp CCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred EeCCCceeecCCcccc--CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 9999998765433221 134589999999998875 68999999999999999999999996442221100 000000
Q ss_pred cCCCchhhhc------ccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 860 ALPDDVMDIV------DSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 860 ~~~~~~~~~~------d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
..+...+.+ .....+... ............+..+.+++.+|++.||++|||++|+++
T Consensus 244 -~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 244 -LIPRHQELFNKNPVFAGVRLPEIK---------EREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp -CCHHHHHHHHHCGGGTTCCCCCCS---------SCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -CChhhhhHhhhccccccccCcccc---------ccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000000 000000000 000000011134567899999999999999999999875
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=337.56 Aligned_cols=247 Identities=18% Similarity=0.217 Sum_probs=196.9
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCCc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 701 (949)
.++|++.+.||+|+||.||+|++..+++.||+|+++... .....++.+|+..+.++ +||||+++++++...+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~----- 84 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD----- 84 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT-----
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC-----
Confidence 467899999999999999999999899999999997543 23456788999999999 8999999999976544
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC-----
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD----- 776 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~----- 776 (949)
..++||||+++++|.+++... ......+++.++..++.|++.||+|||++ +|+||||||+||+++.
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~ 155 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISEN------YRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPN 155 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHH------HHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC------
T ss_pred eEEEEEEecCCCcHHHHHHhh------cccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCc
Confidence 789999999999999999621 11125589999999999999999999988 9999999999999984
Q ss_pred --------------CCceEEeecccceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCC
Q 039533 777 --------------YMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKK 841 (949)
Q Consensus 777 --------------~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~ 841 (949)
...+||+|||.+........ ..||+.|+|||++.+. .++.++|||||||++|||++|.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~------~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~ 229 (289)
T 1x8b_A 156 AASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV------EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP 229 (289)
T ss_dssp --------------CCCEEECCCTTCEETTCSCC------CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCC
T ss_pred ccccccccccccCCceEEEEcccccccccCCccc------cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCC
Confidence 44799999999987654332 3489999999998876 56689999999999999999998
Q ss_pred CCccccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCH
Q 039533 842 PIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNM 921 (949)
Q Consensus 842 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 921 (949)
|+.... .... +........+ ...+..+.+++.+|++.||++|||+
T Consensus 230 ~~~~~~----~~~~------------~~~~~~~~~~-------------------~~~~~~~~~li~~~l~~dp~~Rps~ 274 (289)
T 1x8b_A 230 LPRNGD----QWHE------------IRQGRLPRIP-------------------QVLSQEFTELLKVMIHPDPERRPSA 274 (289)
T ss_dssp CCSSSH----HHHH------------HHTTCCCCCS-------------------SCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCcchh----HHHH------------HHcCCCCCCC-------------------cccCHHHHHHHHHHhCCCcccCCCH
Confidence 764211 1110 1111110000 0223467899999999999999999
Q ss_pred HHHHH
Q 039533 922 TNVVH 926 (949)
Q Consensus 922 ~ev~~ 926 (949)
.|+++
T Consensus 275 ~~ll~ 279 (289)
T 1x8b_A 275 MALVK 279 (289)
T ss_dssp HHHHT
T ss_pred HHHhh
Confidence 99975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=335.59 Aligned_cols=249 Identities=25% Similarity=0.343 Sum_probs=193.9
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
.++|.+.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|+.++++++||||+++++++...+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 84 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT----- 84 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC-----
Confidence 467999999999999999999999889999999997432 233467899999999999999999999976544
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++++|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 85 ~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~ 151 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYIC----------KHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAK 151 (276)
T ss_dssp EEEEEEECCCSCBHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEE
T ss_pred eEEEEEeccCCCcHHHHHh----------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEE
Confidence 7899999999999999996 234589999999999999999999988 899999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCcc-CCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEV-STNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
|+|||.+.......... ...|++.|+|||++.+..+ +.++||||||+++|||++|+.||+..... ...
T Consensus 152 l~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~------ 220 (276)
T 2h6d_A 152 IADFGLSNMMSDGEFLR---TSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--TLF------ 220 (276)
T ss_dssp ECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH------
T ss_pred EeecccccccCCCccee---cccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--HHH------
Confidence 99999998765433211 3458999999999988765 68999999999999999999999642111 000
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
+.+.......+ ...+..+.+++.+|++.||++|||++|+++.
T Consensus 221 ------~~~~~~~~~~~-------------------~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 221 ------KKIRGGVFYIP-------------------EYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ------HHHHHCCCCCC-------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ------HHhhcCcccCc-------------------hhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000000000 0123457889999999999999999999873
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=363.24 Aligned_cols=251 Identities=20% Similarity=0.246 Sum_probs=196.1
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
.++|++.+.||+|+||+||+|++..+++.||+|+++... ......+.+|+.++++++||||+++++++.... .
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~ 110 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR-----N 110 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----E
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-----E
Confidence 346889999999999999999999899999999997543 233578899999999999999999999976544 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC---CCc
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD---YMT 779 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~---~~~ 779 (949)
.++||||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.
T Consensus 111 ~~lv~e~~~~g~L~~~~~----------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 177 (494)
T 3lij_A 111 YYLVMECYKGGELFDEII----------HRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDAL 177 (494)
T ss_dssp EEEEEECCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCC
T ss_pred EEEEEecCCCCcHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCc
Confidence 899999999999999886 235689999999999999999999987 9999999999999975 455
Q ss_pred eEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 780 ARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 780 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
+||+|||+|+........ ....||+.|+|||++. ..++.++||||+||++|+|++|+.||....... ...
T Consensus 178 ~kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~---- 247 (494)
T 3lij_A 178 IKIVDFGLSAVFENQKKM---KERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE--ILR---- 247 (494)
T ss_dssp EEECCCTTCEECBTTBCB---CCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH----
T ss_pred EEEEECCCCeECCCCccc---cccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH----
Confidence 999999999876544322 2356999999999986 468999999999999999999999996432111 000
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.+......... +.....+..+.+++.+|++.||++|||+.|+++
T Consensus 248 -------~i~~~~~~~~~----------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 248 -------KVEKGKYTFDS----------------PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp -------HHHHTCCCCCS----------------GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -------HHHhCCCCCCc----------------hhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 00000000000 001123456789999999999999999999985
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=346.23 Aligned_cols=275 Identities=21% Similarity=0.250 Sum_probs=195.9
Q ss_pred HHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc-----chHHHHHHHHHHHhcCCCcceeEEeeeeccc
Q 039533 622 YNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG-----ASRSFIAECKALKSIRHRNLVKVLTACLGAD 696 (949)
Q Consensus 622 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 696 (949)
....++|.+.+.||+|+||.||+|++..+++.||||+++..... ..+.+.+|++++++++||||+++++++...+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 34567899999999999999999999888999999998743221 2357889999999999999999999975443
Q ss_pred ccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC
Q 039533 697 YRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD 776 (949)
Q Consensus 697 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~ 776 (949)
..++||||+++ +|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.
T Consensus 86 -----~~~lv~e~~~~-~l~~~~~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~ 147 (346)
T 1ua2_A 86 -----NISLVFDFMET-DLEVIIKD---------NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDE 147 (346)
T ss_dssp -----CCEEEEECCSE-EHHHHHTT---------CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred -----ceEEEEEcCCC-CHHHHHHh---------cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcC
Confidence 78999999986 89888862 234578889999999999999999988 8999999999999999
Q ss_pred CCceEEeecccceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhh
Q 039533 777 YMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHN 855 (949)
Q Consensus 777 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~ 855 (949)
++.+||+|||+++......... ....||+.|+|||++.+. .++.++|||||||++|||++|.+||......+. +..
T Consensus 148 ~~~~kl~Dfg~a~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~-~~~ 224 (346)
T 1ua2_A 148 NGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-LTR 224 (346)
T ss_dssp TCCEEECCCGGGSTTTSCCCCC--CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH
T ss_pred CCCEEEEecccceeccCCcccC--CcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHH
Confidence 9999999999998765433221 234589999999998764 488999999999999999999999864322111 111
Q ss_pred hcc---ccCCCchhhh---cccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 856 FGR---KALPDDVMDI---VDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 856 ~~~---~~~~~~~~~~---~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
... ....+.+.+. .+........ .. + ........+..+.+++.+|++.||++|||++|+++.
T Consensus 225 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~-~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 225 IFETLGTPTEEQWPDMCSLPDYVTFKSFP-------GI-P--LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp HHHHHCCCCTTTSSSTTSSTTCCCCCCCC-------CC-C--HHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHcCCCChhhhhhhccCcccccccccC-------CC-C--hHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 100 0000000000 0000000000 00 0 000011334678999999999999999999999863
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=351.44 Aligned_cols=281 Identities=19% Similarity=0.173 Sum_probs=202.9
Q ss_pred CHHHHHHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc-----------chHHHHHHHHHHHhcCCCcc
Q 039533 617 SYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG-----------ASRSFIAECKALKSIRHRNL 685 (949)
Q Consensus 617 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~ni 685 (949)
...++....++|++.+.||+|+||.||+|.+. +++.||||++...... ..+.+.+|++++++++||||
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 45678888999999999999999999999987 4899999998643221 12678999999999999999
Q ss_pred eeEEeeeecccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 039533 686 VKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHC 765 (949)
Q Consensus 686 v~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHr 765 (949)
+++++++...+.......++||||++ |+|.+++.. ....+++..+..++.|++.||+|||++ +|+||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~ 158 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---------QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHR 158 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---------TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCC
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEec
Confidence 99999986654344557899999998 588888762 234689999999999999999999988 89999
Q ss_pred CCCCCCeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCc
Q 039533 766 DLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPID 844 (949)
Q Consensus 766 Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~ 844 (949)
||||+||+++.++.+||+|||+++........ ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 159 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 235 (362)
T 3pg1_A 159 DLHPGNILLADNNDITICDFNLAREDTADANK---THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR 235 (362)
T ss_dssp CCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCChHHEEEcCCCCEEEEecCccccccccccc---ceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999865443322 23458999999999877 678999999999999999999999996
Q ss_pred cccccCchhhhhccccCC-----------CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccC
Q 039533 845 IMFEGDINLHNFGRKALP-----------DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSME 913 (949)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~-----------~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 913 (949)
...... .........-. ....+.+.......+.. .........+..+.+++.+|++.
T Consensus 236 ~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~li~~~L~~ 303 (362)
T 3pg1_A 236 GSTFYN-QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPAR-----------AWTAVVPTADPVALDLIAKMLEF 303 (362)
T ss_dssp CSSHHH-HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCC-----------CHHHHSTTSCHHHHHHHHHHTCS
T ss_pred CCCHHH-HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChh-----------hHHhhCCCCCHHHHHHHHHHhcC
Confidence 432111 00000000000 00111111111111100 00011113345688999999999
Q ss_pred CCCCCCCHHHHHH
Q 039533 914 LPQDRTNMTNVVH 926 (949)
Q Consensus 914 dP~~RPs~~ev~~ 926 (949)
||++|||+.|+++
T Consensus 304 dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 304 NPQRRISTEQALR 316 (362)
T ss_dssp SGGGSCCHHHHHT
T ss_pred ChhhCCCHHHHHc
Confidence 9999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=373.24 Aligned_cols=253 Identities=23% Similarity=0.355 Sum_probs=198.7
Q ss_pred CeeeeecCceEEEEEEc--CCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEe
Q 039533 632 NLVGVGSFGSVYKGIID--EGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVY 707 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 707 (949)
+.||+|+||.||+|.+. .+++.||||+++.... ...+++.+|++++++++||||+++++++... ..++||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------~~~lv~ 448 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE------SWMLVM 448 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS------SEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC------CEEEEE
Confidence 47999999999999663 4568899999975432 3357899999999999999999999997422 478999
Q ss_pred eeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccc
Q 039533 708 EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGL 787 (949)
Q Consensus 708 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~ 787 (949)
||+++|+|.+++. ....+++.++..|+.||+.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 449 E~~~~g~L~~~l~----------~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGl 515 (635)
T 4fl3_A 449 EMAELGPLNKYLQ----------QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGL 515 (635)
T ss_dssp ECCTTEEHHHHHH----------HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTH
T ss_pred EccCCCCHHHHHh----------hCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCC
Confidence 9999999999996 235689999999999999999999988 899999999999999999999999999
Q ss_pred ceecCCCCCc-cccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCCch
Q 039533 788 ARILSPDHTQ-TSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPDDV 865 (949)
Q Consensus 788 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 865 (949)
|+........ .......+|..|+|||++.+..++.++|||||||++|||++ |+.||....... +
T Consensus 516 a~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--------------~ 581 (635)
T 4fl3_A 516 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--------------V 581 (635)
T ss_dssp HHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------------H
T ss_pred ccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------------H
Confidence 9877554321 12223346789999999998899999999999999999998 999996432211 1
Q ss_pred hhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhh
Q 039533 866 MDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNIL 935 (949)
Q Consensus 866 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~ 935 (949)
.+.+........ ...++..+.+++..||+.||++||++++|++.|+++...+
T Consensus 582 ~~~i~~~~~~~~------------------p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 582 TAMLEKGERMGC------------------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp HHHHHTTCCCCC------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCCCC------------------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 111111100000 0134567889999999999999999999999999987654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=351.53 Aligned_cols=201 Identities=25% Similarity=0.356 Sum_probs=174.2
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.... ...+.+.+|+.++++++||||+++++++...+ ..
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 106 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-----EI 106 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT-----EE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC-----EE
Confidence 3578999999999999999999998999999999976532 33467899999999999999999999976544 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++||||+++++|.+++. ....+++..+..++.|++.||+|||+.+ +|+||||||+||+++.++.+||+
T Consensus 107 ~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~ 174 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLK----------KAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLC 174 (360)
T ss_dssp EEEECCCTTCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEECCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEE
Confidence 99999999999999996 2345899999999999999999999732 79999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccc
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIM 846 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~ 846 (949)
|||+++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 175 Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 175 DFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp CCCCCHHHHHHC--------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred ECCCCccccccc----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999987553221 12346899999999999999999999999999999999999999743
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=344.63 Aligned_cols=280 Identities=19% Similarity=0.259 Sum_probs=201.8
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccc---cC
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADY---RG 699 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~ 699 (949)
.++|++.+.||+|+||.||+|++..+++.||||++..... .....+.+|++++++++||||+++++++..... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 4679999999999999999999988999999999864432 234678899999999999999999999875431 11
Q ss_pred CccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCc
Q 039533 700 NDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMT 779 (949)
Q Consensus 700 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~ 779 (949)
....++||||+++ ++.+.+.. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~ 162 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN---------VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGV 162 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC---------TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred CceEEEEEeccCC-CHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCC
Confidence 3468999999985 77777652 234589999999999999999999988 9999999999999999999
Q ss_pred eEEeecccceecCCCCC--ccccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCch--hh
Q 039533 780 ARVGDFGLARILSPDHT--QTSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDIN--LH 854 (949)
Q Consensus 780 ~kl~DfG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~--~~ 854 (949)
+||+|||+|+....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ..
T Consensus 163 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 242 (351)
T 3mi9_A 163 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 242 (351)
T ss_dssp EEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred EEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 99999999987653322 112224568999999998876 45799999999999999999999999754222110 00
Q ss_pred hhccccCCCc-hhh-----hcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 855 NFGRKALPDD-VMD-----IVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 855 ~~~~~~~~~~-~~~-----~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
... ...+.. ... ..+....... .......... .......+.+++.+|++.||++|||++|+++
T Consensus 243 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 243 QLC-GSITPEVWPNVDNYELYEKLELVKG-------QKRKVKDRLK-AYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HHH-CCCCTTTSTTGGGCGGGTSSCCCSS-------CCCCHHHHHH-HHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHh-CCCChhhccccccchhhcccccccc-------cccCHHHHhh-hccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 000 011111 000 0000000000 0000000000 0112456889999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=348.45 Aligned_cols=280 Identities=19% Similarity=0.179 Sum_probs=197.8
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeeccccc-CCc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYR-GND 701 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~~ 701 (949)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.++++++||||+++++++...+.. ...
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 3578899999999999999999999999999999975432 2346788999999999999999999998654421 122
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+. ++|.+++. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 121 ~~~lv~e~~~-~~l~~~~~------------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~k 184 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG------------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELK 184 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEE
T ss_pred eEEEEEcccc-ccHHHHhh------------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEE
Confidence 3499999997 58888874 2389999999999999999999988 999999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
|+|||.++....... ...||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+. +......
T Consensus 185 L~Dfg~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~- 257 (371)
T 4exu_A 185 ILDFGLARHADAEMT-----GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILKV- 257 (371)
T ss_dssp ECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHH-
T ss_pred EEecCcccccccCcC-----CcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHH-
Confidence 999999986543322 3458999999999887 6789999999999999999999999964321110 0000000
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
......+..+.............................+..+.+++.+|++.||++|||++|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 258 TGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000000000000000000000000000000000111335678999999999999999999999763
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=339.63 Aligned_cols=252 Identities=22% Similarity=0.286 Sum_probs=198.1
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ..+.+.+|+.++++++||||+++++++...+ ..
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~ 99 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNT-----DL 99 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETT-----EE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCC-----EE
Confidence 3467999999999999999999999889999999997543 3567899999999999999999999976544 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++||||+++++|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 100 ~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~ 167 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRL---------RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLA 167 (314)
T ss_dssp EEEEECCTTEEHHHHHHH---------HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEEC
T ss_pred EEEeecCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEe
Confidence 999999999999999851 235689999999999999999999987 99999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCC
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
|||.+.......... ....||..|+|||++.+..++.++||||||+++|||++|+.||.......... ......
T Consensus 168 dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~-- 241 (314)
T 3com_A 168 DFGVAGQLTDTMAKR--NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF--MIPTNP-- 241 (314)
T ss_dssp CCTTCEECBTTBSCB--CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--HHHHSC--
T ss_pred ecccchhhhhhcccc--CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHhcCC--
Confidence 999998765432211 23468999999999999899999999999999999999999996432111000 000000
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.... . .....+..+.+++.+|++.||++|||+.|+++
T Consensus 242 ------~~~~-~-------------------~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 242 ------PPTF-R-------------------KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ------CCCC-S-------------------SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ------Cccc-C-------------------CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0000 0 00122456889999999999999999999976
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=347.54 Aligned_cols=284 Identities=20% Similarity=0.215 Sum_probs=203.6
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
.++|.+.+.||+|+||.||+|++..+++.||||+++.... ....++.+|++++++++||||+++++++....+......
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 4689999999999999999999998999999999964432 234578899999999999999999999876655556688
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++||||++ ++|.+++. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 90 ~lv~e~~~-~~L~~~~~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~ 154 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIS-----------TQMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVC 154 (353)
T ss_dssp EEEECCCS-EEHHHHHH-----------HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEEC
T ss_pred EEEEeccC-ccHHHHHh-----------hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEE
Confidence 99999997 58999885 23589999999999999999999987 99999999999999999999999
Q ss_pred ecccceecCCCCCcc--------ccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCchh-
Q 039533 784 DFGLARILSPDHTQT--------SSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINL- 853 (949)
Q Consensus 784 DfG~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~- 853 (949)
|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..........
T Consensus 155 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 234 (353)
T 2b9h_A 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234 (353)
T ss_dssp CCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 999998765432211 1123468999999998654 678999999999999999999999996432111000
Q ss_pred -hhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 854 -HNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 854 -~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
................. .....+.+..................+..+.+++.+|++.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 235 IFGIIGTPHSDNDLRCIE---SPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHHHCCCCSTTTTTTCC---CHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhCCCchhccccccc---cchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000000000000000 00000000000000000000001134567889999999999999999999987
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=338.59 Aligned_cols=255 Identities=22% Similarity=0.241 Sum_probs=185.0
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc-c-hHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG-A-SRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
.++|++.+.||+|+||.||+|++..+++.||||+++..... . .+.+.++...++.++||||+++++++...+ .
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~-----~ 80 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG-----D 80 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----S
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC-----C
Confidence 46789999999999999999999889999999999754322 2 233445555678889999999999986544 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||++ |+|.+++... ......+++..+..++.|++.||+|||+++ +|+||||||+||+++.++.+||
T Consensus 81 ~~lv~e~~~-~~l~~~l~~~------~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl 151 (290)
T 3fme_A 81 VWICMELMD-TSLDKFYKQV------IDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKM 151 (290)
T ss_dssp EEEEEECCS-EEHHHHHHHH------HHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEB
T ss_pred EEEEEehhc-cchHHHHHHH------HhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEE
Confidence 899999997 4888877521 113456899999999999999999999742 8999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCcccc----CCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcc
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYG----VGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGR 858 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~ 858 (949)
+|||.++......... ...||+.|+|||++ .+..++.++||||+||++|||++|+.||+............
T Consensus 152 ~Dfg~~~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-- 226 (290)
T 3fme_A 152 CDFGISGYLVDDVAKD---IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV-- 226 (290)
T ss_dssp CCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHH--
T ss_pred eecCCccccccccccc---ccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHH--
Confidence 9999998765443322 23589999999995 55678999999999999999999999996432211111111
Q ss_pred ccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 859 KALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 859 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
+.......+. ...+..+.+++.+|++.||++|||++|+++
T Consensus 227 ----------~~~~~~~~~~------------------~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 227 ----------VEEPSPQLPA------------------DKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ----------HHSCCCCCCT------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----------hccCCCCccc------------------ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1111100000 022456789999999999999999999987
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=351.83 Aligned_cols=288 Identities=20% Similarity=0.207 Sum_probs=201.0
Q ss_pred HHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccc----
Q 039533 622 YNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADY---- 697 (949)
Q Consensus 622 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---- 697 (949)
....++|++.+.||+|+||.||+|++..+++.||||++..... ...+|++++++++||||+++++++.....
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 4556789999999999999999999998999999999864432 23479999999999999999999865331
Q ss_pred -----------------------------cCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHH
Q 039533 698 -----------------------------RGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIA 748 (949)
Q Consensus 698 -----------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~ 748 (949)
......++||||++ |+|.+.+... ......+++..+..++.|++
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~------~~~~~~l~~~~~~~i~~qi~ 151 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSF------IRSGRSIPMNLISIYIYQLF 151 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHH------HHTTCCCCHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHH------HhcCCCCCHHHHHHHHHHHH
Confidence 23345789999998 5877776521 11345689999999999999
Q ss_pred HHHHHHhhCCCCCeEecCCCCCCeeec-CCCceEEeecccceecCCCCCccccccccCccCccCccccCCC-ccCCccch
Q 039533 749 YALNYLHHDCQPVTAHCDLKPSNVLLD-DYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDV 826 (949)
Q Consensus 749 ~gL~~LH~~~~~~ivHrDlkp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi 826 (949)
+||+|||++ +|+||||||+||+++ .++.+||+|||.|+......... ...||..|+|||++.+. .++.++||
T Consensus 152 ~aL~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~Di 225 (383)
T 3eb0_A 152 RAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSV---AYICSRFYRAPELMLGATEYTPSIDL 225 (383)
T ss_dssp HHHHHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCC---CCCCCSSCCCHHHHTTCSSCCTHHHH
T ss_pred HHHHHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCc---CcccCCCccCHHHhcCCCCCCcchhh
Confidence 999999977 999999999999998 68899999999999775544322 34589999999998775 48999999
Q ss_pred HHHHHHHHHHHhCCCCCccccccCchhhhhccccCCC---chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHH
Q 039533 827 YSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPD---DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISM 903 (949)
Q Consensus 827 wSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 903 (949)
||+||++|||++|+.||......+ .+.......-.. .+.. .++....... ..... ...........+..+
T Consensus 226 wslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~g~p~~~~~~~-~~~~~~~~~~---~~~~~--~~~~~~~~~~~~~~~ 298 (383)
T 3eb0_A 226 WSIGCVFGELILGKPLFSGETSID-QLVRIIQIMGTPTKEQMIR-MNPHYTEVRF---PTLKA--KDWRKILPEGTPSLA 298 (383)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHH-HCTTC--CCC---CCCCC--CCHHHHSCTTCCHHH
T ss_pred hhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHHH-hCcccccccC---CccCc--ccHHhhCCCCCCHHH
Confidence 999999999999999997432211 111111000000 0000 0000000000 00000 000000011235568
Q ss_pred HHHhhccccCCCCCCCCHHHHHH--HHHHhHH
Q 039533 904 VRIGVACSMELPQDRTNMTNVVH--ELQSIKN 933 (949)
Q Consensus 904 ~~l~~~cl~~dP~~RPs~~ev~~--~L~~i~~ 933 (949)
.+++.+|++.||++|||+.|+++ .+++++.
T Consensus 299 ~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 299 IDLLEQILRYEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred HHHHHHHccCChhhCCCHHHHhcCHHHHHHHh
Confidence 89999999999999999999984 3444444
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=335.80 Aligned_cols=255 Identities=21% Similarity=0.313 Sum_probs=199.6
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC----CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH----HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
.++|.+.+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|+.++++++||||+++++++... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 80 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE---EK 80 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-----
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC---CC
Confidence 478999999999999999999998899999999997432 23456799999999999999999999997532 23
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
...++||||++++ +.+++... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 81 ~~~~lv~e~~~~~-l~~~~~~~--------~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~ 148 (305)
T 2wtk_C 81 QKMYMVMEYCVCG-MQEMLDSV--------PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTL 148 (305)
T ss_dssp -CEEEEEECCSEE-HHHHHHHS--------TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred CeEEEEehhccCC-HHHHHHhC--------cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcE
Confidence 4789999999876 77776521 234689999999999999999999988 99999999999999999999
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCCCc--cCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcc
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCE--VSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGR 858 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~ 858 (949)
||+|||.+................||..|+|||++.+.. ++.++||||||+++|||++|+.||...... ....
T Consensus 149 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~--- 223 (305)
T 2wtk_C 149 KISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY--KLFE--- 223 (305)
T ss_dssp EECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHH---
T ss_pred EeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHH---
Confidence 999999998876543333333456999999999987643 478999999999999999999999632111 0000
Q ss_pred ccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 859 KALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 859 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
.+..... ..+ ..++..+.+++.+|++.||++|||++|+++.
T Consensus 224 --------~i~~~~~-~~~-------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 224 --------NIGKGSY-AIP-------------------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp --------HHHHCCC-CCC-------------------SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --------HHhcCCC-CCC-------------------CccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000000 000 1234567899999999999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=339.43 Aligned_cols=252 Identities=21% Similarity=0.245 Sum_probs=195.5
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--------cchHHHHHHHHHHHhcCCCcceeEEeeeeccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--------GASRSFIAECKALKSIRHRNLVKVLTACLGAD 696 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 696 (949)
.++|.+.+.||+|+||.||+|++..+++.||||++..... .....+.+|++++++++||||+++++++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 87 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 87 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-
Confidence 4579999999999999999999998999999999864321 1224588999999999999999999987432
Q ss_pred ccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC
Q 039533 697 YRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD 776 (949)
Q Consensus 697 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~ 776 (949)
..++||||+++++|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.
T Consensus 88 -----~~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~ 149 (322)
T 2ycf_A 88 -----DYYIVLELMEGGELFDKVV----------GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSS 149 (322)
T ss_dssp -----SEEEEEECCTTEETHHHHS----------TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESS
T ss_pred -----ceEEEEecCCCCcHHHHHh----------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEec
Confidence 3799999999999999986 234689999999999999999999987 9999999999999987
Q ss_pred CCc---eEEeecccceecCCCCCccccccccCccCccCccccC---CCccCCccchHHHHHHHHHHHhCCCCCccccccC
Q 039533 777 YMT---ARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGV---GCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850 (949)
Q Consensus 777 ~~~---~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~ 850 (949)
++. +||+|||+++........ ....||+.|+|||++. ...++.++|||||||++|||++|+.||.......
T Consensus 150 ~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 226 (322)
T 2ycf_A 150 QEEDCLIKITDFGHSKILGETSLM---RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 226 (322)
T ss_dssp SSSSCCEEECCCTTCEECCCCHHH---HHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS
T ss_pred CCCCCeEEEccCccceeccccccc---ccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH
Confidence 654 999999999876543221 1345899999999863 5678999999999999999999999996432211
Q ss_pred chhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 851 INLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 851 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
. . .+.+......... ......+..+.+++.+|++.||++|||++|+++
T Consensus 227 ~-~------------~~~~~~~~~~~~~---------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 227 S-L------------KDQITSGKYNFIP---------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp C-H------------HHHHHHTCCCCCH---------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred H-H------------HHHHHhCccccCc---------------hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1 0 0100000000000 001133567889999999999999999999974
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=342.24 Aligned_cols=254 Identities=23% Similarity=0.269 Sum_probs=197.3
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
..++|++.+.||+|+||.||+|++..+++.||+|++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~ 91 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG-----KL 91 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC------CE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC-----eE
Confidence 3467999999999999999999999889999999998666666788999999999999999999999976544 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++||||+++++|.+++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+
T Consensus 92 ~lv~e~~~~~~l~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 159 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLE---------LDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLA 159 (302)
T ss_dssp EEEEECCTTEEHHHHHHH---------HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEEC
T ss_pred EEEEEeCCCCcHHHHHHh---------hccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEE
Confidence 999999999999998862 234589999999999999999999987 99999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCcccc-----CCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcc
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYG-----VGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGR 858 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~ 858 (949)
|||++....... .......||..|+|||++ .+..++.++||||||+++|||++|+.||........ ......
T Consensus 160 Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~ 236 (302)
T 2j7t_A 160 DFGVSAKNLKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-LLKIAK 236 (302)
T ss_dssp CCHHHHHHHHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHH
T ss_pred ECCCCccccccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-HHHHhc
Confidence 999875432111 111134589999999987 466789999999999999999999999964321110 000000
Q ss_pred ccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 859 KALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 859 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
...+ .. .. ....+..+.+++.+|++.||++|||+.|+++
T Consensus 237 ~~~~---------~~-~~-------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 237 SDPP---------TL-LT-------------------PSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp SCCC---------CC-SS-------------------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred cCCc---------cc-CC-------------------ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000 00 00 0123456789999999999999999999975
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=335.94 Aligned_cols=253 Identities=21% Similarity=0.276 Sum_probs=201.5
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC---------cchHHHHHHHHHHHhcC-CCcceeEEeeee
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH---------GASRSFIAECKALKSIR-HRNLVKVLTACL 693 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 693 (949)
..++|.+.+.||+|+||.||+|.+..+++.||||+++.... ...+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 45789999999999999999999998999999999975431 12356789999999995 999999999976
Q ss_pred cccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCee
Q 039533 694 GADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVL 773 (949)
Q Consensus 694 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIl 773 (949)
... ..++||||+++++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+
T Consensus 95 ~~~-----~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil 156 (298)
T 1phk_A 95 TNT-----FFFLVFDLMKKGELFDYLT----------EKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENIL 156 (298)
T ss_dssp CSS-----EEEEEEECCTTCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred cCC-----eEEEEEeccCCCcHHHHHh----------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEE
Confidence 443 7899999999999999996 234689999999999999999999987 9999999999999
Q ss_pred ecCCCceEEeecccceecCCCCCccccccccCccCccCccccC------CCccCCccchHHHHHHHHHHHhCCCCCcccc
Q 039533 774 LDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGV------GCEVSTNGDVYSYGILLLELVIGKKPIDIMF 847 (949)
Q Consensus 774 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~ 847 (949)
++.++.+||+|||.+.......... ...|++.|+|||++. ...++.++||||||+++|||++|+.||....
T Consensus 157 ~~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 233 (298)
T 1phk_A 157 LDDDMNIKLTDFGFSCQLDPGEKLR---EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233 (298)
T ss_dssp ECTTCCEEECCCTTCEECCTTCCBC---CCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EcCCCcEEEecccchhhcCCCcccc---cccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc
Confidence 9999999999999998776543322 345899999999874 4568899999999999999999999995321
Q ss_pred ccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 848 EGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 848 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
... .. ..+......... +.....+..+.+++.+|++.||++|||+.|+++
T Consensus 234 ~~~--~~-----------~~~~~~~~~~~~----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 234 QML--ML-----------RMIMSGNYQFGS----------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHH--HH-----------HHHHHTCCCCCT----------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHH--HH-----------HHHhcCCcccCc----------------ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 110 00 000000000000 000133456889999999999999999999975
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=369.14 Aligned_cols=259 Identities=27% Similarity=0.423 Sum_probs=206.3
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.++|++.+.||+|+||.||+|.+. ++..||||+++.... ..+.+.+|++++++++||||+++++++.. ...+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~~ 337 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY 337 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred hhhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccce
Confidence 456788899999999999999997 457899999975442 35689999999999999999999999753 2579
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++|+|.+++... ....+++.+++.|+.||+.||+|||++ +|+||||||+|||+++++.+||+|
T Consensus 338 lv~e~~~~gsL~~~l~~~--------~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~D 406 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGE--------TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVAD 406 (535)
T ss_dssp EEECCCTTEEHHHHHSHH--------HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred EeeehhcCCcHHHHHhhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcc
Confidence 999999999999999621 224589999999999999999999987 899999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCC
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
||+++...... ........++..|+|||++.+..++.++|||||||++|||++ |+.||......+ ..
T Consensus 407 FG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~--~~--------- 474 (535)
T 2h8h_A 407 FGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VL--------- 474 (535)
T ss_dssp TTSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH--HH---------
T ss_pred cccceecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HH---------
Confidence 99998654321 111123347789999999988889999999999999999999 999996432111 00
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhh
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNIL 935 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~ 935 (949)
+.+...... +....++..+.+++.+||+.||++|||+++|++.|+++....
T Consensus 475 ---~~i~~~~~~------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 475 ---DQVERGYRM------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp ---HHHHTTCCC------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred ---HHHHcCCCC------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 000000000 000134556889999999999999999999999999876543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=339.56 Aligned_cols=261 Identities=25% Similarity=0.336 Sum_probs=195.6
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcC-CC--EEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeeccccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDE-GR--TTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYR 698 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 698 (949)
.++|++.+.||+|+||.||+|++.. ++ ..||||+++... ....+.+.+|++++++++||||+++++++...
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 93 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--- 93 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence 3578899999999999999998743 22 369999987542 23456889999999999999999999997542
Q ss_pred CCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC
Q 039533 699 GNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM 778 (949)
Q Consensus 699 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~ 778 (949)
..++||||+++++|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 94 ---~~~~v~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~ 158 (291)
T 1u46_A 94 ---PMKMVTELAPLGSLLDRLRK---------HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRD 158 (291)
T ss_dssp ---SCEEEEECCTTCBHHHHHHH---------HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETT
T ss_pred ---CceeeEecccCCCHHHHHHh---------ccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCC
Confidence 37899999999999999962 234589999999999999999999987 999999999999999999
Q ss_pred ceEEeecccceecCCCCCcc-ccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhh
Q 039533 779 TARVGDFGLARILSPDHTQT-SSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNF 856 (949)
Q Consensus 779 ~~kl~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~ 856 (949)
.+||+|||+++......... ......+|..|+|||++.+..++.++||||||+++|||++ |+.||....... ...
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~- 235 (291)
T 1u46_A 159 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--ILH- 235 (291)
T ss_dssp EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHH-
T ss_pred CEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH--HHH-
Confidence 99999999998876544321 1223457889999999988889999999999999999999 999996432111 000
Q ss_pred ccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHh
Q 039533 857 GRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNI 934 (949)
Q Consensus 857 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 934 (949)
.+........ ....++..+.+++.+|++.||++|||+.|+++.|+++...
T Consensus 236 ----------~~~~~~~~~~------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 236 ----------KIDKEGERLP------------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp ----------HHHTSCCCCC------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ----------HHHccCCCCC------------------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 0000000000 0012345688999999999999999999999999988654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=344.79 Aligned_cols=266 Identities=23% Similarity=0.305 Sum_probs=199.8
Q ss_pred cCHHHHHHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhc-CCCcceeEEeeeec
Q 039533 616 LSYQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSI-RHRNLVKVLTACLG 694 (949)
Q Consensus 616 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 694 (949)
+++.++....++|++.+.||+|+||.||+|++..+++.||||++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 334445556788999999999999999999998889999999997543 3357889999999999 79999999999875
Q ss_pred ccccC-CccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCee
Q 039533 695 ADYRG-NDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVL 773 (949)
Q Consensus 695 ~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIl 773 (949)
....+ ....++||||+++++|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+||+
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl 161 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNT--------KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVL 161 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHS--------GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhc--------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEE
Confidence 43211 34689999999999999999621 234688999999999999999999987 8999999999999
Q ss_pred ecCCCceEEeecccceecCCCCCccccccccCccCccCccccC-----CCccCCccchHHHHHHHHHHHhCCCCCccccc
Q 039533 774 LDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGV-----GCEVSTNGDVYSYGILLLELVIGKKPIDIMFE 848 (949)
Q Consensus 774 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~ 848 (949)
++.++.+||+|||++......... .....||+.|+|||++. +..++.++|||||||++|||++|+.||.....
T Consensus 162 ~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 239 (326)
T 2x7f_A 162 LTENAEVKLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 239 (326)
T ss_dssp ECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred EcCCCCEEEeeCcCceecCcCccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH
Confidence 999999999999999876433221 12345899999999987 45689999999999999999999999964321
Q ss_pred cCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 849 GDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 849 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
... ........ .+.... ...+..+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~-~~~~~~~~---------~~~~~~---------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 240 MRA-LFLIPRNP---------APRLKS---------------------KKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHH-HHHHHHSC---------CCCCSC---------------------SCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHH-HHHhhcCc---------cccCCc---------------------cccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 110 00000000 000000 012346789999999999999999999976
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=348.93 Aligned_cols=259 Identities=11% Similarity=0.010 Sum_probs=180.3
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC---cchHHHHHHHHHHHhc--CCCcceeEEee-------ee
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH---GASRSFIAECKALKSI--RHRNLVKVLTA-------CL 693 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~~~~~-------~~ 693 (949)
.+|.+.+.||+|+||.||+|++..+++.||||+++.... ...+.+.+|+.+++.+ +||||++++.. +.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 458889999999999999999998999999999986543 2345677885555544 69998886533 22
Q ss_pred ccccc------------CCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHH------HHHHHHHHHHHHHHh
Q 039533 694 GADYR------------GNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQR------LNIAIDIAYALNYLH 755 (949)
Q Consensus 694 ~~~~~------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~------~~i~~qi~~gL~~LH 755 (949)
..... .....++||||++ |+|.+++... ...+.+..+ ..++.|++.||+|||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---------~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH 211 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---------DFVYVFRGDEGILALHILTAQLIRLAANLQ 211 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---------HHSCCCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---------ccccchhhhhhhhhHHHHHHHHHHHHHHHH
Confidence 11100 0134799999998 8999999721 122344455 678899999999999
Q ss_pred hCCCCCeEecCCCCCCeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCC--CccCCccchHHHHHHH
Q 039533 756 HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG--CEVSTNGDVYSYGILL 833 (949)
Q Consensus 756 ~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlGvvl 833 (949)
++ +|+||||||+|||++.++.+||+|||+|+....... ...+|+.|+|||++.+ ..++.++|||||||++
T Consensus 212 ~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il 283 (371)
T 3q60_A 212 SK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP-----ASSVPVTYAPREFLNASTATFTHALNAWQLGLSI 283 (371)
T ss_dssp HT---TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEEE-----GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHH
T ss_pred HC---CCccCcCCHHHEEECCCCCEEEEecceeeecCCCcc-----CccCCcCCcChhhccCCCCCcCccccHHHHHHHH
Confidence 88 899999999999999999999999999987643221 2347799999999987 6799999999999999
Q ss_pred HHHHhCCCCCccccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccC
Q 039533 834 LELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSME 913 (949)
Q Consensus 834 ~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 913 (949)
|||++|+.||......... .+...... ........ ++.....+..+.+++.+||+.
T Consensus 284 ~elltg~~Pf~~~~~~~~~--~~~~~~~~----~~~~~~~~------------------~~~~~~~~~~~~~li~~~L~~ 339 (371)
T 3q60_A 284 YRVWCLFLPFGLVTPGIKG--SWKRPSLR----VPGTDSLA------------------FGSCTPLPDFVKTLIGRFLNF 339 (371)
T ss_dssp HHHHHSSCSTTBCCTTCTT--CCCBCCTT----SCCCCSCC------------------CTTSSCCCHHHHHHHHHHTCS
T ss_pred HHHHhCCCCCCCcCccccc--chhhhhhh----hccccccc------------------hhhccCCCHHHHHHHHHHcCC
Confidence 9999999999754322111 00000000 00000000 000012345688999999999
Q ss_pred CCCCCCCHHHHHH
Q 039533 914 LPQDRTNMTNVVH 926 (949)
Q Consensus 914 dP~~RPs~~ev~~ 926 (949)
||++|||+.|+++
T Consensus 340 dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 340 DRRRRLLPLEAME 352 (371)
T ss_dssp STTTCCCHHHHTT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999974
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=370.36 Aligned_cols=245 Identities=22% Similarity=0.253 Sum_probs=198.9
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecC---CCcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccC
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ---HHGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRG 699 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 699 (949)
..++|.+.++||+|+||.||+|++..+++.||||+++.. .....+.+..|..++..+ +||+|+++++++...+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~--- 415 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD--- 415 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS---
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC---
Confidence 457899999999999999999999989999999999743 233456788999999988 7999999999865443
Q ss_pred CccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCc
Q 039533 700 NDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMT 779 (949)
Q Consensus 700 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~ 779 (949)
..++||||+++|+|.+++. ....+++..++.|+.||+.||+|||++ +|+||||||+|||++.+++
T Consensus 416 --~~~lV~E~~~gg~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ 480 (674)
T 3pfq_A 416 --RLYFVMEYVNGGDLMYHIQ----------QVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGH 480 (674)
T ss_dssp --EEEEEEECCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSC
T ss_pred --EEEEEEeCcCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCc
Confidence 7899999999999999996 234689999999999999999999988 9999999999999999999
Q ss_pred eEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 780 ARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 780 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
+||+|||+|+........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .
T Consensus 481 ikL~DFGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~--~------ 550 (674)
T 3pfq_A 481 IKIADFGMCKENIWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--L------ 550 (674)
T ss_dssp EEECCCTTCEECCCTTCC--BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H------
T ss_pred EEEeecceeeccccCCcc--cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH--H------
Confidence 999999999865433322 224569999999999999999999999999999999999999996432110 0
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCH
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNM 921 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 921 (949)
...++..... .+ ...+..+.+++.+|++.||++||++
T Consensus 551 -----~~~i~~~~~~-~p-------------------~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 551 -----FQSIMEHNVA-YP-------------------KSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp -----HHHHHSSCCC-CC-------------------TTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred -----HHHHHhCCCC-CC-------------------ccCCHHHHHHHHHHccCCHHHCCCC
Confidence 0111111110 00 0224567899999999999999997
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=340.22 Aligned_cols=269 Identities=19% Similarity=0.301 Sum_probs=184.3
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
..++|.+.+.||+|+||.||+|.+..+++.||||++.... ....+++.+|+.++++++||||+++++++...+ .
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~ 87 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD-----E 87 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS-----C
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC-----C
Confidence 4578999999999999999999998788999999986443 233467889999999999999999999976554 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++++|.+++....... ......+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl 162 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKG--EHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQI 162 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTT--TTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEE
T ss_pred cEEEehhccCCchHHHHHHHhhcc--ccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEE
Confidence 899999999999999986211100 01235689999999999999999999987 8999999999999999999999
Q ss_pred eecccceecCCCCC---ccccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcc
Q 039533 783 GDFGLARILSPDHT---QTSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGR 858 (949)
Q Consensus 783 ~DfG~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~ 858 (949)
+|||.+........ ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||........... ...
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~ 241 (303)
T 2vwi_A 163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML-TLQ 241 (303)
T ss_dssp CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH-HHT
T ss_pred EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH-Hhc
Confidence 99999976654321 111123458999999999875 4688999999999999999999999965422211100 000
Q ss_pred ccCCCchh-hhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 859 KALPDDVM-DIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 859 ~~~~~~~~-~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
. ...... ...+.... ...+..+.+++.+|++.||++|||+.|+++
T Consensus 242 ~-~~~~~~~~~~~~~~~----------------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 242 N-DPPSLETGVQDKEML----------------------KKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp S-SCCCTTC-----CCC----------------------CCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred c-CCCccccccccchhh----------------------hhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0 000000 00000000 122346789999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=339.20 Aligned_cols=280 Identities=19% Similarity=0.262 Sum_probs=196.7
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeeccc--------
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGAD-------- 696 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------- 696 (949)
.++|.+.+.||+|+||.||+|.+..+++.||+|++........+.+.+|++++++++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 367899999999999999999999889999999998666556678999999999999999999999875332
Q ss_pred -ccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec
Q 039533 697 -YRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD 775 (949)
Q Consensus 697 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~ 775 (949)
.......++||||++ |+|.+++. ...+++..+..++.|++.||+|||++ +|+||||||+||+++
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 154 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE-----------QGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFIN 154 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT-----------TCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh-----------cCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEc
Confidence 123456899999998 69999986 23588999999999999999999987 999999999999997
Q ss_pred -CCCceEEeecccceecCCCCCc-cccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCch
Q 039533 776 -DYMTARVGDFGLARILSPDHTQ-TSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDIN 852 (949)
Q Consensus 776 -~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~ 852 (949)
+++.+||+|||.++........ .......+|..|+|||++.+ ..++.++|||||||++|||++|+.||....... .
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~ 233 (320)
T 2i6l_A 155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE-Q 233 (320)
T ss_dssp TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-H
T ss_pred CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-H
Confidence 5679999999999876543221 11123457999999998765 678999999999999999999999996432211 0
Q ss_pred hhhhccccCCC----chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 853 LHNFGRKALPD----DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 853 ~~~~~~~~~~~----~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
..... ...+. ...++.+. . +. ....................+..+.+++.+|++.||++|||++|+++
T Consensus 234 ~~~~~-~~~~~~~~~~~~~~~~~-~---~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 234 MQLIL-ESIPVVHEEDRQELLSV-I---PV-YIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHH-HHSCCCCHHHHHHHHTT-S---CH-HHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHH-HhcCCCchhhhhhhhhc-C---cc-cccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 00000 00000 00000000 0 00 00000000000000001134567899999999999999999999976
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=343.46 Aligned_cols=291 Identities=20% Similarity=0.228 Sum_probs=194.2
Q ss_pred HHHHHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeeccccc
Q 039533 619 QDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYR 698 (949)
Q Consensus 619 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 698 (949)
.+.....++|++.+.||+|+||.||+|++..+++.||||++.... .......+|++.+++++||||+++++++...+..
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 455677889999999999999999999999899999999986443 2335677888889999999999999998654321
Q ss_pred --CCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHh--hCCCCCeEecCCCCCCeee
Q 039533 699 --GNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLH--HDCQPVTAHCDLKPSNVLL 774 (949)
Q Consensus 699 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH--~~~~~~ivHrDlkp~NIll 774 (949)
.....++||||+++ ++.+.+... ......+++..+..++.|++.||.||| +. +|+||||||+||++
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~------~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll 164 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNY------YRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLV 164 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHH------HTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEE
T ss_pred cccceeEEEEeecccc-cHHHHHHHH------hhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEE
Confidence 22237899999986 444433210 013456889999999999999999999 55 99999999999999
Q ss_pred cC-CCceEEeecccceecCCCCCccccccccCccCccCccccCCCc-cCCccchHHHHHHHHHHHhCCCCCccccccCch
Q 039533 775 DD-YMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCE-VSTNGDVYSYGILLLELVIGKKPIDIMFEGDIN 852 (949)
Q Consensus 775 ~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~ 852 (949)
+. ++.+||+|||+++......... ...||+.|+|||++.+.. ++.++|||||||++|||++|+.||....... .
T Consensus 165 ~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-~ 240 (360)
T 3e3p_A 165 NEADGTLKLCDFGSAKKLSPSEPNV---AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG-Q 240 (360)
T ss_dssp ETTTTEEEECCCTTCBCCCTTSCCC---STTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-H
T ss_pred eCCCCcEEEeeCCCceecCCCCCcc---cccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH-H
Confidence 96 8999999999998766543322 345899999999987654 8999999999999999999999996432211 1
Q ss_pred hhhhcccc--CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 853 LHNFGRKA--LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 853 ~~~~~~~~--~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
+....+.. .+......+++...... ....................+..+.+++.+|++.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 241 LHEIVRVLGCPSREVLRKLNPSHTDVD--LYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHHHHHCCCCHHHHHHHCTTCCCGG--GGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHcCCCCHHHHHhcccchhhcc--ccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11111100 00011111111100000 00000000000000001124567899999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=345.43 Aligned_cols=256 Identities=22% Similarity=0.276 Sum_probs=198.4
Q ss_pred hcCCCCCCeeeeecCceEEEEEEc---CCCEEEEEEEEecCC----CcchHHHHHHHHHHHhc-CCCcceeEEeeeeccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIID---EGRTTIAVKVFNLQH----HGASRSFIAECKALKSI-RHRNLVKVLTACLGAD 696 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 696 (949)
.++|.+.+.||+|+||.||+|++. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 467999999999999999999984 478999999986432 12345677899999999 6999999999876544
Q ss_pred ccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC
Q 039533 697 YRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD 776 (949)
Q Consensus 697 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~ 776 (949)
..++||||+++++|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.
T Consensus 133 -----~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~ 194 (355)
T 1vzo_A 133 -----KLHLILDYINGGELFTHLS----------QRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDS 194 (355)
T ss_dssp -----EEEEEECCCCSCBHHHHHH----------HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred -----eEEEEeecCCCCCHHHHHH----------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECC
Confidence 7899999999999999996 234589999999999999999999987 8999999999999999
Q ss_pred CCceEEeecccceecCCCCCccccccccCccCccCccccCCC--ccCCccchHHHHHHHHHHHhCCCCCccccccCchhh
Q 039533 777 YMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC--EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLH 854 (949)
Q Consensus 777 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~ 854 (949)
++.+||+|||+++......... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ..
T Consensus 195 ~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~ 272 (355)
T 1vzo_A 195 NGHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QA 272 (355)
T ss_dssp TSCEEESCSSEEEECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HH
T ss_pred CCcEEEeeCCCCeecccCCCCc-ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-HH
Confidence 9999999999998765433222 2245699999999998863 478999999999999999999999964321111 00
Q ss_pred hhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHHHH
Q 039533 855 NFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRT-----NMTNVVHEL 928 (949)
Q Consensus 855 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~~L 928 (949)
.... .+... ....+ .+.+..+.+++.+|++.||++|| +++|+++..
T Consensus 273 ~~~~--------~~~~~-~~~~~-------------------~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 273 EISR--------RILKS-EPPYP-------------------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp HHHH--------HHHHC-CCCCC-------------------TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred HHHH--------HHhcc-CCCCC-------------------cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 0000 00000 00000 12344678999999999999999 999998643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=342.32 Aligned_cols=271 Identities=16% Similarity=0.186 Sum_probs=201.4
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcc---h--------------HHHHHHHHHHHhcCCCccee
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGA---S--------------RSFIAECKALKSIRHRNLVK 687 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~--------------~~~~~E~~~l~~l~h~niv~ 687 (949)
.++|++.+.||+|+||.||+|++ +++.||||++....... . +.+.+|++++++++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 46899999999999999999999 78999999997432111 1 78999999999999999999
Q ss_pred EEeeeecccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecC
Q 039533 688 VLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHH-DCQPVTAHCD 766 (949)
Q Consensus 688 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~~~~ivHrD 766 (949)
+++++...+ ..++||||+++++|.+++....... ......+++..+..++.|++.||+|||+ + +|+|||
T Consensus 108 ~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~l~--~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~d 177 (348)
T 2pml_X 108 CEGIITNYD-----EVYIIYEYMENDSILKFDEYFFVLD--KNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRD 177 (348)
T ss_dssp CSEEEESSS-----EEEEEEECCTTCBSSEESSSEESSC--SSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCC
T ss_pred EEEEEeeCC-----eEEEEEeccCCCcHHHHHHHhhhhh--hccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecC
Confidence 999976544 7899999999999999943110000 0124568999999999999999999998 6 999999
Q ss_pred CCCCCeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCC-ccCC-ccchHHHHHHHHHHHhCCCCCc
Q 039533 767 LKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVST-NGDVYSYGILLLELVIGKKPID 844 (949)
Q Consensus 767 lkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDiwSlGvvl~elltg~~Pf~ 844 (949)
|||+||+++.++.+||+|||.+....... .....||..|+|||++.+. .++. ++|||||||++|||++|+.||.
T Consensus 178 l~p~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 253 (348)
T 2pml_X 178 VKPSNILMDKNGRVKLSDFGESEYMVDKK----IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253 (348)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECBTTE----ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CChHhEEEcCCCcEEEecccccccccccc----ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999998764431 1235699999999999887 6665 9999999999999999999997
Q ss_pred cccccCchhhhhccc--cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHH
Q 039533 845 IMFEGDINLHNFGRK--ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMT 922 (949)
Q Consensus 845 ~~~~~~~~~~~~~~~--~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 922 (949)
............... ..+........+.... . ........+..+.+++.+|++.||++|||++
T Consensus 254 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~--------------~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ 318 (348)
T 2pml_X 254 LKISLVELFNNIRTKNIEYPLDRNHFLYPLTNK-K--------------STCSNNFLSNEDIDFLKLFLRKNPAERITSE 318 (348)
T ss_dssp CSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC-----------------------CCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred CCCcHHHHHHHHhccCcCCccchhhhhcccccc-c--------------cccchhhcCHHHHHHHHHHccCChhhCCCHH
Confidence 443211111111111 0110000000000000 0 0000123356788999999999999999999
Q ss_pred HHHH
Q 039533 923 NVVH 926 (949)
Q Consensus 923 ev~~ 926 (949)
|+++
T Consensus 319 e~l~ 322 (348)
T 2pml_X 319 DALK 322 (348)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9976
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=346.17 Aligned_cols=283 Identities=19% Similarity=0.230 Sum_probs=201.5
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcC--------CCcceeEEeeeecccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIR--------HRNLVKVLTACLGADY 697 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~~~~~ 697 (949)
++|++.+.||+|+||+||+|++..+++.||||+++.. ....+.+.+|++++++++ |+||+++++++....
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~- 114 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG- 114 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE-
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC-
Confidence 6799999999999999999999989999999999643 233467889999999995 788999999876332
Q ss_pred cCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCC
Q 039533 698 RGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDY 777 (949)
Q Consensus 698 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~ 777 (949)
......++||||+ ++++.+++.. .....+++..++.|+.||+.||+|||+++ +|+||||||+|||++.+
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~--------~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~ 183 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIK--------SNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVN 183 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHH--------TTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCC
T ss_pred CCCceEEEEEecc-CccHHHHHHh--------cccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEecc
Confidence 1234789999999 5566666541 12245899999999999999999999753 89999999999999977
Q ss_pred C-------------------------------------------------ceEEeecccceecCCCCCccccccccCccC
Q 039533 778 M-------------------------------------------------TARVGDFGLARILSPDHTQTSSFSVKGSLG 808 (949)
Q Consensus 778 ~-------------------------------------------------~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~ 808 (949)
+ .+||+|||.|+....... ...||..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~-----~~~gt~~ 258 (397)
T 1wak_A 184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFT-----EDIQTRQ 258 (397)
T ss_dssp HHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSC-----SCCSCGG
T ss_pred chhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCc-----cCCCCCc
Confidence 5 799999999987654322 3458999
Q ss_pred ccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCch----hhhhc---cccCCCch-------hhhcccCCC
Q 039533 809 YIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDIN----LHNFG---RKALPDDV-------MDIVDSSLL 874 (949)
Q Consensus 809 y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~----~~~~~---~~~~~~~~-------~~~~d~~l~ 874 (949)
|+|||++.+..++.++|||||||++|||++|+.||......... ..... ....+... .+.+.....
T Consensus 259 y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 338 (397)
T 1wak_A 259 YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGD 338 (397)
T ss_dssp GCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSS
T ss_pred ccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccc
Confidence 99999999999999999999999999999999999754322110 00000 00000000 000000000
Q ss_pred -CCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 875 -PDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 875 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
....+.............+....+.+..+.+++.+||+.||++|||++|+++
T Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 339 LKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp BSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0000000000000000111122466778999999999999999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=346.91 Aligned_cols=199 Identities=25% Similarity=0.307 Sum_probs=170.7
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhc------CCCcceeEEeeeeccccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSI------RHRNLVKVLTACLGADYR 698 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~ 698 (949)
..+|++.+.||+|+||.||+|.+..+++.||||+++... ...+.+.+|+++++.+ .|+||+++++++....
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~-- 172 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN-- 172 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT--
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC--
Confidence 457999999999999999999999899999999996432 2345677888888887 5779999999976544
Q ss_pred CCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC
Q 039533 699 GNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM 778 (949)
Q Consensus 699 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~ 778 (949)
..++||||+. ++|.+++... ....+++..+..|+.||+.||+|||++ +|+||||||+|||++.++
T Consensus 173 ---~~~lv~e~~~-~~L~~~l~~~--------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~ 237 (429)
T 3kvw_A 173 ---HICMTFELLS-MNLYELIKKN--------KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQG 237 (429)
T ss_dssp ---EEEEEECCCC-CBHHHHHHHT--------TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTT
T ss_pred ---eEEEEEeccC-CCHHHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCC
Confidence 7899999996 6999988621 223489999999999999999999988 899999999999999988
Q ss_pred c--eEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccc
Q 039533 779 T--ARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIM 846 (949)
Q Consensus 779 ~--~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~ 846 (949)
. +||+|||+|+....... ...||+.|+|||++.+..++.++|||||||++|||++|++||...
T Consensus 238 ~~~vkL~DFG~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 238 RSGIKVIDFGSSCYEHQRVY-----TYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp SCCEEECCCTTCEETTCCCC-----SSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CcceEEeecccceecCCccc-----ccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 7 99999999987543322 345899999999999999999999999999999999999999644
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=341.67 Aligned_cols=279 Identities=19% Similarity=0.186 Sum_probs=196.8
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccc-cCCc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADY-RGND 701 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 701 (949)
.++|.+.+.||+|+||.||+|++..+++.||||++..... ...+++.+|+.++++++||||+++++++..... ....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 3578899999999999999999998999999999975432 234678899999999999999999999865431 1122
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||++ ++|.+++. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 103 ~~~lv~e~~~-~~l~~~~~------------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~k 166 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG------------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELK 166 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEE
T ss_pred eEEEEecccc-CCHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEE
Confidence 4599999997 58888774 2388999999999999999999988 999999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
|+|||.++...... ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ .+..... .
T Consensus 167 l~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~i~~-~ 239 (353)
T 3coi_A 167 ILDFGLARHADAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILK-V 239 (353)
T ss_dssp ECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-HHHHHHH-H
T ss_pred EeecccccCCCCCc-----cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-H
Confidence 99999998654322 13458999999999877 678999999999999999999999996432111 0000000 0
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
......+.............+..................+..+.+++.+|++.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 240 TGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000000000000000000000000000000001134567899999999999999999999985
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=347.22 Aligned_cols=275 Identities=19% Similarity=0.232 Sum_probs=195.4
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccc-cCCccce
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADY-RGNDFKA 704 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~ 704 (949)
.+|++.+.||+|+||.||+|++..+++.||||++..... ...+|++++++++||||+++++++..... .+....+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 358888999999999999999998899999999864332 23479999999999999999999865432 1233467
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCC-CceEEe
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDY-MTARVG 783 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~-~~~kl~ 783 (949)
+||||+++ ++.+.+... ......+++..+..++.||++||+|||++ +|+||||||+|||++.+ +.+||+
T Consensus 130 lv~e~~~~-~l~~~~~~~------~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~ 199 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHY------SRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLC 199 (420)
T ss_dssp EEEECCCE-EHHHHHHHH------HHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEEC
T ss_pred eehhcccc-cHHHHHHHH------hhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEec
Confidence 89999986 666655411 11345689999999999999999999977 99999999999999955 678999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
|||+++......... ...||+.|+|||++.+. .++.++|||||||++|||++|+.||......+ .+.......-.
T Consensus 200 DFG~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~-~l~~i~~~lg~ 275 (420)
T 1j1b_A 200 DFGSAKQLVRGEPNV---SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGT 275 (420)
T ss_dssp CCTTCEECCTTCCCC---SCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCS
T ss_pred cchhhhhcccCCCce---eeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCC
Confidence 999999765443322 34689999999998765 78999999999999999999999996432211 11111110000
Q ss_pred ---CchhhhcccCCCCCchhhhhhhchhhhhhhhhh--HHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 863 ---DDVMDIVDSSLLPDDEDLILTGNQRQKQARINS--IIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 863 ---~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
+.+.+. ++....... ... ....+.. ....+..+.+++.+|++.||++|||+.|+++
T Consensus 276 p~~~~~~~~-~~~~~~~~~------p~~-~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 276 PTREQIREM-NPNYTEFKF------PQI-KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CCHHHHHHH-CSCCCCCCC------CCC-CCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCHHHHHhh-Chhhhhhcc------Ccc-CCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 001110 000000000 000 0000000 0123456889999999999999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=330.58 Aligned_cols=252 Identities=23% Similarity=0.267 Sum_probs=199.9
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
..++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++....
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 94 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS----- 94 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCC-----
Confidence 3468999999999999999999998889999999997543 234578899999999999999999999976544
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCC---C
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDY---M 778 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~---~ 778 (949)
..++||||+++++|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.+ +
T Consensus 95 ~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~ 161 (287)
T 2wei_A 95 SFYIVGELYTGGELFDEII----------KRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDC 161 (287)
T ss_dssp EEEEEECCCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred eEEEEEEccCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcc
Confidence 7899999999999999885 234589999999999999999999987 99999999999999754 4
Q ss_pred ceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcc
Q 039533 779 TARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGR 858 (949)
Q Consensus 779 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~ 858 (949)
.+||+|||++.......... ...||+.|+|||++.+ .++.++||||||+++|+|++|+.||....... ...
T Consensus 162 ~~kL~Dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~--- 232 (287)
T 2wei_A 162 DIKIIDFGLSTCFQQNTKMK---DRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--ILK--- 232 (287)
T ss_dssp CEEECSTTGGGTBCCCSSCS---CHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH---
T ss_pred cEEEeccCcceeecCCCccc---cccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH--HHH---
Confidence 79999999998765443221 2348899999999876 48999999999999999999999996432111 000
Q ss_pred ccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 859 KALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 859 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.+......... +.....+..+.+++.+|++.||++|||+.|+++
T Consensus 233 --------~~~~~~~~~~~----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 233 --------RVETGKYAFDL----------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp --------HHHHCCCCCCS----------------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------HHHcCCCCCCc----------------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 00000000000 001123456889999999999999999999987
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=330.90 Aligned_cols=276 Identities=23% Similarity=0.299 Sum_probs=202.4
Q ss_pred HHhcCCCCCCeeeeecCceEEEEEEc-CCCEEEEEEEEecCCC--cchHHHHHHHHHHHhc---CCCcceeEEeeeeccc
Q 039533 623 NATSGFSSANLVGVGSFGSVYKGIID-EGRTTIAVKVFNLQHH--GASRSFIAECKALKSI---RHRNLVKVLTACLGAD 696 (949)
Q Consensus 623 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~ 696 (949)
.+.++|++.+.||+|+||.||+|++. .+++.||+|+++.... .....+.+|+.+++++ +||||+++++++....
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 34578999999999999999999994 6789999999974332 2234567788877776 8999999999987443
Q ss_pred ccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC
Q 039533 697 YRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD 776 (949)
Q Consensus 697 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~ 776 (949)
.......++||||++ |+|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~--------~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~ 155 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKV--------PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTS 155 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHS--------CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhc--------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcC
Confidence 334457899999998 6999998622 123489999999999999999999987 9999999999999999
Q ss_pred CCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhh
Q 039533 777 YMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNF 856 (949)
Q Consensus 777 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~ 856 (949)
++.+||+|||.++....... .....||..|+|||++.+..++.++|||||||++|||++|+.||........ ....
T Consensus 156 ~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~i 231 (326)
T 1blx_A 156 SGQIKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKI 231 (326)
T ss_dssp TCCEEECSCCSCCCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHH
T ss_pred CCCEEEecCcccccccCCCC---ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHH
Confidence 99999999999986543221 2245689999999999998999999999999999999999999964422110 0000
Q ss_pred cc-------ccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 857 GR-------KALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 857 ~~-------~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.. ..++.... ..+........ ... .......+..+.+++.+|++.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---------~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 232 LDVIGLPGEEDWPRDVA-LPRQAFHSKSA---------QPI--EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HHHHCCCCGGGSCTTCS-SCGGGSCCCCC---------CCG--GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHcCCCCcccCccccc-cchhhhcccCc---------chh--hhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 00000000 00000000000 000 0001133456789999999999999999999985
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=341.83 Aligned_cols=269 Identities=21% Similarity=0.246 Sum_probs=192.5
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccc-cCCccce
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADY-RGNDFKA 704 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~ 704 (949)
.+|++.+.||+|+||.||+|++..+++ ||+|++...... ..+|++++++++||||+++++++..... .+....+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 468889999999999999999985554 888887543322 2369999999999999999999865442 2333478
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec-CCCceEEe
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD-DYMTARVG 783 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~-~~~~~kl~ 783 (949)
+||||++++.+...... ......+++..+..++.|+++||+|||++ +|+||||||+||+++ .++.+||+
T Consensus 115 lv~e~~~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~ 184 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHY-------AKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLI 184 (394)
T ss_dssp EEEECCSEEHHHHHHHH-------HHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEEC
T ss_pred EEeeccCccHHHHHHHH-------HhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEe
Confidence 99999987544333210 11235689999999999999999999987 999999999999999 79999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC-
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL- 861 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~- 861 (949)
|||+|+......... ...||+.|+|||++.+. .++.++||||+||++|||++|+.||......+ .+.......-
T Consensus 185 DFG~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g~ 260 (394)
T 4e7w_A 185 DFGSAKILIAGEPNV---SYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID-QLVEIIKVLGT 260 (394)
T ss_dssp CCTTCEECCTTCCCC---SSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCC
T ss_pred eCCCcccccCCCCCc---ccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCC
Confidence 999998875443322 34689999999998765 58999999999999999999999996432211 1111111000
Q ss_pred CC--chhhh----cccC---CCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 862 PD--DVMDI----VDSS---LLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 862 ~~--~~~~~----~d~~---l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
+. .+... .+.. ....+. .. ......+..+.+++.+|++.||++|||+.|+++
T Consensus 261 p~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~--~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 261 PSREQIKTMNPNYMEHKFPQIRPHPF-----------SK--VFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp CCHHHHHHHCGGGSSSCCCCCCCCCH-----------HH--HSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCHHHHHhhChhhhhhccccccCCcH-----------HH--hccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 00 00000 0000 000000 00 000123457899999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=339.12 Aligned_cols=263 Identities=22% Similarity=0.293 Sum_probs=195.5
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
..++|++.+.||+|+||.||+|++.. .||+|+++... ....+.+.+|+.++++++||||+++++++...+
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 102 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP----- 102 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS-----
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC-----
Confidence 45789999999999999999999863 49999987443 223356788999999999999999999986544
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++++|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+||+++ ++.+|
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~ 169 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRD---------AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVV 169 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTS---------SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCE
T ss_pred ceEEEeecccCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEE
Confidence 78999999999999999972 234588999999999999999999988 999999999999998 67999
Q ss_pred EeecccceecCCCCC---ccccccccCccCccCccccCC---------CccCCccchHHHHHHHHHHHhCCCCCcccccc
Q 039533 782 VGDFGLARILSPDHT---QTSSFSVKGSLGYIAPEYGVG---------CEVSTNGDVYSYGILLLELVIGKKPIDIMFEG 849 (949)
Q Consensus 782 l~DfG~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~ 849 (949)
|+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 170 l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 249 (319)
T 2y4i_B 170 ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE 249 (319)
T ss_dssp ECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH
T ss_pred EeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999876532211 111123458999999999864 35788999999999999999999999643221
Q ss_pred CchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 039533 850 DINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQ 929 (949)
Q Consensus 850 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 929 (949)
. ........ ..+.... ...+..+.+++.+||+.||++|||+.|+++.|+
T Consensus 250 ~--~~~~~~~~--------~~~~~~~---------------------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~ 298 (319)
T 2y4i_B 250 A--IIWQMGTG--------MKPNLSQ---------------------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298 (319)
T ss_dssp H--HHHHHHTT--------CCCCCCC---------------------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHT
T ss_pred H--HHHHhccC--------CCCCCCc---------------------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 1 00000000 0000000 012334788999999999999999999999999
Q ss_pred HhHHhhccC
Q 039533 930 SIKNILLGV 938 (949)
Q Consensus 930 ~i~~~~~~~ 938 (949)
++.+.....
T Consensus 299 ~l~~~~~~~ 307 (319)
T 2y4i_B 299 KLPKRNRRL 307 (319)
T ss_dssp TC-------
T ss_pred HHHHhhccC
Confidence 998775443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=334.73 Aligned_cols=279 Identities=19% Similarity=0.213 Sum_probs=200.4
Q ss_pred hcCCCCCCeeeeecCceEEEEEE-cCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCc------ceeEEeeeecccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGII-DEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRN------LVKVLTACLGADY 697 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~ 697 (949)
.++|++.+.||+|+||.||+|.+ ..+++.||||+++... ...+.+.+|++++++++|++ ++++++++...+
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~- 90 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG- 90 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT-
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC-
Confidence 35899999999999999999998 5578999999986432 33467889999999987654 999999976544
Q ss_pred cCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC-
Q 039533 698 RGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD- 776 (949)
Q Consensus 698 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~- 776 (949)
..++||||+ +++|.+++... ....+++.++..++.|++.||+|||++ +|+||||||+||+++.
T Consensus 91 ----~~~lv~e~~-~~~l~~~l~~~--------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~ 154 (339)
T 1z57_A 91 ----HICIVFELL-GLSTYDFIKEN--------GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQS 154 (339)
T ss_dssp ----EEEEEEECC-CCBHHHHHHHT--------TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCC
T ss_pred ----cEEEEEcCC-CCCHHHHHHhc--------CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEecc
Confidence 789999999 88999998621 223588999999999999999999987 9999999999999987
Q ss_pred ------------------CCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh
Q 039533 777 ------------------YMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI 838 (949)
Q Consensus 777 ------------------~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt 838 (949)
++.+||+|||.++....... ...||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 229 (339)
T 1z57_A 155 DYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHS-----TLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 229 (339)
T ss_dssp CEEEEEC----CEEEEESCCCEEECCCSSCEETTSCCC-----SSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHH
T ss_pred ccccccCCccccccccccCCCceEeeCcccccCccccc-----cccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHh
Confidence 67899999999987544322 3458999999999999899999999999999999999
Q ss_pred CCCCCccccccCc-hhhhhccccCCCchhhhcc---------cCCCCCch-hhhhhhchhhhhhhhhhHHHHHHHHHHHh
Q 039533 839 GKKPIDIMFEGDI-NLHNFGRKALPDDVMDIVD---------SSLLPDDE-DLILTGNQRQKQARINSIIECLISMVRIG 907 (949)
Q Consensus 839 g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~d---------~~l~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 907 (949)
|+.||......+. ..........+........ ........ ....................++..+.+++
T Consensus 230 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 309 (339)
T 1z57_A 230 GFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLI 309 (339)
T ss_dssp SSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHH
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHH
Confidence 9999964322110 0000000111111000000 00000000 00000000000000111124567899999
Q ss_pred hccccCCCCCCCCHHHHHH
Q 039533 908 VACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 908 ~~cl~~dP~~RPs~~ev~~ 926 (949)
.+|++.||++|||++|+++
T Consensus 310 ~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 310 QKMLEYDPAKRITLREALK 328 (339)
T ss_dssp HHHTCSSTTTSCCHHHHTT
T ss_pred HHHhCcCcccccCHHHHhc
Confidence 9999999999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=334.93 Aligned_cols=259 Identities=22% Similarity=0.240 Sum_probs=176.7
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-cchHHHHHHHH-HHHhcCCCcceeEEeeeecccccCCcc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECK-ALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
.++|.+.+.||+|+||.||+|.+..+++.||||+++.... ....++..|+. +++.++||||+++++++...+ .
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~-----~ 95 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG-----D 95 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS-----E
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC-----c
Confidence 3678999999999999999999998999999999975533 23345566666 677789999999999986544 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++ +|.+++.... ......+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~-----~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl 167 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVY-----SVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKL 167 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHH-----HTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEE
T ss_pred eEEEEeecCC-ChHHHHHHHH-----hhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEE
Confidence 8999999985 8877764110 012356899999999999999999999642 7999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCcccc----CCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcc
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYG----VGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGR 858 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~ 858 (949)
+|||+++......... ...||+.|+|||++ .+..++.++|||||||++|||++|+.||.............
T Consensus 168 ~Dfg~~~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-- 242 (327)
T 3aln_A 168 CDFGISGQLVDSIAKT---RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-- 242 (327)
T ss_dssp CCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCC--
T ss_pred ccCCCceecccccccc---cCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHH--
Confidence 9999998765433221 23589999999998 45678999999999999999999999996432111111000
Q ss_pred ccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 859 KALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 859 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
...... .+.... ....+..+.+++.+||+.||++|||+.|+++
T Consensus 243 --~~~~~~-----~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 243 --VKGDPP-----QLSNSE------------------EREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp --CCSCCC-----CCCCCS------------------SCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --hcCCCC-----CCCCcc------------------cccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000000 000000 0022456889999999999999999999965
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=364.40 Aligned_cols=259 Identities=22% Similarity=0.345 Sum_probs=202.8
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcC---CCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDE---GRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
.++|.+.+.||+|+||.||+|.+.. .+..||||+++.... ...+.+.+|+.++++++||||+++++++.+
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------ 462 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------ 462 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS------
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec------
Confidence 4678889999999999999999853 356799999864332 234678999999999999999999998732
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
+..++||||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~---------~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~v 530 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQV---------RKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCV 530 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHH---------TTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEE
T ss_pred CceEEEEEcCCCCcHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCE
Confidence 257999999999999999962 234589999999999999999999987 99999999999999999999
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccc
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~ 859 (949)
||+|||+++.......... ....+|+.|+|||++.+..++.++|||||||++|||++ |..||......+ ....
T Consensus 531 kL~DFG~a~~~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~~~--- 604 (656)
T 2j0j_A 531 KLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGR--- 604 (656)
T ss_dssp EECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHH---
T ss_pred EEEecCCCeecCCCcceec-cCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHH---
Confidence 9999999987654432221 23347789999999988889999999999999999997 999996432111 0000
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHh
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNI 934 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 934 (949)
+.+....+. ...++..+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 605 --------i~~~~~~~~-------------------~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 605 --------IENGERLPM-------------------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp --------HHHTCCCCC-------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------HHcCCCCCC-------------------CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 000000000 013345688999999999999999999999999998754
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=334.31 Aligned_cols=257 Identities=18% Similarity=0.200 Sum_probs=174.4
Q ss_pred hcCCCCCC-eeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 625 TSGFSSAN-LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 625 ~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
.++|.+.+ +||+|+||.||+|++..+++.||||++... ..........++.++||||+++++++.... .+....
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~ 101 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMH-HGKRCL 101 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCceE
Confidence 56788854 699999999999999989999999998642 122223333456679999999999986532 223468
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC---CCce
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD---YMTA 780 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~---~~~~ 780 (949)
++||||+++|+|.+++... ....+++.+++.++.|++.||+|||++ +|+||||||+||+++. ++.+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~--------~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~ 170 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQER--------GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVL 170 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC---------CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCE
T ss_pred EEEEeccCCCCHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceE
Confidence 9999999999999999731 224689999999999999999999988 9999999999999975 4569
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
||+|||+++........ ...||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 171 kl~Dfg~~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------- 239 (336)
T 3fhr_A 171 KLTDFGFAKETTQNALQ----TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP------- 239 (336)
T ss_dssp EECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------
T ss_pred EEeccccceeccccccc----cCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh-------
Confidence 99999999876543221 3458999999999988899999999999999999999999996432211100
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.....+.......+ .+.....+..+.+++.+|++.||++|||++|+++
T Consensus 240 ---~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 240 ---GMKRRIRLGQYGFP---------------NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp --------------CCC---------------TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---hHHHhhhccccccC---------------chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000000000000 0000123456889999999999999999999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=339.96 Aligned_cols=203 Identities=24% Similarity=0.299 Sum_probs=171.0
Q ss_pred HHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcC-CC-----cceeEEeeeeccc
Q 039533 623 NATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIR-HR-----NLVKVLTACLGAD 696 (949)
Q Consensus 623 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~~ 696 (949)
...++|++.+.||+|+||+||+|++..+++.||||+++... ...+++..|+.+++.++ |+ +|+++++++...+
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 34578999999999999999999999899999999996432 23466778999988885 55 4999999876544
Q ss_pred ccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec-
Q 039533 697 YRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD- 775 (949)
Q Consensus 697 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~- 775 (949)
..++||||++ ++|.+++... ....+++..+..++.|++.||+|||++ ..+|+||||||+||+++
T Consensus 130 -----~~~lv~e~~~-~~L~~~l~~~--------~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~ 194 (382)
T 2vx3_A 130 -----HLCLVFEMLS-YNLYDLLRNT--------NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCN 194 (382)
T ss_dssp -----EEEEEEECCC-CBHHHHHHHT--------TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESS
T ss_pred -----ceEEEEecCC-CCHHHHHhhc--------CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEec
Confidence 7899999996 5999998621 124589999999999999999999964 45899999999999994
Q ss_pred -CCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccc
Q 039533 776 -DYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIM 846 (949)
Q Consensus 776 -~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~ 846 (949)
.++.+||+|||+|+....... ...||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 195 ~~~~~~kL~DFG~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 195 PKRSAIKIVDFGSSCQLGQRIY-----QYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp TTSCCEEECCCTTCEETTCCCC-----SSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCCcEEEEeccCceecccccc-----cccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 578899999999988754322 345899999999999999999999999999999999999999743
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=332.54 Aligned_cols=253 Identities=21% Similarity=0.331 Sum_probs=191.5
Q ss_pred HhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcC--CCcceeEEeeeecccccC
Q 039533 624 ATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIR--HRNLVKVLTACLGADYRG 699 (949)
Q Consensus 624 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~ 699 (949)
..++|++.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|++++++++ ||||+++++++...+
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~--- 101 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ--- 101 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS---
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC---
Confidence 4567899999999999999999986 588999999975432 23467899999999997 599999999976544
Q ss_pred CccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCc
Q 039533 700 NDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMT 779 (949)
Q Consensus 700 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~ 779 (949)
..++||| +.+++|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||++++ +.
T Consensus 102 --~~~lv~e-~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~ 164 (313)
T 3cek_A 102 --YIYMVME-CGNIDLNSWLK----------KKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GM 164 (313)
T ss_dssp --EEEEEEC-CCSEEHHHHHH----------HCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TE
T ss_pred --EEEEEEe-cCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-Ce
Confidence 7899999 56789999996 234689999999999999999999988 9999999999999975 89
Q ss_pred eEEeecccceecCCCCCccccccccCccCccCccccCC-----------CccCCccchHHHHHHHHHHHhCCCCCccccc
Q 039533 780 ARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-----------CEVSTNGDVYSYGILLLELVIGKKPIDIMFE 848 (949)
Q Consensus 780 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~ 848 (949)
+||+|||+++...............||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 165 ~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (313)
T 3cek_A 165 LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 244 (313)
T ss_dssp EEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred EEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH
Confidence 99999999987655443222224568999999999875 4688899999999999999999999964322
Q ss_pred cCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 849 GDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 849 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
..... ...++........ ...+..+.+++.+||+.||++|||++|+++.
T Consensus 245 ~~~~~------------~~~~~~~~~~~~~------------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 245 QISKL------------HAIIDPNHEIEFP------------------DIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHHH------------HHHHCTTSCCCCC------------------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHH------------HHHHhcccccCCc------------------ccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 11111 1111111110000 0113457889999999999999999999863
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=329.42 Aligned_cols=258 Identities=24% Similarity=0.311 Sum_probs=192.3
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeeccc--------
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGAD-------- 696 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------- 696 (949)
.++|++.+.||+|+||.||+|++..+++.||||+++.. ....+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 45789999999999999999999889999999999643 233467889999999999999999999876431
Q ss_pred ccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC
Q 039533 697 YRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD 776 (949)
Q Consensus 697 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~ 776 (949)
.......++||||+++++|.+++.. ....+++.+++.++.|++.||+|||++ +|+||||||+||+++.
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~ 151 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS---------ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDE 151 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH---------SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECT
T ss_pred cccCCceEEEEecCCCCCHHHhhhc---------cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcC
Confidence 1224568999999999999999962 234578889999999999999999988 8999999999999999
Q ss_pred CCceEEeecccceecCCCCC------------ccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCC
Q 039533 777 YMTARVGDFGLARILSPDHT------------QTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPI 843 (949)
Q Consensus 777 ~~~~kl~DfG~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf 843 (949)
++.+||+|||.++....... ........||..|+|||++.+. .++.++|||||||++|||++ ||
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~ 228 (303)
T 1zy4_A 152 SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PF 228 (303)
T ss_dssp TSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CC
T ss_pred CCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---cc
Confidence 99999999999987643211 1111234589999999998764 68999999999999999998 55
Q ss_pred ccccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHH
Q 039533 844 DIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTN 923 (949)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 923 (949)
....... ......... .....+.. ....+..+.+++.+|++.||++|||++|
T Consensus 229 ~~~~~~~-~~~~~~~~~---------~~~~~~~~------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ 280 (303)
T 1zy4_A 229 STGMERV-NILKKLRSV---------SIEFPPDF------------------DDNKMKVEKKIIRLLIDHDPNKRPGART 280 (303)
T ss_dssp SSHHHHH-HHHHHHHST---------TCCCCTTC------------------CTTTSHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCchhHH-HHHHhcccc---------ccccCccc------------------cccchHHHHHHHHHHHhcCcccCcCHHH
Confidence 3221110 000000000 00000000 0123456789999999999999999999
Q ss_pred HHH
Q 039533 924 VVH 926 (949)
Q Consensus 924 v~~ 926 (949)
+++
T Consensus 281 ll~ 283 (303)
T 1zy4_A 281 LLN 283 (303)
T ss_dssp HHH
T ss_pred HhC
Confidence 986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=338.51 Aligned_cols=284 Identities=18% Similarity=0.252 Sum_probs=200.9
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcC-----------CCcceeEEeeee
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIR-----------HRNLVKVLTACL 693 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~ 693 (949)
.++|++.+.||+|+||.||+|++..+++.||||++... ....+.+.+|+.++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 35799999999999999999999889999999998643 223467889999999886 899999999986
Q ss_pred cccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCee
Q 039533 694 GADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVL 773 (949)
Q Consensus 694 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIl 773 (949)
..+ ......++||||+ +++|.+++... ....+++..+..++.||+.||+|||+++ +|+||||||+||+
T Consensus 97 ~~~-~~~~~~~lv~e~~-~~~L~~~~~~~--------~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIl 164 (373)
T 1q8y_A 97 HKG-PNGVHVVMVFEVL-GENLLALIKKY--------EHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVL 164 (373)
T ss_dssp EEE-TTEEEEEEEECCC-CEEHHHHHHHT--------TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEE
T ss_pred ccC-CCCceEEEEEecC-CCCHHHHHHHh--------hccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeE
Confidence 543 2233689999999 88999998632 2345899999999999999999999753 8999999999999
Q ss_pred ec------CCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCcccc
Q 039533 774 LD------DYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMF 847 (949)
Q Consensus 774 l~------~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~ 847 (949)
++ ..+.+||+|||+++....... ...||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 165 l~~~~~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 165 MEIVDSPENLIQIKIADLGNACWYDEHYT-----NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp EEEEETTTTEEEEEECCCTTCEETTBCCC-----SCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EeccCCCcCcceEEEcccccccccCCCCC-----CCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 94 445899999999987654322 3458999999999999999999999999999999999999997432
Q ss_pred ccCc-----hhhhhcc--ccCCCch-------hhhcccC-CCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhcccc
Q 039533 848 EGDI-----NLHNFGR--KALPDDV-------MDIVDSS-LLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSM 912 (949)
Q Consensus 848 ~~~~-----~~~~~~~--~~~~~~~-------~~~~d~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 912 (949)
.... ....... ...+... ...+... ...........................+..+.+++.+|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 319 (373)
T 1q8y_A 240 GHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ 319 (373)
T ss_dssp -----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGC
T ss_pred ccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhc
Confidence 1110 0000000 0000000 0000000 0000000000000000011112224667889999999999
Q ss_pred CCCCCCCCHHHHHH
Q 039533 913 ELPQDRTNMTNVVH 926 (949)
Q Consensus 913 ~dP~~RPs~~ev~~ 926 (949)
.||++|||++|+++
T Consensus 320 ~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 320 LDPRKRADAGGLVN 333 (373)
T ss_dssp SSTTTCBCHHHHHT
T ss_pred cCccccCCHHHHhh
Confidence 99999999999987
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=334.91 Aligned_cols=243 Identities=21% Similarity=0.270 Sum_probs=197.5
Q ss_pred HHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc------chHHHHHHHHHHHhcC--CCcceeEEeeeec
Q 039533 623 NATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG------ASRSFIAECKALKSIR--HRNLVKVLTACLG 694 (949)
Q Consensus 623 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~~~~~~~~ 694 (949)
...++|++.+.||+|+||.||+|++..+++.||||+++..... ..+.+.+|+.++++++ |+||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 3457899999999999999999999989999999999754321 2245778999999996 5999999999765
Q ss_pred ccccCCccceeEeeeccC-CChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCee
Q 039533 695 ADYRGNDFKASVYEFMHY-GSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVL 773 (949)
Q Consensus 695 ~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIl 773 (949)
.+ ..++|||++.+ ++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+
T Consensus 120 ~~-----~~~lv~e~~~~~~~L~~~l~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIl 181 (320)
T 3a99_A 120 PD-----SFVLILERPEPVQDLFDFIT----------ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENIL 181 (320)
T ss_dssp SS-----EEEEEEECCSSEEEHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred CC-----cEEEEEEcCCCCccHHHHHh----------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEE
Confidence 44 78999999976 89999986 235689999999999999999999987 9999999999999
Q ss_pred ec-CCCceEEeecccceecCCCCCccccccccCccCccCccccCCCcc-CCccchHHHHHHHHHHHhCCCCCccccccCc
Q 039533 774 LD-DYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEV-STNGDVYSYGILLLELVIGKKPIDIMFEGDI 851 (949)
Q Consensus 774 l~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~ 851 (949)
++ +++.+||+|||+++........ ...||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....
T Consensus 182 l~~~~~~~kL~Dfg~~~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--- 254 (320)
T 3a99_A 182 IDLNRGELKLIDFGSGALLKDTVYT----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--- 254 (320)
T ss_dssp EETTTTEEEECCCTTCEECCSSCBC----CCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---
T ss_pred EeCCCCCEEEeeCcccccccccccc----CCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh---
Confidence 99 7899999999999877543221 3458999999999877665 6889999999999999999999963210
Q ss_pred hhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 852 NLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 852 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
........ . ...+..+.+++.+||+.||++|||++|+++
T Consensus 255 ----------------~~~~~~~~-~-------------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 255 ----------------IIRGQVFF-R-------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ----------------HHHCCCCC-S-------------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----------------hhcccccc-c-------------------ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000000 0 012345789999999999999999999976
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=331.92 Aligned_cols=244 Identities=21% Similarity=0.263 Sum_probs=191.2
Q ss_pred HHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc------chHHHHHHHHHHHhc----CCCcceeEEee
Q 039533 622 YNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG------ASRSFIAECKALKSI----RHRNLVKVLTA 691 (949)
Q Consensus 622 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~~~~~ 691 (949)
....++|++.+.||+|+||.||+|++..+++.||||+++..... ....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34467899999999999999999999888999999999654321 223456799999998 89999999999
Q ss_pred eecccccCCccceeEeee-ccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 039533 692 CLGADYRGNDFKASVYEF-MHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPS 770 (949)
Q Consensus 692 ~~~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~ 770 (949)
+...+ ..++|||| +.+++|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+
T Consensus 107 ~~~~~-----~~~~v~e~~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~ 168 (312)
T 2iwi_A 107 FETQE-----GFMLVLERPLPAQDLFDYIT----------EKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDE 168 (312)
T ss_dssp C----------CEEEEECCSSEEEHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGG
T ss_pred EecCC-----eEEEEEEecCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChh
Confidence 75443 78999999 78999999996 234589999999999999999999988 8999999999
Q ss_pred Ceeec-CCCceEEeecccceecCCCCCccccccccCccCccCccccCCCcc-CCccchHHHHHHHHHHHhCCCCCccccc
Q 039533 771 NVLLD-DYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEV-STNGDVYSYGILLLELVIGKKPIDIMFE 848 (949)
Q Consensus 771 NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlGvvl~elltg~~Pf~~~~~ 848 (949)
||+++ .++.+||+|||+++....... ....||..|+|||++.+..+ +.++||||||+++|||++|+.||.....
T Consensus 169 Nil~~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 244 (312)
T 2iwi_A 169 NILIDLRRGCAKLIDFGSGALLHDEPY----TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE 244 (312)
T ss_dssp GEEEETTTTEEEECCCSSCEECCSSCB----CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH
T ss_pred hEEEeCCCCeEEEEEcchhhhcccCcc----cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH
Confidence 99999 889999999999987754432 23458999999999876665 4589999999999999999999963210
Q ss_pred cCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 849 GDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 849 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
..+..... + ...+..+.+++.+|++.||++|||++|+++
T Consensus 245 -------------------~~~~~~~~-~-------------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 245 -------------------ILEAELHF-P-------------------AHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -------------------HHHTCCCC-C-------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------------------HhhhccCC-c-------------------ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000000 0 012345788999999999999999999987
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=341.41 Aligned_cols=210 Identities=21% Similarity=0.314 Sum_probs=155.0
Q ss_pred CCCC-CCeeeeecCceEEEEEEc--CCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 627 GFSS-ANLVGVGSFGSVYKGIID--EGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 627 ~y~~-~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
.|.+ .++||+|+||.||+|++. .+++.||||++.... ....+.+|+.++++++||||+++++++... .....
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---~~~~~ 95 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSH---ADRKV 95 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEET---TTTEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecC---CCCeE
Confidence 3555 568999999999999976 457899999986432 345788999999999999999999998532 23478
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeee----cCCCc
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL----DDYMT 779 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll----~~~~~ 779 (949)
++||||++ ++|.+++....... .......+++..++.|+.|++.||+|||++ +|+||||||+||++ +.++.
T Consensus 96 ~lv~e~~~-~~l~~~~~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 96 WLLFDYAE-HDLWHIIKFHRASK-ANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEECCS-EEHHHHHHHHHHHC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTC
T ss_pred EEEEeCCC-CCHHHHHHHhcccc-ccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCc
Confidence 99999997 48888775211000 001223589999999999999999999988 89999999999999 67889
Q ss_pred eEEeecccceecCCCCC-ccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccc
Q 039533 780 ARVGDFGLARILSPDHT-QTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIM 846 (949)
Q Consensus 780 ~kl~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~ 846 (949)
+||+|||+|+....... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 99999999987654322 1222245689999999998874 5899999999999999999999999643
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=353.70 Aligned_cols=239 Identities=21% Similarity=0.212 Sum_probs=147.6
Q ss_pred ccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeeccc
Q 039533 296 IKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLND 375 (949)
Q Consensus 296 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 375 (949)
|++|+|++|.|++..|..|+.+++|++|+|++|.+++. .++.+++|+.|++++|.+++ +...++|+.|++++
T Consensus 149 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~ 220 (597)
T 3oja_B 149 LTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST-----LAIPIAVEELDASH 220 (597)
T ss_dssp CCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC---CGGGCTTCSEEECCSSCCSE-----EECCTTCSEEECCS
T ss_pred CCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc---ChhhhhhhhhhhcccCcccc-----ccCCchhheeeccC
Confidence 33333444444433444444444444555555444432 13334455555555555543 12233455555555
Q ss_pred ccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccC
Q 039533 376 NFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEI 455 (949)
Q Consensus 376 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 455 (949)
|.++...+.. .++|+.|+|++|++++ +..+..+++| +.|+|++|.+++.+|..++.+++|+.|+|++|++++ +
T Consensus 221 n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l~~L-~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l 293 (597)
T 3oja_B 221 NSINVVRGPV---NVELTILKLQHNNLTD--TAWLLNYPGL-VEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-L 293 (597)
T ss_dssp SCCCEEECSC---CSCCCEEECCSSCCCC--CGGGGGCTTC-SEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-E
T ss_pred Cccccccccc---CCCCCEEECCCCCCCC--ChhhccCCCC-CEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-C
Confidence 5554332221 1456667777777664 3556666666 567777777777777777777888888888888874 5
Q ss_pred CcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCcCcccccCCccceEeCCCCcCcCccccccccccc
Q 039533 456 PSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLSLNNLNLSYNDLEGMVTTEGVFKNA 535 (949)
Q Consensus 456 p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~ls~N~l~~~~~~~~~~~~~ 535 (949)
|..++.+++|+.|+|++|.++ .+|..+..+++|+.|+|++|+|++..+..+ ..|+.|++++|++++... ...+..+
T Consensus 294 ~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~~~~~--~~L~~L~l~~N~~~~~~~-~~~~~~~ 369 (597)
T 3oja_B 294 NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTH--HTLKNLTLSHNDWDCNSL-RALFRNV 369 (597)
T ss_dssp ECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCCCCTT--CCCSEEECCSSCEEHHHH-HHHTTTC
T ss_pred CcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcChhhc--CCCCEEEeeCCCCCChhH-HHHHHHH
Confidence 666777788888888888887 567777788888888888888876532222 138888888888887643 2345666
Q ss_pred ccccccCCCCCCCCCCCC
Q 039533 536 SATRILGNSKLCGGISEF 553 (949)
Q Consensus 536 ~~~~~~gn~~~c~~~~~~ 553 (949)
....+.+++..|+.+...
T Consensus 370 ~~~~~~~~~~~C~~~~~~ 387 (597)
T 3oja_B 370 ARPAVDDADQHCKIDYQL 387 (597)
T ss_dssp CTTTBCCCCCCCCTTCEE
T ss_pred hhhccccccccCCcchhc
Confidence 677788899999875443
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=332.38 Aligned_cols=232 Identities=22% Similarity=0.225 Sum_probs=129.5
Q ss_pred EEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecccccc
Q 039533 299 LFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFL 378 (949)
Q Consensus 299 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 378 (949)
|++++|++++..|..+..+++|++|++++|++++. .+..+++|+.|++++|.+++. ...++|+.|++++|.+
T Consensus 146 L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~~-----~~~~~L~~L~l~~n~l 217 (390)
T 3o6n_A 146 LSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSI 217 (390)
T ss_dssp EECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSEE-----ECCSSCSEEECCSSCC
T ss_pred EECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccccc-----CCCCcceEEECCCCee
Confidence 33333333333333344444444444444444422 133344444444444444421 1223444555555554
Q ss_pred cccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccCCcc
Q 039533 379 EVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPST 458 (949)
Q Consensus 379 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 458 (949)
+.. |..+ .++|+.|++++|++++. ..+..+++| +.|++++|.+++..|..+..+++|+.|+|++|++++ +|..
T Consensus 218 ~~~-~~~~--~~~L~~L~l~~n~l~~~--~~l~~l~~L-~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~ 290 (390)
T 3o6n_A 218 NVV-RGPV--NVELTILKLQHNNLTDT--AWLLNYPGL-VEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLY 290 (390)
T ss_dssp CEE-ECCC--CSSCCEEECCSSCCCCC--GGGGGCTTC-SEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECS
T ss_pred eec-cccc--cccccEEECCCCCCccc--HHHcCCCCc-cEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcc
Confidence 432 2211 24566666666666532 345555555 566666666666666667777777777777777763 5555
Q ss_pred cccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCcCcccccCCc-cceEeCCCCcCcCccccccccccccc
Q 039533 459 FGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLS-LNNLNLSYNDLEGMVTTEGVFKNASA 537 (949)
Q Consensus 459 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~l~ls~N~l~~~~~~~~~~~~~~~ 537 (949)
+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|++++.. +..++ |+.|++++|++++... ...+..+..
T Consensus 291 ~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~---~~~~~~L~~L~l~~N~~~~~~~-~~~~~~~~~ 365 (390)
T 3o6n_A 291 GQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWDCNSL-RALFRNVAR 365 (390)
T ss_dssp SSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCEEHHHH-HHHTTTCCT
T ss_pred cCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeC---chhhccCCEEEcCCCCccchhH-HHHHHHHHh
Confidence 666777777777777777 45556677777777777777777543 23333 7788888888776422 233455556
Q ss_pred ccccCCCCCCCCC
Q 039533 538 TRILGNSKLCGGI 550 (949)
Q Consensus 538 ~~~~gn~~~c~~~ 550 (949)
..+.+++..|..+
T Consensus 366 ~~~~~~~~~c~~~ 378 (390)
T 3o6n_A 366 PAVDDADQHCKID 378 (390)
T ss_dssp TTBCCCCSCCCTT
T ss_pred hcccccCceeccc
Confidence 6677777777654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=331.74 Aligned_cols=279 Identities=18% Similarity=0.205 Sum_probs=197.5
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCC-EEEEEEEEecCCCcchHHHHHHHHHHHhcCCCc------ceeEEeeeecccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGR-TTIAVKVFNLQHHGASRSFIAECKALKSIRHRN------LVKVLTACLGADY 697 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~ 697 (949)
.++|++.+.||+|+||.||+|.+..++ +.||+|+++... ...+.+.+|+.++++++|++ ++.+++++....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~- 95 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG- 95 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT-
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC-
Confidence 368999999999999999999997665 799999996432 33467888999999997665 888888865444
Q ss_pred cCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeee---
Q 039533 698 RGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL--- 774 (949)
Q Consensus 698 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll--- 774 (949)
..++||||+ ++++.+++... ....+++.++..++.|++.||+|||++ +|+||||||+||++
T Consensus 96 ----~~~lv~e~~-~~~l~~~l~~~--------~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~ 159 (355)
T 2eu9_A 96 ----HMCIAFELL-GKNTFEFLKEN--------NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNS 159 (355)
T ss_dssp ----EEEEEEECC-CCBHHHHHHHT--------TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCC
T ss_pred ----eEEEEEecc-CCChHHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecc
Confidence 789999999 56777776521 224589999999999999999999977 99999999999999
Q ss_pred ----------------cCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh
Q 039533 775 ----------------DDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI 838 (949)
Q Consensus 775 ----------------~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt 838 (949)
+.++.+||+|||+++....... ...||+.|+|||++.+..++.++|||||||++|||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 234 (355)
T 2eu9_A 160 EFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHT-----TIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234 (355)
T ss_dssp CEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCCC-----SSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccCCCcEEEeecCcccccccccc-----CCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHh
Confidence 5678999999999987544322 3459999999999999999999999999999999999
Q ss_pred CCCCCccccccCc-hhhhhccccCCCchhhhcc-------c--CCCCCchh-hhhhhchhhhhhhhhhHHHHHHHHHHHh
Q 039533 839 GKKPIDIMFEGDI-NLHNFGRKALPDDVMDIVD-------S--SLLPDDED-LILTGNQRQKQARINSIIECLISMVRIG 907 (949)
Q Consensus 839 g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~d-------~--~l~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 907 (949)
|+.||........ ..........+........ . .......+ .......................+.+++
T Consensus 235 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 314 (355)
T 2eu9_A 235 GFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLM 314 (355)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHH
Confidence 9999974322110 0000000111111000000 0 00000000 0000000000000011123456789999
Q ss_pred hccccCCCCCCCCHHHHHH
Q 039533 908 VACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 908 ~~cl~~dP~~RPs~~ev~~ 926 (949)
.+|++.||++|||++|+++
T Consensus 315 ~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 315 RRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHHTCSSTTTSCCHHHHTT
T ss_pred HHHhcCChhhCcCHHHHhc
Confidence 9999999999999999974
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=352.02 Aligned_cols=287 Identities=22% Similarity=0.257 Sum_probs=204.5
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC-CcchHHHHHHHHHHHhcCCCcceeEEeeeeccc-ccCCcc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLTACLGAD-YRGNDF 702 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~ 702 (949)
.++|++.+.||+|+||.||+|.+..+++.||||+++... ....+.+.+|++++++++||||+++++++.... +.....
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 478999999999999999999998889999999987542 233467899999999999999999999875522 223557
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCc---
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMT--- 779 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~--- 779 (949)
.++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~-------~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~ 162 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFE-------NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLI 162 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSS-------CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCE
T ss_pred EEEEEEeCCCCCHHHHHHhcc-------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCcee
Confidence 899999999999999997321 123588889999999999999999987 9999999999999997665
Q ss_pred eEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 780 ARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 780 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
+||+|||.++........ ....||..|+|||++.+..++.++|||||||++|||++|+.||..... ...|...
T Consensus 163 vKL~DFG~a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~----~~~~~~~ 235 (676)
T 3qa8_A 163 HKIIDLGYAKELDQGELC---TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ----PVQWHGK 235 (676)
T ss_dssp EEECSCCCCCBTTSCCCC---CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH----HHHSSTT
T ss_pred EEEccccccccccccccc---ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc----hhhhhhh
Confidence 999999999876554332 235699999999999999999999999999999999999999964311 1111111
Q ss_pred cCCCchhh-hcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHH-----HHHHHHHhHH
Q 039533 860 ALPDDVMD-IVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTN-----VVHELQSIKN 933 (949)
Q Consensus 860 ~~~~~~~~-~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e-----v~~~L~~i~~ 933 (949)
........ ........... . ......+. ......+..+.+++.+|++.||++|||++| +.+.++.+.+
T Consensus 236 i~~~~~~~~~~~~~l~g~~~--~-~~~lp~p~---~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 236 VREKSNEHIVVYDDLTGAVK--F-SSVLPTPN---HLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp CC------CCSCCCCSSSCC--C-CSSSCCSC---CCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhcccchhhhhhhhhccccc--c-ccccCCch---hhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 11000000 00000000000 0 00000000 001134667899999999999999999988 5566666654
Q ss_pred h
Q 039533 934 I 934 (949)
Q Consensus 934 ~ 934 (949)
.
T Consensus 310 ~ 310 (676)
T 3qa8_A 310 L 310 (676)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=326.84 Aligned_cols=255 Identities=31% Similarity=0.492 Sum_probs=220.9
Q ss_pred cccEEEccCccccC--CCCCCCCCCCcccEEEeec-ceecccCCCcccccCCCCEEecCCcccccccCccccccccccee
Q 039533 295 TIKTLFLNNNKIYG--SIPAGIGNFVNLQRLDMWN-NQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNL 371 (949)
Q Consensus 295 ~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 371 (949)
+++.|+|++|++++ .+|..++.+++|++|+|++ |.+.+.+|..|+++++|++|+|++|++++.+|..|.++++|++|
T Consensus 51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 130 (313)
T 1ogq_A 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEE
Confidence 57788888888887 7788888888888888884 88888888888888888888888888888888888888888888
Q ss_pred ecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCc-ccceeeccCCCccCCCCccccccccccceeeecccc
Q 039533 372 FLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLS-SLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENR 450 (949)
Q Consensus 372 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~-~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 450 (949)
+|++|.+++.+|..|..+++|++|++++|++++.+|..++.+. .| +.|++++|++++.+|..+..++ |++|+|++|+
T Consensus 131 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L-~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~ 208 (313)
T 1ogq_A 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLF-TSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM 208 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTC-CEEECCSSEEEEECCGGGGGCC-CSEEECCSSE
T ss_pred eCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcC-cEEECcCCeeeccCChHHhCCc-ccEEECcCCc
Confidence 8888888888888888888888888888888888888888887 56 7888888888888888888887 9999999999
Q ss_pred ccccCCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCcCcccccCCc-cceEeCCCCcCcCccccc
Q 039533 451 LEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLS-LNNLNLSYNDLEGMVTTE 529 (949)
Q Consensus 451 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~l~ls~N~l~~~~~~~ 529 (949)
+++.+|..|..+++|+.|+|++|++++.+|. +..+++|++|+|++|++++.+|..+..++ |+.|+|++|+++|.+|..
T Consensus 209 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~ 287 (313)
T 1ogq_A 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287 (313)
T ss_dssp EEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred ccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC
Confidence 9988889999999999999999999877766 88899999999999999999999888776 999999999999999888
Q ss_pred ccccccccccccCCCCCCCCCCC
Q 039533 530 GVFKNASATRILGNSKLCGGISE 552 (949)
Q Consensus 530 ~~~~~~~~~~~~gn~~~c~~~~~ 552 (949)
+.+.++..+.+.||+++||.|.+
T Consensus 288 ~~l~~L~~l~l~~N~~lc~~p~~ 310 (313)
T 1ogq_A 288 GNLQRFDVSAYANNKCLCGSPLP 310 (313)
T ss_dssp TTGGGSCGGGTCSSSEEESTTSS
T ss_pred ccccccChHHhcCCCCccCCCCC
Confidence 88889999999999999997643
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=316.88 Aligned_cols=241 Identities=12% Similarity=0.042 Sum_probs=183.1
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc---chHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG---ASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+.+|+..+++++||||+++++++...+ .
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-----~ 105 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA-----G 105 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-----E
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECC-----c
Confidence 5799999999999999999999988999999999754332 2367899999999999999999999976544 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++++|.+++.. .....++.+|+.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 106 ~~lv~e~~~g~~L~~~l~~------------~~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl 170 (286)
T 3uqc_A 106 GLVVAEWIRGGSLQEVADT------------SPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVL 170 (286)
T ss_dssp EEEEEECCCEEEHHHHHTT------------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEE
T ss_pred EEEEEEecCCCCHHHHHhc------------CCChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEE
Confidence 8999999999999999951 135567889999999999999988 9999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
+++| |++ .++.++|||||||++|||+||+.||.......... .......
T Consensus 171 ~~~~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~--~~~~~~~ 219 (286)
T 3uqc_A 171 AYPA----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA--PAERDTA 219 (286)
T ss_dssp CSCC----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE--ECCBCTT
T ss_pred Eecc----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH--HHHHHhc
Confidence 8543 333 26789999999999999999999997432211000 0000000
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhhccCCCCC
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILLGVELCP 942 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~~~~ 942 (949)
.. . ..+. ......+..+.+++.+||+.||++| |+.|+++.|+++..........|
T Consensus 220 ~~--------~-~~~~---------------~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~~~~~~~ 274 (286)
T 3uqc_A 220 GQ--------P-IEPA---------------DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVADRTEVLG 274 (286)
T ss_dssp SC--------B-CCHH---------------HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---------
T ss_pred cC--------C-CChh---------------hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCCccCCCC
Confidence 00 0 0000 0001335568899999999999999 99999999999987765543333
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-36 Score=327.60 Aligned_cols=273 Identities=20% Similarity=0.276 Sum_probs=172.2
Q ss_pred cCCCChhhHHHHHHHHhccCCCCCCCccCc----cCCCCcceeeeeEEeC--------CCCcEEEEEcCCCCCCccccCC
Q 039533 17 AGTGNETDRVALLEFKSKSTYDPVGVLGTW----NESIHFCKWYGVTCSR--------RHQRVTLLDLRSLKLAGSVSHF 84 (949)
Q Consensus 17 ~~~~~~~~~~aLl~~k~~~~~~~~~~l~sW----~~~~~~C~w~gv~C~~--------~~~~v~~l~l~~~~l~g~~~~~ 84 (949)
..++..+|++||++||+++..|+.+.+++| ....++|.|.|++|+. ...+|+.|+|++++++ .+|+.
T Consensus 21 ~~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~ 99 (328)
T 4fcg_A 21 GSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQ 99 (328)
T ss_dssp --CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSC
T ss_pred ccccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChh
Confidence 345668999999999998877898889999 4567899999999953 2345666666666666 55666
Q ss_pred CCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCc
Q 039533 85 IGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTE 164 (949)
Q Consensus 85 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~ 164 (949)
++++++|++|+|++|.++ .+|..|+++++|++|+|++|.++ .+|..|+++++| +
T Consensus 100 l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L------------------------~ 153 (328)
T 4fcg_A 100 AFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRL------------------------R 153 (328)
T ss_dssp GGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTC------------------------C
T ss_pred hhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCC------------------------C
Confidence 666666666666666666 56666666666666666666665 555555444444 5
Q ss_pred EEECCCCCCCCCCCCCcC---------CCCCccEEeccccccCCCCCCcccCCCccccccccCcccccccccccCCCCCh
Q 039533 165 ILNLGSNHLTGSIPSSLG---------NLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSL 235 (949)
Q Consensus 165 ~L~Ls~N~l~~~~p~~~~---------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l 235 (949)
+|+|++|.+.+.+|..++ ++++|++|+|++|+++ .+|..++.+++|++|+|++|.++.
T Consensus 154 ~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~------------ 220 (328)
T 4fcg_A 154 ELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA------------ 220 (328)
T ss_dssp EEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC------------
T ss_pred EEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc------------
Confidence 555555555445554443 3566666666666665 555555555555555555444332
Q ss_pred hhhccccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCC
Q 039533 236 EKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIG 315 (949)
Q Consensus 236 ~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~ 315 (949)
+|..+..+ ++|++|+|++|++.+.+|..++
T Consensus 221 -------------------------------------------------l~~~l~~l-~~L~~L~Ls~n~~~~~~p~~~~ 250 (328)
T 4fcg_A 221 -------------------------------------------------LGPAIHHL-PKLEELDLRGCTALRNYPPIFG 250 (328)
T ss_dssp -------------------------------------------------CCGGGGGC-TTCCEEECTTCTTCCBCCCCTT
T ss_pred -------------------------------------------------CchhhccC-CCCCEEECcCCcchhhhHHHhc
Confidence 12223333 2355666666666666666666
Q ss_pred CCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeeccccccc
Q 039533 316 NFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLE 379 (949)
Q Consensus 316 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 379 (949)
.+++|++|+|++|.+.+.+|..+.++++|+.|+|++|++.+.+|..++++++|+.+++..|.+.
T Consensus 251 ~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 251 GRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp CCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred CCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 6666666666666666666666666666666666666666666666666666666666655543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=339.31 Aligned_cols=256 Identities=20% Similarity=0.235 Sum_probs=181.6
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCCcccee
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
.|.+.++||+|+||+||.+... +++.||||++.... .+.+.+|+++++++ +||||+++++++.... ..++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~-~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~-----~~~l 86 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSF-QGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDR-----FLYI 86 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEES-SSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSS-----EEEE
T ss_pred eeeccCeEeeCCCeEEEEEEEE-CCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCC-----eEEE
Confidence 3445688999999999876544 68999999986432 35678999999987 8999999999875443 7899
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCC--------
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDY-------- 777 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~-------- 777 (949)
||||+. |+|.+++....... ......++..++.++.||+.||+|||++ +|+||||||+||+++.+
T Consensus 87 v~E~~~-gsL~~~l~~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~ 159 (434)
T 2rio_A 87 ALELCN-LNLQDLVESKNVSD---ENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQ 159 (434)
T ss_dssp EECCCS-EEHHHHHHTC---------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCT
T ss_pred EEecCC-CCHHHHHhccCCCc---hhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccc
Confidence 999996 69999997322110 0111123445678999999999999987 99999999999999754
Q ss_pred -----CceEEeecccceecCCCCCcc--ccccccCccCccCccccCC-------CccCCccchHHHHHHHHHHHh-CCCC
Q 039533 778 -----MTARVGDFGLARILSPDHTQT--SSFSVKGSLGYIAPEYGVG-------CEVSTNGDVYSYGILLLELVI-GKKP 842 (949)
Q Consensus 778 -----~~~kl~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~sDiwSlGvvl~ellt-g~~P 842 (949)
+.+||+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.|
T Consensus 160 ~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~P 239 (434)
T 2rio_A 160 TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239 (434)
T ss_dssp TCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCT
T ss_pred cCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCC
Confidence 489999999999876543211 1123469999999999875 568999999999999999999 9999
Q ss_pred CccccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHH
Q 039533 843 IDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMT 922 (949)
Q Consensus 843 f~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 922 (949)
|.......... ........ .. ... .....+..+.+++.+|++.||++|||+.
T Consensus 240 f~~~~~~~~~i---~~~~~~~~-------~~-~~~-----------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ 291 (434)
T 2rio_A 240 FGDKYSRESNI---IRGIFSLD-------EM-KCL-----------------HDRSLIAEATDLISQMIDHDPLKRPTAM 291 (434)
T ss_dssp TCSTTTHHHHH---HHTCCCCC-------CC-TTC-----------------CCHHHHHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCchhhHHHH---hcCCCCcc-------cc-ccc-----------------ccccchHHHHHHHHHHhhCChhhCCCHH
Confidence 96432211111 00000000 00 000 0124566789999999999999999999
Q ss_pred HHHH
Q 039533 923 NVVH 926 (949)
Q Consensus 923 ev~~ 926 (949)
||++
T Consensus 292 eil~ 295 (434)
T 2rio_A 292 KVLR 295 (434)
T ss_dssp HHHT
T ss_pred HHHh
Confidence 9975
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=326.73 Aligned_cols=253 Identities=22% Similarity=0.233 Sum_probs=177.3
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcc--hHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGA--SRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
.++|++.+.||+|+||.||+|++..+++.||||++....... .+.+..+..+++.++||||+++++++...+ .
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~-----~ 98 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT-----D 98 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-----E
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-----c
Confidence 467888999999999999999999889999999997554322 233445555788889999999999986544 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+ ++.+..+.. .....+++..+..++.|++.||+|||+++ +|+||||||+||+++.++.+||
T Consensus 99 ~~lv~e~~-~~~~~~l~~---------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl 166 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLKK---------RMQGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKL 166 (318)
T ss_dssp EEEEECCC-SEEHHHHHH---------HHTSCCCHHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCGGGEEECTTSCEEE
T ss_pred EEEEEecc-CCcHHHHHH---------HhccCCCHHHHHHHHHHHHHHHHHHHhhC--CEEeCCCCHHHEEECCCCCEEE
Confidence 89999999 455555543 12346899999999999999999999732 8999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccC-----CCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhc
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGV-----GCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFG 857 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~ 857 (949)
+|||.+.......... ...||+.|+|||++. +..++.++|||||||++|||++|+.||..............
T Consensus 167 ~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 243 (318)
T 2dyl_A 167 CDFGISGRLVDDKAKD---RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL 243 (318)
T ss_dssp CCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred EECCCchhccCCcccc---ccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHh
Confidence 9999997765433221 345899999999984 45688999999999999999999999964321111111110
Q ss_pred cccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 858 RKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 858 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.... +.... ....+..+.+++.+||+.||++|||++|+++
T Consensus 244 ~~~~---------~~~~~--------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 244 QEEP---------PLLPG--------------------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HSCC---------CCCCS--------------------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccCC---------CCCCc--------------------cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0000 00000 0012446789999999999999999999976
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=333.94 Aligned_cols=249 Identities=21% Similarity=0.267 Sum_probs=179.5
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCCccce
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.+|.+.++||+|+||+||.... .+++.||||++..... ..+.+|+++++++ +||||+++++++.+.. ..+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~-----~~~ 94 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQ-----FQY 94 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETT-----EEE
T ss_pred EEEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCC-----EEE
Confidence 4578889999999999764433 3688999999865432 2356899999999 7999999999876544 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC-----CCc
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD-----YMT 779 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~-----~~~ 779 (949)
+||||+. |+|.+++.... ......++..++.||+.||+|||++ +|+||||||+||+++. ...
T Consensus 95 lv~E~~~-g~L~~~l~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~ 161 (432)
T 3p23_A 95 IAIELCA-ATLQEYVEQKD---------FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIK 161 (432)
T ss_dssp EEEECCS-EEHHHHHHSSS---------CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCC
T ss_pred EEEECCC-CCHHHHHHhcC---------CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCcee
Confidence 9999996 59999997321 2233445678999999999999988 8999999999999953 346
Q ss_pred eEEeecccceecCCCCC-ccccccccCccCccCccccC---CCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhh
Q 039533 780 ARVGDFGLARILSPDHT-QTSSFSVKGSLGYIAPEYGV---GCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLH 854 (949)
Q Consensus 780 ~kl~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~ 854 (949)
+||+|||+|+....... ........||+.|+|||++. +..++.++|||||||++|||++ |..||..........
T Consensus 162 ~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~- 240 (432)
T 3p23_A 162 AMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI- 240 (432)
T ss_dssp EEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-
T ss_pred EEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-
Confidence 88999999987754432 12222456999999999987 4567889999999999999999 999985332111000
Q ss_pred hhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 855 NFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 855 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
. ....... ...+ .......+.+++.+|++.||++|||++||++
T Consensus 241 --~---~~~~~~~----~~~~--------------------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 241 --L---LGACSLD----CLHP--------------------EKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp --H---TTCCCCT----TSCT--------------------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --H---hccCCcc----ccCc--------------------cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0 0000000 0000 0123445788999999999999999999983
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=351.52 Aligned_cols=246 Identities=20% Similarity=0.257 Sum_probs=196.2
Q ss_pred cCCCCCCeeeeecCceEEEEEEcC-CCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDE-GRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
++|++.+.||+|+||.||+|++.. +++.||||++..... .....+.+|+.++++++||||+++++++...+..+....
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 689999999999999999999975 689999999864332 334578899999999999999999999876553233336
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++||||+++++|.+++. ..+++.+++.|+.||+.||+|||++ +|+||||||+||+++.+ .+||+
T Consensus 160 ~lv~E~~~g~~L~~~~~------------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~ 223 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKG------------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLI 223 (681)
T ss_dssp EEEEECCCCEECC----------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEEC
T ss_pred EEEEEeCCCCcHHHHHh------------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEE
Confidence 99999999999988775 2589999999999999999999988 89999999999999985 99999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCC
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
|||+++..... ....||+.|+|||++.+. ++.++|||||||++|||++|.+||....... .+
T Consensus 224 DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------~~- 285 (681)
T 2pzi_A 224 DLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG----------LP- 285 (681)
T ss_dssp CCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS----------CC-
T ss_pred ecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc----------cc-
Confidence 99999876543 134599999999998764 4889999999999999999998875321110 00
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-CHHHHHHHHHHhHH
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRT-NMTNVVHELQSIKN 933 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~ev~~~L~~i~~ 933 (949)
...+ .......+.+++.+|++.||++|| +++++.+.+..+..
T Consensus 286 ----------~~~~------------------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 286 ----------EDDP------------------VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp ----------TTCH------------------HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred ----------cccc------------------ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 0000 112345688999999999999999 57777777777643
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-35 Score=331.76 Aligned_cols=251 Identities=15% Similarity=0.093 Sum_probs=180.7
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC---cchHHHHHHHHHHHhcCC-CcceeEE---------eee
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH---GASRSFIAECKALKSIRH-RNLVKVL---------TAC 692 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv~~~---------~~~ 692 (949)
..|...++||+|+||.||+|++..+++.||||+++.... ...+.+.+|+.+++.++| +|...+. ...
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 346677899999999999999998999999999874332 235789999999999987 3221111 111
Q ss_pred ------------ecccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 039533 693 ------------LGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQP 760 (949)
Q Consensus 693 ------------~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~ 760 (949)
...........+++|+++ +++|.+++...... ......+++..++.++.|+++||+|||++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~---~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--- 230 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSH---SSTHKSLVHHARLQLTLQVIRLLASLHHY--- 230 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHH---TTTSHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcc---cccCCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 000000012345666655 68999988411000 01234578889999999999999999987
Q ss_pred CeEecCCCCCCeeecCCCceEEeecccceecCCCCCccccccccCccCccCcccc----------CCCccCCccchHHHH
Q 039533 761 VTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYG----------VGCEVSTNGDVYSYG 830 (949)
Q Consensus 761 ~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDiwSlG 830 (949)
+|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++||||||
T Consensus 231 ~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlG 304 (413)
T 3dzo_A 231 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG 304 (413)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHH
T ss_pred CcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHH
Confidence 9999999999999999999999999999875433 123457 999999998 666789999999999
Q ss_pred HHHHHHHhCCCCCccccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhcc
Q 039533 831 ILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVAC 910 (949)
Q Consensus 831 vvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c 910 (949)
|++|||++|+.||........ ...++... ...+..+.+++.+|
T Consensus 305 vil~elltg~~Pf~~~~~~~~-------------~~~~~~~~------------------------~~~~~~~~~li~~~ 347 (413)
T 3dzo_A 305 LAIYWIWCADLPNTDDAALGG-------------SEWIFRSC------------------------KNIPQPVRALLEGF 347 (413)
T ss_dssp HHHHHHHHSSCCCCTTGGGSC-------------SGGGGSSC------------------------CCCCHHHHHHHHHH
T ss_pred HHHHHHHHCCCCCCCcchhhh-------------HHHHHhhc------------------------ccCCHHHHHHHHHH
Confidence 999999999999964321110 00011000 01234688999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 039533 911 SMELPQDRTNMTNVVH 926 (949)
Q Consensus 911 l~~dP~~RPs~~ev~~ 926 (949)
|+.||++||++.|+++
T Consensus 348 l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 348 LRYPKEDRLLPLQAME 363 (413)
T ss_dssp TCSSGGGSCCHHHHTT
T ss_pred ccCChhhCcCHHHHHh
Confidence 9999999999877743
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=313.92 Aligned_cols=168 Identities=23% Similarity=0.327 Sum_probs=92.8
Q ss_pred ccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeeccc
Q 039533 296 IKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLND 375 (949)
Q Consensus 296 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 375 (949)
|++|++++|++++..+ +..+++|++|++++|.+++..+ +..+++|+.|+|++|++++..+ +..+++|++|++++
T Consensus 179 L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~ 252 (347)
T 4fmz_A 179 LYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGT 252 (347)
T ss_dssp CSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred CCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCC
Confidence 4455555555443222 4455555555555555553332 4555555555555555553222 44555555555555
Q ss_pred ccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccC
Q 039533 376 NFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEI 455 (949)
Q Consensus 376 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 455 (949)
|.+++. +.+..+++|++|++++|+++ +. ..+..+++|+.|++++|++++..
T Consensus 253 n~l~~~--~~~~~l~~L~~L~l~~n~l~-------------------------~~--~~~~~l~~L~~L~L~~n~l~~~~ 303 (347)
T 4fmz_A 253 NQISDI--NAVKDLTKLKMLNVGSNQIS-------------------------DI--SVLNNLSQLNSLFLNNNQLGNED 303 (347)
T ss_dssp SCCCCC--GGGTTCTTCCEEECCSSCCC-------------------------CC--GGGGGCTTCSEEECCSSCCCGGG
T ss_pred CccCCC--hhHhcCCCcCEEEccCCccC-------------------------CC--hhhcCCCCCCEEECcCCcCCCcC
Confidence 555432 23444555555555555544 22 23555666667777777776666
Q ss_pred CcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCC
Q 039533 456 PSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLS 500 (949)
Q Consensus 456 p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 500 (949)
|..|+.+++|+.|++++|++++..| +..+++|+.|++++|.|+
T Consensus 304 ~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 304 MEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp HHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred hhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 6666777777777777777776555 667777777777777764
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=314.25 Aligned_cols=305 Identities=22% Similarity=0.352 Sum_probs=199.5
Q ss_pred cCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCcccccccccccCCCCChhh
Q 039533 158 SSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEK 237 (949)
Q Consensus 158 ~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~ 237 (949)
..+++|+.|++++|.++ .+| .+..+++|++|+|++|++++. +. +..+++|++|+|++|.++.+ +.+..
T Consensus 41 ~~l~~L~~L~l~~~~i~-~~~-~~~~~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~~--------~~~~~ 108 (347)
T 4fmz_A 41 EELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITDI--------SALQN 108 (347)
T ss_dssp HHHTTCSEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCC--------GGGTT
T ss_pred hhcccccEEEEeCCccc-cch-hhhhcCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccCc--------hHHcC
Confidence 34555566666666665 333 255566666666666666533 22 55666666666666655432 12333
Q ss_pred hccccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCC
Q 039533 238 LQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNF 317 (949)
Q Consensus 238 l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l 317 (949)
+++|++|++++|++ ++..+ +..+ ++|++|++++|.....++ .+..+
T Consensus 109 l~~L~~L~l~~n~i------------------------------~~~~~--~~~l-~~L~~L~l~~n~~~~~~~-~~~~l 154 (347)
T 4fmz_A 109 LTNLRELYLNEDNI------------------------------SDISP--LANL-TKMYSLNLGANHNLSDLS-PLSNM 154 (347)
T ss_dssp CTTCSEEECTTSCC------------------------------CCCGG--GTTC-TTCCEEECTTCTTCCCCG-GGTTC
T ss_pred CCcCCEEECcCCcc------------------------------cCchh--hccC-CceeEEECCCCCCccccc-chhhC
Confidence 33333333333333 32211 2222 235555555554432322 26666
Q ss_pred CcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEe
Q 039533 318 VNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINL 397 (949)
Q Consensus 318 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 397 (949)
++|++|++++|.+.+..+ +..+++|+.|++++|++++..+ +..+++|+.|++++|.+++..+ +..+++|++|++
T Consensus 155 ~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l 228 (347)
T 4fmz_A 155 TGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKI 228 (347)
T ss_dssp TTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEEC
T ss_pred CCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEc
Confidence 677777777777664333 6667777777777777764322 6667777777777777765443 666777777777
Q ss_pred eCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccCCcccccccchhhcccCcccccc
Q 039533 398 SNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQG 477 (949)
Q Consensus 398 ~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 477 (949)
++|++++ +|. +..++++ +.|++++|.+++. ..+..+++|++|++++|++++. +.+..+++|+.|++++|++++
T Consensus 229 ~~n~l~~-~~~-~~~l~~L-~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~ 301 (347)
T 4fmz_A 229 GNNKITD-LSP-LANLSQL-TWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGN 301 (347)
T ss_dssp CSSCCCC-CGG-GTTCTTC-CEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCG
T ss_pred cCCccCC-Ccc-hhcCCCC-CEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCC
Confidence 7777763 333 6667777 6777777777753 4678899999999999999964 468999999999999999999
Q ss_pred ccCCCcCCCCCCCEEECCCCcCCCcCcccccCCc-cceEeCCCCcCc
Q 039533 478 PISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLS-LNNLNLSYNDLE 523 (949)
Q Consensus 478 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~l~ls~N~l~ 523 (949)
..|..|+.+++|+.|+|++|++++.+| +..++ |+.|++++|+++
T Consensus 302 ~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 302 EDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp GGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred cChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 999999999999999999999998777 55555 999999999986
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=307.08 Aligned_cols=236 Identities=18% Similarity=0.223 Sum_probs=179.7
Q ss_pred hcCCCCC-CeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHH-HhcCCCcceeEEeeeecccccCCcc
Q 039533 625 TSGFSSA-NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKAL-KSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 625 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
.++|.+. +.||+|+||.||+|.+..+++.||+|+++. ...+.+|++++ +..+||||+++++++.... .+...
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~ 89 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLY-AGRKC 89 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCce
Confidence 3567776 789999999999999988999999999863 35677899888 5558999999999976421 23447
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC---CCc
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD---YMT 779 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~---~~~ 779 (949)
.++||||+++|+|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~ 158 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDR--------GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAI 158 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHC--------TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCC
T ss_pred EEEEEeecCCCcHHHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCc
Confidence 89999999999999999731 224589999999999999999999987 8999999999999997 789
Q ss_pred eEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 780 ARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 780 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
+||+|||++.... +..++.++|||||||++|||++|+.||.........
T Consensus 159 ~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~------- 207 (299)
T 3m2w_A 159 LKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------- 207 (299)
T ss_dssp EEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------
T ss_pred EEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-------
Confidence 9999999986532 234678999999999999999999999643211100
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
......+.......+ .+.....+..+.+++.+|++.||++|||++|+++
T Consensus 208 ---~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 208 ---PGMKTRIRMGQYEFP---------------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp ---CCSCCSSCTTCCSSC---------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---HHHHHHHhhccccCC---------------chhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000000000000000 0011234567889999999999999999999987
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-33 Score=306.36 Aligned_cols=126 Identities=24% Similarity=0.314 Sum_probs=74.8
Q ss_pred CceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECCC
Q 039533 91 LKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGS 170 (949)
Q Consensus 91 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~ 170 (949)
++.+++++|.++ .+|..+. ++|++|+|++|.+++..|..|+++++|++|++++|++++..+..|.++++|++|+|++
T Consensus 35 l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 111 (332)
T 2ft3_A 35 LRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111 (332)
T ss_dssp TTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred CCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence 444555555544 4444432 4555555555555544445555555555555555555555566666666667777777
Q ss_pred CCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCcccc
Q 039533 171 NHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLS 222 (949)
Q Consensus 171 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 222 (949)
|.++ .+|..+. ++|++|+|++|++++..+..|..+++|++|++++|.++
T Consensus 112 n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~ 160 (332)
T 2ft3_A 112 NHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLE 160 (332)
T ss_dssp SCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCB
T ss_pred CcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccc
Confidence 7766 4554443 56777777777777555556666666666666666654
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-33 Score=305.95 Aligned_cols=83 Identities=19% Similarity=0.312 Sum_probs=50.6
Q ss_pred ccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEec
Q 039533 113 RRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISL 192 (949)
Q Consensus 113 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 192 (949)
.+|+.+++++|.++ .+|..+. ++| ++|+|++|.+++..|..|.++++|++|+|
T Consensus 33 c~l~~l~~~~~~l~-~ip~~~~--~~l------------------------~~L~l~~n~i~~~~~~~~~~l~~L~~L~L 85 (332)
T 2ft3_A 33 CHLRVVQCSDLGLK-AVPKEIS--PDT------------------------TLLDLQNNDISELRKDDFKGLQHLYALVL 85 (332)
T ss_dssp EETTEEECCSSCCS-SCCSCCC--TTC------------------------CEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred ccCCEEECCCCCcc-ccCCCCC--CCC------------------------eEEECCCCcCCccCHhHhhCCCCCcEEEC
Confidence 36888888888887 6776553 344 55555555555444555555666666666
Q ss_pred cccccCCCCCCcccCCCccccccccCcccc
Q 039533 193 AYNNLDGTIPNSFGWFENLVFLSLAANNLS 222 (949)
Q Consensus 193 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 222 (949)
++|++++..|..|+++++|++|+|++|+++
T Consensus 86 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 115 (332)
T 2ft3_A 86 VNNKISKIHEKAFSPLRKLQKLYISKNHLV 115 (332)
T ss_dssp CSSCCCEECGGGSTTCTTCCEEECCSSCCC
T ss_pred CCCccCccCHhHhhCcCCCCEEECCCCcCC
Confidence 666665555555555555555555555544
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=303.12 Aligned_cols=277 Identities=24% Similarity=0.307 Sum_probs=168.4
Q ss_pred CCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEEC
Q 039533 89 SFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNL 168 (949)
Q Consensus 89 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~L 168 (949)
+.|++|+|++|++++..+..|+++++|++|+|++|.+++..|..| ..+++|++|+|
T Consensus 52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~------------------------~~l~~L~~L~L 107 (330)
T 1xku_A 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAF------------------------APLVKLERLYL 107 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTT------------------------TTCTTCCEEEC
T ss_pred CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHh------------------------cCCCCCCEEEC
Confidence 355555555555554444455555555555555555554444444 44445566666
Q ss_pred CCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCcccccccccccCCCCChhhhcccccccccc
Q 039533 169 GSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITS 248 (949)
Q Consensus 169 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~ 248 (949)
++|+++ .+|..+. ++|++|++++|++++..+..|.++++|++|++++|.++...
T Consensus 108 s~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~----------------------- 161 (330)
T 1xku_A 108 SKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG----------------------- 161 (330)
T ss_dssp CSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGG-----------------------
T ss_pred CCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccC-----------------------
Confidence 666665 4444433 56666666666666555555666666666666655543210
Q ss_pred CCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeecc
Q 039533 249 NSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNN 328 (949)
Q Consensus 249 N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 328 (949)
..+..+..+ ++|++|++++|+++. +|..+. ++|++|+|++|
T Consensus 162 -----------------------------------~~~~~~~~l-~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n 202 (330)
T 1xku_A 162 -----------------------------------IENGAFQGM-KKLSYIRIADTNITT-IPQGLP--PSLTELHLDGN 202 (330)
T ss_dssp -----------------------------------BCTTGGGGC-TTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTS
T ss_pred -----------------------------------cChhhccCC-CCcCEEECCCCcccc-CCcccc--ccCCEEECCCC
Confidence 112222222 235555555555552 344333 67888888888
Q ss_pred eecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCC
Q 039533 329 QLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPP 408 (949)
Q Consensus 329 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 408 (949)
++++..|..|.++++|+.|+|++|++++..+..+.++++|+.|+|++|+++ .+|..+..+++|++|++++|++++..+.
T Consensus 203 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~ 281 (330)
T 1xku_A 203 KITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSN 281 (330)
T ss_dssp CCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTT
T ss_pred cCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChh
Confidence 888877888888888888888888888777778888888888888888887 6777888888888888888888744343
Q ss_pred cccCCcccceeeccCCCccCCCCccccccccccceeeeccccccc--cCCcccccccchhhcccCccc
Q 039533 409 QFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEG--EIPSTFGNCIRLEQLGMGGNL 474 (949)
Q Consensus 409 ~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~l~~N~ 474 (949)
.|..... ......|+.|++++|.+.. ..|..|..+.+|+.++|++|+
T Consensus 282 ~f~~~~~-------------------~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 282 DFCPPGY-------------------NTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp SSSCSSC-------------------CTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred hcCCccc-------------------ccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 3332210 0123456666666666642 344555556666666665553
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-32 Score=301.80 Aligned_cols=289 Identities=20% Similarity=0.276 Sum_probs=143.0
Q ss_pred ccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEec
Q 039533 113 RRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISL 192 (949)
Q Consensus 113 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 192 (949)
.+|+.++++++.++ .+|..+. ++ |++|+|++|.+++..+..|+++++|++|+|
T Consensus 31 c~l~~l~~~~~~l~-~lp~~~~--~~------------------------l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L 83 (330)
T 1xku_A 31 CHLRVVQCSDLGLE-KVPKDLP--PD------------------------TALLDLQNNKITEIKDGDFKNLKNLHTLIL 83 (330)
T ss_dssp EETTEEECTTSCCC-SCCCSCC--TT------------------------CCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCCeEEEecCCCcc-ccCccCC--CC------------------------CeEEECCCCcCCEeChhhhccCCCCCEEEC
Confidence 35677777777766 5555442 23 345555555555444445555555555555
Q ss_pred cccccCCCCCCcccCCCccccccccCcccccccccccCCCCChhhhccccccccccCCCCCCCCCCcchhccccccCccc
Q 039533 193 AYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLT 272 (949)
Q Consensus 193 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~ 272 (949)
++|++++..|..|+.+++|++|+|++|+++.++..+ .++|+
T Consensus 84 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~---------------------------------------~~~L~ 124 (330)
T 1xku_A 84 INNKISKISPGAFAPLVKLERLYLSKNQLKELPEKM---------------------------------------PKTLQ 124 (330)
T ss_dssp CSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSSC---------------------------------------CTTCC
T ss_pred CCCcCCeeCHHHhcCCCCCCEEECCCCcCCccChhh---------------------------------------ccccc
Confidence 555555555555555555555555555544322110 01233
Q ss_pred EEEccCCCCCccCCchhhcccccccEEEccCccccC--CCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecC
Q 039533 273 WMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYG--SIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLN 350 (949)
Q Consensus 273 ~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 350 (949)
+|++++|++++..+..+..+ ++|++|++++|.++. ..+..+..+++|++|++++|.++ .+|..+. ++|+.|+|+
T Consensus 125 ~L~l~~n~l~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~ 200 (330)
T 1xku_A 125 ELRVHENEITKVRKSVFNGL-NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLD 200 (330)
T ss_dssp EEECCSSCCCBBCHHHHTTC-TTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECT
T ss_pred EEECCCCcccccCHhHhcCC-ccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECC
Confidence 44444444443333334443 245566666665532 44555555666666666666655 2343332 455555555
Q ss_pred CcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCC
Q 039533 351 RNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGS 430 (949)
Q Consensus 351 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~ 430 (949)
+|++++..|..|.++++|+.|+|++|.+++..+..|..+++|++|+|++|+++ .
T Consensus 201 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~------------------------- 254 (330)
T 1xku_A 201 GNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-K------------------------- 254 (330)
T ss_dssp TSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-S-------------------------
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-c-------------------------
Confidence 55555555555555555555555555555544445555555555555555544 3
Q ss_pred CccccccccccceeeeccccccccCCccccc------ccchhhcccCcccccc--ccCCCcCCCCCCCEEECCCC
Q 039533 431 LPIEVGKLKILEFLYVYENRLEGEIPSTFGN------CIRLEQLGMGGNLFQG--PISSSLGSLRGLRVLDLSQN 497 (949)
Q Consensus 431 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~L~Ls~N 497 (949)
+|..+..+++|++|++++|+|++..+..|.. ...|+.|++++|.+.. ..|..|..+.+|+.++|++|
T Consensus 255 lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N 329 (330)
T 1xku_A 255 VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329 (330)
T ss_dssp CCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC---
T ss_pred CChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEeccc
Confidence 3333444445555555555555433333322 2344445555554432 33344444555555555444
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=316.37 Aligned_cols=196 Identities=18% Similarity=0.155 Sum_probs=160.7
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--------cchHHHHHHHHHHHhcC---------CCccee
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--------GASRSFIAECKALKSIR---------HRNLVK 687 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---------h~niv~ 687 (949)
.++|++.+.||+|+||+||+|++ +++.||||+++.... ...+.+.+|+.++++++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 35789999999999999999998 479999999985532 22377899999999886 667766
Q ss_pred EEeeeeccc-------------------------ccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHH
Q 039533 688 VLTACLGAD-------------------------YRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLN 742 (949)
Q Consensus 688 ~~~~~~~~~-------------------------~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~ 742 (949)
+.+.+.... +.+....++||||+++|++.+.+. ...+++.+++.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----------~~~~~~~~~~~ 165 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----------TKLSSLATAKS 165 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----------TTCCCHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----------hcCCCHHHHHH
Confidence 666532110 112457899999999998777664 13478999999
Q ss_pred HHHHHHHHHHHHh-hCCCCCeEecCCCCCCeeecCCC--------------------ceEEeecccceecCCCCCccccc
Q 039533 743 IAIDIAYALNYLH-HDCQPVTAHCDLKPSNVLLDDYM--------------------TARVGDFGLARILSPDHTQTSSF 801 (949)
Q Consensus 743 i~~qi~~gL~~LH-~~~~~~ivHrDlkp~NIll~~~~--------------------~~kl~DfG~a~~~~~~~~~~~~~ 801 (949)
|+.||+.||+||| +. +|+||||||+|||++.++ .+||+|||+|+.....
T Consensus 166 i~~qi~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------- 235 (336)
T 2vuw_A 166 ILHQLTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------- 235 (336)
T ss_dssp HHHHHHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------
T ss_pred HHHHHHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------
Confidence 9999999999999 77 899999999999999887 8999999999876532
Q ss_pred cccCccCccCccccCCCccCCccchHHHHHH-HHHHHhCCCCCc
Q 039533 802 SVKGSLGYIAPEYGVGCEVSTNGDVYSYGIL-LLELVIGKKPID 844 (949)
Q Consensus 802 ~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvv-l~elltg~~Pf~ 844 (949)
...||+.|+|||++.+.. +.++||||+|++ .+++++|..||.
T Consensus 236 ~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 236 IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 235999999999998766 899999998777 788899999985
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-36 Score=349.88 Aligned_cols=384 Identities=17% Similarity=0.134 Sum_probs=196.6
Q ss_pred CCceeeccCceeccccCC-cccCcccCcEEeeccccccC----cCCCCCCCCccceeecCCCccccccccccc-cCCC--
Q 039533 90 FLKQLYLQVNSFTHEIPS-EIGGLRRLKVLALNNNSICG----EIPTNISRCSTLIPIHPQNNQLVGKILSRF-SSLS-- 161 (949)
Q Consensus 90 ~L~~L~L~~n~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~-~~L~-- 161 (949)
+|++|+|++|+++..... .+..+++|++|+|++|.+++ .+|..+..+++|++|++++|.+....+..+ ..++
T Consensus 4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~ 83 (461)
T 1z7x_W 4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 83 (461)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhC
Confidence 345555555555432222 24445555555555555542 223344444445555555554443322222 2233
Q ss_pred --CCcEEECCCCCCCC----CCCCCcCCCCCccEEeccccccCCCCCCccc-----CCCccccccccCcccccccccccC
Q 039533 162 --KTEILNLGSNHLTG----SIPSSLGNLSSIHTISLAYNNLDGTIPNSFG-----WFENLVFLSLAANNLSVVENKLTG 230 (949)
Q Consensus 162 --~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~~~~~l~~ 230 (949)
+|++|+|++|.++. .+|..+..+++|++|+|++|.+++..+..+. ..++|++|+|++|.++.....
T Consensus 84 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~--- 160 (461)
T 1z7x_W 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE--- 160 (461)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH---
T ss_pred CCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHH---
Confidence 45556666555552 3344555555555555555555432222221 123455555554444321100
Q ss_pred CCCChhhhccccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhc----ccccccEEEccCccc
Q 039533 231 EVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISN----LSKTIKTLFLNNNKI 306 (949)
Q Consensus 231 ~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~----l~~~L~~L~L~~N~l 306 (949)
.+...+..+++|++|++++|.++...+..+.. -.++|++|+|++|.+
T Consensus 161 -----------------------------~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l 211 (461)
T 1z7x_W 161 -----------------------------PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGV 211 (461)
T ss_dssp -----------------------------HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCC
T ss_pred -----------------------------HHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCC
Confidence 01112233444555555555544333322221 112466666666666
Q ss_pred cCC----CCCCCCCCCcccEEEeecceecccC-----CCcccccCCCCEEecCCcccccc----cCcccccccccceeec
Q 039533 307 YGS----IPAGIGNFVNLQRLDMWNNQLSGTI-----PPAIGELQNLKILGLNRNKLSGN----IPPSIGNLKMLLNLFL 373 (949)
Q Consensus 307 ~~~----~~~~~~~l~~L~~L~L~~N~l~~~~-----p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L 373 (949)
++. ++..+..+++|++|+|++|.+++.. +..+..+++|+.|+|++|++++. ++..+.++++|++|++
T Consensus 212 ~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L 291 (461)
T 1z7x_W 212 TSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSL 291 (461)
T ss_dssp BTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEEC
T ss_pred cHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEEC
Confidence 542 3444555666666666666665322 22223456666666666666643 4555555666666666
Q ss_pred ccccccccCCCCCCC-----CCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeecc
Q 039533 374 NDNFLEVSIPSSLGQ-----CESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYE 448 (949)
Q Consensus 374 ~~N~l~~~~p~~~~~-----l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 448 (949)
++|.+++..+..+.. .++|++|++++|.+++.... .++..+..+++|++|+|++
T Consensus 292 s~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~---------------------~l~~~l~~~~~L~~L~Ls~ 350 (461)
T 1z7x_W 292 AGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCS---------------------HFSSVLAQNRFLLELQISN 350 (461)
T ss_dssp TTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH---------------------HHHHHHHHCSSCCEEECCS
T ss_pred CCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHH---------------------HHHHHHhhCCCccEEEccC
Confidence 666655332222221 24555555555555421000 1344556667777777777
Q ss_pred ccccccCCccccc-----ccchhhcccCcccccc----ccCCCcCCCCCCCEEECCCCcCCCcCcc----cccC--Cccc
Q 039533 449 NRLEGEIPSTFGN-----CIRLEQLGMGGNLFQG----PISSSLGSLRGLRVLDLSQNNLSGEIPK----FLAG--LSLN 513 (949)
Q Consensus 449 N~l~~~~p~~~~~-----l~~L~~L~l~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~--~~L~ 513 (949)
|++++..+..+.. .++|+.|+|++|.+++ .+|..+..+++|+.|||++|++++.-.. .+.. ..|+
T Consensus 351 n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~ 430 (461)
T 1z7x_W 351 NRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 430 (461)
T ss_dssp SBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCC
T ss_pred CccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchh
Confidence 7776554544443 5677888888887775 6777777788888888888888753211 1111 1377
Q ss_pred eEeCCCCcCcCcc
Q 039533 514 NLNLSYNDLEGMV 526 (949)
Q Consensus 514 ~l~ls~N~l~~~~ 526 (949)
.|.+.+|.+....
T Consensus 431 ~L~~~~~~~~~~~ 443 (461)
T 1z7x_W 431 QLVLYDIYWSEEM 443 (461)
T ss_dssp EEECTTCCCCHHH
T ss_pred heeecccccCHHH
Confidence 7887777776543
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-35 Score=338.13 Aligned_cols=353 Identities=19% Similarity=0.189 Sum_probs=237.9
Q ss_pred cEEEEEcCCCCCCccccCC-CCCCCCCceeeccCceecc----ccCCcccCcccCcEEeeccccccCcCCCCCC-CCc--
Q 039533 66 RVTLLDLRSLKLAGSVSHF-IGNLSFLKQLYLQVNSFTH----EIPSEIGGLRRLKVLALNNNSICGEIPTNIS-RCS-- 137 (949)
Q Consensus 66 ~v~~l~l~~~~l~g~~~~~-l~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~-- 137 (949)
+++.|||++++++...... +..+++|++|+|++|++++ .++..+..+++|++|+|++|.+++..+..+. .++
T Consensus 4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~ 83 (461)
T 1z7x_W 4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 83 (461)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhC
Confidence 6889999999997655433 7789999999999999985 4677888999999999999999865443332 344
Q ss_pred --cceeecCCCccccc----cccccccCCCCCcEEECCCCCCCCCCCCCc-----CCCCCccEEeccccccCCCC----C
Q 039533 138 --TLIPIHPQNNQLVG----KILSRFSSLSKTEILNLGSNHLTGSIPSSL-----GNLSSIHTISLAYNNLDGTI----P 202 (949)
Q Consensus 138 --~L~~L~l~~n~l~~----~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~~----p 202 (949)
+|++|++++|.++. .++..|..+++|++|+|++|.+++..+..+ ...++|++|+|++|++++.. +
T Consensus 84 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~ 163 (461)
T 1z7x_W 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 163 (461)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHH
Confidence 79999999999985 568899999999999999999985444332 23568999999999998643 5
Q ss_pred CcccCCCccccccccCcccccccccccCCCCChhhhccccccccccCCCCCCCCCCcchhccc-cccCcccEEEccCCCC
Q 039533 203 NSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSL-TNATRLTWMHINSNNF 281 (949)
Q Consensus 203 ~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l-~~~~~L~~L~L~~N~l 281 (949)
..+..+++|++|+|++|.++..... .+.. .+ ...++|++|++++|++
T Consensus 164 ~~l~~~~~L~~L~L~~n~i~~~~~~------~l~~--------------------------~l~~~~~~L~~L~L~~n~l 211 (461)
T 1z7x_W 164 SVLRAKPDFKELTVSNNDINEAGVR------VLCQ--------------------------GLKDSPCQLEALKLESCGV 211 (461)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHH------HHHH--------------------------HHHHSCCCCCEEECTTSCC
T ss_pred HHHhhCCCCCEEECcCCCcchHHHH------HHHH--------------------------HHhcCCCCceEEEccCCCC
Confidence 6677789999999999987643211 0110 00 0123455566666655
Q ss_pred Ccc----CCchhhcccccccEEEccCccccCCC-----CCCCCCCCcccEEEeecceeccc----CCCcccccCCCCEEe
Q 039533 282 GGL----LPGCISNLSKTIKTLFLNNNKIYGSI-----PAGIGNFVNLQRLDMWNNQLSGT----IPPAIGELQNLKILG 348 (949)
Q Consensus 282 ~~~----~p~~~~~l~~~L~~L~L~~N~l~~~~-----~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~ 348 (949)
++. ++..+..+ ++|++|+|++|+++... +..+..+++|++|+|++|.+++. ++..+..+++|++|+
T Consensus 212 ~~~~~~~l~~~l~~~-~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~ 290 (461)
T 1z7x_W 212 TSDNCRDLCGIVASK-ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELS 290 (461)
T ss_dssp BTTHHHHHHHHHHHC-TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEE
T ss_pred cHHHHHHHHHHHHhC-CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEE
Confidence 543 34444444 35777777777765432 22233567888888888888753 566677788888888
Q ss_pred cCCcccccccCcccccc-----cccceeeccccccccc----CCCCCCCCCCCcEEEeeCccccCCCCCcccC-----Cc
Q 039533 349 LNRNKLSGNIPPSIGNL-----KMLLNLFLNDNFLEVS----IPSSLGQCESLIEINLSNNNLSGTIPPQFFS-----LS 414 (949)
Q Consensus 349 Ls~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-----l~ 414 (949)
|++|++++..+..+... ++|+.|++++|.+++. ++..+..+++|++|++++|++++..+..+.. .+
T Consensus 291 Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~ 370 (461)
T 1z7x_W 291 LAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGS 370 (461)
T ss_dssp CTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTC
T ss_pred CCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCC
Confidence 88888876544444433 6888888888888754 4555666788888888888876433322221 22
Q ss_pred ccceeeccCCCccCC----CCccccccccccceeeecccccc
Q 039533 415 SLSISLDWSRNKLTG----SLPIEVGKLKILEFLYVYENRLE 452 (949)
Q Consensus 415 ~l~~~L~ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~ 452 (949)
++ +.|++++|.+++ .+|..+..+++|++|++++|+++
T Consensus 371 ~L-~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~ 411 (461)
T 1z7x_W 371 VL-RVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411 (461)
T ss_dssp CC-CEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred ce-EEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCC
Confidence 33 344444444443 33444444444444444444443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-31 Score=293.66 Aligned_cols=291 Identities=20% Similarity=0.182 Sum_probs=198.2
Q ss_pred CccCCCCcceeeeeEEeCCCCcEEEEEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeecccc
Q 039533 45 TWNESIHFCKWYGVTCSRRHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNS 124 (949)
Q Consensus 45 sW~~~~~~C~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~ 124 (949)
.|.....+|.|.|+ |+ +++++++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|+
T Consensus 22 ~~~~~~~~C~~~~~-c~----------~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 87 (353)
T 2z80_A 22 SSNQASLSCDRNGI-CK----------GSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNG 87 (353)
T ss_dssp -----CCEECTTSE-EE----------CCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred CCCccCCCCCCCeE-ee----------CCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCc
Confidence 45566778999998 75 4566666 5666554 589999999999997777789999999999999999
Q ss_pred ccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECCCCCCCCCCC-CCcCCCCCccEEecccc-ccCCCCC
Q 039533 125 ICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIP-SSLGNLSSIHTISLAYN-NLDGTIP 202 (949)
Q Consensus 125 l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N-~l~~~~p 202 (949)
+++..|..|+++++|++|++++|++++..+..|.++++|++|+|++|++++..+ ..+.++++|++|++++| .+++..+
T Consensus 88 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~ 167 (353)
T 2z80_A 88 INTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQR 167 (353)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECT
T ss_pred cCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCH
Confidence 998888899999999999999999998888889999999999999999995443 47889999999999998 4776667
Q ss_pred CcccCCCccccccccCcccccccccccCCCCChhhhccccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCC
Q 039533 203 NSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFG 282 (949)
Q Consensus 203 ~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~ 282 (949)
..|+++++|++|++++|.++.+... .+.++++|++|++++|+++
T Consensus 168 ~~~~~l~~L~~L~l~~n~l~~~~~~------------------------------------~l~~l~~L~~L~l~~n~l~ 211 (353)
T 2z80_A 168 KDFAGLTFLEELEIDASDLQSYEPK------------------------------------SLKSIQNVSHLILHMKQHI 211 (353)
T ss_dssp TTTTTCCEEEEEEEEETTCCEECTT------------------------------------TTTTCSEEEEEEEECSCST
T ss_pred HHccCCCCCCEEECCCCCcCccCHH------------------------------------HHhccccCCeecCCCCccc
Confidence 7888888888888888876543211 1223334444444444443
Q ss_pred ccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCccccc----cc
Q 039533 283 GLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSG----NI 358 (949)
Q Consensus 283 ~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~----~~ 358 (949)
. +|..+....++|++|++++|++++..+..+.. ......++.++|++|.+++ .+
T Consensus 212 ~-~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~---------------------~~~~~~l~~l~L~~~~l~~~~l~~l 269 (353)
T 2z80_A 212 L-LLEIFVDVTSSVECLELRDTDLDTFHFSELST---------------------GETNSLIKKFTFRNVKITDESLFQV 269 (353)
T ss_dssp T-HHHHHHHHTTTEEEEEEESCBCTTCCCC---------------------------CCCCCCEEEEESCBCCHHHHHHH
T ss_pred c-chhhhhhhcccccEEECCCCcccccccccccc---------------------ccccchhhccccccccccCcchhhh
Confidence 2 22222221234555555555554433222211 1123344455555555443 35
Q ss_pred CcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCC
Q 039533 359 PPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIP 407 (949)
Q Consensus 359 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 407 (949)
|..+.++++|+.|++++|+++...+..|.++++|++|++++|.+++..|
T Consensus 270 ~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 270 MKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp HHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred HHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 6667777777777777777773333335777888888888887775433
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-30 Score=287.25 Aligned_cols=107 Identities=22% Similarity=0.283 Sum_probs=54.3
Q ss_pred cccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEe
Q 039533 112 LRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTIS 191 (949)
Q Consensus 112 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 191 (949)
++.....++++|.++ .+|..+. ++|++|++++|.+++..+..|.++++|++|+|++|.+++..|..|+++++|++|+
T Consensus 30 C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (353)
T 2z80_A 30 CDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLD 106 (353)
T ss_dssp ECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEE
Confidence 334444555566555 4555443 2444444444444444444455555555566666655555555555555666666
Q ss_pred ccccccCCCCCCcccCCCccccccccCccc
Q 039533 192 LAYNNLDGTIPNSFGWFENLVFLSLAANNL 221 (949)
Q Consensus 192 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 221 (949)
|++|++++..+..|+++++|++|+|++|++
T Consensus 107 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l 136 (353)
T 2z80_A 107 LSYNYLSNLSSSWFKPLSSLTFLNLLGNPY 136 (353)
T ss_dssp CCSSCCSSCCHHHHTTCTTCSEEECTTCCC
T ss_pred CCCCcCCcCCHhHhCCCccCCEEECCCCCC
Confidence 666655533333344444444444444443
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-30 Score=304.53 Aligned_cols=296 Identities=21% Similarity=0.293 Sum_probs=169.4
Q ss_pred CCCCCccCccCCCCcceeeeeEEe------CCCCcEEEEEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccC
Q 039533 38 DPVGVLGTWNESIHFCKWYGVTCS------RRHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGG 111 (949)
Q Consensus 38 ~~~~~l~sW~~~~~~C~w~gv~C~------~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~ 111 (949)
|....+++|..+.+||.|+|..|. -....++.|++++++++ .+|..+. ++|++|+|++|+|+ .+|. .
T Consensus 7 ~~~~~w~~W~~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~ 79 (622)
T 3g06_A 7 EYDAVWSAWRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---L 79 (622)
T ss_dssp ---CHHHHHHHTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---C
T ss_pred HHHHHHHHHHhcCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---c
Confidence 344567789888899999774321 11124778888888888 6776665 78888888888887 5665 5
Q ss_pred cccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEe
Q 039533 112 LRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTIS 191 (949)
Q Consensus 112 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 191 (949)
+++|++|+|++|+|+ .+|. .+++|++|++++|.|++... .+++|+.|+|++|+|++ +|.. +++|++|+
T Consensus 80 l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~l~~----~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~ 147 (622)
T 3g06_A 80 PPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTHLPA----LPSGLCKLWIFGNQLTS-LPVL---PPGLQELS 147 (622)
T ss_dssp CTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCCCCC----CCTTCCEEECCSSCCSC-CCCC---CTTCCEEE
T ss_pred CCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCCCCC----CCCCcCEEECCCCCCCc-CCCC---CCCCCEEE
Confidence 678888888888887 4665 45556555555555554332 34445555555555552 3332 24455555
Q ss_pred ccccccCCCCCCcccCCCccccccccCcccccccccccCCCCChhhhccccccccccCCCCCCCCCCcchhccccccCcc
Q 039533 192 LAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRL 271 (949)
Q Consensus 192 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L 271 (949)
|++|++++ +|. .+++|+.|++++|.|+.+
T Consensus 148 Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~l----------------------------------------------- 176 (622)
T 3g06_A 148 VSDNQLAS-LPA---LPSELCKLWAYNNQLTSL----------------------------------------------- 176 (622)
T ss_dssp CCSSCCSC-CCC---CCTTCCEEECCSSCCSCC-----------------------------------------------
T ss_pred CcCCcCCC-cCC---ccCCCCEEECCCCCCCCC-----------------------------------------------
Confidence 55555542 222 123344444444433321
Q ss_pred cEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCC
Q 039533 272 TWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNR 351 (949)
Q Consensus 272 ~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 351 (949)
| ..+++|+.|+|++|+|++ +|.. +++|+.|++++|.++ .+|.. +++|+.|+|++
T Consensus 177 --------------~----~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~ 230 (622)
T 3g06_A 177 --------------P----MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSG 230 (622)
T ss_dssp --------------C----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-SCCCC---CTTCCEEECCS
T ss_pred --------------c----ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccc-ccCCC---CCCCCEEEccC
Confidence 1 011235555555555543 2221 245555555555555 33332 24566666666
Q ss_pred cccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCC
Q 039533 352 NKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSL 431 (949)
Q Consensus 352 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~ 431 (949)
|+|++ +| ..+++|+.|+|++|.|+ .+|. .+++|+.|+|++|+|+ .+|..+..+++| +.|+|++|.+++..
T Consensus 231 N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L-~~L~L~~N~l~~~~ 300 (622)
T 3g06_A 231 NRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSE-TTVNLEGNPLSERT 300 (622)
T ss_dssp SCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTT-CEEECCSCCCCHHH
T ss_pred CccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhcccc-CEEEecCCCCCCcC
Confidence 66663 34 33455666666666665 3444 4566777777777776 667667777776 56777777777766
Q ss_pred cccccccc
Q 039533 432 PIEVGKLK 439 (949)
Q Consensus 432 p~~~~~l~ 439 (949)
|..+..++
T Consensus 301 ~~~l~~L~ 308 (622)
T 3g06_A 301 LQALREIT 308 (622)
T ss_dssp HHHHHHHH
T ss_pred HHHHHhcc
Confidence 66665554
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.9e-34 Score=339.67 Aligned_cols=434 Identities=14% Similarity=0.118 Sum_probs=301.4
Q ss_pred CcceeeeeEEeCCCCcEEEEEcCCCCCCccccCCCCCCCCCceeeccCcee---ccccCCccc------------CcccC
Q 039533 51 HFCKWYGVTCSRRHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSF---THEIPSEIG------------GLRRL 115 (949)
Q Consensus 51 ~~C~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l---~~~~p~~~~------------~l~~L 115 (949)
-|++|.++.+... + .+.+.+ .....++..+..+++|++|+|+++.. .+.+|..++ .+++|
T Consensus 40 vck~W~~~~~~~~--~--~l~~~~-~~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L 114 (592)
T 3ogk_B 40 VCRRWFKIDSETR--E--HVTMAL-CYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQL 114 (592)
T ss_dssp SCHHHHHHHHHHC--C--EEEESC-GGGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTC
T ss_pred HhHHHHHhhhccc--c--EEEEee-ccccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCC
Confidence 3568999854322 1 223332 23333445566788899999987532 134554444 68899
Q ss_pred cEEeeccccccCcCCCCCCCC--ccceeecCCCcc-ccc-cccccccCCCCCcEEECCCCCCCCC----CCCCcCCCCCc
Q 039533 116 KVLALNNNSICGEIPTNISRC--STLIPIHPQNNQ-LVG-KILSRFSSLSKTEILNLGSNHLTGS----IPSSLGNLSSI 187 (949)
Q Consensus 116 ~~L~Ls~N~l~~~~p~~~~~l--~~L~~L~l~~n~-l~~-~~~~~~~~L~~L~~L~Ls~N~l~~~----~p~~~~~l~~L 187 (949)
++|+|++|.+++..+..++.+ ++|++|++++|. +.. ..+.....+++|++|+|++|.+++. ++..+.++++|
T Consensus 115 ~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L 194 (592)
T 3ogk_B 115 KSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSL 194 (592)
T ss_dssp CEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCC
T ss_pred CeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCc
Confidence 999999999987777777664 459999999887 222 1233445889999999999998765 33345678899
Q ss_pred cEEeccccccCC----CCCCcccCCCccccccccCcccccccccccCCCCChhhhccccccccccCCCCCCCCCCcchhc
Q 039533 188 HTISLAYNNLDG----TIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLC 263 (949)
Q Consensus 188 ~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~ 263 (949)
++|+|++|.+++ .++..+.++++|++|+|++|.+..++ ..+..+++|++|+++........ .....
T Consensus 195 ~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~-------~~~~~~~~L~~L~l~~~~~~~~~---~~~~~ 264 (592)
T 3ogk_B 195 EVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELV-------GFFKAAANLEEFCGGSLNEDIGM---PEKYM 264 (592)
T ss_dssp CEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGH-------HHHHHCTTCCEEEECBCCCCTTC---TTSSS
T ss_pred cEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHHH-------HHHhhhhHHHhhcccccccccch---HHHHH
Confidence 999999999973 34445677899999999998876543 23677888999999864332111 12234
Q ss_pred cccccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCC-CCCCCCCcccEEEeecceecccCCCcccccC
Q 039533 264 SLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIP-AGIGNFVNLQRLDMWNNQLSGTIPPAIGELQ 342 (949)
Q Consensus 264 ~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 342 (949)
.+..+++|+.++++++. .+.+|..+..+ ++|++|+|++|.+++... ..+..+++|++|+|+++...+.++..+..++
T Consensus 265 ~l~~~~~L~~L~l~~~~-~~~l~~~~~~~-~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~ 342 (592)
T 3ogk_B 265 NLVFPRKLCRLGLSYMG-PNEMPILFPFA-AQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCK 342 (592)
T ss_dssp CCCCCTTCCEEEETTCC-TTTGGGGGGGG-GGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCT
T ss_pred HhhccccccccCccccc-hhHHHHHHhhc-CCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCC
Confidence 56777889999998753 34556666555 469999999999765433 3357889999999994433344445556788
Q ss_pred CCCEEecC-----------Cccccccc-CcccccccccceeecccccccccCCCCCCC-CCCCcEEEee----CccccCC
Q 039533 343 NLKILGLN-----------RNKLSGNI-PPSIGNLKMLLNLFLNDNFLEVSIPSSLGQ-CESLIEINLS----NNNLSGT 405 (949)
Q Consensus 343 ~L~~L~Ls-----------~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~l~----~N~l~~~ 405 (949)
+|++|+|+ .|.+++.. +..+.++++|++|+++.|.+++..+..+.. +++|+.|+++ .|++++.
T Consensus 343 ~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~ 422 (592)
T 3ogk_B 343 QLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDL 422 (592)
T ss_dssp TCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSC
T ss_pred CCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCc
Confidence 99999999 46776542 233456889999999888888776666665 8889999996 6777743
Q ss_pred -----CCCcccCCcccceeeccCCC--ccCCCCcccccc-ccccceeeeccccccc-cCCcccccccchhhcccCccccc
Q 039533 406 -----IPPQFFSLSSLSISLDWSRN--KLTGSLPIEVGK-LKILEFLYVYENRLEG-EIPSTFGNCIRLEQLGMGGNLFQ 476 (949)
Q Consensus 406 -----~p~~~~~l~~l~~~L~ls~N--~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~ 476 (949)
++..+..+++| +.|+++++ .+++..+..+.. +++|++|+|++|++++ .++..+..+++|+.|+|++|.++
T Consensus 423 p~~~~~~~~~~~~~~L-~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~ 501 (592)
T 3ogk_B 423 PLDNGVRSLLIGCKKL-RRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFS 501 (592)
T ss_dssp CCHHHHHHHHHHCTTC-CEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCB
T ss_pred hHHHHHHHHHHhCCCC-CEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCc
Confidence 22335567777 67888743 366555555543 7788888888888876 34555677888888888888876
Q ss_pred cc-cCCCcCCCCCCCEEECCCCcCCCc
Q 039533 477 GP-ISSSLGSLRGLRVLDLSQNNLSGE 502 (949)
Q Consensus 477 ~~-~~~~~~~l~~L~~L~Ls~N~l~~~ 502 (949)
+. ++..+..+++|+.|+|++|++++.
T Consensus 502 ~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 502 ERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp HHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred HHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 54 333445678888888888888765
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=274.44 Aligned_cols=250 Identities=25% Similarity=0.248 Sum_probs=217.3
Q ss_pred cEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeecceecc--cCCCcccccCCCCEEec
Q 039533 272 TWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSG--TIPPAIGELQNLKILGL 349 (949)
Q Consensus 272 ~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L 349 (949)
+.++++++.++.. |.. ++++|++|+|++|+++...+..|..+++|++|+|++|.++. ..|..+..+++|++|+|
T Consensus 10 ~~l~c~~~~l~~i-p~~---~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L 85 (306)
T 2z66_A 10 TEIRCNSKGLTSV-PTG---IPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85 (306)
T ss_dssp TEEECCSSCCSSC-CSC---CCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEEC
T ss_pred CEEEcCCCCcccC-CCC---CCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEEC
Confidence 4677777777743 433 23579999999999986555568899999999999999983 33677778999999999
Q ss_pred CCcccccccCcccccccccceeecccccccccCC-CCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccC
Q 039533 350 NRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIP-SSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLT 428 (949)
Q Consensus 350 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~ 428 (949)
++|+++ .+|..+.++++|++|++++|.+++..+ ..+..+++|++|++++|++++..|..+..+++| +.|++++|.++
T Consensus 86 s~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~l~~n~l~ 163 (306)
T 2z66_A 86 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL-EVLKMAGNSFQ 163 (306)
T ss_dssp CSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTC-CEEECTTCEEG
T ss_pred CCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCC-CEEECCCCccc
Confidence 999998 567779999999999999999987655 688999999999999999998888889899999 78999999998
Q ss_pred C-CCccccccccccceeeeccccccccCCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCcCcccc
Q 039533 429 G-SLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFL 507 (949)
Q Consensus 429 ~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 507 (949)
+ .+|..+..+++|++|+|++|++++..|..|..+++|+.|+|++|++++..+..+..+++|+.|||++|++++.+|..+
T Consensus 164 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 243 (306)
T 2z66_A 164 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQEL 243 (306)
T ss_dssp GGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSC
T ss_pred cccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHH
Confidence 7 688899999999999999999998889999999999999999999998888889999999999999999999999888
Q ss_pred cCC--ccceEeCCCCcCcCccc
Q 039533 508 AGL--SLNNLNLSYNDLEGMVT 527 (949)
Q Consensus 508 ~~~--~L~~l~ls~N~l~~~~~ 527 (949)
..+ +|++|+|++|++++..+
T Consensus 244 ~~~~~~L~~L~L~~N~~~~~c~ 265 (306)
T 2z66_A 244 QHFPSSLAFLNLTQNDFACTCE 265 (306)
T ss_dssp CCCCTTCCEEECTTCCEECSGG
T ss_pred HhhhccCCEEEccCCCeecccC
Confidence 876 39999999999988654
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=6.9e-29 Score=286.20 Aligned_cols=228 Identities=23% Similarity=0.213 Sum_probs=141.8
Q ss_pred CCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEEC
Q 039533 89 SFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNL 168 (949)
Q Consensus 89 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~L 168 (949)
++|++|+|++|++++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|+...+..|..+++|++|+|
T Consensus 75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 154 (452)
T 3zyi_A 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL 154 (452)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence 46666777777776666666666777777777777666655666666666666666666666666666666666666666
Q ss_pred CCCCCCCCCCCCcCCCCCccEEeccc-cccCCCCCCcccCCCccccccccCcccccccccccCCCCChhhhccccccccc
Q 039533 169 GSNHLTGSIPSSLGNLSSIHTISLAY-NNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTIT 247 (949)
Q Consensus 169 s~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~ 247 (949)
++|.|+...+..|.++++|++|+|++ |.+....+..|.++++|++|+|++|+++.++
T Consensus 155 ~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~---------------------- 212 (452)
T 3zyi_A 155 RNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMP---------------------- 212 (452)
T ss_dssp CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSCC----------------------
T ss_pred CCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccccc----------------------
Confidence 66666644445566666666666665 3333333334555555555555555443221
Q ss_pred cCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeec
Q 039533 248 SNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWN 327 (949)
Q Consensus 248 ~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 327 (949)
.+..+ ++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus 213 ----------------------------------------~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 251 (452)
T 3zyi_A 213 ----------------------------------------NLTPL-VGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMN 251 (452)
T ss_dssp ----------------------------------------CCTTC-TTCCEEECTTSCCSEECGGGGTTCTTCCEEECTT
T ss_pred ----------------------------------------ccccc-ccccEEECcCCcCcccCcccccCccCCCEEEeCC
Confidence 11222 2466666666666666666666667777777777
Q ss_pred ceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeeccccccc
Q 039533 328 NQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLE 379 (949)
Q Consensus 328 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 379 (949)
|++++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus 252 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 252 SQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred CcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence 7777666667777777777777777777665666667777777777777665
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-31 Score=289.59 Aligned_cols=152 Identities=17% Similarity=0.181 Sum_probs=91.0
Q ss_pred CccCccCCCCcceeeeeEEeCCCCcEEEEEcCCCCCCccccCCCCCCCCCceeeccCcee-ccccCCccc-------Ccc
Q 039533 42 VLGTWNESIHFCKWYGVTCSRRHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSF-THEIPSEIG-------GLR 113 (949)
Q Consensus 42 ~l~sW~~~~~~C~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l-~~~~p~~~~-------~l~ 113 (949)
...+|.....|+.|..+.......+++.++++++.+ .+|..+... |+.|+|++|.+ .+.+|..+. +++
T Consensus 20 ~~~~~~~~~~c~~~~~~~~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~ 95 (312)
T 1wwl_A 20 PKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGIS 95 (312)
T ss_dssp SSCCGGGGGGSSSCSEEEEEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTS
T ss_pred cccchHHHhhhhccccEEEEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcC
Confidence 355787666777776654332233566677777777 555555444 77777777777 345666555 677
Q ss_pred cCcEEeeccccccCcCCCCC--CCCccceeecCCCccccccccccccCC-----CCCcEEECCCCCCCCCCCCCcCCCCC
Q 039533 114 RLKVLALNNNSICGEIPTNI--SRCSTLIPIHPQNNQLVGKILSRFSSL-----SKTEILNLGSNHLTGSIPSSLGNLSS 186 (949)
Q Consensus 114 ~L~~L~Ls~N~l~~~~p~~~--~~l~~L~~L~l~~n~l~~~~~~~~~~L-----~~L~~L~Ls~N~l~~~~p~~~~~l~~ 186 (949)
+|++|+|++|++++.+|..+ +.+++|++|++++|++++. |..|..+ ++|++|+|++|++++..|..|+++++
T Consensus 96 ~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~ 174 (312)
T 1wwl_A 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPA 174 (312)
T ss_dssp CCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSS
T ss_pred CccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCC
Confidence 77777777777777777665 5666665555555555554 4444444 55555555555555444455555555
Q ss_pred ccEEeccccccC
Q 039533 187 IHTISLAYNNLD 198 (949)
Q Consensus 187 L~~L~L~~N~l~ 198 (949)
|++|+|++|++.
T Consensus 175 L~~L~Ls~N~l~ 186 (312)
T 1wwl_A 175 LSTLDLSDNPEL 186 (312)
T ss_dssp CCEEECCSCTTC
T ss_pred CCEEECCCCCcC
Confidence 555555555544
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.4e-29 Score=271.60 Aligned_cols=282 Identities=22% Similarity=0.222 Sum_probs=159.0
Q ss_pred cEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCcccccccccccCCCCChhhhccccc
Q 039533 164 EILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQH 243 (949)
Q Consensus 164 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~ 243 (949)
+.++.+++.++ .+|..+. ++|++|+|++|+++...+..|+++++|++|+|++|.++.+.. .+
T Consensus 10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~-----~~---------- 71 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGC-----CS---------- 71 (306)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEE-----EE----------
T ss_pred CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccC-----cc----------
Confidence 46677777776 5555443 567777777777774444456777777777777776653310 00
Q ss_pred cccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCC-CCCCCCCcccE
Q 039533 244 FTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIP-AGIGNFVNLQR 322 (949)
Q Consensus 244 L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~ 322 (949)
..+..+++|++|++++|.+++ +|..+..+ ++|++|++++|++++..+ ..+..+++|++
T Consensus 72 -------------------~~~~~~~~L~~L~Ls~n~i~~-l~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 130 (306)
T 2z66_A 72 -------------------QSDFGTTSLKYLDLSFNGVIT-MSSNFLGL-EQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 130 (306)
T ss_dssp -------------------HHHHSCSCCCEEECCSCSEEE-EEEEEETC-TTCCEEECTTSEEESSTTTTTTTTCTTCCE
T ss_pred -------------------cccccccccCEEECCCCcccc-ChhhcCCC-CCCCEEECCCCcccccccchhhhhccCCCE
Confidence 011123344444444444442 23333333 346666666666664433 45666666666
Q ss_pred EEeecceecccCCCcccccCCCCEEecCCccccc-ccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCcc
Q 039533 323 LDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSG-NIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNN 401 (949)
Q Consensus 323 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 401 (949)
|++++|.+++..+..|.++++|++|+|++|++++ .+|..+..+++|++|++++|.+++..|..|..+++|++|+|++|+
T Consensus 131 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~ 210 (306)
T 2z66_A 131 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN 210 (306)
T ss_dssp EECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred EECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCc
Confidence 6666666666666666666666666666666665 456666666666666666666666556666666666666666666
Q ss_pred ccCCCCCcccCCcccceeeccCCCccCCCCcccccccc-ccceeeeccccccccCC--cccccccchhhcccCccccccc
Q 039533 402 LSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLK-ILEFLYVYENRLEGEIP--STFGNCIRLEQLGMGGNLFQGP 478 (949)
Q Consensus 402 l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~ 478 (949)
+++..+..+..+++| +.|++++|++++..|..+..++ +|++|+|++|++++..+ .....+...+.+.+..+.+...
T Consensus 211 l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~ 289 (306)
T 2z66_A 211 FFSLDTFPYKCLNSL-QVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECA 289 (306)
T ss_dssp CSBCCSGGGTTCTTC-CEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEE
T ss_pred cCccChhhccCcccC-CEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccC
Confidence 664444455555555 4566666666555555555553 56666666666654321 1122233444444444444444
Q ss_pred cCCCcCC
Q 039533 479 ISSSLGS 485 (949)
Q Consensus 479 ~~~~~~~ 485 (949)
.|..+.+
T Consensus 290 ~p~~~~g 296 (306)
T 2z66_A 290 TPSDKQG 296 (306)
T ss_dssp ESGGGTT
T ss_pred CchhhCC
Confidence 4444433
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.8e-29 Score=272.77 Aligned_cols=226 Identities=21% Similarity=0.226 Sum_probs=189.1
Q ss_pred ccccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeec
Q 039533 294 KTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFL 373 (949)
Q Consensus 294 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 373 (949)
..++.|+|++|+++ .+|..++.+++|++|+|++|.++ .+|..++++++|++|+|++|+++ .+|..++++++|++|+|
T Consensus 81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L 157 (328)
T 4fcg_A 81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSI 157 (328)
T ss_dssp TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEE
T ss_pred cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEEC
Confidence 35777888888887 66777777888888888888887 77777888888888888888887 67777888888888888
Q ss_pred ccccccccCCCCCCC---------CCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCcccccccccccee
Q 039533 374 NDNFLEVSIPSSLGQ---------CESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFL 444 (949)
Q Consensus 374 ~~N~l~~~~p~~~~~---------l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L 444 (949)
++|.+.+.+|..+.. +++|++|+|++|+++ .+|..+..+++| +.|++++|++++ +|..++.+++|++|
T Consensus 158 ~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L-~~L~L~~N~l~~-l~~~l~~l~~L~~L 234 (328)
T 4fcg_A 158 RACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNL-KSLKIRNSPLSA-LGPAIHHLPKLEEL 234 (328)
T ss_dssp EEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTC-CEEEEESSCCCC-CCGGGGGCTTCCEE
T ss_pred CCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCC-CEEEccCCCCCc-CchhhccCCCCCEE
Confidence 887777777777654 888999999999988 888888888888 789999999884 66678889999999
Q ss_pred eeccccccccCCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCcCcccccCCc-cceEeCCCCcCc
Q 039533 445 YVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLS-LNNLNLSYNDLE 523 (949)
Q Consensus 445 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~l~ls~N~l~ 523 (949)
+|++|++.+.+|..|+.+++|+.|+|++|++.+.+|..++.+++|+.|+|++|++.+.+|..+..++ ++.+++..|.+.
T Consensus 235 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp ECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred ECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 9999999889999999999999999999998889999999999999999999999999999888887 888888877766
Q ss_pred Cc
Q 039533 524 GM 525 (949)
Q Consensus 524 ~~ 525 (949)
..
T Consensus 315 ~l 316 (328)
T 4fcg_A 315 QL 316 (328)
T ss_dssp C-
T ss_pred HH
Confidence 54
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-28 Score=280.28 Aligned_cols=249 Identities=21% Similarity=0.193 Sum_probs=209.2
Q ss_pred ccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecC
Q 039533 271 LTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLN 350 (949)
Q Consensus 271 L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 350 (949)
...++.+++.++. +|.. +++++++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|.++++|++|+|+
T Consensus 56 ~~~v~c~~~~l~~-iP~~---~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~ 131 (452)
T 3zyi_A 56 FSKVVCTRRGLSE-VPQG---IPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF 131 (452)
T ss_dssp SCEEECCSSCCSS-CCSC---CCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CcEEEECCCCcCc-cCCC---CCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECC
Confidence 4567777777774 4443 34578899999999988888889999999999999999998888889999999999999
Q ss_pred CcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCC-cccCCcccceeeccCCCccCC
Q 039533 351 RNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPP-QFFSLSSLSISLDWSRNKLTG 429 (949)
Q Consensus 351 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~l~~~L~ls~N~l~~ 429 (949)
+|+|++..+..|.++++|++|+|++|.++...+..|.++++|++|++++|+..+.+|. .|..+++| +.|++++|++++
T Consensus 132 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L-~~L~L~~n~l~~ 210 (452)
T 3zyi_A 132 DNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNL-KYLNLGMCNIKD 210 (452)
T ss_dssp SSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTC-CEEECTTSCCSS
T ss_pred CCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCC-CEEECCCCcccc
Confidence 9999877777788899999999999999877777888999999999998544445554 57778888 789999999985
Q ss_pred CCccccccccccceeeeccccccccCCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCcCcccccC
Q 039533 430 SLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAG 509 (949)
Q Consensus 430 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 509 (949)
. | .+..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++.++..+..
T Consensus 211 ~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 288 (452)
T 3zyi_A 211 M-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTP 288 (452)
T ss_dssp C-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTT
T ss_pred c-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcc
Confidence 3 4 5788899999999999999888999999999999999999999888999999999999999999999877777777
Q ss_pred Cc-cceEeCCCCcCcCcc
Q 039533 510 LS-LNNLNLSYNDLEGMV 526 (949)
Q Consensus 510 ~~-L~~l~ls~N~l~~~~ 526 (949)
++ |+.|+|++|++....
T Consensus 289 l~~L~~L~L~~Np~~CdC 306 (452)
T 3zyi_A 289 LRYLVELHLHHNPWNCDC 306 (452)
T ss_dssp CTTCCEEECCSSCEECST
T ss_pred ccCCCEEEccCCCcCCCC
Confidence 76 999999999987654
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.8e-30 Score=278.95 Aligned_cols=267 Identities=19% Similarity=0.172 Sum_probs=168.9
Q ss_pred ceeecCCCccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccC
Q 039533 139 LIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAA 218 (949)
Q Consensus 139 L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 218 (949)
++.++++.+.+.......+..+++|++|+|++|.+++..|..|+++++|++|+|++|++++..+ |..+++|++|+|++
T Consensus 12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~ 89 (317)
T 3o53_A 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNN 89 (317)
T ss_dssp EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCS
T ss_pred eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcC
Confidence 3445666666666666667777778888888888887666778888888888888888875544 77777777777777
Q ss_pred cccccccccccCCCCChhhhccccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccE
Q 039533 219 NNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKT 298 (949)
Q Consensus 219 N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~ 298 (949)
|+|+.++. .++ |++
T Consensus 90 n~l~~l~~-----------------------------------------~~~-------------------------L~~ 103 (317)
T 3o53_A 90 NYVQELLV-----------------------------------------GPS-------------------------IET 103 (317)
T ss_dssp SEEEEEEE-----------------------------------------CTT-------------------------CCE
T ss_pred CccccccC-----------------------------------------CCC-------------------------cCE
Confidence 76653321 122 333
Q ss_pred EEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccc-cccccceeeccccc
Q 039533 299 LFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIG-NLKMLLNLFLNDNF 377 (949)
Q Consensus 299 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~ 377 (949)
|++++|+|++..+.. +++|++|++++|++++..+..++.+++|+.|+|++|++++..|..+. .+++|++|+|++|.
T Consensus 104 L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~ 180 (317)
T 3o53_A 104 LHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180 (317)
T ss_dssp EECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSC
T ss_pred EECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCc
Confidence 444444443322221 34455555555555554455555555555555555555554444442 45556666666665
Q ss_pred ccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeecccccc-ccCC
Q 039533 378 LEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLE-GEIP 456 (949)
Q Consensus 378 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p 456 (949)
+++. |. ...+++|++|+|++|+++ .+|..+..+++| +.|++++|+++ .+|..+..+++|+.|++++|++. +.+|
T Consensus 181 l~~~-~~-~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L-~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~ 255 (317)
T 3o53_A 181 IYDV-KG-QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGV-TWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLR 255 (317)
T ss_dssp CCEE-EC-CCCCTTCCEEECCSSCCC-EECGGGGGGTTC-SEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHH
T ss_pred Cccc-cc-ccccccCCEEECCCCcCC-cchhhhcccCcc-cEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHH
Confidence 5543 22 223566777777777766 344456666666 56777777776 45667777888888888888887 6777
Q ss_pred cccccccchhhcccC-ccccccccCC
Q 039533 457 STFGNCIRLEQLGMG-GNLFQGPISS 481 (949)
Q Consensus 457 ~~~~~l~~L~~L~l~-~N~l~~~~~~ 481 (949)
..++.+++|+.|+++ .+.++|..|.
T Consensus 256 ~~~~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 256 DFFSKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp HHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred HHHhccccceEEECCCchhccCCchh
Confidence 888888888888888 4556665544
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-28 Score=264.39 Aligned_cols=227 Identities=23% Similarity=0.193 Sum_probs=126.5
Q ss_pred cEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCC
Q 039533 272 TWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNR 351 (949)
Q Consensus 272 ~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 351 (949)
+.++.+++.++.. |.. ++++|++|+|++|+|++..+..|..+++|++|+|++|.+++..|..|.++++|++|+|++
T Consensus 14 ~~~~c~~~~l~~i-p~~---~~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 89 (285)
T 1ozn_A 14 VTTSCPQQGLQAV-PVG---IPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (285)
T ss_dssp CEEECCSSCCSSC-CTT---CCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred eEEEcCcCCcccC-CcC---CCCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence 4566666666543 322 234566666666666655555566666666666666666655566666666666666666
Q ss_pred cc-cccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCC
Q 039533 352 NK-LSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGS 430 (949)
Q Consensus 352 N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~ 430 (949)
|+ ++...|..|.++++|++|++++|.+++..|..|.++++|++|++++|++++..+
T Consensus 90 n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~----------------------- 146 (285)
T 1ozn_A 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPD----------------------- 146 (285)
T ss_dssp CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT-----------------------
T ss_pred CCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCH-----------------------
Confidence 65 554445556666666666666666665555556666666666666666553333
Q ss_pred CccccccccccceeeeccccccccCCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCcCcccccCC
Q 039533 431 LPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL 510 (949)
Q Consensus 431 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 510 (949)
..++.+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++.++..+..+
T Consensus 147 --~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 224 (285)
T 1ozn_A 147 --DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPL 224 (285)
T ss_dssp --TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTC
T ss_pred --hHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccC
Confidence 334444455555555555554333445555555555555555555555555555555555555555555444444444
Q ss_pred c-cceEeCCCCcCcCccc
Q 039533 511 S-LNNLNLSYNDLEGMVT 527 (949)
Q Consensus 511 ~-L~~l~ls~N~l~~~~~ 527 (949)
+ |+.|++++|++.+..+
T Consensus 225 ~~L~~L~l~~N~~~c~~~ 242 (285)
T 1ozn_A 225 RALQYLRLNDNPWVCDCR 242 (285)
T ss_dssp TTCCEEECCSSCEECSGG
T ss_pred cccCEEeccCCCccCCCC
Confidence 3 5555555555554433
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-28 Score=278.27 Aligned_cols=248 Identities=23% Similarity=0.240 Sum_probs=214.0
Q ss_pred ccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecC
Q 039533 271 LTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLN 350 (949)
Q Consensus 271 L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 350 (949)
...++.++++++. +|..+ +++++.|+|++|+|++..+..|.++++|++|+|++|.|++..+..|.++++|++|+|+
T Consensus 45 ~~~v~c~~~~l~~-iP~~~---~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~ 120 (440)
T 3zyj_A 45 FSKVICVRKNLRE-VPDGI---STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120 (440)
T ss_dssp SCEEECCSCCCSS-CCSCC---CTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred CCEEEeCCCCcCc-CCCCC---CCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence 4567777777774 45433 3578999999999998888899999999999999999998888899999999999999
Q ss_pred CcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCC-cccCCcccceeeccCCCccCC
Q 039533 351 RNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPP-QFFSLSSLSISLDWSRNKLTG 429 (949)
Q Consensus 351 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~l~~~L~ls~N~l~~ 429 (949)
+|+|++..+..|.++++|++|+|++|.++...+..|.++++|++|+|++|+..+.++. .|..+++| +.|++++|+++
T Consensus 121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L-~~L~L~~n~l~- 198 (440)
T 3zyj_A 121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNL-RYLNLAMCNLR- 198 (440)
T ss_dssp SSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSC-CEEECTTSCCS-
T ss_pred CCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhccccc-CeecCCCCcCc-
Confidence 9999977777899999999999999999988888899999999999998554445554 67788888 78999999998
Q ss_pred CCccccccccccceeeeccccccccCCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCcCcccccC
Q 039533 430 SLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAG 509 (949)
Q Consensus 430 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 509 (949)
.+| .+..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|+|++..+..+..
T Consensus 199 ~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 277 (440)
T 3zyj_A 199 EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTP 277 (440)
T ss_dssp SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSS
T ss_pred ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhcc
Confidence 455 4888999999999999999888999999999999999999999999999999999999999999999888888877
Q ss_pred Cc-cceEeCCCCcCcCc
Q 039533 510 LS-LNNLNLSYNDLEGM 525 (949)
Q Consensus 510 ~~-L~~l~ls~N~l~~~ 525 (949)
++ |+.|+|++|++..-
T Consensus 278 l~~L~~L~L~~Np~~Cd 294 (440)
T 3zyj_A 278 LHHLERIHLHHNPWNCN 294 (440)
T ss_dssp CTTCCEEECCSSCEECS
T ss_pred ccCCCEEEcCCCCccCC
Confidence 76 99999999998764
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.4e-28 Score=278.44 Aligned_cols=244 Identities=23% Similarity=0.210 Sum_probs=172.2
Q ss_pred EEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccc
Q 039533 70 LDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQL 149 (949)
Q Consensus 70 l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l 149 (949)
++..+.+++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|.|++..|..|.++++|++|+|++|+|
T Consensus 48 v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 124 (440)
T 3zyj_A 48 VICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124 (440)
T ss_dssp EECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCC
T ss_pred EEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcC
Confidence 334444555 5555554 6788888888888877778888888888888888888866667777777777777777777
Q ss_pred cccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEecccc-ccCCCCCCcccCCCccccccccCcccccccccc
Q 039533 150 VGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYN-NLDGTIPNSFGWFENLVFLSLAANNLSVVENKL 228 (949)
Q Consensus 150 ~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l 228 (949)
+...+..|..+++|++|+|++|.|+...+..|.++++|++|+|++| .++...+..|.++++|++|+|++|+++.++
T Consensus 125 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~--- 201 (440)
T 3zyj_A 125 TTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIP--- 201 (440)
T ss_dssp SSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSCC---
T ss_pred CeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcccc---
Confidence 7766667777777777777777777555566777777777777763 344333345666666666666666554322
Q ss_pred cCCCCChhhhccccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccC
Q 039533 229 TGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYG 308 (949)
Q Consensus 229 ~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~ 308 (949)
. +..+ ++|++|+|++|+|++
T Consensus 202 -----~------------------------------------------------------~~~l-~~L~~L~Ls~N~l~~ 221 (440)
T 3zyj_A 202 -----N------------------------------------------------------LTPL-IKLDELDLSGNHLSA 221 (440)
T ss_dssp -----C------------------------------------------------------CTTC-SSCCEEECTTSCCCE
T ss_pred -----c------------------------------------------------------cCCC-cccCEEECCCCccCc
Confidence 0 1122 246677777777776
Q ss_pred CCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeeccccccc
Q 039533 309 SIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLE 379 (949)
Q Consensus 309 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 379 (949)
..|..|..+++|++|+|++|+|++..+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus 222 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 222 IRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp ECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred cChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence 66777777778888888888888777777888888888888888888766677777888888888888775
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=265.14 Aligned_cols=252 Identities=20% Similarity=0.214 Sum_probs=195.1
Q ss_pred cccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCccc
Q 039533 242 QHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQ 321 (949)
Q Consensus 242 ~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 321 (949)
++++.+++.++..+.. -.++|++|++++|++++..+..+..+ ++|++|+|++|++++..|..|..+++|+
T Consensus 14 ~~~~c~~~~l~~ip~~---------~~~~l~~L~l~~n~i~~~~~~~~~~~-~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 83 (285)
T 1ozn_A 14 VTTSCPQQGLQAVPVG---------IPAASQRIFLHGNRISHVPAASFRAC-RNLTILWLHSNVLARIDAAAFTGLALLE 83 (285)
T ss_dssp CEEECCSSCCSSCCTT---------CCTTCSEEECTTSCCCEECTTTTTTC-TTCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred eEEEcCcCCcccCCcC---------CCCCceEEEeeCCcCCccCHHHcccC-CCCCEEECCCCccceeCHhhcCCccCCC
Confidence 5688888888765432 23689999999999999888888887 4699999999999988899999999999
Q ss_pred EEEeecce-ecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCc
Q 039533 322 RLDMWNNQ-LSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNN 400 (949)
Q Consensus 322 ~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 400 (949)
+|+|++|. +++..|..|..+++|++|+|++|++++..|..|.++++|++|++++|.+++..+..|..+++|++|+|++|
T Consensus 84 ~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 163 (285)
T 1ozn_A 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN 163 (285)
T ss_dssp EEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred EEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCC
Confidence 99999997 88777899999999999999999999888999999999999999999999888888999999999999999
Q ss_pred cccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccCCcccccccchhhcccCccccccccC
Q 039533 401 NLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPIS 480 (949)
Q Consensus 401 ~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~ 480 (949)
++++..+..+ ..+++|+.|+|++|++++..|..|+.+++|+.|++++|++++..+
T Consensus 164 ~l~~~~~~~~-------------------------~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 218 (285)
T 1ozn_A 164 RISSVPERAF-------------------------RGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPT 218 (285)
T ss_dssp CCCEECTTTT-------------------------TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCH
T ss_pred cccccCHHHh-------------------------cCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCH
Confidence 8874333334 444555566666666665556666666666666666666666555
Q ss_pred CCcCCCCCCCEEECCCCcCCCcCcccccCCccceEeCCCCcCcCcccc
Q 039533 481 SSLGSLRGLRVLDLSQNNLSGEIPKFLAGLSLNNLNLSYNDLEGMVTT 528 (949)
Q Consensus 481 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~ls~N~l~~~~~~ 528 (949)
..+..+++|+.|+|++|.++...+.......++.+..+.|.+.+..|.
T Consensus 219 ~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~~l~~~~~~~~~~~c~~p~ 266 (285)
T 1ozn_A 219 EALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQ 266 (285)
T ss_dssp HHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEESG
T ss_pred HHcccCcccCEEeccCCCccCCCCcHHHHHHHHhcccccCccccCCch
Confidence 567777777777777777765443221101145555666666666554
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.6e-30 Score=279.27 Aligned_cols=247 Identities=21% Similarity=0.225 Sum_probs=193.0
Q ss_pred ccCcccEEEccCCCCCccCCchhhcccccccEEEccCcccc-CCCCCCCC-------CCCcccEEEeecceecccCCCcc
Q 039533 267 NATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIY-GSIPAGIG-------NFVNLQRLDMWNNQLSGTIPPAI 338 (949)
Q Consensus 267 ~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~-~~~~~~~~-------~l~~L~~L~L~~N~l~~~~p~~~ 338 (949)
..++|+.+++++|.+ .+|..+... |++|+|++|+++ +.+|..+. .+++|++|+|++|++++.+|..+
T Consensus 41 ~~~~L~~l~l~~n~l--~~p~~~~~~---L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 115 (312)
T 1wwl_A 41 GGRSLEYLLKRVDTE--ADLGQFTDI---IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL 115 (312)
T ss_dssp EEEECTTHHHHCCTT--CCCHHHHHH---HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCS
T ss_pred cCCCceeEeeccccc--ccHHHHHHH---HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHH
Confidence 445566677777777 566655543 788888888883 45565554 67888889999998888888876
Q ss_pred --cccCCCCEEecCCcccccccCcccccc-----cccceeecccccccccCCCCCCCCCCCcEEEeeCccccCC--CCCc
Q 039533 339 --GELQNLKILGLNRNKLSGNIPPSIGNL-----KMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGT--IPPQ 409 (949)
Q Consensus 339 --~~l~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--~p~~ 409 (949)
..+++|++|+|++|++++. |..++.+ ++|++|+|++|++++..|..|+++++|++|+|++|++.+. +|..
T Consensus 116 ~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 194 (312)
T 1wwl_A 116 LEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194 (312)
T ss_dssp SSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHH
T ss_pred HHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHH
Confidence 7888899999999988876 7778877 8888999999988887878888888999999999887755 2333
Q ss_pred c--cCCcccceeeccCCCccCCC--Cc-cccccccccceeeeccccccccCC-cccccccchhhcccCccccccccCCCc
Q 039533 410 F--FSLSSLSISLDWSRNKLTGS--LP-IEVGKLKILEFLYVYENRLEGEIP-STFGNCIRLEQLGMGGNLFQGPISSSL 483 (949)
Q Consensus 410 ~--~~l~~l~~~L~ls~N~l~~~--~p-~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~~~ 483 (949)
+ ..+++| +.|++++|++++. ++ ..+..+++|++|+|++|++++..| ..+..+++|+.|+|++|+|+ .+|..+
T Consensus 195 ~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~ 272 (312)
T 1wwl_A 195 LCPLKFPTL-QVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL 272 (312)
T ss_dssp SCTTSCTTC-CEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSC
T ss_pred HHhccCCCC-CEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhc
Confidence 3 677777 7888888888831 22 344577899999999999998775 56677889999999999998 777777
Q ss_pred CCCCCCCEEECCCCcCCCcCcccccCCc-cceEeCCCCcCcCc
Q 039533 484 GSLRGLRVLDLSQNNLSGEIPKFLAGLS-LNNLNLSYNDLEGM 525 (949)
Q Consensus 484 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~l~ls~N~l~~~ 525 (949)
. ++|+.|||++|+|++. |. +..++ |++|++++|++++.
T Consensus 273 ~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 273 P--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp C--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTCC
T ss_pred c--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCCC
Confidence 6 8899999999999876 65 55555 99999999998863
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=282.80 Aligned_cols=265 Identities=25% Similarity=0.316 Sum_probs=156.9
Q ss_pred CCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECC
Q 039533 90 FLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLG 169 (949)
Q Consensus 90 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls 169 (949)
.++.|++++|+++ .+|..+. ++|++|+|++|.|+ .+|. .+ ++|++|+|+
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l------------------------~~L~~L~Ls 89 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LP------------------------PELRTLEVS 89 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CC------------------------TTCCEEEEC
T ss_pred CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cC------------------------CCCCEEEcC
Confidence 4777888888777 6676665 67777888777776 4554 23 445666666
Q ss_pred CCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCcccccccccccCCCCChhhhccccccccccC
Q 039533 170 SNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSN 249 (949)
Q Consensus 170 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N 249 (949)
+|+|+ .+|. .+++|++|+|++|+|++ +|. .+++|++|+|++|+|+.++..
T Consensus 90 ~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~lp~~---------------------- 139 (622)
T 3g06_A 90 GNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTSLPVL---------------------- 139 (622)
T ss_dssp SCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSCCCCC----------------------
T ss_pred CCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCcCCCC----------------------
Confidence 66665 3443 45566666666666663 333 345666666666655433210
Q ss_pred CCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeecce
Q 039533 250 SLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQ 329 (949)
Q Consensus 250 ~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 329 (949)
+++|++|++++|++++. |. .+.+|+.|++++|+|++ +| ..+++|+.|+|++|.
T Consensus 140 ------------------l~~L~~L~Ls~N~l~~l-~~----~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~ 192 (622)
T 3g06_A 140 ------------------PPGLQELSVSDNQLASL-PA----LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQ 192 (622)
T ss_dssp ------------------CTTCCEEECCSSCCSCC-CC----CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSC
T ss_pred ------------------CCCCCEEECcCCcCCCc-CC----ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCC
Confidence 12344444444444432 22 12457788888888874 45 445778888888888
Q ss_pred ecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCc
Q 039533 330 LSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQ 409 (949)
Q Consensus 330 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 409 (949)
|++ +|.. +++|+.|++++|+++ .+|.. +++|+.|+|++|.|++ +| ..+++|+.|+|++|+|+ .+|.
T Consensus 193 l~~-l~~~---~~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~- 258 (622)
T 3g06_A 193 LAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM- 258 (622)
T ss_dssp CSC-CCCC---CTTCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC-
T ss_pred CCC-CCCc---cchhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc-
Confidence 874 4443 367778888888877 34432 3567777777777764 44 33466677777777666 4454
Q ss_pred ccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccCCcccc
Q 039533 410 FFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFG 460 (949)
Q Consensus 410 ~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 460 (949)
.+++| +.|+|++|+|+ .+|..+.++++|+.|+|++|++++..|..+.
T Consensus 259 --~~~~L-~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~ 305 (622)
T 3g06_A 259 --LPSGL-LSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALR 305 (622)
T ss_dssp --CCTTC-CEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHH
T ss_pred --ccccC-cEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHH
Confidence 23344 45555555555 4455555555555555555555554444433
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-28 Score=270.47 Aligned_cols=269 Identities=18% Similarity=0.187 Sum_probs=191.3
Q ss_pred cEEEEEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCC
Q 039533 66 RVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQ 145 (949)
Q Consensus 66 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 145 (949)
+....+++.+.+...+...+..+++|++|+|++|++++..|..|+++++|++|+|++|.+++..| +..+++|++|+++
T Consensus 11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls 88 (317)
T 3o53_A 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN 88 (317)
T ss_dssp EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECC
T ss_pred ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECc
Confidence 45666777777765555556677888888888888887777788888888888888888886555 8888888888888
Q ss_pred CccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCccccccc
Q 039533 146 NNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVE 225 (949)
Q Consensus 146 ~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 225 (949)
+|++++.. ..++|++|++++|++++..+.. +++|++|+|++|++++..+..++.+++|++|+|++|.++.+.
T Consensus 89 ~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 160 (317)
T 3o53_A 89 NNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN 160 (317)
T ss_dssp SSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEE
T ss_pred CCcccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCccc
Confidence 88887554 3378888888888888655443 567888888888888777777888888888888888776443
Q ss_pred ccccCCCCChhhhccccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCcc
Q 039533 226 NKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNK 305 (949)
Q Consensus 226 ~~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~ 305 (949)
.. .+ ...+++|++|++++|++++..+.. .+ ++|++|+|++|+
T Consensus 161 ~~------~~-----------------------------~~~l~~L~~L~L~~N~l~~~~~~~--~l-~~L~~L~Ls~N~ 202 (317)
T 3o53_A 161 FA------EL-----------------------------AASSDTLEHLNLQYNFIYDVKGQV--VF-AKLKTLDLSSNK 202 (317)
T ss_dssp GG------GG-----------------------------GGGTTTCCEEECTTSCCCEEECCC--CC-TTCCEEECCSSC
T ss_pred HH------HH-----------------------------hhccCcCCEEECCCCcCccccccc--cc-ccCCEEECCCCc
Confidence 11 01 113345555556665555442111 12 457777777777
Q ss_pred ccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccc-cccCcccccccccceeeccc-ccccccCC
Q 039533 306 IYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLS-GNIPPSIGNLKMLLNLFLND-NFLEVSIP 383 (949)
Q Consensus 306 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~-N~l~~~~p 383 (949)
|++ +|..+..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+++ +.+|..+..+++|+.|++++ +.+++..|
T Consensus 203 l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~ 280 (317)
T 3o53_A 203 LAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE 280 (317)
T ss_dssp CCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSS
T ss_pred CCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCch
Confidence 774 3444777778888888888887 46677777788888888888877 66777777778888887773 34555444
Q ss_pred C
Q 039533 384 S 384 (949)
Q Consensus 384 ~ 384 (949)
.
T Consensus 281 ~ 281 (317)
T 3o53_A 281 E 281 (317)
T ss_dssp C
T ss_pred h
Confidence 4
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-30 Score=313.10 Aligned_cols=420 Identities=13% Similarity=0.037 Sum_probs=309.1
Q ss_pred CcEEEEEcCCCCC---CccccCCCC------------CCCCCceeeccCceeccccCCcccCc--ccCcEEeecccc-cc
Q 039533 65 QRVTLLDLRSLKL---AGSVSHFIG------------NLSFLKQLYLQVNSFTHEIPSEIGGL--RRLKVLALNNNS-IC 126 (949)
Q Consensus 65 ~~v~~l~l~~~~l---~g~~~~~l~------------~l~~L~~L~L~~n~l~~~~p~~~~~l--~~L~~L~Ls~N~-l~ 126 (949)
.++..|+|+++.. .|.+|..++ .+++|++|+|++|.+++..+..+..+ .+|++|+|++|. ++
T Consensus 73 ~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~ 152 (592)
T 3ogk_B 73 PNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFT 152 (592)
T ss_dssp TTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEE
T ss_pred CCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcC
Confidence 3588899977532 234444433 78999999999999998777777764 459999999987 32
Q ss_pred C-cCCCCCCCCccceeecCCCcccccc----ccccccCCCCCcEEECCCCCCCC----CCCCCcCCCCCccEEecccccc
Q 039533 127 G-EIPTNISRCSTLIPIHPQNNQLVGK----ILSRFSSLSKTEILNLGSNHLTG----SIPSSLGNLSSIHTISLAYNNL 197 (949)
Q Consensus 127 ~-~~p~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~L~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l 197 (949)
. .++..+.++++|++|+|++|.+++. ++..+..+++|++|+|++|.+++ .++..+.++++|++|+|++|.+
T Consensus 153 ~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~ 232 (592)
T 3ogk_B 153 TDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEI 232 (592)
T ss_dssp HHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBG
T ss_pred HHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccH
Confidence 1 1233345789999999999998766 45567789999999999999983 3344566889999999999999
Q ss_pred CCCCCCcccCCCccccccccCcccccccccccCCCCChhhhccccccccccCCCCCCCCCCcchhccccccCcccEEEcc
Q 039533 198 DGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHIN 277 (949)
Q Consensus 198 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~ 277 (949)
.+ +|..+..+++|++|+++.+....-. ......+..+++|+.|+++++... ..+..+..+++|++|+++
T Consensus 233 ~~-l~~~~~~~~~L~~L~l~~~~~~~~~---~~~~~~l~~~~~L~~L~l~~~~~~-------~l~~~~~~~~~L~~L~Ls 301 (592)
T 3ogk_B 233 LE-LVGFFKAAANLEEFCGGSLNEDIGM---PEKYMNLVFPRKLCRLGLSYMGPN-------EMPILFPFAAQIRKLDLL 301 (592)
T ss_dssp GG-GHHHHHHCTTCCEEEECBCCCCTTC---TTSSSCCCCCTTCCEEEETTCCTT-------TGGGGGGGGGGCCEEEET
T ss_pred HH-HHHHHhhhhHHHhhcccccccccch---HHHHHHhhccccccccCccccchh-------HHHHHHhhcCCCcEEecC
Confidence 85 7788999999999999864322110 112234666788888888875332 233456678899999999
Q ss_pred CCCCCccCCch-hhcccccccEEEccCccccCCCCCCCCCCCcccEEEee-----------cceecccC-CCcccccCCC
Q 039533 278 SNNFGGLLPGC-ISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMW-----------NNQLSGTI-PPAIGELQNL 344 (949)
Q Consensus 278 ~N~l~~~~p~~-~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~-----------~N~l~~~~-p~~~~~l~~L 344 (949)
+|.+++..... +..+ ++|++|+++++...+.++..+..+++|++|+|+ .|.+++.. +..+..+++|
T Consensus 302 ~~~l~~~~~~~~~~~~-~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L 380 (592)
T 3ogk_B 302 YALLETEDHCTLIQKC-PNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQEL 380 (592)
T ss_dssp TCCCCHHHHHHHHTTC-TTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTC
T ss_pred CCcCCHHHHHHHHHhC-cCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccC
Confidence 99987654433 3444 579999999433333344445678899999999 46776442 2334568999
Q ss_pred CEEecCCcccccccCccccc-ccccceeecc----ccccccc-----CCCCCCCCCCCcEEEeeCcc--ccCCCCCcccC
Q 039533 345 KILGLNRNKLSGNIPPSIGN-LKMLLNLFLN----DNFLEVS-----IPSSLGQCESLIEINLSNNN--LSGTIPPQFFS 412 (949)
Q Consensus 345 ~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~L~----~N~l~~~-----~p~~~~~l~~L~~L~l~~N~--l~~~~p~~~~~ 412 (949)
+.|+|+.|++++..+..++. +++|+.|+++ .|.+++. ++..+.++++|++|++++|. +++..+..+..
T Consensus 381 ~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~ 460 (592)
T 3ogk_B 381 EYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQ 460 (592)
T ss_dssp SEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHH
T ss_pred eEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHH
Confidence 99999999999887777776 8999999996 6777753 33346678999999998543 66554444444
Q ss_pred -CcccceeeccCCCccCC-CCccccccccccceeeecccccccc-CCcccccccchhhcccCccccccccCCCc-CCCCC
Q 039533 413 -LSSLSISLDWSRNKLTG-SLPIEVGKLKILEFLYVYENRLEGE-IPSTFGNCIRLEQLGMGGNLFQGPISSSL-GSLRG 488 (949)
Q Consensus 413 -l~~l~~~L~ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~~~~~-~~l~~ 488 (949)
+++| +.|++++|++++ .++..+..+++|+.|+|++|.+++. ++..+..+++|+.|+|++|++++.-...+ ..++.
T Consensus 461 ~~~~L-~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~ 539 (592)
T 3ogk_B 461 YSPNV-RWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPY 539 (592)
T ss_dssp SCTTC-CEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTT
T ss_pred hCccc-eEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCC
Confidence 6667 899999999986 4555668899999999999998755 44455679999999999999986543333 35677
Q ss_pred CCEEECCCC
Q 039533 489 LRVLDLSQN 497 (949)
Q Consensus 489 L~~L~Ls~N 497 (949)
+....+..+
T Consensus 540 l~~~~~~~~ 548 (592)
T 3ogk_B 540 WNIELIPSR 548 (592)
T ss_dssp EEEEEECCC
T ss_pred cEEEEecCc
Confidence 776666655
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=276.85 Aligned_cols=238 Identities=20% Similarity=0.189 Sum_probs=151.8
Q ss_pred CCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCcccccccccccCCCCChhhh
Q 039533 159 SLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKL 238 (949)
Q Consensus 159 ~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l 238 (949)
..++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..| |+.+++|++|+|++|.|+.++.
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~------------ 97 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV------------ 97 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE------------
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC------------
Confidence 34467777777777777666777777777777777777775554 6777777777777776553321
Q ss_pred ccccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCC
Q 039533 239 QRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFV 318 (949)
Q Consensus 239 ~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~ 318 (949)
.+ +|++|+|++|.|++..+. .++
T Consensus 98 -----------------------------~~-------------------------~L~~L~L~~N~l~~~~~~---~l~ 120 (487)
T 3oja_A 98 -----------------------------GP-------------------------SIETLHAANNNISRVSCS---RGQ 120 (487)
T ss_dssp -----------------------------CT-------------------------TCCEEECCSSCCCCEEEC---CCS
T ss_pred -----------------------------CC-------------------------CcCEEECcCCcCCCCCcc---ccC
Confidence 01 244444444444433332 234
Q ss_pred cccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccc-cccccceeecccccccccCCCCCCCCCCCcEEEe
Q 039533 319 NLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIG-NLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINL 397 (949)
Q Consensus 319 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 397 (949)
+|++|+|++|.|++..|..|+++++|+.|+|++|+|++.+|..+. ++++|+.|+|++|.+++..+ +..+++|+.|+|
T Consensus 121 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~L 198 (487)
T 3oja_A 121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDL 198 (487)
T ss_dssp SCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEEC
T ss_pred CCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEEC
Confidence 556666666666655555666666666666666666655555554 56666666666666654422 224667777777
Q ss_pred eCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeecccccc-ccCCcccccccchhhcccCc
Q 039533 398 SNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLE-GEIPSTFGNCIRLEQLGMGG 472 (949)
Q Consensus 398 ~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~l~~ 472 (949)
++|+|++ +|..+..+++| ..|+|++|.+++ +|..+..+++|+.|++++|.+. +.+|..++.++.|+.|+++.
T Consensus 199 s~N~l~~-~~~~~~~l~~L-~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~~ 271 (487)
T 3oja_A 199 SSNKLAF-MGPEFQSAAGV-TWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT 271 (487)
T ss_dssp CSSCCCE-ECGGGGGGTTC-SEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHHH
T ss_pred CCCCCCC-CCHhHcCCCCc-cEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEeccc
Confidence 7777764 44446666666 567777777763 5666777788888888888887 66777788888888888863
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.7e-28 Score=278.85 Aligned_cols=214 Identities=22% Similarity=0.171 Sum_probs=123.4
Q ss_pred cccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecc
Q 039533 295 TIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLN 374 (949)
Q Consensus 295 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 374 (949)
+|++|+|++|.|++..|..|+.+++|++|+|++|.+++..| |..+++|++|+|++|+|++..+ .++|+.|+++
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~ 107 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAA 107 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEECC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEECc
Confidence 45555555555555555555555666666666666654444 5555666666666666553221 2556666666
Q ss_pred cccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccc-cccccceeeeccccccc
Q 039533 375 DNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVG-KLKILEFLYVYENRLEG 453 (949)
Q Consensus 375 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~ 453 (949)
+|.+++..+.. +++|+.|+|++|++++..|..+..+++| +.|+|++|.+++.+|..+. .+++|+.|+|++|.|++
T Consensus 108 ~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~ 183 (487)
T 3oja_A 108 NNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRV-QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD 183 (487)
T ss_dssp SSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSE-EEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE
T ss_pred CCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCC-CEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccc
Confidence 66665544432 3456666666666665555556566665 5566666666665555554 56666666666666664
Q ss_pred cCCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCcCcccccCCc-cceEeCCCCcCc
Q 039533 454 EIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLS-LNNLNLSYNDLE 523 (949)
Q Consensus 454 ~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~l~ls~N~l~ 523 (949)
. |. +..+++|+.|+|++|.|++.+| .+..+++|+.|+|++|+|++ +|..+..++ |+.|++++|++.
T Consensus 184 ~-~~-~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~ 250 (487)
T 3oja_A 184 V-KG-QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFH 250 (487)
T ss_dssp E-EC-CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBC
T ss_pred c-cc-cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCc
Confidence 4 22 2346666666666666665333 36666666666666666664 444444443 666666666665
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.4e-26 Score=243.47 Aligned_cols=218 Identities=27% Similarity=0.329 Sum_probs=126.1
Q ss_pred CCcceeeeeEEeCCCCcEEEEEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcC
Q 039533 50 IHFCKWYGVTCSRRHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEI 129 (949)
Q Consensus 50 ~~~C~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 129 (949)
.++|.|.|+.|.-. ..++.+++++++++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|.++...
T Consensus 2 ~~~C~~~~~~C~c~-~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~ 77 (270)
T 2o6q_A 2 EALCKKDGGVCSCN-NNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLP 77 (270)
T ss_dssp CCCBGGGTCSBEEE-TTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCC
T ss_pred CccCCCCCCCCEeC-CCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeC
Confidence 47899999988643 23556888888887 3555444 56777777777777655566777777777777777776333
Q ss_pred CCCCCCCccceeecCCCccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCC
Q 039533 130 PTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFE 209 (949)
Q Consensus 130 p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 209 (949)
+..|.++++| ++|+|++|++++..+..|.++++|++|+|++|++++..+..|+.++
T Consensus 78 ~~~~~~l~~L------------------------~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 133 (270)
T 2o6q_A 78 AGIFKELKNL------------------------ETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLT 133 (270)
T ss_dssp TTTTSSCTTC------------------------CEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCT
T ss_pred hhhhcCCCCC------------------------CEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCc
Confidence 3334555555 5555555555544444455555555555555555544444444444
Q ss_pred ccccccccCcccccccccccCCCCChhhhccccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchh
Q 039533 210 NLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCI 289 (949)
Q Consensus 210 ~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~ 289 (949)
+|++|+|++|.|+.++. ..+
T Consensus 134 ~L~~L~Ls~n~l~~~~~------------------------------------------------------------~~~ 153 (270)
T 2o6q_A 134 KLTYLSLGYNELQSLPK------------------------------------------------------------GVF 153 (270)
T ss_dssp TCCEEECCSSCCCCCCT------------------------------------------------------------TTT
T ss_pred CCCEEECCCCcCCccCH------------------------------------------------------------hHc
Confidence 44444444444332211 011
Q ss_pred hcccccccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCccccc
Q 039533 290 SNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSG 356 (949)
Q Consensus 290 ~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 356 (949)
..+ ++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|.+..
T Consensus 154 ~~l-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 219 (270)
T 2o6q_A 154 DKL-TSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC 219 (270)
T ss_dssp TTC-TTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred cCC-cccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence 111 234445555555554444455666666666666666665555556666667777777776653
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-28 Score=285.99 Aligned_cols=187 Identities=19% Similarity=0.023 Sum_probs=128.6
Q ss_pred eeeeecCceEEEEEEcCCCEEEEEEEEecCCC----------cchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCCc
Q 039533 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH----------GASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 633 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 701 (949)
..+.|+.|.+..++....|+.+|+|++..... ...+++.+|+++|+++ .|+||+++++++.+..
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~----- 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQ----- 315 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSS-----
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECC-----
Confidence 34567777777666655678899999975421 1225699999999999 7999999999975444
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..|+||||++|++|.+++.. ...++.. +|+.||+.||+|+|++ |||||||||+|||++++|++|
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~----------~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vK 379 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAA----------GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHAR 379 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHT----------TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEE
T ss_pred EEEEEEecCCCCcHHHHHHh----------CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEE
Confidence 89999999999999999972 2345543 5899999999999988 999999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCC
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPI 843 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf 843 (949)
|+|||+|+......... ....||+.|||||++.+ .+..++|+||+|++++++.++..|+
T Consensus 380 L~DFGlAr~~~~~~~~~--~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 380 LIDFGSIVTTPQDCSWP--TNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ECCCTTEESCC---CCS--HHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred EeecccCeeCCCCCccc--cCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 99999998765543322 24569999999999876 4677899999999988876665543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.9e-26 Score=241.73 Aligned_cols=209 Identities=20% Similarity=0.172 Sum_probs=125.9
Q ss_pred ccccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeec
Q 039533 294 KTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFL 373 (949)
Q Consensus 294 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 373 (949)
++|++|+|++|+|++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|++
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 45677777777776655556666777777777777776655666666777777777777776666666666666666666
Q ss_pred ccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccc
Q 039533 374 NDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEG 453 (949)
Q Consensus 374 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 453 (949)
++|.+++..+..+..+++|++|++++|++++. .+|..++.+++|+.|+|++|++++
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~------------------------~l~~~~~~l~~L~~L~Ls~N~l~~ 163 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSF------------------------KLPEYFSNLTNLEHLDLSSNKIQS 163 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCC------------------------CCCGGGGGCTTCCEEECCSSCCCE
T ss_pred CCCCccccCchhcccCCCCCEEECcCCcccee------------------------cCchhhccCCCCCEEECCCCCCCc
Confidence 66666655555666666666666666666532 134444455555555555555554
Q ss_pred cCCcccccccchh----hcccCccccccccCCCcCCCCCCCEEECCCCcCCCcCcccccCCc-cceEeCCCCcCcCccc
Q 039533 454 EIPSTFGNCIRLE----QLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLS-LNNLNLSYNDLEGMVT 527 (949)
Q Consensus 454 ~~p~~~~~l~~L~----~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~l~ls~N~l~~~~~ 527 (949)
..+..|..+.+|+ .|++++|.+++..+..+.. .+|+.|+|++|+|++.++..+..++ |+.|++++|++++..+
T Consensus 164 ~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 164 IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp ECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred CCHHHhhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 4444555554444 4555666665444433333 3566666666666655555455444 6666666666666544
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=240.96 Aligned_cols=225 Identities=23% Similarity=0.252 Sum_probs=180.9
Q ss_pred EEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeeccccc
Q 039533 298 TLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNF 377 (949)
Q Consensus 298 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 377 (949)
.++..+..++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|.
T Consensus 11 ~~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 87 (276)
T 2z62_A 11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87 (276)
T ss_dssp EEECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred eEEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCc
Confidence 4566666665 4565543 478888888888887777788888888888888888887666677777777777777777
Q ss_pred ccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeecccccccc-CC
Q 039533 378 LEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGE-IP 456 (949)
Q Consensus 378 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p 456 (949)
+++..+..|.++++|++|++++|++++ ..+..++.+++|++|++++|++++. +|
T Consensus 88 l~~~~~~~~~~l~~L~~L~l~~n~l~~-------------------------~~~~~~~~l~~L~~L~l~~n~l~~~~l~ 142 (276)
T 2z62_A 88 IQSLALGAFSGLSSLQKLVAVETNLAS-------------------------LENFPIGHLKTLKELNVAHNLIQSFKLP 142 (276)
T ss_dssp CCEECTTTTTTCTTCCEEECTTSCCCC-------------------------STTCCCTTCTTCCEEECCSSCCCCCCCC
T ss_pred cCccChhhhcCCccccEEECCCCCccc-------------------------cCchhcccCCCCCEEECcCCccceecCc
Confidence 777766777777777777777776652 3334567788999999999999874 69
Q ss_pred cccccccchhhcccCccccccccCCCcCCCCCCC----EEECCCCcCCCcCcccccCCccceEeCCCCcCcCccccc-cc
Q 039533 457 STFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLR----VLDLSQNNLSGEIPKFLAGLSLNNLNLSYNDLEGMVTTE-GV 531 (949)
Q Consensus 457 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~----~L~Ls~N~l~~~~p~~~~~~~L~~l~ls~N~l~~~~~~~-~~ 531 (949)
..|+++++|+.|+|++|++++..+..|..+++|+ .|++++|++++..+..+...+|+.|++++|.+++.++.. ..
T Consensus 143 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~ 222 (276)
T 2z62_A 143 EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDR 222 (276)
T ss_dssp GGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSCCSCCCTTTTTT
T ss_pred hhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCCCcccEEECCCCceeecCHhHhcc
Confidence 9999999999999999999998888888888887 999999999988888888778999999999999987653 55
Q ss_pred ccccccccccCCCCCCCCC
Q 039533 532 FKNASATRILGNSKLCGGI 550 (949)
Q Consensus 532 ~~~~~~~~~~gn~~~c~~~ 550 (949)
+.++..+.+.+|++.|.-+
T Consensus 223 l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 223 LTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp CCSCCEEECCSSCBCCCTT
T ss_pred cccccEEEccCCcccccCC
Confidence 7778889999999998643
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.4e-29 Score=300.00 Aligned_cols=430 Identities=13% Similarity=0.103 Sum_probs=245.1
Q ss_pred CcceeeeeEEeCCCCcEEEEEcCCCCCCccccCCCCCCCCCceeeccCceeccc---cCC------------cccCcccC
Q 039533 51 HFCKWYGVTCSRRHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHE---IPS------------EIGGLRRL 115 (949)
Q Consensus 51 ~~C~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~---~p~------------~~~~l~~L 115 (949)
=|++|.++... ....+++.+..-. .....+..+++|++|+|+++..... .|. .+..+++|
T Consensus 33 vck~W~~~~~~----~~~~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L 107 (594)
T 2p1m_B 33 VCKSWYEIERW----CRRKVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWL 107 (594)
T ss_dssp SCHHHHHHHHH----HCCEEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTC
T ss_pred HHHHHHHhhhh----hceEEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCC
Confidence 35678888211 2344566543321 1123456678899999998753321 221 13467899
Q ss_pred cEEeeccccccCcCCCCCC-CCccceeecCCCc-ccccc-ccccccCCCCCcEEECCCCCCCCCCCCCcC----CCCCcc
Q 039533 116 KVLALNNNSICGEIPTNIS-RCSTLIPIHPQNN-QLVGK-ILSRFSSLSKTEILNLGSNHLTGSIPSSLG----NLSSIH 188 (949)
Q Consensus 116 ~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~l~~n-~l~~~-~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~----~l~~L~ 188 (949)
++|+|++|.+++..+..+. .+++|++|++++| .+... ++..+..+++|++|+|++|.+++..+..+. .+++|+
T Consensus 108 ~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~ 187 (594)
T 2p1m_B 108 EEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLV 187 (594)
T ss_dssp CEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCC
T ss_pred CeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCc
Confidence 9999999998877776665 6889999999988 55543 445556899999999999998865544443 667899
Q ss_pred EEeccccc--cCC-CCCCcccCCCccccccccCc-ccccccccccCCCC-ChhhhccccccccccCCCCCCCCCCcchhc
Q 039533 189 TISLAYNN--LDG-TIPNSFGWFENLVFLSLAAN-NLSVVENKLTGEVP-SLEKLQRLQHFTITSNSLGSGGNDDLSFLC 263 (949)
Q Consensus 189 ~L~L~~N~--l~~-~~p~~~~~l~~L~~L~Ls~N-~l~~~~~~l~~~~~-~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~ 263 (949)
+|+|++|. ++. .++..+..+++|++|+|++| .++. ++ .+..+++|++|+++.+.........-....
T Consensus 188 ~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~--------l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~ 259 (594)
T 2p1m_B 188 SLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK--------LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSV 259 (594)
T ss_dssp EEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH--------HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHH
T ss_pred EEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH--------HHHHHhcCCcceEcccccccCccchhhHHHHHH
Confidence 99999987 221 11122345689999999987 2221 22 255677888888765542111111111223
Q ss_pred cccccCcccEE-EccCCCCCccCCchhhcccccccEEEccCccccCCCC-CCCCCCCcccEEEeecceeccc-CCCcccc
Q 039533 264 SLTNATRLTWM-HINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIP-AGIGNFVNLQRLDMWNNQLSGT-IPPAIGE 340 (949)
Q Consensus 264 ~l~~~~~L~~L-~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~ 340 (949)
.+.++++|+.+ .+.... .+.++..+..+ ++|++|+|++|.+++... ..+..+++|++|++++| ++.. ++.....
T Consensus 260 ~l~~~~~L~~Ls~~~~~~-~~~l~~~~~~~-~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~ 336 (594)
T 2p1m_B 260 ALSGCKELRCLSGFWDAV-PAYLPAVYSVC-SRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLAST 336 (594)
T ss_dssp HHHTCTTCCEEECCBTCC-GGGGGGGHHHH-TTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHH
T ss_pred HHhcCCCcccccCCcccc-hhhHHHHHHhh-CCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHh
Confidence 45677778777 333322 22334433344 468888888888764322 22457788888888888 4422 2223335
Q ss_pred cCCCCEEec---------CCcccccccCcccc-cccccceeecccccccccCCCCCC-CCCCCcEEEee--C----cccc
Q 039533 341 LQNLKILGL---------NRNKLSGNIPPSIG-NLKMLLNLFLNDNFLEVSIPSSLG-QCESLIEINLS--N----NNLS 403 (949)
Q Consensus 341 l~~L~~L~L---------s~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~l~--~----N~l~ 403 (949)
+++|+.|+| +.|.+++.....+. ++++|+.|.++.|.+++..+..+. .+++|+.|+++ + |+++
T Consensus 337 ~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~ 416 (594)
T 2p1m_B 337 CKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLT 416 (594)
T ss_dssp CTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTT
T ss_pred CCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCccccc
Confidence 788888888 34556543333333 477888888877877765544444 47788888888 3 4444
Q ss_pred CCCCC------cccCCcccceeeccCCCccCCCCcccccc-ccccceeeeccccccccCCccc-ccccchhhcccCcccc
Q 039533 404 GTIPP------QFFSLSSLSISLDWSRNKLTGSLPIEVGK-LKILEFLYVYENRLEGEIPSTF-GNCIRLEQLGMGGNLF 475 (949)
Q Consensus 404 ~~~p~------~~~~l~~l~~~L~ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~l~~N~l 475 (949)
..|. .+..+++| +.|++++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|.+
T Consensus 417 -~~~~~~~~~~l~~~~~~L-~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~ 493 (594)
T 2p1m_B 417 -LEPLDIGFGAIVEHCKDL-RRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF 493 (594)
T ss_dssp -CCCTHHHHHHHHHHCTTC-CEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSC
T ss_pred -CCchhhHHHHHHhhCCCc-cEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCC
Confidence 1111 12233444 4455544 333333333333 4445555555555443333222 3344444444444444
Q ss_pred ccccCC-CcCCCCCCCEEECCCCcC
Q 039533 476 QGPISS-SLGSLRGLRVLDLSQNNL 499 (949)
Q Consensus 476 ~~~~~~-~~~~l~~L~~L~Ls~N~l 499 (949)
++.... .+..+++|+.|++++|++
T Consensus 494 ~~~~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 494 GDKALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp CHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred cHHHHHHHHHhCCCCCEEeeeCCCC
Confidence 322221 122244444444444444
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-24 Score=229.72 Aligned_cols=202 Identities=28% Similarity=0.331 Sum_probs=105.6
Q ss_pred ccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeeccc
Q 039533 296 IKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLND 375 (949)
Q Consensus 296 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 375 (949)
.+++++++|+++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|+++...+..|.++++|++|+|++
T Consensus 18 ~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~ 94 (270)
T 2o6q_A 18 KNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTD 94 (270)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCS
T ss_pred CCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCC
Confidence 344555555554 2343332 3455555555555544444555555555555555555543334445555555555555
Q ss_pred ccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccC
Q 039533 376 NFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEI 455 (949)
Q Consensus 376 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 455 (949)
|.+++..+..|..+++|++|++++|++++..|..|..+++| +.|++++|++++..+..+..+++|+.|+|++|++++..
T Consensus 95 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 173 (270)
T 2o6q_A 95 NKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKL-TYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVP 173 (270)
T ss_dssp SCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTC-CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCC-CEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeC
Confidence 55554444455555555555555555554333334444444 34444444444333334555555666666666665444
Q ss_pred CcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCC
Q 039533 456 PSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSG 501 (949)
Q Consensus 456 p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 501 (949)
+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|.+..
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 219 (270)
T 2o6q_A 174 EGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC 219 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred hhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence 4455555555555555555555444455555666666666665543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-24 Score=232.35 Aligned_cols=207 Identities=24% Similarity=0.263 Sum_probs=104.9
Q ss_pred ccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCE
Q 039533 267 NATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKI 346 (949)
Q Consensus 267 ~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 346 (949)
.+++|+.|++++|.++.. ..+..+ ++|++|+|++|++++. ..+..+++|++|+|++|.+++..+..|.++++|++
T Consensus 39 ~l~~L~~L~l~~~~i~~~--~~l~~l-~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 113 (272)
T 3rfs_A 39 ELNSIDQIIANNSDIKSV--QGIQYL-PNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKE 113 (272)
T ss_dssp HHTTCCEEECTTSCCCCC--TTGGGC-TTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred cccceeeeeeCCCCcccc--cccccC-CCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCE
Confidence 344455555555554422 123333 2355555555555532 24555555555555555555554555555555555
Q ss_pred EecCCcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCc
Q 039533 347 LGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNK 426 (949)
Q Consensus 347 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~ 426 (949)
|+|++|++++..+..|.++++|++|++++|.+++..+..|..+++|++|++++|++++..+..+..+++| +.|++++|+
T Consensus 114 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~L~~N~ 192 (272)
T 3rfs_A 114 LVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQL-KDLRLYQNQ 192 (272)
T ss_dssp EECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC-CEEECCSSC
T ss_pred EECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccC-CEEECCCCc
Confidence 5555555555444445555555555555555555444455555555555555555554444444444444 445555555
Q ss_pred cCCCCccccccccccceeeeccccccccCCcccccccchhhcccCccccccccCCCcCCC
Q 039533 427 LTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSL 486 (949)
Q Consensus 427 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l 486 (949)
+++..|..+..+++|+.|+|++|.+.+. +++|+.|+++.|.++|.+|.+++.+
T Consensus 193 l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~ 245 (272)
T 3rfs_A 193 LKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSV 245 (272)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCB
T ss_pred CCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCccccc
Confidence 5544444445555555555555554432 2234445555555555554444433
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.3e-24 Score=230.85 Aligned_cols=200 Identities=24% Similarity=0.207 Sum_probs=112.0
Q ss_pred cccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecc
Q 039533 295 TIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLN 374 (949)
Q Consensus 295 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 374 (949)
+++++++++|+++ .+|..+. +++++|+|++|.|++..|..|.++++|+.|+|++|+|++..+. +.+
T Consensus 11 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l--------- 76 (290)
T 1p9a_G 11 SHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTL--------- 76 (290)
T ss_dssp TCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCC---------
T ss_pred CccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCC---------
Confidence 3555555555555 3343332 3555555555555555555555555555555555555533221 344
Q ss_pred cccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeecccccccc
Q 039533 375 DNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGE 454 (949)
Q Consensus 375 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 454 (949)
++|++|++++|+++ .+|..+..+++| +.|++++|++++..|..|..+++|++|+|++|+|++.
T Consensus 77 ---------------~~L~~L~Ls~N~l~-~l~~~~~~l~~L-~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~ 139 (290)
T 1p9a_G 77 ---------------PVLGTLDLSHNQLQ-SLPLLGQTLPAL-TVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTL 139 (290)
T ss_dssp ---------------TTCCEEECCSSCCS-SCCCCTTTCTTC-CEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCC
T ss_pred ---------------CcCCEEECCCCcCC-cCchhhccCCCC-CEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCcc
Confidence 44555555555554 444444444544 4455555555544455566666666666666666655
Q ss_pred CCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCcCcccccCCccceEeCCCCcCcCc
Q 039533 455 IPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLSLNNLNLSYNDLEGM 525 (949)
Q Consensus 455 ~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~ls~N~l~~~ 525 (949)
.+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+...+..+....|+.++|++|++...
T Consensus 140 ~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 140 PPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp CTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred ChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCc
Confidence 55556666666666666666665555556667777777777777763333333333377777777776553
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-24 Score=230.31 Aligned_cols=213 Identities=18% Similarity=0.227 Sum_probs=170.3
Q ss_pred hhhhccccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCC
Q 039533 235 LEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGI 314 (949)
Q Consensus 235 l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~ 314 (949)
+..+++|+.|++++|.++.. ..+..+++|++|++++|++++. ..+..+ ++|++|+|++|++++..+..|
T Consensus 37 ~~~l~~L~~L~l~~~~i~~~--------~~l~~l~~L~~L~l~~n~l~~~--~~l~~l-~~L~~L~L~~n~l~~~~~~~~ 105 (272)
T 3rfs_A 37 QNELNSIDQIIANNSDIKSV--------QGIQYLPNVRYLALGGNKLHDI--SALKEL-TNLTYLILTGNQLQSLPNGVF 105 (272)
T ss_dssp HHHHTTCCEEECTTSCCCCC--------TTGGGCTTCCEEECTTSCCCCC--GGGTTC-TTCCEEECTTSCCCCCCTTTT
T ss_pred cccccceeeeeeCCCCcccc--------cccccCCCCcEEECCCCCCCCc--hhhcCC-CCCCEEECCCCccCccChhHh
Confidence 45666666666666666542 2355677788888888887763 355665 468888888888887777778
Q ss_pred CCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecccccccccCCCCCCCCCCCcE
Q 039533 315 GNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIE 394 (949)
Q Consensus 315 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 394 (949)
..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..+.++++|+.|++++|++++..+..|..+++|++
T Consensus 106 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 185 (272)
T 3rfs_A 106 DKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKD 185 (272)
T ss_dssp TTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred cCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCE
Confidence 88889999999999998777777888889999999999988777777888899999999999988877777888899999
Q ss_pred EEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccCCcccccccchh
Q 039533 395 INLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLE 466 (949)
Q Consensus 395 L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 466 (949)
|++++|++++..|..+..+++| +.|++++|.+.+. +++|++|+++.|.++|.+|.+++.+....
T Consensus 186 L~L~~N~l~~~~~~~~~~l~~L-~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~~~~~ 249 (272)
T 3rfs_A 186 LRLYQNQLKSVPDGVFDRLTSL-QYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSVAPDS 249 (272)
T ss_dssp EECCSSCCSCCCTTTTTTCTTC-CEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCBCGGG
T ss_pred EECCCCcCCccCHHHHhCCcCC-CEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcccccCCCC
Confidence 9999999987777777888888 7899999988754 44688999999999999999988776543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.91 E-value=9.6e-29 Score=296.13 Aligned_cols=423 Identities=12% Similarity=0.115 Sum_probs=288.3
Q ss_pred CcEEEEEcCCCCCCccc---c------------CCCCCCCCCceeeccCceeccccCCccc-CcccCcEEeeccc-cccC
Q 039533 65 QRVTLLDLRSLKLAGSV---S------------HFIGNLSFLKQLYLQVNSFTHEIPSEIG-GLRRLKVLALNNN-SICG 127 (949)
Q Consensus 65 ~~v~~l~l~~~~l~g~~---~------------~~l~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~Ls~N-~l~~ 127 (949)
.++..|+|+++.....+ + .....+++|++|+|++|.+++..+..+. .+++|++|+|++| .++.
T Consensus 66 ~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~ 145 (594)
T 2p1m_B 66 PKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFST 145 (594)
T ss_dssp TTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEH
T ss_pred CCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCH
Confidence 35778888876532211 1 1124678999999999999887777776 6899999999999 5653
Q ss_pred c-CCCCCCCCccceeecCCCcccccccccccc----CCCCCcEEECCCCC--CCCC-CCCCcCCCCCccEEecccc-ccC
Q 039533 128 E-IPTNISRCSTLIPIHPQNNQLVGKILSRFS----SLSKTEILNLGSNH--LTGS-IPSSLGNLSSIHTISLAYN-NLD 198 (949)
Q Consensus 128 ~-~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~----~L~~L~~L~Ls~N~--l~~~-~p~~~~~l~~L~~L~L~~N-~l~ 198 (949)
. ++..+.++++|++|++++|.+++..+..+. .+++|+.|+|++|. ++.. ++..+.++++|++|+|++| .++
T Consensus 146 ~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~ 225 (594)
T 2p1m_B 146 DGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLE 225 (594)
T ss_dssp HHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHH
T ss_pred HHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHH
Confidence 3 455556899999999999998876554443 66799999999997 2211 1112245689999999998 455
Q ss_pred CCCCCcccCCCccccccccCcccccccccccCCCCChhhhcccccc-ccccCCCCCCCCCCcchhccccccCcccEEEcc
Q 039533 199 GTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHF-TITSNSLGSGGNDDLSFLCSLTNATRLTWMHIN 277 (949)
Q Consensus 199 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L-~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~ 277 (949)
+ +|..+..+++|++|+++.+....-.+.+.+..+.+.++++|+.+ .+.+... -.+...+..+++|+.|+++
T Consensus 226 ~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~-------~~l~~~~~~~~~L~~L~L~ 297 (594)
T 2p1m_B 226 K-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVP-------AYLPAVYSVCSRLTTLNLS 297 (594)
T ss_dssp H-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCG-------GGGGGGHHHHTTCCEEECT
T ss_pred H-HHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccch-------hhHHHHHHhhCCCCEEEcc
Confidence 4 77888889999999977654322223333333346667777776 3332211 1122223467889999999
Q ss_pred CCCCCccCCch-hhcccccccEEEccCccccCC-CCCCCCCCCcccEEEeec---------ceecccCCCccc-ccCCCC
Q 039533 278 SNNFGGLLPGC-ISNLSKTIKTLFLNNNKIYGS-IPAGIGNFVNLQRLDMWN---------NQLSGTIPPAIG-ELQNLK 345 (949)
Q Consensus 278 ~N~l~~~~p~~-~~~l~~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~---------N~l~~~~p~~~~-~l~~L~ 345 (949)
+|.+++..... +..+ ++|++|++++| +... ++.....+++|++|+|++ |.+++.....+. ++++|+
T Consensus 298 ~~~l~~~~l~~~~~~~-~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~ 375 (594)
T 2p1m_B 298 YATVQSYDLVKLLCQC-PKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLE 375 (594)
T ss_dssp TCCCCHHHHHHHHTTC-TTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCC
T ss_pred CCCCCHHHHHHHHhcC-CCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHH
Confidence 99877543333 3344 57999999988 4422 222233578899999843 556543333333 478999
Q ss_pred EEecCCcccccccCcccc-cccccceeecc--c----cccccc-----CCCCCCCCCCCcEEEeeCccccCCCCCcccC-
Q 039533 346 ILGLNRNKLSGNIPPSIG-NLKMLLNLFLN--D----NFLEVS-----IPSSLGQCESLIEINLSNNNLSGTIPPQFFS- 412 (949)
Q Consensus 346 ~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~--~----N~l~~~-----~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~- 412 (949)
.|+++.|++++..+..+. ++++|+.|+++ + |.++.. ++..+..+++|+.|+|++ .+++..+..+..
T Consensus 376 ~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~ 454 (594)
T 2p1m_B 376 SVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTY 454 (594)
T ss_dssp EEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHH
T ss_pred HHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHh
Confidence 999999999876666665 58899999998 4 555521 112256778999999977 666554445554
Q ss_pred CcccceeeccCCCccCCCCcccc-ccccccceeeeccccccccCCc-ccccccchhhcccCccccccccCCCc-CCCCCC
Q 039533 413 LSSLSISLDWSRNKLTGSLPIEV-GKLKILEFLYVYENRLEGEIPS-TFGNCIRLEQLGMGGNLFQGPISSSL-GSLRGL 489 (949)
Q Consensus 413 l~~l~~~L~ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~~~~~-~~l~~L 489 (949)
+++| +.|++++|.+++..+..+ ..+++|+.|+|++|.+++..+. .+..+++|+.|++++|.++......+ ..+++|
T Consensus 455 ~~~L-~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l 533 (594)
T 2p1m_B 455 AKKM-EMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKL 533 (594)
T ss_dssp CTTC-CEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTE
T ss_pred chhc-cEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCC
Confidence 6677 789999999987655555 6789999999999999655444 44568999999999999864433334 456777
Q ss_pred CEEECCCCcC
Q 039533 490 RVLDLSQNNL 499 (949)
Q Consensus 490 ~~L~Ls~N~l 499 (949)
+...+..+.-
T Consensus 534 ~i~~~~~~~~ 543 (594)
T 2p1m_B 534 NVEVIDERGA 543 (594)
T ss_dssp EEEEECSSSC
T ss_pred EEEEecCCCc
Confidence 7666665543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2e-24 Score=227.90 Aligned_cols=191 Identities=25% Similarity=0.305 Sum_probs=164.3
Q ss_pred CcceeeeeEEeCCCCcEEEEEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCC
Q 039533 51 HFCKWYGVTCSRRHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIP 130 (949)
Q Consensus 51 ~~C~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 130 (949)
+||.|.|++|... .+.+|+++++++ .+|..+. ++|+.|+|++|++++..|..|+++++|++|+|++|.|++..|
T Consensus 3 ~Cp~~~gC~C~~~---~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 76 (251)
T 3m19_A 3 TCETVTGCTCNEG---KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSA 76 (251)
T ss_dssp -CHHHHSSEEEGG---GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCT
T ss_pred cCCCCCceEcCCC---CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCH
Confidence 6899999999753 346899999998 5666665 689999999999999888899999999999999999998888
Q ss_pred CCCCCCccceeecCCCccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCc
Q 039533 131 TNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFEN 210 (949)
Q Consensus 131 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 210 (949)
..|.++++|++|++++|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|+.+++
T Consensus 77 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 156 (251)
T 3m19_A 77 GVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTN 156 (251)
T ss_dssp TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred hHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcC
Confidence 88999999999999999999999999999999999999999999777777899999999999999999887878999999
Q ss_pred cccccccCcccccccccccCCCCChhhhccccccccccCCCCC
Q 039533 211 LVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGS 253 (949)
Q Consensus 211 L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N~l~~ 253 (949)
|++|+|++|+|+.++.. .+..+++|++|++++|.+..
T Consensus 157 L~~L~L~~N~l~~~~~~------~~~~l~~L~~L~l~~N~~~c 193 (251)
T 3m19_A 157 LQTLSLSTNQLQSVPHG------AFDRLGKLQTITLFGNQFDC 193 (251)
T ss_dssp CCEEECCSSCCSCCCTT------TTTTCTTCCEEECCSCCBCT
T ss_pred CCEEECCCCcCCccCHH------HHhCCCCCCEEEeeCCceeC
Confidence 99999999988755421 24455566666666666543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=8.9e-24 Score=227.48 Aligned_cols=206 Identities=22% Similarity=0.183 Sum_probs=159.5
Q ss_pred ccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccC
Q 039533 263 CSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQ 342 (949)
Q Consensus 263 ~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 342 (949)
|.+.++++++.+++++|+++.. |..+ +++++.|+|++|+|++..+..|..+++|++|+|++|.|++..+. +.++
T Consensus 4 C~~~~l~~l~~l~~~~~~l~~i-p~~~---~~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~ 77 (290)
T 1p9a_G 4 CEVSKVASHLEVNCDKRNLTAL-PPDL---PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLP 77 (290)
T ss_dssp SEEECSTTCCEEECTTSCCSSC-CSCC---CTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCT
T ss_pred ccccccCCccEEECCCCCCCcC-CCCC---CCCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCC
Confidence 4567778888999999988854 4433 35799999999999988888999999999999999999965443 7899
Q ss_pred CCCEEecCCcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeecc
Q 039533 343 NLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDW 422 (949)
Q Consensus 343 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~l 422 (949)
+|++|+|++|+|+ .+|..+.++++|++|+|++|++++..|..|.++++|++|+|++|++++..+
T Consensus 78 ~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~--------------- 141 (290)
T 1p9a_G 78 VLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPP--------------- 141 (290)
T ss_dssp TCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCT---------------
T ss_pred cCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccCh---------------
Confidence 9999999999998 677788888888888888888887777778888888888888877774333
Q ss_pred CCCccCCCCccccccccccceeeeccccccccCCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCC
Q 039533 423 SRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSG 501 (949)
Q Consensus 423 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 501 (949)
..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+.+|+.|+|++|.+..
T Consensus 142 ----------~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 142 ----------GLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp ----------TTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred ----------hhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 33444555666666666666444455666777777777777777 566777777788888888888864
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=9e-25 Score=255.08 Aligned_cols=186 Identities=17% Similarity=0.130 Sum_probs=143.4
Q ss_pred CCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc--------chHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 629 SSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG--------ASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 629 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
...++||+|+||.||+|.. .++.+++|+....... ..+++.+|++++++++||||+++..++...+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~---- 412 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD---- 412 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT----
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC----
Confidence 4567999999999999954 4788999987543221 1245899999999999999995554544332
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
..++||||+++++|.+++.. +..++.|+++||+|||++ +|+||||||+|||++. .+
T Consensus 413 -~~~lVmE~~~ggsL~~~l~~------------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~ 468 (540)
T 3en9_A 413 -NKRIMMSYINGKLAKDVIED------------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DL 468 (540)
T ss_dssp -TTEEEEECCCSEEHHHHSTT------------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SE
T ss_pred -ccEEEEECCCCCCHHHHHHH------------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eE
Confidence 56999999999999999971 457999999999999987 8999999999999999 99
Q ss_pred EEeecccceecCCCCCcc-----ccccccCccCccCccccCC--CccCCccchHHHHHHHHHHHhCCCCCc
Q 039533 781 RVGDFGLARILSPDHTQT-----SSFSVKGSLGYIAPEYGVG--CEVSTNGDVYSYGILLLELVIGKKPID 844 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlGvvl~elltg~~Pf~ 844 (949)
||+|||+|+......... ......||+.|||||++.. ..|+..+|+||..+-..+-+.++.+|.
T Consensus 469 kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 469 YIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp EECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred EEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 999999999876543211 1124569999999999887 568888999999999998888877763
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=4.6e-26 Score=254.39 Aligned_cols=123 Identities=13% Similarity=0.103 Sum_probs=61.7
Q ss_pred cccEEEeecceecccCCCccc----cc-CCCCEEecCCcccccc----cCccccc-ccccceeecccccccccCC----C
Q 039533 319 NLQRLDMWNNQLSGTIPPAIG----EL-QNLKILGLNRNKLSGN----IPPSIGN-LKMLLNLFLNDNFLEVSIP----S 384 (949)
Q Consensus 319 ~L~~L~L~~N~l~~~~p~~~~----~l-~~L~~L~Ls~N~l~~~----~p~~~~~-l~~L~~L~L~~N~l~~~~p----~ 384 (949)
+|++|+|++|+|++..+..+. .+ ++|+.|+|++|+|++. ++..+.. .++|++|+|++|.+++..+ .
T Consensus 168 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~ 247 (362)
T 3goz_A 168 NVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKL 247 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHH
T ss_pred cccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHH
Confidence 444555555554433332222 22 3555555555555531 2333333 2355555555555554322 3
Q ss_pred CCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccCCccc
Q 039533 385 SLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTF 459 (949)
Q Consensus 385 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 459 (949)
.+..+++|++|+|++|.+.+..+..+. .++..+..+++|+.||+++|++....+..+
T Consensus 248 ~~~~l~~L~~L~L~~n~l~~i~~~~~~------------------~l~~~~~~l~~L~~LdL~~N~l~~~~~~~~ 304 (362)
T 3goz_A 248 LKDSLKHLQTVYLDYDIVKNMSKEQCK------------------ALGAAFPNIQKIILVDKNGKEIHPSHSIPI 304 (362)
T ss_dssp TTTTTTTCSEEEEEHHHHTTCCHHHHH------------------HHHTTSTTCCEEEEECTTSCBCCGGGCHHH
T ss_pred HHhcCCCccEEEeccCCccccCHHHHH------------------HHHHHhccCCceEEEecCCCcCCCcchHHH
Confidence 445667777888887776532221110 223345556667777777777665544433
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-25 Score=250.51 Aligned_cols=261 Identities=18% Similarity=0.178 Sum_probs=156.6
Q ss_pred EEcCCCCCCccccCCCCCCCCCceeeccCceeccccC----CcccCcc-cCcEEeeccccccCcCCCCCCCC-----ccc
Q 039533 70 LDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIP----SEIGGLR-RLKVLALNNNSICGEIPTNISRC-----STL 139 (949)
Q Consensus 70 l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~L 139 (949)
.+|+.++++|.++..+...++|++|+|++|.+++..+ ..|.+++ +|++|+|++|.+++..+..+..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 4566777777776666666667777777777765544 5566666 67777777777766555555543 666
Q ss_pred eeecCCCccccccccccccC----C-CCCcEEECCCCCCCCCCCCCc----CC-CCCccEEeccccccCCCCCCc----c
Q 039533 140 IPIHPQNNQLVGKILSRFSS----L-SKTEILNLGSNHLTGSIPSSL----GN-LSSIHTISLAYNNLDGTIPNS----F 205 (949)
Q Consensus 140 ~~L~l~~n~l~~~~~~~~~~----L-~~L~~L~Ls~N~l~~~~p~~~----~~-l~~L~~L~L~~N~l~~~~p~~----~ 205 (949)
++|++++|.+++..+..+.. + ++|++|+|++|.|++..+..+ .. .++|++|+|++|++++..+.. +
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l 162 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQIL 162 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHH
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHH
Confidence 66666666666555543332 2 566666666666664443332 22 245666666666665433222 2
Q ss_pred cCCC-ccccccccCcccccccccccCCCCChhhhccccccccccCCCCCCCCCCcchhcccccc-CcccEEEccCCCCCc
Q 039533 206 GWFE-NLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNA-TRLTWMHINSNNFGG 283 (949)
Q Consensus 206 ~~l~-~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~-~~L~~L~L~~N~l~~ 283 (949)
..++ +|++|+|++|+|+... .. .+...+... ++|++|+|++|++++
T Consensus 163 ~~~~~~L~~L~Ls~n~l~~~~------------------------------~~--~l~~~l~~~~~~L~~L~Ls~N~i~~ 210 (362)
T 3goz_A 163 AAIPANVNSLNLRGNNLASKN------------------------------CA--ELAKFLASIPASVTSLDLSANLLGL 210 (362)
T ss_dssp HTSCTTCCEEECTTSCGGGSC------------------------------HH--HHHHHHHTSCTTCCEEECTTSCGGG
T ss_pred hcCCccccEeeecCCCCchhh------------------------------HH--HHHHHHHhCCCCCCEEECCCCCCCh
Confidence 3333 5555555555543221 11 011122333 467777777777775
Q ss_pred c----CCchhhcccccccEEEccCccccCCCC----CCCCCCCcccEEEeecceeccc-------CCCcccccCCCCEEe
Q 039533 284 L----LPGCISNLSKTIKTLFLNNNKIYGSIP----AGIGNFVNLQRLDMWNNQLSGT-------IPPAIGELQNLKILG 348 (949)
Q Consensus 284 ~----~p~~~~~l~~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~-------~p~~~~~l~~L~~L~ 348 (949)
. ++..+...+++|++|+|++|+|++..+ ..+..+++|++|+|++|.+.+. ++..+..+++|+.||
T Consensus 211 ~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~Ld 290 (362)
T 3goz_A 211 KSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVD 290 (362)
T ss_dssp SCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEEC
T ss_pred hHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEe
Confidence 3 344455545578888888888876443 3456678888888888884432 344677788888888
Q ss_pred cCCcccccccCccc
Q 039533 349 LNRNKLSGNIPPSI 362 (949)
Q Consensus 349 Ls~N~l~~~~p~~~ 362 (949)
|++|++.+..+..+
T Consensus 291 L~~N~l~~~~~~~~ 304 (362)
T 3goz_A 291 KNGKEIHPSHSIPI 304 (362)
T ss_dssp TTSCBCCGGGCHHH
T ss_pred cCCCcCCCcchHHH
Confidence 88888876655444
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.3e-23 Score=219.75 Aligned_cols=180 Identities=21% Similarity=0.231 Sum_probs=125.2
Q ss_pred cccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecc
Q 039533 295 TIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLN 374 (949)
Q Consensus 295 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 374 (949)
..++++++++.++ .+|..+. ++|+.|+|++|++++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 4667777777777 4555444 467777777777776666677777777777777777776666666666666666666
Q ss_pred cccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeecccccccc
Q 039533 375 DNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGE 454 (949)
Q Consensus 375 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 454 (949)
+|++++..+..|..+++|++|+|++|+|+ +..+..+..+++|++|+|++|+|++.
T Consensus 92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-------------------------~~~~~~~~~l~~L~~L~Ls~N~l~~~ 146 (251)
T 3m19_A 92 NNQLASLPLGVFDHLTQLDKLYLGGNQLK-------------------------SLPSGVFDRLTKLKELRLNTNQLQSI 146 (251)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCC-------------------------CCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred CCcccccChhHhcccCCCCEEEcCCCcCC-------------------------CcChhHhccCCcccEEECcCCcCCcc
Confidence 66666555566666666666666666655 23333455566677777777777765
Q ss_pred CCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCc
Q 039533 455 IPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGE 502 (949)
Q Consensus 455 ~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 502 (949)
.+..|+.+++|+.|+|++|+|++..+..|..+++|+.|+|++|++++.
T Consensus 147 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 147 PAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 555677777777777777777777777788888888888888888765
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.4e-23 Score=216.73 Aligned_cols=197 Identities=18% Similarity=0.166 Sum_probs=112.5
Q ss_pred ccccEEEccCccccCCCCCCCCCCCcccEEEeecce-ecccCCCcccccCCCCEEecCC-cccccccCccccccccccee
Q 039533 294 KTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQ-LSGTIPPAIGELQNLKILGLNR-NKLSGNIPPSIGNLKMLLNL 371 (949)
Q Consensus 294 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L 371 (949)
.+|++|++++|+|++..+..|..+++|++|+|++|. +++..+..|.++++|++|+|++ |++++..+..|.++++|++|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 356666666666665555566666666666666665 6555555666666666666666 66665555556666666666
Q ss_pred ecccccccccCCCCCCCCCCCc---EEEeeCc-cccCCCCCcccCCcccceeeccCCCccCCCCccccccccccc-eeee
Q 039533 372 FLNDNFLEVSIPSSLGQCESLI---EINLSNN-NLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILE-FLYV 446 (949)
Q Consensus 372 ~L~~N~l~~~~p~~~~~l~~L~---~L~l~~N-~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~-~L~L 446 (949)
++++|.+++ +|. |..+++|+ +|++++| +++ +..+..|..+++|+ .|++
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~-------------------------~i~~~~~~~l~~L~~~L~l 163 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMT-------------------------SIPVNAFQGLCNETLTLKL 163 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCC-------------------------EECTTTTTTTBSSEEEEEC
T ss_pred eCCCCCCcc-ccc-cccccccccccEEECCCCcchh-------------------------hcCcccccchhcceeEEEc
Confidence 666666654 444 55555555 5555555 444 33344455555556 6666
Q ss_pred ccccccccCCcccccccchhhcccCccc-cccccCCCcCCC-CCCCEEECCCCcCCCcCcccccCCccceEeCCCC
Q 039533 447 YENRLEGEIPSTFGNCIRLEQLGMGGNL-FQGPISSSLGSL-RGLRVLDLSQNNLSGEIPKFLAGLSLNNLNLSYN 520 (949)
Q Consensus 447 s~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~ls~N 520 (949)
++|+++ .+|......++|+.|+|++|+ +++..+..|..+ ++|+.|+|++|+|++..+..+ ..|+.|+++++
T Consensus 164 ~~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~~~--~~L~~L~l~~~ 236 (239)
T 2xwt_C 164 YNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGL--EHLKELIARNT 236 (239)
T ss_dssp CSCCCC-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCTTC--TTCSEEECTTC
T ss_pred CCCCCc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChhHh--ccCceeeccCc
Confidence 666665 333322222566666666663 665555566666 666666666666664333311 13666666654
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-25 Score=248.35 Aligned_cols=164 Identities=16% Similarity=0.220 Sum_probs=102.3
Q ss_pred CCcceeeeeEEeCCCCcEEEEEcCCCCCCccccCCCCCC--CCCceeeccCceeccccCCcccCcccCcEEeeccccccC
Q 039533 50 IHFCKWYGVTCSRRHQRVTLLDLRSLKLAGSVSHFIGNL--SFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICG 127 (949)
Q Consensus 50 ~~~C~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 127 (949)
.-|.+|.++.|+.. .++.+|++++.+. +..+..+ ++++.|++++|.+.+..+. +.++++|++|+|++|.+++
T Consensus 34 ~vc~~W~~~~~~~~--~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~ 107 (336)
T 2ast_B 34 GVCKRWYRLASDES--LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEV 107 (336)
T ss_dssp SSCHHHHHHHTCST--TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECH
T ss_pred HHHHHHHHHhcCch--hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCH
Confidence 34668999988643 4677888887766 2345555 6777778887777766554 4567777777777777765
Q ss_pred c-CCCCCCCCccceeecCCCccccccccccccCCCCCcEEECCCC-CCCCC-CCCCcCCCCCccEEecccc-ccCCC-CC
Q 039533 128 E-IPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSN-HLTGS-IPSSLGNLSSIHTISLAYN-NLDGT-IP 202 (949)
Q Consensus 128 ~-~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~-~p 202 (949)
. +|..+.++++|++|++++|.+++..+..|+.+++|++|+|++| .+++. ++..+.++++|++|+|++| ++++. ++
T Consensus 108 ~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~ 187 (336)
T 2ast_B 108 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQ 187 (336)
T ss_dssp HHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHH
T ss_pred HHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHH
Confidence 4 6666666666666666666666666666666666666666666 45532 3444555556666666666 55432 33
Q ss_pred CcccCCC-ccccccccCc
Q 039533 203 NSFGWFE-NLVFLSLAAN 219 (949)
Q Consensus 203 ~~~~~l~-~L~~L~Ls~N 219 (949)
..+..++ +|++|+|++|
T Consensus 188 ~~~~~l~~~L~~L~l~~~ 205 (336)
T 2ast_B 188 VAVAHVSETITQLNLSGY 205 (336)
T ss_dssp HHHHHSCTTCCEEECCSC
T ss_pred HHHHhcccCCCEEEeCCC
Confidence 3344444 4444444444
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.2e-23 Score=215.34 Aligned_cols=208 Identities=17% Similarity=0.162 Sum_probs=167.9
Q ss_pred ccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcc-cccccCcccccccccceeeccc-ccccccCC
Q 039533 306 IYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNK-LSGNIPPSIGNLKMLLNLFLND-NFLEVSIP 383 (949)
Q Consensus 306 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p 383 (949)
++ .+|. +. ++|++|+|++|++++..+..|.++++|++|+|++|+ +++..+..|.++++|++|++++ |.+++..+
T Consensus 23 l~-~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~ 98 (239)
T 2xwt_C 23 IQ-RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDP 98 (239)
T ss_dssp CS-SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECT
T ss_pred cc-ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCH
Confidence 44 4565 43 489999999999998777789999999999999997 8877777899999999999998 99987777
Q ss_pred CCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccc-cccccCCcccccc
Q 039533 384 SSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYEN-RLEGEIPSTFGNC 462 (949)
Q Consensus 384 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l 462 (949)
..|.++++|++|++++|++++ +|. +..+.++ +.|++|++++| ++++..+..|.++
T Consensus 99 ~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L----------------------~~L~~L~l~~N~~l~~i~~~~~~~l 154 (239)
T 2xwt_C 99 DALKELPLLKFLGIFNTGLKM-FPD-LTKVYST----------------------DIFFILEITDNPYMTSIPVNAFQGL 154 (239)
T ss_dssp TSEECCTTCCEEEEEEECCCS-CCC-CTTCCBC----------------------CSEEEEEEESCTTCCEECTTTTTTT
T ss_pred HHhCCCCCCCEEeCCCCCCcc-ccc-ccccccc----------------------ccccEEECCCCcchhhcCcccccch
Confidence 888899999999999998874 553 3332222 22459999999 9998777889999
Q ss_pred cchh-hcccCccccccccCCCcCCCCCCCEEECCCCc-CCCcCcccccCC-c-cceEeCCCCcCcCcccccccccccccc
Q 039533 463 IRLE-QLGMGGNLFQGPISSSLGSLRGLRVLDLSQNN-LSGEIPKFLAGL-S-LNNLNLSYNDLEGMVTTEGVFKNASAT 538 (949)
Q Consensus 463 ~~L~-~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~~-~-L~~l~ls~N~l~~~~~~~~~~~~~~~~ 538 (949)
++|+ .|++++|+++...+..|.. ++|+.|+|++|+ +++..+..+..+ + |+.|++++|++++.++. .|..+..+
T Consensus 155 ~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~--~~~~L~~L 231 (239)
T 2xwt_C 155 CNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK--GLEHLKEL 231 (239)
T ss_dssp BSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT--TCTTCSEE
T ss_pred hcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh--HhccCcee
Confidence 9999 9999999999444444555 899999999995 997778888887 5 99999999999987554 57777777
Q ss_pred cccCCC
Q 039533 539 RILGNS 544 (949)
Q Consensus 539 ~~~gn~ 544 (949)
.+.++.
T Consensus 232 ~l~~~~ 237 (239)
T 2xwt_C 232 IARNTW 237 (239)
T ss_dssp ECTTC-
T ss_pred eccCcc
Confidence 666553
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=8.5e-24 Score=230.63 Aligned_cols=199 Identities=20% Similarity=0.179 Sum_probs=112.0
Q ss_pred cccEEEeecceecccCCCcc--cccCCCCEEecCCcccccccC----cccccccccceeecccccccccCCCCCCCCCCC
Q 039533 319 NLQRLDMWNNQLSGTIPPAI--GELQNLKILGLNRNKLSGNIP----PSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESL 392 (949)
Q Consensus 319 ~L~~L~L~~N~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 392 (949)
+|++|+|++|.+++..|..+ ..+++|++|+|++|++++..+ ..+..+++|++|+|++|.+++..|..|..+++|
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 171 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL 171 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence 34444444444444444444 444444444444444443322 222344555555555555554445555555555
Q ss_pred cEEEeeCccccCC--C--CCcccCCcccceeeccCCCccCCCCcc----ccccccccceeeeccccccccCCcccccc--
Q 039533 393 IEINLSNNNLSGT--I--PPQFFSLSSLSISLDWSRNKLTGSLPI----EVGKLKILEFLYVYENRLEGEIPSTFGNC-- 462 (949)
Q Consensus 393 ~~L~l~~N~l~~~--~--p~~~~~l~~l~~~L~ls~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-- 462 (949)
++|+|++|++.+. + +..+..+++| ++|+|++|+++ .++. .++.+++|++|+|++|++++..|..+..+
T Consensus 172 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L-~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ 249 (310)
T 4glp_A 172 TSLDLSDNPGLGERGLMAALCPHKFPAI-QNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMW 249 (310)
T ss_dssp CEEECCSCTTCHHHHHHTTSCTTSSCCC-CSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCC
T ss_pred CEEECCCCCCccchhhhHHHhhhcCCCC-CEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccC
Confidence 5555555554421 1 1122344555 45666666665 2222 24566777777777777777667666666
Q ss_pred -cchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCcCcccccCCc-cceEeCCCCcCcC
Q 039533 463 -IRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLS-LNNLNLSYNDLEG 524 (949)
Q Consensus 463 -~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~l~ls~N~l~~ 524 (949)
++|+.|+|++|+|+ .+|..+. ++|+.|||++|+|++. |. +..++ |+.|+|++|+++.
T Consensus 250 ~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 250 SSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred cCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 57777777777777 5566654 6778888888888753 32 23333 7788888887764
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.6e-23 Score=226.80 Aligned_cols=201 Identities=19% Similarity=0.159 Sum_probs=173.7
Q ss_pred ccccEEEccCccccCCCCCCC--CCCCcccEEEeecceecccCC----CcccccCCCCEEecCCcccccccCcccccccc
Q 039533 294 KTIKTLFLNNNKIYGSIPAGI--GNFVNLQRLDMWNNQLSGTIP----PAIGELQNLKILGLNRNKLSGNIPPSIGNLKM 367 (949)
Q Consensus 294 ~~L~~L~L~~N~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 367 (949)
++|++|++++|++++..|..+ ..+++|++|+|++|.+++..+ ..+..+++|++|+|++|++++..|..|+++++
T Consensus 91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~ 170 (310)
T 4glp_A 91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA 170 (310)
T ss_dssp SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence 359999999999999999988 899999999999999997655 34557899999999999999888899999999
Q ss_pred cceeeccccccccc--C--CCCCCCCCCCcEEEeeCccccCCCCCc----ccCCcccceeeccCCCccCCCCccccccc-
Q 039533 368 LLNLFLNDNFLEVS--I--PSSLGQCESLIEINLSNNNLSGTIPPQ----FFSLSSLSISLDWSRNKLTGSLPIEVGKL- 438 (949)
Q Consensus 368 L~~L~L~~N~l~~~--~--p~~~~~l~~L~~L~l~~N~l~~~~p~~----~~~l~~l~~~L~ls~N~l~~~~p~~~~~l- 438 (949)
|++|+|++|++.+. + +..+..+++|++|+|++|+++ .+|.. +..+++| +.|+|++|++++..|..+..+
T Consensus 171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L-~~L~Ls~N~l~~~~p~~~~~~~ 248 (310)
T 4glp_A 171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQP-HSLDLSHNSLRATVNPSAPRCM 248 (310)
T ss_dssp CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCC-SSEECTTSCCCCCCCSCCSSCC
T ss_pred CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCC-CEEECCCCCCCccchhhHHhcc
Confidence 99999999998652 2 344578999999999999997 44442 4567888 789999999998888888777
Q ss_pred --cccceeeeccccccccCCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCC
Q 039533 439 --KILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSG 501 (949)
Q Consensus 439 --~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 501 (949)
++|++|+|++|+|+ .+|..+. ++|+.|+|++|+|++. |. +..+++|+.|+|++|+|+.
T Consensus 249 ~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 249 WSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred CcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 69999999999999 7788775 7999999999999965 43 7889999999999999974
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.8e-23 Score=243.71 Aligned_cols=136 Identities=21% Similarity=0.266 Sum_probs=87.4
Q ss_pred CccCccCCCCcc-----eeeee-EEeCCCCcEEEEEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccC
Q 039533 42 VLGTWNESIHFC-----KWYGV-TCSRRHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRL 115 (949)
Q Consensus 42 ~l~sW~~~~~~C-----~w~gv-~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L 115 (949)
.+.+|..+.++| .|.|+ .|.. .+++.|+|+++++++ +|..++ ++|++|+|++|+|+ .+| +.+++|
T Consensus 32 ~l~~W~~~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L 102 (571)
T 3cvr_A 32 AWDKWEKQALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASL 102 (571)
T ss_dssp HHHHHHTTCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTC
T ss_pred HHHHHhccCCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCC
Confidence 356787777778 79999 7864 368889999998887 776663 78888888888888 677 457888
Q ss_pred cEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEecccc
Q 039533 116 KVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYN 195 (949)
Q Consensus 116 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 195 (949)
++|+|++|+|++ +|. +.+ +|++|++++|+|++... .+++|++|+|++|.|++ +|. .+++|++|+|++|
T Consensus 103 ~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~lp~----~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N 170 (571)
T 3cvr_A 103 EYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTMLPE----LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNN 170 (571)
T ss_dssp CEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSS
T ss_pred CEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCCCCC----cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCC
Confidence 888888888885 676 544 55555555555544222 34444444444444443 332 2344444444444
Q ss_pred ccC
Q 039533 196 NLD 198 (949)
Q Consensus 196 ~l~ 198 (949)
+|+
T Consensus 171 ~L~ 173 (571)
T 3cvr_A 171 QLT 173 (571)
T ss_dssp CCS
T ss_pred CCC
Confidence 444
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-22 Score=225.81 Aligned_cols=222 Identities=21% Similarity=0.216 Sum_probs=124.8
Q ss_pred ceeecCCCccccccccccccCCCCCcEEECCCCCCCCCCC-CCcCCCCCccE-EeccccccCCCCCCcccCCCccccccc
Q 039533 139 LIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIP-SSLGNLSSIHT-ISLAYNNLDGTIPNSFGWFENLVFLSL 216 (949)
Q Consensus 139 L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~-L~L~~N~l~~~~p~~~~~l~~L~~L~L 216 (949)
+++|+|++|+|+.+.+.+|.+|++|++|+|++|++.+.+| ..|.++++|++ +.+++|+|++..|..|..+++|++|++
T Consensus 32 l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l 111 (350)
T 4ay9_X 32 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLI 111 (350)
T ss_dssp CSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEE
T ss_pred CCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccc
Confidence 3444444444443334444444555555555555443333 23445544433 334445555444555555555555555
Q ss_pred cCcccccccccccCCCCChhhhccccccccccCCCCCCCCCCcchhccccccCcccEEEccC-CCCCccCCchhhccccc
Q 039533 217 AANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINS-NNFGGLLPGCISNLSKT 295 (949)
Q Consensus 217 s~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~-N~l~~~~p~~~~~l~~~ 295 (949)
++|+|+.++.. .+....++..+++.+ |++....+..+..+...
T Consensus 112 ~~n~l~~~~~~------------------------------------~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~ 155 (350)
T 4ay9_X 112 SNTGIKHLPDV------------------------------------HKIHSLQKVLLDIQDNINIHTIERNSFVGLSFE 155 (350)
T ss_dssp EEECCSSCCCC------------------------------------TTCCBSSCEEEEEESCTTCCEECTTSSTTSBSS
T ss_pred cccccccCCch------------------------------------hhcccchhhhhhhccccccccccccchhhcchh
Confidence 55554432211 011112233444433 33444444455555556
Q ss_pred ccEEEccCccccCCCCCCCCCCCcccEEEeec-ceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecc
Q 039533 296 IKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWN-NQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLN 374 (949)
Q Consensus 296 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 374 (949)
++.|+|++|+|+. +|......++|++|++++ |.++...++.|.++++|+.|||++|+|+...+..|.++++|+.+++.
T Consensus 156 l~~L~L~~N~i~~-i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~~ 234 (350)
T 4ay9_X 156 SVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 234 (350)
T ss_dssp CEEEECCSSCCCE-ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTCT
T ss_pred hhhhccccccccC-CChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccCC
Confidence 7888888888884 455555567888888874 66765445678888899999999999885555556666666555442
Q ss_pred cccccccCCCCCCCCCCCcEEEeeCcc
Q 039533 375 DNFLEVSIPSSLGQCESLIEINLSNNN 401 (949)
Q Consensus 375 ~N~l~~~~p~~~~~l~~L~~L~l~~N~ 401 (949)
.++ .+| .+..+++|+.++++++.
T Consensus 235 --~l~-~lP-~l~~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 235 --NLK-KLP-TLEKLVALMEASLTYPS 257 (350)
T ss_dssp --TCC-CCC-CTTTCCSCCEEECSCHH
T ss_pred --CcC-cCC-CchhCcChhhCcCCCCc
Confidence 233 556 37778888888887654
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=7.1e-25 Score=247.23 Aligned_cols=255 Identities=22% Similarity=0.269 Sum_probs=125.7
Q ss_pred ccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECCCC---CCCCCCCCC
Q 039533 104 EIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSN---HLTGSIPSS 180 (949)
Q Consensus 104 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N---~l~~~~p~~ 180 (949)
.++..+..+++|++|+|++|.+++..+.. +...|..+++|++|+|++| ++++.+|..
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~--------------------l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~ 82 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARW--------------------LSENIASKKDLEIAEFSDIFTGRVKDEIPEA 82 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHH--------------------HHHTTTTCTTCCEEECCSCCTTSCGGGSHHH
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHH--------------------HHHHHHhCCCccEEeCcccccCccccchhHH
Confidence 45566667777777777777776542221 1122334444455555553 223333333
Q ss_pred c-------CCCCCccEEeccccccCC----CCCCcccCCCccccccccCcccccccccccCCCCC-hhhhcccccccccc
Q 039533 181 L-------GNLSSIHTISLAYNNLDG----TIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPS-LEKLQRLQHFTITS 248 (949)
Q Consensus 181 ~-------~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~-l~~l~~L~~L~l~~ 248 (949)
+ ..+++|++|+|++|++++ .+|..+..+++|++|+|++|.++...... ++. +..+ . .
T Consensus 83 ~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~---l~~~l~~l---~-----~ 151 (386)
T 2ca6_A 83 LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAK---IARALQEL---A-----V 151 (386)
T ss_dssp HHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHH---HHHHHHHH---H-----H
T ss_pred HHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHH---HHHHHHHH---h-----h
Confidence 3 455566666666666554 24445555566666666665554221000 000 1111 0 0
Q ss_pred CCCCCCCCCCcchhccccccCcccEEEccCCCCC-ccCC---chhhcccccccEEEccCcccc--C---CCCCCCCCCCc
Q 039533 249 NSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFG-GLLP---GCISNLSKTIKTLFLNNNKIY--G---SIPAGIGNFVN 319 (949)
Q Consensus 249 N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~-~~~p---~~~~~l~~~L~~L~L~~N~l~--~---~~~~~~~~l~~ 319 (949)
|++. ...++|++|++++|+++ +.+| ..+..+ ++|++|+|++|+|+ | ..+..+..+++
T Consensus 152 ~~~~-------------~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~-~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~ 217 (386)
T 2ca6_A 152 NKKA-------------KNAPPLRSIICGRNRLENGSMKEWAKTFQSH-RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQE 217 (386)
T ss_dssp HHHH-------------HTCCCCCEEECCSSCCTGGGHHHHHHHHHHC-TTCCEEECCSSCCCHHHHHHHHHTTGGGCTT
T ss_pred hhhc-------------ccCCCCcEEECCCCCCCcHHHHHHHHHHHhC-CCcCEEECcCCCCCHhHHHHHHHHHhhcCCC
Confidence 0000 00034555555555554 2222 123333 24666666666655 2 23335566666
Q ss_pred ccEEEeecceec----ccCCCcccccCCCCEEecCCcccccc----cCccc--ccccccceeecccccccc----cCCCC
Q 039533 320 LQRLDMWNNQLS----GTIPPAIGELQNLKILGLNRNKLSGN----IPPSI--GNLKMLLNLFLNDNFLEV----SIPSS 385 (949)
Q Consensus 320 L~~L~L~~N~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~--~~l~~L~~L~L~~N~l~~----~~p~~ 385 (949)
|++|+|++|.|+ +.+|..+..+++|+.|+|++|+|++. +|..+ +.+++|+.|+|++|.+++ .+|..
T Consensus 218 L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~ 297 (386)
T 2ca6_A 218 LKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTV 297 (386)
T ss_dssp CCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHH
T ss_pred ccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHH
Confidence 666666666664 44555666666666666666666544 34444 225555555555555554 24444
Q ss_pred C-CCCCCCcEEEeeCcccc
Q 039533 386 L-GQCESLIEINLSNNNLS 403 (949)
Q Consensus 386 ~-~~l~~L~~L~l~~N~l~ 403 (949)
+ .++++|++|++++|+++
T Consensus 298 l~~~l~~L~~L~l~~N~l~ 316 (386)
T 2ca6_A 298 IDEKMPDLLFLELNGNRFS 316 (386)
T ss_dssp HHHHCTTCCEEECTTSBSC
T ss_pred HHhcCCCceEEEccCCcCC
Confidence 4 33455555555555555
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.87 E-value=6.7e-24 Score=234.60 Aligned_cols=250 Identities=17% Similarity=0.200 Sum_probs=204.8
Q ss_pred cccEEEccCCCCCccCCchhhcc-cccccEEEccCccccCCCCCCCCCCCcccEEEeecceeccc-CCCcccccCCCCEE
Q 039533 270 RLTWMHINSNNFGGLLPGCISNL-SKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGT-IPPAIGELQNLKIL 347 (949)
Q Consensus 270 ~L~~L~L~~N~l~~~~p~~~~~l-~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L 347 (949)
.++.+++++|.+. +..+..+ ...++.|++++|.+.+..+. +..+++|++|+|++|.+++. +|..+..+++|++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 4678888888876 3444443 24699999999999977665 66789999999999999866 78888999999999
Q ss_pred ecCCcccccccCcccccccccceeecccc-ccccc-CCCCCCCCCCCcEEEeeCc-cccCC-CCCcccCCc-ccceeecc
Q 039533 348 GLNRNKLSGNIPPSIGNLKMLLNLFLNDN-FLEVS-IPSSLGQCESLIEINLSNN-NLSGT-IPPQFFSLS-SLSISLDW 422 (949)
Q Consensus 348 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~l~~N-~l~~~-~p~~~~~l~-~l~~~L~l 422 (949)
+|++|++++..|..++.+++|++|++++| .+++. ++..+.++++|++|++++| .+++. ++..+..++ +| +.|++
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L-~~L~l 202 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETI-TQLNL 202 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTC-CEEEC
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCC-CEEEe
Confidence 99999999888889999999999999999 67753 6667888999999999999 88854 577778888 88 78999
Q ss_pred CCC--ccC-CCCccccccccccceeeecccc-ccccCCcccccccchhhcccCccc-cccccCCCcCCCCCCCEEECCCC
Q 039533 423 SRN--KLT-GSLPIEVGKLKILEFLYVYENR-LEGEIPSTFGNCIRLEQLGMGGNL-FQGPISSSLGSLRGLRVLDLSQN 497 (949)
Q Consensus 423 s~N--~l~-~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l~~L~~L~Ls~N 497 (949)
++| .++ +.+|..+..+++|+.|++++|. +++..+..++.+++|+.|++++|. +.......++.+++|+.|++++|
T Consensus 203 ~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~ 282 (336)
T 2ast_B 203 SGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 282 (336)
T ss_dssp CSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc
Confidence 999 565 4677788899999999999999 787888899999999999999995 33222236888999999999999
Q ss_pred cCCCcCcccccCC-c-cceEeCCCCcCcCcccc
Q 039533 498 NLSGEIPKFLAGL-S-LNNLNLSYNDLEGMVTT 528 (949)
Q Consensus 498 ~l~~~~p~~~~~~-~-L~~l~ls~N~l~~~~~~ 528 (949)
++. ..+..+ . +..|++++|++++..|.
T Consensus 283 -i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~ 311 (336)
T 2ast_B 283 -VPD---GTLQLLKEALPHLQINCSHFTTIARP 311 (336)
T ss_dssp -SCT---TCHHHHHHHSTTSEESCCCSCCTTCS
T ss_pred -cCH---HHHHHHHhhCcceEEecccCccccCC
Confidence 432 233333 2 88889999999998775
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=1.8e-22 Score=219.52 Aligned_cols=191 Identities=20% Similarity=0.295 Sum_probs=131.3
Q ss_pred cccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecc
Q 039533 295 TIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLN 374 (949)
Q Consensus 295 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 374 (949)
+|++|++++|.++. ++ .+..+++|++|+|++|.+++..+ +..+++|++|+|++|++++. +.+.++++|+.|+++
T Consensus 42 ~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~ 115 (308)
T 1h6u_A 42 GITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLT 115 (308)
T ss_dssp TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECT
T ss_pred CcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEEECC
Confidence 46666666666653 33 46666777777777777764433 66777777777777777642 256677777777777
Q ss_pred cccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeecccccccc
Q 039533 375 DNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGE 454 (949)
Q Consensus 375 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 454 (949)
+|.+++. +. +..+++|++|++++|++++. +. +..+++| +.|++++|++++..+ +..+++|+.|++++|++++.
T Consensus 116 ~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L-~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~ 188 (308)
T 1h6u_A 116 STQITDV-TP-LAGLSNLQVLYLDLNQITNI-SP-LAGLTNL-QYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDI 188 (308)
T ss_dssp TSCCCCC-GG-GTTCTTCCEEECCSSCCCCC-GG-GGGCTTC-CEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC
T ss_pred CCCCCCc-hh-hcCCCCCCEEECCCCccCcC-cc-ccCCCCc-cEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcC
Confidence 7777643 22 66777777777777777643 32 6666666 667777777775333 77778888888888888754
Q ss_pred CCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCc
Q 039533 455 IPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGE 502 (949)
Q Consensus 455 ~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 502 (949)
.+ +..+++|+.|+|++|++++..+ +..+++|+.|+|++|++++.
T Consensus 189 ~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~ 232 (308)
T 1h6u_A 189 SP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQ 232 (308)
T ss_dssp GG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEECC
T ss_pred hh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeecC
Confidence 33 7778888888888888886553 78888888888888888753
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=3.2e-22 Score=217.61 Aligned_cols=192 Identities=24% Similarity=0.388 Sum_probs=112.1
Q ss_pred CCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCcccccccccccCCCCChhhh
Q 039533 159 SLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKL 238 (949)
Q Consensus 159 ~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l 238 (949)
.+++|++|++++|.++ .+| .+..+++|++|+|++|++++..+ +..+++|++|+|++|+++.+ +.+..+
T Consensus 39 ~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--------~~~~~l 106 (308)
T 1h6u_A 39 DLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--------SAIAGL 106 (308)
T ss_dssp HHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--------GGGTTC
T ss_pred HcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--------hhhcCC
Confidence 4455566666666665 233 45566666666666666653332 55666666666666555432 122222
Q ss_pred ccccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCC
Q 039533 239 QRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFV 318 (949)
Q Consensus 239 ~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~ 318 (949)
+ +|++|++++|++++. + .+..+ ++|++|++++|++++..+ +..++
T Consensus 107 ~------------------------------~L~~L~l~~n~l~~~-~-~l~~l-~~L~~L~l~~n~l~~~~~--l~~l~ 151 (308)
T 1h6u_A 107 Q------------------------------SIKTLDLTSTQITDV-T-PLAGL-SNLQVLYLDLNQITNISP--LAGLT 151 (308)
T ss_dssp T------------------------------TCCEEECTTSCCCCC-G-GGTTC-TTCCEEECCSSCCCCCGG--GGGCT
T ss_pred C------------------------------CCCEEECCCCCCCCc-h-hhcCC-CCCCEEECCCCccCcCcc--ccCCC
Confidence 3 333333333333332 1 13333 346666666666654333 66677
Q ss_pred cccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEee
Q 039533 319 NLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLS 398 (949)
Q Consensus 319 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 398 (949)
+|++|+|++|++++..+ +..+++|+.|+|++|++++..+ +..+++|+.|+|++|++++..+ +..+++|+.|+++
T Consensus 152 ~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~ 225 (308)
T 1h6u_A 152 NLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225 (308)
T ss_dssp TCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEE
T ss_pred CccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEcc
Confidence 77777777777764333 6677777777777777774433 6777777777777777775443 6777777777777
Q ss_pred Ccccc
Q 039533 399 NNNLS 403 (949)
Q Consensus 399 ~N~l~ 403 (949)
+|+++
T Consensus 226 ~N~i~ 230 (308)
T 1h6u_A 226 NQTIT 230 (308)
T ss_dssp EEEEE
T ss_pred CCeee
Confidence 77776
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=7.1e-22 Score=219.18 Aligned_cols=202 Identities=15% Similarity=0.109 Sum_probs=113.7
Q ss_pred cEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCC-CcccccCCCCE-Eec
Q 039533 272 TWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIP-PAIGELQNLKI-LGL 349 (949)
Q Consensus 272 ~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~-L~L 349 (949)
+.++.++++++. +|..+ ++++++|+|++|+|+.+.+.+|.++++|++|+|++|++.+.+| .+|.++++++. +.+
T Consensus 12 ~~v~C~~~~Lt~-iP~~l---~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~ 87 (350)
T 4ay9_X 12 RVFLCQESKVTE-IPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87 (350)
T ss_dssp TEEEEESTTCCS-CCTTC---CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred CEEEecCCCCCc-cCcCc---CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence 345666666663 34332 3456677777777765444566677777777777776654444 45666666554 455
Q ss_pred CCcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeC-ccccCCCCCcccCCcccceeeccCCCccC
Q 039533 350 NRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSN-NNLSGTIPPQFFSLSSLSISLDWSRNKLT 428 (949)
Q Consensus 350 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~l~~~L~ls~N~l~ 428 (949)
++|+|+...|..|.++++|++|++++|++++..+..+....++..|++.+ |++....+..|..+...++.|+|++|+|+
T Consensus 88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~ 167 (350)
T 4ay9_X 88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 167 (350)
T ss_dssp EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred cCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc
Confidence 56666666666666677777777777766655555555666666666654 44543333344444433355666666665
Q ss_pred CCCccccccccccceeeecc-ccccccCCcccccccchhhcccCccccccc
Q 039533 429 GSLPIEVGKLKILEFLYVYE-NRLEGEIPSTFGNCIRLEQLGMGGNLFQGP 478 (949)
Q Consensus 429 ~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 478 (949)
. +|.......+|+.|++++ |.++...+..|.++++|+.|+|++|+|+..
T Consensus 168 ~-i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~l 217 (350)
T 4ay9_X 168 E-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSL 217 (350)
T ss_dssp E-ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCC
T ss_pred C-CChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCcc
Confidence 3 333333344555555553 444432233455556666666666665533
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.5e-24 Score=244.59 Aligned_cols=200 Identities=19% Similarity=0.205 Sum_probs=110.3
Q ss_pred CCCCcccEEEeecceecc----cCCCcccccCCCCEEecCCcccccccCcccccc-cccceeecccccccccCCCCCCCC
Q 039533 315 GNFVNLQRLDMWNNQLSG----TIPPAIGELQNLKILGLNRNKLSGNIPPSIGNL-KMLLNLFLNDNFLEVSIPSSLGQC 389 (949)
Q Consensus 315 ~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l 389 (949)
..+++|++|+|++|.+++ .+|..+..+++|++|+|++|.+++..+..+... ..+ ..|.+.+. .
T Consensus 91 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l-----~~~~~~~~-------~ 158 (386)
T 2ca6_A 91 LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQEL-----AVNKKAKN-------A 158 (386)
T ss_dssp TTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHH-----HHHHHHHT-------C
T ss_pred hhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHH-----hhhhhccc-------C
Confidence 455566666666666654 345555556666666666666653333222221 000 00000000 0
Q ss_pred CCCcEEEeeCcccc-CCCC---CcccCCcccceeeccCCCccC--C---CCccccccccccceeeecccccc----ccCC
Q 039533 390 ESLIEINLSNNNLS-GTIP---PQFFSLSSLSISLDWSRNKLT--G---SLPIEVGKLKILEFLYVYENRLE----GEIP 456 (949)
Q Consensus 390 ~~L~~L~l~~N~l~-~~~p---~~~~~l~~l~~~L~ls~N~l~--~---~~p~~~~~l~~L~~L~Ls~N~l~----~~~p 456 (949)
++|++|+|++|+++ +.+| ..+..+++| +.|++++|+++ | ..|..+..+++|+.|+|++|+++ +.+|
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L-~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~ 237 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLL-HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 237 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTC-CEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHH
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCc-CEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHH
Confidence 44445555555443 2222 233334444 44555555554 1 23335666677777777777774 4566
Q ss_pred cccccccchhhcccCccccccc----cCCCc--CCCCCCCEEECCCCcCCC----cCcccc-cCCc-cceEeCCCCcCcC
Q 039533 457 STFGNCIRLEQLGMGGNLFQGP----ISSSL--GSLRGLRVLDLSQNNLSG----EIPKFL-AGLS-LNNLNLSYNDLEG 524 (949)
Q Consensus 457 ~~~~~l~~L~~L~l~~N~l~~~----~~~~~--~~l~~L~~L~Ls~N~l~~----~~p~~~-~~~~-L~~l~ls~N~l~~ 524 (949)
..+..+++|+.|+|++|.+++. ++..+ +.+++|+.|+|++|++++ .+|..+ ..++ |+.|++++|++++
T Consensus 238 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~ 317 (386)
T 2ca6_A 238 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 317 (386)
T ss_dssp HHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCc
Confidence 6677777777777777777654 45555 337778888888888876 366655 3333 7888888888877
Q ss_pred ccc
Q 039533 525 MVT 527 (949)
Q Consensus 525 ~~~ 527 (949)
..+
T Consensus 318 ~~~ 320 (386)
T 2ca6_A 318 EDD 320 (386)
T ss_dssp TSH
T ss_pred chh
Confidence 654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=3.5e-22 Score=213.50 Aligned_cols=165 Identities=20% Similarity=0.088 Sum_probs=127.6
Q ss_pred HHHHHHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC------------------cchHHHHHHHHHHHh
Q 039533 618 YQDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH------------------GASRSFIAECKALKS 679 (949)
Q Consensus 618 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~ 679 (949)
...+......|.+.+.||+|+||.||+|.+ .+++.||||+++.... .....+.+|++++++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~ 160 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK 160 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence 344555666788889999999999999999 6899999999964321 123568899999999
Q ss_pred cCCCcceeEEeeeecccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 039533 680 IRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQ 759 (949)
Q Consensus 680 l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~ 759 (949)
++| +++.+++.. ...++||||+++++|.+ +.. .....++.|++.||+|||+.
T Consensus 161 l~~---~~v~~~~~~------~~~~lvmE~~~g~~L~~-l~~----------------~~~~~i~~qi~~~l~~lH~~-- 212 (282)
T 1zar_A 161 LQG---LAVPKVYAW------EGNAVLMELIDAKELYR-VRV----------------ENPDEVLDMILEEVAKFYHR-- 212 (282)
T ss_dssp TTT---SSSCCEEEE------ETTEEEEECCCCEEGGG-CCC----------------SCHHHHHHHHHHHHHHHHHT--
T ss_pred ccC---CCcCeEEec------cceEEEEEecCCCcHHH-cch----------------hhHHHHHHHHHHHHHHHHHC--
Confidence 994 555554321 25799999999999998 531 12446999999999999987
Q ss_pred CCeEecCCCCCCeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCC----------CccCCccchHH
Q 039533 760 PVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG----------CEVSTNGDVYS 828 (949)
Q Consensus 760 ~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~sDiwS 828 (949)
+|+||||||+||+++ ++.+||+|||+|+. +..|+|||++.+ .++...+|+|.
T Consensus 213 -giiHrDlkp~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 213 -GIVHGDLSQYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp -TEECSCCSTTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred -CCEeCCCCHHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 999999999999999 99999999999863 345788888653 34555566654
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.9e-21 Score=197.38 Aligned_cols=174 Identities=24% Similarity=0.239 Sum_probs=94.0
Q ss_pred cccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEee
Q 039533 319 NLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLS 398 (949)
Q Consensus 319 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 398 (949)
+|++|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|.+++..+..|..+++|++|+++
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 108 (208)
T 2o6s_A 29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALN 108 (208)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcC
Confidence 44445555555444334444445555555555555544333344445555555555555554444444555555555555
Q ss_pred CccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccCCcccccccchhhcccCccccccc
Q 039533 399 NNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGP 478 (949)
Q Consensus 399 ~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 478 (949)
+|++++..+..+..+++| +.|++++|++++..+..+..+++|+.|++++|.+.+ .+++|+.|+++.|+++|.
T Consensus 109 ~N~l~~~~~~~~~~l~~L-~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ 180 (208)
T 2o6s_A 109 TNQLQSLPDGVFDKLTQL-KDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGV 180 (208)
T ss_dssp SSCCCCCCTTTTTTCTTC-CEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTT
T ss_pred CCcCcccCHhHhccCCcC-CEEECCCCccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCce
Confidence 555553333334445555 455555555554444456666777777777776653 344677777777777777
Q ss_pred cCCCcCCCCCCCEEECCCCcCCCcCc
Q 039533 479 ISSSLGSLRGLRVLDLSQNNLSGEIP 504 (949)
Q Consensus 479 ~~~~~~~l~~L~~L~Ls~N~l~~~~p 504 (949)
+|..++.++. ++..+...|..+
T Consensus 181 ip~~~~~l~~----~~~~C~~~~~~~ 202 (208)
T 2o6s_A 181 VRNSAGSVAP----DSAKCSGSGKPV 202 (208)
T ss_dssp BBCTTSSBCT----TCSBBTTTCCBG
T ss_pred eeccCccccC----CccccccCCCcc
Confidence 7777776655 444444444333
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.3e-21 Score=227.98 Aligned_cols=186 Identities=28% Similarity=0.310 Sum_probs=105.4
Q ss_pred ccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeeccc
Q 039533 296 IKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLND 375 (949)
Q Consensus 296 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 375 (949)
++.|+|++|+|++ +|..+. ++|++|+|++|+|+ .+| ..+++|+.|+|++|+|++ +|. +.+ +|+.|+|++
T Consensus 61 L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~ 129 (571)
T 3cvr_A 61 FSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDN 129 (571)
T ss_dssp CSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCS
T ss_pred ccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCC
Confidence 4455555555543 333332 44555555555555 344 234555555555555554 444 333 555555555
Q ss_pred ccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccC
Q 039533 376 NFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEI 455 (949)
Q Consensus 376 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 455 (949)
|.|++ +|. .+++|+.|+|++|+|++ +|. .+++| +.|+|++|+|++ +|. +. ++|+.|+|++|+|+ .+
T Consensus 130 N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L-~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~l 195 (571)
T 3cvr_A 130 NQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSL-EVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SL 195 (571)
T ss_dssp SCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTC-CEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SC
T ss_pred CcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCc-CEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-ch
Confidence 55554 333 34556666666666553 444 23444 455666666654 444 43 66677777777776 55
Q ss_pred Ccccccccch-------hhcccCccccccccCCCcCCCCCCCEEECCCCcCCCcCcccccCC
Q 039533 456 PSTFGNCIRL-------EQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL 510 (949)
Q Consensus 456 p~~~~~l~~L-------~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 510 (949)
|. |.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|..+..+
T Consensus 196 p~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l 253 (571)
T 3cvr_A 196 PA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ 253 (571)
T ss_dssp CC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHH
T ss_pred hh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHh
Confidence 55 444 55 77777777777 467777778888888888888887777766543
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.85 E-value=8e-21 Score=194.06 Aligned_cols=194 Identities=19% Similarity=0.162 Sum_probs=158.6
Q ss_pred cEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCC
Q 039533 272 TWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNR 351 (949)
Q Consensus 272 ~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 351 (949)
+.++++++.++.. |.. ++++|++|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++
T Consensus 10 ~~v~c~~~~l~~~-p~~---~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~ 85 (208)
T 2o6s_A 10 TTVECYSQGRTSV-PTG---IPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST 85 (208)
T ss_dssp TEEECCSSCCSSC-CSC---CCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEEecCCCccCC-CCC---CCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence 4567777777644 332 235789999999999977777788999999999999999977777788999999999999
Q ss_pred cccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCC
Q 039533 352 NKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSL 431 (949)
Q Consensus 352 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~ 431 (949)
|++++..+..|.++++|++|++++|++++..+..|..+++|++|++++|++++..+..+..+++| +.|++++|.+.+
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L-~~L~l~~N~~~~-- 162 (208)
T 2o6s_A 86 NQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSL-QYIWLHDNPWDC-- 162 (208)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTC-CEEECCSCCBCC--
T ss_pred CcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCc-cEEEecCCCeec--
Confidence 99997777778999999999999999998777788999999999999999996666667888888 789999998875
Q ss_pred ccccccccccceeeeccccccccCCcccccccchhhcccCccccccccCC
Q 039533 432 PIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISS 481 (949)
Q Consensus 432 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~ 481 (949)
.++.|++|+++.|+++|.+|..++.++. ++..+...+..+.
T Consensus 163 -----~~~~l~~L~~~~n~~~g~ip~~~~~l~~----~~~~C~~~~~~~~ 203 (208)
T 2o6s_A 163 -----TCPGIRYLSEWINKHSGVVRNSAGSVAP----DSAKCSGSGKPVR 203 (208)
T ss_dssp -----CTTTTHHHHHHHHHCTTTBBCTTSSBCT----TCSBBTTTCCBGG
T ss_pred -----CCCCHHHHHHHHHhCCceeeccCccccC----CccccccCCCcce
Confidence 3457999999999999999999988765 4555555444443
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.84 E-value=7.5e-21 Score=197.12 Aligned_cols=162 Identities=24% Similarity=0.248 Sum_probs=142.7
Q ss_pred CccCCCCcceeeeeEEeCCCCcEEEEEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeecccc
Q 039533 45 TWNESIHFCKWYGVTCSRRHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNS 124 (949)
Q Consensus 45 sW~~~~~~C~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~ 124 (949)
-|..+.+.|+|.+|.|+.. +++ .+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|+
T Consensus 11 ~~~~~~~~Cs~~~v~c~~~------------~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~ 75 (229)
T 3e6j_A 11 AACPSQCSCSGTTVDCRSK------------RHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQ 75 (229)
T ss_dssp CCCCTTCEEETTEEECTTS------------CCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred ccCCCCCEEeCCEeEccCC------------CcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCC
Confidence 3445678899999999643 232 5555444 899999999999999889999999999999999999
Q ss_pred ccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCc
Q 039533 125 ICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNS 204 (949)
Q Consensus 125 l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 204 (949)
|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..
T Consensus 76 l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~ 154 (229)
T 3e6j_A 76 LGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGA 154 (229)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTT
T ss_pred CCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHH
Confidence 98655667899999999999999999999999999999999999999999 78999999999999999999999777788
Q ss_pred ccCCCccccccccCcccc
Q 039533 205 FGWFENLVFLSLAANNLS 222 (949)
Q Consensus 205 ~~~l~~L~~L~Ls~N~l~ 222 (949)
|..+++|++|+|++|.+.
T Consensus 155 ~~~l~~L~~L~l~~N~~~ 172 (229)
T 3e6j_A 155 FDRLSSLTHAYLFGNPWD 172 (229)
T ss_dssp TTTCTTCCEEECTTSCBC
T ss_pred HhCCCCCCEEEeeCCCcc
Confidence 999999999999999865
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.84 E-value=3.5e-22 Score=241.86 Aligned_cols=191 Identities=22% Similarity=0.219 Sum_probs=100.0
Q ss_pred CChhhHHHHHHHHhccCCCCCCCccCcc-CCCCcceeeeeEEeCCCCcEEEEEcCCCCCCccccCCCCCCCCCceeeccC
Q 039533 20 GNETDRVALLEFKSKSTYDPVGVLGTWN-ESIHFCKWYGVTCSRRHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQV 98 (949)
Q Consensus 20 ~~~~~~~aLl~~k~~~~~~~~~~l~sW~-~~~~~C~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~ 98 (949)
..+.++++|+++..+...+....-..|. ..+..+.|.+++++. .+++.|+|.++++... +..+ |+.++|+.
T Consensus 129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~~-~~~~-----l~~l~Ls~ 200 (727)
T 4b8c_D 129 LVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST--PLTPKIELFANGKDEA-NQAL-----LQHKKLSQ 200 (727)
T ss_dssp ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred ccccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC--CccceEEeeCCCCCcc-hhhH-----hhcCccCc
Confidence 4578999999999776444444555674 335678999999875 5799999999988863 3333 33344444
Q ss_pred ceecc---------ccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECC
Q 039533 99 NSFTH---------EIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLG 169 (949)
Q Consensus 99 n~l~~---------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls 169 (949)
|.+.+ ..|..|..+++|+.|+|++|.+. .+|..+.++++|++|+|++|.|+ .+|..|.+|++|++|+|+
T Consensus 201 ~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls 278 (727)
T 4b8c_D 201 YSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLS 278 (727)
T ss_dssp ---------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECT
T ss_pred ccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCc
Confidence 44332 45777888888888888888887 77877778888888888888887 566777888888888888
Q ss_pred CCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCcccc
Q 039533 170 SNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLS 222 (949)
Q Consensus 170 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 222 (949)
+|+|+ .+|..|+++++|++|+|++|.|+ .+|..|+.+++|++|+|++|.|+
T Consensus 279 ~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~ 329 (727)
T 4b8c_D 279 HNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLE 329 (727)
T ss_dssp TSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCC
T ss_pred CCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccC
Confidence 88888 66777888888888888888876 66767777777777777766654
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.82 E-value=5.4e-20 Score=189.33 Aligned_cols=149 Identities=19% Similarity=0.260 Sum_probs=135.0
Q ss_pred EcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCcccc
Q 039533 71 DLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLV 150 (949)
Q Consensus 71 ~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~ 150 (949)
++++++++ .+|..+. ++|+.|+|++|++++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|+
T Consensus 17 ~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~ 93 (220)
T 2v9t_B 17 DCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT 93 (220)
T ss_dssp ECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCC
T ss_pred EcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCC
Confidence 33445555 4565554 78999999999999877889999999999999999999888999999999999999999999
Q ss_pred ccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCcccc
Q 039533 151 GKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLS 222 (949)
Q Consensus 151 ~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 222 (949)
...+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|++|+|++|.+.
T Consensus 94 ~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 94 ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 998899999999999999999999988999999999999999999999888888999999999999999875
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=2.7e-19 Score=184.02 Aligned_cols=151 Identities=26% Similarity=0.272 Sum_probs=136.8
Q ss_pred EEEcCCCCCCccccCCCCCCCCCceeeccCceeccccC-CcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCc
Q 039533 69 LLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIP-SEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNN 147 (949)
Q Consensus 69 ~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n 147 (949)
.+++++++++ .+|..+. ..+++|+|++|++++..| ..|.++++|++|+|++|+|++..|..|+++++|++|+|++|
T Consensus 15 ~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 4666777776 4666554 456899999999998765 46899999999999999999877889999999999999999
Q ss_pred cccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCcccc
Q 039533 148 QLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLS 222 (949)
Q Consensus 148 ~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 222 (949)
+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.++
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 166 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence 999999999999999999999999999988999999999999999999999998999999999999999999876
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.80 E-value=8.9e-20 Score=215.17 Aligned_cols=101 Identities=22% Similarity=0.235 Sum_probs=48.1
Q ss_pred cccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEe
Q 039533 112 LRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTIS 191 (949)
Q Consensus 112 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 191 (949)
+.++..++|+.+.+.+.++ +..|.+|+.|++++|.|.... .|..+++|+.|+|++|.|++..| +..+++|+.|+
T Consensus 20 l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~ 93 (605)
T 1m9s_A 20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLF 93 (605)
T ss_dssp HHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCCT--TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEE
T ss_pred HHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCCh--HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEE
Confidence 3445555666666553332 344555555555555554332 34455555555555555553332 44555555555
Q ss_pred ccccccCCCCCCcccCCCccccccccCcc
Q 039533 192 LAYNNLDGTIPNSFGWFENLVFLSLAANN 220 (949)
Q Consensus 192 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 220 (949)
|++|+|++ +| .+..+++|++|+|++|.
T Consensus 94 Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~ 120 (605)
T 1m9s_A 94 LDENKIKD-LS-SLKDLKKLKSLSLEHNG 120 (605)
T ss_dssp CCSSCCCC-CT-TSTTCTTCCEEECTTSC
T ss_pred CcCCCCCC-Ch-hhccCCCCCEEEecCCC
Confidence 55555542 12 34444444444444443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.79 E-value=1.2e-19 Score=214.20 Aligned_cols=125 Identities=20% Similarity=0.268 Sum_probs=89.2
Q ss_pred CCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEE
Q 039533 88 LSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILN 167 (949)
Q Consensus 88 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~ 167 (949)
+..+..+.|+.+.+...++ +..|++|+.|+|++|.+. .+| .|+.|++|+.|+|++|.|.+..+ |..+++|+.|+
T Consensus 20 l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~ 93 (605)
T 1m9s_A 20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLF 93 (605)
T ss_dssp HHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEE
T ss_pred HHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEE
Confidence 3445556667777765443 567788888888888886 444 57788888888888888877665 77888888888
Q ss_pred CCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCcccc
Q 039533 168 LGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLS 222 (949)
Q Consensus 168 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 222 (949)
|++|.|++ +| .+..+++|++|+|++|+|++. ..+..+++|+.|+|++|.|+
T Consensus 94 Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~ 144 (605)
T 1m9s_A 94 LDENKIKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKIT 144 (605)
T ss_dssp CCSSCCCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCC
T ss_pred CcCCCCCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccC
Confidence 88888874 33 677888888888888888742 34666666666666666544
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=2.9e-22 Score=235.03 Aligned_cols=217 Identities=18% Similarity=0.187 Sum_probs=150.3
Q ss_pred cCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccE
Q 039533 110 GGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHT 189 (949)
Q Consensus 110 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 189 (949)
..+++|+.|+|++|+|+ .+|..+++|++|+.|++++|......+..+ ..+.+.+.+|..++++++|+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll-----------~~~~~~~~~~~~l~~l~~L~~ 413 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLM-----------RALDPLLYEKETLQYFSTLKA 413 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHH-----------HHHCTGGGHHHHHHHHHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHH-----------HhcccccCCHHHHHHHHhccc
Confidence 56778888888888887 788888888888888887775322222111 112334567777888888888
Q ss_pred Ee-ccccccCCCCCCcccCCCccccccccCcccccccccccCCCCChhhhccccccccccCCCCCCCCCCcchhcccccc
Q 039533 190 IS-LAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNA 268 (949)
Q Consensus 190 L~-L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~ 268 (949)
|+ ++.|.+ .+|+.+.+++|.|+.++..
T Consensus 414 L~~l~~n~~-----------~~L~~l~l~~n~i~~l~~~----------------------------------------- 441 (567)
T 1dce_A 414 VDPMRAAYL-----------DDLRSKFLLENSVLKMEYA----------------------------------------- 441 (567)
T ss_dssp HCGGGHHHH-----------HHHHHHHHHHHHHHHHHHT-----------------------------------------
T ss_pred Ccchhhccc-----------chhhhhhhhcccccccCcc-----------------------------------------
Confidence 88 677754 3677788888888865421
Q ss_pred CcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEe
Q 039533 269 TRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILG 348 (949)
Q Consensus 269 ~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 348 (949)
.|+.|+|++|++++ +|. +..+ ++|+.|+|++|+|+ .+|..++.+++|++|+|++|+|++ +| .|+++++|+.|+
T Consensus 442 -~L~~L~Ls~n~l~~-lp~-~~~l-~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~ 514 (567)
T 1dce_A 442 -DVRVLHLAHKDLTV-LCH-LEQL-LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELL 514 (567)
T ss_dssp -TCSEEECTTSCCSS-CCC-GGGG-TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEE
T ss_pred -CceEEEecCCCCCC-CcC-cccc-ccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEE
Confidence 24455566666655 344 5555 35777777777777 667777778888888888888875 55 777788888888
Q ss_pred cCCccccccc-CcccccccccceeecccccccccCCCC---CCCCCCCcEEEe
Q 039533 349 LNRNKLSGNI-PPSIGNLKMLLNLFLNDNFLEVSIPSS---LGQCESLIEINL 397 (949)
Q Consensus 349 Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~---~~~l~~L~~L~l 397 (949)
|++|+|++.. |..++++++|+.|+|++|.+++..|.. +..+++|+.|++
T Consensus 515 Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 515 LCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp CCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred CCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 8888887665 777888888888888888887654432 223677887764
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.79 E-value=2.6e-19 Score=199.32 Aligned_cols=175 Identities=25% Similarity=0.264 Sum_probs=115.1
Q ss_pred cEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCC-CCCcccEEEeecceecccCCCcccccCCCCEEecC
Q 039533 272 TWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIG-NFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLN 350 (949)
Q Consensus 272 ~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 350 (949)
+.+++++|+++. +|..+ +..++.|+|++|+|++..+..+. .+++|++|+|++|+|++..+..|.++++|+.|+|+
T Consensus 21 ~~l~c~~~~l~~-iP~~~---~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 96 (361)
T 2xot_A 21 NILSCSKQQLPN-VPQSL---PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS 96 (361)
T ss_dssp TEEECCSSCCSS-CCSSC---CTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CEEEeCCCCcCc-cCccC---CCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence 567888887775 44433 34577788888888776666676 77788888888888877666777777888888888
Q ss_pred CcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcc----cCCcccceeeccCCCc
Q 039533 351 RNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQF----FSLSSLSISLDWSRNK 426 (949)
Q Consensus 351 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~----~~l~~l~~~L~ls~N~ 426 (949)
+|+|++..+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|+ .+|..+ ..+++| +.|+|++|+
T Consensus 97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~~~~l~~L-~~L~L~~N~ 174 (361)
T 2xot_A 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKL-MLLDLSSNK 174 (361)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCGGGTC----CTTC-CEEECCSSC
T ss_pred CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC-eeCHHHhcCcccCCcC-CEEECCCCC
Confidence 88877666667777777777777777777777777777777777777777777 344433 234444 445555555
Q ss_pred cCCCCccccccccc--cceeeecccccc
Q 039533 427 LTGSLPIEVGKLKI--LEFLYVYENRLE 452 (949)
Q Consensus 427 l~~~~p~~~~~l~~--L~~L~Ls~N~l~ 452 (949)
|++..+..+..++. |+.|+|++|.+.
T Consensus 175 l~~l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 175 LKKLPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp CCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred CCccCHHHhhhccHhhcceEEecCCCcc
Confidence 54333334444443 244444444443
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=4.1e-19 Score=182.67 Aligned_cols=155 Identities=21% Similarity=0.196 Sum_probs=89.9
Q ss_pred cEEEeecceecccCCCcccccCCCCEEecCCcccccccC-cccccccccceeecccccccccCCCCCCCCCCCcEEEeeC
Q 039533 321 QRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIP-PSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSN 399 (949)
Q Consensus 321 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 399 (949)
+.+++++|.++ .+|..+. ..++.|+|++|+|++..| ..|.++++|+.|+|++|+|++..+..|.++++|++|+|++
T Consensus 14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 35666666666 3454443 234566666666665433 2355555555555555555554444555555555555544
Q ss_pred ccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccCCcccccccchhhcccCcccccccc
Q 039533 400 NNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPI 479 (949)
Q Consensus 400 N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 479 (949)
|+++ +..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..
T Consensus 91 N~l~-------------------------~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 145 (220)
T 2v70_A 91 NRLE-------------------------NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVA 145 (220)
T ss_dssp SCCC-------------------------CCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBC
T ss_pred CccC-------------------------ccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEEC
Confidence 4444 333444555666666666666666665666666666666666666666666
Q ss_pred CCCcCCCCCCCEEECCCCcCCCcC
Q 039533 480 SSSLGSLRGLRVLDLSQNNLSGEI 503 (949)
Q Consensus 480 ~~~~~~l~~L~~L~Ls~N~l~~~~ 503 (949)
|..|..+++|+.|+|++|.+++..
T Consensus 146 ~~~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 146 PGAFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp TTTTTTCTTCCEEECCSCCEECSG
T ss_pred HHHhcCCCCCCEEEecCcCCcCCC
Confidence 666666666666666666666443
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.78 E-value=8.4e-19 Score=180.36 Aligned_cols=151 Identities=19% Similarity=0.194 Sum_probs=76.2
Q ss_pred EEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeeccccc
Q 039533 298 TLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNF 377 (949)
Q Consensus 298 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 377 (949)
.+++++|.++ .+|..+. ++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|++|+|++|+
T Consensus 15 ~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 15 IVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp EEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred EEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 3444444444 2333322 345555555555554444445555555555555555554445555555555555555555
Q ss_pred ccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeecccccc
Q 039533 378 LEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLE 452 (949)
Q Consensus 378 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 452 (949)
|+...+..|.++++|++|+|++|+|++..|..|..+++| +.|+|++|++++..+..+..+++|+.|+|++|.+.
T Consensus 92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNL-NLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC-CEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCC-CEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 554444444555555555555555554444444444444 44555555555444445555666666666666665
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.78 E-value=4.8e-19 Score=197.17 Aligned_cols=178 Identities=20% Similarity=0.129 Sum_probs=155.0
Q ss_pred ccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCccc-ccCCCCEEecCCcccccccCcccccccccceeecc
Q 039533 296 IKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIG-ELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLN 374 (949)
Q Consensus 296 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 374 (949)
-+.+++++|+++ .+|..+. +.++.|+|++|+|++..+..|. ++++|+.|+|++|+|++..+..|.++++|++|+|+
T Consensus 20 ~~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 96 (361)
T 2xot_A 20 SNILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS 96 (361)
T ss_dssp TTEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence 468999999998 5676554 4689999999999988888887 89999999999999998888889999999999999
Q ss_pred cccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCcccc---ccccccceeeeccccc
Q 039533 375 DNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEV---GKLKILEFLYVYENRL 451 (949)
Q Consensus 375 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l 451 (949)
+|+|++..+..|.++++|++|+|++|+|++..|..|..+++| +.|+|++|+|++..+..+ ..+++|+.|+|++|+|
T Consensus 97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L-~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l 175 (361)
T 2xot_A 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQL-QKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKL 175 (361)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTC-CEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCC
T ss_pred CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccC-CEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCC
Confidence 999998888899999999999999999998888899999999 789999999996555555 6799999999999999
Q ss_pred cccCCcccccccc--hhhcccCcccccc
Q 039533 452 EGEIPSTFGNCIR--LEQLGMGGNLFQG 477 (949)
Q Consensus 452 ~~~~p~~~~~l~~--L~~L~l~~N~l~~ 477 (949)
++..+..|..++. |+.|+|++|.+..
T Consensus 176 ~~l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 176 KKLPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp CCCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred CccCHHHhhhccHhhcceEEecCCCccC
Confidence 9766678888887 4889999998873
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.78 E-value=6.3e-19 Score=189.74 Aligned_cols=151 Identities=25% Similarity=0.338 Sum_probs=71.4
Q ss_pred CCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecccccccccCCCCCCCCCCCc
Q 039533 314 IGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLI 393 (949)
Q Consensus 314 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 393 (949)
+..+++|++|+|++|++++..+ +.++++|+.|+|++|++++ +| .+.++++|+.|++++|++++. ..+..+++|+
T Consensus 64 ~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~ 137 (291)
T 1h6t_A 64 IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLE 137 (291)
T ss_dssp GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCC
T ss_pred HhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCC
Confidence 3344444444444444443222 4444444444444444442 11 244444444444444444431 2344444445
Q ss_pred EEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccCCcccccccchhhcccCcc
Q 039533 394 EINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGN 473 (949)
Q Consensus 394 ~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 473 (949)
+|++++|++++. ..+..+++| +.|++++|++++..| +..+++|+.|+|++|++++ +| .+..+++|+.|++++|
T Consensus 138 ~L~l~~n~l~~~--~~l~~l~~L-~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n 210 (291)
T 1h6t_A 138 SLYLGNNKITDI--TVLSRLTKL-DTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQ 210 (291)
T ss_dssp EEECCSSCCCCC--GGGGGCTTC-SEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEE
T ss_pred EEEccCCcCCcc--hhhccCCCC-CEEEccCCccccchh--hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCC
Confidence 555555544422 334444444 445555555553333 5555666666666666653 33 2556666666666666
Q ss_pred cccc
Q 039533 474 LFQG 477 (949)
Q Consensus 474 ~l~~ 477 (949)
+++.
T Consensus 211 ~i~~ 214 (291)
T 1h6t_A 211 ECLN 214 (291)
T ss_dssp EEEC
T ss_pred cccC
Confidence 6653
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.77 E-value=2.5e-19 Score=192.89 Aligned_cols=187 Identities=26% Similarity=0.350 Sum_probs=127.8
Q ss_pred EEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeeccccc
Q 039533 298 TLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNF 377 (949)
Q Consensus 298 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 377 (949)
.+.+..+.+++.. .+..+++|++|++++|.++. ++ .+..+++|+.|+|++|++++..+ +.++++|+.|++++|.
T Consensus 28 ~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~ 101 (291)
T 1h6t_A 28 KDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENK 101 (291)
T ss_dssp HHHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred HHHhcCCCccccc--chhhcCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCc
Confidence 3445555555322 24567888899999998884 34 48889999999999999986544 8889999999999998
Q ss_pred ccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccCCc
Q 039533 378 LEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPS 457 (949)
Q Consensus 378 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 457 (949)
+++ +| .+..+++|++|++++|++++ + +.+..+++| +.|++++|++++. ..+..+++|+.|+|++|++++..|
T Consensus 102 l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L-~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~- 173 (291)
T 1h6t_A 102 VKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQL-ESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP- 173 (291)
T ss_dssp CCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTC-CEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-
T ss_pred CCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCC-CEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh-
Confidence 875 33 38888888888888888874 3 345566666 5666666666643 456666666666666666664333
Q ss_pred ccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCC
Q 039533 458 TFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSG 501 (949)
Q Consensus 458 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 501 (949)
+..+++|+.|+|++|++++. + .+..+++|+.|++++|+++.
T Consensus 174 -l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 174 -LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp -GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred -hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence 66666666666666666642 2 35666666666666666654
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.77 E-value=1e-19 Score=220.22 Aligned_cols=190 Identities=25% Similarity=0.278 Sum_probs=110.1
Q ss_pred EeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCcccc
Q 039533 324 DMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLS 403 (949)
Q Consensus 324 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 403 (949)
+++.|.+. ..|+.|..+++|+.|+|++|++. .+|..+.++++|++|+|++|.|+ .+|..|+++++|++|+|++|+|+
T Consensus 207 ~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~ 283 (727)
T 4b8c_D 207 DDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT 283 (727)
T ss_dssp ----------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS
T ss_pred ccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC
Confidence 44455555 55677777778888888888877 66766777788888888888877 67777778888888888888887
Q ss_pred CCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccCCcccccccc-hhhcccCccccccccCCC
Q 039533 404 GTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIR-LEQLGMGGNLFQGPISSS 482 (949)
Q Consensus 404 ~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~l~~N~l~~~~~~~ 482 (949)
.+|..|..+++| +.|+|++|.|+ .+|..|+.+++|+.|+|++|+|++.+|..+..+.. +..|+|++|.+++.+|..
T Consensus 284 -~lp~~~~~l~~L-~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~ 360 (727)
T 4b8c_D 284 -SLPAELGSCFQL-KYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE 360 (727)
T ss_dssp -SCCSSGGGGTTC-SEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_pred -ccChhhcCCCCC-CEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc
Confidence 778778777777 67888888887 66777888888888888888888888887766533 345788888888887764
Q ss_pred cCCCCCCCEEECCCC--------cCCCcCcccccCCc-cceEeCCCCcCcCc
Q 039533 483 LGSLRGLRVLDLSQN--------NLSGEIPKFLAGLS-LNNLNLSYNDLEGM 525 (949)
Q Consensus 483 ~~~l~~L~~L~Ls~N--------~l~~~~p~~~~~~~-L~~l~ls~N~l~~~ 525 (949)
|+.|++++| .|.+..+..+..+. +....+++|-+.+.
T Consensus 361 ------l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~~ 406 (727)
T 4b8c_D 361 ------RRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLCQH 406 (727)
T ss_dssp -----------------------------------------------CCCGG
T ss_pred ------cceeEeecccccccccCCccccccchhhcccccceeeeeccccccc
Confidence 455667766 33333333333333 45556667766543
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.77 E-value=2.3e-18 Score=178.38 Aligned_cols=153 Identities=27% Similarity=0.281 Sum_probs=96.8
Q ss_pred ccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeeccc
Q 039533 296 IKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLND 375 (949)
Q Consensus 296 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 375 (949)
.+.+++++++++ .+|..+. ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 345666666665 4444332 5666666666666666666666666666666666666654445566666666666666
Q ss_pred ccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccc
Q 039533 376 NFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEG 453 (949)
Q Consensus 376 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 453 (949)
|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++| +.|+|++|+|++..+..+..+++|+.|+|++|.+.+
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHL-THLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTC-SEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCC-CEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence 6666555566666777777777777776 566666666665 556666666665555556666666777777776664
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=2.4e-20 Score=218.78 Aligned_cols=190 Identities=19% Similarity=0.163 Sum_probs=110.7
Q ss_pred CCCCcccEEEeecceecccCCCcccccCCCCEEecCCcc-------------cccccCcccccccccceee-cccccccc
Q 039533 315 GNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNK-------------LSGNIPPSIGNLKMLLNLF-LNDNFLEV 380 (949)
Q Consensus 315 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-------------l~~~~p~~~~~l~~L~~L~-L~~N~l~~ 380 (949)
...++|+.|+|++|+|+ .+|+.++++++|+.|++++|. +.+.+|..++++++|+.|+ ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence 44566777777777776 567777777777777776664 4556677777777777777 5665442
Q ss_pred cCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccCCcccc
Q 039533 381 SIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFG 460 (949)
Q Consensus 381 ~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 460 (949)
+|+.+.+++|.+++..+. .+ +.|+|++|+|++ +|. ++.+++|+.|+|++|+|+ .+|..|+
T Consensus 424 ----------~L~~l~l~~n~i~~l~~~------~L-~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~ 483 (567)
T 1dce_A 424 ----------DLRSKFLLENSVLKMEYA------DV-RVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALA 483 (567)
T ss_dssp ----------HHHHHHHHHHHHHHHHHT------TC-SEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGG
T ss_pred ----------hhhhhhhhcccccccCcc------Cc-eEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhh
Confidence 344444555554421111 12 445555555553 343 555556666666666665 5555566
Q ss_pred cccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCcC-cccccCCc-cceEeCCCCcCcCcccc
Q 039533 461 NCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEI-PKFLAGLS-LNNLNLSYNDLEGMVTT 528 (949)
Q Consensus 461 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~~~-L~~l~ls~N~l~~~~~~ 528 (949)
++++|+.|+|++|+|++ +| .|+.+++|+.|+|++|+|++.+ |..+..++ |+.|+|++|+|++.+|.
T Consensus 484 ~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 551 (567)
T 1dce_A 484 ALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 551 (567)
T ss_dssp GCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred cCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence 66666666666666654 34 5556666666666666665554 55555544 66666666666655543
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=5.7e-19 Score=186.99 Aligned_cols=167 Identities=23% Similarity=0.275 Sum_probs=96.4
Q ss_pred ccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeeccc
Q 039533 296 IKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLND 375 (949)
Q Consensus 296 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 375 (949)
+..+++++|.+++. + .+..+++|++|++++|.|+ .+| .+..+++|+.|+|++|+|++..+ +.++++|+.|+|++
T Consensus 21 l~~l~l~~~~i~~~-~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~ 94 (263)
T 1xeu_A 21 AVKQNLGKQSVTDL-V-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNR 94 (263)
T ss_dssp HHHHHHTCSCTTSE-E-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCS
T ss_pred HHHHHhcCCCcccc-c-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCC
Confidence 45555666666532 2 3555556666666666555 233 45555555666665555553322 55555555555555
Q ss_pred ccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccC
Q 039533 376 NFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEI 455 (949)
Q Consensus 376 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 455 (949)
|++++ +|.... ++|++ |++++|++++ ++ .+..+++|+.|+|++|++++.
T Consensus 95 N~l~~-l~~~~~--~~L~~-------------------------L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~- 143 (263)
T 1xeu_A 95 NRLKN-LNGIPS--ACLSR-------------------------LFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI- 143 (263)
T ss_dssp SCCSC-CTTCCC--SSCCE-------------------------EECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-
T ss_pred CccCC-cCcccc--CcccE-------------------------EEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-
Confidence 55543 222111 44444 4444444443 22 366667777777777777743
Q ss_pred CcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCc
Q 039533 456 PSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGE 502 (949)
Q Consensus 456 p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 502 (949)
| .++.+++|+.|+|++|++++. ..+..+++|+.|+|++|++++.
T Consensus 144 ~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 144 V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 3 567777777777777777755 5677777788888888877755
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=3.9e-18 Score=179.96 Aligned_cols=140 Identities=19% Similarity=0.138 Sum_probs=107.9
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEE--EEEEEEecCCCc------------------------chHHHHHHHHHHHh
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTT--IAVKVFNLQHHG------------------------ASRSFIAECKALKS 679 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~ 679 (949)
.-|.+.+.||+|+||.||+|.+..+|+. ||||+++..... ....+.+|+.++.+
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3466788999999999999999557888 999997543111 01367899999999
Q ss_pred cCCCcc--eeEEeeeecccccCCccceeEeeeccC-C----ChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHH
Q 039533 680 IRHRNL--VKVLTACLGADYRGNDFKASVYEFMHY-G----SLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALN 752 (949)
Q Consensus 680 l~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~ 752 (949)
+.|+++ +.++++ ...++||||+.+ | +|.++... .++..+..++.|++.|+.
T Consensus 127 l~~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~-------------~~~~~~~~i~~qi~~~l~ 184 (258)
T 1zth_A 127 AKEAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE-------------LKELDVEGIFNDVVENVK 184 (258)
T ss_dssp HHHTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG-------------GGGSCHHHHHHHHHHHHH
T ss_pred HHhCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc-------------cChHHHHHHHHHHHHHHH
Confidence 988754 444432 156899999943 3 66665431 123457789999999999
Q ss_pred HHh-hCCCCCeEecCCCCCCeeecCCCceEEeecccceecC
Q 039533 753 YLH-HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILS 792 (949)
Q Consensus 753 ~LH-~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~ 792 (949)
||| +. +|+||||||+|||+++ .++|+|||+|....
T Consensus 185 ~lH~~~---givHrDlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 185 RLYQEA---ELVHADLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp HHHHTS---CEECSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred HHHHHC---CEEeCCCCHHHEEEcC--cEEEEECcccccCC
Confidence 999 77 9999999999999998 99999999998653
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=2.1e-18 Score=182.61 Aligned_cols=82 Identities=21% Similarity=0.204 Sum_probs=42.8
Q ss_pred CCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEE
Q 039533 87 NLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEIL 166 (949)
Q Consensus 87 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L 166 (949)
++.++..++|+.|.+++. + .+..+++|++|+|++|.++ .+| .++.+++|++|++++|+|++..+ |..+++|++|
T Consensus 17 ~l~~l~~l~l~~~~i~~~-~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDL-V-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTSE-E-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCcccc-c-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 344555566666666532 2 4556666666666666665 344 45555555555555555444333 4444444444
Q ss_pred ECCCCCCC
Q 039533 167 NLGSNHLT 174 (949)
Q Consensus 167 ~Ls~N~l~ 174 (949)
+|++|+++
T Consensus 91 ~L~~N~l~ 98 (263)
T 1xeu_A 91 SVNRNRLK 98 (263)
T ss_dssp ECCSSCCS
T ss_pred ECCCCccC
Confidence 44444444
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=3.8e-18 Score=172.42 Aligned_cols=154 Identities=15% Similarity=0.140 Sum_probs=98.0
Q ss_pred CCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecccccccccCCCCCCCCCCCc
Q 039533 314 IGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLI 393 (949)
Q Consensus 314 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 393 (949)
.+.+++|++|++++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|.+++..|..|..+++|+
T Consensus 40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 115 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115 (197)
T ss_dssp HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence 466778888888888887 555 5778888888888888665 234567777777777777777766666677777777
Q ss_pred EEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeecccc-ccccCCcccccccchhhcccCc
Q 039533 394 EINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENR-LEGEIPSTFGNCIRLEQLGMGG 472 (949)
Q Consensus 394 ~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~l~~ 472 (949)
+|++++|++++.. |..++.+++|++|++++|+ ++ .+| .+..+++|+.|++++
T Consensus 116 ~L~Ls~n~i~~~~-------------------------~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~ 168 (197)
T 4ezg_A 116 LLDISHSAHDDSI-------------------------LTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQF 168 (197)
T ss_dssp EEECCSSBCBGGG-------------------------HHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTT
T ss_pred EEEecCCccCcHh-------------------------HHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCC
Confidence 7766666666433 4444455555555555555 33 333 455555666666666
Q ss_pred cccccccCCCcCCCCCCCEEECCCCcCC
Q 039533 473 NLFQGPISSSLGSLRGLRVLDLSQNNLS 500 (949)
Q Consensus 473 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 500 (949)
|++++ ++ .+..+++|+.|++++|++.
T Consensus 169 n~i~~-~~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 169 DGVHD-YR-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp BCCCC-CT-TGGGCSSCCEEEECBC---
T ss_pred CCCcC-hH-HhccCCCCCEEEeeCcccC
Confidence 66554 22 5556666666666666654
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.73 E-value=9e-18 Score=168.69 Aligned_cols=130 Identities=24% Similarity=0.302 Sum_probs=70.2
Q ss_pred EEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCcc-ccccccccceeeeccccccccCCcccccccchhhcccCc
Q 039533 394 EINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPI-EVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGG 472 (949)
Q Consensus 394 ~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 472 (949)
.+++++|+++ .+|..+.. .+ +.|++++|++++..+. .++.+++|++|+|++|+|++..|..|.++++|+.|+|++
T Consensus 12 ~l~~s~~~l~-~ip~~~~~--~l-~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 12 TVDCTGRGLK-EIPRDIPL--HT-TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EEECTTSCCS-SCCSCCCT--TC-SEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred EEEcCCCCcC-cCccCCCC--CC-CEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 4444444443 34443322 22 3445555555433332 255555555666666666555555565666666666666
Q ss_pred cccccccCCCcCCCCCCCEEECCCCcCCCcCcccccCCc-cceEeCCCCcCcCccc
Q 039533 473 NLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLS-LNNLNLSYNDLEGMVT 527 (949)
Q Consensus 473 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~l~ls~N~l~~~~~ 527 (949)
|+|++..+..|..+++|+.|+|++|+|++.+|..+..++ |++|+|++|++++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 666655555566666666666666666655555555554 6666666666665544
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.2e-17 Score=168.59 Aligned_cols=149 Identities=18% Similarity=0.275 Sum_probs=107.0
Q ss_pred cEEEEEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCC
Q 039533 66 RVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQ 145 (949)
Q Consensus 66 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 145 (949)
+++.|++++++++ .++ .+..+++|++|+|++|.++ .+..+..+++|++|+|++|.+++..|..|+.+++|++|+++
T Consensus 45 ~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls 120 (197)
T 4ezg_A 45 SLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS 120 (197)
T ss_dssp TCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECC
T ss_pred CccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEec
Confidence 4667777777777 444 5777788888888877554 33467777888888888888877777777778888888888
Q ss_pred CccccccccccccCCCCCcEEECCCCC-CCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCcccc
Q 039533 146 NNQLVGKILSRFSSLSKTEILNLGSNH-LTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLS 222 (949)
Q Consensus 146 ~n~l~~~~~~~~~~L~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 222 (949)
+|++++..+..|..+++|++|+|++|. ++ .+| .+..+++|++|+|++|++++ ++ .+..+++|++|++++|+|.
T Consensus 121 ~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 121 HSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp SSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC---
T ss_pred CCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcccC
Confidence 887777777777777778888888777 54 444 57777777777777777774 33 5677777777777777654
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.72 E-value=6.8e-18 Score=185.41 Aligned_cols=301 Identities=11% Similarity=0.051 Sum_probs=165.8
Q ss_pred CccccCCCCC--CCCCceeeccCceeccccCCcccC-cccCcEEeecccccc--CcCCCCCCCCccceeecCCCcccccc
Q 039533 78 AGSVSHFIGN--LSFLKQLYLQVNSFTHEIPSEIGG-LRRLKVLALNNNSIC--GEIPTNISRCSTLIPIHPQNNQLVGK 152 (949)
Q Consensus 78 ~g~~~~~l~~--l~~L~~L~L~~n~l~~~~p~~~~~-l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~l~~n~l~~~ 152 (949)
.|.++..+.. +.+++.|.++++ +.+.--..+.. +++|++|||++|+|. ...+.. ++.+..+.+..|. +
T Consensus 12 ~g~l~~~l~~~~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~---~~~~~~~~~~~~~---I 84 (329)
T 3sb4_A 12 PGTLISMMTEEEANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGT---YPNGKFYIYMANF---V 84 (329)
T ss_dssp TTCGGGGSCHHHHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSS---SGGGCCEEECTTE---E
T ss_pred CCcHHhhccchhhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCcccc---ccccccccccccc---c
Confidence 4455555554 777888888764 22211123333 788999999999887 222222 2224444445553 3
Q ss_pred ccccccC--------CCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCcccccc
Q 039533 153 ILSRFSS--------LSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVV 224 (949)
Q Consensus 153 ~~~~~~~--------L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 224 (949)
...+|.+ +++|+.|+|.+ .++...+.+|.++++|+.|+|++|.++...+.+|.+..++.++.+..+....-
T Consensus 85 ~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~ 163 (329)
T 3sb4_A 85 PAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRF 163 (329)
T ss_dssp CTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHT
T ss_pred CHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhc
Confidence 4556666 88888888888 77756667788888888888888888877777888877777776655321100
Q ss_pred cccccCCCCChhhhcccc-ccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccC
Q 039533 225 ENKLTGEVPSLEKLQRLQ-HFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNN 303 (949)
Q Consensus 225 ~~~l~~~~~~l~~l~~L~-~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~ 303 (949)
...+. -..+..+..|+ .+.+.... .. .-..........+++.+.+.++-.. .....+.....+|+.|+|++
T Consensus 164 ~~~i~--~~~f~~~~~L~~~i~~~~~~--~l---~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~ 235 (329)
T 3sb4_A 164 KNRWE--HFAFIEGEPLETTIQVGAMG--KL---EDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISK 235 (329)
T ss_dssp STTTT--TSCEEESCCCEEEEEECTTC--CH---HHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTT
T ss_pred ccccc--ccccccccccceeEEecCCC--cH---HHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCC
Confidence 00000 00011111222 11111000 00 0000000112333444444433111 11111112124566777776
Q ss_pred ccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCC-EEecCCcccccccCcccccccccceeecccccccccC
Q 039533 304 NKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLK-ILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSI 382 (949)
Q Consensus 304 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 382 (949)
|+++.+.+..|.++++|+.|+|.+| ++.+.+.+|.++.+|+ .+++.+ .++.+.+.+|.++++|+.+++++|.++...
T Consensus 236 n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~ 313 (329)
T 3sb4_A 236 TNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLG 313 (329)
T ss_dssp BCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEEC
T ss_pred CCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccc
Confidence 6666555556666667777777666 5555556666676676 677666 555455566666667777776666666666
Q ss_pred CCCCCCCCCCcEEE
Q 039533 383 PSSLGQCESLIEIN 396 (949)
Q Consensus 383 p~~~~~l~~L~~L~ 396 (949)
+.+|.++++|+.|+
T Consensus 314 ~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 314 DELFGNGVPSKLIY 327 (329)
T ss_dssp TTTTCTTCCCCEEE
T ss_pred hhhhcCCcchhhhc
Confidence 66666666666665
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.70 E-value=3.3e-17 Score=164.59 Aligned_cols=131 Identities=23% Similarity=0.265 Sum_probs=93.9
Q ss_pred eeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCC-cccCCcccceeeccCCCccCCCCccccccccccceeeecc
Q 039533 370 NLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPP-QFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYE 448 (949)
Q Consensus 370 ~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 448 (949)
.+++++|.++ .+|..+.. +|++|++++|++++..+. .|..+++| +.|+|++|+|++..|..|.++++|++|+|++
T Consensus 12 ~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 12 TVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHL-VKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTC-CEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred EEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCC-CEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 3444444443 33333322 555666666666543333 25555555 5666666666666677777888888888888
Q ss_pred ccccccCCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCcCc
Q 039533 449 NRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIP 504 (949)
Q Consensus 449 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 504 (949)
|+|++..|..|.++++|+.|+|++|+|++.+|..|..+++|+.|+|++|.+++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 88888888888888999999999999998889999999999999999999997765
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.68 E-value=4.6e-17 Score=159.83 Aligned_cols=137 Identities=17% Similarity=0.194 Sum_probs=113.9
Q ss_pred CCCCCceeeccCceec-cccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcE
Q 039533 87 NLSFLKQLYLQVNSFT-HEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEI 165 (949)
Q Consensus 87 ~l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~ 165 (949)
..++|++|+|++|.++ +.+|..+..+++|++|+|++|.+++. ..++.+++|++|++++|++++.++..+..+++|++
T Consensus 22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 99 (168)
T 2ell_A 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99 (168)
T ss_dssp CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence 3477888888888887 77888888888999999999988854 77888888888888888888877888888999999
Q ss_pred EECCCCCCCCCC-CCCcCCCCCccEEeccccccCCCCC---CcccCCCccccccccCccccccc
Q 039533 166 LNLGSNHLTGSI-PSSLGNLSSIHTISLAYNNLDGTIP---NSFGWFENLVFLSLAANNLSVVE 225 (949)
Q Consensus 166 L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~~~~ 225 (949)
|+|++|.|++.. +..+..+++|++|+|++|.+++..+ ..|..+++|++|++++|.+..++
T Consensus 100 L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~ 163 (168)
T 2ell_A 100 LNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEAP 163 (168)
T ss_dssp EECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBCC
T ss_pred EeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhcc
Confidence 999999998542 2678889999999999999986555 47888999999999988877654
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.66 E-value=3.2e-16 Score=155.26 Aligned_cols=134 Identities=23% Similarity=0.241 Sum_probs=92.9
Q ss_pred cceeeeeEEeCCCCcEEEEEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCC
Q 039533 52 FCKWYGVTCSRRHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPT 131 (949)
Q Consensus 52 ~C~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 131 (949)
.|+|.+|.|+.. +++ .+|..+ .++|++|+|++|++++..+..|+++++|++|+|++|+|++..+.
T Consensus 6 ~C~~~~l~~~~~------------~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 70 (177)
T 2o6r_A 6 SCSGTEIRCNSK------------GLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDG 70 (177)
T ss_dssp EEETTEEECCSS------------CCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTT
T ss_pred EeCCCEEEecCC------------CCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChh
Confidence 478888888643 333 334333 36888999999988876666788888888898888888865555
Q ss_pred CCCCCccceeecCCCccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCC
Q 039533 132 NISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGT 200 (949)
Q Consensus 132 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 200 (949)
.|+++++|++|++++|+|++..+..|..+++|++|+|++|.|++..+..+..+++|++|+|++|.+++.
T Consensus 71 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 139 (177)
T 2o6r_A 71 VFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 139 (177)
T ss_dssp TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred HccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence 667777777777777777666666666666666666666666654444556666666666666666543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.65 E-value=7.7e-17 Score=154.75 Aligned_cols=129 Identities=17% Similarity=0.207 Sum_probs=105.3
Q ss_pred CCCCCceeeccCceec-cccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcE
Q 039533 87 NLSFLKQLYLQVNSFT-HEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEI 165 (949)
Q Consensus 87 ~l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~ 165 (949)
..++|+.|++++|.++ +.+|..++.+++|++|+|++|.+++. ..++++++|++|++++|.+++.++..+..+++|++
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence 3467888888888888 78888888888888888888888855 77888888888888888888877788888888888
Q ss_pred EECCCCCCCCC-CCCCcCCCCCccEEeccccccCCCCC---CcccCCCcccccccc
Q 039533 166 LNLGSNHLTGS-IPSSLGNLSSIHTISLAYNNLDGTIP---NSFGWFENLVFLSLA 217 (949)
Q Consensus 166 L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~Ls 217 (949)
|+|++|.+++. .+..++.+++|++|++++|++++..+ ..++.+++|++|+++
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 88888888863 34778888888888888888886655 467888888888876
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=3.7e-16 Score=156.83 Aligned_cols=125 Identities=22% Similarity=0.314 Sum_probs=78.4
Q ss_pred EEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccc
Q 039533 70 LDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQL 149 (949)
Q Consensus 70 l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l 149 (949)
+++++++++ .+|..+. ++|++|+|++|+|+ .+|..|.++++|++|+|++|.|++..|..|.++++|++|+|++|+|
T Consensus 15 l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l 90 (193)
T 2wfh_A 15 VRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90 (193)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCcc
Confidence 455566665 4555443 57777888888776 6677777777777777777777766566666666666666666665
Q ss_pred cccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccC
Q 039533 150 VGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLD 198 (949)
Q Consensus 150 ~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 198 (949)
++..+..|.++++|++|+|++|.|++..+..|..+++|++|+|++|.+.
T Consensus 91 ~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 91 RCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 5555555555555555555555555443444555555555555555544
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=5.6e-16 Score=155.50 Aligned_cols=129 Identities=24% Similarity=0.286 Sum_probs=87.3
Q ss_pred cEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccCCcccccccchhhcccCc
Q 039533 393 IEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGG 472 (949)
Q Consensus 393 ~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 472 (949)
+.+++++|+++ .+|..+. ..+ +.|++++|+++ .+|..+..+++|+.|+|++|+|++..+..|.++++|+.|+|++
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l-~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~ 87 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDV-TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSY 87 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTC-CEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCC-CEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCC
Confidence 34555555555 4454432 233 45666666665 5556677777777777777777766666777777777777777
Q ss_pred cccccccCCCcCCCCCCCEEECCCCcCCCcCcccccCCc-cceEeCCCCcCcCcc
Q 039533 473 NLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLS-LNNLNLSYNDLEGMV 526 (949)
Q Consensus 473 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~l~ls~N~l~~~~ 526 (949)
|+|++..|..|..+++|+.|+|++|+|++..+..+..++ |+.|+|++|++.+..
T Consensus 88 N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c 142 (193)
T 2wfh_A 88 NRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDC 142 (193)
T ss_dssp SCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred CccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCC
Confidence 777777777777777777777777777766665666555 777888888776643
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.63 E-value=5.5e-16 Score=152.13 Aligned_cols=108 Identities=25% Similarity=0.208 Sum_probs=49.6
Q ss_pred CCCCEEecCCcccc-cccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceee
Q 039533 342 QNLKILGLNRNKLS-GNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISL 420 (949)
Q Consensus 342 ~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L 420 (949)
++|+.|+|++|+++ +.+|..+..+++|+.|++++|.+++. ..+..+++|++|++++|++++.+|..+..+++| +.|
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L-~~L 100 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNL-THL 100 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTC-CEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCC-CEE
Confidence 34455555555544 34444444555555555555554433 445555556666665555554333333333333 333
Q ss_pred ccCCCccCCCC-ccccccccccceeeecccccc
Q 039533 421 DWSRNKLTGSL-PIEVGKLKILEFLYVYENRLE 452 (949)
Q Consensus 421 ~ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~ 452 (949)
++++|++++.. +..+..+++|+.|++++|+++
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~ 133 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGG
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCc
Confidence 33333333211 133444444444444444444
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.63 E-value=2.1e-15 Score=165.50 Aligned_cols=285 Identities=14% Similarity=0.063 Sum_probs=202.0
Q ss_pred cEEEEEcCCCCCCccccCCCCC-CCCCceeeccCceec--cccCCcccCcccCcEEeeccccccCcCCCCCCC-------
Q 039533 66 RVTLLDLRSLKLAGSVSHFIGN-LSFLKQLYLQVNSFT--HEIPSEIGGLRRLKVLALNNNSICGEIPTNISR------- 135 (949)
Q Consensus 66 ~v~~l~l~~~~l~g~~~~~l~~-l~~L~~L~L~~n~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------- 135 (949)
+++.|+++++ +.+.--..+.. +++|+.|||++|++. ...+.. ++.++.+.+..|.|. +..|.+
T Consensus 26 ~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~---~~~~~~~~~~~~~I~---~~aF~~~~~~~~~ 98 (329)
T 3sb4_A 26 SITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGT---YPNGKFYIYMANFVP---AYAFSNVVNGVTK 98 (329)
T ss_dssp HCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSS---SGGGCCEEECTTEEC---TTTTEEEETTEEE
T ss_pred ceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCcccc---ccccccccccccccC---HHHhccccccccc
Confidence 3556666542 11111112333 889999999999998 333323 333677777777443 345667
Q ss_pred -CccceeecCCCccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccc----cCCCCCCcccCCCc
Q 039533 136 -CSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNN----LDGTIPNSFGWFEN 210 (949)
Q Consensus 136 -l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~----l~~~~p~~~~~l~~ 210 (949)
|++|+.|+|.+ .++.+...+|.++++|+.|+|++|.++...+..|.++.++..+.+..+. .......+|.++.+
T Consensus 99 g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~ 177 (329)
T 3sb4_A 99 GKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEP 177 (329)
T ss_dssp ECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCC
T ss_pred ccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccc
Confidence 99999999999 9999999999999999999999999987777899998888888877643 33344556777777
Q ss_pred cc-cccccCcccccccccccCCCCChhhhccccccccccCCCCCCCCCCcchhccc-cccCcccEEEccCCCCCccCCch
Q 039533 211 LV-FLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSL-TNATRLTWMHINSNNFGGLLPGC 288 (949)
Q Consensus 211 L~-~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l-~~~~~L~~L~L~~N~l~~~~p~~ 288 (949)
|+ .+.+.... .++..+.. ......++..+.+.++-.. .. ...+ ..+++|+.+++++|+++...+.+
T Consensus 178 L~~~i~~~~~~--~l~~~~~~---~~~~~~~~~~l~~~~~l~~------~~-~~~l~~~~~~L~~l~L~~n~i~~I~~~a 245 (329)
T 3sb4_A 178 LETTIQVGAMG--KLEDEIMK---AGLQPRDINFLTIEGKLDN------AD-FKLIRDYMPNLVSLDISKTNATTIPDFT 245 (329)
T ss_dssp CEEEEEECTTC--CHHHHHHH---TTCCGGGCSEEEEEECCCH------HH-HHHHHHHCTTCCEEECTTBCCCEECTTT
T ss_pred cceeEEecCCC--cHHHHHhh---cccCccccceEEEeeeecH------HH-HHHHHHhcCCCeEEECCCCCcceecHhh
Confidence 76 44443211 11110000 0011334444444433110 00 0111 23688999999999999887778
Q ss_pred hhcccccccEEEccCccccCCCCCCCCCCCccc-EEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccc
Q 039533 289 ISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQ-RLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKM 367 (949)
Q Consensus 289 ~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 367 (949)
|.++ .+|+.|+|.+| ++.+.+.+|.++++|+ .+++.+ +++.+.+.+|.++++|+.|++++|+++...+.+|.++++
T Consensus 246 F~~~-~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~ 322 (329)
T 3sb4_A 246 FAQK-KYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVP 322 (329)
T ss_dssp TTTC-TTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCC
T ss_pred hhCC-CCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcc
Confidence 8887 46999999998 8877788899999999 999999 787677899999999999999999999888889999999
Q ss_pred cceeec
Q 039533 368 LLNLFL 373 (949)
Q Consensus 368 L~~L~L 373 (949)
|+.++.
T Consensus 323 L~~ly~ 328 (329)
T 3sb4_A 323 SKLIYK 328 (329)
T ss_dssp CCEEEC
T ss_pred hhhhcc
Confidence 999874
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.61 E-value=2.7e-15 Score=148.53 Aligned_cols=129 Identities=19% Similarity=0.223 Sum_probs=114.2
Q ss_pred CceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECCC
Q 039533 91 LKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGS 170 (949)
Q Consensus 91 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~ 170 (949)
.+.+++++|+++ .+|..+ .++|++|+|++|++++..+..|+++++|++|++++|++++..+..|..+++|++|+|++
T Consensus 9 ~~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 468899999998 567554 37999999999999977677789999999999999999988888899999999999999
Q ss_pred CCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCcccc
Q 039533 171 NHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLS 222 (949)
Q Consensus 171 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 222 (949)
|+|++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|.++
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 137 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 137 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCee
Confidence 9999877778899999999999999999777777889999999999998765
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.60 E-value=3.9e-16 Score=170.29 Aligned_cols=145 Identities=13% Similarity=0.110 Sum_probs=104.2
Q ss_pred HHHHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--------------cchHH--------HHHHHHHH
Q 039533 620 DLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--------------GASRS--------FIAECKAL 677 (949)
Q Consensus 620 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~E~~~l 677 (949)
.+.....-|++.+.||+|++|.||+|.+. +|+.||||+++.... ..... ..+|...+
T Consensus 89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL 167 (397)
T 4gyi_A 89 THAARKDVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM 167 (397)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHCCCEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence 34444455899999999999999999986 689999999863210 00011 23466666
Q ss_pred HhcCCCcce--eEEeeeecccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHh
Q 039533 678 KSIRHRNLV--KVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLH 755 (949)
Q Consensus 678 ~~l~h~niv--~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH 755 (949)
.++.+.++. ..+++ ...++||||++|++|.++... .....++.|++.++.|||
T Consensus 168 ~rL~~~gv~vp~p~~~---------~~~~LVME~i~G~~L~~l~~~----------------~~~~~l~~qll~~l~~lH 222 (397)
T 4gyi_A 168 KALYEEGFPVPEPIAQ---------SRHTIVMSLVDALPMRQVSSV----------------PDPASLYADLIALILRLA 222 (397)
T ss_dssp HHHHHTTCSCCCEEEE---------ETTEEEEECCSCEEGGGCCCC----------------SCHHHHHHHHHHHHHHHH
T ss_pred HHHHhcCCCCCeeeec---------cCceEEEEecCCccHhhhccc----------------HHHHHHHHHHHHHHHHHH
Confidence 666444332 22221 134799999999888766530 123568899999999999
Q ss_pred hCCCCCeEecCCCCCCeeecCCC----------ceEEeecccceecCC
Q 039533 756 HDCQPVTAHCDLKPSNVLLDDYM----------TARVGDFGLARILSP 793 (949)
Q Consensus 756 ~~~~~~ivHrDlkp~NIll~~~~----------~~kl~DfG~a~~~~~ 793 (949)
.. |||||||||.|||+++++ .+.|+||+-+.....
T Consensus 223 ~~---gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~h 267 (397)
T 4gyi_A 223 KH---GLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMDH 267 (397)
T ss_dssp HT---TEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEETTS
T ss_pred HC---CCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccCCC
Confidence 77 899999999999998776 389999998876443
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.59 E-value=3.4e-14 Score=159.18 Aligned_cols=105 Identities=11% Similarity=0.104 Sum_probs=67.9
Q ss_pred cccEEEccCccccCCCCCCCCCCCcccEEEeecceec-----ccCCCcccccCCCCEEecCCcccccccCcccccccccc
Q 039533 295 TIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLS-----GTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLL 369 (949)
Q Consensus 295 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 369 (949)
+|+.+.+ .+.++.+...+|.++++|+.+++.+|.+. ...+.+|.++++|+.++|. |.++.+-..+|.++++|+
T Consensus 249 ~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~ 326 (401)
T 4fdw_A 249 GITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVT 326 (401)
T ss_dssp CCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCC
T ss_pred CccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCcc
Confidence 4666666 34455455666777777777777776654 3455667777777777777 346645556677777777
Q ss_pred eeecccccccccCCCCCCCCCCCcEEEeeCcccc
Q 039533 370 NLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLS 403 (949)
Q Consensus 370 ~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 403 (949)
.+.|.+| ++...+.+|.++ +|+.|++++|.+.
T Consensus 327 ~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~ 358 (401)
T 4fdw_A 327 QLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPP 358 (401)
T ss_dssp EEEECTT-CCEECTTSSSSS-CCCEEEECCSSCC
T ss_pred EEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCc
Confidence 7777444 555556677777 7777777777665
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.58 E-value=9.5e-16 Score=147.09 Aligned_cols=125 Identities=21% Similarity=0.179 Sum_probs=52.0
Q ss_pred CCCEEecCCcccc-cccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeec
Q 039533 343 NLKILGLNRNKLS-GNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLD 421 (949)
Q Consensus 343 ~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ 421 (949)
+|+.|++++|+++ +.+|..+..+++|+.|++++|.+++. ..+..+++|++|++++|++++.+|..+..+++| +.|+
T Consensus 18 ~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L-~~L~ 94 (149)
T 2je0_A 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNL-THLN 94 (149)
T ss_dssp GCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTC-CEEE
T ss_pred cCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCC-CEEE
Confidence 3444444444443 33343344444444444444444332 334444555555555555543333333333333 3333
Q ss_pred cCCCccCCC-CccccccccccceeeeccccccccCC---cccccccchhhccc
Q 039533 422 WSRNKLTGS-LPIEVGKLKILEFLYVYENRLEGEIP---STFGNCIRLEQLGM 470 (949)
Q Consensus 422 ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~l 470 (949)
+++|++++. .+..++.+++|++|++++|++++..+ ..++.+++|+.|++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l 147 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDG 147 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETT
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccC
Confidence 333333321 12344444444444444444443322 23444444444443
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.58 E-value=3.5e-14 Score=159.09 Aligned_cols=266 Identities=11% Similarity=0.063 Sum_probs=190.9
Q ss_pred CCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEE
Q 039533 88 LSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILN 167 (949)
Q Consensus 88 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~ 167 (949)
...++.+.+.+ +++..-..+|.++ +|+.++|..| ++..-...|.++ +|+.+.+.+ .+..+...+|.++++|+.++
T Consensus 112 ~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~ 186 (401)
T 4fdw_A 112 LKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKAD 186 (401)
T ss_dssp CSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEE
T ss_pred cCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeee
Confidence 35666666654 4554445577775 6888888766 653444566664 688888875 67777778888888888888
Q ss_pred CCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCcccccccccccCCCCChhhhccccccccc
Q 039533 168 LGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTIT 247 (949)
Q Consensus 168 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~ 247 (949)
|++|.++......|. .++|+.+.|..+ ++.....+|.++++|+.+++..| ++.++...
T Consensus 187 l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~a------------------- 244 (401)
T 4fdw_A 187 LSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEA------------------- 244 (401)
T ss_dssp CTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTT-------------------
T ss_pred cCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCccccc-------------------
Confidence 888888844445555 578888888744 66566778888888888887754 44443221
Q ss_pred cCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCcccc-----CCCCCCCCCCCcccE
Q 039533 248 SNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIY-----GSIPAGIGNFVNLQR 322 (949)
Q Consensus 248 ~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~-----~~~~~~~~~l~~L~~ 322 (949)
|.+ .+|+.+.+ .++++.....+|.+. .+|+.+.+.+|.+. .+.+..|.++++|+.
T Consensus 245 -----------------F~~-~~L~~i~l-p~~i~~I~~~aF~~c-~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~ 304 (401)
T 4fdw_A 245 -----------------FRE-SGITTVKL-PNGVTNIASRAFYYC-PELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLAR 304 (401)
T ss_dssp -----------------TTT-CCCSEEEE-ETTCCEECTTTTTTC-TTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCE
T ss_pred -----------------ccc-CCccEEEe-CCCccEEChhHhhCC-CCCCEEEeCCccccCCcccEECHHHhhCCccCCe
Confidence 222 34556666 344554555566655 45778887777664 456778999999999
Q ss_pred EEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecccccccccCCCCCCCCC-CCcEEEeeCcc
Q 039533 323 LDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCE-SLIEINLSNNN 401 (949)
Q Consensus 323 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~l~~N~ 401 (949)
++|. |.++.+...+|.++.+|+.++|..| ++..-+.+|.++ +|+.+++.+|.+....+..|.+++ +++.|++..+.
T Consensus 305 l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~ 381 (401)
T 4fdw_A 305 FEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAES 381 (401)
T ss_dssp ECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGG
T ss_pred EEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHH
Confidence 9999 4577677789999999999999665 776777889999 999999999998877788888884 78899988877
Q ss_pred cc
Q 039533 402 LS 403 (949)
Q Consensus 402 l~ 403 (949)
+.
T Consensus 382 ~~ 383 (401)
T 4fdw_A 382 VE 383 (401)
T ss_dssp HH
T ss_pred HH
Confidence 65
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.57 E-value=1.6e-15 Score=150.04 Aligned_cols=135 Identities=16% Similarity=0.121 Sum_probs=112.4
Q ss_pred CCCCCCCCCceeeccCceeccccCCcccCcc-cCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCC
Q 039533 83 HFIGNLSFLKQLYLQVNSFTHEIPSEIGGLR-RLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLS 161 (949)
Q Consensus 83 ~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~ 161 (949)
+.+.++++|++|+|++|+++ .+|. +..+. +|++|+|++|.|++. ..|+++++|++|++++|+|++..+..|..++
T Consensus 13 ~~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 88 (176)
T 1a9n_A 13 AQYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALP 88 (176)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred HhcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCC
Confidence 34567888999999999998 4554 55554 999999999999854 6788999999999999999887777789999
Q ss_pred CCcEEECCCCCCCCCCCC--CcCCCCCccEEeccccccCCCCCCc----ccCCCccccccccCccccc
Q 039533 162 KTEILNLGSNHLTGSIPS--SLGNLSSIHTISLAYNNLDGTIPNS----FGWFENLVFLSLAANNLSV 223 (949)
Q Consensus 162 ~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~~ 223 (949)
+|++|+|++|.|+ .+|. .+..+++|++|+|++|.++ .+|.. ++.+++|++||+++|.+..
T Consensus 89 ~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 89 DLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp TCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred CCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 9999999999997 5665 7888999999999999998 55664 8889999999999888764
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.55 E-value=5.1e-17 Score=164.18 Aligned_cols=132 Identities=26% Similarity=0.279 Sum_probs=61.1
Q ss_pred ccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccc
Q 039533 361 SIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKI 440 (949)
Q Consensus 361 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~ 440 (949)
.+.++++|++|++++|.+++ +| .+..+++|++|++++|+++ .+|..+..+++| +.|++++|++++ +| .+..+++
T Consensus 43 ~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L-~~L~L~~N~l~~-l~-~~~~l~~ 116 (198)
T 1ds9_A 43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL-EELWISYNQIAS-LS-GIEKLVN 116 (198)
T ss_dssp HHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC-SEEEEEEEECCC-HH-HHHHHHH
T ss_pred HHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcC-CEEECcCCcCCc-CC-ccccCCC
Confidence 34444444444444444443 33 4444444444444444444 333333333333 333333333332 22 3455556
Q ss_pred cceeeeccccccccCC-cccccccchhhcccCccccccccCCC----------cCCCCCCCEEECCCCcCC
Q 039533 441 LEFLYVYENRLEGEIP-STFGNCIRLEQLGMGGNLFQGPISSS----------LGSLRGLRVLDLSQNNLS 500 (949)
Q Consensus 441 L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~~----------~~~l~~L~~L~Ls~N~l~ 500 (949)
|++|++++|++++..+ ..+..+++|+.|++++|.+++.+|.. +..+++|+.|| +|.++
T Consensus 117 L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 117 LRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp SSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred CCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 6666666666653221 24555555555555555555544432 55555566554 44443
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.52 E-value=6.3e-13 Score=149.61 Aligned_cols=311 Identities=13% Similarity=0.076 Sum_probs=164.5
Q ss_pred cCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCC
Q 039533 82 SHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLS 161 (949)
Q Consensus 82 ~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~ 161 (949)
..+|.++++|+.+.|.. +++..-..+|.++++|+.++|.++ ++..-...|.++++|+.+.+..+ +......+|.+..
T Consensus 64 ~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~ 140 (394)
T 4fs7_A 64 YAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCD 140 (394)
T ss_dssp TTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCC
T ss_pred HHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeeccc
Confidence 35677788888888864 366444567888888888888755 54333456778888887776644 5555566677665
Q ss_pred CCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCcccccccccccCCCCChhhhccc
Q 039533 162 KTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRL 241 (949)
Q Consensus 162 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L 241 (949)
.++......... .....|.++++|+.+.+.++. ......+|.++.+|+.+++..| ++.++.. .+..+..|
T Consensus 141 ~~~~~~~~~~~~--i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~------~F~~~~~L 210 (394)
T 4fs7_A 141 FKEITIPEGVTV--IGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDY------CFAECILL 210 (394)
T ss_dssp CSEEECCTTCCE--ECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTT------TTTTCTTC
T ss_pred ccccccCccccc--cchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCch------hhcccccc
Confidence 554444333322 234567788888888886553 3355667777888888877655 4433322 12233333
Q ss_pred cccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCccc
Q 039533 242 QHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQ 321 (949)
Q Consensus 242 ~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 321 (949)
+.+.+..+.. . +....... ..|+.+.+..+ ++......+..+.+|+
T Consensus 211 ~~i~~~~~~~------------------------------~--i~~~~~~~-~~l~~i~ip~~-~~~i~~~~f~~~~~l~ 256 (394)
T 4fs7_A 211 ENMEFPNSLY------------------------------Y--LGDFALSK-TGVKNIIIPDS-FTELGKSVFYGCTDLE 256 (394)
T ss_dssp CBCCCCTTCC------------------------------E--ECTTTTTT-CCCCEEEECTT-CCEECSSTTTTCSSCC
T ss_pred ceeecCCCce------------------------------E--eehhhccc-CCCceEEECCC-ceecccccccccccce
Confidence 3333322211 1 00111111 23455554432 2223344555666666
Q ss_pred EEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCcc
Q 039533 322 RLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNN 401 (949)
Q Consensus 322 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 401 (949)
.+.+..+... .....|..+..++.+.+..+.+. ...|.++.+|+.+.+.++ ++.....+|.++++|+.+++.++
T Consensus 257 ~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~- 330 (394)
T 4fs7_A 257 SISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL- 330 (394)
T ss_dssp EEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-
T ss_pred eEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-
Confidence 6666655443 44556666666666665554322 234555666666666544 44444555666666666655432
Q ss_pred ccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeec
Q 039533 402 LSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVY 447 (949)
Q Consensus 402 l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls 447 (949)
++..-...|.++.+| +.+++..| ++..-..+|.++.+|+.+++.
T Consensus 331 v~~I~~~aF~~c~~L-~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp 374 (394)
T 4fs7_A 331 VEEIGKRSFRGCTSL-SNINFPLS-LRKIGANAFQGCINLKKVELP 374 (394)
T ss_dssp CCEECTTTTTTCTTC-CEECCCTT-CCEECTTTBTTCTTCCEEEEE
T ss_pred ccEEhHHhccCCCCC-CEEEECcc-ccEehHHHhhCCCCCCEEEEC
Confidence 331112233333444 33444333 332333344444444444443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.52 E-value=1.1e-16 Score=161.76 Aligned_cols=150 Identities=20% Similarity=0.271 Sum_probs=90.7
Q ss_pred cccEEEccCccccCCCCC------CCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCccccccccc
Q 039533 295 TIKTLFLNNNKIYGSIPA------GIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKML 368 (949)
Q Consensus 295 ~L~~L~L~~N~l~~~~~~------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 368 (949)
.++.++++.+.++|.+|. .+..+++|++|+|++|.+++ +| .+.++++|+.|+|++|+++ .+|..+..+++|
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L 95 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL 95 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence 466666666666666555 56666666666666666664 44 5666666666666666666 455555555666
Q ss_pred ceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCc-cccccccccceeeec
Q 039533 369 LNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLP-IEVGKLKILEFLYVY 447 (949)
Q Consensus 369 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p-~~~~~l~~L~~L~Ls 447 (949)
+.|++++|++++ +| .+..+++|++|++++|+++ +..+ ..+..+++|++|+++
T Consensus 96 ~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~-------------------------~~~~~~~l~~l~~L~~L~l~ 148 (198)
T 1ds9_A 96 EELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKIT-------------------------NWGEIDKLAALDKLEDLLLA 148 (198)
T ss_dssp SEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECC-------------------------CHHHHHHHTTTTTCSEEEEC
T ss_pred CEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCC-------------------------chhHHHHHhcCCCCCEEEec
Confidence 666666666654 23 3455555555555555554 2111 355666777777777
Q ss_pred cccccccCCcc----------cccccchhhcccCccccc
Q 039533 448 ENRLEGEIPST----------FGNCIRLEQLGMGGNLFQ 476 (949)
Q Consensus 448 ~N~l~~~~p~~----------~~~l~~L~~L~l~~N~l~ 476 (949)
+|++++.+|.. +..+++|+.|| +|.++
T Consensus 149 ~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 149 GNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp SCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred CCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 77777665543 66777777766 55554
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.52 E-value=9.7e-15 Score=144.32 Aligned_cols=133 Identities=17% Similarity=0.162 Sum_probs=83.3
Q ss_pred ccccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCC
Q 039533 265 LTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNL 344 (949)
Q Consensus 265 l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 344 (949)
+.++++|++|++++|+++.. |. +..+.++|++|+|++|+|++. ..+..+++|++|+|++|+|++..+..|..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 34455666677777766643 33 444444577777777777654 566677777777777777775544445667777
Q ss_pred CEEecCCcccccccCc--ccccccccceeecccccccccCCCC----CCCCCCCcEEEeeCcccc
Q 039533 345 KILGLNRNKLSGNIPP--SIGNLKMLLNLFLNDNFLEVSIPSS----LGQCESLIEINLSNNNLS 403 (949)
Q Consensus 345 ~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~----~~~l~~L~~L~l~~N~l~ 403 (949)
+.|+|++|+|+ .+|. .+.++++|+.|++++|.++ .+|.. +..+++|+.|++++|.+.
T Consensus 91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 77777777775 3444 5666666666666666665 34443 566666666666666554
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.49 E-value=6.8e-13 Score=149.33 Aligned_cols=317 Identities=12% Similarity=0.071 Sum_probs=161.7
Q ss_pred eccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECCCCCCCCCCCCC
Q 039533 101 FTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSS 180 (949)
Q Consensus 101 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~ 180 (949)
++..-..+|.++++|+.+.|..+ ++..-...|.+|++|+.+++.++ ++.+...+|.++.+|+.+.+..+ +.......
T Consensus 59 VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~a 135 (394)
T 4fs7_A 59 VVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEA 135 (394)
T ss_dssp EEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTT
T ss_pred EeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeeccee
Confidence 44344557888888888888643 65334456788888888888654 56566677777777777766554 33244455
Q ss_pred cCCCCCccEEeccccccCCCCCCcccCCCccccccccCcccccccccccCCCCChhhhccccccccccCCCCCCCCCCcc
Q 039533 181 LGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLS 260 (949)
Q Consensus 181 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~ 260 (949)
|.+...+........ ......+|.++++|+.+.+..+. ..++..
T Consensus 136 F~~~~~~~~~~~~~~--~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~--------------------------------- 179 (394)
T 4fs7_A 136 FKGCDFKEITIPEGV--TVIGDEAFATCESLEYVSLPDSM-ETLHNG--------------------------------- 179 (394)
T ss_dssp TTTCCCSEEECCTTC--CEECTTTTTTCTTCCEEECCTTC-CEECTT---------------------------------
T ss_pred eecccccccccCccc--cccchhhhcccCCCcEEecCCcc-ceeccc---------------------------------
Confidence 655544333332222 22334566667777776665432 222211
Q ss_pred hhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccc
Q 039533 261 FLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGE 340 (949)
Q Consensus 261 ~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 340 (949)
.+.++++|+.+.+..| ++.....++.+. ..|+.+.+..+... +.+.....++|+.+.+..+. +......|.+
T Consensus 180 ---~F~~c~~L~~i~l~~~-~~~I~~~~F~~~-~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~~-~~i~~~~f~~ 251 (394)
T 4fs7_A 180 ---LFSGCGKLKSIKLPRN-LKIIRDYCFAEC-ILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDSF-TELGKSVFYG 251 (394)
T ss_dssp ---TTTTCTTCCBCCCCTT-CCEECTTTTTTC-TTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTTC-CEECSSTTTT
T ss_pred ---cccCCCCceEEEcCCC-ceEeCchhhccc-cccceeecCCCceE--eehhhcccCCCceEEECCCc-eecccccccc
Confidence 1222333333333322 222222223222 23455544444332 22333344566666665432 2234455666
Q ss_pred cCCCCEEecCCcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceee
Q 039533 341 LQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISL 420 (949)
Q Consensus 341 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L 420 (949)
+.+|+.+.+..+..+ .....|.++..++.+....+.+ ....|..+.+|+.+.+.++ ++
T Consensus 252 ~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~----------------- 309 (394)
T 4fs7_A 252 CTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VK----------------- 309 (394)
T ss_dssp CSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEE---CTTTTTTCTTCCEEEECTT-CC-----------------
T ss_pred cccceeEEcCCCcce-eeccccccccccceeccCceee---ccccccccccccccccccc-cc-----------------
Confidence 666666666655443 4455566666666665554432 2335556666666666443 33
Q ss_pred ccCCCccCCCCccccccccccceeeeccccccccCCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCC
Q 039533 421 DWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQ 496 (949)
Q Consensus 421 ~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 496 (949)
.+-..+|.++.+|+.++|.++ ++..-..+|.+|.+|+.+++..| ++..-..+|.++.+|+.+++..
T Consensus 310 --------~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~ 375 (394)
T 4fs7_A 310 --------FIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPK 375 (394)
T ss_dssp --------EECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEG
T ss_pred --------eechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECC
Confidence 222334444444555544332 33333445555555555555444 4434444555555555555543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.47 E-value=1.2e-13 Score=135.43 Aligned_cols=87 Identities=29% Similarity=0.297 Sum_probs=45.8
Q ss_pred ccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEec
Q 039533 113 RRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISL 192 (949)
Q Consensus 113 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 192 (949)
++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 109 (170)
T 3g39_A 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL 109 (170)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence 33444444444444333444444444444444444444444444555556666666666666555555666666666666
Q ss_pred cccccCC
Q 039533 193 AYNNLDG 199 (949)
Q Consensus 193 ~~N~l~~ 199 (949)
++|.++.
T Consensus 110 ~~N~~~c 116 (170)
T 3g39_A 110 LNNPWDC 116 (170)
T ss_dssp CSSCBCT
T ss_pred CCCCCCC
Confidence 6666653
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.46 E-value=1.4e-13 Score=134.81 Aligned_cols=106 Identities=22% Similarity=0.264 Sum_probs=96.7
Q ss_pred cCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEecc
Q 039533 114 RLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLA 193 (949)
Q Consensus 114 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 193 (949)
..+.|++++|.++ .+|..+. ++|++|++++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 10 ~~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 10 SGTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 4578999999998 6888774 889999999999999999999999999999999999998777788999999999999
Q ss_pred ccccCCCCCCcccCCCccccccccCcccc
Q 039533 194 YNNLDGTIPNSFGWFENLVFLSLAANNLS 222 (949)
Q Consensus 194 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 222 (949)
+|+|++..+..|..+++|++|+|++|.++
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 99999877788999999999999999875
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.45 E-value=2.3e-13 Score=133.82 Aligned_cols=86 Identities=28% Similarity=0.286 Sum_probs=43.4
Q ss_pred ccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEec
Q 039533 113 RRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISL 192 (949)
Q Consensus 113 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 192 (949)
++|++|+|++|+|++..|..|+++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|
T Consensus 33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L 112 (174)
T 2r9u_A 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL 112 (174)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence 34444444444444333334444444433333333333333344455555566666666666444444666666666666
Q ss_pred cccccC
Q 039533 193 AYNNLD 198 (949)
Q Consensus 193 ~~N~l~ 198 (949)
++|.+.
T Consensus 113 ~~N~~~ 118 (174)
T 2r9u_A 113 YNNPWD 118 (174)
T ss_dssp CSSCBC
T ss_pred CCCCcc
Confidence 666665
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.44 E-value=2.5e-13 Score=133.57 Aligned_cols=106 Identities=20% Similarity=0.266 Sum_probs=95.5
Q ss_pred CcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccc
Q 039533 115 LKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAY 194 (949)
Q Consensus 115 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 194 (949)
-+.+++++|+++ .+|..+. ++|++|++++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 378999999996 7888775 8899999999999999999999999999999999999977667789999999999999
Q ss_pred cccCCCCCCcccCCCccccccccCccccc
Q 039533 195 NNLDGTIPNSFGWFENLVFLSLAANNLSV 223 (949)
Q Consensus 195 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 223 (949)
|+|++..+..|..+++|++|+|++|.+..
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred CccceeCHHHhccccCCCEEEeCCCCccc
Confidence 99997777779999999999999998764
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.31 E-value=2.2e-12 Score=142.62 Aligned_cols=108 Identities=23% Similarity=0.297 Sum_probs=69.8
Q ss_pred ceeeeeEEeCCCCcEEEEEcCCCCCCccccCCCCCCCCCceeeccC-ceeccccCCcccCcccCcEEeeccccccCcCCC
Q 039533 53 CKWYGVTCSRRHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQV-NSFTHEIPSEIGGLRRLKVLALNNNSICGEIPT 131 (949)
Q Consensus 53 C~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 131 (949)
|+|.+|.|++. ++|+ .+|. |+.+++|++|+|++ |.|++..|..|++|++|++|+|++|+|++..|.
T Consensus 8 C~~~~v~~~~~-----------n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 74 (347)
T 2ifg_A 8 HGSSGLRCTRD-----------GALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74 (347)
T ss_dssp SSSSCEECCSS-----------CCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT
T ss_pred ccCCEEEcCCC-----------CCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHH
Confidence 78877777431 1455 3666 77777777777775 777766666777777777777777777765555
Q ss_pred CCCCCccceeecCCCccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccC
Q 039533 132 NISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLD 198 (949)
Q Consensus 132 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 198 (949)
.|++|++ |++|+|++|+|++..+..|..++ |+.|+|++|.+.
T Consensus 75 ~~~~l~~------------------------L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 75 AFHFTPR------------------------LSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp GGGSCSC------------------------CCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred HhcCCcC------------------------CCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 5555554 46666666666644444444444 666666666665
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.29 E-value=3.9e-12 Score=140.59 Aligned_cols=106 Identities=25% Similarity=0.175 Sum_probs=75.8
Q ss_pred eeccCCC-ccCCCCccccccccccceeeecc-ccccccCCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCC
Q 039533 419 SLDWSRN-KLTGSLPIEVGKLKILEFLYVYE-NRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQ 496 (949)
Q Consensus 419 ~L~ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 496 (949)
.++++++ +|+ .+|. +..+++|+.|+|++ |+|++..|..|+++++|+.|+|++|+|++..|..|.+|++|+.|||++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 3566665 666 3555 67777777777775 777766667777777777777777777777777777777777777777
Q ss_pred CcCCCcCcccccCCccceEeCCCCcCcCcc
Q 039533 497 NNLSGEIPKFLAGLSLNNLNLSYNDLEGMV 526 (949)
Q Consensus 497 N~l~~~~p~~~~~~~L~~l~ls~N~l~~~~ 526 (949)
|+|++.++..+..++|+.|+|++|+|....
T Consensus 90 N~l~~~~~~~~~~~~L~~l~l~~N~~~c~c 119 (347)
T 2ifg_A 90 NALESLSWKTVQGLSLQELVLSGNPLHCSC 119 (347)
T ss_dssp SCCSCCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred CccceeCHHHcccCCceEEEeeCCCccCCC
Confidence 777766666666666777777777777643
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.26 E-value=3.3e-10 Score=127.25 Aligned_cols=131 Identities=15% Similarity=0.139 Sum_probs=89.2
Q ss_pred CCCCCCC-CCceeeccCceeccccCCcccCcccCcEEeecccc---ccCcCCCCCCCCccceeecCCCcccccccccccc
Q 039533 83 HFIGNLS-FLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNS---ICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFS 158 (949)
Q Consensus 83 ~~l~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~---l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 158 (949)
.+|.+.. .|+.+.+-.+ ++..-..+|.++++|+.+.++.|. ++..-...|.++.+|+.+.+..+ ++.+....|.
T Consensus 57 ~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~ 134 (394)
T 4gt6_A 57 RVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFH 134 (394)
T ss_dssp TTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTT
T ss_pred hhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhh
Confidence 4566664 5888888654 665556788899999999988774 55333456888888888877654 5556677788
Q ss_pred CCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccC
Q 039533 159 SLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAA 218 (949)
Q Consensus 159 ~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 218 (949)
...+|+.+.+..+. +......|..+.+|+.+.+..+ ++.....+|.. .+|+.+.+..
T Consensus 135 ~c~~L~~i~lp~~~-~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~ 191 (394)
T 4gt6_A 135 HCEELDTVTIPEGV-TSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPA 191 (394)
T ss_dssp TCTTCCEEECCTTC-CEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECT
T ss_pred hhccccccccccee-eeecccceecccccccccccce-eeEeccccccc-cceeEEEECC
Confidence 88888888887543 3245567778888888888654 44344445543 4566666543
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.24 E-value=9e-14 Score=154.22 Aligned_cols=38 Identities=24% Similarity=0.294 Sum_probs=17.0
Q ss_pred CCccEEeccccccCC----CCCCcccCCCccccccccCcccc
Q 039533 185 SSIHTISLAYNNLDG----TIPNSFGWFENLVFLSLAANNLS 222 (949)
Q Consensus 185 ~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~ 222 (949)
++|++|+|++|.|+. .++..+...++|++|+|++|.|+
T Consensus 155 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~ 196 (372)
T 3un9_A 155 CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLG 196 (372)
T ss_dssp CCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCH
T ss_pred CccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCC
Confidence 344555555554432 12222344445555555555443
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=2.6e-11 Score=128.19 Aligned_cols=149 Identities=16% Similarity=0.063 Sum_probs=114.4
Q ss_pred HHHHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcC-CCcceeEEeeeeccccc
Q 039533 620 DLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIR-HRNLVKVLTACLGADYR 698 (949)
Q Consensus 620 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 698 (949)
.+.....+|++...++.|+.+.||++... ++.+++|+...........+.+|+++++.+. +..++++++++...
T Consensus 8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--- 82 (263)
T 3tm0_A 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD--- 82 (263)
T ss_dssp HHHHHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET---
T ss_pred HHHHHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecC---
Confidence 34556678988888998999999999754 6789999987532233346889999999984 67788898886543
Q ss_pred CCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhC---------------------
Q 039533 699 GNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHD--------------------- 757 (949)
Q Consensus 699 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~--------------------- 757 (949)
...++||||++|.++.+.+.. ......++.+++++++.||+.
T Consensus 83 --~~~~lv~e~i~G~~l~~~~~~---------------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~ 145 (263)
T 3tm0_A 83 --GWSNLLMSEADGVLCSEEYED---------------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYL 145 (263)
T ss_dssp --TEEEEEEECCSSEEHHHHCCT---------------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHH
T ss_pred --CceEEEEEecCCeehhhccCC---------------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHH
Confidence 367999999999999876420 112346889999999999981
Q ss_pred -----------------------------------CCCCeEecCCCCCCeeecCCCceEEeeccccee
Q 039533 758 -----------------------------------CQPVTAHCDLKPSNVLLDDYMTARVGDFGLARI 790 (949)
Q Consensus 758 -----------------------------------~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~ 790 (949)
..+.++|||++|.||+++++..+.|+||+.+..
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 146 LNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 014699999999999998765667999998753
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.20 E-value=6.7e-14 Score=155.28 Aligned_cols=88 Identities=17% Similarity=0.157 Sum_probs=43.4
Q ss_pred ccccccceeeecccccccc----CCcccccccchhhcccCccccccc----cCCCcCCCCCCCEEECCCCcCCCcCcccc
Q 039533 436 GKLKILEFLYVYENRLEGE----IPSTFGNCIRLEQLGMGGNLFQGP----ISSSLGSLRGLRVLDLSQNNLSGEIPKFL 507 (949)
Q Consensus 436 ~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 507 (949)
..+++|++|+|++|+|+.. ++..+..+++|+.|+|++|.|+.. ++..+...++|+.|||++|.|+..-...+
T Consensus 180 ~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L 259 (372)
T 3un9_A 180 AGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVL 259 (372)
T ss_dssp HTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHH
T ss_pred hcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHH
Confidence 3344455555555554421 133344455566666666655532 33344456778888888888875443333
Q ss_pred cCC---c---cceEe--CCCCcCc
Q 039533 508 AGL---S---LNNLN--LSYNDLE 523 (949)
Q Consensus 508 ~~~---~---L~~l~--ls~N~l~ 523 (949)
... . ++.+. +..|.++
T Consensus 260 ~~~~~~~~~~L~~l~~ll~~~~~~ 283 (372)
T 3un9_A 260 RDLGGAAEGGARVVVSLTEGTAVS 283 (372)
T ss_dssp HHCC------CEEECCCC----CH
T ss_pred HHHhcCCCccchhhHhhhcCCccC
Confidence 221 1 55555 5555554
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.17 E-value=7.2e-10 Score=124.52 Aligned_cols=115 Identities=10% Similarity=0.119 Sum_probs=74.9
Q ss_pred eccccCCcccCcc-cCcEEeeccccccCcCCCCCCCCccceeecCCCcc---ccccccccccCCCCCcEEECCCCCCCCC
Q 039533 101 FTHEIPSEIGGLR-RLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQ---LVGKILSRFSSLSKTEILNLGSNHLTGS 176 (949)
Q Consensus 101 l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~---l~~~~~~~~~~L~~L~~L~Ls~N~l~~~ 176 (949)
++..-..+|.++. .|+.+.+..+ ++..-...|.+|++|+.+.+..|. ++.+...+|.+..+|+.+.+.++ ++..
T Consensus 51 Vt~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I 128 (394)
T 4gt6_A 51 VSKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEI 128 (394)
T ss_dssp EEEECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEE
T ss_pred eeEcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-ccee
Confidence 3433445787774 5888888754 554445678888888888877664 55566677777777777766554 3434
Q ss_pred CCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccC
Q 039533 177 IPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAA 218 (949)
Q Consensus 177 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 218 (949)
....|..+.+|+.+.+..+ +......+|....+|+.+.+..
T Consensus 129 ~~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~ 169 (394)
T 4gt6_A 129 DSEAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPD 169 (394)
T ss_dssp CTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCT
T ss_pred hhhhhhhhcccccccccce-eeeecccceecccccccccccc
Confidence 4456777777777777543 3334555666677777666654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.96 E-value=5.6e-10 Score=117.71 Aligned_cols=139 Identities=19% Similarity=0.065 Sum_probs=97.9
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCc--ceeEEeeeecccccCCcc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRN--LVKVLTACLGADYRGNDF 702 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~ 702 (949)
..+|.+....+.|..+.||++... +|+.+++|+.... ....+.+|+++++.+.+.+ +++++++.... ..
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~-~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~-----~~ 89 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEA-----GR 89 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECT-TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS-----SC
T ss_pred cCCCceEecccCCCCceEEEEecC-CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCC-----CC
Confidence 344544333345566999999754 5678999997543 2346788999999985444 55677775433 35
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCC------------------------
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDC------------------------ 758 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~------------------------ 758 (949)
.++||||++|.++. ... . ....++.++++.++.||+..
T Consensus 90 ~~~v~e~i~G~~l~--~~~-------------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (264)
T 1nd4_A 90 DWLLLGEVPGQDLL--SSH-------------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAG 151 (264)
T ss_dssp EEEEEECCSSEETT--TSC-------------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTT
T ss_pred CEEEEEecCCcccC--cCc-------------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcC
Confidence 79999999998884 220 1 12357788888888888641
Q ss_pred -------------------------------CCCeEecCCCCCCeeecCCCceEEeeccccee
Q 039533 759 -------------------------------QPVTAHCDLKPSNVLLDDYMTARVGDFGLARI 790 (949)
Q Consensus 759 -------------------------------~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~ 790 (949)
...++|||++|+||++++++.+.|+|||.+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 152 LVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876677999998754
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.94 E-value=2.1e-12 Score=134.27 Aligned_cols=147 Identities=15% Similarity=0.164 Sum_probs=66.6
Q ss_pred cceeeeeEEeCCCCcEEEEEcCC---CCCCccccC-CCCCCCCCceeeccCceeccccCC-cccCcccCcE--Eeecccc
Q 039533 52 FCKWYGVTCSRRHQRVTLLDLRS---LKLAGSVSH-FIGNLSFLKQLYLQVNSFTHEIPS-EIGGLRRLKV--LALNNNS 124 (949)
Q Consensus 52 ~C~w~gv~C~~~~~~v~~l~l~~---~~l~g~~~~-~l~~l~~L~~L~L~~n~l~~~~p~-~~~~l~~L~~--L~Ls~N~ 124 (949)
.|+|.|+.|+..+.+|+.+-..+ ..++|.+.+ .+..++. .|...+|.-++.++- .|...+.|+. ++++.|.
T Consensus 77 l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~ 154 (267)
T 3rw6_A 77 LKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNR 154 (267)
T ss_dssp HHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTS
T ss_pred HHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCH
Confidence 58999999998777887666554 233333321 1111111 122233333332221 2334444444 4455553
Q ss_pred cc---CcCCCCCCCCccceeecCCCccccc--cccccccCCCCCcEEECCCCCCCCCCCCCcCCCC--CccEEecccccc
Q 039533 125 IC---GEIPTNISRCSTLIPIHPQNNQLVG--KILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLS--SIHTISLAYNNL 197 (949)
Q Consensus 125 l~---~~~p~~~~~l~~L~~L~l~~n~l~~--~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~L~~N~l 197 (949)
.. +.++....++++|+.|+|++|+|++ .++..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+
T Consensus 155 ~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl 232 (267)
T 3rw6_A 155 RSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSL 232 (267)
T ss_dssp HHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTT
T ss_pred HHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcC
Confidence 22 1111111234444444444444444 2234444555555555555555533 1222222 555555555555
Q ss_pred CCCCC
Q 039533 198 DGTIP 202 (949)
Q Consensus 198 ~~~~p 202 (949)
.+.+|
T Consensus 233 ~~~~~ 237 (267)
T 3rw6_A 233 CDTFR 237 (267)
T ss_dssp GGGCS
T ss_pred ccccC
Confidence 54443
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.89 E-value=6.5e-08 Score=107.91 Aligned_cols=125 Identities=7% Similarity=-0.046 Sum_probs=61.3
Q ss_pred CCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCc
Q 039533 85 IGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTE 164 (949)
Q Consensus 85 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~ 164 (949)
+..-.+|+.+.+.. .++..-..+|.+|++|+.++|..+ ++..-...|.++ +|+.+.+..+ ++.+...+|... +|+
T Consensus 42 ~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~-~L~ 116 (379)
T 4h09_A 42 YKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQGT-DLD 116 (379)
T ss_dssp GGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTTC-CCS
T ss_pred cccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceeccC-Ccc
Confidence 44456677777753 355444557778888888887644 542333455555 4555554432 333444445442 566
Q ss_pred EEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCcccccccc
Q 039533 165 ILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLA 217 (949)
Q Consensus 165 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 217 (949)
.+.+..+... .....|.+. +|+.+.+..+ ++......|....+++...+.
T Consensus 117 ~i~lp~~~~~-i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~ 166 (379)
T 4h09_A 117 DFEFPGATTE-IGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVS 166 (379)
T ss_dssp EEECCTTCCE-ECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEEC
T ss_pred cccCCCcccc-ccccccccc-eeeeeeccce-eeccccchhcccccccccccc
Confidence 6666544221 222333332 3444443322 222333444444444444433
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.89 E-value=6.8e-10 Score=119.93 Aligned_cols=190 Identities=19% Similarity=0.190 Sum_probs=123.9
Q ss_pred CCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcC-CCc--ceeEEeeeecccccCCccceeEe
Q 039533 631 ANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIR-HRN--LVKVLTACLGADYRGNDFKASVY 707 (949)
Q Consensus 631 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~~~~~~~~~~~~~~~~~~lv~ 707 (949)
.+.++.|....||++. ..+++|+.... .....+.+|+++++.+. +.. +.+++......+ .....++||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~--~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSE--TYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCS--SCSCSCEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCC--CCCcceEEE
Confidence 5679999999999874 34889986422 23467889999999883 333 445544432111 112358899
Q ss_pred eeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhC------------------------------
Q 039533 708 EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHD------------------------------ 757 (949)
Q Consensus 708 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~------------------------------ 757 (949)
++++|.++.+... ..++..++..++.++++.++.||+.
T Consensus 96 ~~i~G~~l~~~~~------------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (304)
T 3sg8_A 96 TKIKGVPLTPLLL------------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSR 163 (304)
T ss_dssp ECCCCEECCHHHH------------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTT
T ss_pred cccCCeECCcccc------------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcc
Confidence 9999988765321 2367778888889999999888861
Q ss_pred -------------------------CCCCeEecCCCCCCeeecC--CCceEEeecccceecCCCCCcccccc--------
Q 039533 758 -------------------------CQPVTAHCDLKPSNVLLDD--YMTARVGDFGLARILSPDHTQTSSFS-------- 802 (949)
Q Consensus 758 -------------------------~~~~ivHrDlkp~NIll~~--~~~~kl~DfG~a~~~~~~~~~~~~~~-------- 802 (949)
..+.++|+|++|.||++++ +..+.|+||+.+....+.........
T Consensus 164 ~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~ 243 (304)
T 3sg8_A 164 ELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGME 243 (304)
T ss_dssp TSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHH
T ss_pred cCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHH
Confidence 1246899999999999998 55678999999876533211110000
Q ss_pred ----ccCccCccC-ccccCCCccCCccchHHHHHHHHHHHhCCCCC
Q 039533 803 ----VKGSLGYIA-PEYGVGCEVSTNGDVYSYGILLLELVIGKKPI 843 (949)
Q Consensus 803 ----~~gt~~y~a-PE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf 843 (949)
....+++.. |+... ......+.|++|.++|.+.+|..+|
T Consensus 244 ~~~~~l~~Y~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 244 FVSKILNHYKHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHTCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHcCCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 000011111 22111 1122368999999999999999886
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.87 E-value=6.3e-09 Score=115.25 Aligned_cols=146 Identities=13% Similarity=0.119 Sum_probs=106.9
Q ss_pred CCCeeeeecCceEEEEEEcCCCEEEEEEEEe--cCCC-cchHHHHHHHHHHHhcC--CCcceeEEeeeecccccCCccce
Q 039533 630 SANLVGVGSFGSVYKGIIDEGRTTIAVKVFN--LQHH-GASRSFIAECKALKSIR--HRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 630 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~-~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
..+.++.|.++.||++... +..+++|+.. .... .....+.+|+++++.+. +..+++++.++.+.. .....+
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~--~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES--VIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT--TTSSCE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC--ccCCeE
Confidence 3567899999999999875 4578888765 3221 12346788999999996 456888888875442 113578
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCC--------------------------
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDC-------------------------- 758 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~-------------------------- 758 (949)
+||||++|..+.+... ..++..++..++.++++.|+.||+..
T Consensus 118 ~vme~v~G~~l~~~~~------------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQSL------------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQ 185 (359)
T ss_dssp EEEECCCCBCCCCTTC------------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHH
T ss_pred EEEEecCCeecCCCcc------------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHH
Confidence 9999999977754221 23678888999999999999999731
Q ss_pred -----------------------------CCCeEecCCCCCCeeecCCCc--eEEeecccceec
Q 039533 759 -----------------------------QPVTAHCDLKPSNVLLDDYMT--ARVGDFGLARIL 791 (949)
Q Consensus 759 -----------------------------~~~ivHrDlkp~NIll~~~~~--~kl~DfG~a~~~ 791 (949)
.+.++|||++|.||+++.++. +.|+||+.+..-
T Consensus 186 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 186 YKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 257999999999999997653 689999998753
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.85 E-value=3.3e-10 Score=124.35 Aligned_cols=102 Identities=12% Similarity=0.164 Sum_probs=66.9
Q ss_pred CcEEEEEcCCCCCCc-c-------ccCCCCCCCCCceeeccCceec---------cccCCcccCcccCcEEeeccccccC
Q 039533 65 QRVTLLDLRSLKLAG-S-------VSHFIGNLSFLKQLYLQVNSFT---------HEIPSEIGGLRRLKVLALNNNSICG 127 (949)
Q Consensus 65 ~~v~~l~l~~~~l~g-~-------~~~~l~~l~~L~~L~L~~n~l~---------~~~p~~~~~l~~L~~L~Ls~N~l~~ 127 (949)
.+|+.|.+...+..| . +..++..+++|+.|.+..+... +.++..+..+++|+.|+|++|.-.
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l- 185 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL- 185 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-
Confidence 468888888776653 2 2445667889999998765431 124445667789999999887311
Q ss_pred cCCCCCCCCccceeecCCCcccccccccccc--CCCCCcEEECC
Q 039533 128 EIPTNISRCSTLIPIHPQNNQLVGKILSRFS--SLSKTEILNLG 169 (949)
Q Consensus 128 ~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~--~L~~L~~L~Ls 169 (949)
.+|. +. +++|+.|++..+.+.......+. .+++|+.|+|+
T Consensus 186 ~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~ 227 (362)
T 2ra8_A 186 SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227 (362)
T ss_dssp BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEE
T ss_pred eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEe
Confidence 2333 33 67788888777777655544544 67777777775
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.83 E-value=4e-10 Score=123.72 Aligned_cols=85 Identities=15% Similarity=0.255 Sum_probs=55.5
Q ss_pred cccccceeeeccccccccCCcccc---cccchhhcccCccccccc----cCCCcCCCCCCCEEECCCCcCCCcCcccccC
Q 039533 437 KLKILEFLYVYENRLEGEIPSTFG---NCIRLEQLGMGGNLFQGP----ISSSLGSLRGLRVLDLSQNNLSGEIPKFLAG 509 (949)
Q Consensus 437 ~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 509 (949)
.+++|+.|+|++|.+....+..+. .+++|+.|+|+.|.|++. ++..+..+++|+.|+|++|.|+...-..+..
T Consensus 250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~ 329 (362)
T 2ra8_A 250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329 (362)
T ss_dssp TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHH
T ss_pred CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHH
Confidence 457788888888777644333332 467888888888887753 4445556788999999998887543333332
Q ss_pred CccceEeCCCCc
Q 039533 510 LSLNNLNLSYND 521 (949)
Q Consensus 510 ~~L~~l~ls~N~ 521 (949)
.-...+++++|+
T Consensus 330 alg~~~~~~~~~ 341 (362)
T 2ra8_A 330 SLPMKIDVSDSQ 341 (362)
T ss_dssp HCCSEEECCSBC
T ss_pred HcCCEEEecCCc
Confidence 113457888776
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.78 E-value=2.2e-07 Score=103.65 Aligned_cols=134 Identities=13% Similarity=0.156 Sum_probs=68.2
Q ss_pred CCcccccCCCCEEecCCcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCc
Q 039533 335 PPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLS 414 (949)
Q Consensus 335 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 414 (949)
...+....+|+.+.+..+ +.......|.++..|+.+.+..+ ++..-..+|.++.+|+.+.+..+
T Consensus 210 ~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-------------- 273 (379)
T 4h09_A 210 AYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-------------- 273 (379)
T ss_dssp TTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC--------------
T ss_pred ecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc--------------
Confidence 344444555555555433 22233344445555555555443 33333444455555555444322
Q ss_pred ccceeeccCCCccCCCCccccccccccceeeeccccccccCCcccccccchhhcccCccccccccCCCcCCCCCCCEEEC
Q 039533 415 SLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDL 494 (949)
Q Consensus 415 ~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 494 (949)
++......|.++.+|+.+.+.++.++..-...|.+|.+|+.+.|..+ ++..-..+|.++++|+.+.+
T Consensus 274 ------------i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~i 340 (379)
T 4h09_A 274 ------------VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISY 340 (379)
T ss_dssp ------------CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCC
T ss_pred ------------ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEE
Confidence 22233344555666666666666665444556666666666666543 44444556666666666666
Q ss_pred CCC
Q 039533 495 SQN 497 (949)
Q Consensus 495 s~N 497 (949)
..+
T Consensus 341 p~~ 343 (379)
T 4h09_A 341 PKS 343 (379)
T ss_dssp CTT
T ss_pred CCc
Confidence 543
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.45 E-value=5e-09 Score=103.71 Aligned_cols=122 Identities=13% Similarity=0.133 Sum_probs=66.2
Q ss_pred ccCCCCCCCCCceeeccCc-eeccc----cCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccc
Q 039533 81 VSHFIGNLSFLKQLYLQVN-SFTHE----IPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILS 155 (949)
Q Consensus 81 ~~~~l~~l~~L~~L~L~~n-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~ 155 (949)
+...+...+.|++|+|++| .+... +...+...++|++|+|++|.|...-.. .+..
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~--------------------~l~~ 87 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAF--------------------ALAE 87 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHH--------------------HHHH
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHH--------------------HHHH
Confidence 4445566677777777777 66532 344455566777777777776532111 1122
Q ss_pred cccCCCCCcEEECCCCCCCCC----CCCCcCCCCCccEEec--cccccCCC----CCCcccCCCccccccccCcccc
Q 039533 156 RFSSLSKTEILNLGSNHLTGS----IPSSLGNLSSIHTISL--AYNNLDGT----IPNSFGWFENLVFLSLAANNLS 222 (949)
Q Consensus 156 ~~~~L~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L--~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 222 (949)
.+...++|++|+|++|.|+.. +...+...++|++|+| ++|.|+.. +...+...++|++|+|++|.+.
T Consensus 88 ~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 88 MLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 233344555555555555522 2334445555666666 55665532 2233444466777777766654
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.39 E-value=2.2e-08 Score=103.99 Aligned_cols=106 Identities=17% Similarity=0.208 Sum_probs=75.7
Q ss_pred CCCCCCCce--eeccCcee---ccccCCcccCcccCcEEeeccccccC--cCCCCCCCCccceeecCCCcccccc-cccc
Q 039533 85 IGNLSFLKQ--LYLQVNSF---THEIPSEIGGLRRLKVLALNNNSICG--EIPTNISRCSTLIPIHPQNNQLVGK-ILSR 156 (949)
Q Consensus 85 l~~l~~L~~--L~L~~n~l---~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~l~~n~l~~~-~~~~ 156 (949)
+...+.|.. ++++.|.. .+.++-...++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|.+. ....
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~ 216 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDK 216 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGG
T ss_pred cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhh
Confidence 444555655 67777743 33333333568899999999999987 5667778899999999999999876 2333
Q ss_pred ccCCCCCcEEECCCCCCCCCCCC-------CcCCCCCccEEe
Q 039533 157 FSSLSKTEILNLGSNHLTGSIPS-------SLGNLSSIHTIS 191 (949)
Q Consensus 157 ~~~L~~L~~L~Ls~N~l~~~~p~-------~~~~l~~L~~L~ 191 (949)
+..+ +|++|+|++|.+.+.+|. .+..+++|+.||
T Consensus 217 l~~l-~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 217 IKGL-KLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GTTS-CCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred cccC-CcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 4444 999999999999987663 245666676665
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=1.3e-06 Score=92.29 Aligned_cols=145 Identities=17% Similarity=0.075 Sum_probs=102.2
Q ss_pred HHhcCCCCCCeeeeecCc-eEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcC-CCcceeEEeeeecccccCC
Q 039533 623 NATSGFSSANLVGVGSFG-SVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIR-HRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 623 ~~~~~y~~~~~lg~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~ 700 (949)
....+|+. +.+..|..+ .||+.....++..+++|+.... ....+.+|.+.++.+. +--+.++++++.+.+
T Consensus 22 ~~l~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~---- 93 (272)
T 4gkh_A 22 ADLYGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPD---- 93 (272)
T ss_dssp HHHTTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETT----
T ss_pred ccccCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECC----
Confidence 33344543 345556665 6999888777888999986532 3456888999998884 334777887765443
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCC----------------------
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDC---------------------- 758 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~---------------------- 758 (949)
..++|||+++|.++.+.... .......++.++++.|+.||+..
T Consensus 94 -~~~lvme~l~G~~~~~~~~~--------------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (272)
T 4gkh_A 94 -DAWLLTTAIPGKTAFQVLEE--------------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMN 158 (272)
T ss_dssp -EEEEEEECCCSEEHHHHHHH--------------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHH
T ss_pred -eEEEEEEeeCCccccccccC--------------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHH
Confidence 67999999999888765431 11233456677777777777421
Q ss_pred ---------------------------------CCCeEecCCCCCCeeecCCCceEEeeccccee
Q 039533 759 ---------------------------------QPVTAHCDLKPSNVLLDDYMTARVGDFGLARI 790 (949)
Q Consensus 759 ---------------------------------~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~ 790 (949)
.+.++|+|+.+.||++++++.+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 159 NGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp TTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 22479999999999999877777999998764
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.30 E-value=2.6e-08 Score=98.56 Aligned_cols=127 Identities=13% Similarity=0.106 Sum_probs=87.2
Q ss_pred cCCcccCcccCcEEeeccc-cccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECCCCCCCCC----CCC
Q 039533 105 IPSEIGGLRRLKVLALNNN-SICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGS----IPS 179 (949)
Q Consensus 105 ~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~----~p~ 179 (949)
+...+...++|++|+|++| .|...-- ..+...+...++|++|+|++|.|... +..
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~--------------------~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~ 87 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTL--------------------KACAEALKTNTYVKKFSIVGTRSNDPVAFALAE 87 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHH--------------------HHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHH
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHH--------------------HHHHHHHHhCCCcCEEECcCCCCChHHHHHHHH
Confidence 3445566677777777777 6653211 11234455667889999999998732 334
Q ss_pred CcCCCCCccEEeccccccCCC----CCCcccCCCccccccc--cCcccccccccccCCCCChhhhccccccccccCCCCC
Q 039533 180 SLGNLSSIHTISLAYNNLDGT----IPNSFGWFENLVFLSL--AANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGS 253 (949)
Q Consensus 180 ~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L--s~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N~l~~ 253 (949)
.+...++|++|+|++|.|+.. +...+...++|++|+| ++|.|....... ....+...++|++|+|++|.++.
T Consensus 88 ~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~--l~~~L~~n~~L~~L~L~~n~i~~ 165 (185)
T 1io0_A 88 MLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEME--IANMLEKNTTLLKFGYHFTQQGP 165 (185)
T ss_dssp HHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHH--HHHHHHHCSSCCEEECCCSSHHH
T ss_pred HHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHH--HHHHHHhCCCcCEEeccCCCCCh
Confidence 455668899999999999843 4567788889999999 889987432110 11135566889999999999864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=3.8e-06 Score=90.28 Aligned_cols=137 Identities=18% Similarity=0.077 Sum_probs=94.1
Q ss_pred CCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCC---cceeEEeeeecccccCCccceeEe
Q 039533 631 ANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHR---NLVKVLTACLGADYRGNDFKASVY 707 (949)
Q Consensus 631 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~~~~~~~~~~lv~ 707 (949)
.+.++.|....||+. +..+++|+.. .......+.+|+++++.+.+. .+.+++.++.. .....++||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~----~~g~~~~v~ 92 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR----SDGNPFVGY 92 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC----TTSCEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc----CCCceEEEE
Confidence 356888888899988 3557888853 223346789999999999642 35666666531 123568999
Q ss_pred eeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhC------------------------------
Q 039533 708 EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHD------------------------------ 757 (949)
Q Consensus 708 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~------------------------------ 757 (949)
||++|.++.+... ..++..+...++.++++.|+.||+.
T Consensus 93 e~i~G~~l~~~~~------------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~ 160 (306)
T 3tdw_A 93 RKVQGQILGEDGM------------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQV 160 (306)
T ss_dssp ECCCSEECHHHHH------------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHT
T ss_pred eccCCeECchhhh------------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhc
Confidence 9999988866321 1134445555566666666665542
Q ss_pred ---------------------------CCCCeEecCCCCCCeeecC---CCc-eEEeeccccee
Q 039533 758 ---------------------------CQPVTAHCDLKPSNVLLDD---YMT-ARVGDFGLARI 790 (949)
Q Consensus 758 ---------------------------~~~~ivHrDlkp~NIll~~---~~~-~kl~DfG~a~~ 790 (949)
..+.++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 161 ~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 161 FPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp GGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred ccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1346799999999999987 455 48999998865
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.00 E-value=1.1e-05 Score=88.88 Aligned_cols=84 Identities=6% Similarity=-0.067 Sum_probs=55.8
Q ss_pred Cee-eeecCceEEEEEEc---C---CCEEEEEEEEecCC---CcchHHHHHHHHHHHhcC-C--CcceeEEeeeeccccc
Q 039533 632 NLV-GVGSFGSVYKGIID---E---GRTTIAVKVFNLQH---HGASRSFIAECKALKSIR-H--RNLVKVLTACLGADYR 698 (949)
Q Consensus 632 ~~l-g~G~~g~Vy~~~~~---~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~~ 698 (949)
+.| +.|....+|+.... . +++.+++|+..... ......+.+|+++++.+. + -.+.+++.++.+...
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~- 104 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV- 104 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT-
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc-
Confidence 566 78888999998753 1 15678999865322 111245788999888884 2 357778877643321
Q ss_pred CCccceeEeeeccCCChhh
Q 039533 699 GNDFKASVYEFMHYGSLEE 717 (949)
Q Consensus 699 ~~~~~~lv~e~~~~gsL~~ 717 (949)
....++||||++|.++.+
T Consensus 105 -~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 -LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp -TSSCEEEEECCCCBCCCB
T ss_pred -cCCceEEEEecCCCChhh
Confidence 124679999999887764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.84 E-value=1.7e-05 Score=88.73 Aligned_cols=76 Identities=14% Similarity=0.059 Sum_probs=49.6
Q ss_pred CCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-------cchHHHHHHHHHHHhcCC--C-cceeEEeeeecccccCC
Q 039533 631 ANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-------GASRSFIAECKALKSIRH--R-NLVKVLTACLGADYRGN 700 (949)
Q Consensus 631 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~~~~~~~~~~~~~~ 700 (949)
.+.+|.|..+.||++....+++.++||....... ....++..|.++++.+.. + .+++++.+. .
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~----- 107 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T----- 107 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T-----
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--C-----
Confidence 4678999999999997655567899998653211 123567889999988742 3 345565442 1
Q ss_pred ccceeEeeeccCC
Q 039533 701 DFKASVYEFMHYG 713 (949)
Q Consensus 701 ~~~~lv~e~~~~g 713 (949)
+..++||||+++.
T Consensus 108 ~~~~lvmE~l~g~ 120 (397)
T 2olc_A 108 EMAVTVMEDLSHL 120 (397)
T ss_dssp TTTEEEECCCTTS
T ss_pred CccEEEEEeCCCc
Confidence 2458999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00024 Score=77.45 Aligned_cols=153 Identities=16% Similarity=0.130 Sum_probs=80.9
Q ss_pred CeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCC--CcceeEEeeeecccc-cCCccceeEee
Q 039533 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRH--RNLVKVLTACLGADY-RGNDFKASVYE 708 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~-~~~~~~~lv~e 708 (949)
+.++.|..+.||++... +..+++|+.... ..+...|+.+++.+.. -.+++++.......+ ...+..++||+
T Consensus 38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTD--SGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEET--TEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeC--CCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 34666778999999875 345899998642 2344456666665531 134444432100000 11235689999
Q ss_pred eccCCChhh--------------hcCCCCC----CCccccCCCCCCHHH-------------------------------
Q 039533 709 FMHYGSLEE--------------WLHPFTG----EDEIDEAPRNLNLLQ------------------------------- 739 (949)
Q Consensus 709 ~~~~gsL~~--------------~l~~~~~----~~~~~~~~~~l~~~~------------------------------- 739 (949)
|++|.++.. .+|.... ..........-.|..
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 999865430 1110000 000000001112211
Q ss_pred HHHHHHHHHHHHHHHhh----------CCCCCeEecCCCCCCeeecCCCceEEeeccccee
Q 039533 740 RLNIAIDIAYALNYLHH----------DCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARI 790 (949)
Q Consensus 740 ~~~i~~qi~~gL~~LH~----------~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~ 790 (949)
...+..++..++++|++ .....++|||+++.||+++.++.+.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 11122234456667763 0246899999999999998888999999998753
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.66 E-value=6.2e-06 Score=79.19 Aligned_cols=34 Identities=12% Similarity=-0.007 Sum_probs=13.8
Q ss_pred CCcEEECCCCC-CCCCCCCCcCCCCCccEEecccc
Q 039533 162 KTEILNLGSNH-LTGSIPSSLGNLSSIHTISLAYN 195 (949)
Q Consensus 162 ~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N 195 (949)
+|++|+|++|. ||..--..+.++++|++|+|+++
T Consensus 115 ~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~~L~L~~c 149 (176)
T 3e4g_A 115 SMLEMEIISCGNVTDKGIIALHHFRNLKYLFLSDL 149 (176)
T ss_dssp HCCEEEEESCTTCCHHHHHHGGGCTTCCEEEEESC
T ss_pred CCCEEEcCCCCcCCHHHHHHHhcCCCCCEEECCCC
Confidence 34555555542 44221122334444444444443
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00021 Score=75.81 Aligned_cols=78 Identities=14% Similarity=0.059 Sum_probs=56.8
Q ss_pred CCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCC---CcceeEEeeeecccccCCccce
Q 039533 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRH---RNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 628 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~~~~~~~~~~ 704 (949)
....+.+|.|..+.||+.+.. +|+.|++|+...........+..|++.|+.+.- --+++++++. ..+
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---------~~~ 86 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---------DRT 86 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---------TTE
T ss_pred eEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc---------Cce
Confidence 344577999999999999987 678999998764444444578899999998842 2355565541 347
Q ss_pred eEeeeccCCCh
Q 039533 705 SVYEFMHYGSL 715 (949)
Q Consensus 705 lv~e~~~~gsL 715 (949)
+||||++++..
T Consensus 87 lv~e~l~~~~~ 97 (288)
T 3f7w_A 87 LAMEWVDERPP 97 (288)
T ss_dssp EEEECCCCCCC
T ss_pred EEEEeecccCC
Confidence 89999987643
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.0006 Score=72.76 Aligned_cols=145 Identities=17% Similarity=0.084 Sum_probs=90.2
Q ss_pred CCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcC---CCcceeEEeeeecccccCCccceeEe
Q 039533 631 ANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIR---HRNLVKVLTACLGADYRGNDFKASVY 707 (949)
Q Consensus 631 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~~~lv~ 707 (949)
.+.++.|....+|+... ++..+++|+.... ....+..|++.++.+. ...++++++++... ...++||
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~-----g~~~lvm 110 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ-----GHSFLLL 110 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS-----SEEEEEE
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC-----CceEEEE
Confidence 35789999999999975 3567889987643 3467889999998883 35688888876433 3689999
Q ss_pred eeccCCChhh-----------hcCCCCCCCcccc------------CCCCCCHHHHH---HHH----------------H
Q 039533 708 EFMHYGSLEE-----------WLHPFTGEDEIDE------------APRNLNLLQRL---NIA----------------I 745 (949)
Q Consensus 708 e~~~~gsL~~-----------~l~~~~~~~~~~~------------~~~~l~~~~~~---~i~----------------~ 745 (949)
||+++..+.. .++.......... ....-+|.+.. ++. .
T Consensus 111 e~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~ 190 (312)
T 3jr1_A 111 EALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNID 190 (312)
T ss_dssp ECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHH
T ss_pred EeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHH
Confidence 9999876521 1221111000000 00112454322 111 1
Q ss_pred HHHHH-HHHHhh-CCCCCeEecCCCCCCeeecCCCceEEeecc
Q 039533 746 DIAYA-LNYLHH-DCQPVTAHCDLKPSNVLLDDYMTARVGDFG 786 (949)
Q Consensus 746 qi~~g-L~~LH~-~~~~~ivHrDlkp~NIll~~~~~~kl~DfG 786 (949)
+++.. ...|.. ...+.++|+|+.+.|++++.++ +.|.|++
T Consensus 191 ~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 191 LIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 11111 223421 2267899999999999999887 8899974
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.46 E-value=3.4e-05 Score=74.07 Aligned_cols=84 Identities=14% Similarity=0.084 Sum_probs=54.1
Q ss_pred CcccEEEeecceecccCCCcccccCCCCEEecCCcc-cccccCcccccc----cccceeeccccc-ccccCCCCCCCCCC
Q 039533 318 VNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNK-LSGNIPPSIGNL----KMLLNLFLNDNF-LEVSIPSSLGQCES 391 (949)
Q Consensus 318 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~L~~N~-l~~~~p~~~~~l~~ 391 (949)
.+|++|||+++.|+..--..+.++++|+.|+|++|. |+..--..+..+ ++|+.|+|++|. ++..--..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 357777777777765544556677777777777774 554333344443 367777777764 65443344566788
Q ss_pred CcEEEeeCcc
Q 039533 392 LIEINLSNNN 401 (949)
Q Consensus 392 L~~L~l~~N~ 401 (949)
|+.|+|+++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 8888888774
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.43 E-value=9.9e-05 Score=83.10 Aligned_cols=80 Identities=11% Similarity=-0.025 Sum_probs=50.9
Q ss_pred CCCeEecCCCCCCeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCC---ccCCccchHHHHHHHHH
Q 039533 759 QPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC---EVSTNGDVYSYGILLLE 835 (949)
Q Consensus 759 ~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDiwSlGvvl~e 835 (949)
.+.++|||++|.||+++.++ ++++||+.+....+.......... -...|.+|+..... ......++.+....+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGN-LILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHH-HHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHH-HHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 55899999999999999876 999999998764332111110000 12346666654321 12234566688888888
Q ss_pred HHhCC
Q 039533 836 LVIGK 840 (949)
Q Consensus 836 lltg~ 840 (949)
.++++
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 88764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.23 E-value=0.0011 Score=70.59 Aligned_cols=74 Identities=9% Similarity=0.055 Sum_probs=45.8
Q ss_pred CCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcc-eeEEeeeecccccCCccceeE
Q 039533 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNL-VKVLTACLGADYRGNDFKASV 706 (949)
Q Consensus 628 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv 706 (949)
+.-.+.|+.|....+|++ ..+++|+....... .....+|+.+++.+....+ .++++++. +..++|
T Consensus 20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~-------~~~~~v 85 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDP-------ATGVMV 85 (301)
T ss_dssp CCSCEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECT-------TTCCEE
T ss_pred ccceeEcCCcccccccee------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEEC-------CCCEEE
Confidence 333688999999999999 34889988643221 1223568888877742222 46665421 134789
Q ss_pred eeec-cCCCh
Q 039533 707 YEFM-HYGSL 715 (949)
Q Consensus 707 ~e~~-~~gsL 715 (949)
+||+ ++.++
T Consensus 86 ~e~i~~g~~l 95 (301)
T 3dxq_A 86 TRYIAGAQTM 95 (301)
T ss_dssp EECCTTCEEC
T ss_pred EeecCCCccC
Confidence 9999 66544
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.18 E-value=0.002 Score=72.61 Aligned_cols=75 Identities=13% Similarity=0.089 Sum_probs=49.0
Q ss_pred CCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcc-eeEEeeeecccccCCccceeEeee
Q 039533 631 ANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNL-VKVLTACLGADYRGNDFKASVYEF 709 (949)
Q Consensus 631 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~ 709 (949)
.+.|+.|-...+|++....++..+++|+......... ...+|..+++.+...++ +++++++. -..||||
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~---------~G~v~e~ 182 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT---------NGRIEEF 182 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET---------TEEEEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC---------CeEEEEe
Confidence 3578888889999999864358899999854322111 22589999998864444 56666541 1359999
Q ss_pred ccCCCh
Q 039533 710 MHYGSL 715 (949)
Q Consensus 710 ~~~gsL 715 (949)
++|.++
T Consensus 183 I~G~~l 188 (458)
T 2qg7_A 183 MDGYAL 188 (458)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 987555
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.07 E-value=3e-05 Score=75.93 Aligned_cols=69 Identities=12% Similarity=0.179 Sum_probs=40.0
Q ss_pred cCCCCCCCCCceeeccCc-eecc----ccCCcccCcccCcEEeeccccccCcCCCCC----CCCccceeecCCCcccc
Q 039533 82 SHFIGNLSFLKQLYLQVN-SFTH----EIPSEIGGLRRLKVLALNNNSICGEIPTNI----SRCSTLIPIHPQNNQLV 150 (949)
Q Consensus 82 ~~~l~~l~~L~~L~L~~n-~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~~l~~L~~L~l~~n~l~ 150 (949)
...+.+-+.|++|+|++| ++.. .+-..+..-+.|+.|+|++|+|...--..| ..-+.|++|+|++|.|.
T Consensus 34 ~~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 34 NRLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp HHHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred HHHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 334555677888888875 6653 244456666778888888888764322222 23344544555555443
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.05 E-value=0.002 Score=69.31 Aligned_cols=169 Identities=14% Similarity=0.072 Sum_probs=89.0
Q ss_pred cCHHHHHHHhcCCCCC-----CeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCc--ceeE
Q 039533 616 LSYQDLYNATSGFSSA-----NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRN--LVKV 688 (949)
Q Consensus 616 ~~~~~l~~~~~~y~~~-----~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~ 688 (949)
++.+++......|.+. +.|+.|....+|+.... ++ .+++|+.... .....+..|+.+++.+.... +.++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 4556676666667663 34666888899999875 33 6889988642 12345667888877774222 3444
Q ss_pred Eeeeecccc-cCCccceeEeeeccCCChhhh--------------cC----CCCCCCccccCCCCCCHHHHHH-------
Q 039533 689 LTACLGADY-RGNDFKASVYEFMHYGSLEEW--------------LH----PFTGEDEIDEAPRNLNLLQRLN------- 742 (949)
Q Consensus 689 ~~~~~~~~~-~~~~~~~lv~e~~~~gsL~~~--------------l~----~~~~~~~~~~~~~~l~~~~~~~------- 742 (949)
+....+..+ ...+..+++|+|++|..+... ++ ....... .......|.....
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~--~~~~~~~w~~~~~~~~~~~~ 160 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRP--NALSVDGWKVLWDKSEERAD 160 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCB--CTTSHHHHHHHHHHHGGGGG
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCccc--CccChHHHHHHHHHHHHHHH
Confidence 322100000 011246889999998654210 11 1000000 0000011211000
Q ss_pred -----HHHHHHHHHHHHhhC----CCCCeEecCCCCCCeeecCCCceEEeeccccee
Q 039533 743 -----IAIDIAYALNYLHHD----CQPVTAHCDLKPSNVLLDDYMTARVGDFGLARI 790 (949)
Q Consensus 743 -----i~~qi~~gL~~LH~~----~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~ 790 (949)
+...+.+.+++++.. ...+++|+|+.+.||+++++..+.|+||+.+..
T Consensus 161 ~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 161 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011234445555431 245799999999999999876668999997753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0019 Score=72.47 Aligned_cols=74 Identities=12% Similarity=0.155 Sum_probs=50.0
Q ss_pred CCeeeeecCceEEEEEEcC-------CCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCc-ceeEEeeeecccccCCcc
Q 039533 631 ANLVGVGSFGSVYKGIIDE-------GRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRN-LVKVLTACLGADYRGNDF 702 (949)
Q Consensus 631 ~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~~~~ 702 (949)
.+.|+.|....||++.... +++.+++|+.... .....+..|..+++.+...+ .+++++.+.
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--------- 146 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--------- 146 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET---------
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC---------
Confidence 3568888889999998753 2578999998432 11245668999998884333 456666532
Q ss_pred ceeEeeeccCCCh
Q 039533 703 KASVYEFMHYGSL 715 (949)
Q Consensus 703 ~~lv~e~~~~gsL 715 (949)
-.+||||++|.++
T Consensus 147 ~g~v~e~l~G~~l 159 (429)
T 1nw1_A 147 GGRLEEYIPSRPL 159 (429)
T ss_dssp TEEEECCCCEEEC
T ss_pred CCEEEEEeCCccc
Confidence 1379999987554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0021 Score=70.53 Aligned_cols=145 Identities=12% Similarity=0.122 Sum_probs=83.9
Q ss_pred CCeeeeecCceEEEEEEcC-------CCEEEEEEEEecCCCcchHHHHHHHHHHHhcC-CCcceeEEeeeecccccCCcc
Q 039533 631 ANLVGVGSFGSVYKGIIDE-------GRTTIAVKVFNLQHHGASRSFIAECKALKSIR-HRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 631 ~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 702 (949)
.+.+..|-...+|++.... +++.+++|+..... .......+|.++++.+. +.-..++++++. +
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~------ 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFP--E------ 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T------
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C------
Confidence 3577778889999998742 34789999864322 23456678999998884 333466666542 1
Q ss_pred ceeEeeeccCCChhhh-c----------------CCCCCCCccccCCCCCC--HHHHHHHHHHHHH--------------
Q 039533 703 KASVYEFMHYGSLEEW-L----------------HPFTGEDEIDEAPRNLN--LLQRLNIAIDIAY-------------- 749 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~-l----------------~~~~~~~~~~~~~~~l~--~~~~~~i~~qi~~-------------- 749 (949)
.+||||++|.++..- + |.... ....... +.+..++..++..
T Consensus 126 -g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~-----~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~ 199 (379)
T 3feg_A 126 -GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEM-----PFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEM 199 (379)
T ss_dssp -EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCC-----SSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHH
T ss_pred -ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCC-----CCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhh
Confidence 389999998665421 1 10000 0011122 3444555544322
Q ss_pred -----HHHHHh----h-CCCCCeEecCCCCCCeeecCC----CceEEeeccccee
Q 039533 750 -----ALNYLH----H-DCQPVTAHCDLKPSNVLLDDY----MTARVGDFGLARI 790 (949)
Q Consensus 750 -----gL~~LH----~-~~~~~ivHrDlkp~NIll~~~----~~~kl~DfG~a~~ 790 (949)
.++.|. . .....++|+|+.+.||+++.+ +.+.++||..|..
T Consensus 200 ~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 200 YSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp TTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 122222 1 124579999999999999876 7899999998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.67 E-value=0.016 Score=62.35 Aligned_cols=169 Identities=14% Similarity=0.110 Sum_probs=89.7
Q ss_pred ccCHHHHHHHhcCCCC-----CCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCC--ccee
Q 039533 615 YLSYQDLYNATSGFSS-----ANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHR--NLVK 687 (949)
Q Consensus 615 ~~~~~~l~~~~~~y~~-----~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~ 687 (949)
..+.+++......|.+ ...++ |....||++... +|+.+++|+..... .....+..|..+++.+... .+++
T Consensus 10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~ 86 (328)
T 1zyl_A 10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAA 86 (328)
T ss_dssp CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCC
T ss_pred CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecc
Confidence 3445555555444432 24566 888899988764 45679999986332 2345677788888887422 2444
Q ss_pred EEeeeeccc-ccCCccceeEeeeccCCChhh-----h---------cCCCCCCCccccCCCCCCHHH-------------
Q 039533 688 VLTACLGAD-YRGNDFKASVYEFMHYGSLEE-----W---------LHPFTGEDEIDEAPRNLNLLQ------------- 739 (949)
Q Consensus 688 ~~~~~~~~~-~~~~~~~~lv~e~~~~gsL~~-----~---------l~~~~~~~~~~~~~~~l~~~~------------- 739 (949)
++.. .+.. ....+..++||+|++|..+.. + +|........ ......++..
T Consensus 87 ~~~~-~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~ 164 (328)
T 1zyl_A 87 PVAF-NGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLF-IHRPTIGLNEYLIEPRKLFEDAT 164 (328)
T ss_dssp CCCB-TTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCC-SSSCBCSHHHHTHHHHHHHHTCS
T ss_pred eeec-CCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCC-ccCCCCCHHHHHhhHHHHHhhcC
Confidence 4433 1110 011234578999998754321 0 1100000000 0001112111
Q ss_pred ---------HHHHHHHHHHHHHHHhh-CCCCCeEecCCCCCCeeecCCCceEEeeccccee
Q 039533 740 ---------RLNIAIDIAYALNYLHH-DCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARI 790 (949)
Q Consensus 740 ---------~~~i~~qi~~gL~~LH~-~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~ 790 (949)
....+.+++..++..-. .....++|||+++.||+++ + .+.++||+.+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 165 LIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 11122222222222211 1245789999999999999 4 899999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0092 Score=64.49 Aligned_cols=33 Identities=27% Similarity=0.206 Sum_probs=28.5
Q ss_pred CCCeEecCCCCCCeeecCC----CceEEeecccceec
Q 039533 759 QPVTAHCDLKPSNVLLDDY----MTARVGDFGLARIL 791 (949)
Q Consensus 759 ~~~ivHrDlkp~NIll~~~----~~~kl~DfG~a~~~ 791 (949)
...++|||+.+.||+++.+ +.+.|+||+.+..-
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 4589999999999999874 68999999988754
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.61 E-value=0.00014 Score=71.23 Aligned_cols=115 Identities=16% Similarity=0.123 Sum_probs=72.4
Q ss_pred CcccCcccCcEEeeccc-cccCc----CCCCCCCCccceeecCCCccccccc----cccccCCCCCcEEECCCCCCCCC-
Q 039533 107 SEIGGLRRLKVLALNNN-SICGE----IPTNISRCSTLIPIHPQNNQLVGKI----LSRFSSLSKTEILNLGSNHLTGS- 176 (949)
Q Consensus 107 ~~~~~l~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~l~~n~l~~~~----~~~~~~L~~L~~L~Ls~N~l~~~- 176 (949)
..+.+-+.|++|+|++| +|... +-+.+..-+.|+.|+|++|+|.... ...+..-+.|++|+|++|.|...
T Consensus 35 ~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~G 114 (197)
T 1pgv_A 35 RLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPEL 114 (197)
T ss_dssp HHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHH
T ss_pred HHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHH
Confidence 34556678999999986 77532 3344556677888888888886443 33444567788888888888732
Q ss_pred ---CCCCcCCCCCccEEeccccc---cCC----CCCCcccCCCccccccccCccc
Q 039533 177 ---IPSSLGNLSSIHTISLAYNN---LDG----TIPNSFGWFENLVFLSLAANNL 221 (949)
Q Consensus 177 ---~p~~~~~l~~L~~L~L~~N~---l~~----~~p~~~~~l~~L~~L~Ls~N~l 221 (949)
+-..+..-+.|++|+|++|. +.. .+...+..-+.|+.|+++.|.+
T Consensus 115 a~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 115 LARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 22345555668888887653 221 1223344456667777766543
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.50 E-value=0.0053 Score=67.46 Aligned_cols=74 Identities=14% Similarity=0.180 Sum_probs=44.3
Q ss_pred CeeeeecCceEEEEEEcC--------CCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCc-ceeEEeeeecccccCCcc
Q 039533 632 NLVGVGSFGSVYKGIIDE--------GRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRN-LVKVLTACLGADYRGNDF 702 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~~~~ 702 (949)
+.++.|....+|++.... .++.+++|+....... ......|.++++.+.... ++++++.. .
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~---------~ 108 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF---------N 108 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE---------T
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec---------C
Confidence 567788888999998753 1267899987543211 112467888888874333 45666542 1
Q ss_pred ceeEeeeccCCCh
Q 039533 703 KASVYEFMHYGSL 715 (949)
Q Consensus 703 ~~lv~e~~~~gsL 715 (949)
-++||||++|.++
T Consensus 109 ~~~v~e~i~G~~l 121 (369)
T 3c5i_A 109 GGRIEEWLYGDPL 121 (369)
T ss_dssp TEEEEECCCSEEC
T ss_pred CcEEEEEecCCcC
Confidence 3689999987544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.34 E-value=0.012 Score=63.75 Aligned_cols=33 Identities=21% Similarity=0.303 Sum_probs=28.9
Q ss_pred CCCeEecCCCCCCeeecCCCceEEeecccceec
Q 039533 759 QPVTAHCDLKPSNVLLDDYMTARVGDFGLARIL 791 (949)
Q Consensus 759 ~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~ 791 (949)
...++|+|+.+.||++++++.+.|+||+.+...
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 457999999999999998888999999887653
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.34 E-value=0.0042 Score=56.63 Aligned_cols=34 Identities=32% Similarity=0.337 Sum_probs=15.5
Q ss_pred cEEECCCCCCCCCCCCCcCCCCCccEEecccccc
Q 039533 164 EILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNL 197 (949)
Q Consensus 164 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 197 (949)
++|+|++|+|+...+..|..+++|++|+|++|.+
T Consensus 34 ~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 34 TELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp SEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred CEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 4444444444433333444444445555555443
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.28 E-value=0.005 Score=56.13 Aligned_cols=56 Identities=20% Similarity=0.251 Sum_probs=29.1
Q ss_pred EEEccCcccc-CCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccc
Q 039533 298 TLFLNNNKIY-GSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLS 355 (949)
Q Consensus 298 ~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 355 (949)
.++.+++.++ ..+|..+. ++|++|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4455555553 23333221 24556666666665444455566666666666666553
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.45 E-value=0.085 Score=51.74 Aligned_cols=104 Identities=15% Similarity=0.047 Sum_probs=67.2
Q ss_pred CCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecccceec
Q 039533 712 YGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARIL 791 (949)
Q Consensus 712 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~ 791 (949)
..+|.+.|. ..+.++++++++.++.|.+.+|.-+-.+.. . ..+=+.|..|++..+|.+...+ +.+.
T Consensus 32 ~vSL~eIL~---------~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~-- 97 (229)
T 2yle_A 32 ALSLEEILR---------LYNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD-- 97 (229)
T ss_dssp EEEHHHHHH---------HHTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-----
T ss_pred cccHHHHHH---------HcCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc--
Confidence 347888886 245779999999999999999877621100 1 1223456889999999888764 1110
Q ss_pred CCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCC
Q 039533 792 SPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842 (949)
Q Consensus 792 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~P 842 (949)
.....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 98 ------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ---------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0233466888764 3456788999999999999975555
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.36 E-value=0.031 Score=62.01 Aligned_cols=74 Identities=9% Similarity=0.086 Sum_probs=48.5
Q ss_pred CeeeeecCceEEEEEEcCC-------CEEEEEEEEecCCCcchHHHHHHHHHHHhcC-CCcceeEEeeeecccccCCccc
Q 039533 632 NLVGVGSFGSVYKGIIDEG-------RTTIAVKVFNLQHHGASRSFIAECKALKSIR-HRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 703 (949)
+.+..|-...+|+.....+ ++.+++|+....... .-...+|.++++.+. +.-..++++.+ .-
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~---------~~ 145 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF---------PE 145 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE---------TT
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc---------CC
Confidence 5677788889999987521 577999987543221 123457888888874 33345666432 23
Q ss_pred eeEeeeccCCCh
Q 039533 704 ASVYEFMHYGSL 715 (949)
Q Consensus 704 ~lv~e~~~~gsL 715 (949)
+.||||++|.++
T Consensus 146 ~~I~efI~G~~l 157 (424)
T 3mes_A 146 GRIEEFIDGEPL 157 (424)
T ss_dssp EEEEECCCSEEC
T ss_pred CEEEEEeCCccC
Confidence 789999998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.95 E-value=0.29 Score=54.11 Aligned_cols=30 Identities=27% Similarity=0.347 Sum_probs=25.5
Q ss_pred CeEecCCCCCCeee------cCCCceEEeeccccee
Q 039533 761 VTAHCDLKPSNVLL------DDYMTARVGDFGLARI 790 (949)
Q Consensus 761 ~ivHrDlkp~NIll------~~~~~~kl~DfG~a~~ 790 (949)
.++|+|+.+.||++ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46899999999999 4567899999998864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=84.25 E-value=2.1 Score=41.85 Aligned_cols=88 Identities=17% Similarity=0.206 Sum_probs=64.7
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecccceecCCCCCccccccccCccCccCc
Q 039533 733 RNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAP 812 (949)
Q Consensus 733 ~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aP 812 (949)
...+...+++++.+|+....+++++ +|--+.|+||+++.++.+++.-.|+...+.+..
T Consensus 76 k~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL~f~~~~~p~i~~RGik~~l~P~~----------------- 133 (215)
T 4ann_A 76 KSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDELFFTRDGLPIAKTRGLQNVVDPLP----------------- 133 (215)
T ss_dssp GGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGEEECTTSCEEESCCEETTTBSCCC-----------------
T ss_pred HhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceEEEcCCCCEEEEEccCccCCCCCC-----------------
Confidence 4478889999999999998777744 788899999999999999999887643332211
Q ss_pred cccCCCccCCccchHHHHHHHHHHHhCCCCCcccccc
Q 039533 813 EYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEG 849 (949)
Q Consensus 813 E~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~ 849 (949)
.++..=.-.+=+++..+++++..|+.-..+
T Consensus 134 -------~~ee~fL~qyKAliiall~~K~~Fe~l~~G 163 (215)
T 4ann_A 134 -------VSEAEFLTRYKALVICAFNEKQSFDALVEG 163 (215)
T ss_dssp -------CCHHHHHHHHHHHHHHHHCTTCCHHHHHHS
T ss_pred -------CCHHHHHHHHHHHHHHHHcCCCCHHHHHcC
Confidence 111112335677889999999999754444
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 949 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-51 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-46 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-46 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-45 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-45 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-44 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-44 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-42 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-42 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-42 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-42 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-41 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-41 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-41 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-41 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-40 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-40 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-40 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-40 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-40 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-39 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-39 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-39 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-39 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-39 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-38 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-38 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-38 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-37 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-36 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-35 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-35 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-34 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-34 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-33 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-33 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-33 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-33 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-33 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-31 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-31 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-31 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-30 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-30 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-29 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-29 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-28 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-06 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-28 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-07 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-28 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-28 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-28 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-27 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-27 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-27 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-27 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-27 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-26 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-25 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-25 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-25 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-25 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-25 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-25 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-21 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 9e-21 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-08 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-08 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-15 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.002 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.003 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 7e-09 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.003 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.003 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 7e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 9e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.003 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.004 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 1e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 3e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 3e-51
Identities = 71/306 (23%), Positives = 120/306 (39%), Gaps = 53/306 (17%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGAS--RSFIAECKALKSIRHRNLVKVL 689
+G GSFG+VYKG +AVK+ N+ ++F E L+ RH N++ +
Sbjct: 14 QRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 690 TACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAY 749
A V ++ SL LH +++ ++IA A
Sbjct: 71 GYSTA------PQLAIVTQWCEGSSLYHHLH---------IIETKFEMIKLIDIARQTAQ 115
Query: 750 ALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGY 809
++YLH H DLK +N+ L + +T ++GDFGLA + S + GS+ +
Sbjct: 116 GMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172
Query: 810 IAPEY---GVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVM 866
+APE S DVY++GI+L EL+ G+ P + D + GR L D+
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS 232
Query: 867 DIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926
+ C +M R+ C + +R ++
Sbjct: 233 KVRS---------------------------NCPKAMKRLMAECLKKKRDERPLFPQILA 265
Query: 927 ELQSIK 932
++ +
Sbjct: 266 SIELLA 271
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 164 bits (417), Expect = 6e-46
Identities = 64/331 (19%), Positives = 125/331 (37%), Gaps = 64/331 (19%)
Query: 617 SYQDLYNATSGFSSA---------NLVGVGSFGSVYKGII---DEGRTTIAVKVFNLQHH 664
+++D A F+ ++G G FG V G + + +A+K +
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 665 -GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFT 723
R F++E + H N++ + + + EFM GSL+ +L
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI-----ITEFMENGSLDSFLRQND 122
Query: 724 GEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783
G+ + Q + + IA + YL H DL N+L++ + +V
Sbjct: 123 GQFTVI---------QLVGMLRGIAAGMKYLADMNYV---HRDLAARNILVNSNLVCKVS 170
Query: 784 DFGLARILSPD---HTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGK 840
DFGL+R L D T TS+ K + + APE + ++ DV+SYGI++ E++
Sbjct: 171 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG 230
Query: 841 KPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECL 900
+ + DV++ ++ R+ ++C
Sbjct: 231 ERP---YWDMT----------NQDVINAIEQDY------------------RLPPPMDCP 259
Query: 901 ISMVRIGVACSMELPQDRTNMTNVVHELQSI 931
++ ++ + C + R +V+ L +
Sbjct: 260 SALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 9e-46
Identities = 62/270 (22%), Positives = 112/270 (41%), Gaps = 25/270 (9%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTA 691
+G GSF +VYKG+ E +A + + F E + LK ++H N+V+ +
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 692 CLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYAL 751
+G V E M G+L+ +L F + + + + I L
Sbjct: 77 WESTV-KGKKCIVLVTELMTSGTLKTYLKRF----------KVMKIKVLRSWCRQILKGL 125
Query: 752 NYLHHDCQPVTAHCDLKPSNVLLDD-YMTARVGDFGLARILSPDHTQTSSFSVKGSLGYI 810
+LH P+ H DLK N+ + + ++GD GLA + + V G+ ++
Sbjct: 126 QFLHTRTPPI-IHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFM 180
Query: 811 APEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVD 870
APE + + DVY++G+ +LE+ + P + N R+ D
Sbjct: 181 APEM-YEEKYDESVDVYAFGMCMLEMATSEYP----YSECQNAAQIYRRVTSGVKPASFD 235
Query: 871 SSLLPDDEDLILTGNQRQKQARINSIIECL 900
+P+ +++I ++ K R SI + L
Sbjct: 236 KVAIPEVKEIIEGCIRQNKDERY-SIKDLL 264
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 4e-45
Identities = 51/218 (23%), Positives = 91/218 (41%), Gaps = 22/218 (10%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRS-FIAECKALKSIRHRNLV 686
F + +G G+ G V+K +A K+ +L+ A R+ I E + L +V
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 687 KVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAID 746
A + + E M GSL++ L + ++I
Sbjct: 68 GFYGAF-----YSDGEISICMEHMDGGSLDQVLK----------KAGRIPEQILGKVSIA 112
Query: 747 IAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGS 806
+ L YL + + H D+KPSN+L++ ++ DFG++ L + G+
Sbjct: 113 VIKGLTYLREKHKIM--HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----FVGT 166
Query: 807 LGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPID 844
Y++PE G S D++S G+ L+E+ +G+ PI
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 5e-45
Identities = 61/300 (20%), Positives = 119/300 (39%), Gaps = 51/300 (17%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTA 691
+G G FG V+ G + +AVK Q + +F+AE +K ++H+ LV++
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTK-VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 692 CLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYAL 751
+ + E+M GSL ++L + L + + L++A IA +
Sbjct: 77 VT------QEPIYIITEYMENGSLVDFLK--------TPSGIKLTINKLLDMAAQIAEGM 122
Query: 752 NYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIA 811
++ H DL+ +N+L+ D ++ ++ DFGLAR++ + K + + A
Sbjct: 123 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTA 178
Query: 812 PEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDS 871
PE + DV+S+GILL E+V + + P+ + ++
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIP------------YPGMTNPEVIQNLERG 226
Query: 872 SLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSI 931
+ ++ C + ++ C E P+DR + L+
Sbjct: 227 YRMVRPDN-------------------CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 1e-44
Identities = 60/313 (19%), Positives = 109/313 (34%), Gaps = 39/313 (12%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACL 693
+G G FG V++G +AVK+F+ + S AE +RH N++ + A
Sbjct: 11 IGKGRFGEVWRGKWRG--EEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADN 67
Query: 694 GADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNY 753
+ V ++ +GSL ++L+ + + + +A+ A L +
Sbjct: 68 KDNGTWTQL-WLVSDYHEHGSLFDYLNR-----------YTVTVEGMIKLALSTASGLAH 115
Query: 754 LHHDC-----QPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSP--DHTQTSSFSVKGS 806
LH + +P AH DLK N+L+ T + D GLA D + G+
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
Query: 807 LGYIAPEY------GVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860
Y+APE E D+Y+ G++ E+ I + + ++
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL---- 231
Query: 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTN 920
+ + + ++ R E L M +I C R
Sbjct: 232 -------VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 284
Query: 921 MTNVVHELQSIKN 933
+ L +
Sbjct: 285 ALRIKKTLSQLSQ 297
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 1e-44
Identities = 62/258 (24%), Positives = 104/258 (40%), Gaps = 21/258 (8%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGAS--RSFIAECKALKSIRHRNLVKVL 689
+G GS+G K + K + + + ++E L+ ++H N+V+
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 690 TACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAY 749
+ R N V E+ G L + T E + L+ L + +
Sbjct: 70 DRIID---RTNTTLYIVMEYCEGGDLASVITKGTKE------RQYLDEEFVLRVMTQLTL 120
Query: 750 ALNYLH--HDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSL 807
AL H D H DLKP+NV LD ++GDFGLARIL+ D + +F G+
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAF--VGTP 178
Query: 808 GYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDI--NLHNFGRKALP--- 862
Y++PE + D++S G LL EL P + ++ + + +P
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 238
Query: 863 -DDVMDIVDSSLLPDDED 879
D++ +I+ L D
Sbjct: 239 SDELNEIITRMLNLKDYH 256
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 1e-42
Identities = 60/312 (19%), Positives = 119/312 (38%), Gaps = 54/312 (17%)
Query: 626 SGFSSANLVGVGSFGSVYKGIIDEG----RTTIAVKVFNLQHHGASR-SFIAECKALKSI 680
S + ++G G FG VYKG++ +A+K + R F+ E +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 681 RHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQR 740
H N++++ + E+M G+L+++L E ++LQ
Sbjct: 67 SHHNIIRLEGVISKYKPM-----MIITEYMENGALDKFLR---------EKDGEFSVLQL 112
Query: 741 LNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSS 800
+ + IA + YL + H DL N+L++ + +V DFGL+R+L D T +
Sbjct: 113 VGMLRGIAAGMKYLANMNYV---HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 169
Query: 801 FS-VKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859
S K + + APE + ++ DV+S+GI++ E++ +
Sbjct: 170 TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS----------- 218
Query: 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRT 919
+VM ++ +C ++ ++ + C + R
Sbjct: 219 --NHEVMKAINDGFRLPTPM------------------DCPSAIYQLMMQCWQQERARRP 258
Query: 920 NMTNVVHELQSI 931
++V L +
Sbjct: 259 KFADIVSILDKL 270
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (390), Expect = 2e-42
Identities = 64/320 (20%), Positives = 118/320 (36%), Gaps = 59/320 (18%)
Query: 632 NLVGVGSFGSVYKG-----IIDEGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNL 685
+G G+FG V++ + E T +AVK+ + F E + + N+
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78
Query: 686 VKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEID--------------EA 731
VK+L C ++E+M YG L E+L +
Sbjct: 79 VKLLGVC-----AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 732 PRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARIL 791
P L+ ++L IA +A + YL H DL N L+ + M ++ DFGL+R +
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSERKFV---HRDLATRNCLVGENMVVKIADFGLSRNI 190
Query: 792 SPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDI 851
+ + + ++ PE +T DV++YG++L E+
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP-------- 242
Query: 852 NLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACS 911
+ A + + + D ++L E+ C + + + C
Sbjct: 243 ----YYGMAHEEVIYYVRDGNILACPEN-------------------CPLELYNLMRLCW 279
Query: 912 MELPQDRTNMTNVVHELQSI 931
+LP DR + ++ LQ +
Sbjct: 280 SKLPADRPSFCSIHRILQRM 299
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 4e-42
Identities = 69/302 (22%), Positives = 112/302 (37%), Gaps = 55/302 (18%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTA 691
+G G FG V G +AVK +++ +++F+AE + +RH NLV++L
Sbjct: 13 QTIGKGEFGDVMLGDYRG--NKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGV 68
Query: 692 CLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYAL 751
V E+M GSL ++L L L ++D+ A+
Sbjct: 69 I----VEEKGGLYIVTEYMAKGSLVDYLR--------SRGRSVLGGDCLLKFSLDVCEAM 116
Query: 752 NYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIA 811
YL + H DL NVL+ + A+V DFGL + S + K + + A
Sbjct: 117 EYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTA 168
Query: 812 PEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDS 871
PE + ST DV+S+GILL E+ + + DV+ V+
Sbjct: 169 PEALREKKFSTKSDVWSFGILLWEIYSFGRVP---YPRI----------PLKDVVPRVEK 215
Query: 872 SLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSI 931
D D C ++ + C R + + +L+ I
Sbjct: 216 GYKMDAPD------------------GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
Query: 932 KN 933
K
Sbjct: 258 KT 259
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 9e-42
Identities = 68/300 (22%), Positives = 117/300 (39%), Gaps = 51/300 (17%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTA 691
+G G FG V+ G G T +A+K +F+ E + +K +RH LV++
Sbjct: 23 VKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV 80
Query: 692 CLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYAL 751
V E+M GSL ++L E + L L Q +++A IA +
Sbjct: 81 VSEEPI------YIVTEYMSKGSLLDFLK--------GETGKYLRLPQLVDMAAQIASGM 126
Query: 752 NYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIA 811
Y+ H DL+ +N+L+ + + +V DFGLAR++ + K + + A
Sbjct: 127 AYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTA 182
Query: 812 PEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDS 871
PE + + DV+S+GILL EL + + G + +V+D V+
Sbjct: 183 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP---YPGMV----------NREVLDQVER 229
Query: 872 SLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSI 931
EC S+ + C + P++R + L+
Sbjct: 230 GYRMPCPP------------------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 1e-41
Identities = 61/271 (22%), Positives = 106/271 (39%), Gaps = 25/271 (9%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLT 690
+G G++G V + +AVK+ +++ + E K + H N+VK
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 691 ACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYA 750
R + + E+ G L + + P G E +
Sbjct: 71 HR-----REGNIQYLFLEYCSGGELFDRIEPDIGMPEP----------DAQRFFHQLMAG 115
Query: 751 LNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYI 810
+ YLH H D+KP N+LLD+ ++ DFGLA + ++ + + G+L Y+
Sbjct: 116 VVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 811 APEYGVGCEVSTNG-DVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIV 869
APE E DV+S GI+L ++ G+ P D + ++ K + +
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 232
Query: 870 DSSLLPDDEDLILTGNQRQKQARINSIIECL 900
DS+ L L+ ARI +I +
Sbjct: 233 DSAPL----ALLHKILVENPSARI-TIPDIK 258
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 3e-41
Identities = 63/312 (20%), Positives = 112/312 (35%), Gaps = 53/312 (16%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTT---IAVKVFN-LQHHGASRSFIAECKALKSIRHRNLVK 687
++G G FG VY G + + AVK N + G F+ E +K H N++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 688 VLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDI 747
+L C R V +M +G L ++ N + + + +
Sbjct: 93 LLGIC----LRSEGSPLVVLPYMKHGDLRNFIRN---------ETHNPTVKDLIGFGLQV 139
Query: 748 AYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPD--HTQTSSFSVKG 805
A + H DL N +LD+ T +V DFGLAR + + + K
Sbjct: 140 AKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 196
Query: 806 SLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDV 865
+ ++A E + +T DV+S+G+LL EL+ P D+N +
Sbjct: 197 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVY------ 246
Query: 866 MDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVV 925
++ L E C + + + C + R + + +V
Sbjct: 247 --LLQGRRLLQPEY-------------------CPDPLYEVMLKCWHPKAEMRPSFSELV 285
Query: 926 HELQSIKNILLG 937
+ +I + +G
Sbjct: 286 SRISAIFSTFIG 297
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 150 bits (379), Expect = 6e-41
Identities = 64/300 (21%), Positives = 119/300 (39%), Gaps = 49/300 (16%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTA 691
+ +G G +G VY+G+ + T+AVK + F+ E +K I+H NLV++L
Sbjct: 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 692 CLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYAL 751
C EFM YG+L ++L + + ++ + L +A I+ A+
Sbjct: 82 CTREPPFYII-----TEFMTYGNLLDYLR--------ECNRQEVSAVVLLYMATQISSAM 128
Query: 752 NYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIA 811
YL + H DL N L+ + +V DFGL+R+++ D + K + + A
Sbjct: 129 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTA 184
Query: 812 PEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDS 871
PE + S DV+++G+LL E+ + G V ++++
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMS---PYPGI----------DLSQVYELLEK 231
Query: 872 SLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSI 931
+ + C + + AC P DR + + +++
Sbjct: 232 DYRMERPE------------------GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 9e-41
Identities = 64/300 (21%), Positives = 109/300 (36%), Gaps = 51/300 (17%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTA 691
+G G FG V+ G + +A+K FI E + + + H LV++
Sbjct: 11 QEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 692 CLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYAL 751
CL V+EFM +G L ++L G + L + +D+ +
Sbjct: 69 CLE-----QAPICLVFEFMEHGCLSDYLRTQRGLFAAE---------TLLGMCLDVCEGM 114
Query: 752 NYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIA 811
YL C H DL N L+ + +V DFG+ R + D TSS K + + +
Sbjct: 115 AYLEEACV---IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWAS 170
Query: 812 PEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDS 871
PE S+ DV+S+G+L+ E+ K +V++ + +
Sbjct: 171 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-------------NSEVVEDIST 217
Query: 872 SLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSI 931
L + +I C E P+DR + ++ +L I
Sbjct: 218 GFRLYKPRL------------------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-40
Identities = 56/305 (18%), Positives = 107/305 (35%), Gaps = 55/305 (18%)
Query: 632 NLVGVGSFGSVYKGIIDEGRT--TIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVK 687
+G G+FG+V KG + T+AVK+ + + +AE ++ + + +V+
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 688 VLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDI 747
++ C + V E G L ++L R++ + + +
Sbjct: 73 MIGICE------AESWMLVMEMAELGPLNKYLQQ----------NRHVKDKNIIELVHQV 116
Query: 748 AYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQ-TSSFSVKGS 806
+ + YL H DL NVLL A++ DFGL++ L D + K
Sbjct: 117 SMGMKYLEESNFV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173
Query: 807 LGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVM 866
+ + APE + S+ DV+S+G+L+ E + + G +V
Sbjct: 174 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP---YRGMK----------GSEVT 220
Query: 867 DIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926
+++ C M + C ++R V
Sbjct: 221 AMLEKGERMGCPA------------------GCPREMYDLMNLCWTYDVENRPGFAAVEL 262
Query: 927 ELQSI 931
L++
Sbjct: 263 RLRNY 267
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 2e-40
Identities = 62/319 (19%), Positives = 121/319 (37%), Gaps = 56/319 (17%)
Query: 619 QDLYNATSGFSSANLV-GVGSFGSVYKGI--IDEGRTTIAVKVFNLQ-HHGASRSFIAEC 674
+ L+ A++ G G+FGSV +G+ + + + +A+KV + + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 675 KALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRN 734
+ + + + +V+++ C V E G L ++L E
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAEAL------MLVMEMAGGGPLHKFLVGKREE--------- 105
Query: 735 LNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPD 794
+ + + ++ + YL H DL NVLL + A++ DFGL++ L D
Sbjct: 106 IPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162
Query: 795 HTQ-TSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLE-LVIGKKPIDIMFEGDIN 852
+ T+ + K L + APE + S+ DV+SYG+ + E L G+KP ++
Sbjct: 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP----YKKMK- 217
Query: 853 LHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSM 912
+VM ++ + EC + + C +
Sbjct: 218 ---------GPEVMAFIEQGKRMECPP------------------ECPPELYALMSDCWI 250
Query: 913 ELPQDRTNMTNVVHELQSI 931
+DR + V +++
Sbjct: 251 YKWEDRPDFLTVEQRMRAC 269
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 7e-40
Identities = 62/274 (22%), Positives = 102/274 (37%), Gaps = 29/274 (10%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTA 691
+G G+FG VYK E A KV + + ++ E L S H N+VK+L A
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 692 CLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYAL 751
+ + EF G+++ + E R L Q + AL
Sbjct: 78 F-----YYENNLWILIEFCAGGAVDAVML---------ELERPLTESQIQVVCKQTLDAL 123
Query: 752 NYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIA 811
NYLH + H DLK N+L ++ DFG++ + + SF G+ ++A
Sbjct: 124 NYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF--IGTPYWMA 178
Query: 812 PEY-----GVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVM 866
PE DV+S GI L+E+ + P + + A +
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP----HHELNPMRVLLKIAKSEPPT 234
Query: 867 DIVDSSLLPDDEDLILTGNQRQKQARINSIIECL 900
S + +D + ++ AR + + L
Sbjct: 235 LAQPSRWSSNFKDFLKKCLEKNVDARW-TTSQLL 267
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 7e-40
Identities = 64/311 (20%), Positives = 119/311 (38%), Gaps = 54/311 (17%)
Query: 628 FSSANLVGVGSFGSVYKGI-IDEGRTT---IAVKVFNLQHHG-ASRSFIAECKALKSIRH 682
F ++G G+FG+VYKG+ I EG +A+K A++ + E + S+ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 683 RNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLN 742
++ ++L CL + + + + M +G L +++ E N+ LN
Sbjct: 71 PHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVR---------EHKDNIGSQYLLN 115
Query: 743 IAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFS 802
+ IA +NYL H DL NVL+ ++ DFGLA++L + + +
Sbjct: 116 WCVQIAKGMNYLEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 172
Query: 803 VKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862
K + ++A E + + DV+SYG+ + EL+ ++G
Sbjct: 173 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK---PYDGIPA---------- 219
Query: 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMT 922
++ I++ C I + I V C M R
Sbjct: 220 SEISSILEKGERLPQPP------------------ICTIDVYMIMVKCWMIDADSRPKFR 261
Query: 923 NVVHELQSIKN 933
++ E +
Sbjct: 262 ELIIEFSKMAR 272
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 7e-40
Identities = 59/300 (19%), Positives = 102/300 (34%), Gaps = 51/300 (17%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTA 691
+G G FG V G +A+K+ FI E K + ++ H LV++
Sbjct: 10 KELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 692 CLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYAL 751
C + E+M G L +L Q L + D+ A+
Sbjct: 68 CTKQRPI-----FIITEYMANGCLLNYLREMRH---------RFQTQQLLEMCKDVCEAM 113
Query: 752 NYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIA 811
YL H DL N L++D +V DFGL+R + D TSS K + +
Sbjct: 114 EYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSP 169
Query: 812 PEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDS 871
PE + + S+ D++++G+L+ E+ K +E + + +
Sbjct: 170 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP---YERFT----------NSETAEHIAQ 216
Query: 872 SLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSI 931
L L + I +C E +R ++ + +
Sbjct: 217 GLRLYRPHL------------------ASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 3e-39
Identities = 54/260 (20%), Positives = 97/260 (37%), Gaps = 38/260 (14%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFN---LQHHGASRSFIAECKALKSIRHRNLVKV 688
+G G FG+VY + + +A+KV L+ G E + +RH N++++
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 689 LTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIA 748
+ E+ G++ L + + ++A
Sbjct: 72 YGYF-----HDATRVYLILEYAPLGTVYRELQKL----------SKFDEQRTATYITELA 116
Query: 749 YALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLG 808
AL+Y H + V H D+KP N+LL ++ DFG + T + G+L
Sbjct: 117 NALSYCHS--KRV-IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLD 169
Query: 809 YIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGR---------K 859
Y+ PE G D++S G+L E ++GK P FE + + R
Sbjct: 170 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPD 225
Query: 860 ALPDDVMDIVDSSLLPDDED 879
+ + D++ L +
Sbjct: 226 FVTEGARDLISRLLKHNPSQ 245
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 3e-39
Identities = 56/269 (20%), Positives = 104/269 (38%), Gaps = 26/269 (9%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTA 691
+G G+ G+VY + +A++ NLQ I E ++ ++ N+V L +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 692 CLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYAL 751
L D V E++ GSL + + ++ Q + + AL
Sbjct: 86 YLVGDEL-----WVVMEYLAGGSLTDVVTETCMDEG-----------QIAAVCRECLQAL 129
Query: 752 NYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIA 811
+LH + H D+K N+LL + ++ DFG ++P+ ++ S+ G+ ++A
Sbjct: 130 EFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTPYWMA 184
Query: 812 PEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIVDS 871
PE D++S GI+ +E++ G+ P + + L A
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP----YLNENPLRALYLIATNGTPELQNPE 240
Query: 872 SLLPDDEDLILTGNQRQKQARINSIIECL 900
L D + + R S E L
Sbjct: 241 KLSAIFRDFLNRCLDMDVEKRG-SAKELL 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (368), Expect = 3e-39
Identities = 58/265 (21%), Positives = 98/265 (36%), Gaps = 37/265 (13%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNL---QHHGASRSFIAECKALKSIRHRN 684
FS +G GSFG+VY +A+K + Q + + I E + L+ +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 685 LVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIA 744
++ L V E+ + + + L ++ +
Sbjct: 77 TIQYRGCYLREHTA-----WLVMEYCLGSASDLLEV----------HKKPLQEVEIAAVT 121
Query: 745 IDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVK 804
L YLH + H D+K N+LL + ++GDFG A I++P ++
Sbjct: 122 HGALQGLAYLHS--HNM-IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS------FV 172
Query: 805 GSLGYIAPEYGVGCEVSTNG---DVYSYGILLLELVIGKKPIDIMFEGDI-------NLH 854
G+ ++APE + + DV+S GI +EL K P+ M
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 232
Query: 855 NFGRKALPDDVMDIVDSSLLPDDED 879
+ + VDS L +D
Sbjct: 233 ALQSGHWSEYFRNFVDSCLQKIPQD 257
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 5e-39
Identities = 61/318 (19%), Positives = 108/318 (33%), Gaps = 58/318 (18%)
Query: 633 LVGVGSFGSVYKGIIDEGRTT-----IAVKVFNLQHHGASR-SFIAECKALKSI-RHRNL 685
++G G+FG V T +AVK+ + + R + ++E K + + H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 686 VKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLH-------------PFTGEDEIDEAP 732
V +L AC + ++E+ YG L +L E +E
Sbjct: 104 VNLLGAC-----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 158
Query: 733 RNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILS 792
L L A +A + +L + H DL NVL+ ++ DFGLAR +
Sbjct: 159 NVLTFEDLLCFAYQVAKGMEFLEF--KSCV-HRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 793 PDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDIN 852
D + + + ++APE + DV+SYGILL E+
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP--------- 266
Query: 853 LHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSM 912
+ + + ++ + D + I +C
Sbjct: 267 ---YPGIPVDANFYKLIQNGFKMDQPF------------------YATEEIYIIMQSCWA 305
Query: 913 ELPQDRTNMTNVVHELQS 930
+ R + N+ L
Sbjct: 306 FDSRKRPSFPNLTSFLGC 323
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 6e-39
Identities = 63/330 (19%), Positives = 119/330 (36%), Gaps = 51/330 (15%)
Query: 615 YLSYQDLYNA------TSGFSSANLVGVGSFGSVYKGII-----DEGRTTIAVKVFNLQH 663
Y S D+Y + + +G GSFG VY+G+ DE T +A+K N
Sbjct: 3 YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 62
Query: 664 -HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPF 722
F+ E +K ++V++L + E M G L+ +L
Sbjct: 63 SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT-----LVIMELMTRGDLKSYLRSL 117
Query: 723 TGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782
+ +L + + +A +IA + YL+ + H DL N ++ + T ++
Sbjct: 118 RPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 174
Query: 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
GDFG+ R + + +++PE +T DV+S+G++L E+ +
Sbjct: 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 234
Query: 843 IDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLIS 902
++G + V+ V L D D C
Sbjct: 235 P---YQGLS----------NEQVLRFVMEGGLLDKPD------------------NCPDM 263
Query: 903 MVRIGVACSMELPQDRTNMTNVVHELQSIK 932
+ + C P+ R + ++ ++
Sbjct: 264 LFELMRMCWQYNPKMRPSFLEIISSIKEEM 293
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-38
Identities = 65/315 (20%), Positives = 106/315 (33%), Gaps = 53/315 (16%)
Query: 632 NLVGVGSFGSVYKG-----IIDEGRTTIAVKVFNLQHHGASR-SFIAECKALKSI-RHRN 684
+G G+FG V + I + T+AVK+ H R + ++E K L + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 685 LVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLH--------PFTGEDEIDEAPRNLN 736
+V +L AC + E+ YG L +L T +++ L+
Sbjct: 89 IVNLLGACTIGGPT-----LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 737 LLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHT 796
L L+ + +A + +L H DL N+LL ++ DFGLAR + D
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 797 QTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNF 856
+ + + ++APE C + DV+SYGI L EL D
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD------ 254
Query: 857 GRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQ 916
++ + M I C P
Sbjct: 255 ------SKFYKMIKEGFRMLSPE------------------HAPAEMYDIMKTCWDADPL 290
Query: 917 DRTNMTNVVHELQSI 931
R +V ++
Sbjct: 291 KRPTFKQIVQLIEKQ 305
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 144 bits (364), Expect = 3e-38
Identities = 55/258 (21%), Positives = 95/258 (36%), Gaps = 31/258 (12%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTAC 692
+G G+FG V++ A K H + E + + +RH LV + A
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 693 LGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALN 752
++ +YEFM G L E + + ++ + + + L
Sbjct: 93 -----EDDNEMVMIYEFMSGGELFEKVA---------DEHNKMSEDEAVEYMRQVCKGLC 138
Query: 753 YLHHDCQPVTAHCDLKPSNVLLDDYMTARV--GDFGLARILSPDHTQTSSFSVKGSLGYI 810
++H + H DLKP N++ + + DFGL L P + G+ +
Sbjct: 139 HMHENNY---VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFA 192
Query: 811 APEYGVGCEVSTNGDVYSYGILLLELVIGKKP---------IDIMFEGDINLHNFGRKAL 861
APE G V D++S G+L L+ G P + + D N+ + +
Sbjct: 193 APEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI 252
Query: 862 PDDVMDIVDSSLLPDDED 879
+D D + LL D
Sbjct: 253 SEDGKDFIRKLLLADPNT 270
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 6e-38
Identities = 61/314 (19%), Positives = 118/314 (37%), Gaps = 52/314 (16%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGAS---RSFIAECKALKSI-RHR 683
+++G G+FG V K I + + + ++ + + R F E + L + H
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 684 NLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDE------IDEAPRNLNL 737
N++ +L AC + E+ +G+L ++L + + L+
Sbjct: 72 NIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 738 LQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQ 797
Q L+ A D+A ++YL Q H DL N+L+ + A++ DFGL+R +
Sbjct: 127 QQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 183
Query: 798 TSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFG 857
T + + ++A E +TN DV+SYG+LL E+V + G
Sbjct: 184 T---MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---PYCGMT------ 231
Query: 858 RKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQD 917
++ + + + C + + C E P +
Sbjct: 232 ----CAELYEKLPQGYRLEKPL------------------NCDDEVYDLMRQCWREKPYE 269
Query: 918 RTNMTNVVHELQSI 931
R + ++ L +
Sbjct: 270 RPSFAQILVSLNRM 283
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-37
Identities = 54/260 (20%), Positives = 97/260 (37%), Gaps = 34/260 (13%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKV 688
++G GSF +V A+K+ +H E + + H VK+
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 689 LTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIA 748
+ ++ + G L +++ + + +I
Sbjct: 74 YFTF-----QDDEKLYFGLSYAKNGELLKYIRKI----------GSFDETCTRFYTAEIV 118
Query: 749 YALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLG 808
AL YLH H DLKP N+LL++ M ++ DFG A++LSP+ Q + S G+
Sbjct: 119 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175
Query: 809 YIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGR---------K 859
Y++PE + D+++ G ++ +LV G P F F + +
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQKIIKLEYDFPE 231
Query: 860 ALPDDVMDIVDSSLLPDDED 879
D+V+ L+ D
Sbjct: 232 KFFPKARDLVEKLLVLDATK 251
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 137 bits (345), Expect = 1e-36
Identities = 61/279 (21%), Positives = 110/279 (39%), Gaps = 23/279 (8%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFN---LQHHGASRSFIAECKALKSIRHRNLVKVL 689
++G G V+ +AVKV + F E + ++ H +V V
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 690 TACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAY 749
G V E++ +L + +H + + + + D
Sbjct: 74 DTGEAETPAGPLP-YIVMEYVDGVTLRDIVHTE----------GPMTPKRAIEVIADACQ 122
Query: 750 ALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQ-TSSFSVKGSLG 808
ALN+ H + H D+KP+N+++ +V DFG+AR ++ T + +V G+
Sbjct: 123 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 809 YIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDI 868
Y++PE G V DVYS G +L E++ G+ P F GD + + D +
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPIPPS 235
Query: 869 VDSSLLPDD-EDLILTGNQRQKQARINSIIECLISMVRI 906
L D + ++L + + R + E +VR+
Sbjct: 236 ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 1e-35
Identities = 62/312 (19%), Positives = 104/312 (33%), Gaps = 48/312 (15%)
Query: 632 NLVGVGSFGSVYKGIIDEGR-----TTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNL 685
+G G+FG V + T+AVK+ H R+ ++E K L I H
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 686 VKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGE------DEIDEAPRNLNLLQ 739
V L GA + + EF +G+L +L E D L L
Sbjct: 79 VVNLL---GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135
Query: 740 RLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTS 799
+ + +A + +L H DL N+LL + ++ DFGLAR + D
Sbjct: 136 LICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 800 SFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859
+ L ++APE + DV+S+G+LL E+ +
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP------------YPGV 240
Query: 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRT 919
+ ++ + D M + + C P R
Sbjct: 241 KIDEEFCRRLKEGTRMRAPD------------------YTTPEMYQTMLDCWHGEPSQRP 282
Query: 920 NMTNVVHELQSI 931
+ +V L ++
Sbjct: 283 TFSELVEHLGNL 294
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 9e-35
Identities = 67/306 (21%), Positives = 105/306 (34%), Gaps = 55/306 (17%)
Query: 634 VGVGSFGSVYKGIIDEG---RTTIAVKVFN---LQHHGASRSFIAECKALKSIRHRNLVK 687
+G GSFG V +G D ++AVK L A FI E A+ S+ HRNL++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 688 VLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDI 747
+ L + V E GSL + L G + L A+ +
Sbjct: 76 LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQG---------HFLLGTLSRYAVQV 120
Query: 748 AYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQ-TSSFSVKGS 806
A + YL H DL N+LL ++GDFGL R L + K
Sbjct: 121 AEGMGYLESKRFI---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 807 LGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVM 866
+ APE S D + +G+ L E+ + + G ++
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE---PWIGLN----------GSQIL 224
Query: 867 DIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926
+D ++ R+ +C + + V C P+DR +
Sbjct: 225 HKID-----------------KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267
Query: 927 ELQSIK 932
L +
Sbjct: 268 FLLEAQ 273
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 133 bits (336), Expect = 1e-34
Identities = 45/255 (17%), Positives = 88/255 (34%), Gaps = 31/255 (12%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTAC 692
+G G+FG V++ + K N + + E + + H L+ + A
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 693 LGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALN 752
+ EF+ G L + + ++ + +N L
Sbjct: 96 -----EDKYEMVLILEFLSGGELFDRIA---------AEDYKMSEAEVINYMRQACEGLK 141
Query: 753 YLHHDCQPVTAHCDLKPSNVLLDDYMTARV--GDFGLARILSPDHTQTSSFSVKGSLGYI 810
++H + H D+KP N++ + + V DFGLA L+PD + +
Sbjct: 142 HMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFA 195
Query: 811 APEYGVGCEVSTNGDVYSYGILLLELVIGKKP---------IDIMFEGDINLHNFGRKAL 861
APE V D+++ G+L L+ G P + + D ++
Sbjct: 196 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV 255
Query: 862 PDDVMDIVDSSLLPD 876
+ D + + L +
Sbjct: 256 SPEAKDFIKNLLQKE 270
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 2e-34
Identities = 62/306 (20%), Positives = 111/306 (36%), Gaps = 60/306 (19%)
Query: 633 LVGVGSFGSVYKGII---DEGRTTIAVKVF-NLQHHGASRSFIAECKALKSIRHRNLVKV 688
+G G FG V++GI + +A+K N F+ E ++ H ++VK+
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 689 LTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIA 748
+ + + E G L +L +L+L + A ++
Sbjct: 74 IGVIT------ENPVWIIMELCTLGELRSFLQ---------VRKYSLDLASLILYAYQLS 118
Query: 749 YALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLG 808
AL YL H D+ NVL+ ++GDFGL+R + D T + K +
Sbjct: 119 TALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIK 174
Query: 809 YIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDI--NLHNFGRKALPDDV 865
++APE ++ DV+ +G+ + E+++ G KP + D+ + N R +P +
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 234
Query: 866 MDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVV 925
P L+ C P R T +
Sbjct: 235 P--------PTLYSLMT--------------------------KCWAYDPSRRPRFTELK 260
Query: 926 HELQSI 931
+L +I
Sbjct: 261 AQLSTI 266
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 4e-33
Identities = 56/247 (22%), Positives = 97/247 (39%), Gaps = 18/247 (7%)
Query: 621 LYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFN-LQHHGASRSFIAECKALKS 679
+++ +++ + +G G++G V + + +A+K + +H + + E K L
Sbjct: 3 VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 62
Query: 680 IRHRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQ 739
RH N++ + +A E M L L + ++L+
Sbjct: 63 FRHENIIGINDII----------RAPTIEQMKDVYLVTHLMGADLYKLLKT--QHLSNDH 110
Query: 740 RLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTS 799
I L Y+H H DLKPSN+LL+ ++ DFGLAR+ PDH T
Sbjct: 111 ICYFLYQILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 167
Query: 800 SF-SVKGSLGYIAPEYGVGCEVSTN-GDVYSYGILLLELVIGKKPIDIMFEGDINLHNFG 857
+ Y APE + + T D++S G +L E++ + D H G
Sbjct: 168 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 227
Query: 858 RKALPDD 864
P
Sbjct: 228 ILGSPSQ 234
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 4e-33
Identities = 59/315 (18%), Positives = 109/315 (34%), Gaps = 54/315 (17%)
Query: 632 NLVGVGSFGSVYKGI-------IDEGRTTIAVKVFNLQH-HGASRSFIAECKALKSI-RH 682
+G G+FG V T +AVK+ I+E + +K I +H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 683 RNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTG------EDEIDEAPRNLN 736
+N++ +L AC + + E+ G+L E+L + L+
Sbjct: 79 KNIINLLGAC-----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 737 LLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHT 796
++ A +A + YL H DL NVL+ + ++ DFGLAR +
Sbjct: 134 SKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 797 QTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNF 856
+ + + + ++APE + DV+S+G+LL E+ + G
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS---PYPGVPV---- 243
Query: 857 GRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQ 916
+++ ++ D C + + C +P
Sbjct: 244 ------EELFKLLKEGHRMDKPS------------------NCTNELYMMMRDCWHAVPS 279
Query: 917 DRTNMTNVVHELQSI 931
R +V +L I
Sbjct: 280 QRPTFKQLVEDLDRI 294
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 5e-33
Identities = 55/258 (21%), Positives = 99/258 (38%), Gaps = 32/258 (12%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTAC 692
+G G FG V++ + + T K ++ E L RHRN++ + +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILNIARHRNILHLHESF 70
Query: 693 LGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALN 752
+ ++EF+ + E ++ + LN + ++ + AL
Sbjct: 71 -----ESMEELVMIFEFISGLDIFERIN---------TSAFELNEREIVSYVHQVCEALQ 116
Query: 753 YLHHDCQPVTAHCDLKPSNVLLD--DYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYI 810
+LH H D++P N++ T ++ +FG AR L P F + Y
Sbjct: 117 FLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPEYY 170
Query: 811 APEYGVGCEVSTNGDVYSYGILLLELVIGKKP---------IDIMFEGDINLHNFGRKAL 861
APE VST D++S G L+ L+ G P I+ + + K +
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI 230
Query: 862 PDDVMDIVDSSLLPDDED 879
+ MD VD L+ + +
Sbjct: 231 SIEAMDFVDRLLVKERKS 248
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 127 bits (321), Expect = 5e-33
Identities = 44/258 (17%), Positives = 84/258 (32%), Gaps = 28/258 (10%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-HGASRSFIAECKALKSIRHRNLVKVLT 690
+++G G+F V + +A+K + G S E L I+H N+V +
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74
Query: 691 ACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYA 750
+ + + G L + + + + A
Sbjct: 75 IY-----ESGGHLYLIMQLVSGGELFDRIV----------EKGFYTERDASRLIFQVLDA 119
Query: 751 LNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYI 810
+ YLH LD+ + DFGL+++ P + + G+ GY+
Sbjct: 120 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS---TACGTPGYV 176
Query: 811 APEYGVGCEVSTNGDVYSYGILLLELVIGKKP---------IDIMFEGDINLHNFGRKAL 861
APE S D +S G++ L+ G P + + + + + +
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI 236
Query: 862 PDDVMDIVDSSLLPDDED 879
D D + + D E
Sbjct: 237 SDSAKDFIRHLMEKDPEK 254
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 126 bits (317), Expect = 9e-33
Identities = 57/273 (20%), Positives = 101/273 (36%), Gaps = 46/273 (16%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGAS---------RSFIAECKALKSIR- 681
++G G V + I AVK+ ++ G+ + + E L+ +
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 682 HRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRL 741
H N++++ N F V++ M G L ++L L+ +
Sbjct: 69 HPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLT----------EKVTLSEKETR 113
Query: 742 NIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSF 801
I + + LH H DLKP N+LLDD M ++ DFG + L P
Sbjct: 114 KIMRALLEVICALHKLNI---VHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR--- 167
Query: 802 SVKGSLGYIAPEYGVGCEVSTNG------DVYSYGILLLELVIGKKP---------IDIM 846
V G+ Y+APE + D++S G+++ L+ G P + ++
Sbjct: 168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 227
Query: 847 FEGDINLHNFGRKALPDDVMDIVDSSLLPDDED 879
G+ + D V D+V L+ +
Sbjct: 228 MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQK 260
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 124 bits (311), Expect = 1e-31
Identities = 48/257 (18%), Positives = 88/257 (34%), Gaps = 39/257 (15%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFN---LQHHGASRSFIAECKALKSIRHRNLVKV 688
+G GSFG V+ A+KV + E L + H ++++
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 689 LTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIA 748
+ + +++ G L L A ++
Sbjct: 70 WGTF-----QDAQQIFMIMDYIEGGELFSLLRKSQRFPNP----------VAKFYAAEVC 114
Query: 749 YALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLG 808
L + + DLKP N+LLD ++ DFG A+ + ++ G+
Sbjct: 115 L---ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPD 166
Query: 809 YIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGR---------K 859
YIAPE + + D +S+GIL+ E++ G P F + + +
Sbjct: 167 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP----FYDSNTMKTYEKILNAELRFPP 222
Query: 860 ALPDDVMDIVDSSLLPD 876
+DV D++ + D
Sbjct: 223 FFNEDVKDLLSRLITRD 239
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 125 bits (314), Expect = 1e-31
Identities = 53/264 (20%), Positives = 95/264 (35%), Gaps = 37/264 (14%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNL------QHHGASRSFIAECKALKSIR 681
FS ++G G FG VY + A+K + Q + + + +
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 682 HRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRL 741
+V + A D + + + M+ G L L E
Sbjct: 66 CPFIVCMSYAF-----HTPDKLSFILDLMNGGDLHYHLSQHGVFSE----------ADMR 110
Query: 742 NIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSF 801
A +I L ++H+ + DLKP+N+LLD++ R+ D GLA S
Sbjct: 111 FYAAEIILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA--- 164
Query: 802 SVKGSLGYIAPEYGV-GCEVSTNGDVYSYGILLLELVIGKKPID--------IMFEGDIN 852
G+ GY+APE G ++ D +S G +L +L+ G P + +
Sbjct: 165 -SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 223
Query: 853 LHNFGRKALPDDVMDIVDSSLLPD 876
+ + ++ +++ L D
Sbjct: 224 MAVELPDSFSPELRSLLEGLLQRD 247
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 2e-31
Identities = 55/257 (21%), Positives = 105/257 (40%), Gaps = 29/257 (11%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFN---LQHHGASRSFIAECKAL-KSIRHRNLVK 687
++G GSFG V+ + A+K + + E + L + H L
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 688 VLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDI 747
+ + + V E+++ G L + + +L + A +I
Sbjct: 68 MFCTF-----QTKENLFFVMEYLNGGDLMYHIQ----------SCHKFDLSRATFYAAEI 112
Query: 748 AYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSL 807
L +LH + DLK N+LLD ++ DFG+ + +T++F G+
Sbjct: 113 ILGLQFLHSKGI---VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF--CGTP 167
Query: 808 GYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP-----IDIMFEGDINLHNFGRKALP 862
YIAPE +G + + + D +S+G+LL E++IG+ P + +F + F + L
Sbjct: 168 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLE 227
Query: 863 DDVMDIVDSSLLPDDED 879
+ D++ + + E
Sbjct: 228 KEAKDLLVKLFVREPEK 244
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 4e-30
Identities = 52/226 (23%), Positives = 97/226 (42%), Gaps = 24/226 (10%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVK 687
++ ++G GSFG VY+ + + +A+K R E + ++ + H N+V+
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVR 77
Query: 688 VLTACLGADYRGND-FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAID 746
+ + + ++ + V +++ H A + L ++
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-------YSRAKQTLPVIYVKLYMYQ 130
Query: 747 IAYALNYLHHDCQPVTAHCDLKPSNVLLD-DYMTARVGDFGLARILSPDHTQTSSFSVKG 805
+ +L Y+H H D+KP N+LLD D ++ DFG A+ L S +
Sbjct: 131 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR- 186
Query: 806 SLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
Y APE G + +++ DV+S G +L EL++G+ F GD
Sbjct: 187 --YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI----FPGD 226
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 8e-30
Identities = 55/233 (23%), Positives = 89/233 (38%), Gaps = 30/233 (12%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH-----HGASRSFIAECKALKSIRHRNLV 686
+ +G G F +VYK +A+K L H G +R+ + E K L+ + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 687 KVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAID 746
+L A + V++FM L +
Sbjct: 64 GLLDAF-----GHKSNISLVFDFMETDLEVIIKDN----------SLVLTPSHIKAYMLM 108
Query: 747 IAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGS 806
L YLH H DLKP+N+LLD+ ++ DFGLA+ + + +
Sbjct: 109 TLQGLEYLHQHWI---LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ--VVT 163
Query: 807 LGYIAPEYGVGCEV-STNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGR 858
Y APE G + D+++ G +L EL++ GD +L R
Sbjct: 164 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF----LPGDSDLDQLTR 212
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 2e-29
Identities = 58/277 (20%), Positives = 101/277 (36%), Gaps = 21/277 (7%)
Query: 632 NLVGVGSFGSVYKGI-IDEGRTTIAVKVFNLQ--HHGASRSF---IAECKALKSIRHRNL 685
+G G++G V+K + G +A+K +Q G S +A + L++ H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 686 VKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAI 745
V++ C + V+E + + ++
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK---------VPEPGVPTETIKDMMF 123
Query: 746 DIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKG 805
+ L++LH H DLKP N+L+ ++ DFGLARI S T SV
Sbjct: 124 QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT---SVVV 177
Query: 806 SLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDV 865
+L Y APE + +T D++S G + E+ K + D LP +
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237
Query: 866 MDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLIS 902
D +L + I+ + + L+
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL 274
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 3e-29
Identities = 51/273 (18%), Positives = 101/273 (36%), Gaps = 26/273 (9%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKAL-KSIRHRNLVKVLTA 691
++G+G G V + + A+K+ E + ++ + ++V+++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDV 73
Query: 692 CLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYAL 751
Y G V E + G L + D + + I I A+
Sbjct: 74 YENL-YAGRKCLLIVMECLDGGELFSRIQ--------DRGDQAFTEREASEIMKSIGEAI 124
Query: 752 NYLHHDCQPVTAHCDLKPSNVLLDDYM---TARVGDFGLARILSPDHTQTSSFSVKGSLG 808
YLH AH D+KP N+L ++ DFG A+ + S + +
Sbjct: 125 QYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH---NSLTTPCYTPY 178
Query: 809 YIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDI 868
Y+APE + + D++S G+++ L+ G P I+ R +
Sbjct: 179 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 238
Query: 869 VDSSLLPDD-EDLILTGNQRQKQARINSIIECL 900
+ S + ++ + LI + + R+ +I E +
Sbjct: 239 PEWSEVSEEVKMLIRNLLKTEPTQRM-TITEFM 270
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 116 bits (291), Expect = 1e-28
Identities = 76/364 (20%), Positives = 133/364 (36%), Gaps = 22/364 (6%)
Query: 158 SSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLA 217
+ L + L + SI + L+++ I+ + N L P LV + +
Sbjct: 41 TDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMN 96
Query: 218 ANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHIN 277
N ++ + + L Q I + N ++++ + L+ +
Sbjct: 97 NNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSL 156
Query: 278 SNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPA 337
G + L+ L+ + S + + NL+ L NNQ+S P
Sbjct: 157 QQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLG 216
Query: 338 IGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINL 397
I NL L LN N+L ++ +L L +L L +N + P L L E+ L
Sbjct: 217 IL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKL 270
Query: 398 SNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPS 457
N +S P L+ L+ + N+ + LK L +L +Y N + P
Sbjct: 271 GANQISNISP-----LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP- 324
Query: 458 TFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL-SLNNLN 516
+ +L++L N SSL +L + L N +S P LA L + L
Sbjct: 325 -VSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLG 379
Query: 517 LSYN 520
L+
Sbjct: 380 LNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 82.0 bits (201), Expect = 5e-17
Identities = 77/367 (20%), Positives = 133/367 (36%), Gaps = 33/367 (8%)
Query: 65 QRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNS 124
+VT L L + + L+ L Q+ N T P + L +L + +NNN
Sbjct: 44 DQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ 99
Query: 125 ICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNL 184
I P T + + + + + + N S+ S +SL L
Sbjct: 100 IADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQL 159
Query: 185 SSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANN------LSVVENKLTGEVPSLEKL 238
S + ++ + T N V L N+++ P L
Sbjct: 160 SFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPL-GIL 218
Query: 239 QRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKT 298
L ++ N L + +L + T LT + + +N L P +S L+K +
Sbjct: 219 TNLDELSLNGNQL--------KDIGTLASLTNLTDLDLANNQISNLAP--LSGLTK-LTE 267
Query: 299 LFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNI 358
L L N+I P + L L++ NQ I L+NL L L N +S
Sbjct: 268 LKLGANQISNISP--LAGLTALTNLELNENQ--LEDISPISNLKNLTYLTLYFNNISDIS 323
Query: 359 PPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSI 418
P + +L L LF +N + S SSL ++ ++ +N +S P +L+ ++
Sbjct: 324 P--VSSLTKLQRLFFANNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRIT- 376
Query: 419 SLDWSRN 425
L +
Sbjct: 377 QLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 66.6 bits (161), Expect = 4e-12
Identities = 66/368 (17%), Positives = 131/368 (35%), Gaps = 44/368 (11%)
Query: 158 SSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLA 217
++L++ LG ++T ++ + +L + T+ + + + NL ++ +
Sbjct: 19 TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFS 74
Query: 218 ANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHIN 277
N L+ ++ L+ L +L + +N + + I+
Sbjct: 75 NNQLT--------DITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDID 126
Query: 278 SNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPA 337
L L++N I I L L + T
Sbjct: 127 PLKNLTNLNRL-----------ELSSNTISD-----ISALSGLTSLQQLSFGNQVTDLKP 170
Query: 338 IGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINL 397
+ L L+ L ++ NK + + L L +L +N + P + +L E++L
Sbjct: 171 LANLTTLERLDISSNK--VSDISVLAKLTNLESLIATNNQISDITPLGI--LTNLDELSL 226
Query: 398 SNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPS 457
+ N L SL++L+ LD + N+++ P+ L L L + N++ P
Sbjct: 227 NGNQLKD--IGTLASLTNLTD-LDLANNQISNLAPL--SGLTKLTELKLGANQISNISP- 280
Query: 458 TFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL-SLNNLN 516
L L + N + S +L+ L L L NN+S P ++ L L L
Sbjct: 281 -LAGLTALTNLELNENQLEDISPIS--NLKNLTYLTLYFNNISDISP--VSSLTKLQRLF 335
Query: 517 LSYNDLEG 524
+ N +
Sbjct: 336 FANNKVSD 343
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 51.2 bits (121), Expect = 4e-07
Identities = 35/167 (20%), Positives = 65/167 (38%), Gaps = 28/167 (16%)
Query: 49 SIHFCKWYGVTCSRRHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIP-- 106
S++ + + +T LDL + +++ + L+ L +L L N ++ P
Sbjct: 225 SLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLA 282
Query: 107 ------------------SEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQ 148
S I L+ L L L N+I P +S + L + NN+
Sbjct: 283 GLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNK 340
Query: 149 LVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYN 195
+ +S ++L+ L+ G N ++ P L NL+ I + L
Sbjct: 341 VSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 4e-06
Identities = 14/102 (13%), Positives = 40/102 (39%), Gaps = 6/102 (5%)
Query: 46 WNESIHFCKWYGVTCSRRHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEI 105
N ++ + ++ + +T L L ++ + +L+ L++L+ N +
Sbjct: 288 TNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-- 343
Query: 106 PSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNN 147
S + L + L+ +N I P ++ + + + +
Sbjct: 344 VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 114 bits (286), Expect = 2e-28
Identities = 85/350 (24%), Positives = 130/350 (37%), Gaps = 51/350 (14%)
Query: 21 NETDRVALLEFKSKSTYDPVGVLGTWNESIHFC--KWYGVTCSR--RHQRVTLLDLRSLK 76
N D+ ALL+ K L +W + C W GV C + RV LDL L
Sbjct: 4 NPQDKQALLQIKKDLGNPTT--LSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLN 61
Query: 77 LAG--SVSHFIGNLSFLKQLYLQVN-SFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNI 133
L + + NL +L LY+ + IP I L +L L + + ++ G IP +
Sbjct: 62 LPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFL 121
Query: 134 SRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGN-LSSIHTISL 192
S+ TL+ + N L G + SSL + N ++G+IP S G+ ++++
Sbjct: 122 SQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTI 181
Query: 193 AYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLG 252
+ N L G IP +F
Sbjct: 182 SRNRLTGKIPPTFANLNLAFVDL------------------------------------- 204
Query: 253 SGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPA 312
+ L S+ + I+ LSK + L L NN+IYG++P
Sbjct: 205 --SRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQ 262
Query: 313 GIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNK-LSGNIPPS 361
G+ L L++ N L G IP G LQ + NK L G+ P+
Sbjct: 263 GLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSPLPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 77.9 bits (190), Expect = 4e-16
Identities = 55/259 (21%), Positives = 94/259 (36%), Gaps = 4/259 (1%)
Query: 266 TNATRLTWMHINSNNFGGL--LPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRL 323
T R+ + ++ N +P ++NL N + G IP I L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 324 DMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIP 383
+ + +SG IP + +++ L L + N LSG +PPSI +L L+ + + N + +IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 384 SSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEF 443
S G L + N P F+ +L+ + + +
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226
Query: 444 LYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEI 503
+ + L N G + L L+ L L++S NNL GEI
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLR--NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284
Query: 504 PKFLAGLSLNNLNLSYNDL 522
P+ + + N
Sbjct: 285 PQGGNLQRFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 52.4 bits (124), Expect = 1e-07
Identities = 22/92 (23%), Positives = 38/92 (41%), Gaps = 3/92 (3%)
Query: 46 WNESIHFCKWYGVTCSRRHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEI 105
+ + + + LDLR+ ++ G++ + L FL L + N+ EI
Sbjct: 225 KIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284
Query: 106 PSEIGGLRRLKVLALNNNSICGEIPTNISRCS 137
P + G L+R V A NN P + C+
Sbjct: 285 P-QGGNLQRFDVSAYANNKCLCGSP--LPACT 313
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 2e-28
Identities = 48/235 (20%), Positives = 91/235 (38%), Gaps = 25/235 (10%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVL 689
+G G+FG V+K + +A+K +++ G + + E K L+ ++H N+V ++
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 690 TACLGADYRGNDFKASVY---EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAID 746
C N K S+Y +F + + L + +
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV----------LVKFTLSEIKRVMQM 125
Query: 747 IAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHT--QTSSFSVK 804
+ LN L++ + H D+K +NVL+ ++ DFGLAR S +
Sbjct: 126 L---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 805 GSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGR 858
+L Y PE +G + D++ G ++ E+ +G+ H
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI----MQGNTEQHQLAL 233
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 114 bits (285), Expect = 2e-28
Identities = 48/268 (17%), Positives = 87/268 (32%), Gaps = 40/268 (14%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTAC 692
+G GSFG +Y G +A+K+ ++ E K K ++ + + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 693 LGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALN 752
D+ V E + + + R +L L +A + +
Sbjct: 72 ----GAEGDYNVMVMELLGPSLEDLFNFC----------SRKFSLKTVLLLADQMISRIE 117
Query: 753 YLHHDCQPVTAHCDLKPSNVL---LDDYMTARVGDFGLARILSPDHTQTSSF-----SVK 804
Y+H H D+KP N L + DFGLA+ T ++
Sbjct: 118 YIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 174
Query: 805 GSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD----INLHNFGR-- 858
G+ Y + +G E S D+ S G +L+ +G P + + +
Sbjct: 175 GTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 234
Query: 859 -------KALPDDVMDIVDSSLLPDDED 879
K P + ++ +D
Sbjct: 235 TPIEVLCKGYPSEFATYLNFCRSLRFDD 262
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 3e-28
Identities = 48/266 (18%), Positives = 88/266 (33%), Gaps = 40/266 (15%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRS------FIAECKALKSIRHRNLV 686
+G G F V K A K + +SR E LK I+H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 687 KVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAID 746
+ + E + G L ++L +L +
Sbjct: 77 TLHEVY-----ENKTDVILILELVAGGELFDFLA----------EKESLTEEEATEFLKQ 121
Query: 747 IAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR----VGDFGLARILSPDHTQTSSFS 802
I + ++ AH DLKP N++L D + + DFGLA + + +
Sbjct: 122 ILNGV---YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--- 175
Query: 803 VKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP---------IDIMFEGDINL 853
+ G+ ++APE + D++S G++ L+ G P + + +
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 235
Query: 854 HNFGRKALPDDVMDIVDSSLLPDDED 879
+ D + L+ D +
Sbjct: 236 EDEYFSNTSALAKDFIRRLLVKDPKK 261
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (277), Expect = 2e-27
Identities = 52/260 (20%), Positives = 83/260 (31%), Gaps = 38/260 (14%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRS------FIAECKALKSIR--HRN 684
L+G G FGSVY GI +A+K E LK +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 685 LVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIA 744
++++L D + E L +
Sbjct: 71 VIRLLDWF-----ERPDSFVLILERPEPVQDLFDFI---------TERGALQEELARSFF 116
Query: 745 IDIAYALNYLHHDCQPVTAHCDLKPSNVLLD-DYMTARVGDFGLARILSPDHTQTSSFSV 803
+ A+ + H+ H D+K N+L+D + ++ DFG +L
Sbjct: 117 WQVLEAVRHCHNCGV---LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD----F 169
Query: 804 KGSLGYIAPEYGVGCEVSTNG-DVYSYGILLLELVIGKKPIDIMFEGD---INLHNFGRK 859
G+ Y PE+ V+S GILL ++V G P FE D I F R+
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP----FEHDEEIIRGQVFFRQ 225
Query: 860 ALPDDVMDIVDSSLLPDDED 879
+ + ++ L D
Sbjct: 226 RVSSECQHLIRWCLALRPSD 245
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 3e-27
Identities = 51/276 (18%), Positives = 94/276 (34%), Gaps = 21/276 (7%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVL 689
+G G++G+V+K E +A+K L G S + E LK ++H+N+V++
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 690 TACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAY 749
+ V+EF + + D + +
Sbjct: 68 DVL-----HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE----------IVKSFLFQLLK 112
Query: 750 ALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGY 809
L + H H DLKP N+L++ ++ +FGLAR + S V
Sbjct: 113 GLGFCHSRNVL---HRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYR 168
Query: 810 IAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDIV 869
ST+ D++S G + EL +P+ + D L R
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228
Query: 870 DSSLLPDDEDLILTGNQRQKQARINSIIECLISMVR 905
+ LPD + + + + +++
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQ 264
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 110 bits (275), Expect = 4e-27
Identities = 37/229 (16%), Positives = 77/229 (33%), Gaps = 29/229 (12%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTAC 692
+G GSFG +++G +A+K + + E + K + + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 693 LGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALN 752
+ + L L + ED +D R ++ A + +
Sbjct: 70 --------------GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 115
Query: 753 YLHHDCQPVTAHCDLKPSNVLLDDYMT-----ARVGDFGLARILSPDHTQTSSF-----S 802
+H + D+KP N L+ + V DFG+ + T+ +
Sbjct: 116 SIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 172
Query: 803 VKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDI 851
+ G+ Y++ +G E S D+ + G + + + G P +
Sbjct: 173 LSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN 221
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 7e-27
Identities = 50/273 (18%), Positives = 94/273 (34%), Gaps = 36/273 (13%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFN---LQHHGASRSFIAECKALKSIRHRNLVKV 688
L+G G+FG V A+K+ + + E + L++ RH L +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 689 LTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIA 748
A + +D V E+ + G L L E + +I
Sbjct: 71 KYAF-----QTHDRLCFVMEYANGGELFFHLSRERVFTEE----------RARFYGAEI- 114
Query: 749 YALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLG 808
++ L + + D+K N++LD ++ DFGL + D + G+
Sbjct: 115 --VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPE 170
Query: 809 YIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD-----INLHNFGR----K 859
Y+APE + D + G+++ E++ G+ P F L +
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP----FYNQDHERLFELILMEEIRFPR 226
Query: 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQAR 892
L + ++ L D + + G K+
Sbjct: 227 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM 259
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 9e-27
Identities = 59/242 (24%), Positives = 92/242 (38%), Gaps = 22/242 (9%)
Query: 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNL 685
F +G G++G VYK +A+K L G + I E LK + H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 686 VKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAI 745
VK+L + V+EF+H + + +
Sbjct: 64 VKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLI---------KSYLF 109
Query: 746 DIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKG 805
+ L + H H DLKP N+L++ ++ DFGLAR +
Sbjct: 110 QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV--V 164
Query: 806 SLGYIAPEYGVGCE-VSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDD 864
+L Y APE +GC+ ST D++S G + E+V + E D F PD+
Sbjct: 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE 224
Query: 865 VM 866
V+
Sbjct: 225 VV 226
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 108 bits (271), Expect = 1e-26
Identities = 61/277 (22%), Positives = 106/277 (38%), Gaps = 25/277 (9%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVL 689
+G G++G VYK + G T A+K L+ G + I E LK ++H N+VK+
Sbjct: 8 EKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 690 TACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAY 749
D + + L++ L D L + + + +
Sbjct: 67 ------DVIHTKKRLVLVFEHLDQDLKKLL---------DVCEGGLESVTAKSFLLQLLN 111
Query: 750 ALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGY 809
+ Y H H DLKP N+L++ ++ DFGLAR +L Y
Sbjct: 112 GIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIVTLWY 166
Query: 810 IAPEYGVGCE-VSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDVMDI 868
AP+ +G + ST D++S G + E+V G + E D L R + +
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKNW 225
Query: 869 VDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVR 905
+ + LP + ++ + + E I ++
Sbjct: 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLS 262
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 106 bits (266), Expect = 2e-25
Identities = 53/251 (21%), Positives = 92/251 (36%), Gaps = 31/251 (12%)
Query: 634 VGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLT 690
+G GSFG V E A+K+ + Q + E + L+++ LVK+
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 691 ACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYA 750
+ + N V E++ G + L + A I
Sbjct: 109 SF-----KDNSNLYMVMEYVAGGEMFSHLR----------RIGRFSEPHARFYAAQIVLT 153
Query: 751 LNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYI 810
YLH + DLKP N+L+D +V DFG A+ + ++++ G+ +
Sbjct: 154 FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEAL 205
Query: 811 APEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK-----ALPDDV 865
APE + + D ++ G+L+ E+ G P I K D+
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 866 MDIVDSSLLPD 876
D++ + L D
Sbjct: 266 KDLLRNLLQVD 276
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 2e-25
Identities = 52/278 (18%), Positives = 101/278 (36%), Gaps = 25/278 (8%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFN--LQHHGASRSFIAECKALKSIRHRNLVKVLT 690
VG G++G+V + +A+K Q ++ E + LK +RH N++ +L
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 691 ACLGADYRGNDFK-ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAY 749
+ + V FM + H GED I + +
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI------------QFLVYQMLK 132
Query: 750 ALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGY 809
L Y+H H DLKP N+ +++ ++ DFGLAR + T + Y
Sbjct: 133 GLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSEMT-----GYVVTRWY 184
Query: 810 IAPEYGVGCE-VSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNF-GRKALPDDVMD 867
APE + + D++S G ++ E++ GK D P + +
Sbjct: 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244
Query: 868 IVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVR 905
+ S + + ++ + + + ++++
Sbjct: 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE 282
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 106 bits (264), Expect = 3e-25
Identities = 41/220 (18%), Positives = 80/220 (36%), Gaps = 9/220 (4%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTAC 692
+G G F +V+ T +A+K+ + + E K L+ + + K +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 693 LGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDE-APRNLNLLQRLNIAIDIAYAL 751
+ D + + + I + R + L+ I+ + L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 752 NYLHHDCQPVTAHCDLKPSNVLLD-DYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYI 810
+Y+H C + H D+KP NVL++ + +A + + + + Y
Sbjct: 139 DYMHRRCGII--HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 811 APEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850
+PE +G D++S L+ EL+ G FE D
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFL----FEPD 232
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 6e-25
Identities = 49/228 (21%), Positives = 87/228 (38%), Gaps = 26/228 (11%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFN--LQHHGASRSFIAECKALKSIRHRNLVKVL 689
+ VG G++GSV + +AVK + Q ++ E + LK ++H N++ +L
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 690 TACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAY 749
A + + L + + L + I
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----------CQKLTDDHVQFLIYQILR 132
Query: 750 ALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGY 809
L Y+H H DLKPSN+ +++ ++ DFGLAR + T + Y
Sbjct: 133 GLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWY 184
Query: 810 IAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNF 856
APE + + D++S G ++ EL+ G+ F G ++
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL----FPGTDHIDQL 228
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 6e-25
Identities = 45/213 (21%), Positives = 77/213 (36%), Gaps = 22/213 (10%)
Query: 633 LVGVGSFGSVYKGIIDEGRTTIAVKVFN--LQHHGASRSFIAECKALKSIRHRNLVKVLT 690
+G G+ G V +A+K + Q+ ++ E +K + H+N++ +L
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 691 ACLGADYRGNDFK-ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAY 749
V E M + E + + +
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE-------------RMSYLLYQMLC 130
Query: 750 ALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGY 809
+ +LH H DLKPSN+++ T ++ DFGLAR T + Y
Sbjct: 131 GIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT---PYVVTRYY 184
Query: 810 IAPEYGVGCEVSTNGDVYSYGILLLELVIGKKP 842
APE +G N D++S G ++ E+V K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 104 bits (260), Expect = 7e-25
Identities = 44/215 (20%), Positives = 83/215 (38%), Gaps = 28/215 (13%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIR-HRNLVKVLT 690
+G G + V++ I + VK+ + E K L+++R N++ +
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLAD 97
Query: 691 ACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYA 750
+ A V+E ++ ++ T + +I +I A
Sbjct: 98 IV---KDPVSRTPALVFEHVNNTDFKQLYQTLT-DYDI------------RFYMYEILKA 141
Query: 751 LNYLHHDCQPVTAHCDLKPSNVLLD-DYMTARVGDFGLARILSPDHTQTSSFSVKGSLGY 809
L+Y H H D+KP NV++D ++ R+ D+GLA P S +
Sbjct: 142 LDYCHSMGIM---HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV---ASRYF 195
Query: 810 IAPEYGVGCE-VSTNGDVYSYGILLLELVIGKKPI 843
PE V + + D++S G +L ++ K+P
Sbjct: 196 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.5 bits (247), Expect = 3e-23
Identities = 51/279 (18%), Positives = 104/279 (37%), Gaps = 36/279 (12%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTT---IAVKVFN----LQHHGASRSFIAECKALKSIRHRN 684
++G G++G V+ G T A+KV +Q + E + L+ IR
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 685 LVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIA 744
+ L ++ + ++++ G L L E + +
Sbjct: 90 FLVTLHYA----FQTETKLHLILDYINGGELFTHLSQRERFTEHE-------------VQ 132
Query: 745 IDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVK 804
I + + L H + + D+K N+LLD + DFGL++ D T ++
Sbjct: 133 IYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFC 191
Query: 805 GSLGYIAPEYGVGCEVSTNG--DVYSYGILLLELVIGKKP---------IDIMFEGDINL 853
G++ Y+AP+ G + + D +S G+L+ EL+ G P + +
Sbjct: 192 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 251
Query: 854 HNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQAR 892
+ + D++ L+ D + + G + + +
Sbjct: 252 EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK 290
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 92.4 bits (228), Expect = 6e-21
Identities = 51/274 (18%), Positives = 91/274 (33%), Gaps = 35/274 (12%)
Query: 290 SNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGL 349
+L L L NNKI N NL L + NN++S P A L L+ L L
Sbjct: 27 KDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 86
Query: 350 NRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQ 409
++N+L +P + L + N+ + ++E+ + SG
Sbjct: 87 SKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGA 145
Query: 410 FFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLG 469
F + LS + +T I G L L++ N++ ++ L +LG
Sbjct: 146 FQGMKKLSYI-RIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLG 201
Query: 470 MGGNLFQGPISS-----------------------SLGSLRGLRVLDLSQNNLSGEIPKF 506
+ N + L + ++V+ L NN+S
Sbjct: 202 LSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSND 261
Query: 507 LAG-------LSLNNLNLSYNDLEGMVTTEGVFK 533
S + ++L N ++ F+
Sbjct: 262 FCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 295
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 89.3 bits (220), Expect = 6e-20
Identities = 63/288 (21%), Positives = 115/288 (39%), Gaps = 19/288 (6%)
Query: 163 TEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLS 222
T +L+L +N +T NL ++HT+ L N + P +F L L L+ N L
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 223 VVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFG 282
+ K+ + Q L+ + + L+ + + + N
Sbjct: 93 ELPEKMPKTL------QELRVHENEITKVRKSVFNGLNQMIVV-------ELGTNPLKSS 139
Query: 283 GLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQ 342
G+ G + K + + + + I +IP G+ +L L + N+++ ++ L
Sbjct: 140 GIENGAFQGMKK-LSYIRIADTNI-TTIPQGL--PPSLTELHLDGNKITKVDAASLKGLN 195
Query: 343 NLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNL 402
NL LGL+ N +S S+ N L L LN+N L +P L + + + L NNN+
Sbjct: 196 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNI 254
Query: 403 SGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENR 450
S F + +S L + P++ +++ F VY
Sbjct: 255 SAIGSNDFCPPGYNTKKASYSGVSLFSN-PVQYWEIQPSTFRCVYVRA 301
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 77.8 bits (190), Expect = 5e-16
Identities = 62/327 (18%), Positives = 104/327 (31%), Gaps = 62/327 (18%)
Query: 53 CKWYGVTCSRRH---------QRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTH 103
C V CS LLDL++ K+ NL L L L N +
Sbjct: 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 104 EIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKT 163
P L +L+ L L+ N + L N++ S F+ L++
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQEL---RVHENEITKVRKSVFNGLNQM 126
Query: 164 EILNLGSNHL--TGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNL 221
++ LG+N L +G + + + I +A N+ TIP G +L L L N +
Sbjct: 127 IVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKI 183
Query: 222 SVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNF 281
+ D + L L N +L + +
Sbjct: 184 T---------------------------------KVDAASLKGLNNLAKLGLSFNSISAV 210
Query: 282 GGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSG------TIP 335
+L + NN +P G+ + +Q + + NN +S P
Sbjct: 211 DNGSLANTPHLRE-----LHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPP 265
Query: 336 PAIGELQNLKILGLNRNKLS-GNIPPS 361
+ + + L N + I PS
Sbjct: 266 GYNTKKASYSGVSLFSNPVQYWEIQPS 292
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 47.0 bits (110), Expect = 6e-06
Identities = 29/139 (20%), Positives = 54/139 (38%), Gaps = 5/139 (3%)
Query: 388 QCE-SLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYV 446
+C+ L + S+ L +P L + LD NK+T + LK L L +
Sbjct: 7 RCQCHLRVVQCSDLGLE-KVPK---DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLIL 62
Query: 447 YENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKF 506
N++ P F ++LE+L + N + +L+ LRV + + +
Sbjct: 63 INNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNG 122
Query: 507 LAGLSLNNLNLSYNDLEGM 525
L + + L + G+
Sbjct: 123 LNQMIVVELGTNPLKSSGI 141
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.4 bits (225), Expect = 9e-21
Identities = 57/260 (21%), Positives = 87/260 (33%), Gaps = 29/260 (11%)
Query: 290 SNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQ-------------------- 329
+ + +FL+ N+I A NL L + +N
Sbjct: 28 VGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDL 87
Query: 330 -----LSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPS 384
L P L L L L+R L P L L L+L DN L+
Sbjct: 88 SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDD 147
Query: 385 SLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFL 444
+ +L + L N +S F L SL L +N++ P L L L
Sbjct: 148 TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH-QNRVAHVHPHAFRDLGRLMTL 206
Query: 445 YVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIP 504
Y++ N L L+ L + N + + L+ S + + +P
Sbjct: 207 YLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLP 265
Query: 505 KFLAGLSLNNLNLSYNDLEG 524
+ LAG L L+ NDL+G
Sbjct: 266 QRLAGRDL--KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.5 bits (176), Expect = 2e-14
Identities = 53/313 (16%), Positives = 86/313 (27%), Gaps = 44/313 (14%)
Query: 189 TISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITS 248
T S L +P + L N +S V +L L +
Sbjct: 15 TTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71
Query: 249 NSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYG 308
+ A ++ + P L + TL L+ +
Sbjct: 72 D-----------AAAFTGLALLEQLDLSDNAQLRSVDPATFHGL-GRLHTLHLDRCGLQE 119
Query: 309 SIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKML 368
P LQ L + +N L +L NL L L+ N++S + L L
Sbjct: 120 LGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSL 179
Query: 369 LNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLT 428
L L+ N + P + L+ + L NNLS L +L L + N
Sbjct: 180 DRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQ-YLRLNDNPWV 238
Query: 429 GSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRG 488
L+ + + +P L G
Sbjct: 239 CDCRA-RPLWAWLQKFRGSSSEVPCSLPQ---------------------------RLAG 270
Query: 489 LRVLDLSQNNLSG 501
+ L+ N+L G
Sbjct: 271 RDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.8 bits (130), Expect = 1e-08
Identities = 47/309 (15%), Positives = 90/309 (29%), Gaps = 75/309 (24%)
Query: 58 VTCSRRH---------QRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEI--- 105
+C ++ + L +++ + L L+L N
Sbjct: 16 TSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75
Query: 106 ----------------------PSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIH 143
P+ GL RL L L+ + P + L ++
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLY 135
Query: 144 PQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPN 203
Q+N L F L L L N ++ + L S+ + L N + P+
Sbjct: 136 LQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPH 195
Query: 204 SFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLC 263
+F L+ L L ANNLS + + + +L+ L+ + N ++C
Sbjct: 196 AFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLR------LNDN----------PWVC 239
Query: 264 SLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRL 323
W+ + +++++ S+P
Sbjct: 240 DCRARPLWAWL----------------------QKFRGSSSEVPCSLPQ---RLAGRDLK 274
Query: 324 DMWNNQLSG 332
+ N L G
Sbjct: 275 RLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.0 bits (128), Expect = 2e-08
Identities = 30/174 (17%), Positives = 52/174 (29%), Gaps = 4/174 (2%)
Query: 49 SIHFCKWYGVTCSRRHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSE 108
+ G R + L L+ L +L L L+L N +
Sbjct: 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERA 172
Query: 109 IGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNL 168
GL L L L+ N + P L+ ++ N L + L + L L
Sbjct: 173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRL 232
Query: 169 GSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLS 222
N + + + + + + ++P LAAN+L
Sbjct: 233 NDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLA---GRDLKRLAANDLQ 282
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 73.7 bits (180), Expect = 2e-15
Identities = 30/217 (13%), Positives = 57/217 (26%), Gaps = 44/217 (20%)
Query: 632 NLVGVGSFGSVYKGIIDEGRTTIAVKVFNL----------QHHGASRSFIAECKALKSIR 681
L+G G +V+ ++ VK + + F
Sbjct: 6 KLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 682 HRNLVKVLTACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRL 741
R L K+ + VY + L E + + + +
Sbjct: 65 FRALQKLQGLAV----------PKVYAWEGNAVLMELIDA--------KELYRVRVENPD 106
Query: 742 NIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSF 801
+ I + +H H DL NVL+ + + DF +
Sbjct: 107 EVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWIIDFPQSV--EVGEEGWREI 160
Query: 802 ---SVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLE 835
V+ + Y + Y D+ S +L+
Sbjct: 161 LERDVRNIITYFSRTYRTEK------DINSAIDRILQ 191
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.7 bits (143), Expect = 3e-10
Identities = 43/215 (20%), Positives = 77/215 (35%), Gaps = 9/215 (4%)
Query: 262 LCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQ 321
+C ++ ++ + N L P +L K L L+ N +Y A + + L
Sbjct: 3 ICEVSKVASHLEVNCDKRNLTAL-P---PDLPKDTTILHLSENLLYTFSLATLMPYTRLT 58
Query: 322 RLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVS 381
+L++ + T G L L L L+ N+L + + + S
Sbjct: 59 QLNLDRAE--LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLT--S 114
Query: 382 IPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKIL 441
+P + ++ N T+PP + + L + N LT + L+ L
Sbjct: 115 LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENL 174
Query: 442 EFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQ 476
+ L + EN L IP F L + GN +
Sbjct: 175 DTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.0 bits (136), Expect = 2e-09
Identities = 45/209 (21%), Positives = 76/209 (36%), Gaps = 7/209 (3%)
Query: 314 IGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFL 373
+ + ++ L+ +PP + ++ IL L+ N L ++ L L L
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 374 NDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPI 433
+ E++ G L ++LS+N L + + D S N+LT
Sbjct: 63 DRA--ELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVL--DVSFNRLTSLPLG 118
Query: 434 EVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLD 493
+ L L+ LY+ N L+ P +LE+L + N + L L L L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 494 LSQNNLSGEIPKFLAGLSLNNLNLSYNDL 522
L +N+L F L L N
Sbjct: 179 LQENSLYTIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.4 bits (124), Expect = 7e-08
Identities = 36/222 (16%), Positives = 63/222 (28%), Gaps = 20/222 (9%)
Query: 133 ISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISL 192
+S+ ++ + ++ L + T IL+L N L ++L + + +
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQL-- 60
Query: 193 AYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLG 252
NLD L L + + +++ L L
Sbjct: 61 ---NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSL-----------PLLGQTLPALTVLD 106
Query: 253 SGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPA 312
N S N LP + + ++ L L NN +
Sbjct: 107 VSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAG 166
Query: 313 GIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKL 354
+ NL L + N L TIP L L+ N
Sbjct: 167 LLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.8 bits (99), Expect = 1e-04
Identities = 38/243 (15%), Positives = 64/243 (26%), Gaps = 42/243 (17%)
Query: 59 TCSRRHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVL 118
S+ + + + L ++ + L+L N + + RL L
Sbjct: 5 EVSKVASHLEV-NCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 119 ALNNNSICGEIPTNISRCSTLIPIHPQNN---------------------QLVGKILSRF 157
L+ + + + +L L
Sbjct: 61 NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120
Query: 158 SSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLA 217
L + + L L N L P L + +SLA NNL ENL L L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 218 ANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHIN 277
N+L + L + N +LC+ W+ N
Sbjct: 181 ENSLYTIP-------KGFFGSHLLPFAFLHGN----------PWLCNCEILYFRRWLQDN 223
Query: 278 SNN 280
+ N
Sbjct: 224 AEN 226
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 53.2 bits (127), Expect = 5e-09
Identities = 24/108 (22%), Positives = 47/108 (43%), Gaps = 4/108 (3%)
Query: 297 KTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSG 356
+ L L + + ++ + + + LD+ +N+L +PPA+ L+ L++L + N L
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALEN 57
Query: 357 NIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSG 404
+ L L N + + L C L+ +NL N+L
Sbjct: 58 VDGVANLPRLQELLLCNN-RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.4 bits (112), Expect = 4e-07
Identities = 25/109 (22%), Positives = 44/109 (40%), Gaps = 5/109 (4%)
Query: 321 QRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEV 380
+ L + + L T+ + +L + L L+ N+L PP++ L+ L L +DN +
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNA--L 55
Query: 381 SIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTG 429
+ L E+ L NN L + Q + L+ N L
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.5 bits (107), Expect = 2e-06
Identities = 31/109 (28%), Positives = 49/109 (44%), Gaps = 7/109 (6%)
Query: 395 INLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGE 454
++L++ +L T+ L ++ LD S N+L P + L+ LE L +N E
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVT-HLDLSHNRLRALPP-ALAALRCLEVLQASDNA--LE 56
Query: 455 IPSTFGNCIRLEQLGMGGN-LFQGPISSSLGSLRGLRVLDLSQNNLSGE 502
N RL++L + N L Q L S L +L+L N+L E
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.6 bits (102), Expect = 1e-05
Identities = 25/115 (21%), Positives = 40/115 (34%), Gaps = 6/115 (5%)
Query: 256 NDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIG 315
+ DL+ LC L +T + ++ N L L+ L + G+
Sbjct: 7 HKDLTVLCHLEQLLLVTHLDLSHNR----LRALPPALAALRCLEVLQASDNALENVDGVA 62
Query: 316 NFVNLQRLDMWNNQLSGTIPP-AIGELQNLKILGLNRNKLSGNIPPSIGNLKMLL 369
N LQ L + NN+L + + L +L L N L L +L
Sbjct: 63 NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.6 bits (97), Expect = 4e-05
Identities = 21/125 (16%), Positives = 42/125 (33%), Gaps = 13/125 (10%)
Query: 221 LSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNN 280
L + LT + LE+L + H ++ N L + +L L + + N
Sbjct: 3 LHLAHKDLT-VLCHLEQLLLVTHLDLSHNRLRALPP-------ALAALRCLEVLQASDNA 54
Query: 281 FGGLLPGCISNLSKTIKTLFLNNNKI-YGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIG 339
+ ++ L L NN++ + + + L L++ N L
Sbjct: 55 LENVDGVANLP---RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQE 110
Query: 340 ELQNL 344
L +
Sbjct: 111 RLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.9 bits (90), Expect = 4e-04
Identities = 26/107 (24%), Positives = 38/107 (35%), Gaps = 7/107 (6%)
Query: 420 LDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPI 479
L + LT + +L ++ L + NRL P+ LE L N +
Sbjct: 3 LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENV- 58
Query: 480 SSSLGSLRGLRVLDLSQNNL-SGEIPKFLAGL-SLNNLNLSYNDLEG 524
+ +L L+ L L N L + L L LNL N L
Sbjct: 59 -DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.0 bits (85), Expect = 0.002
Identities = 23/127 (18%), Positives = 48/127 (37%), Gaps = 9/127 (7%)
Query: 116 KVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTG 175
+VL L + + + ++ + + + +N+L ++L E+L ++
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALP-PALAALRCLEVLQ--ASDNAL 55
Query: 176 SIPSSLGNLSSIHTISLAYNNL-DGTIPNSFGWFENLVFLSLAANNLSVVEN---KLTGE 231
+ NL + + L N L LV L+L N+L E +L
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 232 VPSLEKL 238
+PS+ +
Sbjct: 116 LPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.6 bits (84), Expect = 0.003
Identities = 30/127 (23%), Positives = 47/127 (37%), Gaps = 12/127 (9%)
Query: 70 LDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEI 129
L L L +V + L + L L N P+ + LR L+V L + E
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEV--LQASDNALEN 57
Query: 130 PTNISRCSTLIPIHPQNNQLVG-KILSRFSSLSKTEILNLGSNHLTG------SIPSSLG 182
++ L + NN+L + S + +LNL N L + L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 183 NLSSIHT 189
++SSI T
Sbjct: 118 SVSSILT 124
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 56.4 bits (134), Expect = 7e-09
Identities = 50/326 (15%), Positives = 95/326 (29%), Gaps = 16/326 (4%)
Query: 67 VTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSIC 126
L+L +L L+ S+ +L + L NS T E+P L+ L V N ++
Sbjct: 40 AHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS 94
Query: 127 GEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSS 186
P + + L + + I + L
Sbjct: 95 DLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEE 154
Query: 187 IHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTI 246
+ + N+ + LSL + + E+ +L L +
Sbjct: 155 LPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNN 214
Query: 247 TSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKI 306
+ ++ + + + + I + + N
Sbjct: 215 LLKT--LPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272
Query: 307 YGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLK 366
I + +L+ L++ NN+L +P L+ L + N L+ +P NLK
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPELPQNLK 327
Query: 367 MLLNLFLNDNFLEVSIPSSLGQCESL 392
L + N L P E L
Sbjct: 328 ---QLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.8 bits (117), Expect = 9e-07
Identities = 15/84 (17%), Positives = 32/84 (38%), Gaps = 10/84 (11%)
Query: 263 CSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQR 322
L +++++N L P L + L + N + +P N L++
Sbjct: 278 SLCDLPPSLEELNVSNNKLIEL-PALPPRL----ERLIASFNHL-AEVPELPQN---LKQ 328
Query: 323 LDMWNNQLSGTIPPAIGELQNLKI 346
L + N L P +++L++
Sbjct: 329 LHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.7 bits (114), Expect = 2e-06
Identities = 50/327 (15%), Positives = 84/327 (25%), Gaps = 37/327 (11%)
Query: 161 SKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANN 220
+ L L + L+ S+P +L S+ + N+L +P ++L+ +
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 221 LSVVENKLTGEVPS--------------LEKLQRLQHFTITSNSLGSGGNDDLSFLCSLT 266
LS + L S K+ + + ++ + ++ +
Sbjct: 93 LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152
Query: 267 NATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMW 326
+ + + N L +
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212
Query: 327 NNQLSGTIPPAIGELQNLKILGLNRNKLSG--------NIPPSIGNLKMLLNLFLNDNFL 378
NN L + L L N
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272
Query: 379 EVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKL 438
I S SL E+N+SNN L +P L L S N L +P L
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE----RLIASFNHLA-EVPELPQNL 326
Query: 439 KILEFLYVYENRLEGEIPSTFGNCIRL 465
K L+V N L E P + L
Sbjct: 327 KQ---LHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.0 bits (94), Expect = 5e-04
Identities = 21/81 (25%), Positives = 31/81 (38%), Gaps = 7/81 (8%)
Query: 445 YVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIP 504
Y N EI S LE+L + N + L L S N+L+ E+P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNN----KLIELPALPPRLERLIASFNHLA-EVP 320
Query: 505 KFLAGLSLNNLNLSYNDLEGM 525
+ +L L++ YN L
Sbjct: 321 ELPQ--NLKQLHVEYNPLREF 339
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 56.4 bits (134), Expect = 7e-09
Identities = 40/330 (12%), Positives = 87/330 (26%), Gaps = 19/330 (5%)
Query: 70 LDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHE----IPSEIGGLRRLKVLALNNNSI 125
LD + + SV + +K++ L N+ E + I + L++ ++
Sbjct: 12 LDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT 71
Query: 126 CGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSL---G 182
L+ + +L LS + + + +
Sbjct: 72 GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNN 131
Query: 183 NLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQ 242
L +A + + L + N L K + +L
Sbjct: 132 GLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTV 191
Query: 243 HFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLN 302
+ L L L + G ++ L LN
Sbjct: 192 KMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN 251
Query: 303 NNKIYGSIPAGIGNFV------NLQRLDMWNNQLSGTIPPAIGE-----LQNLKILGLNR 351
+ + A + + LQ L + N++ + + +L L LN
Sbjct: 252 DCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNG 311
Query: 352 NKLSGNIPPSIGNLKMLLNLFLNDNFLEVS 381
N+ S + ++ + + E+
Sbjct: 312 NRFSE-EDDVVDEIREVFSTRGRGELDELD 340
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 44.9 bits (104), Expect = 3e-05
Identities = 40/337 (11%), Positives = 86/337 (25%), Gaps = 16/337 (4%)
Query: 214 LSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLS-FLCSLTNATRLT 272
SL + ++ L + ++ ++ N++G+ LS + S +
Sbjct: 8 KSLKLDAIT--TEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAE 65
Query: 273 WMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSG 332
+ I + +P + L + + + + S A + +
Sbjct: 66 FSDIFTGRVKDEIPEALRLLLQALLKC-PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124
Query: 333 TIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESL 392
+ L + R + N L ++ N LE +
Sbjct: 125 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184
Query: 393 IEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLE 452
+ + + I P+ L K+ L ++
Sbjct: 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 244
Query: 453 GEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL-- 510
+ + F S GL+ L L N + + + L +
Sbjct: 245 LRELGLNDCLLSARGAAAVVDAF------SKLENIGLQTLRLQYNEIELDAVRTLKTVID 298
Query: 511 ----SLNNLNLSYNDLEGMVTTEGVFKNASATRILGN 543
L L L+ N + +TR G
Sbjct: 299 EKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.6 bits (93), Expect = 6e-04
Identities = 48/377 (12%), Positives = 100/377 (26%), Gaps = 41/377 (10%)
Query: 155 SRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDG----TIPNSFGWFEN 210
+RFS K+ L+ + S+ + L S+ I L+ N + + + ++
Sbjct: 1 ARFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKD 60
Query: 211 LVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATR 270
L + ++ E+P E L+ L + L + D +F +
Sbjct: 61 LEIAEFSDIFT----GRVKDEIP--EALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLI 114
Query: 271 LTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQL 330
L + + ++ N L+ + N+L
Sbjct: 115 DFLSKHTPLEHLYLHNNGLGP----QAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL 170
Query: 331 SGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCE 390
+ L+ K+ N G +LL L+V
Sbjct: 171 ENGSMKEWAK-TFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTH 229
Query: 391 SLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENR 450
+ + LS + + L+ L + N
Sbjct: 230 LGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD-----AFSKLENIGLQTLRLQYNE 284
Query: 451 LEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLS--GEIPKFLA 508
+E + T I + L L+L+ N S ++ +
Sbjct: 285 IELDAVRTLKTVID-------------------EKMPDLLFLELNGNRFSEEDDVVDEIR 325
Query: 509 GLSLNNLNLSYNDLEGM 525
+ ++L+ M
Sbjct: 326 EVFSTRGRGELDELDDM 342
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 53.1 bits (126), Expect = 3e-08
Identities = 33/229 (14%), Positives = 62/229 (27%), Gaps = 21/229 (9%)
Query: 291 NLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLN 350
L+ IK + + + ++ + + L + ++ + L NL L L
Sbjct: 17 ALANAIK-IAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELK 71
Query: 351 RNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQF 410
N+++ P L L N +I + +
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 411 FSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGM 470
L + + Y+ + + N +L L
Sbjct: 132 QVLYLDLNQITNISPLA-----------GLTNLQYLSIGNAQVSDLTPLANLSKLTTLKA 180
Query: 471 GGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL-SLNNLNLS 518
N L SL L + L N +S P LA +L + L+
Sbjct: 181 DDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 33/236 (13%), Positives = 72/236 (30%), Gaps = 31/236 (13%)
Query: 183 NLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQ 242
L++ I+ +N+ T+ + + + LS ++ +E ++ L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTIEG--------VQYLNNLI 66
Query: 243 HFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLN 302
+ N + + + ++++ + ++ L
Sbjct: 67 GLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA 126
Query: 303 NNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSI 362
+ + N+ L N + + +
Sbjct: 127 GLSNLQVLYLDLNQITNISPLAGLTNLQYL-----------------SIGNAQVSDLTPL 169
Query: 363 GNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSI 418
NL L L +DN + P L +LIE++L NN +S P + S+L I
Sbjct: 170 ANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFI 221
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.003
Identities = 36/243 (14%), Positives = 72/243 (29%), Gaps = 35/243 (14%)
Query: 87 NLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQN 146
L+ ++ ++ T + L + L+ +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGV--------------------- 53
Query: 147 NQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFG 206
+ L+ L L N +T P + +S I
Sbjct: 54 -----TTIEGVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQS 108
Query: 207 WFENLVF--LSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCS 264
+ L+ + N + + +T+ S GN +S L
Sbjct: 109 IKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTP 168
Query: 265 LTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLD 324
L N ++LT + + N + P +++L + + L NN+I P + N NL +
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPN-LIEVHLKNNQISDVSP--LANTSNLFIVT 223
Query: 325 MWN 327
+ N
Sbjct: 224 LTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.003
Identities = 36/211 (17%), Positives = 74/211 (35%), Gaps = 18/211 (8%)
Query: 316 NFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLND 375
N ++ + ++ T+ A +L + L ++ I + L L+ L L D
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72
Query: 376 NFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEV 435
N + ++L +I + + + +LD + ++T P+
Sbjct: 73 NQITDLA-----PLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAG 127
Query: 436 GKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLS 495
LY+ N++ P ++ +G + L +L L L
Sbjct: 128 LSNLQ--VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDL----TPLANLSKLTTLKAD 181
Query: 496 QNNLSGEIPKFLAGL-SLNNLNLSYNDLEGM 525
N +S P LA L +L ++L N + +
Sbjct: 182 DNKISDISP--LASLPNLIEVHLKNNQISDV 210
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.6 bits (127), Expect = 4e-08
Identities = 41/247 (16%), Positives = 85/247 (34%), Gaps = 12/247 (4%)
Query: 284 LLPGCISNL-SKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAI-GEL 341
L P L S+ + + + + F +Q +D+ N+ + + I +
Sbjct: 12 LHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVSTLHGILSQC 70
Query: 342 QNLKILGLNRNKLSGNIPPSIGNLKML--LNLFLNDNFLEVSIPSSLGQCESLIEINL-- 397
L+ L L +LS I ++ L LNL F E ++ + L C L E+NL
Sbjct: 71 SKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSW 130
Query: 398 ----SNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEG 453
+ ++ + +++ L++S + + + ++ L+
Sbjct: 131 CFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKN 190
Query: 454 EIPSTFGNCIRLEQLGMGG-NLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLSL 512
+ F L+ L + LG + L+ L + G + L
Sbjct: 191 DCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPH 250
Query: 513 NNLNLSY 519
+N S+
Sbjct: 251 LQINCSH 257
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.8 bits (125), Expect = 7e-08
Identities = 47/301 (15%), Positives = 86/301 (28%), Gaps = 35/301 (11%)
Query: 68 TLLDLRSLKLAGSVSHFIGNLSFLKQLYLQV-NSFTHEIPSEIGGLRRLKVLALNNNSIC 126
LDL L V G L + + SF + +E R++ + L+N+ I
Sbjct: 3 QTLDLTGKNLHPDV---TGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIE 59
Query: 127 GE-IPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLS 185
+ +S+CS L + L+L L+ I ++L S
Sbjct: 60 VSTLHGILSQCSKL------------------------QNLSLEGLRLSDPIVNTLAKNS 95
Query: 186 SIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFT 245
++ ++L+ + L NLS + V
Sbjct: 96 NLVRLNLSGCSGFSEFALQTLLSS---CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQ 152
Query: 246 ITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNK 305
+ + + +S L+
Sbjct: 153 LNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYD 212
Query: 306 IYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNL 365
I +G L+ L ++ GT+ L +L+I N + + P+IGN
Sbjct: 213 IIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQI---NCSHFTTIARPTIGNK 269
Query: 366 K 366
K
Sbjct: 270 K 270
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.0 bits (110), Expect = 6e-06
Identities = 35/255 (13%), Positives = 76/255 (29%), Gaps = 15/255 (5%)
Query: 271 LTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYG-SIPAGIGNFVNLQRLDMWNNQ 329
+ + L S ++ + L+N+ I ++ + LQ L + +
Sbjct: 25 VIAFRCPRSFMDQPLAEHFSPFR--VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 82
Query: 330 LSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQC 389
LS I + + NL L L+ LN ++ +
Sbjct: 83 LSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVA 142
Query: 390 ESLIEINLSNNNLSG--------TIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKIL 441
+ + ++ NLSG + +L L E +L L
Sbjct: 143 VAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYL 202
Query: 442 EFLYVYE-NRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLS 500
+ L + + E G L+ L + G + G + +L L++ + ++ +
Sbjct: 203 QHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQI---NCSHFT 259
Query: 501 GEIPKFLAGLSLNNL 515
+ +
Sbjct: 260 TIARPTIGNKKNQEI 274
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.4 bits (98), Expect = 1e-04
Identities = 14/103 (13%), Positives = 36/103 (34%), Gaps = 2/103 (1%)
Query: 347 LGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTI 406
L L L ++ + + ++ +F++ + + ++LSN+ + +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVST 62
Query: 407 PPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYEN 449
S S +L +L+ + + K L L +
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGC 105
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.1 bits (120), Expect = 5e-07
Identities = 20/107 (18%), Positives = 37/107 (34%), Gaps = 22/107 (20%)
Query: 318 VNLQRLDMWNNQLSGT-IPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDN 376
+++Q LD+ +LS + LQ +++ L+ L+ I
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDI-------------- 47
Query: 377 FLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFS-LSSLSISLDW 422
S+L +L E+NL +N L L + S +
Sbjct: 48 ------SSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQK 88
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 2e-05
Identities = 17/104 (16%), Positives = 35/104 (33%), Gaps = 9/104 (8%)
Query: 272 TWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKI----YGSIPAGIGNFVNLQRLDMWN 327
+ + L + ++ L+L + + S+ A + +L+ LD+ N
Sbjct: 347 ISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSN 406
Query: 328 NQLSGTIPPAIGE-----LQNLKILGLNRNKLSGNIPPSIGNLK 366
N L + E L+ L L S + + L+
Sbjct: 407 NCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 5e-05
Identities = 22/114 (19%), Positives = 37/114 (32%), Gaps = 23/114 (20%)
Query: 415 SLSI-SLDWSRNKLTGSLPIEV-GKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGG 472
SL I SLD +L+ + E+ L+ + + + + L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCK--------------- 45
Query: 473 NLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLA-GLSLNNLNLSYNDLEGM 525
ISS+L L L+L N L + GL + + L+
Sbjct: 46 -----DISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 5e-05
Identities = 10/93 (10%), Positives = 36/93 (38%), Gaps = 12/93 (12%)
Query: 267 NATRLTWMHINSNNFGGLLPGCISNL---SKTIKTLFLNNNKIYGSIPAGIG-----NFV 318
+ L + + + ++ + +++ L L+NN + + +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 319 NLQRLDMWNNQLSGTIPPAIGELQ----NLKIL 347
L++L +++ S + + L+ +L+++
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 8e-05
Identities = 15/87 (17%), Positives = 26/87 (29%), Gaps = 9/87 (10%)
Query: 441 LEFLYVYENRLEGE----IPSTFGNCIRLEQLGMGGNLFQGPISSSLGS-----LRGLRV 491
L L++ + + + +T L +L + N L L
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 492 LDLSQNNLSGEIPKFLAGLSLNNLNLS 518
L L S E+ L L + +L
Sbjct: 431 LVLYDIYWSEEMEDRLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 16/118 (13%), Positives = 34/118 (28%), Gaps = 21/118 (17%)
Query: 91 LKQLYLQVNSFTHEIPSEI-GGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQL 149
++ L +Q + +E+ L++ +V+ L++ + +IS
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSA------------- 50
Query: 150 VGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGW 207
LNL SN L + + + +L G
Sbjct: 51 -------LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGC 101
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 1e-04
Identities = 12/88 (13%), Positives = 27/88 (30%), Gaps = 5/88 (5%)
Query: 296 IKTLFLNNNKI-YGSIPAGIGNFVNLQRLDMWNNQLSG----TIPPAIGELQNLKILGLN 350
I++L + ++ + Q + + + L+ I A+ L L L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 351 RNKLSGNIPPSIGNLKMLLNLFLNDNFL 378
N+L + + + L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 18/125 (14%), Positives = 38/125 (30%), Gaps = 9/125 (7%)
Query: 273 WMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSG 332
+ ++F +L L I L + + L+ L + + +S
Sbjct: 324 FTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSD 383
Query: 333 T----IPPAIGELQNLKILGLNRNKLSGNIPPSIG-----NLKMLLNLFLNDNFLEVSIP 383
+ + + +L+ L L+ N L + +L L L D + +
Sbjct: 384 SSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEME 443
Query: 384 SSLGQ 388
L
Sbjct: 444 DRLQA 448
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 9/91 (9%), Positives = 28/91 (30%), Gaps = 4/91 (4%)
Query: 271 LTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKI----YGSIPAGIGNFVNLQRLDMW 326
+ + I + L + + + L++ + I + + L L++
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 327 NNQLSGTIPPAIGELQNLKILGLNRNKLSGN 357
+N+L + + + + L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.002
Identities = 13/83 (15%), Positives = 27/83 (32%), Gaps = 5/83 (6%)
Query: 145 QNNQLVGKILSR-FSSLSKTEILNLGSNHLTG----SIPSSLGNLSSIHTISLAYNNLDG 199
Q +L + L + +++ L LT I S+L ++ ++L N L
Sbjct: 10 QCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGD 69
Query: 200 TIPNSFGWFENLVFLSLAANNLS 222
+ + +L
Sbjct: 70 VGVHCVLQGLQTPSCKIQKLSLQ 92
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.003
Identities = 14/81 (17%), Positives = 31/81 (38%), Gaps = 9/81 (11%)
Query: 342 QNLKILGLNRNKLSGN----IPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQ-----CESL 392
L++L L +S + + ++ L L L++N L + L + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 393 IEINLSNNNLSGTIPPQFFSL 413
++ L + S + + +L
Sbjct: 429 EQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.003
Identities = 13/100 (13%), Positives = 30/100 (30%), Gaps = 8/100 (8%)
Query: 155 SRFSSLSKTEILNLGSNHLTG----SIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFEN 210
S +L L ++ S+ ++L S+ + L+ N L E+
Sbjct: 363 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLV--ES 420
Query: 211 LVFLSLAANNLSVVENKLTGEVPSL--EKLQRLQHFTITS 248
+ L + + + E+ + + S
Sbjct: 421 VRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 49.2 bits (116), Expect = 5e-07
Identities = 33/195 (16%), Positives = 72/195 (36%), Gaps = 11/195 (5%)
Query: 158 SSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLA 217
+ ++T NL +T ++ + L+SI I +++ + N+ L L
Sbjct: 21 DAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLN 76
Query: 218 ANNLS---VVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWM 274
N L+ + N L++ + ++ + + + + + L +
Sbjct: 77 GNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQL 136
Query: 275 HINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTI 334
+ + + + TL L +N+I +P + LQ L + N +S
Sbjct: 137 ESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-- 192
Query: 335 PPAIGELQNLKILGL 349
A+ L+NL +L L
Sbjct: 193 LRALAGLKNLDVLEL 207
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 9e-06
Identities = 41/224 (18%), Positives = 72/224 (32%), Gaps = 24/224 (10%)
Query: 301 LNNNKIYGSIPAGIG------NFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKL 354
L + I ++P I F + ++ ++ + EL ++ + N + +
Sbjct: 3 LGSETI--TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDI 58
Query: 355 SGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLS 414
I L + LFLN N L P + NL N + LS
Sbjct: 59 KSVQG--IQYLPNVTKLFLNGNKLTDIKPLA----------NLKNLGWLFLDENKVKDLS 106
Query: 415 SLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNL 474
SL L + ++ L L L T + + +
Sbjct: 107 SLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDN 166
Query: 475 FQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLSLNNLNLS 518
I L L L+ L LS+N++S ++ +L+ L L
Sbjct: 167 QISDIVP-LAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.003
Identities = 34/209 (16%), Positives = 70/209 (33%), Gaps = 18/209 (8%)
Query: 260 SFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVN 319
+ S ++ + + + L+ I + NN+ I GI N
Sbjct: 15 KQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNS-IDQIIANNSDI--KSVQGIQYLPN 69
Query: 320 LQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLE 379
+ +L + N+L+ P L NLK LG + S L ++
Sbjct: 70 VTKLFLNGNKLTDIKP-----LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGI 124
Query: 380 VSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLK 439
I + + +N T+ + L +LS+ + + + + L
Sbjct: 125 SDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISD------IVPLAGLT 178
Query: 440 ILEFLYVYENRLEGEIPSTFGNCIRLEQL 468
L+ LY+ +N + ++ + L+ L
Sbjct: 179 KLQNLYLSKNHIS-DLRA-LAGLKNLDVL 205
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 43.6 bits (101), Expect = 3e-05
Identities = 37/213 (17%), Positives = 67/213 (31%), Gaps = 33/213 (15%)
Query: 288 CISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAI-GELQNLKI 346
C + T+ + IP I ++ L + +N+L + G L +L
Sbjct: 2 CPAMCHCEGTTVDCTGRGLK-EIPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVK 58
Query: 347 LGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTI 406
L L RN+L+G P + + L L +N ++ L +NL +N +S +
Sbjct: 59 LELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVM 118
Query: 407 PPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLE 466
P F L+SL+ S + + PS
Sbjct: 119 PGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRK--KSLNGGAARCGAPS--------- 167
Query: 467 QLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNL 499
+R +++ DL +
Sbjct: 168 ------------------KVRDVQIKDLPHSEF 182
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.1 bits (102), Expect = 4e-05
Identities = 32/229 (13%), Positives = 72/229 (31%), Gaps = 10/229 (4%)
Query: 297 KTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSG 356
+ +K+ IP+ + N L +L A +L+ + +++N +
Sbjct: 11 RVFLCQESKV-TEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 67
Query: 357 NIPPSIGNLKMLLNLFLN---DNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSL 413
I + + L+ +N L ++ + + + + SL
Sbjct: 68 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSL 127
Query: 414 SSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGN 473
+ + + + N T VG L++ +N ++ F E N
Sbjct: 128 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNN 187
Query: 474 LFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL----SLNNLNLS 518
+ + G +LD+S+ + L L + + NL
Sbjct: 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.8 bits (96), Expect = 2e-04
Identities = 22/215 (10%), Positives = 48/215 (22%), Gaps = 18/215 (8%)
Query: 161 SKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANN 220
L L + + I ++ N++ I +
Sbjct: 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88
Query: 221 LSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNN 280
+++ L T + L + ++
Sbjct: 89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSF 148
Query: 281 FGGLLPGCISNLSKTIKT--------------LFLNNNKIYGSIPAGI-GNFVNLQRLDM 325
G I L+K L L++N +P + LD+
Sbjct: 149 VGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDI 208
Query: 326 WNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPP 360
++ + L+ L+ K +P
Sbjct: 209 SRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (91), Expect = 8e-04
Identities = 30/244 (12%), Positives = 63/244 (25%), Gaps = 15/244 (6%)
Query: 165 ILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVV 224
+ + +T IPS L + + L +F F +L + ++ N+
Sbjct: 12 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQND---- 64
Query: 225 ENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGL 284
+ + ++ + N+
Sbjct: 65 -----VLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLP 119
Query: 285 LPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNL 344
I +L K + + N N + +G L + N + A Q
Sbjct: 120 DVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLD 179
Query: 345 KILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSG 404
++ + N L + L ++ + L + L S NL
Sbjct: 180 ELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA--RSTYNLK- 236
Query: 405 TIPP 408
+P
Sbjct: 237 KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (91), Expect = 8e-04
Identities = 35/218 (16%), Positives = 64/218 (29%), Gaps = 6/218 (2%)
Query: 290 SNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGL 349
S+L + L K+ F +L+++++ N + I +
Sbjct: 25 SDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR 84
Query: 350 N---RNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTI 406
N L N + L N + + + ++ N N+
Sbjct: 85 IEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIE 144
Query: 407 PPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLE 466
F LS S+ L ++N + ++ E N LE F
Sbjct: 145 RNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPV 204
Query: 467 QLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIP 504
L + S L +L+ LR NL ++P
Sbjct: 205 ILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP 239
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (85), Expect = 0.004
Identities = 19/86 (22%), Positives = 25/86 (29%), Gaps = 3/86 (3%)
Query: 118 LALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSI 177
L LN N I + NN L F S IL++ +
Sbjct: 158 LWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 217
Query: 178 PSSLGNLSSIHTISLAYNNLDGTIPN 203
L NL + S NL +P
Sbjct: 218 SYGLENLKKLRARST--YNL-KKLPT 240
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (95), Expect = 1e-04
Identities = 23/135 (17%), Positives = 38/135 (28%), Gaps = 2/135 (1%)
Query: 381 SIPSSLGQCESLIEINLSNNNLSGTIPPQFFS-LSSLSISLDWSRNKLTGSLPIEVGKLK 439
L E+L E+ + N + + L L +L ++ L P
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELR-NLTIVKSGLRFVAPDAFHFTP 80
Query: 440 ILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNL 499
L L + N LE T E + G L L + + + L
Sbjct: 81 RLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKL 140
Query: 500 SGEIPKFLAGLSLNN 514
LA + +
Sbjct: 141 QCHGQGPLAHMPNAS 155
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (92), Expect = 3e-04
Identities = 25/128 (19%), Positives = 47/128 (36%), Gaps = 5/128 (3%)
Query: 290 SNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGL 349
+N + + L L KI I +D +N++ L+ LK L +
Sbjct: 15 TNAVR-DRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLV 70
Query: 350 NRNKLSGNIPPSIGNLKMLLNLFLNDNFL-EVSIPSSLGQCESLIEINLSNNNLSGTIPP 408
N N++ L L L L +N L E+ L +SL + + N ++
Sbjct: 71 NNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHY 130
Query: 409 QFFSLSSL 416
+ + + +
Sbjct: 131 RLYVIYKV 138
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.9 bits (87), Expect = 0.002
Identities = 29/157 (18%), Positives = 60/157 (38%), Gaps = 11/157 (7%)
Query: 226 NKLTGEVPSLEKLQRL--QHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGG 283
N+L E +E+L+ + + + + +L G L + L ++
Sbjct: 2 NELKPE--QVEQLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLN----RRSSMAA 55
Query: 284 LLPGCISNLSKTIKTLFLNNNKIYG--SIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGEL 341
L N+ + + +L L+NN++Y + + + NL+ L++ N+L +
Sbjct: 56 TLRIIEENIPE-LLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKG 114
Query: 342 QNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFL 378
L+ L L+ N LS + + F L
Sbjct: 115 LKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRL 151
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.003
Identities = 33/196 (16%), Positives = 61/196 (31%), Gaps = 17/196 (8%)
Query: 316 NFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLND 375
+ + ++ T+ +L + L +R + SI ++ L NL
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-----SIDGVEYLNNL---- 64
Query: 376 NFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEV 435
+ S L + ++ L++L+ + + +
Sbjct: 65 TQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPL 124
Query: 436 GKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLS 495
L L L + N + S L+QL N L +L L LD+S
Sbjct: 125 KNLTNLNRLELSSNTIS--DISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDIS 180
Query: 496 QNNLSGEIPKFLAGLS 511
N +S LA L+
Sbjct: 181 SNKVSD--ISVLAKLT 194
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 949 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.83 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.83 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.78 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.78 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.75 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.75 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.74 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.67 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.67 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.67 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.54 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.51 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.49 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.47 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.46 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.44 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.39 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.38 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.29 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.28 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.28 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.24 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.42 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.4 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.36 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.91 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.67 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.41 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.31 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.9 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.54 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.51 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.17 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.75 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-50 Score=425.55 Aligned_cols=264 Identities=27% Similarity=0.414 Sum_probs=204.0
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
.++|++.+.||+|+||+||+|+.+ ..||||+++... ....+.+.+|++++++++|||||++++++.. ..
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------~~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQ 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------cE
Confidence 467999999999999999999865 359999987443 3345789999999999999999999998643 25
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++|+|.+++.. ....+++.++..|+.||++||+|||++ +||||||||+|||++.++.+||
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~---------~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl 145 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHI---------IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKI 145 (276)
T ss_dssp CEEEEECCCEEEHHHHHHT---------SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEE
T ss_pred EEEEEecCCCCCHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEE
Confidence 7999999999999999962 234589999999999999999999987 8999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCC---ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC---EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
+|||+|+...............||+.|||||++.+. .++.++|||||||++|||+||+.||..............+.
T Consensus 146 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~ 225 (276)
T d1uwha_ 146 GDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG 225 (276)
T ss_dssp CCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHT
T ss_pred ccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcC
Confidence 999999877654443333356799999999998643 47899999999999999999999996432211111000011
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhhc
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILL 936 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~ 936 (949)
...+...+ ....+++.+.+++.+||+.||++||||+||++.|+.+++++.
T Consensus 226 ~~~p~~~~---------------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 226 YLSPDLSK---------------------------VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp SCCCCGGG---------------------------SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CCCCcchh---------------------------ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 01100000 011345678999999999999999999999999999987654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=420.23 Aligned_cols=254 Identities=20% Similarity=0.291 Sum_probs=204.0
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
.++|++.+.||+|+||+||+|++..+++.||||+++.... ...+++.+|++++++++||||+++++++.+.+ ..
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~-----~~ 78 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN-----IQ 78 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETT-----EE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc-----ee
Confidence 3579999999999999999999998999999999975432 23467899999999999999999999976554 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++||||+++|+|.+++. ....+++.+++.++.|++.||+|||++ +|+||||||+|||+++++.+||+
T Consensus 79 ~ivmEy~~gg~L~~~l~----------~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~ 145 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIE----------PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKIS 145 (271)
T ss_dssp EEEEECCTTEEGGGGSB----------TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEEC
T ss_pred EEEEeccCCCcHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEc
Confidence 99999999999999996 235689999999999999999999987 99999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCCcc-CCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEV-STNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
|||+|+...............||+.|||||++.+..+ +.++||||+||++|||+||+.||................
T Consensus 146 DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~--- 222 (271)
T d1nvra_ 146 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--- 222 (271)
T ss_dssp CCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTT---
T ss_pred cchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcC---
Confidence 9999998755444333345679999999999988776 578999999999999999999996443222111111100
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.....+ ....+..+.+++.+|++.||++|||++|+++
T Consensus 223 ---------~~~~~~------------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 223 ---------KTYLNP------------------WKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ---------CTTSTT------------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---------CCCCCc------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000000 0123445778999999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=415.47 Aligned_cols=250 Identities=21% Similarity=0.295 Sum_probs=206.7
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
++|++.+.||+|+||+||+|++..+|+.||||+++.......+.+.+|++++++++||||+++++++...+ ..++
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-----ELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC-----EEEE
Confidence 47999999999999999999999899999999998766666678999999999999999999999976554 7899
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
||||+++|+|.+++. ...+++.+++.|+.||+.||+|||++ +|+||||||+|||++.++++||+||
T Consensus 95 vmEy~~gg~L~~~~~-----------~~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DF 160 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVT-----------ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDF 160 (293)
T ss_dssp EEECCTTCBHHHHHH-----------HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCC
T ss_pred EEEecCCCcHHHHhh-----------ccCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccc
Confidence 999999999999875 23589999999999999999999987 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCch
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDV 865 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 865 (949)
|+|+......... ....||+.|+|||++.+..++.++||||+||++|||+||+.||........ .........+
T Consensus 161 G~a~~~~~~~~~~--~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~~~~~~~~--- 234 (293)
T d1yhwa1 161 GFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTP--- 234 (293)
T ss_dssp TTCEECCSTTCCB--CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHHCSC---
T ss_pred hhheeeccccccc--cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH-HHHHHhCCCC---
Confidence 9999876544322 245699999999999999999999999999999999999999964321110 0000000000
Q ss_pred hhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 866 MDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 866 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.. . .....+..+.+++.+||+.||++|||++|+++
T Consensus 235 ------~~-~-------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 235 ------EL-Q-------------------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp ------CC-S-------------------SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ------CC-C-------------------CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0 00123456789999999999999999999864
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=412.52 Aligned_cols=257 Identities=23% Similarity=0.369 Sum_probs=197.9
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
++|++.+.||+|+||+||+|++. +++.||||+++... ...+++.+|++++++++||||++++|+|...+ ..++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-----~~~l 77 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-----PICL 77 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SCEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCC-----ceEE
Confidence 57888999999999999999987 57889999987543 34578999999999999999999999986554 7899
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
||||+++|+|.+++.. ....+++..++.|+.|+|.||+|||++ +|+||||||+||++++++.+||+||
T Consensus 78 v~E~~~~g~L~~~l~~---------~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DF 145 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRT---------QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDF 145 (263)
T ss_dssp EEECCTTCBHHHHHHT---------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSC
T ss_pred EEEecCCCcHHHHhhc---------cccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEeccc
Confidence 9999999999999862 235688999999999999999999987 8999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhC-CCCCccccccCchhhhhccccCCCc
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIG-KKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
|+|+......... .....||+.|+|||++.+..++.++|||||||++|||+|+ ++||...... .....
T Consensus 146 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~--~~~~~-------- 214 (263)
T d1sm2a_ 146 GMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVED-------- 214 (263)
T ss_dssp C-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH--HHHHH--------
T ss_pred chheeccCCCcee-ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH--HHHHH--------
Confidence 9998765543322 2235689999999999999999999999999999999995 5554321110 11111
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHh
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNI 934 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 934 (949)
+........ +..++.++.+++.+||+.||++||||+||++.|++|+++
T Consensus 215 ----i~~~~~~~~------------------p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 215 ----ISTGFRLYK------------------PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp ----HHHTCCCCC------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHhcCCCCC------------------ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 000000000 012345688999999999999999999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-48 Score=420.27 Aligned_cols=260 Identities=23% Similarity=0.393 Sum_probs=195.5
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCE---EEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRT---TIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
++|++.++||+|+||+||+|++..+++ .||||++..... ...+++.+|++++++++|||||+++|+|...+
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~----- 100 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST----- 100 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-----
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC-----
Confidence 345667899999999999999875543 688898764433 33467999999999999999999999986554
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++|+|.+++.. ....+++.++..|+.||++||+|||++ +|+||||||+|||++.++++|
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~---------~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~K 168 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQ---------NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCK 168 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHT---------TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEE
T ss_pred EEEEEEEecCCCcceeeecc---------ccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEE
Confidence 78999999999999998862 234689999999999999999999987 899999999999999999999
Q ss_pred EeecccceecCCCCCcc---ccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhc
Q 039533 782 VGDFGLARILSPDHTQT---SSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFG 857 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~ 857 (949)
|+|||+|+......... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||...... ...
T Consensus 169 l~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--~~~--- 243 (299)
T d1jpaa_ 169 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--DVI--- 243 (299)
T ss_dssp ECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHH---
T ss_pred ECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--HHH---
Confidence 99999998776543321 1223457899999999999999999999999999999998 89999643211 111
Q ss_pred cccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHh
Q 039533 858 RKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNI 934 (949)
Q Consensus 858 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 934 (949)
..+....... ...+++..+.+++.+||+.||++||||+||++.|+++.+.
T Consensus 244 ---------~~i~~~~~~~------------------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 244 ---------NAIEQDYRLP------------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp ---------HHHHTTCCCC------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---------HHHHcCCCCC------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 1111110000 0113456788999999999999999999999999988653
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=408.91 Aligned_cols=246 Identities=21% Similarity=0.305 Sum_probs=203.7
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecC---CCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ---HHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
++|++.+.||+|+||+||+|++..+++.||+|++... .....+.+.+|++++++++||||+++++++.+.+ .
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT-----R 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----E
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC-----E
Confidence 5799999999999999999999989999999998643 2334567899999999999999999999976554 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++|+|.+++. ....+++.++..|+.||+.||+|||++ +|+||||||+|||++.++.+||
T Consensus 81 ~~ivmEy~~~g~L~~~l~----------~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl 147 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQ----------KLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKI 147 (263)
T ss_dssp EEEEEECCTTCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEE
T ss_pred EEEEEeecCCCcHHHHHh----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEee
Confidence 899999999999999996 235689999999999999999999987 9999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
+|||+|+....... ....||+.|+|||++.+..++.++|||||||++|||++|+.||+...... ...
T Consensus 148 ~DFG~a~~~~~~~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--~~~------- 214 (263)
T d2j4za1 148 ADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--TYK------- 214 (263)
T ss_dssp CCCCSCSCCCCCCC----EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHH-------
T ss_pred cccceeeecCCCcc----cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH--HHH-------
Confidence 99999987654332 23569999999999999999999999999999999999999996432110 000
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.+...... .+ ...++.+.+++.+|++.||++|||++|+++
T Consensus 215 ----~i~~~~~~-~p-------------------~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 215 ----RISRVEFT-FP-------------------DFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ----HHHTTCCC-CC-------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HHHcCCCC-CC-------------------ccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 00000000 00 023456789999999999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-48 Score=407.55 Aligned_cols=258 Identities=24% Similarity=0.377 Sum_probs=205.6
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.++|++.+.||+|+||+||+|+++ +++.||||+++... ...+.+.+|++++++++|||||++++++.+. ..+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~------~~~ 83 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQE------PIY 83 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS------SCE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeeccC------CeE
Confidence 357888999999999999999987 67899999997543 3457899999999999999999999987432 468
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++|+|.+++.. .....+++.+++.|+.||++||+|||++ +|+||||||+|||+++++.+||+|
T Consensus 84 iv~Ey~~~g~L~~~~~~--------~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~D 152 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKT--------PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIAD 152 (272)
T ss_dssp EEEECCTTCBHHHHTTS--------HHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECC
T ss_pred EEEEeCCCCcHHHHHhh--------cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeecc
Confidence 99999999999998862 1234589999999999999999999987 899999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCc
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
||+|+......... .....||+.|+|||++.+..++.++|||||||++|||+||..|+....... .....
T Consensus 153 FGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-~~~~~-------- 222 (272)
T d1qpca_ 153 FGLARLIEDNEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQN-------- 222 (272)
T ss_dssp CTTCEECSSSCEEC-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHH--------
T ss_pred ccceEEccCCcccc-ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH-HHHHH--------
Confidence 99999876543322 224568999999999998899999999999999999999666543221111 01000
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHH
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKN 933 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 933 (949)
+........ +..++..+.+++.+||+.||++||||+||++.|+.+-.
T Consensus 223 ----i~~~~~~~~------------------p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 223 ----LERGYRMVR------------------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp ----HHTTCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHhcCCCCC------------------cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 100000000 01234568899999999999999999999999998754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=411.76 Aligned_cols=259 Identities=22% Similarity=0.295 Sum_probs=194.4
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
.++|++.+.||+|+||+||+|++..+|+.||||+++.... ...+.+.+|++++++++||||+++++++.+.. ...
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~---~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT---NTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC---CCE
Confidence 3679999999999999999999998999999999975532 23457889999999999999999999986432 336
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeEecCCCCCCeeecCCCce
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDC--QPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~--~~~ivHrDlkp~NIll~~~~~~ 780 (949)
.++||||+++|+|.+++... ......+++..++.++.|++.||+|||++. ..+|+||||||+|||++.++.+
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~------~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~v 153 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKG------TKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV 153 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHH------HHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCE
T ss_pred EEEEEecCCCCcHHHHHHhc------cccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcE
Confidence 79999999999999998621 113456999999999999999999999862 1259999999999999999999
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
||+|||+|+......... ....||+.|+|||++.+..++.++|||||||++|||+||+.||......+ ...
T Consensus 154 kl~DFG~a~~~~~~~~~~--~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~--~~~----- 224 (269)
T d2java1 154 KLGDFGLARILNHDTSFA--KAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--LAG----- 224 (269)
T ss_dssp EECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHH-----
T ss_pred EEeeccceeecccCCCcc--ccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH--HHH-----
Confidence 999999998876543322 24569999999999999999999999999999999999999996432111 100
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.+.+......+ ...++++.+++.+||+.||++|||++|+++
T Consensus 225 ------~i~~~~~~~~~-------------------~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 225 ------KIREGKFRRIP-------------------YRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ------HHHHTCCCCCC-------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------HHHcCCCCCCC-------------------cccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 01111111000 123456889999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=413.72 Aligned_cols=252 Identities=23% Similarity=0.267 Sum_probs=204.2
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
+.|++.+.||+|+||+||+|++..+++.||||+++.......+.+.+|++++++++|||||++++++.+.+ ..++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN-----NLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-----eEEE
Confidence 46888999999999999999999999999999998776666788999999999999999999999986554 7899
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
||||+++|+|.+++.. ....+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 87 vmEy~~~g~L~~~~~~---------~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DF 154 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLE---------LERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADF 154 (288)
T ss_dssp EEECCTTEEHHHHHHH---------HTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred EEecCCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEec
Confidence 9999999999999752 234699999999999999999999988 8999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccC-----CCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGV-----GCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
|+|+....... ......||+.|+|||++. +..++.++|||||||++|||+||+.||......+. +
T Consensus 155 G~a~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~-~------- 224 (288)
T d2jfla1 155 GVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-L------- 224 (288)
T ss_dssp TTCEECHHHHH--HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-H-------
T ss_pred hhhhccCCCcc--cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH-H-------
Confidence 99976533211 122456999999999874 45688999999999999999999999964322110 0
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
..+....... .......+..+.+++.+||+.||++|||++|+++
T Consensus 225 -----~~i~~~~~~~-----------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 225 -----LKIAKSEPPT-----------------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -----HHHHHSCCCC-----------------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----HHHHcCCCCC-----------------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111000000 0001133456889999999999999999999875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-48 Score=414.63 Aligned_cols=260 Identities=24% Similarity=0.391 Sum_probs=210.5
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.++|++.+.||+|+||+||+|++..+++.||||+++... ...+++.+|++++++++|||||+++++|.+.+ ..+
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~~~ 89 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-----PFY 89 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SCE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCC-----eeE
Confidence 457888899999999999999999889999999986543 34578999999999999999999999986544 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++|+|.+++... ....+++..++.|+.||+.||+|||++ +|+||||||+|||+++++.+||+|
T Consensus 90 iv~E~~~~g~l~~~l~~~--------~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~D 158 (287)
T d1opja_ 90 IITEFMTYGNLLDYLREC--------NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVAD 158 (287)
T ss_dssp EEEECCTTCBHHHHHHHS--------CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred EEeecccCcchHHHhhhc--------cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEcc
Confidence 999999999999998621 235689999999999999999999987 899999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCc
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
||+|+......... .....|++.|+|||++.+..++.++|||||||++|||++|..||....... .
T Consensus 159 FG~a~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-~------------ 224 (287)
T d1opja_ 159 FGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-Q------------ 224 (287)
T ss_dssp CCCTTTCCSSSSEE-ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-H------------
T ss_pred ccceeecCCCCcee-eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH-H------------
Confidence 99998766544322 223458999999999999999999999999999999999777763221110 0
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHH
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKN 933 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 933 (949)
+.+.+........ ...++..+.+++.+||+.||++||||+||++.|+.+.+
T Consensus 225 ~~~~i~~~~~~~~------------------~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 225 VYELLEKDYRMER------------------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp HHHHHHTTCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred HHHHHhcCCCCCC------------------CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1111111111100 01335568899999999999999999999999988743
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=402.94 Aligned_cols=251 Identities=23% Similarity=0.353 Sum_probs=197.3
Q ss_pred CCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeE
Q 039533 629 SSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASV 706 (949)
Q Consensus 629 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 706 (949)
+..++||+|+||+||+|++..+++.||+|++.... ....+.+.+|++++++++|||||++++++.... .+....++|
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~iv 90 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVLV 90 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEEE
Confidence 55678999999999999999899999999987543 233467899999999999999999999986532 334568999
Q ss_pred eeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec-CCCceEEeec
Q 039533 707 YEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD-DYMTARVGDF 785 (949)
Q Consensus 707 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~-~~~~~kl~Df 785 (949)
|||+++|+|.+++. ....+++.+++.++.||++||+|||++ .++|+||||||+|||++ +++.+||+||
T Consensus 91 mE~~~~g~L~~~l~----------~~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DF 159 (270)
T d1t4ha_ 91 TELMTSGTLKTYLK----------RFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDL 159 (270)
T ss_dssp EECCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred EeCCCCCcHHHHHh----------ccccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeec
Confidence 99999999999996 235689999999999999999999987 33499999999999996 5789999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCch
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDV 865 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 865 (949)
|+|+....... ....||+.|||||++.+ +++.++|||||||++|||++|+.||...........
T Consensus 160 Gla~~~~~~~~----~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~----------- 223 (270)
T d1t4ha_ 160 GLATLKRASFA----KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR----------- 223 (270)
T ss_dssp TGGGGCCTTSB----EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH-----------
T ss_pred CcceeccCCcc----CCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHH-----------
Confidence 99986443322 24569999999999876 599999999999999999999999963321111000
Q ss_pred hhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 866 MDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 866 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.+.....+.. + ....++++.+++.+||+.||++|||++|+++
T Consensus 224 --~i~~~~~~~~---------------~--~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 224 --RVTSGVKPAS---------------F--DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp --HHTTTCCCGG---------------G--GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --HHHcCCCCcc---------------c--CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 0000000000 0 0012345789999999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=406.60 Aligned_cols=263 Identities=23% Similarity=0.371 Sum_probs=208.6
Q ss_pred cCCCCCCe-eeeecCceEEEEEEc--CCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 626 SGFSSANL-VGVGSFGSVYKGIID--EGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 626 ~~y~~~~~-lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
++|.+.+. ||+|+||+||+|.+. .++..||||+++.... ...+++.+|++++++++|||||+++|++...
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------ 81 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE------ 81 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS------
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC------
Confidence 34555664 999999999999875 3456899999975433 3357899999999999999999999997532
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++|+|.+++.. ....+++.++..|+.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~---------~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~K 149 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVG---------KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAK 149 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTT---------CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEE
T ss_pred eEEEEEEeCCCCcHHHHhhc---------cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCcee
Confidence 47899999999999999862 234689999999999999999999987 999999999999999999999
Q ss_pred EeecccceecCCCCCc-cccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccc
Q 039533 782 VGDFGLARILSPDHTQ-TSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~ 859 (949)
|+|||+|+........ .......||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .....
T Consensus 150 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~~~~--- 224 (285)
T d1u59a_ 150 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAF--- 224 (285)
T ss_dssp ECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHH---
T ss_pred eccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--HHHHH---
Confidence 9999999987654432 22224458999999999998899999999999999999998 99999643211 11111
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhhccC
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILLGV 938 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~~ 938 (949)
+....... .+..++..+.+++.+||+.||++||||.+|.+.|+.+..++...
T Consensus 225 ---------i~~~~~~~------------------~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~ 276 (285)
T d1u59a_ 225 ---------IEQGKRME------------------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276 (285)
T ss_dssp ---------HHTTCCCC------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred ---------HHcCCCCC------------------CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhc
Confidence 11000000 01134567889999999999999999999999999887665444
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-47 Score=397.94 Aligned_cols=255 Identities=24% Similarity=0.374 Sum_probs=208.9
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.++|++.++||+|+||+||+|+++ +++.||||+++.... ..+++.+|+.++++++||||++++|+|.+.+ ..+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~-----~~~ 75 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR-----PIF 75 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSS-----SEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCC-----ceE
Confidence 368999999999999999999986 788999999986543 3578999999999999999999999986544 789
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEee
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGD 784 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 784 (949)
+||||+++|++.+++.. ....+++..+.+++.|+++||+|||++ +|+||||||+||++++++.+||+|
T Consensus 76 iv~Ey~~~g~l~~~~~~---------~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~D 143 (258)
T d1k2pa_ 76 IITEYMANGCLLNYLRE---------MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSD 143 (258)
T ss_dssp EEEECCTTEEHHHHHHS---------GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECC
T ss_pred EEEEccCCCcHHHhhhc---------cccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECc
Confidence 99999999999999752 345688999999999999999999987 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCC
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||+.....+ ....
T Consensus 144 fG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--~~~~------- 213 (258)
T d1k2pa_ 144 FGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEH------- 213 (258)
T ss_dssp CSSCCBCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHH-------
T ss_pred chhheeccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH--HHHH-------
Confidence 9999876554332 2224568999999999999999999999999999999998 899996442221 1110
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHh
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSI 931 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 931 (949)
+.+......+ ..+++++.+++.+||+.||++|||++|+++.|.+|
T Consensus 214 ----i~~~~~~~~p-------------------~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 214 ----IAQGLRLYRP-------------------HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp ----HHTTCCCCCC-------------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ----HHhCCCCCCc-------------------ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 0000000111 12345688999999999999999999999998654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=409.17 Aligned_cols=250 Identities=20% Similarity=0.267 Sum_probs=201.6
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecC---CCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ---HHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
++|++.+.||+|+||+||+|++..+++.||||+++.. .....+.+.+|++++++++||||+++++++.+.+ .
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE-----K 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS-----E
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC-----E
Confidence 5799999999999999999999989999999999743 2334567999999999999999999999976544 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++|+|.+++. ..+.+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||
T Consensus 83 ~~ivmEy~~gg~L~~~~~----------~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl 149 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIR----------KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQI 149 (288)
T ss_dssp EEEEECCCTTEEHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEE
T ss_pred EEEEEEccCCCCHHHhhh----------ccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEe
Confidence 899999999999999986 345699999999999999999999987 9999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
+|||+|+.+.............||+.|+|||++.+..++.++||||+||++|||+||+.||....... ..
T Consensus 150 ~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~~-------- 219 (288)
T d1uu3a_ 150 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL--IF-------- 219 (288)
T ss_dssp CCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH--------
T ss_pred cccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH--HH--------
Confidence 99999998765544333345679999999999999999999999999999999999999996431110 00
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
..+...... .+ ...++.+.+++.+||+.||++|||++|+.+
T Consensus 220 ---~~i~~~~~~-~p-------------------~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 220 ---QKIIKLEYD-FP-------------------EKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ---HHHHTTCCC-CC-------------------TTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ---HHHHcCCCC-CC-------------------ccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 001100000 00 022345789999999999999999999754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=405.86 Aligned_cols=262 Identities=22% Similarity=0.392 Sum_probs=199.7
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCC----EEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccC
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGR----TTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRG 699 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 699 (949)
.+.|+..++||+|+||+||+|.++.++ ..||||+++.... ....++.+|++++++++|||||+++|++.+.+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~--- 82 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK--- 82 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS---
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC---
Confidence 356888899999999999999987543 5799999975433 23457899999999999999999999986554
Q ss_pred CccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCc
Q 039533 700 NDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMT 779 (949)
Q Consensus 700 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~ 779 (949)
..++||||+.++++.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+|||++.++.
T Consensus 83 --~~~~v~e~~~~~~l~~~~~~---------~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~ 148 (283)
T d1mqba_ 83 --PMMIITEYMENGALDKFLRE---------KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLV 148 (283)
T ss_dssp --SEEEEEECCTTEEHHHHHHH---------TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCC
T ss_pred --ceEEEEEecccCcchhhhhc---------ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCe
Confidence 78999999999999998752 345699999999999999999999987 8999999999999999999
Q ss_pred eEEeecccceecCCCCCcc-ccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcc
Q 039533 780 ARVGDFGLARILSPDHTQT-SSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGR 858 (949)
Q Consensus 780 ~kl~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~ 858 (949)
+||+|||+|+......... ......||+.|+|||++.+..++.++|||||||++|||++|..|+....... .
T Consensus 149 ~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-~------ 221 (283)
T d1mqba_ 149 CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-E------ 221 (283)
T ss_dssp EEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-H------
T ss_pred EEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH-H------
Confidence 9999999998765543321 2223458999999999999999999999999999999999766653221110 0
Q ss_pred ccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHh
Q 039533 859 KALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNI 934 (949)
Q Consensus 859 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 934 (949)
+.+.+........ ..+++..+.+++.+||+.||++||||+||++.|+++.+.
T Consensus 222 ------~~~~i~~~~~~~~------------------~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 222 ------VMKAINDGFRLPT------------------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ------HHHHHHTTCCCCC------------------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ------HHHHHhccCCCCC------------------chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 1111111111110 113456788999999999999999999999999988764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=414.52 Aligned_cols=201 Identities=25% Similarity=0.355 Sum_probs=176.8
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
.++|++.+.||+|+||+||+|++..+++.||+|+++.... ...+++.+|+.++++++|||||+++++|.+.+ ..
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~ 79 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-----EI 79 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS-----EE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----EE
Confidence 5689999999999999999999998999999999975433 33467899999999999999999999986554 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++||||+++|+|.+++. ....+++..+..++.|++.||.|||+++ +|+||||||+|||++.++++||+
T Consensus 80 ~iVmEy~~gg~L~~~l~----------~~~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~ 147 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLK----------KAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLC 147 (322)
T ss_dssp EEEEECCTTEEHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEcCCCCcHHHHHh----------hcCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEe
Confidence 99999999999999996 2346899999999999999999999632 79999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccc
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIM 846 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~ 846 (949)
|||+|+...+... ....||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 148 DFGla~~~~~~~~----~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 148 DFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp CCCCCHHHHHHTC-------CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred eCCCccccCCCcc----ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 9999987643222 2457999999999999999999999999999999999999999643
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-47 Score=401.26 Aligned_cols=251 Identities=23% Similarity=0.353 Sum_probs=199.3
Q ss_pred CeeeeecCceEEEEEEcC--CCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeEe
Q 039533 632 NLVGVGSFGSVYKGIIDE--GRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASVY 707 (949)
Q Consensus 632 ~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 707 (949)
++||+|+||+||+|.+.. .++.||||+++... ....+++.+|++++++++|||||+++++|... ..++||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~------~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE------SWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS------SEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC------CEEEEE
Confidence 579999999999998753 45789999996432 23346799999999999999999999997432 468999
Q ss_pred eeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeeccc
Q 039533 708 EFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGL 787 (949)
Q Consensus 708 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~ 787 (949)
||+++|+|.+++. ....+++.+++.|+.||+.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 87 E~~~~g~L~~~l~----------~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGl 153 (277)
T d1xbba_ 87 EMAELGPLNKYLQ----------QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGL 153 (277)
T ss_dssp ECCTTEEHHHHHH----------HCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred EcCCCCcHHHHHh----------hccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhh
Confidence 9999999999986 345699999999999999999999987 899999999999999999999999999
Q ss_pred ceecCCCCCc-cccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCCch
Q 039533 788 ARILSPDHTQ-TSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPDDV 865 (949)
Q Consensus 788 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 865 (949)
|+........ .......||+.|+|||++.+..++.++|||||||++|||+| |+.||...... ..
T Consensus 154 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~~------------ 219 (277)
T d1xbba_ 154 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EV------------ 219 (277)
T ss_dssp CEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HH------------
T ss_pred hhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--HH------------
Confidence 9987655442 22234568999999999999999999999999999999998 89999643211 11
Q ss_pred hhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHH
Q 039533 866 MDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKN 933 (949)
Q Consensus 866 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 933 (949)
...+....... .+..++.++.+++.+||+.||++||||+||.+.|+....
T Consensus 220 ~~~i~~~~~~~------------------~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 220 TAMLEKGERMG------------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHHHHTTCCCC------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCCCCC------------------CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 11111100000 011345678899999999999999999999999988643
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.4e-46 Score=411.54 Aligned_cols=253 Identities=21% Similarity=0.293 Sum_probs=206.7
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.++|++.+.||+|+||.||+|++..+|+.||||++........+.+.+|+.++++++|||||++++++.+.+ ..+
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~~~ 99 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN-----EMV 99 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT-----EEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----EEE
Confidence 468999999999999999999999899999999997666555678899999999999999999999976544 799
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec--CCCceEE
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD--DYMTARV 782 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~--~~~~~kl 782 (949)
+||||+++|+|.+++.. ....+++.+++.|+.||+.||+|||++ +|+||||||+|||++ .++.+||
T Consensus 100 ivmE~~~gg~L~~~l~~---------~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL 167 (350)
T d1koaa2 100 MIYEFMSGGELFEKVAD---------EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKL 167 (350)
T ss_dssp EEECCCCSCBHHHHHTC---------TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEE
T ss_pred EEEEcCCCCCHHHHHHh---------hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEE
Confidence 99999999999999852 234699999999999999999999988 999999999999995 4678999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
+|||+|+......... ...||+.|||||++.+..++.++||||+||++|||++|+.||......+ .+.
T Consensus 168 ~DFG~a~~~~~~~~~~---~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~-------- 235 (350)
T d1koaa2 168 IDFGLTAHLDPKQSVK---VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-TLR-------- 235 (350)
T ss_dssp CCCTTCEECCTTSCEE---EECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHH--------
T ss_pred eecchheecccccccc---eecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH-HHH--------
Confidence 9999999876554332 3569999999999999999999999999999999999999996332110 000
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.+.......... .....++.+.+++.+|++.||++|||++|+++
T Consensus 236 ----~i~~~~~~~~~~----------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 236 ----NVKSCDWNMDDS----------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp ----HHHHTCCCSCCG----------------GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ----HHHhCCCCCCcc----------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011000000000 00123456789999999999999999999976
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.3e-47 Score=407.92 Aligned_cols=252 Identities=20% Similarity=0.245 Sum_probs=188.2
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
.+.|++.+.||+|+||+||+|++..+++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+ ..
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~ 82 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGG-----HL 82 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSS-----EE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----EE
Confidence 3569999999999999999999998999999999975432 33456889999999999999999999976544 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec---CCCce
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD---DYMTA 780 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~---~~~~~ 780 (949)
++||||+++|+|.+++. ....+++.++..++.||+.||+|||++ +|+||||||+||++. +++.+
T Consensus 83 ~lvmE~~~gg~L~~~l~----------~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~v 149 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIV----------EKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKI 149 (307)
T ss_dssp EEEECCCCSCBHHHHHH----------TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCE
T ss_pred EEEEeccCCCcHHHhhh----------cccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceE
Confidence 99999999999999996 235699999999999999999999987 999999999999994 57899
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
||+|||+|+........ ....||+.|||||++.+..++.++||||+||++|||++|+.||....... ...
T Consensus 150 kl~DFG~a~~~~~~~~~---~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~~~----- 219 (307)
T d1a06a_ 150 MISDFGLSKMEDPGSVL---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK--LFE----- 219 (307)
T ss_dssp EECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHH-----
T ss_pred EEeccceeEEccCCCee---eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH--HHH-----
Confidence 99999999876544322 23569999999999999999999999999999999999999996432111 000
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.+......... +.....++.+.+++.+|++.||++|||++|+++
T Consensus 220 ------~i~~~~~~~~~----------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 220 ------QILKAEYEFDS----------------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp ------HHHTTCCCCCT----------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ------HHhccCCCCCC----------------ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 01110000000 000123456789999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-47 Score=411.58 Aligned_cols=266 Identities=23% Similarity=0.336 Sum_probs=205.4
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCC-----EEEEEEEEecC-CCcchHHHHHHHHHHHhc-CCCcceeEEeeeeccccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGR-----TTIAVKVFNLQ-HHGASRSFIAECKALKSI-RHRNLVKVLTACLGADYR 698 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 698 (949)
++|++.++||+|+||+||+|++...+ ..||||++... .......+.+|+.++.++ +|||||++++++...+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~-- 114 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG-- 114 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC--
Confidence 57889999999999999999986443 36999998643 233456789999999998 8999999999986554
Q ss_pred CCccceeEeeeccCCChhhhcCCCCCCCc-------------cccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 039533 699 GNDFKASVYEFMHYGSLEEWLHPFTGEDE-------------IDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHC 765 (949)
Q Consensus 699 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------------~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHr 765 (949)
..++||||+++|+|.++++....... .......+++.+++.|+.||+.||+|||++ +|+||
T Consensus 115 ---~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHR 188 (325)
T d1rjba_ 115 ---PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 188 (325)
T ss_dssp ---SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred ---eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeec
Confidence 78999999999999999974322100 011234689999999999999999999987 89999
Q ss_pred CCCCCCeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCc
Q 039533 766 DLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPID 844 (949)
Q Consensus 766 Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~ 844 (949)
||||+||+++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987665544333334568999999999999999999999999999999998 899996
Q ss_pred cccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHH
Q 039533 845 IMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNV 924 (949)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev 924 (949)
...... .+ .+++......+. +..++.++.+++.+||+.||++||||+||
T Consensus 269 ~~~~~~-~~------------~~~~~~~~~~~~------------------p~~~~~~l~~li~~cl~~dP~~RPt~~ei 317 (325)
T d1rjba_ 269 GIPVDA-NF------------YKLIQNGFKMDQ------------------PFYATEEIYIIMQSCWAFDSRKRPSFPNL 317 (325)
T ss_dssp TCCCSH-HH------------HHHHHTTCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCHHH-HH------------HHHHhcCCCCCC------------------CCcCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 432211 11 111111111100 11335578899999999999999999999
Q ss_pred HHHHHH
Q 039533 925 VHELQS 930 (949)
Q Consensus 925 ~~~L~~ 930 (949)
++.|..
T Consensus 318 ~~~L~~ 323 (325)
T d1rjba_ 318 TSFLGC 323 (325)
T ss_dssp HHHHHH
T ss_pred HHHHhC
Confidence 999853
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3e-46 Score=409.25 Aligned_cols=252 Identities=17% Similarity=0.229 Sum_probs=205.8
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
++|++.+.||+|+||.||+|++..+++.||||+++.......+.+.+|++++++++|||||++++++.+.+ ..++
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-----~~~i 103 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY-----EMVL 103 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS-----EEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----EEEE
Confidence 57999999999999999999999899999999998665555677889999999999999999999976544 7899
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec--CCCceEEe
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD--DYMTARVG 783 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~--~~~~~kl~ 783 (949)
||||+++|+|.+++.. ....+++.+++.|+.||+.||+|||++ +|+||||||+|||++ .++.+||+
T Consensus 104 vmE~~~gg~L~~~~~~---------~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~ 171 (352)
T d1koba_ 104 ILEFLSGGELFDRIAA---------EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKII 171 (352)
T ss_dssp EEECCCCCBHHHHTTC---------TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEEC
T ss_pred EEEcCCCChHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEe
Confidence 9999999999988762 234699999999999999999999987 999999999999998 67899999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCC
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPD 863 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 863 (949)
|||+|+......... ...||+.|+|||++.+..++.++||||+||++|||+||+.||....... ...
T Consensus 172 DFGla~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--~~~-------- 238 (352)
T d1koba_ 172 DFGLATKLNPDEIVK---VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--TLQ-------- 238 (352)
T ss_dssp CCTTCEECCTTSCEE---EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHH--------
T ss_pred ecccceecCCCCcee---eccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--HHH--------
Confidence 999999876654332 3459999999999999999999999999999999999999996432111 000
Q ss_pred chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 864 DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 864 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.+......... ......+..+.+++.+|++.||++|||++|+++
T Consensus 239 ---~i~~~~~~~~~----------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 239 ---NVKRCDWEFDE----------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp ---HHHHCCCCCCS----------------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ---HHHhCCCCCCc----------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000000 000123456789999999999999999999976
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-46 Score=403.95 Aligned_cols=245 Identities=24% Similarity=0.303 Sum_probs=198.4
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc---chHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG---ASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
.|+..+.||+|+||+||+|++..+++.||||+++..... ..+.+.+|++++++++|||||++++++.+.+ ..
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-----~~ 90 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-----TA 90 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----EE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC-----EE
Confidence 488899999999999999999999999999999755432 2356889999999999999999999986554 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++||||+++|++..++. ....+++.+++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 91 ~iv~E~~~~g~l~~~~~----------~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~ 157 (309)
T d1u5ra_ 91 WLVMEYCLGSASDLLEV----------HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLG 157 (309)
T ss_dssp EEEEECCSEEHHHHHHH----------HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEEC
T ss_pred EEEEEecCCCchHHHHH----------hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEe
Confidence 99999999999987764 235689999999999999999999988 89999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCC---CccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG---CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
|||+|+...... ...||+.|||||++.+ ..|+.++|||||||++|||++|+.||........ +
T Consensus 158 DFG~a~~~~~~~------~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~-~------- 223 (309)
T d1u5ra_ 158 DFGSASIMAPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-L------- 223 (309)
T ss_dssp CCTTCBSSSSBC------CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-H-------
T ss_pred ecccccccCCCC------ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH-H-------
Confidence 999998654322 3469999999999864 4589999999999999999999999964321110 0
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
..+.......... ...++.+.+++.+||+.||++|||++|+++
T Consensus 224 -----~~i~~~~~~~~~~------------------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 224 -----YHIAQNESPALQS------------------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -----HHHHHSCCCCCSC------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----HHHHhCCCCCCCC------------------CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 0011000000000 022456789999999999999999999875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-46 Score=398.23 Aligned_cols=252 Identities=19% Similarity=0.235 Sum_probs=204.0
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC------cchHHHHHHHHHHHhcCCCcceeEEeeeeccccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH------GASRSFIAECKALKSIRHRNLVKVLTACLGADYR 698 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 698 (949)
.++|++.+.||+|+||+||+|++..+|+.||||+++.... ...+.+.+|++++++++|||||++++++.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-- 86 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT-- 86 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--
Confidence 3579999999999999999999998999999999974321 23467999999999999999999999976554
Q ss_pred CCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC
Q 039533 699 GNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM 778 (949)
Q Consensus 699 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~ 778 (949)
..++||||+++|+|.+++. ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 87 ---~~~iv~E~~~gg~L~~~i~----------~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~ 150 (293)
T d1jksa_ 87 ---DVILILELVAGGELFDFLA----------EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRN 150 (293)
T ss_dssp ---EEEEEEECCCSCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSS
T ss_pred ---EEEEEEEcCCCccccchhc----------cccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCC
Confidence 8899999999999999996 235699999999999999999999988 999999999999998776
Q ss_pred ----ceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhh
Q 039533 779 ----TARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLH 854 (949)
Q Consensus 779 ----~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~ 854 (949)
.+|++|||+|+......... ...||+.|+|||++.+..++.++||||+||++|||++|+.||......+. +
T Consensus 151 ~~~~~vkl~DfG~a~~~~~~~~~~---~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-~- 225 (293)
T d1jksa_ 151 VPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-L- 225 (293)
T ss_dssp SSSCCEEECCCTTCEECTTSCBCS---CCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-H-
T ss_pred CcccceEecchhhhhhcCCCcccc---ccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH-H-
Confidence 59999999998876543322 34689999999999999999999999999999999999999964321110 0
Q ss_pred hhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 855 NFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 855 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
..+........ .+.....+..+.+++.+||+.||++|||++|+++
T Consensus 226 -----------~~i~~~~~~~~----------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 226 -----------ANVSAVNYEFE----------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -----------HHHHTTCCCCC----------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----------HHHHhcCCCCC----------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000000 0011133456789999999999999999999975
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.3e-46 Score=397.01 Aligned_cols=265 Identities=20% Similarity=0.309 Sum_probs=204.3
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC---cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH---GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
.++|++.+.||+|+||+||+|++..+++.||||+++.... ...+++.+|++++++++||||+++++++...+ ....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence 3679999999999999999999998999999999975433 23357899999999999999999999986543 2233
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++++|.+++. ....+++.+++.|+.||+.||+|||++ +|+||||||+||+++.++..+
T Consensus 85 ~~~lvmE~~~g~~L~~~~~----------~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~ 151 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVH----------TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVK 151 (277)
T ss_dssp EEEEEEECCCEEEHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEE
T ss_pred eEEEEEECCCCCEehhhhc----------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccce
Confidence 5789999999999999886 345699999999999999999999987 999999999999999999999
Q ss_pred EeecccceecCCCCC-ccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcccc
Q 039533 782 VGDFGLARILSPDHT-QTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 782 l~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
++|||.++....... ........||+.|+|||++.+..++.++||||+||++|||+||+.||......+.. .
T Consensus 152 l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~-~------ 224 (277)
T d1o6ya_ 152 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA-Y------ 224 (277)
T ss_dssp ECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-H------
T ss_pred eehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHH-H------
Confidence 999999987654332 22233456999999999999999999999999999999999999999643211100 0
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-CHHHHHHHHHHhH
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRT-NMTNVVHELQSIK 932 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~ev~~~L~~i~ 932 (949)
..+...... +. ......++.+.+++.+|++.||++|| |++|+.+.|.+++
T Consensus 225 ------~~~~~~~~~-~~---------------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 225 ------QHVREDPIP-PS---------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ------HHHHCCCCC-GG---------------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ------HHHhcCCCC-Cc---------------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 000000000 00 00012345688999999999999999 8999999998875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-46 Score=396.20 Aligned_cols=259 Identities=25% Similarity=0.388 Sum_probs=200.8
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
++|++.+.||+|+||.||+|+++ +++.||||+++... ...+.+.+|+.++++++|||||+++++|.+. ..++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~-~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~------~~~l 88 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE------PIYI 88 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS------SCEE
T ss_pred HHEEEeeEEeeCCCeEEEEEEEC-CCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEecC------CeEE
Confidence 57899999999999999999997 45779999997443 3457899999999999999999999997432 4789
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
||||+++|+|..++.. .....+++.+++.|+.||+.||+|||++ +|+||||||+|||++.++++||+||
T Consensus 89 v~Ey~~~g~l~~~~~~--------~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~Df 157 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKG--------ETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADF 157 (285)
T ss_dssp EECCCTTCBHHHHHSH--------HHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCC
T ss_pred EEEecCCCchhhhhhh--------cccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEccc
Confidence 9999999999999862 1234689999999999999999999987 8999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCch
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDDV 865 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 865 (949)
|+|+......... .....||+.|+|||++.+..++.++|||||||++|||+||..|+....... ..
T Consensus 158 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~-~~------------ 223 (285)
T d1fmka3 158 GLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EV------------ 223 (285)
T ss_dssp CTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HH------------
T ss_pred chhhhccCCCcee-eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH-HH------------
Confidence 9998765443322 223568999999999999999999999999999999999766653221111 11
Q ss_pred hhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhh
Q 039533 866 MDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNIL 935 (949)
Q Consensus 866 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~ 935 (949)
...+........ ...+++++.+++.+||+.||++||||+||++.|+......
T Consensus 224 ~~~i~~~~~~~~------------------~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 224 LDQVERGYRMPC------------------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHHTTCCCCC------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHhcCCCCC------------------CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 111111110000 1134567889999999999999999999999998865543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-46 Score=403.68 Aligned_cols=259 Identities=24% Similarity=0.406 Sum_probs=203.7
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCE----EEEEEEEecC-CCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCC
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRT----TIAVKVFNLQ-HHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGN 700 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 700 (949)
++|++.++||+|+||+||+|++..+++ +||+|+++.. .....+++.+|++++++++|||||+++++|.+.
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~----- 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----
Confidence 469999999999999999999976665 6888888643 334457899999999999999999999998653
Q ss_pred ccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCce
Q 039533 701 DFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTA 780 (949)
Q Consensus 701 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 780 (949)
..++++||+.+|+|.+++.. ....+++..++.|+.|||.||+|||++ +|+||||||+||+++.++++
T Consensus 84 -~~~~v~e~~~~~~l~~~~~~---------~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~ 150 (317)
T d1xkka_ 84 -TVQLITQLMPFGCLLDYVRE---------HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 150 (317)
T ss_dssp -SEEEEEECCTTCBHHHHHHH---------TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEE
T ss_pred -CeeEEEEeccCCcccccccc---------cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCe
Confidence 36789999999999998862 345689999999999999999999987 89999999999999999999
Q ss_pred EEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccc
Q 039533 781 RVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 781 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~ 859 (949)
||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+| |++||+......
T Consensus 151 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--------- 221 (317)
T d1xkka_ 151 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------- 221 (317)
T ss_dssp EECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---------
T ss_pred EeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---------
Confidence 9999999998765554333334568999999999999999999999999999999999 788886432211
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHh
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNI 934 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 934 (949)
+...+...... +.+..++..+.+++.+||+.||++|||+.||++.|+.+...
T Consensus 222 -----~~~~i~~~~~~------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 222 -----ISSILEKGERL------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp -----HHHHHHHTCCC------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -----HHHHHHcCCCC------------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 11111111100 00113455688999999999999999999999999988653
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-46 Score=403.80 Aligned_cols=274 Identities=23% Similarity=0.385 Sum_probs=211.3
Q ss_pred HHHHHhcCCCCCCeeeeecCceEEEEEEcC-----CCEEEEEEEEecCCCc-chHHHHHHHHHHHhcCCCcceeEEeeee
Q 039533 620 DLYNATSGFSSANLVGVGSFGSVYKGIIDE-----GRTTIAVKVFNLQHHG-ASRSFIAECKALKSIRHRNLVKVLTACL 693 (949)
Q Consensus 620 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~ 693 (949)
+++-..++|++.+.||+|+||+||+|++.. +++.||||+++..... ..+++.+|++++++++||||++++++|.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 334455789999999999999999999853 4588999998754333 3467999999999999999999999986
Q ss_pred cccccCCccceeEeeeccCCChhhhcCCCCCCC--------------ccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 039533 694 GADYRGNDFKASVYEFMHYGSLEEWLHPFTGED--------------EIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQ 759 (949)
Q Consensus 694 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~ 759 (949)
..+ ..++||||+++|+|.+++....... ........+++..++.|+.|++.||+|||++
T Consensus 87 ~~~-----~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~-- 159 (301)
T d1lufa_ 87 VGK-----PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-- 159 (301)
T ss_dssp SSS-----SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred cCC-----ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC--
Confidence 554 7899999999999999996322110 0112234589999999999999999999987
Q ss_pred CCeEecCCCCCCeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhC
Q 039533 760 PVTAHCDLKPSNVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIG 839 (949)
Q Consensus 760 ~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg 839 (949)
+||||||||+|||++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 160 -~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~ 238 (301)
T d1lufa_ 160 -KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238 (301)
T ss_dssp -TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred -CeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHcc
Confidence 8999999999999999999999999999876554443333345689999999999999999999999999999999998
Q ss_pred C-CCCccccccCchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCC
Q 039533 840 K-KPIDIMFEGDINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDR 918 (949)
Q Consensus 840 ~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 918 (949)
. +||......+ .... +.+....+.+ ..++..+.+++.+||+.||++|
T Consensus 239 ~~~p~~~~~~~e--~~~~-----------v~~~~~~~~p-------------------~~~~~~~~~li~~cl~~~P~~R 286 (301)
T d1lufa_ 239 GLQPYYGMAHEE--VIYY-----------VRDGNILACP-------------------ENCPLELYNLMRLCWSKLPADR 286 (301)
T ss_dssp TCCTTTTSCHHH--HHHH-----------HHTTCCCCCC-------------------TTCCHHHHHHHHHHTCSSGGGS
T ss_pred CCCCCCCCCHHH--HHHH-----------HHcCCCCCCC-------------------ccchHHHHHHHHHHcCCChhHC
Confidence 6 5665332111 1111 1111111111 1334568899999999999999
Q ss_pred CCHHHHHHHHHHhHH
Q 039533 919 TNMTNVVHELQSIKN 933 (949)
Q Consensus 919 Ps~~ev~~~L~~i~~ 933 (949)
|||.||++.|++|.+
T Consensus 287 Pt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 287 PSFCSIHRILQRMCE 301 (301)
T ss_dssp CCHHHHHHHHHHTTC
T ss_pred cCHHHHHHHHHHhcC
Confidence 999999999999863
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-46 Score=389.77 Aligned_cols=252 Identities=27% Similarity=0.358 Sum_probs=196.5
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
++|++.+.||+|+||.||+|+++ ++.||||+++.. ...+.+.+|++++++++||||++++|+|.+. .+..++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~~l 78 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYI 78 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEE
T ss_pred HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEec----CCcEEE
Confidence 46788899999999999999985 789999998643 3457899999999999999999999998543 235799
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
||||+++|+|.+++.. .....+++..+++|+.||+.||+|||+. +|+||||||+||+++.++.+|++||
T Consensus 79 v~ey~~~g~L~~~l~~--------~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~df 147 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRS--------RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDF 147 (262)
T ss_dssp EECCCTTEEHHHHHHH--------HHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCC
T ss_pred EEeccCCCCHHHHHHh--------cCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeeccc
Confidence 9999999999999962 1223589999999999999999999987 8999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhccccCCCc
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
|+++....... ...+|..|+|||++.+..++.++|||||||++|||+| |++||...... ......
T Consensus 148 g~s~~~~~~~~-----~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--~~~~~i------- 213 (262)
T d1byga_ 148 GLTKEASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRV------- 213 (262)
T ss_dssp CC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHH-------
T ss_pred ccceecCCCCc-----cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--HHHHHH-------
Confidence 99987544322 2348899999999998899999999999999999998 68877533211 111111
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHH
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKN 933 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 933 (949)
.....+.. +..++.++.+++.+||+.||++||||.||++.|++|+.
T Consensus 214 -----~~~~~~~~------------------~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 214 -----EKGYKMDA------------------PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp -----TTTCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HcCCCCCC------------------CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 10000000 01234568899999999999999999999999999875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-45 Score=393.95 Aligned_cols=280 Identities=22% Similarity=0.289 Sum_probs=205.8
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHH--HHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFI--AECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~--~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
.+|...+.||+|+||.||+|++. |+.||||+++... .+.+. .|+..+.+++||||++++++|...+ ......
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEE
Confidence 45677889999999999999974 7999999986432 23333 4555566789999999999997654 233367
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhC-----CCCCeEecCCCCCCeeecCCC
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHD-----CQPVTAHCDLKPSNVLLDDYM 778 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~-----~~~~ivHrDlkp~NIll~~~~ 778 (949)
++||||+++|+|.++++. ..+++.++++++.|+|.||+|+|+. ..++|+||||||+|||+++++
T Consensus 77 ~lv~Ey~~~g~L~~~l~~-----------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~ 145 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNR-----------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 145 (303)
T ss_dssp EEEEECCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS
T ss_pred EEEEecccCCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC
Confidence 999999999999999962 3589999999999999999999963 135999999999999999999
Q ss_pred ceEEeecccceecCCCCCc--cccccccCccCccCccccCCC------ccCCccchHHHHHHHHHHHhCCCCCccccccC
Q 039533 779 TARVGDFGLARILSPDHTQ--TSSFSVKGSLGYIAPEYGVGC------EVSTNGDVYSYGILLLELVIGKKPIDIMFEGD 850 (949)
Q Consensus 779 ~~kl~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~ 850 (949)
.+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|||+||..||.......
T Consensus 146 ~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~ 225 (303)
T d1vjya_ 146 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 225 (303)
T ss_dssp CEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC
T ss_pred CeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccc
Confidence 9999999999987554332 122346799999999998754 36789999999999999999999885433222
Q ss_pred chhhhhccccCC-Cc-hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 039533 851 INLHNFGRKALP-DD-VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHEL 928 (949)
Q Consensus 851 ~~~~~~~~~~~~-~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 928 (949)
............ +. .....+....+...+ + ....+.+..+.+++.+||+.||++||||.||++.|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~------------~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L 292 (303)
T d1vjya_ 226 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPN------------R-WQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292 (303)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCG------------G-GGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHH
T ss_pred cchhhcccccchHHHHHHHHhccccCCCCCc------------c-cCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 111111100000 00 111222222222111 0 01124567789999999999999999999999999
Q ss_pred HHhHHhh
Q 039533 929 QSIKNIL 935 (949)
Q Consensus 929 ~~i~~~~ 935 (949)
+++.+.-
T Consensus 293 ~~i~~~~ 299 (303)
T d1vjya_ 293 SQLSQQE 299 (303)
T ss_dssp HHHHHHH
T ss_pred HHHHHhc
Confidence 9998653
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=392.04 Aligned_cols=258 Identities=22% Similarity=0.350 Sum_probs=196.1
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCC---CEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEG---RTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
++|++.+.||+|+||.||+|++..+ +..||||+++.... ...+.+.+|+.++++++||||+++++++.+ +
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------~ 80 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------N 80 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------S
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------C
Confidence 5788899999999999999998643 35688998864433 334679999999999999999999999742 2
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++|++.+++.. ....+++..++.++.||++||+|||++ +|+||||||+||+++.++.+|
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~---------~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~K 148 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQV---------RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVK 148 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHH---------TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEE
T ss_pred eEEEEEEeccCCcHHhhhhc---------cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEE
Confidence 57999999999999998752 335689999999999999999999988 899999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhcccc
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFGRKA 860 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 860 (949)
|+|||+|+......... .....||+.|+|||++.+..++.++|||||||++|||+| |.+||......+ ....
T Consensus 149 l~DfG~a~~~~~~~~~~-~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--~~~~---- 221 (273)
T d1mp8a_ 149 LGDFGLSRYMEDSTYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGR---- 221 (273)
T ss_dssp ECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHH----
T ss_pred EccchhheeccCCccee-ccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH--HHHH----
Confidence 99999998765443322 224558999999999999999999999999999999998 899986432221 1100
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHh
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNI 934 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 934 (949)
+.+....+.+ ..++..+.+++.+||+.||++||||+||++.|++|.+.
T Consensus 222 -------i~~~~~~~~~-------------------~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 222 -------IENGERLPMP-------------------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp -------HHTTCCCCCC-------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------HHcCCCCCCC-------------------CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 0000000000 13456788999999999999999999999999998664
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=398.35 Aligned_cols=249 Identities=21% Similarity=0.233 Sum_probs=204.1
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecC---CCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ---HHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
.++|.+.+.||+|+||.||+|++..+++.||||+++.. .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----- 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD----- 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS-----
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc-----
Confidence 46799999999999999999999999999999999743 2334577899999999999999999999976554
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+++|+|.+++. ....+++..++.++.|++.||+|||++ +|+||||||+|||++++|.+|
T Consensus 79 ~~~iv~ey~~gg~L~~~~~----------~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vk 145 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLS----------RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIK 145 (337)
T ss_dssp EEEEEEECCTTCBHHHHHH----------HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEE
T ss_pred ccccceeccCCCchhhhhh----------cccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEE
Confidence 8999999999999999987 345689999999999999999999988 999999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
|+|||+|+......... ....||+.|+|||++.+..++.++||||+||++|||++|++||....... ...
T Consensus 146 l~DFG~a~~~~~~~~~~--~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~------ 215 (337)
T d1o6la_ 146 ITDFGLCKEGISDGATM--KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LFE------ 215 (337)
T ss_dssp ECCCTTCBCSCCTTCCB--CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH------
T ss_pred EeecccccccccCCccc--ccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH--HHH------
Confidence 99999998765433222 24569999999999999999999999999999999999999996432111 000
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC-----HHHHHH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTN-----MTNVVH 926 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~~ 926 (949)
.+..... ..+ ...+..+.+++.+|++.||++||+ ++|+++
T Consensus 216 -----~i~~~~~-~~p-------------------~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 216 -----LILMEEI-RFP-------------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -----HHHHCCC-CCC-------------------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----HHhcCCC-CCC-------------------ccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 0000000 000 122445788999999999999995 777765
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=396.09 Aligned_cols=272 Identities=23% Similarity=0.291 Sum_probs=200.3
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcC-----CCEEEEEEEEecCCC-cchHHHHHHHHHHHhc-CCCcceeEEeeeecccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDE-----GRTTIAVKVFNLQHH-GASRSFIAECKALKSI-RHRNLVKVLTACLGADY 697 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 697 (949)
.++|++.+.||+|+||.||+|++.. +++.||||+++.... ...+.+.+|...+.++ +|+||+++++++...
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-- 89 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-- 89 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST--
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC--
Confidence 3679999999999999999999753 347899999874332 3346788888888887 689999999987543
Q ss_pred cCCccceeEeeeccCCChhhhcCCCCCCC------ccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCC
Q 039533 698 RGNDFKASVYEFMHYGSLEEWLHPFTGED------EIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSN 771 (949)
Q Consensus 698 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~N 771 (949)
....++||||+++|+|.++++...... ........+++.++..++.||++||+|||++ +|+||||||+|
T Consensus 90 --~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~N 164 (299)
T d1ywna1 90 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARN 164 (299)
T ss_dssp --TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred --CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccc
Confidence 346899999999999999996322100 0011234689999999999999999999987 89999999999
Q ss_pred eeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCC-CCCccccccC
Q 039533 772 VLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGK-KPIDIMFEGD 850 (949)
Q Consensus 772 Ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~-~Pf~~~~~~~ 850 (949)
||+++++++||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+||. +||......
T Consensus 165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~- 243 (299)
T d1ywna1 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID- 243 (299)
T ss_dssp EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-
T ss_pred eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH-
Confidence 999999999999999998776555444444567999999999999999999999999999999999974 567533211
Q ss_pred chhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHH
Q 039533 851 INLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQS 930 (949)
Q Consensus 851 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 930 (949)
..+.. .+........ ...+++.+.+++.+||+.||++||||+||++.|++
T Consensus 244 ~~~~~------------~~~~~~~~~~------------------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 244 EEFCR------------RLKEGTRMRA------------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp HHHHH------------HHHHTCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHH------------HHhcCCCCCC------------------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11111 1111100000 01234568899999999999999999999999999
Q ss_pred hHHh
Q 039533 931 IKNI 934 (949)
Q Consensus 931 i~~~ 934 (949)
|.++
T Consensus 294 ilq~ 297 (299)
T d1ywna1 294 LLQA 297 (299)
T ss_dssp HHHH
T ss_pred HHhC
Confidence 8764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.9e-45 Score=394.20 Aligned_cols=245 Identities=22% Similarity=0.232 Sum_probs=202.1
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecC---CCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ---HHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
++|++.+.||+|+||+||+|++..+|+.||||+++.. .....+.+.+|+.++++++||||+++++++.+.+ .
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ-----Q 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS-----E
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC-----e
Confidence 5799999999999999999999989999999999743 2334578899999999999999999999976554 8
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+++|++..++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||
T Consensus 79 ~~ivmE~~~gg~l~~~~~----------~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL 145 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLR----------KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKI 145 (316)
T ss_dssp EEEEECCCCSCBHHHHHH----------HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEE
T ss_pred eeeEeeecCCcccccccc----------ccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEE
Confidence 999999999999999986 345678889999999999999999977 9999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
+|||+|+....... ...||+.|+|||++.+..++.++||||+||++|||+||+.||....... .
T Consensus 146 ~DFG~a~~~~~~~~-----~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~--------- 209 (316)
T d1fota_ 146 TDFGFAKYVPDVTY-----TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK--T--------- 209 (316)
T ss_dssp CCCSSCEECSSCBC-----CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--H---------
T ss_pred ecCccceEeccccc-----cccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH--H---------
Confidence 99999998654322 4569999999999999999999999999999999999999996431110 0
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRT-----NMTNVVH 926 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~ 926 (949)
...+....... + ...++.+.+++.+|++.||++|| |++|+++
T Consensus 210 --~~~i~~~~~~~-p-------------------~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 210 --YEKILNAELRF-P-------------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp --HHHHHHCCCCC-C-------------------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --HHHHHcCCCCC-C-------------------CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 00111100000 0 02234578899999999999996 8999875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.6e-45 Score=384.90 Aligned_cols=251 Identities=22% Similarity=0.297 Sum_probs=201.9
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc---------chHHHHHHHHHHHhcC-CCcceeEEeeeecc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG---------ASRSFIAECKALKSIR-HRNLVKVLTACLGA 695 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 695 (949)
++|++.+.||+|+||+||+|++..+++.||||+++..... ..+++.+|+.++++++ ||||+++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5799999999999999999999989999999999754322 1246889999999997 99999999997654
Q ss_pred cccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec
Q 039533 696 DYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD 775 (949)
Q Consensus 696 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~ 775 (949)
+ ..++||||+++|+|.+++. ....+++.+++.++.||+.||+|||++ +|+||||||+||+++
T Consensus 83 ~-----~~~ivmE~~~~g~L~~~l~----------~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~ 144 (277)
T d1phka_ 83 T-----FFFLVFDLMKKGELFDYLT----------EKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLD 144 (277)
T ss_dssp S-----EEEEEEECCTTCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred c-----ceEEEEEcCCCchHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEc
Confidence 4 8999999999999999996 245699999999999999999999987 999999999999999
Q ss_pred CCCceEEeecccceecCCCCCccccccccCccCccCccccCC------CccCCccchHHHHHHHHHHHhCCCCCcccccc
Q 039533 776 DYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG------CEVSTNGDVYSYGILLLELVIGKKPIDIMFEG 849 (949)
Q Consensus 776 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~ 849 (949)
.++.+||+|||+|+......... ...||+.|+|||++.+ ..++.++||||+||++|||++|+.||......
T Consensus 145 ~~~~~kl~DFG~a~~~~~~~~~~---~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~ 221 (277)
T d1phka_ 145 DDMNIKLTDFGFSCQLDPGEKLR---EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 221 (277)
T ss_dssp TTCCEEECCCTTCEECCTTCCBC---CCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CCCCeEEccchheeEccCCCcee---eeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH
Confidence 99999999999999876543322 3569999999998753 35788999999999999999999999643211
Q ss_pred CchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 850 DINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 850 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.. . ..+........ .+.....++++.+++.+|++.||++|||++||++
T Consensus 222 ~~-~------------~~i~~~~~~~~----------------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 222 LM-L------------RMIMSGNYQFG----------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HH-H------------HHHHHTCCCCC----------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HH-H------------HHHHhCCCCCC----------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 10 0 00111000000 0001134456889999999999999999999864
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=389.24 Aligned_cols=257 Identities=25% Similarity=0.340 Sum_probs=195.7
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCC---CEEEEEEEEecCC---CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccC
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEG---RTTIAVKVFNLQH---HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRG 699 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 699 (949)
++|++.+.||+|+||.||+|++... ...||||+++... ....+++.+|+.++++++||||++++|+|.+.
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~---- 83 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---- 83 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec----
Confidence 5688999999999999999987532 2478999986432 33346899999999999999999999998532
Q ss_pred CccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCc
Q 039533 700 NDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMT 779 (949)
Q Consensus 700 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~ 779 (949)
..++||||+++|++.+++.. ....+++..++.++.|+++||.|||++ +|+||||||+||+++.++.
T Consensus 84 --~~~lv~e~~~~~~l~~~~~~---------~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~ 149 (273)
T d1u46a_ 84 --PMKMVTELAPLGSLLDRLRK---------HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDL 149 (273)
T ss_dssp --SCEEEEECCTTCBHHHHHHH---------HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTE
T ss_pred --chheeeeeecCcchhhhhhc---------ccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccc
Confidence 46899999999999998762 335699999999999999999999987 8999999999999999999
Q ss_pred eEEeecccceecCCCCCcc-ccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCccccccCchhhhhc
Q 039533 780 ARVGDFGLARILSPDHTQT-SSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEGDINLHNFG 857 (949)
Q Consensus 780 ~kl~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~ 857 (949)
+||+|||+++......... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||......+ ...
T Consensus 150 vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~--~~~-- 225 (273)
T d1u46a_ 150 VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--ILH-- 225 (273)
T ss_dssp EEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHH--
T ss_pred eeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH--HHH--
Confidence 9999999999876654422 2223457889999999999999999999999999999998 899996432211 100
Q ss_pred cccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHh
Q 039533 858 RKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSI 931 (949)
Q Consensus 858 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i 931 (949)
.+........ ....++..+.+++.+||+.||++||||+||.+.|++.
T Consensus 226 ---------~i~~~~~~~~------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 226 ---------KIDKEGERLP------------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ---------HHHTSCCCCC------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------HHHhCCCCCC------------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1111110000 0113345688999999999999999999999988874
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=389.53 Aligned_cols=261 Identities=23% Similarity=0.389 Sum_probs=204.3
Q ss_pred CCeeeeecCceEEEEEEcCCC---EEEEEEEEecC-CCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccceeE
Q 039533 631 ANLVGVGSFGSVYKGIIDEGR---TTIAVKVFNLQ-HHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKASV 706 (949)
Q Consensus 631 ~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 706 (949)
.++||+|+||+||+|++..++ ..||||+++.. .....+++.+|++++++++||||++++|++...+ ...++|
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~~lv 107 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSPLVV 107 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT----TEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC----CceEEE
Confidence 468999999999999986432 46899998743 3334578999999999999999999999986432 367999
Q ss_pred eeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeecc
Q 039533 707 YEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDFG 786 (949)
Q Consensus 707 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG 786 (949)
|||+++|+|.+++.. ....+++..+++++.|+++||.|+|+. +|+||||||+|||+++++.+||+|||
T Consensus 108 ~E~~~~g~l~~~~~~---------~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG 175 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRN---------ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFG 175 (311)
T ss_dssp EECCTTCBHHHHHHC---------TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSG
T ss_pred EEEeecCchhhhhcc---------ccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEeccc
Confidence 999999999999872 334577889999999999999999977 89999999999999999999999999
Q ss_pred cceecCCCCCc--cccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCCCc
Q 039533 787 LARILSPDHTQ--TSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALPDD 864 (949)
Q Consensus 787 ~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 864 (949)
+++........ .......||+.|+|||.+.+..++.++||||||+++|||+||+.||....... ......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~i------- 247 (311)
T d1r0pa_ 176 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYL------- 247 (311)
T ss_dssp GGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHH-------
T ss_pred chhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHHH-------
Confidence 99877554332 12223568999999999999999999999999999999999888875332111 111111
Q ss_pred hhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhhccC
Q 039533 865 VMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILLGV 938 (949)
Q Consensus 865 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~~ 938 (949)
....-...+ ..++..+.+++.+||+.||++||||.||++.|+++.+++...
T Consensus 248 ----~~g~~~~~p-------------------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 248 ----LQGRRLLQP-------------------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp ----HTTCCCCCC-------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred ----HcCCCCCCc-------------------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 000000000 123456889999999999999999999999999998876554
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=389.60 Aligned_cols=252 Identities=21% Similarity=0.294 Sum_probs=203.8
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccce
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
.++|++.+.||+|+||+||+|.+..+++.||||+++... .....+.+|++++++++||||+++++++.+.+ ..|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-----~~~ 77 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESME-----ELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT-----EEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-----EEE
Confidence 367999999999999999999999999999999997543 23456889999999999999999999976544 799
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC--CCceEE
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD--YMTARV 782 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~--~~~~kl 782 (949)
+||||+++|+|.+++.. ....+++.+++.|+.||+.||+|||++ +|+||||||+|||++. ...+||
T Consensus 78 lvmE~~~gg~L~~~i~~---------~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl 145 (321)
T d1tkia_ 78 MIFEFISGLDIFERINT---------SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKI 145 (321)
T ss_dssp EEECCCCCCBHHHHHTS---------SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEE
T ss_pred EEEecCCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEE
Confidence 99999999999999962 234689999999999999999999987 9999999999999984 458999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
+|||+++......... ...||+.|+|||...+..++.++||||+||++|||++|+.||......+ .
T Consensus 146 ~DFG~~~~~~~~~~~~---~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~--~--------- 211 (321)
T d1tkia_ 146 IEFGQARQLKPGDNFR---LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ--I--------- 211 (321)
T ss_dssp CCCTTCEECCTTCEEE---EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--H---------
T ss_pred cccchhhccccCCccc---ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH--H---------
Confidence 9999998875543322 3458999999999999999999999999999999999999996432110 0
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
...+......... +.....+..+.+++.+|++.||++|||++|+++
T Consensus 212 --~~~i~~~~~~~~~----------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 212 --IENIMNAEYTFDE----------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp --HHHHHHTCCCCCH----------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --HHHHHhCCCCCCh----------------hhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111111111000 001123456789999999999999999999986
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.8e-44 Score=392.84 Aligned_cols=183 Identities=31% Similarity=0.575 Sum_probs=136.5
Q ss_pred CCChhhHHHHHHHHhccCCCCCCCccCccCCCCcc--eeeeeEEeCCC--CcEEEEEcCCCCCCc--cccCCCCCCCCCc
Q 039533 19 TGNETDRVALLEFKSKSTYDPVGVLGTWNESIHFC--KWYGVTCSRRH--QRVTLLDLRSLKLAG--SVSHFIGNLSFLK 92 (949)
Q Consensus 19 ~~~~~~~~aLl~~k~~~~~~~~~~l~sW~~~~~~C--~w~gv~C~~~~--~~v~~l~l~~~~l~g--~~~~~l~~l~~L~ 92 (949)
-|.++||+|||+||+++. || ..+++|..++||| .|.||+|+..+ +||+.|||++++++| .+|+++++|++|+
T Consensus 2 ~c~~~e~~aLl~~k~~~~-~~-~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~ 79 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLG-NP-TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTT-CC-GGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHHCC-CC-CcCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccc
Confidence 489999999999999975 54 3799999889999 59999998754 489999999999998 5788899999999
Q ss_pred eeeccC-ceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECCCC
Q 039533 93 QLYLQV-NSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSN 171 (949)
Q Consensus 93 ~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N 171 (949)
+|+|++ |+++|.+|.+|++|++|++|+|++|++.+..|..+..+.+|+.+++++|.+.+.+|..|.++++|+++++++|
T Consensus 80 ~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n 159 (313)
T d1ogqa_ 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred ccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccc
Confidence 999986 8898889999999999999999999988777776766666666555555555555555555555555555555
Q ss_pred CCCCCCCCCcCCCCCc-cEEeccccccCCCCCC
Q 039533 172 HLTGSIPSSLGNLSSI-HTISLAYNNLDGTIPN 203 (949)
Q Consensus 172 ~l~~~~p~~~~~l~~L-~~L~L~~N~l~~~~p~ 203 (949)
.++|.+|..+..+.++ +.+++++|++++..|.
T Consensus 160 ~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~ 192 (313)
T d1ogqa_ 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP 192 (313)
T ss_dssp CCEEECCGGGGCCCTTCCEEECCSSEEEEECCG
T ss_pred ccccccccccccccccccccccccccccccccc
Confidence 5555555555444443 4455555555444443
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=389.95 Aligned_cols=268 Identities=23% Similarity=0.345 Sum_probs=206.2
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCC-------EEEEEEEEecCCC-cchHHHHHHHHHHHhc-CCCcceeEEeeeeccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGR-------TTIAVKVFNLQHH-GASRSFIAECKALKSI-RHRNLVKVLTACLGAD 696 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 696 (949)
++|.+.+.||+|+||.||+|+....+ ..||||+++.... ....++.+|+..+.++ +|||||+++++|.+.+
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 57888999999999999999975433 5799999975543 3346788999999998 7999999999986544
Q ss_pred ccCCccceeEeeeccCCChhhhcCCCCCCC------ccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 039533 697 YRGNDFKASVYEFMHYGSLEEWLHPFTGED------EIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPS 770 (949)
Q Consensus 697 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~ 770 (949)
..++||||+++|+|.+++....... ........+++.+++.++.|++.||+|||++ +||||||||+
T Consensus 93 -----~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~ 164 (299)
T d1fgka_ 93 -----PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 164 (299)
T ss_dssp -----SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred -----eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccc
Confidence 7899999999999999997432211 1112345689999999999999999999988 8999999999
Q ss_pred CeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHh-CCCCCcccccc
Q 039533 771 NVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVI-GKKPIDIMFEG 849 (949)
Q Consensus 771 NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~ellt-g~~Pf~~~~~~ 849 (949)
|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |++||......
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~ 244 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence 99999999999999999998766555444445679999999999999999999999999999999998 68888633211
Q ss_pred CchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 039533 850 DINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQ 929 (949)
Q Consensus 850 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 929 (949)
. . .+.+........ +..++..+.+++.+||+.||++||||+||++.|+
T Consensus 245 ~--~------------~~~i~~~~~~~~------------------p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~ 292 (299)
T d1fgka_ 245 E--L------------FKLLKEGHRMDK------------------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292 (299)
T ss_dssp H--H------------HHHHHTTCCCCC------------------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H--H------------HHHHHcCCCCCC------------------CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence 1 1 111111111100 0123456889999999999999999999999999
Q ss_pred HhHH
Q 039533 930 SIKN 933 (949)
Q Consensus 930 ~i~~ 933 (949)
+|.+
T Consensus 293 ~i~a 296 (299)
T d1fgka_ 293 RIVA 296 (299)
T ss_dssp HHHH
T ss_pred HHhh
Confidence 9865
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.7e-44 Score=395.99 Aligned_cols=250 Identities=21% Similarity=0.249 Sum_probs=196.3
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC---CcchHHHHH---HHHHHHhcCCCcceeEEeeeeccccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH---HGASRSFIA---ECKALKSIRHRNLVKVLTACLGADYR 698 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~ 698 (949)
.++|++.+.||+|+||.||+|++..+|+.||||++.... ......+.+ |+.+++.++|||||++++++...+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~-- 80 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD-- 80 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS--
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC--
Confidence 368999999999999999999999899999999986332 112233444 466677778999999999976554
Q ss_pred CCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC
Q 039533 699 GNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM 778 (949)
Q Consensus 699 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~ 778 (949)
..++||||+++|+|.+++. ....+++.+++.++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 81 ---~~~ivmE~~~gg~L~~~l~----------~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g 144 (364)
T d1omwa3 81 ---KLSFILDLMNGGDLHYHLS----------QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHG 144 (364)
T ss_dssp ---EEEEEECCCCSCBHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSS
T ss_pred ---EEEEEEEecCCCcHHHHHH----------hcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCC
Confidence 7899999999999999996 345688999999999999999999987 999999999999999999
Q ss_pred ceEEeecccceecCCCCCccccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhc
Q 039533 779 TARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFG 857 (949)
Q Consensus 779 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~ 857 (949)
.+||+|||+|+........ ...||+.|+|||++.. ..++.++|||||||++|||+||+.||......... ...
T Consensus 145 ~iKl~DFGla~~~~~~~~~----~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--~~~ 218 (364)
T d1omwa3 145 HVRISDLGLACDFSKKKPH----ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EID 218 (364)
T ss_dssp CEEECCCTTCEECSSSCCC----SCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH--HHH
T ss_pred cEEEeeeceeeecCCCccc----ccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH--HHH
Confidence 9999999999977654332 3469999999999875 56899999999999999999999999643222110 000
Q ss_pred cccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC-----HHHHHH
Q 039533 858 RKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTN-----MTNVVH 926 (949)
Q Consensus 858 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~~ 926 (949)
+...... ...+ ...++.+.+++.+||+.||++||| ++|+++
T Consensus 219 ~~~~~~~---------~~~~-------------------~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 219 RMTLTMA---------VELP-------------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HHSSSCC---------CCCC-------------------SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred HhcccCC---------CCCC-------------------CCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0000000 0000 022446789999999999999999 677764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-44 Score=390.68 Aligned_cols=257 Identities=18% Similarity=0.190 Sum_probs=200.4
Q ss_pred hcCCCCCC-eeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCCcc
Q 039533 625 TSGFSSAN-LVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 625 ~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 702 (949)
.++|.+.+ .||+|+||+||+|++..+++.||||+++. .+.+.+|++++.++ +|||||++++++.+.. .....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLY-AGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCE
Confidence 46788764 69999999999999988999999999863 35678899987665 8999999999875432 23457
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC---CCc
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD---YMT 779 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~---~~~ 779 (949)
.|+||||++||+|.+++... ....+++.+++.|+.||+.||+|||++ +|+||||||+|||++. .+.
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~--------~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~ 152 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDR--------GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAI 152 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSC--------SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCC
T ss_pred EEEEEECCCCCcHHHHHHhc--------CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccc
Confidence 89999999999999999621 234689999999999999999999987 9999999999999985 567
Q ss_pred eEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccc
Q 039533 780 ARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRK 859 (949)
Q Consensus 780 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 859 (949)
+||+|||+|+......... ...||+.|+|||++.+..++.++|||||||++|||+||+.||......... .....
T Consensus 153 ~Kl~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~--~~~~~ 227 (335)
T d2ozaa1 153 LKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--PGMKT 227 (335)
T ss_dssp EEECCCTTCEECCCCCCCC---CCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------
T ss_pred ccccccceeeeccCCCccc---cccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH--HHHHH
Confidence 9999999999876544322 356999999999999999999999999999999999999999643211100 00000
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
. +..... ..+ .+.....++++.+++.+|++.||++|||+.|+++
T Consensus 228 ~-------i~~~~~-~~~---------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 228 R-------IRMGQY-EFP---------------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp C-------CCSCSS-SCC---------------TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred H-------HhcCCC-CCC---------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0 000000 000 0112245667899999999999999999999976
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=390.09 Aligned_cols=268 Identities=24% Similarity=0.328 Sum_probs=205.6
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEE--EEEEEEecC-CCcchHHHHHHHHHHHhc-CCCcceeEEeeeecccccCCc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTT--IAVKVFNLQ-HHGASRSFIAECKALKSI-RHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 701 (949)
++|++.++||+|+||+||+|++..++.. ||||+++.. .....+.+.+|+++++++ +||||++++++|...+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~----- 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG----- 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT-----
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC-----
Confidence 6788899999999999999999877764 677877533 233456799999999998 7999999999987654
Q ss_pred cceeEeeeccCCChhhhcCCCCCC------CccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGE------DEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD 775 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~------~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~ 775 (949)
..++||||+++|+|.++++..... .........+++..+..++.|||+||.|+|++ +|+||||||+|||++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG 161 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEc
Confidence 789999999999999999732110 00112346799999999999999999999987 999999999999999
Q ss_pred CCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCC-CCccccccCchhh
Q 039533 776 DYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKK-PIDIMFEGDINLH 854 (949)
Q Consensus 776 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~-Pf~~~~~~~~~~~ 854 (949)
.++.+||+|||+|+......... ...||..|+|||.+.+..++.++|||||||++|||++|.. ||...... .+.
T Consensus 162 ~~~~~kl~DfG~a~~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~--~~~ 236 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVYVKKT---MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELY 236 (309)
T ss_dssp GGGCEEECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHH
T ss_pred CCCceEEcccccccccccccccc---ceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH--HHH
Confidence 99999999999998654333221 3458999999999999999999999999999999999764 56432111 111
Q ss_pred hhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHh
Q 039533 855 NFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNI 934 (949)
Q Consensus 855 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~ 934 (949)
+.+........ ...+++++.+++.+||+.||++||||+||++.|+++.+.
T Consensus 237 ------------~~i~~~~~~~~------------------~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 237 ------------EKLPQGYRLEK------------------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp ------------HHGGGTCCCCC------------------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ------------HHHHhcCCCCC------------------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 11110000000 012345788999999999999999999999999998765
Q ss_pred hc
Q 039533 935 LL 936 (949)
Q Consensus 935 ~~ 936 (949)
..
T Consensus 287 ~~ 288 (309)
T d1fvra_ 287 RK 288 (309)
T ss_dssp SS
T ss_pred Cc
Confidence 43
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=389.51 Aligned_cols=270 Identities=24% Similarity=0.350 Sum_probs=210.5
Q ss_pred cCCCCCCeeeeecCceEEEEEEc-----CCCEEEEEEEEecCCC-cchHHHHHHHHHHHhc-CCCcceeEEeeeeccccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIID-----EGRTTIAVKVFNLQHH-GASRSFIAECKALKSI-RHRNLVKVLTACLGADYR 698 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 698 (949)
++|++.++||+|+||.||+|++. .+++.||||+++.... .....+.+|+.+++++ +|||||+++++|....
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~-- 100 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG-- 100 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC--
Confidence 57888999999999999999873 3567899999975443 3345789999999999 6999999999986554
Q ss_pred CCccceeEeeeccCCChhhhcCCCCCCC--------ccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 039533 699 GNDFKASVYEFMHYGSLEEWLHPFTGED--------EIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPS 770 (949)
Q Consensus 699 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~ 770 (949)
..++||||+++|+|.++++...... ........+++..+..++.||++||+|||++ +|+||||||+
T Consensus 101 ---~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~ 174 (311)
T d1t46a_ 101 ---PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAAR 174 (311)
T ss_dssp ---SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred ---EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccc
Confidence 7899999999999999997432211 1112344689999999999999999999988 8999999999
Q ss_pred CeeecCCCceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhC-CCCCcccccc
Q 039533 771 NVLLDDYMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIG-KKPIDIMFEG 849 (949)
Q Consensus 771 NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg-~~Pf~~~~~~ 849 (949)
||+++.++.+|++|||.++...............||+.|+|||++.+..++.++|||||||++|||+|+ ++||... ..
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~-~~ 253 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-PV 253 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-CS
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC-CH
Confidence 999999999999999999987665554444456799999999999999999999999999999999995 5554322 11
Q ss_pred CchhhhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 039533 850 DINLHNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQ 929 (949)
Q Consensus 850 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 929 (949)
...+ .++++....... ....+..+.+++.+||+.||++||||+||++.|+
T Consensus 254 ~~~~------------~~~i~~~~~~~~------------------~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~ 303 (311)
T d1t46a_ 254 DSKF------------YKMIKEGFRMLS------------------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303 (311)
T ss_dssp SHHH------------HHHHHHTCCCCC------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHH------------HHHHhcCCCCCC------------------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 1111 112211111110 0123456899999999999999999999999998
Q ss_pred HhHHh
Q 039533 930 SIKNI 934 (949)
Q Consensus 930 ~i~~~ 934 (949)
++...
T Consensus 304 ~~i~~ 308 (311)
T d1t46a_ 304 KQISE 308 (311)
T ss_dssp HHHHH
T ss_pred Hhhcc
Confidence 76443
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-44 Score=394.57 Aligned_cols=245 Identities=20% Similarity=0.207 Sum_probs=202.0
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecC---CCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ---HHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
++|++.+.||+|+||.||+|++..+|+.||||+++.. .....+.+.+|++++++++||||+++++++.... .
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS-----N 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----E
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccc-----c
Confidence 5799999999999999999999989999999998643 2234567899999999999999999999976544 7
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.++||||+.+|+|.+++. ....+++..++.|+.||+.||.|||++ +||||||||+|||++.++.+||
T Consensus 116 ~~~v~e~~~~g~l~~~l~----------~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL 182 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLR----------RIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQV 182 (350)
T ss_dssp EEEEEECCTTCBHHHHHH----------HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEE
T ss_pred cccccccccccchhhhHh----------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEe
Confidence 899999999999999986 235689999999999999999999987 8999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
+|||+|+....... ...||+.|||||++.+..++.++|||||||++|||+||+.||...... ...
T Consensus 183 ~DFG~a~~~~~~~~-----~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~-------- 247 (350)
T d1rdqe_ 183 TDFGFAKRVKGRTW-----TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI--QIY-------- 247 (350)
T ss_dssp CCCTTCEECSSCBC-----CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH--------
T ss_pred eeceeeeecccccc-----cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH--HHH--------
Confidence 99999998654322 356999999999999999999999999999999999999999632111 000
Q ss_pred CchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 039533 863 DDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRT-----NMTNVVH 926 (949)
Q Consensus 863 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~ 926 (949)
..+....... + ...+..+.+++.+|++.||++|+ |++|+++
T Consensus 248 ---~~i~~~~~~~-p-------------------~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 248 ---EKIVSGKVRF-P-------------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---HHHHHCCCCC-C-------------------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---HHHhcCCCCC-C-------------------ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 0011100000 0 12345678999999999999994 8999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=390.93 Aligned_cols=248 Identities=23% Similarity=0.310 Sum_probs=200.3
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecC---CCcchHHHHHHHHHHH-hcCCCcceeEEeeeecccccCCc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ---HHGASRSFIAECKALK-SIRHRNLVKVLTACLGADYRGND 701 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~ 701 (949)
++|.+.+.||+|+||+||+|++..+++.||||+++.. .....+.+..|..++. .++||||+++++++.+.+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~----- 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE----- 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS-----
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC-----
Confidence 5799999999999999999999999999999999743 2233456777777765 689999999999976655
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..|+||||+++|+|.+++. ....+++.+++.++.||+.||+|||++ +|+||||||+|||+++++++|
T Consensus 77 ~~yivmEy~~~g~L~~~i~----------~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~k 143 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQ----------SCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIK 143 (320)
T ss_dssp EEEEEEECCTTCBHHHHHH----------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEE
T ss_pred ceeEEEeecCCCcHHHHhh----------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCcee
Confidence 7999999999999999996 345689999999999999999999988 899999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
|+|||+|+......... ....||+.|+|||++.+..++.++||||+||++|||+||+.||....... ........
T Consensus 144 l~DFG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~--~~~~i~~~- 218 (320)
T d1xjda_ 144 IADFGMCKENMLGDAKT--NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--LFHSIRMD- 218 (320)
T ss_dssp ECCCTTCBCCCCTTCCB--CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHC-
T ss_pred ccccchhhhcccccccc--cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH--HHHHHHcC-
Confidence 99999998765443322 23569999999999999999999999999999999999999996432111 10000000
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHH-HHHH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMT-NVVH 926 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-ev~~ 926 (949)
.+.. + ..++.++.+++.+|++.||++|||+. |+++
T Consensus 219 --------~~~~---p-------------------~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 --------NPFY---P-------------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --------CCCC---C-------------------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --------CCCC---C-------------------ccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 0000 0 12345678999999999999999995 6753
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-45 Score=394.13 Aligned_cols=269 Identities=20% Similarity=0.322 Sum_probs=210.0
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcC-----CCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeeccccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDE-----GRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYR 698 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 698 (949)
.++|++.+.||+|+||+||+|++.. +++.||||+++.... .....+.+|+.++++++||||++++++|...+
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~-- 96 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ-- 96 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS--
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC--
Confidence 4678889999999999999998852 357899999974432 33356899999999999999999999986544
Q ss_pred CCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC
Q 039533 699 GNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM 778 (949)
Q Consensus 699 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~ 778 (949)
..++||||+++|+|.+++...............+++..+..++.|+|+||.|||++ +|+||||||+|||+++++
T Consensus 97 ---~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 97 ---PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp ---SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred ---ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCc
Confidence 78999999999999999863221111112234578999999999999999999987 899999999999999999
Q ss_pred ceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCC-CCCccccccCchhhhhc
Q 039533 779 TARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGK-KPIDIMFEGDINLHNFG 857 (949)
Q Consensus 779 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~-~Pf~~~~~~~~~~~~~~ 857 (949)
++||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||+||. .||....... .
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~-~----- 244 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-V----- 244 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-H-----
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH-H-----
Confidence 99999999998776554444344456899999999999999999999999999999999985 6664321110 0
Q ss_pred cccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHH
Q 039533 858 RKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKN 933 (949)
Q Consensus 858 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 933 (949)
...+.+....+.+ ..++..+.+++.+||+.||++||||+||++.|++..+
T Consensus 245 -------~~~i~~~~~~~~p-------------------~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 245 -------LRFVMEGGLLDKP-------------------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp -------HHHHHTTCCCCCC-------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -------HHHHHhCCCCCCc-------------------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 0111111111111 1334578999999999999999999999999987644
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-44 Score=385.59 Aligned_cols=264 Identities=21% Similarity=0.236 Sum_probs=193.4
Q ss_pred CCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc-----chHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 631 ANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG-----ASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 631 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
+++||+|+||+||+|++..+++.||||+++..... ..+.+.+|+.++++++|||||++++++...+ ..++
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~-----~~~i 77 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS-----NISL 77 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT-----CCEE
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC-----ceee
Confidence 47899999999999999989999999998643321 2357889999999999999999999976544 7899
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEeec
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVGDF 785 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 785 (949)
||||++++++..+.. ....+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 78 vmE~~~~~~~~~~~~----------~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DF 144 (299)
T d1ua2a_ 78 VFDFMETDLEVIIKD----------NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADF 144 (299)
T ss_dssp EEECCSEEHHHHHTT----------CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred hhhhhcchHHhhhhh----------cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccC
Confidence 999999988777664 245688889999999999999999987 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcc---ccC
Q 039533 786 GLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGR---KAL 861 (949)
Q Consensus 786 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~---~~~ 861 (949)
|.|+......... ....||+.|+|||++.+. .++.++||||+||++|||+||++||......+. +..... ...
T Consensus 145 G~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-l~~i~~~~~~~~ 221 (299)
T d1ua2a_ 145 GLAKSFGSPNRAY--THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-LTRIFETLGTPT 221 (299)
T ss_dssp GGGSTTTSCCCCC--CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCC
T ss_pred ccccccCCCcccc--cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH-HHHHHHhcCCCC
Confidence 9998765543322 235699999999988754 579999999999999999999999964322211 100000 000
Q ss_pred CCchhhhcc----cCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 862 PDDVMDIVD----SSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 862 ~~~~~~~~d----~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
.+...+... ......+. ...... .....+.+.+++.+|++.||++||||+|+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~--------~~~~~~---~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 222 EEQWPDMCSLPDYVTFKSFPG--------IPLHHI---FSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TTTSSSTTSSTTCCCCCCCCC--------CCHHHH---CTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhccchhccchhhhhccCCC--------CChHHh---cccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000000000 00000000 000000 0122456889999999999999999999875
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=382.47 Aligned_cols=278 Identities=24% Similarity=0.251 Sum_probs=199.2
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
++|++.+.||+|+||+||+|++..+++.||||+++.... ...+++.+|++++++++||||+++++++.+.+ ..
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~-----~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN-----KL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----EE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccccc-----ce
Confidence 589999999999999999999998999999999964432 23578999999999999999999999986554 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++||||+.++.+..... .....+++..++.++.|++.||+|||++ +||||||||+|||++.++.+||+
T Consensus 77 ~iv~e~~~~~~~~~~~~---------~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~ 144 (298)
T d1gz8a_ 77 YLVFEFLHQDLKKFMDA---------SALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLA 144 (298)
T ss_dssp EEEEECCSEEHHHHHHH---------TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred eEEEeecCCchhhhhhh---------hcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceec
Confidence 99999997654443322 1245689999999999999999999988 89999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCCc-cCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccCC
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCE-VSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKALP 862 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 862 (949)
|||.|+......... ....||+.|+|||+..... ++.++||||+||++|||++|+.||......+...........+
T Consensus 145 DFG~a~~~~~~~~~~--~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~ 222 (298)
T d1gz8a_ 145 DFGLARAFGVPVRTY--THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 222 (298)
T ss_dssp STTHHHHHCCCSBCT--TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred cCCcceeccCCcccc--eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999998775543322 2346999999999877665 5789999999999999999999996432211110000000000
Q ss_pred C-chhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 863 D-DVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 863 ~-~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
. .....+........ .. ..................+.+++.+|++.||++|||++|+++-
T Consensus 223 ~~~~~~~~~~~~~~~~--~~---~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 223 DEVVWPGVTSMPDYKP--SF---PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CTTTSTTGGGSTTCCT--TS---CCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred chhhcccccccccccc--cc---ccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0 00000000000000 00 0000000000111233567899999999999999999999863
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-43 Score=381.23 Aligned_cols=281 Identities=20% Similarity=0.229 Sum_probs=201.1
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcC-CCEEEEEEEEecCC--CcchHHHHHHHHHHHhc---CCCcceeEEeeeeccccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDE-GRTTIAVKVFNLQH--HGASRSFIAECKALKSI---RHRNLVKVLTACLGADYR 698 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~ 698 (949)
.++|++.+.||+|+||+||+|++.. +++.||||+++... ......+.+|+.+++.+ +||||++++++|......
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 4689999999999999999999964 47889999987432 22334567788877766 799999999998765555
Q ss_pred CCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC
Q 039533 699 GNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM 778 (949)
Q Consensus 699 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~ 778 (949)
.....+++|||++++.+..... .....+++..++.++.|++.||+|||++ +|+||||||+|||++.++
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~ 153 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK---------VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSG 153 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH---------SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTC
T ss_pred cCceEEEEEEeccCCchhhhhh---------ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCC
Confidence 5667899999999887765543 1345689999999999999999999987 899999999999999999
Q ss_pred ceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcc
Q 039533 779 TARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGR 858 (949)
Q Consensus 779 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~ 858 (949)
.+||+|||.++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+. +.....
T Consensus 154 ~~kl~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~i~~ 229 (305)
T d1blxa_ 154 QIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILD 229 (305)
T ss_dssp CEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHH
T ss_pred Ceeecchhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH-HHHHHH
Confidence 99999999988654332 22345699999999999999999999999999999999999999964422111 111000
Q ss_pred ccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 859 KALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 859 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
........++.. .... +............. .......+.+.+++.+|++.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~---~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 230 VIGLPGEEDWPR-DVAL-PRQAFHSKSAQPIE---KFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp HHCCCCGGGSCT-TCSS-CGGGSCCCCCCCGG---GTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhCCCchhcccc-cccc-hhhhhccccccchh---hccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000000000 0000 00000000000000 001123446788999999999999999999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-44 Score=377.38 Aligned_cols=240 Identities=21% Similarity=0.263 Sum_probs=194.0
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc------chHHHHHHHHHHHhcC--CCcceeEEeeeecccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG------ASRSFIAECKALKSIR--HRNLVKVLTACLGADY 697 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~ 697 (949)
++|++.+.||+|+||+||+|++..+++.||||+++..... ...++.+|+.++++++ ||||+++++++...+
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~- 82 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD- 82 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS-
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC-
Confidence 5799999999999999999999989999999999743211 1234678999999996 899999999976544
Q ss_pred cCCccceeEeeeccC-CChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC
Q 039533 698 RGNDFKASVYEFMHY-GSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD 776 (949)
Q Consensus 698 ~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~ 776 (949)
..++||||+.+ +++.+++. ....+++.+++.++.|++.||+|||++ +|+||||||+||+++.
T Consensus 83 ----~~~lv~e~~~~~~~l~~~~~----------~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~ 145 (273)
T d1xwsa_ 83 ----SFVLILERPEPVQDLFDFIT----------ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDL 145 (273)
T ss_dssp ----EEEEEEECCSSEEEHHHHHH----------HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEET
T ss_pred ----eEEEEEEeccCcchHHHHHh----------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEec
Confidence 78999999976 67888875 345689999999999999999999987 9999999999999985
Q ss_pred -CCceEEeecccceecCCCCCccccccccCccCccCccccCCCcc-CCccchHHHHHHHHHHHhCCCCCccccccCchhh
Q 039533 777 -YMTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEV-STNGDVYSYGILLLELVIGKKPIDIMFEGDINLH 854 (949)
Q Consensus 777 -~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~ 854 (949)
++.+||+|||+|+....... ....||+.|+|||++.+..+ +.++||||+||++|||+||+.||..... .
T Consensus 146 ~~~~vkl~DFG~a~~~~~~~~----~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----i- 216 (273)
T d1xwsa_ 146 NRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----I- 216 (273)
T ss_dssp TTTEEEECCCTTCEECCSSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----H-
T ss_pred CCCeEEECccccceecccccc----cccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH----H-
Confidence 57999999999987654322 23569999999999887665 5779999999999999999999963210 0
Q ss_pred hhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 855 NFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 855 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
....... + ...+.++.+++.+|++.||++|||++|+++
T Consensus 217 --------------~~~~~~~-~-------------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 217 --------------IRGQVFF-R-------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp --------------HHCCCCC-S-------------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------------hhcccCC-C-------------------CCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0000000 0 012345788999999999999999999975
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1e-42 Score=372.94 Aligned_cols=273 Identities=21% Similarity=0.246 Sum_probs=198.2
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCC--CcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQH--HGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
++|++.++||+|+||+||+|+++ +++.||||+++... ....+++.+|+.++++++||||+++++++...+ ..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-----RL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-----CE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC-----ce
Confidence 58999999999999999999997 77999999997543 233578999999999999999999999976554 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
+++|||+.++.+..+.. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|++
T Consensus 76 ~i~~e~~~~~~~~~~~~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~ 142 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDV----------CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIA 142 (286)
T ss_dssp EEEEECCSEEHHHHHHT----------STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred eEEEEeehhhhHHHHHh----------hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEec
Confidence 99999998877777765 345699999999999999999999987 89999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcc---c
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGR---K 859 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~---~ 859 (949)
|||.|.......... ....|++.|+|||.+.+. .++.++||||+||++|||++|+.||......+. +..... .
T Consensus 143 DfG~a~~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~-~~~i~~~~~~ 219 (286)
T d1ob3a_ 143 DFGLARAFGIPVRKY--THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGT 219 (286)
T ss_dssp CTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCC
T ss_pred ccccceecccCcccc--ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH-HHHHHHhhCC
Confidence 999998775543322 234589999999998764 568999999999999999999999964432211 110000 0
Q ss_pred cCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 860 ALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 860 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
............. .... ....... .............+.+++.+|++.||++|||++|+++
T Consensus 220 ~~~~~~~~~~~~~-~~~~--~~~~~~~---~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 220 PNSKNWPNVTELP-KYDP--NFTVYEP---LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCTTTSTTGGGST-TCCT--TCCCCCC---CCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CChhhccchhhhh-hccc--ccccccC---cchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000000 0000 0000000 0000001123456789999999999999999999974
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-42 Score=379.52 Aligned_cols=286 Identities=19% Similarity=0.206 Sum_probs=200.0
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC-cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH-GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
+++|++.+.||+|+||+||+|++..+++.||||+++.... ...+++.+|++++++++||||+++++++....+......
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 4579999999999999999999998999999999975432 334678999999999999999999999876654444444
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++ ++|+.+|+|.+++. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 87 ~l-~~~~~~g~L~~~l~-----------~~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~ 151 (345)
T d1pmea_ 87 YL-VTHLMGADLYKLLK-----------TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKIC 151 (345)
T ss_dssp EE-EEECCCEEHHHHHH-----------HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred EE-EEeecCCchhhhhh-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEc
Confidence 44 55667999999996 23589999999999999999999988 99999999999999999999999
Q ss_pred ecccceecCCCCCc-cccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 784 DFGLARILSPDHTQ-TSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 784 DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
|||+|+........ .......||+.|+|||++... .++.++||||+||++|||++|+.||......+..... .....
T Consensus 152 DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~-~~~~~ 230 (345)
T d1pmea_ 152 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI-LGILG 230 (345)
T ss_dssp CCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HHHHC
T ss_pred ccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHH-hhhcc
Confidence 99999876544331 122345699999999998554 5789999999999999999999999644322111000 00000
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE 927 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 927 (949)
...... .................................++.+++.+|++.||++|||++|+++.
T Consensus 231 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 231 SPSQED-LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp SCCHHH-HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCChhh-hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000 00000000000000000000000000001223467899999999999999999999863
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=369.71 Aligned_cols=284 Identities=19% Similarity=0.239 Sum_probs=199.2
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecC--CCcchHHHHHHHHHHHhcCCCcceeEEeeeecccc---cC
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ--HHGASRSFIAECKALKSIRHRNLVKVLTACLGADY---RG 699 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~ 699 (949)
.++|++.+.||+|+||+||+|++..+|+.||||++... .....+++.+|+.++++++||||+++++++..... ..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47899999999999999999999989999999998643 23345788999999999999999999999865321 22
Q ss_pred CccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCc
Q 039533 700 NDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMT 779 (949)
Q Consensus 700 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~ 779 (949)
....++||||++++.+..+.. ....++...++.++.|++.||.|||++ +|+||||||+|||++.++.
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~----------~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~ 155 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN----------VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGV 155 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC----------TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSC
T ss_pred CceEEEEEeccCCCccchhhh----------cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCc
Confidence 446899999998887766654 345688899999999999999999987 9999999999999999999
Q ss_pred eEEeecccceecCCCCCc--cccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCc--hhh
Q 039533 780 ARVGDFGLARILSPDHTQ--TSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDI--NLH 854 (949)
Q Consensus 780 ~kl~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~--~~~ 854 (949)
+||+|||+|+........ .......||+.|+|||++.+. .+++++||||+||++|||++|+.||+....... ...
T Consensus 156 ~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~ 235 (318)
T d3blha1 156 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 235 (318)
T ss_dssp EEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred EEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHH
Confidence 999999999876644321 122235699999999998765 689999999999999999999999964322111 011
Q ss_pred hhccccCCCchhhhcccCCCCCchhhhhhh--chhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 855 NFGRKALPDDVMDIVDSSLLPDDEDLILTG--NQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 855 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
... ...++....-.+.... ...+... ........+. .......+.+++.+|++.||++||||+|+++
T Consensus 236 ~~~-~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~-~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 236 QLC-GSITPEVWPNVDNYEL---YEKLELVKGQKRKVKDRLK-AYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HHH-CCCCTTTSTTCCCC----------CCSSCCBCHHHHHH-HHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred Hhc-CCCChhhccccchhhh---hhhhcccccccccchhhhc-cccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 111 1111111000000000 0000000 0000000000 1122345678999999999999999999984
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.2e-41 Score=362.79 Aligned_cols=274 Identities=15% Similarity=0.128 Sum_probs=212.7
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCC-CcceeEEeeeecccccCCccc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRH-RNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~ 703 (949)
.++|++.+.||+|+||+||+|++..+++.||||+++... ..+.+.+|++.++.+.| +|++.+++++.... ..
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~-----~~ 76 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL-----HN 76 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT-----EE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCC-----cc
Confidence 367999999999999999999999899999999986543 23457889999999965 89999998875444 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecC-----CC
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDD-----YM 778 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~-----~~ 778 (949)
++||||+ +++|.+++.. ....++..++..++.|++.||+|||++ +|+||||||+||+++. ++
T Consensus 77 ~~vme~~-~~~l~~~~~~---------~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~ 143 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDL---------CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNAN 143 (293)
T ss_dssp EEEEECC-CCBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTT
T ss_pred EEEEEec-CCCHHHHHHh---------hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCC
Confidence 9999998 6899998862 234689999999999999999999977 9999999999999974 57
Q ss_pred ceEEeecccceecCCCCCc-----cccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchh
Q 039533 779 TARVGDFGLARILSPDHTQ-----TSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINL 853 (949)
Q Consensus 779 ~~kl~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~ 853 (949)
.+||+|||+|+........ .......||+.|||||++.+..++.++|||||||++|||+||+.||..........
T Consensus 144 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~ 223 (293)
T d1csna_ 144 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ 223 (293)
T ss_dssp CEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH
T ss_pred ceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH
Confidence 8999999999987543321 12224569999999999999999999999999999999999999996432211100
Q ss_pred hhhccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHH
Q 039533 854 HNFGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKN 933 (949)
Q Consensus 854 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~ 933 (949)
. ...+.+....... .+....+++++.+++..|++.+|++||+++.+.+.++++.+
T Consensus 224 --~--------~~~i~~~~~~~~~---------------~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 224 --K--------YERIGEKKQSTPL---------------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp --H--------HHHHHHHHHHSCH---------------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred --H--------HHHHHhccCCCCh---------------HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 0 0000000000000 00011345678899999999999999999999999999988
Q ss_pred hhccCCCCCC
Q 039533 934 ILLGVELCPP 943 (949)
Q Consensus 934 ~~~~~~~~~~ 943 (949)
........|+
T Consensus 279 ~~~~~~~~~~ 288 (293)
T d1csna_ 279 RLNTTEDENF 288 (293)
T ss_dssp HTTCCSCSCC
T ss_pred HcCCCCCCCC
Confidence 7776666554
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-41 Score=365.53 Aligned_cols=274 Identities=19% Similarity=0.219 Sum_probs=205.9
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcccee
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFKAS 705 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 705 (949)
++|++.+.||+|+||.||+|++..+++.||||++..... .+++..|++++++++|++++..+..+.. ..+..++
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~----~~~~~~i 80 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVM 80 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEE----ETTEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEe----cCCEEEE
Confidence 579999999999999999999998999999999875432 3457899999999988776666555432 2347889
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeec---CCCceEE
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLD---DYMTARV 782 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~---~~~~~kl 782 (949)
||||+. +++.+.+.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++ .+..+||
T Consensus 81 vme~~~-~~l~~~~~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl 147 (299)
T d1ckia_ 81 VMELLG-PSLEDLFNF---------CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYI 147 (299)
T ss_dssp EEECCC-CBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEE
T ss_pred EEEEcC-Cchhhhhhh---------ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeee
Confidence 999994 566666541 345689999999999999999999988 899999999999985 4567999
Q ss_pred eecccceecCCCCCc-----cccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhc
Q 039533 783 GDFGLARILSPDHTQ-----TSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFG 857 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~ 857 (949)
+|||+|+.+...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||...........
T Consensus 148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~--- 224 (299)
T d1ckia_ 148 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK--- 224 (299)
T ss_dssp CCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC----------
T ss_pred eccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH---
Confidence 999999987654331 122345699999999999999999999999999999999999999964322211000
Q ss_pred cccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHHhHHhhcc
Q 039533 858 RKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHELQSIKNILLG 937 (949)
Q Consensus 858 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~ 937 (949)
........... ........++.++.+++..|++.+|++||+++++.+.|+.+......
T Consensus 225 -------~~~~~~~~~~~---------------~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~ 282 (299)
T d1ckia_ 225 -------YERISEKKMST---------------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 282 (299)
T ss_dssp -------HHHHHHHHHHS---------------CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred -------HHHhhcccCCC---------------ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCC
Confidence 00000000000 00000113456789999999999999999999999999998766555
Q ss_pred CCCCCC
Q 039533 938 VELCPP 943 (949)
Q Consensus 938 ~~~~~~ 943 (949)
....|+
T Consensus 283 ~~~~~~ 288 (299)
T d1ckia_ 283 SYDYVF 288 (299)
T ss_dssp CCSCCC
T ss_pred CCCCCc
Confidence 555554
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-42 Score=376.59 Aligned_cols=282 Identities=19% Similarity=0.246 Sum_probs=198.1
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccc-cCCc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADY-RGND 701 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 701 (949)
.++|++.+.||+|+||+||+|++..+|+.||||+++.... ...+.+.+|++++++++|||||+++++|...+. ....
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 4689999999999999999999998999999999975432 234678899999999999999999999875442 2344
Q ss_pred cceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceE
Q 039533 702 FKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTAR 781 (949)
Q Consensus 702 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 781 (949)
..++||||+ +.+|..+.+ ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~-----------~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~k 161 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK-----------HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELK 161 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH-----------HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEE
T ss_pred eEEEEEecc-cccHHHHHH-----------hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccc
Confidence 679999999 567877764 34599999999999999999999988 999999999999999999999
Q ss_pred EeecccceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcc--
Q 039533 782 VGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGR-- 858 (949)
Q Consensus 782 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~-- 858 (949)
++|||.|+....... ...||+.|+|||++.+. .++.++||||+||++|||++|++||......+. +.....
T Consensus 162 l~Dfg~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~-~~~~~~~~ 235 (346)
T d1cm8a_ 162 ILDFGLARQADSEMT-----GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-LKEIMKVT 235 (346)
T ss_dssp ECCCTTCEECCSSCC-----SSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHH
T ss_pred cccccceeccCCccc-----cccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH-HHHHHhcc
Confidence 999999987654432 35699999999998764 568999999999999999999999964422111 000000
Q ss_pred ccCCCchhhhcccCCCCCchhhhhhhc-hhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHHH--HHHh
Q 039533 859 KALPDDVMDIVDSSLLPDDEDLILTGN-QRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVHE--LQSI 931 (949)
Q Consensus 859 ~~~~~~~~~~~d~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~--L~~i 931 (949)
...+.+...... ........... .................+.+++.+|++.||++|||++|+++. ++++
T Consensus 236 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 236 GTPPAEFVQRLQ----SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp CCCCHHHHHTCS----CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CCCcHHHHhhhc----chhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 000000000000 00000000000 000000000001223457889999999999999999999873 5444
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=365.11 Aligned_cols=272 Identities=20% Similarity=0.250 Sum_probs=203.4
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDFK 703 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 703 (949)
++|++.++||+|+||+||+|++..+++.||||+++.... ...+++.+|+.++++++||||+++++++...+ ..
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-----~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-----KL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----EE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccccc-----ce
Confidence 579999999999999999999999999999999975433 34578899999999999999999999986655 78
Q ss_pred eeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEEe
Q 039533 704 ASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARVG 783 (949)
Q Consensus 704 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 783 (949)
++|+|++.++++..++. ..+.+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 77 ~iv~~~~~~~~l~~~~~----------~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~ 143 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDS----------CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLA 143 (292)
T ss_dssp EEEEECCSEEHHHHHHH----------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEEC
T ss_pred eEEeeeccccccccccc----------cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeee
Confidence 99999999999988876 345688999999999999999999987 99999999999999999999999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCCc-cCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhc---cc
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCE-VSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFG---RK 859 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~---~~ 859 (949)
|||.|+.......... ...++..|+|||++.+.. ++.++||||+||++|||++|+.||.............. ..
T Consensus 144 DFG~a~~~~~~~~~~~--~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 221 (292)
T d1unla_ 144 NFGLARAFGIPVRCYS--AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 221 (292)
T ss_dssp CCTTCEECCSCCSCCC--SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCC
T ss_pred ecchhhcccCCCccce--eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCC
Confidence 9999998765443222 345788999999987665 68999999999999999999999743222111111110 00
Q ss_pred cCCCch---hhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 860 ALPDDV---MDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 860 ~~~~~~---~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
...... ....+........ ...............+.+++.+|++.||++||||+|+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 222 PTEEQWPSMTKLPDYKPYPMYP---------ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCTTTCTTGGGSTTCCCCCCCC---------TTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CChhhhhhhhhccccccccccc---------ccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 0000000000000 000000001122345788999999999999999999875
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-41 Score=372.21 Aligned_cols=282 Identities=18% Similarity=0.209 Sum_probs=197.4
Q ss_pred CCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCcceeEEeeeecccc-cCCcccee
Q 039533 627 GFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRNLVKVLTACLGADY-RGNDFKAS 705 (949)
Q Consensus 627 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~l 705 (949)
+|+..++||+|+||+||+|++..+++.||||+++..... ..+|++++++++||||+++++++..... .+..+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 578889999999999999999989999999999754322 3479999999999999999999865432 33445789
Q ss_pred EeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC-ceEEee
Q 039533 706 VYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM-TARVGD 784 (949)
Q Consensus 706 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kl~D 784 (949)
||||++++.+..... .......+++.+++.|+.||+.||+|||++ +|+||||||+|||++.++ .+||+|
T Consensus 97 v~Ey~~~~~~~~l~~-------~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~D 166 (350)
T d1q5ka_ 97 VLDYVPETVYRVARH-------YSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCD 166 (350)
T ss_dssp EEECCSEEHHHHHHH-------HHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECC
T ss_pred EEeccCCccHHHHHh-------hhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEec
Confidence 999998764433322 011345699999999999999999999977 999999999999999765 899999
Q ss_pred cccceecCCCCCccccccccCccCccCccccCC-CccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcc---cc
Q 039533 785 FGLARILSPDHTQTSSFSVKGSLGYIAPEYGVG-CEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGR---KA 860 (949)
Q Consensus 785 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~---~~ 860 (949)
||+|+......... ...||..|+|||.+.+ ..++.++||||+||++|||++|+.||......+. +..... ..
T Consensus 167 FG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~-l~~i~~~~g~~ 242 (350)
T d1q5ka_ 167 FGSAKQLVRGEPNV---SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEIIKVLGTP 242 (350)
T ss_dssp CTTCEECCTTSCCC---SCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHHHHCCC
T ss_pred ccchhhccCCcccc---cccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH-HHHHHHHhCCC
Confidence 99998876544322 3569999999998765 4689999999999999999999999964432111 111000 00
Q ss_pred CCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH--HHHHhH
Q 039533 861 LPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH--ELQSIK 932 (949)
Q Consensus 861 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~--~L~~i~ 932 (949)
..+...+............ ....+... .......+.+.+++.+|++.||++|||++|+++ .+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~-~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 243 TREQIREMNPNYTEFKFPQ-----IKAHPWTK-VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp CHHHHHHHCC---CCCCCC-----CCCCCGGG-TSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hHHhhhhhccchhhccccc-----cccCchhh-hcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 0000000000000000000 00000000 000122445789999999999999999999986 355543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.2e-41 Score=366.58 Aligned_cols=196 Identities=22% Similarity=0.313 Sum_probs=169.6
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcC-CCcceeEEeeeecccccCCccce
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIR-HRNLVKVLTACLGADYRGNDFKA 704 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 704 (949)
++|++.++||+|+||+||+|++..+++.||||+++.. ..+++.+|++++++++ ||||+++++++... .....+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~---~~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEec---CCCcee
Confidence 5799999999999999999999989999999998643 3467899999999995 99999999997643 234689
Q ss_pred eEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCC-ceEEe
Q 039533 705 SVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYM-TARVG 783 (949)
Q Consensus 705 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kl~ 783 (949)
+||||+++++|..+.+ .+++.+++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+
T Consensus 109 ~v~e~~~~~~L~~~~~-------------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~ 172 (328)
T d3bqca1 109 LVFEHVNNTDFKQLYQ-------------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLI 172 (328)
T ss_dssp EEEECCCSCBGGGTTT-------------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred EEEeecCCCcHHHHhc-------------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeec
Confidence 9999999999977653 488999999999999999999988 999999999999998655 69999
Q ss_pred ecccceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccc
Q 039533 784 DFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIM 846 (949)
Q Consensus 784 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~ 846 (949)
|||+|+......... ...||+.|+|||.+.+. .++.++||||+||++|||++|+.||...
T Consensus 173 DFG~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~ 233 (328)
T d3bqca1 173 DWGLAEFYHPGQEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233 (328)
T ss_dssp CGGGCEECCTTCCCC---SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccceeccCCCccc---ccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence 999999876544322 34589999999997765 4799999999999999999999999643
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=367.78 Aligned_cols=281 Identities=19% Similarity=0.146 Sum_probs=195.4
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccc-cCCcc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADY-RGNDF 702 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 702 (949)
++|++.++||+|+||+||+|++..+|+.||||+++.... ...+++.+|+.++++++||||+++++++...+. +....
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 679999999999999999999998999999999975432 234578899999999999999999999865432 34567
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.|+||||+.++.+. .+. ..+++..++.++.|++.||+|||+. ||+||||||+|||++.++.+|+
T Consensus 97 ~~iv~Ey~~~~l~~-~~~------------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl 160 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQ------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKI 160 (355)
T ss_dssp EEEEEECCSEEHHH-HHT------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEE
T ss_pred eEEEEeccchHHHH-hhh------------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceee
Confidence 89999999765554 443 2478999999999999999999988 9999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhcc----
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGR---- 858 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~---- 858 (949)
+|||.++......... ...||+.|+|||++.+..+++++||||+||++|||++|+.||........ ......
T Consensus 161 ~df~~~~~~~~~~~~~---~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~-~~~i~~~~~~ 236 (355)
T d2b1pa1 161 LDFGLARTAGTSFMMT---PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGT 236 (355)
T ss_dssp CCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCC
T ss_pred echhhhhccccccccc---cccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHH-HHHHHHhccC
Confidence 9999988765443322 34589999999999999999999999999999999999999964321110 000000
Q ss_pred ------ccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 859 ------KALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 859 ------~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
........+..+................................+.+++.+|++.||++||||+|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp CCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00001111111111111000000000000001111123345677899999999999999999999974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-41 Score=372.34 Aligned_cols=280 Identities=19% Similarity=0.197 Sum_probs=198.1
Q ss_pred hcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCC--cchHHHHHHHHHHHhcCCCcceeEEeeeecccccCCcc
Q 039533 625 TSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHH--GASRSFIAECKALKSIRHRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 625 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 702 (949)
+++|++.++||+|+||+||+|++..+|+.||||+++.... ...+++.+|++++++++||||+++++++..........
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 5689999999999999999999998999999999975433 23457889999999999999999999986554333345
Q ss_pred ceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCCCceEE
Q 039533 703 KASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDYMTARV 782 (949)
Q Consensus 703 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 782 (949)
.+++|+|+.+|+|.+++. ...+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+|+
T Consensus 97 ~~~i~~~~~gg~L~~~~~-----------~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl 162 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK-----------CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKI 162 (348)
T ss_dssp CCEEEEECCSEEHHHHHT-----------TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred eEEEEEeecCCchhhhcc-----------cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccc
Confidence 567788888999999986 23589999999999999999999988 9999999999999999999999
Q ss_pred eecccceecCCCCCccccccccCccCccCccccCCC-ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhhhccccC
Q 039533 783 GDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC-EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHNFGRKAL 861 (949)
Q Consensus 783 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 861 (949)
+|||.|...... .....||+.|+|||+..+. .++.++||||+||++|||++|+.||........ .........
T Consensus 163 ~dfg~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~-~~~i~~~~~ 236 (348)
T d2gfsa1 163 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRLVG 236 (348)
T ss_dssp CCC----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHC
T ss_pred cccchhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcC
Confidence 999999764322 2245689999999987665 468999999999999999999999964321110 000000000
Q ss_pred CCchhhhcccCCCCCchhhhhhhchhhhhhhh-hhHHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 039533 862 PDDVMDIVDSSLLPDDEDLILTGNQRQKQARI-NSIIECLISMVRIGVACSMELPQDRTNMTNVVH 926 (949)
Q Consensus 862 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 926 (949)
. ...+..... ...............+...+ .........+.+++.+|++.||++||||+|+++
T Consensus 237 ~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 237 T-PGAELLKKI-SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp C-CCHHHHTTC-CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C-CChHHhhhc-cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0 000000000 00000000000000000000 001123456789999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-41 Score=363.30 Aligned_cols=253 Identities=23% Similarity=0.283 Sum_probs=197.4
Q ss_pred cCCCCCCeeeeecCceEEEEEEc---CCCEEEEEEEEecCC----CcchHHHHHHHHHHHhcCC-CcceeEEeeeecccc
Q 039533 626 SGFSSANLVGVGSFGSVYKGIID---EGRTTIAVKVFNLQH----HGASRSFIAECKALKSIRH-RNLVKVLTACLGADY 697 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~ 697 (949)
++|++.+.||+|+||+||+|+.. .+|+.||||+++... ....+.+.+|++++++++| |||+++++++.+..
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~- 102 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET- 102 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT-
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC-
Confidence 67999999999999999999873 468999999986432 2234678899999999976 89999999976554
Q ss_pred cCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeeecCC
Q 039533 698 RGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLLDDY 777 (949)
Q Consensus 698 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll~~~ 777 (949)
..++||||+.+|+|.+++. ....++...+..++.|++.||+|+|+. +|+||||||+||+++.+
T Consensus 103 ----~~~~v~e~~~~~~L~~~i~----------~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~ 165 (322)
T d1vzoa_ 103 ----KLHLILDYINGGELFTHLS----------QRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSN 165 (322)
T ss_dssp ----EEEEEECCCCSCBHHHHHH----------HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT
T ss_pred ----ceeeeeecccccHHHHHHH----------hcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCC
Confidence 7899999999999999986 334578889999999999999999987 89999999999999999
Q ss_pred CceEEeecccceecCCCCCccccccccCccCccCccccCCC--ccCCccchHHHHHHHHHHHhCCCCCccccccCchhhh
Q 039533 778 MTARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGC--EVSTNGDVYSYGILLLELVIGKKPIDIMFEGDINLHN 855 (949)
Q Consensus 778 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDiwSlGvvl~elltg~~Pf~~~~~~~~~~~~ 855 (949)
+.+||+|||+|+.+....... .....|++.|+|||.+.+. .++.++||||+||++|||++|+.||...........
T Consensus 166 ~~vkL~DFG~a~~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~- 243 (322)
T d1vzoa_ 166 GHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE- 243 (322)
T ss_dssp SCEEESCSSEEEECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH-
T ss_pred CCEEEeeccchhhhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-
Confidence 999999999998765443322 2245699999999998764 468899999999999999999999965432221100
Q ss_pred hccccCCCchhhhcccCCCCCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccCCCCCCCC-----HHHHHH
Q 039533 856 FGRKALPDDVMDIVDSSLLPDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSMELPQDRTN-----MTNVVH 926 (949)
Q Consensus 856 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~~ 926 (949)
... ....... . .....+.++.+++.+|+++||++||| ++|+++
T Consensus 244 i~~--------~~~~~~~-~-------------------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 244 ISR--------RILKSEP-P-------------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HHH--------HHHHCCC-C-------------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHH--------hcccCCC-C-------------------CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 000 0000000 0 00134567889999999999999994 788875
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-35 Score=330.28 Aligned_cols=283 Identities=18% Similarity=0.201 Sum_probs=190.7
Q ss_pred cCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcC-----------CCcceeEEeeeec
Q 039533 626 SGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIR-----------HRNLVKVLTACLG 694 (949)
Q Consensus 626 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~ 694 (949)
++|+++++||+|+||+||+|++..+|+.||||+++... ...+.+.+|+.++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 35999999999999999999999899999999997442 23467788999888875 5789999988753
Q ss_pred ccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeee
Q 039533 695 ADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKPSNVLL 774 (949)
Q Consensus 695 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp~NIll 774 (949)
.. ....+.+|+++..+........ ......+++..+..++.|++.||+|||+.. +|+||||||+|||+
T Consensus 92 ~~---~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll 159 (362)
T d1q8ya_ 92 KG---PNGVHVVMVFEVLGENLLALIK-------KYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLM 159 (362)
T ss_dssp EE---TTEEEEEEEECCCCEEHHHHHH-------HTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEE
T ss_pred cc---ccceeeeeeecccccccccccc-------cccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeee
Confidence 22 3345666666654433222210 113456888999999999999999999732 89999999999999
Q ss_pred cCCC------ceEEeecccceecCCCCCccccccccCccCccCccccCCCccCCccchHHHHHHHHHHHhCCCCCccccc
Q 039533 775 DDYM------TARVGDFGLARILSPDHTQTSSFSVKGSLGYIAPEYGVGCEVSTNGDVYSYGILLLELVIGKKPIDIMFE 848 (949)
Q Consensus 775 ~~~~------~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl~elltg~~Pf~~~~~ 848 (949)
+.++ .++++|||.|........ ...||+.|+|||++.+..++.++||||+||+++||++|+.||.....
T Consensus 160 ~~~~~~~~~~~~kl~dfg~s~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~ 234 (362)
T d1q8ya_ 160 EIVDSPENLIQIKIADLGNACWYDEHYT-----NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 234 (362)
T ss_dssp EEEETTTTEEEEEECCCTTCEETTBCCC-----SCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred eccCcccccceeeEeecccccccccccc-----cccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcc
Confidence 8654 399999999986543322 35699999999999999999999999999999999999999964321
Q ss_pred cCc-----hhhhhcc--ccCCCch-------hhhcccCCC-CCchhhhhhhchhhhhhhhhhHHHHHHHHHHHhhccccC
Q 039533 849 GDI-----NLHNFGR--KALPDDV-------MDIVDSSLL-PDDEDLILTGNQRQKQARINSIIECLISMVRIGVACSME 913 (949)
Q Consensus 849 ~~~-----~~~~~~~--~~~~~~~-------~~~~d~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 913 (949)
... ....... ...+... ....+.... ............................+.+++.+|++.
T Consensus 235 ~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~ 314 (362)
T d1q8ya_ 235 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314 (362)
T ss_dssp ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred ccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCC
Confidence 110 0000000 0000000 000000000 000000000000001111222346677899999999999
Q ss_pred CCCCCCCHHHHHH
Q 039533 914 LPQDRTNMTNVVH 926 (949)
Q Consensus 914 dP~~RPs~~ev~~ 926 (949)
||++||||+|+++
T Consensus 315 dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 315 DPRKRADAGGLVN 327 (362)
T ss_dssp STTTCBCHHHHHT
T ss_pred ChhHCcCHHHHhc
Confidence 9999999999875
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=2.1e-33 Score=304.82 Aligned_cols=255 Identities=31% Similarity=0.492 Sum_probs=228.0
Q ss_pred cccEEEccCccccC--CCCCCCCCCCcccEEEeec-ceecccCCCcccccCCCCEEecCCcccccccCccccccccccee
Q 039533 295 TIKTLFLNNNKIYG--SIPAGIGNFVNLQRLDMWN-NQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNL 371 (949)
Q Consensus 295 ~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 371 (949)
+++.|+|++|.++| .+|..++++++|++|+|++ |+++|.+|..|+++++|++|+|++|+|.+..|..+.++.+|+.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 47888888888887 4788899999999999986 88988899999999999999999999998888889999999999
Q ss_pred ecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccc
Q 039533 372 FLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRL 451 (949)
Q Consensus 372 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 451 (949)
++++|.+.+.+|..+.+++.|+.+++++|.++|.+|..+..+..+...+++++|++++..|..+..+..+ .+++++|.+
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~ 209 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEE
T ss_pred ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence 9999999888999999999999999999999999999998888887889999999999888888887655 699999999
Q ss_pred cccCCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCcCcccccCCc-cceEeCCCCcCcCcccccc
Q 039533 452 EGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLS-LNNLNLSYNDLEGMVTTEG 530 (949)
Q Consensus 452 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~l~ls~N~l~~~~~~~~ 530 (949)
.|.+|..++.+++|+.+++++|.+++.+| .++.+++|+.|+|++|+|+|.+|..+..++ |++|+|++|+|+|.+|..+
T Consensus 210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~ 288 (313)
T d1ogqa_ 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred ccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcc
Confidence 99999999999999999999999997765 688899999999999999999999888887 9999999999999999888
Q ss_pred cccccccccccCCCCCCCCCC
Q 039533 531 VFKNASATRILGNSKLCGGIS 551 (949)
Q Consensus 531 ~~~~~~~~~~~gn~~~c~~~~ 551 (949)
.+..+..+.+.||+.+||.|.
T Consensus 289 ~L~~L~~l~l~~N~~l~g~pl 309 (313)
T d1ogqa_ 289 NLQRFDVSAYANNKCLCGSPL 309 (313)
T ss_dssp TGGGSCGGGTCSSSEEESTTS
T ss_pred cCCCCCHHHhCCCccccCCCC
Confidence 888999999999999999864
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=3.3e-29 Score=280.05 Aligned_cols=186 Identities=26% Similarity=0.372 Sum_probs=91.8
Q ss_pred cccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecc
Q 039533 295 TIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLN 374 (949)
Q Consensus 295 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 374 (949)
.++.+++++|.+++..| +..+++|++|++++|+++. + +.+..+++|+.|++++|++++..+ +..+++|++|+++
T Consensus 198 ~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~ 271 (384)
T d2omza2 198 NLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLG 271 (384)
T ss_dssp TCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECC
T ss_pred ccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCCc--ccccccCCEeecc
Confidence 35555555555554332 2344555555555555552 1 244555555555555555553322 4555555555555
Q ss_pred cccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeecccccccc
Q 039533 375 DNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGE 454 (949)
Q Consensus 375 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 454 (949)
+|.+++.. .+..++.++.+++++|++++ +..+..+.++ +.|++++|++++.. .+..+++|+.|++++|+|++
T Consensus 272 ~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l-~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~- 343 (384)
T d2omza2 272 ANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNL-TYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD- 343 (384)
T ss_dssp SSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTC-SEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-
T ss_pred CcccCCCC--cccccccccccccccccccc--ccccchhccc-CeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-
Confidence 55554322 14445555555555555542 1223344444 44555555554332 14455555555555555542
Q ss_pred CCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCC
Q 039533 455 IPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQN 497 (949)
Q Consensus 455 ~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N 497 (949)
+| .|+++++|++|++++|+|++.+| +.++++|+.|+|++|
T Consensus 344 l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 344 VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 22 35555555555555555554433 455555555555554
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=1.3e-28 Score=275.30 Aligned_cols=341 Identities=26% Similarity=0.345 Sum_probs=228.2
Q ss_pred CcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEE
Q 039533 111 GLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTI 190 (949)
Q Consensus 111 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 190 (949)
.+.+|++|++++|.|+. + +.+..|++|++|++++|+|++..+ |+++++|++|+|++|++++.. .++++++|+.|
T Consensus 42 ~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L 115 (384)
T d2omza2 42 DLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT--PLANLTNLTGL 115 (384)
T ss_dssp HHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEE
T ss_pred HhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCcc--ccCCccccccccccccccccc--ccccccccccc
Confidence 34455555555555542 2 234455555555555555554432 555666666666666665432 25566666666
Q ss_pred eccccccCCCCCCcccCCCccccccccCcccccccccccCCCCChhhhccccccccccCCCCCCCCCCcchhccccccCc
Q 039533 191 SLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATR 270 (949)
Q Consensus 191 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~ 270 (949)
++++|.+++..+ ......+..+....|.+..+...... ....
T Consensus 116 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~------------------------------------~~~~ 157 (384)
T d2omza2 116 TLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGL------------------------------------TSLQ 157 (384)
T ss_dssp ECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTC------------------------------------TTCS
T ss_pred cccccccccccc--cccccccccccccccccccccccccc------------------------------------cccc
Confidence 666666653322 22334444444444444322211000 0000
Q ss_pred ccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecC
Q 039533 271 LTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLN 350 (949)
Q Consensus 271 L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 350 (949)
..........+ ..+... ..........|... ....+..+++++.+++++|.+++..| +...++|+.|+++
T Consensus 158 ~~~~~~~~~~~-----~~~~~~-~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~ 227 (384)
T d2omza2 158 QLSFGNQVTDL-----KPLANL-TTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLN 227 (384)
T ss_dssp EEEEEESCCCC-----GGGTTC-TTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECC
T ss_pred ccccccccchh-----hhhccc-cccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECC
Confidence 00111111111 111111 22344555555553 34557788999999999999997654 4667899999999
Q ss_pred CcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCC
Q 039533 351 RNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGS 430 (949)
Q Consensus 351 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~ 430 (949)
+|+++. + +.+..+++|+.|++++|.+++..+ +..+++|++|++++|++++. + .+..+..+ ..+++++|++++
T Consensus 228 ~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~-~-~~~~~~~l-~~l~~~~n~l~~- 299 (384)
T d2omza2 228 GNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI-S-PLAGLTAL-TNLELNENQLED- 299 (384)
T ss_dssp SSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCC-G-GGTTCTTC-SEEECCSSCCSC-
T ss_pred CCCCCC-c-chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCC-C-cccccccc-cccccccccccc-
Confidence 999985 3 468899999999999999986544 78899999999999999854 3 36677777 789999999985
Q ss_pred CccccccccccceeeeccccccccCCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCcCcccccCC
Q 039533 431 LPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGL 510 (949)
Q Consensus 431 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 510 (949)
...+..+++++.|++++|++++.. .+..+++|++|++++|+|++ ++ .|+++++|++|+|++|+|++.+| +..+
T Consensus 300 -~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l 372 (384)
T d2omza2 300 -ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANL 372 (384)
T ss_dssp -CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTC
T ss_pred -ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccC
Confidence 345888999999999999999653 38899999999999999985 44 69999999999999999997765 5666
Q ss_pred c-cceEeCCCC
Q 039533 511 S-LNNLNLSYN 520 (949)
Q Consensus 511 ~-L~~l~ls~N 520 (949)
+ |+.|+|++|
T Consensus 373 ~~L~~L~L~~N 383 (384)
T d2omza2 373 TRITQLGLNDQ 383 (384)
T ss_dssp TTCSEEECCCE
T ss_pred CCCCEeeCCCC
Confidence 5 999999998
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=1.2e-26 Score=250.29 Aligned_cols=270 Identities=23% Similarity=0.326 Sum_probs=156.9
Q ss_pred ceeeeeEEeCCCCcEEEEEcCCCCCCccccCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCC
Q 039533 53 CKWYGVTCSRRHQRVTLLDLRSLKLAGSVSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTN 132 (949)
Q Consensus 53 C~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 132 (949)
|.|.+|.|++ .+++ ++|+.+. +++++|+|++|+|+...+.+|.++++|++|++++|.+....|..
T Consensus 10 c~~~~~~C~~------------~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~ 74 (305)
T d1xkua_ 10 CHLRVVQCSD------------LGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 74 (305)
T ss_dssp EETTEEECTT------------SCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTT
T ss_pred ecCCEEEecC------------CCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhh
Confidence 7888888864 2344 4454443 46677777777776444446666677777777776666444555
Q ss_pred CCCCccceeecCCCccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccc
Q 039533 133 ISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLV 212 (949)
Q Consensus 133 ~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 212 (949)
|.++++| ++|++++|+++ .+|..+ ...++.|++++|.+.+..+..+.....+.
T Consensus 75 f~~l~~L------------------------~~L~l~~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~ 127 (305)
T d1xkua_ 75 FAPLVKL------------------------ERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMI 127 (305)
T ss_dssp TTTCTTC------------------------CEEECCSSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCC
T ss_pred hhCCCcc------------------------CEecccCCccC-cCccch--hhhhhhhhccccchhhhhhhhhhcccccc
Confidence 5555555 55555555555 333322 23455566666666554444455555555
Q ss_pred cccccCcccccccccccCCCCChhhhccccccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcc
Q 039533 213 FLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNL 292 (949)
Q Consensus 213 ~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l 292 (949)
.++...|....... . ...+..+++|+++++++|+++. +|.. .
T Consensus 128 ~l~~~~n~~~~~~~-----~-----------------------------~~~~~~l~~L~~l~l~~n~l~~-l~~~---~ 169 (305)
T d1xkua_ 128 VVELGTNPLKSSGI-----E-----------------------------NGAFQGMKKLSYIRIADTNITT-IPQG---L 169 (305)
T ss_dssp EEECCSSCCCGGGB-----C-----------------------------TTGGGGCTTCCEEECCSSCCCS-CCSS---C
T ss_pred ccccccccccccCC-----C-----------------------------ccccccccccCccccccCCccc-cCcc---c
Confidence 55555543321110 0 0112233444445555554442 2221 1
Q ss_pred cccccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceee
Q 039533 293 SKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLF 372 (949)
Q Consensus 293 ~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 372 (949)
.++|++|++++|.+++..+..|..++.+++|++++|.+++..+..|.++++|++|+|++|+|+ .+|.+|.++++|++|+
T Consensus 170 ~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~ 248 (305)
T d1xkua_ 170 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY 248 (305)
T ss_dssp CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEE
T ss_pred CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEE
Confidence 235667777777776666666777777777777777777666677777777777777777776 4566677777777777
Q ss_pred cccccccccCCCCC------CCCCCCcEEEeeCcccc
Q 039533 373 LNDNFLEVSIPSSL------GQCESLIEINLSNNNLS 403 (949)
Q Consensus 373 L~~N~l~~~~p~~~------~~l~~L~~L~l~~N~l~ 403 (949)
|++|+|+......| ..+.+|+.|+|++|.++
T Consensus 249 Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 249 LHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp CCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred CCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 77777764433333 34566777777777664
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=8.1e-26 Score=243.64 Aligned_cols=284 Identities=23% Similarity=0.335 Sum_probs=183.1
Q ss_pred cCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEecc
Q 039533 114 RLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLA 193 (949)
Q Consensus 114 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 193 (949)
.++.+|=++++++ .+|..+. +++++|+|++|+|+...+..|.++++|++|++++|.+....|..|.++++|++|+++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 3445555555555 5555543 356666666666666666677788888999999999998778899999999999999
Q ss_pred ccccCCCCCCcccCCCccccccccCcccccccccccCCCCChhhhccccccccccCCCCCCCCCCcchhccccccCcccE
Q 039533 194 YNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSLTNATRLTW 273 (949)
Q Consensus 194 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~ 273 (949)
+|+++ .+|..+ ...|..|++++|.+..++... +.....+..
T Consensus 88 ~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~------------------------------------~~~~~~~~~ 128 (305)
T d1xkua_ 88 KNQLK-ELPEKM--PKTLQELRVHENEITKVRKSV------------------------------------FNGLNQMIV 128 (305)
T ss_dssp SSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHH------------------------------------HTTCTTCCE
T ss_pred CCccC-cCccch--hhhhhhhhccccchhhhhhhh------------------------------------hhccccccc
Confidence 99999 566543 457888888888876543211 122233444
Q ss_pred EEccCCCCC--ccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCC
Q 039533 274 MHINSNNFG--GLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNR 351 (949)
Q Consensus 274 L~L~~N~l~--~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 351 (949)
++...|... ...+..+..+ ++|+.+++++|.++ .+|..+ +++|+.|++++|.+++..+..|.+++.++.|++++
T Consensus 129 l~~~~n~~~~~~~~~~~~~~l-~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~ 204 (305)
T d1xkua_ 129 VELGTNPLKSSGIENGAFQGM-KKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 204 (305)
T ss_dssp EECCSSCCCGGGBCTTGGGGC-TTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCS
T ss_pred cccccccccccCCCccccccc-cccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhcccccccccccc
Confidence 555554332 2233344444 35777777777776 344332 45677777777777767777777777777777777
Q ss_pred cccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCC
Q 039533 352 NKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSL 431 (949)
Q Consensus 352 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~ 431 (949)
|++++..+..+.++++|++|+|++|.|+ .+|.+|..+++|++|+|++|+|+ .++...+..
T Consensus 205 n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~-~i~~~~f~~------------------ 264 (305)
T d1xkua_ 205 NSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCP------------------ 264 (305)
T ss_dssp SCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC-CCCTTSSSC------------------
T ss_pred ccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccC-ccChhhccC------------------
Confidence 7777666677777777777777777776 45667777777777777777776 343322211
Q ss_pred ccccccccccceeeecccccc--ccCCccccccc
Q 039533 432 PIEVGKLKILEFLYVYENRLE--GEIPSTFGNCI 463 (949)
Q Consensus 432 p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~ 463 (949)
+.....+.+|+.|+|++|+++ ...|..|.-+.
T Consensus 265 ~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~~ 298 (305)
T d1xkua_ 265 PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY 298 (305)
T ss_dssp SSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCC
T ss_pred cchhcccCCCCEEECCCCcCccCcCCHhHhcccc
Confidence 112234556777777777664 23344444433
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=3.2e-25 Score=236.10 Aligned_cols=224 Identities=23% Similarity=0.193 Sum_probs=121.9
Q ss_pred EEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecC-C
Q 039533 273 WMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLN-R 351 (949)
Q Consensus 273 ~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls-~ 351 (949)
.++.++++++. +|.. +++++++|+|++|+|++..+.+|.++++|++|++++|++.+..+..+..+..+..++.. .
T Consensus 15 ~v~c~~~~L~~-iP~~---ip~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~ 90 (284)
T d1ozna_ 15 TTSCPQQGLQA-VPVG---IPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (284)
T ss_dssp EEECCSSCCSS-CCTT---CCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred EEEcCCCCCCc-cCCC---CCCCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence 34555555552 3432 23455666666666665444556666666666666666665555555555555555443 4
Q ss_pred cccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCC
Q 039533 352 NKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSL 431 (949)
Q Consensus 352 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~ 431 (949)
|.++...|..|.++++|++|++++|.+....+..+..+++|+.+++++|+|+ +..
T Consensus 91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~-------------------------~i~ 145 (284)
T d1ozna_ 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-------------------------ALP 145 (284)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-------------------------CCC
T ss_pred cccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhcccccc-------------------------ccC
Confidence 4454444555555555555555555555444445555555555555555555 333
Q ss_pred ccccccccccceeeeccccccccCCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCcCcccccCCc
Q 039533 432 PIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLS 511 (949)
Q Consensus 432 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~ 511 (949)
+..|..+++|+.|++++|++++..+..|.++++|+.+++++|++++..|..|..+++|+.||+++|++++.+|..+..+.
T Consensus 146 ~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~ 225 (284)
T d1ozna_ 146 DDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLR 225 (284)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCT
T ss_pred hhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccccccccccccccccccccc
Confidence 44444455555555555555544455555555555555555555555555555555555555555555555555554444
Q ss_pred -cceEeCCCCcCcCc
Q 039533 512 -LNNLNLSYNDLEGM 525 (949)
Q Consensus 512 -L~~l~ls~N~l~~~ 525 (949)
|++|++++|++.+.
T Consensus 226 ~L~~L~l~~N~l~C~ 240 (284)
T d1ozna_ 226 ALQYLRLNDNPWVCD 240 (284)
T ss_dssp TCCEEECCSSCEECS
T ss_pred ccCEEEecCCCCCCC
Confidence 55555555555544
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=2.8e-25 Score=236.48 Aligned_cols=223 Identities=21% Similarity=0.246 Sum_probs=166.5
Q ss_pred ccccccCCCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccE
Q 039533 243 HFTITSNSLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQR 322 (949)
Q Consensus 243 ~L~l~~N~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 322 (949)
.++.++++++..+. .+ .+.+++|+|++|+|++..+..|.+++ +|++|++++|+|.+..+..+..++.+..
T Consensus 15 ~v~c~~~~L~~iP~-------~i--p~~~~~L~Ls~N~i~~i~~~~f~~l~-~L~~L~ls~n~l~~i~~~~~~~~~~~~~ 84 (284)
T d1ozna_ 15 TTSCPQQGLQAVPV-------GI--PAASQRIFLHGNRISHVPAASFRACR-NLTILWLHSNVLARIDAAAFTGLALLEQ 84 (284)
T ss_dssp EEECCSSCCSSCCT-------TC--CTTCSEEECTTSCCCEECTTTTTTCT-TCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred EEEcCCCCCCccCC-------CC--CCCCCEEECcCCcCCCCCHHHhhccc-cccccccccccccccccccccccccccc
Confidence 45667777776532 12 24689999999999988888888884 6999999999999988888999999999
Q ss_pred EEee-cceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCcc
Q 039533 323 LDMW-NNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNN 401 (949)
Q Consensus 323 L~L~-~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 401 (949)
++.. .|.++...|..|.++++|++|++++|.+....+..+...++|+.+++++|++++..+..|..+++|+.|++++|+
T Consensus 85 l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~ 164 (284)
T d1ozna_ 85 LDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNR 164 (284)
T ss_dssp EECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred cccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCc
Confidence 8765 677887778999999999999999999997788889999999999999999998888899999999999999999
Q ss_pred ccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccCCcccccccchhhcccCccccc
Q 039533 402 LSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQ 476 (949)
Q Consensus 402 l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 476 (949)
+++..+..|..++++ ..+++++|++++..|..|..+++|++|++++|++.+..|..|+++++|+.|+|++|.+.
T Consensus 165 l~~l~~~~f~~l~~L-~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~ 238 (284)
T d1ozna_ 165 ISSVPERAFRGLHSL-DRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238 (284)
T ss_dssp CCEECTTTTTTCTTC-CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred ccccchhhhcccccc-chhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCC
Confidence 885555555555555 45555555555544555555555555555555554444444444444444444444443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=3.1e-23 Score=217.97 Aligned_cols=177 Identities=22% Similarity=0.143 Sum_probs=89.3
Q ss_pred cccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEee
Q 039533 319 NLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLS 398 (949)
Q Consensus 319 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 398 (949)
+|++|+|++|+|++..+.+|.++++|++|+|++|+|+. +| .++.+++|++|+|++|+++ ..+..+.++++|++|+++
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~ 108 (266)
T d1p9ag_ 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS 108 (266)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECC
T ss_pred CCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-ccccccccccccccccccc-cccccccccccccccccc
Confidence 45555555555554444445555555555555555542 22 1344455555555555554 234445555555555555
Q ss_pred CccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccCCcccccccchhhcccCccccccc
Q 039533 399 NNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGP 478 (949)
Q Consensus 399 ~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 478 (949)
+|.+.+..+..+..+.++ ..|++++|.++...+..+..+++|+.|++++|+|++..+..|..+++|+.|+|++|+|+ .
T Consensus 109 ~~~~~~~~~~~~~~l~~l-~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~ 186 (266)
T d1p9ag_ 109 FNRLTSLPLGALRGLGEL-QELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-T 186 (266)
T ss_dssp SSCCCCCCSSTTTTCTTC-CEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-C
T ss_pred ccccceeecccccccccc-ccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-c
Confidence 555553333333333333 34444444444344444445555555555555555544455555555555555555555 4
Q ss_pred cCCCcCCCCCCCEEECCCCcCC
Q 039533 479 ISSSLGSLRGLRVLDLSQNNLS 500 (949)
Q Consensus 479 ~~~~~~~l~~L~~L~Ls~N~l~ 500 (949)
+|..+..+++|+.|+|++|.+.
T Consensus 187 lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 187 IPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp CCTTTTTTCCCSEEECCSCCBC
T ss_pred cChhHCCCCCCCEEEecCCCCC
Confidence 5555555555555555555554
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=3.3e-23 Score=217.85 Aligned_cols=205 Identities=24% Similarity=0.252 Sum_probs=178.6
Q ss_pred ccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccC
Q 039533 263 CSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQ 342 (949)
Q Consensus 263 ~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 342 (949)
|.+.+.+.+..++.++++++. +|..+ ++++++|+|++|+|++..+..|.++++|++|+|++|+|+. +| .++.++
T Consensus 4 C~~~~~~~~~~v~C~~~~L~~-iP~~l---p~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~ 77 (266)
T d1p9ag_ 4 CEVSKVASHLEVNCDKRNLTA-LPPDL---PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLP 77 (266)
T ss_dssp SEEECSTTCCEEECTTSCCSS-CCSCC---CTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCT
T ss_pred cEEcccCCCeEEEccCCCCCe-eCcCc---CcCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-cccccc
Confidence 455666777788999999985 56543 4679999999999997777889999999999999999984 44 357899
Q ss_pred CCCEEecCCcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeecc
Q 039533 343 NLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDW 422 (949)
Q Consensus 343 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~l 422 (949)
+|+.|+|++|+++ ..+..+.++++|+.|++++|.+.+..+..+..+.++++|++++|.+++..+..+..++.+ ..+++
T Consensus 78 ~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l-~~l~l 155 (266)
T d1p9ag_ 78 VLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKL-EKLSL 155 (266)
T ss_dssp TCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTC-CEEEC
T ss_pred ccccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccc-hhccc
Confidence 9999999999998 567789999999999999999998888899999999999999999996666666677888 78999
Q ss_pred CCCccCCCCccccccccccceeeeccccccccCCcccccccchhhcccCccccc
Q 039533 423 SRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQ 476 (949)
Q Consensus 423 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 476 (949)
++|++++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.+.
T Consensus 156 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp TTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred ccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 999999888888999999999999999999 88988999999999999999876
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=6.2e-22 Score=196.54 Aligned_cols=169 Identities=20% Similarity=0.128 Sum_probs=120.7
Q ss_pred CCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCc------------------chHHHHHHHHHHHhcCCCcceeEE
Q 039533 628 FSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHG------------------ASRSFIAECKALKSIRHRNLVKVL 689 (949)
Q Consensus 628 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~h~niv~~~ 689 (949)
+.+.++||+|+||+||+|++. +|+.||||+++..... ......+|...+.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 346789999999999999986 6899999997532110 012345788899999999999887
Q ss_pred eeeecccccCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 039533 690 TACLGADYRGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDCQPVTAHCDLKP 769 (949)
Q Consensus 690 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivHrDlkp 769 (949)
++. ..++||||+++..+.++ +...+..++.|+++|++|||++ +|+||||||
T Consensus 81 ~~~---------~~~lvme~~~~~~~~~l-----------------~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP 131 (191)
T d1zara2 81 AWE---------GNAVLMELIDAKELYRV-----------------RVENPDEVLDMILEEVAKFYHR---GIVHGDLSQ 131 (191)
T ss_dssp EEE---------TTEEEEECCCCEEGGGC-----------------CCSCHHHHHHHHHHHHHHHHHT---TEECSCCST
T ss_pred Eec---------CCEEEEEeeccccccch-----------------hhHHHHHHHHHHHHHHHHHhhC---CEEEccCCh
Confidence 652 34799999987655432 2234567999999999999987 999999999
Q ss_pred CCeeecCCCceEEeecccceecCCCCCccccc-cccCccCccCccccCCCccCCccchHHHHHHH
Q 039533 770 SNVLLDDYMTARVGDFGLARILSPDHTQTSSF-SVKGSLGYIAPEYGVGCEVSTNGDVYSYGILL 833 (949)
Q Consensus 770 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDiwSlGvvl 833 (949)
+|||++++ .++|+|||.|+....+....... ..... .|. ....|+.++|+||..--+
T Consensus 132 ~NILv~~~-~~~liDFG~a~~~~~~~~~~~l~rd~~~~-----~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 132 YNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVRNI-----ITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TSEEEETT-EEEECCCTTCEETTSTTHHHHHHHHHHHH-----HHH-HHHHHCCCCCHHHHHHHH
T ss_pred hheeeeCC-CEEEEECCCcccCCCCCcHHHHHHHHHHH-----HHH-HcCCCCCcccHHHHHHHH
Confidence 99999975 58999999998765433211000 00000 011 134678999999975443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.83 E-value=5.6e-19 Score=193.51 Aligned_cols=168 Identities=26% Similarity=0.273 Sum_probs=81.0
Q ss_pred cEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecccc
Q 039533 297 KTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDN 376 (949)
Q Consensus 297 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 376 (949)
+.+...++.+. .++ .+..++.|+.+++++|... .+|.. ..++..+.+.+|++.. .+.. ...+...++..|
T Consensus 185 ~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~-~~~~~---~~~l~~~~~~~~~~~~-~~~~---~~~l~~~~~~~~ 254 (353)
T d1jl5a_ 185 ESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLK-TLPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSEN 254 (353)
T ss_dssp CEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCS-SCCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSS
T ss_pred ccccccccccc-ccc-ccccccccccccccccccc-ccccc---cccccccccccccccc-cccc---cccccccccccc
Confidence 34444444443 222 2445556666666666554 23322 2345555566655542 2222 223333444443
Q ss_pred cccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccCC
Q 039533 377 FLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIP 456 (949)
Q Consensus 377 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 456 (949)
.+.+. +.. .......++..|.+.+ ++. .+++| ++|++++|+|+ .+|.. +++|+.|+|++|+|+ .+|
T Consensus 255 ~~~~l-~~l---~~~~~~~~~~~~~~~~-~~~---~~~~L-~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~ 320 (353)
T d1jl5a_ 255 IFSGL-SEL---PPNLYYLNASSNEIRS-LCD---LPPSL-EELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVP 320 (353)
T ss_dssp CCSEE-SCC---CTTCCEEECCSSCCSE-ECC---CCTTC-CEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCC
T ss_pred ccccc-ccc---cchhcccccccCcccc-ccc---cCCCC-CEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccc
Confidence 33321 100 1223444555555442 221 12344 55666666666 44432 456677777777776 455
Q ss_pred cccccccchhhcccCccccccccCCCcCCCCCCCEEECC
Q 039533 457 STFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLS 495 (949)
Q Consensus 457 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls 495 (949)
.. +++|++|+|++|+|+ .+|.. ..+|+.|.+.
T Consensus 321 ~~---~~~L~~L~L~~N~L~-~lp~~---~~~L~~L~~~ 352 (353)
T d1jl5a_ 321 EL---PQNLKQLHVEYNPLR-EFPDI---PESVEDLRMN 352 (353)
T ss_dssp CC---CTTCCEEECCSSCCS-SCCCC---CTTCCEEECC
T ss_pred cc---cCCCCEEECcCCcCC-CCCcc---ccccCeeECc
Confidence 43 346777777777776 45543 2345566553
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.83 E-value=5.4e-19 Score=193.59 Aligned_cols=299 Identities=23% Similarity=0.290 Sum_probs=150.7
Q ss_pred CCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECC
Q 039533 90 FLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLG 169 (949)
Q Consensus 90 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls 169 (949)
++++|||++|+++ .+|+. +++|++|+|++|+|+ .+|+.+ .+|+.|+++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---------------------------~~L~~L~l~ 86 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---------------------------QSLKSLLVD 86 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---------------------------TTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---------------------------hhhhhhhhh
Confidence 4556666666665 45542 345666666666665 445432 244666677
Q ss_pred CCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCcccccccccccCCCCChhhhccccccccccC
Q 039533 170 SNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSN 249 (949)
Q Consensus 170 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N 249 (949)
+|+++ .++.- .+.|++|+|++|.++ .+|. ++.+++|++|++++|.+...+..
T Consensus 87 ~n~l~-~l~~l---p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~~---------------------- 138 (353)
T d1jl5a_ 87 NNNLK-ALSDL---PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPDL---------------------- 138 (353)
T ss_dssp SSCCS-CCCSC---CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCCC----------------------
T ss_pred hcccc-hhhhh---ccccccccccccccc-cccc-hhhhccceeeccccccccccccc----------------------
Confidence 77666 33321 135788888888887 4553 56777888888777765432210
Q ss_pred CCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeecce
Q 039533 250 SLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQ 329 (949)
Q Consensus 250 ~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 329 (949)
...+..+.+..+.... +..+..+ ..++.|++++|.+.. .+.. ....+.+...++.
T Consensus 139 ------------------~~~l~~l~~~~~~~~~--~~~l~~l-~~l~~L~l~~n~~~~-~~~~---~~~~~~l~~~~~~ 193 (353)
T d1jl5a_ 139 ------------------PPSLEFIAAGNNQLEE--LPELQNL-PFLTAIYADNNSLKK-LPDL---PLSLESIVAGNNI 193 (353)
T ss_dssp ------------------CTTCCEEECCSSCCSS--CCCCTTC-TTCCEEECCSSCCSS-CCCC---CTTCCEEECCSSC
T ss_pred ------------------cccccchhhccccccc--ccccccc-ccceecccccccccc-cccc---ccccccccccccc
Confidence 1223334443333321 1222222 346667777776653 2221 1233455555555
Q ss_pred ecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCc
Q 039533 330 LSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQ 409 (949)
Q Consensus 330 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 409 (949)
+. .++ .+..++.|+.+++++|... .+|.. ..++..+.+.+|.+.. .+.. ...+...++..|.+.+
T Consensus 194 ~~-~~~-~~~~l~~L~~l~l~~n~~~-~~~~~---~~~l~~~~~~~~~~~~-~~~~---~~~l~~~~~~~~~~~~----- 258 (353)
T d1jl5a_ 194 LE-ELP-ELQNLPFLTTIYADNNLLK-TLPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSG----- 258 (353)
T ss_dssp CS-SCC-CCTTCTTCCEEECCSSCCS-SCCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSE-----
T ss_pred cc-ccc-ccccccccccccccccccc-ccccc---cccccccccccccccc-cccc---cccccccccccccccc-----
Confidence 54 333 3455666777777776665 23332 3345555566665542 2221 2345555555555442
Q ss_pred ccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccCCcccccccchhhcccCccccccccCCCcCCCCCC
Q 039533 410 FFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGL 489 (949)
Q Consensus 410 ~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 489 (949)
+..+.......++..|.+.+. ...+++|++|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|.. +++|
T Consensus 259 l~~l~~~~~~~~~~~~~~~~~----~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L 326 (353)
T d1jl5a_ 259 LSELPPNLYYLNASSNEIRSL----CDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNL 326 (353)
T ss_dssp ESCCCTTCCEEECCSSCCSEE----CCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTC
T ss_pred cccccchhcccccccCccccc----cccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCC
Confidence 111111113344445544421 123455666666666665 44432 344555556666555 33432 3355
Q ss_pred CEEECCCCcCC
Q 039533 490 RVLDLSQNNLS 500 (949)
Q Consensus 490 ~~L~Ls~N~l~ 500 (949)
+.|+|++|+|+
T Consensus 327 ~~L~L~~N~L~ 337 (353)
T d1jl5a_ 327 KQLHVEYNPLR 337 (353)
T ss_dssp CEEECCSSCCS
T ss_pred CEEECcCCcCC
Confidence 55555555555
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=8.8e-19 Score=181.04 Aligned_cols=216 Identities=16% Similarity=0.111 Sum_probs=110.7
Q ss_pred EEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCccccccc-Ccccccccccceeecc-c
Q 039533 298 TLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNI-PPSIGNLKMLLNLFLN-D 375 (949)
Q Consensus 298 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~-~ 375 (949)
.++.+++.++ .+|..+. +++++|+|++|+|+...+.+|.++++|++|+|++|.+...+ +..|.++++++++.+. .
T Consensus 12 ~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~ 88 (242)
T d1xwdc1 12 VFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88 (242)
T ss_dssp EEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred EEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence 3444444444 3333331 34555555555555333344555555555555555554332 2344555555555543 2
Q ss_pred ccccccCCCCCCCCCCCcEEEeeCccccCCCCCcc-cCCcccceeeccCCCccCCCCcccccccc-ccceeeeccccccc
Q 039533 376 NFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQF-FSLSSLSISLDWSRNKLTGSLPIEVGKLK-ILEFLYVYENRLEG 453 (949)
Q Consensus 376 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~~l~~~L~ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~ 453 (949)
|.+....+..|.++++|++|++++|++....+..+ ..+..+ ..+..+++.+....+..+.+++ .++.|++++|+++.
T Consensus 89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l-~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~ 167 (242)
T d1xwdc1 89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKV-LLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 167 (242)
T ss_dssp TTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCE-EEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred ccccccccccccccccccccccchhhhccccccccccccccc-ccccccccccccccccccccccccceeeecccccccc
Confidence 44544455555555555555555555542222221 122233 3444455555544444454443 56667777777774
Q ss_pred cCCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCCcCcccccCCc-cceEeC
Q 039533 454 EIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSGEIPKFLAGLS-LNNLNL 517 (949)
Q Consensus 454 ~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~l~l 517 (949)
..+..|.....++.+++++|+++...+..|.++++|++|||++|+|+...+..+..+. |+.+++
T Consensus 168 i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 168 IHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp ECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred cccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence 4333333332333445667777755555677778888888888888755455555544 444443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=3.9e-19 Score=183.74 Aligned_cols=221 Identities=21% Similarity=0.199 Sum_probs=113.3
Q ss_pred ceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECCCC
Q 039533 92 KQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSN 171 (949)
Q Consensus 92 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N 171 (949)
+.++.++++++ .+|..+. +++++|||++|+|+...+..|.++++| ++|+|++|
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L------------------------~~L~ls~n 63 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDL------------------------EKIEISQN 63 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTC------------------------CEEEEESC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchh------------------------hhhhhccc
Confidence 45566666665 5554442 356666666666653222344555555 55555555
Q ss_pred CCCCCCC-CCcCCCCCccEEecc-ccccCCCCCCcccCCCccccccccCcccccccccccCCCCChhhhccccccccccC
Q 039533 172 HLTGSIP-SSLGNLSSIHTISLA-YNNLDGTIPNSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSN 249 (949)
Q Consensus 172 ~l~~~~p-~~~~~l~~L~~L~L~-~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N 249 (949)
.+...+| ..|.+++.+++|++. .|++....+..|.++++|++|++++|.+...+. ..
T Consensus 64 ~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~--------~~------------- 122 (242)
T d1xwdc1 64 DVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPD--------VH------------- 122 (242)
T ss_dssp TTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCC--------CT-------------
T ss_pred cccceeeccccccccccccccccccccccccccccccccccccccccchhhhccccc--------cc-------------
Confidence 4443322 234445555555443 244444444445555555555555544432210 00
Q ss_pred CCCCCCCCCcchhccccccCcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEE-Eeecc
Q 039533 250 SLGSGGNDDLSFLCSLTNATRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRL-DMWNN 328 (949)
Q Consensus 250 ~l~~~~~~~~~~~~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L-~L~~N 328 (949)
.+..+..+..+..+++++....+..+..++..++.|++++|+++...+. ....++++.+ ++++|
T Consensus 123 --------------~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~-~~~~~~l~~~~~l~~n 187 (242)
T d1xwdc1 123 --------------KIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNC-AFNGTQLDELNLSDNN 187 (242)
T ss_dssp --------------TTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTT-TTTTCCEEEEECTTCT
T ss_pred --------------ccccccccccccccccccccccccccccccccceeeecccccccccccc-cccchhhhcccccccc
Confidence 0111222333344444444444444444444567777777777743333 3334444444 45667
Q ss_pred eecccCCCcccccCCCCEEecCCcccccccCcccccccccceeeccc
Q 039533 329 QLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLND 375 (949)
Q Consensus 329 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 375 (949)
+|+...+..|.++++|++|+|++|+|+...+..|.++++|+.+++.+
T Consensus 188 ~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp TCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred ccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence 77744445677777777777777777754445566666666666543
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=7.6e-19 Score=179.41 Aligned_cols=96 Identities=27% Similarity=0.432 Sum_probs=57.3
Q ss_pred cccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecc
Q 039533 295 TIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLN 374 (949)
Q Consensus 295 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 374 (949)
.++.+.++.+.+.... .+..+++|++|++++|.+++.. .++++++|+.|+|++|++++ ++ .++++++|++|+|+
T Consensus 130 ~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls 203 (227)
T d1h6ua2 130 NLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLK 203 (227)
T ss_dssp TCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECT
T ss_pred chhhhhchhhhhchhh--hhccccccccccccccccccch--hhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECc
Confidence 3555555555554322 2455566666666666665322 25666677777777777664 22 26666777777777
Q ss_pred cccccccCCCCCCCCCCCcEEEee
Q 039533 375 DNFLEVSIPSSLGQCESLIEINLS 398 (949)
Q Consensus 375 ~N~l~~~~p~~~~~l~~L~~L~l~ 398 (949)
+|++++..| +.++++|++|+++
T Consensus 204 ~N~lt~i~~--l~~l~~L~~L~ls 225 (227)
T d1h6ua2 204 NNQISDVSP--LANTSNLFIVTLT 225 (227)
T ss_dssp TSCCCBCGG--GTTCTTCCEEEEE
T ss_pred CCcCCCCcc--cccCCCCCEEEee
Confidence 777664332 6667777777765
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=4.4e-22 Score=226.98 Aligned_cols=210 Identities=18% Similarity=0.139 Sum_probs=109.2
Q ss_pred cccEEEccCccccCC----CCCCCCCCCcccEEEeecceecc-----cCCCcccccCCCCEEecCCcccccc----cCcc
Q 039533 295 TIKTLFLNNNKIYGS----IPAGIGNFVNLQRLDMWNNQLSG-----TIPPAIGELQNLKILGLNRNKLSGN----IPPS 361 (949)
Q Consensus 295 ~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~-----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~ 361 (949)
....+++..+.+... ....+...+.++.+++++|.+.. ..+..+.....++.|++++|.+... ....
T Consensus 199 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~ 278 (460)
T d1z7xw1 199 QLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRV 278 (460)
T ss_dssp CCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred cccccccccccccchhhhcccccccccccccccchhhccccccccchhhccccccccccccccccccccccccccccccc
Confidence 345566665554321 11123345566777777776532 1222333455677777777766532 1223
Q ss_pred cccccccceeecccccccccCCCC-----CCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccc
Q 039533 362 IGNLKMLLNLFLNDNFLEVSIPSS-----LGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVG 436 (949)
Q Consensus 362 ~~~l~~L~~L~L~~N~l~~~~p~~-----~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~ 436 (949)
+...+.++.+++++|.++...... ......|+.+++++|.++..-... +...+.
T Consensus 279 l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~---------------------l~~~~~ 337 (460)
T d1z7xw1 279 LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSH---------------------FSSVLA 337 (460)
T ss_dssp HHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHH---------------------HHHHHH
T ss_pred ccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhh---------------------cccccc
Confidence 344556666666666654221111 112245666666666554211110 111223
Q ss_pred cccccceeeecccccccc----CCcccc-cccchhhcccCccccccc----cCCCcCCCCCCCEEECCCCcCCCcCccc-
Q 039533 437 KLKILEFLYVYENRLEGE----IPSTFG-NCIRLEQLGMGGNLFQGP----ISSSLGSLRGLRVLDLSQNNLSGEIPKF- 506 (949)
Q Consensus 437 ~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~- 506 (949)
..++|++|+|++|+++.. ++..+. ..+.|+.|+|++|.|+.. ++..+..+++|++|||++|+|+......
T Consensus 338 ~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l 417 (460)
T d1z7xw1 338 QNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL 417 (460)
T ss_dssp HCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHH
T ss_pred cccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHH
Confidence 344566777777766532 222222 345577777777777632 3445556677888888888876432222
Q ss_pred ---cc--CCccceEeCCCCcCcCc
Q 039533 507 ---LA--GLSLNNLNLSYNDLEGM 525 (949)
Q Consensus 507 ---~~--~~~L~~l~ls~N~l~~~ 525 (949)
+. ...|+.|++++|.+...
T Consensus 418 ~~~l~~~~~~L~~l~l~~~~~~~~ 441 (460)
T d1z7xw1 418 VESVRQPGCLLEQLVLYDIYWSEE 441 (460)
T ss_dssp HHHHTSTTCCCCEEECTTCCCCHH
T ss_pred HHHHHhCCCccCEEECCCCCCCHH
Confidence 21 11377888888877654
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=1e-18 Score=178.43 Aligned_cols=98 Identities=21% Similarity=0.355 Sum_probs=68.7
Q ss_pred CcccEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEe
Q 039533 269 TRLTWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILG 348 (949)
Q Consensus 269 ~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 348 (949)
+.+..++++++.+....+ +... ++|++|++++|++.... .++++++|++|+|++|++++ ++ .++++++|++|+
T Consensus 129 ~~~~~l~~~~~~~~~~~~--~~~~-~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~ 201 (227)
T d1h6ua2 129 SNLQVLYLDLNQITNISP--LAGL-TNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVH 201 (227)
T ss_dssp TTCCEEECCSSCCCCCGG--GGGC-TTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEE
T ss_pred cchhhhhchhhhhchhhh--hccc-cccccccccccccccch--hhcccccceecccCCCccCC-Ch-hhcCCCCCCEEE
Confidence 344555555555543322 2333 45888888888876432 37788899999999999885 33 378889999999
Q ss_pred cCCcccccccCcccccccccceeeccc
Q 039533 349 LNRNKLSGNIPPSIGNLKMLLNLFLND 375 (949)
Q Consensus 349 Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 375 (949)
|++|+|++. + .+.++++|+.|++++
T Consensus 202 Ls~N~lt~i-~-~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 202 LKNNQISDV-S-PLANTSNLFIVTLTN 226 (227)
T ss_dssp CTTSCCCBC-G-GGTTCTTCCEEEEEE
T ss_pred CcCCcCCCC-c-ccccCCCCCEEEeeC
Confidence 999998854 3 388889999998864
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.75 E-value=2e-18 Score=171.00 Aligned_cols=128 Identities=25% Similarity=0.333 Sum_probs=79.5
Q ss_pred cEEEccCCCCCccCCchhhcccccccEEEccCccccCCC-CCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecC
Q 039533 272 TWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSI-PAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLN 350 (949)
Q Consensus 272 ~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 350 (949)
+.++.++|+++. +|.. ++.++++|+|++|+|++.+ +..|..+++|++|+|++|.+.+..+..|..+++|++|+|+
T Consensus 11 ~~v~Cs~~~L~~-iP~~---lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 11 TTVDCTGRGLKE-IPRD---IPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TEEECTTSCCSS-CCSC---CCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CEEEEeCCCcCc-cCCC---CCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 456677776663 3432 2345666666666665433 4445666666666666666666666666666666666666
Q ss_pred CcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCcccc
Q 039533 351 RNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLS 403 (949)
Q Consensus 351 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 403 (949)
+|+|++..|..|.++++|++|+|++|+|++..|++|..+++|++|+|++|.+.
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccc
Confidence 66666555556666666666666666666666666666666666666666554
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.74 E-value=2.2e-18 Score=170.76 Aligned_cols=174 Identities=21% Similarity=0.237 Sum_probs=115.5
Q ss_pred ccEEEccCccccCCCCCCCCCCCcccEEEeecceecccC-CCcccccCCCCEEecCCcccccccCcccccccccceeecc
Q 039533 296 IKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTI-PPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLN 374 (949)
Q Consensus 296 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 374 (949)
.+++++++|+++ .+|..+. +++++|+|++|+|++.+ +..|.++++|+.|+|++|++.+..+..|..+++|++|+|+
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 457888888888 5676553 57888888888887544 5667888888888888888887777788888888888888
Q ss_pred cccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeecccccccc
Q 039533 375 DNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGE 454 (949)
Q Consensus 375 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 454 (949)
+|+|+...|.+|.++++|++|+|++|+|++..|..|..+ ++|++|+|++|.+...
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l-------------------------~~L~~l~L~~N~~~~~ 141 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHL-------------------------NSLTSLNLASNPFNCN 141 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTC-------------------------TTCCEEECTTCCBCCS
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCC-------------------------cccccccccccccccc
Confidence 888887777778888888888877777774444444444 4455555555555432
Q ss_pred CCcccccccchhhcccCccccccccCCCcCCCCCCCEEECCCCcCCC
Q 039533 455 IPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLSQNNLSG 501 (949)
Q Consensus 455 ~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 501 (949)
. ....-...++.+.+..|.++...|.. +.+++.+||+.|.|+-
T Consensus 142 ~-~~~~~~~~l~~~~l~~~~~~c~~p~~---l~~~~l~~L~~n~l~C 184 (192)
T d1w8aa_ 142 C-HLAWFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFKC 184 (192)
T ss_dssp G-GGHHHHHHHHHHCCSGGGCBBCSSTT---TTTSBGGGSCTTTCCC
T ss_pred c-chHHHhhhhhhhcccCCCeEeCCChh---hcCCEeeecCHhhCcC
Confidence 2 11111234555666666666555543 3344555666666653
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=7.6e-18 Score=169.34 Aligned_cols=179 Identities=25% Similarity=0.362 Sum_probs=88.8
Q ss_pred EccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCccc
Q 039533 275 HINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKL 354 (949)
Q Consensus 275 ~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 354 (949)
+++.+.+++.++. ..+ .+|++|++++|.++.. + .+..+++|++|+|++|+|++.. .++.+++|+.|++++|+|
T Consensus 30 ~l~~~~~~~~~~~--~~L-~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i 102 (210)
T d1h6ta2 30 NLKKKSVTDAVTQ--NEL-NSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKV 102 (210)
T ss_dssp HTTCSCTTSEECH--HHH-HTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred HhCcCccCCccCH--HHh-cCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccc
Confidence 3444555444332 112 2355555555555432 1 2445555555555555555322 234555555555555555
Q ss_pred ccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccc
Q 039533 355 SGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIE 434 (949)
Q Consensus 355 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~ 434 (949)
++ +| .+.++++|+.|++++|.+.. ...+..+++|+.+++++|. +++ +..
T Consensus 103 ~~-l~-~l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~-------------------------l~~--~~~ 151 (210)
T d1h6ta2 103 KD-LS-SLKDLKKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNK-------------------------ITD--ITV 151 (210)
T ss_dssp CC-GG-GGTTCTTCCEEECTTSCCCC--CGGGGGCTTCCEEECCSSC-------------------------CCC--CGG
T ss_pred cc-cc-cccccccccccccccccccc--ccccccccccccccccccc-------------------------ccc--ccc
Confidence 52 22 24444445555554444431 1123344444444444444 432 123
Q ss_pred cccccccceeeeccccccccCCcccccccchhhcccCccccccccCCCcCCCCCCCEEECC
Q 039533 435 VGKLKILEFLYVYENRLEGEIPSTFGNCIRLEQLGMGGNLFQGPISSSLGSLRGLRVLDLS 495 (949)
Q Consensus 435 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls 495 (949)
+..+++|+++++++|++++ ++ .++++++|+.|+|++|+++. +| .|.++++|++|+|+
T Consensus 152 ~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 152 LSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp GGGCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred ccccccccccccccccccc-cc-cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence 4455666666666666663 22 25666666666666666663 33 46666666666665
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=2.1e-17 Score=166.08 Aligned_cols=59 Identities=17% Similarity=0.281 Sum_probs=34.6
Q ss_pred CCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCcccc
Q 039533 160 LSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNLS 222 (949)
Q Consensus 160 L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 222 (949)
|.+|++|++++|.++. ++ .+..+++|++|+|++|+|++.. .++.+++|++|++++|+|+
T Consensus 45 L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~ 103 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVK 103 (210)
T ss_dssp HHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred hcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCcc--ccccCcccccccccccccc
Confidence 4455666666666663 22 3566666666666666666432 2455666666666666554
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.67 E-value=1.1e-16 Score=159.18 Aligned_cols=145 Identities=29% Similarity=0.400 Sum_probs=78.0
Q ss_pred cccEEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecc
Q 039533 295 TIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLN 374 (949)
Q Consensus 295 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 374 (949)
++++|++++|.|+. + +.+..+++|++|++++|++++..| ++++++|+.|++++|.+.. ++ .+.++++|+.|+++
T Consensus 41 ~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l~ 114 (199)
T d2omxa2 41 QVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTLF 114 (199)
T ss_dssp TCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECC
T ss_pred CCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-cccccccccccccc
Confidence 46666666666653 2 235666677777777777764332 6666777777777776653 22 35666666666666
Q ss_pred cccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeecccccc
Q 039533 375 DNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLE 452 (949)
Q Consensus 375 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 452 (949)
+|.+... ..+..+++|+.|++++|++. .++ .+..++++ +.|++++|++++. + .++++++|++|++++|+++
T Consensus 115 ~~~~~~~--~~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L-~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~ 185 (199)
T d2omxa2 115 NNQITDI--DPLKNLTNLNRLELSSNTIS-DIS-ALSGLTSL-QQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVS 185 (199)
T ss_dssp SSCCCCC--GGGTTCTTCSEEECCSSCCC-CCG-GGTTCTTC-SEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC
T ss_pred ccccccc--cccchhhhhHHhhhhhhhhc-ccc-cccccccc-cccccccccccCC-c-cccCCCCCCEEECCCCCCC
Confidence 6665532 23555666666666666654 222 23334444 3444444444421 1 1334444444444444443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=3.7e-20 Score=210.83 Aligned_cols=381 Identities=18% Similarity=0.178 Sum_probs=182.9
Q ss_pred cEEEEEcCCCCCCccc-cCCCCCCCCCceeeccCceecc----ccCCcccCcccCcEEeeccccccCc----CCCCCC-C
Q 039533 66 RVTLLDLRSLKLAGSV-SHFIGNLSFLKQLYLQVNSFTH----EIPSEIGGLRRLKVLALNNNSICGE----IPTNIS-R 135 (949)
Q Consensus 66 ~v~~l~l~~~~l~g~~-~~~l~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~-~ 135 (949)
++..||++++++++.. ...+..+++++.|+|++|+++. .++..+..+++|++|||++|.|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 5677888888776642 3345566777788888887763 3455566777788888887777521 222222 2
Q ss_pred CccceeecCCCcccccc----ccccccCCCCCcEEECCCCCCCCCCCCCc-----CCCCCccEEeccccccCCCC----C
Q 039533 136 CSTLIPIHPQNNQLVGK----ILSRFSSLSKTEILNLGSNHLTGSIPSSL-----GNLSSIHTISLAYNNLDGTI----P 202 (949)
Q Consensus 136 l~~L~~L~l~~n~l~~~----~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~~----p 202 (949)
..+|++|++++|+++.. ++..+..+++|++|+|++|.++......+ ........+......+.... -
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 162 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccc
Confidence 23566667766666543 23445566666666666666652111000 01111222222222221000 0
Q ss_pred CcccCCCccccccccCcccccccccccCCCCChhhhccccccccccCCCCCCCCCCcchhccc-cccCcccEEEccCCCC
Q 039533 203 NSFGWFENLVFLSLAANNLSVVENKLTGEVPSLEKLQRLQHFTITSNSLGSGGNDDLSFLCSL-TNATRLTWMHINSNNF 281 (949)
Q Consensus 203 ~~~~~l~~L~~L~Ls~N~l~~~~~~l~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l-~~~~~L~~L~L~~N~l 281 (949)
..+.....++.++++.+.+...... . ....+ ........+++..+.+
T Consensus 163 ~~l~~~~~~~~~~ls~~~~~~~~~~------------------------------~--~~~~l~~~~~~~~~l~~~~~~~ 210 (460)
T d1z7xw1 163 SVLRAKPDFKELTVSNNDINEAGVR------------------------------V--LCQGLKDSPCQLEALKLESCGV 210 (460)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHH------------------------------H--HHHHHHHSCCCCCEEECTTSCC
T ss_pred ccccccccccccccccccccccccc------------------------------c--cccccccccccccccccccccc
Confidence 0112223344444444332211000 0 00000 0111233444444433
Q ss_pred CccCC----chhhcccccccEEEccCccccC-----CCCCCCCCCCcccEEEeecceeccc----CCCcccccCCCCEEe
Q 039533 282 GGLLP----GCISNLSKTIKTLFLNNNKIYG-----SIPAGIGNFVNLQRLDMWNNQLSGT----IPPAIGELQNLKILG 348 (949)
Q Consensus 282 ~~~~p----~~~~~l~~~L~~L~L~~N~l~~-----~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~ 348 (949)
..... ..+.. ...++.+++++|++.. ..+........|+.|++++|.+... ....+...+.++.++
T Consensus 211 ~~~~~~~~~~~l~~-~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~ 289 (460)
T d1z7xw1 211 TSDNCRDLCGIVAS-KASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELS 289 (460)
T ss_dssp BTTHHHHHHHHHHH-CTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEE
T ss_pred cchhhhcccccccc-cccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccc
Confidence 32110 01111 1235555555555421 1122223344566666666655422 112233455666666
Q ss_pred cCCcccccccCccc-----ccccccceeecccccccccCCC----CCCCCCCCcEEEeeCccccCC----CCCcccC-Cc
Q 039533 349 LNRNKLSGNIPPSI-----GNLKMLLNLFLNDNFLEVSIPS----SLGQCESLIEINLSNNNLSGT----IPPQFFS-LS 414 (949)
Q Consensus 349 Ls~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~l~~N~l~~~----~p~~~~~-l~ 414 (949)
+++|.++......+ .....|+.+++++|.++..... .+...++|++|+|++|+++.. ++..+.. ..
T Consensus 290 l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~ 369 (460)
T d1z7xw1 290 LAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGS 369 (460)
T ss_dssp CTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTC
T ss_pred cccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccC
Confidence 66666543211111 1234566666666665533211 223345677777777766521 2222322 23
Q ss_pred ccceeeccCCCccCCC----CccccccccccceeeeccccccccCCcccc-----cccchhhcccCccccccccC
Q 039533 415 SLSISLDWSRNKLTGS----LPIEVGKLKILEFLYVYENRLEGEIPSTFG-----NCIRLEQLGMGGNLFQGPIS 480 (949)
Q Consensus 415 ~l~~~L~ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~l~~N~l~~~~~ 480 (949)
.| +.|+|++|.|+.. ++..+...++|++|+|++|+|+......|. +...|+.|++.+|.+.....
T Consensus 370 ~L-~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~ 443 (460)
T d1z7xw1 370 VL-RVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEME 443 (460)
T ss_dssp CC-CEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHH
T ss_pred CC-CEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHHH
Confidence 34 5677777777632 344455667788888888887643332222 23368888888887764433
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.67 E-value=5.4e-17 Score=161.53 Aligned_cols=164 Identities=21% Similarity=0.337 Sum_probs=100.8
Q ss_pred EEEccCccccCCCCCCCCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeeccccc
Q 039533 298 TLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNF 377 (949)
Q Consensus 298 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 377 (949)
.+.++.+.+++.++ ...+.+|++|++++|.++. + +.+..+++|++|+|++|+|++..| ++++++|++|++++|.
T Consensus 22 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~ 95 (199)
T d2omxa2 22 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ 95 (199)
T ss_dssp HHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred HHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCcccccccccccc
Confidence 34566677765432 3457788899999998873 3 357788889999999998885433 7888888888888888
Q ss_pred ccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCcccceeeccCCCccCCCCccccccccccceeeeccccccccCCc
Q 039533 378 LEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLSSLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIPS 457 (949)
Q Consensus 378 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 457 (949)
+.. ++ .+.++++|+.|++++|.+... ..+..++++ +.|++++|++.. ++ .+..+++|+.|++++|++++. +
T Consensus 96 ~~~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L-~~L~l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~l-~- 166 (199)
T d2omxa2 96 IAD-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNL-NRLELSSNTISD-IS-ALSGLTSLQQLNFSSNQVTDL-K- 166 (199)
T ss_dssp CCC-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTC-SEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCC-G-
T ss_pred ccc-cc-ccccccccccccccccccccc--cccchhhhh-HHhhhhhhhhcc-cc-cccccccccccccccccccCC-c-
Confidence 763 33 377788888888888777632 224444444 445555555442 22 344444455555555544421 1
Q ss_pred ccccccchhhcccCccccc
Q 039533 458 TFGNCIRLEQLGMGGNLFQ 476 (949)
Q Consensus 458 ~~~~l~~L~~L~l~~N~l~ 476 (949)
.++++++|+.|++++|+++
T Consensus 167 ~l~~l~~L~~L~ls~N~i~ 185 (199)
T d2omxa2 167 PLANLTTLERLDISSNKVS 185 (199)
T ss_dssp GGTTCTTCCEEECCSSCCC
T ss_pred cccCCCCCCEEECCCCCCC
Confidence 1444444444444444444
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=2.3e-15 Score=143.40 Aligned_cols=128 Identities=16% Similarity=0.093 Sum_probs=92.2
Q ss_pred CCCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCC
Q 039533 84 FIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKT 163 (949)
Q Consensus 84 ~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L 163 (949)
.+.+...|++|+|++|+|+ .+|..+..+++|++||||+|+|+ .++ .|..+++|++|++++|+++...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence 4556777888888888887 45666677888888888888887 453 47778888888888888877776677777888
Q ss_pred cEEECCCCCCCCCCC-CCcCCCCCccEEeccccccCCCCCC----cccCCCcccccc
Q 039533 164 EILNLGSNHLTGSIP-SSLGNLSSIHTISLAYNNLDGTIPN----SFGWFENLVFLS 215 (949)
Q Consensus 164 ~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~ 215 (949)
+.|+|++|+|+.... ..+..+++|++|++++|.++ ..|. .+..+++|++||
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred ccceeccccccccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence 888888887773221 35667777777777777776 3332 456667777766
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.51 E-value=9.6e-15 Score=132.10 Aligned_cols=102 Identities=21% Similarity=0.229 Sum_probs=57.6
Q ss_pred ceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECCCC
Q 039533 92 KQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSN 171 (949)
Q Consensus 92 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N 171 (949)
|.|+|++|+++ .+| .++++++|++|||++|+|+ .+|..|+.+++|+.|++++|+|+... .|..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l~--~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVD--GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccccC--ccccccccCeEECCCC
Confidence 45666666666 344 3666667777777777666 45555666666655555555555431 3555555555555555
Q ss_pred CCCCCCC-CCcCCCCCccEEeccccccC
Q 039533 172 HLTGSIP-SSLGNLSSIHTISLAYNNLD 198 (949)
Q Consensus 172 ~l~~~~p-~~~~~l~~L~~L~L~~N~l~ 198 (949)
+|+.... ..++.+++|++|++++|.++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 5553221 34455555555555555554
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.49 E-value=2.3e-15 Score=158.44 Aligned_cols=58 Identities=19% Similarity=0.173 Sum_probs=30.5
Q ss_pred ccceeecCCCcccccc-ccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEeccc
Q 039533 137 STLIPIHPQNNQLVGK-ILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAY 194 (949)
Q Consensus 137 ~~L~~L~l~~n~l~~~-~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 194 (949)
.+|++||++++.+... ....+..+++|++|+|++|.+++..+..++.+++|++|+|++
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~ 104 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 104 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccc
Confidence 3444555554444322 233345555666666666665554445555555666666655
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=1.7e-15 Score=159.51 Aligned_cols=247 Identities=17% Similarity=0.184 Sum_probs=156.6
Q ss_pred cEEEccCCCCCccCCchhhcccccccEEEccCccccCCCCCCCCCCCcccEEEeecceeccc-CCCcccccCCCCEEecC
Q 039533 272 TWMHINSNNFGGLLPGCISNLSKTIKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNNQLSGT-IPPAIGELQNLKILGLN 350 (949)
Q Consensus 272 ~~L~L~~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls 350 (949)
+.+|++++.+.......+.. ..+..+.++...+..... ......+|++|||+++.+++. ++..+..+++|++|+|+
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~--~~~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~ 79 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLS--QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLE 79 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHH--TTCSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECT
T ss_pred CEEECCCCCCCchHHHHHHh--ccceEeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccc
Confidence 35677766654322222211 235667777766653333 334556899999999888743 34557788999999999
Q ss_pred CcccccccCcccccccccceeecccc-ccccc-CCCCCCCCCCCcEEEeeCc-cccCC-CCCcccCC-cccceeeccCCC
Q 039533 351 RNKLSGNIPPSIGNLKMLLNLFLNDN-FLEVS-IPSSLGQCESLIEINLSNN-NLSGT-IPPQFFSL-SSLSISLDWSRN 425 (949)
Q Consensus 351 ~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~l~~N-~l~~~-~p~~~~~l-~~l~~~L~ls~N 425 (949)
+|.+++..+..++.+++|++|+++++ .++.. +...+.++++|++|+++++ +++.. ++..+... +.+ +.|++++.
T Consensus 80 ~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L-~~L~l~~~ 158 (284)
T d2astb2 80 GLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETI-TQLNLSGY 158 (284)
T ss_dssp TCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTC-CEEECCSC
T ss_pred ccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhccccccc-chhhhccc
Confidence 99988877888888899999999885 45422 1222346788999999885 34311 11222222 344 67777754
Q ss_pred --ccCCC-Cccccccccccceeeeccc-cccccCCcccccccchhhcccCc-cccccccCCCcCCCCCCCEEECCCCcCC
Q 039533 426 --KLTGS-LPIEVGKLKILEFLYVYEN-RLEGEIPSTFGNCIRLEQLGMGG-NLFQGPISSSLGSLRGLRVLDLSQNNLS 500 (949)
Q Consensus 426 --~l~~~-~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 500 (949)
.++.. +.....++++|+.|++++| .+++..+..+..+++|++|+|++ +.+++.....++++++|+.|+++++ ++
T Consensus 159 ~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~ 237 (284)
T d2astb2 159 RKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP 237 (284)
T ss_dssp GGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC
T ss_pred ccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CC
Confidence 33321 2233456778888888875 46766777788888888888888 4677666667778888888888876 33
Q ss_pred CcCcccccCC--ccceEeCCCCcCcCcc
Q 039533 501 GEIPKFLAGL--SLNNLNLSYNDLEGMV 526 (949)
Q Consensus 501 ~~~p~~~~~~--~L~~l~ls~N~l~~~~ 526 (949)
. ..+..+ .+..|.+..+++++..
T Consensus 238 d---~~l~~l~~~lp~L~i~~~~ls~~~ 262 (284)
T d2astb2 238 D---GTLQLLKEALPHLQINCSHFTTIA 262 (284)
T ss_dssp T---TCHHHHHHHSTTSEESCCCSCCTT
T ss_pred H---HHHHHHHHhCccccccCccCCCCC
Confidence 1 111111 1445556666666653
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.46 E-value=2.6e-14 Score=129.16 Aligned_cols=105 Identities=21% Similarity=0.301 Sum_probs=89.3
Q ss_pred cEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEecccc
Q 039533 116 KVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISLAYN 195 (949)
Q Consensus 116 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 195 (949)
|+|||++|+|+ .+| .++++++|++|++++|+|+.. |..|+.+++|++|++++|.|++ +| .++++++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~l-p~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCCC-CGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccCcc-hhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 68999999998 555 489999999999999999864 5678999999999999999994 44 5889999999999999
Q ss_pred ccCCCC-CCcccCCCccccccccCccccccc
Q 039533 196 NLDGTI-PNSFGWFENLVFLSLAANNLSVVE 225 (949)
Q Consensus 196 ~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~ 225 (949)
+|+... ...++.+++|++|++++|+++..+
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~ 106 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEE 106 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcCc
Confidence 998543 257888999999999999987553
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.44 E-value=3.5e-14 Score=135.09 Aligned_cols=87 Identities=21% Similarity=0.227 Sum_probs=46.6
Q ss_pred CCCCCcccEEEeecceecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecccccccccCCCCCCCCCCCc
Q 039533 314 IGNFVNLQRLDMWNNQLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLI 393 (949)
Q Consensus 314 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 393 (949)
+.+..+|++|+|++|+|+ .++..+..+++|+.|+|++|+|+. ++ .|..+++|++|++++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCccccccccccc
Confidence 445555666666666665 345545556666666666666652 22 355555555555555555543333344455555
Q ss_pred EEEeeCcccc
Q 039533 394 EINLSNNNLS 403 (949)
Q Consensus 394 ~L~l~~N~l~ 403 (949)
+|++++|+++
T Consensus 91 ~L~L~~N~i~ 100 (162)
T d1a9na_ 91 ELILTNNSLV 100 (162)
T ss_dssp EEECCSCCCC
T ss_pred cceecccccc
Confidence 5555555544
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.39 E-value=5.4e-15 Score=160.77 Aligned_cols=109 Identities=24% Similarity=0.293 Sum_probs=66.5
Q ss_pred cccEEEccCccccCC-----CCCCCCCCCcccEEEeecceeccc----CCCcccccCCCCEEecCCcccccccCcc----
Q 039533 295 TIKTLFLNNNKIYGS-----IPAGIGNFVNLQRLDMWNNQLSGT----IPPAIGELQNLKILGLNRNKLSGNIPPS---- 361 (949)
Q Consensus 295 ~L~~L~L~~N~l~~~-----~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~---- 361 (949)
.|++|+|++|+|+.. +...+..+++|+.|+|++|.++.. +...+..+++|++|+|++|.|++.-...
T Consensus 187 ~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~ 266 (344)
T d2ca6a1 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDA 266 (344)
T ss_dssp TCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHH
T ss_pred hhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHH
Confidence 456666666655421 234456667777777777776532 2344566777778888887776532222
Q ss_pred ccc--ccccceeecccccccccC----CCCCC-CCCCCcEEEeeCcccc
Q 039533 362 IGN--LKMLLNLFLNDNFLEVSI----PSSLG-QCESLIEINLSNNNLS 403 (949)
Q Consensus 362 ~~~--l~~L~~L~L~~N~l~~~~----p~~~~-~l~~L~~L~l~~N~l~ 403 (949)
+.. .+.|++|++++|.|+... ...+. ++++|+.|+|++|++.
T Consensus 267 l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 267 FSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp HHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred hhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 222 346778888888775321 22222 4667888888888886
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.38 E-value=2.9e-15 Score=162.90 Aligned_cols=91 Identities=18% Similarity=0.243 Sum_probs=50.5
Q ss_pred cccccccceeeecccccccc----CCcccccccchhhcccCccccccccC----CCcC--CCCCCCEEECCCCcCCCc--
Q 039533 435 VGKLKILEFLYVYENRLEGE----IPSTFGNCIRLEQLGMGGNLFQGPIS----SSLG--SLRGLRVLDLSQNNLSGE-- 502 (949)
Q Consensus 435 ~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~~----~~~~--~l~~L~~L~Ls~N~l~~~-- 502 (949)
+...++|+.|+|++|.++.. +...+..+++|++|+|++|.|++.-. ..+. ..+.|+.||+++|+|+..
T Consensus 211 l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~ 290 (344)
T d2ca6a1 211 LAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAV 290 (344)
T ss_dssp GGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHH
T ss_pred hcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHH
Confidence 44455566666666655422 23344555666666666666654311 1222 235688888888887642
Q ss_pred --Cccccc-CC-ccceEeCCCCcCcCc
Q 039533 503 --IPKFLA-GL-SLNNLNLSYNDLEGM 525 (949)
Q Consensus 503 --~p~~~~-~~-~L~~l~ls~N~l~~~ 525 (949)
+...+. .. .|+.|+|++|.+...
T Consensus 291 ~~l~~~l~~~~~~L~~L~l~~N~~~~~ 317 (344)
T d2ca6a1 291 RTLKTVIDEKMPDLLFLELNGNRFSEE 317 (344)
T ss_dssp HHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred HHHHHHHHccCCCCCEEECCCCcCCCc
Confidence 222232 22 378888888888653
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.29 E-value=3.3e-14 Score=140.34 Aligned_cols=113 Identities=25% Similarity=0.339 Sum_probs=54.5
Q ss_pred CCcccccCCCCEEecCCcccccccCcccccccccceeecccccccccCCCCCCCCCCCcEEEeeCccccCCCCCcccCCc
Q 039533 335 PPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLNDNFLEVSIPSSLGQCESLIEINLSNNNLSGTIPPQFFSLS 414 (949)
Q Consensus 335 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 414 (949)
|..+..+++|+.|+|++|+|+ .++ .+.++++|+.|+|++|.|+ .+|..+..+++|++|++++|+++
T Consensus 41 ~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~----------- 106 (198)
T d1m9la_ 41 DATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA----------- 106 (198)
T ss_dssp HHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-----------
T ss_pred hhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-----------
Confidence 344555666666666666665 232 3555555555555555554 23333333334444444444443
Q ss_pred ccceeeccCCCccCCCCccccccccccceeeeccccccccCC-cccccccchhhcccCcccccc
Q 039533 415 SLSISLDWSRNKLTGSLPIEVGKLKILEFLYVYENRLEGEIP-STFGNCIRLEQLGMGGNLFQG 477 (949)
Q Consensus 415 ~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~ 477 (949)
. + ..+..+++|+.|++++|+|+.... ..+..+++|+.|+|++|.+..
T Consensus 107 --------------~-l-~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 107 --------------S-L-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp --------------C-H-HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred --------------c-c-ccccccccccccccccchhccccccccccCCCccceeecCCCcccc
Confidence 1 1 124445555555555555552111 234445555555555555443
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.28 E-value=9.4e-15 Score=144.29 Aligned_cols=114 Identities=25% Similarity=0.310 Sum_probs=78.2
Q ss_pred ccCCCCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCC
Q 039533 81 VSHFIGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSL 160 (949)
Q Consensus 81 ~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L 160 (949)
++.++..|++|++|+|++|+++ .++ .|.++++|++|+|++|.|+ .+|..+..+++|+.|++++|+|+.. +.+..+
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l 114 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKL 114 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHH
T ss_pred hhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--cccccc
Confidence 3445777888888888888887 454 5888888888888888887 5665555556677777777777653 236666
Q ss_pred CCCcEEECCCCCCCCCCC-CCcCCCCCccEEeccccccCC
Q 039533 161 SKTEILNLGSNHLTGSIP-SSLGNLSSIHTISLAYNNLDG 199 (949)
Q Consensus 161 ~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~ 199 (949)
++|++|+|++|+|+.... ..+..+++|++|+|++|.+..
T Consensus 115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred ccccccccccchhccccccccccCCCccceeecCCCcccc
Confidence 667777777777663211 345666666666666666653
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.28 E-value=4.2e-12 Score=119.56 Aligned_cols=106 Identities=23% Similarity=0.103 Sum_probs=67.2
Q ss_pred ccEEEccCccccCCCCCCCCCCCcccEEEeecc-eecccCCCcccccCCCCEEecCCcccccccCcccccccccceeecc
Q 039533 296 IKTLFLNNNKIYGSIPAGIGNFVNLQRLDMWNN-QLSGTIPPAIGELQNLKILGLNRNKLSGNIPPSIGNLKMLLNLFLN 374 (949)
Q Consensus 296 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 374 (949)
.+.++++++.+. ..|..+..+++|++|++++| .|+...+++|.++++|+.|+|++|+|+.+.|.+|.++++|++|+|+
T Consensus 10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence 345667776666 45666666777777777654 3665555667777777777777777776666666667777777777
Q ss_pred cccccccCCCCCCCCCCCcEEEeeCcccc
Q 039533 375 DNFLEVSIPSSLGQCESLIEINLSNNNLS 403 (949)
Q Consensus 375 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 403 (949)
+|+|+...+..|.. .+|+.|+|++|.+.
T Consensus 89 ~N~l~~l~~~~~~~-~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 89 FNALESLSWKTVQG-LSLQELVLSGNPLH 116 (156)
T ss_dssp SSCCSCCCSTTTCS-CCCCEEECCSSCCC
T ss_pred CCCCcccChhhhcc-ccccccccCCCccc
Confidence 77666444444433 35666666666653
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.24 E-value=9e-12 Score=117.27 Aligned_cols=106 Identities=16% Similarity=0.162 Sum_probs=65.9
Q ss_pred cCcEEeeccccccCcCCCCCCCCccceeecCCCc-cccccccccccCCCCCcEEECCCCCCCCCCCCCcCCCCCccEEec
Q 039533 114 RLKVLALNNNSICGEIPTNISRCSTLIPIHPQNN-QLVGKILSRFSSLSKTEILNLGSNHLTGSIPSSLGNLSSIHTISL 192 (949)
Q Consensus 114 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n-~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 192 (949)
....++.+++.+. .+|..+..+++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|+...|..|..+++|++|+|
T Consensus 9 ~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 87 (156)
T d2ifga3 9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (156)
T ss_dssp SSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred CCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceec
Confidence 3444555555555 45555555666666666444 355566666777777777777777777655666777777777777
Q ss_pred cccccCCCCCCcccCCCccccccccCccc
Q 039533 193 AYNNLDGTIPNSFGWFENLVFLSLAANNL 221 (949)
Q Consensus 193 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 221 (949)
++|+|+...+..|..+ +|++|+|++|.+
T Consensus 88 s~N~l~~l~~~~~~~~-~l~~L~L~~Np~ 115 (156)
T d2ifga3 88 SFNALESLSWKTVQGL-SLQELVLSGNPL 115 (156)
T ss_dssp CSSCCSCCCSTTTCSC-CCCEEECCSSCC
T ss_pred cCCCCcccChhhhccc-cccccccCCCcc
Confidence 7777774334444333 577777777665
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.42 E-value=2.9e-07 Score=94.27 Aligned_cols=150 Identities=16% Similarity=0.054 Sum_probs=102.5
Q ss_pred HHHHHHhcCCCCCCeeeeecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcC-CCcceeEEeeeecccc
Q 039533 619 QDLYNATSGFSSANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIR-HRNLVKVLTACLGADY 697 (949)
Q Consensus 619 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 697 (949)
.++......|+..+..+.++.+.||+... ++..+++|+...........+.+|...+..+. +--+.+++.+....
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~-- 82 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD-- 82 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET--
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecC--
Confidence 35666667777666555555678999864 45667889887555444556788988888774 43466777665433
Q ss_pred cCCccceeEeeeccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhCC-------------------
Q 039533 698 RGNDFKASVYEFMHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHDC------------------- 758 (949)
Q Consensus 698 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~------------------- 758 (949)
+..++||++++|.++.+.... ......++.++++.++.||+..
T Consensus 83 ---~~~~lv~~~l~G~~~~~~~~~---------------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~ 144 (263)
T d1j7la_ 83 ---GWSNLLMSEADGVLCSEEYED---------------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDY 144 (263)
T ss_dssp ---TEEEEEEECCSSEEHHHHTTT---------------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHH
T ss_pred ---CceEEEEEecccccccccccc---------------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHH
Confidence 367899999999888665431 0112335566666666666321
Q ss_pred -------------------------------------CCCeEecCCCCCCeeecCCCceEEeeccccee
Q 039533 759 -------------------------------------QPVTAHCDLKPSNVLLDDYMTARVGDFGLARI 790 (949)
Q Consensus 759 -------------------------------------~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~ 790 (949)
...++|+|+.|.||++++++..-|+||+.+..
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 145 LLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 22479999999999999876677999998764
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.40 E-value=4.6e-09 Score=99.09 Aligned_cols=64 Identities=22% Similarity=0.105 Sum_probs=25.6
Q ss_pred cCCCCCcEEECCCCCCCCCC--CCCcCCCCCccEEeccccccCCCCCCcccCCCccccccccCccc
Q 039533 158 SSLSKTEILNLGSNHLTGSI--PSSLGNLSSIHTISLAYNNLDGTIPNSFGWFENLVFLSLAANNL 221 (949)
Q Consensus 158 ~~L~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 221 (949)
..+++|++|+|++|+|+..- +..+..+++|+.|+|++|+|+...+-.+....+|+.|+|++|.+
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl 127 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTT
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCc
Confidence 33444444444444444221 12233444444444444444422221222223344444444444
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.36 E-value=9e-09 Score=97.00 Aligned_cols=89 Identities=17% Similarity=0.079 Sum_probs=44.7
Q ss_pred CCCCCCCceeeccCceeccccCCcccCcccCcEEeeccccccCc--CCCCCCCCccceeecCCCccccccccccccCCCC
Q 039533 85 IGNLSFLKQLYLQVNSFTHEIPSEIGGLRRLKVLALNNNSICGE--IPTNISRCSTLIPIHPQNNQLVGKILSRFSSLSK 162 (949)
Q Consensus 85 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L~~ 162 (949)
+..+..+..+++..+... .++..+..+++|++|+|++|+|+.. ++..+..+++|+.|++++|+|+....-.+....+
T Consensus 38 l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~ 116 (162)
T d1koha1 38 LVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLK 116 (162)
T ss_dssp TTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCC
T ss_pred hhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccc
Confidence 344444444554444332 4444455677777777777777632 1233444555555555555554433323333334
Q ss_pred CcEEECCCCCCC
Q 039533 163 TEILNLGSNHLT 174 (949)
Q Consensus 163 L~~L~Ls~N~l~ 174 (949)
|+.|+|++|.+.
T Consensus 117 L~~L~L~~Npl~ 128 (162)
T d1koha1 117 LEELWLDGNSLS 128 (162)
T ss_dssp CSSCCCTTSTTS
T ss_pred cceeecCCCCcC
Confidence 455555555544
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.91 E-value=2.2e-05 Score=79.28 Aligned_cols=131 Identities=17% Similarity=0.053 Sum_probs=84.4
Q ss_pred eeeeecC-ceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcC--CCcceeEEeeeecccccCCccceeEeee
Q 039533 633 LVGVGSF-GSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIR--HRNLVKVLTACLGADYRGNDFKASVYEF 709 (949)
Q Consensus 633 ~lg~G~~-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~lv~e~ 709 (949)
.+..|.. +.||+.... ++..+++|...... ...+..|++.++.+. .-.+.+++.+.... ...++||++
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~-----~~~~~v~~~ 87 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEA-----GRDWLLLGE 87 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS-----SCEEEEEEC
T ss_pred EcCCcccCCeEEEEEeC-CCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccc-----cceEEEEEe
Confidence 4455554 678999875 56678899865433 234677888887773 23366677665433 367899999
Q ss_pred ccCCChhhhcCCCCCCCccccCCCCCCHHHHHHHHHHHHHHHHHHhhC--------------------------------
Q 039533 710 MHYGSLEEWLHPFTGEDEIDEAPRNLNLLQRLNIAIDIAYALNYLHHD-------------------------------- 757 (949)
Q Consensus 710 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~-------------------------------- 757 (949)
++|.++.+... . ...++.++++.++-||+.
T Consensus 88 i~G~~~~~~~~---------------~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (255)
T d1nd4a_ 88 VPGQDLLSSHL---------------A---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDL 149 (255)
T ss_dssp CSSEETTTSCC---------------C---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSC
T ss_pred eeccccccccc---------------c---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccc
Confidence 99876644211 1 111233444444444421
Q ss_pred -----------------------CCCCeEecCCCCCCeeecCCCceEEeeccccee
Q 039533 758 -----------------------CQPVTAHCDLKPSNVLLDDYMTARVGDFGLARI 790 (949)
Q Consensus 758 -----------------------~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~ 790 (949)
..+.++|+|+.|.||+++++..+-|+||+.+..
T Consensus 150 ~~~~~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 150 DEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cchhhhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 023489999999999999876678999998754
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.67 E-value=6.4e-05 Score=80.90 Aligned_cols=77 Identities=16% Similarity=0.074 Sum_probs=50.0
Q ss_pred CCeeeeecCceEEEEEEcCCCEEEEEEEEecC-------CCcchHHHHHHHHHHHhcC-C--CcceeEEeeeecccccCC
Q 039533 631 ANLVGVGSFGSVYKGIIDEGRTTIAVKVFNLQ-------HHGASRSFIAECKALKSIR-H--RNLVKVLTACLGADYRGN 700 (949)
Q Consensus 631 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~~~~ 700 (949)
.+.||.|....||++....+++.|+||.-... ......+...|++.++.+. + ..+++++.+..
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~------- 103 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT------- 103 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET-------
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC-------
Confidence 35789999999999998777888999976421 1122345667888887772 3 35666765521
Q ss_pred ccceeEeeeccCCC
Q 039533 701 DFKASVYEFMHYGS 714 (949)
Q Consensus 701 ~~~~lv~e~~~~gs 714 (949)
+..++|||++++..
T Consensus 104 ~~~~lvmE~L~~~~ 117 (392)
T d2pula1 104 EMAVTVMEDLSHLK 117 (392)
T ss_dssp TTTEEEECCCTTSE
T ss_pred CCCEEEEeccCCcc
Confidence 24588999997644
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.41 E-value=1.2e-05 Score=75.40 Aligned_cols=41 Identities=15% Similarity=0.222 Sum_probs=25.0
Q ss_pred CCCCCceeeccCc-eeccc----cCCcccCcccCcEEeeccccccC
Q 039533 87 NLSFLKQLYLQVN-SFTHE----IPSEIGGLRRLKVLALNNNSICG 127 (949)
Q Consensus 87 ~l~~L~~L~L~~n-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~ 127 (949)
+.+.|++|+|+++ .++.. +-..+...++|++|+|++|.+..
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~ 58 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISD 58 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccch
Confidence 4566777777753 45432 23345566677777777777653
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.31 E-value=1.2e-05 Score=75.30 Aligned_cols=110 Identities=15% Similarity=0.103 Sum_probs=63.4
Q ss_pred cCcccCcEEeeccc-cccCc----CCCCCCCCccceeecCCCccccccc----cccccCCCCCcEEECCCCCCCCC----
Q 039533 110 GGLRRLKVLALNNN-SICGE----IPTNISRCSTLIPIHPQNNQLVGKI----LSRFSSLSKTEILNLGSNHLTGS---- 176 (949)
Q Consensus 110 ~~l~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~l~~n~l~~~~----~~~~~~L~~L~~L~Ls~N~l~~~---- 176 (949)
.+.++|+.|+|+++ .++.. +-..+...+.|++|+|++|.+.... ...+...+.|++|+|++|.|+..
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 34578899999874 46532 2334556667777777777775432 23344556777777777777632
Q ss_pred CCCCcCCCCCccEEeccccccCCC-------CCCcccCCCccccccccCc
Q 039533 177 IPSSLGNLSSIHTISLAYNNLDGT-------IPNSFGWFENLVFLSLAAN 219 (949)
Q Consensus 177 ~p~~~~~l~~L~~L~L~~N~l~~~-------~p~~~~~l~~L~~L~Ls~N 219 (949)
+-..+...++|++|+|++|.+... +...+..-+.|+.|+++.+
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~ 141 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFA 141 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCC
T ss_pred HHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCC
Confidence 122345556677777777655421 1223333455555555543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.90 E-value=0.0028 Score=65.71 Aligned_cols=174 Identities=14% Similarity=0.046 Sum_probs=88.8
Q ss_pred ccccCHHHHHHHhcCC--CCC-Ceee-eecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcCCCc--ce
Q 039533 613 LLYLSYQDLYNATSGF--SSA-NLVG-VGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIRHRN--LV 686 (949)
Q Consensus 613 ~~~~~~~~l~~~~~~y--~~~-~~lg-~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv 686 (949)
....+.+.+..+...+ ... +.+. .+---.||+++.. +|+.|++|+.+.... ..+++..|.+.+..+.... ++
T Consensus 5 f~~L~pd~i~~al~~~g~~~~~~~~~L~s~EN~vy~v~~~-dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~ 82 (325)
T d1zyla1 5 FQTLHPDTIMDALFEHGIRVDSGLTPLNSYENRVYQFQDE-DRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVA 82 (325)
T ss_dssp CCCCCHHHHHHHHHHTTCCCCSCCEEECCSSSEEEEECCT-TCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBC
T ss_pred ccccCHHHHHHHHHHcCCCCCcCccccccccceeEEEEcC-CCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCC
Confidence 3445556665555333 221 2221 2233589999986 678899999875432 3466788988888874222 22
Q ss_pred eEEeeeecccccCCccceeEeeeccCCChhh------------------hcCCCCCCCccc--------------cCCCC
Q 039533 687 KVLTACLGADYRGNDFKASVYEFMHYGSLEE------------------WLHPFTGEDEID--------------EAPRN 734 (949)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~------------------~l~~~~~~~~~~--------------~~~~~ 734 (949)
..+..............+.++++++|..+.. ............ .....
T Consensus 83 ~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~ 162 (325)
T d1zyla1 83 APVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATL 162 (325)
T ss_dssp CCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSS
T ss_pred CceecCCCeeeeeeeEEEEEEeecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCc
Confidence 2221111111223345778899987643311 001110000000 00011
Q ss_pred CCHH---HHHHHHHHHHHHHHHH-hhCCCCCeEecCCCCCCeeecCCCceEEeeccccee
Q 039533 735 LNLL---QRLNIAIDIAYALNYL-HHDCQPVTAHCDLKPSNVLLDDYMTARVGDFGLARI 790 (949)
Q Consensus 735 l~~~---~~~~i~~qi~~gL~~L-H~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~ 790 (949)
++.. .....+.++...+.-. .+....++||+|+.|.|||++++ ..++||+-+..
T Consensus 163 ~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 163 IPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp SCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 1111 1222233333333222 12224579999999999999753 45899998764
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.54 E-value=7.2e-05 Score=69.77 Aligned_cols=115 Identities=14% Similarity=0.140 Sum_probs=55.7
Q ss_pred CCCCCCceeeccC-ceeccc----cCCcccCcccCcEEeeccccccCcCCCCCCCCccceeecCCCccccccccccccCC
Q 039533 86 GNLSFLKQLYLQV-NSFTHE----IPSEIGGLRRLKVLALNNNSICGEIPTNISRCSTLIPIHPQNNQLVGKILSRFSSL 160 (949)
Q Consensus 86 ~~l~~L~~L~L~~-n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~L 160 (949)
.+.+.|++|+|++ +.++.. +-.++...++|++|+|++|.++...-.. +...+...
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~--------------------L~~~l~~~ 73 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFA--------------------LAEMLKVN 73 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHH--------------------HHHHHHHC
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHH--------------------HHHHHhhc
Confidence 3456666666665 445421 2334455666666666666665321111 12223334
Q ss_pred CCCcEEECCCCCCCCC----CCCCcCCCCCccEEec--cccccCC----CCCCcccCCCccccccccCcc
Q 039533 161 SKTEILNLGSNHLTGS----IPSSLGNLSSIHTISL--AYNNLDG----TIPNSFGWFENLVFLSLAANN 220 (949)
Q Consensus 161 ~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L--~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~ 220 (949)
+.++.|++++|.++.. +-..+...++|+.++| ++|.+.. .+...+...++|+.|+++.+.
T Consensus 74 ~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 74 NTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp SSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred ccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCC
Confidence 4555555555555421 1133444555554333 3444432 223334455666666666554
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.51 E-value=0.0033 Score=67.16 Aligned_cols=74 Identities=11% Similarity=0.120 Sum_probs=50.4
Q ss_pred CCeeeeecCceEEEEEEcC-------CCEEEEEEEEecCCCcchHHHHHHHHHHHhcC-CCcceeEEeeeecccccCCcc
Q 039533 631 ANLVGVGSFGSVYKGIIDE-------GRTTIAVKVFNLQHHGASRSFIAECKALKSIR-HRNLVKVLTACLGADYRGNDF 702 (949)
Q Consensus 631 ~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 702 (949)
++.|+.|-.-.+|++.... ..+.|++++... .. ......+|..+++.+. +.-.+++++++.
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~--------- 115 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PE-TESHLVAESVIFTLLSERHLGPKLYGIFS--------- 115 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CC-CHHHHHHHHHHHHHHHHTTSSSCEEEEET---------
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcC---------
Confidence 3578878888999998753 235688888752 22 2335668999988884 444557777652
Q ss_pred ceeEeeeccCCCh
Q 039533 703 KASVYEFMHYGSL 715 (949)
Q Consensus 703 ~~lv~e~~~~gsL 715 (949)
-.+||||++|.++
T Consensus 116 ~g~I~efi~g~~l 128 (395)
T d1nw1a_ 116 GGRLEEYIPSRPL 128 (395)
T ss_dssp TEEEECCCCEEEC
T ss_pred CceEEEEeccccC
Confidence 2678999987544
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.17 E-value=6.9e-05 Score=69.90 Aligned_cols=17 Identities=0% Similarity=-0.009 Sum_probs=8.2
Q ss_pred cCCCCCcEEECCCCCCC
Q 039533 158 SSLSKTEILNLGSNHLT 174 (949)
Q Consensus 158 ~~L~~L~~L~Ls~N~l~ 174 (949)
...++|++|+|++|.++
T Consensus 43 ~~n~~L~~L~Ls~n~l~ 59 (166)
T d1io0a_ 43 KTNTYVKKFSIVGTRSN 59 (166)
T ss_dssp TTCCSCCEEECTTSCCC
T ss_pred hcCCccCeeeccCCccc
Confidence 34444555555555444
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.75 E-value=0.047 Score=55.68 Aligned_cols=62 Identities=8% Similarity=0.104 Sum_probs=39.7
Q ss_pred cCHHHHHHHhcCCCCCCeee-----eecCceEEEEEEcCCCEEEEEEEEecCCCcchHHHHHHHHHHHhcC
Q 039533 616 LSYQDLYNATSGFSSANLVG-----VGSFGSVYKGIIDEGRTTIAVKVFNLQHHGASRSFIAECKALKSIR 681 (949)
Q Consensus 616 ~~~~~l~~~~~~y~~~~~lg-----~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~ 681 (949)
.+.+++.....+|.+++... .|---+.|+.+.. +| .+++|++.... ..+.+..|++++..+.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~ 69 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV--EKNDLPFFLGLMQHLA 69 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----CCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCCC--CHHHHHHHHHHHHhhh
Confidence 46688888889998876544 4555678999876 33 48999986432 2345556677777763
|